<SEC-DOCUMENT>0000885725-22-000006.txt : 20220223
<SEC-HEADER>0000885725-22-000006.hdr.sgml : 20220223
<ACCEPTANCE-DATETIME>20220223163425
ACCESSION NUMBER:		0000885725-22-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		98
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220223
DATE AS OF CHANGE:		20220223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		22664356

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>bsx-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3eeb153c-443d-4b7c-bc48-13c100a9196f,g:5aeaa418-7365-4294-a466-e7b8cf11828b,d:4513a36fb1aa4e44acd87206b0aed737--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:bsx="http://www.bostonscientific.com/20211231" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV8zLTEtMS0xLTA_80ff7d57-bda2-44e9-a159-29b36545942c">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV80LTEtMS0xLTA_66c6aa69-8aac-4bf4-93bc-7b5550de5989">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV81LTEtMS0xLTA_60cf21a2-3c03-4ae2-8bcb-c23d11f81bdd">2021</ix:nonNumeric><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV82LTEtMS0xLTA_54327b3e-f064-42fc-ad5b-15b35facb9fd">FY</ix:nonNumeric><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV83LTEtMS0xLTA_905f2a62-22d8-47b0-8e92-abf58f4922d1">false</ix:nonNumeric><ix:nonNumeric contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_5c57a388-4a11-402a-ac98-8db5289b32b1">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_02fd6496-c14e-4d01-8da6-bd43092a2153">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_2643a84a-4741-454c-9f77-8a94ad26cb86">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_18293d37-bb2b-40b9-aa4f-ac327a0961c8">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_1ed815c9-5da2-4587-b032-4aa6994bd099">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_bbf05a7c-f990-4fcb-b0f0-f7abb412ae4f">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68f3333d6cce460dbc252aac2c3a29cb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i6094d98b0e484f6ab786282879ded28e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17733ef333a04949b7d70a7bfa14f475_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a14163a2a74f7b8d354e3243028f49_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcacc25eca514356a1de06415cfc5492_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55c9f4684ac746bda57f532f6a87f684_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bb4626ce5af43629527f19d1f2b8d8f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d1794a80bb4fe2a6e1462adf2ed270_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a5ab205543a48ddb58369506f4258e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23a174508ba44dd89de3efafe40cfb80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc589c795204965a3cc585ab55e4724_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47fffe98c44745d5abab2aa20b5ce269_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie22723d6721640b7a59646827025bd5f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a72129993b9407296d812a52123d5e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621567053d2744019f158e373637541a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4747802c7e754ca399dcd04b1ba8d7fb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief44305703574f549e1b0deefa30aa9b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic842d867786b4ccea9cfa96a40cf30df_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic81c4f4cfd734a44bbbfbc03be7529de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4703f4563ef24622b191ace91b7046bb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e1494b00924399b0198cf1908c6eac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d7cdad179c64659939a57d640d0398e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d65743aa83c4feba194be59d23ff5b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a84911e7b44222a521b4865d0ca338_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aa6d669fbe84dada7c5bed68a7bab52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief259e9b815d43c6b3e7f2b9f85ad45e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e19129d2b6b49af9f944cde90d53a9c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcaaf4e1347a49e2be525edf65b64c63_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8acaf977546b4524b2309e825920c392_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11e39577dbf144d782e2e16d4feea22d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f487090abb844d5b6124d5eab360ef6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42c0c9a4fac74bfb842c3bdb6adfa49b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3423ba3a4510459d9315c471a11407a9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if652d38406174006a7b4700327ea9b78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icea25cb690174465b8215ce1c263a42a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80c252fab7084dbaa7b52601cb17955e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fba96124454331976d8e4961c807b5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e8f5b2e3704a63ba7c4e8c062839c7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7862dc97bbe245dc92c012be4bc24ff9_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4c1e55cd1e444d88c6ef56f87ecf676_D20220214-20220214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-14</xbrli:startDate><xbrli:endDate>2022-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a1b72be8d74d5eb954a3448a0598e7_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i07946074b2524113bd25ea3602907bae_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27aafceb9a8241bb8a7b5487131b9106_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0930e389c7ed4a8a9b076aa4c40709ee_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d60e95a9ad4691b3c08057fb408f2c_D20210901-20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DevoroMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-08</xbrli:startDate><xbrli:endDate>2021-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d817719bd624f91ba936d54cd189dd0_I20211108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DevoroMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e35130934fd4a358eacac841a7a82fb_I20211108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25282a1ba939439980c46921de6f92f4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375363a8a82747f993aef5796e14a72c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i977a60dd4a094b4badc4cc6074972559_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied21f3ab578a46919e7241d90ab45962_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5890dc3bad44013810b2e4b67e759c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8960237fdb4c4623ae9438f6a20ff081_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c4c18e74ac94029b4ed8c497c643638_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2bd7513127242f78e881962dac45e4b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1a2eb59807f4fa98038488a67c899d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72d131180c20411ba4a7c16e8fbe7351_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56df3da0ec92473699d19c087728742d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24bd565b73f44fe7aea51a237868fa51_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca66a6bcf654c779a82ae88dfb8e058_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf5c1ca1458c4c31b1e096eda7cca942_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia67dafbfe3fe4b0bb926c4c9c35b4c4d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i401803de34c347149bdb6b113441fe31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9051905a0e9457a9c8249141096c7af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic188f63db33d43519ebe846287701578_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1005dbdd4f84094bb2b629f0c0ad6f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8442535b691b4124862b82abe60ed41b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9cf6036d3a467d98b57608db9b9c7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3f2a730fb2840249b185833474b5453_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b7493616504921a135abba92ddaa2e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ccc97c93104644b760b49a50825d0f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2558040a1a42e4bd8cc29eb78555e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe24aea88d3d42d5b34c3e42f204cbb6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6132cb03cef491d949660bfc42e7b5c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-19</xbrli:startDate><xbrli:endDate>2019-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="ic42ef98edc4741318f57c64a9bfb2735_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbpPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id69301cd870d43dd80ea71d12d42a76b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7b4ebd9d21548d3b495be941b489706_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i326847b5c1684d50bd21f2c964e25e95_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i031288d26dbe4dad9111cf8a737a815e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4831b01bd4334a1abd79911b16ed4c3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13cb159d3e45462a9c50314d05440d78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f4b506c8c24f178b63a4f53ff627dd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f53f48683c54762a784b30fca510244_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id35802ead11946739ec96eb588e199b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7059a74267434518bbc0ed0077d56f7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i236d0e3aac6448faa715c3f08ec819a6_D20190611-20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-11</xbrli:startDate><xbrli:endDate>2019-06-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60e5a145ef214a48b006713d03a06923_I20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8efe8988e2544797a55f44fb65e85f88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0136ac01ee9747ddbfdbac14e429ec42_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b58c1611a834f2ca3ba6c6410d7b13e_I20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fffb8b77bc043679725e5bc32404c66_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ddb1f3b42b943b98458f1def7473e27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia220fba2afe640c5b10959e748bdc0f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e6697aaff074326a490c1c4df961df1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0222b251d46f4b5b9adba6a70f6ca5b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc5e6407019d4c5ba9239b2dc0326dc9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e20a416e72492f8ea6b11da4fca76d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i934dc3da23a444f68c5411629abd5c05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6cfcec597e408b9a5fd82f4348c035_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia390ec0e6c2945b8ac3c143bec1f4d48_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b52c801fa3443fba640800528e27d89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286ca5ae382c4a2c8eb259f86f360abc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2ada5aeb391411cb94688ce1c7bf045_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1679fab0c33040bea869e31b477d8218_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i240029b128a642eb92a242ba01b28e5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fc5a1a4adc4ccfa36556f49b411e45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5279e9ef42dd4b35a8efebed33d86874_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c6aab66b44f4082a6966e817d9f00ca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44e14e1f91774b6ca60421226afdf115_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cff2f3a775c477eb7e3299584301fe4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2deb61987c348f792b6cc878f078498_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief5124b672194097aa937d5abf34195e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eaa1423fdfa4907a958a048b0c0d9d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79008fc3f7c7470e85ee26a22fb45478_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a03dfab4d54a0eb2135b969c2e72db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia490ede05d664ada928496a145ece1b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b1c6c4cd7c54799b4fa99f477778cb0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f8b467de7e3474592af98d693a17cc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893db808ea6d4f7ead3577ea17638692_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd5942d7cff84bfcb443a0b4ee20e405_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e92b1090f6e4a34bdde827d0faa1850_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341295b5472d4fd5adb9a8a46d925465_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i297b6847ff994bb0832cc1355bf182cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ed6b73fff7f49ae9d9bbaf6f9c9bd80_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id527155f2d674c79ab6ae71c08673835_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4f44a484dff44c3b6ed7ba7f19327d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i246516f377cc4e69991858548b75cc3a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac6c44071294ea9849175fac9191b7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4143ca6110b349138f60bc19e3247ec2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ac69cebdf54652867c133c8113b7f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7df2e64a9b0450b929459426005d498_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71634376771a4713b50f023688e510ea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57688279666042d3a293e8a1628747b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic90da61ebdeb44219dc8a12648b8a069_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82aece15df8345618f0e67a8da516a4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f668b88714f457e8c79337cd7f50e8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc2a9aaec8d24401867d89d8e7f12627_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2019AggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i89b2d96f4b3f4582940e4f6463a44151_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782d01afd07e478a931537d96fdb53e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i626ff39017e34162b100364f2724ec05_D20190819-20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-19</xbrli:startDate><xbrli:endDate>2019-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a660eb1a9ef41b289c2fd72520e03d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9531280867949db9464c43e67215202_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55bdce8f6e9a4122a9891e58c6011e24_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812f08c4fbcb4aff9a4d22c42cf9c6b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7facfda412415a861148c501e1b519_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87edfb08cbb845159b6b5e6f1d4f21b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76233e3f8eda4f81b4c34b9f8f97cec6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c84f93b28ad41b9b47b5c208f7efc54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed12a7015134ea4942cb2107d893933_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib55f19bd5c9d4d2daf3efa38fdb0d083_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="units"><xbrli:measure>bsx:units</xbrli:measure></xbrli:unit><xbrli:context id="i59bf5213305c406f8aae709bc179528e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieef9394ae96e42548978301b4001ac22_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i097a22a349ff4abea29f95badcb8b81d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12c5ecd8e9d04fb5bfb0c044ab0e9c6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c4da7805cf34686993ec3f55d35e90c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id80ca8f87e8c4cb484a3d263b3bb637e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idda6065f68154a37934825525972e22e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief10444ff3084ac7bc054c27341e827b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i109998db04ff4f648674392ae1a723c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2731c2a351fe4a4f840aa3d75204b39a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d8505202864b7385a6cea691031d04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd4847b37d67457bab88ed655a398e6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f4b0d184cc492b8a1c645c1eb819da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3c7842f764a4d47946a0b5c9fc60c6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd00d55e3da24a278600f1257c6a759f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725a0c2c245d477a866680ee271fef5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9da8aea23bd441c979d30b5eca1589d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3918eea06dc645afa81bf6b59e512ffc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5cd80680db2415fa27296f65f1a788c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i134d607092fd4a008581e04dfcac820e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ae77b262464a3faa59c2a3cd00d12e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57785f8465894b2daed454aefed9a6ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cc3f8952c054ec69239a226f72abbe5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc26837a45614b51bb4eed0c541ba0df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65b9acc5b0d846c29779b6e5a0529569_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b6427b107a4b6893f3bce6a59d182f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5080b79d26164c5da882a84779417883_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5ac76f7fccd4691a0a4ef3f2d0fcf1b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80725583ad834079902d53e2aadcf36e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d5a471f86e4b9f9ffbc69b60fdba65_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2567fd9e6c448c6bd8df0511e4e2148_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib369619c4f02462baf6c43cb80f23d68_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i159eed8645cb401f99a8d7dc6909d9ff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313491a2c13d4ea18bb58480b90499ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i969bdf20fd234556a472ac3c3bd91a4e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d55e0941456418590fcc0b66bb0dae8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie093a7adfb86426a9b678f6d156bac3b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e36a30cc5194c4fb5b6a7caf9030f5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407f649729a04a849ad43194e1cb4088_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic347736243d746bda91e919b3077d630_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73cc4ab1dd684ec58982d5866047dbdf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40cd8405c4eb41baa85544a9136ba611_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8b35b770901410ca52fdc805a2e9579_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f4593a60912482fab2688cbdaa05100_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99294feafedf4ee49fa109e2229c4b49_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e6c70077d8421abaf6a0195ae09d2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69988c85621b476fa63c489ced0e8284_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f20c3d1ba7a4b9393b313eeabdf8773_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a45203f1a3447988e6706b1059e3a29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7bcc19872444969a853a9139102340a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d7f3635455746f3b28295c2ea994f38_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0f97fadb3df48bda0decc6fefc848f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if320e56a752a41e88cfb08c43d245e51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b460c38790240a9aa867c6fed4202a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0ce36bb88f54225ab4c1a3a6ffe1e0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3977734d09ce4c1ab17af6a4ee2899d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99deafdf2a70460e9d8c50f4d6973f0e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if741aa50339b4ba18fff942b2ac8318a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9f6423b1ae248ea89c9e621bfea9ed0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81e19c0a1fc4ab48f45f7fa43d479fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90d2c756a94c45ae93fcd4c66aefc816_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37d082b275694367bb539a8515b1a5af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie054bf7025744c0e8874ea68a52321e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a267278831c49c780031fe1e50cd725_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b8a56164792489dafeb7028a867339e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3d831f9c48348a68d8597ce5baaaf5e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c6e285fb891405ebda3f5864aefc402_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idda6217ac6554ef59c1b054231dd5711_I20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic538cbc1ea4a4e6482d96eb75deaeea9_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7ecae3134a4534a02c0c55e5ca169a_D20200518-20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-18</xbrli:startDate><xbrli:endDate>2020-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3c94b7687874bd48df338dc146a6811_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e2c1e2b027e497dbd0261bab6602a47_I20200227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c914099e6904d71a94dc97f6783d3fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2f4f8def2974bd3ad9e71fd663edb3d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i197c21f8e68c4cc2ae4d6604948b055c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica6d67210a5b40639571e17472201a15_I20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie47d736dd834426ab929b497f1361581_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7abc3bd638524e8bbfed8a8d71278d8b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b3fc2a867647d786b7994f29b2db88_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:AggregateSeniorUnsecuredDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7686ee5deffa4dbd9d2a8c5eaf9db505_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15a93de21f3f486280e4d2a80f4564b7_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2174cbca29474ac7a29b9341a392c4c4_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94a8abe8b67a41ecae72f9a4a146bf9d_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c0adf6547af4ea1bf69150f334d3a2d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie936008df8bc47b7bb4819618486c3bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8fc502671304865bc79e37327645508_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i444a310bc0c4448b9123ec72d5545a72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfMarch312021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70271503dce14eb097b21a37884cad0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfJune302021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ec855f40caa42989882af458e570454_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfSeptember302021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i308b229a078349f4a6b8fa547142e74e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourQuartersFollowingMaterialAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie61164ba53424b53a89a01bcfc962d28_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5411c3c5e25b4c5390bd6cd699a689af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ab540e0baa4ea8b3e7d94197263283_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia398c25f0ce342b09028c1fce6e28c7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17445cfa0b9425d9591416f99eabbb5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb9666c9b5d47758f0f329b195d28fd_D20201229-20201229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-29</xbrli:startDate><xbrli:endDate>2020-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97e680c0ff1f4c26929f74c3434a3c3b_I20201229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae6cce43b414bfb9f7507f8a47db081_I20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020SNAggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a666428edd40358c27d96bac0e5b06_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db5d14246b341c3b63536f6f5b51606_D20200518-20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-18</xbrli:startDate><xbrli:endDate>2020-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0464d11ab42f4a12b77d118c34369f89_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e347625da0413196bed00d6571b0aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e308f2a8c574f68b80ca9eb8be35b85_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib447fd8998e74765b84c8b606bde736d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib44c6e8af734489b858d59c23974cbb2_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6709a77d8fee4017926528030492bcbd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf03c18e48745718c15c78dddd26e7d_I20190225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:February2019AggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8225f5ac9e2d4a35b19f518f7b34a8cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib21d26613df8433b90b18e4269afc46c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50090a44ed3648b09d9a32e978a34b4d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d747a9536d94fb7b60a93be1cbd161c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4bf916bbcc84dc4825df5c3ccaa8aae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6c464c8023048e696d029db1389bebd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9fce21be2de4c2485cc6ac5d19a3d23_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e961c1a10f4c2c92f033e86ef7a70c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc579bbe1d5474b81205d71f15e00f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07e0816ac73d4823bbb1284d2da621ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i485f0a72de344efcb418b11eeb6678cb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic77ad771abd648f3a41ae116c98b285d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63949649e58e46738f2ae4a1fa93fc28_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba5a4c30a3134fd9bb5496536fd667f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af204e5236d4e009be09c240fec1f8c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0444bfe732324384a1a99c91c94db100_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88fa01f8ca884ebd86e9a4890726f80d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i048f5701adc84d0daa997ae6c06ef6ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i617fc320c955455ab7389624fb17f118_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4b63f2e0707444f8d067bcb2fe459f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98488b74746f4325a718729aa016bf1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59918f0ebd684c1d8379289da4defc20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i579de7aa53774d52a5d838a68bce863a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2af2c7ed77b498eb719fa78d5da83ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica411c80fdf24d109ac19137eaa6f96e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1252f564c6d428c98f594fc337b97b7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd865108013d4bcca24cc4a6e429770d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050247ca3e5f4d8792f99eed4db2251f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9881105cc7c458785ea4390c09d5c34_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc33409cd1684f7c94717750ee9c914f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5fab8b1c884ba48ab6fe7638fedd7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80ab67bc08d646feb8bcd26b4e7f25d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc81bf26f074c4781cd0bbddfe60c72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ea968104af64d01994c09ee3b458889_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764b1d4f04ed46a6948921a252c5d8a3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33c2d5faf95f49dc9254955b9429d578_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ebacdb932654dc8a1cdfd75fbdd467c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7bc828b5a044f45b01faf25a60e9c78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96e07352147f42009d9cd8b62d7b1df6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a809506747427492eaf2ed10add804_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id117a9767e20473d910b25f606a1e323_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c56158760a14fc7b71e8385501fece8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9348686cc963447c935d4482b79d2c75_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63979d9af7f74e27b56796a2814939d0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d63013b85484f03ad0cce1d4df4bc84_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8259fbfc86d41e2b865f4365a602b30_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f2550ce37a400e84700479f1651ade_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee11ea97704a4ea8a16e4725ab7a428a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5803b285b4d846bea82279aeafe39223_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a55a21282ed4611a789274532e46db2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib86edd9c6f8940f09b7cb40123e5cf7e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i356a0c4641ce409d99e92a91a23e56f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ea22f9173a842c3a6a6aa67253d4913_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i335029b57a154f92b77a7911aeddac43_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8e3e16a28194313a0ad082eb5bb8785_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id412cfa512b949ec907ca18d0cd1c46b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id57a42ba8f784b46a76bcdd531d63e18_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3645a52d5198438e9a8689f203c0cf54_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba2692c4ecf242c1b4befbf697da23d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90551e630dbe44ad87da029f9c03ab34_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f1bd6c6a8a9457c865b6f6d2377b05f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4ba129a320747d88fecf483bb2dc190_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670166b7b500445f9d43034e4175db7b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b35f447b40b455ead67f66c9f4bfa5b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7264ea4939f4943af5a24c4278c439f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ace6dde67bd4f898df25357d3c29937_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i244bfd1f3457405c99a68939b39f1e1c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87e1cea449b84a3abb1aa082d8446440_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied974547e60f42538926f26d479f2cd4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ad73371f1eb4bf5b2448c9cc099490a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d2f64bd733453ab060f8ba6b991f03_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10777e0a13844245a66a3a04333ca671_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia32581cb18484982a8776dc9b9f8eea2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1785b428f97549d8ae81b21532bc254f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i379c2756c93a4bf38d84777eb83466fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fad2ab117924655ba224551660eddab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02efe013a1cb40fa9325d57e55e78b92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1626115a196044c7964d18ab75d20b9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eb67a96dc904adf81eb688fc53e83cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df90b8ebd7c4c70bb72f12619218a79_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f8abbaa26ce4c349b56fdf51f523b44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0683bdec183a43d1af27f889bfe2f888_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4119e3f71c984843b6e8313e74d94802_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id80ded4802ba46d3832724842de8285c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fed35511829459da5a38d83c0ca798b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id02c5663b02141118d004b9caa3424ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61ba8102128e4d5ca7ba5fd85188b839_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193a2e3116b8454aa87e65f1058e0278_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb74a863f3154f8db49c64618640bd85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c897d04f2364feeb5c3c6a2fa36d797_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b55c014808f40fa88ef1b3f959db8d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93bd60f6d70c420a9bc09e7c7bf6fc5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d817c2bd28479980edad681c6a2071_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb1d6977085e41d8b212c9975e19b482_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dbe26c3626844cc8fca8bfbd336dd73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6419e203999942329c84202801da4c46_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f8fa0b6c8c432d9384623e2768c3a3_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a23f29987844bacb827e4e0bf7ebd5b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9e3d1c87f245508ec3d21cac73b819_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa4713eca034411386bd8958667ff155_I20190115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-01-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30b040b90f0b41758b9ded39e98a67e1_I20220126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claims"><xbrli:measure>bsx:claims</xbrli:measure></xbrli:unit><xbrli:context id="i3a44a33716c34232840446222d515685_I20220126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if82ad8d4e79140ae9ff32488143d6d7b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66f21ac1ac454c5d80b0c27572fa871f_D20171110-20171110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-10</xbrli:startDate><xbrli:endDate>2017-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b7da4d442341ae9e6ed840e1f4cd33_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c11391a90f343a8a29ca5a651461834_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0157a31857394755b58f1cb928f3509e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb7cb06378a4432bb97c143cc5f5952_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id85bcc6a4b684d52a383187a1856dd57_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419713e280d4402f8c14fa84298a0ccd_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72aa8f882331458e90a94bf23ae61e59_I20130125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d5c1eb8c3c498e932fff915c09dd38_I20201214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9728f3b38444f35b64ff2f079ea4b3d_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bsx:A2011LtipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59bff74575c44e3a5039251cf9b8592_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51e61128384f479281522b42f68d88de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d964f1e8fde4f869b9572107e4cd663_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a649302b88643399da73bbaa811ad27_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03336283c2ff4b398efa41236e67a2d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b7e7bf22b2b40ce8673e049908bce94_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0db9ac2d795d4e17aee7151bfb6ee932_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ae1671df59943f7acd666541a997122_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92048bcac2e04d9983b5f962b19cad96_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie188534f742842feac06df7e1c74aa45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aae52091d8944baa48514791518f001_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d0f7d58dbe4881a08e6c6c4d798dc7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28b5c1f16ae04ad0863e335580139350_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bc526be42e743bb9a8a6576a16447ee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aad1bab8c3f42188e8caee5487fc161_I20210217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58d60bf54d9b477b9441568e22f085d1_I20200218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9292f58cc599475cbe04d0e8c11e9935_I20190221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d2063406334ffa9e99fa12a46b4055_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57fa53402a1e4d61946e5928f0177f07_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69bc7b2173af4ec4be135c607f06064b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dcc1d9f587e4bdf84dc58e0c744f18f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc7a0cac76948efb6e5fa18d4642442_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i979c7d5f5f30414bb30ba5f9f9d3c752_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportablesegments"><xbrli:measure>bsx:reportablesegments</xbrli:measure></xbrli:unit><xbrli:context id="i04991ed25715473bae686eada34ce8e3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3595f016be44152b0810b7941073c20_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfdac215247a41d5a190631edb467695_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i998fc4c852bb4712a6ac361d50f1addb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c616e504e944e48bc57a78d5f0bcc4f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd23720dcf441b893aa13e8563d15ef_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6d4db93b38040f2a515f954395082f3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3af6a1df22a242a4b23b635ddeb5a981_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f0a448c20c42a59fc6c0a04e829f95_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb04350660a44a988ce323d0808bb5a2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb392f0b52d04562bbafef2c2e3bd024_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2aee8e67d5473ca756655b97f76be1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id43b6011336d44cda836897ad0a99eef_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i248c898d732b4314b0a88247e5686fb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1917903eab064ebd8f9b5c4561e2f754_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25175389829c4c00b8fd64f6b1b9bf50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb9ed43167d04cf5a5e8be0581a2d3c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib195a39da918458daa4a2a7c922e5626_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia58f50b0109e41fd8e438c82c71e3141_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af8a989c1284f24a421723a037abca7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a5ed8dbde274fb797a84e2782bb541f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id384c54f72144cdf8fee9a2d43b64754_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a97fc47966f4c888c420993a4ecc84c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4883d6ab73714fa080e66ddc8068d9e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id679dd594dfe40169b0716db7018f794_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a0e6b8dba74575aee5f5f86c271bbb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8968316c251443599b1cc42fc078d2fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee1badc1b55e4c3580f690a018638da5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ca302daf1c74047b3c5899ea8e0aca6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i411673321b714ce89c57299921fae970_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0381e81002ea48aea3c5b8276a4bdfe2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib323af1d123f4f288409892c6d582c3a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i492788538a3b4d079d5f2e01ce834568_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83749835aad04c27823ee7e3e441d8d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieebda7efcc984eaaa323a3965ae8afc2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice8b818c14fa4356b602a04c1ab17b68_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief070d59a8a74c6883609bd434bfbfdd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e08cc88e42477f8b204d52aefeefae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4226949d0cdc471da19b2ef5376d32b7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296c600288ba4126abba2c8e6654d659_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7877e3175114481298066be0fb237a24_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46048892559447039913345bc4184710_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d0a46f763a34fcfbb98da18cb232850_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98c2a656422d4982be4f1876ef15fbd7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05500613984e4170ae63706134751f68_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7e6f6584f284ab5b2bbf59c9911ab30_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d69f6e362124b848580bbf31ad6ad84_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1fb275aaa7347e884e5e734e95e6439_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0296cee599414719bd3d27b8e535a348_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47108644abed4ca48d40f6618e8766e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66be153aa8a64bd3a8549033c030d988_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d91f24a77dd4e05a3909ceb50bdb176_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i139438da5f5c43439b7f6cb237aefe53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5414046eeaee4c90baf8f05d81103cf9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1028c0ccdd44e579fc1a7e93e864c8e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e624f8fff1b4416a9d5d3cd9c9a3a8c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e89d505d51c40cf9c9b06a4a255d695_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0559f366b4db4027814a50efc3811d7c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i792d16e027b94051b1350ad706ae61b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbec07d746b4648b462392b1200914a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a8d5dfc7cc449b8eaea3d0a207bca7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f761ed299c43aaba3aeb4c183b4bb1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie15626b1bdc1459ebc740a7d9123e3a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3ee6b1033014d9e89c4ef9c0d696921_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46e7887ed9b64aaa828480abdd1350e3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7f200406b1741da8d29e0597b3ef799_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6ac600b424e4c36ae326ac78fc6acb0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b2d57381d214a61974a25af56e0fe97_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7c862ab83b44a6823252694cfedafa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b9a583488948c3ac09adffaa7c62b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61903be42d074c65b668c3852b09debb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fc90b63ec344bb382c1ac4ac757ec55_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2950edca24e646cf92832d6acc6da711_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ecfae37eff349aabd3cffa238c04a7a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i448b76a8a955443b853399bdede98723_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ed2f4d1bd545449a2f19715b187d67_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3c8df2ca0184543adf70bfad9cb539d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6851f3461e914845861fc25f808129ff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b6ff9b41f34af7bf8811c4d7d9280c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7448b8ca366f4827bc4f258c57c93261_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb61ff1feec4e518decbdf1ca114591_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969834eefc47426fa7387f6ee8b1085b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4178008f18a6432bb79c295f035843c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5edb697c55bc4cf4b947643bcd30a7fd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i363f7457787448d5a0978accd8392066_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i990fcdb4d4d64102a6e2a01d782d3da7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i219bdc71c5134494a8e8468f8d87edbf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a4631fadd7470dbdb228646d0d1e64_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id47b9b05ad00409f8e34ab200b239f73_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f59541845b541a398a1c956947b253e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia608cda32d2c4a75acba41461285ef9f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddebf93ed35b4294bfc7d57c147f14a0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i230686786fb8479c8e8b3aa250c6294a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5daeb0eea7624d95bd33a61b6630acf1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if745267c77af430eb139ec47097f83b4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce9f4d10e55459c9da61e0b45861feb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic65e05bd72794ad69c38ad937bbdd8c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic11feaaacdaf46dbbaad088de02198bb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0798aac718394b2e885e3eec15b7a1b7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e3a0a6440d4892b49e46f886fbcb2a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7510a4849a314540abc54995d58f29a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba9db017ca54a60b7e7c1ea9f933ffd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6afa1156f16c40a9bfe1aaca76cb5002_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa17098a29b48e894a6b05f541a6034_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e61f5e37fc74a6f81ea7c5928a92766_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37d5ca208074462f876fe31f23b1fed5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3934f348ffb740b0af4a20a77601e650_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbd3c076197c4394a0b5a998e05dbd49_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia58a0bdc221345bfbf3c6181a5c06176_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c7d84961bb4190a76e256fa88277af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia85ece485aa444be8199976328f65690_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38022f0994a44701b3f50846a6fd4016_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i240079c64e2b40068b8e05779f120de1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97644286dfd2411eb21e3c030a24a491_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93b9e8e344744818491704b2f2d822e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie419b41857fe446fb2fd54d0467e3cc3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if99c383051264d1c8e894654e1c8eea9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i876002865abc4f97ba83a0ef52267bbf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b08a70a845343069de514f02498dcd4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093d7ccd7bf04c0db289d031e28a2247_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="countries"><xbrli:measure>bsx:countries</xbrli:measure></xbrli:unit><xbrli:context id="idd2a04e716dc4d76ada198ae8de3512c_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9677d942cddf415f979a5572240cb314_D20190819-20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-19</xbrli:startDate><xbrli:endDate>2019-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2959d13185e44b0b5c23911f7e0c9b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96369c0f230346708d64ca28018edad7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1704cd4a6e4d4195bd594fd45e78d251_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ba8f98eb3545039f395219720cc097_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2233b84039de4a86bf1e039d4ebd672b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84912b2290e843e7ba4e06ea51b35268_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25ddf18419df442eb0b2829d76375ae3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f13d53946094d0597052e0d0c1fed72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b179ab6b284836b5b7e104d9b796fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibadf8b569527469ab651f550d716b4c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if28e5bd9680c4874b621bceaa941ea18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c99c0d845c344c2aaaa4f9075b3cc36_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f7c5cd724b943808b5b4a790359037e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9107422a10134aa88c15d6264e4b0a15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32babe1b5a2d4787946bcd2130f04a6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i479839a4abc848c0822e4fc438e2f790_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e137b5ac4e443db82fce619d7addda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieed3b64471e4431396082d1b7661d187_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4fe210a6ecd4082b33c83f96d710db0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57226788691947098831b210f4d9e6f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7387bc40a28d42d3a310a107abc8db02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5cd235ef6f2496e8f2b3c361e6c2083_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia22158488b3a459c88e0b1f6a927db8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc049394c7014a64935dbc97f6fdef13_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i699d1eb2cebb41f1bfb906a93a9f96f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51845faa20174064ac84a92ea5ff121a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4513a36fb1aa4e44acd87206b0aed737_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjA4_270b3357-e3db-4087-ba7e-1770a84f57d1">10-K</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:3.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6YWRhMmUyNmMzYmEyNGI4YThiMThiZWViMGViZjcwOTcvdGFibGVyYW5nZTphZGEyZTI2YzNiYTI0YjhhOGIxOGJlZWIwZWJmNzA5N18wLTAtMS0xLTA_815f4cca-0cc6-4675-af1e-5d018e1ff59e">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, or</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18xMTU_c992284f-bd5b-4656-95e3-dabe95642e17">December&#160;31, 2021</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:3.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NjlkNjhkNGY5NjE1NDYzOWE0NjEyNDgzNzU4Nzk4MjIvdGFibGVyYW5nZTo2OWQ2OGQ0Zjk2MTU0NjM5YTQ2MTI0ODM3NTg3OTgyMl8wLTAtMS0xLTA_c62a52d3-fca6-4d10-9cc2-f1aae7196773">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjA5_dd392202-e8d5-442f-8ac1-9c4d0efce2c1">1-11083</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjEz_666274be-67f7-400f-9ea9-ef1acc5e3cb6">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.596%"><tr><td style="width:1.0%"></td><td style="width:42.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6YWI4OTMzMGE4YmIxNDM1YzgyNmIwMGUwNTkxZDMwZTEvdGFibGVyYW5nZTphYjg5MzMwYThiYjE0MzVjODI2YjAwZTA1OTFkMzBlMV8wLTAtMS0xLTA_e1f41603-faf6-437b-bb07-9ef8f2e1f50e">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6YWI4OTMzMGE4YmIxNDM1YzgyNmIwMGUwNTkxZDMwZTEvdGFibGVyYW5nZTphYjg5MzMwYThiYjE0MzVjODI2YjAwZTA1OTFkMzBlMV8wLTItMS0xLTA_b7a1b416-edaf-4c70-9b3d-d3f3f308f4db">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE5_0df64919-ffe3-4a20-9298-26f9e17ded67">300 Boston Scientific Way</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE0_d2d93b3c-a361-4874-8e5f-903fc31c3241">Marlborough</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIx_a721e49f-24ec-4faa-b1e1-c9cc84ec426e">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE1_3826213e-3c74-4908-bade-c92946ef9118">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE2_72778211-b960-4eb8-8fe1-803151cfe4fb">508</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE3_cdd7b4f0-0324-45ed-9c72-dd08d7bd8afc">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:34.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.341%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18xLTAtMS0xLTA_5cc737b3-4a5a-401a-9bad-08dea9b07e0b">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18xLTItMS0xLTA_fe2da0e2-242f-47fa-9a1a-44b4e302fe3f">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18xLTQtMS0xLTA_9175ba26-cb52-4f64-bd32-58adf0c1bd09">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18yLTAtMS0xLTA_87954fde-c8c6-46a8-85cc-d279ab0c5796">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18yLTItMS0xLTA_0a44aae3-5f19-4393-9e0e-043f8549b9fa">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18yLTQtMS0xLTA_79b5ca0d-f706-4f1d-832e-61409e699b96">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18zLTAtMS0xLTA_496435d2-d883-4ec5-9946-6da16d16437f">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18zLTItMS0xLTA_db91ab3b-8daf-4fe6-b0d5-22742d9b9a9a">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18zLTQtMS0xLTA_41d35995-dd39-4870-b041-f866bceb4d3a">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NONE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIy_c74cd557-4390-481d-8472-0f522b256f9f">Yes</ix:nonNumeric>: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section 15(d) of the Act. Yes: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIw_0db1aade-58f4-4ad6-a02e-33e08b9b34e0">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports) and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIz_5e7a44fd-4a5b-4cf9-8194-29cbe7de1e5c">Yes</ix:nonNumeric>: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorted period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjEw_740a008b-2d68-4232-9e10-76198b8b0898">Yes</ix:nonNumeric>: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NDZmMzVmYTVkZjJlNGZiOWEwN2UxMDgyNGRlMjI0YjEvdGFibGVyYW5nZTo0NmYzNWZhNWRmMmU0ZmI5YTA3ZTEwODI0ZGUyMjRiMV8wLTAtMS0xLTA_7782f291-b3cc-4d84-aea9-1f9ad2916723">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NDZmMzVmYTVkZjJlNGZiOWEwN2UxMDgyNGRlMjI0YjEvdGFibGVyYW5nZTo0NmYzNWZhNWRmMmU0ZmI5YTA3ZTEwODI0ZGUyMjRiMV8xLTMtMS0xLTA_d87d9637-acc5-482c-ac8f-2a4d7451756e">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NDZmMzVmYTVkZjJlNGZiOWEwN2UxMDgyNGRlMjI0YjEvdGFibGVyYW5nZTo0NmYzNWZhNWRmMmU0ZmI5YTA3ZTEwODI0ZGUyMjRiMV8yLTMtMS0xLTA_7043a743-d677-4ddb-9a56-3e0ea512f32c">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjEx_c45301f8-f03c-42a2-87cd-c65342e4a3c1">&#9745;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act). Yes: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjI0_0f1689c6-547d-47e1-8b5c-ebfdcc92446b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approximately $<ix:nonFraction unitRef="usd" contextRef="i68f3333d6cce460dbc252aac2c3a29cb_I20210630" decimals="-6" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18yNjcx_2fc59f0c-cbc0-4b6e-853b-40d3fd937e74">60.6</ix:nonFraction> billion based on the last reported sale price of $42.76 of the registrant&#8217;s common stock on the New York Stock Exchange on June&#160;30, 2021, the last business day of the registrant&#8217;s most recently completed second fiscal quarter. (For this computation, the registrant has excluded the market value of all shares of common stock of the registrant reported as beneficially owned by executive officers, and directors of the registrant; such exclusion shall not be deemed to constitute an admission that any such person is an affiliate of the registrant.)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares outstanding of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="dei:EntityListingParValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zMjY1_2c9c7b16-28ca-4b6a-a372-f6cd3700aaa8">0.01</ix:nonFraction> par value per share,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> as of January&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> was <ix:nonFraction unitRef="shares" contextRef="i6094d98b0e484f6ab786282879ded28e_I20220131" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zMzE2_be298712-d567-44ef-9584-bddc4b346601">1,426,724,712</ix:nonFraction>.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Documents Incorporated by Reference</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive proxy statement to be filed within 120 days of December&#160;31, 2021 with the Securities and Exchange Commission in connection with its 2022 Annual Meeting of Stockholders are incorporated by reference into Part&#160;III of this Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_16">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_16">BUSINESS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_19">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_19">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_19">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_22">ITEM 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_22">UNRESOLVED STAFF COMMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_22">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_25">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_25">PROPERTIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_25">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_28">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_28">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_28">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_31">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_31">MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_31">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_34">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_34">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_37">ITEM 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_37">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_37">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_40">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_40">RESERVED</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_40">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_43">ITEM 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_43">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_43">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_67">ITEM 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_67">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_67">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_73">ITEM 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_73">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_73">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_157">ITEM 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_157">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_157">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_160">ITEM 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_160">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_160">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_163">ITEM 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_163">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_163">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_1944">ITEM 9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_1944">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_1944">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_166">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_166">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_169">ITEM 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_169">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_169">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_172">ITEM 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_172">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_172">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_175">ITEM 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_175">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_175">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_178">ITEM 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_178">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_178">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_181">ITEM 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_181">PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_181">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_184">PART IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_184">136</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_187">ITEM 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_187">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_187">136</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_190">&#160;ITEM 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_190">FORM 10-K SUMMARY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_190">148</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_193">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4513a36fb1aa4e44acd87206b0aed737_193">149</a></span></div></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_16"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for more than 40 years, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions and improve patients&#8217; quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. Our net sales have increased substantially since our formation, fueled in part by strategic acquisitions designed to improve our ability to take advantage of growth opportunities in the medical device industry and to build diversified portfolios within our core businesses. We advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate pursuant to five strategic imperatives: Strengthen Category Leadership, Expand into High Growth Adjacencies, Drive Global Expansion, Fund the Journey to Fuel Growth and Develop Key Capabilities. We believe that our execution of these strategic imperatives will drive innovation, profitable revenue growth and increase stockholder value while strengthening our leadership position in the medical device industry. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to invest in our core franchises and pursue opportunities to diversify and further expand our presence in strategic, high-growth adjacencies and new global markets, including growth within the countries we define as emerging markets. Our research and development efforts are focused largely on the development of next-generation and novel technology offerings across multiple programs and all divisions. In the past several years, we have completed numerous acquisitions in support of our growth strategy, both strengthening our core franchises and expanding into high growth adjacent markets. We have also accelerated the development of digital tools and technologies to enable us to compete more effectively in the current healthcare environment, where our customers are looking for ways to improve outcomes and lower costs, and to make it easier to do business with Boston Scientific across multiple sites of care. Specifically, we are scaling our digital capabilities to deliver first class physician education, drive deeper patient engagement and increase digitally-enabled sales force productivity. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Enterprise Risk Management program analyzes the key risks inherent to achieving our strategic and organizational imperatives. Our ongoing risk assessment helps us to anticipate and adapt to potential challenges to preserve and grow stockholder value. Our Board of Directors oversees our risk management program and focuses on monitoring, and, together with management, mitigating the most significant risks facing the Company, including strategic, operational, reputational, financial, legal and compliance risks. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a firm commitment to corporate social responsibility and living our values as a global business and global corporate citizen. This includes taking actions to combat discrimination and advancing equality and diversity, including through financial support of racial equity initiatives in the communities where we live and work, protecting the environment, investing in our employees' health and well-being, and many other initiatives that ultimately help us create value responsibly. Refer to discussion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Community Outreach </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Sustainability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for additional information regarding measures we are undertaking.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Offerings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The following describes our key product offerings and new product innovations by reportable segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gastroenterology and Pulmonary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less invasive technologies. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Resolution 360&#8482; Clips and Resolution 360&#8482; ULTRA Clips, hemostatic clipping technology designed to stop and help prevent bleeding during endoscopic procedures, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">WallFlex&#8482; Biliary Stent Systems, used for relieving biliary obstructions by providing bile drainage in both malignant and benign strictures,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AXIOS&#8482; Stents and Electrocautery Enhanced Delivery Systems, the first, and currently only stents in the U.S. indicated for endoscopic drainage of pancreatic pseudocysts,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SpyGlass&#8482; DS II Direct Visualization Systems, which bring digital imaging, a wider field of view and a simpler set-up (compared to our legacy SpyGlass System), thus enabling cholangioscopy to play a greater role in the diagnosis and treatment of pancreatico-biliary diseases,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SpyGlass&#8482; Discover Digital Catheters, the first single-use scopes to enable physicians to take a single-stage approach to diagnostic and therapeutic procedures in the pancreaticobiliary system, including treating patients with bile duct stones,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">EXALT&#8482; Model B Single-Use Bronchoscopes for use in a wide range of bronchoscopy procedures in the intensive care unit (ICU) and operating room (OR), such as secretion management, airway intubation, percutaneous tracheostomy, double lumen endotracheal tube placement and biopsies,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">EXALT&#8482; Model D Single-Use Duodenoscopes for use in endoscopic retrograde cholangiopancreatography (ERCP) procedures, the first U.S. Food and Drug Administration (FDA)-cleared single-use (disposable) duodenoscopes on the market,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquire&#8482; Endoscopic Ultrasound Fine Needle Biopsy Devices, which are designed to obtain larger tissue specimens for histological assessment and are useful when diagnosing diseases such as pancreatic cancer, liver cancer and stomach lesions,</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our endoluminal surgery portfolio featuring ORISE&#8482; Gel and ORISE&#8482; ProKnife, designed to be used for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions prior to excision with a snare or other endoscopic device, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our infection prevention portfolio, which includes a customizable Compliance EndoKit&#8482; and single-use Orca&#8482; Valves, designed to minimize the risk of infection transmission and improve operational efficiencies by streamlining manual cleaning or eliminating the need for cleaning and tracking.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2021, we launched our next-generation Resolution 360&#8482; ULTRA Clip, featuring increased jaw length, thickness and volume capacity, and currently the largest through-the-scope hemostasis clip on the market, designed to approximate greater amount of tissue and facilitate stronger closing strength. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology and Pelvic Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia (BPH), prostate cancer, erectile dysfunction, incontinence and pelvic floor disorders. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a comprehensive line of stone management products, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons and stone laser devices,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LithoVue&#8482; Single-Use Digital Flexible Ureteroscopes, which deliver detailed high-resolution digital images for high-quality visualization and seamless navigation, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Prosthetic Urology portfolio, which includes our penile implants to treat erectile dysfunction and urinary control systems to treat male urinary incontinence,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BPH therapies, which include our GreenLight XPS&#8482; Laser System, MoXy&#8482; Fiber, and Rez&#363;m&#8482; System, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SpaceOAR&#8482; Hydrogel Systems which help reduce side effects that men may experience after receiving radiotherapy to treat prostate cancer, and our SpaceOAR Vue&#8482; Hydrogel, providing clinicians with enhanced product visualization using computerized tomography (CT) scans instead of magnetic resonance imaging (MRI), and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.53pt">our Pelvic Floor portfolio, which includes a comprehensive offering of female stress urinary incontinence solutions, including our innovative Solyx&#8482; Single-Incision Sling System.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, we completed the acquisition of the global surgical business of Lumenis LTD (Lumenis), a privately-held company that develops and commercializes energy-based medical solutions, including innovative laser systems, fibers and accessories used for urology and otolaryngology procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rhythm and Neuro</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiac Rhythm Management</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiac Rhythm Management (CRM) business develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implantable cardioverter defibrillators (ICD) and implantable cardiac resynchronization therapy defibrillators (CRT-D) as well as the world's first, and currently only, commercially available subcutaneous implantable cardiac defibrillators (S-ICD),</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pacemakers and implantable cardiac resynchronization therapy pacemakers (CRT-P),</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LATITUDE&#8482; Remote Patient Management Systems, which allow for more frequent monitoring and better guided treatment decisions by enabling physicians to monitor implantable system performance remotely and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) systems, new, long-term diagnostic devices implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in the first quarter of 2021, we completed the acquisition of Preventice Solutions, Inc., a privately-held company that offers a full portfolio of mobile health solutions and remote monitoring services, ranging from ambulatory cardiac monitors &#8211; including short and long-term holter monitors &#8211; to cardiac event monitors and mobile cardiac telemetry, complementing our existing ICM offering. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current generation of defibrillators, the RESONATE&#8482; family of devices, include our proprietary HeartLogic&#8482; Heart Failure (HF) Diagnostic and SmartCRT&#8482; Technology with Multisite pacing in CRT-D. Our entire transvenous defibrillator portfolio leverages our EnduraLife&#8482; Battery Technology, including our extended longevity ICD, our CRT-D&#8217;s and our smallest and thinnest MINI ICD. We have magnetic resonance imaging (MRI) conditional labeling across our defibrillator portfolio around the world when used with our current generation of leads, including our current generation devices as well as our prior generation of DYNAGEN&#8482; and INOGEN&#8482; devices. Our implantable defibrillator portfolio is complemented by our suite of ACUITY&#8482; X4 Quadripolar LV Leads, RELIANCE&#8482; family of ICD Leads and our INGEVITY&#8482; Pacing Lead.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our transvenous defibrillator portfolio, we offer our EMBLEM&#8482; MRI S-ICD System, which provides physicians the ability to treat patients who are at risk for sudden cardiac arrest without touching the heart or invading the vasculature. Our EMBLEM S-ICD devices have MRI conditional labeling and LATITUDE Remote Patient Management in most major markets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our ACCOLADE&#8482; family of pacemaker systems in nearly all major markets around the world. Approval of our ACCOLADE Pacemaker family in the U.S., Europe and Japan also included approval for use of these products in patients undergoing MRI scans. Much like our defibrillator portfolio, our pacemakers leverage our INGEVITY Pacing Leads and LATITUDE&#8482; Remote Patient Management in nearly all major markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrophysiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Electrophysiology business develops and manufactures less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, including a broad portfolio of therapeutic and diagnostic catheters and a variety of equipment used in the Electrophysiology lab. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rhythmia&#8482; Mapping Systems, catheter-based, 3-D cardiac mapping and navigation solutions designed to help diagnose and guide treatment of a variety of arrhythmias, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Blazer&#8482; Therapeutic Ablation Catheters,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our broad portfolio of diagnostic catheters including Blazer&#8482; Dx-20, Dynamic Tip&#8482; and Viking&#8482; Catheters,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">IntellaMap Orion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Mapping Catheters, for use with our Rhythmia Mapping System to provide high-density, high-resolution maps of the heart, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">POLARx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cryoablation single shot ablation systems, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intracardiac ultrasound catheters, delivery sheaths and other accessories.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cooled ablation catheter portfolio includes our U.S. and CE Mark approved Blazer&#8482; Open-Irrigated, IntellaNav&#8482; Open-Irrigated, and IntellaNav MiFi&#8482; Open-Irrigated ablation catheters with a unique Total Tip Cooling&#8482; Design. We also offer our IntellaNav XP and IntellaNav MiFi XP solid tip catheters, as well as the CE Mark and Japanese Pharmaceuticals and Medical Device Agency (PMDA) approved IntellaNav STABLEPOINT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Ablation Catheter. Certain of our IntellaNav Catheters include MicroFidelity (MiFi) sensor technology in the catheter tip, and all are designed to allow magnetic tracking when used with our Rhythmia Mapping System. Additionally, all major markets have access to our DIRECTSENSE&#8482; Software, a tool for monitoring radiofrequency (RF) energy delivery during cardiac ablation procedures, providing meaningful information on tissue to catheter tip proximity, catheter stability, and other local tissue characteristics. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second half of 2021, we received Japanese PMDA approval and commenced the Japanese launch of our POLARx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cryoablation Single-shot Pulmonary Vein Isolation Technology. During 2021, we completed enrollment in the FROZEN-AF investigational device exemption (IDE) study for POLARx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, in the third quarter of 2021, we completed the acquisition of Farapulse, Inc. (Farapulse), a privately-held company that has developed a Pulsed Field Ablation (PFA) System - a non-thermal single-shot ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. Farapulse became the first company to commercialize a cardiac PFA technology after receiving CE Mark in Europe in the first quarter of 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Precision&#8482;, Precision Spectra&#8482;, Precision Montage&#8482;, Precision Novi&#8482;, Spectra WaveWriter&#8482; and WaveWriter Alpha&#8482;</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Spinal Cord Stimulator (SCS)&#160;Systems, designed to provide improved pain relief to a wide range of patients who suffer from chronic pain,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Superion&#8482; Indirect Decompression Systems, minimally-invasive devices used to improve physical function and reduce pain in patients with moderate lumbar spinal stenosis (LSS) purchased as part of the acquisition of Vertiflex, Inc. in the second quarter of 2019,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our G4&#8482; Generator and consumable portfolio in Radiofrequency Ablation (RFA) for pain management used by physicians to treat patients with chronic pain, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vercise&#8482;, Vercise&#8482; PC, Vercise Gevia&#8482; and Vercise Genus&#8482; Deep Brain Stimulation (DBS) Systems for the treatment of Parkinson's disease, tremor, and intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Spectra WaveWriter&#8482; SCS System is the first system approved by the FDA to simultaneously provide paresthesia-based and sub-perception therapy. The Precision Spectra SCS System is the world's first and only SCS system with 32 contacts and 32 dedicated power sources. We believe that we continue to have a technological advantage due to our proprietary features such as Multiple Independent Current Control and our Illumina 3D&#8482; Proprietary Programming Software, which together are intended to allow the physician to target specific areas of pain and customize stimulation of nerve fibers more precisely. We announced the European launch of the WaveWriter Alpha&#8482; Spinal Cord Stimulator (SCS) System in the third quarter of 2020 and received FDA approval in the fourth quarter of 2020 and followed with U.S. launch, indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with failed back surgery syndrome and complex regional pain syndrome.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Vercise&#8482; DBS Systems are approved in the U.S. as an adjunctive therapy that aids in reducing some of the symptoms of moderate to advanced Parkinson&#8217;s disease as well as for patients diagnosed with essential tremor. In the third quarter of 2020, we received CE Mark and initiated a limited market release of the fourth generation Vercise Genus&#8482; DBS System in Europe, and launched in the U.S in the first quarter of 2021, following FDA approval. The Vercise Genus&#8482; DBS platform features a full portfolio of primary cell and rechargeable MRI conditional systems with Bluetooth connectivity and the Cartesia&#8482; Directional Lead, providing multi-directional stimulation designed for greater precision, intended to minimize side effects for patients. In Europe, we also market the GUIDE&#8482; XT System, the first DBS visualization system built for directionality that utilizes patient specific anatomy and stimulation field modeling. This technology provides physicians with 3-D image planning capability and when used in conjunction with the Vercise DBS Systems, enables physicians to personalize and optimize DBS treatment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Cardiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Interventional Cardiology business develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Our broad, innovative product offerings have led to our leadership in the global interventional cardiology market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Drug-Eluting Coronary Stent Systems </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our drug-eluting coronary stent product offerings are an important element of our global Interventional Cardiology market leadership. We believe we have enhanced the outcomes associated with the use of coronary stents, particularly the processes that lead to restenosis (the growth of neointimal tissue within an artery after angioplasty and stenting), through our scientific research and product development of drug-eluting stent systems. Our coronary stent offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SYNERGY&#8482;, SYNERGY MEGATRON&#8482; and SYNERGY&#8482; XD Everolimus-Eluting Platinum Chromium Coronary Stent Systems, featuring an ultra-thin abluminal (outer) bioabsorbable polymer coating and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Promus ELITE&#8482; and Promus PREMIER&#8482; Everolimus-Eluting Stent Systems.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complex PCI</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product offerings to perform complex percutaneous coronary interventions (PCI) include a broad line of products used to treat patients with atherosclerosis, a principal cause of coronary artery obstructive disease. These include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, crossing and re-entry devices for the treatment of chronically occluded coronary vessels and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PCI Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PCI Guidance offerings include a family of intravascular catheter-directed ultrasound imaging catheters, complemented by our intravascular ultrasound (IVUS) imaging system and our fractional flow reserve (FFR) devices and systems for use in coronary arteries and heart chambers as well as certain peripheral vessels to assist in the diagnosis of coronary artery disease. Our PCI Guidance product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">OptiCross&#8482; IVUS Imaging Catheters,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">COMET&#8482; FFR Pressure Guidewires, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AVVIGO&#8482; Guidance Systems and AVVIGO&#8482; Guidance System II, incorporating high-definition IVUS all in a mobile or integrated platform, and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iLab&#8482; Ultrasound Imaging Systems with Polaris Software, designed to enhance the diagnosis and treatment of blocked vessels and other heart disorders, which are compatible with our full line of imaging catheters and coronary physiology devices. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The iLab Ultrasound Imaging System has been placed in cardiology labs worldwide and provides an installed base through which we expect to continue to sell associated single-use products. Our next-generation AVVIGO&#8482; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidance System II is a streamlined multi-modality guidance system platform that features intuitive software for an easy workflow and specialized tools for IVUS and coronary physiology. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Structural Heart Therapies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Structural heart therapies are one of the fastest growing areas of the medical technology market and are highly synergistic with our Interventional Cardiology and Rhythm Management businesses. Our current structural heart product offerings include the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Devices, designed to close the left atrial appendage in patients with non-valvular atrial fibrillation who are at risk for ischemic stroke,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">neo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482; and ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">neo2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482; Aortic Valve Systems, which are based on a self-expanding architecture, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Safari2&#8482; Pre-Shaped Guidewires, intended to facilitate the introduction and placement of interventional devices within the heart, including those used with transcatheter aortic valve implantation or replacement procedures, and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SENTINEL&#8482; Cerebral Embolic Protection Systems.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The WATCHMAN&#8482; LAAC Device is the first device to offer a non-pharmacologic alternative to oral anti-coagulants that has been studied in a randomized clinical trial and is the leading device in percutaneous LAAC globally. During 2021, we completed the full U.S. launch and transition to the next-generation WATCHMAN FLX LAAC Device, designed to advance procedural performance and safety while expanding the treatable patient population. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Transcatheter Aortic Valve Replacement (TAVR) portfolio includes the ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">neo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Valve based on self-expanding architecture for supra-annular cases. Our ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">neo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2 Aortic Valve System, commercialized in Europe, is built on a new platform designed with a number of features to improve upon the clinical performance of the original ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">neo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Valve platform. In addition, our SENTINEL&#8482; Cerebral Protection System is used to reduce the risk of stroke in TAVR procedures and is clinically proven to decrease cerebral embolization and its associated neurological effects. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. In the third quarter of 2019, we completed the acquisition of BTG plc (BTG). We integrated BTG's Interventional Medicine (IM) portfolio into our Peripheral Interventions division, adding complementary technologies in the areas of venous disease and interventional oncology. Our combined broad peripheral portfolio includes products to treat arterial diseases (stents, balloon catheters, wires and atherectomy) and venous diseases (thrombectomy, acoustic pulse thrombolysis, wires and stents) and for use in interventional oncology techniques to treat various cancers (peripheral embolization devices, radioactive microspheres, radiofrequency and cryotherapy ablation systems, microcatheters and drainage catheters). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our peripheral arterial technologies include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">EPIC&#8482; Vascular Self-Expanding Stent Systems, nitinol stents designed to sustain vessel patency while providing enhanced visibility and accuracy during placement,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Innova&#8482; Self-Expanding Stent Systems, laser-cut nitinol stents built for the superficial femoral artery (SFA, a large artery in the thigh) with flexibility, strength and fracture resistance,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Eluvia&#8482; Drug Eluting Vascular Stent Systems, innovative stents built on the Innova stent platform, designed to deliver a sustained dosage of paclitaxel during the time when restenosis is most likely to occur,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mustang&#8482; PTA Balloon Catheters, 0.035" balloons with superior crossing and tracking, powerful dilatation, longer lengths and smaller sheath sizes,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coyote&#8482; Balloon Catheters, highly deliverable and ultra-low profile balloon dilatation catheters designed for a wide range of peripheral angioplasty procedures,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sterling&#8482; Balloon Catheters, 0.018" PTA balloon catheters designed for post-stent dilatation as well as conventional balloon angioplasty to open blocked peripheral arteries, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ranger&#8482; Drug-Coated Balloons, innovative balloons built on the Sterling balloon platform, featuring a low-dose of paclitaxel. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, we received approval from Japan's Ministry of Health, Labor and Welfare (MHLW) for the Ranger&#8482; Drug-Coated Balloon and initiated a full launch. We are the first company to provide physicians with both a drug-eluting stent and drug-coated balloon for the treatment of patients with peripheral artery disease. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our venous disease technologies include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AngioJet&#8482; Thrombectomy Systems, used in endovascular procedures to remove blood clots from blocked arteries and veins and our AngioJet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zelante DVT&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thrombectomy Catheters to treat deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">EKOS&#8482; Ultrasound Assisted Thrombolysis systems used to treat pulmonary embolisms, purchased as part of the BTG acquisition in 2019, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Varithena&#8482; Polidocanol Injectable Foam used to improve the symptoms of superficial venous incompetence and the appearance of visible varicosities, also purchased as part of the BTG acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we completed our acquisition of Devoro Medical Inc., developer of the WOLF Thrombectomy&#174; Platform, an innovative non-console and lytic-free technology which rapidly captures and removes blood clots, complementing our full suite of interventional strategies for thromboemboli in the arterial and venous systems.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interventional oncology product offerings include the following:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TheraSphere&#8482; Y-90 radioactive glass microspheres used in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer, purchased as part of the BTG acquisition,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interventional oncology solutions, including the Renegade&#8482; HI-FLO&#8482; Fathom&#8482; Microcatheter and Guidewire System and Interlock&#8482; - 35 Fibered IDC&#8482; and 18 Fibered IDC&#8482; Occlusion System for peripheral embolization, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cryoablation image-guided needles used to enable cryoablation visualization for optimal tumor coverage, purchased as part of the BTG acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, we received FDA approval for our TheraSphere&#8482; Y-90 radioactive glass microspheres for the treatment of HCC after 20 years as a humanitarian exemption (HDE) device and secured FDA Breakthrough Device designation for TheraSphere treatment for patients with glioblastoma, an aggressive form of brain cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Pharmaceuticals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business for a purchase price of approximately $800 million. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We encounter significant competition across our product lines and in each market in which we sell our products and solutions, some from companies that may have greater financial, sales and marketing resources than we do. Our primary competitors include Abbott Laboratories and Medtronic plc, as well as a wide range of medical device companies that sell a single or limited number of competitive products or participate in only a specific market segment. In certain countries, we face competition from domestic medical device companies that may benefit from their status as local suppliers. We also face competition from non-medical device companies, which may offer alternative therapies for disease states that could also be treated using our products, or from companies offering technologies that could augment or replace procedures using our products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our products and solutions compete primarily on their ability to deliver both differentiated clinical and economic outcomes for our customers by enabling physicians to perform diagnostic and therapeutic procedures safely and effectively often in a less-invasive and cost effective manner. We also compete on ease of use, comparative effectiveness, reliability and physician familiarity. In the current environment of managed care, with economically motivated buyers, consolidation among healthcare providers, increasing prevalence and importance of regional and national tenders, increased competition and declining reimbursement rates, we have been increasingly required to compete on the basis of price, value, reliability and efficiency. We believe the current global economic conditions and healthcare reform measures could continue to put additional competitive pressure on us, including on our average selling prices, overall procedure rates and addressable market sizes. We recognize that our continued competitive success will depend upon our ability to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">offer products and solutions that provide differentiated clinical and economic outcomes,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create or acquire innovative, scientifically advanced technologies,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">apply our technology and solutions cost-effectively and with superior quality across product lines and markets,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">develop or acquire proprietary products and solutions,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract and retain qualified personnel, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain patent or other protection for our products,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain required regulatory and reimbursement approvals,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compete in regional and national tenders for our products,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continually provide quality products and enhance our quality systems, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture and market our products and solutions either directly or through third parties, and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supply sufficient inventory at competitive prices to meet customer demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in research and development is critical to driving our future growth. Our investment in research and development supports the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal research and development programs, regulatory design and clinical science, as well as other programs obtained through our strategic acquisitions and alliances, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engineering efforts that incorporate customer feedback into continuous improvement efforts for currently marketed and next-generation products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have directed our development efforts toward innovative technologies designed to expand current markets or enter adjacent markets. We are transforming how we conduct research and development by identifying best practices, driving efficiencies and optimizing our cost structure, which we believe will enable increased development activity and faster concept-to-market timelines. Focused, cross-functional teams take a formal approach to new product design and development, helping us to manufacture and offer innovative products consistently and efficiently. Involving cross-functional teams early in the process is the cornerstone of our product development cycle. We believe this collaboration allows our teams to concentrate resources on the most viable and clinically relevant new products and technologies and to maximize cost and time savings as we bring them to market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to internal development, we work with hundreds of leading research institutions, universities and clinicians around the world to develop, evaluate and clinically test our products. We are expanding our collaborations to include research and development teams in our emerging market countries; these teams will focus on both global and local market requirements at a lower cost of development. We believe that these efforts will play a significant role in our future success.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing and Sales</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we marketed our products and solutions to approximately 35,000 hospitals, clinics, outpatient facilities and medical offices in more than 120 countries worldwide. Large group purchasing organizations, hospital networks and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. We have a dedicated corporate accounts organization in the United States (U.S.) and Europe, Middle East and Africa (EMEA) focused principally on selling to major buying groups and integrated healthcare networks. We consistently strive to understand and exceed the expectations of our customers. Each of our businesses maintains dedicated sales forces and marketing teams focused on physicians who specialize in the diagnosis and treatment of different medical conditions, as well as on key hospital service line administrators. We believe that this dual focus on disease state management and hospital administrators enables us to develop highly knowledgeable and dedicated sales representatives and to foster collaborative relationships with both physicians and key service line administrators. We believe that our strong working relationships with physicians, service line administrators and others in the medical industry enable us to gain a detailed understanding of new therapeutic and diagnostic alternatives and to respond quickly to our customers' changing needs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our net sales are derived from countries in which we have direct sales organizations. We also have a network of distributors and dealers who offer our products in certain countries and markets. We expect to continue to leverage our infrastructure in markets where commercially appropriate and use third party distributors in those markets where it is not economical or strategic to establish or maintain a direct presence. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintaining and expanding our international presence is an important component of our long-term growth strategy. Through our international presence, we seek to increase net sales and market share, leverage our relationships with leading physicians and their clinical research programs, accelerate the time to bring new products to market and gain access to worldwide technological developments that we can implement across our product lines. We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. We have increased our investment in infrastructure in these countries in order to maximize opportunities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. Our Emerging Markets net sales represented 12 percent of our consolidated net sales in 2021 and 11 percent in 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we maintained various international manufacturing facilities, in addition to our facilities in the U.S. &amp; Puerto Rico, in Ireland, Costa Rica, Brazil, Malaysia, Israel, Canada, the U.K. and Switzerland. In 2021, approximately 50 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">percent of our manufactured products were produced at these international facilities. We also maintain research and development capabilities in Canada, China, Costa Rica, India, Ireland and Israel, and provide localized training programs through our Institutes for Advancing Science (IAS) facilities around the world.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Resources</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing and Raw Materials</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on continuously improving our supply chain effectiveness, strengthening our manufacturing processes and increasing operational efficiencies within our organization. We strive to improve the efficiency of our sourcing operations and to leverage the technical expertise of the broader market by partnering with strategic suppliers. In doing so, we seek to focus our internal resources on the development and commercial launch of new products and the enhancement of existing products. We continue to implement new systems designed to provide improved quality, reliability, service, greater efficiency and lower supply chain costs. We also drive continuous improvement in product quality through process controls and validations, supplier and distribution controls and training and tools for our operations team. In addition, we remain focused on examining our operations and general business activities to enhance our operational effectiveness by identifying cost-improvement opportunities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to maintaining appropriate investments to ensure supply chain stability. We have an ongoing supplier resiliency program which identifies and mitigates risk and have taken measures to mitigate the impact of challenges within the global supply chain resulting from the COVID-19 pandemic. We consistently monitor our inventory levels, manufacturing, sterilization and distribution capabilities and partnerships and maintain recovery plans to address potential disruptions. Many components used in the manufacturing of our products are readily fabricated from commonly available raw materials or off-the-shelf items available from multiple supply sources; however, certain items are custom made to meet our specifications. We believe that in most cases, redundant capacity exists at our suppliers and that alternative sources of supply are available or could be developed within a reasonable period of time. We have recently experienced increased levels of unpredictability in the supply of certain raw materials and components used in the manufacturing of our products. While we continue to believe we will have access to the raw materials and components that we need, these supply chain dynamics could result in increased costs to us or an inability to fully meet customer demand for certain of our products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an on-going basis, we track supplier status and inventory in risk areas and take action to prevent shortages, monitoring safety stock levels and building up product supplies as warranted, and mitigating risk of technology and material shortages by identifying new vendors. Our approach to supplier selection involves building diversity, equity and inclusion throughout the Boston Scientific supplier network. We are committed to the increased and sustained support of diverse businesses that share our dedication to improving the quality of patient care. As part of our strategy to combat racism, we have taken steps to further expand the number of Black-owned enterprises that provide supply chain services for our business in the U.S. We are also supporting small and diverse vendors by shortening payment terms for those whose business with us is under $250,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary Rights and Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of patents, trademarks, trade secrets and other forms of intellectual property to protect our proprietary rights. We generally file patent applications in the U.S. and other countries where patent protection for our technology is appropriate and available. As of December&#160;31, 2021, we held more than 18,000 patents and had approximately 6,000 patent applications pending worldwide that cover various aspects of our technology. In addition, we hold exclusive and non-exclusive licenses to a variety of third-party technologies covered by patents and patent applications. In the aggregate, these intellectual property assets and licenses are of material importance to our business; however, we believe that no single patent, technology, trademark, intellectual property asset or license is material in relation to our business as a whole.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on non-disclosure and non-competition agreements with employees, consultants and other parties to protect, in part, trade secrets and other proprietary technology. There has been substantial litigation regarding patent and other intellectual property rights in the medical device industry, particularly in the areas in which we compete. We continue to defend ourselves against claims and legal actions alleging infringement of the patent rights of others. Additionally, we may find it necessary to initiate litigation to enforce our patent rights, to protect our trade secrets or know-how and to determine the scope and validity of the proprietary rights of others. Accordingly, we may seek to settle some or all of our pending litigation, particularly to manage risk over time. Settlement may include cross licensing of the patents that are the subject of the litigation as well as our other intellectual property and may involve monetary payments to or from third parties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain insurance policies providing limited coverage against securities claims. We are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our 2021 consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for a discussion of intellectual property, product liability and other litigation and proceedings in which we are involved. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Environment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Device Regulatory Approvals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical devices that we manufacture and market are subject to regulation by numerous worldwide regulatory bodies, including the FDA and comparable international regulatory agencies. These agencies require manufacturers of medical devices to comply with applicable laws and regulations governing development, testing, manufacturing, labeling, marketing and distribution. Medical devices are also generally subject to varying levels of regulatory control based on risk level of the device. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., authorization to distribute a new device can generally be met in one of three ways. The first process requires that a premarket notification (510(k)) be made to the FDA to demonstrate that the device is as safe and effective as, or substantially equivalent to, a legally marketed device (the &#8220;predicate&#8221; device). Applicants must submit performance data to establish substantial equivalence. In some instances, data from human clinical trials must also be submitted in support of a 510(k) premarket notification. If so, these data must be collected in a manner that conforms to the applicable Investigational Device Exemption (IDE)&#160;regulations. The FDA must issue a decision finding substantial equivalence before commercial distribution can occur. Changes to cleared devices that could not significantly affect the safety or effectiveness of the device can generally be made without additional 510(k) premarket notifications; otherwise, a new 510(k) is required.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second process requires the submission of a premarket approval (PMA) application to the FDA to demonstrate that the device is safe and effective for its intended use. This approval process applies to most Class&#160;III devices and generally requires clinical data to support the safety and effectiveness of the device, obtained in adherence with IDE requirements. The FDA will approve the PMA application if it finds that there is a reasonable assurance that the device is safe and effective for its intended purpose and that the proposed manufacturing is in compliance with the Quality System Regulation (QSR). For novel technologies, the FDA may seek input from an advisory panel of medical experts and seek their views on the safety, effectiveness and benefit-risk of the device. The PMA process is generally more detailed, lengthier and more expensive than the 510(k) process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The third process requires that an application for a Humanitarian Device Exemption (HDE)&#160;be made to the FDA for the use of a Humanitarian Use Device (HUD). A HUD is intended to benefit patients by treating or diagnosing a disease or condition that affects, or is manifested in, not more than 8,000 individuals in the U.S. per year. The application submitted to the FDA for an HDE must demonstrate that the device does not expose the patient to unreasonable risk and that the benefit of device use outweighs the risk. The HUD provision of the regulation provides an incentive for the development of devices for use in the treatment or diagnosis of diseases affecting smaller patient populations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union (EU), we are required to comply with the Medical Device Regulation (MDR or EU MDR) which became effective May 2021, superseding existing Medical Device Directives. Medical devices which have a valid CE Certificate to the prior Directives (issued before May 2021) can continue to be sold until May 2024 or until the CE Certificate expires, whichever comes first, providing there are no significant changes to the design or intended use. The CE Mark, which is required to sell medical devices in the EU is affixed following a Conformity Assessment and either approval from the appointed independent Notified Body or through self-certification by the manufacturer. The selected pathway to CE marking is based on device risk classification. CE marking indicates conformity to the applicable General Safety and Performance Requirements (GSPRs) for the MDR. The MDR changes multiple aspects of the regulatory framework for CE marking, such as increased clinical evidence requirements, changes to labelling, and new requirements, including Unique Device Identification (UDI), and many new post-market reporting obligations. MDR also modifies and increases the compliance requirements for the medical device industry and will continue to require significant investment over the next few years to transition all products by May 2024. The CE mark continues to be a prerequisite for successful registration in many other global geographies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to comply with the regulations of every other country where we commercialize products before we can launch or maintain new products on the market, such as the requirements that we obtain approval from the Japanese Ministry of Health, Labor and Welfare (MHLW), through the review at Japanese Pharmaceutical &amp; Medical Device Agency (PMDA). Regulatory requirements are becoming more stringent, with the China National Medical Product Administration (NMPA) recently increasing the regulatory requirements to market and maintain products in China, and the introduction of such regulatory requirements in many countries in the Middle East and Southeast Asia that previously did not have medical device regulations, or had minimal regulations. As a result of the United Kingdom's departure from the European Union (EU), we also </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expect a U.K. Regulation to be implemented beginning July 2023, with requirements to sell in the U.K. already in place including appointment of a U.K. Responsible Person and device registration with The Medicines and Healthcare products Regulatory Agency (MHRA). In addition, other EU countries continue to impose significant local registration requirements despite the implementation of MDR. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and other worldwide regulatory agencies and competent authorities actively monitor compliance to local laws and regulations through review and inspection of design and manufacturing practices, record-keeping, reporting of adverse events, labeling and promotional practices. The FDA can ban certain medical devices, detain or seize adulterated or misbranded medical devices, order recall or market withdrawal of these devices and require notification of health professionals and others with regard to medical devices that present unreasonable risks of substantial harm to the public health. The FDA may also enjoin and restrain a company for certain violations of the Food, Drug and Cosmetic Act and the Safe Medical Devices Act, pertaining to medical devices, or initiate action for criminal prosecution of such violations. Regulatory agencies and authorities in the countries where we do business can halt production in or distribution within their respective country or otherwise take action in accordance with local laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales of medical devices manufactured in the U.S. that are not approved by the FDA for use in the U.S., or that are banned or deviate from lawful performance standards, are subject to FDA export requirements. Additionally, exported devices are subject to the regulatory requirements of each country to which the device is exported. Some countries do not have medical device regulations, but in most foreign countries, medical devices are regulated. Frequently, regulatory approval may first be obtained in a foreign country prior to application in the U.S. due to differing regulatory requirements; however, other countries, such as China, for example, require approval in the country of origin first. Most countries outside of the U.S. require that product approvals be recertified on a regular basis. The recertification process requires that we evaluate any device changes and any new regulations or standards relevant to the device and, where needed, conduct appropriate testing to document continued compliance. Where recertification applications are required, they must be approved in order to continue selling our products in those countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quality Assurance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to providing high quality products to our customers and the patients they serve. Our quality system starts with the initial product specification and continues through the design of the product, component specification process and the manufacturing, sale and servicing of the product. Our quality system is intended to build in quality and process control and to utilize continuous improvement concepts throughout the product life. Our quality system is also designed to enable us to satisfy various international quality system regulations, including those of the U.S. FDA with respect to products sold in the U.S. All of our medical device manufacturing facilities and distribution centers are certified under the ISO 13485 quality system standard, established by the International Standards Organization (ISO) for medical devices, which includes requirements for an implemented quality system that applies to component quality, supplier control, product design and manufacturing operations. This certification can be obtained only after a complete audit of a company&#8217;s quality system by an independent outside auditor, and maintenance of the certification requires that these facilities undergo periodic re-examination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Policies and Reimbursement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a global Government Affairs presence, headquartered in Washington, D.C., to actively monitor and advocate on myriad legislation and policies that may potentially impact the Company, both on a domestic and an international front. The Government Affairs office works closely with members of Congress and committee staff, the White House and Administration offices, state Governors, legislatures and regulatory agencies, embassies and global governments on issues affecting our business. Our proactive approach and depth of political and policy expertise are aimed at having our positions heard by federal, state and global decision-makers to improve patient care and to advance our business objectives by educating policymakers on our positions, key priorities and the value of our technologies. The Government Affairs office manages our political action committee and works closely with trade groups on issues affecting our industry and healthcare in general. The Government Affairs office also advocates for public policy that benefits our employees and the patients we serve, and supports the communities in which we live. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political, economic and regulatory influences around the world continue to subject the healthcare industry to potential fundamental changes that could substantially affect our results of operations. Government and private sector initiatives related to limiting the growth of healthcare costs (including price regulation), coverage and payment policies, comparative effectiveness reviews of therapies, technology assessments and healthcare delivery structure reforms, are continuing in many countries where we do business. We believe that these changes are causing the marketplace to place increased emphasis on the delivery of treatments that can reduce costs, improve efficiencies and/or increase patient access. Although we believe our less-invasive products and technologies generate favorable clinical outcomes, value and cost efficiency, the resources necessary to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demonstrate value to our customers, patients, payers and other stakeholders are significant and new therapies may now take longer periods of time to gain widespread adoption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that pricing of medical devices will remain under pressure as price transparency, expansion of site neutrality, or consistent reimbursement regardless of treatment location, alternative payment reform, value-based purchasing, and accountable care organizations (ACOs), continue to take shape in the U.S. and abroad. We also expect marketplace changes to place pressure on medical device pricing as hospitals consolidate and large group purchasing organizations, hospital networks and other groups continue to seek to aggregate purchasing power. Similarly, governments are increasing the use of regional and national tenders, placing pressure on medical device pricing. Some governments also seek to limit the growth of healthcare costs through price regulation. Implementation of cost containment initiatives and healthcare reforms in significant markets such as the U.S., China, Australia, and other markets may limit the price of, or the level at which reimbursement is provided for, our products, which in turn may make it less likely that a hospital or physician will select our products to treat patients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by hospitals, physicians and other healthcare providers around the world that typically bill various third-party payers, including government programs (e.g., Medicare and Medicaid in the U.S.) and private insurance payers, for the services provided to their patients. Third-party payers and governments may approve or deny coverage for certain technologies and associated procedures based on independently determined assessment criteria. Coverage decisions by payers for these technologies and associated procedures are based on a wide range of methodologies that may reflect the assessed resource costs, clinical outcomes and economic value of the technologies and associated procedures. The current U.S. Administration may support the introduction of healthcare legislation, or take regulatory action, that could lead to significant changes to Medicare's reimbursement practices defined in the inpatient prospective payment system, outpatient prospective payment system, ambulatory surgical center, and/or Physician Fee Schedule rules. At this point, the impact of any such changes are unclear as specific changes have not been introduced or promulgated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Regulation and Management</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various environmental laws, directives and regulations both in the U.S. and abroad. Our operations involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. We believe that strong performance across relevant environmental, health and safety metrics enhances our competitive strength while benefiting our patients, customers, stockholders and employees. We are focused on continuous improvement in these areas with a goal of reducing pollution, minimizing depletion of natural resources and reducing our overall environmental footprint. Specifically, we are working to optimize energy and resource usage, ultimately reducing greenhouse gas emissions and waste. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Sustainability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for further discussion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Boston Scientific, our work is guided by core values that define our culture and empower our employees, including Caring, Diversity, Global Collaboration, High Performance, Meaningful Innovation and Winning Spirit. As of December&#160;31, 2021, we had approximately 41,000 employees, including approximately 16,000 in operations, 20,000 in selling, marketing, distribution and administration, and 5,000 in clinical, regulatory and research and development. Of these employees, we employed approximately 21,000 outside the U.S., approximately 10,000 of whom are in the manufacturing operations function. We believe the collective talent of our employees and our shared corporate culture and values give us a competitive advantage.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hiring, developing and retaining talented employees are key parts of our strategy and are critical to our success, particularly in the current environment of labor shortages and unprecedented job market conditions. We strive to do this by fostering a diverse, equitable and inclusive workplace, providing competitive pay and benefits and flexible work conditions, offering ongoing employee growth and development opportunities and cultivating a culture that prioritizes employee health, safety and wellness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity, Equity and Inclusion </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do our best work to advance health care when we have a diverse range of perspectives and experience on our team. Innovation thrives in a culture of engagement, inclusion and equity. The society in which we live and the customers and patients we serve are diverse and our employees at all levels of the organization must reflect this. In recent years, we have made steady progress to increase the overall representation of employees who identify as women and as African American/Black, Asian, Hispanic/Latinx, American Indian/Alaska Native, Native Hawaiian/Other Pacific Islander, and two or more races (together, multicultural talent). As of December&#160;31, 2021, women represented 30 percent of our Board of Directors, and 48 percent of our employees. In addition, 36 percent of employees in the U.S. and Puerto Rico identified as multicultural. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to our goal of making further progress toward expanding our workforce diversity. We have set measurable Diversity, Equity &amp; Inclusion (DE&amp;I) goals with our &#8220;3UP by 2023&#8221; initiative, including a three percentage point increase in representation of both women and multicultural talent at the supervisor and manager level to 43 percent and 23 percent, respectively by December 31, 2022. As of December&#160;31, 2021, 41 percent of management roles were held by women and, within the U.S and Puerto Rico, 22 percent were held by multicultural employees. Our Executive Committee and our Board of Directors have oversight over employee diversity metrics and hiring trends. As evidence of our commitment to expand diversity, equity and inclusion, in 2021, we introduced a human capital performance metric to our Annual Bonus Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our nine Employee Resource Groups (ERGs) are at the heart of our DE&amp;I strategy. ERGs are voluntary, company-sponsored employee groups that foster and celebrate our diverse work environment. They provide forums for us to learn from one another, celebrate our differences and develop inclusive leadership skills. We support each ERG by designating global and local executive sponsors and providing financial resources. Our ERG chapters around the world collaborate across the business at all levels and are powerful voices for change in the company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are proud to be a globally recognized leader for workplace inclusion, a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">chieving top marks on Disability:IN&#8217;s 2021 Disability Equality Index (DEI), the Human Rights Campaign's Corporate Equality Index (CEI) for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ)+ Equality, the JUST Capital Top 100 list of Companies Supporting Healthy Families and Communities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Forbes Best Employer for Women 2021 list, as well as ranked in the top 10 of Forbes's list of America's Best Employers for Diversity. We also received the prestigious Catalyst award in 2022, in recognition of our organizational DE&amp;I initiatives that drive representation and inclusion for women. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer competitive, performance-based compensation programs, recognizing that employee well-being, safety, culture, engagement and recognition are all critical to a healthy work environment and productive workforce. We offer programs that acknowledge, respect and support an individual&#8217;s life and work choices. Our holistic programs are guided by overall workforce health, focusing on physical, financial and emotional well-being as well as a healthy work environment. We believe that investing in employee well-being leads to improved performance for the individual and the organization. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our broader rewards portfolio, we offer competitive pay and benefits that are flexible and affordable to meet the individual needs of our employees. In addition to cash-based salaries, our rewards portfolio includes cash bonus programs, sales incentives, stock awards, recognition awards, health insurance, paid time off and family leave, retirement savings plans, childcare and Employee Assistance Programs that encourage overall well-being, including help with finances, inclusive family planning and support, elder/child care, legal support and mental health.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equal pay for equal work is rooted in our values and foundational to fostering an inclusive environment. Pay equity is an important part of our long-standing global compensation planning practices. Sustaining pay equity requires constant measurement and attention, so we regularly conduct comprehensive audits, internal and external analyses and company-wide benchmarking of salaries to identify and eliminate disparities. In addition, we periodically contract with an independent, third party to assess pay equity across all positions. In 2021, we again reported no statistically significant pay disparity for approximately 99 percent of our employees across gender globally and for multicultural talent in the U.S. and Puerto Rico. We continue to educate and train our people, update policies and expand benefits to decrease bias, increase gender and racial representation within our organization, and foster a culture where all employees feel valued and included.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Health and Safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take a global approach to prioritizing and monitoring employee safety and we strive to foster a safety-oriented culture in all of our offices and facilities. We set health and safety goals which measure the number of injuries per 100 employees for every manufacturing and distribution site. Our Employee Health &amp; Safety Operations Council reviews performance monthly to discuss trends and risks, as well as opportunities for improvement. We have established a company-wide safety goal of 0.25 or fewer injuries per 100 employees by 2030, cutting our year-over-year incident rate by approximately 50 percent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Growth and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing our people professionally is one of the most important things we do. We have robust succession planning to ensure our future leaders are ready to assume roles as they become available. At every level of the company, employees have access to training and tools they can use to advance their skills and expertise and create greater possibilities for their careers. We offer professional and technical courses, including on-the-job training, skills-based learning, mentoring opportunities and leadership development programs for high-potential employees.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek ongoing feedback from our employees to better understand what we are doing well and, conversely, how we can improve their experience. In addition to encouraging ongoing communication and feedback between employees and their managers, we conduct periodic employee engagement surveys to ensure all employees have an opportunity to share their insights and we take appropriate action in response. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Community Outreach</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are united by a goal to make a difference in the lives of the over 30 million patients we serve annually. We seek to give our time, talent and resources to make positive impacts upon those communities where we live, work, and serve. Guided by our core values, we seek to improve access to healthcare, to invest in educational programming and opportunities for underserved and underrepresented minority students, and to embrace the spirit of volunteerism within our global workforce, while adhering to strong ethical standards. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some parts of the world, access to health information, screening, care and services can be limited. Our collaborations with non-profit community organizations raise awareness of chronic disease and decrease these health disparities by improving health outcomes for underserved populations. We accomplish this through our focus on 3 P&#8217;s - Prevent, Provide and Prepare. We work to prevent chronic disease through education and awareness, provide access to healthcare through increasing the quantity and quality of healthcare workers and screenings, and preparing and empowering children at high risk of or who already have a chronic disease to successfully navigate their health journey. Since 2016, we have partnered with organizations like Children&#8217;s HeartLink, Project HOPE, Partners in Health, and Population Services International to support health equity for populations across the globe. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within many of the communities in which we operate, we have launched and funded a multi-year program to combat racism, inequity and injustice focused on five pillars: community, economic empowerment, education, healthcare disparities and government policies. We also continue our long-term Close the Gap initiative, which focuses on raising awareness and empowering healthcare providers to reach more patients of color, fight longstanding inequities, and address barriers to care. Through Close the Gap, hospitals and health systems are provided with zip code level data that highlight the disease prevalence and disparities occurring in their communities. The information, along with our health equity resources, allows health care administrators and providers to focus on improving care to underserved populations within their communities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also passionate about inspiring young learners to see themselves in a Science, Technology, Engineering and Math (STEM) role in the future. Employees on our 17 global STEM teams worldwide work with underrepresented K-12 students to share their passion for STEM by providing interactive product demos, development programs, and hands-on activities for young learners in their communities. Through our outreach efforts, we are helping to develop the diverse future talent that will enable Boston Scientific and the greater healthcare community to create innovative health solutions for generations to come.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beyond the classroom, we empower our employees to participate in and influence the way we care for people in their local communities. Many employees chose to support their communities through the use of the Employee Matching Gifts program. Through their contributions and the Boston Scientific match, more than $1 million was donated to causes employees cared most about across the world. In addition, as employees looked to engage in their communities safely, we provided several virtual volunteer opportunities and resources as well as limited in person opportunities where appropriate. These opportunities included at-home kit packing, virtual classroom and tutoring platforms, and volunteer days of service. We are proud of our collective efforts and the impact we have on advancing possibilities across the globe. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also support the U.S. communities where we have significant business presences through the Boston Scientific Foundation. The mission of the Foundation is simple: to help expand access to quality healthcare and educational opportunities for underserved populations. The Boston Scientific Foundation awarded scholarships to children of employees and grant awards across the U.S. in 2021. Employee volunteers evaluated proposals for the Boston Scientific Foundation Board review and approval, upon which the Boston Scientific Foundation was able to help fuel grassroots innovative solutions to improve access to quality healthcare and create new opportunities for students to learn and achieve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales are influenced by many factors, including product launches, acquisitions, regulatory and reimbursement approvals, patient, physician and employee holiday schedules and other macro-economic conditions. While our consolidated </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net sales do not reflect any significant degree of seasonality, customer purchases of our medical devices have historically been lower in the first and third quarters of the year. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Copies of our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act), are available free of charge on our website (www.bostonscientific.com) as soon as reasonably practicable after we electronically file the material with or furnish it to the U.S. Securities and Exchange Commission (SEC). Additionally, the SEC maintains an internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Printed copies of these posted materials are also available free of charge to stockholders who request them in writing from Investor Relations, 300 Boston Scientific Way, Marlborough, MA 01752-1234. Information on our website or linked to our website is not incorporated by reference into this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safe Harbor for Forward-Looking Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we may make from time to time, including statements contained in this Annual Report on Form 10-K and information incorporated by reference into this Annual Report on Form 10-K, constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;aim,&#8221; "goal," "target," "continue," "hope" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Annual Report on Form 10-K are based on certain risks and uncertainties, including the risk factors described in Item&#160;1A under the heading &#8220;Risk Factors&#8221; and the specific risk factors discussed below and in connection with forward-looking statements throughout this Annual Report on Form 10-K, which could cause actual results to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this Annual Report on Form 10-K.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Risks and uncertainties that may cause such differences include, among other things: the impact of the ongoing COVID-19 pandemic on our operations and financial results; future U.S. and global economic, political, competitive, reimbursement and regulatory conditions; manufacturing, distribution and supply chain disruptions and cost increases; disruptions caused by cybersecurity events; disruptions caused by extreme weather or other climate change-related events; labor shortages and increases in labor costs; new product introductions and the market acceptance of those products; markets for our products; expected pricing environment; expected procedural volumes; the closing and integration of acquisitions; clinical trial results; demographic trends; intellectual property rights; litigation; financial market conditions; the execution and effect of our restructuring program; the execution and effect of our business strategy, including our cost-savings and growth initiatives; our ability to achieve environmental, social and governance goals and commitments; and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic.&#160;All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A. Risk Factors&#160;contained within this Annual Report on Form 10-K filed with the SEC, which we may update in Part II, Item 1A.&#160;Risk Factors&#160;in subsequent Quarterly Reports on Form 10-Q that we will file hereafter.&#160;We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.&#160;This cautionary statement is applicable to all forward-looking statements contained in this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some of the important risk factors that could cause our actual results to differ materially from our expectations in any forward-looking statements. For further discussion of these and other risk factors, see Item 1A. Risk Factors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Businesses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on the worldwide economy and financial markets, and developments related to the disease, including the time it will take for vaccines to be broadly distributed and administered worldwide, and the effectiveness of such vaccines in slowing or stopping the spread of COVID-19 and variants thereof and mitigating the economic effects of the pandemic,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The economic effects of the COVID-19 pandemic, including inflation, labor shortages and supply chain disruptions</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic upon the scheduling of elective and semi-emergent procedures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on our global manufacturing and distribution system, including the quality of our products and the availability and cost of raw materials and direct labor,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Our ability to recover from the impact of the COVID-19 pandemic on our business and increase net sales, expand the markets in which we participate, capture market share and adapt to market volatility,</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of natural disasters, climate change, additional future public health crises and other catastrophic events on our ability to manufacture, distribute and sell our products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive offerings and related declines in average selling prices for our products,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ongoing impact on our business of physician alignment to hospitals, governmental investigations and audits of hospitals and other market and economic conditions on the overall number of procedures performed,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The performance of, and physician and patient confidence in, our products and technologies or those of our competitors,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact and outcome of ongoing and future clinical trials and market studies undertaken by us, our competitors or other third parties or perceived product performance of our or our competitors' products,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variations in clinical results, reliability or product performance of our and our competitors' products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to acquire or develop, launch and supply new or next-generation products and technologies worldwide and in line with our commercialization strategies in a timely and successful manner and with respect to our recent acquisitions,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of consolidation and competition in the markets in which we do business or plan to do business,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption in the manufacture or supply of certain components, materials or products, or the failure to secure in a timely manner alternative manufacturing or additional or replacement components, materials or products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as some of our products are more profitable than others,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to attract and retain talent, including key personnel associated with recent acquisitions, and to maintain our robust corporate culture, especially in light of the remote working conditions imposed by the COVID-19 pandemic and execute plans to return employees to offices in jurisdictions where safe and feasible,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The inability of certain of our employees to return to work full-time due to impacts of the COVID-19 pandemic, or our inability to recruit personnel into direct labor roles for the duration of the pandemic,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain and maintain regulatory approval in the U.S. and around the world, including EU MDR and the associated timing and cost of product approval, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased pressure on the availability and rate of third-party reimbursement for our products and procedures in the U.S. and around the world, including with respect to the timing and costs of creating and expanding markets for new products and technologies, </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The issuance of new or revised accounting standards by the Financial Accounting Standards Board or the Securities and Exchange Commission, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of potential goodwill and intangible asset impairment charges on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Compliance, Litigation and Data Protection</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of healthcare policy changes and legislative or regulatory efforts in the U.S., the EU and around the world to modify product approval or reimbursement processes, including a trend toward demonstrating clinical outcomes, comparative effectiveness and cost efficiency, as well as the impact of other healthcare reform legislation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with our regulatory compliance and quality systems and activities in the U.S., the EU and around the world, including meeting regulatory standards applicable to manufacturing and quality processes,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of legal, regulatory or market responses to global climate change,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to minimize or avoid future field actions or FDA warning letters relating to our products and processes and the ongoing inherent risk of potential physician advisories related to our or our competitors' products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased scrutiny of and heightened global regulatory enforcement facing the medical device industry arising from political and regulatory changes, economic pressures or otherwise, including under U.S. Anti-Kickback Statute, U.S. False Claims Act and similar laws in other jurisdictions, U.S. Foreign Corrupt Practices Act (FCPA) and similar laws in other jurisdictions, and U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs and risks associated with current and future asserted litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of our litigation and risk management practices, including self-insurance and compliance activities on our loss contingencies, legal provisions and cash flows,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of, diversion of management attention as a result of, and costs to cooperate with, litigate and/or resolve governmental investigations and our class action, product liability, contract and other legal proceedings,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of failure to protect our intellectual property rights and the outcome of patent litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to operate properly our information systems that support our business operations and protect our data integrity and products from a cyber-attack or other breach that has a material adverse effect on our business, reputation or results of operations, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact to internal control over financial reporting relating to potential restrictions to access to consigned inventory at customer locations for our inventory count procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovation and Certain Growth Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing, size and nature of our strategic growth initiatives and market opportunities, including with respect to our internal research and development platforms and externally available research and development platforms and technologies and the ultimate cost and success of those initiatives and opportunities,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to complete planned clinical trials successfully, obtain regulatory approvals and launch new and next generation products in a timely manner consistent with cost estimates, including the successful completion of projects from in-process research and development,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to identify and prioritize our internal research and development project portfolio and our external investment portfolio on profitable net sales growth opportunities as well as to maintain the estimated timing and costs of such projects and expected revenue levels for the resulting products and technologies,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop, manufacture and market new products and technologies successfully and in a timely manner and the ability of our competitors and other third parties to develop products or technologies that render our products or technologies noncompetitive or obsolete, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute appropriate decisions to discontinue, write-down or reduce the funding of any of our research and development projects, including projects from in-process research and development from our acquisitions, in our growth adjacencies or otherwise,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on acquisitions, alliances or investments to introduce new products or technologies and to enter new or adjacent growth markets and our ability to fund them or to fund contingent payments with respect to those acquisitions, alliances and investments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential failure to successfully integrate and realize the expected benefits, including cost synergies, from the strategic acquisitions, alliances and investments we have consummated or may consummate in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependency on international net sales to achieve growth, including in emerging markets,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing and collectability of customer payments, as well as our ability to continue factoring customer receivables where we have factoring arrangements, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact on pricing due to national and regional tenders,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geopolitical and economic conditions, including civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">The impact of the United Kingdom&#8217;s departure from the European Union,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Protection of our intellectual property, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including FCPA, EU MDR and similar laws in other jurisdictions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in reimbursement practices and policies,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of significant developments or uncertainties stemming from changes in the U.S. government following presidential and congressional elections, including changes in U.S. trade policies, tariffs and the reaction of other countries thereto, particularly China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to maintain or expand our worldwide market positions in the various markets in which we compete or seek to compete, including through investments in product diversification and emerging markets such as Brazil, Russia, India and China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute and realize anticipated benefits from our investments in emerging markets, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, expenses and resulting margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to generate sufficient cash flow to fund operations, capital expenditures, global expansion initiatives, any litigation settlements and judgments, share repurchases and strategic investments and acquisitions as well as maintaining our investment grade ratings and managing our debt levels and financial covenant compliance, particularly in light of the COVID-19 pandemic and lower demand for our products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to access the public and private capital markets when desired and to issue debt or equity securities on terms reasonably acceptable to us,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open tax matters, exposure to additional tax liabilities and the impact of changes in U.S. and international tax laws,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open litigation matters, exposure to additional loss contingencies and legal provisions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of examinations and assessments by domestic and international taxing authorities on our tax provisions, financial condition or results of operations,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of counterparty default on our derivative financial instruments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to collect outstanding and future receivables and/or sell receivables under our factoring programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Reduction and Optimization Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with changes made or expected to be made to our organizational and operational structure, pursuant to our restructuring plans as well as any further restructuring or optimization plans we may undertake in the future and our ability to recognize benefits and cost reductions from such programs and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Business disruption and employee distraction as we execute our global compliance program, restructuring and optimization plans and divestitures of assets or businesses and implement our other strategic and cost reduction initiatives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information contained in this Annual Report on Form 10-K and the exhibits hereto, the following risk factors should be considered carefully in evaluating our business. Our business, financial condition, cash flows or results of operations could be materially adversely affected by any of these risks. This section contains forward-looking statements. You should refer to the explanation of the qualifications and limitations on forward-looking statements set forth at the end of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form 10-K. The considerations and risks that follow are organized within relevant headings but may be relevant to other headings as well. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business, financial condition, cash flows or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing global COVID-19 pandemic and related impacts are having an adverse effect on our operations, financial performance and cash flows. We are unable to predict the extent to which the pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position and the achievement of our strategic objectives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our operations, financial performance and cash flows have been negatively impacted by the ongoing COVID-19 pandemic, and the challenging macroeconomic conditions caused by the pandemic, including, but not limited to, disruptions in economic activity, including procedures using our products, disruptions in global supply chains, labor markets, and significant volatility in price and availability of goods and services. These conditions and others may persist and worsen, leading to broader economic downturns, including another U.S. and global economic recession. Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing, and difficult to predict, the pandemic&#8217;s impact on our results of operations and financial performance, as well as its impact on our ability to execute our business strategies and initiatives successfully, remains uncertain and difficult to predict. Further, the ultimate impact of the COVID-19 pandemic on our results of operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business and individuals&#8217; actions that have been and continue to be taken in response to the pandemic (including restrictions on travel, vaccine mandates, transport and workforce pressures, and voluntary or mandated deferrals or postponements of elective procedures); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; and the timing and pace of recovery when the COVID-19 pandemic subsides, which could be impacted by a number of factors, including limited provider capacity to perform procedures using our products that were deferred as a result of the pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has subjected, and may continue to subject, our results of operations, financial performance and financial condition to a number of risks, including, but not limited to those discussed below:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Operations-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Across our businesses, we have faced operational challenges from the need to protect employee health and safety. Some of these challenges include site shutdowns, workplace disruptions and restrictions on the movement of people, raw materials and goods, both at our facilities and at customers and suppliers'. We also experienced, and may continue experiencing, lower demand and volume for certain products and services, customer requests for payment deferrals or other contract modifications, delays of deliveries and other factors related directly and indirectly to the COVID-19 pandemic that adversely impact our businesses. We are also experiencing increases in prices for, and shortages of, certain parts or components required to manufacture certain of our products. We expect that the longer the period of economic and global supply chain disruption continues, the more material the cumulative adverse impact will be on our business operations, financial performance and results of operations. Our ability to manufacture our products is highly dependent on our ability to maintain the safety and health of our employees. The ability of our employees to work may be significantly impacted by employees contracting or being exposed to COVID-19. Additionally, when economic recovery following the COVID-19 pandemic occurs, we may experience unpredictable increases in demand for certain products, which could exceed our capacity to meet such demand on a timely basis or at all, which could have a material adverse impact on our financial performance and results of operations. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Customer-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In particular, as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken to quell the spread of COVID-19 and protect our customers, employees, and the patients receiving our products, we have experienced significant and unpredictable reductions in demand for certain of our products as health care customers re-prioritize the treatment of patients. In certain jurisdictions in the U.S., governmental authorities have recommended, and in certain cases required, that elective procedures be suspended or canceled to avoid non-essential patient exposure to medical environments and potential </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">infection with COVID-19 and to focus limited resources and personnel capacity toward the treatment of COVID-19. Further, staffing shortages within healthcare facilities, and resulting procedural delays, have and may continue to negatively impact demand for our products. These measures and challenges significantly reduced our net sales and could continue to do so in the future. Further, once the pandemic subsides, we anticipate there may be some continued reluctance upon the part of some patients to seek medical attention in a hospital setting.&#160;In addition, for the majority of patients who do seek appointments with physicians and surgeries to be performed at hospitals and ambulatory surgery centers relating to a variety of medical conditions, we anticipate there may be a substantial backlog. As a result, patients seeking to schedule or reschedule elective or deferrable procedures utilizing our products may have to navigate potentially limited healthcare provider capacity. We believe this on-going patient reluctance and potential healthcare provider capacity could continue to have an adverse effect on our net sales. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Employee-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing, and difficult to predict, and we may have to take actions to reduce costs and preserve jobs, including reductions to salary and work hours, restructuring, layoffs and other measures, which may negatively impact our workforce and our business. These negative impacts could include inhibiting our ability to quickly respond to increased customer demand and to take advantage of more favorable economic and market conditions after the pandemic subsides as well as lower productivity and higher employee attrition. Additionally, the COVID-19 pandemic has given rise to conditions that have created a highly competitive environment for talent. Our ability to attract and retain key talent at all levels of our organization has been and could continue to be challenged by these conditions, and inability to attract and retain talent could result in material adverse impacts to our business and results of operations.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting-related risks: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally accepted accounting principles and the related authoritative guidance are complex and involve subjective judgments.&#160;In particular, the accounting for revenue, inventory, goodwill, intangible assets, income taxes and other assets and liabilities requires reliance on forward looking estimates of sales and/or results of operations.&#160;Due to the uncertainty surrounding the COVID-19 pandemic, estimating the future performance of our business is extremely challenging and the range of deviation from internal estimates could be more significant in this environment. Changes in the underlying estimates, assumptions or judgments could have a material adverse impact on our future results of operations and/or financial position.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Leverage- and market-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The current financial market dynamics and volatility pose heightened risks to our previously announced timelines for decreasing our leverage, which we expect to be delayed as we seek to maintain appropriate liquidity to compensate for lower cash flows from operations or as variables impacting our leverage ratios fluctuate with extreme market volatility. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity- and funding-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: While we have significant sources of cash and liquidity and access to committed credit lines, a prolonged period of generating lower cash from operations could adversely affect our financial condition and the achievement of our strategic objectives. Additionally, there can also be no assurance that we will not face credit rating downgrades as a result of weaker than anticipated performance of our businesses, slower progress in decreasing our leverage or other factors. Future downgrades could further adversely affect our cost of funds and related margins, liquidity, competitive position and access to capital markets, and a significant downgrade could have an adverse commercial impact on our business. Conditions in the financial and credit markets may also limit the availability of funding or increase the cost of funding (including for receivables monetization or supply chain finance programs, as well as increased borrowing costs and higher interest rates), which could adversely affect our business, financial position and results of operations. Although the U.S. federal and other governments have instituted and/or announced a number of funding programs to support businesses, our ability or willingness to access funding under such programs may be limited by regulations or other guidance, or by further change or uncertainty related to the terms of these programs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic continues to adversely affect our results of operations and/or financial position, it may also have the effect of heightening many of the other risks described in the risk factors in this Annual Report on Form 10-K. Further, the COVID-19 pandemic may also affect our results of operations and/or financial position in a manner that is not presently known to us or that we currently do not expect to present significant risks, particularly if the COVID-19 pandemic and its associated impacts reoccur in successive waves.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition and may not be able to keep pace with the rapid technological changes in the medical devices industry, which could have an adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device markets in which we participate are highly competitive. We encounter significant competition across our product lines and in each market in which our products are sold from various medical device companies. Some of our competitors may have greater financial and marketing resources than we do, including as a result of consolidation among companies in our industry. Our primary competitors include Abbott Laboratories and Medtronic plc, as well as a wide range of medical device companies that sell a single or limited number of competitive products or which participate in only a specific market segment or segments. We also face competition from non-medical device companies, including pharmaceutical companies and providers of various diagnostic tests, which may offer alternative therapies or diagnostics for disease states also amenable to treatment or diagnosis using our products. New competitors may emerge in the future, potentially including companies introducing new sales or distribution models to our industry or leveraging genomic robotic, navigation, and/or other automation technologies. Digital technologies have and may continue to increase in their applicability and importance to various aspects of our business, operating and competitive environments, R&amp;D pipeline and product portfolio. We believe we will need to develop new and enhanced digital capabilities and competences in order to remain competitive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the medical device markets in which we participate are characterized by extensive research and development and rapid technological change. Developments by other companies of products and/or services, processes or technologies may make our products or proposed products obsolete or less competitive and may negatively impact our net sales. It is necessary for us to devote continued efforts and financial resources to the development or acquisition of scientifically advanced technologies and products. In addition, we will need to apply our technologies cost-effectively across product lines and markets, obtain patent and other protection for our technologies and products, obtain required regulatory and reimbursement approvals and successfully manufacture and market our products consistent with our quality standards. If we fail to develop or acquire new products or enhance existing products, such failure could have a material adverse effect on our business, financial condition or results of operations. In addition, a delay in the timing of the launch of next-generation products and the overall performance of, and continued physician confidence in, those products may result in declines in our market share and have an adverse impact on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience declines in market size, average selling prices for our products, medical procedure volumes and our share of the markets in which we compete, which may materially adversely affect our results of operations and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to experience pressures across many of our businesses due to competitive activity, increased market power of our customers as the healthcare industry consolidates, national and regional government tenders, economic pressures experienced by our customers, public perception of our products, and the impact of managed care organizations and other third-party payers. These and other factors may adversely impact market sizes, as well as our share of the markets in which we compete, the average selling prices for our products or medical procedure volumes. There can be no assurance that the size of the markets in which we compete will increase, that we will be able to hold or gain market share or compete effectively on the basis of price or that the number of procedures in which our products are used will increase. Decreases in market sizes or our market share and declines in average selling prices or procedural volumes could materially adversely affect our results of operations or financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continued consolidation in the healthcare industry or additional governmental controls exerted over pricing and access in key markets could lead to increased demands for price concessions or limit or eliminate our ability to sell to certain of our significant market segments, which could have an adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous initiatives and reforms by legislators, regulators and third-party payers to curb the rising cost of healthcare, and to increase access to care, have catalyzed a consolidation of aggregate purchasing power within the markets in which we sell our products. Additionally, a growing number of countries have instituted or are contemplating introducing regional or national tender processes driven primarily by price. In some cases, such processes may favor local companies to multinational companies like Boston Scientific. In other instances, multinationals may be subject to a separate tender bidding process in which they compete only with each other and not with domestic companies. Further, in certain markets, the regulatory process through which new medical devices are approved may be faster and/or less burdensome for domestic companies compared to multinationals. As the healthcare industry consolidates, competition to provide products and services is expected to continue to intensify, resulting in pricing pressures, decreased average selling prices and the exclusion of certain suppliers from important market segments. We expect that market demand, government regulation, third-party coverage and reimbursement policies, government contracting requirements and societal pressures will continue to change the worldwide healthcare industry, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulting in further business consolidations and alliances among our customers, which may increase competition, exert further downward pressure on the prices of our products and services and may adversely impact our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare cost containment pressures, government payment and delivery system reforms, changes in private payer policies, and marketplace consolidations could decrease the demand for our products, the prices which customers are willing to pay for those products and/or the number of procedures performed using our devices, which could have an adverse effect on our business, financial condition or results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by hospitals, physicians and other healthcare providers around the world that typically bill various third-party payers, including government programs, authorities or agencies (e.g., Medicare and Medicaid in the U.S.) and private health plans, for the healthcare services provided to their patients. Governments and payers may also institute changes in healthcare delivery systems that may reduce funding for services or encourage greater scrutiny of healthcare costs. The ability of customers to obtain appropriate reimbursement for their products and services is critical to the success of medical technology companies because it affects which products customers purchase and the prices they are willing to pay. Reimbursement and funding vary by country and can significantly impact the acceptance of new products and technologies and the use of established products and technologies. We may find limited demand for promising new products unless reimbursement approval is obtained from private and governmental third-party payers. Further legislative or administrative reforms to the reimbursement systems in the U.S., Japan, or other countries in a manner that significantly reduce or eliminate reimbursement for procedures using our medical devices, including price regulation, site of service requirements, competitive bidding and tendering, coverage and payment policies, comparative effectiveness of therapies, heightened clinical data requirements, technology assessments and managed-care arrangements, could have a material adverse effect on our business, financial condition or results of operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geopolitical Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to a number of market, business, financial, legal and regulatory risks and uncertainties with respect to our international operations that could have a material impact on our business, financial condition or results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International net sales accounted for 42 percent of our global net sales in 2021. An important part of our strategy is to continue pursuing growth opportunities in net sales and market share outside of the U.S. by expanding global presence, including in Emerging Markets. Our international operations are subject to a number of market, business and financial risks and uncertainties, including those related to our use of channel partners, geopolitical and economic instability, foreign currency exchange and interest rate fluctuations, competitive product offerings, local changes in healthcare financing and payment systems and healthcare delivery systems, local product preferences and requirements, including preferences for local manufacturers, workforce instability, weaker intellectual property protection in certain countries than exists in the U.S. and longer accounts receivable cycles. Such risks and uncertainties may adversely impact our ability to implement our growth strategy in these markets and, as a result, our sales growth, market share and operating profits from our international operations may be adversely affected. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations are subject to established and developing legal and regulatory requirements for medical devices in each country in which our products are marketed and sold. Most foreign countries have medical device regulations. Further, most countries outside of the U.S. require product approvals be renewed or re-certified on a regular basis in order to continue to be marketed and sold there. In addition, several countries that previously did not have regulatory requirements for medical devices have established such requirements in recent years and other countries have expanded, or plan to expand, existing regulations, including requiring local clinical data in addition to global clinical data. These factors have caused or may cause us to experience more uncertainty, risk, expense and delay in obtaining approvals and commercializing products in certain jurisdictions, which could adversely impact our net sales, market share and operating profits from our international operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, international markets are affected by economic pressure to contain healthcare costs, which can lead to more rigorous evidence requirements and lower reimbursement rates for either our products directly or procedures in which our products are used. Governments and payers may also institute changes in healthcare delivery systems that may reduce funding for services or encourage greater scrutiny of healthcare costs. In addition, certain international markets may also be affected by foreign government efforts to reference reimbursement rates in other countries. All of these types of changes may ultimately reduce selling prices of our products and/or reduce the number of procedures in which our products are used, which may adversely impact our net sales, market share and operating profits from our international operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our international operations are subject to other established and developing U.S. and foreign legal and regulatory requirements, including FCPA and/or similar laws in other countries and U.S. and foreign import and export controls and licensing requirements, trade protection and embargo measures and customs laws. Global businesses, including those in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">medical device industry, are facing increasing scrutiny of, and heightened enforcement efforts with respect to, their international operations. Any alleged or actual failure to comply with legal and regulatory requirements may subject us to government scrutiny, civil and/or criminal proceedings, sanctions and other liabilities, which may have a material adverse effect on our international operations, financial condition, results of operations and/or liquidity. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The US-China relationship will continue to shape the geopolitical stage, with uncertainty created by the change in administration and strategic direction, and difficult political conditions for major actions. Legislation aimed at boosting competitiveness of U.S. businesses may have unintended effects on our business. Ultimately, tariffs and other protectionist measures, as well as prolonged uncertainty, may have adverse effects on our ability to source and manufacture products in a timely and cost effective manner, thereby adversely affecting our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lastly, sanctions and export restrictions are expected to proliferate, leading to greater uncertainty in emerging and growth markets. Notably the Russia-Ukraine crisis is expected to create barriers to doing business in Russia, as well as creating geopolitical shifts in Asia. Any significant changes in the political, economic, financial, competitive, legal and regulatory or reimbursement conditions where we conduct, or plan to expand, our international operations may have a material impact on our business, financial condition or results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit and Financial Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to manage our debt levels, maintain investment grade credit ratings at the three ratings agencies, or if we experience a disruption in our cash flows, it could have an adverse effect on our cost of borrowing, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy to maximize stockholder value, we use financial leverage to manage our cost of capital. Our outstanding debt balance was $9.065 billion as of December&#160;31, 2021. Although we currently have investment grade ratings at Moody's Investor Service, Standard &amp; Poor's Rating Service and Fitch Ratings, our inability to maintain investment grade credit ratings could increase our cost of borrowing funds in the future and reduce our access to liquidity. Delays in our product development and new product launches could result in disruption in our cash flow or our ability to continue to effectively manage our debt levels could have an adverse effect on our cost of borrowing, financial condition or results of operations. In addition, our credit agreements contain a financial covenant that require us to maintain a minimum specified leverage ratio and place other limits on our business. If we are unable to satisfy this covenant, we may be required to obtain waivers from our lenders and no assurance can be made that our lenders would grant such waivers on favorable terms or at all and we could be required to repay any borrowings on demand. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may record future intangible asset impairment charges related to one or more of our global reporting units, which could materially adversely impact our results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. We assess goodwill for impairment at the reporting unit level. We also test our indefinite-lived intangible assets at least annually, or more frequently if impairment indicators are present, and we review intangible assets subject to amortization quarterly for impairment. In evaluating the potential for impairment, we make assumptions regarding estimated revenue projections, growth rates, cash flows and discount rates. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, we monitor the key drivers of fair value to detect events or other changes that would warrant an interim impairment test of our goodwill and other intangible assets. Relatively small declines in the future performance and cash flows of a reporting unit or asset group, changes in our reporting units or in the structure of our business as a result of future reorganizations, acquisitions or divestitures of assets or businesses, or small changes in other key assumptions, may result in the recognition of significant asset impairment charges, which could have a material adverse impact on our results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current domestic and international economic conditions could adversely affect our cash flows and results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertainty about global economic conditions, including those resulting from credit and sovereign debt issues, has caused and may continue to cause disruption in the financial markets, including diminished liquidity and credit availability. These conditions may adversely affect our suppliers, leading them to experience financial difficulties or be unable to borrow money to fund their operations, which could cause disruptions in our ability to produce our products. Our customers may experience financial difficulties or be unable to borrow money to fund their operations, which may adversely impact their ability or decision to purchase our products, particularly capital equipment, or to pay for our products that they purchase on a timely basis, if at all. In addition, we have accounts receivable factoring programs in certain European and Asian countries. Deterioration of the global economy or increase in sovereign debt issues may impact our ability to transfer receivables to third </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">parties in certain of those countries. Third parties, such as banks, offering factoring programs in these countries are looking to reduce their exposure levels to government owned or supported debt. This could result in terminations of, or changes to the costs or credit limits of our existing factoring programs. Such terminations or changes could have a negative impact on our cash flow and days sales outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strength and timing of economic recovery remains uncertain and there can be no assurance that there will not be further deterioration in the global economy. Accordingly, we cannot predict to what extent global economic conditions, including sovereign debt issues and increased focus on healthcare systems and costs in the U.S. and abroad, may continue to impact negatively our average selling prices, net sales and profit margins, procedural volumes and reimbursement rates from third party payers. In addition, conditions in the financial markets and other factors beyond our control may adversely affect our ability to borrow money in the credit markets, access the capital markets and obtain financing for mergers and acquisitions (M&amp;A) or other general purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business and Operational Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to integrate acquired businesses into our operations successfully could adversely affect our business, financial condition and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy to realign our business portfolio, we have completed multiple acquisitions in recent years and may pursue additional acquisitions in the future. Our integration of acquired businesses requires significant efforts, including corporate restructuring and the coordination of information technologies, research and development, sales and marketing, operations, regulatory, supply chain, manufacturing, quality systems and finance. These efforts result in additional expenses and involve significant management time. Some of the factors that could affect the success of our acquisitions include, among others, the effectiveness of our due diligence process, our ability to execute our business plan for the acquired companies, the strength of the acquired technology, results of clinical trials, regulatory approvals and reimbursement levels of the acquired products and related procedures, the continued performance of critical transition services, our ability to adequately fund acquired in-process research and development projects and retain key employees and our ability to achieve synergies with our acquired companies, such as increasing sales of our products, achieving cost savings and effectively combining technologies to develop new products. In addition, foreign acquisitions involve unique risks, including those related to integration of operations across different geographies, cultures and languages, currency risks and risks associated with the economic, political, legal and regulatory environment in specific countries. Our failure to manage successfully and coordinate the growth of the acquired companies could have an adverse impact on our business and our future growth. In addition, we cannot be certain that the businesses we acquire will become profitable or remain so, and if our acquisitions are not successful, we may record related asset impairment charges in the future or experience other negative consequences on our results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in our strategy relating to future strategic acquisitions of, investments in, or alliances with, other companies and businesses, which have been a significant source of historical growth for us, and will be key to our diversification into new markets and technologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategic acquisitions, investments and alliances are intended to further expand our ability to offer customers effective, high quality medical devices. These acquisitions, investments and alliances have been a significant source of our growth. We face competition for acquisitions from other healthcare and non-healthcare acquirers, financial sponsors, and from the market for Initial Public Offerings (IPOs). Some of our competitors in the medical device sector may have access to substantially greater amounts of cash than we do that could be deployed into M&amp;A or strategic investments if they so choose. Strength in the market for IPOs may also reduce the opportunities available to us for M&amp;A and/or cause us to need to pay higher prices. If we are unsuccessful in our acquisitions, investments and alliances, we may be unable to grow our business. Any potential future acquisitions we consummate may be dilutive to our earnings and may require additional debt or equity financing, depending on their size or nature. The success of our strategy relating to future acquisitions, investments or alliances will depend on a number of factors, including our ability to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify suitable opportunities for acquisition, investment or alliance, if at all,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manage acquisition, investment or alliance opportunities within our capital capacity and prioritize those investments to execute on our strategy, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manage our due diligence process to uncover potential issues with targets,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">finance any future acquisition, investment or alliance on terms acceptable to us, if at all,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complete acquisitions, investments or alliances in a timely manner on terms that are satisfactory to us, if at all, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully integrate and operate acquired businesses,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully identify and retain key target employees,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with applicable laws and regulations, including foreign laws and regulations, and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protect intellectual property and to prevail in litigation related to newly acquired technologies.&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize the expected benefits from our restructuring and optimization initiatives, our long-term cost savings programs may result in an increase in short-term expenses and our efforts may lead to unintended consequences. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the dynamics of the economy, the healthcare industry and the markets in which we compete, and assess opportunities for improved operational effectiveness and efficiency and to better align expenses with revenues, while preserving our ability to make investments in research and development projects, capital and our people, which we believe is important to our long-term success. As a result of these assessments, we have undertaken restructuring and optimization initiatives to enhance our growth potential and position us for long-term success. In November 2018, we announced a restructuring initiative (the 2019 Restructuring Plan) intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021. In addition, on February 22, 2022, the Company increased and our Board of Directors approved cost estimates to complete additional activities identified under the program. The 2019 Restructuring Plan is expected to result in total pre-tax charges of approximately $425 million to $525 million and reduce gross annual pre-tax expenses by approximately $250 million to $300 million by the end of 2023 as program benefits are realized. We expect a substantial portion of the savings to be reinvested in strategic growth initiatives. These measures could yield unintended consequences, such as distraction of our management and employees, business disruption, inability to attract or retain key personnel and reduced employee productivity, which could negatively affect our business, sales, financial condition and results of operations. Moreover, our restructuring and optimization initiatives result in charges and expenses some of which impact our operating results. We cannot guarantee that the activities under our restructuring plans or other optimization initiatives will result in the desired efficiencies and estimated cost savings.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth is dependent upon the development of new products and enhancement of existing products, which requires significant research and development, clinical trials and regulatory approvals, all of which may be very expensive and time-consuming and may not result in commercially viable products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to develop new products and enhance existing products, we focus our research and development programs largely on the development of next-generation and novel technology offerings across multiple programs and businesses. The development of new products and enhancement of existing products requires significant investment in research and development, clinical trials and regulatory approvals. The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products, complete clinical trials, obtain regulatory approvals and reimbursement in the U.S. and abroad, manufacture products in a cost-effective manner, obtain appropriate intellectual property protection for our products and gain and maintain market approval of our products. There can be no assurance that any products now in development or that we may seek to develop in the future will achieve technological feasibility, obtain regulatory approval or gain market acceptance. If we are unable to develop and launch new products and enhanced products, our ability to maintain or expand our market position in the markets in which we participate may be materially adversely impacted. Further, we are continuing to investigate and have completed several acquisitions that involve opportunities to further expand our presence in and diversify into, priority growth areas by accessing new products and technologies. There can be no assurance that our investments will be successful or that we will be able to access new products and technologies on terms favorable to us, or that these products and technologies will achieve commercial feasibility, obtain regulatory approval or gain market acceptance. A delay in the development or approval of new products and technologies or our decision to reduce or terminate our investments may adversely impact the contribution of these technologies to our future growth.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain products or groups of products, in particular new products or enhancements of existing products, may have a disproportionate impact on our business, financial condition and results of operations. Failure to meet growth projections, poor clinical outcomes, increasing regulatory requirements, launch delays and inability to effectively scale manufacturing and achieve targeted margins with respect to any of these products or groups of products in particular may materially adversely impact on our business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interruption of our supply chain or manufacturing operations, including resulting from natural disasters, further public heath crises and other catastrophic events or other events outside of our control could adversely affect our results of operations and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are designed and manufactured in technology centers around the world, either by us or third parties. In most cases, the manufacturing of any specific product is concentrated in one or a few locations. Factors such as a failure to follow specific internal protocols and procedures, equipment malfunction, environmental factors or damage to one or more of our facilities could adversely affect our ability to manufacture our products. In the event of an interruption in manufacturing, we may be unable to quickly move to alternate means of producing affected products or to meet customer demand. In the event of a significant interruption, for example, as a result of a failure to follow regulatory protocols and procedures, we may experience lengthy delays in resuming production of affected products due primarily to needs for regulatory approvals. As a result, we may experience loss of market share, which we may be unable to recapture and harm to our reputation, which could adversely affect our results of operations and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions in the supply of the materials and components used in manufacturing our products or the sterilization of our products by third-party vendors could adversely affect our results of operations and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase the majority of the materials and components used in manufacturing our products from third-party vendors. Certain of these materials and components are purchased from single sources due to quality considerations, expertise, costs or constraints resulting from regulatory requirements. In certain cases, we may not be able to establish additional or replacement vendors for such materials or components in a timely or cost effective manner, largely as a result of FDA regulations that require validation of materials and components prior to their use in our products and the complex nature of our and many of our vendors' manufacturing processes. A reduction or interruption in the supply of materials and components used in manufacturing our products, an inability to timely develop and validate alternative sources if required or a significant increase in the price of such materials or components could adversely affect our results of operations and financial condition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many of our products require sterilization prior to sale and we utilize a mix of internal resources and contract sterilizers to perform this service. To the extent we or our contract sterilizers are unable to sterilize our products, whether due to capacity, availability of materials for sterilization, regulatory or other constraints, including federal and state regulations on the use of ethylene oxide, we may be unable to transition to alternative internal or external resources or methods in a timely or cost effective manner or at all, which could have a material impact on our results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal and Regulatory Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare policy changes may have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political, economic and policy influences are leading the healthcare industry to make substantial structural and financial changes that will continue affecting our results of operations. Government and private sector initiatives limiting the growth of healthcare costs (including price regulation), coverage and payment policies, comparative effectiveness of therapies, technology assessments and healthcare delivery structure reforms, are continuing in many countries where we do business. We believe that these changes are causing the marketplace to put increased emphasis on the delivery of treatments that can reduce costs, improve efficiencies and/or increase patient access. Although we believe our less-invasive products and technologies generate favorable clinical outcomes, value and cost efficiency, the resources and evidence necessary to demonstrate value to our customers, patients, payers and other stakeholders may be significant, and it may take a significant period of time to gain widespread adoption. Moreover, there can be no assurance that our strategies will succeed for every product.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the specific healthcare programs and regulations that will be ultimately implemented by regional and national governments globally. However, any changes that lower reimbursements for either our products and/or procedures using our products reduce medical procedure volumes and/or increase cost containment pressures on us or others in the healthcare sector could adversely affect our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive and dynamic medical device regulation, which may impede or hinder the approval or sale of our products and, in some cases, may ultimately result in an inability to obtain approval of certain products or may result in the recall or seizure of previously approved products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products, marketing, sales and development activities and manufacturing processes are subject to extensive and rigorous regulation by the FDA pursuant to the Federal Food, Drug and Cosmetic Act (FDC Act), by comparable agencies in foreign countries and by other regulatory agencies and governing bodies. Under the FDC Act, medical devices must receive FDA </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clearance or approval or an exemption from such clearance or approval before they can be commercially marketed in the U.S. In the EU, we are required to comply with the new Medical Device Regulation (MDR or EU MDR) effective May 2021 which supersedes the Medical Device Directives. Medical devices which have a valid CE Certificate to the current Directives (issued before May 2021) can continue to be sold until the earlier of May 2024 or when the CE Certificate expires, providing there are no significant changes to the design or intended use. The CE Mark is applied following approval from an independent notified body or declaration of conformity. The process of obtaining marketing approval or clearance from the FDA or by comparable agencies in foreign countries for new products, or with respect to enhancements or modifications to existing products, could:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">take a significant period of time,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require the expenditure of substantial resources,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">involve rigorous pre-clinical and clinical testing, as well as increased post-market surveillance,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require changes to products and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">result in limitations on the indicated uses of products.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, exported devices are subject to the regulatory requirements of each country to which the device is exported. Some countries do not have medical device regulations, but in most countries, medical devices are regulated. Frequently, regulatory approval may first be obtained in a foreign country prior to application in the U.S. due to differing regulatory requirements; however, other countries, such as China for example, require approval in the country of origin or legal manufacturer first. Most countries outside of the U.S. require that product approvals be renewed or recertified on a regular basis, generally every four to five years. The renewal or recertification process requires that we evaluate any device changes and any new regulations or standards relevant to the device and conduct appropriate testing to document continued compliance. Where renewal or recertification applications are required, they may need to be renewed and/or approved in order to continue selling our products in those countries. There can be no assurance that we will receive the required approvals for new products or modifications to existing products on a timely basis or that any approval will not be subsequently withdrawn or conditioned upon extensive post-market study requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global regulatory environment is becoming increasingly stringent and unpredictable, which could increase the time, cost and complexity of obtaining regulatory approvals, as well as the clinical and regulatory costs of supporting those approvals. Several countries that did not have regulatory requirements for medical devices have established such requirements in recent years and other countries have expanded on existing regulations. Certain regulators are exhibiting less flexibility and are requiring local preclinical and clinical data in addition to global data. While harmonization of global regulations has been pursued, requirements continue to differ significantly among countries. We expect this global regulatory environment will continue to evolve, which could impact our ability, or increase the time and cost, to obtain future approvals for our products. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and other worldwide regulatory agencies actively monitor compliance with local laws and regulations through review and inspection of design and manufacturing practices, recordkeeping, reporting of adverse events, labeling and promotional practices. The FDA can ban certain medical devices, detain or seize adulterated or misbranded medical devices, order repair, replacement or refund of these devices and require notification of health professionals and others with regard to medical devices that present unreasonable risks of substantial harm to the public health. The FDA can take action against a company that promotes "off-label" uses. The FDA may also enjoin and restrain a company for certain violations of the FDC Act and other amending Acts pertaining to medical devices, or initiate action for criminal prosecution of such violations. Any adverse regulatory action, depending on its magnitude, may restrict a company from effectively marketing and selling its products, may limit a company's ability to obtain future premarket clearances or approvals and could result in a substantial modification to our business practices and operations. International sales of medical devices manufactured in the U.S. that are not approved by the FDA for use in the U.S., or that are banned or deviate from lawful performance standards, are subject to FDA export requirements. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations regarding the development, manufacture and sale of medical devices are evolving and subject to future change. We cannot predict what impact, if any, those changes might have on our business. Failure to comply with regulatory requirements could have a material adverse effect on our business, financial condition and results of operations. Later discovery of previously unknown problems with a product or manufacturer could result in fines, delays or suspensions of regulatory clearances or approvals, seizures or recalls of products, physician advisories or other field actions, operating restrictions and/or criminal prosecution. We may also initiate field actions as a result of a failure to strictly comply with our internal quality policies. The failure to receive product approval clearance on a timely basis, suspensions of regulatory clearances, seizures or recalls of products, physician advisories or other field actions, or the withdrawal of product approval by the FDA or by comparable agencies in foreign countries could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products are continually subject to clinical trials and other analyses conducted by us, our competitors or other third parties, the results of which may be unexpected, or perceived as unfavorable by the market, and could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a part of the regulatory process of obtaining marketing clearance for new products and new indications for existing products, we conduct and participate in numerous clinical trials with a variety of study designs, patient populations and trial endpoints. Unexpected or inconsistent clinical data from existing or future clinical trials or other analyses conducted by us, by our competitors or by third parties, including acquired businesses prior to acquisition by us, or the FDA's or the market's perception of this clinical data, may adversely impact our ability to obtain product approvals, our position in, and share of, the markets in which we participate and our business, financial condition, results of operations or future prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The medical device industry and its customers continue to face scrutiny and regulation by governmental authorities and are often the subject of numerous investigations, often involving marketing and other business practices or product quality issues including device recalls or advisories. These investigations could result in the commencement of civil and criminal proceedings; imposition of substantial fines, penalties and administrative remedies, including corporate integrity agreements, stipulated judgments or exclusion; diversion of our employees' and management's attention; imposition of administrative costs and have an adverse effect on our financial condition, results of operations and liquidity; and may lead to greater governmental regulation in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical devices we design, develop, manufacture and market are subject to rigorous regulation by the FDA and numerous other federal, state and foreign governmental authorities. These authorities continue to closely scrutinize our industry. We have received and in the future may receive, subpoenas and other requests for information from Congress and state and federal governmental agencies, including, among others, the U.S. Department of Justice (DOJ), the Office of Inspector General of the Department of Health and Human Services (HHS) and the Department of Defense, as well as from foreign governments and agencies. The requests and/or subpoenas we have received relate primarily to financial arrangements with healthcare providers, regulatory compliance and sale and/or product promotional practices. We have cooperated with these subpoenas and other requests for information and expect to continue to do so in the future. We cannot predict when a matter will be resolved, the outcome of the matter or its impact on us and cooperation may involve significant costs, including document production costs. An adverse outcome in any matter could include the commencement of an investigation, civil and criminal proceedings, substantial fines, penalties and administrative remedies, including exclusion from government reimbursement programs, entry into Corporate Integrity Agreements (CIAs) with governmental agencies and amendments to any existing CIAs. In addition, resolution of any matter could involve the imposition of additional and costly compliance obligations. Cooperation with requests and investigations from external agencies result in employee resource costs and diversion of employee focus. If any requests or investigations continue over a long period of time, they could divert the attention of management from the day-to-day operations of our business and impose significant additional administrative burdens on us. These potential consequences, as well as any adverse outcome from these requests or investigations, could have a material adverse effect on our financial condition, results of operations and liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain foreign governments, state governments (including that of Massachusetts, where we are headquartered) and the U.S. federal government have enacted legislation aimed at increasing transparency of our interactions with healthcare providers. As an example, compliance with the U.S. Physician Payment Sunshine Act requires us by law to disclose payments and other transfers of value to all U.S. physicians and U.S. teaching hospitals at the U.S. federal level made after August 1, 2013. Any failure to comply with these legal and regulatory requirements could impact our business. In addition, we have and may continue to devote substantial additional time and financial resources to further develop and implement enhanced structure, policies, systems and processes to comply with enhanced legal and regulatory requirements, which may also impact our business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that governmental authorities will continue to scrutinize our industry closely and that additional regulation may increase compliance and legal cost and exposure to litigation and have additional adverse effects on our operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws, unfavorable resolution of tax contingencies, or exposure to additional income tax liabilities could have a material impact on our financial condition, results of operations and/or liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes as well as non-income based taxes and tariffs, in the U.S. and numerous foreign jurisdictions. We are subject to ongoing tax audits in various jurisdictions. Tax authorities may disagree with certain positions we have taken and assess additional taxes. We regularly assess the likely outcomes of these audits to determine the appropriateness of our tax provision, and we have established contingency reserves for material, known tax exposures. However, the calculation of such tax exposures involves the application of complex tax laws and regulations in many jurisdictions, as well as interpretations as to the legality under European Union state aid rules of tax advantages granted in certain jurisdictions. Therefore, there can be no assurance that we will accurately predict the outcomes of these disputes or other tax audits or that issues raised by tax </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">authorities will be resolved at a financial cost that does not exceed our related reserves and the actual outcomes of these disputes and other tax audits could have a material impact on our results of operations or financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and regulations, or their interpretation and application, in the jurisdictions where we are subject to tax could materially impact our effective tax rate. The U.S. enacted the Tax Cuts and Jobs Act (TCJA) on December 22, 2017 and we expect the U.S. Treasury to issue future notices and regulations under the TCJA. Certain provisions of the TCJA and the regulations issued thereunder could have a significant impact on our future results of operations as could interpretations made by the Company in the absence of regulatory guidance and judicial interpretations. Additionally, the U.S. Congress has recently been debating changes to U.S. corporate income tax laws, including provisions that may alter the U.S. taxation of the profits of foreign subsidiary corporations. If ultimately enacted, these changes could have a material impact on our future effective tax rate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group of Twenty (G20), the Organization for Economic Co-operation and Development (OECD), the European Commission (EC) and individual taxing jurisdictions where we and our affiliates do business have recently focused on issues related to the taxation of multinational corporations. The OECD/G20 Inclusive Framework (IF) on base erosion and profit shifting (BEPS) includes actions intended to equip governments with domestic and international rules and instruments to address tax avoidance, ensuring that profits are taxed where economic activities generating the profits are performed and where value is created. The actions include a two-pillar solution to address the tax challenges of the digitalized economy, for which political agreement has been reached among 136 of the 140 members of the IF. In addition, individual countries are examining changes to how taxing rights should be allocated among countries considering the digital economy. Accordingly, the tax laws in the U.S. and other countries in which we and our affiliates do business could change on a prospective or retroactive basis and any such changes could have a material adverse effect on our business. Furthermore, changes in customs laws and regulations in the U.S. and various foreign jurisdictions could have a material impact on our results of operations or financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in Puerto Rico and Costa Rica presently benefit from various tax incentives and grants. Unless these incentives and grants are extended, they will expire between 2027 and 2035. If we are unable to renew, extend, or obtain new incentive and grants, the expiration of the existing incentives and grants could have a material impact on our financial results in future periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not effectively be able to protect our intellectual property or other sensitive data, which could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. Physician customers have historically moved quickly to new products and new technologies. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. However, intellectual property litigation is inherently complex and unpredictable and appellate courts can overturn lower court decisions. Furthermore, as our business increasingly relies on technology systems and infrastructure, our intellectual property, other proprietary technology and other sensitive data are potentially vulnerable to loss, damage or misappropriation. Finally, our ability to protect novel business models is uncertain. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competing parties in our industry frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These forces frequently drive settlement not only of individual cases, but also of a series of pending and potentially related and unrelated cases. In addition, although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of third parties have asserted that our current and former product offerings infringe patents owned or licensed by them. We have similarly asserted that products sold by our competitors infringe patents owned or licensed by us. Adverse outcomes in one or more of the proceedings against us could limit our ability to sell certain products in certain jurisdictions, or reduce our operating margin on the sale of these products and could have a material adverse effect on our financial condition, results of operations or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents and other proprietary rights are and will continue to be essential to our business, and our ability to compete effectively with other companies will be dependent upon the proprietary nature of our technologies. We rely upon trade secrets, know-how, continuing technological innovations, strategic alliances, and licensing opportunities to develop, maintain and strengthen our competitive position. We pursue a policy of generally obtaining patent protection in both the U.S. and abroad for patentable subject matter in our proprietary devices and attempt to review third-party patents and patent applications to the extent publicly </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">available in order to develop an effective patent strategy, avoid infringement of third-party patents, identify licensing opportunities and monitor the patent claims of others. We own numerous U.S. and foreign patents and have numerous patent applications pending. We also are party to license agreements pursuant to which patent rights have been obtained or granted in consideration for cash, cross-licensing rights or royalty payments. No assurance can be made that any pending or future patent applications will result in the issuance of patents, that any current or future patents issued to, or licensed by, us will not be challenged or circumvented by our competitors, or that our patents will not be found invalid. In addition, we may have to take legal action in the future to protect our patents, trade secrets or know-how or to assert them against claimed infringement by others. Any legal action of that type could be costly and time consuming and no assurances can be made that any lawsuit will be successful. We are generally involved as both a plaintiff and a defendant in a number of patent infringement and other intellectual property-related actions. The invalidation of key patents or proprietary rights that we own, or an unsuccessful outcome in lawsuits to protect our intellectual property, could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the laws of certain countries in which we market and plan on manufacturing some of our products in the near future, do not protect our intellectual property rights to the same extent as the laws of the U.S. If we are unable to protect our intellectual property in these countries, it could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our intellectual property, other proprietary technology and other sensitive data are potentially vulnerable to loss, damage or misappropriation from system malfunction, computer viruses and unauthorized access to our data or misappropriation or misuse thereof by those with permitted access and other events. While we have invested to protect our intellectual property, products and other data and continue to work diligently in this area, there can be no assurance that our precautionary measures will prevent breakdowns, breaches, cyber-attacks or other events. Such events could have a material adverse effect on our reputation, business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending and future intellectual property litigation could be costly and disruptive to us.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in an industry that is susceptible to significant intellectual property litigation and, in recent years, it has been common for companies in the medical device field to aggressively challenge the patent rights of other companies. We are currently the subject of various patent litigation proceedings and other proceedings described in more detail under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Intellectual property litigation is expensive, complex and lengthy and its outcome is difficult to predict. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial condition, results of operation or liquidity. Pending or future patent litigation may result in significant royalty or other payments or injunctions that can prevent the sale of products and may significantly divert the attention of our technical and management personnel. In the event that our right to market any of our products is successfully challenged, we may be required to obtain a license on terms which may not be favorable to us, if at all. If we fail to obtain a required license or are unable to design around a patent, our business, financial condition or results of operations could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending and future product liability claims and other litigation, including private securities litigation, stockholder derivative suits and contract litigation, may adversely affect our financial condition and results of operations or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design, manufacturing and marketing of medical devices of the types that we produce entail an inherent risk of product liability claims. Many of the medical devices that we manufacture and market are designed to be implanted in the human body for long periods of time or indefinitely. A number of factors could result in an unsafe condition or injury to, or death of, a patient with respect to these or other products that we manufacture or sell, including physician technique and experience in performing the surgical procedure, component failures, manufacturing flaws, design defects, off-label use or inadequate disclosure of product-related risks or product-related information. These factors could result in product liability claims, a recall of one or more of our products or a safety alert relating to one or more of our products. Product liability claims may be brought by individuals or by groups seeking to represent a class.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently the subject of product liability litigation proceedings and other proceedings described in more detail under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The outcome of litigation, particularly class action lawsuits, is difficult to assess or quantify. Plaintiffs in these types of lawsuits often seek recovery of very large or indeterminate amounts, including not only actual damages, but also punitive damages. The magnitude of the potential losses relating to these lawsuits may remain unknown for substantial periods of time. In addition, the cost to defend against any future litigation may be significant. Product liability claims, securities and commercial litigation and other litigation in the future, regardless of the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">outcome, could have a material adverse effect on our financial condition, results of operations or liquidity. Additionally, we maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The fact that we do not maintain third-party insurance coverage for all categories of losses increases our exposure to unanticipated claims and adverse decisions and these losses could have a material adverse effect on our financial condition, results of operations or liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to meet regulatory quality standards applicable to our manufacturing and quality processes could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device manufacturer, we are required to register our establishments and list our devices with the FDA and are subject to periodic inspection by the FDA for compliance with its Quality System Regulation requirements, which require manufacturers of medical devices to adhere to certain regulations, including testing, quality control and documentation procedures. In addition, the Federal Medical Device Reporting regulations require us to provide information to the FDA whenever there is evidence that reasonably suggests that a device may have caused or contributed to a death or serious injury or, if a malfunction were to occur, could cause or contribute to a death or serious injury. Compliance with applicable regulatory requirements is subject to continual review and is monitored rigorously through periodic inspections by the FDA which may result in observations on Form&#160;483 and in some cases warning letters that require corrective action. In the European Community, we are required to maintain certain International Standards Organization (ISO)&#160;certifications in order to sell our products and must undergo periodic inspections by notified bodies to obtain and maintain these certifications. Many other countries in which we do business have similar requirements and other foreign governments or agencies may subject us to periodic inspections.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we, or our manufacturers, fail to adhere to quality system regulations or ISO requirements, this could delay production of our products and lead to fines, difficulties in obtaining regulatory clearances, recalls, enforcement actions, including injunctive relief or consent decrees, or other consequences, which could, in turn, have a material adverse effect on our financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We rely on the proper function, availability and security of information technology systems to operate our business and a cyber-attack or other breach of these systems could have a material adverse effect on our business, financial condition or results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We rely on information technology (IT) systems, including technology from third party vendors, to process, transmit and store electronic information in our day-to-day operations. Similar to other large multi-national companies, the size and complexity of our IT systems makes them vulnerable to a cyber-attack, malicious intrusion, breakdown, destruction, loss of data privacy, or other significant disruption. Our information systems require an ongoing commitment of significant resources to maintain, protect and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, the increasing need to protect patient and customer information and changing customer patterns. In addition, third parties have and may continue to attempt to hack into our products to obtain data relating to patients or disrupt performance of our products or to access our proprietary information and the technology from third party vendors that we rely upon may have defects or vulnerabilities which, in turn, create vulnerabilities or disruptions in our system. Cyber attacks continue to evolve in complexity and scope, and inherently may be difficult to detect. We have seen, and could continue to see, vulnerabilities, such as the Log4j vulnerability reported in December 2021, which could affect our systems and the systems of our third-party vendors and business partners</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any failure by us to maintain or protect our information technology systems, products and data integrity, including from cyber-attacks, intrusions or other breaches, could result in the unauthorized access to patient data and personally identifiable information, theft of intellectual property or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations, or, in the worst case, could result in harm to patients. In addition, such attackers may make demands for ransom, which could result in financial loss, or, if we determine not to pay such ransom, other harm, loss, or misappropriation of our data and assets. Such failure, or demonstration of vulnerability to such failure, may also result in additional regulatory scrutiny. We also grow our company through acquisitions and may face risks associated with defects and vulnerabilities in their systems as we work to integrate the acquisitions into our IT system. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., federal and state privacy and security laws require certain parts of our operations to protect the confidentiality of personal information including patient medical records and other health information, and to comply with other requirements with respect to personal data. In Europe, the Data Protection Directive requires us to manage individually identifiable information in the EU and, the General Data Protection Regulation (GDPR) may impose fines of up to four percent of our global revenue. Internationally, some countries have also passed laws that require individually identifiable data on their citizens to be maintained on local servers and that may restrict transfer or processing of that data. We believe that we meet the expectations of applicable regulations and that the ongoing costs and impacts of ensuring compliance with such rules are not material to our business. However, there is no guarantee that we will avoid enforcement actions by governmental bodies or civil actions based on this growing body of regulations. Enforcement actions could be costly and interrupt regular operations of our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business. Any of these events, in turn, may cause us to lose existing customers, have difficulty preventing, detecting and controlling fraud, have disputes with customers, physicians and other healthcare professionals, be subject to legal claims and liability, have regulatory sanctions or penalties imposed, have increases in operating expenses, incur expenses or lose revenues as a result of a data privacy breach or theft of intellectual property, or suffer other adverse consequences, any of which could have a material adverse effect on our business, financial condition or results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and operations are subject to risks related to climate change.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of global climate change present risks to our business. Natural disasters, extreme weather and other conditions caused by or related to climate change could adversely impact our supply chain, including manufacturing and distribution networks, the availability and cost of raw materials and components, energy supply, transportation, or other inputs necessary for the operation of our business. Climate change and natural disasters could also result in physical damage to our facilities as well as those of our suppliers, customers, and other business partners, which could cause disruption in our business and operations or increase costs to operate our business. Additionally, increased environmental regulation, including to address climate change, may result in increases in our costs to operate our business or restrict certain aspects of our activities. The extent and severity of climate change impacts are unknown, and therefore, the scope of potential impact on our business may be difficult to predict and it may be difficult to adequately prepare.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our business could be negatively impacted by corporate social responsibility and sustainability matters.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there has been an increased focus from certain investors, customers, employees, and other stakeholders concerning corporate social responsibility and sustainability matters. From time to time, we announce certain initiatives, including goals, regarding our focus areas, which include environmental matters, responsible sourcing, social investments and diversity, equity and inclusion. We could fail, or be perceived to fail, in our achievement of such initiatives or goals, or we could fail in accurately reporting our progress on such initiatives and goals. Such failures could be due to changes in our business. Moreover, the standards by which corporate social responsibility and sustainability efforts and related matters are measured are developing and evolving, and certain areas are subject to assumptions that could change over time. In addition, we could be criticized for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters. Any such matters, or related corporate social responsibility and sustainability matters, could have a material adverse impact on our future results of operations, financial position and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our world headquarters is located in the U.S, in Marlborough, Massachusetts, with principal regional headquarters located in Singapore and Voisins-le-Bretonneux, France. As of December&#160;31, 2021, we maintained 16 principal manufacturing facilities, including eight in the U.S. and Puerto Rico, three in Ireland, two in Costa Rica, one in Malaysia, one in Brazil and one in Switzerland, as well as various distribution and technology centers around the world. Many of these facilities produce and manufacture products for more than one of our divisions, and also perform research activities. Our products are distributed worldwide from primary customer fulfillment centers in Massachusetts, the Netherlands, and Japan. The following is a summary of our facilities as of December&#160;31, 2021 (in approximate square feet):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,043,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,300,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200,042&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916,968&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117,010&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,243,083</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,174,674</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,417,757</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Includes our principal manufacturing facilities in Minnesota, Ireland, Puerto Rico and one facility in Costa Rica, our manufacturing facility in Malaysia, our primary customer fulfillment centers in Massachusetts, the Netherlands and Japan, and our global headquarters location in Marlborough, Massachusetts.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Includes our principal manufacturing facilities in California, Indiana, Brazil, Switzerland and one in Costa Rica, and our regional headquarters located in Singapore and Voisins-le-Bretonneux, France.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_28"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-Kand incorporated herein by reference.</span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_31"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Market Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal market on which our common stock is traded is the New York Stock Exchange (NYSE)&#160;under the symbol &#8220;BSX.&#8221; </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Holders of Record</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there were 6,226 holders of record of our common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not pay a cash dividend in 2021, 2020 or 2019 on our common stock and currently we do not intend to pay cash dividends on our common stock. We may consider declaring and paying a cash dividend in the future; however, there can be no assurance that we will do so.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see Item 12. "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters" under Part III of this Annual Report on Form 10-K for information on where to find information required by Item 201(d) of Regulation S-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Purchases of Equity Securities by the Issuer and Affiliated Purchases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2013, our Board of Directors approved, and on January 29, 2013, we announced, a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). In 2020, we repurchased approximately $535 million or 15.7 million shares of our common stock under the 2013 share repurchase program, which represented the full amount remaining under that authorization. On December 14, 2020, our Board of Directors approved, and we announced, a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program). We made no share repurchases in 2021 and, as of December&#160;31, 2021, had the full $1.000 billion remaining available under the 2020 share repurchase program. Refer to Note L &#8211; Stockholders' Equity to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional information. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no purchases of equity securities by the issuer or affiliated purchases in the fourth quarter of 2021, required to be reported here.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares the five-year total return to stockholders on our common stock with the return of the Standard &amp; Poor&#8217;s (S&amp;P) 500 Stock Index and the S&amp;P Healthcare Equipment Index. The graph assumes $100 was invested in our common stock and in each of the named indices on December&#160;31, 2016 and that any dividends were reinvested.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><img src="bsx-20211231_g1.jpg" alt="bsx-20211231_g1.jpg" style="height:547px;margin-bottom:5pt;vertical-align:text-bottom;width:588px"/></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note: The stock price performance shown on the graph above is not indicative of future price performance. This graph shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filing. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. RESERVED </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis provides information management believes to be relevant to understanding the financial condition and results of operations of Boston Scientific Corporation and its subsidiaries for the years ended December 31, 2021 and 2020. For a full understanding of our financial condition and results of operations, this discussion should be read in conjunction with our consolidated financial statements and accompanying notes included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our financial condition and results of operations for the year ended December 31, 2019, refer to our previously filed Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the novel strain of coronavirus (SARS-Cov-2), and its disease commonly known as COVID-19 (COVID-19), was reported in China and has since widely impacted the global public health and economic environment. In March 2020, the World Health Organization declared COVID-19, including all additional variations and strains thereof, a global pandemic (COVID-19 pandemic). While the majority of procedures using our products are deferrable, most of the conditions that we treat are generally fairly acute and cannot be deferred for extended periods. As the pandemic spread worldwide, many elective and semi-emergent procedures have been postponed, particularly during the second half of 2020 and first half of 2021, enabling hospital staff to focus critical resources on caring for COVID-19 patients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences continue to be uncertain, the pandemic&#8217;s impact on our operations and financial performance, as well as its impact on our ability to execute our business strategies and initiatives successfully, remains uncertain and difficult to predict. Procedural delays from the further resurgence of COVID-19 infections and the emergence of new, more contagious variant strains of COVID-19, as well as staffing shortages within healthcare facilities, have and may continue to negatively impact demand for our products, net sales, gross profit margin and operating expenses as a percentage of net sales. In addition, conditions created by the COVID-19 pandemic, the economic recovery that has followed in many areas and other macroeconomic factors have led to a challenging labor market in which we compete, which affects our ability to retain and attract new talent as well as put inflationary pressure on certain operational costs due to wage increases. Further, we face and may continue to face, increases in the cost and limited availability of raw materials, components, and other inputs necessary to manufacture and distribute our products due to constraints within the global supply chain, as well as increases in the cost and time to distribute our products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to focus our efforts on the health and safety of patients, healthcare providers and employees, while executing our mission of transforming lives through innovative medical solutions to improve the health of patients around the world. Since the onset of the COVID-19 pandemic, our global crisis management team has focused on protecting our employees and customers, optimizing our operations and securing our supply chain. We have successfully implemented business continuity plans including establishing a medical advisory group for employees, leveraging work from home infrastructure to facilitate social distancing and accelerating capabilities to provide remote physician support. We will continue to be guided by our values and mission and monitor our return-to-office strategy based on science and data for the health and safety of our employees. While we expect the COVID-19 pandemic will continue to negatively impact our performance to an extent, we continue to believe our long-term fundamentals remain strong and we will manage through these challenges with strategic focus and the winning spirit of our global team. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Executive Summary</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Highlights and Trends</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we generated net sales of $11.888 billion, as compared to $9.913 billion&#160;in 2020. This increase of $1.975 billion, or 19.9 percent, included operational growth of 18.7 percent and the positive impact of 130 basis points from foreign currency fluctuations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales included $212 million in 2021 associated with our acquisitions of Preventice Solutions, Inc. (Preventice), Farapulse, Inc. (Farapulse) and the global surgical business of Lumenis, LTD (Lumenis), for which there were no prior period net sales. Operational net sales also included $202&#160;million in 2020 associated with our intrauterine health franchise and the Specialty Pharmaceuticals business, divested in the second quarter of 2020 and first quarter of 2021, respectively. The increase in our net sales was primarily driven by the recovery of elective and semi-emergent procedure volumes compared to the prior year when the COVID-19 pandemic had a more significant impact on our net sales. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business and Market Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section for further discussion of our net sales by global business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders in 2021 was $985 million, or $0.69 per diluted share. Our reported results for 2021 included certain charges and/or credits totaling $1.351 billion (after-tax), or $0.94 per diluted share. Excluding these items, adjusted net income available to common stockholders for 2021 was $2.336 billion, or $1.63 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net loss available to common stockholders in 2020 was $115 million, or $0.08 per diluted share. Our reported results for 2020 included certain charges and/or credits totaling $1.492 billion (after-tax), or $1.04 per diluted share. Excluding these items, adjusted net income for 2020 was $1.378 billion, or $0.96 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational net sales growth rates, which exclude the impact of foreign currency fluctuations and adjusted measures, which exclude certain items required by generally accepted accounting principles in the United States (U.S. GAAP), are not prepared in accordance with U.S. GAAP and should not be considered in isolation from, or as a replacement for, the most directly comparable GAAP measure. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for a discussion of management&#8217;s use of these non-GAAP financial measures. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In May 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. Refer to the reconciliations below for the impact of the MCPS cumulative preferred stock dividends on our calculations of earnings per share (EPS).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of each reconciling item:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,041</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">985</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.69</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.00)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,587</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,391</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,336</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> For 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our consolidated statements of operations, for purposes of calculating GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income (loss) available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. </span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(115)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,411</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> For 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our consolidated statements of operations, for purposes of calculating GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income (loss) available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. We have assumed dilution of 13.8 million common stock equivalents related to employee stock options for all or a portion of the non-GAAP adjustments, which were anti-dilutive for GAAP purposes due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> position.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business and Market Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section describes our results of operations by reportable segment and business unit. For additional information on our businesses and their product offerings, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less invasive technologies. Our net sales of Endoscopy products of $2.141 billion represented 18 percent of our consolidated net sales in 2021. Our Endoscopy net sales increased&#160;$361 million, or 20.3 percent, in 2021, as compared to 2020. This increase included operational net sales growth of 18.9 percent and the positive impact of 130 basis points from foreign currency fluctuations, as compared to 2020. These year-over-year changes were primarily driven by our biliary, single-use imaging, hemostasis and infection prevention franchises due to the recovery of elective and semi-emergent procedure volumes compared to the prior year when the COVID-19 pandemic had a significant negative impact on our net sales. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology and Pelvic Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies. Our net sales of Urology and Pelvic Health products of $1.583 billion represented 13 percent of our consolidated net sales in 2021. Urology and Pelvic Health net sales increased $297 million, or 23.1 percent, in 2021, as compared to 2020. This increase included operational net sales growth of 22.1 percent and the positive impact of 100 basis points from foreign currency fluctuations, as compared to 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales growth included organic net sales growth of 19.2 percent in 2021 and the net positive impact of 280 basis points due to our Lumenis, LTD. (Lumenis) acquisition less the impact of the divestiture of the Intrauterine Health business in the second quarter of 2020. In the third quarter of 2021, we completed the acquisition of the global surgical business of Lumenis, a privately-held company that develops and commercializes energy-based medical solutions, including innovative laser systems, fibers and accessories used for urology and otolaryngology procedures. Organic net sales growth was driven by our stone management and prostate health franchises and prosthetic urology franchise due to the recovery of elective and semi-emergent procedure volumes compared to the prior year when the COVID-19 pandemic had a significant negative impact on our net sales. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rhythm and Neuro</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiac Rhythm Management</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiac Rhythm Management (CRM) business develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. Our net sales of CRM products of $2.019 billion represented 17 percent of our consolidated net sales in 2021. Our net sales of CRM products increased $315 million, or 18.5 percent, in 2021, as compared to 2020. This increase included operational net sales growth of 17.1 percent and the positive impact of 140 basis points from foreign currency fluctuations, as compared to 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales growth included organic net sales growth of 7.7 percent in 2021 and the positive impact of 950 basis points from the acquisition of Preventice Solutions, adding to our CRM business a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. Organic sales growth was attributable to our defibrillator and pacemaker franchises, due to the recovery of semi-emergent and emergent procedure volumes compared to the prior year when the COVID-19 pandemic had a significant negative impact on our net sales, as well as our cardiac diagnostics franchise, led by our ICM system.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrophysiology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Electrophysiology business develops and manufactures less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Our net sales of Electrophysiology products of $365 million represented three percent of our consolidated net sales in 2021. Our Electrophysiology net sales increased $79 million, or 27.4 percent, in 2021, as compared to 2020. This increase included operational net sales growth of 25.8 percent and the positive impact of 160 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis points from foreign currency fluctuations, as compared to 2020. Operational net sales growth was primarily driven by the recovery of elective procedure volumes compared to the prior year when the COVID-19 pandemic had a significant negative impact on our net sales, as well as the success of our ongoing POLARx&#8482; Cryoablation System and Stablepoint Force-Sensing Catheter international launches in Europe and Japan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Our net sales of Neuromodulation products of $909 million represented eight percent of our consolidated net sales in 2021. Neuromodulation net sales increased $148 million, or 19.5 percent, in 2021, as compared to 2020. This increase included operational net sales growth of 18.6 percent and the positive impact of 90 basis points from foreign currency fluctuations, as compared to 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales growth was primarily driven by our spinal cord stimulation (SCS) systems, led by our next generation WaveWriter Alpha&#8482; SCS System and our deep brain stimulation (DBS) systems, including our Vercise Genus&#8482; DBS System, due to the recovery of elective procedure volumes in the first half of 2021 compared to the prior year when the COVID-19 pandemic had a more significant negative impact on our net sales. During the second half of 2021, procedure volumes continued to be negatively impacted by the COVID-19 pandemic due to their elective nature.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Cardiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Interventional Cardiology business develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Our net sales of Interventional Cardiology products of $3.038 billion represented 26 percent of our consolidated net sales in 2021. Our Interventional Cardiology net sales increased $739 million, or 32.2 percent, in 2021, as compared to 2020. This increase included operational net sales growth of 30.7 percent and the positive impact of 150 basis points from foreign currency fluctuations, as compared to 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales growth was driven by our WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device, our percutaneous coronary intervention guidance (PCIG) franchise, our complex PCI product offerings, and our drug-eluting stent (DES) systems due to the recovery of procedure volumes compared to the prior year when the COVID-19 pandemic had a significant negative impact on our net sales. In addition, growth was positively impacted by $179 million in reserves recorded in the second half of 2020 primarily related to our conversion to a consignment inventory model for our LAAC franchise with the launch of our WATCHMAN FLX&#8482; Device in the U.S. These increases were partially offset by the discontinuation of our LOTUS Edge&#8482; Aortic Value System in the fourth quarter of 2020, general price declines associated with our DES systems and the unfavorable impact of China tender pricing on both DES systems and balloon catheter net sales following a reduction in prices in the first quarter of 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. In the third quarter of 2019, we completed the acquisition of BTG plc (BTG). We integrated BTG's Interventional Medicine (IM) portfolio into our Peripheral Interventions division, adding complementary technologies in the areas of venous disease and interventional oncology. Our net sales of Peripheral Interventions products of $1.820 billion represented 15 percent of our consolidated net sales in 2021. Our Peripheral Interventions net sales increased $243 million, or 15.4 percent, in 2021, as compared to 2020. This increase included operational net sales growth of 14.2 percent and the positive impact of 120 basis points from foreign currency fluctuations, as compared to 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales growth was primarily driven by the Interventional Oncology franchise, including our TheraSphere&#8482; Y-90 Radioactive Glass Microspheres, which received U.S. Food and Drug Administration approval in the first quarter of 2021 after 20 years as a humanitarian exemption (HDE) device. In addition, growth was driven by our drug-eluting portfolio, including the Eluvia&#8482; Drug-Eluting Stent and Ranger&#8482; Drug-Coated Balloon due to the recovery of procedure volumes compared to the prior year when the COVID-19 pandemic had a significant negative impact on our net sales, as well as continued worldwide commercial execution and adoption in recently approved countries. In the first quarter of 2021, we received approval from Japan's Ministry of Health, Labor and Welfare (MHLW) for Ranger&#8482; and initiated a full launch.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Pharmaceuticals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business for a purchase price of approximately $800 million. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic imperative to drive global expansion, described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form 10-K, we are seeking to grow net sales and market share by expanding our global presence, including in Emerging Markets. We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. We have increased our investment in infrastructure in these countries in order to maximize opportunities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation. Our Emerging Markets net sales represented 12 percent of our consolidated net sales in 2021 and 11 percent in 2020. In 2021, our Emerging Markets net sales grew 25.5 percent on a reported basis including operational net sales growth of 22.3 percent and the positive impact of 320 basis points from foreign currency fluctuations, as compared to 2020. Operational net sales growth was driven primarily by our net sales in China, which have largely recovered from the impact of the COVID-19 pandemic on procedural volumes. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Sales</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides our net sales by business and the relative change in growth on a reported basis: </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 versus 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 versus 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93.9)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.2%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7.7)%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Summary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion of our net sales and a comparison of our 2021 and 2020 net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we generated net sales of $9.913 billion, as compared to $10.735 billion in 2019. This decrease of $823 million, or 7.7 percent, included operational declines of 7.8 percent and the positive impact of 10 basis points from foreign currency fluctuations. Operational net sales included $413 million in 2020 associated with our acquisition of Vertiflex, Inc. (Vertiflex) for the period prior to June 2020 and our acquisition of BTG plc (BTG) for the period prior to mid-August 2020, for both of which there were no prior period net sales. Operational net sales also included $41 million in 2019 associated with our global embolic microspheres portfolio, for which there were no comparable period sales in 2020 following our divestiture in the third quarter of 2019, and our intra-uterine health business, for which there were no comparable period sales in 2020 following our divestiture in the second quarter of 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit was $8.177 billion in 2021 and $6.448 billion in 2020. As a percentage of net sales, our gross profit increased to 68.8 percent in 2021, as compared to 65.0 percent in 2020. The following is a rollforward of our gross profit margins and a description of the drivers of the change from period to period:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit Margin</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.0%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing, volume and mix</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abnormal production variances</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WATCHMAN FLX&#8482; transition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOTUS Edge&#8482; discontinuation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other period expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.0%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing, volume and mix</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year abnormal production variances</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year LOTUS Edge&#8482; discontinuation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other period expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.8%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary factors contributing to the increase in our gross profit margin for 2021 as compared to 2020 were higher sales volumes and favorable product mix associated with the resumption of the procedures using higher-margin products following reduced elective procedure volumes due to the COVID-19 pandemic. In addition, our gross profit margin in 2020 was negatively impacted by abnormal production variances attributable to manufacturing plant shut-downs, inventory charges related to the discontinuation of our LOTUS platform and sales return reserves due to our WATCHMAN FLX&#8482; consignment conversion. These improvements were partially offset by price declines related primarily to sales of our coronary drug-eluting stent systems and foreign currency fluctuations. In addition, macro-environment factors have negatively impacted our gross profit margin, including the cost of operating manufacturing plants with COVID-19 specific health and safety measures and increases in costs of certain raw materials, direct labor and freight. We expect our gross margin to continue to be negatively impacted in 2022 while these factors persist. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant factor contributing to the decrease in our gross profit margin for 2020 as compared to 2019 was manufacturing costs of $149 million associated with abnormally low production levels resulting from manufacturing plant shutdowns and reduced operations. In addition, we recorded $119 million of inventory charges associated with the global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System and discontinuation of the LOTUS platform. Our gross margin was further negatively impacted in 2020 due to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device. In addition, the unfavorable product mix due to the deferral of procedures using higher-margin products, price declines related primarily to sales of our coronary drug-eluting stent products, excess and obsolete inventory charges due to lower forecasted demand for certain of our products as well as the amortization of the inventory fair value step up recorded in connection with our acquisition of BTG contributed to a decrease in gross margin. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EU MDR Implementation Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Union Medical Device Regulation (EU MDR) replaced the existing European Medical Devices Directive (MDD) regulatory framework, and manufacturers of medical devices were required to comply with EU MDR beginning in May 2021 for new product registrations and by May 2024 for medical devices which have a valid CE Certificate to the prior Directives (issued before May 2021).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the adoption of EU MDR to be a significant change to a regulatory framework, and therefore, certain incremental costs specific to complying with EU MDR for previously registered products are not considered to be ordinary course </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenditures in connection with regulatory matters. As such, certain of these costs are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance. We began our implementation efforts in late 2019 and incurred associated expenses of $83 million in 2021 and $51 million in 2020. We expect to incur total expenses of approximately $250 million to $300 million over the five year implementation period, which will be recorded primarily within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our operating expenses:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:35.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative (SG&amp;A) Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $572 million, or 15 percent, as compared to 2020 and were 150 basis points lower as a percentage of net sales. The increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was due primarily to higher selling costs driven by higher global net sales and the targeted lifting of spending controls implemented in 2020 in response to the escalating COVID-19 pandemic. In addition, SG&amp;A expenses in 2021 were further impacted by higher restructuring-related spend and acquisition-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $154 million, or 4 percent, as compared to 2019 and were 150 basis points higher as a percentage of net sales. The decrease in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was primarily due to our efforts to reduce expenditures to minimize the impact of the COVID-19 pandemic on our results of operations. We implemented several cost reduction initiatives, including decreases in travel, meetings and customer events, hiring and other variable spending. We also implemented a temporary four-day work week for many employees globally and reduced employee compensation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development (R&amp;D) Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to advancing medical technologies and investing in meaningful research and development projects across our businesses. In 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $61 million, or 5 percent, as compared to 2020, and were 140 basis points lower as a percentage of net sales. We expect to continue to make investments across our businesses in order to maintain a pipeline of new products that we believe will contribute to profitable sales growth. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> decreased $31 million, or 3 percent, as compared to 2019, and were 60 basis points higher as a percentage of sales as a result of investments across our businesses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $3 million, or 8 percent, as compared to 2020 and was 10 basis points lower as a percentage of net sales primarily due to global net sales growth in 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $20 million, or 31 percent, as compared to 2019 and was 10 basis points lower as a percentage of net sales. The decrease relates primarily to the expiration of certain royalty agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our other operating expenses, which are excluded by management for purposes of evaluating operating performance, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further description of certain operating expenses:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:56.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of businesses and assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $48 million, or 6 percent, as compared to 2020. The decrease was driven by the divestiture of the Specialty Pharmaceuticals business partially offset by the addition of amortizable intangible assets associated with our recent acquisitions. In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $90 million, or 13 percent, as compared to 2019. The increase was driven by an increase in the balance of amortizable intangible assets due to acquisitions, including BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $73 million related to the execution of a definitive agreement to sell our Specialty Pharmaceuticals business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional information and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of key assumptions used in our goodwill impairment testing and future events that could have a negative impact on the recoverability of our goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Asset Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $370 million, primarily associated with intangible assets established in connection with our acquisitions of Millipede, Inc. and VENITI, Inc. In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $460 million, primarily associated with intangible assets established in connection with our acquisitions of Sadra Medical, Inc., Apama Medical Inc. and nVision Medical Corporation (nVision). Each of these impairment charges were recorded following management&#8217;s decision to cancel the programs due to the length of time, and remaining cost, to complete and commercialize the technology; the cost to remediate quality issues; or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of key assumptions used in our intangible asset impairment testing and future events that could have a negative impact on the recoverability of our intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Net Expense (Benefit)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To recognize changes in the fair value of our contingent consideration liability, we recorded net benefits of $136 million and $100 million in 2021 and 2020, respectively. The net benefits related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or, in the case of Millipede and nVision, for milestones that would not be achieved due to management's discontinuation of the associated R&amp;D program. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional details related to our contingent consideration arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Net Charges (Credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, our Board of Directors approved, and we committed to, a global restructuring program (the 2019 Restructuring Plan). In addition, on February 22, 2022, we increased and our Board of Directors approved cost estimates to complete additional activities identified under the program. The 2019 Restructuring Plan is expected to result in total pre-tax charges of approximately $425 million to $525 million and approximately $375 million to $475 million of these charges are expected to result in cash outlays. We expect the majority of activity associated with our 2019 Restructuring Plan to be substantially complete by the end of 2022. A substantial portion of the savings are being reinvested in strategic growth initiatives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring and restructuring-related net charges pursuant to this program were $172 million in 2021 and $116&#160;million in 2020. In addition, on November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS&#8482; Valve platform. We recorded restructuring and restructuring-related net charges associated with the product discontinuation of $20 million in 2021 and $55 million in 2020. The restructuring activities were completed in 2021 and resulted in total pre-tax restructuring and restructuring-related net charges of approximately $80 million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional details on our restructuring plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related Net Charges (Credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $430 million in 2021, primarily related to ongoing litigation associated with our transvaginal surgical mesh products principally in the U.S. and Australia, as well as anticipated legal fees to defend certain other legal matters. We increased the accrual associated with transvaginal mesh claims to account for increased settlement and litigation activity related to the remaining cases and claims we face, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity and changes to our expectations regarding the rate of incoming cases and claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $278 million in 2020, primarily related to transvaginal surgical mesh product litigation, inclusive of a reserve related to claims made by a coalition of state attorneys general, which has since been settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation, and therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with the financial covenant required by our credit agreements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional discussion of our material legal proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Gain on disposal of businesses and assets</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gains on disposal of businesses and assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $78 million in 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gain related primarily to the sale of certain intellectual property, as well as subsequent adjustments associated with the divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our global embolic microspheres business in 2019, our intrauterine health business in 2020, and Specialty Pharmaceutical business in 2021. We did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gains (losses) on disposal of businesses and assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2020. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and average borrowing rate:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average borrowing rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased and our average borrowing rate remained flat in 2021, as compared to the prior year, primarily due to refinancing short-term, floating rate debt to long-term fixed rate senior notes during the second quarter of 2020 as well as a lower balance of outstanding debt, due to prepayments made in the fourth quarter of 2020. Interest expense and our average borrowing rate decreased in 2020, as compared to 2019, primarily due to our euro-denominated senior notes offering in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2019, which carry lower interest rates than the senior notes we partially repaid with proceeds from the offering. In addition, in 2019, we incurred debt extinguishment charges of $86 million presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations associated with repayments of debt using proceeds from our November 2019 offering. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in this Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note E &#8211; Hedging Activities and Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for information regarding our debt obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other, net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign currency gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, in connection with our acquisitions of Farapulse, Preventice and Devoro Medical, Inc. we remeasured the fair value of our previously-held interests in the acquired companies, which resulted in $475 million of gains recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we recorded a loss of $178 million in 2021, and a gain of $363 million in 2020 on our investment in Pulmonx Corporation (Pulmonx) presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the remeasurement of our investment to fair value based on observable market prices, as well as the disposition of our remaining ownership.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains on previously held interests are included within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Acquisition/divestiture-related net charges (credits) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the Pulmonx net gain (loss) is included in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Investment portfolio net losses (gains)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the reconciliation and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of management's use of non-GAAP financial measures.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_52"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rate</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our reported tax rate:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of certain receipts/charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;These receipts/charges are taxed at different rates than our effective tax rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rate for 2021, as compared to 2020, relates primarily to the jurisdictional mix of earnings and the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include acquisition/divestiture-related net charges, restructuring and restructuring-related net charges, litigation-related net charges, as well as certain discrete tax items primarily related to the resolution of an Internal Revenue Service (IRS) audit, as explained below, tax windfall benefits associated with share-based payments, and impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act, enacted on March 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91&#160;million to release the reserves related to these years. We received a refund of $62&#160;million from the IRS reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we did not apply for government loans, we took advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional details on our tax rate.</span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_55"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current business plan, we believe our existing balance of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, future cash generated from operations, access to capital markets and existing credit facilities will be sufficient to fund our operations, invest in our infrastructure, pay our legal-related liabilities, pay taxes due, service and repay our existing debt and fund possible acquisitions for the next 12 months and for the foreseeable future. On February 14, 2022, we funded the acquisition of Baylis Medical Company, Inc. for $1.750 billion using cash on hand. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for additional details on our future payment obligations and commitments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of December&#160;31, 2021 or December&#160;31, 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, due to the uncertainty of the impact of the COVID-19 pandemic on our business, we took proactive steps to reduce costs and ensure we remained in a strong position to support customers and patients as healthcare systems recovered and elective and semi-emergent procedures resumed. These actions included taking steps to manage outstanding borrowings and increase available liquidity, preemptively amending our financial covenant requirement for our outstanding credit arrangements, implementing significant cost reductions and slowing planned capital expenditures. We also created a cross-functional strategic cash management team to take appropriate actions to ensure we continue to optimize funds to execute our core mission. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $1.925 billion of unrestricted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on hand, comprised of $1.632 billion invested in money market funds and time deposits and $293 million in interest bearing and non-interest-bearing bank accounts. We invest excess cash on hand in short-term financial instruments that earn at market interest rates while mitigating principal risk through instrument and counterparty diversification, as well as what we believe to be prudent instrument selection. We limit our direct exposure to securities in any one industry or issuer. As of&#160;December&#160;31, 2021, we had no commercial paper debt outstanding, resulting in an additional $2.750 billion of available liquidity.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional details related to our debt obligations, including our financial covenant requirement, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K, which is incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a summary and description of our net cash inflows (outflows):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, cash provided by operating activities increased $362 million, as compared to 2020. This increase was primarily due to comparatively higher net sales and operating income compared to the same period in the prior year. In 2020, cash provided by operating activities decreased $328 million, as compared to 2019. This decrease was primarily due to revenue declines resulting from the COVID-19 pandemic, partially offset by implementation of spend controls. In addition, included in 2020 was a settlement payment related to litigation with Channel Medsystems, Inc., whereas 2019 included a litigation-related receipt of $180 million from Edwards Lifesciences Corporation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, cash used for investing activities primarily included payments for acquisitions of $2.258 billion and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchases of property, plant and equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and internal use software</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $554 million partially offset by proceeds of $826 million from the divestiture of the Specialty Pharmaceuticals business, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from investments and acquisitions of certain technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $279 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Proceeds from royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $82 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, cash used for investing activities primarily included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchases of property, plant and equipment and internal use software</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $376 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for investments and acquisitions of certain technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $146 million, partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $87 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, cash used by financing activities primarily included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $85 million and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash dividends paid on preferred stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $55 million partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $110 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our cash flows provided by financing activities reflect issuances and repayments of debt, including our senior notes, term loans, commercial paper program and 2021 Revolving Credit Facility as well as net proceeds from issuances of our common stock and preferred stock in connection with public offerings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for repurchase of common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our financing activities included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payment of contingent consideration previously established in purchase accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $15 million in 2021 and $49 million in 2020 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $85 million in 2021 and $97 million in 2020. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity plans are subject to a number of risks and uncertainties, including those described in Item 1A. Risk Factors of this Annual Report on Form 10-K, some of which are outside our control. Macroeconomic conditions, adverse tax and litigation matter outcomes and other risks and uncertainties could limit our ability to successfully execute our business plans and adversely affect our liquidity plans.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the current and long-term portions of our total debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:61.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the portions of our total debt that are comprised of fixed and variable rate debt instruments, which are presented on an amortized cost basis:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:61.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate debt instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable rate debt instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through December&#160;31, 2021, we were in compliance with the financial covenant required by the credit facilities described above. For additional details related to our debt obligations, including our financial covenant requirements, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. On May 27, 2020, we also completed an offering of 29,382,500 shares of our common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, during 2021 we received $110 million in proceeds from stock issuances related to our stock option and employee stock purchase plans, as compared to $111 million in 2020. Proceeds from the exercise of employee stock options and employee stock purchases vary from period to period based upon, among other factors, fluctuations in the trading price of our common stock and in the exercise and stock purchase patterns of employees. Stock-based compensation expense related to our stock ownership plans was $194 million in 2021 and $170 million in 2020. Stock-based compensation expense varies from period to period based upon, among other factors, the timing, number and fair value of awards granted during the period, forfeiture levels related to unvested awards and employee contributions to our employee stock purchase plan, as well as the retirement eligibility of stock award recipients. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $535 million in cash, which represented the full amount remaining under that authorization. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during 2021 and as of December&#160;31, 2021, we had the full amount remaining available under the 2020 share repurchase program. There were approximately 263 million shares in treasury as of December&#160;31, 2021 and 263 million shares in treasury as of December&#160;31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contractual Obligations and Commitments</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal reserves</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One-time transition tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,597</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">791</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,495</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,135</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   Debt obligations are comprised of our senior notes outstanding as of December 31, 2021. This does not include unamortized debt issuance discounts, deferred financing costs and gain on fair value hedges or finance lease obligations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional information.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    In accordance with U.S. GAAP, these obligations relate primarily to expenses associated with future periods and, with the exception of $83 million of accrued interest, are not reflected in our consolidated balance sheet as of December 31, 2021. Interest payments included above are calculated based on rates and required fees applicable to our outstanding debt obligations as of December 31, 2021 described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report. Interest payments above do not include interest on variable rate debt instruments.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing of payment for our long-term liability for legal matters that are probable and estimable of $284 million is uncertain and as such it is excluded from the table above. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for more information,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in the table above with respect to purchase obligations relate primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above does not include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any future obligations to make payments of contingent consideration pursuant to certain of our acquisition agreements, due to the exact amount and timing of payments being uncertain. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for more information,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Adjustments to increase our estimated one-time transition tax totaling $91 million, which are pending review by the U.S. Internal Revenue Service (IRS), and unrecognized tax benefits, accrued interest and penalties and other related items totaling $103 million because the timing of their future cash settlement is uncertain. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for more information,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With certain of our acquisitions, we acquired IPR&amp;D projects that require future funding to complete. We estimate that the total remaining cost to complete acquired IPR&amp;D projects is between $40 million and $50 million. Net cash inflows from the projects currently in development are expected to continue through 2039, following the respective launches of these technologies in the U.S., Europe and Japan. Certain of our acquisitions also involve the potential payment of contingent consideration, but the timing and amounts are uncertain. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for more information,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Holders of our MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations, and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical) for an upfront cash payment of $1.750 billion. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional information. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our material legal proceedings see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.</span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_58"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results are affected by the selection and application of accounting policies and methods. We have adopted accounting policies to prepare our consolidated financial statements in conformity with U.S. GAAP. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, including our contingent liabilities, as of the date of our financial statements and the reported amounts of our revenues and expenses during the reporting periods. Our actual results may differ from these estimates. We consider estimates to be critical (i)&#160;if we are required to make assumptions about material matters that are uncertain at the time of estimation or (ii) if materially different estimates could have been made or it is reasonably likely that the accounting estimate will change from period to period. The following are areas considered to be critical and require management&#8217;s judgment: Revenue Recognition, Bad Debt Reserves, Inventory Provisions, Valuation of Intangible Assets and Contingent Consideration Liability, Goodwill Valuation, Legal and Product Liability Accruals and Income Taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional information related to our accounting policies and our consideration of these critical accounting areas. </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiac Rhythm Management (CRM) business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. The use of alternative assumptions could impact the period over which revenue is recognized.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers and record these as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers to ensure the safe and effective use of certain implanted devices. We forward accrue the costs to provide these services at the time the devices are sold by estimating the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory Provisions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Valuation of Intangible Assets and Contingent Consideration Liability</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. Further, for those arrangements that involve potential future contingent consideration, we record on the date of acquisition a liability equal to the fair value of the estimated additional consideration we may be obligated to pay in the future. We re-measure this liability each reporting period and record changes in the fair value through a separate line item within our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, cash flows, discount rates, useful life or probability of achieving clinical, regulatory or revenue-based milestones could result in different purchase price allocations and recognized amortization expense and contingent consideration expense or benefit in current and future periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or adjustment to the remaining useful life. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. If the carrying value of the intangible asset is determined not recoverable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we will write the carrying value down to fair value in the period the impairment is identified. We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset using a risk-adjusted discount rate. The use of alternative assumptions, including estimated cash flows, discount rates and alternative estimated remaining useful lives could result in different calculations of impairment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we test our indefinite-lived intangible assets at least annually for impairment and reassess their classification as indefinite-lived assets, or more frequently if indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 350)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to fair value. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, cash flows and discount rates could result in different fair value estimates. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill Valuation</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. We performed our annual goodwill impairment test for all of our reporting units and concluded that the fair value of each reporting unit exceeded its carrying value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. We identified the following reporting units in our 2021 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we utilized the quantitative assessment approach to test all of our reporting units. In addition, we assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors. After assessing the totality of events, when performing our annual goodwill impairment test, we determined that it was more likely than not that the fair value of each of our reporting units had sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When allocating goodwill from business combinations to our reporting units, we assign goodwill to the reporting units that we expect to benefit from the respective business combination at the time of acquisition. In addition, for purposes of performing our goodwill impairment tests, assets and liabilities, including corporate assets, which relate to a reporting unit&#8217;s operations, and would be considered in determining its fair value, are allocated to the individual reporting units. We allocate assets and liabilities not directly related to a specific reporting unit, but from which the reporting unit benefits, based primarily on the respective revenue contribution of each reporting unit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing annual impairment assessments, when a quantitative test is performed, we typically use only the income approach, specifically the Discounted Cash Flow method, to derive the fair value of each of our reporting units in preparing our goodwill impairment assessments. We historically selected this method as being the most meaningful in preparing our goodwill assessments because we believe the income approach most appropriately measures our income producing assets. We have considered using the market approach and cost approach but concluded they are not appropriate in valuing our reporting units given the lack of relevant market comparisons available for application of the market approach and the inability to replicate the value of the specific technology-based assets within our reporting units for application of the cost approach. Therefore, we believe that the income approach represents the most appropriate valuation technique for which sufficient data are available to determine the fair value of our reporting units.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In applying the income approach to our accounting for goodwill, we make assumptions about the amount and timing of future expected cash flows, terminal value growth rates and appropriate discount rates. The amount and timing of future cash flows within our Discounted Cash Flow analysis is based on our most recent operational budgets, long range strategic plans and other estimates. The terminal value growth rate reflects our best estimates for stable, perpetual growth of our reporting units. We use estimates of market-participant risk-adjusted weighted average cost of capital as a basis for determining the discount rates to apply to our reporting units&#8217; future expected cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we use consistent methodologies in developing the assumptions and estimates underlying the fair value calculations used in our impairment tests, these estimates are uncertain by nature and can vary from actual results. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, cash flows and discount rates could result in different fair value estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future events that could have a negative impact on the levels of excess fair value over carrying value of our reporting units include, but are not limited to, the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in estimated market sizes or market growth rates due to greater-than-expected declines in procedural volumes inclusive of those resulting from the ongoing COVID-19 pandemic, pricing pressures, reductions in reimbursement levels, product actions and/or competitive technology developments, </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">declines in our market share and penetration assumptions due to increased competition, an inability to develop or launch new and next-generation products and technology features in line with our commercialization strategies and market and/or regulatory conditions that may cause significant launch delays or product recalls, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in our forecasted profitability due to an inability to implement successfully and achieve timely and sustainable cost improvement measures consistent with our expectations, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative developments in intellectual property litigation that may impact our ability to market certain products or increase our costs to sell certain products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of success of ongoing and future research and development efforts, including those related to acquisitions and increases in the research and development costs necessary to obtain regulatory approvals and launch new products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of success in managing the growth of acquired companies, achieving sustained profitability consistent with our expectations, establishing government and third-party payer reimbursement, supplying the market and increases in the costs and time necessary to integrate acquired businesses into our operations successfully, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our reporting units or in the structure of our business as a result of future reorganizations, acquisitions or divestitures of assets or businesses and </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in our market-participant risk-adjusted weighted average cost of capital (WACC) and increases in our market-participant tax rate and/or changes in tax laws or macroeconomic conditions.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative changes in one or more of these factors, among others, could result in future impairment charges.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal and Product Liability Accruals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities litigation and product liability suits. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. Litigation and product liability matters are inherently uncertain, and the outcomes of individual matters are difficult to predict and quantify. As such, significant judgment is required in determining our legal and product liability accruals. Our estimates related to our legal and product liability accruals may change as additional information becomes available to us, including information related to the nature or existence of claims against us, trial court or appellate proceedings, and mediation, arbitration or settlement proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We establish reserves when we believe that certain positions are likely to be challenged despite our belief that our tax return positions are fully supportable. The calculation of our tax liabilities involves significant judgment based on individual facts, circumstances and information available in addition to applying complex tax regulations in various jurisdictions across our global operations. Under U.S. GAAP, in order to recognize an uncertain tax benefit, the taxpayer must determine it is more likely than not the position will be sustained, and the measurement of the benefit is calculated as the largest amount that is more than 50 percent likely to be realized upon resolution of the benefit. Although we believe that we have adequately provided for liabilities resulting from tax assessments by taxing authorities, positions taken by these tax authorities could have a material impact on our effective tax rate, results of operations, financial position and/or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Tax Cut and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as a part of continuing operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for additional information on standards implemented during 2021 and standards to be implemented.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Sustainability</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sustainable environmental, social and governance practices underpin all aspects of our global business. Our approach is aligned with the United Nations Sustainable Development Goals and our material topics and practices are informed by a broad range of internal and external stakeholders &#8211; locally, nationally and globally. Our employees around the world work with suppliers and other organizations that share our commitment to these practices that help address issues related to health inequity, economic disparity, climate change and environmental protection. These efforts are supported by our cross-functional Corporate Social Responsibility Steering Committee, our Corporate Social Responsibility Council, our Environmental Health and Safety teams and policies, our Global Council for Inclusion, as well as our local, regional and national employee and community engagement programs. In addition, our Executive Committee performance is measured, among other things, against global gender and U.S. (inclusive of Puerto Rico) multicultural goals and performance against annual renewable energy and recycling index goals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also making measurable progress toward shaping a better future for our planet by proactively addressing energy consumption, carbon emissions and waste management. We have committed to a goal of carbon neutrality in our manufacturing and key distribution sites by 2030. Our Environment, Health &amp; Safety (EH&amp;S) Center of Excellence is responsible for rigorously measuring, assessing and reporting progress toward these goals globally. We are focused on a &#8220;C3&#8221; strategy: Cutting energy use, Converting to renewable energy sources and Compensating with carbon offset projects where needed. Our Corporate Headquarters, U.S. distribution center and our manufacturing plant in Puerto Rico all utilize solar energy from on-site installations. Our goal is to fully source or generate electricity from renewable sources by 2024, and by 2027, our goal is that 90 percent of all energy used across our facilities, including electricity and natural gas, will be from renewable sources, representing an important milestone toward our 2030 carbon neutrality commitment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained ISO 50001:2018 - Energy Management Systems certification for our Corporate headquarters in Marlborough, Massachusetts, our U.S. distribution center in Quincy, Massachusetts and our manufacturing plant in Spencer, Indiana. This brings the total number of ISO 50001:2018 certified sites in our global network to nine. We have also obtained ISO 14001:2015 - Environment Management Systems certification at our major manufacturing plants and Tier 1 distribution centers around the world, as well as our Corporate headquarters in Marlborough, Massachusetts. Additionally, we have obtained ISO 45001:2018 Occupational Health and Safety Management System at four of our manufacturing sites. ISO 45001:2018, ISO 50001:2018 and ISO 14001:2015 are globally recognized standards for employee Occupational Health and Safety, Environmental and Energy Management Systems, established by the International Standards Organization, which provide a voluntary framework to identify key occupational health and safety, environmental and energy aspects associated with our business. Using these management systems and the specific attributes of our certified locations in the U.S., Ireland, Costa Rica and the Netherlands, we continue to improve our environmental performance and reduce our environmental footprint. We also have 16 Leadership in Energy and Environmental Design (LEED) certified buildings on campuses in the U.S., Latin America, Europe and Asia. LEED is an internationally recognized certification program that seeks to ensure the mindful development, construction and maintenance of buildings in a way that benefits occupants and the environment by reducing waste and conserving resources.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we were proud to be the recipient of multiple awards that placed us in a select group of companies with a demonstrated commitment to responsible business practices and sound social and environmental policies. We were selected for inclusion in the 2021 Dow Jones Sustainability North America Index, comprised of sustainability leaders identified by S&amp;P based on performance across long-term environmental, social and governance and economic criteria. We were also honored to be the recipient of multiple Diversity, Equity an Inclusion (DE&amp;I) awards, as detailed within Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established controls and procedures to escalate enterprise level issues, including cybersecurity matters, to the appropriate management levels within our organization and our Board of Directors, or members or committees thereof, as appropriate. Under our framework, cybersecurity issues, including those involving vulnerabilities introduced by our use of third-party software, are analyzed by subject matter experts and a crisis committee for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to our financial results, operations, and/or reputation are immediately reported by management to the Board of Directors, or individual members or committees thereof, as appropriate, in accordance with our escalation framework. In addition, we have established procedures to ensure that members of management responsible for overseeing the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effectiveness of disclosure controls are informed in a timely manner of known cybersecurity risks and incidents that may materially impact our operations and that timely public disclosure is made, as appropriate.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share that exclude certain amounts, and operational net sales, which exclude the impact of foreign currency fluctuations. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share we exclude certain charges (credits) from GAAP net income and GAAP net income available to common stockholders as detailed below. Amounts are presented after-tax using our effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with FASB ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GAAP financial measure most directly comparable to adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) available to common stockholders and GAAP net income (loss) per common share - assuming dilution, respectively.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. The GAAP financial measure most directly comparable to operational net sales and operational net sales growth is net sales and net sales growth on a GAAP basis. </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the relevant sections of this Annual Report on Form 10-K.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) available to common stockholders adjusted net income (loss) per share that exclude certain amounts, and operational net sales growth rates that exclude the impact of changes in foreign currency exchange rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an explanation of each of the adjustments that management excluded as part of these non-GAAP financial measures as well as reasons for excluding each of these individual items. In each case, management has excluded the item for purposes of calculating the relevant non-GAAP financial measure to facilitate an evaluation of our current operating performance and a comparison to our past operating performance:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted Net Income (loss), Adjusted Net Income (loss) Available to Common Stockholders and Adjusted Net Income (loss) per Share</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Amortization expense&#160;- We record intangible assets at historical cost and amortize them over their estimated useful lives. Amortization expense is excluded from management's assessment of operating performance and is also excluded from our operating segments' measures of profit and loss used for making operating decisions and assessing performance. </span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Goodwill and other intangible asset impairment charges&#160;- These amounts represent write-downs of certain goodwill and/or other intangible asset balances. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment and test our goodwill and other indefinite-lived intangible assets at least annually for impairment. If we determine the carrying value of the amortizable intangible asset is not recoverable, goodwill of a reporting unit is impaired or it is more likely than not that the indefinite-lived asset is impaired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we will write the carrying value down to fair value in the period identified. Impairment charges are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Acquisition/divestiture-related net charges (credits) - These adjustments may consist of (a) contingent consideration fair value adjustments; (b) gains on previously held investments; (c) due diligence, deal fees and other fees and costs related to our acquisition and divestiture transactions; (d) inventory step-up amortization and accelerated compensation expense; (e) integration and exit costs; and (f) separation costs and gains or losses primarily associated with the sale of a business or portion of a business. The contingent consideration fair value adjustments represent accounting adjustments to state contingent consideration liabilities at their estimated fair value. These adjustments can be highly variable depending on the assessed likelihood and amount of future contingent consideration. Gains on previously held investments, due diligence, deal fees and other fees and costs, inventory step-up amortization, accelerated compensation expense, and other expenses and gains or losses associated with divestitures or acquisitions can be highly variable and not representative of ongoing operations. Integration, separation and exit costs, include contract cancellations, severance and other compensation-related charges and costs, project management fees and costs, and other direct costs associated with the integration of our acquisitions or separation of our divested businesses. These integration, separation and exit activities take place over a defined timeframe and have distinct project timelines, are incremental to activities and costs that arise in the ordinary course of our business and are not considered part of our core, ongoing operations. These acquisition/divestiture-related net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Restructuring and restructuring-related net charges (credits)&#160;- These adjustments primarily represent compensation-related charges, fixed asset write-offs, contract cancellations, project management fees and other direct costs associated with our restructuring plans. These restructuring plans each consist of distinct initiatives that are fundamentally different from our ongoing, core cost reduction initiatives in terms of, among other things, the frequency with which each action is performed and the required planning, resourcing, cost and timing. Examples of such initiatives include the movement of business activities, facility consolidations and closures and the transfer of product lines between manufacturing facilities, which, due to the highly regulated nature of our industry, requires a significant investment in time and cost to create duplicate manufacturing lines, run product validations and seek regulatory approvals. Restructuring initiatives take place over a defined timeframe and have a distinct project timeline that requires, and begins subsequent to, approval by our Board of Directors. In contrast to our ongoing cost reduction initiatives, restructuring initiatives typically result in duplicative cost and exit costs over the defined timeframe and are not considered part of our core, ongoing operations. In addition, during the fourth quarter of 2020, we incurred restructuring and restructuring-related net charges associated with management&#8217;s decision to retire the LOTUS platform. These restructuring plans are incremental to the core activities that arise in the ordinary course of our business. Restructuring and restructuring-related net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Litigation-related net charges (credits) - These adjustments include certain significant product liability and other litigation-related charges and credits. We record these charges and credits, which we consider to be unusual or infrequent and significant, within the litigation-related charges line in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within selling general and administrative expenses. Certain litigation-related net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">EU MDR implementation costs - These adjustments represent certain incremental costs specific to complying with new regulatory requirements in the EU. EU MDR replaced the existing European Medical Devices Directive (MDD) regulatory framework, and manufacturers of medical devices were required to comply with EU MDR beginning in May 2021 for new product registrations and by May 2024 for medical devices which have a valid CE Certificate to the prior Directives (issued before May 2021). We expect to incur significant expenditures in connection with the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adoption of the EU MDR requirements and we consider the adoption of EU MDR to be a significant change to a regulatory framework, and therefore, these expenditures are not considered to be ordinary course expenditures in connection with regulatory matters. As such, certain of these costs are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Debt extinguishment net charges (credits) - These amounts relate to the early extinguishment of certain outstanding principal amounts of our senior notes. Certain debt extinguishment net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Investment portfolio net losses (gains) - These amounts represent write-downs or fair value remeasurement gains and losses related to our investment portfolio. Each reporting period, we evaluate our investments without a readily determinable fair value to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value and determine if the impairment is other-than-temporary, and recognize an impairment loss. In addition, for those investments accounted for under the measurement alternative method of accounting, we record gains and losses to remeasure the carrying value of the investments to their fair values based on observable market prices or implied market values. Investment impairment charges and fair value remeasurements can be highly variable dependent on external market factors and conditions relative to the underlying investee, which are generally outside of the control of management, as such these amounts are excluded from management's assessment of performance.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:22.02pt">Deferred tax expenses (benefits) - This adjustment relates to a significant non-cash tax benefit arising from an intra-entity asset transfer of intellectual property completed in the fourth quarter of 2019 which resulted in our recording a $4.102 billion net deferred tax asset. The deferred tax benefit associated with the establishment of the net deferred tax asset as well as any deferred tax expense resulting from the reversal of the deferred tax asset are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Discrete tax items - These items represent adjustments of certain tax positions including those which a) are related to the finalization of the enactment date impact of the TCJA, or b) are related to the tax consequences of a non-GAAP adjustment item booked in a prior period. These discrete tax items are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance. </span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operational Net Sales Excluding the Impact of Foreign Currency Fluctuations</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">The impact of foreign currency fluctuations is highly variable and difficult to predict. Accordingly, management excludes the impact of foreign currency fluctuations for purposes of reviewing net sales and growth rates to facilitate an evaluation of our current operating performance and a comparison to our past operating performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rule&#160;10b5-1 Trading Plans by Executive Officers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, certain of our executive officers adopt written stock trading plans in accordance with Rule 10b5-1 under the Exchange Act and our own Stock Trading Policy. A Rule 10b5-1 Trading Plan is a written document that pre-establishes the amount, prices and dates (or formulas for determining the amounts, prices and dates) of future purchases or sales of our stock, including shares issued upon exercise of stock options or vesting of deferred stock units. These plans are entered into at a time when the person is not in possession of material non-public information about our company. We disclose details regarding individual Rule 10b5-1 Trading Plans on the Investor Relations section of our website.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the management of Boston Scientific Corporation, we are responsible for establishing and maintaining adequate internal control over financial reporting. We designed our internal control process to provide reasonable assurance to management and the Board of Directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2021. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control&#8211;Integrated Framework (2013 framework). Based on our assessment, we believe that, as of December&#160;31, 2021, our internal control over financial reporting is effective at a reasonable assurance level based on these criteria.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the SEC Staff 's interpretive guidance for newly acquired businesses, we are permitted to omit an assessment of an acquired business's internal control over financial reporting from our assessment of internal control for up to one year from the acquisition date. As such, we have excluded certain businesses, namely Preventice Solutions, Inc. and the surgical business of Lumenis, LTD., acquired during the year ended December 31, 2021 from our annual assessment of internal controls over financial reporting as of December 31, 2021. These represented less than one percent of total assets in the aggregate, as of December 31, 2021 and approximately two percent of net sales for the year then ended. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &amp; Young LLP, an independent registered public accounting firm, has issued an audit report on the effectiveness of our internal control over financial reporting. This report, in which they expressed an unqualified opinion, is included below.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.784%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael F. Mahoney</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel J. Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief<br/>Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_64"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Boston Scientific Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Boston Scientific Corporation&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Boston Scientific Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As indicated in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Preventice Solutions, Inc. and the surgical business of Lumenis, LTD., which are included in the 2021 consolidated financial statements of the Company and constituted less than 1% of total assets as of December 31, 2021 and approximately 2% of revenues for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Preventice Solutions, Inc. and the surgical business of Lumenis, LTD.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2021 consolidated financial statements of the Company and our report dated February 23, 2022 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2022 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell medical devices globally and our earnings and cash flows are exposed to market risk from changes in currency exchange rates and interest rates. We address these risks through a risk management program that includes the use of derivative financial instruments. We operate the program pursuant to documented corporate risk management policies. We do not enter derivative transactions for speculative purposes. Gains and losses on derivative financial instruments substantially offset losses and gains on underlying hedged exposures. Furthermore, we manage our exposure to counterparty risk on derivative instruments by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our currency risk consists primarily of foreign currency denominated firm commitments, forecasted foreign currency denominated intercompany and third-party transactions and net investments in certain subsidiaries. We use both nonderivative (primarily manufacturing operations outside the U.S.) and derivative instruments to manage our earnings and cash flow exposure to changes in currency exchange rates. We had currency derivative instruments outstanding in the contract amount of $8.381 billion as of December&#160;31, 2021 and $10.481 billion as of December&#160;31, 2020. A ten percent appreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would increase the derivative instruments&#8217; fair value by $298 million as of December&#160;31, 2021 as compared to $333&#160;million as of December&#160;31, 2020. A ten percent depreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would decrease the derivative instruments&#8217; fair value by $364&#160;million as of December&#160;31, 2021 as compared to $407&#160;million as of December&#160;31, 2020. Any increase or decrease in the fair value of our currency exchange rate sensitive derivative instruments would be substantially offset by a corresponding decrease or increase in the fair value of the hedged underlying asset, liability or forecasted transaction, resulting in minimal impact on our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar and euro-denominated borrowings partially offset by U.S. dollar cash investments. We have historically used interest rate derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. We had no interest rate derivative instruments outstanding as of December&#160;31, 2021 and December&#160;31, 2020. As of December&#160;31, 2021, $9.121 billion in aggregate principal amount of our outstanding debt obligations were at fixed interest rates, representing approximately 100 percent of our total debt, on an amortized cost basis. As of December&#160;31, 2021, our outstanding debt obligations at fixed interest rates were comprised of senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for further information regarding our derivative financial instruments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_70"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Boston Scientific Corporation (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 23, 2022 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.257%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Business Combinations</span></div></td></tr><tr style="height:315pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Note B to the consolidated financial statements, during 2021, the Company completed four acquisitions for total aggregate purchase price of $3.3 billion, net of cash acquired. The transactions were accounted for as business combinations. In certain acquisitions, the Company has recognized a liability for acquisition consideration that is contingent upon achieving either research and development, commercialization, or sales-based milestones. The Company determines the fair value of these contingent consideration arrangements, both as part of the initial purchase price allocation, and on an ongoing basis each reporting period until the arrangements are settled. As of December 31, 2021, the amount accrued for future estimated contingent consideration is $486 million, which represents a Level 3 estimate in the fair value hierarchy due to the significant unobservable inputs used in determining the fair value and the use of management judgment about the assumptions that market participants would use in pricing the liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing the Company&#8217;s accounting for its acquisitions was complex due to the significant estimation required by management to determine the fair value of identified intangible assets, which totaled $1.2 billion and principally consisted of developed technology, and to determine the fair value of contingent consideration arrangements. A significant emphasis is placed on the appropriateness of the estimates used by management to determine the fair value of acquired intangible assets due to the sensitivity of the respective fair values to the underlying assumptions. The Company used an income approach to measure the technology-related intangible assets. The significant assumptions used to estimate the value of the intangible assets included discount rates and certain assumptions that form the basis of the forecasted results, including revenue growth rates, estimates of technological obsolescence, operating profit margin and market participant synergies. The significance of the estimations used by management to determine the fair value of contingent consideration was primarily due to the sensitivity of the respective fair values to the underlying assumptions. The significant assumptions include estimation of the probability and timing of payment, future sales forecasts, as well as the appropriate discount rate based on the estimated timing of payments. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of the controls over the Company&#8217;s accounting for acquisitions. For example, we tested controls over the identification and valuation of intangible assets, including the valuation models and underlying assumptions used to develop such estimates. We also tested controls over the valuation of the contingent consideration liability, including the valuation models and underlying assumptions used to develop such estimates. For each of the Company's acquisitions, we read the purchase agreements, evaluated the significant assumptions and methods used in developing the fair value estimates, and tested the recognition of (1) the tangible assets acquired and liabilities assumed at fair value; (2) the identifiable intangible assets acquired at fair value; and (3) goodwill measured as a residual.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test the estimated fair value of the intangible assets, we performed audit procedures that included, among others, evaluating the Company's use of the income approach and testing the significant assumptions used in the model, as described above. In testing the valuation of contingent consideration, we assessed, among other things, the terms of the arrangements and the conditions that must be met for the amounts to become payable. We evaluated the completeness and accuracy of the underlying data used in the analyses. For example, we compared the significant assumptions to current industry, market and economic trends, to the assumptions used to value similar assets in other acquisitions, to the historical results of the acquired business and to other guideline companies within the same industry. We involved our valuation professionals to assist with our evaluation of the methodology used by the Company and significant assumptions included in the fair value estimates.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183MC9mcmFnOmM2OTM3ZTk5NGNkODRjMGI4Y2ZkYzcyMzk2OTMzMTJjL3RleHRyZWdpb246YzY5MzdlOTk0Y2Q4NGMwYjhjZmRjNzIzOTY5MzMxMmNfMjE5OTAyMzI3NzkyNA_027a1f36-8627-42b8-8f99-78215fad42ec">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1992.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183MC9mcmFnOmM2OTM3ZTk5NGNkODRjMGI4Y2ZkYzcyMzk2OTMzMTJjL3RleHRyZWdpb246YzY5MzdlOTk0Y2Q4NGMwYjhjZmRjNzIzOTY5MzMxMmNfMjE5OTAyMzI3NzkyNg_cca8ebcd-0f7a-4684-9a8c-3c0363cd95e9">Boston, Massachusetts</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2022 </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMy0xLTEtMS0w_537a8d2a-beb7-4fe1-96c1-41595999d3e5">11,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMy0zLTEtMS0w_f746b2f8-3b53-47f0-9cb1-04730c02201c">9,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMy01LTEtMS0w_6d926400-ade9-472e-a416-1a70820f3fc9">10,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNC0xLTEtMS0w_a725d8b1-a6ae-4826-95b1-08fe723cae5c">3,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNC0zLTEtMS0w_abe2d9ff-cbfe-43ed-aff5-16b877a63b7d">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNC01LTEtMS0w_7539f9f1-d01d-44f8-8eec-e539eda39562">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNS0xLTEtMS0w_7bfb102c-0710-4097-950b-688f3b8052e1">8,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNS0zLTEtMS0w_a16d0d3a-945e-437a-a31e-fb045487f8b4">6,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNS01LTEtMS0w_5518e448-5734-41b4-8837-c22221af39b5">7,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOC0xLTEtMS0w_0c282c1c-1c6f-450c-b47d-38507c49ae87">4,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOC0zLTEtMS0w_7475ecdf-987d-4ccc-9ab5-d5008397a97d">3,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOC01LTEtMS0w_f5557baf-e3f8-4108-b651-a6f4df84b7d1">3,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOS0xLTEtMS0w_8580b271-473b-4819-ad41-8ee805543883">1,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOS0zLTEtMS0w_aceda4bf-5599-4be2-ae67-074c083609ad">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOS01LTEtMS0w_e8f808c5-2215-4afd-97c2-cde308fa4c1e">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTAtMS0xLTEtMA_a33820df-58f1-4d58-8b44-0bb610add402">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTAtMy0xLTEtMA_82f38be3-c9ea-4de8-94d3-0e525020e830">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTAtNS0xLTEtMA_a519446e-9b0a-42ab-9376-f1c1e589b7ae">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTEtMS0xLTEtMA_43192cde-a409-4109-ae32-df8c0ba28450">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTEtMy0xLTEtMA_5231a5e0-e5c9-4974-a9e6-1cda483f3a85">789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTEtNS0xLTEtMA_10e798d6-9c86-44d0-b09b-ec731329fe08">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTItMS0xLTEtMA_6ce0a0ac-4b56-4fb3-a55b-93dbddd94fe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTItMy0xLTEtMA_781d2c58-31be-4ea1-bec9-c377fa96c674">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTItNS0xLTEtMA_15dde5b7-21d3-453a-8dc1-640e9e9fe394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTMtMS0xLTEtMA_0a71ea9d-7ac9-4ff1-8a0c-aa506615aea8">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTMtMy0xLTEtMA_0f1da7b9-49f0-470c-82a5-3ae931f03230">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTMtNS0xLTEtMA_9743aa41-97da-4386-92fa-3d2bbb535be9">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTQtMS0xLTEtMA_0aec8765-7c08-4fc0-8343-8c7e97bb1dd2">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTQtMy0xLTEtMA_72f179b4-da98-48b2-b894-d6f1c9041894">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTQtNS0xLTEtMA_2bf3002d-3a0d-48e5-bcc5-e0cd457f254e">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTUtMS0xLTEtMA_88dba87d-2809-49f3-be74-5f83f0fa7335">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTUtMy0xLTEtMA_d3644e77-11aa-4335-a924-94cbc2ae3ffc">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTUtNS0xLTEtMA_0b0ee396-070f-430b-a0cf-9683d78d2f7d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTYtMS0xLTEtMA_44b6b3bc-f400-49db-bc76-ade645239fe0">430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTYtMy0xLTEtMA_6ffa83c5-7487-4d92-bd4c-afd08eec32b8">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTYtNS0xLTEtMA_eebac84a-d848-4205-bfd7-73ba6e1f8a3b">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on disposal of businesses and assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTctMS0xLTEtMA_b81c9f8f-00ff-4ebf-9c37-f75492a9e7a2">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTctMy0xLTEtMA_866f150c-ec79-41e1-8f27-18ca74c5e2af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTctNS0xLTEtMA_a4997dd5-7a75-4538-8890-7f130613e7da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTgtMS0xLTEtMA_e0d32333-b5f4-4f4c-b239-c09af7c563d5">6,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTgtMy0xLTEtMA_a8e3dfe4-2221-46c2-9346-e89aa185a88d">6,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTgtNS0xLTEtMA_f729d63b-5546-464f-b881-d91341526e26">6,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTktMS0xLTEtMA_3b05d976-32d9-4a74-8ba7-3d1c4896ae7b">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTktMy0xLTEtMA_61b9e62d-3f69-440b-968b-174f858c4418">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTktNS0xLTEtMA_022040ed-e817-4721-8819-800b34d96635">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjItMS0xLTEtMA_f3831a3a-9b1e-4a63-9568-de19f061eb7d">341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjItMy0xLTEtMA_4d1f9aa8-07f3-41e2-b2a0-b0c88fa14599">361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjItNS0xLTEtMA_0d411b56-35dd-4f59-812e-91473c81912a">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjMtMS0xLTEtMA_2696627f-9bbb-465d-832e-56afc65cde99">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjMtMy0xLTEtMA_47ebab64-f222-4708-ac2d-d7360fc30f22">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjMtNS0xLTEtMA_7136146b-fba6-48cb-830d-20c4390db7ab">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjQtMS0xLTEtMA_4f9fb957-d8d9-416c-b9b1-1261c017aab8">1,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjQtMy0xLTEtMA_9770da8c-5dcb-4ec5-8fe3-ab11f89b16e2">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjQtNS0xLTEtMA_4e8f5bcd-4eaf-4aa7-afb2-e804b08044e7">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjUtMS0xLTEtMA_5d41bb8f-aeb4-4bd1-bf03-7c877d7731c6">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjUtMy0xLTEtMA_01389e8f-cabf-4c98-836c-c15604d256bd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjUtNS0xLTEtMA_4c2dcc4c-a962-4e53-9d3d-ff3f3b163f3f">4,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjYtMS0xLTEtMA_409623b3-002c-4ac4-8223-d9741a77119d">1,041</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjYtMy0xLTEtMA_2a31a583-dc08-4370-962a-89e7c5e3827c">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjYtNS0xLTEtMA_01e7dde7-bbe5-4d24-9a8b-90d97710e24c">4,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjctMS0xLTEtMA_3a148871-5709-415a-ac05-30ccd1c1069b">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjctMy0xLTEtMA_3fcc4c82-0463-4c77-88a1-0cc62df021db">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:DividendsPreferredStockStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjctNS0xLTEtMA_7b2cb90f-18c4-4630-af68-1bc65da92eaf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjgtMS0xLTEtMA_7f219dd1-78ba-4f53-a888-c9ffc89bb90e">985</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjgtMy0xLTEtMA_5f66d964-d0b4-459c-8d66-5d93fcbea596">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjgtNS0xLTEtMA_27b85515-6d11-486d-8b20-cea11d89af25">4,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share &#8212; basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzAtMS0xLTEtMA_11228891-119b-4aef-892a-e21322bdae1a">0.69</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzAtMy0xLTEtMA_580ef798-ccc1-4e9e-83b8-94e32173078b">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzAtNS0xLTEtMA_f0ec209a-02e0-4e02-8ccc-a440a11f6309">3.38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share &#8212; assuming dilution</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzEtMS0xLTEtMA_55c529e9-b432-4985-b7c0-2aac3a29c443">0.69</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzEtMy0xLTEtMA_ca5134ec-60d8-4428-abd7-ac7e94328273">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzEtNS0xLTEtMA_a61226e7-f514-4574-a967-776d2a0b0a06">3.33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzQtMS0xLTEtMA_9d179421-772a-49df-9f0b-724eecc6df3b">1,422.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzQtMy0xLTEtMA_d08e578e-6377-4d79-b528-532fb3d8a5b1">1,416.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzQtNS0xLTEtMA_5c4231f3-226a-4215-ba1b-0898fdc7b3b0">1,391.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzUtMS0xLTEtMA_a94e6c5f-bb62-4b76-9704-09dffa0a9fbb">1,433.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzUtMy0xLTEtMA_8b21447a-9f89-4d98-be9c-4d8ba5e1ca04">1,416.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzUtNS0xLTEtMA_8e338b1d-f69c-4d57-812d-e68fc608a5e2">1,410.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfMi0xLTEtMS0w_409623b3-002c-4ac4-8223-d9741a77119d">1,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfMi0zLTEtMS0w_2a31a583-dc08-4370-962a-89e7c5e3827c">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfMi01LTEtMS0w_01e7dde7-bbe5-4d24-9a8b-90d97710e24c">4,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNC0xLTEtMS0w_b44d4e4a-887b-465d-bc34-1f2ce07551c9">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNC0zLTEtMS0w_13017434-f635-4505-af00-980a3069e6fd">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNC01LTEtMS0w_024bfb53-26f6-44c4-bbaf-e17f01ef50a8">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNS0xLTEtMS0w_3560ed04-c7a4-43d7-90ea-b51d9f897e8e">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNS0zLTEtMS0w_7287c84e-06b4-43b3-aa8f-b5f666dd5baa">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNS01LTEtMS0w_e5041cf2-a3ff-4a25-9f4c-6a1bf05652e8">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNy0xLTEtMS0w_14f25da8-2cdf-4de2-bfde-264f4e75ff49">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNy0zLTEtMS0w_ca3efc00-fc79-4455-93b0-818ee6e218e5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNy01LTEtMS0w_ea88118c-f492-4cda-86fe-3b5676cc9ae1">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOC0xLTEtMS0w_d9b1fd6c-c4d9-4856-8b37-5ef4c1019cf1">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOC0zLTEtMS0w_1c6c3f35-b8de-4aea-9419-9b8ccf285583">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOC01LTEtMS0w_a5538da3-f58a-47f5-85b6-a6ae00744ebb">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOS0xLTEtMS0w_8d990b67-a91d-4ecf-a13f-74d6412b0ef8">1,096</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOS0zLTEtMS0w_d0610484-9201-422b-a1f3-3f75253c1e8a">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOS01LTEtMS0w_41abff15-dfa9-46ab-afb0-5093e380db60">4,937</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNC0xLTEtMS0w_9cc55fe9-0863-4471-b85b-5002e6c3eba4">1,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNC0zLTEtMS0w_af9cb53c-a0c5-4f71-8942-baef1d9bb646">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNS0xLTEtMS0w_31ca29ab-b094-4694-a0ba-592a7f5a3d96">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNS0zLTEtMS0w_f04dd21d-b489-4aa1-b3a9-9433d7a495cb">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNi0xLTEtMS0w_d81045b2-3bd6-4f66-a037-78368a694316">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNi0zLTEtMS0w_51e6c901-96d2-4ae1-a426-caa3f38ea0df">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNy0xLTEtMS0w_3fe4ec01-e1e9-46b9-84c0-819cad7b4dd0">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNy0zLTEtMS0w_39aa3c44-250e-4daf-998b-88a722848c8f">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOC0xLTEtMS0w_49a65c93-cc6d-4525-be23-f89d606a0759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOC0zLTEtMS0w_cac68737-2c66-4423-9d53-90285ac35a6e">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOS0xLTEtMS0w_ff914c79-4ef4-476a-96e0-d30815dde453">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOS0zLTEtMS0w_d6076ce2-ea56-4681-88cd-cc52dbfdf1a7">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTAtMS0xLTEtMA_c00354a6-e562-4b5e-9ed1-1bb0b107362b">6,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTAtMy0xLTEtMA_53656906-f0af-43f9-8df8-ac74ccca980c">6,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTEtMS0xLTEtMA_75402024-2eb8-4d08-982c-fee92516c59d">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTEtMy0xLTEtMA_040c97ee-a3d4-46f4-a4d6-f5555087db68">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTItMS0xLTEtMA_4e76c49e-a4cd-4128-9b97-d35ce1893863">11,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTItMy0xLTEtMA_a3088370-fca3-4a36-9d7e-ec4a8df41e89">9,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTMtMS0xLTEtMA_5c52718c-7822-4f24-ac06-4d6f5bf062f9">6,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTMtMy0xLTEtMA_8267de7a-3467-4c60-98cd-09558539f448">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTQtMS0xLTEtMA_d7682f57-7d7f-49a8-9a0a-03b0bf510807">4,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTQtMy0xLTEtMA_9c6dbbb6-7a32-496d-8e5b-ecfbf62d1512">4,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTUtMS0xLTEtMA_cffd3252-9f38-4b08-8c04-24227e71a37f">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTUtMy0xLTEtMA_f0375f0a-854d-4321-bb1b-49c755363b56">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTYtMS0xLTEtMA_0c1858d0-1182-46bf-ba53-39b80e271fe8">32,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTYtMy0xLTEtMA_96910ff1-86fc-4a22-bb33-47d53daa1d5b">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjAtMS0xLTEtMA_b44b8d9d-5a0f-4f30-8b98-a8a554065768">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjAtMy0xLTEtMA_7eb550aa-731a-47aa-a4d1-705e803139dc">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjEtMS0xLTEtMA_a72541dd-970f-4aab-aba2-8fb01e0035cd">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjEtMy0xLTEtMA_04802a11-8d47-49c8-9598-b06233343715">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjItMS0xLTEtMA_e1a806c0-f054-42b4-94f8-3bf3f44a6a36">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjItMy0xLTEtMA_328cd582-5b2f-4bd7-b294-33161e2678a1">2,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjMtMS0xLTEtMA_13b5f27a-18e2-432f-b1c6-204bc85f498d">783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjMtMy0xLTEtMA_0631e340-79ab-4c7d-a600-f7fa37f353c1">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjQtMS0xLTEtMA_6b524fca-3cd1-4df6-af6d-8c88e4b0bc5f">4,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjQtMy0xLTEtMA_a6890b19-ac3c-4ff0-a222-09604fb57c75">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjUtMS0xLTEtMA_b9e9f9ab-5822-409d-b297-931748f80e67">8,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjUtMy0xLTEtMA_c42903f0-8b3a-4883-bbe3-ce917f38a05a">9,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjYtMS0xLTEtMA_e11d2269-55aa-43e6-b6f6-618c06b055df">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjYtMy0xLTEtMA_97fc6b99-d6d5-461f-8c29-09825b73032e">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjctMS0xLTEtMA_9ee60578-b483-442a-af73-595aa3e11695">2,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjctMy0xLTEtMA_a75181b7-9601-4b58-972e-c0ba8d2037df">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjktMS0xLTEtMA_d826aa58-b3f4-4d17-9276-7e4aa86f9e41"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjktMy0xLTEtMA_e26de844-285a-4c7d-a830-34e1997568c3"></ix:nonFraction></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzIx_22567360-ad6d-4b0c-ac91-d91cad508ace"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzIx_c7abce91-aa08-4d0d-8e7e-37a2925f0fd0">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzQ3_5b084393-0366-477d-a1df-3a10f8e6632f"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzQ3_b8201cd6-fb9f-44b7-8c39-ef6685cb71bf">50,000,000</ix:nonFraction></ix:nonFraction> shares; issued <ix:nonFraction unitRef="shares" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzY2_dd29c944-1260-4c37-9fb7-148c70ed8a15"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzY2_ffeef025-010b-4a8f-a296-4fe6d02db977">10,062,500</ix:nonFraction></ix:nonFraction> shares as of December 31, 2021 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMS0xLTEtMA_e39bffff-66b9-4cce-b169-669105ba90cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMy0xLTEtMA_e08ac0ba-28cb-4ea9-80e0-fc09f1ebcdb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzE4_91bb6a8e-7a0d-4293-978c-2e2c41608809"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzE4_dc479340-c26b-4602-8c51-d5e089f3a217">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzQ0_3da4e1c7-7eef-4ec2-85e5-234b321e081b"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzQ0_42afa559-5e15-472c-93c9-7fc25385f296">2,000,000,000</ix:nonFraction></ix:nonFraction> shares; issued <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzYy_c864c0cb-bd69-4698-b940-5f79ae19f0c1">1,688,810,052</ix:nonFraction> shares as of December 31, 2021 and <ix:nonFraction unitRef="shares" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzEwMA_72623022-7d5b-4e88-9364-cb7864f5d88b">1,679,911,918</ix:nonFraction> shares as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMS0xLTEtMA_a246c932-5d72-4025-875d-c3c9b85dfc4f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMy0xLTEtMA_6601d3c5-5384-480e-958c-7c70c4e015e4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmU1M2RiMWYwMzkyMDQ1MGI4YzQzYzY2NzA1OTQzMWQzXzMw_29535674-2840-47ab-82f4-f178ab55e767"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmU1M2RiMWYwMzkyMDQ1MGI4YzQzYzY2NzA1OTQzMWQzXzMw_50628e7f-b70a-46f1-b685-0a43afeac69f">263,289,848</ix:nonFraction></ix:nonFraction> shares as of December 31, 2021 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMS0xLTEtMA_7d1b1b76-d045-4e7d-87a3-d06b6ea74cb5">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMy0xLTEtMA_9d56dbc2-8510-4439-b1da-244c2a159ac6">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzUtMS0xLTEtMA_b7e84e8d-419c-4893-a8df-771d66858d7d">19,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzUtMy0xLTEtMA_83a26968-991b-4f3d-a24e-aef5e49878b1">19,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzYtMS0xLTEtMA_64b29961-da46-4c72-9187-a19d907584ad">1,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzYtMy0xLTEtMA_42ccae92-e401-4419-8e57-35dbaaede052">2,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzgtMS0xLTEtMA_40d3fb68-3169-4e5e-ae76-54bda6a71b5d">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzgtMy0xLTEtMA_7656cbda-fcfb-49fb-b7aa-5fe789737f86">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzktMS0xLTEtMA_d1f159f2-a6b7-43d4-90f5-d79988da2841">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzktMy0xLTEtMA_fef294af-5e72-44b0-8bb8-1ba4367f71bc">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized costs associated with defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDEtMS0xLTEtMA_0c363137-87cb-4c29-84ec-8f6f8129e6b5">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDEtMy0xLTEtMA_713913d9-c35b-4c17-a6f5-40af81acfaa2">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDItMS0xLTEtMA_ce4c7f01-964b-412b-ab13-29d592afd625">16,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDItMy0xLTEtMA_38d22967-151d-434b-ae57-ce8633e40218">15,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDMtMS0xLTEtMA_5a9daae0-bff5-4ec0-aa3a-8135d3dc9aa7">32,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDMtMy0xLTEtMA_b54a9f1c-389a-4f07-8069-3a283aefbcde">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred stock shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMy0xLTEtMS00MTI2NQ_08168746-b9ac-43a2-9b7a-65e7b95db899">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231" decimals="0" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMy0zLTEtMS00MTI2NQ_069a5815-e212-47f8-9aef-bfc82295337f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55c9f4684ac746bda57f532f6a87f684_I20181231" decimals="0" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMy01LTEtMS00MTI2NQ_d262d026-c4bf-480a-b9d1-d3e6132a72fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1bb4626ce5af43629527f19d1f2b8d8f_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNC0xLTEtMS02ODczNw_b0fc4233-0021-4825-948c-be478283ed2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86d1794a80bb4fe2a6e1462adf2ed270_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNC0zLTEtMS00MTcxNA_769ef740-fb1e-452f-ae52-c3609c915f4d">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a5ab205543a48ddb58369506f4258e1_D20190101-20191231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNC01LTEtMS00MTgwOA_c2682310-d68e-424c-b1d5-a27f08fe68ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23a174508ba44dd89de3efafe40cfb80_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNS0xLTEtMS00MTI2NQ_a0fc3146-9b86-4676-8643-0838af4fd9e9">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNS0zLTEtMS00MTI2NQ_08168746-b9ac-43a2-9b7a-65e7b95db899">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231" decimals="0" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNS01LTEtMS00MTI2NQ_069a5815-e212-47f8-9aef-bfc82295337f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNy0xLTEtMS00MTI2NQ_781cc470-482f-40f7-9fb7-9aaa7c6c335e">1,679,911,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNy0zLTEtMS00MTI2NQ_8fcd52eb-f0a1-4174-9bea-3fd901c3f71e">1,642,488,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47fffe98c44745d5abab2aa20b5ce269_I20181231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNy01LTEtMS00MTI2NQ_7b1918cb-3283-4c8d-af1c-bc22a47f7eae">1,632,148,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOC0xLTEtMS02ODczOQ_4c12a200-fed6-4e08-8c9a-b7216e190e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOC0zLTEtMS00MTcxNA_fc372eb9-04ec-46f3-a481-5972780f7826">29,382,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOC01LTEtMS00MTI2NQ_1714178e-8082-4d28-a870-750388435946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOS0xLTEtMS00MTI2NQ_8ff16dc0-47a2-47d0-a573-b46de3e7301b">8,898,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOS0zLTEtMS00MTI2NQ_8e20b773-ac46-4621-865f-5ad365fd6622">8,040,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOS01LTEtMS00MTI2NQ_020a502e-39f8-4d1f-9429-32545791067f">10,340,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a72129993b9407296d812a52123d5e9_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTAtMS0xLTEtNDEyNjU_86b13e1d-8e11-426f-8d09-24c7843f7116">1,688,810,052</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTAtMy0xLTEtNDEyNjU_781cc470-482f-40f7-9fb7-9aaa7c6c335e">1,679,911,918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTAtNS0xLTEtNDEyNjU_8fcd52eb-f0a1-4174-9bea-3fd901c3f71e">1,642,488,911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTMtMS0xLTEtNDEyNjU_d82fa1c7-3e69-4ee7-8888-b710749979cf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTMtMy0xLTEtNDEyNjU_ce7093ef-a38c-4eec-b7e0-314c9ad2e38f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c9f4684ac746bda57f532f6a87f684_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTMtNS0xLTEtNDEyNjU_0bb43fe3-c549-455f-a45c-20c4756a210b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb4626ce5af43629527f19d1f2b8d8f_D20210101-20211231" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTQtMS0xLTEtNjg3NDU_3251f6d3-9ad1-44b8-85ad-f7eed6f89f9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d1794a80bb4fe2a6e1462adf2ed270_D20200101-20201231" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTQtMy0xLTEtNjg3NDk_f6b23fdc-7976-46f4-8b79-2ed10e5932a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5ab205543a48ddb58369506f4258e1_D20190101-20191231" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTQtNS0xLTEtNjg3NTE_f3485091-40a8-47d8-9aff-9f01d81fa992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a174508ba44dd89de3efafe40cfb80_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTUtMS0xLTEtNDEyNjU_89090d17-2446-45c6-b191-e53eb00e65b3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTUtMy0xLTEtNDEyNjU_d82fa1c7-3e69-4ee7-8888-b710749979cf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTUtNS0xLTEtNDEyNjU_ce7093ef-a38c-4eec-b7e0-314c9ad2e38f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTctMS0xLTEtNDEyNjU_fd13a044-4f79-4e51-85cb-5f794b41c1f0">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTctMy0xLTEtNDEyNjU_6703ca0e-2371-427b-98a2-4dbabac3bda6">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47fffe98c44745d5abab2aa20b5ce269_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTctNS0xLTEtNDEyNjU_5ab7ce08-2dcc-4413-aab4-9b5c19c46480">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTgtMS0xLTEtNjg3NTQ_15dd8a91-44de-4f68-8f68-9175fb851eb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTgtMy0xLTEtNDE3MjY_59a3d736-099e-440e-8b8f-e35829a612b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTgtNS0xLTEtNjg3NTc_dbf7ae0b-ca9b-46e9-b763-1bd56de57893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTktMS0xLTEtNjg3NjA_c08347a2-5bca-47cd-b134-337a3a4cdf94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTktMy0xLTEtNjg3NjM_2166de55-daf7-4db7-bbd9-1148300bd8dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTktNS0xLTEtNjg3NjY_ad3202be-05f7-49a3-b7dd-8882e7508713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a72129993b9407296d812a52123d5e9_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjAtMS0xLTEtNDEyNjU_eb805ece-f612-481e-b8b4-875b1f76e789">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjAtMy0xLTEtNDEyNjU_fd13a044-4f79-4e51-85cb-5f794b41c1f0">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjAtNS0xLTEtNDEyNjU_6703ca0e-2371-427b-98a2-4dbabac3bda6">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i621567053d2744019f158e373637541a_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjItMS0xLTEtNDEyNjU_5bec2caa-0a7e-4241-9d76-35d067af51f3">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4747802c7e754ca399dcd04b1ba8d7fb_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjItMy0xLTEtNDEyNjU_0bee1a62-e14e-48d3-a9e2-1257bf9d6c25">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief44305703574f549e1b0deefa30aa9b_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjItNS0xLTEtNDEyNjU_c43c3d9d-1aee-4cf3-b108-ac13d21bb7c0">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic842d867786b4ccea9cfa96a40cf30df_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjMtMS0xLTEtNDE3Mjk_eb516fc4-cd52-4690-aa68-b628346bc6cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic81c4f4cfd734a44bbbfbc03be7529de_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjMtMy0xLTEtNDE3Mjk_e889b7c7-0f5d-4745-a7c6-3f1d877da8b4">535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4703f4563ef24622b191ace91b7046bb_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjMtNS0xLTEtNDEyNjU_f7c8599f-50e8-47c2-98ec-7772893f374b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e1494b00924399b0198cf1908c6eac_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjQtMS0xLTEtNDEyNjU_6b14171f-3b1e-402e-8478-0c53f7fbd37b">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i621567053d2744019f158e373637541a_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjQtMy0xLTEtNDEyNjU_5bec2caa-0a7e-4241-9d76-35d067af51f3">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4747802c7e754ca399dcd04b1ba8d7fb_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjQtNS0xLTEtNDEyNjU_0bee1a62-e14e-48d3-a9e2-1257bf9d6c25">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7cdad179c64659939a57d640d0398e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjYtMS0xLTEtNDEyNjU_3036b4f2-0f87-4a04-83b4-8db08d04fb78">19,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d65743aa83c4feba194be59d23ff5b6_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjYtMy0xLTEtNDEyNjU_74c26478-53dd-4a87-a650-beea97256f45">17,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a84911e7b44222a521b4865d0ca338_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjYtNS0xLTEtNDEyNjU_c48c197c-4260-4eec-81da-8e1410f396fe">17,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjctMS0xLTEtNjg3Nzc_8f5ed86b-6874-4e32-accd-2025f9e53aeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjctMy0xLTEtNDE3Mzc_0684f755-6f63-4edf-ba21-f9e77d025e8d">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjctNS0xLTEtNDEyNjU_7b917cb4-7df8-420a-a8f8-e37da742a47e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjgtMS0xLTEtNjg3Nzc_1e34a299-0163-4c89-80ae-751ad24ae624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjgtMy0xLTEtNDE3Mzc_77eadfd5-8450-4687-a8ba-ca3d9410a57c">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjgtNS0xLTEtNDEyNjU_4398ce82-a60a-4dd5-acae-42192fa63096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjktMS0xLTEtNDEyNjU_0d041e98-6c05-442f-bbc9-93d25bfe31b8">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjktMy0xLTEtNDEyNjU_202e6855-a84e-4f73-9fe9-d193b7c35bef">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjktNS0xLTEtNDEyNjU_07a2f3ac-d647-4ea2-b537-642334e7bd0a">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa6d669fbe84dada7c5bed68a7bab52_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzAtMS0xLTEtNDEyNjU_641b0d18-535c-481f-be5a-b22ec1750d6e">19,986</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7cdad179c64659939a57d640d0398e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzAtMy0xLTEtNDEyNjU_3036b4f2-0f87-4a04-83b4-8db08d04fb78">19,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d65743aa83c4feba194be59d23ff5b6_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzAtNS0xLTEtNDEyNjU_74c26478-53dd-4a87-a650-beea97256f45">17,561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief259e9b815d43c6b3e7f2b9f85ad45e_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzItMS0xLTEtNDEyNjU_270f5079-0ef6-48a1-b115-070f5a70753a">2,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e19129d2b6b49af9f944cde90d53a9c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzItMy0xLTEtNDEyNjU_f2a2d5bd-0c3f-4e21-b2fd-b1acc8d32d5a">2,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcaaf4e1347a49e2be525edf65b64c63_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzItNS0xLTEtNDEyNjU_acdc307c-93fb-476b-9264-37b0f8ba4447">6,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzMtMS0xLTEtNDEyNjU_26ebaa57-16e4-40ae-b58b-ce8280431da5">1,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzMtMy0xLTEtNDEyNjU_fbc31275-7238-4616-9a56-e0acceac28fb">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8acaf977546b4524b2309e825920c392_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzMtNS0xLTEtNDEyNjU_60442249-927f-4d12-a91b-fc32c21aec75">4,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231" decimals="-6" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzQtMS0xLTEtNDE3NDI_1cce2415-6024-4598-8ed4-ae919fd4c646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzQtMy0xLTEtNDE3NDI_734ac306-34a8-47a8-ac6e-6c6291219ff6">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8acaf977546b4524b2309e825920c392_D20190101-20191231" decimals="-6" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzQtNS0xLTEtNDEyNjU_de99ba89-1ff5-433b-9661-e77113b8678f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzUtMS0xLTEtNDEyNjU_d5ae8b3f-dcbc-4f31-80a2-ab4b9321d3e8">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzUtMy0xLTEtNDEyNjU_7d104350-feed-404f-bd31-306944402c6d">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8acaf977546b4524b2309e825920c392_D20190101-20191231" decimals="-6" name="us-gaap:DividendsPreferredStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzUtNS0xLTEtNDEyNjU_f8c845fb-9ba0-49f9-a364-253d831d641c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11e39577dbf144d782e2e16d4feea22d_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzYtMS0xLTEtNDEyNjU_5a7ca6c7-fdda-4a5a-a95d-0d00f588d828">1,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief259e9b815d43c6b3e7f2b9f85ad45e_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzYtMy0xLTEtNDEyNjU_270f5079-0ef6-48a1-b115-070f5a70753a">2,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e19129d2b6b49af9f944cde90d53a9c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzYtNS0xLTEtNDEyNjU_f2a2d5bd-0c3f-4e21-b2fd-b1acc8d32d5a">2,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss), Net of Tax </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f487090abb844d5b6124d5eab360ef6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzgtMS0xLTEtNDEyNjU_d13a275c-c71e-44ac-a484-b1a43db3565f">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c0c9a4fac74bfb842c3bdb6adfa49b_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzgtMy0xLTEtNDEyNjU_9ef11585-e59c-4ea0-ab51-256892978c09">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3423ba3a4510459d9315c471a11407a9_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzgtNS0xLTEtNDEyNjU_25ba0551-c8a1-451d-951f-fd86f9fb69b8">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMS0xLTEtNDE3ODE_79a662a9-99d4-4105-9428-632f401ecc42">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMy0xLTEtNDE3ODE_30897712-9289-453b-b600-c2f0aa042fce">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtNS0xLTEtNDE3ODE_6a1bf73c-4170-4ad7-a0f6-589fe0810b84">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMS0xLTEtNDE3ODE_89b4a817-76a3-4b34-9e49-3e7bed311be3">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMy0xLTEtNDE3ODE_e84a9d4e-7f66-4e46-8040-e94054b10409">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtNS0xLTEtNDE3ODE_0219d497-e7e0-4993-894d-8bf438b667ab">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDItMS0xLTEtNDE3ODE_73ca48bf-a785-4285-9614-1b4436fe7019">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDItMy0xLTEtNDE3ODE_cbe42362-3d74-48cc-85df-2947e5d356cd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDItNS0xLTEtNDE3ODE_c218f36a-5e5a-4924-beeb-7c9f01600a13">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if652d38406174006a7b4700327ea9b78_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMS0xLTEtNDEyNjU_c2f30fd6-d6dd-477d-9602-a3c01e8c3672">263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f487090abb844d5b6124d5eab360ef6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMy0xLTEtNDEyNjU_d13a275c-c71e-44ac-a484-b1a43db3565f">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c0c9a4fac74bfb842c3bdb6adfa49b_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtNS0xLTEtNDEyNjU_9ef11585-e59c-4ea0-ab51-256892978c09">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMS0xLTEtNDEyNjU_7346dbfd-42f3-412b-b3d9-a5884f59187b">16,622</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMy0xLTEtNDEyNjU_921ec559-596f-4208-90d9-c94743c344a8">15,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtNS0xLTEtNDEyNjU_014f5f58-471e-4bd2-8ef3-4844bc439800">13,877</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.067%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMy0xLTEtMS0w_f2057220-5916-4f1f-a271-0ff78b7e91e3">1,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMy0zLTEtMS0w_09e5300f-7883-4905-9ec9-5894b60aa19e">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMy01LTEtMS0w_38a01ddd-dad0-4212-bf47-eb25822d562e">4,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on disposal of businesses and assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNS0xLTEtMS0w_60daecee-6b56-4b36-8d8e-dfdf09eedaab">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNS0zLTEtMS0w_9d6a4dc7-05c6-4f18-b640-8ddf05d7c73e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNS01LTEtMS0w_f47c1eff-02c9-49e9-99e7-486b44b2419b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNy0xLTEtMS0w_b60302ad-2b6c-4b62-9bdf-345f0853d447">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNy0zLTEtMS0w_d36a5e4a-3271-434f-9648-5abab42172e9">1,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNy01LTEtMS0w_9405ad2f-a806-43de-8eec-43f84300a7f0">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred and prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOC0xLTEtMS0w_693f13b3-f715-4fad-99fc-3dcdb61623f8">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOC0zLTEtMS0w_4ef8e7e0-9658-4cda-9201-7c1b84d18bc4">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOC01LTEtMS0w_b17b118a-cba9-4645-a99b-6ed2219a82f5">4,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOS0xLTEtMS0w_ed06ff94-67cb-4f54-9a13-0450de42468d">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOS0zLTEtMS0w_9a61a3f9-33df-4756-adf3-681f63d8bb83">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOS01LTEtMS0w_c565a49d-e1cd-4f73-ae00-c4f2c9327262">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTEtMS0xLTEtMA_68da4daa-19ac-49a8-916f-42d0fe680343">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTEtMy0xLTEtMA_1948ec71-0e09-4dba-9c13-68751659e6c5">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTEtNS0xLTEtMA_0cba274f-17aa-4260-8652-19fff04068b2">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss (gain) on investments and notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTItMS0xLTEtMA_6d4b7ba7-97d1-4efa-a089-c3850df89290">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTItMy0xLTEtMA_c152e95a-a052-4893-bdd4-6c63ac461f9c">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTItNS0xLTEtMA_cdcff114-e138-4e26-bde0-60665a7951ed">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTMtMS0xLTEtMA_7f63e4c8-03ab-4006-95f3-8f2be829b705">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTMtMy0xLTEtMA_9f34fe3b-73b7-4c86-a268-18dab5d7f6ba">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTMtNS0xLTEtMA_34bb2b33-6564-4e9e-8d85-7dd2ac68bc57">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTUtMS0xLTEtMA_ce7f8ed8-cd93-471d-ba1c-8217fb189e0a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTUtMy0xLTEtMA_b2e0c563-0287-40d8-a45c-6f546c0e4056">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTUtNS0xLTEtMA_80727fd0-5e9a-40ea-85dc-7d2b2f3e1946">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTYtMS0xLTEtMA_c241140f-db7d-4c78-bf62-84ce67f512f3">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTYtMy0xLTEtMA_7edc1ab0-328d-488f-b875-9fb2344f83ec">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTYtNS0xLTEtMA_273258d7-22a1-4237-a48d-4d343e7533a4">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTctMS0xLTEtMA_3ada8dfb-a94f-4aac-81f0-97a00b9df9e1">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTctMy0xLTEtMA_4a5b401e-398d-4450-a466-a29b04b2735d">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTctNS0xLTEtMA_e915e322-65b8-4ed6-8a25-aba1df7ad102">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTktMS0xLTEtMA_d6023ac5-7592-4e59-8fcc-cb57da461177">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTktMy0xLTEtMA_dd0b19b8-e197-4b5b-bca5-43da29a49a37">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTktNS0xLTEtMA_dc5fab9c-4387-4d65-a29d-2a4bd7848f4a">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjAtMS0xLTEtMA_7e54f427-cb3a-4a81-8138-a62d2f640a61">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjAtMy0xLTEtMA_8d1b76f2-66db-423e-8b91-371c2b66f924">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjAtNS0xLTEtMA_3935c8b6-e427-46eb-85d2-4a149b4426fe">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjEtMS0xLTEtMA_9cb470ff-e8d5-45b5-9c53-3a8ebfe37735">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjEtMy0xLTEtMA_792300a8-0683-4fab-9df9-6a2c3c0269a2">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjEtNS0xLTEtMA_b4dd0097-a4d3-45ce-b3fa-df7799a48fd0">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjItMS0xLTEtMA_9b9c7ad6-8e69-47c2-8253-94fd06ce2d2b">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjItMy0xLTEtMA_b66d8fde-05e7-4308-a10a-de8f26f381b2">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjItNS0xLTEtMA_5457073c-a742-4f4d-af1a-3244e0966d06">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjQtMS0xLTEtMA_17bba986-636d-422f-979c-25c6f47a4d42">1,870</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjQtMy0xLTEtMA_b60f9e5b-1ec7-4d2e-9e41-ef0647acc783">1,508</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjQtNS0xLTEtMA_c688f698-f718-41fd-8f7c-5abe6cc4b3b0">1,836</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment and internal use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjYtMS0xLTEtMA_ae86d499-8ee9-401e-9825-28a94c70ab99">554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjYtMy0xLTEtMA_a7b97756-99a2-46d9-b620-1e07b1cfa885">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjYtNS0xLTEtMA_b038de4e-4124-435f-b5d0-4af2dcedbf0f">461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjctMS0xLTEtMA_719b0146-3aa0-4e39-a294-26c78597dd0f">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjctMy0xLTEtMA_40921d94-e357-4210-80ec-85a3b58a14fc">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjctNS0xLTEtMA_d5cbd677-3591-4b06-bcee-e37d84e2e66b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for acquisitions of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjgtMS0xLTEtMA_0ef2ed5e-311c-4e71-bf11-dcc45a55419a">2,258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjgtMy0xLTEtMA_4141c699-174e-4fa3-b0ed-aa0632618095">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjgtNS0xLTEtMA_06f7ed9b-0e14-4679-ae67-342cdd1d4eda">4,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from divestiture of certain businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjktMS0xLTEtMA_37ad0bcb-6dff-4eac-87cf-6562a83f2a41">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjktMy0xLTEtMA_f8a03dc3-9afb-4c9c-968d-c25b28c338d9">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjktNS0xLTEtMA_3ce3edce-4a81-49da-8348-04c64293f1b2">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzAtMS0xLTEtMA_1e2a0338-ac83-47c4-93cc-283dd22fe913">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzAtMy0xLTEtMA_fa97fbdb-fc53-461c-8e6c-4e5c52872609">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzAtNS0xLTEtMA_0cab727d-cb99-4cc4-b3a1-e604fb95605f">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from (payments for) settlements of hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzEtMS0xLTEtMA_16f7c90a-dead-44c8-94d6-e595f1fce556">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzEtMy0xLTEtMA_97d3aa3f-1cd9-4cb4-aef9-1bd849d158b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzEtNS0xLTEtMA_de4b91d3-7f42-4865-898d-cbd9e5f135df">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from (payments for) investments and acquisitions of certain technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzItMS0xLTEtMA_2a18bc28-909c-47bc-8404-35c7623c2564">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzItMy0xLTEtMA_8ec1bdf5-241b-4159-832a-6acb46d354f7">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzItNS0xLTEtMA_b2f10c19-1c5a-411d-b0a2-850fa8d3cd9c">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzQtMS0xLTEtMA_52f65ed9-bc98-453d-80e3-b587ac521c08">1,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzQtMy0xLTEtMA_456ab3c4-1a33-4dd8-b834-e84c5ce9978b">411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzQtNS0xLTEtMA_e4b42926-275e-4df8-ad81-39c0fafd2cf8">5,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent consideration previously established in purchase accounting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzYtMS0xLTEtMA_3356f252-ebd5-414b-902e-e4109bdb42e4">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzYtMy0xLTEtMA_5bc75417-d4cc-4541-ae9a-3f9d7330926d">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzYtNS0xLTEtMA_f2386aec-90a3-49f8-b4f4-36472699dcd6">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzctMS0xLTEtMA_7a1ada5b-5896-432a-af35-902bf3fc6919">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzctMy0xLTEtMA_9772cb62-69de-4a67-9986-4d488986c5e7">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzctNS0xLTEtMA_57f6ead5-0ef6-4e29-94ac-6bcb73f2ad93">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from royalty rights transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzgtMS0xLTEtMA_b0fecd73-b330-48aa-9278-a72c4d9e3a4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzgtMy0xLTEtMA_ff6caccc-4d7d-4c4e-9fea-f8e28b70ea99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzgtNS0xLTEtMA_85fa2a98-e0fb-4394-9de0-2a653cb02e1a">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzktMS0xLTEtMA_70b7e4bf-c79f-40b5-b57e-fcd9cfd4ede6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzktMy0xLTEtMA_b461aa91-ba2d-45f3-be67-bec1be94163f">2,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzktNS0xLTEtMA_5f94afa7-38f4-48bb-8483-6ff7e936f39b">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDAtMS0xLTEtMA_da440046-fca1-4895-91f7-aa65ddd9186b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDAtMy0xLTEtMA_8f68f969-77cd-4899-86aa-7ba2d3c848cd">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDAtNS0xLTEtMA_3af208ce-e8af-49cc-a67e-e528a61f9cae">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDEtMS0xLTEtMA_e9663614-3224-4435-9604-9245ba6b1df0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDEtMy0xLTEtMA_35f95917-f9b9-4e5e-aecc-23749f652e4d">714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDEtNS0xLTEtMA_239a8620-eb97-46c8-9b8c-3572fba6e399">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on borrowings from credit facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDItMS0xLTEtMA_9a1b261e-4a08-4c5b-8359-d953edfc4dea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDItMy0xLTEtMA_7a628640-123d-4f82-973c-d23add3a8b4a">1,919</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDItNS0xLTEtMA_92e283f7-9136-4a71-9dab-435bfb3d2c0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from borrowings on credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDMtMS0xLTEtMA_398f9886-4a5b-4396-912e-2c3434740105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDMtMy0xLTEtMA_65faf017-daf7-4835-a9f3-d8b6aa9037ad">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDMtNS0xLTEtMA_39d46aad-f97c-4f90-be58-24d3b8152a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on long-term borrowings and debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDQtMS0xLTEtMA_c5451a74-855f-4732-8892-69ea1c5d6d04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDQtMy0xLTEtMA_15236290-9806-4fce-b668-e6dec9261230">1,260</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDQtNS0xLTEtMA_3eb65c33-95a8-4d61-9b06-a77790642dda">3,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDUtMS0xLTEtMA_26ec5b40-e2d3-4367-a70a-694c2d8e26d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDUtMy0xLTEtMA_465fa66a-8437-4e9c-89e9-95563a53d284">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDUtNS0xLTEtMA_fa169d7d-c618-4e91-a39b-b85d700329ec">7,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDYtMS0xLTEtMA_3a81b480-addf-4fc8-81dc-66d126692b48">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDYtMy0xLTEtMA_d464b69f-c821-495b-8363-1eaffc8fc8db">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDYtNS0xLTEtMA_6fc647f2-330f-40b4-afd3-e29aa6b2f71f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuance of preferred stock in connection with public offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDctMS0xLTEtMA_feaa166b-3542-46fe-af37-664fab2054e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDctMy0xLTEtMA_0ab32628-0176-45ce-bda6-181a253984df">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDctNS0xLTEtMA_aa3bb86f-c492-4d1f-856f-c4ff9c101e26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock in connection with public offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDgtMS0xLTEtMA_1f50b1ce-1bb3-47f4-a67e-ddf5951f4a4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDgtMy0xLTEtMA_09403b9b-485f-4a84-86c5-2703f8f1ba3c">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDgtNS0xLTEtMA_7bea5ad5-a426-4654-b538-e921ca2e25c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDktMS0xLTEtMA_661f83d8-aa46-4574-8882-6aad8d833696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDktMy0xLTEtMA_195d8527-f011-4ba5-b4a0-2ee30da732be">535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDktNS0xLTEtMA_b5582c5a-89bd-4d90-8f63-bf201a26268a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash used to net share settle employee equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTAtMS0xLTEtMA_c1a0ddd9-7d73-4d33-9886-74e38b24e91f">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTAtMy0xLTEtMA_7a22760c-96eb-4388-b2fa-e27ceb9254b8">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTAtNS0xLTEtMA_3fa344ba-fd0b-4511-96dc-6eb379a46cd4">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTEtMS0xLTEtMA_598b6817-1265-477c-95e7-ab5970e11088">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTEtMy0xLTEtMA_9335a649-1e15-4d9b-ad6b-9198a9c99a6e">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTEtNS0xLTEtMA_27fa3a6f-a682-43cd-8631-285f5bab06a3">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTItMS0xLTEtMA_ae1250f0-7d16-4237-b2bb-79d219d50455">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTItMy0xLTEtMA_1cbead08-8cb8-4f22-b6bf-87838ddabe51">293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTItNS0xLTEtMA_81edd036-1a3d-4ceb-a628-22c6b0d8aadb">2,973</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTMtMS0xLTEtMA_7908214f-b174-4ffc-9fa9-1f9c58544de5">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTMtMy0xLTEtMA_14d17baa-b766-48b6-ac43-2bc4d4f1a9d0">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTMtNS0xLTEtMA_6624364a-e41a-4c2e-8225-8dd8525b8e20">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTQtMS0xLTEtMA_7691bdb6-6bae-4990-add2-b684ab05dc69">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTQtMy0xLTEtMA_8904d060-9837-4ab3-845c-99ec1fe80d56">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTQtNS0xLTEtMA_0f2926fc-60fe-44e1-8850-b8e22ccbc94d">222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTUtMS0xLTEtMA_0375b3ff-9e3b-4a5e-8850-c158d2c4ba6e">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTUtMy0xLTEtMA_d4d0528a-cee5-4d62-be37-6118e83cc53b">607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTUtNS0xLTEtMA_db768a5f-9c82-4fe9-8417-e48e96e4a160">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTYtMS0xLTEtMA_3b7e0551-44e9-4229-a7e3-06fc7e7c2802">2,168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTYtMy0xLTEtMA_7bdece91-b304-437d-b799-a01db1371a12">1,995</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTYtNS0xLTEtMA_4076f759-358a-4752-8337-515a5fd053ec">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (SUPPLEMENTAL INFORMATION)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.067%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Supplemental Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash (received) paid for income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMy0xLTEtMS0w_2e4df21e-457c-4c0d-a2de-1bb3e6a2d927">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMy0zLTEtMS0w_5d6c5a3b-1105-47f5-a236-d0c31f1c061c">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMy01LTEtMS0w_6ce81610-0363-4151-943a-712ad74605a9">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNC0xLTEtMS0w_3ffdf567-ab47-4f34-83b2-704fb9d021ae">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNC0zLTEtMS0w_321e5860-73f5-4da6-8e5d-dd8b6784f6dd">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNC01LTEtMS0w_94ccb1e0-6820-4190-a758-8c054aa5cbad">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of contingent consideration recorded in purchase accounting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNS0xLTEtMS0w_f495e3bc-8ca9-4a89-a0ea-8f21af21b6b3">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNS0zLTEtMS0w_b1258929-ea23-4dc3-baf5-52ae74459e36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNS01LTEtMS0w_eb1d2e38-a2b4-4f14-9040-248ed162e07c">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" sign="-" name="bsx:NonCashImpactOfTransferredRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNi0xLTEtMS0w_437a5c6f-9036-4f93-be67-a2e4b18e338a">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" sign="-" name="bsx:NonCashImpactOfTransferredRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNi0zLTEtMS0w_11fb8864-6089-423f-9437-aa01c5a53d8a">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="bsx:NonCashImpactOfTransferredRoyaltyRights" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNi01LTEtMS0w_34419848-ca87-4716-9d41-4a6c57e7200b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation to amounts within the consolidated balance sheets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTEtMS0xLTEtMA_b82f3703-3870-4b0b-96cd-c3a57575ea89">1,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTEtMy0xLTEtMA_a805072c-001b-441e-a078-8b99995841fd">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTEtNS0xLTEtMA_6b2c6851-e299-40fa-a5c6-732badae452c">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTItMS0xLTEtMA_aac0ba3f-c1fc-44d8-b5b6-1379e120b8bd">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTItMy0xLTEtMA_3f0251d4-3940-4b17-9228-11696ebdc429">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTItNS0xLTEtMA_f0905ac9-7e93-4a6e-9f28-a6721a227a23">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTMtMS0xLTEtMA_0e6b7fcf-bdf6-4e27-b77b-70f8f6734403">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTMtMy0xLTEtMA_6c42cca0-df00-4486-b96e-b6cc7183ac1e">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTMtNS0xLTEtMA_78a80c7c-991b-4a20-902f-b51703aef8ad">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTQtMS0xLTEtMA_c275a0ab-3d27-4803-bc60-33d590dd8c0b">2,168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTQtMy0xLTEtMA_9e097783-5fad-442c-846e-b3e52207dff0">1,995</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTQtNS0xLTEtMA_7fde62d4-6145-445f-a462-f90a0cecaf67">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_94"></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyMTM_5bb85086-fb6b-4958-b8c9-5f1b10760075" continuedAt="ib6dad6408e344df7af6c8b45ad7f4dfe" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; SIGNIFICANT ACCOUNTING POLICIES</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNDk_091055c5-02ce-40a9-8238-b933be0b06ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#8217;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2021, 2020 or 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyMDg_d9f58d19-d6dd-45a6-9a2d-d21934366aa3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note O &#8211; Segment Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTQ_58166162-1cb1-4d8e-8c38-4a6064142bc1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for further discussion.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxNzc_df95f8d3-2fbc-442e-9d2b-99234231bae5" continuedAt="i82257a9a74ba4cb896ea6108fc2f4965" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib6dad6408e344df7af6c8b45ad7f4dfe" continuedAt="id6a73921254f4d77be99b9aed2e2cbf3"><ix:continuation id="i82257a9a74ba4cb896ea6108fc2f4965" continuedAt="i364730dcb0e545e88c3598d6fb6adad9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash Equivalents</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i364730dcb0e545e88c3598d6fb6adad9" continuedAt="i8b42a51b01c748c3a7a21c65f3c4e286"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8b42a51b01c748c3a7a21c65f3c4e286">caption within our consolidated balance sheets are related to deferred compensation plans.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxOTc_6a80a50d-5576-4962-b07f-61fa7e48cae9" continuedAt="i0eada5d9eb9d4ea3b4fea14fad89b32e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We write-off amounts determined to be uncollectible against this reserve. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2021, 2020 and 2019; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i0eada5d9eb9d4ea3b4fea14fad89b32e" continuedAt="i9f8e40d6a83142a08fc118a1a837d57e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes in the U.S. toward non-hospital settings, particularly ambulatory surgery centers and office-based labs. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9f8e40d6a83142a08fc118a1a837d57e"> is adequate as of December&#160;31, 2021; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase.</ix:continuation> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxNjM_ed25a185-364d-4cb7-8f86-3b81ceb8c12e" continuedAt="iae7b67e29e6b4f17b71052bcfd3df5a1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a contract with a customer that creates enforceable rights and obligations,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Promised products or services are identified,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The transaction price, or the amount we expect to receive, is determinable and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have transferred control of the promised items to the customer.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id6a73921254f4d77be99b9aed2e2cbf3" continuedAt="i7913a93b3a964cf7ad642e478ada0d79"><ix:continuation id="iae7b67e29e6b4f17b71052bcfd3df5a1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management (CRM) product offerings combine the sale of a device with our LATITUDE&#8482; Patient Management System, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers, where necessary, to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these services at the time the devices are sold. We record these costs to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczNDU_61ecc4cb-3ace-4323-bc27-247c3abfb52b" continuedAt="i15777e7fd07e4a5f8f7d8b461801df8d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7913a93b3a964cf7ad642e478ada0d79" continuedAt="i02fd826fff0542e2a535b0c295586d10"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i15777e7fd07e4a5f8f7d8b461801df8d">liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczODU_830ae477-2ebc-4962-9502-891742bf16ac" continuedAt="ia71dba64a966462ca53e05d7d117ab09" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During 2020, we recorded $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProductionRelatedImpairmentsOrCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzg0ODI5MDczNjYyNg_7ac2255e-bb24-4ffb-b352-c2768ac35940">149</ix:nonFraction>&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2021 or 2019.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia71dba64a966462ca53e05d7d117ab09">We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMDg_e0f020e0-819e-43c0-b6a9-4adcb17a356c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNjk_3a096eea-46cd-45ab-8c90-82a38ace1e24" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Business Combinations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where we acquire a company in which we previously held an equity stake, we attribute a portion of the purchase price to the previously-held equity interest, which is implied based on the total purchase consideration allocable to each of the shareholders, including Boston Scientific, according to priority of equity interests. We record a gain or loss in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equal to the difference between the implied fair value of our prior ownership and the book value immediately prior to the acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration net expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:InProcessResearchAndDevelopmentPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTE_5584475c-7c76-4ba3-9650-698852bc256c" continuedAt="ic84a3840daa24472838db03c635da695" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived Intangibles and IPR&amp;D </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which are foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, as well as IPR&amp;D intangible assets acquired in a business combination. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i02fd826fff0542e2a535b0c295586d10" continuedAt="i115e52e393144a4eac0e99fe1c72acba"><ix:continuation id="ic84a3840daa24472838db03c635da695" continuedAt="idad5dbaa43a34c96b8fdb366c7d794c9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;D intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the income approach to determine the fair values of our IPR&amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#8217; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to indefinite-lived intangibles, including IPR&amp;D.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idad5dbaa43a34c96b8fdb366c7d794c9">For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczNjQ_8b92fd05-1118-4432-aaaf-2713e65746b4" continuedAt="i758d7fa99a494902bf68982a8d7c6981" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization and Impairment of Intangible Assets </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to impairments of intangible assets.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i758d7fa99a494902bf68982a8d7c6981">For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNzA_f10269a4-3697-459e-82ea-947f2698fb8b" continuedAt="i791a469958ca42b1849bd23e35276960" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Valuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i115e52e393144a4eac0e99fe1c72acba" continuedAt="ie6f1ed06b28c4e11a3397bd66f2d1864"><ix:continuation id="i791a469958ca42b1849bd23e35276960" continuedAt="i32478ab636f745e3b7f80ae7d4533527"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2021 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. For purposes of the goodwill impairment test, we aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i32478ab636f745e3b7f80ae7d4533527">In the second quarter of&#160;2021, we performed our annual goodwill impairment test utilizing the quantitative assessment approach to test all of our reporting units. We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTI_13181b69-58bf-47e6-af2e-f8c4e60d5e8d" continuedAt="i58d8d1142d2140d08d038dfc62dde1cb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Publicly Traded and Privately-Held Entities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities for which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Investments - Debt and Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details on our investment balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#8217;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment is impaired and we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i58d8d1142d2140d08d038dfc62dde1cb" continuedAt="i6dea0cdb169c4cdcb1505082eb638fd8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses and impairments associated with our investment portfolio are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6dea0cdb169c4cdcb1505082eb638fd8">in our consolidated statements of operations.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMzQ_022529a9-b44a-430b-a2a4-6afd70f8e036" continuedAt="if178261aec0f4e43a30ecdb259c2cee9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie6f1ed06b28c4e11a3397bd66f2d1864" continuedAt="ic15c937eee444c97927d7e11cd16530f"><div style="text-align:justify"><ix:continuation id="if178261aec0f4e43a30ecdb259c2cee9" continuedAt="i7d91f04ad3494a1ab1dfd8601b16671d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7d91f04ad3494a1ab1dfd8601b16671d"> for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA</ix:continuation>.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMTA_f8616ea1-79ae-4952-9dad-30057cc39bed" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Product Liability Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities and product liability litigation. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of our individual material legal proceedings.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMjg_e7f1c4c0-17b5-46ab-80e6-9d30280468d3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record employee termination costs in accordance with FASB ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. We record such costs into expense over the employee&#8217;s future service period, if any. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information and discussion of our restructuring plans.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczNTA_7d040f05-6b96-45f0-8a40-96f4b3b55a54" continuedAt="i97601cdcd2e042918ce1e38540045744" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currency</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i97601cdcd2e042918ce1e38540045744" continuedAt="i5ae361cc909d41d382d2e2fb753f8e66"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency transaction gains and losses are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5ae361cc909d41d382d2e2fb753f8e66">in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments.</ix:continuation> </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic15c937eee444c97927d7e11cd16530f"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTM_0b44e97f-6fc6-45cb-84a6-25875bb2df90" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments<ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" xsi:nil="true" name="bsx:ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxNjg_951b35b3-f878-4a8b-9941-d1ed88194c65" escape="true"></ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our hedging instruments.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMTU_c87eba7d-8963-46b0-ba59-8c07cf45728d" continuedAt="i26ab5a23ff6649ef974ca957bb4b6abd" escape="true">Shipping and Handling Costs</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i26ab5a23ff6649ef974ca957bb4b6abd" continuedAt="ifcdac77262e94562926acffeba05e6df"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not bill customers for shipping and handling of our products. We treat shipping costs incurred after a customer obtains control of the good as a fulfillment cost and record in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifcdac77262e94562926acffeba05e6df">within our consolidated statements of operations. Shipping costs were $<ix:nonFraction unitRef="usd" contextRef="i80c252fab7084dbaa7b52601cb17955e_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzY3ODY_da8e1bbe-c44f-426e-93d5-818944b6abdd">194</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i09fba96124454331976d8e4961c807b5_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzY3OTY_ba277019-dfb2-4222-adfe-5621252e049d">146</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i58e8f5b2e3704a63ba7c4e8c062839c7_D20190101-20191231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzY4MDk_a2339be3-51fd-4535-bf5b-57ebb179cd4b">144</ix:nonFraction> million in 2019</ix:continuation>.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNDM_f48b3348-c4a1-497f-bf83-204f7386e64a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development (R&amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Indefinite-lived Intangibles and IPR&amp;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for our policy regarding R&amp;D projects acquired in connection with our business combinations and asset purchases.</span></div></ix:nonNumeric></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_97"></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7862dc97bbe245dc92c012be4bc24ff9_D20210806-20210806" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwNzE_e89db4b3-43e9-45d3-911b-7555bee97a89" continuedAt="i01d9bb58caa54a06ab4b43c0e89f5ba0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS AND STRATEGIC INVESTMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed four acquisitions and one divestiture in 2021 and did not complete any material acquisitions during 2020. We have not presented supplemental pro forma financial information for any of our recent acquisitions given their results are not material to our consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which has developed the radiofrequency (RF) NRG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and VersaCross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which will expand our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment using cash on hand of $<ix:nonFraction unitRef="usd" contextRef="ia4c1e55cd1e444d88c6ef56f87ecf676_D20220214-20220214" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzExOQ_45e7b7f8-cf3c-40c2-bda0-e2d592ef05a3">1.750</ix:nonFraction> billion subject to closing adjustments. We plan to integrate the Baylis Medical business into our Electrophysiology division, supported by our structural heart sales force.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed our acquisition of the remaining shares of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODI4Nw_e42660a7-da36-4fd7-85a1-7610985bdd35">925</ix:nonFraction> million and up to an additional $<ix:nonFraction unitRef="usd" contextRef="i43a1b72be8d74d5eb954a3448a0598e7_I20210301" decimals="-6" name="bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODI5NQ_73c39128-9dae-49a6-a79d-895bc387da0b">300</ix:nonFraction> million in a potential commercial milestone payment. We had been an investor in Preventice since 2015 and held an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="i43a1b72be8d74d5eb954a3448a0598e7_I20210301" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMwMQ_f9fdeed0-71f0-4f72-a5d7-cf2da122a454">22</ix:nonFraction> percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $<ix:nonFraction unitRef="usd" contextRef="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMwOA_ad5b2872-c3d3-4ec7-8798-7fd65ec887e0">196</ix:nonFraction> million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMxNQ_8f7b242a-785c-46ab-bf83-8538dc98a7d0">706</ix:nonFraction> million, net of cash acquired, and up to approximately $<ix:nonFraction unitRef="usd" contextRef="i43a1b72be8d74d5eb954a3448a0598e7_I20210301" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMyNg_b267b9a4-0fa6-4808-b086-8de33d490b9e">230</ix:nonFraction> million in future milestone payments. The Preventice business is being managed by our Cardiac Rhythm Management division. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i01d9bb58caa54a06ab4b43c0e89f5ba0" continuedAt="ie0de6963aff84eaaa3e8a0a16a62d0a9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse, Inc. (Farapulse), a privately-held company that has developed a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i07946074b2524113bd25ea3602907bae_D20210806-20210806" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODg4OA_bc500af3-4864-4b0f-8d2b-83a07df97aa8">450</ix:nonFraction> million, up to $<ix:nonFraction unitRef="usd" contextRef="i27aafceb9a8241bb8a7b5487131b9106_I20210806" decimals="-6" name="bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODg5OQ_236831bf-3ad5-4be4-9ebc-ccf128541adc">125</ix:nonFraction> million upon achievement of certain clinical and regulatory milestones and additional revenue-based payments over the next <ix:nonNumeric contextRef="i07946074b2524113bd25ea3602907bae_D20210806-20210806" name="bsx:BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkxNg_9e86f45b-b97c-429b-abd3-0f1ba8f77510">three years</ix:nonNumeric>. We had been an investor in Farapulse since 2014 and held an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="i27aafceb9a8241bb8a7b5487131b9106_I20210806" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkxOQ_7f93b43a-af02-472b-bc09-52cf465ab638">27</ix:nonFraction> percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests which resulted in a $<ix:nonFraction unitRef="usd" contextRef="i07946074b2524113bd25ea3602907bae_D20210806-20210806" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkyNg_0beb0c7e-b4d4-4cad-9f97-c823e0e9f739">222</ix:nonFraction> million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i0930e389c7ed4a8a9b076aa4c40709ee_D20210806-20210806" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkzNg_97fecd1a-beaa-40b7-a84b-d064d1835137">268</ix:nonFraction> million, net of cash acquired, and up to approximately $<ix:nonFraction unitRef="usd" contextRef="i27aafceb9a8241bb8a7b5487131b9106_I20210806" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODk0Mw_4ca11cd0-ccc3-48dd-b9bd-447ff4e640e9">92</ix:nonFraction> million in future milestone payments. The Farapulse business is being integrated into our Electrophysiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2021, we completed our acquisition of the global surgical business of Lumenis LTD. (Lumenis), a privately-held company that develops and commercializes energy-based medical solutions, including innovative laser systems, fibers and accessories used for urology and otolaryngology procedures. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i30d60e95a9ad4691b3c08057fb408f2c_D20210901-20210901" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODk0OQ_60c750e2-0070-44eb-adb1-e55b6f6c6c5a">1.032</ix:nonFraction> billion, net of cash acquired. The Lumenis business is being integrated into our Urology and Pelvic Health division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2021, we completed our acquisition of the remaining shares of Devoro Medical, Inc. (Devoro Medical), a privately-held company which has developed the WOLF Thrombectomy&#174; Platform, a non-console and lytic-free platform designed to rapidly capture and extract blood clots in arterial, venous and pulmonary embolism procedures. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTMxOTQxMzk1ODQxNjM_814defa1-de29-43d2-a8ec-6008fea172c4">320</ix:nonFraction> million and up to $<ix:nonFraction unitRef="usd" contextRef="i9d817719bd624f91ba936d54cd189dd0_I20211108" decimals="-6" name="bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTMxOTQxMzk1ODQxOTk_e8ad2d4a-2a05-4ce9-baf2-992f6fcad12d">80</ix:nonFraction> million upon achievement of certain clinical and regulatory milestones. We had been an investor in Devoro Medical since 2019 and held an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="i2e35130934fd4a358eacac841a7a82fb_I20211108" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MTEzNw_bb5fa2e5-85d8-48aa-9f3c-c91d23706b43">16</ix:nonFraction> percent. We remeasured the fair value of our previously held investment based on the allocation of the purchase price according to priority of equity interests which resulted in a $<ix:nonFraction unitRef="usd" contextRef="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTA5OTUxMTY3MDc4MQ_2f133948-ad74-487b-94ed-83ee8f8c7f6d">57</ix:nonFraction> million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwOTI3Mw_8b0a2a82-fefe-4d78-ae20-804d5aa6a846">251</ix:nonFraction> million, net of cash acquired, and up to approximately $<ix:nonFraction unitRef="usd" contextRef="i9d817719bd624f91ba936d54cd189dd0_I20211108" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwOTI5MA_b58b0730-9e16-4148-9839-eeb50e5c6ea4">67</ix:nonFraction> million in future milestone payments. The Devoro Medical business is being integrated into our Peripheral Interventions division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price for the acquisitions completed during 2021 were comprised of the components presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. <ix:nonNumeric contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwODg0Mg_edb0c580-aed2-4832-a70b-4c537f93de52" continuedAt="i7d7520b4f82d443580599b34d8b95727" escape="true">The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, </ix:nonNumeric></span><ix:continuation id="i7d7520b4f82d443580599b34d8b95727" continuedAt="i3910c9a4938b4d799f1b4f59b5f57d06"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i3910c9a4938b4d799f1b4f59b5f57d06"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preventice</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lumenis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375363a8a82747f993aef5796e14a72c_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS0xLTEtMS00MzA5Ng_15702b9c-40c7-4c1d-a5e4-8e2abedf146e">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977a60dd4a094b4badc4cc6074972559_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS0zLTEtMS00MzA5Ng_3a5e653c-aa25-4280-9a49-befae9da6c60">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied21f3ab578a46919e7241d90ab45962_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS01LTEtMS00MzA5Ng_36daa52f-019c-49b3-8c14-7ea43e4c668c">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS02LTEtMS00MzA5Ng_6182a9a2-a5ce-4188-bf5e-ae134fa8ff48">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi0xLTEtMS00MzA5Ng_818c68c0-e855-4897-af04-dd157d0a58a1">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi0zLTEtMS00MzA5Ng_92c4aeea-3494-43e4-b284-2b706e783b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi01LTEtMS00MzA5Ng_f9cf56c6-ce5d-47fa-8b7f-a5b3f1d48d2c">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi02LTEtMS00MzA5Ng_ac728c84-f77e-4321-8784-f73257ccd9db">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375363a8a82747f993aef5796e14a72c_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy0xLTEtMS00MzA5Ng_66d46d3c-93bf-43e5-8a43-e6f6c98365f5">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977a60dd4a094b4badc4cc6074972559_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy0zLTEtMS00MzA5Ng_c7130142-ae67-411b-86bb-a5c385475be4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied21f3ab578a46919e7241d90ab45962_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy01LTEtMS00MzA5Ng_cba41e9b-1824-46cb-8e9d-892fbd37010a">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy02LTEtMS00MzA5Ng_f16c57be-9281-4572-afea-05548a873495">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC0xLTEtMS00MzA5Ng_936aaa2d-5413-4ccc-9941-da022144dacd">1,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC0zLTEtMS00MzA5Ng_ee759ca6-daa0-4d16-a02e-2a1bd5004c6b">1,032</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC01LTEtMS00MzA5Ng_6a85ffbe-13db-4d60-aa00-0d4e0ac56377">1,025</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC02LTEtMS00MzA5Ng_93069b01-2927-4626-980a-fc3d563717b8">3,254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwODg0NA_33cdca37-4aef-4aea-a378-a8ddcd8c47ef" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation for these acquisitions was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preventice</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lumenis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS0xLTEtMS00MzA5Ng_8a0f1e56-40dd-47f5-878e-c42817ab42d2">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS0zLTEtMS00MzA5Ng_5f5f4d34-4072-4615-8715-944486b23bc3">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS01LTEtMS00MzA5Ng_44ee3187-a069-4b9f-9a33-a27969d4c603">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS02LTEtMS00MzA5Ng_6f37ffe3-720d-4fa5-b8d6-7b0bcea83af9">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi0xLTEtMS00MzA5Ng_7e7c5281-8c39-4bac-974b-09c3dcd31f71">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi0zLTEtMS00MzA5Ng_9edcf485-33fa-4045-ac16-559bee538532">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi01LTEtMS00MzA5Ng_9e9090c6-a22c-4a66-9444-001898b5f16c">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi02LTEtMS00MzA5Ng_cc2880b2-add3-44ce-81c8-9b94ea466736">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy0xLTEtMS00MzA5Ng_479c15ef-8bf1-457f-865a-b2b9a7e0b912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy0zLTEtMS00MzA5Ng_53b10272-bbef-4d3b-af97-e315cfd71408">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy01LTEtMS00MzA5Ng_c3b4ac7c-1413-4bc5-8d45-c401fc5caaf1">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy02LTEtMS00MzA5Ng_d1c7aa15-ec48-4c75-b3ed-68a47f7c983d">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC0xLTEtMS00MzA5Ng_dac11ed8-7ba1-493c-a1fe-7772afb63a38">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC0zLTEtMS00MzA5Ng_3429dac1-73d9-4d0b-ad97-58f37625b3a9">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC01LTEtMS00MzA5Ng_b2415e58-1268-4a4b-a763-a0e0fe611936">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC02LTEtMS00MzA5Ng_7f31ec85-8ba9-4582-82c7-2efb0ff98b8f">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi0xLTEtMS00MzA5Ng_a56e41a1-068c-4785-a635-2cf7a2b44b5c">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi0zLTEtMS00MzA5Ng_5f7115f7-6293-434e-bc68-18b50f8a2d95">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi01LTEtMS00MzA5Ng_2410158a-05a7-4827-91db-c60c25f5c73a">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi02LTEtMS00MzA5Ng_bca2b0ec-8838-444e-a73d-b158927bd3aa">144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy0xLTEtMS00MzA5Ng_86578dfe-d5ce-4457-9553-5d63327838bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy0zLTEtMS00MzA5Ng_58be5d95-80f6-48d9-9e61-002b59cfa355">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy01LTEtMS00MzA5Ng_d6717bd3-d6b6-4bde-97e3-1352f985c643">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy02LTEtMS01NzYwNg_7c979715-a011-46bd-bd6f-331d0f46cb13">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC0xLTEtMS00MzA5Ng_25efbe36-2d38-49e0-b11e-db9a37975e58">1,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC0zLTEtMS00MzA5Ng_6003a6e1-ddbb-4f51-81a4-566d75c15f13">1,032</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC01LTEtMS00MzA5Ng_d5d564e0-b2bd-456b-9bf9-6eb7992a6816">1,025</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC02LTEtMS00MzA5Ng_b441d6f8-d0aa-4411-8ea3-06b21dfaa9f9">3,254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie0de6963aff84eaaa3e8a0a16a62d0a9" continuedAt="if2d54e1cba0a4447a6fa8e98576d4328"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwODg0NQ_aee52995-1fe6-4ae2-b05f-b1a1627efbe0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Preventice:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4c18e74ac94029b4ed8c497c643638_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMy0xLTEtMS00MzA5Ng_cc1518dd-80b6-4ca7-881e-cc41261aece8">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2bd7513127242f78e881962dac45e4b_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMy0zLTEtMS00MzA5Ng_1bdf7a1b-ec4c-4a41-9d44-4d2935b3d560">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1a2eb59807f4fa98038488a67c899d4_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMy01LTEtMS00MzA5Ng_dd4b2351-ae9a-473c-b67c-0499e81e942d">10</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72d131180c20411ba4a7c16e8fbe7351_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfNS0xLTEtMS00MzA5Ng_46dc796f-3bf1-4bc6-86fc-5f3f2a47b232">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i56df3da0ec92473699d19c087728742d_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfNS0zLTEtMS00MzA5Ng_53f57919-8da8-48ed-aa8d-5567af28a4ba">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24bd565b73f44fe7aea51a237868fa51_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfNS01LTEtMS00MzA5Ng_247dc64d-5706-449d-b36d-9568de7fb891">10</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfOC0xLTEtMS00MzA5Ng_43ebcb2a-64d7-4684-b884-c6562863863c">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lumenis:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca66a6bcf654c779a82ae88dfb8e058_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTEtMS0xLTEtNDMwOTY_cf181ff3-fd71-4719-9b52-433fddfefc15">388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf5c1ca1458c4c31b1e096eda7cca942_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTEtMy0xLTEtNDMwOTY_85276785-96a8-4665-95a2-a2d8d61a7cde">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia67dafbfe3fe4b0bb926c4c9c35b4c4d_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTEtNS0xLTMtNjc4Mzk_1290670d-0368-40f3-9c14-82d879b3e63d">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401803de34c347149bdb6b113441fe31_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTMtMS0xLTEtNDMwOTY_3ab9797c-d96b-4161-8127-45bba9d717af">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if9051905a0e9457a9c8249141096c7af_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTMtMy0xLTEtNDMwOTY_1626b262-6b08-4572-acb5-1cd75c3dd302">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic188f63db33d43519ebe846287701578_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTMtNS0xLTMtNjc4Mzk_6d0708f1-78ab-4539-aeb3-1a37842711be">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1005dbdd4f84094bb2b629f0c0ad6f4_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTUtMS0xLTEtNDMwOTY_4c109b1a-c79c-4241-b67e-efc399370365">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8442535b691b4124862b82abe60ed41b_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTUtNS0xLTEtNDMwOTY_2285726d-c0ec-47e1-8ccd-5d6dab63711d">12</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTYtMS0xLTEtNDMwOTY_6e2001d0-4c80-47d1-afbe-0607e9d65319">492</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">All Other:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9cf6036d3a467d98b57608db9b9c7a_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktMS0xLTEtNDMwOTY_b0ade060-1ff1-4c2c-8b95-7d178801ae5b">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3f2a730fb2840249b185833474b5453_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktMy0xLTEtNDMwOTY_9c15ac38-552e-48f1-881c-2095be2c8b18">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i54b7493616504921a135abba92ddaa2e_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktNS0xLTEtNDMwOTY_55c26a4a-a641-4c40-8ab5-4241c30cf122">16</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14ccc97c93104644b760b49a50825d0f_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktNy0xLTEtNTc4ODA_0b137853-d016-4eb4-993f-532f792f79f6">17</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2558040a1a42e4bd8cc29eb78555e7_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMjMtMS0xLTEtNDMwOTY_e8da4a57-2f3b-4166-8812-4af16efed5c2">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe24aea88d3d42d5b34c3e42f204cbb6_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMjMtNS0xLTEtNDMwOTY_5e689c00-d8f2-472e-b755-1fde7b2d40c1">17</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMjQtMS0xLTEtNDMwOTY_3de6f5b4-d9d5-47a1-9c81-51f588e018b6">508</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzEzNw_8da66411-7af9-4c2b-ad3f-ef91c437d590">800</ix:nonFraction> million. The agreement included the transfer of <ix:nonFraction unitRef="usd" contextRef="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301" decimals="INF" name="bsx:DivestitureAgreementTransferOfFacilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzE2MQ_ac61593d-374e-4272-a3ee-bf6a154d9777">five</ix:nonFraction> facilities and approximately <ix:nonFraction unitRef="usd" contextRef="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301" decimals="INF" name="bsx:DivestitureAgreementTransferOfGlobalEmployees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzE2OQ_90035ea7-d494-4e7c-94c1-752048355c4e">280</ix:nonFraction> employees globally. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheet as of December 31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BTG plc</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;19, 2019, we completed our acquisition of BTG plc (BTG), a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we integrated BTG's Interventional Medicine business into our Peripheral Interventions division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Interventional Medicine product lines, the BTG portfolio also included the Specialty Pharmaceuticals business, comprised of acute care antidotes to treat overexposure to certain medications and toxins. On March 1, 2021, we completed the divestiture of Specialty Pharmaceuticals for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjQyNw_98999cdd-4e00-4d40-a269-654a34634e5f">800</ix:nonFraction> million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if2d54e1cba0a4447a6fa8e98576d4328" continuedAt="i7069d3964ba743948d1353bd6bd83e2d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BTG portfolio further included a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. In connection with the acquisition, we acquired rights to future royalties associated with the Zytiga&#8482; Drug used to treat certain forms of prostate cancer. In the fourth quarter of 2019, we sold our rights to these royalties for $<ix:nonFraction unitRef="usd" contextRef="id6132cb03cef491d949660bfc42e7b5c_D20190101-20191231" decimals="-6" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjg4Ng_9aad64fc-e622-413e-bd6a-e8e3f5e38219">256</ix:nonFraction> million in cash, included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price for the acquisition of BTG consisted of upfront cash in the aggregate amount of &#163;<ix:nonFraction unitRef="gbp" contextRef="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzA2Nw_ef068c32-13c9-423a-a51a-358db1d63a32">3.312</ix:nonFraction> billion (or $<ix:nonFraction unitRef="usd" contextRef="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzA3NA_8851c2bc-6839-4817-a951-85bf8cbb0df7">4.023</ix:nonFraction> billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received <ix:nonFraction unitRef="gbpPerShare" contextRef="ic42ef98edc4741318f57c64a9bfb2735_I20190819" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzIyMg_efc7a49b-d3df-4478-aefa-cfc2bd51b85e">840</ix:nonFraction> pence (or $<ix:nonFraction unitRef="usdPerShare" contextRef="ic42ef98edc4741318f57c64a9bfb2735_I20190819" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzIyOQ_6dba3adb-c97e-41f5-8863-438e8e0f319d">10.20</ix:nonFraction> based on the exchange rate at closing) in cash for each BTG share. The transaction price included $<ix:nonFraction unitRef="usd" contextRef="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzMzMA_5df4ee44-ada4-427f-9293-e4757fdec1a5">404</ix:nonFraction> million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#160;Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. <ix:nonNumeric contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMjI_f31d293a-7da8-4ec0-bbb4-00b8b9d3894d" continuedAt="idf0b8468652a4a4a8d884b1a36c0620f" escape="true">The final purchase price was comprised of the following components:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="idf0b8468652a4a4a8d884b1a36c0620f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6132cb03cef491d949660bfc42e7b5c_D20190101-20191231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmFhOTQ4NmUwOWYzNzQ1MmY5MTU3ZGRhMmZiODg4ODY1L3RhYmxlcmFuZ2U6YWE5NDg2ZTA5ZjM3NDUyZjkxNTdkZGEyZmI4ODg4NjVfMS0xLTEtMS0w_81c8bb1e-3269-402b-858b-7ac5cc3c5d3c">3,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><ix:nonNumeric contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMjA_d5773b9a-006d-45ca-bd6a-7c0c53c80237" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase price allocation was comprised of the following components:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMS0xLTEtMS0w_e4fa88c4-a8bb-4da9-b0f0-607fec596559">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMy0xLTEtMS0w_e2736c1a-90c0-4e4e-b0d4-cc2e5851b9f0">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNC0xLTEtMS0w_acec2c35-953f-48cb-ad04-9b4d8304e65a">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNS0xLTEtMS0w_9ed39eab-0848-4ba4-99b2-9b2e7ac41099">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNi0xLTEtMS0w_c2b460fb-a1ac-47a4-b167-96b92c7e7819">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNy0xLTEtMS0w_6a657afb-9a7c-4698-9715-2cd8f3733b9c">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfOC0xLTEtMS0w_3294646a-8b20-4e35-a897-152f66061ac5">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfOS0xLTEtMS0w_81fec69c-d490-463b-abff-845d37de334b">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMTAtMS0xLTEtMA_7989848b-3e3f-4b8e-9ed4-d64b27802320">349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMTEtMS0xLTEtMA_738dc3ea-9f0b-461a-9d9e-e889fc55b7d8">3,619</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div><ix:nonNumeric contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwNzM_c3fab591-bb76-4449-9473-daf93720860e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7b4ebd9d21548d3b495be941b489706_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi0xLTEtMS0w_7eb2b649-756b-4d75-bac2-e98a6e73d08f">1,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i326847b5c1684d50bd21f2c964e25e95_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi0zLTEtMS0w_21c64df7-c12e-4a61-a9ee-8e5973deedf6">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i031288d26dbe4dad9111cf8a737a815e_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi01LTEtMS0w_0451346b-a9da-4621-9346-7bf30fe14ee2">18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i326847b5c1684d50bd21f2c964e25e95_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi03LTEtMS0w_4883740e-6305-47f9-8d10-c6da1d07a088">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i031288d26dbe4dad9111cf8a737a815e_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi05LTEtMS0w_ea679ebd-1437-4138-9b59-c67c9c20e2f1">12</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4831b01bd4334a1abd79911b16ed4c3c_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS0xLTEtMS0w_bf1ff931-580f-441f-ab83-68b82fc9b8d5">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i13cb159d3e45462a9c50314d05440d78_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS0zLTEtMS0w_586b3521-e245-458b-af7c-0ac19b0297a4">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia6f4b506c8c24f178b63a4f53ff627dd_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS01LTEtMS0w_e019f7f6-a9c1-4867-82f7-a8489fd811e8">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f53f48683c54762a784b30fca510244_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS03LTEtMS0w_b5157859-721d-41e8-a873-57887e10cbf9">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfOC0xLTEtMS0w_52d4be18-b14d-4a8e-81e1-ba16afbeffea">1,785</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized goodwill of $<ix:nonFraction unitRef="usd" contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNDA1Nw_e4fa88c4-a8bb-4da9-b0f0-607fec596559">1.635</ix:nonFraction> billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. We allocated $<ix:nonFraction unitRef="usd" contextRef="id35802ead11946739ec96eb588e199b4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNDIyNw_07c7d02d-108a-4e85-9a13-2ce49fddea43">1.399</ix:nonFraction> billion to our Peripheral Interventions reporting unit and $<ix:nonFraction unitRef="usd" contextRef="i7059a74267434518bbc0ed0077d56f7d_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNDI4MQ_cee5f3c9-f345-46fe-bcc4-8e10b34dbd2f">236</ix:nonFraction> million to the Specialty Pharmaceuticals reporting unit. In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of  $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NDEzOA_781d2c58-31be-4ea1-bec9-c377fa96c674">73</ix:nonFraction> million related to the execution of a definitive agreement to sell our Specialty Pharmaceuticals business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7069d3964ba743948d1353bd6bd83e2d" continuedAt="i78e5804e434a470a9ba7b49ed7183e6e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vertiflex, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2019, we completed our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#8482; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i236d0e3aac6448faa715c3f08ec819a6_D20190611-20190611" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjAyOA_a3acf473-ea5d-4f04-8e83-f5bf1d0eebc5">465</ix:nonFraction> million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of <ix:nonFraction unitRef="usd" contextRef="i60e5a145ef214a48b006713d03a06923_I20190611" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjI2Nw_eec07331-c302-401c-a26b-a37857ac3ab8">zero</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i60e5a145ef214a48b006713d03a06923_I20190611" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjI3Mw_68172cce-0e58-4909-9367-8d407d0e0e8b">100</ix:nonFraction> million; however, the payments are uncapped over the three year earn-out period. Through December&#160;31, 2021, we have made incremental payments of $<ix:nonFraction unitRef="usd" contextRef="i8efe8988e2544797a55f44fb65e85f88_I20211231" decimals="-6" name="bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjM5OA_7df924a1-a2fb-49fa-8f02-2ca0e497ee48">20</ix:nonFraction> million to the prior shareholders of Vertiflex in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Millipede, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we completed our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i0136ac01ee9747ddbfdbac14e429ec42_D20190129-20190129" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzEzMg_fe8433e4-0456-44f9-8ceb-2607cb23a93c">90</ix:nonFraction> million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately <ix:nonFraction unitRef="number" contextRef="i2b58c1611a834f2ca3ba6c6410d7b13e_I20190129" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzM0MQ_9cb65d45-5eac-4473-9fd4-ec8759d8ed4c">20</ix:nonFraction> percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i0136ac01ee9747ddbfdbac14e429ec42_D20190129-20190129" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzY2NA_02cb6d6e-bacc-4745-940c-2f39bd73cad4">325</ix:nonFraction> million and up to an additional $<ix:nonFraction unitRef="usd" contextRef="i2b58c1611a834f2ca3ba6c6410d7b13e_I20190129" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzY5MQ_1143bdfd-2249-4ec4-9b71-470c4277312a">125</ix:nonFraction> million payment upon achievement of a commercial milestone. During 2021, we cancelled the Millipede mitral valve IPR&amp;D program, recording intangible asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i0fffb8b77bc043679725e5bc32404c66_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTA5OTUxMTY4MDUxNg_7310086d-74e4-4314-b855-f0a86fb8e9b8">242</ix:nonFraction> million, and a contingent consideration benefit of $<ix:nonFraction unitRef="usd" contextRef="i0fffb8b77bc043679725e5bc32404c66_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwMzczMw_0a3feb90-9388-4af6-b8dc-cfe2a3e39692">104</ix:nonFraction> million for milestones that would not be achieved due to the cancellation of the program due to the time and financial investment required to commercialize the platform.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. <ix:nonNumeric contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwODA_8ff14a44-bffe-44e2-9ae5-2ead161a62ee" continuedAt="ic781969a2bc24a8d8fdbbff1eafeb977" escape="true">The final purchase prices were comprised of the following components:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="ic781969a2bc24a8d8fdbbff1eafeb977"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfMS0xLTEtMS0w_0cbe42b1-5025-41d2-ba35-0ec8fc8754fe">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfMi0xLTEtMS0w_194a2dcd-3884-4ab5-9388-3e2e01804d81">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfMy0xLTEtMS0w_cf49ee35-b38f-4599-a54c-f8bc08300a2f">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfNC0xLTEtMS0w_02e867b9-c75e-409b-a2c4-0c81706e635e">992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMDI_8c9f0181-902b-4d4e-b69d-142447b6372e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfMS0xLTEtMS0w_69584f3a-4d3c-4c76-91de-d4d8e94fbfce">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfMi0xLTEtMS0w_3bfebd14-4556-42a9-803a-284ec51bb029">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfMy0xLTEtMS0w_94ccaec0-da62-472d-a062-6d423e95a501">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNC0xLTEtMS0w_a141c05b-c367-4aa2-bdbc-81bd4d9bc912">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNS0xLTEtMS0w_4d70c28e-6bba-4057-bbb3-07382a0ce9b1">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNi0xLTEtMS0w_a026775b-042a-4c29-ad4e-67d54c24ce99">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNy0xLTEtMS0w_aae31627-104e-41ad-b352-30e1875d99b3">992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i78e5804e434a470a9ba7b49ed7183e6e" continuedAt="i67d6b13e52c1416a964f29e0c7577299"><div><ix:nonNumeric contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMTQ_b6646816-20a7-440e-8acd-a256cf77353e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia220fba2afe640c5b10959e748bdc0f4_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfMi0xLTEtMS0w_7138d518-5ded-4f5b-9de4-ef426608804a">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e6697aaff074326a490c1c4df961df1_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfMi0zLTEtMS0w_a675a33f-1663-4ca7-87d3-007684dd13b4">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e6697aaff074326a490c1c4df961df1_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfMi03LTEtMS0w_bdf5d8c3-76f5-4991-965c-aa1f3a7216e5">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0222b251d46f4b5b9adba6a70f6ca5b4_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNC0xLTEtMS0w_68084c11-b778-429c-9097-35c4c8e60798">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icc5e6407019d4c5ba9239b2dc0326dc9_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNC0zLTEtMS0w_f36f2f07-4f8d-4222-b827-e4d7c70e62e6">12</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc5e6407019d4c5ba9239b2dc0326dc9_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNC03LTEtMS0w_7dd47fa5-86c8-482b-a258-a65f34d3f0e7">15</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e20a416e72492f8ea6b11da4fca76d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNi0xLTEtMS0w_3ab52442-84f6-4668-a44b-e3f32d42e1bf">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i934dc3da23a444f68c5411629abd5c05_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNi03LTEtMS0w_da48d9a4-be6a-4949-bb38-d58c23253e5e">19</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNy0xLTEtMS0w_6f7cadde-4f89-49bb-a177-2620586908ae">461</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies. The goodwill recorded relating to our acquisitions is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMDQ_b487d601-07a9-42c7-8fe5-b3d4f182f391" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMS0xLTEtMS0w_3de42c7e-5c06-4e25-9781-e3c0288993ff">354</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNS0xLTEtMS0w_94884c9f-3438-4ac8-8f6f-d18a08da2359">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNi0xLTEtMS0w_e17d1430-c446-4853-9308-49ceefe42795">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNy0xLTEtMS0w_69efde8e-4063-4ef0-860a-814c34d7b68d">196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNS0xLTEtMS00NzUyMA_64943492-eb44-4303-bd5a-ff2c8c16bbad">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMTAtMS0xLTEtMA_08b212c8-5610-42e9-8c22-043a7135385a">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMTEtMS0xLTEtMA_7210e115-c40b-4452-ae37-6e08cdb2cb0a">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMTItMS0xLTEtMA_be53adc6-fbbd-45ca-9dc6-d731a5bb4c22">486</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $<ix:nonFraction unitRef="usd" contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTQ3MjM_f6a69ab9-4c88-456f-8da8-a70000afd713">986</ix:nonFraction> million, which includes amounts related to our recently completed acquisitions of Preventice, Farapulse and Devoro Medical.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net benefits of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NTA5OQ_0aec8765-7c08-4fc0-8343-8c7e97bb1dd2">136</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NTE1MQ_72f179b4-da98-48b2-b894-d6f1c9041894">100</ix:nonFraction> million recorded in 2021 and 2020, respectively, related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or, in the case of Millipede and nVision, for milestones that would not be achieved due to management's discontinuation of the associated R&amp;D program.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i67d6b13e52c1416a964f29e0c7577299" continuedAt="i4e1365d322684a0bb5c261df2102a73f"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwOTQ_599ce76b-a7d7-4874-a5dc-107e6e3d5a7b" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2b6cfcec597e408b9a5fd82f4348c035_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS0xLTEtMS0w_7ba12383-37ac-4e55-9a77-ed9d2e4aa65a">143</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia390ec0e6c2945b8ac3c143bec1f4d48_D20210101-20211231" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS00LTEtMS0w_be714cdf-dde9-4e74-8657-73c0a010834e">1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b52c801fa3443fba640800528e27d89_D20210101-20211231" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS02LTEtMS01MjkxMg_9acc325e-5e3f-40e7-85ea-e7bb1a2b8cad">2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i286ca5ae382c4a2c8eb259f86f360abc_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS03LTEtMS0w_3cf955ce-4c02-4ba1-9a77-f070d330d014">1</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2ada5aeb391411cb94688ce1c7bf045_I20211231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMi00LTEtMS0w_9943256f-c18f-4753-9b89-1542eeceed6f">80</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1679fab0c33040bea869e31b477d8218_I20211231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMi02LTEtMS01MjkxOQ_c502af2f-9443-4005-ba55-60eba24635f8">95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i240029b128a642eb92a242ba01b28e5b_I20211231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMi03LTEtMS0w_f3e23d09-b4e9-4e18-a858-da5c0ef53349">92</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i87fc5a1a4adc4ccfa36556f49b411e45_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC0xLTEtMS0w_b2b5f955-bf60-42b2-8fd4-7f5c647e5be2">343</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5279e9ef42dd4b35a8efebed33d86874_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC00LTEtMS0w_1c845bfa-d8a8-4574-b690-e66d1c70c84a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c6aab66b44f4082a6966e817d9f00ca_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC02LTEtMS0w_44070146-4563-48df-907b-1be1301de05b">14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44e14e1f91774b6ca60421226afdf115_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC03LTEtMS0w_403a8162-7369-4567-b83f-16f4e743da24">6</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cff2f3a775c477eb7e3299584301fe4_I20211231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNS00LTEtMS0w_f4a82f76-0406-47fa-8592-cd908529cf50">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2deb61987c348f792b6cc878f078498_I20211231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNS02LTEtMS0w_96ca9c16-f555-4b78-9041-99a77bbea8d1">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief5124b672194097aa937d5abf34195e_I20211231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNS03LTEtMS0w_04f43b18-a584-40d5-80fa-892e6f85bf5f">100</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to our R&amp;D, regulatory and commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMTA_8ff0850e-cd0e-4907-be5d-02e20578db31" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMi0xLTEtMS0w_47bf4340-0df9-4737-aceb-9174d03d1314">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMi0zLTEtMS0w_5ed40041-718f-47fb-8917-2c2ee26304c3">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMy0xLTEtMS0w_8c1753f8-0b86-40e6-a546-1d6e0beb30a6">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMy0zLTEtMS0w_db22d08b-0801-476c-8068-61960d06d265">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNC0xLTEtMS0w_d76a1f8d-b3de-489d-9fb7-ec6fa80420ee">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNC0zLTEtMS0w_05ec7278-4441-4f50-ac2b-919b8b1aebf4">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNS0xLTEtMS0w_486b9241-cd9a-4db3-8d3c-e21c54c371ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNS0zLTEtMS0w_ac60d9c4-d429-4994-8a50-6d9ff2b24edc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNi0xLTEtMS0w_33c880ae-77e1-491e-b4b4-0c4086e94d8e">412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNi0zLTEtMS0w_2a40fc78-779f-4a92-87f9-1e60a8e9514d">918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated statements of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i4e1365d322684a0bb5c261df2102a73f" continuedAt="ibe449ef01f244621886d94bf587d2ed5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NjMwOQ_61b51125-929c-4d21-adc8-ed5eff565df2">178</ix:nonFraction> million loss in 2021 and a $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NjMxMw_5479c258-1258-4fb4-bc27-aa66740db691">363</ix:nonFraction> million gain in 2020 on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibe449ef01f244621886d94bf587d2ed5"> associated with the remeasurement of our investment during the period to fair value based on observable market prices, as well as the disposition of our remaining ownership during 2021. As of December&#160;31, 2021, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTY5NTc_d1bef803-ba40-4efa-ac29-6e242bd5ad43">289</ix:nonFraction> million, which represents amortizable intangible assets, IPR&amp;D, goodwill and deferred tax liabilities.</ix:continuation> </span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_100"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzE0NTE_1079b178-49a7-484f-b076-cfb3436c26fc" continuedAt="ife5cb8053c214cab80976193e906b43f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; ASSETS AND LIABILITIES HELD FOR SALE</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group. On March 1, 2021, we completed the divestiture for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzI5Ng_98999cdd-4e00-4d40-a269-654a34634e5f">800</ix:nonFraction> million, which was subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of <ix:nonFraction unitRef="usd" contextRef="i9eaa1423fdfa4907a958a048b0c0d9d3_I20201231" decimals="INF" name="bsx:DivestitureAgreementTransferOfFacilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzIxOTkwMjMyNTc3OTQ_0ff6b1d3-a799-48cd-8020-219e2705823a">five</ix:nonFraction> facilities and approximately <ix:nonFraction unitRef="usd" contextRef="i9eaa1423fdfa4907a958a048b0c0d9d3_I20201231" decimals="INF" name="bsx:DivestitureAgreementTransferOfGlobalEmployees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzIxOTkwMjMyNTc4MDc_10509744-117c-4010-bfc7-d22226bb05e7">280</ix:nonFraction> employees globally. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheet as of December 31, 2020.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ife5cb8053c214cab80976193e906b43f" continuedAt="i245ec504892a41c0aa6944a76e617b33"><ix:nonNumeric contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzE0NTM_09cea33f-cbec-41fb-9c0f-82b4c7ef7146" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEtMS0xLTEtMA_d7ad5ce2-5981-4b45-ba2a-7a8bdb62acd9">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzItMS0xLTEtMA_962a635a-719f-499c-a9a9-6c47ba6373bd">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzMtMS0xLTEtMA_ff6a13ba-114e-43fa-8f88-8918bb80f1e4">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzQtMS0xLTEtMA_bcdb4eab-3064-489a-a67e-743ad1c9ebb8">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzUtMS0xLTEtMA_d7e4e52e-114a-4a8a-9cb2-d54c6c607adb">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzYtMS0xLTEtMA_c9776d16-d1da-4448-a0d0-9fbbda8c9eaa">758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="bsx:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzctMS0xLTEtMA_8480e8b7-004d-475e-80d4-faf1a2cf2643">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzgtMS0xLTEtMA_5106d95a-9309-47ae-80f0-5e47c40c00f1">1,133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEwLTEtMS0xLTA_bbe6d3d1-f4e8-4342-95bc-14671d4957db">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzExLTEtMS0xLTA_60ce901f-909e-4e21-a591-02e913cb6977">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEyLTEtMS0xLTA_42d99e4f-7f73-4478-89f5-2c4319d85fea">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other current liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEzLTEtMS0xLTA_343c9f56-44d2-472f-bba8-8386df4d50e6">200</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i245ec504892a41c0aa6944a76e617b33" continuedAt="ib879e2bb5ce24b0d9bc49b3d1511be0c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of December 31, 2020, we had foreign currency translation adjustments of $<ix:nonFraction unitRef="usd" contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzEyNjc_781e269a-e092-4cfe-ae73-d2436dd8e98e">107</ix:nonFraction> million contained within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib879e2bb5ce24b0d9bc49b3d1511be0c"> attributable to the Specialty Pharmaceuticals business that were released upon the closing of the transaction.</ix:continuation> </span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_103"></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NzA_ea66e7f3-bd0c-41d4-adb1-801371f941fd" continuedAt="i8a56155b28424e4ea48709caad9176f9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NzE_a85fc0eb-f6e1-4a3f-a14d-4a7bf5882311" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization/Write-offs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79008fc3f7c7470e85ee26a22fb45478_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItMS0xLTEtMA_ebb0b81a-9762-43c6-8481-f24f6c2315c2">11,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79008fc3f7c7470e85ee26a22fb45478_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItMy0xLTEtMA_78ab737e-de63-46da-8c67-52d59f0c0812">6,754</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a03dfab4d54a0eb2135b969c2e72db_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItNS0xLTEtMA_e9b22748-7e1c-409d-91e6-9cce4965d99d">11,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32a03dfab4d54a0eb2135b969c2e72db_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItNy0xLTEtMA_f844a07c-da22-4af1-a892-3a927f88c24a">6,179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia490ede05d664ada928496a145ece1b3_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtMS0xLTEtMA_5f30e4ac-1f16-4a5a-9842-f6dd62960740">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia490ede05d664ada928496a145ece1b3_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtMy0xLTEtMA_c5a62daa-edc5-40e6-8f57-02ba9ec8d877">398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1c6c4cd7c54799b4fa99f477778cb0_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtNS0xLTEtMA_b597a059-20d6-42c7-927e-1e862e576ca1">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b1c6c4cd7c54799b4fa99f477778cb0_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtNy0xLTEtMA_67766ecc-a381-42f7-9573-73b95aa69da3">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8b467de7e3474592af98d693a17cc6_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtMS0xLTEtMA_f07dd9b5-788d-4d5e-8830-c7c37b07be27">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f8b467de7e3474592af98d693a17cc6_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtMy0xLTEtMA_4d82d778-bb09-4200-b61b-f8705d570de5">1,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893db808ea6d4f7ead3577ea17638692_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtNS0xLTEtMA_1388b02a-812e-43f5-b892-509cf7e3bd07">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893db808ea6d4f7ead3577ea17638692_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtNy0xLTEtMA_a4a553f2-e12d-4b18-8185-18621a5341df">1,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtMS0xLTEtMA_51c78816-f327-45d2-92cb-df9fe462fa2a">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtMy0xLTEtMA_7ae2c8b0-99e4-4351-be37-f2a60a5a6466">8,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtNS0xLTEtMA_09a3f3eb-8bc3-47c3-b6d5-8726f6576e55">13,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtNy0xLTEtMA_94d74551-1afb-428f-a594-2bc7849cb019">7,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctMS0xLTEtMA_78bc23c6-dbcd-4fa4-b0ea-5a8eda698cc0">21,888</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctMy0xLTEtMA_3039b996-9138-4dfb-9c74-939676f67577">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctNS0xLTEtMA_245f2857-8c5c-460d-b2b5-1721710e6fca">19,924</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctNy0xLTEtMA_aa8ab595-8447-48e3-b712-7746962f764e">9,973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5942d7cff84bfcb443a0b4ee20e405_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzktMS0xLTEtMA_5fe51801-1e62-4157-bcf2-ab11a3c34fc9">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e92b1090f6e4a34bdde827d0faa1850_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzktNS0xLTEtMA_6c5f3202-baf3-4c15-ac07-552c060f07ce">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341295b5472d4fd5adb9a8a46d925465_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzEwLTEtMS0xLTA_f9c0362c-e365-4d87-bf55-6e00b8f3bef5">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i297b6847ff994bb0832cc1355bf182cd_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzEwLTUtMS0xLTA_f4bc35d4-f1fd-4933-93b3-248ef98a0623">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzExLTEtMS0xLTA_8809962a-a8ae-49f5-8ead-40930548bc7c">246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzExLTUtMS0xLTA_51a62d0c-d4ed-4e2c-90e1-9a3a99df82ae">377</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzIxOTkwMjMyNTgwODA_5336355d-484f-4bd3-915d-52c49c7c2538">73</ix:nonFraction>&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzIxOTkwMjMyNTgwOTQ_5336355d-484f-4bd3-915d-52c49c7c2538">73</ix:nonFraction>&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of December 31, 2021.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzQ5NA_0a71ea9d-7ac9-4ff1-8a0c-aa506615aea8">370</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzUwNA_0f1da7b9-49f0-470c-82a5-3ae931f03230">460</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzUxNw_9743aa41-97da-4386-92fa-3d2bbb535be9">105</ix:nonFraction> million in 2019. The impairment charges recorded in 2021 were primarily associated with intangible assets established in connection with our acquisition of Millipede, Inc. and VENITI, Inc. The impairment charges recorded in 2020 were primarily associated with intangible assets established in connection with our acquisitions of Sadra Medical, Inc., Apama Medical Inc. and nVision Medical Corporation (nVision). Each of these impairment charges were recorded following management&#8217;s decision to cancel </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8a56155b28424e4ea48709caad9176f9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the programs due to the length of time, and remaining cost to complete and commercialize the technology, the cost to remediate quality issues or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NzM_66a21c45-1d38-40b9-a4e5-9278f9cafa16" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed6b73fff7f49ae9d9bbaf6f9c9bd80_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtMS0xLTEtMA_2fcffc93-8ae0-4143-b1fd-c6a27310feda">2,061</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id527155f2d674c79ab6ae71c08673835_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtMy0xLTEtMA_04268ed0-9a94-4967-915a-dd77ac73d4e7">2,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f44a484dff44c3b6ed7ba7f19327d1_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtNS0xLTEtMA_8c5f4196-0090-4faa-aeac-dd1c1f637779">5,676</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246516f377cc4e69991858548b75cc3a_I20191231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtNy0xLTEtMA_c90e3eb6-e334-4a50-8a8f-41e87bc7e5e1">247</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtOS0xLTEtMA_2ca8e45c-008a-4054-a191-56b23d1eb3ef">10,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtMS0xLTEtMA_9c9d4203-780d-4fe7-bad1-83c6f1f6f020">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtMy0xLTEtMA_4ab9284b-6587-4039-ae5d-b5aa7711106b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtNS0xLTEtMA_7affa332-ef65-4eb3-a33e-8ff553f11de0">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtNy0xLTEtMA_38759aba-d9d3-4075-a037-14c95868dd1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtOS0xLTEtMA_144de141-a2d9-43fc-8ab0-8139f9772a1f">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtMS0xLTEtNjg3ODU_f5cd80fd-5109-4e2f-ad6a-bd68101af9c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtMy0xLTEtNjg3ODE_3c55aebd-f0f7-4612-990d-a74ff473f9f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtNS0xLTEtNjg3NzQ_98dc12ce-5a16-436b-8fe8-fe7d9f3ca8ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtNy0xLTEtMTM0_434ac5cc-4f74-4f59-9206-d8fbf76f71f8">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtOS0xLTEtMTQw_1406e8e8-2435-4379-99c4-156d7dc73df8">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current assets held for sale</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtMS0xLTEtNjg3ODU_7bc78831-bf7a-4f6f-82b4-92d4e1d9b118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtMy0xLTEtNjg3ODE_b80e1946-eeca-482b-8daf-dbd517362665">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtNS0xLTEtNjg3NzQ_4a10b191-ee23-4aec-b0fa-2e96e0cfb2c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtNy0xLTEtMTA2_658463f3-021b-415e-a330-73b34ba4adc7">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtOS0xLTEtMTA5_88d0bcc2-69c2-41c0-947b-4c2ecdab9fd6">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac6c44071294ea9849175fac9191b7e_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtMS0xLTEtMA_a00ccb73-8f4f-44ed-a7ba-823d77fdd350">2,059</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4143ca6110b349138f60bc19e3247ec2_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtMy0xLTEtMA_e6812696-55ce-4fb1-bb45-e739e594b5ef">2,194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ac69cebdf54652867c133c8113b7f6_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtNS0xLTEtMA_e871d16f-aab4-4f9a-9499-9f17dddf0c37">5,697</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7df2e64a9b0450b929459426005d498_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtNy0xLTEtMA_a310473b-473e-4dc0-8386-c8dbf6744fad">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtOS0xLTEtMA_1b01da17-7489-411e-ae67-042170ec4647">9,951</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtMS0xLTEtMA_e73616a6-444c-46b0-9bbf-51e24285f7e4">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtMy0xLTEtMA_1ef9dea1-c4ce-48c6-9022-f575bf5d4a51">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtNS0xLTEtMA_d542f3c0-eee3-46bc-9dcb-ff0d9f77818e">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtNy0xLTEtMA_f7b3804a-70da-4af7-96e7-94d7217efcb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtOS0xLTEtMA_e2d076a7-baee-4af3-af0f-bc050ffdbfcd">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktMS0xLTEtMA_98c20cb3-3b28-474b-aff5-07d2fb6e5d65">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktMy0xLTEtMA_39459c6d-9f2e-4ecf-8de0-3db95ed9bf48">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktNS0xLTEtMA_a6d7a815-1b54-40cd-8658-674ff273c794">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktNy0xLTEtMA_ec065608-bad0-4442-8aa8-25612f6066f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktOS0xLTEtMA_c53d885f-68f2-4c6a-80a5-3ea94790f5b0">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57688279666042d3a293e8a1628747b3_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTEtMS0xLTA_d2a75757-3e7e-4c02-85b7-198a8507f756">2,598</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90da61ebdeb44219dc8a12648b8a069_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTMtMS0xLTA_33949560-6a36-4550-9ba0-b30ca058b425">3,503</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82aece15df8345618f0e67a8da516a4c_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTUtMS0xLTA_d4b10b99-58bb-4a00-a81f-bc7f8df50447">5,887</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f668b88714f457e8c79337cd7f50e8d_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTctMS0xLTA_b6ef00e2-932d-4298-ade9-1f7176ee6261">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTktMS0xLTA_749eff53-3fda-4ef3-a1a8-29a11f98d8a2">11,988</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzIxOTkwMjMyNTkwNTM_dbb06548-0815-4774-b434-879536a8f811">73</ix:nonFraction>&#160;million related to our Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. We did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of our goodwill and intangible asset impairment testing.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NjQ_21549510-742c-45e7-b9c7-a55c778e39d4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2021 is as follows (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:83.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzItMS0xLTEtMA_47e77264-7b8e-4384-9bf1-27a340e62b04">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzMtMS0xLTEtMA_428e9278-e6ba-4b1a-bced-90eeb30cca6b">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzQtMS0xLTEtMA_a6a951bf-fa36-4e22-b045-a0d7f0b55eab">703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzUtMS0xLTEtMA_d028dfdc-180f-46e5-a0ee-ace05f4e960c">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzYtMS0xLTEtMA_42bf459a-eaa2-4831-bf48-cae669151bbc">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_106"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjU0_e2d3e168-f6f3-4e56-85e2-705b80281f38" continuedAt="ib7464c9705214855a760f1066211c2b0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib7464c9705214855a760f1066211c2b0" continuedAt="i1a886bb1f32e4f3fadfd885213dfcb5d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecasted. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. For these derivative instruments, we elected to use the spot method to assess hedge effectiveness. We also elected to exclude the spot-forward difference, referred to as the excluded component, from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. As such, we defer recognition of foreign currency gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we reclassify amortization of the excluded component from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of December 31, 2021 and 2020, we designated as a net investment hedge a portion of our &#8364;<ix:nonFraction unitRef="eur" contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzQ2MDg_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55">900</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzQ2MzE_26f223d7-3e89-42f5-9029-24c13e9d9bb6">0.625</ix:nonFraction>% senior notes issued in November 2019 and due in 2027. For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains and losses within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1a886bb1f32e4f3fadfd885213dfcb5d" continuedAt="i374a2fc786b74185bb14ff71900e6435"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In 2019, we settled all outstanding contracts, for $<ix:nonFraction unitRef="usd" contextRef="i782d01afd07e478a931537d96fdb53e2_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForHedgeInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU1MDk_993dfa3b-be7e-4f15-84a7-c4f75b4e6df6">294</ix:nonFraction> million, which is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for settlements of hedge contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Upon settlement in 2019, we received &#163;<ix:nonFraction unitRef="gbp" contextRef="i626ff39017e34162b100364f2724ec05_D20190819-20190819" decimals="-6" name="us-gaap:DerivativeCashReceivedOnHedge" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU2MzE_4b10e2df-3db3-4ee9-837a-657ee95873c2">3.312</ix:nonFraction> billion of cash to fund our acquisition of BTG, which translated into $<ix:nonFraction unitRef="usd" contextRef="i626ff39017e34162b100364f2724ec05_D20190819-20190819" decimals="-6" name="us-gaap:DerivativeCashReceivedOnHedge" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU2OTY_3a824ca1-5f09-42f6-aed8-7d0e7c7a6a64">4.303</ix:nonFraction> billion based on hedged currency exchange rates. We recognized a $<ix:nonFraction unitRef="usd" contextRef="i0a660eb1a9ef41b289c2fd72520e03d0_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU3NTY_d137dfdd-5d39-4fcb-a0d5-93d33c271df9">323</ix:nonFraction> million loss in 2019  in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to changes in fair value of the contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar and euro-denominated borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of December&#160;31, 2021 and December&#160;31, 2020. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzc1NTE_d1329da1-5109-4e1d-b69c-831a12606d95">24</ix:nonFraction> million loss as of December&#160;31, 2021 and a $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzc1NzQ_80962ef5-be09-4a24-80c5-7e372c80831d">29</ix:nonFraction> million loss as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as fair value hedges outstanding as of December&#160;31, 2021 and December&#160;31, 2020. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. </span></div><div style="text-align:justify"><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4Njky_d5de3367-f714-420a-af18-963595cc8ebe" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.213%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9531280867949db9464c43e67215202_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzItNC0xLTEtMA_b815d6a1-60ba-4bef-aa24-0f8419bb2ab5">3,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55bdce8f6e9a4122a9891e58c6011e24_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzItNi0xLTEtMA_8c1ad47b-edc0-4e83-848e-62cc3d33e42d">4,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i812f08c4fbcb4aff9a4d22c42cf9c6b6_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzMtNC0xLTEtMA_39286d1f-3d53-487a-8628-0a7be7706d60">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7facfda412415a861148c501e1b519_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzMtNi0xLTEtMA_0f17c998-f70c-4602-be5c-41337d23517f">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87edfb08cbb845159b6b5e6f1d4f21b4_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzQtNC0xLTEtMA_f0540ac5-be20-45f6-92c2-799af50fc38a">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76233e3f8eda4f81b4c34b9f8f97cec6_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzQtNi0xLTEtMA_78c15c7e-b20b-4028-91b0-2e663c5fb69c">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c84f93b28ad41b9b47b5c208f7efc54_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzUtNC0xLTEtMA_8b3762e0-dbe1-4907-bd76-17a6fa108e15">3,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed12a7015134ea4942cb2107d893933_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzUtNi0xLTEtMA_7afc8fba-3e02-4f64-8acb-132e140bf2fb">4,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzctNC0xLTEtMA_8ce75c1b-68f4-4ca3-9547-e300e2f138ed">9,378</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzctNi0xLTEtMA_7c2a193e-e0ba-4154-a0c7-599613157862">11,349</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;<ix:nonFraction unitRef="eur" contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzg5MTc_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55">900</ix:nonFraction> million debt principal designated as a net investment hedge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of December&#160;31, 2021 is within <ix:nonFraction unitRef="units" contextRef="ib55f19bd5c9d4d2daf3efa38fdb0d083_I20211231" decimals="INF" name="bsx:ForwardCurrencyContractsTimetoMaturity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzkyMDc_68d6a0c7-35d9-48ae-bc0a-9b660cbadb75">60</ix:nonFraction>&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next year. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i374a2fc786b74185bb14ff71900e6435" continuedAt="ia63e7da5a2504c898c930fc928498ed6"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjY0_26a371bc-d3ad-4832-9f55-9f47340597e9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note Q &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMS0xLTEtMA_969ab18c-2f4b-45da-9bcd-3df04aebb71c">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMi0xLTEtMA_95be04d2-da96-45fb-9da8-7311938ebcfb">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMy0xLTEtMA_d64eb835-6527-447b-ab52-d524a9e8cd18">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtNi0xLTEtMA_a725d8b1-a6ae-4826-95b1-08fe723cae5c">3,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtOC0xLTEtMA_a3250867-cecd-4225-8259-99d1a34d00a2">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtOS0xLTEtMA_fa4e5b88-7078-492a-b522-9ced343c4c56">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMTAtMS0xLTA_6ed743cb-cb7a-47e7-ad46-4056a82ed6dd">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMS0xLTEtMA_1a6fd16d-aad9-4869-bd06-5be81efb017a">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMi0xLTEtMA_6770cbea-ac5f-404f-8568-0381ef3e199d">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMy0xLTEtMA_791d0fa7-85b6-4b7a-8ae0-e03a3af2efbe">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtNi0xLTEtMA_6fc08023-851c-4a0c-b7f6-c99f2a4f6159">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtOC0xLTEtMA_12b9d8f6-ff85-4777-bb77-6b91bcf3364c">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtOS0xLTEtMA_1ab4229f-0349-42ce-8b3c-9b54e1fc176d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMTAtMS0xLTA_539f925b-54d2-48d8-9d10-7a79d9094ea6">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMS0xLTEtMA_6e5c3072-4571-4269-8fd1-3be872543cf1">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMi0xLTEtMA_199c853d-e57c-473f-96f8-265fbd05221d">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMy0xLTEtMA_b24a0c57-aa71-4cdd-96ed-e3a7bc8ed5f7">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtNi0xLTEtMA_bfe9f675-646f-4780-9ca0-eb307411d46b">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtOC0xLTEtMA_dd1ad90e-35b5-4ad4-91eb-ee21a58657d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtOS0xLTEtMA_e6555b6d-5e6b-431d-8b61-d3bf61407e6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMTAtMS0xLTA_c2372858-fe6a-4f9a-9c7d-7e7d96e44739">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTEtMS0xLTA_2f05d65c-6e75-4703-b83a-ab689cba64cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTItMS0xLTA_3db09e97-6ee8-4307-88bf-9038053a0161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTMtMS0xLTA_307e9e89-d21c-4224-98d5-6dd81e7ab995">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTYtMS0xLTA_6fc08023-851c-4a0c-b7f6-c99f2a4f6159">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTgtMS0xLTA_cd0edb4c-f288-47b2-bf39-b908e1686046">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTktMS0xLTA_d852d5af-879b-408b-aded-550dbf23de9b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTEwLTEtMS0w_3f4d61e7-3561-4026-a99b-f3a6eba8e920">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTEtMS0xLTA_7997e98c-43d6-46ed-ab1b-a264f69a0702">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTItMS0xLTA_c777d138-0cd4-4cae-a2a4-c04108d8ac22">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTMtMS0xLTA_f2f52276-995b-43dd-8654-147d7492983b">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTYtMS0xLTA_abe2d9ff-cbfe-43ed-aff5-16b877a63b7d">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTgtMS0xLTA_313be5a7-5b36-451e-8b37-719a8da9b02d">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTktMS0xLTA_e2fe56a5-2106-45aa-956f-d8870ad838a0">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTEwLTEtMS0w_671d7492-46a7-49b8-9712-f216819a00ab">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTEtMS0xLTA_fa520193-7a88-402e-a246-61514c010d5d">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTItMS0xLTA_204eb553-46a8-4d8e-85fc-a29974a6b7fb">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTMtMS0xLTA_5aa29678-54ca-4036-a914-022650316210">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTYtMS0xLTA_9f41421d-10c2-44d4-b29a-130a206d4fa8">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTgtMS0xLTA_f98f0a14-6b83-42c3-9136-9224f2955c4c">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTktMS0xLTA_33d32d61-3d8c-42be-996a-88d2347ad711">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTEwLTEtMS0w_49c1ab5e-4d34-4cc2-837a-8fcd9f475430">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTEtMS0xLTA_c00f5d56-c828-47c0-a1e7-10014bd59049">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTItMS0xLTA_bd5ed852-29ae-4765-83ee-6f92d1efed96">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTMtMS0xLTA_1a7471f1-7a2c-4b18-963a-ca2476b164d4">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTYtMS0xLTA_b19c2879-db30-426c-8675-b07bb3558f83">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTgtMS0xLTA_30f140e3-c17d-43f7-a0cb-b0fe23fe0785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTktMS0xLTA_189864fd-6127-4e30-8a27-efd87b95f4e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTEwLTEtMS0w_96395a8b-0077-41e5-b1f3-bf5adf9d0732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTEtMS0xLTA_d13bc4b3-3598-4397-95d4-1445cc953a63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTItMS0xLTA_9f4554d8-a8fd-4bab-9d11-5139ad9b5a66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTMtMS0xLTA_3cc360bd-5144-49a8-87b6-66f0097619b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTYtMS0xLTA_9f41421d-10c2-44d4-b29a-130a206d4fa8">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTgtMS0xLTA_059ae571-e061-4b77-9d64-d59afdb17b3c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTktMS0xLTA_2b9337bb-3192-4b0f-af3e-b1ee3c0ee323">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTEwLTEtMS0w_4768d6b9-408e-4f10-bdc1-3c2f43bf3d08">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTEtMS0xLTA_310c7069-3183-4ac4-8637-c36dd5818105">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTItMS0xLTA_911272ca-bc31-44ce-ac6b-6be5aa0ba8ac">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTMtMS0xLTA_5d17acc9-6285-4f96-8d9c-4fe681e0bcf5">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTYtMS0xLTA_7539f9f1-d01d-44f8-8eec-e539eda39562">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTgtMS0xLTA_2f3e43b7-4c60-4384-9067-7a3722d26c8a">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTktMS0xLTA_bb4dd928-2292-454d-a96a-e1b51709e94d">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTEwLTEtMS0w_157dad1a-83b1-415f-bf69-8e379ebbfa6d">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTEtMS0xLTA_a196392c-7e7a-4ec7-baaf-265e45a2d411">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTItMS0xLTA_6775824e-dedd-4a1d-9ba8-4efdd6778c50">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTMtMS0xLTA_f4acbd83-82be-478e-ba62-d119b91e5b88">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTYtMS0xLTA_be80fb9c-976d-4176-a7d0-21195ee5a6b8">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTgtMS0xLTA_8ba68c13-bbab-45c8-b975-4bee203f287d">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTktMS0xLTA_f96fd10b-d590-485d-9441-5e9193033678">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTEwLTEtMS0w_3410117e-4f6d-4612-88bc-b001945edd24">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEtMS0xLTQ4MjM2_1753ea5a-036c-4d5f-ba21-36973540952d">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTItMS0xLTQ4MjQ0_7a99f66d-fcce-44ef-8212-3ac0fe9022ac">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTMtMS0xLTQ4MjUy_aff56438-a862-4a54-8100-1b4456ec7b75">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTYtMS0xLTQ4MjYy_57d29d43-297f-4e08-971f-200dee82e476">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTgtMS0xLTQ4Mjcw_4c3d8d94-f270-40d2-9242-3dc2e013328d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTktMS0xLTQ4Mjc3_703ce884-1454-4e32-b9e2-a4896ba576e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEwLTEtMS00ODI4NA_53ca14b2-550b-41af-9fca-0b93664a0559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEtMS0xLTA_f1640050-5184-4d18-bced-7f793eb19c90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTItMS0xLTA_c1bca3c3-6358-4f4d-a0c0-e9cd603ca3b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTMtMS0xLTA_538e4ec0-9feb-4518-a516-d268c27d19e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTYtMS0xLTA_be80fb9c-976d-4176-a7d0-21195ee5a6b8">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTgtMS0xLTA_6003ea0d-2f72-4dd5-a70f-d87cda13da76">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTktMS0xLTA_9a1d9831-9ade-4edc-8f3c-ca355e1cc7ea">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEwLTEtMS0w_b4931efb-8d63-4473-88d8-5798564b9924">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia63e7da5a2504c898c930fc928498ed6" continuedAt="id3d5e4d59253486cbbe14a6877d4060d"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjMy_74bf0e90-7bfd-4261-9ec5-1be6e919df32" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.564%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097a22a349ff4abea29f95badcb8b81d_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozOTNjYjU2ZWJmYjA0Y2I2YmY1YjliOWE0YjliNTBlYy90YWJsZXJhbmdlOjM5M2NiNTZlYmZiMDRjYjZiZjViOWI5YTRiOWI1MGVjXzEtNi0xLTEtMA_89b53a31-2991-476d-b133-157c88ad84c8">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c5ecd8e9d04fb5bfb0c044ab0e9c6d_I20211231" decimals="-6" name="bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozOTNjYjU2ZWJmYjA0Y2I2YmY1YjliOWE0YjliNTBlYy90YWJsZXJhbmdlOjM5M2NiNTZlYmZiMDRjYjZiZjViOWI5YTRiOWI1MGVjXzItNi0xLTEtMA_dfaf2324-f64e-4593-9967-7efbeeb9550e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4da7805cf34686993ec3f55d35e90c_I20211231" decimals="-6" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozOTNjYjU2ZWJmYjA0Y2I2YmY1YjliOWE0YjliNTBlYy90YWJsZXJhbmdlOjM5M2NiNTZlYmZiMDRjYjZiZjViOWI5YTRiOWI1MGVjXzMtNi0xLTEtMA_91ff3199-950e-4f12-b638-35b3a0c92b00">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4Njg0_0f2bfbd1-ef55-41a9-a7f5-6b317ec0e073" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:41.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.035%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzItNC0xLTEtMA_52a44406-405c-4710-ae65-b8e9e08d9259">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzItNi0xLTEtMA_860309a3-3f93-41bc-8512-7804b3bdd217">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzItOC0xLTEtMA_0cf68b25-4f8b-46a7-bce6-96b37c3dfbfa">343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzMtNC0xLTEtMA_2be37e02-0c37-422d-8034-b4611977af31">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzMtNi0xLTEtMA_27495d6b-e1d4-48fd-a683-f070956f61f8">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzMtOC0xLTEtMA_b6d5cb95-6ab2-4f16-9085-29f480711baa">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzQtNC0xLTEtMA_c3695f1d-112f-4a89-b062-93fee7b380d5">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzQtNi0xLTEtMA_40032b1b-9b89-4f57-bc0c-9b36159f043b">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzQtOC0xLTEtMA_8227e904-1fcb-4def-bb18-5563b50cc849">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id3d5e4d59253486cbbe14a6877d4060d" continuedAt="if29cab974fa94b8cb6ffe6e1a7fac24d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NzA2_7b28efc6-039c-408b-8ea1-98d3a42141b6" continuedAt="i682c6ce346de4df1ae1b4e3ed859a724" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i682c6ce346de4df1ae1b4e3ed859a724">, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means.</ix:continuation> <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjQ2_5bfe5cf9-64b1-4708-8ad0-b77bf0c0d570" continuedAt="i8be4dfc06e0e436595611ee88c920f6f" escape="true">The following are the balances of our derivative and nonderivative assets and liabilities:</ix:nonNumeric></span></div><ix:continuation id="i8be4dfc06e0e436595611ee88c920f6f"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.559%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80ca8f87e8c4cb484a3d263b3bb637e_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzQtNC0xLTEtMA_fb90fea3-ca5b-4979-876a-ff4716f7689b">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda6065f68154a37934825525972e22e_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzQtNi0xLTEtMA_765f75b3-cba0-4e0d-889c-414122bc2ad3">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief10444ff3084ac7bc054c27341e827b_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzUtNC0xLTEtMA_bee9a3e0-412a-45dd-987d-fe2dd4841905">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109998db04ff4f648674392ae1a723c2_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzUtNi0xLTEtMA_7dc5f9e9-15a8-4e15-a66d-fa559f0776f3">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2731c2a351fe4a4f840aa3d75204b39a_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzYtNC0xLTEtMA_3d9c7270-18e7-4daa-b010-aebf734d8f9b">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d8505202864b7385a6cea691031d04_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzYtNi0xLTEtMA_2048bf86-1622-46ac-a631-9b4f2f65a049">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd4847b37d67457bab88ed655a398e6b_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzgtNC0xLTEtMA_970a1b34-e23b-4324-9dfd-7e575a32237d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f4b0d184cc492b8a1c645c1eb819da_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzgtNi0xLTEtMA_c110188a-2ba7-42c1-9693-28b8026a8e5d">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzktNC0xLTEtMA_a71e29e8-b13a-4295-815b-a5a1dbfb418b">394</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzktNi0xLTEtMA_2fc60b70-19ae-4ec6-96df-939ef080fb58">242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c7842f764a4d47946a0b5c9fc60c6f_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzEzLTQtMS0xLTA_eb74e3fe-5256-42a2-99ed-678b317bed09">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd00d55e3da24a278600f1257c6a759f_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzEzLTYtMS0xLTA_f0b8fbfa-0b54-4ff9-b886-06f7bc94f6fc">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725a0c2c245d477a866680ee271fef5b_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE0LTQtMS0xLTA_de6abb7d-fcac-4c61-a5f4-c5c06ece10aa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9da8aea23bd441c979d30b5eca1589d_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE0LTYtMS0xLTA_e8182a00-832e-4b12-a4bc-b3d9fd953746">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3918eea06dc645afa81bf6b59e512ffc_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE1LTQtMS0xLTA_ca4f8200-2378-4d18-9ab9-e2ce2f89c8ef">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5cd80680db2415fa27296f65f1a788c_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE1LTYtMS0xLTA_533132e8-de71-40f9-86bb-8b27f8a6bbf1">1,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2731c2a351fe4a4f840aa3d75204b39a_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE3LTQtMS0xLTA_d2af1357-b930-4d45-8737-19c93e353da9">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d8505202864b7385a6cea691031d04_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE3LTYtMS0xLTA_541001ef-dbcb-410a-8c59-9ca2ddad7fe6">1,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134d607092fd4a008581e04dfcac820e_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE5LTQtMS0xLTA_7d5870ed-f458-4e1f-8c7a-39c8021fb469">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ae77b262464a3faa59c2a3cd00d12e_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE5LTYtMS0xLTA_787a1593-efe1-42c7-af79-00d4f59ef07f">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzIwLTQtMS0xLTA_f540c11c-8021-4fda-979b-1cb422da5176">1,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzIwLTYtMS0xLTA_8e21c86c-db8d-4399-8b9d-4bf2916b3a80">1,262</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency-denominated debt is the portion of the &#8364;<ix:nonFraction unitRef="eur" contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzEyNzgz_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55">900</ix:nonFraction> million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if29cab974fa94b8cb6ffe6e1a7fac24d" continuedAt="icc1d49e4946c43febc394fc2780e21ce"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjQ3_2b3be7b0-d0a7-4c92-bff0-53da9023bb40" continuedAt="i8c6df18dba6647ecb506e844800c89fd" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:31.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMS0xLTEtMA_31e8be6c-69c7-4b69-aee4-e9deef852856">1,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMy0xLTEtMA_68f604ef-085e-4f2f-8a5e-c900b6344806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtNS0xLTEtMA_2f88a280-1bd5-4546-95ca-6fc0b6c648bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtNy0xLTEtMA_a5e3a88f-870c-4d46-b626-b45dab8a0a3e">1,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtOS0xLTEtMA_7a8e8a90-5d30-4f6e-81f5-c6d86709e841">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMTEtMS0xLTA_d6d362f5-c876-4a04-a4fd-dcff9dd1a1ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMTMtMS0xLTA_131cd7f8-e214-48fa-9cbe-0bcffe1558de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMTUtMS0xLTA_5f5e0b79-c648-4406-a3ec-4a38bba8568c">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMS0xLTEtMA_78535792-5450-4cc4-a2bd-8a6ddc487e0c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMy0xLTEtMA_f1ef0c4e-e3ed-478b-a699-e02fa2110fec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtNS0xLTEtMA_df3d1a4b-f081-43cc-a782-6977fdd45c44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtNy0xLTEtMA_2957a7a6-5809-4d37-b21a-34a12a979775">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtOS0xLTEtMA_8a72e839-bfe3-43dc-aefa-0c5e5a9e4dfc">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMTEtMS0xLTA_81f54893-07fc-4e53-b2f1-c0fa1661cac0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMTMtMS0xLTA_4b98f9c6-40b8-48ca-96da-81b6237e085c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMTUtMS0xLTA_67c1e0aa-9570-497d-8af4-013ac42c3c5a">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMS0xLTEtMA_28ea88de-14ef-400a-81ef-fb8c19b73c3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMy0xLTEtMA_0817a00c-cd43-4a3b-befb-f3ceaca2de7d">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtNS0xLTEtMA_dc1958c8-0aba-4f0e-a45a-145853f38b91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtNy0xLTEtMA_b0e8689a-a493-48a4-a9fb-8d6702834596">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtOS0xLTEtMA_00f12fc0-c696-49cd-b295-d608d04643b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMTEtMS0xLTA_dfd1dce7-c894-4e03-aa61-f90497f29d1b">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMTMtMS0xLTA_739d2d9e-38d7-4f04-8b88-7c695922911f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMTUtMS0xLTA_ac7a489f-4bbf-420d-a7bd-41b24002c866">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="bsx:LicensingArrangementsAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMS0xLTEtMA_26f60b80-6fae-448d-8576-c6c9c66be458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="bsx:LicensingArrangementsAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMy0xLTEtMA_4242010d-eb2f-4279-a217-a4a1abdf2635">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctNS0xLTEtMA_64df3dd5-792d-4d0b-b7f1-f8a95639b81b">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctNy0xLTEtMA_81ca8ddc-1455-45ea-803d-d08194ba61a7">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctOS0xLTEtMA_326a878c-440a-4310-8d5f-6e712935330f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMTEtMS0xLTA_cca70296-ddb0-4de5-abc6-22d3f3264540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMTMtMS0xLTA_3d399070-ac8b-4858-824f-783c75df5767">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMTUtMS0xLTA_49d73988-08d5-4cc4-84e8-4005479a60a6">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMS0xLTEtMA_676e2f07-a1ee-4a5a-833c-330f46d029b2">1,642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMy0xLTEtMA_37295675-7450-4596-85fe-1a3ba2d21673">394</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtNS0xLTEtMA_1024a292-5118-4355-b114-535632a45204">246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtNy0xLTEtMA_11a97873-b1cb-408e-8e53-a2b7a0126c00">2,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtOS0xLTEtMA_04c484b1-7437-480d-bd27-d7ed6bbb9d85">1,998</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMTEtMS0xLTA_2ea478ba-1424-4e55-9272-8ffa1a16b4a7">242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMTMtMS0xLTA_b2774155-7b1e-426a-a2b5-3705e6497d22">365</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMTUtMS0xLTA_f2711c31-41d3-4354-bde7-87e4dc4cba6a">2,605</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTEtMS0xLTA_f86c7381-c476-49e9-858b-ec64251ec1b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTMtMS0xLTA_b5d42db8-3ffd-41b9-8524-9fed5e5e198c">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTUtMS0xLTA_b4c24411-9fe1-4160-9ac7-29151d532ea5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTctMS0xLTA_377ba2f2-1079-475f-a21b-57dd81450311">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTktMS0xLTA_bbe1cb54-db3b-45d9-a6df-accb3217b539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTExLTEtMS0w_3b0821ef-dcf8-4e39-bfcb-039968a38eaa">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTEzLTEtMS0w_fc17e472-20f2-42c8-b52c-7137711b5fbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTE1LTEtMS0w_515d99c4-735c-4425-a09b-f2973a4bbe91">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTEtMS0xLTA_b697b19a-5d1f-46e3-97e5-49ec4de2e6e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTMtMS0xLTA_c0870f4c-576e-4798-b19a-c78a3e6ae8fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTUtMS0xLTA_3ed73b25-add0-4ea2-b9b1-9719425be463">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTctMS0xLTA_1f34dfab-762c-4f4a-a67f-e92dba94c36d">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTktMS0xLTA_52b89569-c349-4814-bbf1-5b43406c5209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTExLTEtMS0w_a0946feb-88bf-431a-ac18-7d8f47153a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTEzLTEtMS0w_ea47e7ce-6c23-4039-a7ac-b9bbf6508baa">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTE1LTEtMS0w_85d6eca1-4435-4e32-a1f8-132e439a895e">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="bsx:LicensingArrangementsLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTEtMS0xLTA_5bed72e1-48e2-4c53-8ee9-16c4a79746d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="bsx:LicensingArrangementsLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTMtMS0xLTA_93f33ba9-a1a5-4b90-9b88-1713a9ac8f97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTUtMS0xLTA_492afbbe-e2e1-44d3-9037-def531e889ae">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTctMS0xLTA_85734b02-e39d-43e9-80e9-563365a876fa">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTktMS0xLTA_52334892-2fed-46ec-9cb2-2bdb1aaa52cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTExLTEtMS0w_0f619879-065f-492c-a2fc-b1ca7ded87f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTEzLTEtMS0w_4a34dddc-1c36-4718-844e-194fcf4d27df">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTE1LTEtMS0w_24b4d286-fc0b-4d41-9c9a-95c0e7512cd9">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTEtMS0xLTA_635bda0a-dc4e-4a47-a6ca-c8f8986b93e2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTMtMS0xLTA_21d56f56-332d-44b3-ab15-77d0c9458e0d">1,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTUtMS0xLTA_a8fd222f-ecb3-4cf1-accb-15256338c508">767</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTctMS0xLTA_088381ff-9d9b-4ed3-b75f-11c032fb6a66">1,838</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTktMS0xLTA_4efa43ae-fad0-44da-9794-092553379cf0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTExLTEtMS0w_34f779c4-7429-4972-9f65-3e33e5a0b54f">1,262</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTEzLTEtMS0w_4c5b67f2-26d4-486d-be8c-1919c8875dfc">603</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTE1LTEtMS0w_ad1d6b57-6afd-486f-aa54-bcf1395b9252">1,865</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $<ix:nonFraction unitRef="usd" contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0NTk0_31e8be6c-69c7-4b69-aee4-e9deef852856">1.632</ix:nonFraction> billion invested in money market funds and time deposits as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0NjU5_7a8e8a90-5d30-4f6e-81f5-c6d86709e841">1.584</ix:nonFraction> billion as of December&#160;31, 2020, we held $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0Njgw_fe600458-cafb-42e5-9a07-da9e316317db">293</ix:nonFraction> million in interest-bearing and non-interest-bearing bank accounts as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0NzU1_12c903de-50ab-4bbb-a13b-8c13e893f2d9">150</ix:nonFraction> million as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We recognized a financial asset and associated liability for our licensing arrangements at fair value in our consolidated balance sheets using the fair value option in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own the contractual right to receive 50 percent of the future Zytiga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Drug royalty payments from the licensee and remit such payments to the inventors associated with the intellectual property. Royalty payments we receive reduce the fair value of the financial asset and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and payments we remit to inventors reduce the fair value of the financial liability and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of cash flows. We sold our right to receive and retain the other 50 percent of the future royalty payments in 2019 for an upfront cash payment, which we accounted for as a secured borrowing in accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Although we sold these rights, we continue to recognize at fair value the future royalty payments as a financial asset and associated liability. Royalty payments associated with the rights we sold no longer impact our cash flows, and we present this activity as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-cash impact of transferred royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the supplemental information to our consolidated statements of cash flows. We reduce the fair value of the financial asset and associated liability when such non-cash activity occurs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded the fair value of the financial asset and associated liability using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of December&#160;31, 2021. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains and losses from the licensing arrangement. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icc1d49e4946c43febc394fc2780e21ce"><ix:continuation id="i8c6df18dba6647ecb506e844800c89fd"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2021 include the following significant unobservable inputs:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5080b79d26164c5da882a84779417883_I20211231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzEtMS0xLTEtMA_7a61cf7a-c113-455b-8fea-9713fedbe832">246</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5ac76f7fccd4691a0a4ef3f2d0fcf1b_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzEtNC0xLTEtMA_965b21ae-773a-43f2-b7a7-511ef5006107">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80725583ad834079902d53e2aadcf36e_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzEtNy0xLTEtMA_baa1b54f-cbd7-4c42-b5d3-73ae94e928b9">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5080b79d26164c5da882a84779417883_I20211231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtMS0xLTEtMA_0fa72080-589e-41c8-83b0-128efc9e1edd">281</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d5a471f86e4b9f9ffbc69b60fdba65_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtNC0xLTEtMA_3b1189b7-b4e6-4e49-96d3-631239a00165">12</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2567fd9e6c448c6bd8df0511e4e2148_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtNi0xLTEtMA_4b2f2ba1-44fb-4b67-ac0e-b73316674377">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib369619c4f02462baf6c43cb80f23d68_D20210101-20211231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtNy0xLTEtMA_a8dac5fc-c6cc-4261-a097-fcce33fefecc">13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i159eed8645cb401f99a8d7dc6909d9ff_I20191231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzEtMS0xLTEtMA_12d8f98e-b44b-4136-a818-e028410c7486">518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzItMS0xLTEtMA_69156576-032b-47c7-918e-c4191b832fa0">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzMtMS0xLTEtMA_2dc68690-261d-4c4c-9809-44ad4b8de590">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzQtMS0xLTEtMA_c262adf5-fac5-446c-bbf9-c3d2b0c48710">365</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313491a2c13d4ea18bb58480b90499ec_I20211231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzUtMS0xLTEtMA_12c11b75-ce53-4b9a-b72c-37087eb96819">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969bdf20fd234556a472ac3c3bd91a4e_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzYtMS0xLTEtMA_e3fd6180-9a64-4b60-9f69-257301c88747">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969bdf20fd234556a472ac3c3bd91a4e_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzctMS0xLTEtMA_2493c501-5c21-4424-9aa4-d822221feb4e">246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d55e0941456418590fcc0b66bb0dae8_I20191231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzEtMS0xLTEtMA_35030659-ff7b-489a-a58c-72a901be966b">571</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie093a7adfb86426a9b678f6d156bac3b_D20200101-20201231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzItMS0xLTEtMA_8f43552c-4eb0-4272-a832-978510d8a4c0">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie093a7adfb86426a9b678f6d156bac3b_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzMtMS0xLTEtMA_47071a83-5409-4aa3-bdde-a9bd0f3a36ea">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e36a30cc5194c4fb5b6a7caf9030f5f_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzQtMS0xLTEtMA_949cf314-bbee-4a94-8af2-48c56c89360c">407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i407f649729a04a849ad43194e1cb4088_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzUtMS0xLTEtMA_1603d6c2-0a91-4ebe-a616-ca3d908228ca">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407f649729a04a849ad43194e1cb4088_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzYtMS0xLTEtMA_a028e42f-ebed-43a8-88e5-a6f7c82c06dc">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic347736243d746bda91e919b3077d630_I20211231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzctMS0xLTEtMA_e3029b07-96ec-4514-9d4b-b2a76cc9c43d">281</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4MTg5_7539bfce-7e30-4ccd-876e-1b2aad55cd2f">10.196</ix:nonFraction> billion as of December&#160;31, 2021, including $<ix:nonFraction unitRef="usd" contextRef="i73cc4ab1dd684ec58982d5866047dbdf_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4MjEy_04db13a2-f9f7-431f-bee9-80f75d58df97">1.020</ix:nonFraction> billion relating to our euro-denominated December 2027 Notes, and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4MjU2_29fadc6d-9adc-4dd6-820e-b3610649d9c6">10.774</ix:nonFraction> billion as of December&#160;31, 2020, including $<ix:nonFraction unitRef="usd" contextRef="i40cd8405c4eb41baa85544a9136ba611_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4Mjc5_fe8783b0-1378-4b3c-9566-45bb61034cbd">1.118</ix:nonFraction> billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NDky_993dd6e8-a2ec-4092-adbe-6745db1a65d0" continuedAt="i05db6067cec847a4b68170f76f78b09a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzgw_85c2724f-7297-408e-8d62-304d2afe3528">9.065</ix:nonFraction> billion as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk2_bc0ce16d-d278-4695-a8cd-e294c93f90fd">9.143</ix:nonFraction> billion as of December&#160;31, 2020, with current maturities of $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEzNg_b44b8d9d-5a0f-4f30-8b98-a8a554065768">261</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE1Mg_7eb550aa-731a-47aa-a4d1-705e803139dc">13</ix:nonFraction> million as of December&#160;31, 2020. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NDk2_14d2ba2e-2250-4567-93d0-27c23e4c3c7d" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b35b770901410ca52fdc805a2e9579_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzItNi0xLTEtMA_32c65e4d-db48-4d89-8550-f47433a92fb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4593a60912482fab2688cbdaa05100_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzItOC0xLTEtMA_59b0cb4e-5949-4a43-93ba-c812860f2693">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8b35b770901410ca52fdc805a2e9579_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzItMTAtMS0xLTA_35c1f010-3a79-4304-b574-cd15bd507f62">3.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzMtNi0xLTEtMA_51978594-7987-43c3-b559-88e8b30a6761">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99294feafedf4ee49fa109e2229c4b49_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzMtOC0xLTEtMA_899a0222-e15d-4d9f-84ba-4cbb55a82d6d">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzMtMTAtMS0xLTA_b8bf0d8a-7374-44ac-b4ed-7569ff0ccfa1">4.125</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzQtNi0xLTEtMA_dcbce02b-b52d-40de-892c-19ce49f67567">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzQtOC0xLTEtMA_86dcc10c-6750-4616-b69d-09c40a892b89">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzQtMTAtMS0xLTA_ddbcc015-5654-47f5-8d66-ae3501d20ce2">3.450</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69988c85621b476fa63c489ced0e8284_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzUtNi0xLTEtMA_66e2f7eb-2cfb-47e7-b498-230a6be1220e">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f20c3d1ba7a4b9393b313eeabdf8773_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzUtOC0xLTEtMA_c2a6c461-f280-461c-ba7d-6dc45e04d4c9">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69988c85621b476fa63c489ced0e8284_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzUtMTAtMS0xLTA_ae1d191d-0049-4bf2-984e-6f4598550b4b">3.850</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a45203f1a3447988e6706b1059e3a29_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzYtNi0xLTEtMA_067f02e1-e2e4-487a-83c0-95032d4287a7">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7bcc19872444969a853a9139102340a_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzYtOC0xLTEtMA_afe6a776-6767-41d6-b2bf-c267ef177f33">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a45203f1a3447988e6706b1059e3a29_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzYtMTAtMS0xLTA_8a43aa38-d86a-446a-91e0-75ec53094aaf">1.900</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzctNi0xLTEtMA_3e07ab2f-e35e-434a-8947-2eb80392c058">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzctOC0xLTEtMA_6d2383cb-0b09-4c49-9e02-9c4ebb1f811f">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzctMTAtMS0xLTA_80a50ad3-3b9d-4cc1-a9ef-1a412127d046">3.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzgtNi0xLTEtMA_a663c383-b7b2-4837-a5e5-6c8ab5091ef8">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7f3635455746f3b28295c2ea994f38_I20201231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzgtOC0xLTEtMA_4bacb529-00d6-4b40-bc08-1e42132b716e">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzgtMTAtMS0xLTA_26f223d7-3e89-42f5-9029-24c13e9d9bb6">0.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzktNi0xLTEtMA_18edc6b3-6248-4f82-8302-553221e02863">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f97fadb3df48bda0decc6fefc848f2_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzktOC0xLTEtMA_ee7c4df3-bf91-47e7-9380-b7ca09331c67">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzktMTAtMS0xLTA_606cf94a-d037-47b3-be03-2711b4bca1d7">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEwLTYtMS0xLTA_836fdaf0-47ad-427f-96db-2f1f745aa262">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEwLTgtMS0xLTA_91bc44e1-212f-494f-b0e9-7688c4766f0e">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEwLTEwLTEtMS0w_77453287-5689-4b92-834b-613f144d92a0">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b460c38790240a9aa867c6fed4202a6_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzExLTYtMS0xLTA_160a2957-5dc9-4132-bac6-873f3921f3d4">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ce36bb88f54225ab4c1a3a6ffe1e0d_I20201231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzExLTgtMS0xLTA_7433d6f3-9588-446d-803e-a320da33e520">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b460c38790240a9aa867c6fed4202a6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzExLTEwLTEtMS0w_86d3a01a-1228-4fd2-ac22-d9970d2207a3">2.650</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3977734d09ce4c1ab17af6a4ee2899d4_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEyLTYtMS0xLTA_bcb11ed9-5e99-4a33-a614-898d5780484c">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99deafdf2a70460e9d8c50f4d6973f0e_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEyLTgtMS0xLTA_96abe131-c821-48c7-b0b3-f315995e2635">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3977734d09ce4c1ab17af6a4ee2899d4_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEyLTEwLTEtMS0w_e95ce8ff-bd56-44e8-b3c1-4147b764c7f6">6.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEzLTYtMS0xLTA_98e99c36-bc2e-4fb0-9186-bb0cc748373d">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEzLTgtMS0xLTA_14c57938-7089-47b3-88c3-3d7827808298">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEzLTEwLTEtMS0w_a95580fd-b9a7-4017-a39e-a972e6cedad2">4.550</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f6423b1ae248ea89c9e621bfea9ed0_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE0LTYtMS0xLTA_ce5f4dc4-10e1-464b-b758-7722d87a4797">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81e19c0a1fc4ab48f45f7fa43d479fe_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE0LTgtMS0xLTA_d2c1defd-ea97-4f58-8228-b7fecd590e2d">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9f6423b1ae248ea89c9e621bfea9ed0_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE0LTEwLTEtMS0w_227661b9-64ae-41b0-aa64-17a3974d4942">7.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE1LTYtMS0xLTA_20f55312-f196-42b9-98e5-9201b457887a">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE1LTgtMS0xLTA_9529c35e-5b8b-4eef-b929-d6f0561293b1">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE1LTEwLTEtMS0w_c74c30c9-cf0f-49fe-b7c7-af99f2658162">4.700</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37d082b275694367bb539a8515b1a5af_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE3LTYtMS0xLTA_f28babbc-02ff-4efa-9737-891d4f73139a">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie054bf7025744c0e8874ea68a52321e2_I20201231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE3LTgtMS0xLTA_bbcbf5bf-6c0a-4eac-b97c-d34c541153b4">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a267278831c49c780031fe1e50cd725_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE4LTYtMS0xLTA_90b34b4e-408b-4673-be4a-2d39aaa6104e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8a56164792489dafeb7028a867339e_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE4LTgtMS0xLTA_d9da4cd5-6953-43ee-8cc3-cc465df8b59d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3d831f9c48348a68d8597ce5baaaf5e_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE5LTYtMS0xLTA_cb8ab5c9-4376-4df2-b359-a8ca4e9b4c66">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c6e285fb891405ebda3f5864aefc402_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE5LTgtMS0xLTA_12e743a6-3321-49b4-be5c-1564d50dd211">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzIwLTYtMS0xLTA_75fe22b9-e35b-44ae-8dcb-c4f28d33cf4e">8,804</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzIwLTgtMS0xLTA_9569486f-bf98-4c8a-a227-e1b2b23d6313">9,130</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the December 2027 Notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective November 15, 2021, the interest rate payable decreased by 0.25 percent and began accruing at a rate of 6.75 percent following recent upgrades to our credit ratings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)  As of December&#160;31, 2021 the outstanding balance is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated balance sheet. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;The December 2027 notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of December&#160;31, 2021 and December&#160;31, 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021, we entered into a new $<ix:nonFraction unitRef="usd" contextRef="idda6217ac6554ef59c1b054231dd5711_I20210510" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk5Nw_a2b3ea25-a69c-48b5-9217-66b57b9dcd5b">2.750</ix:nonFraction> billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of December&#160;31, 2021 or December&#160;31, 2020.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i05db6067cec847a4b68170f76f78b09a" continuedAt="iace12368019c4d9aa1e80b4fe2a6a10d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $<ix:nonFraction unitRef="usd" contextRef="ic538cbc1ea4a4e6482d96eb75deaeea9_I20200421" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODM4NTc_2a34571a-19a5-4925-9bb9-ad0841ce1fe5">1.250</ix:nonFraction> billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the 2018 Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $<ix:nonFraction unitRef="usd" contextRef="i9e7ecae3134a4534a02c0c55e5ca169a_D20200518-20200518" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODM4NjM_59ae0d2f-4465-4809-b2f3-a67c054103c8">500</ix:nonFraction> million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our Mandatory Convertible Preferred Stock (MCPS) and common stock offerings to repay in full the remaining $<ix:nonFraction unitRef="usd" contextRef="ie3c94b7687874bd48df338dc146a6811_D20200527-20200527" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODQwMzc_3fa6b1bb-d549-474b-962e-7497cf3ef2c5">750</ix:nonFraction> million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i5e2c1e2b027e497dbd0261bab6602a47_I20200227" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODQyMDQ_44e1e518-afe6-4c8b-a2c5-aad5f6c4b6e4">1.000</ix:nonFraction> billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding on the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="i1c914099e6904d71a94dc97f6783d3fb_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODQ4Njg_d341100a-85ca-46a0-8ad2-9a7bd0ad2651">0.85</ix:nonFraction>%. The credit agreement is subject to a financial covenant described below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $<ix:nonFraction unitRef="usd" contextRef="id2f4f8def2974bd3ad9e71fd663edb3d_D20200401-20200630" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODUxODk_e742f829-9b39-449d-9e8f-14bdc85befc8">750</ix:nonFraction> million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $<ix:nonFraction unitRef="usd" contextRef="i197c21f8e68c4cc2ae4d6604948b055c_D20200701-20200930" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODUzMzY_1ee3d4f3-98a8-4072-a8c0-92c5a8ccda17">250</ix:nonFraction> million and terminated the February 2021 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, we entered into a $<ix:nonFraction unitRef="usd" contextRef="ica6d67210a5b40639571e17472201a15_I20191205" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODU0MjU_8c371c20-f37c-49d9-bce7-06fde5fb460f">700</ix:nonFraction> million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December 31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="ie47d736dd834426ab929b497f1361581_I20191231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODU1NTI_b081a324-9cef-44e3-af64-b510a50e9cfe">700</ix:nonFraction> million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $<ix:nonFraction unitRef="usd" contextRef="i7abc3bd638524e8bbfed8a8d71278d8b_D20200101-20200331" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODU3MzE_edf57951-505a-4cda-bae7-3ba22d2c795e">300</ix:nonFraction> million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into a $<ix:nonFraction unitRef="usd" contextRef="ic1b3fc2a867647d786b7994f29b2db88_I20181219" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODYwNzA_d29c3712-da82-4ca4-8be1-329075e58ec5">2.000</ix:nonFraction> billion senior unsecured delayed-draw term loan facility consisting of a $<ix:nonFraction unitRef="usd" contextRef="i7686ee5deffa4dbd9d2a8c5eaf9db505_I20181219" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODYxMzk_7d88243e-b7f7-418f-9fb3-9af4cc9345c3">1.000</ix:nonFraction> billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $<ix:nonFraction unitRef="usd" contextRef="i15a93de21f3f486280e4d2a80f4564b7_I20181219" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODYzMDg_30cf1365-e1c2-4fc4-9249-8d86a32c5241">1.000</ix:nonFraction> billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August 19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $<ix:nonFraction unitRef="usd" contextRef="i2174cbca29474ac7a29b9341a392c4c4_I20190819" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODY1NjE_a89d759b-2c0c-491d-8f17-742b6b9d4a36">1.000</ix:nonFraction> billion under the Two-Year Delayed Draw Term Loan and $<ix:nonFraction unitRef="usd" contextRef="i94a8abe8b67a41ecae72f9a4a146bf9d_I20190819" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODY2MTE_a9a1639c-5cf1-412e-be0d-38de3db9ecd5">1.000</ix:nonFraction> billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, the December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="i4c0adf6547af4ea1bf69150f334d3a2d_I20191231" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODY5MDc_67944624-e8d3-4395-950f-7e8b91432af3">1.000</ix:nonFraction> billion outstanding under the Three-Year Delayed Draw Term Loan. In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of December&#160;31, 2021, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzkzNDU4NDg4Njk2NzI_db3be93d-5b85-431c-a1f1-335ac4c0f044" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through December&#160;31, 2021, we were in compliance with the financial covenant required by our credit facilities described above. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.047%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement<br/>as of December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual<br/>as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie936008df8bc47b7bb4819618486c3bb_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpmYmQ1ZGM5NzY2ZTM0MWJhYWQyNGNhNDZlYzJkODExNi90YWJsZXJhbmdlOmZiZDVkYzk3NjZlMzQxYmFhZDI0Y2E0NmVjMmQ4MTE2XzEtMS0xLTEtNDQ1NzI_c4a324bb-6eb3-49f7-94a0-2db72b1b9369">3.75</ix:nonFraction> times</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8fc502671304865bc79e37327645508_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpmYmQ1ZGM5NzY2ZTM0MWJhYWQyNGNhNDZlYzJkODExNi90YWJsZXJhbmdlOmZiZDVkYzk3NjZlMzQxYmFhZDI0Y2E0NmVjMmQ4MTE2XzEtMy0xLTEtNDQ1NzI_aac14817-7acd-409f-8fd8-fb26884a966e">2.71</ix:nonFraction> times</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the following financial covenant requirement for all of our credit arrangements (i) maintain the maximum permitted leverage ratio of <ix:nonFraction unitRef="number" contextRef="i444a310bc0c4448b9123ec72d5545a72_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA3MTc_1c4c5d23-b6de-49f6-911c-70554872f2f5">4.50</ix:nonFraction> times for the first quarter of 2021, with a step-down for each succeeding fiscal quarter end to <ix:nonFraction unitRef="number" contextRef="i70271503dce14eb097b21a37884cad0e_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA3OTE_699e8bcb-8451-4e39-8b49-4717c9d1e68a">4.25</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="i7ec855f40caa42989882af458e570454_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1NTY_36580630-8274-4a04-b761-5087f0fe223c">4.00</ix:nonFraction> times, and ultimately <ix:nonFraction unitRef="number" contextRef="ie936008df8bc47b7bb4819618486c3bb_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1NjA_c4a324bb-6eb3-49f7-94a0-2db72b1b9369">3.75</ix:nonFraction> times for the fourth quarter of 2021 and through the remaining term of the 2021 Revolving Credit Facility. The agreement provides for higher leverage ratios for the period following a qualified acquisition, at our election, for which consideration exceeds $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:DeemedConsolidatedEBITDA" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1Nzc_2f14885b-f4f2-4580-886d-fb78dd9f663d">1.000</ix:nonFraction> billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iace12368019c4d9aa1e80b4fe2a6a10d" continuedAt="i3737c58f1b4f4db89dd8e87ebf493bc7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">leverage ratio is <ix:nonFraction unitRef="number" contextRef="i308b229a078349f4a6b8fa547142e74e_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1OTM_572c2658-c54a-44c1-9c49-214b72bcb6ad">4.75</ix:nonFraction> times. It steps down for the fifth, sixth and seventh succeeding quarters to <ix:nonFraction unitRef="number" contextRef="ie61164ba53424b53a89a01bcfc962d28_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2MDY_9a30d4cc-a7df-4835-aced-dabdfccdf075">4.50</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="i5411c3c5e25b4c5390bd6cd699a689af_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2MTk_5c140d37-61bb-49d6-91c3-92c4bee4edff">4.25</ix:nonFraction> times and <ix:nonFraction unitRef="number" contextRef="i93ab540e0baa4ea8b3e7d94197263283_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2MzI_14d89614-0091-4d66-af15-d5b46dfc8cb1">4.00</ix:nonFraction> times, respectively. Thereafter, a maximum leverage ratio of <ix:nonFraction unitRef="number" contextRef="ia398c25f0ce342b09028c1fce6e28c7a_I20211231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2NDY_5a61ebf2-e02c-433d-938d-1f64852dcdc8">3.75</ix:nonFraction> times is required through the remaining term of the 2021 Revolving Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreement, through maturity, of any non-cash charges and up to $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:ExclusionFromEbitdaForRestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzE4NzY_69f76a19-22f4-47e2-a23e-4ca9d06aff0c">500</ix:nonFraction> million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzIwMDc_1cd3c276-1aad-4620-8696-49f816d52b40">376</ix:nonFraction> million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:LitigationAndDebtExclusionFromEbitda" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzIzNDU_562b8210-1889-4748-9c26-656bd04807dd">1.455</ix:nonFraction> billion in the aggregate. As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzIzODU_ac18d000-f619-4607-9918-21af9fad74ed">1.122</ix:nonFraction> billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to further renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ia17445cfa0b9425d9591416f99eabbb5_D20210101-20211231" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NDg1_360e6875-a6b0-45fc-9875-b29b6a3dd9e4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of December&#160;31, 2021 and December&#160;31, 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $<ix:nonFraction unitRef="usd" contextRef="i37d082b275694367bb539a8515b1a5af_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3MTE_643ad2a0-8149-4c3f-b34c-0a51c3766c7e">9.121</ix:nonFraction> billion as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ie054bf7025744c0e8874ea68a52321e2_I20201231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODM1Njk_b96cb792-69c9-4fb2-9d2f-b9018a158078">9.205</ix:nonFraction> billion as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2020, we redeemed $<ix:nonFraction unitRef="usd" contextRef="i1eb9666c9b5d47758f0f329b195d28fd_D20201229-20201229" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3NzU_93f6d4ba-9073-445d-bcd3-21498dfe7422">250</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i97e680c0ff1f4c26929f74c3434a3c3b_I20201229" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3ODU_73f8df89-ebd0-4fc1-a6a3-141901d1b587">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ib8b35b770901410ca52fdc805a2e9579_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3ODg_35c1f010-3a79-4304-b574-cd15bd507f62">3.375</ix:nonFraction>% senior notes due 2022 (May 2022 Notes) at a redemption price calculated in accordance with the terms of the May 2022 Notes and its indenture, plus accrued and unpaid interest through, but excluding, the date of redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="icae6cce43b414bfb9f7507f8a47db081_I20200518" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMDMy_381fe647-853b-4095-86fc-0932c735928d">1.700</ix:nonFraction> billion in aggregate principal amount of senior notes comprised of $<ix:nonFraction unitRef="usd" contextRef="ic7bcc19872444969a853a9139102340a_I20201231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMDk0_f72f1a1f-083c-41b8-b6af-12e69eee2a7a">500</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i2a45203f1a3447988e6706b1059e3a29_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMTAw_8a43aa38-d86a-446a-91e0-75ec53094aaf">1.900</ix:nonFraction>% senior notes due June 2025 and $<ix:nonFraction unitRef="usd" contextRef="ib0ce36bb88f54225ab4c1a3a6ffe1e0d_I20201231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMTM0_61271a49-2f0d-4685-8f7b-75b6f1c90f2e">1.200</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="i7b460c38790240a9aa867c6fed4202a6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMTQw_86d3a01a-1228-4fd2-ac22-d9970d2207a3">2.650</ix:nonFraction>% senior notes due June 2030. We used the net proceeds from the offering to refinance $<ix:nonFraction unitRef="usd" contextRef="ie3a666428edd40358c27d96bac0e5b06_D20200401-20200630" decimals="-6" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMjI3_31e5af92-88bf-432c-8650-f6656a707de6">450</ix:nonFraction> million of amounts outstanding under the 2018 Revolving Credit Facility, prepay $<ix:nonFraction unitRef="usd" contextRef="i4db5d14246b341c3b63536f6f5b51606_D20200518-20200518" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMjk3_069ecadd-93db-4318-8a94-3b81a494041a">750</ix:nonFraction> million of amounts outstanding under the $<ix:nonFraction unitRef="usd" contextRef="i5e2c1e2b027e497dbd0261bab6602a47_I20200227" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMzMz_44e1e518-afe6-4c8b-a2c5-aad5f6c4b6e4">1.000</ix:nonFraction> billion February 2021 Term Loan, prepay $<ix:nonFraction unitRef="usd" contextRef="i9e7ecae3134a4534a02c0c55e5ca169a_D20200518-20200518" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMzY4_13ef10e3-17d8-42da-acae-95f1866e0c60">500</ix:nonFraction> million of amounts outstanding under the $<ix:nonFraction unitRef="usd" contextRef="ic538cbc1ea4a4e6482d96eb75deaeea9_I20200421" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNDA0_2a34571a-19a5-4925-9bb9-ad0841ce1fe5">1.250</ix:nonFraction> billion April 2021 Term Loan and pay related fees, expenses and premiums.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;<ix:nonFraction unitRef="eur" contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNTIw_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNTM4_a232b853-d585-4ef2-af0e-afcf6ad69721">1.000</ix:nonFraction> billion) in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNTc1_26f223d7-3e89-42f5-9029-24c13e9d9bb6">0.625</ix:nonFraction>% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $<ix:nonFraction unitRef="usd" contextRef="i0464d11ab42f4a12b77d118c34369f89_D20191001-20191231" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk2_cbbf79b0-0d87-4fb3-ab4b-4b55eda26454">206</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i19e347625da0413196bed00d6571b0aa_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDA2_a6406229-bd38-4964-aa6b-5de244a13e1b">450</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDA5_b8bf0d8a-7374-44ac-b4ed-7569ff0ccfa1">4.125</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i8e308f2a8c574f68b80ca9eb8be35b85_D20191001-20191231" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDM1_3f049a3f-4f54-4732-b659-451106302200">566</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="ib447fd8998e74765b84c8b606bde736d_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDQ1_796f4cb4-fbb7-446a-87aa-6d814381c1b4">1.000</ix:nonFraction> billion <ix:nonFraction unitRef="number" contextRef="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDQ4_606cf94a-d037-47b3-be03-2711b4bca1d7">4.000</ix:nonFraction>% senior notes due 2028 and $<ix:nonFraction unitRef="usd" contextRef="ib44c6e8af734489b858d59c23974cbb2_D20191001-20191231" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDc3_aa4f2662-87d0-46ce-812f-d5e456ecd04c">227</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i6709a77d8fee4017926528030492bcbd_I20191231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDg3_9910c032-99d5-426c-9422-10891b1e2a5e">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i69988c85621b476fa63c489ced0e8284_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDkw_ae1d191d-0049-4bf2-984e-6f4598550b4b">3.850</ix:nonFraction>% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in connection with the transaction. In 2019, we incurred associated debt extinguishment charges of $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMjc5_05fea6a9-d72c-4b06-9624-a8139282b4f6">86</ix:nonFraction> million presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="i3cf03c18e48745718c15c78dddd26e7d_I20190225" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMzcw_f2fc43c7-ff4c-497c-a97b-5f3476056afa">4.300</ix:nonFraction> billion in aggregate principal amount of senior notes comprised of $<ix:nonFraction unitRef="usd" contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0MTY_86dcc10c-6750-4616-b69d-09c40a892b89">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNDM4_ddbcc015-5654-47f5-8d66-ae3501d20ce2">3.450</ix:nonFraction>% senior notes due March 2024, $<ix:nonFraction unitRef="usd" contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0MjI_6d2383cb-0b09-4c49-9e02-9c4ebb1f811f">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNDc2_80a50ad3-3b9d-4cc1-a9ef-1a412127d046">3.750</ix:nonFraction>% senior notes due March 2026, $<ix:nonFraction unitRef="usd" contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0Mjg_91bc44e1-212f-494f-b0e9-7688c4766f0e">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNTE0_77453287-5689-4b92-834b-613f144d92a0">4.000</ix:nonFraction>% senior notes due March 2029, $<ix:nonFraction unitRef="usd" contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0MzQ_14c57938-7089-47b3-88c3-3d7827808298">750</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNTUy_a95580fd-b9a7-4017-a39e-a972e6cedad2">4.550</ix:nonFraction>% senior notes due March 2039 and $<ix:nonFraction unitRef="usd" contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0NDA_9529c35e-5b8b-4eef-b929-d6f0561293b1">1.000</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNTkz_c74c30c9-cf0f-49fe-b7c7-af99f2658162">4.700</ix:nonFraction>% senior notes due March 2049. We used a portion of the net proceeds from the offering to repay the $<ix:nonFraction unitRef="usd" contextRef="i8225f5ac9e2d4a35b19f518f7b34a8cd_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNjk0_654277ab-c02b-4ed4-950f-2f434a2e8831">850</ix:nonFraction> million plus accrued interest and premium of our <ix:nonFraction unitRef="number" contextRef="ib21d26613df8433b90b18e4269afc46c_I20201231" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0NDc_bd92a78d-95e4-4942-8b44-9648ef43e8d6">6.000</ix:nonFraction>% senior notes due in January 2020, the $<ix:nonFraction unitRef="usd" contextRef="i50090a44ed3648b09d9a32e978a34b4d_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNzc5_64049141-1c24-4221-8bf4-b0aec9e39626">600</ix:nonFraction> million plus accrued interest and premium of our <ix:nonFraction unitRef="number" contextRef="i0d747a9536d94fb7b60a93be1cbd161c_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0NTQ_eac02200-dbe4-4b91-b511-539df0d6a095">2.850</ix:nonFraction>% senior notes due in May 2020 and the $<ix:nonFraction unitRef="usd" contextRef="ie4bf916bbcc84dc4825df5c3ccaa8aae_D20200101-20201231" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExODYz_bff2885a-7ef2-4155-b1db-915965fd94ef">1.000</ix:nonFraction> billion plus accrued interest of our August 2019 Term Loan. In 2019, the remaining proceeds were used to finance a portion of our acquisition of BTG.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3737c58f1b4f4db89dd8e87ebf493bc7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our senior notes contain a change-in-control provision, which provides that each holder of the senior notes may require us to repurchase all or a portion of the notes at a price equal to <ix:nonFraction unitRef="number" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="2" name="bsx:ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEyNTgx_f9462ab5-52fb-41fa-a2bb-051ff012e307">101</ix:nonFraction> percent of the aggregate repurchased principal, plus accrued and unpaid interest, if a rating event, as defined in the indenture, occurs as a result of a change-in-control, as defined in the indenture. Any other credit rating changes may impact our borrowing cost, but do not require us to repay any borrowings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NTYz_f1806162-5595-42a9-a988-893872f1817d" continuedAt="ic14ec21a88aa4eca866494f98030392d" escape="true">Amounts de-recognized for accounts and notes receivable, which are excluded from </ix:nonNumeric></span><ix:continuation id="ic14ec21a88aa4eca866494f98030392d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c464c8023048e696d029db1389bebd_I20211231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItMS0xLTEtMA_bb38a0c3-280f-4be6-86f1-0e45e37c6950">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9fce21be2de4c2485cc6ac5d19a3d23_D20210101-20211231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItMy0xLTEtMA_b4910fd8-f068-433a-bb76-f695d2d62612">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e961c1a10f4c2c92f033e86ef7a70c_I20201231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItNS0xLTEtMA_c8250da5-00df-47e2-91c4-424d81d0b8d8">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bc579bbe1d5474b81205d71f15e00f3_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItNy0xLTEtMA_8901385f-2cdb-45b1-8db3-1663d0149f44">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e0816ac73d4823bbb1284d2da621ac_I20211231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtMS0xLTEtMA_6ec3b964-efa1-4900-b7a6-57cebffbeae5">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i485f0a72de344efcb418b11eeb6678cb_D20210101-20211231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtMy0xLTEtMA_5a7663e0-a55d-4857-8dd6-b49ef225e7a5">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77ad771abd648f3a41ae116c98b285d_I20201231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtNS0xLTEtMA_e044c9b3-ede7-456d-8caa-67bdcb32112a">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63949649e58e46738f2ae4a1fa93fc28_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtNy0xLTEtMA_e55b696f-ff62-4bc7-923d-8a93a8add0c6">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renminbi denominated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba5a4c30a3134fd9bb5496536fd667f5_I20211231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtMS0xLTEtMA_825fc6c5-bf86-43d8-be9b-f4b1646d8dd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2af204e5236d4e009be09c240fec1f8c_D20210101-20211231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtMy0xLTEtMA_9b3bcff9-f2cf-4ba9-a0f5-fd623ffc8390">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0444bfe732324384a1a99c91c94db100_I20201231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtNS0xLTEtMjg4_5a5e19a9-c8e2-4d20-8137-08ebb194b62d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88fa01f8ca884ebd86e9a4890726f80d_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtNy0xLTEtMjg4_8dc4d635-6c66-4360-98fb-07b91a378cea">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEzOTA5_d6e313b3-6f16-4013-af20-907a5d6535f1">134</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEzOTI1_afafb7a1-cfc1-4452-a444-e90b7d21f3e2">124</ix:nonFraction> million as of December&#160;31, 2020, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of December&#160;31, 2021 and December&#160;31, 2020, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our consolidated balance sheets as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum purchase obligations, relating primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business, were as of December&#160;31, 2021 (in millions):</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:LongTermPurchaseCommitmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NTQ2_59eab7e9-7f6d-4ee9-af28-74b5087bb70f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecorded Purchase Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzEtMS0xLTEtMA_67da3e5d-c9f0-47f4-b7b3-24ca970b71cd">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PurchaseObligationDueInSecondYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzItMS0xLTEtMA_ac395c41-37c2-4c04-96bc-79e8287ee41b">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PurchaseObligationDueInThirdYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzMtMS0xLTEtMA_5387f512-e7b0-44f7-9813-2869808368d1">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PurchaseObligationDueInFourthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzQtMS0xLTEtMA_b18a987d-0290-439a-9322-01abb7c156af">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PurchaseObligationDueInFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzUtMS0xLTEtMA_5508480a-4916-460d-9457-671c1f413a90">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PurchaseObligationDueAfterFifthYear" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzYtMS0xLTEtMA_d8243a4c-6520-469f-87c6-28f8efb6fad2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PurchaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzctMS0xLTEtMA_ed47aa33-a30a-4e3a-9b7b-a6dbe83c7e50">812</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MzI_45715bb6-e995-4051-9a0e-291b0a8d7eba" continuedAt="if1032762dbcf4f938b2ea8b05a42324f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; LEASES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance leases for real estate including corporate offices, land, warehouse space, and vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet, unless the arrangement includes an option to purchase the underlying asset, or an option to renew the arrangement, that we are reasonably certain to exercise (short-term leases). We recognize lease expense on a straight-line basis over the lease term for short-term leases that we do not record on our balance sheet. If there is a change in our assessment of the lease term and, as a result, the remaining lease term extends more than 12 months from the end of the previously determined lease term, or we subsequently become reasonably certain that we will exercise an option to purchase the underlying asset, the lease no longer meets the definition of a short-term lease and is accounted for as either an operating or finance lease and recognized on the balance sheet. In accordance with FASB ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we account for the lease components and the non-lease components as a single lease component, with the exception of our warehouse leases. Our leases have remaining lease terms of less than <ix:nonNumeric contextRef="i048f5701adc84d0daa997ae6c06ef6ea_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzEyMzM_a73ab03c-2d91-4b22-950f-7749ba6743c5">1</ix:nonNumeric> year to approximately <ix:nonNumeric contextRef="i617fc320c955455ab7389624fb17f118_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzEyNTM_f0d0571a-bdf7-468a-a2d3-1186f952b0b6">55</ix:nonNumeric> years, some of which may include options to extend the leases for up to <ix:nonNumeric contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231" name="bsx:LesseeOperatingAndFinanceLeasesOptionToExtend" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzEzMjI_4faa50c9-fce7-4813-bcfb-b41b19d48ab8">15</ix:nonNumeric> years. If we are reasonably certain we will exercise an option to extend the lease, the time period covered by the extension option is included in the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of the arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, we utilize the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease right-of-use assets are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and corresponding liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated balance sheets. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information regarding our finance leases. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MTg_3e3daa1b-0c13-4712-96e9-0e3a6382c99b" continuedAt="i9d8a4d3f132d4da1afc67c68ff6efdbb" escape="true">The following table presents supplemental balance sheet information related to our operating leases:</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i9d8a4d3f132d4da1afc67c68ff6efdbb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:52.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzMtMS0xLTEtMA_0816bc38-3c5a-4747-ac84-83ac3fbbaaa5">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzMtMy0xLTEtMA_d724538a-a052-4256-80f8-1280a330a170">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_5c57a388-4a11-402a-ac98-8db5289b32b1"><ix:nonFraction unitRef="usd" contextRef="ie4b63f2e0707444f8d067bcb2fe459f0_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_e71c9d43-f4ce-479f-bbdf-c29f84c6ddc1">71</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_02fd6496-c14e-4d01-8da6-bd43092a2153"><ix:nonFraction unitRef="usd" contextRef="i98488b74746f4325a718729aa016bf1f_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_1cee8cb9-6fc6-4d53-8fa2-93166f559964">70</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_2643a84a-4741-454c-9f77-8a94ad26cb86"><ix:nonFraction unitRef="usd" contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_820ab817-7208-49e9-ab9f-43b254250edd">389</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_18293d37-bb2b-40b9-aa4f-ac327a0961c8"><ix:nonFraction unitRef="usd" contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_3930432e-335b-45b3-9fa0-f02f1753b40c">401</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0Mjg_35b009cf-48fd-4a39-be8b-407868e43d0f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:52.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzItMS0xLTEtMA_b0347ae7-7c54-4503-b5f4-c233a8d5cde8">10</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzItMy0xLTEtMA_dc393725-03b4-4282-b7d7-6f57509a6480">11</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzMtMS0xLTEtMA_bb14a6ed-a47f-4f2e-97c4-f53f90537c45">2.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzMtMy0xLTEtMA_16bc7215-02b1-4a6d-bc18-6dd9cf07306b">2.4</ix:nonFraction>%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease cost under FASB ASC Topic 842 was $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzI3OTU_1c5f36fa-f57f-4713-bbd5-d013904b47de">90</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzI4MDg_3570d7f5-8e22-47e1-8e87-d425fd06b445">92</ix:nonFraction>&#160;million in 2020 and $80&#160;million in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MTk_0cb09b30-13a2-4853-985b-5ef7df462e7c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:52.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTplNGJmMmU2MWQ5MmU0N2M2YmI2ZTdhMTAwMGZmNjY1NS90YWJsZXJhbmdlOmU0YmYyZTYxZDkyZTQ3YzZiYjZlN2ExMDAwZmY2NjU1XzMtMS0xLTEtMA_d964f60a-37db-4a70-98d5-5a480b73fe47">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTplNGJmMmU2MWQ5MmU0N2M2YmI2ZTdhMTAwMGZmNjY1NS90YWJsZXJhbmdlOmU0YmYyZTYxZDkyZTQ3YzZiYjZlN2ExMDAwZmY2NjU1XzMtMy0xLTEtMA_97f9ce9f-1a0a-4887-b527-f849f40846d0">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for operating lease obligations were $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzMwNDE_d5cfe4fb-cd0d-45c7-bb62-e646813e3285">68</ix:nonFraction> million as of December 31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzMwNzA_6871573a-ee2d-4484-833e-fa2de427ebf1">202</ix:nonFraction> million as of December 31, 2020.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="if1032762dbcf4f938b2ea8b05a42324f"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:MaturitiesOfLeaseLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MjU_610630d0-0845-48e9-96d0-b10beac6656a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2021 (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzEtMS0xLTEtMA_73bb5d9d-3715-4045-8864-8a175c5bdfab">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzItMS0xLTEtMA_6ff40207-15e1-44e1-a333-e4bbeb264279">69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzMtMS0xLTEtMA_9d81319f-6172-4d17-a885-a39f20582d9c">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzQtMS0xLTEtMA_3eb9e768-afff-4d90-b9f8-5f179d66c182">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzUtMS0xLTEtMA_7c4b9c56-0795-45e9-b550-ceb4bba65a1a">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzYtMS0xLTEtMA_a1b7ea87-6be5-4409-9b12-da9addaa113f">228</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzctMS0xLTEtMA_17ba3c51-8b04-489f-b2f0-110b1e930159">528</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzgtMS0xLTEtMA_09c62e33-f719-43a7-bcc8-80283b956b13">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzktMS0xLTEtMA_1c0b3807-90bb-4824-8613-dcd58cc1bb6a">460</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i4513a36fb1aa4e44acd87206b0aed737_115"></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4Nzg_bca29d4b-af9b-43ae-9f4a-0735f8e4bf28" continuedAt="i97417ad3d18f4b19a152c2c058c69538" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE H &#8211; RESTRUCTURING-RELATED ACTIVITIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2018, our Board of Directors approved, and we committed to a global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan is intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, our Board of Directors approved an extension and expansion of the 2019 Restructuring Plan to include additional cost optimization activities, including the centralization of certain functional capabilities within the international regions in which we operate, and a one-year extension of the program to complete these activities along with certain other initiatives that were delayed in 2020 due to restrictions related to the COVID-19 pandemic. In addition, on February 22, 2022, we increased and our Board of Directors approved cost estimates to complete additional activities identified under the program. We continue to expect the majority of activity associated with our 2019 Restructuring Plan, including the recent expansion, to be substantially complete by the end of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ia2af2c7ed77b498eb719fa78d5da83ce_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4NTU_48201228-b394-4157-933d-2bf59741aad6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, by major type of cost, of which approximately $<ix:nonFraction unitRef="usd" contextRef="ica411c80fdf24d109ac19137eaa6f96e_D20210101-20211231" decimals="-6" name="us-gaap:EffectOnFutureCashFlowsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzE2ODY_d264b394-ced9-4547-8012-bcb2d931c4a6">375</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="if1252f564c6d428c98f594fc337b97b7_D20210101-20211231" decimals="-6" name="us-gaap:EffectOnFutureCashFlowsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzE2OTI_484a4fab-5148-417a-afd0-7b4c14386374">475</ix:nonFraction> million are expected to result in cash outlays:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Estimated Amount Expected to be Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icd865108013d4bcca24cc4a6e429770d_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzItMS0xLTEtMA_8d0d615f-5a19-4490-a4cf-6507a5f34936">75</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i050247ca3e5f4d8792f99eed4db2251f_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzItMy0xLTEtMA_a6272a61-ec45-4390-a907-e265814eea41">100</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9881105cc7c458785ea4390c09d5c34_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzMtMS0xLTEtMA_717ed4f9-b83c-459e-98bb-e2e3ba8ea852">25</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc33409cd1684f7c94717750ee9c914f_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzMtMy0xLTEtMA_c19cac51-4cb2-4b16-94e1-cde3c07de46e">50</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5fab8b1c884ba48ab6fe7638fedd7e_I20211231" decimals="-6" name="bsx:RestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzUtMS0xLTEtMA_c78e1c1a-96a4-460a-806f-b71debab20da">325</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ab67bc08d646feb8bcd26b4e7f25d7_I20211231" decimals="-6" name="bsx:RestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzUtMy0xLTEtMA_62f5d5ba-189b-407d-a961-aac446e6469d">375</ix:nonFraction> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibbc81bf26f074c4781cd0bbddfe60c72_I20211231" decimals="-6" name="bsx:RestructuringandRestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzYtMS0xLTEtMA_1c70199d-24d4-4c06-9246-eba7085829fc">425</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8ea968104af64d01994c09ee3b458889_I20211231" decimals="-6" name="bsx:RestructuringandRestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzYtMy0xLTEtMA_d0700ee5-cc01-413f-b1f4-e2632281af2e">525</ix:nonFraction> </span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2016, our Board of Directors approved, and we committed to a restructuring initiative (the 2016 Restructuring Plan). The 2016 Restructuring Plan was intended to&#160;develop global commercialization, technology and manufacturing capabilities in key growth markets, build on our Plant Network Optimization (PNO) strategy which is intended to simplify our manufacturing plant structure by transferring certain production lines among facilities and expand operational efficiencies in support of our operating income margin goals. Key activities under the 2016 Restructuring Plan included strengthening global infrastructure through evolving global real estate assets and workplaces, developing global commercial and technical competencies, </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i97417ad3d18f4b19a152c2c058c69538" continuedAt="i84c559325ba84947aa0618a895468839"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enhancing manufacturing and distribution expertise in certain regions and continuing implementation of our PNO strategy. These activities were initiated in the second quarter of 2016 and substantially completed in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i764b1d4f04ed46a6948921a252c5d8a3_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4MzU_bb9f3760-1eb1-4fae-ad64-a364d83305d1" continuedAt="ic8ac05d75000419f97dd4a671ce9fd9d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $<ix:nonFraction unitRef="usd" contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzMxODg_9b0d37a6-4e98-46f3-81ab-f7b75bbac087">255</ix:nonFraction> million resulted in cash outlays:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzItMS0xLTEtMA_46b23ea2-a03d-4592-bd8f-c0c4d982fcae">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzMtMS0xLTEtMA_dfda1117-5786-4eeb-b0f6-e1b7b7935dd4">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzUtMS0xLTEtMA_45a8e3a2-1215-4df9-942e-1e9a5bdbe8a1">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzYtMS0xLTEtMA_66e614ae-0641-410e-a519-8e008dc3928e">271</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ic8ac05d75000419f97dd4a671ce9fd9d">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4Nzc_c30e26f9-6228-46a4-981b-270e33f53144" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtMS0xLTEtMA_75188935-4147-4e52-8490-d8e29eb0cc39">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231" decimals="-6" name="bsx:TransferCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtMy0xLTEtMA_7465ea55-017b-4879-af67-7fa57b7eaf32">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtNS0xLTEtMA_d6f24653-5cad-4811-89b1-a8e7b12cb81c">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtNy0xLTEtMA_2bee5bf7-e1fe-4c0c-8c26-587883f7ef5d">40</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebacdb932654dc8a1cdfd75fbdd467c_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtMS0xLTEtMA_a37bfe04-bd8d-465a-9510-c34a1fa76ff9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bc828b5a044f45b01faf25a60e9c78_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtMy0xLTEtMA_5e0bedf0-659c-4868-9cc2-9402419a7a83">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e07352147f42009d9cd8b62d7b1df6_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtNS0xLTEtMA_8f73b6ce-1bad-439f-bb48-bb6e22b02b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a809506747427492eaf2ed10add804_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtNy0xLTEtMA_10d09db1-7c8f-4474-bd4c-7399644235d8">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id117a9767e20473d910b25f606a1e323_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtMS0xLTEtMA_b8d29bde-2c2e-4a41-a5b5-dc3a27b4b1f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c56158760a14fc7b71e8385501fece8_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtMy0xLTEtMA_cde5da3b-bec0-4321-8392-fe0816c7274e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9348686cc963447c935d4482b79d2c75_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtNS0xLTEtMA_ee398368-65f5-44ec-b4e1-2edde548651e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63979d9af7f74e27b56796a2814939d0_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtNy0xLTEtMA_6c74b7bd-7a23-4f03-aead-0688b6190370">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d63013b85484f03ad0cce1d4df4bc84_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtMS0xLTEtMA_6787ab8a-b0be-4727-91a1-3efde2a2f464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8259fbfc86d41e2b865f4365a602b30_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtMy0xLTEtMA_6643b251-6f6a-4b96-aa8f-c5de46692848">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f2550ce37a400e84700479f1651ade_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtNS0xLTEtMA_ed8f7be9-657e-4874-8df4-867355644564">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee11ea97704a4ea8a16e4725ab7a428a_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtNy0xLTEtMA_c4a92823-d746-4d28-a062-13d4917d2592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtMS0xLTEtMA_4a716d7e-8dc1-458b-baae-0d7e745a46af">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtMy0xLTEtMA_c349331d-0aaf-4dc0-aaee-a57632ebe917">79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtNS0xLTEtMA_84e47a04-26b0-4702-8e0e-4110fbffe1d3">72</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtNy0xLTEtMA_49d6356c-c3e8-4575-8841-284f617bc5d1">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctMS0xLTEtMA_79f91fa7-44cc-4187-b0b2-e8fadab68388">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctMy0xLTEtMA_efec6a6f-2c38-4c04-8b0c-bb8adcc47eae">79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctNS0xLTEtMA_b4a0479f-931e-400d-83d6-f1da58f5f1db">92</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctNy0xLTEtMA_8f870fc7-21e6-43a6-a03f-f6a6e8d68a6f">191</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5803b285b4d846bea82279aeafe39223_D20200101-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtMS0xLTEtMA_3294ed4e-e2b9-4e7b-88b2-b177c41695c5">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a55a21282ed4611a789274532e46db2_D20200101-20201231" decimals="-6" name="bsx:TransferCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtMy0xLTEtMA_d8a020ff-4458-44e4-b37f-4b5426a420f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtNS0xLTEtMA_ff0ed30c-7861-41be-9e3c-018c94c35c58">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtNy0xLTEtMA_832999e3-7cbe-4464-9568-1f17a5f11283">52</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib86edd9c6f8940f09b7cb40123e5cf7e_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtMS0xLTEtMA_1115e04a-222f-4044-b452-afb3df8ba14e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356a0c4641ce409d99e92a91a23e56f3_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtMy0xLTEtMA_da4f218c-c713-4a26-8b3e-ee0a3e46ee18">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea22f9173a842c3a6a6aa67253d4913_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtNS0xLTEtMA_511ee6bb-4377-4388-b08e-5e42844386fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i335029b57a154f92b77a7911aeddac43_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtNy0xLTEtMA_27183dd4-06df-42a6-a040-982b72b47362">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e3e16a28194313a0ad082eb5bb8785_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtMS0xLTEtMA_8990da51-259a-42a1-b05f-be8c0c6722d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id412cfa512b949ec907ca18d0cd1c46b_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtMy0xLTEtMA_69571890-d860-4d45-be72-9aa1f8005e28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57a42ba8f784b46a76bcdd531d63e18_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtNS0xLTEtMA_694e8647-fe41-4fa5-a07f-259dcde0f54e">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3645a52d5198438e9a8689f203c0cf54_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtNy0xLTEtMA_bfb93c15-dc39-430d-be4f-8ca044a87b8f">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2692c4ecf242c1b4befbf697da23d4_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtMS0xLTEtMA_d117d1a3-b86f-448d-bbfd-7ad4c4b5aecb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90551e630dbe44ad87da029f9c03ab34_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtMy0xLTEtMA_c1f58122-c5ff-48c1-90e0-3b16ae94c91f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1bd6c6a8a9457c865b6f6d2377b05f_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtNS0xLTEtMA_eefa8086-7e6b-4b53-bf6b-d2c678210458">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4ba129a320747d88fecf483bb2dc190_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtNy0xLTEtMA_ef823738-d27e-4c13-b6b9-3322449ee4a1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5803b285b4d846bea82279aeafe39223_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtMS0xLTEtMA_839cb632-a6ae-4d4b-a14f-615081f73d7e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a55a21282ed4611a789274532e46db2_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtMy0xLTEtMA_181e3ebe-66bd-4428-beb2-05a74f954ec2">64</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtNS0xLTEtMA_e55f9ac3-9ee9-4280-8e8d-e802e5e4a00a">55</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtNy0xLTEtMA_508016b5-91b2-4db3-b848-07fc8c455fd6">119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5803b285b4d846bea82279aeafe39223_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctMS0xLTEtMzEw_6c32f98d-01b6-4d17-a9dc-52785ee6b24b">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a55a21282ed4611a789274532e46db2_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctMy0xLTEtMzE0_3513afa6-ed5c-4226-9c1e-884e6176a9ce">64</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctNS0xLTEtMzE4_4c23187b-1ecc-4947-9c2b-aa114b81c3ca">79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctNy0xLTEtMzIy_823d2aa9-f36a-42db-b4a5-66b98cff2cef">171</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtMS0xLTEtMA_a6498e6d-cdef-470b-8b06-0503398e2420">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231" decimals="-6" name="bsx:TransferCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtMy0xLTEtMA_a23daeb5-018d-425a-8afd-f584c2489982">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231" decimals="-6" name="us-gaap:OtherRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtNS0xLTEtMA_8dba8eee-a98c-43e1-8d85-acca0ae282e7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670166b7b500445f9d43034e4175db7b_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtNy0xLTEtMA_287f24aa-1982-436e-a411-7b4d2db0acaa">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b35f447b40b455ead67f66c9f4bfa5b_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtMS0xLTEtMA_a78b8e9e-8bea-4cd5-b075-54c466e1a57b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7264ea4939f4943af5a24c4278c439f_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtMy0xLTEtMA_05720bdf-aa7a-4dc4-9da1-361de96789b2">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ace6dde67bd4f898df25357d3c29937_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtNS0xLTEtMA_783e8314-51cb-434d-b6af-442efa568a10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244bfd1f3457405c99a68939b39f1e1c_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtNy0xLTEtMA_53785b5f-b7c1-435f-ae5c-d999bd360a8b">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e1cea449b84a3abb1aa082d8446440_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtMS0xLTEtMA_923afa67-59d3-4d21-bfd8-8c91ad25bb87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied974547e60f42538926f26d479f2cd4_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtMy0xLTEtMA_355e957a-013d-41d9-b353-452f50ae7e63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad73371f1eb4bf5b2448c9cc099490a_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtNS0xLTEtMA_56ec2fa8-a538-43b7-9f05-4348f468e233">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d2f64bd733453ab060f8ba6b991f03_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtNy0xLTEtMA_2a16179a-5358-4a7c-8a42-23389b45cab3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtMS0xLTEtMA_3add2141-588b-4b21-a65a-d2ff71c83b7d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtMy0xLTEtMA_78cb4a46-4295-434e-90bf-3736aa085f09">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtNS0xLTEtMA_86404e9f-8226-48da-8b6d-9b2cea330e5e">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670166b7b500445f9d43034e4175db7b_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtNy0xLTEtMA_bcfdca9a-50e7-4031-b5a6-3a3c40e45b94">44</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtMS0xLTEtMA_5f26c897-bc2b-4849-95a6-350c37690c2d">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtMy0xLTEtMA_c2a2edaf-53f3-4e99-99ac-fb932a69bb3a">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtNS0xLTEtMA_cc043507-9a16-43a0-aad4-29f8d111d211">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670166b7b500445f9d43034e4175db7b_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtNy0xLTEtMA_d66aa673-418b-4297-8880-35d37a199dd2">82</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i84c559325ba84947aa0618a895468839"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:CumulativeRestructuringChargesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4MTg_8dda5e54-4a74-4fcc-bc4a-650162a502c2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2021, related to our ongoing Restructuring Plans by major type: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzEtMS0xLTEtMA_7317d193-7198-4a08-b96d-924e6b0b4394">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10777e0a13844245a66a3a04333ca671_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzEtMy0xLTEtMA_010b2613-9499-4f2d-9d3a-573460148058">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32581cb18484982a8776dc9b9f8eea2_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzEtNy0xLTEtMA_1d90a964-bdca-4846-b41c-a62b23defb18">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzItMS0xLTEtMA_3d56d5e8-71c2-4c8a-9a04-83faabaa86ff">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1785b428f97549d8ae81b21532bc254f_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzItMy0xLTEtMA_aa10cfbd-ef3c-44c1-9b47-8017a77d0b2a">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i379c2756c93a4bf38d84777eb83466fd_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzItNy0xLTEtMA_16b389bb-8b75-41fb-a82b-a4d2877b5a14">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzMtMS0xLTEtMA_afb0dca2-605f-4b29-8fa2-1a73344b73a7">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzMtMy0xLTEtMA_3a0def53-7224-4c46-85c9-0a7d65ce9931">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fad2ab117924655ba224551660eddab_I20211231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzMtNy0xLTEtMA_52d6025d-798a-4744-9b42-1d6c9e9cd036">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02efe013a1cb40fa9325d57e55e78b92_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzQtMS0xLTEtMA_b6dc47e5-7f7d-4bce-98e6-20119fdd7dde">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1626115a196044c7964d18ab75d20b9c_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzQtMy0xLTEtMA_a9e5d260-b47e-483b-bb8b-9e079b64303d">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb67a96dc904adf81eb688fc53e83cf_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzQtNy0xLTEtMA_6200c8dc-7c47-4ad0-befb-ea495941283a">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzUtMS0xLTEtMA_fd4e1f7c-41a3-492a-880a-97fb155f3276">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1785b428f97549d8ae81b21532bc254f_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzUtMy0xLTEtMA_64c3e75f-0b23-452e-a674-411ab82a64ab">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i379c2756c93a4bf38d84777eb83466fd_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzUtNy0xLTEtMA_70119425-92e4-4c60-b725-61e237a9e1a9">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzYtMS0xLTEtMA_f673845b-fa0e-4698-962e-08a0f8213558">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzYtMy0xLTEtMA_cbc6659b-826f-4061-b3ed-a6fdc2d1ea75">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fad2ab117924655ba224551660eddab_I20211231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzYtNy0xLTEtMA_9222df96-304b-47f7-8444-08c62eba0967">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzctMS0xLTEtMA_2da66e16-29d8-4932-9231-b5d917c5bb71">271</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzctMy0xLTEtMA_3e9f4333-9675-4d3b-86b3-beaec510d7f3">351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fad2ab117924655ba224551660eddab_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzctNy0xLTEtMA_2930aee9-2500-442a-ac47-d1964b363875">622</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ5MDY_c2d3bd66-6b7b-4bd3-9948-dea71b6a19ea" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzEtMS0xLTEtMA_6862d305-fb57-4739-a948-b37c8c59ef1e">89</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10777e0a13844245a66a3a04333ca671_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzEtMy0xLTEtMA_dc800d18-46eb-46fe-b527-89a95cccc629">35</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32581cb18484982a8776dc9b9f8eea2_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzEtNS0xLTEtMA_211b4229-0cb6-4c88-90fb-a057a6e5f7de">123</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02efe013a1cb40fa9325d57e55e78b92_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzItMS0xLTEtMA_f601eb6c-0a41-470f-b4f5-5b2f7409d976">125</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1626115a196044c7964d18ab75d20b9c_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzItMy0xLTEtMA_0707e255-d479-421d-8011-63921c51b20b">156</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb67a96dc904adf81eb688fc53e83cf_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzItNS0xLTEtMA_33e214a4-93b9-4d38-94ca-1a10db866b7a">281</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzMtMS0xLTEtMA_361de6d0-6a1a-4fec-a367-248a3092cf98">41</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1785b428f97549d8ae81b21532bc254f_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzMtMy0xLTEtMA_5a35ba38-44dd-4bd5-9089-a004c93b1d07">72</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i379c2756c93a4bf38d84777eb83466fd_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzMtNS0xLTEtMA_9e16489b-041b-414e-bee5-35d8e5ae314a">114</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzQtMS0xLTEtMA_832f1065-cdd2-4c03-9f2c-21b71c05d4ca">255</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzQtMy0xLTEtMA_af67a8e4-c615-4aaf-a18a-04c8dceeb6e6">263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fad2ab117924655ba224551660eddab_I20211231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzQtNS0xLTEtMA_c65d00c0-c286-4f6d-934d-ca4774836ed8">517</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LOTUS Discontinuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS&#8482; Valve platform. We recorded restructuring and restructuring-related net charges associated with the product discontinuation of $<ix:nonFraction unitRef="usd" contextRef="i0df90b8ebd7c4c70bb72f12619218a79_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjM3ODU_c4c4943f-eafd-45f1-a063-e7f69ca2bcc8">20</ix:nonFraction> million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="i8f8abbaa26ce4c349b56fdf51f523b44_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjM3OTc_fb41c292-5862-4019-8cd5-572d7f962010">55</ix:nonFraction> million in 2020, which are included in the tables above for the year ended December 31, 2021 and December 31, 2020. The restructuring activities were completed in 2021 and resulted in total pre-tax restructuring and restructuring-related net charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i0683bdec183a43d1af27f889bfe2f888_I20211231" decimals="-6" name="bsx:RestructuringandRestructuringrelatedCostExpectedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjM5MTI_490f5240-6851-44ef-a86c-c31f98d6bb68">80</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2020 we recorded $<ix:nonFraction unitRef="usd" contextRef="i4119e3f71c984843b6e8313e74d94802_D20210101-20211231" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjQwMDk_40d792d2-ffc3-4da2-af24-089009e84afa">119</ix:nonFraction> million of inventory charges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and $<ix:nonFraction unitRef="usd" contextRef="i0df90b8ebd7c4c70bb72f12619218a79_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjQwNjc_c9d28c21-767e-4acf-9eee-dff5e94e8333">8</ix:nonFraction> million of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> associated with the product discontinuation.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNTI_c2cd0a84-cf26-4a9f-a96e-753709f7f7b3" continuedAt="ia2f0fedb8052446ebdc060a46e853b14" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying consolidated balance sheets are as follows:</span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNTc_84c5ff3e-9fb4-4c60-b7d7-0e703c5c3f17" continuedAt="i5388abfc0ac34f55a5e0e6363ba570af" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzItMS0xLTEtMA_7a208425-c272-42e6-8b7b-bb3969e334d7">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzItMy0xLTEtMA_ae40b77f-7334-4eb2-8f46-685c8a3f6971">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzMtMS0xLTEtMA_5af66706-5c9c-4a83-8727-52888a6b8ca3">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzMtMy0xLTEtMA_eab25138-55f0-4ac0-beee-fdf83da69bb6">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzUtMS0xLTEtMA_e58e9a71-9a90-45eb-8dcf-fd293e0ef644">1,778</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzUtMy0xLTEtMA_cec5c5e4-b74d-4e2b-ae30-97870498b144">1,531</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzItMS0xLTEtMA_bd2a027b-e2b5-41ff-b0ca-803320ed1b85">105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzItMy0xLTEtMA_73887a69-b411-4311-bca6-795ce665fe4b">74</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzItNS0xLTEtMA_3edd9654-cee7-4a2b-abc1-d149b006e172">68</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzMtMy0xLTEtNDg1OTU_12be1cdf-900d-4a34-8fe9-a3c3a3c7d65f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzQtMS0xLTEtMA_d1203326-5e22-4d9e-9437-6526a6f0b9f1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzQtMy0xLTEtMA_0e1159c3-03f2-447a-87ab-a9f9104e372a">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzQtNS0xLTEtMA_e116028f-d264-4bc6-9d1e-a1df00916446">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzUtMS0xLTEtMA_a749d49c-c293-4191-a18c-2b20d897c6f6">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzUtMy0xLTEtMA_10393d49-bf56-4729-b0ba-6c65c6e29fde">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzUtNS0xLTEtMA_6ca61b72-d638-424f-8631-449332504856">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzYtMS0xLTEtMA_bc3a862a-17e6-4f26-99d2-5636b3fbe40e">108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzYtMy0xLTEtMA_397cabda-b14b-4064-aafc-b9522f0ca241">105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzYtNS0xLTEtMA_e8fa04a5-653b-4695-ae00-672d1bfe7546">74</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:18pt"><ix:continuation id="i5388abfc0ac34f55a5e0e6363ba570af" continuedAt="id654847f7f954cf087cdd42837eacb1e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 310</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="id654847f7f954cf087cdd42837eacb1e">.</ix:continuation> </span></div><div style="padding-left:18pt"><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNDg_f7982083-e313-483b-b23e-dc5da258d5ad" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzItMS0xLTEtMA_eaae286e-05c0-424e-8cb7-cb22f7b43ef5">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzItMy0xLTEtMA_fcdb9fca-aa4f-4e23-a687-fccb69164b7b">893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzMtMS0xLTEtMA_e971fd44-ff13-4fbc-a011-814dfe455414">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzMtMy0xLTEtMA_70f29432-c395-430c-8a13-a297452cfd8a">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzQtMS0xLTEtMA_96eff83e-ee2c-46ad-90e0-67ee17454a62">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzQtMy0xLTEtMA_0ea19b4d-b119-44bc-8891-8c619ba5245d">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzUtMS0xLTEtMA_f0ba7bfa-7420-4c7a-aba3-e221f01fde9a">1,610</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzUtMy0xLTEtMA_86b9f44c-780f-440b-adb2-a9f3e0995b50">1,351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="2" name="bsx:PercentOfFinishedGoodsAtConsignment" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzU5Mg_b7bf8cdc-937d-4058-be84-f2c3050e31de">30</ix:nonFraction> percent of our finished goods inventory as of December&#160;31, 2021 and approximately <ix:nonFraction unitRef="number" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="2" name="bsx:PercentOfFinishedGoodsAtConsignment" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzY1NA_9e96d74b-2d74-47ac-95ae-822838cd8f66">33</ix:nonFraction> percent as of December 31, 2020 was at customer locations pursuant to consignment arrangements or held by sales representatives.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMjc_d648d3e4-536e-43d8-b0cf-2543355ed36c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzItMS0xLTEtMA_9e62258b-0fd8-4a11-ab7d-ff1c35dc839d">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzItMy0xLTEtMA_c34989d6-8f48-4a71-862a-42a138ac815f">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzMtMS0xLTEtMA_c59ad85b-4299-4b9b-a411-38a2bcd2c55f">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzMtMy0xLTEtMA_d3cfc672-6483-479a-b049-3ce26f6811f2">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:LicensingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzQtMS0xLTEtMA_9c2ec21d-cd9c-47f0-8604-d9214ea0d681">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:LicensingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzQtMy0xLTEtMA_5112fae7-62d1-47c8-9bed-003797c13815">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzYtMS0xLTEtMA_169f011b-92ee-4ad7-9a77-c2a50cb86ade">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzYtMy0xLTEtMA_0950c227-fc0e-4c89-869c-3ba8d238b8d0">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzctMS0xLTEtMA_4da3d35b-87f4-4314-8319-d6c8ac280f25">799</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzctMy0xLTEtMA_13c4f7d6-4fd7-4525-aa05-dfd48892135e">751</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia2f0fedb8052446ebdc060a46e853b14" continuedAt="ic2676158a2fc4891b30e10eec5247412"><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNTk_da152f71-c080-4849-ade1-3be004dcd5b2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzItMS0xLTEtMA_0eeeabc9-ae4d-4d9c-a61b-6fc7246efaa7">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzItMy0xLTEtMA_8987b05a-ac1d-4a1c-861b-18d9b2d68edb">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzMtMS0xLTEtMA_3d5daeb6-15ce-4a98-a0a2-e881ee9b6e8d">1,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzMtMy0xLTEtMA_adcb4a37-478a-40d1-af05-00d8c34b52dd">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:EquipmentFurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzQtMS0xLTEtMA_39f01405-4d96-435d-8242-073f0e78f10b">3,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:EquipmentFurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzQtMy0xLTEtMA_f61bcf73-13ef-461a-bf87-b46fe613d2f5">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzUtMS0xLTEtMA_20bc5415-7efa-4f66-a059-9d322173d3b2">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzUtMy0xLTEtMA_4705309b-0e3d-40d3-a10c-072fc8e2da56">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzYtMS0xLTEtMA_ad880048-ebf8-4191-a4a2-517ed4d77599">5,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzYtMy0xLTEtMA_08ac8ab2-2be8-4a29-9781-b29929e0e619">5,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzctMS0xLTEtMA_6b5d56bc-5b82-4bfb-9128-6a0a8d98dcda">3,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzctMy0xLTEtMA_77f8cfdb-ea09-454e-a24a-16208509885a">3,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzgtMS0xLTEtMA_d39034e4-9b7a-4e17-be46-fc8fb3d78bfa">2,252</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzgtMy0xLTEtMA_86d4b18c-cea4-4df1-a9a9-da7965a4e64c">2,084</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzg2NA_c48cfca4-c5a3-4c02-95a8-8d10332443d6">352</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzg3NA_227752b4-0ce5-4392-b6fc-68ba9f65a2cb">333</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzg4Nw_93299047-d833-4d6d-9626-9cc2637d973d">311</ix:nonFraction> million in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMDY_44e58940-eed6-4a3b-b16e-4ea474d77647" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzItMS0xLTEtMA_a0f9640a-7d98-49c0-b029-941776e46ecd">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzItMy0xLTEtMA_7e282d4a-bf15-4489-9950-936674055352">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80ded4802ba46d3832724842de8285c_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzMtMS0xLTEtMA_86b132cf-932a-41a0-8fd6-e83a0ade93e5">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fed35511829459da5a38d83c0ca798b_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzMtMy0xLTEtMA_0ba13a5d-5fd0-4d75-ac5c-1ca79a740e7a">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzQtMS0xLTEtMA_765c7ff5-b756-4c62-8593-bc168362d328">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzQtMy0xLTEtMA_aa36ec5a-5655-4cef-9e2e-03443a683913">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzUtMS0xLTEtMA_b81e7f5a-9fa9-4d41-b62d-688a4235e9b8">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzUtMy0xLTEtMA_4ba3350d-00f6-45b6-9267-e9a9f1cfe514">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzYtMS0xLTEtMA_33af333d-16a9-4149-a93c-db66a2c39ff2">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzYtMy0xLTEtMA_ac476060-71c7-4510-972a-8a41bfe92237">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:OtherOtherLongTermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzctMS0xLTEtMA_38cf3aca-9c9e-4788-abec-52a906bdb684">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:OtherOtherLongTermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzctMy0xLTEtMA_5a927c9f-4d91-4787-9ddc-df0faaf85ee8">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzgtMS0xLTEtMA_c9f435c5-ac52-45e3-8f01-67c9b1c5f0a9">1,410</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzgtMy0xLTEtMA_5c4f81f5-1d15-4eb6-8d36-502ae3d5ef08">1,921</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMjg_87b32b60-f667-464e-8837-8a1302060696" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzItMS0xLTEtMA_7e0ceb2c-dca0-4df0-8958-084335d9ee34">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzItMy0xLTEtMA_dc30b93f-dbb6-4bfb-8ffe-4c77c068c123">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzMtMS0xLTEtMA_42b0415c-399c-4d50-9627-0292b3756728">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzMtMy0xLTEtMA_c9955e50-2333-485b-a5a3-9d128e8e9551">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzQtMS0xLTEtMA_61dbfbf0-0746-4148-9839-429cdc147bb1">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzQtMy0xLTEtMA_4fc4a0cd-5352-42c4-93cc-a0f2b51c9f52">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzUtMS0xLTEtMA_76eafdf5-4fe6-4216-85e4-1eca8e9f40aa">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzUtMy0xLTEtMA_19aee47e-8422-4cb9-9b24-236c4af4dac1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzYtMS0xLTEtMA_d35bf3b4-e251-4811-bb05-4fd4aa62350c">686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzYtMy0xLTEtMA_a2daaf3f-c240-4af2-95da-c3ee8753478b">656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzctMS0xLTEtMA_1a07543b-93f7-4c22-bce3-70f7ec363dbb">2,436</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzctMy0xLTEtMA_7c00a002-5c41-43ac-a92a-8b96a2a1631b">2,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic2676158a2fc4891b30e10eec5247412"><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMzk_6a05dc93-f92a-45d8-84ce-62f882745c6a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzItMS0xLTEtMA_4561f928-5772-4ed8-9f54-dd23638f9ad3">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzItMy0xLTEtMA_d9151341-4608-49ac-9270-94b97501f6c9">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzMtMS0xLTEtMA_7c21493d-bb77-45dc-958d-684b85921b17">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzMtMy0xLTEtMA_b117dfca-4b1a-4f88-b5c9-08e283820977">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzQtMS0xLTEtMA_abda3adc-061e-4487-a077-18db23634e6f">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzQtMy0xLTEtMA_91a821c3-becc-4229-808e-92e52dc63cc1">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzUtMS0xLTEtMA_6234d9a1-16b6-4e01-8456-bf118b5c6ccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzUtMy0xLTEtMA_c2722f75-98ff-4879-9186-36b191d325b4">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzYtMS0xLTEtMA_c9c724f4-28c7-4260-8db7-9b24790d2b44">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzYtMy0xLTEtMA_66072e13-e7ad-4489-a84c-58af487a0155">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzctMS0xLTEtMA_6913e841-98a2-4255-a701-1a537044fa3a">783</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzctMy0xLTEtMA_309afe14-cfa1-4e6d-a42c-067d0da25c1e">958</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMjI_901b319e-7faf-49d8-9d8e-8448aadda760" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzItMS0xLTEtMA_d8e24c89-4c5f-46d1-b8ba-baed6bc2ae2d">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzItMy0xLTEtMA_1d31bdbc-dcc9-47af-a86c-124653b6dc69">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzMtMS0xLTEtMA_b95a86bb-5317-4f9e-874f-89d5c9a74f41">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzMtMy0xLTEtMA_e232e51d-4e85-46f4-9210-d21c9dc6c2f9">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzQtMS0xLTEtMA_8bf607a8-c397-42d4-b22e-d582d61ca310">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzQtMy0xLTEtMA_78739f36-98f1-402a-80c9-430d792ad6a7">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzUtMS0xLTEtMA_6f3da8ab-9008-4c54-bf11-d02e1b1bc1c0">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzUtMy0xLTEtMA_ca1054bd-373d-4f3b-bcc4-9086ecc6307c">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_1ed815c9-5da2-4587-b032-4aa6994bd099"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_7e90ba1e-cec3-457d-b651-b50748ed3ece">389</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_bbf05a7c-f990-4fcb-b0f0-f7abb412ae4f"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_f4d2fb04-7238-475f-8525-ab855157d3e8">401</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzctMS0xLTEtMA_ab9431bd-1241-408f-abd4-ca2ce2d4a51d">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzctMy0xLTEtMA_e3215d0e-a753-4425-85d1-7cb422c8d945">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzgtMS0xLTEtMA_5df10f46-34be-4ba0-8403-05e042eb777c">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzgtMy0xLTEtMA_3c605bfe-925b-41a4-b581-4693e18e82c8">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzktMS0xLTEtMA_8601f805-586d-4d5a-af0f-64d45a8c31e0">2,220</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzktMy0xLTEtMA_26fd67ec-bb7d-42e4-a4f3-92c758093841">2,309</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_121"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNzA_786e5de8-b8d1-43e3-962a-67b6a9d22e44" continuedAt="i58f79ea28a634a9a9571f316863cf084" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNDk_514b83b1-b345-4e3f-b5f6-1b41418ac966" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzItMS0xLTEtMA_93f1450a-3199-4f94-86b2-6689d21f6de7">648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzItMy0xLTEtMA_cb564ace-35f7-46cb-980d-e79011f4758d">660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzItNS0xLTEtMA_9eb0052a-6ef4-44df-bdf3-bef83e26aa19">1,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzMtMS0xLTEtMA_96559e9b-a8ff-41fb-8efa-2810501549c3">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzMtMy0xLTEtMA_f3d8c49b-2611-428f-bbfb-52e8e9ae0cbc">581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzMtNS0xLTEtMA_85dcd1f2-420d-4043-bf2e-fce2195cbbc6">1,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzQtMS0xLTEtMA_b689577a-c967-4dcb-89f4-f0f8074737c3">1,076</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzQtMy0xLTEtMA_3c7c6b5f-b28c-4163-84fb-43e2f65b89da">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzQtNS0xLTEtMA_54f9496c-1b0c-4e0b-8b01-f1a32927b4e8">687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i58f79ea28a634a9a9571f316863cf084" continuedAt="i1d7e8181263b4756b9e38e41f4edda0a"><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzMTg_4d3a8b8e-9c1e-46f1-818c-6171924d990f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related expense (benefit) for income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzMtMS0xLTEtMA_e9b5f651-9a2f-48b4-9b17-ae5cf9b15cb4">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzMtMy0xLTEtMA_d17fb634-21f0-45fa-8b33-e496a9d4cbe9">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzMtNS0xLTEtMA_9e0f02a1-151a-4770-8b61-3b463a65c6a7">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzQtMS0xLTEtMA_08c6125b-d306-42dc-9c6b-40096cb23184">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzQtMy0xLTEtMA_04be3dab-d874-4ed6-a46d-a054f1edcfd2">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzQtNS0xLTEtMA_b27cf1c8-076b-46e5-b462-40c5853a1784">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzUtMS0xLTEtMA_c308d052-0f44-4946-801f-4dbc8dc7e59c">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzUtMy0xLTEtMA_edc188be-3b2e-4450-866d-1f4e43f21ce7">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzUtNS0xLTEtMA_c5c8ce2d-72e0-4720-863a-07e5e7a2ecae">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzYtMS0xLTEtMA_eb9a452f-ee92-4684-8f9e-6dfa3d88d02f">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzYtMy0xLTEtMA_c9d2aacc-5c44-4f00-9675-214ce12978ff">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzYtNS0xLTEtMA_73ffcd45-32f5-4bcf-ab59-c3d651e6bbba">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzktMS0xLTEtMA_1cf5bce1-dd48-4283-91da-1f88bb65687e">256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzktMy0xLTEtMA_6908e328-2095-4bfe-8390-3e672bc5990c">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzktNS0xLTEtMA_e458f23b-7d12-4aef-9f9f-d04daa94a287">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEwLTEtMS0xLTA_86279fb1-0949-47e3-9257-237c372d99d0">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEwLTMtMS0xLTA_350e5e5b-167f-476e-b671-9687a11f1211">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEwLTUtMS0xLTA_0deb380e-046c-436a-8490-85d5c314804f">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzExLTEtMS0xLTA_a403ada1-7118-4c49-a334-0486bf763519">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzExLTMtMS0xLTA_83e4ac46-0b3a-4746-bcd6-d1b94b0959d5">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzExLTUtMS0xLTA_3d43d33e-9dd4-4d57-b911-ca0f82da6876">4,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEyLTEtMS0xLTA_b4ea7cdc-2e67-4cf1-9e32-93b7a4efaad0">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEyLTMtMS0xLTA_8e2b3ebc-0a63-4e9b-85b7-d7b79fa6d161">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEyLTUtMS0xLTA_b8986b48-0eb5-4ed0-800e-b674f8c4592b">4,288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEzLTEtMS0xLTA_7e31240f-4c76-419a-a6b4-f8396e1bd5b7">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEzLTMtMS0xLTA_35aedb1f-9b9d-4aac-ab30-38e1a894c99c">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEzLTUtMS0xLTA_1dc40a82-2ab7-4508-a592-05934fea84fb">4,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNTE_6346e01f-6d7b-408a-8dd5-5f1a6182dbd3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzMtMS0xLTEtMA_d2c0f4aa-9d11-4ba1-b608-340773ffe5d3">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzMtMy0xLTEtMA_cd04a318-0e81-4c54-9cae-061b358b41d1">21.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzMtNS0xLTEtMA_ab81c3ad-3221-4828-a381-117c4289e99c">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzQtMS0xLTEtMA_4852e9d8-fafe-4dd6-94d8-621840a95080">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzQtMy0xLTEtMA_871bbdf6-7ff9-4690-a41d-dbf135c505ed">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzQtNS0xLTEtMA_2d724d9b-9d97-4d68-8887-5b6cb7d3ff55">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic taxes on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzUtMS0xLTEtMA_2b159cf8-5199-4bdd-9411-b2a8f9653cff">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzUtMy0xLTEtMA_fa2aa1ac-515d-43e4-9fc2-e8d11cffdbca">155.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzUtNS0xLTEtMA_9716cf46-8e1f-4846-b1a5-3203e7b232d6">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzYtMS0xLTEtMA_7ece31ef-9a31-4280-aec5-53a266a32dbf">14.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzYtMy0xLTEtMA_f13e998b-8060-4aef-9e0d-df2fd17c04c1">40.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzYtNS0xLTEtMA_be0a4b3c-55a3-4cd0-ac12-56a0f9a3fd5d">47.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzctMS0xLTEtMA_d59ccac2-2308-4376-8641-e7dc975eacf4">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzctMy0xLTEtMA_3afee21f-e89a-47ba-ac1c-f6fcc11f4d22">16.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzctNS0xLTEtMA_7262867a-41d1-4586-b8ef-19a7b53847d7">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzgtMS0xLTEtMA_9bae33cc-7805-4ee2-8c07-606a1bac8915">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzgtMy0xLTEtMA_1fcd6d6a-5f16-4d0e-b93e-d95ebf09e1f0">43.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzgtNS0xLTEtMA_155647cc-2b26-4cb1-bc4b-60a246de753a">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzktMS0xLTEtMA_f0b8a88c-ae10-4883-b798-3ec17abfec7b">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzktMy0xLTEtMA_a382a3f9-073e-4f65-9e07-eb32269d7893">42.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzktNS0xLTEtMA_c96aa240-3ddb-4007-8acf-707489167b1b">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzExLTEtMS0xLTA_7eebcb92-3f43-4a80-a67b-84468cfa6a47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzExLTMtMS0xLTA_096d28ff-9444-445a-97ec-3018ba64e5bd">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzExLTUtMS0xLTA_11fef62a-205e-4e63-96bd-17a9a6d8c759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEyLTEtMS0xLTA_5795371a-4f20-4bb7-b3a1-1ae56e6bed9c">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEyLTMtMS0xLTA_f1638662-a532-488c-b8b9-c9a969f348eb">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEyLTUtMS0xLTA_60e3feaf-38f1-49cf-903e-035f0356958a">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEzLTEtMS0xLTA_3d386d9f-4c83-4110-be26-2ffa33ca5d95">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEzLTMtMS0xLTA_a3e86f72-2413-418f-8782-03987db5c230">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEzLTUtMS0xLTA_1b042561-93ff-4d28-af8e-42eac05d4d65">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE0LTEtMS0xLTA_bb00b383-b6b0-42c8-9484-6ded0b21be52">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE0LTMtMS0xLTA_b99cc965-6fc5-43ae-89db-7b196b100195">96.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" name="bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE0LTUtMS0xLTA_233ca52b-62bb-480c-a83b-c13bed86aa7b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intra-entity asset transfers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE2LTEtMS0xLTA_584d1000-7d20-4bd4-bae2-d4fe81c46255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE2LTMtMS0xLTA_05cb20b9-604f-4a3f-b86e-0a0e8b45d224">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE2LTUtMS0xLTA_51bc8971-4dda-4043-8973-fb5b630098ab">597.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE4LTEtMS0xLTA_cc3defaf-fd9d-47a7-ac36-96bffcdd2380">5.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE4LTMtMS0xLTA_832af8f2-b376-4ab2-9af6-f31229ec91c3">37.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE4LTUtMS0xLTA_96127435-f1e5-4512-821e-a08302caed48">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE5LTEtMS0xLTA_cd137c0e-b783-4bad-844a-d9ea5a3ef72d">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE5LTMtMS0xLTA_14acc412-da89-4e2d-bead-36bddf64f5a9">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE5LTUtMS0xLTA_3f090dc6-7454-4a13-be1d-c6575084267d">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIwLTEtMS0xLTA_0b82f75b-42f1-4051-b6ad-42cbd3e8d6bf">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIwLTMtMS0xLTA_b42091f4-537a-4896-94fe-eccf4e8c6fd3">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIwLTUtMS0xLTA_3ab59dc4-9501-4e61-a15d-af15156c48eb">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIxLTEtMS0xLTA_5c6a9f5b-dd92-4b35-84db-afe0cb8b5546">3.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIxLTMtMS0xLTA_e8d8041b-0ffc-4605-a50a-3488d69bab09">2.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIxLTUtMS0xLTA_094d3a72-6cf4-4463-ab0b-40c82d0f1660">584.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1d7e8181263b4756b9e38e41f4edda0a" continuedAt="i8f233c4b8c1645a8987cb142a1e3061f"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNzY_4d73d1e5-64e4-47bf-b4cf-291e2c3bf532" continuedAt="i121e225bc00d4733b00d78bfaa276870" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:70.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.729%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzQtMS0xLTEtMA_c390d9fd-e1f4-411c-ad79-0a6a909160f3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzQtMy0xLTEtMA_4cf206b2-5ddb-4015-9775-222028fb7c5a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit of net operating losses and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzUtMS0xLTEtMA_62457995-47f7-45e2-8b4e-d951a7906614">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzUtMy0xLTEtMA_7e9af25c-74bc-4017-85e7-eaa287e3dc79">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzYtMS0xLTEtMA_2aa7d206-2259-451c-bb2f-33cec486376e">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzYtMy0xLTEtMA_99983cb4-5cad-40cd-9a00-18c3d2489e45">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzctMS0xLTEtMA_9d4fcaa2-ee82-48f9-bbc5-fba41cdec79c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzctMy0xLTEtMA_454d2f2e-12f0-4ea1-a923-163b6c9c24ef">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and product liability reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzgtMS0xLTEtMA_c0187302-e3bd-467c-ba19-33387baf9632">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzgtMy0xLTEtMA_51f26bb6-9f41-459c-8aa1-29461716a118">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzktMS0xLTEtMA_924936f8-7dbc-4ba2-96a5-23a417e16160">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzktMy0xLTEtMA_05a18510-87da-4eb9-8d78-e4f80f8920af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEwLTEtMS0xLTA_6e3259f9-0c75-41ca-a1f5-33f66f498300">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEwLTMtMS0xLTA_be12f91f-db91-4979-af77-197c00a25ccb">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal benefit of uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:FederalBenefitOfUncertainTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzExLTEtMS0xLTA_b7e6b158-5d12-4e30-834f-70910951da9a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:FederalBenefitOfUncertainTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzExLTMtMS0xLTA_ae997dbc-d4bf-4695-b45a-abf226702977">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEyLTEtMS0xLTA_d4f199e7-01e7-471c-aa59-97614eeb42b4">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEyLTMtMS0xLTA_024a8a4d-1681-4518-bebf-97ba82b86181">3,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTEtMS0xLTU4NjI1_e4db2bc9-5935-4c79-987b-5fcd83748bc2">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTMtMS0xLTU4NjI1_d6dc3659-7713-49e0-96df-af38f4b6228f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTEtMS0xLTU4NjI1_a03c7207-f8af-4250-b746-7063464d7175">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTMtMS0xLTU4NjI1_0b7916a9-e3a0-4235-af5b-7ea1442e02ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTEtMS0xLTA_958354f9-2598-41af-b481-7632359ef216">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" sign="-" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTMtMS0xLTA_1336ecf4-21bb-41e4-b44a-1152f2d6cba3">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTEtMS0xLTA_9ac5058d-1dfb-46b8-801b-0f1a00edb186">4,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTMtMS0xLTA_27afdd19-dd29-4182-850a-e1c04cb212a6">4,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE1LTEtMS0xLTA_6fd36407-06e8-4197-b2f9-462a7d8e1f76">1,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE1LTMtMS0xLTA_d3dcc897-0f08-4b77-b6fa-19657d16dd06">887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE2LTEtMS0xLTA_f79dc010-9e62-439d-8bc9-6541b63f38bf">3,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE2LTMtMS0xLTA_33e2eb91-87b7-431e-809d-733fbcb180ea">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE4LTEtMS0xLTA_7e977a51-a731-4f2f-8cfa-441ebb890280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE4LTMtMS0xLTA_72bb18a7-9825-463e-bb1d-53d06cb8a739">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses on derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE5LTEtMS0xLTA_32c3ef8d-98b1-4f62-9625-9dd5ed9e7c7e">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE5LTMtMS0xLTA_6b4c9c66-8a4c-43a9-95f7-1c8406e3b5ce">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIwLTEtMS0xLTA_307aef47-b288-455a-97e1-0549b979a51f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIwLTMtMS0xLTA_7407fca8-aafb-4bc5-abae-c791e1f6095c">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIzLTEtMS0xLTA_f6030a32-ffdd-4f1b-812a-0a7f5df6ec4e">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIzLTMtMS0xLTA_42f9f7f5-d007-4155-940d-9fb8b4d25442">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI1LTEtMS0xLTA_001a92ad-e136-490b-8f62-6a7dfa482e74">3,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI1LTMtMS0xLTA_ab3269a7-58ec-4a9c-a831-0a89d14e377c">3,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI2LTEtMS0xLTA_9ffd2b75-3cc7-4832-8da0-a009637af291">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI2LTMtMS0xLTA_c1b418c8-a113-4b42-89a0-085ea0750b50">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI3LTEtMS0xLTA_9f7328d5-bedf-4cba-9558-89155530d8de">4,038</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI3LTMtMS0xLTA_5e7fa9c4-fd2c-4b44-a961-f870821b645c">3,928</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional deferred items in 2021, we have reclassified select items in prior years to align with the new categories disclosed in the current year.</span></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i121e225bc00d4733b00d78bfaa276870"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Component</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id02c5663b02141118d004b9caa3424ef_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzItMi0xLTEtMA_2c72034b-a748-41fb-be53-7d8192bf46a8">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ba8102128e4d5ca7ba5fd85188b839_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzItNC0xLTEtMA_b07618d8-2152-487f-9953-ccd4fc6450eb">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193a2e3116b8454aa87e65f1058e0278_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzMtMi0xLTEtMA_7cfd7791-4e9a-40b5-a8f2-0fa2d148b509">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb74a863f3154f8db49c64618640bd85_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzMtNC0xLTEtMA_a15b144a-018a-48d5-b545-cb52ebae4a1b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c897d04f2364feeb5c3c6a2fa36d797_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzQtMi0xLTEtMA_70b47e39-c5d9-43aa-af52-8c522cd879ea">4,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b55c014808f40fa88ef1b3f959db8d2_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzQtNC0xLTEtMA_b836b34d-33ca-42c7-8ca4-595df51d9e14">4,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzUtMi0xLTEtMA_b047accf-2c9a-453b-9913-eb896f761357">4,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzUtNC0xLTEtMA_65a229af-9258-48da-9ef3-1ca6a81cdee1">4,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93bd60f6d70c420a9bc09e7c7bf6fc5f_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzctMi0xLTEtMA_9fae340d-b7f4-4e1c-a33a-eda51c66a74b">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d817c2bd28479980edad681c6a2071_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzctNC0xLTEtMA_d4f298d6-48fb-4632-9a6f-6acccf0125ac">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb1d6977085e41d8b212c9975e19b482_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzktMi0xLTEtMA_f0058019-1792-4cb7-8032-7fdfae7de503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dbe26c3626844cc8fca8bfbd336dd73_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzktNC0xLTEtMA_17378f43-80f3-4e4b-a4fe-43790e778350">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEwLTItMS0xLTA_ef659cd4-f8dc-46f9-a982-ef86883999d1">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEwLTQtMS0xLTA_a2f5ae9e-9794-4e2c-b647-53ca9454b265">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEyLTItMS0xLTA_8c5ed14c-e9eb-4bad-8753-8df7eb1798e2">4,038</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEyLTQtMS0xLTA_23409947-7dc7-43e9-a1da-5b6035bb96db">3,928</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzg3OA_2cb65b73-cca8-4489-b960-12caf494d51c">560</ix:nonFraction> million. As of December&#160;31, 2020, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzEwMDQ_8f2388a3-0e3e-4651-b0c1-78f93862ff53">474</ix:nonFraction> million. In addition, we had foreign tax net operating loss carryforwards and tax </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8f233c4b8c1645a8987cb142a1e3061f" continuedAt="i035e6fc1b48645f29eaae7874829eac9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">credits, the tax effect of which was $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzExMTg_a58ba60c-a9d4-4c65-94fa-ea296eac74cd">60</ix:nonFraction> million as of December&#160;31, 2021, as compared to $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzExNDY_b1987b22-41ac-4e68-a51e-43f9a536a8ce">83</ix:nonFraction> million as of December&#160;31, 2020. These tax attributes expire periodically beginning in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, we completed intra-entity asset transfers of certain intellectual property rights among various wholly owned subsidiaries. These transactions occurred to more closely align the global economic ownership of our intellectual property rights with our current and future business operations. These transactions did not result in a taxable gain in any jurisdiction, however, some of the transactions did create a step-up in the tax-deductible basis in the transferred intellectual property rights in certain jurisdictions. As a result, we recorded deferred tax assets in the amount of $<ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzE4MzU_3a8b3b35-8fdd-4643-a312-359b79949177">4.102</ix:nonFraction> billion, which represents the book and tax basis differences measured at applicable statutory tax rates, net of a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="bsx:DeferredTaxAssetValuationAllowanceIntraEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzE5Njc_cf61e4a8-56a6-4a94-9b36-1f90bf9200c6"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="bsx:DeferredTaxAssetValuationAllowanceIntraEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzE5Njc_fc514005-b277-4fb3-86ad-c599681d7ce9">542</ix:nonFraction></ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After consideration of all positive and negative evidence, we believe that it is more likely than not that a portion of our deferred tax assets will not be realized. As a result, we recorded a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTE_6fd36407-06e8-4197-b2f9-462a7d8e1f76">1,014</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIyMDc_d3dcc897-0f08-4b77-b6fa-19657d16dd06">887</ix:nonFraction> million as of December&#160;31, 2020, representing an increase of $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:ChangeinDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIyMzk_62abcb22-fc06-4250-9b8a-b21dfe33cc04">127</ix:nonFraction> million. The increase in the valuation allowance as of December&#160;31, 2021, as compared to December&#160;31, 2020, is primarily due to an increase of US state loss carryforwards and the concurrent build of the related valuation allowance. The income tax impact of the unrealized gain or loss component of other comprehensive income and stockholders' equity was a charge of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI1NzE_8f9c033b-5f73-4f9f-977c-4d1457110ff7">81</ix:nonFraction> million in 2021, a benefit of $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI1OTM_ec8fdca9-5b79-4221-a0ef-a1c48a3f655c">78</ix:nonFraction> million in 2020 and a charge of $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI2MTg_12059cb0-1a00-45b5-a518-3f95defda103">13</ix:nonFraction> million in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain tax incentives through Free Trade Zone Regime offered in Costa Rica which allows 100.0 percent exemption from income tax in the first eight years of operations and 50.0 percent exemption in the following four years. This tax incentive resulted in income tax savings of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:FreeTradeZoneRegimeTaxIncentive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI5MDk_0d549799-91d0-42af-8f00-e5d38f496e8b">149</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:FreeTradeZoneRegimeTaxIncentive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI5MjA_db8de4cb-503c-45aa-be46-36dd996b1e76">64</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:FreeTradeZoneRegimeTaxIncentive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI5MzQ_64e56835-4e9a-46af-9db1-3553aafcf31d">173</ix:nonFraction> million for 2019. The tax incentive for 100.0 percent exemption from income tax was renewed during 2019 and is expected to expire in 2027. The impact on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="2" name="bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzU5Njc_c978e5c2-0e1f-4e0e-b116-607364653d5b">0.10</ix:nonFraction> for 2021, $<ix:nonFraction unitRef="usdPerShare" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="2" name="bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzU5ODQ_8fd5e774-67d1-4791-850a-df54b2f93e82">0.04</ix:nonFraction> for 2020 and $<ix:nonFraction unitRef="usdPerShare" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="2" name="bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzYwMDA_7e695703-5500-45e3-9053-dd2387fab096">0.12</ix:nonFraction> for 2019. Additionally, we benefit from tax incentives in Puerto Rico resulting in income tax savings of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:TaxIncentivesInPuertoRico" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNjUwNzI_c81372b8-a192-4b14-b87b-5b16a5421650">27</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:TaxIncentivesInPuertoRico" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNjUwNDQ_88148784-091b-44bf-b740-dc27595e09b6">30</ix:nonFraction> million for 2020 and immaterial amounts for 2019. The impact on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="2" name="bsx:TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzYwOTI_fb2cb211-7f42-40f8-b7e5-ab4700cc0463">0.02</ix:nonFraction> for 2021 and 2020, and less than $0.01 for 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzMzMzc_a54198b0-4070-4aca-93fc-7cc63a5ee2bd">255</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzMzOTE_a7c2cb63-7907-438a-a095-0f032ba4bb3f">177</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM0NjQ_e3545016-453b-4fd6-bcad-8a79fdf32a96">261</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM1MTg_02a92c52-23e0-450b-bfff-af22a4ee1d2c">183</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM1OTE_272dc6b9-b532-428e-a422-970608db5582">455</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM2NDU_d5f0485e-9bd8-46d4-9d74-12cec8cfe293">355</ix:nonFraction> million, if recognized, would affect our effective tax rate. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNDU_91855ff3-b8b9-46a8-ad1b-5a4c1c24042a" continuedAt="ic0370e7217e74c9293250ace33d455db" escape="true">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="ic0370e7217e74c9293250ace33d455db"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzItMS0xLTEtMA_419a898f-f448-48a2-a93e-c97a01cb3d72">261</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzItMy0xLTEtMA_fecd6dfc-63be-4572-a361-549cebd98df7">455</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzItNS0xLTEtMA_f83dd147-ca34-44bd-b6b5-8c38809cfe54">427</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzMtMS0xLTEtMA_b51c85ce-19f6-40b0-968e-99a61bbcb690">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzMtMy0xLTEtMA_4b1c3cc3-eafe-4630-a464-826df71dc91a">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzMtNS0xLTEtMA_49a6d75b-beef-4794-96c1-89291b60a304">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzQtMS0xLTEtMA_46309aa2-d136-4afa-8ed0-e8c3c74420cf">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzQtMy0xLTEtMA_7cccc69b-020f-44be-8955-528357930d62">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzQtNS0xLTEtMA_8ac02a01-53f4-419b-8668-1785611f9aa3">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzUtMS0xLTEtMA_601127a3-342c-43d2-b4c1-c80c592c774f">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzUtMy0xLTEtMA_27c827ca-3107-4c3d-9f01-c89df8ddb5b1">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzUtNS0xLTEtMA_dbd2484a-2764-41d6-b444-bfa690336afc">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzYtMS0xLTEtMA_2b795ccd-2db6-474d-afc8-9ad364166654">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzYtMy0xLTEtMA_e47e7c7b-ff97-4287-87e7-22755d3df131">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzYtNS0xLTEtMA_f20e07f7-1565-4259-aaf6-7638bcd60326">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation expirations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzctMS0xLTEtMA_687e4438-8150-485d-9788-74d1b62e34b7">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzctMy0xLTEtMA_2a3b5c4e-e837-412d-8d28-ba67772dc198">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzctNS0xLTEtMA_ef3b397d-67b0-4a7a-8612-a805ddaf1561">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzgtMS0xLTEtMA_a54198b0-4070-4aca-93fc-7cc63a5ee2bd">255</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzgtMy0xLTEtMA_e3545016-453b-4fd6-bcad-8a79fdf32a96">261</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzgtNS0xLTEtMA_272dc6b9-b532-428e-a422-970608db5582">455</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. Federal income tax as well as income tax of multiple state and foreign jurisdictions. We have concluded all U.S. federal income tax matters through 2016 and substantially all material state and local income tax matters through 2010. We have concluded all foreign income tax matters through 2013, with the exception of issues for Italy, which have concluded through 2002.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i6419e203999942329c84202801da4c46_D20200701-20200930" decimals="-6" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzU2MjQ_b29f9928-5d91-44cd-bb00-51c20b500e1b">91</ix:nonFraction>&#160;million to release the reserves related to these years. We received a refund of $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzU3Mjg_37985d09-defc-4400-a4be-aec57d601907">62</ix:nonFraction>&#160;million from the IRS reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i035e6fc1b48645f29eaae7874829eac9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to income taxes as a component of income tax expense. We had $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzYwMDI_ca1aef5e-7522-4cb8-9299-b121a3db9d63">43</ix:nonFraction> million accrued for gross interest and penalties as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzYwNTk_1c04874b-91f4-4395-b6cb-2420b80da248">41</ix:nonFraction> million as of December&#160;31, 2020. Net tax expense related to interest and penalties was immaterial in 2021, 2020 and 2019. The increase in our net tax expense related to interest and penalties as of December&#160;31, 2021, as compared to December&#160;31, 2020, is related to reaching settlements with the taxing authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12&#160;months we will resolve transactional-related issues with foreign and state taxing authorities, in which case we could record a reduction in our balance of unrecognized tax benefits of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzY2NzA_cfa66d85-04fd-4c16-ae9d-876152e3fdf9">54</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2017, we were required under the TCJA to calculate a one-time transition tax based on our total post-1986 foreign subsidiaries' earnings and profits (E&amp;P) that we previously deferred from U.S. income taxes. As a result of various audit activities, the revised amount of transition tax was approximately $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzMxNzI_7a7baa1b-0060-4008-a8d5-d5911df3176a">938</ix:nonFraction> million as of December 31, 2021 as compared to $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzcyNzY_5edbbbc9-5a1f-46f6-a528-7e16181b7cfb">939</ix:nonFraction> million as of December 31, 2020. We anticipate offsetting this liability against existing tax attributes reducing the required payment to approximately $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:Onetimetransactiontaxpost1986EPnetpayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzc0MjM_c287dcaa-40a3-4267-b0e9-c216e956f821">590</ix:nonFraction> million, which will be remitted over an eight-year period. We have begun remitting the required installment payments, with a balance remaining of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:TransitionTaxPaymentRemaining" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzMxODE_cf6f5235-ca5d-4541-aafe-1074234d9d66">430</ix:nonFraction> million as of December&#160;31, 2021. In addition, we have provided for U.S. state income taxes of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzc2Mzg_5d031da1-2a09-4181-9ae2-cfa965330379">19</ix:nonFraction> million on all U.S. dollar-denominated E&amp;P accumulated through December 31, 2017, which constitutes the preponderance of our foreign subsidiaries' accumulated E&amp;P through December 31, 2017. We intend to indefinitely reinvest the unremitted foreign earnings of all other subsidiaries as of December 31, 2017, as well as all subsequent earnings generated by all of our foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings and additional outside basis difference in these entities is not practicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a territorial tax system under the TCJA, in which we are required to provide for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have established an accounting policy election to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:TheCARESAct" format="ixt:num-dot-decimal" scale="12" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzg3NTU_c361bd00-2073-4c07-a39e-1434a9a30bd1">2.2</ix:nonFraction> trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we did not apply for government loans, we took advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_124"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzI3NTM1_d9ad75a8-7445-483c-9d35-95e58dbf4b04" continuedAt="ie3a10ce7411b488aa34230e698048aec" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie3a10ce7411b488aa34230e698048aec" continuedAt="i4756214441e3439ea8701f36c298c61c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i46f8fa0b6c8c432d9384623e2768c3a3_D20211001-20211231" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzI3NTQw_210b40cb-32ea-4825-9359-0af08ed7417a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM5MTY_7cab1e5d-2a0f-401c-a11b-f35ffb1963c6">548</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM5MzI_c37672b4-3990-4db8-bd12-11a423c4fa95">569</ix:nonFraction> million as of December&#160;31, 2020 and includes certain estimated costs of settlement, damages and defense. We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzkzNDU4NDg5MTAzMTE_44b6b3bc-f400-49db-bc76-ade645239fe0">430</ix:nonFraction> million in 2021, primarily related to ongoing litigation associated with our transvaginal surgical mesh products principally in the U.S. and Australia, as well as anticipated legal fees to defend certain other legal matters. We increased the accrual associated with transvaginal mesh claims to account for increased settlement and litigation activity related to the remaining cases and claims we face, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity and changes to our expectations regarding the rate of incoming cases and claims. These increases were partially offset by settlement payments, primarily associated with a coalition of state attorneys general. A portion of our legal accrual for transvaginal surgical mesh product claims is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ0Njg_84a81e43-b988-4534-aaab-d995e9c73279">188</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ0ODQ_02d6f285-ec4c-4e77-82af-a37bf5765d4c">208</ix:nonFraction> million as of December&#160;31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2MjE_6ffa83c5-7487-4d92-bd4c-afd08eec32b8">278</ix:nonFraction> million in 2020, primarily related to transvaginal surgical mesh product litigation, inclusive of a reserve related to claims made by a coalition of state attorneys general, which has since been settled. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NTU4MjM_eebac84a-d848-4205-bfd7-73ba6e1f8a3b">115</ix:nonFraction> million in 2019, which included a net charge of $<ix:nonFraction unitRef="usd" contextRef="i9a23f29987844bacb827e4e0bf7ebd5b_D20201001-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2MzI_5af2889e-4227-4454-bd2d-555425b3fc0c">223</ix:nonFraction> million, primarily related to litigation with Channel Medsystems, Inc., net charges of $<ix:nonFraction unitRef="usd" contextRef="i6419e203999942329c84202801da4c46_D20200701-20200930" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2NDI_53b08e22-499e-47c7-842e-60e622e10114">40</ix:nonFraction> million primarily related to transvaginal surgical mesh product liability litigation, and a gain of $<ix:nonFraction unitRef="usd" contextRef="i6c9e3d1c87f245508ec3d21cac73b819_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2NTQ_aa06037f-c438-4cf9-afb8-9c85d837530c">148</ix:nonFraction> million, which represents a portion of the total $<ix:nonFraction unitRef="usd" contextRef="iaa4713eca034411386bd8958667ff155_I20190115" decimals="-6" name="bsx:LitigationSettlementReceivedGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2NjA_a8e2b91a-8e0f-42d9-b73c-425263176c67">180</ix:nonFraction> million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from this settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant. In management's opinion, we are not currently involved in any legal proceedings other than those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against the four asserted patents. All IPRs have concluded, and Cook and the Company both appealed the Patent Office&#8217;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Company's patents remain valid, remanding two of the patents for further review by the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USPTO's Patent Trial and Appeal Board. In November 2020, the Patent Office issued remand rulings invalidating several additional claims. The district court stayed the case pending the appeals court decision on </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4756214441e3439ea8701f36c298c61c" continuedAt="id208fcb4bac940ba9b601d8ec9bf323b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the IPRs, which is now complete. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in February 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro Corp. (Nevro) in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro's Senza&#8482; Spinal Cord Stimulation (SCS) System. The company seeks lost profits, a reasonable royalty and a permanent injunction. At a trial held in October and November 2021 regarding six of Boston Scientific's originally asserted patent claims, a jury granted Boston Scientific a monetary award, finding that each asserted claim is valid, that four of the six claims are infringed by Nevro, and that two of the claims are willfully infringed by Nevro. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#8217;s Senza&#8482; I and Senza&#8482; II SCS Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our SCS systems infringe five Nevro patents. Nevro seeks lost profits, a reasonable royalty and a permanent injunction.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial date has been set for the theft of trade secrets and patent counterclaims. The patent infringement claims from case 18-cv-664 were stayed pending IPRs. On January 6, 2021, the court stayed one of the patent infringement claims from case 16-cv-1163, such that it will proceed with the stayed patent infringement claims from case 18-cv-664.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, Nevro filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#8217;s spinal cord stimulation systems. Nevro seeks lost profits, a reasonable royalty and a permanent injunction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2017, The Board of Regents, University of Texas System (UT) and TissueGen. Inc., served a lawsuit against us in the Western District of Texas. The complaint against us alleges patent infringement of two U.S. patents owned by UT, relating to &#8220;Drug Releasing Biodegradable Fiber Implant&#8221; and &#8220;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#8221; and affects the manufacture, use and sale of our Synergy&#8482; Stent System. UT seeks a reasonable royalty. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the UT&#8217;s Petition for Certiorari. UT is proceeding with its case against BSC in Delaware. Trial is scheduled for November 14, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 26, 2022, in the United States, approximately <ix:nonFraction unitRef="claims" contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126" decimals="0" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwMDQ4_f783c11c-4e03-4cfe-b576-4bf76b4abafd">54,500</ix:nonFraction> product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. Outside the United States, approximately <ix:nonFraction unitRef="usd" contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126" decimals="INF" name="bsx:AssertedClaimsOutsideTheUS" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMzMjE0MDA_e1c7d934-38ad-4e66-ac2f-550fc258dc1b">2,700</ix:nonFraction> cases or claims have been asserted, predominantly in Canada, the United Kingdom, Ireland and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 26, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately&#160;<ix:nonFraction unitRef="claims" contextRef="i3a44a33716c34232840446222d515685_I20220126" decimals="0" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwNDI1_428ec294-a814-449e-815a-ae330daf32c5">52,500</ix:nonFraction>&#160;cases and claims in the United States, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately <ix:nonFraction unitRef="claims" contextRef="i3a44a33716c34232840446222d515685_I20220126" decimals="0" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwNzkz_428ec294-a814-449e-815a-ae330daf32c5">52,500</ix:nonFraction> cases and claims, approximately <ix:nonFraction unitRef="claims" contextRef="i3a44a33716c34232840446222d515685_I20220126" decimals="0" name="bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwODI4_95eb2e1e-1996-4233-a0b7-34e681697a92">51,000</ix:nonFraction> have met the conditions of the settlement and are final. In Canada, we have settled approximately <ix:nonFraction unitRef="claims" contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126" decimals="INF" name="bsx:CanadaSettledClaims" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM4NDgyOTA3NjMxNTM_13c775ee-5dac-4347-818e-43ba545e67fd">300</ix:nonFraction> claims. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 26, 2022, the company is facing fewer than <ix:nonFraction unitRef="claims" contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126" decimals="0" name="bsx:PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM4NDgyOTA3NzE0MjE_182efefe-7a7d-4e53-bc94-dddba1fa147c">300</ix:nonFraction> pending cases and claims asserted in various jurisdictions in the United States. Outside the United States, the company is facing fewer than <ix:nonFraction unitRef="claims" contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEyMTk5_59a0454e-6305-4548-9042-8ecd11066033">90</ix:nonFraction> cases and claims in the United Kingdom, Ireland and Canada. In Australia, <ix:nonFraction unitRef="claims" contextRef="if82ad8d4e79140ae9ff32488143d6d7b_I20210331" decimals="0" name="bsx:CertifiedClassActionsInAustraliaMesh" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMzNDc5NTg_80b6df81-1db1-4796-abe1-c93fb8c2fc1e">two</ix:nonFraction> class actions were filed against the Company in in the first quarter of 2021. In the second quarter of 2021, <ix:nonFraction unitRef="claims" contextRef="i68f3333d6cce460dbc252aac2c3a29cb_I20210630" decimals="INF" name="bsx:PermanentlyStayedClassActionInAustraliaMesh" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMzNDc5NTk_4ac1fd9d-8931-44e7-95c9-06ca51bc9a8f">one</ix:nonFraction> of these class actions was permanently stayed, while the other was allowed to proceed. The registration process for this Australian action closed on January 28, 2022. Complete registration information is not yet available but preliminary </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id208fcb4bac940ba9b601d8ec9bf323b" continuedAt="i15f2743273af4b58b176a13316309e17"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information indicates that approximately <ix:nonFraction unitRef="usd" contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126" decimals="0" name="bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEyMjQ2_7a5b7bbc-6919-4b3e-bd5b-747146c974b5">2,250</ix:nonFraction> women have completed registration forms alleging they received and were injured by Boston Scientific implants in Australia. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In February 2021, the Multi-District Litigation (MDL) established in February 2012 by the United States Federal Courts was closed after all pending cases were dismissed or remanded to courts of primary jurisdiction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle, and expect that more cases will go to trial through 2023. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in <ix:nonFraction unitRef="claims" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="bsx:ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMyODMxMDI_10edb065-3519-4220-8ea6-0496c860698c">67</ix:nonFraction> filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and actively selling in the fourth quarter of 2018. The plaintiffs assert they are entitled to monetary damages related to alleged injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional <ix:nonFraction unitRef="claims" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMyODMxMDg_02c5aad0-34ad-4447-adb5-22a6d9396230">377</ix:nonFraction> claims, none of which have been filed. As of January 26, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering with certain plaintiffs' counsel to resolve approximately <ix:nonFraction unitRef="claims" contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126" decimals="0" name="bsx:CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NjY0MDM_ba129460-3ace-4451-82b6-9689636a50fa">200</ix:nonFraction> cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#8217;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. The full Commission is considering this recommendation but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#8217;s decision.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments are due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents. Labcoat seeks monetary damages related to an earn-out provision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i15f2743273af4b58b176a13316309e17" continuedAt="ic1374ad7f67840ca93919baa1246f57a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all others similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. Under the terms of the Court-approved Scheduling Order, Counsel for Mr. Errichiello was required to file an Amended Complaint on or before June 4, 2021, which they did. The Amended Complaint seeks unspecified compensatory damages in favor of the alleged class as well as unspecified equitable relief. In response, the Company brought a Motion to Dismiss the Amended Complaint which it filed on July 19, 2021, and argued on November 19, 2021. On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#8217;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company cooperated fully with the requests, and on January 3, 2022, the SEC informed us that it was concluding its investigation and that it did not intend to recommend an enforcement action. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above. The Company received letters on behalf of the Union Excavators Local 731 Pension Fund and Diane Nachbaur, two stockholders of the Company, on July 26, 2021, and July 29, 2021, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for Boston Scientific and three of its employees, as well as numerous other defendants charged in criminal proceedings. The charges arose from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials. A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Boston Scientific employee but acquitted two others and levied a fine of &#8364;<ix:nonFraction unitRef="eur" contextRef="i66f21ac1ac454c5d80b0c27572fa871f_D20171110-20171110" decimals="-3" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NjcxNDk_6ead058a-6d08-41cc-81e1-06063f8ffa35">245</ix:nonFraction> thousand against us and imposed joint and several civil damages of &#8364;<ix:nonFraction unitRef="eur" contextRef="i66f21ac1ac454c5d80b0c27572fa871f_D20171110-20171110" decimals="-3" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NjcyMTE_48ce6def-238f-4d8b-8116-4104b0a37743">620</ix:nonFraction> thousand on all defendants. We continued to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against Boston Scientific and its employee and acquitted them of all charges. This judgment of acquittal became final as to the Company and its employee on April 15, 2021 when the prosecution chose not to appeal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general regarding our transvaginal surgical mesh products and related alleged violations of states&#8217; consumer protection statutes. On December 12, 2019, the Mississippi Attorney General filed suit against us in a Mississippi state court alleging violations of the Mississippi Consumer Protection Act. In the fourth quarter of 2020 and the first quarter of 2021, we reached settlements with 48 states, including Mississippi, and the District of Columbia. These settlements were finalized in March of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. On April 8, 2021, the parties settled the dispute, and, on April 12, 2021, the parties filed stipulations with the court to dismiss the remaining legal proceedings. The settlement did not result in any material benefit or liability to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena sought information related to the launch of the Cognis&#8482; CRT-D and Teligen&#8482; ICD line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of our Physician Guided Learning Program. We cooperated with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. federal government and the State of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic1374ad7f67840ca93919baa1246f57a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to our Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint. We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018. In February 2021, we filed a motion for summary judgment, which the relator opposed, and on August 13, 2021, the Court granted the motion in its entirety. Subsequently, the parties resolved the matter, effective October 4, 2021, and the matter is now concluded. The resolution did not result in any material liability to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, Koninklijke Philips N.V. and IP2IPO Innovations, Ltd. (Philips) served a complaint against the Company in the United States District Court for the District of Delaware. The complaint alleged that certain BSC cardiovascular diagnostic devices infringed six Philips patents. The parties have settled the dispute through a confidential settlement agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc., alleged indirect purchasers of ZYTIGA&#8482;, filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia. The complaint alleges that the defendants violated the Sherman Act and the antitrust and consumer protections laws of several states by pursuing patent litigation relating to ZYTIGA&#8482; in order to delay generic entry. On June 21, 2019, the case was transferred to the United States District Court for the District of New Jersey and has been consolidated with similar complaints.</span><span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 27, 2021, the court granted BTG and Janssen's motion to dismiss all claims in the indirect purchaser action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2017, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed on behalf of the United States, 29 states, and the District of Columbia. The complaint, which was filed in the United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA to the government in connection with direct government sales and government-funded drug reimbursement programs. The case has been transferred to United States District Court for the District of New Jersey. On June 20, 2019, the complaint was amended to include BTG International Limited as a defendant. In May 2020, a class action complaint was filed in New Jersey federal court against Janssen and BTG by a direct purchaser of Zytiga on behalf of similarly situated entities. The complaint was amended in February 2021 and alleges that BTG and Janssen violated antitrust laws by attempting to enforce certain patents against potential generic competitors. On October 12, 2021, the court granted BTG and Janssen&#8217;s motion to compel arbitration in the direct purchaser action and stayed all direct purchaser proceedings. On December 17, 2021, the court granted BTG&#8217;s motion to dismiss the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> action. On January 10, 2022, the court granted the parties&#8217; stipulation of dismissal with prejudice as to the claims of the direct purchaser plaintiff, whose claims had been stayed in the October 12, 2021, order compelling arbitration.</span></div></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_127"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2ODE_e41d74ca-25cd-4616-88ea-396c707d2aba" continuedAt="i9e792f00739e440ea8a2fc9ac84b16ac" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; STOCKHOLDERS' EQUITY </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU1_c12845f9-1076-492c-837c-f3c244c09916">50</ix:nonFraction> million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="ia1b7da4d442341ae9e6ed840e1f4cd33_I20200527" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU1Mg_3eecba56-9e94-4441-b718-2f7accaf4427">10,062,500</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2NQ_0e477b4a-9b09-4aee-8341-0503ef33b4be">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia1b7da4d442341ae9e6ed840e1f4cd33_I20200527" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzY3OA_03a361eb-ba25-4346-8bc5-1cf1663e4198">100</ix:nonFraction> per share. The net proceeds from the MCPS offering were approximately $<ix:nonFraction unitRef="usd" contextRef="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1Xzc1MQ_05e54756-541c-411c-b349-8baa43759100">975</ix:nonFraction> million after deducting underwriting discounts and commissions and offering expenses. As of December&#160;31, 2021, our MCPS had an aggregate liquidation preference of $<ix:nonFraction unitRef="usd" contextRef="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231" decimals="-6" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1Xzg5NA_ef32461f-c7a0-4e75-a0b5-1b650aa8fdf2">1.006</ix:nonFraction>&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of <ix:nonFraction unitRef="number" contextRef="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzExMTk_0e477b4a-9b09-4aee-8341-0503ef33b4be">5.50</ix:nonFraction>% of the liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzExNTU_d9e11a25-b47a-48b3-9a2a-849583918a16">100</ix:nonFraction> per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9e792f00739e440ea8a2fc9ac84b16ac"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzIyNjM_d9e11a25-b47a-48b3-9a2a-849583918a16">100</ix:nonFraction> per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between <ix:nonNumeric contextRef="i2c11391a90f343a8a29ca5a651461834_D20210101-20211231" name="us-gaap:ConvertiblePreferredStockTermsOfConversion" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzI0ODA_15c628d4-602e-497a-b9d5-e921cdbfbb66">2.3834</ix:nonNumeric> and <ix:nonNumeric contextRef="i0157a31857394755b58f1cb928f3509e_D20210101-20211231" name="us-gaap:ConvertiblePreferredStockTermsOfConversion" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzI0ODc_4283ea6b-1ddf-47ae-ace0-16927e5237a6">2.9197</ix:nonNumeric> shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared and we paid quarterly cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzM1Njg_67729731-f764-454e-b406-26c5ba79cf41">1.3750</ix:nonFraction> per MCPS share to holders, representing dividend periods through November 2021. On February 1, 2022, the Committee declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5bb7cb06378a4432bb97c143cc5f5952_D20220201-20220201" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzIxOTkwMjMyNjQzMDc_7803e8a8-e23c-468b-a17a-2be97b4ed4fd">1.3750</ix:nonFraction> per MCPS share to holders of our MCPS as of February 15, 2022, representing a dividend period from December 2021 through February 2022. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets as of December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzQzMTc_0cbe2f0f-70f6-4b40-904d-8872e3d5f297">2.000</ix:nonFraction> billion shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzQzNDQ_9de384b0-6f0a-4dc6-bb14-1d2c28046f9c">0.01</ix:nonFraction> par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="id85bcc6a4b684d52a383187a1856dd57_D20200527-20200527" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzUwODA_65e89811-7e30-4b2a-864c-89823bf3034b">29,382,500</ix:nonFraction> shares of common stock at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i419713e280d4402f8c14fa84298a0ccd_I20200527" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzUxMzY_543e8820-02ef-4dd7-971d-0239c8e9730b">34.25</ix:nonFraction> per share. The net proceeds from the common stock offering were approximately $<ix:nonFraction unitRef="usd" contextRef="id85bcc6a4b684d52a383187a1856dd57_D20200527-20200527" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzUyMTc_c67d6792-d25a-4a13-8391-d614f26cb618">975</ix:nonFraction> million after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remaining proceeds were used for general corporate purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i72aa8f882331458e90a94bf23ae61e59_I20130125" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MDE_79f8e933-caa6-49a9-8e47-3db37c1ae55a">1.000</ix:nonFraction> billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-3" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MDc_6d4ecc21-5368-44ea-b858-53347abda38f">15.7</ix:nonFraction> million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MTM_6c32d1ea-bf60-4fc8-92bc-6ff9ecb04f16">535</ix:nonFraction> million in cash, which represented the full amount remaining under that authorization. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i76d5c1eb8c3c498e932fff915c09dd38_I20201214" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MjM_38fe6cba-6adb-4862-b0b2-8680c0eb471f">1.000</ix:nonFraction> billion of our common stock (2020 share repurchase program) and as of December&#160;31, 2021, we had the full amount remaining available under the 2020 share repurchase program. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during 2021. There were approximately <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2NTQ_c64383f6-bcc7-4efe-9664-6267822d7fce">263</ix:nonFraction> million shares in treasury as of December&#160;31, 2021 and December&#160;31, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MDE_58da0afc-5ada-4eb0-a863-3f68466e802f" continuedAt="ice7cf4dcdaa144db8eb194b5237178b4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; STOCK INCENTIVE AND PURCHASE PLANS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Director Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Board of Directors and stockholders approved amendments to our 2011 Long-Term Incentive Plan effective October 1, 2020 (Amended and Restated 2011 LTIP), authorizing for issuance up to <ix:nonFraction unitRef="shares" contextRef="id9728f3b38444f35b64ff2f079ea4b3d_I20201001" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzI1Mw_b616d84c-acaa-4a0c-bf89-d9116f1a8147">171</ix:nonFraction> million shares of our common stock. The Amended and Restated 2011 LTIP covers officers, directors, employees and consultants and provides for the grant of restricted or unrestricted common stock, restricted stock units (RSUs), options to acquire our common stock, stock appreciation rights, performance awards (market-based and performance-based RSUs) and other stock and non-stock awards. Shares reserved under our current and former stock incentive plans totaled approximately <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzY5OQ_fd7f44c0-0282-46f2-ab72-f70af4dd1a0d">180</ix:nonFraction> million as of December&#160;31, 2021. The Executive Compensation and Human Resources Committee (the Committee) of the Board of Directors, consisting of independent, non-employee directors may authorize the issuance of common stock and cash awards under the Amended and Restated 2011 LTIP in recognition of the achievement of long-term performance objectives established by the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-qualified options issued to employees are generally granted with an exercise price equal to the market price of our stock on the grant date, vest over a four-year service period and have a ten-year contractual life. In the case of qualified options, if the recipient owns more than <ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:VotingPowerOfAllClassesOfStock" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzEzMTk_78e1bf24-8e94-4894-ae6f-cb1820e6ff96">ten</ix:nonFraction> percent of the voting power of all classes of stock, the option granted will be at an exercise price of <ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzE0MjY_eaae602b-9a9b-4833-9ce8-35cfde7af72f">110</ix:nonFraction> percent&#160;of the fair market value of our common stock on the date of grant and will expire over a period not to exceed five years. Non-vested stock awards, including restricted stock awards (RSAs), RSUs and deferred stock units (DSUs) issued to employees are generally granted with an exercise price of <ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="bsx:Nonvestedstockawardsexerciseprice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzE3MjE_6e209436-e977-4e3d-b022-cd2db5e62304">zero</ix:nonFraction> and typically vest in four or five equal annual installments. These awards represent our commitment to issue shares to recipients after the vesting period. Upon each vesting date, such awards are no longer subject to risk of forfeiture and we issue shares of our common stock to the recipient.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MjQ_cb2074fb-7774-4314-93e1-d0d843cd10fd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the impact of stock-based compensation on our consolidated statements of operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if59bff74575c44e3a5039251cf9b8592_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzItMS0xLTEtMA_6a5482a1-942c-4b94-9b61-7c64d342bd3b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e61128384f479281522b42f68d88de_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzItMy0xLTEtMA_35d99e43-74c4-4087-bab2-50b7b8e8132f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d964f1e8fde4f869b9572107e4cd663_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzItNS0xLTEtMA_c8ea8910-e359-44c4-a9d3-3da30b418e83">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a649302b88643399da73bbaa811ad27_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzMtMS0xLTEtMA_4172e3fa-f48e-47d7-b683-1f79c160c7e0">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03336283c2ff4b398efa41236e67a2d1_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzMtMy0xLTEtMA_35603e0b-5823-48d8-b426-68ba6d901ee9">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7e7bf22b2b40ce8673e049908bce94_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzMtNS0xLTEtMA_b61459e2-6cff-47a8-b590-a5634a17e1be">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db9ac2d795d4e17aee7151bfb6ee932_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzQtMS0xLTEtMA_9f6be812-5f40-4632-a59c-25c7c02e81cd">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae1671df59943f7acd666541a997122_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzQtMy0xLTEtMA_9b63143c-4f0d-4401-8401-89fa2a6d17be">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92048bcac2e04d9983b5f962b19cad96_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzQtNS0xLTEtMA_3ba96741-2f01-4647-892a-d57b845c5702">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzUtMS0xLTEtMA_26e36d58-15da-4ca9-b547-4a6992bc9081">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzUtMy0xLTEtMA_85fa94f1-fd88-49ee-ab2d-960b920bdbbb">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzUtNS0xLTEtMA_dfe94eed-2ea8-4362-88ca-11d34d55d506">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzYtMS0xLTEtMA_cfd5a0d6-7dcb-4e68-a928-c4d0677a4eb1">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzYtMy0xLTEtMA_d97645fb-580b-4917-855f-05a39a9ea7f1">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzYtNS0xLTEtMA_bd232886-e7e4-4f54-9264-7a328bd2fc03">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:ShareBasedCompensationNetOfTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzctMS0xLTEtMA_51e20579-e437-419d-bf3d-37b3a0623d46">165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:ShareBasedCompensationNetOfTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzctMy0xLTEtMA_0c204fa5-3636-490a-b98b-64c960bf117c">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:ShareBasedCompensationNetOfTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzctNS0xLTEtMA_5339afef-1c89-4e80-bf12-b92348d0fa75">133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:CompensationExpensePerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzgtMS0xLTEtMA_7621b0b4-e4f7-4e76-9cab-13ba83249c2e">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" name="bsx:CompensationExpensePerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzgtMy0xLTEtMA_ad553a47-d4f8-4576-8742-42c9b4127c06">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="bsx:CompensationExpensePerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzgtNS0xLTEtMA_8a39ae69-3ab7-4a07-83c1-c8298c22e454">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:CompensationExpensePerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzktMS0xLTEtMA_dc6d80f8-8831-4f6d-bbc7-4f554541613d">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" name="bsx:CompensationExpensePerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzktMy0xLTEtMA_a28ca517-1ffd-44ee-a9dd-03044800939b">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="bsx:CompensationExpensePerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzktNS0xLTEtMA_204d4677-61bd-433b-8df9-bcaa4448be34">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MTg_12f0e766-8278-42a6-b30b-5f058970d1b0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzItMS0xLTEtMA_af6888f5-f361-4a4c-bce9-ea9ba9c52463">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzItNS0xLTEtMA_b66fcf07-7fc0-4a3e-9bff-a0f1e18b4355">3,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzItOS0xLTEtMA_661ef1ed-8bc8-494e-be6e-add8b6f5884f">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzMtMS0xLTEtMA_b65f498d-f092-409e-bd71-cab6f497dec2">37.69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzMtNS0xLTEtMA_49e09d70-7e5c-4b67-ad15-cb271531f421">41.79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzMtOS0xLTEtMA_cc15678e-1602-4731-9186-cc939dbe5b24">40.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzQtMS0xLTEtMA_0bf58f5c-333e-439b-8f45-ebf241578440">10.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzQtNS0xLTEtMA_81e470d9-aaa6-42ff-a284-6b095919b6c9">10.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzQtOS0xLTEtMA_a9f78dd5-fe68-4f92-9c9f-6d50e1cc74ee">11.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Black-Scholes Assumptions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzYtMS0xLTEtMA_3f7ec6cf-9fd6-4774-9208-77e6f00f979b">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzYtNS0xLTEtMA_795f8e6b-0c3e-430b-b0db-65c3ca926d60">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzYtOS0xLTEtMA_aa02ec8d-4aae-46da-b281-321e6bd16aab">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years, weighted)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzctMS0xLTEtMA_698cc882-384d-4d88-b390-9bb56370f283">5.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzctNS0xLTEtMA_aea1fb7d-9714-48d6-9d12-6d9662641de5">5.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzctOS0xLTEtMA_2632a865-6757-45b2-a818-779f4e0dcb16">6.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie188534f742842feac06df7e1c74aa45_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtMS0xLTEtMA_e60f0bad-3ccb-4c12-b41f-668bfb1f66d0">0.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtMy0xLTEtMA_8cdff411-fd23-44fe-b6b8-33cbecc19e2a">1.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0aae52091d8944baa48514791518f001_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtNS0xLTEtMA_1fcf2b99-b6a1-4995-84b7-5377ee6c43c6">0.27</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18d0f7d58dbe4881a08e6c6c4d798dc7_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtNy0xLTEtMA_e02739d9-77f5-4f14-9be0-4acdafc4e5c8">1.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28b5c1f16ae04ad0863e335580139350_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtOS0xLTEtMA_736c396f-3bce-4bb9-82ff-723a9c886e19">1.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7bc526be42e743bb9a8a6576a16447ee_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtMTEtMS0xLTA_5fe5864e-cb1d-4adf-baaa-0d591193d106">2.61</ix:nonFraction>%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Volatility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our historical volatility and implied volatility as a basis to estimate expected volatility in our valuation of stock options.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ice7cf4dcdaa144db8eb194b5237178b4" continuedAt="i389c26a62414404d85627280d6ca5304"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Term</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the expected term of options using historical exercise and forfeiture data. We believe that this historical data provides the best estimate of the expected term of new option grants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk-Free Interest Rate</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use yield rates on U.S. Treasury securities for a period approximating the expected term of the award to estimate the risk-free interest rate in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Dividend Yield</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not historically paid cash dividends on our common stock and currently we do not intend to pay cash dividends on our common stock. Therefore, we have assumed an expected dividend yield of zero in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MDg_785430fe-cb48-4e35-8d86-21f61466692b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to stock options under stock incentive plans are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:49.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzUtMS0xLTEtMA_7354bfcb-3608-407f-928c-721d8e571b04">25,304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzUtMy0xLTEtMA_b24f25e6-5940-4d15-a0ca-9296b9696e5b">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzYtMS0xLTEtMA_41e6e2d9-f239-42ac-b07c-411761dad31b">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzYtMy0xLTEtMA_b4192bc4-754b-4845-95df-f592655b2c52">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzctMS0xLTEtMA_87e71f36-552d-47b4-85b3-2f34a96aded0">4,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzctMy0xLTEtMA_be81df8b-7c57-4775-8281-78a445b91bcd">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzgtMS0xLTEtMA_b5b830b5-e5d6-49a0-80b7-ffc95cfe0880">359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzgtMy0xLTEtMA_9e1b3b15-fc62-41be-9d0e-76885afcfdc1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzktMS0xLTEtMA_f2152516-9317-4246-9c94-e03348617dc3">23,065</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzktMy0xLTEtMA_f30e3a1d-22a2-4c14-9091-0af74d79861e">19</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEwLTEtMS0xLTA_f3b90bfa-2bac-4265-bd33-e7d03c17bebe">3,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEwLTMtMS0xLTA_b4d863a7-7eb0-452e-ae7f-f813c1e63520">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzExLTEtMS0xLTA_18ec695a-3794-4982-a9d5-05983604a75a">3,096</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzExLTMtMS0xLTA_3ab76744-7ff6-4e48-b36e-2c9cc1aa24dd">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEyLTEtMS0xLTA_40be8b13-8904-4f0d-b722-e7642eb8bec4">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEyLTMtMS0xLTA_096046a3-a884-4f9c-8133-86facf36495b">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEzLTEtMS0xLTA_f33534d1-8c1f-4153-bd96-b01f246d844b">23,122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEzLTMtMS0xLTA_2996eb7c-2e71-452d-b586-d9c9f1f283d4">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTEtMS0xLTQwMA_cf71c0ea-ca74-42f2-a560-5e44a61c18cc">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTMtMS0xLTQwMA_468d7749-af0c-4353-8bf4-16cd49d7ff58">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTEtMS0xLTQwMA_0289a0d6-416c-4451-b907-dd671d14bd90">4,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTMtMS0xLTQwMA_1adf8d39-add0-47b5-a2fb-b3bb77e32857">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTEtMS0xLTQwMA_9a2d85fb-6b2a-4d38-83ec-fb3a2ef5ce2a">699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTMtMS0xLTQwMA_e16b89d1-2c9b-4bd5-b3c8-bcad739684d9">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTEtMS0xLTQwMA_6ca330d6-7809-4b09-a33f-9eaa46bffe91">21,448</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTMtMS0xLTQwMA_e35e109c-cc17-4747-b308-c6ca1f5abeab">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTUtMS0xLTQwNg_583c3a66-578e-471c-8888-dd607db1ef9e">5.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTctMS0xLTQwNg_7b3d7485-0003-4f26-838f-e497248c1426">296</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTEtMS0xLTA_d9859cfb-9393-4fe8-b9a9-1a3198bc19ce">13,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTMtMS0xLTA_c62477ae-f360-444f-b2f8-75a53aaff427">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTUtMS0xLTA_9c20c5d3-e7cf-47b5-b111-0386c199dc3f">4.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTctMS0xLTA_46eebe64-e2d0-467e-b569-7995390394bf">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-3" name="bsx:OptionsExpectedToVest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTEtMS0xLTA_2f5123df-0766-4a2e-9ca4-96112e6b2878">7,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="bsx:OptionsExpectedToVestWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTMtMS0xLTA_0cb800e2-af72-45cd-b49a-726468d9c568">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:OptionsExpectedToVestWeightedAverageRemainingContractualLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTUtMS0xLTA_106f347f-beec-4ef6-a88f-e188263d67fb">8.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTctMS0xLTA_49017475-37cb-414e-bdc0-ab526f2685b1">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total vested and expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTEtMS0xLTA_e28a2869-e71a-4465-9294-ca33c22bb2df">21,141</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTMtMS0xLTA_63f04bd2-47ba-4c4f-bccd-b1e39b6b76a2">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTUtMS0xLTA_aa50e527-6375-43fe-918c-bf703c1bd02b">5.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTctMS0xLTA_64bd8bcc-db46-43c6-b099-b5d551cba791">295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzMzNjU_9d7caf60-8c88-4367-83d7-b324f9b8380e">137</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzMzNzU_a8d323ae-13da-4fb7-9c7e-6454635b5bb5">84</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzMzODg_ead91237-44e7-45eb-94f6-a6735cebba93">140</ix:nonFraction> million in 2019.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i389c26a62414404d85627280d6ca5304" continuedAt="i0beed35c26fc4873916737879615f1a2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Vested Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value RSAs, RSUs and DSUs based on the closing trading value of our shares on the date of grant. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5Njc_ab01b4c0-c751-4e8e-9059-70356d143336" continuedAt="ideea157fd80d4e5b811933eaf6b8e22c" escape="true">Information related to non-vested stock awards is as follows:</ix:nonNumeric></span></div><ix:continuation id="ideea157fd80d4e5b811933eaf6b8e22c"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Award Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzUtMS0xLTEtMA_0d31eab6-c4bb-4a91-a0d7-cb1301829fad">12,683</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzUtMy0xLTEtMA_81321546-afa7-4144-a710-5325938887db">22</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzYtMS0xLTEtMA_ec049422-a3a7-4bd8-84b1-1ffbd9553272">3,656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzYtMy0xLTEtMA_69970d5d-6e97-48c0-8cca-db223fa07944">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzctMS0xLTEtMA_557161ab-a279-45d0-a797-b83975f1cad9">4,811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzctMy0xLTEtMA_21981fdc-a2f2-45c0-bd37-85abe1675a65">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzgtMS0xLTEtMA_e9391597-ef28-4a21-9115-c010d9f0ab19">449</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzgtMy0xLTEtMA_12866fb4-4965-4bca-8b93-3618ee7bca1a">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzktMS0xLTEtMA_8a982c67-a6ac-47cb-ab91-3d7b6971637a">11,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzktMy0xLTEtMA_3b6f9399-a517-472c-8822-6edaf42dd449">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEwLTEtMS0xLTA_916cc3d9-014b-4531-9ca3-0bf3ab70c6ce">3,609</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEwLTMtMS0xLTA_d43674a5-5ca1-47ae-bc19-4b522917521d">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzExLTEtMS0xLTA_ab2e12e0-a803-4249-8235-b0082ace0ab8">4,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzExLTMtMS0xLTA_50433a25-47aa-4308-b065-59189e1aadf0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEyLTEtMS0xLTA_ca17f52d-5b51-4665-946d-4a35a7e04543">554</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEyLTMtMS0xLTA_b4caca77-32b9-45ec-8548-534d8b2e9a5b">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEzLTEtMS0xLTA_d20850b8-e2aa-42cc-bed3-7553ba907841">9,987</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEzLTMtMS0xLTA_dfed17db-d091-4766-8c17-740dda2f51c1">34</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE0LTEtMS0xLTQzNw_cce2ce62-af8b-4bcd-a117-33219fa7947c">4,240</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE0LTMtMS0xLTQ0MQ_20e2a17c-211f-4eaa-bce3-3414a5f51b2e">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE1LTEtMS0xLTQzNw_67b58450-9f36-4945-a3e7-d485ce874d55">3,823</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE1LTMtMS0xLTQ0MQ_a6bcfb22-82cb-4a72-98bb-5b9f76cd8656">31</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE2LTEtMS0xLTQzNw_44c8639b-bd40-4ccf-8423-ad591b1fa751">658</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE2LTMtMS0xLTQ0MQ_0cb40d50-8292-4326-bb9b-942fe1f376a8">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE3LTEtMS0xLTQzNw_b78eade1-ab4e-4b01-81b9-3847b388dbd9">9,745</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE3LTMtMS0xLTQ0MQ_6c3a1b1a-1e71-46e1-a346-edf68fda94e6">37</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.43pt">The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of shares that vested was approximately $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzM3ODQ_847d96bf-b689-4395-bd29-1e6ea6dbd040">148</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzM3OTQ_908b04b6-1eeb-48af-870f-404b138126d7">172</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzM4MDc_cd04a785-0944-4e68-98f6-b3ec7a078e3f">193</ix:nonFraction> million in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market-based RSU and DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we granted market-based RSU awards, and in 2020 and 2019, we granted market-based DSU awards to certain members of our senior management team. The number of shares ultimately issued to the recipient is based on the total stockholder return (TSR) of our common stock as compared to the TSR of the common stock of the other companies in the S&amp;P 500 Healthcare Index over a three-year performance period. The number of RSUs and DSUs ultimately granted under this program range from <ix:nonFraction unitRef="number" contextRef="ie188534f742842feac06df7e1c74aa45_D20210101-20211231" decimals="2" name="bsx:RangeofthetargetnumberofmarketbasedDSUsawarded" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQyNzc_64fa8dce-a01e-4fbb-baf4-21abf8984e8d">0 percent</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231" decimals="2" name="bsx:RangeofthetargetnumberofmarketbasedDSUsawarded" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQyODM_5fc3e241-6d7e-41eb-b33b-c391cc58d8b6">200</ix:nonFraction> percent of the target number awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout the three-year performance period to attain the full amount of the market-based RSU's and DSUs that satisfied the market performance criteria.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5NjE_0b2893cd-91fe-42ac-8f9e-96c0e1be3ca1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the market-based RSU and DSU awards to be approximately $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:Fairvalueofmarketbasedawards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQ3Mjc_f6638e5f-84ca-442b-bf93-9fecec1147b8">11</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:Fairvalueofmarketbasedawards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQ3Mzg_48a57b0c-195d-424b-af6f-0cdcfb3582c1">8</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:Fairvalueofmarketbasedawards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQ3NTI_19fa0c55-1ecb-49c9-9bf5-281e75792ae4">10</ix:nonFraction> million for 2019. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price on date of grant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2aad1bab8c3f42188e8caee5487fc161_I20210217" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzItMS0xLTEtMA_b06e54e0-e729-42a8-842d-00c7f541d7e0">37.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58d60bf54d9b477b9441568e22f085d1_I20200218" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzItMy0xLTEtMA_3b82f167-2ebe-4798-8ce2-f45f6fca0f7f">42.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9292f58cc599475cbe04d0e8c11e9935_I20190221" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzItNS0xLTEtMA_b0749930-82fc-416b-8821-f2565e287a50">40.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> (in years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:Measurementperiodmarketbasedaward" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzMtMS0xLTEtMA_7047c081-503a-4b24-86f0-15462191dbaa">2.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" name="bsx:Measurementperiodmarketbasedaward" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzMtMy0xLTEtMA_a1b7b3ed-4f78-4cdd-9598-3eb39bb437ba">2.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" name="bsx:Measurementperiodmarketbasedaward" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzMtNS0xLTEtMA_ee2ed28a-f215-45a1-a610-feca6f745435">2.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzQtMS0xLTEtMA_d310bc56-38bc-464b-b04c-ef55f6082043">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzQtMy0xLTEtMA_4c8914d3-849f-4456-9ad3-455f6cd96b30">1.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzQtNS0xLTEtMA_61b029f9-f548-4464-b199-e111ab612a97">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations on a straight-line basis over the three-year measurement period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i0beed35c26fc4873916737879615f1a2" continuedAt="ifab41ff2338347c09758391a30f246fc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow Performance-based RSU and DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2021, we granted free-cash flow performance-based RSU awards, and in 2020 and 2019, we granted free-cash flow performance-based DSU awards to certain members of our senior management team. The attainment of these performance-based RSUs and DSUs is based on our adjusted free cash flow (AFCF) measured against our goal set by the Executive Compensation and Human Resources Committees of our Board, based on our internal annual financial plan performance for AFCF. AFCF is measured over a one-year performance period beginning January 1st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of each year and ending December 31st. The number of RSUs and DSUs ultimately granted under this program range from <ix:nonFraction unitRef="number" contextRef="ie188534f742842feac06df7e1c74aa45_D20210101-20211231" decimals="2" name="bsx:RangeofthetargetnumberofperformancebasedDSUsawarded" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzU1MzA_b2ca6e63-d5a1-449b-a623-428e11a3e140">0 percent</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231" decimals="2" name="bsx:RangeofthetargetnumberofperformancebasedDSUsawarded" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzU1MzY_deca2896-3812-4a51-b9e7-e86477ef5614">150</ix:nonFraction> percent of the target number of performance-based RSUs and DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout a three-year service period (inclusive of the one-year performance period) to attain the full amount of the performance-based RSUs and DSUs that satisfied the performance criteria. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MzE_c9d132e6-9838-4b11-b423-8bcc8a326de7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 AFCF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, net of forfeitures to date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:FairValueOfFreeCashFlowFcfPerformanceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzEtMS0xLTEtMA_07767e81-52e4-4104-aef3-f0812f66e0c0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:FairValueOfFreeCashFlowFcfPerformanceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzEtMy0xLTEtMA_252b4073-3dbd-418e-b210-d86052647b4a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:FairValueOfFreeCashFlowFcfPerformanceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzEtNS0xLTEtMA_487937b7-4672-4633-819f-90b8ef8cec9c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achievement of target payout</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzItMS0xLTEtMA_5b28b43e-40ed-4d4a-a1af-b4aeb02b5507">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" name="bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzItMy0xLTEtMA_345d06c0-9e75-47a3-9387-81ef21a4f2bf">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="2" name="bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzItNS0xLTEtMA_eb8b6074-6be7-4f92-a727-1219e5bfa245">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end stock price used in determining fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzMtMS0xLTEtMA_a6eb490a-4fc2-4154-a5eb-bd9a3100cbba">42.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzMtMy0xLTEtMA_bd1cd11b-2617-486e-96a2-507e99ff3f2f">35.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzMtNS0xLTEtMA_28562fe6-aaa9-4a59-8bcd-c6e6b01b1a34">45.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations over the vesting period which is three years after the date of grant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expense Attribution</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize compensation expense for our stock incentive plan using a straight-line method over the substantive vesting period. Most of our stock awards provide for immediate vesting upon death or disability of the participant. In addition, our stock grants to employees provide for accelerated vesting of our stock-based awards, other than performance-based and market-based awards, upon retirement, if the stock award has been held for at least one year by the recipient. In accordance with the terms of our stock grants, for employees who will become retirement eligible prior to the vest date we expense stock-based awards, other than performance-based and market-based awards, over the greater of one year or the period between grant date and retirement-eligibility. The performance-based and market-based awards discussed above do not contain provisions that would accelerate the full vesting of the awards upon retirement-eligibility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation expense for the value of the portion of awards that are ultimately expected to vest. FASB ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allows forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term &#8220;forfeitures&#8221; is distinct from &#8220;cancellations&#8221; or &#8220;expirations&#8221; and represents only the unvested portion of the surrendered stock-based award. We have applied, based on an analysis of our historical forfeitures, a weighted-average annual forfeiture rate of approximately <ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:Annualweightedaverageforfeiturerate" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzc3Mjg_01846671-c43f-46f6-8e73-e223bf3bd902">five</ix:nonFraction> percent to all unvested stock-based awards as of December&#160;31, 2021, which represents the portion that we expect will be forfeited each year over the vesting period. We re-evaluate this analysis annually or more frequently if there are significant changes in circumstances and adjust the forfeiture rate as necessary. Ultimately, we will only recognize expense for those shares that vest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Compensation Cost</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5NDA_2e43a1c1-24d9-49f1-91aa-b2a734be31a7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Cost</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:UnrecognizedCompensationCostStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzEtMS0xLTEtMA_08bc7ad8-aefd-4a63-94ce-c1adf8ae6892">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:UnrecognizedCompensationCostNonVestedStockAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzItMS0xLTEtMA_af892d82-9a6d-4bd9-967b-686859375fac">178</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="bsx:UnrecognizedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzMtMS0xLTEtMA_4db835b9-874b-4348-90a3-4cb8f5189a81">214</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:WeightedAverageRemainingVestingPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzMtMy0xLTEtMA_f129f6c6-beea-487f-869b-a58063253b3f">1.7</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Amounts presented represent compensation cost, net of estimated forfeitures.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ifab41ff2338347c09758391a30f246fc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global employee stock purchase plan provides for the granting of options to purchase up to <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzg0MzA_de58a562-08c1-478a-9a89-bca917bdddcb">50</ix:nonFraction> million shares of our common stock to all eligible employees. Under the global employee stock purchase plan, we grant each eligible employee, at the beginning of each six-month offering period, an option to purchase shares of our common stock equal to not more than <ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzg2OTE_3f842289-ae3b-4443-9c47-55f158e8d231">ten</ix:nonFraction> percent of the employee&#8217;s eligible compensation or the statutory limit under the U.S. Internal Revenue Code. Such options may be exercised only to the extent of accumulated payroll deductions at the end of the offering period, at a purchase price equal to <ix:nonFraction unitRef="number" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="bsx:GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzg5NTA_d4181d87-9873-41c8-873b-cf12ce552ec1">85</ix:nonFraction> percent of the fair market value of our common stock at the beginning or end of each offering period, whichever is less. As of December&#160;31, 2021, there were approximately <ix:nonFraction unitRef="shares" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzkxMDE_553bd9af-ed91-4929-87ed-b75f81e01c61">4</ix:nonFraction> million shares available for future issuance under the employee stock purchase plan. We temporarily suspended our global employee stock purchase plan for the offering period for the second half of 2020 due to cost-savings initiatives in response to the COVID-19 pandemic and resumed the plan beginning with the offering period for the first half of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5NTg_8439ed0b-66b5-4cd6-9685-29400c6ecf4a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:51.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued or to be issued&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzItMS0xLTEtMA_2cbc0e73-9f00-4813-a5ff-8acefcc585c0">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzItNS0xLTEtMA_4b9a580c-a10e-4b6f-8ee7-8681e3b18773">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzItOS0xLTEtMA_df270175-aac1-4031-b56e-aeb5f9231e38">2,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Range of purchase prices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtMS0xLTEtMA_8450cbaa-f361-4752-add2-53e200ec6e74">29.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtMy0xLTEtNTc0ODI_7d06a3a7-e5f6-4bb9-b9a3-08e081ca40af">36.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtNS0xLTEtMA_6234887f-695f-4af5-9e14-bb64133da619">29.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i28b5c1f16ae04ad0863e335580139350_D20190101-20191231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtOS0xLTEtMA_0110caac-bd29-4a1c-9848-e62f92ba3531">29.29</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i7bc526be42e743bb9a8a6576a16447ee_D20190101-20191231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtMTEtMS0xLTA_a0b782b7-1a39-41b4-9442-54e0138a164a">36.47</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recognized&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzQtMS0xLTEtMA_9e3d707c-a6ef-483d-ba64-515d26d239e3">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzQtNS0xLTEtMA_d6d7a413-2dd6-4999-a31e-a29302071a27">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzQtOS0xLTEtMA_aef0f5e7-a378-4594-aa94-693ca2130403">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of shares issued under the employee stock purchase plan. We recognize expense related to shares purchased through the employee stock purchase plan ratably over the offering period.</span></div></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_133"></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90ZXh0cmVnaW9uOmY1OTE0YmY4ZDg3OTRjNTVhNjg2MWNlNjNhZTU1ZTE0XzE3NDM_3d962af3-fced-420f-9941-5578520aab05" continuedAt="i954f68adb4744034a0e2d6b5014b947a" escape="true"><div style="margin-top:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90ZXh0cmVnaW9uOmY1OTE0YmY4ZDg3OTRjNTVhNjg2MWNlNjNhZTU1ZTE0XzE3MjM_ee63350c-7179-495d-9ae7-9ecfa71a7a57" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzItMS0xLTEtMA_9d179421-772a-49df-9f0b-724eecc6df3b">1,422.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzItMy0xLTEtMA_d08e578e-6377-4d79-b528-532fb3d8a5b1">1,416.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzItNS0xLTEtMA_5c4231f3-226a-4215-ba1b-0898fdc7b3b0">1,391.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzMtMS0xLTEtMA_aa0c4c7c-f92d-4d3f-bc25-6cd97f53ecbf">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzMtMy0xLTEtMA_ea5ba9a3-4c31-40c2-9df0-53d855d00f1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzMtNS0xLTEtMA_7f4de6e8-cc2b-496f-901f-56563fd53e8d">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzQtMS0xLTEtMA_fdc032fb-450c-408e-9c98-fa57daed566b">1,433.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzQtMy0xLTEtMA_04fae409-81f2-465a-8b70-b78928cebfb6">1,416.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzQtNS0xLTEtMA_fd788a8e-6f83-48c5-81cf-2b43748a53b8">1,410.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90ZXh0cmVnaW9uOmY1OTE0YmY4ZDg3OTRjNTVhNjg2MWNlNjNhZTU1ZTE0XzE3MjQ_867fd612-1e42-4a6f-ba39-a0c5be3cdeff" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56d2063406334ffa9e99fa12a46b4055_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzItMy0xLTEtMA_179addfd-12f6-4609-9038-f269a94d32ba">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57fa53402a1e4d61946e5928f0177f07_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzMtMS0xLTEtMA_9e24f847-ab05-484b-913e-0b8b84c40b3d">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69bc7b2173af4ec4be135c607f06064b_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzMtMy0xLTEtMA_1e4ed3cb-45f0-4679-b383-89c50a94c6a2">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3dcc1d9f587e4bdf84dc58e0c744f18f_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzMtNS0xLTEtMA_c2d4bc5e-9d54-4d10-80bf-d4098ab6b46a">0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcc7a0cac76948efb6e5fa18d4642442_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzQtMS0xLTEtMA_a4f75e6b-0051-49d3-8850-683eb4bbc72b">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i979c7d5f5f30414bb30ba5f9f9d3c752_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzQtMy0xLTEtMA_b63b7ee6-2aea-406a-828d-9713830c847b">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in this period.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i954f68adb4744034a0e2d6b5014b947a" continuedAt="ie89d190622934a3093b796a110f44d89"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021 and 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented in our consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) available to common stockholders</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie89d190622934a3093b796a110f44d89">.</ix:continuation> </span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_136"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2NTA_8d4b7905-005b-4b42-a7e2-769eca4e417e" continuedAt="i249b20e8560e4c488482f46e80e7762c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE O &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our core businesses are organized into <ix:nonFraction unitRef="reportablesegments" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzU1_3152b077-bd86-447d-af6b-e70e12aa05b9">three</ix:nonFraction> reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), certain investment portfolio net losses (gains) and EU Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations and are included in the reconciliation below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we are reorganizing our operational structure in order to strengthen our category leadership in the markets we serve, and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we will aggregate our core businesses into two reportable segments: MedSurg and Cardiovascular.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI1NzI_e9132fe3-b9c2-4f3c-99c2-dda98a76d0c8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzItMS0xLTEtMA_eb316aa9-a3ce-4f2d-bcf6-dd87c9514d10">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzItMy0xLTEtMA_c1f53f11-3355-4d05-849e-84582f1543a0">3,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzItNS0xLTEtMA_e23af42f-81ca-4752-8724-5940a10a5923">3,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzMtMS0xLTEtMA_821fecdf-b87e-4a23-a4d7-dfec4b3d6038">3,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzMtMy0xLTEtMA_277a387d-3f91-4af6-a259-71987644b5f7">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzMtNS0xLTEtMA_df5c03a2-2730-4fde-9be2-7efe2296f8ee">3,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzQtMS0xLTEtMA_6b24d2e6-93e1-485c-903e-29f3913264ce">4,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzQtMy0xLTEtMA_450ef1a8-1325-464e-9d65-645724db1cca">3,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzQtNS0xLTEtMA_bd55b44b-f19d-4d17-9186-964bac13aa4b">4,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdac215247a41d5a190631edb467695_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzUtMS0xLTEtMA_ab55ea39-6038-4483-8cdb-feb81ca5797f">11,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzUtMy0xLTEtMA_f14c10b4-9fb2-4c50-b737-6948117773a0">9,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzUtNS0xLTEtMA_5cc7bdeb-4896-4485-83c6-9fee07e6db5e">10,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzYtMS0xLTEtMA_df3a1bd9-44e8-463e-b430-3c50bb29bec1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzYtMy0xLTEtMA_f74589d3-be8f-4116-8772-914c18f13770">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzYtNS0xLTEtMA_7f0a264f-41fc-4b09-b0cc-0707bef8357f">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzctMS0xLTEtMA_87b78e8f-5558-4fa8-bf9a-a9a31bf246a1">11,888</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzctMy0xLTEtMA_18807ea1-0f7d-4b6d-b7b9-6a2a7d111db5">9,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzctNS0xLTEtMA_5d170cd5-bbdc-47f4-bf67-935d67dbb4ce">10,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2NDU_8e36ddec-e7cc-4ea0-a52f-72e4b0a44684" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzItMS0xLTEtMA_b2f3cc7e-a57a-4f3f-8075-5c0afb8a0c14">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzItMy0xLTEtMA_4bd06d7a-98dc-4f49-a345-ae127a1ede82">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzItNS0xLTEtMA_527f6aec-760b-47e2-9b8e-6526c0df2820">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzMtMS0xLTEtMA_20c653ac-f0fd-41c1-9a11-ad4d08883cf9">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzMtMy0xLTEtMA_a4f9a4fb-18a5-40c7-9026-28862a80d767">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzMtNS0xLTEtMA_67e74291-1fa8-49ec-83a3-f36412be11c2">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzQtMS0xLTEtMA_26fd7bc5-a1ab-4e2d-8cd7-046727de76aa">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzQtMy0xLTEtMA_fdab94ff-4b8b-48fb-85ec-401f4377c523">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzQtNS0xLTEtMA_28d3d0ac-0776-4056-a573-83b857bdb0ab">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdac215247a41d5a190631edb467695_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzUtMS0xLTEtMA_84423087-9c9c-4aab-ae20-c6915d1471ad">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzUtMy0xLTEtMA_f389f9b4-77a0-4465-a47e-58121bad17fc">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzUtNS0xLTEtMA_d1bb469b-d60a-49df-a135-c05f63d6aa60">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzYtMS0xLTEtMA_6ec0acab-2014-4d96-b27e-fa3021bb61e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzYtMy0xLTEtMA_a69c086d-862b-4576-8953-0fb51cf12af9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998fc4c852bb4712a6ac361d50f1addb_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzYtNS0xLTEtMA_381986c0-0bc3-4a73-999e-b9b6579b00d8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated depreciation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzctMS0xLTEtMA_a4e73f77-255c-42d0-b82b-cc696c50743d">352</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzctMy0xLTEtMA_fff3e2f0-4c2f-4a7f-8305-cea0b0acdafe">333</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzctNS0xLTEtMA_6bbc45ca-d8e2-4a97-85e2-b900c658e5ff">311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i249b20e8560e4c488482f46e80e7762c" continuedAt="i8762907d2fc44529800eb358dc3b2daa"><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI1Nzk_28679f2a-f600-4296-8bb6-3834233f754e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzItMS0xLTEtMA_cc11985c-08c5-486d-93ac-e2db03f3b438">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzItMy0xLTEtMA_3bd0ca95-6e01-4301-9f3e-5173ad3a0e18">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzItNS0xLTEtMA_7fdf6b51-8773-4a64-a754-759756135793">1,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzMtMS0xLTEtMA_205efa0b-6e02-4421-b5c6-52913e84011d">607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzMtMy0xLTEtMA_9142a755-99e7-4225-bfb3-1a83f6d6c184">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzMtNS0xLTEtMA_3bce66bf-cecb-471e-9c93-f1d7e00c978b">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzQtMS0xLTEtMA_9f972e83-cae8-45f2-830d-5497589a78ae">1,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzQtMy0xLTEtMA_059493a3-6c1a-4d49-8011-a51fb7cd82c1">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzQtNS0xLTEtMA_de1d7272-cced-4af2-8887-e307a2f4e916">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c616e504e944e48bc57a78d5f0bcc4f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzUtMS0xLTEtMA_42b70322-43e8-4277-a8ab-9b79630db2b4">3,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd23720dcf441b893aa13e8563d15ef_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzUtMy0xLTEtMA_e4e0a532-0e14-4500-97c1-0c4a38200700">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4db93b38040f2a515f954395082f3_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzUtNS0xLTEtMA_f24e4880-edcd-488c-9630-347e00d35142">3,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzYtMS0xLTEtMA_26dacf02-3c87-4c65-9a5b-ce69c037e6f9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzYtMy0xLTEtMA_522daffd-cd8c-4638-b771-4e9d63a81f12">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998fc4c852bb4712a6ac361d50f1addb_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzYtNS0xLTEtNDY1_635a6a63-8866-4f29-ba7d-f937fc521e6e">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3af6a1df22a242a4b23b635ddeb5a981_D20210101-20211231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzgtMS0xLTEtMA_22fac884-6fdb-4466-88a5-99055bcdb6d1">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88f0a448c20c42a59fc6c0a04e829f95_D20200101-20201231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzgtMy0xLTEtMA_404465c2-355e-47b9-9752-95f4cc15bac0">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb04350660a44a988ce323d0808bb5a2_D20190101-20191231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzgtNS0xLTEtMA_629e3038-7b45-4c77-ae2a-4d9ad2dcd2be">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb392f0b52d04562bbafef2c2e3bd024_D20210101-20211231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzktMS0xLTEtMA_30a91274-7b8f-4de9-9ff0-c7b87da21d0d">1,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d2aee8e67d5473ca756655b97f76be1_D20200101-20201231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzktMy0xLTEtMA_269b1b61-26ef-44ec-9718-b768acffd386">1,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id43b6011336d44cda836897ad0a99eef_D20190101-20191231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzktNS0xLTEtMA_ffe24ddb-5dc8-4c12-bee1-178ffa72a012">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEwLTEtMS0xLTA_dbed11af-284f-4ad5-a70a-d3751da0e02d">741</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEwLTMtMS0xLTA_ff7cdae9-e7fb-4231-a4c6-3e03e2796f05">789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEwLTUtMS0xLTA_03ac60e1-136b-4415-a9ee-7d2b5e1fd275">699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzExLTEtMS0xLTA_6d10cbb9-cef3-43f7-b078-1c9f24def8bd">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzExLTMtMS0xLTA_1a3e59d0-7abc-49a4-8c9d-734adb9c5deb">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzExLTUtMS0xLTA_41db3d2b-768f-4d47-aee8-1699cd5024a8">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEyLTEtMS0xLTA_f0538627-c0ef-41e8-a05f-c663f3521a97">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEyLTMtMS0xLTA_11ba1c12-04ac-4a33-891f-4fae4ffe84fe">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEyLTUtMS0xLTA_bc9018c1-e41f-478e-865d-92170769d025">831</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEzLTEtMS0xLTA_b72d74c8-9d91-4f68-89d3-df6445dc90f9">1,076</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEzLTMtMS0xLTA_90b065d3-76a2-4b0c-ba0c-21de1ae62dc4">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEzLTUtMS0xLTA_26dedb6f-a4cb-4d0c-a0c3-7acf4be28e11">687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2NDA_acbbedc3-64a5-469e-acc2-c61f2357b221" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzItMS0xLTEtMA_5ae0da87-f37f-49b0-85ab-504fc8c7e715">37.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzItMy0xLTEtMA_5c047d72-fb0b-4e8f-bec2-b4a12e1cbef1">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzItNS0xLTEtMA_52706b8d-a8fc-4005-a083-13fad98bf3c4">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzMtMS0xLTEtMA_88828721-1617-4b06-85c1-7a705bc4e77f">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzMtMy0xLTEtMA_f9523d70-1b1f-45ca-af7c-4832766eda2e">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzMtNS0xLTEtMA_78ca7f7d-cf8f-416a-b2da-d07377e1c23e">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzQtMS0xLTEtMA_91bea39b-fcbe-4b92-9146-8aac93e80a2e">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzQtMy0xLTEtMA_e956b9f4-36f2-4854-950b-db5989244d67">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzQtNS0xLTEtMA_17622f84-3254-4d47-aab1-3434c527b48a">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2MjY_7f98abb6-09ec-4aec-87cb-513573c1b0ed" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57688279666042d3a293e8a1628747b3_I20211231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzItMS0xLTEtMA_0a263bd9-33ba-4e38-bdea-9750127a68b3">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac6c44071294ea9849175fac9191b7e_I20201231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzItMy0xLTEtMA_af5431e9-b6ab-45de-8110-e6cd9c976b43">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90da61ebdeb44219dc8a12648b8a069_I20211231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzMtMS0xLTEtMA_a6b25a6f-3f70-4052-9904-5a80e49f044e">1,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4143ca6110b349138f60bc19e3247ec2_I20201231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzMtMy0xLTEtMA_a4314e5b-0fcb-4d54-849b-4b33d9e86506">1,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82aece15df8345618f0e67a8da516a4c_I20211231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzQtMS0xLTEtMA_716c7206-e270-49e4-a1f5-1370f028c4ad">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ac69cebdf54652867c133c8113b7f6_I20201231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzQtMy0xLTEtMA_3ef3c87f-ddbe-4596-9649-07cf3f37f18c">2,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248c898d732b4314b0a88247e5686fb7_I20211231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzUtMS0xLTEtMA_628e0bd1-ad9d-4bac-a98e-3383df79cd43">6,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1917903eab064ebd8f9b5c4561e2f754_I20201231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzUtMy0xLTEtMA_1be7d354-c2df-4258-9a65-2750b35959b4">5,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25175389829c4c00b8fd64f6b1b9bf50_I20211231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzYtMS0xLTEtMA_a786d1fa-4c9a-47a4-abfc-2a0f061c6dd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7df2e64a9b0450b929459426005d498_I20201231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzYtMy0xLTEtMA_a9fbf08b-7f0a-4aee-bc18-434e9d20c86d">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzctMS0xLTEtMA_4e76c49e-a4cd-4128-9b97-d35ce1893863">11,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzctMy0xLTEtMA_a3088370-fca3-4a36-9d7e-ec4a8df41e89">9,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzgtMS0xLTEtMA_5c52718c-7822-4f24-ac06-4d6f5bf062f9">6,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzgtMy0xLTEtMA_8267de7a-3467-4c60-98cd-09558539f448">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9ed43167d04cf5a5e8be0581a2d3c4_I20211231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzktMS0xLTEtMA_6dafa1e2-3f6a-440e-b9c7-302468a1cfcc">7,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib195a39da918458daa4a2a7c922e5626_I20201231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzktMy0xLTEtMA_7f5e4303-cfb7-4fed-9ac1-6a083f3583ff">7,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia58f50b0109e41fd8e438c82c71e3141_I20211231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzEwLTEtMS0xLTA_88c18cbf-3d61-4a2e-a855-35f62f6ef203">32,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af8a989c1284f24a421723a037abca7_I20201231" decimals="-6" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzEwLTMtMS0xLTA_9a6a1397-ec67-4d89-939a-442e74bfe96f">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the announcement of our plan to sell our Specialty Pharmaceuticals business, as of December 31, 2020, we classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet at their respective carrying values, which approximated fair value, less costs to sell. Accordingly, the total assets of the Specialty Pharmaceuticals business as of December 31, 2020 reflected above include goodwill and intangible assets attributable to the disposal group that were not previously allocated to our reportable segments.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i8762907d2fc44529800eb358dc3b2daa"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2MzY_7315f8f3-b270-4548-acf8-6019605b8d14" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5ed8dbde274fb797a84e2782bb541f_I20211231" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzItMS0xLTEtMA_b78b9a62-8f2b-42fa-ac4a-1245fa1df654">1,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id384c54f72144cdf8fee9a2d43b64754_I20201231" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzItMy0xLTEtMA_84d8ab39-b956-4033-acf4-49b34e34397f">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a97fc47966f4c888c420993a4ecc84c_I20191231" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzItNS0xLTEtMA_a64477d1-b164-482e-b1b2-accc01537698">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4883d6ab73714fa080e66ddc8068d9e4_I20211231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzMtMS0xLTEtMA_f382d6fb-85b0-41e1-9577-65536e0f99e7">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id679dd594dfe40169b0716db7018f794_I20201231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzMtMy0xLTEtMA_b0f1adc3-7f12-4b06-a105-3253e40495b7">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a0e6b8dba74575aee5f5f86c271bbb_I20191231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzMtNS0xLTEtMA_50244f29-6c49-41a6-a38c-2309d91ed3e9">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8968316c251443599b1cc42fc078d2fa_I20211231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzQtMS0xLTEtMA_ee6deffe-8cad-49be-a256-664132d55825">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1badc1b55e4c3580f690a018638da5_I20201231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzQtMy0xLTEtMA_b6ba981a-f813-4ee8-b6d3-d738706f9a9b">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca302daf1c74047b3c5899ea8e0aca6_I20191231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzQtNS0xLTEtMA_576281ca-e248-4550-8160-457dd1353569">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzUtMS0xLTEtMA_75402024-2eb8-4d08-982c-fee92516c59d">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzUtMy0xLTEtMA_040c97ee-a3d4-46f4-a4d6-f5555087db68">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzUtNS0xLTEtMA_69d0e31b-4f99-4ed7-b10f-c78d78fc9834">2,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzYtMS0xLTEtMA_d1ef4ca6-e98f-404a-a0d0-e6d1064e7b76">11,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzYtMy0xLTEtMA_18c06cf8-de8e-40b2-aee3-47f551680e51">9,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzYtNS0xLTEtMA_88a8260b-43e2-4da3-b253-df3bba266e84">10,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzctMS0xLTEtMA_b1aec063-5a8d-4ed1-9f76-cb163b536b94">6,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzctMy0xLTEtMA_b69e709e-7639-490c-9ad7-7bdc577e3eea">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzctNS0xLTEtMA_b49b4968-4a71-4b88-8b04-020212cdb9f6">7,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzgtMS0xLTEtMA_0816bc38-3c5a-4747-ac84-83ac3fbbaaa5">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fed35511829459da5a38d83c0ca798b_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzgtMy0xLTEtMA_66275872-d31a-428d-b484-b45e59d80acc">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411673321b714ce89c57299921fae970_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzgtNS0xLTEtMA_3510ead4-7921-4d29-ba3f-19c9aabdac3f">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzktMS0xLTEtMA_2d25bf23-57f9-4100-a480-647ea1638f9a">20,795</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzktMy0xLTEtMA_e20fa2c8-8aed-411f-a5c5-ff9ad7d7ffbd">18,409</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzktNS0xLTEtMA_fe2e6e36-95c5-4eba-8125-f9d68e9569f8">20,477</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i4513a36fb1aa4e44acd87206b0aed737_139"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzI5Mjk_2e629fca-c793-451a-b267-30a2ce1fd1d7" continuedAt="ia9cdebab003348efa76408e563b7f335" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE P &#8211; REVENUE </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our consolidated statements of operations. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzI5MzQ_8bf81edc-9b2b-4fef-a50e-496d55ceb20f" continuedAt="i17d168e1d31543c9a593b7274b9497e6" escape="true">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): </ix:nonNumeric></span></div><ix:continuation id="i17d168e1d31543c9a593b7274b9497e6" continuedAt="ibe4738fd18024d37882a6eed1dc25847"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0381e81002ea48aea3c5b8276a4bdfe2_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMS0xLTEtMA_14cf5a34-adcd-4f42-8bc0-a66ab93fa407">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib323af1d123f4f288409892c6d582c3a_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMy0xLTEtMA_e52d1ac8-b2ba-4d16-b0ca-c7f5b0b1d6f3">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i492788538a3b4d079d5f2e01ce834568_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtNS0xLTEtMA_3c0c9eaf-09f8-4094-b077-e20c49f97678">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83749835aad04c27823ee7e3e441d8d5_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtNy0xLTEtMA_d789b3b1-ba58-4b9b-8e1b-1221a7fb5b81">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebda7efcc984eaaa323a3965ae8afc2_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtOS0xLTEtMA_7830f180-bdf7-4dbe-9bfa-47d7c2bee112">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice8b818c14fa4356b602a04c1ab17b68_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTEtMS0xLTA_b7bc376c-e8d0-4b91-89f3-d887efae694d">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief070d59a8a74c6883609bd434bfbfdd_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTMtMS0xLTA_c26a5d0e-6692-4851-a118-021fcfa036a1">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e08cc88e42477f8b204d52aefeefae_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTUtMS0xLTA_5388e7a3-4596-4472-a908-cf3f516237f2">814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4226949d0cdc471da19b2ef5376d32b7_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTctMS0xLTA_853640b2-a58f-455c-849e-e931f2dd296d">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296c600288ba4126abba2c8e6654d659_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMS0xLTEtMA_954a78ed-c5b6-42b2-9944-86ce44265b8d">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7877e3175114481298066be0fb237a24_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMy0xLTEtMA_af34035e-6377-4674-9d8f-e3c1019707b6">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46048892559447039913345bc4184710_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtNS0xLTEtMA_a9094612-6589-4a2a-a904-7619774a6447">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d0a46f763a34fcfbb98da18cb232850_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtNy0xLTEtMA_f83181a4-aa22-4038-ba0f-3c0fab048826">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c2a656422d4982be4f1876ef15fbd7_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtOS0xLTEtMA_13bfd5fe-8d01-43c4-a7c6-f1aef18a6b27">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05500613984e4170ae63706134751f68_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTEtMS0xLTA_7429cf07-b02d-4fc4-ba6e-35afd0c4f11b">1,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7e6f6584f284ab5b2bbf59c9911ab30_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTMtMS0xLTA_fa8265d7-1c86-4e1d-ab0d-88b7bde4ba6e">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69f6e362124b848580bbf31ad6ad84_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTUtMS0xLTA_ee41b45a-d286-48da-97f1-1b52576a4f8c">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1fb275aaa7347e884e5e734e95e6439_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTctMS0xLTA_65a6fa98-df03-41e9-8bba-e9e71d65b44c">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0296cee599414719bd3d27b8e535a348_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMS0xLTEtMA_070711b0-9163-4f00-abfb-4e92b2933334">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47108644abed4ca48d40f6618e8766e6_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMy0xLTEtMA_2a6ae24a-1156-4f8c-a62e-1b693c42f60b">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66be153aa8a64bd3a8549033c030d988_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtNS0xLTEtMA_64227d20-b99d-4f19-b8ee-17bf457b8d86">2,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d91f24a77dd4e05a3909ceb50bdb176_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtNy0xLTEtMA_611b5aea-38c1-41a1-83c6-9cd93d0d3a78">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i139438da5f5c43439b7f6cb237aefe53_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtOS0xLTEtMA_3a582696-7274-43aa-a300-401479d07cd6">712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5414046eeaee4c90baf8f05d81103cf9_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTEtMS0xLTA_0e8b641b-39e9-4823-8816-f4abc69b3656">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1028c0ccdd44e579fc1a7e93e864c8e_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTMtMS0xLTA_d031974b-b389-4417-8f4f-716f14d8ad16">1,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e624f8fff1b4416a9d5d3cd9c9a3a8c_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTUtMS0xLTA_d5062ca8-5b7a-4aab-8bbe-91c97a6a31c4">804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e89d505d51c40cf9c9b06a4a255d695_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTctMS0xLTA_3230989c-e24e-46eb-b6fd-7119b025f2e4">1,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0559f366b4db4027814a50efc3811d7c_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMS0xLTEtMA_3c82adca-394b-4674-bd95-ac1ff24bb45d">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792d16e027b94051b1350ad706ae61b8_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMy0xLTEtMA_1e583090-3e43-4193-b7ac-581ce8bec266">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbec07d746b4648b462392b1200914a_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtNS0xLTEtMA_44cf92bf-c28b-47fa-aa9f-a6ee970df11e">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a8d5dfc7cc449b8eaea3d0a207bca7_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtNy0xLTEtMA_4ce7efee-1cf8-4d48-b2f5-bb2c460bb681">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f761ed299c43aaba3aeb4c183b4bb1_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtOS0xLTEtMA_05188b08-ca01-44bb-893c-e5725c7d413d">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15626b1bdc1459ebc740a7d9123e3a0_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTEtMS0xLTA_42e97fb2-d977-48e3-906f-427f8f6f542a">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ee6b1033014d9e89c4ef9c0d696921_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTMtMS0xLTA_d1bf9f1f-a938-4f26-9934-3334994348ab">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7887ed9b64aaa828480abdd1350e3_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTUtMS0xLTA_f7f4f276-2887-47ec-b48d-530ea444386e">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7f200406b1741da8d29e0597b3ef799_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTctMS0xLTA_acd8af1c-b15d-4cdf-807a-2e93111a4551">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6ac600b424e4c36ae326ac78fc6acb0_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMS0xLTEtMA_c12ebefe-41b0-4a33-a41d-fb9d61693400">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b2d57381d214a61974a25af56e0fe97_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMy0xLTEtMA_847bb395-4914-4407-b270-954a893db433">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b7c862ab83b44a6823252694cfedafa_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctNS0xLTEtMA_e1297273-8800-4f8f-af48-7b9f3a82270b">909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b9a583488948c3ac09adffaa7c62b4_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctNy0xLTEtMA_0dfe561c-ed98-4cb6-9058-d2c171f62cd8">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61903be42d074c65b668c3852b09debb_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctOS0xLTEtMA_6246bde6-f7dd-45e5-b713-7e020e52e578">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc90b63ec344bb382c1ac4ac757ec55_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTEtMS0xLTA_14526fe1-2472-4816-b9df-951826cd3bc1">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2950edca24e646cf92832d6acc6da711_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTMtMS0xLTA_a9f41009-9d10-4f97-864c-ebd6f890155a">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecfae37eff349aabd3cffa238c04a7a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTUtMS0xLTA_fdccc31d-81af-41d9-bcd4-504d3a350847">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448b76a8a955443b853399bdede98723_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTctMS0xLTA_feee13da-ced1-4130-ac2d-8ff12e53fcfb">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ed2f4d1bd545449a2f19715b187d67_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMS0xLTEtMA_23f3b0f3-8982-48c9-9b81-e8f88dfaa1c4">1,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8df2ca0184543adf70bfad9cb539d_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMy0xLTEtMA_14f22a8d-e2d4-4e52-9951-e67cf818d4b0">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6851f3461e914845861fc25f808129ff_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtNS0xLTEtMA_79a70508-d790-4967-a2d1-97e7693db6c6">3,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b6ff9b41f34af7bf8811c4d7d9280c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtNy0xLTEtMA_d050f1c6-fa37-444a-8734-3f0a48c1df23">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7448b8ca366f4827bc4f258c57c93261_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtOS0xLTEtMA_f5ba1e8b-0924-4b00-9bd2-18b6774cc974">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcb61ff1feec4e518decbdf1ca114591_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTEtMS0xLTA_16d9bb16-7cab-4f1e-a5da-16bddf1a7e93">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969834eefc47426fa7387f6ee8b1085b_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTMtMS0xLTA_82afedc1-89e7-41bb-a9c8-fc7b715083ab">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4178008f18a6432bb79c295f035843c1_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTUtMS0xLTA_6d2628a4-eece-49b8-a57d-ee57b6cc036e">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edb697c55bc4cf4b947643bcd30a7fd_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTctMS0xLTA_778316d1-2d9e-41d1-959f-522c5b932345">2,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363f7457787448d5a0978accd8392066_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMS0xLTEtMA_cecb3631-2c43-46e5-a51c-0c1771aef951">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990fcdb4d4d64102a6e2a01d782d3da7_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMy0xLTEtMA_ee659b82-bb9b-4bf2-bb58-a7be348708e7">824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219bdc71c5134494a8e8468f8d87edbf_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktNS0xLTEtMA_e3190057-313d-48fb-a78e-c22f399e925c">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a4631fadd7470dbdb228646d0d1e64_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktNy0xLTEtMA_6dee6bc7-72c2-4d5d-a551-d15e42fb5d5c">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47b9b05ad00409f8e34ab200b239f73_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktOS0xLTEtMA_5bfbd338-86e9-4ce3-96c0-4a90cdadf1d9">689</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f59541845b541a398a1c956947b253e_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTEtMS0xLTA_be311cf6-2439-42f4-bd1b-94053b039849">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia608cda32d2c4a75acba41461285ef9f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTMtMS0xLTA_44bc2228-dea3-4fcd-861d-59e54862ee02">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddebf93ed35b4294bfc7d57c147f14a0_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTUtMS0xLTA_dd49f53d-f4ed-4aa6-b5af-a1a7d29db95d">651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230686786fb8479c8e8b3aa250c6294a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTctMS0xLTA_5bfcd0a2-891f-41c3-84e7-950c55495af0">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daeb0eea7624d95bd33a61b6630acf1_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTEtMS0xLTA_0aae7f4a-837b-4185-85f6-a84cb2232f61">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if745267c77af430eb139ec47097f83b4_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTMtMS0xLTA_7131fa64-c70a-411c-9371-de8b29d514ae">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTUtMS0xLTA_df3a1bd9-44e8-463e-b430-3c50bb29bec1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce9f4d10e55459c9da61e0b45861feb_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTctMS0xLTA_cff60cc3-c931-481e-8ca1-5e23e7cdf94f">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic65e05bd72794ad69c38ad937bbdd8c1_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTktMS0xLTA_ba70d2aa-233e-4490-a83f-b3b388dc5fe0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTExLTEtMS0w_f74589d3-be8f-4116-8772-914c18f13770">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11feaaacdaf46dbbaad088de02198bb_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTEzLTEtMS00NzI_39d93e9f-2065-42da-a502-34708d8b640d">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0798aac718394b2e885e3eec15b7a1b7_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTE1LTEtMS00NzY_ee661b86-7246-4c5d-b70e-314de0075359">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTE3LTEtMS00ODA_66af8ca6-a42a-4625-819f-8d658402788b">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e3a0a6440d4892b49e46f886fbcb2a_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTEtMS0xLTA_86832892-9997-4126-9a8a-c25ec2ad1f92">6,911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7510a4849a314540abc54995d58f29a1_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTMtMS0xLTA_391b7f78-dab8-4f40-8d8f-e23e50106028">4,978</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTUtMS0xLTA_281d06f2-e1f9-4904-afdb-a138206b155a">11,888</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba9db017ca54a60b7e7c1ea9f933ffd_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTctMS0xLTA_bddf3662-033e-4171-bb10-8fa173f4f732">5,701</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6afa1156f16c40a9bfe1aaca76cb5002_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTktMS0xLTA_e56aec33-5a13-4ed9-bc4b-b524d7d2d0ca">4,212</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTExLTEtMS0w_18807ea1-0f7d-4b6d-b7b9-6a2a7d111db5">9,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa17098a29b48e894a6b05f541a6034_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTEzLTEtMS0w_d5068758-4ae3-4a50-b258-eb3c93e11d6a">6,167</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e61f5e37fc74a6f81ea7c5928a92766_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTE1LTEtMS0w_8cbd8b4a-eecf-45ba-85a4-0c88b0c6b97f">4,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTE3LTEtMS0w_5d170cd5-bbdc-47f4-bf67-935d67dbb4ce">10,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d5ca208074462f876fe31f23b1fed5_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzItMS0xLTEtMA_dbc706d3-9060-4ee0-81ce-8005ad6afc10">6,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3934f348ffb740b0af4a20a77601e650_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzItMy0xLTEtMA_7647c234-2f60-433a-bf9c-3362d5891fac">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbd3c076197c4394a0b5a998e05dbd49_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzItNS0xLTEtMA_e3094697-6004-4903-a17d-243971419c17">6,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia58a0bdc221345bfbf3c6181a5c06176_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzMtMS0xLTEtMA_5455200f-294f-4b21-ae1d-4bdf937c8035">2,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c7d84961bb4190a76e256fa88277af_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzMtMy0xLTEtMA_52b755eb-41cc-40de-b714-628fa5c143a4">2,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85ece485aa444be8199976328f65690_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzMtNS0xLTEtMA_57193b36-6752-4caa-84d6-b83f9c95e67c">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38022f0994a44701b3f50846a6fd4016_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzQtMS0xLTEtMA_8bf6db42-2812-4f1b-8af0-3d33f6819485">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240079c64e2b40068b8e05779f120de1_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzQtMy0xLTEtMA_6f43aa4b-a9d1-47ac-bbef-b1e0d6c24f77">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97644286dfd2411eb21e3c030a24a491_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzQtNS0xLTEtMA_6efe11e0-de56-4b24-97ea-f25ad6ee2c7b">1,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93b9e8e344744818491704b2f2d822e_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzUtMS0xLTEtMA_7c9b0620-4a0b-4503-9228-e98703da181b">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie419b41857fe446fb2fd54d0467e3cc3_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzUtMy0xLTEtMA_57ca4a5e-afe7-4e91-a432-ea7d220d11f0">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99c383051264d1c8e894654e1c8eea9_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzUtNS0xLTEtMA_f8004dd9-7b78-494e-8ad5-3dae9670a109">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdac215247a41d5a190631edb467695_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzYtMS0xLTEtMA_864c875a-6ffb-4100-ae25-c367f5e646ea">11,875</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzYtMy0xLTEtMA_c4b3a610-9ec4-4396-b58d-a9412d2cd496">9,694</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzYtNS0xLTEtMA_d6d6652f-9ca9-4904-a862-cf9345c1a418">10,654</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daeb0eea7624d95bd33a61b6630acf1_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzctMS0xLTEtMA_0aae7f4a-837b-4185-85f6-a84cb2232f61">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce9f4d10e55459c9da61e0b45861feb_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzctMy0xLTEtMA_cff60cc3-c931-481e-8ca1-5e23e7cdf94f">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11feaaacdaf46dbbaad088de02198bb_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzctNS0xLTEtNDA5NjQ_39d93e9f-2065-42da-a502-34708d8b640d">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if745267c77af430eb139ec47097f83b4_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzgtMS0xLTEtMA_7131fa64-c70a-411c-9371-de8b29d514ae">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic65e05bd72794ad69c38ad937bbdd8c1_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzgtMy0xLTEtMA_ba70d2aa-233e-4490-a83f-b3b388dc5fe0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0798aac718394b2e885e3eec15b7a1b7_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzgtNS0xLTEtNDA5NjQ_ee661b86-7246-4c5d-b70e-314de0075359">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzktMS0xLTEtMA_df3a1bd9-44e8-463e-b430-3c50bb29bec1">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzktMy0xLTEtMA_f74589d3-be8f-4116-8772-914c18f13770">219</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzktNS0xLTEtNDA5NjQ_66af8ca6-a42a-4625-819f-8d658402788b">81</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEwLTEtMS0xLTA_56441e32-75b9-452d-8269-184e0c51aee8">11,888</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEwLTMtMS0xLTA_f2a77e51-b508-4191-9ffb-c05ffb99076e">9,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEwLTUtMS0xLTA_771f34e7-ac37-4513-a8d5-bdf95579e853">10,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876002865abc4f97ba83a0ef52267bbf_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEyLTEtMS0xLTA_7a728ce2-c35f-42b4-9314-cd58c8842a70">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b08a70a845343069de514f02498dcd4_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEyLTMtMS0xLTA_2c41c729-2ddb-47f3-8269-b690f0d8dec3">1,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093d7ccd7bf04c0db289d031e28a2247_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEyLTUtMS0xLTA_eb553cc3-37e9-41da-a6fe-96c6b1159884">1,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ibe4738fd18024d37882a6eed1dc25847">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the <ix:nonFraction unitRef="countries" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="0" name="bsx:EmergingMarketsTotalNumberOfCountries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzMwNA_08ae090d-2d0c-4b6b-95b3-914d94de0130">20</ix:nonFraction> countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation.</ix:continuation> </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ia9cdebab003348efa76408e563b7f335"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying consolidated balance sheets. Our deferred revenue balance was $<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzYwOQ_fee19bf8-d2c7-4d7f-a59a-02bba22c326e">484</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzYyNQ_46cf77f0-a791-404c-ab87-99b58b7dc1a6">395</ix:nonFraction> million as of December&#160;31, 2020. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiac Rhythm Management (CRM) business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzg4OA_c877401c-33c4-4a58-a9d9-b4e7dafc07b8">159</ix:nonFraction> million in 2021 that was included in the above contract liability balance as of December&#160;31, 2020. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales force commissions related to contracts with customers when the associated revenue is expected to be earned over a period that exceeds one year. Deferred commissions are primarily related to the sale of devices enabled with our LATITUDE&#8482; Patient Management System. We have elected to expense commission costs when incurred for contracts with an expected duration of one year or less. Capitalized commission fees are amortized over the period the associated products or services are transferred. Similarly, we capitalize certain recoverable costs related to the delivery of the LATITUDE&#8482; Remote Monitoring Service. These fulfillment costs are amortized over the average service period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received FDA approval in mid-2020 and began the U.S. launch of our next generation WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#8482; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In 2020, we recorded $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzI0ODU_51a15128-99b0-48d6-8286-1973ed1fa7f7">179</ix:nonFraction> million in revenue reserves primarily related to our conversion to a consignment commercial model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. In connection with the conversion, we repurchased customer-owned inventory and will recognize revenue for consigned units as they are consumed by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our accounting policies relating to revenue recognition.</span></div></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_142"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90ZXh0cmVnaW9uOmE1MzBkNjVhYWMyZTQwOGU4OTZkOWFmZGVmMGNkZTI5XzYwMg_1646ef76-e55a-469f-bb1e-aa3618b97ad3" continuedAt="id8ea3c4590b94401b0f8cae87f80187b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE Q &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90ZXh0cmVnaW9uOmE1MzBkNjVhYWMyZTQwOGU4OTZkOWFmZGVmMGNkZTI5XzYxNQ_b44959d3-0e0a-4bae-b2e8-1b70e02c0c49" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtMS0xLTEtMA_d718a00a-d774-48c8-baf5-ad7dff41c6a2">218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtMy0xLTEtMA_54028fa1-73f6-4a99-ad55-12de85addd94">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtNy0xLTEtMA_18535293-0f8e-4065-996c-5393c7e5a1ad">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtOS0xLTEtMA_843c7679-f2f8-426a-9e5e-9a0d7daaaa3e">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItMS0xLTEtMA_e66ac216-5aad-4171-b814-b1ca4ac51e56">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItMy0xLTEtMA_eb41b50e-f97e-482f-a077-953617bdf89c">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItNy0xLTEtMA_4cd42c39-d5c9-45cd-9eab-b04b89460725">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItOS0xLTEtMA_740ba57c-0973-4475-9e48-54f3db649aa9">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtMS0xLTEtMA_8d08c46e-b3e6-4283-a0c2-1fb47f118b02">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtMy0xLTEtMA_9bff7635-b458-4818-b27a-1f151c559b42">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtNy0xLTEtMA_6343de7c-5d1f-402b-938e-2f34af0d7ce9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtOS0xLTEtMA_1f6aa64f-3613-4062-a5eb-5d41dfc81290">173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtMS0xLTEtMA_b44d4e4a-887b-465d-bc34-1f2ce07551c9">125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtMy0xLTEtMA_3560ed04-c7a4-43d7-90ea-b51d9f897e8e">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtNy0xLTEtMA_14f25da8-2cdf-4de2-bfde-264f4e75ff49">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtOS0xLTEtMA_74b78182-fa7e-4b0b-beac-d07020d0017f">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtMS0xLTEtMA_37b693a2-9bfa-4ca6-9475-aa660e1a0aec">93</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtMy0xLTEtMA_32979c3b-147a-428f-8dd9-3c91fed4ac6e">206</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtNy0xLTEtMA_66b88c54-9030-40a6-8391-5f944ca4c9e5">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtOS0xLTEtMA_64b2bf90-3a51-4e81-b157-25781222e9f7">263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtMS0xLTEtMA_d470c76f-2e6e-4e69-a1da-d07917228d73">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtMy0xLTEtMA_ce5fb1a6-bead-4695-b789-102845dcd5c4">173</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtNy0xLTEtMA_c54df623-e077-4a0e-8f34-88bcd8d343e0">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtOS0xLTEtMA_074d423c-69e2-4603-b404-1729f042812b">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItMS0xLTEtMA_15732711-8486-4fa7-9288-d157a1406dfc">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItMy0xLTEtMA_a614bd2b-031c-4f56-b546-5c7e1f85098b">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItNy0xLTEtMA_d7f56712-506d-482d-9760-8d9d6a30a263">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItOS0xLTEtMA_1f6776da-d3fd-4b4d-b62f-2b87ad804fad">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtMS0xLTEtMA_59fda323-f2aa-4beb-b113-3922bc22bed1">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtMy0xLTEtMA_2fc67334-37d9-4379-beb1-08f0939c4622">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtNy0xLTEtMA_11e7eba6-5c60-49bd-927f-ef401984b055">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtOS0xLTEtMA_5940ae71-e1fb-4300-968d-93d230cd151e">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtMS0xLTEtMA_13017434-f635-4505-af00-980a3069e6fd">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtMy0xLTEtMA_7287c84e-06b4-43b3-aa8f-b5f666dd5baa">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtNy0xLTEtMA_ca3efc00-fc79-4455-93b0-818ee6e218e5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtOS0xLTEtMA_8abe1284-b8e7-47b2-8ad8-52d77755ac07">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtMS0xLTEtMA_ef858bef-c986-41d4-9a59-d4e8767a6137">218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtMy0xLTEtMA_c185e99a-7e3a-43c2-94b7-845bb65501ff">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtNy0xLTEtMA_215802bd-f754-465c-bacd-d29b16e1bfe7">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtOS0xLTEtMA_8255bafb-f9f6-4489-a3d5-2b52b863bb5e">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="id8ea3c4590b94401b0f8cae87f80187b" continuedAt="i55127e11e696468a8e1f57e1d4448eb2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i55127e11e696468a8e1f57e1d4448eb2" continuedAt="i906848dae0144b1b90f5598a688a61c8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i906848dae0144b1b90f5598a688a61c8"> were reduced by immaterial income tax impacts in 2021 and in 2020.</ix:continuation> </span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_145"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:NewAccountingPronouncementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3Mzc_69f48ab3-2541-49f0-af0e-55b5b2297dae" continuedAt="ic21aea9924e0400f8b1919c34e5b5b01" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE R &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Standards Implemented in 2021</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzIxOTkwMjMyNzE4ODQ_52aa9163-a34a-49ba-9696-51c715981c57" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-08</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASC Update No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in Update No. 2021-08 improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Update No. 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2021-08 in the fourth quarter of 2021. We applied the amendments retroactively to all business combinations that we completed during 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3MjE_069f000d-e47c-480f-acce-eefc35b184e5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. We adopted Update No. 2020-10 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3MzI_1b75f5eb-a579-4ad6-9803-7ba5e48c1cdb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. We adopted Update No. 2020-06 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3Mjc_6fe62edd-cbf5-4e2a-a68c-bead27012c3a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. We adopted Update No. 2019-12 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic21aea9924e0400f8b1919c34e5b5b01"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="bsx:ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzIxOTkwMjMyNzA3NTk_a7015672-2fad-4eb9-8e50-1e3b36dc7845" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively. The adoption did not have a material impact on our financial position or results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements, issued or effective, during the period had, or is expected to have, a material impact on our consolidated financial statements.</span></div></ix:continuation><div id="i4513a36fb1aa4e44acd87206b0aed737_151"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNzA_be120695-2bb2-4f29-933a-85ab957f0d6f" continuedAt="i2daacebb189744568bcf146c5a3afa29" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE S &#8211; EMPLOYEE RETIREMENT PLANS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Domestic Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our 2006 acquisition of Guidant, we assumed the Guidant Supplemental Retirement Plan, a frozen, non-qualified defined benefit plan for certain former officers and employees of Guidant. The Guidant Supplemental Retirement Plan was partially funded through a Rabbi Trust that contains segregated company assets within restricted cash used to pay the benefit obligations related to the plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain an Executive Retirement Plan, a defined benefit plan covering executive officers and other key contributors. Participants may retire with benefits once retirement conditions have been satisfied. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.K. Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our acquisition of BTG, we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom (U.K.) employees (U.K. Plan). The U.K. Plan was closed to new entrants as of June 1, 2004. Prior to the acquisition close date of August&#160;19, 2019, the Trustees of the U.K. Plan executed buy-in arrangements (Buy-in Contracts), which effectively, as structured under the Buy-in Contracts, are intended to provide payments designed to equal all future designated contractual benefit payments to covered participants. The benefit obligation of the pension plan is not transferred to the insurers, and we remain responsible for paying pension benefits. We do not anticipate any additional material contributions or payments to the U.K. Plan or the insurer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the final purchase price allocation of BTG, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNzQ_e459b26a-ba48-43de-8914-01da491130c7" continuedAt="ia6e80b9fb892476ea6b21de32f816dcf" escape="true">The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:</ix:nonNumeric></span></div><ix:continuation id="ia6e80b9fb892476ea6b21de32f816dcf" continuedAt="idb3405c7c927401a8e7afc0293a55dea"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rate of Compensation Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpjYTQ3OGI2M2NhZDc0MzM3YWU5NWFlZWEyNTFmZGU0MS90YWJsZXJhbmdlOmNhNDc4YjYzY2FkNzQzMzdhZTk1YWVlYTI1MWZkZTQxXzEtMS0xLTEtMA_ae316208-a3f3-49b3-a66d-acd2bcb4345b">0.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9677d942cddf415f979a5572240cb314_D20190819-20190819" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpjYTQ3OGI2M2NhZDc0MzM3YWU5NWFlZWEyNTFmZGU0MS90YWJsZXJhbmdlOmNhNDc4YjYzY2FkNzQzMzdhZTk1YWVlYTI1MWZkZTQxXzEtMy0xLTEtMA_c2c09678-e083-4eb2-b8de-d4d6991df56c">0.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpjYTQ3OGI2M2NhZDc0MzM3YWU5NWFlZWEyNTFmZGU0MS90YWJsZXJhbmdlOmNhNDc4YjYzY2FkNzQzMzdhZTk1YWVlYTI1MWZkZTQxXzEtNS0xLTEtMA_928421b7-0942-4f09-b9b4-2dae8588779b">3.4</ix:nonFraction>%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the measurement date of August&#160;19, 2019, the funded status was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:84.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2YjYxMTk3ODZlNmM0MGYyOTJiZjFkNjhiMTYyZjU2OC90YWJsZXJhbmdlOjZiNjExOTc4NmU2YzQwZjI5MmJmMWQ2OGIxNjJmNTY4XzEtMS0xLTEtMA_d3842ef7-2e9d-4e9a-a00b-afd73271b517">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2YjYxMTk3ODZlNmM0MGYyOTJiZjFkNjhiMTYyZjU2OC90YWJsZXJhbmdlOjZiNjExOTc4NmU2YzQwZjI5MmJmMWQ2OGIxNjJmNTY4XzItMS0xLTEtMA_2bf17e69-c3be-4dd0-83d4-763439601d31">216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2YjYxMTk3ODZlNmM0MGYyOTJiZjFkNjhiMTYyZjU2OC90YWJsZXJhbmdlOjZiNjExOTc4NmU2YzQwZjI5MmJmMWQ2OGIxNjJmNTY4XzMtMS0xLTEtMA_b3d9bd84-5650-4b2c-a952-b0ae1319df57">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the U.K. Plan presented below is as of the December 31, 2021 and 2020 measurement dates.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2daacebb189744568bcf146c5a3afa29" continuedAt="i853522feff8f47b1b53c5d5694333a1a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other International Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we maintain retirement plans covering certain international employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNjI_7f01581d-a6f5-4709-8a8a-73cf30a7cff5" continuedAt="ida57e71c914c40968e2ed087ac8d4d79" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ida57e71c914c40968e2ed087ac8d4d79">.</ix:continuation> As of December 31, 2021 and 2020, the funded status of our plans were unfunded or underfunded in aggregate. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNzk_9d837581-32eb-48da-8a5c-ee8fb03f1645" continuedAt="id237e2d0330648bbbe2a8c64ce65551d" escape="true">The outstanding obligation is as follows:</ix:nonNumeric></span></div><ix:continuation id="id237e2d0330648bbbe2a8c64ce65551d"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:44.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded<br/>PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItMS0xLTEtMA_1397f4a5-5737-4334-b0a5-87857e728513">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItMy0xLTEtMA_1dd7cd29-30f5-49fd-80a2-8dc20f435211">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItNS0xLTEtMA_85648f01-1f17-4941-b50f-7e73cb6c2e6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItNy0xLTEtMA_e6be04ad-be79-4065-8246-ebe323281d80">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtMS0xLTEtMA_955e22b5-43d6-41bf-b35f-b3c81f4e09c0">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtMy0xLTEtMA_93e3ca83-b693-4ee3-8e5a-a85dac17ad24">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtNS0xLTEtMA_4a72bcea-64d1-404f-a651-005db1e5f02c">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtNy0xLTEtMA_e7099fd8-5c4a-4a27-9b1d-d5aceee51342">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96369c0f230346708d64ca28018edad7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtMS0xLTEtMA_e283ad4a-237f-4f2e-b803-6b04fce2358b">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96369c0f230346708d64ca28018edad7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtMy0xLTEtMA_2d142420-e0a3-4aaa-a230-dbd8919eb2da">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96369c0f230346708d64ca28018edad7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtNS0xLTEtMA_3625e9d0-0186-4dd7-8357-abd21e22f5fa">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96369c0f230346708d64ca28018edad7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtNy0xLTEtMA_9fea900e-9c0b-44a2-836a-b6ddb38b97c7">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtMS0xLTEtMA_ed4d2dee-c23d-4cf5-a85a-7e6d3326acc1">478</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtMy0xLTEtMA_cd964117-cafb-42c8-8d63-5ef0442dc330">502</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtNS0xLTEtMA_ab7f5076-5b83-4c8d-8caf-61913b60948d">336</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtNy0xLTEtMA_0873c6dc-d660-4bf0-8ddb-f066aab814b5">166</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:44.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItMS0xLTEtMA_469b52a7-420b-45ef-acea-acb03202a6dd">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItMy0xLTEtMA_83695620-5402-4a94-98e7-0cdb8848659f">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItNS0xLTEtMA_a129fc26-d070-4f2d-9e43-0281372daac2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItNy0xLTEtMA_20db4fd8-64c6-416d-8936-f6321cf4ba24">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtMS0xLTEtMA_c02c0336-ebb5-464a-86ce-d4411a7e5acc">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtMy0xLTEtMA_b7ea2e5e-cea5-4079-b4f0-3cf6933ac300">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtNS0xLTEtMA_7136282e-0084-4c8c-a1ac-9eddb3896767">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtNy0xLTEtMA_a0138e41-f9ad-48e8-9dca-0a2b69c599d0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtMS0xLTEtMA_9ddf8af5-8778-4c5b-bc4e-e0fbabb22b8c">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtMy0xLTEtMA_af0217c3-3886-4d2a-92ed-a8fd79b175a9">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtNS0xLTEtMA_d7aa7ea1-553e-4947-a4f4-24f80184f063">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtNy0xLTEtMA_fba86b00-fa9e-41da-a1bb-a217f6486e18">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtMS0xLTEtMA_f8b786e7-1011-4ee4-aca6-936a57a8cb47">506</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtMy0xLTEtMA_480c631a-92c7-413c-bf0b-269dd63733da">532</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtNS0xLTEtMA_112af46e-ef07-4e79-93d0-42afefcce4f8">355</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtNy0xLTEtMA_da2ca774-a1e6-4b18-90fe-b9ab07918b66">177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzODA_3612e7fe-1c40-45fc-8548-eecdeb7963f9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the PBO for our retirement plans is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzItMS0xLTEtMA_0720e043-4d68-4bdf-ab22-863b4c8c10db">532</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzItMy0xLTEtMA_873b0c91-083f-4498-90e1-4c4ab84f9f8f">488</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzMtMS0xLTEtMA_5df4e31d-3e92-4283-8171-d953a0414289">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzMtMy0xLTEtMA_dd4f6e40-90ce-4f84-837d-5d507ff29091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzQtMS0xLTEtMA_46c38fa7-736c-4526-9d57-232c5cbd0276">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzQtMy0xLTEtMA_2056f2b8-2d1e-4630-a456-c6029e1748e4">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzUtMS0xLTEtMA_3f612de9-340e-4776-bb46-03b2e17fb985">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzUtMy0xLTEtMA_35b4c03a-c31d-4d9b-9773-81390d535b3f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzYtMS0xLTEtMA_6de20178-4f6e-49e7-a9c8-7aa902ae9197">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzYtMy0xLTEtMA_d54268eb-e599-44ff-b408-9de3f93c8412">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments and assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzctMS0xLTEtMA_a7479601-aed4-4893-b955-57fce2beebff">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzctMy0xLTEtMA_a9016452-d232-472e-b2de-9efb05bcf980">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:Pensionbenefitobligationbenefitspaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzgtMS0xLTEtMA_5b157289-d12f-4ce7-8da3-f60e3ba3879e">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:Pensionbenefitobligationbenefitspaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzgtMy0xLTEtMA_e77eb24e-9019-4eea-87c7-cbb73030f00a">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzktMS0xLTEtMA_1ea91cc0-cb4a-4c30-ab31-26cb36146cfd">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzktMy0xLTEtMA_be11ca1b-32f5-47f3-92fd-3dd182832857">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending obligation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzEwLTEtMS0xLTA_66aaa718-5a94-484e-9204-5e2da39f66ef">502</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzEwLTMtMS0xLTA_34ce5f38-6f6c-4c04-8c32-a844fbf8745b">532</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:continuation id="idb3405c7c927401a8e7afc0293a55dea" continuedAt="i212cc5dcfa50440c88b45b785867ffe3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2021 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:45.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.083%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84912b2290e843e7ba4e06ea51b35268_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzItMS0xLTEtMA_d4a539b7-0b22-40c2-9121-48bd73e9b3a9">2.40</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84912b2290e843e7ba4e06ea51b35268_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzItOS0xLTEtMA_4e3e7a2b-b60a-4d2c-b1b6-faa0e7d364f1">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25ddf18419df442eb0b2829d76375ae3_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzMtMS0xLTEtMA_2becff28-152c-4b40-ba84-36dd64533f87">0.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25ddf18419df442eb0b2829d76375ae3_I20211231" decimals="3" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzMtNS0xLTEtMA_bd6f1207-2f29-4e96-b272-993392dba68f">0.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f13d53946094d0597052e0d0c1fed72_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzQtMS0xLTEtMA_73f1cc43-6918-4fee-a183-5e106abe2c80">0.82</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f13d53946094d0597052e0d0c1fed72_I20211231" decimals="4" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzQtNS0xLTEtMA_652e4598-4c2e-4fce-b722-51d20728122c">2.16</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f13d53946094d0597052e0d0c1fed72_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzQtOS0xLTEtMA_a6a120cc-a926-4c2e-a5f6-a2e6b4b9a98e">2.60</ix:nonFraction>%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i853522feff8f47b1b53c5d5694333a1a" continuedAt="ie3ebe46e356e407d91724f86cf2b5bb8"><ix:continuation id="i212cc5dcfa50440c88b45b785867ffe3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2020 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98b179ab6b284836b5b7e104d9b796fa_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzEtMS0xLTEtMA_a87c93d4-cc5e-4e5d-94bb-66997b75fec3">1.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98b179ab6b284836b5b7e104d9b796fa_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzEtNS0xLTEtMA_e7e40c28-09ca-43af-b466-e19ba2ef2006">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibadf8b569527469ab651f550d716b4c3_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzItMS0xLTEtMA_4bcfe07f-44a2-4835-b41b-26071ed498e9">0.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibadf8b569527469ab651f550d716b4c3_I20201231" decimals="3" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzItMy0xLTEtMA_ace80736-5eb0-4f68-8512-3fd4782eee3f">0.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if28e5bd9680c4874b621bceaa941ea18_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzMtMS0xLTEtMA_ae4fb592-7d8a-4427-aa4f-44696d3d2918">0.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if28e5bd9680c4874b621bceaa941ea18_I20201231" decimals="4" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzMtMy0xLTEtMA_626c88da-0b4f-41f6-8e99-aa3f84010961">1.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if28e5bd9680c4874b621bceaa941ea18_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzMtNS0xLTEtMA_f08bb31a-cb32-4556-91a3-2c7b7ee081a4">2.40</ix:nonFraction>%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation><div style="padding-left:36pt;text-indent:-13.5pt"><span><br/></span></div><div><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNTY_72ea5b39-2ca2-4333-b486-a04a33efe971" continuedAt="i08921519a3ea4c05988ec118e3cb3ef3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzItMS0xLTEtMA_324045dd-c9a3-45d5-b129-7eef327509fc">355</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzItMy0xLTEtMA_f1300caa-bfca-4c64-b7b1-266ab2891a24">332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzMtMS0xLTEtMA_f02d1c3d-a837-4233-9a5b-3859070f65e5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzMtMy0xLTEtMA_b4ea93a5-f481-4e38-bbad-f7c22e3bb44c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzQtMS0xLTEtMA_f36308d0-8815-4ed5-8a13-99ceaac70489">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzQtMy0xLTEtMA_c2ae183f-e776-4699-8e78-69d3b6385a45">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzUtMS0xLTEtMA_66a743ce-6481-4b6d-b475-4f33fb3b7253">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzUtMy0xLTEtMA_f4b73608-5e82-480f-b8f8-56fa07ef39e0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzYtMS0xLTEtMA_77f30e9f-af04-4a7f-8574-3614db2961d2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzYtMy0xLTEtMA_a3e13a77-9a20-4413-9956-d3ea7f5fd0e3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzctMS0xLTEtMA_be132391-3f4c-4b78-9283-b3ac561f389d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzctMy0xLTEtMA_667eb10c-b2bd-49f8-8185-c7a35aaecfe2">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzgtMS0xLTEtMA_1e5971a9-bbbd-4638-baac-f811989c4852">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzgtMy0xLTEtMA_2acdc997-b163-4b77-af89-0dc9e623a611">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzktMS0xLTEtMA_5df7ce41-7fc1-4761-b318-97e3cb989d8c">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzktMy0xLTEtMA_ddf1ad40-61fb-4af0-801f-b573293aa834">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzEwLTEtMS0xLTA_7bbbc37a-cc7f-4b99-9836-8ceef3448e83">336</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzEwLTMtMS0xLTA_4902f965-cebd-42e3-a815-098c897fa204">355</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our defined benefit plans excluding our U.K. Plan, we base our discount rate on the rates of return available on high-quality bonds with maturities approximating the expected period over which benefits will be paid. The rate of compensation increase is based on historical and expected rate increases. We base our rate of expected return on plan assets on historical experience, our investment guidelines and expectations for long-term rates of return. Our assets are invested in a variety of securities, primarily equity securities and government bonds. These securities are considered Level 1 and Level 2 investments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our U.K. Plan, we utilize the insurance buy-in methodology and base our discount rate on a yield curve reflective of the market pricing obtained in the most recent buy-in transaction, which occurred prior to the acquisition of BTG, and movements in market-observed buy-in pricing as of December&#160;31, 2021. We believe this is a reasonable proxy for an effective settlement rate of the buy-in assets. The discount rate is calculated as the single equivalent assumption that gives the same value of the liabilities as if the figures were calculated using the full yield curve. We assume that all pension increases will continue to be linked to the Retail Price Inflation (RPI), both before and after retirement, for all members, with the exception of post-88 Guaranteed Minimum Pensions (GMP), which will be based on Consumer Price Inflation (CPI). We base our rate of expected return on plan assets as equal to the discount rate used to value the buy-in assets. The U.K. Plan assets' investment policy is to invest in fully matching assets. This has been achieved through the purchase of two buy-in policies (Buy-in contracts), which provide payments designed to equal all future benefit payments due from the fund. As of December&#160;31, 2021, the Buy-in contracts represented 100 percent of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. As of December 31, 2020, the Buy-in contracts represented 100 percent of the total plan assets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzODM_1a7cf7e2-dff3-4876-b724-b08045ac9160" continuedAt="i0866bd245be2442dbb26aa4ff907b8c2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2021: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c99c0d845c344c2aaaa4f9075b3cc36_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtMS0xLTEtMA_1bfc84e5-fca4-4b82-ba82-3d500926aa07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f7c5cd724b943808b5b4a790359037e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtMy0xLTEtMA_e8f91df8-f9b6-4efa-9325-07893a9a985f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9107422a10134aa88c15d6264e4b0a15_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtNS0xLTEtMA_b14e7836-9fa0-4975-8883-9a66d2cb24bd">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32babe1b5a2d4787946bcd2130f04a6f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtNy0xLTEtMA_f241975b-f3e8-4e5f-9fdb-e72bff177811">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i479839a4abc848c0822e4fc438e2f790_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtMS0xLTEtMA_3792d39d-7ca6-428f-89d6-7b125640cf78">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e137b5ac4e443db82fce619d7addda_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtMy0xLTEtMA_93a4ee25-2979-42a2-9007-2e5be517c6ff">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieed3b64471e4431396082d1b7661d187_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtNS0xLTEtMA_a6212ce4-f603-4ba7-af18-889e8e7296bf">205</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtNy0xLTEtMA_bfa9052a-33d8-482b-8c8a-2ac45ff37024">205</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie3ebe46e356e407d91724f86cf2b5bb8"><div style="text-align:justify"><ix:continuation id="i0866bd245be2442dbb26aa4ff907b8c2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4fe210a6ecd4082b33c83f96d710db0_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtMS0xLTEtMA_c2329ae5-5cdf-4130-9a58-f3e134dd1f58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57226788691947098831b210f4d9e6f8_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtMy0xLTEtMA_80e65338-438c-4a31-b100-d8041216920c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7387bc40a28d42d3a310a107abc8db02_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtNS0xLTEtMA_738424b6-ae6c-4ea1-acb3-47596b6beb52">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cd235ef6f2496e8f2b3c361e6c2083_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtNy0xLTEtMA_c7ee8d52-5249-4409-a2da-903a6cc86d82">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia22158488b3a459c88e0b1f6a927db8c_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtMS0xLTEtMA_b1ca23e4-9611-441b-b88d-d9dae77afe92">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc049394c7014a64935dbc97f6fdef13_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtMy0xLTEtMA_2f6b6225-07a9-4c6c-8339-f0b402150d27">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699d1eb2cebb41f1bfb906a93a9f96f0_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtNS0xLTEtMA_a5ece1eb-e8fe-4757-a0c0-b9cd055194f0">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtNy0xLTEtMA_234dc023-ac88-43cc-bca1-c6f05ae24c89">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div><ix:continuation id="i08921519a3ea4c05988ec118e3cb3ef3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the U.K. Plan Level 3 assets were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Buy-in Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzEtMS0xLTEtMA_f3bc045b-3c75-4e12-862f-6c4e4dd5ee86">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzItMS0xLTEtMA_a726f9d0-f576-4ce7-97e7-a16e5f5007d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzMtMS0xLTEtMA_5757b137-24af-4f5d-a36c-59119ae2a608">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out for benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzYtMS0xLTEtMA_c6dce3b5-3fb8-4fbe-a2b8-71ba79636593">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzctMS0xLTEtMA_40187e18-6d85-4fa7-ae03-30941991062b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzgtMS0xLTEtMA_d7102e56-a5f2-4e31-bd18-267bef35d109">205</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments are estimated based on the same assumptions used in determining our benefit obligation as of December&#160;31, 2021. Actual benefit payments will depend on future employment and compensation, average years employed and average life spans, in addition to other factors. Changes in any of these factors could significantly impact these estimated future benefit payments. <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjM1OTQ_7c6c490e-0937-4a29-88ce-04b49e205de3" continuedAt="i0dd8930d699c48deb00b8174024068c4" escape="true">Benefit payments expected to be paid during the next ten years for our Domestic Retirement Plans, our U.K. Plan and our Other International Retirement Plans are as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i0dd8930d699c48deb00b8174024068c4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post Retirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzEtMS0xLTEtNTMyNzE_bf3b395b-a29c-4636-8d3b-4b1146bc0f50">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzItMS0xLTEtNTMyNzE_6dcc76d2-4669-4751-bd3a-c1ed0e4269d8">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzMtMS0xLTEtNTMyNzE_b7964729-cbf6-423e-8df0-2ad6f925cfd4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzQtMS0xLTEtNTMyNzE_63188f8d-7197-4b27-90bc-fe72cfe52140">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzUtMS0xLTEtNTMyNzE_ebde7aba-645d-49f6-9d53-1d873ffd014f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzYtMS0xLTEtNTMyNzE_3eaaa753-c7ba-4bd8-8c33-190b494a968e">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzOTA_9ebd8e95-7dac-4714-9282-aa3db170dbf1" escape="true">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="bsx:ExpenseRelatedToMatchingContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjE5ODA_59e95ecb-9050-49c2-b156-4e5576dba5d8">118</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="bsx:ExpenseRelatedToMatchingContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjE5NzY_70531a89-2a21-475c-a262-8c46c180f290">102</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="bsx:ExpenseRelatedToMatchingContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjE5NzI_a36534db-b99f-46fa-a53d-2a18d5cc1dfc">98</ix:nonFraction> million in 2019.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_160"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (CEO) and Executive Vice President and Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of December&#160;31, 2021 pursuant to Rule&#160;13a-15(b) of the Securities Exchange Act of 1934, as amended. Disclosure controls and procedures are designed to ensure that material information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and ensure that such material information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on their evaluation, our CEO and CFO concluded that as of December&#160;31, 2021, our disclosure controls and procedures were effective.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s annual report on our internal control over financial reporting is contained in Item&#160;7 of this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The report of Ernst &amp; Young LLP on our internal control over financial reporting is contained in Item&#160;7 of this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended December&#160;31, 2021, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Further, while many of our employees worked remotely to adhere to COVID-19 social distancing requirements, this did not affect our ability to maintain financial reporting systems, internal controls over financial reporting or disclosure controls and procedures. Prior to the COVID-19 pandemic, we were leveraging electronic tools to facilitate our global close process and to connect our physically dispersed team of finance professionals in offices around the world. While the quarterly close cycle was performed remotely, fundamentally, the work performed, and the processes and controls executed did not change. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we will begin a multi-year implementation of a new global enterprise resource planning (ERP) system, which will replace our existing system. The implementation is expected to occur in phases over the next several years. As the phased implementation occurs, it may result in changes to our processes and procedures which may result in changes to our internal controls over financial reporting. As such changes occur, we will evaluate quarterly whether they materially affect our internal control over financial reporting.</span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_163"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_1944"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_169"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2021 and is incorporated into this Annual Report on Form 10-K by reference.</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_172"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2021 and is incorporated into this Annual Report on Form 10-K by reference.</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_175"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2021 and is incorporated into this Annual Report on Form 10-K by reference.</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_178"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2021 and is incorporated into this Annual Report on Form 10-K by reference.</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_181"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm is Ernst &amp; Young LLP, New York, NY, (PCAOB ID <ix:nonNumeric contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xODEvZnJhZzphOGFjM2ZmYzM4MGQ0OWQyYWUxNTBlZTE4OGRhMDJjOS90ZXh0cmVnaW9uOmE4YWMzZmZjMzgwZDQ5ZDJhZTE1MGVlMTg4ZGEwMmM5XzIxOTkwMjMyNTU5Mjk_1a35f972-7936-4398-828f-b5805c1612c0">42</ix:nonNumeric>).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2021 and is incorporated into this Annual Report on Form 10-K by reference.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_187"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1) Financial Statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this portion of Item&#160;15 is set forth under Item&#160;8.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2) Financial Statement Schedules.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this portion of Item&#160;15 (Schedule&#160;II) follows the signature page to this report. All other financial statement schedules are not required under the related instructions or are inapplicable and therefore have been omitted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(3) Exhibits (* documents filed or furnished with this report, ** certain schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K.&#160;We agree to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request, # compensatory plans or arrangements)</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT<br/>NO.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TITLE</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit21-amsagreement.htm">Purchase Agreement among American Medical Systems Holdings, Inc., Endo Health Solutions Inc. and the Company, dated as of March 2, 2015 (incorporated by reference to Exhibit 2.1, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083).**</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308000584/exhibit3-2_15759.txt">Third Restated Certificate of Incorporation (incorporated herein by reference to Exhibit&#160;3.2, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2007, File No.&#160;1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465919029732/a19-9977_1ex3d1.htm">Amended and Restated By-Laws of the Company (incorporated herein by reference to Exhibit 3.1, Current Report on Form 8-K dated May 15, 2019, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0301.htm">Certificate of Designations of the 5.50% Mandatory Convertible Preferred Stock, Series A, filed with the Secretary of State of the State of Delaware on May 26, 2020 (incorporated herein by reference to Exhibit 3.1, Current Report on Form 8-K dated May 27, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen Certificate for shares of the Company's Common Stock (incorporated herein by reference to Exhibit&#160;4.1, Registration No. 33-46980).</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit42-descriptionofthe.htm">Description of the Registrant&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013504003276/b509658kexv4w1.txt">Indenture dated as of June&#160;25, 2004, between the Company and JPMorgan Chase Bank, as Trustee (incorporated herein by reference to Exhibit&#160;4.1, Current Report on Form&#160;8-K dated June&#160;25, 2004, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002201/exh4-1_13106.txt">Indenture dated as of November&#160;18, 2004, between the Company and J.P. Morgan Trust Company, National Association, as Trustee (incorporated herein by reference to Exhibit&#160;4.1, Current Report on Form&#160;8-K dated November&#160;18, 2004, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465906027974/a06-8189_4ex99d4.htm">First Supplemental Indenture dated as of April&#160;21, 2006 (incorporated herein by reference to Exhibit&#160;99.4, Current Report on Form 8-K dated April&#160;21, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465906027974/a06-8189_4ex99d6.htm">Second Supplemental Indenture dated as of April&#160;21, 2006 (incorporated herein by reference to Exhibit&#160;99.6, Current Report on Form&#160;8-K dated April&#160;21, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305002690/exh4-2_13988.htm">Form of Global Security for the 6.25% Notes due 2035 in the aggregate principal amount of $350,000,000, and form of Notice to holders thereof (incorporated herein by reference to Exhibit&#160;4.2, Current Report on Form&#160;8-K dated November&#160;17, 2005 and Exhibit&#160;99.7, Current Report on Form&#160;8-K dated April&#160;21, 2006, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013506003879/b61236bsexv4w1.txt">Indenture dated as of June&#160;1, 2006, between the Company and JPMorgan Chase Bank, N.A., as Trustee (incorporated herein by reference to Exhibit&#160;4.1, Current Report on Form&#160;8-K dated June&#160;9, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095012309070623/b78468exv4w4.htm">7.375% Senior Note due January&#160;15, 2040 in the aggregate principal amount of $300,000,000 (incorporated herein by reference to Exhibit 4.4, Current Report on Form&#160;8-K dated December&#160;10, 2009, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913063328/a13-18170_1ex4d3.htm">4.125% Senior Note Due October 1, 2023 in the aggregate principle amount of $450,000,000 (incorporated herein by reference to Exhibit 4.3, Current Report on Form&#160;8-K dated August 8, 2013, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915037235/a15-11340_1ex4d3.htm">3.375% Senior Notes due 2022 (incorporated herein by reference to Exhibit 4.3, Current Report on Form 8-K dated May 12, 2015, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915037235/a15-11340_1ex4d4.htm">3.850% Senior Notes due 2025 (incorporated herein by reference to Exhibit 4.4, Current Report on Form 8-K dated May 12, 2015, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746913006559/a2215392zex-4_1.htm">Indenture dated as of May 29, 2013, between the Company and U.S. Bank Association, as Trustee (incorporated herein by reference to Exhibit 4.1, Registration Statement on Form S-3 (File No 333-188918) filed on May 29, 2013).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000015/exhibit42-xxxnotesdue2028.htm">4.000% Senior Notes Due 2028 (incorporated herein by reference to Exhibit 4.2, Current Report on Form 8-K dated February 26, 2018, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit42-3450notesdue2024.htm">3.450% Senior Note due 2024 (incorporated herein by reference to exhibit 4.2, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit43-3750notesdue2026.htm">3.750% Senior Note due 2026 (incorporated herein by reference to exhibit 4.3, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit44-4000notesdue2029.htm">4.000% Senior Note due 2029 (incorporated herein by reference to exhibit 4.4, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit45-4550notesdue2039.htm">4.550% Senior Note due 2039 (incorporated herein by reference to exhibit 4.5, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit46-4700notesdue2049.htm">4.700% Senior Note Due 2049 (incorporated herein by reference to Exhibit 4.6, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787119000804/ss156905_ex0402.htm">Form of 0.625% Senior Note Due 2027 (incorporated herein by reference to Exhibit 4.2, Current Report on Form 8-K dated November 6, 2019, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_ex0402.htm">Form of 1.900% Senior Note due 2025 (incorporated herein by reference to Exhibit 4.2, Current Report on Form 8-K dated May 14, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_ex0403.htm">Form of 2.650% Senior Note due 2030 (incorporated herein by reference to Exhibit 4.3, Current Report on Form 8-K dated May 14, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0301.htm">Specimen Certificate of the Mandatory Convertible Preferred Stock (incorporated herein by reference to Exhibit 4.1, Current Report on Form 8-K dated May 27, 2020, File No. 1-11083).</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000885725/000110465906027974/a06-8189_48k.htm">Second Supplemental Indenture dated as of April 21, 2006 between Boston Scientific Corporation and The Bank of New York Mellon Trust Company, N.A., as successor to J.P. Morgan Trust Company, National Association, as Trustee (incorporated herein by reference to Exhibit 99.6, Current Report on Form 8-K dated April 21, 2006, File No. 1-11083)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261307000570/exh10-2_14949.htm">Form of Omnibus Amendment dated as of December&#160;21, 2006, among the Company, Boston Scientific Funding Corporation, Variable Funding Capital Company LLC, Victory Receivables Corporation and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch (Amendment No.&#160;1 to Receivables Sale Agreement and Amendment No.&#160;9 to Credit and Security Agreement) (incorporated herein by reference to Exhibit&#160;10.2, Annual Report on 10-K for the year ended December&#160;31, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261307002697/exhibit10-2_15574.txt">Form of Amended and Restated Receivables Sale Agreement dated as of November&#160;7, 2007 between the Company and each of its Direct or Indirect Wholly-Owned Subsidiaries that Hereafter Becomes a Seller Hereunder, as the Sellers, and Boston Scientific Funding LLC, as the Buyer (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated November&#160;7, 2007, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000014/creditagreement.htm">Credit Agreement dated as of April 18, 2012, by and among the Company, the several lenders parties thereto, and Bank of America, N.A., as Syndication Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 18, 2012, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915027462/a15-9108_1ex10d1.htm">Credit Agreement dated as of April 10, 2015, by and among Boston Scientific Corporation, the several lenders parties thereto, Bank of America, N.A., as Syndication Agent and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 14, 2015, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000028/ex105_bscfirstamendmenttor.htm">First Amendment, dated as of October 23, 2015, to the Credit Agreement, dated as of April 10, 2015, among Boston Scientific Corporation, the several lenders party thereto, Bank of America, N.A., as Syndication Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.5, Annual Report on Form 10-K for the year ended December 31, 2015, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013503002096/b45658bsexv10w6.txt">License Agreement among Angiotech Pharmaceuticals, Inc., Cook Incorporated and the Company dated July 9, 1997, and related Agreement dated December&#160;13, 1999 (incorporated herein by reference to Exhibit&#160;10.6, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2002, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002236/exh10-1_13122.txt">Amendment between Angiotech Pharmaceuticals, Inc. and the Company dated November&#160;23, 2004 modifying July&#160;9, 1997 License Agreement among Angiotech Pharmaceuticals, Inc., Cook Incorporated and the Company (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated November&#160;23, 2004, File No.&#160;1-11083).</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Agreement, dated as of January&#160;8, 2006, as amended, between the Company and Abbott Laboratories (incorporated herein by reference to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_47.htm">Exhibit&#160;10.47</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_48.htm">Exhibit&#160;10.48</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_49.htm">Exhibit&#160;10.49</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_50.htm">Exhibit&#160;10.50</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Annual Report on Form&#160;10-K for year ended December&#160;31, 2005 and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465906023741/a06-8189_2ex10d1.htm">Exhibit&#160;10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated April&#160;7, 2006, File No.&#160;1-11083).</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit101-jjagreement.htm">Settlement Agreement among Johnson &amp; Johnson, Guidant LLC and the Company, dated as of February 13, 2015 (incorporated by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-5_13134.txt">Form of Non-Qualified Stock Option Agreement (Non-Employee Directors) (incorporated herein by reference to Exhibit&#160;10.5, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-6_13134.txt">Form of Restricted Stock Award Agreement (Non-Employee Directors) (incorporated herein by reference to Exhibit&#160;10.6, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000029/exhibit101-q2201210xq.htm">Form of Restricted Stock Award Agreement (Non-Employee Directors) under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit&#160;10.1, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Boston Scientific Corporation Excess Benefit Plan, as amended (incorporated herein by reference to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001649/form8-k_13649.htm">Exhibit&#160;10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated June&#160;29, 2005 and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308002226/exhibit10-4_16230.htm">Exhibit&#160;10.4</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated December&#160;16, 2008, File No.&#160;1-11083).#</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001649/exhibit10-2_13649.htm">Form of Trust under the Boston Scientific Corporation Excess Benefit Plan (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated June&#160;29, 2005, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261310000567/exh10-1_16834.htm">Boston Scientific Corporation Deferred Bonus Plan (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated May 11, 2010, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095012311015112/b83548exv10w39.htm">Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated, effective as of January&#160;1, 2011 (incorporated herein by reference to Exhibit 10.39, Annual Report on Form&#160;10-K for year ended December&#160;31, 2010, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1044-401k.htm">Amendment to Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated, effective as of January&#160;1, 2011 (incorporated herein by reference to Exhibit 10.44, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000029/exhibit102-q2201210xq.htm">Form of Second Amendment of Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated (incorporated herein by reference to Exhibit&#160;10.2, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000043/exhibit101-q3201210xq.htm">Form of Third Amendment of the Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated (incorporated herein by reference to Exhibit&#160;10.1, Quarterly Report on Form&#160;10-Q for the quarter ended September 30, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston Scientific Corporation 2000 Long-Term Incentive Plan, as amended (incorporated herein by reference to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013500001894/0000950135-00-001894.txt">Exhibit&#160;10.20</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Annual Report on Form&#160;10-K for the year ended December&#160;31, 1999, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000091205702011989/a2074671zex-10_18.txt%20">Exhibit&#160;10.18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2001, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002392/exh10-1_13161.txt">Exhibit&#160;10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated December&#160;22, 2004, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001188/exh10-3_13524.htm">Exhibit&#160;10.3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated May&#160;9, 2005, and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308002226/exhibit10-3_16230.htm">Exhibit&#160;10.3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form 8-K dated December&#160;16, 2008, File No.&#160;1-11083).#</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308001138/exh10-1_15891.htm">Boston Scientific Corporation 2003 Long-Term Incentive Plan, as Amended and Restated, Effective June 1, 2008 (incorporated herein by reference to Exhibit&#160;10.1, Quarterly Report on Form&#160;10-Q for the quarter ended March&#160;31, 2008, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1049-ltip.htm">Boston Scientific Corporation 2011 Long-Term Incentive Plan, as amended (incorporated herein by reference to Exhibit 10.49, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-1_13134.txt">Form of Non-Qualified Stock Option Agreement (vesting over three years) (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-2_13134.txt">Form of Non-Qualified Stock Option Agreement (vesting over four years) (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div><div><span><br/></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308000584/exhibit10-20_15759.txt">Form of Non-Qualified Stock Option Agreement (vesting over two years) (incorporated herein by reference to Exhibit&#160;10.20, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2007, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001671/exhibit10-1_13660.htm">Form of Non-Qualified Stock Option Agreement dated July&#160;1, 2005 (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form 8-K dated July&#160;1, 2005, File No.&#160;1-11083).#</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095012310101570/b82677exv10w6.htm">Form of Stock Option Agreement (with one year service requirement for vesting upon Retirement) (incorporated herein by reference to Exhibit&#160;10.6, Quarterly Report on Form&#160;10-Q dated September&#160;30, 2010, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572511000042/exhibit104rsa.htm">Form of Restricted Stock Award Agreement (Non-Employee Directors) under the 2003 and 2011 Long-Term Incentive Plans (incorporated herein by reference to Exhibit&#160;10.4, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572511000042/exhibit105nq.htm">Form of Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit&#160;10.5, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1070-formoftsrpsuag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.70, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1071-formoffcfpsuag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.71, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1072-execallowanced.htm">Form of Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (Special) (incorporated herein by reference to Exhibit 10.72, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000129993309005008/exhibit3.htm">Form of Change in Control Agreement between the Company and certain Executive Officers (incorporated herein by reference to Exhibit&#160;10.3, Current Report on Form&#160;8-K dated December&#160;15, 2009, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572511000046/exhibit101_michaelmahoneyo.htm">Form of Offer Letter dated September 6, 2011 between the Company and Michael F. Mahoney, as supplemented September 13, 2011 (incorporated herein by reference to Exhibit 10.1, Current Report on Form&#160;8-K dated September 19, 2011, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit10100-mahoneyofferl.htm">Form of Amendment, dated February 14, 2012, to Offer Letter dated September 6, 2011 between the Company and Michael F. Mahoney, as supplemented September 13, 2011 (incorporated herein by reference to Exhibit 10.100, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit102-offerletterfitz.htm">Form of Offer Letter by and between the Company and Joseph M. Fitzgerald dated February 27, 2014 (incorporated by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit103-offerletterball.htm">Form of Offer Letter by and between the Company and Kevin J. Ballinger dated December 14, 2012 (incorporated by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261302001397/exhibit4-1_11477.txt">The Boston Scientific Deferred Compensation Option Program (incorporated herein by reference to Exhibit 4.1, Registration No. 333-98755).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000007/exhibit10118domesticreloca.htm">Boston Scientific Corporation Domestic Relocation Policy Tier 5 Executive Officer Homeowner, effective January 2007 (incorporated herein by reference to Exhibit&#160;10.118, Annual Report on Form&#160;10-K for the year ended December 31, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913017992/a13-6792_1ex10d1.htm">Form of Letter to Key Management Personnel re: Change in Control Agreement (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated February 28, 2013, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913077459/a13-22722_1ex10d2.htm">Form of Offer Letter by and between the Company and Daniel J. Brennan, dated October 22, 2013 (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated October 24, 2013 File No. 1-11083). #</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913078031/a13-22722_2ex10d2.htm">Boston Scientific Corporation Total Shareholder Return Performance Share Program, Performance Period January 1, 2014 - December 31, 2016 (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated October 22, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913078031/a13-22722_2ex10d3.htm">Boston Scientific Corporation Free Cash Flow Performance Share Program, Performance Period January 1, 2014 - December 31, 2014 (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K dated October 22, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000037/exhibit103-formofdeferreds.htm">Form of 2011 Long-Term Incentive Plan Global Deferred Stock Unit Award Agreement (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000037/exhibit104-formofnonxquali.htm">Form of 2011 Long-Term Incentive Plan Global Non-Qualified Stock Option Agreement (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000037/exhibit106-usseveranceplan.htm">Boston Scientific Corporation U.S. Severance Plan for Exempt Employees, as amended and restated, effective August 1, 2013 (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308001968/exhibit10-1_16156.htm">Boston Scientific Corporation Non-Employee Director Deferred Compensation Plan, as amended and restated, effective January&#160;1, 2009 (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated October&#160;28, 2008, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000045/exhibit106-bscnonxemployee.htm">Boston Scientific Corporation Non-Employee Director Deferred Compensation Plan, as amended and restated, effective January 1, 2014 (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000005/exhibit1099-tsrpsuagreement.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (2014 Total Shareholder Return) incorporated herein by reference to Exhibit 10.99, Annual Report on Form 10-K for the year ended December 31, 2013 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000005/exhibit10100fcfpsuagreement.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (2014 Free Cash Flow) incorporated herein by reference to Exhibit 10.100, Annual Report on Form 10-K for the year ended December 31, 2013 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000022/exhibit101-globalemployees.htm">Boston Scientific Corporation 2006 Global Employee Stock Ownership Plan, as amended and restated, effective July 1, 2014 (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465914075249/a14-23099_1ex10d1.htm">Boston Scientific Corporation 2015 Annual Bonus Plan, effective as of January&#160;1, 2015 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated October 28, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465914075249/a14-23099_1ex10d2.htm">Boston Scientific Corporation 2015 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated October 28, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465914075249/a14-23099_1ex10d3.htm">Boston Scientific Corporation 2015 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K dated October 28, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916135014/a16-15337_1ex10d1.htm">Boston Scientific Corporation Executive Retirement Plan, as amended and restated effective August 1, 2016 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated July 25, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit101-formofnonxquali.htm">Form of Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (Non-Employee Directors) (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit102-formofrestricte.htm">Form of Restricted Stock Award Agreement under the 2011 Long-Term Incentive Plan (Non-Employee Directors) (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.58</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit103-formofdeferreds.htm">Form of Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (Non-Employee Directors) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit104-formofperforman.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit105-formofperforman.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit106-firstamendmentt.htm">First Amendment to Boston Scientific Corporation Deferred Bonus Plan, effective January 1, 2015 (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915069104/a15-20070_1ex10d1.htm">Boston Scientific Corporation 2016 Annual Bonus Plan, effective as of January 1, 2016 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed October 5, 2015, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915069104/a15-20070_1ex10d2.htm">Boston Scientific Corporation 2016 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed October 5, 2015, File No. 001-11083)#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.64</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915069104/a15-20070_1ex10d3.htm">Boston Scientific Corporation 2016 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed October 5, 2015, File No. 001-11083)#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.65</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000024/ex104-2016tsrformofawardag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.66</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000024/ex105-2016fcfformofawardag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.67</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit101-emackeyofferlet.htm">Form of Offer Letter by and between the Company and Edward Mackey dated December 24, 2014 (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.68</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit102-formofnqsoagree.htm">Form of Global Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.69</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit103-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.70</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit104-2016_psuxtsr.htm">Form of 2016 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.71</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit105-2016_psuxfcf.htm">Form of 2016 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.72</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916158618/a16-22008_1ex10d1.htm">Boston Scientific Corporation 2017 Annual Bonus Plan, effective as of January&#160;1, 2017 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 22, 2016, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.73</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916158618/a16-22008_1ex10d2.htm">Boston Scientific Corporation 2017 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 22, 2016, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.74</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916158618/a16-22008_1ex10d3.htm">Boston Scientific Corporation 2017 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 22, 2016, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.75</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787117000618/ss54238_ex1001.htm">Credit Agreement dated as of August 4, 2017 by and among Boston Scientific Corporation, the several lenders party thereto, Bank of America, N.A. and Wells Fargo Bank, National Association, as Syndication Agents and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed on August 7, 2017, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.76</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000040/a101-2018annualbonusplan.htm">Boston Scientific Corporation 2018 Annual Bonus Plan, effective as of January&#160;1, 2018 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 17, 2017, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.77</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000040/a102-2018tsrpsp.htm">Boston Scientific Corporation 2018 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 17, 2017 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.78</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000040/a103-2018fcfpsp.htm">Boston Scientific Corporation 2018 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 17, 2017, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.79</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit101-formofnqsoagree.htm">Form of Global Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.80</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit102-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.81</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit103-2017_tsrpsuxawa.htm">Form of 2017 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.82</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit104-2017_fcfpsuxawa.htm">Form of 2017 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.83</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787117000108/ss29948_ex1001.htm">Second Amended and Restated Credit and Security Agreement, dated as of February 7, 2017, by and among Boston Scientific Funding LLC, Boston Scientific Corporation, Wells Fargo Bank, National Association and Sumitomo Mitsui Banking Corporation, New York Branch, as Lenders, Wells Fargo Bank, National Association and SMBC Nikko Securities America, Inc., as Co-Agents, and Wells Fargo Bank, National Association, as Administrative Agent (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated February 10, 2017, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.84</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787117000108/ss29948_ex1002.htm">Second Amended and Restated Receivables Sale Agreement, dated as of February 7, 2017, by and among Boston Scientific Corporation, each of its direct or indirect wholly-owned subsidiaries that become a seller thereunder and Boston Scientific Funding LLC (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated February 10, 2017, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.85</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit101-formofnqsoagree.htm">Form of Global Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.86</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit102-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.87</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit103-2018_tsrpsuxawa.htm">Form of 2018 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.88</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit104-2018_fcfpsuxawa.htm">Form of 2018 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.89</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit105-acquisitionxrel.htm">Form of Acquisition-Related Non-Qualified Stock Option Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). # </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.90</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit106-acquisitionxrel.htm">Form of Acquisition-Related Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.91</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit107-2018_rsaxawardx.htm">Form of Restricted Stock Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan incorporated herein by reference to Exhibit 10.7, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.92</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit108-2018_dsuxawardx.htm">Form of Deferred Stock Unit Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan incorporated herein by reference to Exhibit 10.8, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.93</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit109-2018_nqsoxaward.htm">Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan# (incorporated herein by reference to Exhibit 10.9, Current Report on Form 10-Q quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.94</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069204/a18-40434_1ex10d1.htm">Boston Scientific Corporation 2019 Annual Bonus Plan, effective as of January&#160;1, 2019 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 19, 2018, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.95</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069204/a18-40434_1ex10d2.htm">Boston Scientific Corporation 2019 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 19, 2018 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.96</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069204/a18-40434_1ex10d3.htm">Boston Scientific Corporation 2019 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 19, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.97</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000036/exhibit101-2018creditagree.htm">Credit Agreement dated as of August 20, 2018, by and among Boston Scientific Corporation, the several lenders parties thereto, Bank of America, N.A., MUFG Bank, LTD., and Sumitomo Mitsui Banking Corporation, as Syndication Agents, and Wells Fargo Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed August 21, 2018, File No. 1-11083.) </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.98</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex2d1.htm">BTG plc Acquisition Rule&#160;2.7 Announcement, dated November&#160;20, 2018. (incorporated herein by reference to Exhibit 2.1, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex2d2.htm">BTG plc Cooperation Agreement, dated November&#160;20, 2018. (incorporated herein by reference to Exhibit 2.2, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.100</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d1.htm">BTG plc Shareholder Undertaking of Invesco Asset Management Limited, dated November 20, 2018 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d2.htm">BTG plc Shareholder Undertaking of Novo Holdings A/S, dated November 20, 2018 (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.102</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d3.htm">BTG plc Shareholder Undertaking of Woodford Asset Management Limited, dated November 20, 2018 (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.103</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d4.htm">BTG plc Form of Director Undertaking (incorporated herein by reference to Exhibit 10.4, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d5.htm">Bridge Credit Agreement, dated as of November&#160;20, 2018 by and among Boston Scientific Corporation, the lenders party thereto and Barclays Bank PLC, as administrative agent, bookrunner and lead arranger (incorporated herein by reference to Exhibit 10.5, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.105</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787118000985/ss119647_ex1001.htm">Credit Agreement, dated as of December 19, 2018, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent and Bank of America, N.A. as syndication agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated December 21, 2018, File No. 1-11083)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.106</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787118000985/ss119647_ex1002.htm">First Amendment to Credit Agreement, dated as of December 19, 2018, among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated December 21, 2018, File No. 1-11083)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.107</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787118000985/ss119647_ex1003.htm">Term Loan Credit Agreement, dated as of December 19, 2018, among Boston Scientific Corporation, the lenders party thereto and Barclays Bank PLC, as administrative agent, Bank of America, N.A., Wells Fargo Bank, National Association and JPMorgan Chase Bank, N.A., as syndication agents (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K dated December 21, 2018, File No. 1-11083)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.108</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit101-formofnqsoagree.htm">Form of Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.109</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit102-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.110</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit103-2019_tsrpsuxawa.htm">Form of 2019 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.111</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit104-2019_fcfpsuxawa.htm">Form of 2019 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.112</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit105-2019acquisition.htm">Form of Acquisition-Related Non-Qualified Stock Option Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.113</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit106-2019acquisition.htm">Form of Acquisition-Related Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.114</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit107-2019_rsaxawardx.htm">Form of Restricted Stock Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.7, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.115</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit108-2019_dsuxawardx.htm">Form of Deferred Stock Unit Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.8, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.116</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exbibit11-underwritingagre.htm">Underwriting Agreement, dated February 21, 2019, as supplemented by the Terms Agreement, dated February 21, 2019, among Boston Scientific Corporation and Barclays Capital Inc., Merrill Lynch, Pierce, Fenner &amp; Smith Inc. and Wells Fargo Securities, LLC, as representatives of the underwriters (incorporated herein by reference to Exhibit 1.1, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.117</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000048/ex-101.htm">Boston Scientific Corporation 2020 Annual Bonus Plan, effective as of January&#160;1, 2020 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 20, 2019, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.118</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000048/ex-102.htm">Boston Scientific Corporation 2020 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 20, 2019 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.119</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000048/ex-103.htm">Boston Scientific Corporation 2020 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 20, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.120</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787119000894/ss159395_ex1001.htm">Credit Agreement, dated as of December 5, 2019, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated December 5, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.121</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000156/ss167320_ex1001.htm">Credit Agreement dated as of February 27, 2020, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated February 27, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.122</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_ex1001.htm">Credit Agreement dated as of April 21, 2020, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 21, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.123</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_ex1002.htm">First Amendment, dated as of April 21, 2020, to Term Loan Credit Agreement dated as of February 27, 2020, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 21, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.124</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_ex1003.htm">First Amendment, dated as of April 21, 2020, to Revolving Credit Agreement, dated as of December 19, 2018, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent and Bank of America, N.A. as syndication agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 21, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.125</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000024/exhibit101amendedandre.htm">Amended and Restated 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated May 7, 2020, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.126</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_ex0101.htm">Underwriting Agreement, dated as of May 14, 2020, as supplemented by the Terms Agreement, dated May 14, 2020, among Boston Scientific Corporation and Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters. (incorporated herein by reference to Exhibit 1.1, Current Report on Form 8-K dated May 14, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.127</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0101.htm">Underwriting Agreement relating to the Common Stock, dated as of May 21, 2020, among Boston Scientific Corporation and J.P. Morgan Securities LLC and BofA Securities Inc., as representatives of the underwriters. (incorporated herein by reference to Exhibit 1.1, Current Report on Form 8-K filed May 28, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.128</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0102.htm">Underwriting Agreement relating to the Mandatory Convertible Preferred Stock, dated as of May 21, 2020, among Boston Scientific Corporation and J.P. Morgan Securities LLC and BofA Securities Inc., as representatives of the underwriters. (incorporated herein by reference to Exhibit 1.2, Current Report on Form 8-K filed May 28, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.129</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000527/ss174648_ex1001.htm">Second Amendment, dated as of May 28, 2020, to February Term Loan Credit Agreement, by and among Boston Scientific Corporation, the several lenders parties thereto, and The Bank of Nova Scotia, as administrative agent. (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed May 29, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.130</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000527/ss174648_ex1002.htm">Second Amendment, dated as of May 28, 2020, to Revolving Credit Agreement, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent. (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed May 29, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.131</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1012021annualbo.htm">Boston Scientific Corporation 2021 Annual Bonus Plan, effective as of January 1, 2021 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 24, 2020, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.132</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1022021totalsha.htm">Boston Scientific Corporation 2021 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 24, 2020, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.133</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1032021freecash.htm">Boston Scientific Corporation 2021 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 24, 2020, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.134</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000885725/000110465921065917/tm2116033d1_ex10-1.htm">Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated May 13, 2021, File No. 1-11083)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.135</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572521000056/exhibit101bostonscientific.htm">Boston Scientific Corporation 2022 Annual Bonus Plan, effective as of January 1, 2022  (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 23, 2021, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.136</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572521000056/exhibit102bostonscientific.htm">Boston Scientific Corporation 2022 Total Shareholder Return Performance Share Program  (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 23, 2021, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.137</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572521000056/exhibit103bostonscientific.htm">Boston Scientific Corporation 2022 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 23, 2021, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21-listofsubsidiari.htm">List of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21-listofsubsidiari.htm">Boston Scientific's subsidiaries as of January 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21-listofsubsidiari.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21-listofsubsidiari.htm">.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit23-2021eyconsent.htm">Consent of Independent Registered Public Accounting Firm, Ernst &amp; Young LLP.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-ceo302202110xk.htm">Certification of Chief Executive Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-cfo302202110xk.htm">Certification of Chief Financial Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-ceo906202110xk.htm">Certification of Chief Executive Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-cfo906202110xk.htm">Certification of Chief Financial Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div id="i4513a36fb1aa4e44acd87206b0aed737_190"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston Scientific Corporation</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(duly authorized officer and principal financial officer)</span></td></tr></table></div><div style="margin-top:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Daniel J. Brennan</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael F. Mahoney</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chairman of the Board, <br/>President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Jonathan R. Monson</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan R. Monson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Global Controller and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Nelda J. Connors</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nelda J. Connors</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Charles J. Dockendorff</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles J. Dockendorff</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Yoshiaki Fujimori</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yoshiaki Fujimori</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donna A. James</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donna A. James</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Edward J. Ludwig</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Edward J. Ludwig</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David J. Roux</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David J. Roux</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John E. Sununu</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John E. Sununu</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David S. Wichmann</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David S. Wichmann</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ellen M. Zane</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ellen M. Zane</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><div id="i4513a36fb1aa4e44acd87206b0aed737_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span><ix:nonNumeric contextRef="i51845faa20174064ac84a92ea5ff121a_D20180101-20181231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90ZXh0cmVnaW9uOjhkYTdmMTljOTMyZDQyNTQ4ZDU0ZDJjNTgyYTY3YWM2XzE0NTI_b25d9071-81a7-4de1-958c-7dd39efbb784" continuedAt="i4a55036470354ebbbd6ec4a08a703508" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.988%"><tr><td style="width:1.0%"></td><td style="width:27.639%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/>&#160;Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13 (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Credit loss exposure (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Write-offs (c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItMS0xLTEtMA_c733287a-3154-4b1e-897f-ecdb543b3fcd">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItNS0xLTEtMA_d1203326-5e22-4d9e-9437-6526a6f0b9f1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItNy0xLTEtMA_a749d49c-c293-4191-a18c-2b20d897c6f6">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItMTEtMS0xLTA_3b4ff472-f6d8-4442-828c-45d43211ad6a">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for credit losses (b)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtMS0xLTEtMA_6e83842f-f182-4af7-80b8-7d5f86847105">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtNS0xLTEtMA_bb1544d4-becf-4913-bd8c-859556c7c6bb">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtNy0xLTEtMA_81ac64df-fd95-443f-9cc6-5b35d7f351dc">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtMTEtMS0xLTA_72d9c088-438e-4acd-9af6-2cbcb601c5c5">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for uncollectible accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtMS0xLTEtMA_7c27c78d-90a4-45de-8d94-f483fb7ab975">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtNS0xLTEtMA_5c301913-c911-4549-b175-ff284dc3cec8">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtNy0xLTEtMA_abc5376f-c13b-4d96-8a97-9d8587814c86">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea25cb690174465b8215ce1c263a42a_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtMTEtMS0xLTA_276edf89-1f3c-466f-8876-3a181fecbe76">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:continuation id="i4a55036470354ebbbd6ec4a08a703508"><div style="margin-top:20pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Following the adoption of FASB ASC Topic 326 as of January 1, 2020, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> account. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Amounts shown within credit loss exposure above were established through selling, general and administrative expense. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Beginning in 2020, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for uncollectible accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Represents actual write-offs of uncollectible accounts.</span></div></ix:continuation><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>exhibit42-descriptionofthe.htm
<DESCRIPTION>EX-4.2 DESCRIPTION OF REGISTERED SECURITIES FY2021
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia8b66e4c39fe43a987cfd7bff6f1f9dc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">REGISTERED PURSUANT TO SECTION 12 OF THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of the date of the Annual Report on Form 10-K of which this exhibit is a part, Boston Scientific Corporation (the &#8220;Company&#8221;) has three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)&#58; (1) our common stock, $.01 par value per share, (2) our 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share, and (3) our 0.625% Senior Notes due 2027. As used in this description, unless otherwise expressly stated or the context otherwise requires, all references to &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; mean Boston Scientific Corporation excluding its subsidiaries.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Description of Common Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description of the terms of the common stock sets forth certain general provisions of the common stock as contained in our Charter and by-laws and is qualified in its entirety by reference to Delaware law and our Charter and by-laws in their entirety.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are currently authorized to issue up to 2,000,000,000 shares of common stock, par value $0.01 per share. As of January 31, 2020, there were 1,396,195,349 shares of our common stock outstanding. All outstanding shares of our common stock are fully paid and nonassessable. Our common stock is listed on the NYSE under the symbol &#8220;BSX.&#8221;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Holders of our common stock have no preemptive, subscription, redemption or conversion rights and the common stock is not subject to redemption. The rights, preferences and privileges of holders of common stock are subject to, and may&#160;be adversely affected by, the rights of holders of any series&#160;of preferred stock, whether currently outstanding or designated and issued in the future. </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the preferences of holders of preferred stock, if any, holders of common stock are entitled to dividends and other distributions when, as and if declared by our board of directors out of funds legally available therefor and shall share equally on a per share basis in all such dividends and other distributions.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Voting Rights</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise provided by law or by the designation of the preferences, limitations and relative rights of any series&#160;of preferred stock, the voting power with respect to us is held by holders of our common stock. Each holder of common stock is entitled to one vote for each share held.  </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidation and Dissolution</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise provided by the certificate of designation and limitations and relative rights of any series&#160;of preferred stock, in the event of any of our liquidation, dissolution, or winding up, whether voluntary or involuntary, after payment of all our liabilities and obligations and after payment has been made to holders of each series&#160;of preferred stock of the full amount to which they are entitled, holders of </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shares of common stock will be entitled to share, ratably according to the number of shares of common stock held by them, in all remaining assets available for distribution to holders of the common stock.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Provisions of Delaware Law, the Charter and the By-laws</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations with Interested Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. We are subject to the provisions of the Delaware General Corporate Law, or the DGCL. Section&#160;203 of the DGCL prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes mergers, consolidations, assets sales, and other transactions resulting in a financial benefit to the interested stockholder. Subject to certain exceptions, an &#8220;interested stockholder&#8221; is a person who, together with affiliates owns, or within three years did own, 15% or more of the corporation&#8217;s voting stock.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Liability of Directors and Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As permitted by the DGCL, our Charter provides that our directors will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except in certain circumstances involving wrongful acts, such as the breach of a director&#8217;s duty of loyalty, acts or omissions which involve intentional misconduct or a knowing violation of law or for any transaction from which the director derives an improper personal benefit. Our directors are also subject to liability under Section&#160;174 of the DGCL, which makes directors personally liable for unlawful dividends or unlawful stock repurchases or redemptions if the unlawful conduct is willful or results from negligence.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under our Charter and by-laws (and in accordance with Section&#160;145 of the DGCL), we will indemnify to the fullest extent permitted by the DGCL any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding. These include civil, criminal, administrative, investigative or other proceedings by reason of the fact that the person is or was one of our directors, officers or employees, or is or was serving in that capacity or as an agent at our request for another entity. Our indemnity covers expenses, judgments, fines and amounts paid or to be paid in settlement actually and reasonably incurred in connection with the defense or settlement of an action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to our best interest and, with respect to any criminal action or proceeding, had no reasonable cause to believe that their conduct was unlawful. We will indemnify a person in a derivative action under the same conditions, except that no indemnification is permitted without judicial approval if the person is adjudged to be liable to us in performance of his or her duty. Derivative actions are actions by us or in our right to procure a judgment in our favor. Our agents may&#160;be similarly indemnified at the discretion of our board of directors. In addition, we have entered into indemnification agreements with each of our directors and executive officers. These agreements provide rights of indemnification substantially similar to and, in certain respects, broader than those provided by the Charter and by-laws.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors&#59; Removal&#59; Vacancies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Our Charter and by-laws provide that the directors shall be elected at each annual meeting or at any special meeting the notice of which specified the election of directors as an item of business for such meeting.  Our by-laws provide that each nominee for director shall be elected to the board of directors by the affirmative vote of the majority of votes cast, in person or by proxy, by the holders of shares entitled to vote at a meeting at which a quorum is present&#59; provided, however, that if the number of nominees exceeds the number of directors to be elected at any such meeting, the directors shall be elected by a plurality of the votes cast, in person or by proxy. Our Charter provides that vacancies on the board of directors may&#160;only be filled by a majority of the board of directors </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">then in office and further provides that directors may&#160;only be removed by the affirmative vote of holders of at least 80% of the voting power of all the then outstanding shares of stock entitled to vote generally in the election of directors. The provisions of our Charter and by-laws that govern the number, election, and terms of the board of directors may&#160;not be amended without the affirmative vote of at least 80% of the voting power of all the then outstanding shares of stock entitled to vote generally in the election of directors.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Meetings of Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Our Charter provides that stockholder action can only be taken at an annual or special meeting of stockholders and that the business permitted to be conducted at any special meeting of stockholders is limited to the business brought before the meeting by the Chairman of the board of directors or our President or at the request of a majority of the members of the board of directors. Our Charter and by-laws provide that special meetings of stockholders can be called only by the Chairman of the board of directors, the Chief Executive Officer (or if there is no Chief Executive Officer, the President), or pursuant to a resolution approved by a majority of the total number of directors which we would have if there were no vacancies on the board of directors. Stockholders are not permitted to call a special meeting or to require that the board of directors call a special meeting of stockholders.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Advance Notice Requirements for Stockholder Proposals and Director Nominees. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our by-laws provide that stockholders seeking to make nominations of candidates for election as directors, or to bring other business before an annual or special meeting of the stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder&#8217;s notice must be delivered to and received at our principal executive offices not less than 120 days prior to the anniversary date that our proxy statement was released to shareholders in connection with the previous year's annual meeting. However, in the event that the date of the annual meeting is more than 30 days before or after the first anniversary date of the preceding year&#8217;s annual meeting, or in the event of a special meeting of stockholders called for the purpose of electing directors, then the deadline is a reasonable time before the we begin to print and mail our proxy materials. Our by-laws also specify certain requirements as to the form and content of a stockholder&#8217;s notice. These provisions may restrict the ability of our stockholders to bring business before our annual meeting of stockholders or to make nominations for directors at our annual meeting or any special meeting of stockholders.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Proxy Access.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Our by-laws permit an eligible stockholder or group of stockholders to include up to a specified number of director nominees in our proxy materials for an annual meeting of stockholders. To qualify, the stockholders (or group of up to twenty stockholders) must have continuously owned for at least three years 3% or more of our outstanding shares of common stock. The maximum number of stockholder nominees permitted under the proxy access provisions of our by-laws is the greater of (i) two or (ii) 20% of the total number of our directors in office as of the last day on which notice of a nomination may be delivered.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of a nomination under our proxy access by-law provisions must generally be submitted to our principal executive offices not less than 120 days nor more than 150 days prior to the first anniversary of the date that we first mailed our proxy statement to stockholders for the immediately preceding annual meeting of stockholders. The notice must contain certain information specified in our by-laws.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchases&#59; Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Our Charter prohibits us, with certain exceptions, from purchasing any shares of our stock from any person, entity or group that beneficially owns 5% or more of our voting stock at an above-market price, unless a majority of our disinterested stockholders approve the transaction. In addition, our Charter empowers the board of directors, when considering a tender offer or </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">merger or acquisition proposal, to take into account factors in addition to potential economic benefits to stockholders and to consider constituencies other than stockholders.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Amendment of Charter and By-Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The DGCL provides generally that the vote of a majority of shares entitled to vote is required to act on most matters and to amend a corporation&#8217;s certificate of incorporation. Our Charter and by-laws contain provisions requiring the affirmative vote of the holders of at least 80% of the voting stock, voting together as a single class, to amend certain provisions of the Charter and our by-laws, including certain of the foregoing provisions. Such a supermajority vote would be in addition to any separate class&#160;vote that might in the future be required with respect to shares of preferred stock then outstanding.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The foregoing and other provisions of Delaware law and the Charter and our by-laws could make it more difficult to acquire us by means of a tender offer, a proxy contest or otherwise. These provisions may&#160;have the effect of delaying, deferring or preventing a change in control of our company, may&#160;discourage bids for the common stock at a premium over the market price of the common stock and may&#160;adversely affect the market price of the common stock.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is Computershare Shareowner Services.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Description of Mandatory Convertible Preferred Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The following is a description of certain provisions of our 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share, or the &#34;Mandatory Convertible Preferred Stock&#34;.  A copy of the certificate of designations setting forth the terms of the Mandatory Convertible Preferred Stock, which we refer to as the &#34;Certificate of Designations,&#34; is incorporated by reference as Exhibit 3.3 to our Annual Report on Form 10-K.  This description of the terms of the Mandatory Convertible Preferred Stock is not complete and is qualified in its entirety by reference to the provisions of our Charter and the Certificate of Designations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For purposes of this description, references to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">&#34;Business Day&#34; refer to any day other than a Saturday or Sunday or other day on which commercial banks in New York City are authorized or required by law or executive order to close or be closed&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">&#34;close of business&#34; refers to 5&#58;00 p.m., New York City time, and &#34;open of business&#34; refers to 9&#58;00 a.m., New York City time.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Under our Charter, our board of directors is authorized to provide, without further stockholder action, for the issuance of up to 50,000,000 shares of preferred stock, par value of $0.01 per share, and the designation of each series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and fix the voting power, full or limited or no voting power, the powers, </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">preferences and relative, participating, option or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of each series. We have no outstanding shares of preferred stock other than the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock is, and our common stock issued upon the conversion of the Mandatory Convertible Preferred Stock will be, fully paid and nonassessable. The holders of the Mandatory Convertible Preferred Stock have no preemptive or preferential rights to purchase or subscribe for any class of our stock, obligations, warrants or other securities. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent, Registrar and Conversion and Dividend Disbursing Agent</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Computershare Inc. is the transfer agent and registrar of our common stock and serves as transfer agent, registrar, conversion and dividend disbursing agent for the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ranking</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock, with respect to dividend rights and&#47;or distribution rights upon our liquidation, winding-up or dissolution, as applicable, will rank&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">senior to (i) our common stock and (ii) each other class or series of our capital stock established after the first original issue date of shares of the Mandatory Convertible Preferred Stock (which we refer to as the &#34;Initial Issue Date&#34;), the terms of which do not expressly provide that such class or series ranks either (x) senior to the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution or (y) on parity with the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution (we refer to our common stock and all such other classes or series of capital stock, collectively, as &#34;Junior Stock&#34;)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">on parity with any class or series of our capital stock established after the Initial Issue Date the terms of which expressly provide that such class or series will rank on parity with the Mandatory Convertible Preferred Stock as to dividend rights and distribution rights upon our liquidation, winding-up or dissolution (which we refer to collectively as &#34;Parity Stock&#34;)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">junior to each class or series of our capital stock established after the Initial Issue Date the terms of which expressly provide that such class or series will rank senior to the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution (which we refer to collectively as &#34;Senior Stock&#34;)&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">junior to our existing and future indebtedness and other liabilities.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In addition, with respect to dividend rights and distribution rights upon our liquidation, winding-up or dissolution, the Mandatory Convertible Preferred Stock will be structurally subordinated to any existing and future indebtedness and other obligations of each of our subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Listing</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock is listed on The New York Stock Exchange (&#34;NYSE&#34;), under the symbol &#34;BSX PR A&#34;. </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to the rights of holders of any class or series of any Senior Stock, holders of the Mandatory Convertible Preferred Stock will be entitled to receive, when, as and if declared by our board of directors, or an authorized committee thereof, out of funds legally available for payment, in the case of dividends paid in cash, and shares of common stock legally permitted to be issued, in the case of dividends paid in shares of common stock, cumulative dividends at the rate per annum of 5.50% of the Liquidation Preference of $100.00 per share of the Mandatory Convertible Preferred Stock (equivalent to $5.50 per annum per share), payable in cash, by delivery of shares of our common stock or through any combination of cash and shares of our common stock, as determined by us in our sole discretion (subject to the limitations on our ability to pay cash dividends and other cash distributions on our capital stock described below with respect to our credit facilities, see &#34;&#8212;Limitation on Cash Payments under our Credit Facilities&#34;). See &#34;&#8212;Method of Payment of Dividends.&#34; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If declared, dividends on the Mandatory Convertible Preferred Stock will be payable quarterly on March 1, June 1, September 1 and December 1 of each year to, and including, June 1, 2023 commencing on September 1, 2020 (each, a &#34;Dividend Payment Date&#34;), at such annual rate, and dividends shall accumulate from the most recent date as to which dividends shall have been paid or, if no dividends have been paid, from the Initial Issue Date of the Mandatory Convertible Preferred Stock, whether or not in any dividend period or periods there have been funds legally available or shares of common stock legally permitted for the payment of such dividends.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If declared, dividends will be payable on the relevant Dividend Payment Date to holders of record of the Mandatory Convertible Preferred Stock as they appear on our stock register at the close of business on the February 15, May 15, August 15 and November 15, as the case may be, immediately preceding the relevant Dividend Payment Date (each, a &#34;Regular Record Date&#34;), whether or not such holders early convert their shares, or such shares are automatically converted, after a Regular Record Date and on or prior to the immediately succeeding Dividend Payment Date. These Regular Record Dates will apply regardless of whether a particular Regular Record Date is a Business Day. If a Dividend Payment Date is not a Business Day, payment will be made on the next succeeding Business Day, without any interest or other payment in lieu of interest accruing with respect to this delay.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A full dividend period is the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial dividend period commenced on, and included, the Initial Issue Date of the Mandatory Convertible Preferred Stock and ended on, and excluded, the September 1, 2020 Dividend Payment Date. The amount of dividends payable on each share of Mandatory Convertible Preferred Stock for each full dividend period (subsequent to the initial dividend period) will be computed by dividing the annual dividend rate by four. Dividends payable on the Mandatory Convertible Preferred Stock for the initial dividend period and any other partial dividend period will be computed based upon the actual number of days elapsed during such period over a 360-day year (consisting of twelve 30-day months). The dividend on the Mandatory Convertible Preferred Stock for each subsequent full dividend period, when, as and if declared, will be $1.375 per share of Mandatory Convertible Preferred Stock (based on the annual dividend rate of 5.50% and a Liquidation Preference of $100.00 per share). Accumulated dividends on shares of the Mandatory Convertible Preferred Stock will not bear interest, nor shall additional dividends be payable thereon, if they are paid subsequent to the applicable Dividend Payment Date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No dividend will be paid unless and until our board of directors, or an authorized committee of our board of directors, declares a dividend payable with respect to the Mandatory Convertible Preferred Stock. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No dividend will be declared or paid upon, or any sum of cash or number of shares of our common stock set apart for the payment of dividends upon, any outstanding shares of Mandatory Convertible Preferred Stock with respect to any dividend period unless all dividends for all preceding dividend periods have been declared and paid upon, or a sufficient sum of cash or number of shares of our common stock has been set apart for the payment of such dividends upon, all outstanding shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Except as described above, dividends on shares of Mandatory Convertible Preferred Stock converted to common stock will cease to accumulate, and all other rights of holders of Mandatory Convertible Preferred Stock will terminate, from and after the Mandatory Conversion Date, the Early Conversion Date and the Fundamental Change Conversion Date (each, as defined below), as applicable.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on cash payments under our credit facilities</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our ability to declare and pay cash dividends and to make other distributions with respect to our capital stock, including the Mandatory Convertible Preferred Stock, is limited by the terms of our term loans and our Revolving Credit Facility. In addition, the terms of our future indebtedness and our subsidiaries' existing and any future indebtedness may contain similar restrictions. In addition, our ability to declare and pay dividends may be limited by applicable Delaware law. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Method of Payment of Dividends</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to the limitations described below, we may pay any declared dividend (or any portion of any declared dividend) on the shares of Mandatory Convertible Preferred Stock (whether or not for a current dividend period or any prior dividend period) determined in our sole discretion&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">in cash&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">by delivery of shares of our common stock&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">through any combination of cash and shares of our common stock.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will make each payment of a declared dividend on the shares of Mandatory Convertible Preferred Stock in cash, except to the extent we elect to make all or any portion of such payment in shares of our common stock. We will give the holders of the Mandatory Convertible Preferred Stock notice of any such election, and the portion of such payment that will be made in cash and the portion that will be made in shares of our common stock no later than 10 Scheduled Trading Days (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) prior to the Dividend Payment Date for such dividend&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if we do not provide timely notice of this election, we will be deemed to have elected to pay the relevant dividend in cash&#59; for the avoidance of doubt, however, we will pay the relevant dividend in shares of our common stock until we amend or terminate our existing credit agreements that contain a restriction on our ability to pay cash dividends on our capital stock, or such restrictions are no longer effective under the terms of such credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        All cash payments to which a holder of the Mandatory Convertible Preferred Stock is entitled in connection with a declared dividend on the shares of Mandatory Convertible Preferred Stock will be rounded to the nearest cent. If we elect to make any such payment of a declared dividend, or any portion thereof, in shares of our common stock, such shares will be valued for such purpose, in the case of any </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">dividend payment or portion thereof, at 97% of the Average VWAP (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) per share of our common stock over the five consecutive Trading Day (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) period commencing on, and including, the seventh Scheduled Trading Day (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) prior to the applicable Dividend Payment Date (such average, the &#34;Average Price&#34;). If the five Trading Day period to determine the Average Price ends on or after the relevant Dividend Payment Date (whether because a Scheduled Trading Day is not a Trading Day due to the occurrence of a Market Disruption Event (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) or otherwise), then the Dividend Payment Date will be postponed until the second Business Day after the final Trading Day of such five Trading Day period&#59; provided that no interest or other amounts will accrue as a result of such postponement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No fractional shares of our common stock will be delivered to the holders of the Mandatory Convertible Preferred Stock in payment or partial payment of a dividend. We will instead, to the extent we are legally permitted to do so (including under our credit agreements), pay a cash amount (computed to the nearest cent) to each holder that would otherwise be entitled to receive a fraction of a share of our common stock based on the Average Price with respect to such dividend. In the event that we cannot pay cash in lieu of a fractional share, we will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent a shelf registration statement is required in our reasonable judgment in connection with the issuance of or for resales of shares of our common stock issued as payment of a dividend on the shares of Mandatory Convertible Preferred Stock, including dividends paid in connection with a conversion, we will, to the extent such a shelf registration statement is not currently filed and effective, use our commercially reasonable efforts to file and maintain the effectiveness of such a shelf registration statement until the earlier of such time as all such shares of common stock have been resold thereunder and such time as all such shares are freely tradable without registration by holders thereof that are not, and have not been within the three months preceding, &#34;affiliates&#34; of ours for purposes of the Securities Act.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent applicable, we will use our commercially reasonable efforts to have the shares of our common stock approved for listing on NYSE (or if our common stock is not listed on NYSE, on the principal other U.S. national or regional securities exchange on which our common stock is then listed), and qualified or registered under applicable state securities laws, if required&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that we will not be required to qualify as a foreign corporation or to take any action that would subject us to general service of process in any such jurisdiction where we are not presently qualified or where we are not presently subject to taxation as a foreign corporation and such qualification or action would subject us to such taxation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Notwithstanding the foregoing, in no event will the number of shares of our common stock to be delivered in connection with any declared dividend, including any declared dividend payable in connection with a conversion, exceed a number equal to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the declared dividend, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">$11.9875, which amount represents approximately 35% of the Initial Price (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;), subject to adjustment in a manner inversely proportional to any anti-dilution adjustment to each Fixed Conversion Rate as set forth below in &#34;&#8212;Anti-Dilution Adjustments&#34; (such dollar amount, the &#34;Floor Price&#34;).</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent that the amount of any declared dividend exceeds the product of (x) the number of shares of our common stock delivered in connection with such declared dividend and (y) 97% of the Average Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness, notwithstanding any notice by us to the contrary, pay such excess amount in cash (computed to the nearest cent). Any such payment in cash may not be permitted by our then existing debt instruments and is not permitted under our existing credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34; To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in respect of such amount, and such amount will not form a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dividend Stopper</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as any share of Mandatory Convertible Preferred Stock remains outstanding, no dividend or distribution shall be declared or paid on our common stock or any other class or series of Junior Stock, and no common stock or any other class or series of Junior Stock or Parity Stock shall be, directly or indirectly, purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid in full in cash, shares of our common stock or a combination thereof, or a sufficient sum of cash or number of shares of our common stock has been set apart for the payment of such dividends upon, all outstanding shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The foregoing limitation shall not apply to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any dividend or distribution payable in shares of common stock or other Junior Stock, together with cash in lieu of any fractional share&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">purchases, redemptions or other acquisitions of common stock, other Junior Stock or Parity Stock in connection with the administration of any benefit or other incentive plan, including any employment contract, in the ordinary course of business (including purchases to offset the Share Dilution Amount pursuant to a publicly announced repurchase plan, or acquisitions of shares of common stock surrendered, deemed surrendered or withheld in connection with the exercise of stock options or the vesting of restricted stock or restricted stock units)&#59; provided that the number of shares purchased to offset the Share Dilution Amount shall in no event exceed the Share Dilution Amount&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">purchases of common stock or other Junior Stock pursuant to a contractually binding agreement to buy such securities that existed prior to the date of this prospectus supplement&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any dividends or distributions of rights in connection with a stockholders' rights plan or any redemption or repurchase of rights pursuant to any stockholders' rights plan&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the exchange or conversion of Junior Stock for or into other Junior Stock or of Parity Stock for or into other Parity Stock (with the same or lesser aggregate liquidation preference) or Junior Stock and, in each case, the payment of cash solely in lieu of fractional shares&#59; and</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the deemed purchase or acquisition of fractional interests in shares of our common stock, other Junior Stock or Parity Stock pursuant to the conversion or exchange provisions of such shares or the security being converted or exchanged.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The phrase &#34;Share Dilution Amount&#34; means the increase in the number of diluted shares of our common stock outstanding (determined in accordance with accounting principles generally accepted in the United States of America, and as measured from the Initial Issue Date) resulting from the grant, vesting or exercise of equity-based compensation to directors, employees and agents and equitably adjusted for any stock split, stock dividend, reverse stock split, reclassification or similar transaction.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        When dividends on shares of the Mandatory Convertible Preferred Stock (i) have not been declared and paid in full on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from such Dividend Payment Dates, on a dividend payment date falling within a regular dividend period related to such Dividend Payment Date), or (ii) have been declared but a sum of cash or number of shares of our common stock sufficient for payment thereof has not been set aside for the benefit of the holders thereof on the applicable Regular Record Date, no dividends may be declared or paid on any shares of Parity Stock unless dividends are declared on the shares of Mandatory Convertible Preferred Stock such that the respective amounts of such dividends declared on the shares of Mandatory Convertible Preferred Stock and such shares of Parity Stock shall be allocated pro rata among the holders of the shares of Mandatory Convertible Preferred Stock and the holders of any shares of Parity Stock then outstanding. For purposes of calculating the pro rata allocation of partial dividend payments, the Company shall allocate those payments so that the respective amounts of those payments for the declared dividend bear the same ratio to each other as all accumulated and unpaid dividends per share on the shares of Mandatory Convertible Preferred Stock and all declared and unpaid dividends per share on such shares of Parity Stock bear to each other (subject to their having been declared by our board of directors, or an authorized committee thereof, out of legally available funds)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any unpaid dividends on the Mandatory Convertible Preferred Stock will continue to accumulate except as described herein. For purposes of this calculation, with respect to non-cumulative Parity Stock, we will use the full amount of dividends that would be payable for the most recent dividend period if dividends were declared in full on such non-cumulative Parity Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to the foregoing, and not otherwise, such dividends as may be determined by our board of directors, or an authorized committee thereof, may be declared and paid (payable in cash or other property or securities) on any securities, including our common stock and other Junior Stock, from time to time out of any funds legally available for such payment, and holders of the Mandatory Convertible Preferred Stock shall not be entitled to participate in any such dividends.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Redemption</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock will not be redeemable. However, at our option, we may purchase or exchange the Mandatory Convertible Preferred Stock from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidation Preference</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event of our voluntary or involuntary liquidation, winding-up or dissolution, each holder of the Mandatory Convertible Preferred Stock will be entitled to receive a Liquidation Preference in the amount of $100.00 per share of the Mandatory Convertible Preferred Stock (the &#34;Liquidation Preference&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> an amount (the &#34;Liquidation Dividend Amount&#34;) equal to accumulated and unpaid dividends on such shares, </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">whether or not declared, to, but excluding, the date fixed for liquidation, winding-up or dissolution to be paid out of our assets legally available for distribution to our stockholders, after satisfaction of debt and other liabilities owed to our creditors and holders of shares of any Senior Stock and before any payment or distribution is made to holders of Junior Stock (including our common stock). If, upon our voluntary or involuntary liquidation, winding-up or dissolution, the amounts payable with respect to (1) the Liquidation Preference plus the Liquidation Dividend Amount on the shares of Mandatory Convertible Preferred Stock and (2) the liquidation preference of, and the amount of accumulated and unpaid dividends (to, but excluding, the date fixed for liquidation, winding-up or dissolution) on, all Parity Stock are not paid in full, the holders of the Mandatory Convertible Preferred Stock and all holders of any such Parity Stock will share equally and ratably in any distribution of our assets in proportion to their respective liquidation preferences and amounts equal to accumulated and unpaid dividends to which they are entitled. After payment of the full amount of the Liquidation Preference and the Liquidation Dividend Amount on the shares of Mandatory Convertible Preferred Stock, the holders of the Mandatory Convertible Preferred Stock will have no right or claim to any of our remaining assets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Neither the sale, lease nor exchange of all or substantially all of our assets or business (other than in connection with our liquidation, winding-up or dissolution), nor our merger or consolidation into or with any other person, will be deemed to be our voluntary or involuntary liquidation, winding-up or dissolution.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our Charter, including the Certificate of Designations for the Mandatory Convertible Preferred Stock, will not contain any provision requiring funds to be set aside to protect the Liquidation Preference of the Mandatory Convertible Preferred Stock even though it is substantially in excess of the par value thereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Voting Rights</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The holders of the Mandatory Convertible Preferred Stock will not have voting rights other than those described below, except as specifically required by Delaware law or by our Charter from time to time.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Whenever dividends on any shares of the Mandatory Convertible Preferred Stock have not been declared and paid for the equivalent of six or more dividend periods (including, for the avoidance of doubt, the dividend period commenced on, and included, the Initial Issue Date and ended on, but excluded, September 1, 2020), whether or not for consecutive dividend periods (a &#34;Nonpayment&#34;), the authorized number of directors on our board of directors will, at the next annual meeting of stockholders or at a special meeting of stockholders as provided below, automatically be increased by two and the holders of such shares of the Mandatory Convertible Preferred Stock, voting together as a single class with holders of any and all other series of Voting Preferred Stock (as defined below) then outstanding, will be entitled, at our next annual meeting of stockholders or at a special meeting of stockholders as provided below, to vote for the election of a total of two additional members of our board of directors (the &#34;Preferred Stock Directors&#34;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the election of any such Preferred Stock Directors will not cause us to violate the corporate governance requirements of NYSE (or any other exchange or automated quotation system on which our securities may be listed or quoted) that requires listed or quoted companies to have a majority of independent directors&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that our board of directors shall, at no time, include more than two Preferred Stock Directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event of a Nonpayment, the holders of at least 25% of the shares of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock may request that a special meeting of </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">stockholders be called to elect such Preferred Stock Directors (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if our next annual or a special meeting of stockholders is scheduled to be held within 90 days of the receipt of such request, the election of such Preferred Stock Directors will be included in the agenda for, and will be held at, such scheduled annual or special meeting of stockholders). The Preferred Stock Directors will stand for reelection annually, at each subsequent annual meeting of the stockholders, so long as the holders of the Mandatory Convertible Preferred Stock continue to have such voting rights.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        At any meeting at which the holders of the Mandatory Convertible Preferred Stock are entitled to elect Preferred Stock Directors, the holders of a majority of the then outstanding shares of the Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock, present in person or represented by proxy, will constitute a quorum and the vote of the holders of a majority of such shares of the Mandatory Convertible Preferred Stock and other Voting Preferred Stock so present or represented by proxy at any such meeting at which there shall be a quorum shall be sufficient to elect the Preferred Stock Directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        As used in this prospectus supplement, &#34;Voting Preferred Stock&#34; means any other class or series of our preferred stock, ranking equally with the Mandatory Convertible Preferred Stock as to dividends and to the distribution of assets upon liquidation, dissolution or winding-up and upon which like voting rights for the election of directors have been conferred and are exercisable. Whether a plurality, majority or other portion in voting power of the Mandatory Convertible Preferred Stock and any other Voting Preferred Stock have been voted in favor of any matter shall be determined by reference to the respective liquidation preference amounts of the Mandatory Convertible Preferred Stock and such other Voting Preferred Stock voted.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If and when all accumulated and unpaid dividends on the Mandatory Convertible Preferred Stock have been paid in full, or declared and a sum or number of shares of our common stock sufficient for such payment shall have been set aside for the benefit of the holders thereof (a &#34;Nonpayment Remedy&#34;), the holders of the Mandatory Convertible Preferred Stock shall immediately and, without any further action by us, be divested of the foregoing voting rights, subject to the revesting of such rights in the event of each subsequent Nonpayment. If such voting rights for the holders of the Mandatory Convertible Preferred Stock and all other holders of Voting Preferred Stock have terminated, the term of office of each Preferred Stock Director so elected will terminate at such time and the authorized number of directors on our board of directors shall automatically decrease by two.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any Preferred Stock Director may be removed at any time, with or without cause, by the holders of record of a majority in voting power of the outstanding shares of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock then outstanding (voting together as a single class) when they have the voting rights described above. In the event that a Nonpayment shall have occurred and there shall not have been a Nonpayment Remedy, any vacancy in the office of a Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment) may be filled by the written consent of the Preferred Stock Director remaining in office, except in the event that such vacancy is created as a result of such Preferred Stock Director being removed or if no Preferred Stock Director remains in office, such vacancy may be filled by a vote of the holders of record of a majority in voting power of the outstanding shares of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock then outstanding (voting together as a single class) when they have the voting rights described above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the election of any such Preferred Stock Directors to fill such vacancy will not cause us to violate the corporate governance requirements of NYSE (or any other exchange or automated quotation system on which our securities may be listed or quoted) that requires </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">listed or quoted companies to have a majority of independent directors. The Preferred Stock Directors will each be entitled to one vote per director on any matter that comes before our board of directors for a vote.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as any shares of Mandatory Convertible Preferred Stock remain outstanding, we will not, without the affirmative vote or consent of the holders of at least two-thirds in voting power of the outstanding shares of Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a single class, given in person or by proxy, either in writing or at an annual or special meeting of such stockholders&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">amend or alter the provisions of our Charter so as to authorize or create, or increase the authorized number of, any class or series of Senior Stock&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">amend, alter or repeal any provision of our Charter or the Certificate of Designations so as to adversely affect the special rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">consummate a binding share exchange or reclassification involving the shares of the Mandatory Convertible Preferred Stock or a merger or consolidation of us with another entity, unless in each case&#58; (i) the shares of Mandatory Convertible Preferred Stock remain outstanding and are not amended in any respect or, in the case of any such merger or consolidation with respect to which we are not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent&#59; and (ii) the shares of the Mandatory Convertible Preferred Stock that remain outstanding or such shares of preference securities, as the case may be, have such rights, preferences, privileges and voting powers that, taken as a whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers of the Mandatory Convertible Preferred Stock immediately prior to the consummation of such transaction&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the event that a transaction would trigger voting rights under both the second and the third bullet point above, the third bullet point will govern&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any increase in the number of our authorized but unissued shares of preferred stock&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any increase in the number of authorized or issued shares of Mandatory Convertible Preferred Stock&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the creation and issuance, or an increase in the authorized or issued number, of any class or series of Parity Stock or Junior Stock,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">will be deemed not to adversely affect the rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock and shall not require the affirmative vote or consent of holders of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our Charter and Delaware law permit us, without the approval of any of our stockholders (including any holders of the Mandatory Convertible Preferred Stock), to establish and issue a new series of preferred stock ranking equally with or junior to the Mandatory Convertible Preferred Stock, which may dilute the voting and other interests of holders of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If any amendment, alteration, repeal, binding share exchange, reclassification, merger or consolidation described above would adversely affect the rights, preferences, privileges or voting powers of one or more but not all series of Voting Preferred Stock (including the Mandatory Convertible Preferred Stock for this purpose), then only the series of Voting Preferred Stock the rights, preferences, privileges or voting powers of which are adversely affected and entitled to vote, shall vote as a class in lieu of all other series of Voting Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Without the consent of the holders of the Mandatory Convertible Preferred Stock, so long as such action does not adversely affect the special rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock, we may amend, alter, supplement or repeal any terms of the Mandatory Convertible Preferred Stock for the following purposes&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">to cure any ambiguity, omission or mistake, or to correct or supplement any provision contained in the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock that may be defective or inconsistent with any other provision contained in such Certificate of Designations&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">to make any provision with respect to matters or questions relating to the Mandatory Convertible Preferred Stock that is not inconsistent with the provisions of our Charter or the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In addition, without the consent of the holders of the Mandatory Convertible Preferred Stock, we may amend, alter, supplement or repeal any terms of the Mandatory Convertible Preferred Stock in order to (i) conform the terms thereof to the description of the terms of the Mandatory Convertible Preferred Stock set forth under &#34;Description of Mandatory Convertible Preferred Stock&#34; in the preliminary prospectus supplement for the Mandatory Convertible Preferred Stock, as supplemented and&#47;or amended by any related pricing term sheet or (ii) file a certificate of correction with respect to the Certificate of Designations to the extent permitted by Section 103(f) of the Delaware General Corporation Law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Mandatory Conversion</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Each outstanding share of the Mandatory Convertible Preferred Stock, unless previously converted, will automatically convert on the Mandatory Conversion Date (as defined under &#34;&#8212;Certain Definitions&#34;), into a number of shares of our common stock equal to the conversion rate described below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The &#34;conversion rate&#34;, which is the number of shares of our common stock issuable upon conversion of each share of the Mandatory Convertible Preferred Stock on the Mandatory Conversion Date (excluding any shares of our common stock issued in respect of accrued and unpaid dividends, as described below), will be as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Applicable Market Value (as defined under &#34;&#8212;Certain Definitions&#34;) of our common stock is greater than the Threshold Appreciation Price, which is approximately $41.96, then the conversion rate will be 2.3834 shares of our common stock per share of Mandatory Convertible Preferred Stock (the &#34;Minimum Conversion Rate&#34;)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Applicable Market Value of our common stock is less than or equal to the Threshold Appreciation Price but equal to or greater than the Initial Price, then the conversion rate will be equal to $100.00 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Applicable Market Value of our common stock, rounded to the nearest ten-thousandth of a share&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Applicable Market Value of our common stock is less than the Initial Price, then the conversion rate will be 2.9197 shares of our common stock per share of Mandatory Convertible Preferred Stock (the &#34;Maximum Conversion Rate&#34;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We refer to the Minimum Conversion Rate and the Maximum Conversion Rate collectively as the &#34;Fixed Conversion Rates&#34;. The Fixed Conversion Rates are subject to adjustment as described in &#34;&#8212;Anti-Dilution Adjustments&#34; below. The &#34;Threshold Appreciation Price&#34; is calculated by dividing $100.00 by the Minimum Conversion Rate and represents an approximately 22.50% appreciation over the Initial Price. The &#34;Initial Price&#34; is calculated by dividing $100.00 by the Maximum Conversion Rate and initially equals $34.25, which is the public offering price of our common stock in the Concurrent Offering.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we declare a dividend on the Mandatory Convertible Preferred Stock for the dividend period ending on, but excluding, June 1, 2023, we will pay such dividend to the holders of record as of the immediately preceding Regular Record Date, as described above under &#34;&#8212;Dividends.&#34; If on or prior to June 1, 2023 we have not declared all or any portion of the accumulated and unpaid dividends on the Mandatory Convertible Preferred Stock, the conversion rate will be adjusted so that holders receive an additional number of shares of our common stock equal to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the amount of such accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been declared (the &#34;Mandatory Conversion Additional Conversion Amount&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the greater of (i) the Floor Price and (ii) 97% of the Average Price (calculated using June 1, 2023 as the applicable Dividend Payment Date).</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent that the Mandatory Conversion Additional Conversion Amount exceeds the product of such number of additional shares and 97% of the Average Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness declare and pay such excess amount in cash (computed to the nearest cent) pro rata per share to the holders of the Mandatory Convertible Preferred Stock. Any such payment in cash may not be permitted by our then existing debt instruments and is not permitted under our existing credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34; To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in respect of such amount, and such amount will not form a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the avoidance of doubt, the conversion rate per share of the Mandatory Convertible Preferred Stock will in no event exceed the Maximum Conversion Rate, subject to adjustment as described under &#34;&#8212;Anti-Dilution Adjustments&#34; below and exclusive of any amounts owing in respect of any Mandatory Conversion Additional Conversion Amount or any accrued and unpaid dividends paid at our election in shares of common stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Hypothetical conversion values upon mandatory conversion</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For illustrative purposes only, the following table shows the number of shares of our common stock that a holder of the Mandatory Convertible Preferred Stock would receive upon mandatory conversion of one share of Mandatory Convertible Preferred Stock at various Applicable Market Values for our common </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">stock. The table assumes that there will be no conversion adjustments as described above for any Mandatory Conversion Additional Conversion Amount or as described below in &#34;&#8212;Anti-Dilution Adjustments&#34; and that dividends on the Mandatory Convertible Preferred Stock will be declared and paid in cash (and not in additional shares of our common stock). The actual Applicable Market Value of our common stock may differ from those set forth in the table below. Given an Initial Price of $34.25 and a Threshold Appreciation Price of approximately $41.96, a holder of Mandatory Convertible Preferred Stock would receive on the Mandatory Conversion Date the number of shares of our common stock per share of Mandatory Convertible Preferred Stock set forth below, subject to the provisions described below with respect to any fractional share of our common stock&#58;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Assumed Applicable Market Value of our common stock</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of shares of our common stock to be received upon mandatory conversion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Assumed conversion value (calculated as Applicable Market Value multiplied by the number of shares of our common stock to be received upon mandatory conversion)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$58.39</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.00</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$72.99</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$87.59</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34.25</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8571</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$37.50</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6667</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.96</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.01</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$107.25</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.00</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$119.17</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$131.09</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.00</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$143.00</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Accordingly, assuming that the market price of our common stock on the Mandatory Conversion Date is the same as the Applicable Market Value of our common stock, the aggregate market value of our common stock the holder receives upon mandatory conversion of a share of Mandatory Convertible Preferred Stock (excluding any shares of our common stock the holder receives in respect of accrued and unpaid dividends) will be&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">greater than the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is greater than the Threshold Appreciation Price&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">equal to the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is less than or equal to the Threshold Appreciation Price and greater than or equal to the Initial Price&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">less than the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is less than the Initial Price.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Certain Definitions</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Applicable Market Value&#34; means the Average VWAP per share of our common stock over the Settlement Period.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Settlement Period&#34; means the 20 consecutive Trading Day period commencing on, and including, the 21st Scheduled Trading Day immediately preceding June 1, 2023.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Mandatory Conversion Date&#34; means the second Business Day immediately following the last Trading Day of the Settlement Period. The Mandatory Conversion Date is expected to be June 1, 2023. If the Mandatory Conversion Date occurs after June 1, 2023 (whether because a Scheduled Trading Day during the Settlement Period is not a Trading Day due to the occurrence of a Market Disruption Event or otherwise), no interest or other amounts will accrue as a result of such postponement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A &#34;Trading Day&#34; means a day on which&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">there is no Market Disruption Event&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">trading in our common stock generally occurs on the Relevant Stock Exchange&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if our common stock is not listed or admitted for trading, &#34;Trading Day&#34; means any Business Day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A &#34;Scheduled Trading Day&#34; is any day that is scheduled to be a Trading Day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Market Disruption Event&#34; means&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a failure by the Relevant Stock Exchange to open for trading during its regular trading session&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the occurrence or existence, prior to 1&#58;00 p.m., New York City time, on any Scheduled Trading Day for our common stock, for more than a one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the Relevant Stock Exchange or otherwise) in our common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Relevant Stock Exchange&#34; means NYSE or, if our common stock is not then listed on NYSE, on the principal other U.S. national or regional securities exchange on which our common stock is then listed or, if our common stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which our common stock is then listed or admitted for trading.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;VWAP&#34; per share of our common stock on any Trading Day means the per share volume-weighted average price as displayed on Bloomberg page &#34;BSX &#60;EQUITY&#62; AQR&#34; (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day (or, if such volume-weighted average price is not available, the market value per share of our common stock on such Trading Day as determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for this purpose, which may include any of the underwriters for this offering). The &#34;Average VWAP&#34; per share over a certain period means the arithmetic average of the VWAP per share for each Trading Day in the relevant period.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Early Conversion at the Option of the Holder</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Other than during a Fundamental Change Conversion Period (as defined in &#34;&#8212;Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount&#34;), holders of Mandatory Convertible Preferred Stock will have the right to convert their Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share of Mandatory </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Convertible Preferred Stock), at any time prior to June 1, 2023 (an &#34;Early Conversion&#34;), into shares of our common stock at the Minimum Conversion Rate per share of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If, as of the conversion date (as defined under &#34;&#8212;Conversion Procedures&#8212;Upon Early Conversion or Upon Early Fundamental Change Conversion&#34;) of any Early Conversion (the &#34;Early Conversion Date&#34;), we have not declared all or any portion of the accumulated and unpaid dividends for all full dividend periods ending on or before a Dividend Payment Date prior to such Early Conversion Date, the conversion rate for such Early Conversion will be adjusted so that holders converting their Mandatory Convertible Preferred Stock at such time receive an additional number of shares of our common stock equal to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">such amount of accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been declared for such prior full dividend periods (the &#34;Early Conversion Additional Conversion Amount&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the greater of (i) the Floor Price and (ii) the Average VWAP per share of our common stock over the 20 consecutive Trading Day period (the &#34;Early Conversion Settlement Period&#34;), commencing on, and including, the 21st Scheduled Trading Day immediately preceding the Early Conversion Date (such average VWAP, the &#34;Early Conversion Average Price&#34;).</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent that the Early Conversion Additional Conversion Amount exceeds the product of such number of additional shares and the Early Conversion Average Price, we will not have any obligation to pay the shortfall in cash or deliver shares of our common stock in respect of such shortfall.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Except as described above, upon any Early Conversion of any Mandatory Convertible Preferred Stock, we will make no payment or allowance for unpaid dividends on such shares of the Mandatory Convertible Preferred Stock, unless such Early Conversion Date occurs after the Regular Record Date for a declared dividend and on or prior to the immediately succeeding Dividend Payment Date, in which case such dividend will be paid on such Dividend Payment Date to the holder of record of the converted shares of the Mandatory Convertible Preferred Stock as of such Regular Record Date, as described under &#34;&#8212;Dividends.&#34;</font></div><div><font><br></font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount</font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If a &#34;Fundamental Change&#34; (as defined below) occurs on or prior to June 1, 2023, holders of Mandatory Convertible Preferred Stock will have the right (the &#34;Fundamental Change Conversion Right&#34;) during the Fundamental Change Conversion Period (as defined below) to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) convert their share of Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share of Mandatory Convertible Preferred Stock), into a number of shares of our common stock (or Units of Exchange Property as described below) at the conversion rate specified in the table below (the &#34;Fundamental Change Conversion Rate&#34;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) with respect to such converted shares, receive a Fundamental Change Dividend Make-Whole Amount (as defined below) payable in cash or shares of our common stock&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii) with respect to such converted shares, receive the Accumulated Dividend Amount (as defined below) payable in cash or shares of our common stock,</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">subject, in the case of clauses (ii) and (iii), to certain limitations with respect to the number of shares of our common stock that we will be required to deliver, all as described below. Notwithstanding clauses (ii) and (iii) above, if the Fundamental Change Effective Date (as defined below) or the Fundamental Change Conversion Date (as defined below) falls after the Regular Record Date for a dividend period for which we have declared a dividend and prior to the next Dividend Payment Date, then we will pay such dividend on the relevant Dividend Payment Date to the holders of record on such Regular Record Date, as described under &#34;&#8212;Dividends,&#34; and the Accumulated Dividend Amount will not include the amount of such dividend, and the Fundamental Change Dividend Make-Whole Amount will not include the present value of the payment of such dividend.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To exercise the Fundamental Change Conversion Right, a holder must submit its shares of Mandatory Convertible Preferred Stock for conversion at any time during the period (the &#34;Fundamental Change Conversion Period&#34;) commencing on, and including, the Fundamental Change Effective Date and ending at the close of business on the date that is 20 calendar days after the Fundamental Change Effective Date (or, if later, the date that is 20 calendar days after the date of notice of such Fundamental Change), but in no event later than June 1, 2023. Holders of the Mandatory Convertible Preferred Stock that submit the shares for conversion during the Fundamental Change Conversion Period shall be deemed to have exercised their Fundamental Change Conversion Right. Holders of the Mandatory Convertible Preferred Stock who do not submit their shares for conversion during the Fundamental Change Conversion Period will not be entitled to convert their Mandatory Convertible Preferred Stock at the relevant Fundamental Change Conversion Rate or to receive the relevant Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount. A conversion date occurring during such Fundamental Change Conversion Period is referred to herein as a &#34;Fundamental Change Conversion Date.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will notify holders of the Fundamental Change Effective Date no later than the second Business Day immediately following such Fundamental Change Effective Date. If we notify holders of a Fundamental Change later than the second Business Day following the Fundamental Change Effective Date, the Fundamental Change Conversion Period will be extended by a number of days equal to the number of days from, and including, such Fundamental Change Effective Date to, but excluding, the date of the notice&#59; provided, however, that the Fundamental Change Conversion Period will not be extended beyond June 1, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A &#34;Fundamental Change&#34; will be deemed to have occurred, at any time after the Initial Issue Date of the Mandatory Convertible Preferred Stock, if any of the following occurs&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) any &#34;person&#34; or &#34;group&#34; (as such terms are used for purposes of Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the &#34;Exchange Act&#34;), whether or not applicable), other than us, any of our wholly-owned subsidiaries or any of our or our wholly-owned subsidiaries' employee benefit plans, filing a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the &#34;beneficial owner&#34; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 50% of the total voting power in the aggregate of all classes of capital stock then outstanding entitled to vote generally in elections of our directors&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) the consummation of (A) any recapitalization, reclassification or change of our common stock (other than changes resulting from a subdivision or combination or change in par value) as a result </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of which our common stock would be converted into, or exchanged for, stock, other securities, other property or assets (including cash or a combination thereof)&#59; (B) any consolidation, merger or other combination of us or binding share exchange pursuant to which our common stock will be converted into, or exchanged for, stock, other securities or other property or assets (including cash or a combination thereof)&#59; or (C) any sale, lease or other transfer or disposition in one transaction or a series of transactions of all or substantially all of the consolidated assets of ours and our subsidiaries taken as a whole, to any person other than one or more of our wholly-owned subsidiaries&#59; or</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii) our common stock (or other Exchange Property (as defined below)) ceases to be listed or quoted for trading on any of NYSE, the NASDAQ Global Select Market or the NASDAQ Global Market (or another U.S. national securities exchange or any of their respective successors).</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        However, a transaction or transactions described in clause (i) or clause (ii) above will not constitute a Fundamental Change if at least 90% of the consideration received or to be received by our common stockholders, excluding cash payments for fractional shares or pursuant to statutory appraisal rights, in connection with such transaction or transactions consists of shares of common stock that are listed or quoted on any of NYSE, the NASDAQ Global Select Market or the NASDAQ Global Market (or any of their respective successors) or will be so listed or quoted when issued or exchanged in connection with such transaction or transactions and as a result of such transaction or transactions such consideration (excluding cash payments for fractional shares or pursuant to statutory appraisal rights) becomes the Exchange Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fundamental Change Conversion Rate</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Fundamental Change Conversion Rate will be determined by reference to the table below and is based on the effective date of such Fundamental Change (the &#34;Fundamental Change Effective Date&#34;), and the price (the &#34;Fundamental Change Share Price&#34;) paid or deemed paid per share of our common stock in such Fundamental Change. If the holders of our common stock receive only cash in such Fundamental Change, the Fundamental Change Share Price shall be the cash amount paid per share of common stock. Otherwise, the Fundamental Change Share Price shall be the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Fundamental Change Effective Date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Fundamental Change Share Prices set forth in the first row of the table below (i.e., the column headers) will be adjusted as of any date on which the Fixed Conversion Rates of the Mandatory Convertible Preferred Stock are adjusted. The adjusted Fundamental Change Share Prices will equal (i) the Fundamental Change Share Prices applicable immediately prior to such adjustment, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) a fraction, the numerator of which is the Minimum Conversion Rate immediately prior to the adjustment giving rise to the Fundamental Change Share Price adjustment and the denominator of which is the Minimum Conversion Rate as so adjusted. Each of the Fundamental Change Conversion Rates in the table below will be subject to adjustment in the same manner and at the same time as each Fixed Conversion Rate as set forth in &#34;&#8212;Anti-Dilution Adjustments&#34;.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The following table sets forth the Fundamental Change Conversion Rate per share of Mandatory Convertible Preferred Stock for each Fundamental Change Share Price and Fundamental Change Effective Date set forth below.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.326%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Fundamental Change Effective Date</font></div></td><td colspan="87" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Fundamental Change Share Price</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$10.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$15.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$20.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$25.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$30.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$34.25</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$37.50</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$40.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$41.96</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$45.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$50.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$55.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$60.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$75.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 27, 2020</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8542</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7933</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7095</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6255</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5532</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5037</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4729</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4529</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4394</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4214</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3988</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3828</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3715</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3544</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3477</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8856</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8539</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7863</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6998</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6145</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5520</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5122</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4863</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4687</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4455</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4169</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3973</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3842</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3660</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3601</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2022</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9050</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9007</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8724</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8033</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7052</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6193</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5610</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5225</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4965</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4633</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4248</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4014</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3878</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3739</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3716</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6667</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The exact Fundamental Change Share Price and Fundamental Change Effective Date may not be set forth in the table, in which case&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Fundamental Change Share Price is between two Fundamental Change Share Price amounts in the table or the Fundamental Change Effective Date is between two Fundamental Change Effective Dates in the table, the Fundamental Change Conversion Rate will be determined by a straight-line interpolation between the Fundamental Change Conversion Rates set forth for the higher and lower Fundamental Change Share Price amounts and the earlier and later Fundamental Change Effective Dates, as applicable, based on a 365- or 366-day year, as applicable&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Fundamental Change Share Price is in excess of $100.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Minimum Conversion Rate&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Fundamental Change Share Price is less than $10.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Maximum Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fundamental Change Dividend Make-Whole Amount and Accumulated Dividend Amount</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For any shares of Mandatory Convertible Preferred Stock that are converted during the Fundamental Change Conversion Period, in addition to the common stock issued upon conversion at the Fundamental Change Conversion Rate, we will, at our option (subject to satisfaction of the requirements described below)&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;pay in cash (computed to the nearest cent), to the extent we are able to do so under applicable law and in compliance with our indebtedness, an amount equal to the present value, calculated using a discount rate of 5.00% per annum, of all dividend payments (excluding any Accumulated Dividend Amount) on the Mandatory Convertible Preferred Stock for (i) the partial dividend period, if any, from, and including, the Fundamental Change Effective Date to, but excluding, the next Dividend Payment Date and (ii) all remaining full dividend periods from, and including, the Dividend Payment Date following the Fundamental Change Effective Date to, but excluding, the Mandatory Conversion Date (the &#34;Fundamental Change Dividend Make-Whole Amount&#34;)&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;increase the number of shares of our common stock (or Units of Exchange Property as described below) to be issued upon conversion by a number equal to (x) the Fundamental </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Change Dividend Make-Whole Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (y) the greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price&#59; or</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;pay the Fundamental Change Dividend Make-Whole Amount through any combination of cash and shares of our common stock (or Units of Exchange Property as described below) in accordance with the provisions of clauses (a) and (b) above.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        As used herein, the term &#34;Accumulated Dividend Amount&#34; means, with respect to any Fundamental Change, the aggregate amount of accumulated and unpaid dividends, if any, that have not been declared for dividend periods prior to the relevant Fundamental Change Effective Date, including (but subject to the second sentence under &#34;&#8212;General&#34; above) for the partial dividend period, if any, from, and including, the Dividend Payment Date immediately preceding such Fundamental Change Effective Date to, but excluding, such Fundamental Change Effective Date. For the avoidance of doubt, if the Regular Record Date for a dividend period for which we have, as of the Fundamental Change Effective Date, declared a dividend occurs before or during the related Fundamental Change Conversion Period, then we will pay such dividend on the relevant Dividend Payment Date to the holders of record at the Close of Business on such Regular Record Date, as described under &#34;&#8212;Dividends,&#34; and the Accumulated Dividend Amount will not include the amount of such dividend, and the Fundamental Change Dividend Make-Whole Amount will not include the present value of such dividend.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Accumulated Dividend Amount will be payable at our option (subject to satisfaction of the requirements described below)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">in cash (computed to the nearest cent), to the extent we are able to do so under applicable law and in compliance with our indebtedness&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">in an additional number of shares of our common stock (or Units of Exchange Property as described below) equal to (x) the Accumulated Dividend Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (y) the greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">through any combination of cash and shares of our common stock (or Units of Exchange Property) in accordance with the provisions of the preceding two bullets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will pay the Fundamental Change Dividend Make-Whole Amount and the Accumulated Dividend Amount in cash, except to the extent we elect on or prior to the second Business Day following the Fundamental Change Effective Date to make all or any portion of such payments in shares of our common stock (or Units of Exchange Property). For the avoidance of doubt, however, our existing credit agreements currently contain a restriction on our ability to pay such amounts in cash. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we elect to deliver common stock (or Units of Exchange Property) in respect of all or any portion of the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount, to the extent that the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount or the dollar amount of any portion thereof paid in common stock (or Units of Exchange Property) exceeds the product of (x) the number of additional shares we deliver in respect thereof and (y) 97% of the Fundamental Change Share Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness, pay such excess amount in cash (computed to the nearest cent). Any such payment in cash may not be permitted by our then existing debt instruments and is not permitted under our existing credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">our Credit Facilities.&#34; To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in respect of such amount.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        However, if we are prohibited from paying or delivering, as the case may be, the Fundamental Change Dividend Make-Whole Amount (whether in cash or in shares of our common stock), in whole or in part, due to limitations of applicable law, then the Fundamental Change Conversion Rate will instead be increased by a number of shares of common stock equal to the cash amount of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price. To the extent that the cash amount of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount exceeds the product of such number of additional shares and 97% of the Fundamental Change Share Price, we will not have any obligation to pay the shortfall in cash or deliver additional shares of our common stock in respect of such amount.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No fractional shares of our common stock (or to the extent applicable, Units of Exchange Property) will be delivered to converting holders of the Mandatory Convertible Preferred Stock in respect of the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount. We will instead, to the extent we are able to do so under applicable law and in compliance with our indebtedness, pay a cash amount (computed to the nearest cent) to each converting holder that would otherwise be entitled to receive a fraction of a share of our common stock (or to the extent applicable, Units of Exchange Property) based on the Average VWAP per share of our common stock (or to the extent applicable, Units of Exchange Property) over the five consecutive Trading Day period commencing on, and including, the seventh Scheduled Trading Day immediately preceding the Fundamental Change Conversion Date. In the event that we cannot pay cash in lieu of a fractional share, we will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34; Not later than the second Business Day following the Fundamental Change Effective Date, we will notify holders of&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Fundamental Change Conversion Rate (if we provide notice to holders prior to the anticipated Fundamental Change Effective Date, specifying how the Fundamental Change Conversion Rate will be determined)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Fundamental Change Dividend Make-Whole Amount and whether we will pay such amount in cash, shares of our common stock (or to the extent applicable, Units of Exchange Property) or a combination thereof, specifying the combination, if applicable&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Accumulated Dividend Amount as of the Fundamental Change Effective Date and whether we will pay such amount in cash, shares of our common stock (or to the extent applicable, Units of Exchange Property) or a combination thereof, specifying the combination, if applicable.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our obligation to deliver shares at the Fundamental Change Conversion Rate in connection with a Fundamental Change and pay the Fundamental Change Dividend Make-Whole Amount (whether in cash, our common stock or any combination thereof) could be considered a penalty under state law, in which case the enforceability thereof would be subject to general principles of reasonableness of economic remedies and therefore may not be enforceable in whole or in part.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conversion Procedures</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Upon Mandatory Conversion</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any outstanding shares of Mandatory Convertible Preferred Stock will mandatorily and automatically convert into shares of common stock on the Mandatory Conversion Date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The holders of the Mandatory Convertible Preferred Stock will not be required to pay any transfer or similar taxes or duties relating to the issuance or delivery of our common stock upon conversion, but each holder will be required to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of the common stock in a name other than such holder&#8217;s own.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as the shares of the Mandatory Convertible Preferred Stock being converted are in global form, the shares of common stock issuable upon conversion will be delivered to the converting holder through the facilities of DTC, in each case together with delivery by us to the converting holder of any cash to which the converting holder is entitled, only after all applicable taxes and duties, if any, payable by such holder have been paid in full, and such shares and cash will be delivered on the later of (i) the Mandatory Conversion Date and (ii) the Business Day after such holder has paid in full all applicable taxes and duties, if any.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The person or persons entitled to receive the shares of our common stock issuable upon mandatory conversion of the Mandatory Convertible Preferred Stock will be treated as the record holder(s) of such shares as of the close of business on the Mandatory Conversion Date. Prior to the close of business on the Mandatory Conversion Date, the common stock issuable upon conversion of the Mandatory Convertible Preferred Stock on the Mandatory Conversion Date will not be deemed to be outstanding for any purpose and such holder will have no rights, powers or preferences with respect to such common stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the common stock, by virtue of holding the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Upon Early Conversion or Upon Early Fundamental Change Conversion</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If a holder elects to convert the Mandatory Convertible Preferred Stock prior to the Mandatory Conversion Date, in the manner described in &#34;&#8212;Early Conversion at the Option of the Holder&#34; or &#34;&#8212;Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount&#34; (an &#34;Early Fundamental Change Conversion&#34;), the holder must observe the following conversion procedures&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if such holder holds a beneficial interest in a global share of Mandatory Convertible Preferred Stock, such holder must deliver to DTC the appropriate instruction form for conversion pursuant to DTC's conversion program&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if such holder holds shares of the Mandatory Convertible Preferred Stock in certificated form, such holder must comply with certain procedures set forth in the Certificate of Designations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In either case, if required, the holder must pay all transfer or similar taxes or duties, if any.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The &#34;conversion date&#34; will be the date on which the holder has satisfied the foregoing requirements with respect to an Early Conversion or an Early Fundamental Change Conversion.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The holders will not be required to pay any transfer or similar taxes or duties relating to the issuance or delivery of our common stock upon conversion, but each holder will be required to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of the common stock in a name other than such holder&#8217;s own.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as the shares of the Mandatory Convertible Preferred Stock being converted are in global form, the shares of common stock will be issued and delivered to the converting holder through the facilities of DTC, together with delivery by us to the converting holder of any cash to which the converting holder is entitled, only after all applicable taxes and duties, if any, payable by the converting holder have been paid in full, and such shares and cash will be delivered on the latest of (i) the second Business Day immediately succeeding the conversion date, (ii) the second Business Day immediately succeeding the last day of the Early Conversion Settlement Period, if applicable, and (iii) the Business Day after the converting holder has paid in full all applicable taxes and duties, if any.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The person or persons entitled to receive the common stock issuable upon early conversion of the Mandatory Convertible Preferred Stock will be treated as the record holder(s) of such shares as of the close of business on the applicable Early Conversion Date or Fundamental Change Conversion Date. Prior to the close of business on the applicable Early Conversion Date or Fundamental Change Conversion Date, the common stock issuable upon conversion of the Mandatory Convertible Preferred Stock will not be deemed to be outstanding for any purpose, and the holder will have no rights, powers or preferences with respect to such common stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the common stock, by virtue of holding the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fractional Shares</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No fractional shares of our common stock will be issued to holders of the Mandatory Convertible Preferred Stock upon conversion. In lieu of any fractional shares of our common stock otherwise issuable in respect of the aggregate number of shares of the Mandatory Convertible Preferred Stock of any holder that are converted, that holder will be entitled to receive an amount in cash (computed to the nearest cent) equal to the product of&#58; (i) that same fraction&#59; and (ii) the Average VWAP of our common stock over the five consecutive Trading Day period commencing on, and including, the seventh Scheduled Trading Day immediately preceding the relevant conversion date. In the event that we cannot pay cash in lieu of a fractional share, we will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to any applicable rules and procedures of DTC, if more than one share of the Mandatory Convertible Preferred Stock is surrendered for conversion at one time by or for the same holder, the number of shares of full shares of our common stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of the Mandatory Convertible Preferred Stock so surrendered.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Anti-Dilution Adjustments</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Each Fixed Conversion Rate will be adjusted as described below, except that we will not make any adjustments to the Fixed Conversion Rates if holders of the Mandatory Convertible Preferred Stock participate (other than in the case of a share split or share combination), at the same time and upon the same terms as holders of our common stock and solely as a result of holding the Mandatory Convertible </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Preferred Stock, in any of the transactions described below without having to convert their Mandatory Convertible Preferred Stock as if they held a number of shares of common stock equal to (i) the Maximum Conversion Rate as of the record date for such transaction, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) the number of shares of Mandatory Convertible Preferred Stock held by such holder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we exclusively issue shares of our common stock as a dividend or distribution on shares of our common stock, or if we effect a share split or share combination, each Fixed Conversion Rate will be adjusted based on the following formula&#58;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k.jpg" src="mcps202010-k.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:256px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date (as defined below) of such dividend or distribution, or immediately prior to the open of business on the effective date of such share split or share combination, as applicable&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on such record date or immediately after the open of business on such effective date, as applicable&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS0 &#61; the number of shares of our common stock outstanding immediately prior to the close of business on such record date or immediately prior to the open of business on such effective date, as applicable, before giving effect to such dividend, distribution, share split or share combination&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS1 &#61; the number of shares of our common stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any adjustment made under this clause (1) shall become effective immediately after the close of business on the record date for such dividend or distribution, or immediately after the open of business on the effective date for such share split or share combination, as applicable. If any dividend or distribution of the type described in this clause (1) is declared but not so paid or made, each Fixed Conversion Rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared. For the purposes of this clause (1), the number of shares of our common stock outstanding immediately prior to the close of business on the record date and the number of shares of our common stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination shall, in each case, not include shares that we hold in treasury. We will not pay any dividend or make any distribution on shares of our common stock that we hold in treasury.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;effective date&#34; as used in this clause (1) means the first date on which the shares of our common stock trade on the Relevant Stock Exchange, regular way, reflecting the relevant share split or share combination, as applicable.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;record date&#34; means, with respect to any dividend, distribution or other transaction or event in which the holders of our common stock (or other applicable security) have the right to receive any cash, </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">securities or other property or in which our common stock (or such other security) is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of our common stock (or such other security) entitled to receive such cash, securities or other property (whether such date is fixed by our board of directors or a duly authorized committee thereof, statute, contract or otherwise).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we issue to all or substantially all holders of our common stock any rights, options or warrants entitling them, for a period of not more than 60 calendar days after the announcement date of such issuance, to subscribe for or purchase shares of our common stock at a price per share that is less than the Average VWAP per share of our common stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:center"><img alt="mcps202010-k2.jpg" src="mcps202010-k2.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:258px"></div><div style="margin-bottom:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such issuance&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on such record date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS0 &#61; the number of shares of our common stock outstanding immediately prior to the close of business on such record date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">X &#61; the total number of shares of our common stock issuable pursuant to such rights, options or warrants&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Y &#61; the number of shares of our common stock equal to (i) the aggregate price payable to exercise such rights, options or warrants, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any increase made under this clause (2) will be made successively whenever any such rights, options or warrants are issued and shall become effective immediately after the close of business on the record date for such issuance. To the extent that such rights, options or warrants are not exercised prior to their expiration or shares of common stock are not delivered after the exercise of such rights, options or warrants, each Fixed Conversion Rate shall be decreased to such Fixed Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of common stock actually delivered, if any. If such rights, options or warrants are not so issued, each Fixed Conversion Rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to such Fixed Conversion Rate that would then be in effect if such record date for such issuance had not occurred.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the purpose of this clause (2), in determining whether any rights, options or warrants entitle the holders of our common stock to subscribe for or purchase shares of our common stock at less than such Average VWAP per share for the 10 consecutive trading day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, and in determining the aggregate offering price of such shares of our common stock, there shall be taken into account any consideration received by us for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by our board of directors or a committee thereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        (3)(A) If we distribute shares of our capital stock, evidences of our indebtedness, other assets or property of ours or rights, options or warrants to acquire our capital stock or other securities, to all or substantially all holders of our common stock, excluding&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">dividends, distributions or issuances as to which the provisions set forth in in clause (1) or (2) shall apply&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">dividends or distributions paid exclusively in cash as to which the provisions set forth in clause (4) below shall apply&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any dividends and distributions upon conversion of, or in exchange for, our common stock in connection with a recapitalization, reclassification, change, consolidation, merger or other combination, share exchange, or sale, lease or other transfer or disposition resulting in the change in the conversion consideration as described below under &#34;&#8212;Recapitalizations, Reclassifications and Changes of Our Common Stock&#34;&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">except as otherwise described below, rights issued pursuant to a shareholder rights plan adopted by us&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">spin-offs as to which the provisions set forth below in clause (3)(B) shall apply&#59; then each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k3.jpg" src="mcps202010-k3.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such distribution&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on such record date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SP0 &#61; the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the ex-date (as defined below) for such distribution&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FMV &#61; the fair market value (as determined by our board of directors or a committee thereof) of the shares of capital stock, evidences of indebtedness, assets, property, rights, options or warrants so distributed, expressed as an amount per share of our common stock on the ex-date for such distribution.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;ex-date&#34; means the first date on which the shares of our common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from us or, if applicable, from the seller of our common stock on such exchange or market (in the form of due bills or otherwise) as determined by such exchange or market.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any increase made under this clause (3)(A) above will become effective immediately after the close of business on the record date for such distribution. If such distribution is not so paid or made, each fixed conversion rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to be such fixed conversion rate that would then be in effect if such distribution had not been declared.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Notwithstanding the foregoing, if &#34;FMV&#34; (as defined above) is equal to or greater than &#34;SP0&#34; (as defined above), or if the difference is less than $1.00, in lieu of the foregoing increase, each holder shall receive, in respect of each share of Mandatory Convertible Preferred Stock, at the same time and upon the same terms as holders of our common stock, the amount and kind of our capital stock, evidences of our indebtedness, other assets or property of ours or rights, options or warrants to acquire our capital stock or other securities that such holder would have received if such holder owned a number of shares of common stock equal to the Maximum Conversion Rate in effect on the record date for the distribution.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we issue rights, options or warrants that are only exercisable upon the occurrence of certain triggering events, then&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">we will not adjust the Fixed Conversion Rates pursuant to the foregoing in this clause (3) until the earliest of these triggering events occurs&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">we will readjust the Fixed Conversion Rates to the extent any of these rights, options or warrants are not exercised before they expire&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the rights, options or warrants trade together with our common stock and will be issued in respect of future issuances of the shares of our common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)(B) With respect to an adjustment pursuant to this clause (3) where there has been a payment of a dividend or other distribution on our common stock of shares of capital stock of any class or series, or similar equity interest, of or relating to a subsidiary or other business unit, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange, which we refer to as a &#34;spin-off,&#34; each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k4.jpg" src="mcps202010-k4.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:189px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the open of business on the ex-date for the spin-off&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the open of business on the ex-date for the spin-off&#59;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FMV0 &#61; the Average VWAP per share of the capital stock or similar equity interest distributed to holders of our common stock applicable to one share of our common stock over the 10 consecutive Trading Day period commencing on, and including, the ex-date for the spin-off, or the &#34;valuation period&#34;&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MP0 &#61; the Average VWAP per share of our common stock over the valuation period.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The increase to each Fixed Conversion Rate under the preceding paragraph will be calculated as of the close of business on the last Trading Day of the valuation period but will be given effect as of immediately after the open of business on the ex-date of the spin-off. Because we will make the adjustment to each Fixed Conversion Rate with retroactive effect, we will delay the settlement of any conversion of Mandatory Convertible Preferred Stock where any date for determining the number of shares of our common stock issuable to a holder occurs during the valuation period until the second Business Day after the last date for determining the number of shares of our common stock issuable to a holder with respect to such conversion occurs. If such dividend or distribution is not so paid, each Fixed Conversion Rate shall be decreased, effective as of the date our board of directors or a committee thereof determines not to make or pay such dividend or distribution, to be such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (4)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any cash dividend or distribution is made to all or substantially all holders of our common stock, each Fixed Conversion Rate will be adjusted based on the following formula&#58;</font></div><div><font><br></font></div><div style="text-align:center"><img alt="mcps202010-k5.jpg" src="mcps202010-k5.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:156px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such dividend or distribution&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on the record date for such dividend or distribution&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SP0 &#61; the last reported sale price of our common stock on the Trading Day immediately preceding the ex-date for such dividend or distribution&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C &#61; the amount in cash per share we distribute to all or substantially all holders of our common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any increase made under this clause (4) shall become effective immediately after the close of business on the record date for such dividend or distribution. If such dividend or distribution is not so paid, each Fixed Conversion Rate shall be decreased, effective as of the date our board of directors or a committee thereof determines not to make or pay such dividend or distribution, to be such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The &#34;last reported sale price&#34; of our common stock on any date means&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prices) on such date as reported in composite transactions for the relevant stock exchange (as defined below)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if our common stock is not listed for trading on a relevant stock exchange on such date, the last quoted bid price for our common stock in the over-the-counter market on such date as reported by OTC Markets Group Inc. or a similar organization&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if our common stock is not so quoted, the average of the mid-point of the last bid and ask prices for our common stock on such date from each of at least three nationally recognized independent investment banking firms selected by us for this purpose.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Notwithstanding the foregoing, if &#34;C&#34; (as defined above) is equal to or greater than &#34;SP0&#34; (as defined above), or if the difference is less than $1.00, in lieu of the foregoing increase, each holder shall receive, for each share of Mandatory Convertible Preferred Stock, at the same time and upon the same terms as holders of shares of our common stock, the amount of cash that such holder would have received if such holder owned a number of shares of our common stock equal to the Maximum Conversion Rate on the record date for such cash dividend or distribution.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we or any of our subsidiaries make a payment in respect of a tender or exchange offer for our common stock, to the extent that the cash and value of any other consideration included in the payment per share of common stock exceeds the Average VWAP per share of our common stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer (the &#34;expiration date&#34;), each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k6.jpg" src="mcps202010-k6.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:207px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the expiration date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on the expiration date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AC &#61; the aggregate value of all cash and any other consideration (as determined by our board of directors or a committee thereof) paid or payable for shares purchased in such tender or exchange offer&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS0 &#61; the number of shares of our common stock outstanding immediately prior to the expiration date (prior to giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer)&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS1 &#61; the number of shares of our common stock outstanding immediately after the expiration date (after giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer)&#59; and</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SP1 &#61; the Average VWAP of our common stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the expiration date (the &#34;averaging period&#34;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The increase to each Fixed Conversion Rate under the preceding paragraph will be calculated at the close of business on the last Trading Day of the averaging period but will be given effect as of immediately after the close of business on the expiration date. Because we will make the adjustment to each Fixed Conversion Rate with retroactive effect, we will delay the settlement of any conversion of Mandatory Convertible Preferred Stock where any date for determining the number of shares of our common stock issuable to a holder occurs during the averaging period until the second Business Day after the last date for determining the number of shares of our common stock issuable to a holder with respect to such conversion occurs. For the avoidance of doubt, no adjustment under this clause (5) will be made if such adjustment would result in a decrease in any Fixed Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event that we or one of our subsidiaries is obligated to purchase shares of common stock pursuant to any such tender offer or exchange offer, but we or such subsidiary is permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded, then each Fixed Conversion Rate shall again be adjusted to be such Fixed Conversion Rate that would then be in effect if such tender offer or exchange offer had not been made.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the avoidance of doubt, for purposes of this subsection (5), the term &#34;tender offer&#34; is used as such term is used in the Exchange Act and the term &#34;exchange offer&#34; means an exchange offer that constitutes a tender offer.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We may, to the extent permitted by law and the rules of NYSE or any other securities exchange on which our common stock or the Mandatory Convertible Preferred Stock is then listed, increase each Fixed Conversion Rate by any amount for a period of at least 20 Business Days if such increase is irrevocable during such 20 Business Days and our board of directors (or a committee thereof) determines that such increase would be in our best interest. In addition, we may make such increases in each Fixed Conversion Rate as we deem advisable in order to avoid or diminish any income tax to holders of our common stock resulting from any dividend or distribution of shares of our common stock (or issuance of rights or warrants to acquire shares of our common stock) or from any event treated as such for income tax purposes or for any other reason. We may only make such a discretionary adjustment if we make the same proportionate adjustment to each Fixed Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Holders of the Mandatory Convertible Preferred Stock may, in certain circumstances, including a distribution of cash dividends to holders of our shares of common stock, be deemed to have received a distribution subject to U.S. Federal income tax as a dividend as a result of an adjustment or the nonoccurrence of an adjustment to the Fixed Conversion Rates. See &#34;Material U.S. Federal Income Tax Considerations.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we have a rights plan in effect upon conversion of the Mandatory Convertible Preferred Stock into common stock, each holder will receive, in addition to any shares of common stock received in connection with such conversion, the rights under the rights plan. However, if, prior to any conversion, the rights have separated from the shares of common stock in accordance with the provisions of the applicable rights plan, each Fixed Conversion Rate will be adjusted at the time of separation as if we distributed to all or substantially all holders of our common stock, shares of our capital stock, evidences of indebtedness, assets, property, rights, options or warrants as described in clause (3)(A) above, subject to readjustment in </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the event of the expiration, termination or redemption of such rights. We do not currently have a stockholder rights plan in effect.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Adjustments to the Fixed Conversion Rates will be calculated to the nearest 1&#47;10,000th of a share of our common stock. No adjustment to any Fixed Conversion Rate will be required unless the adjustment would require an increase or decrease of at least 1% of the Fixed Conversion Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if an adjustment is not made because the adjustment does not change the Fixed Conversion Rates by at least 1%, then such adjustment will be carried forward and taken into account in any future adjustment. Notwithstanding the foregoing, on each date for determining the number of shares of our common stock issuable to a holder upon any conversion of the Mandatory Convertible Preferred Stock we will give effect to all adjustments that we have otherwise deferred pursuant to this sentence, and those adjustments will no longer be carried forward and taken into account in any future adjustment.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Fixed Conversion Rates will not be adjusted&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">upon the issuance of any shares of our common stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on our securities and the investment of additional optional amounts in common stock under any plan&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">upon the issuance of any shares of our common stock or rights or warrants to purchase those shares pursuant to any present or future benefit or other incentive plan or program of or assumed by us or any of our subsidiaries&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">upon the issuance of any shares of our common stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in the preceding bullet and outstanding as of the Initial Issue Date&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">for a change in the par value of our common stock&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">for stock repurchases that are not tender offers referred to in clause (5) of the adjustments above, including structured or derivative transactions or pursuant to a stock repurchase program approved by our board of directors&#59; or for accumulated dividends on the Mandatory Convertible Preferred Stock, except as described above under &#34;&#8212;Mandatory Conversion,&#34; &#34;&#8212;Early Conversion at the Option of the Holder&#34; and &#34;&#8212;Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Except as otherwise provided above, we will be responsible for making all calculations called for under the Mandatory Convertible Preferred Stock. These calculations include, but are not limited to, determinations of the Fundamental Change Share Price, the VWAPs, the Average VWAPs, the last reported sale price and the Fixed Conversion Rates of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will be required, within 10 Business Days after the Fixed Conversion Rates are adjusted, to provide or cause to be provided written notice of the adjustment to the holders of the Mandatory Convertible Preferred Stock. We will also be required to deliver a statement setting forth in reasonable detail the method by which the adjustment to each Fixed Conversion Rate was determined and setting forth each adjusted Fixed Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the avoidance of doubt, if an adjustment is made to the Fixed Conversion Rates, no separate inversely proportionate adjustment will be made to the Initial Price or the Threshold Appreciation Price </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">because the Initial Price is equal to $100.00 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Maximum Conversion Rate (as adjusted in the manner described herein) and the Threshold Appreciation Price is equal to $100.00 divided by the Minimum Conversion Rate (as adjusted in the manner described herein).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Whenever the terms of the Mandatory Convertible Preferred Stock require us to calculate the VWAP per share of our common stock over a span of multiple days, our board of directors or an authorized committee thereof will make appropriate adjustments (including, without limitation, to the Applicable Market Value, the Early Conversion Average Price, the Fundamental Change Share Price and the Average Price (as the case may be)) to account for any adjustments to the Fixed Conversion Rates (as the case may be) that become effective, or any event that would require such an adjustment if the ex-date, effective date, record date or expiration date (as the case may be) of such event occurs, during the relevant period used to calculate such prices or values (as the case may be).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the record date for a dividend or distribution on shares of our common stock occurs after the end of the 20 consecutive Trading Day period used for calculating the Applicable Market Value and before the Mandatory Conversion Date&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">that dividend or distribution would have resulted in an adjustment of the number of shares issuable to the holders of the Mandatory Convertible Preferred Stock had such record date occurred on or before the last Trading Day of such 20-Trading Day period,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">then we will deem the holders of the Mandatory Convertible Preferred Stock to be holders of record of our common stock for purposes of that dividend or distribution. In this case, the holders of the Mandatory</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Convertible Preferred Stock would receive the dividend or distribution on our common stock together with the number of shares of our common stock issuable upon mandatory conversion of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recapitalizations, Reclassifications and Changes of Our Common Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event of&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any consolidation or merger of us with or into another person (other than a merger or consolidation in which we are the surviving corporation and in which the shares of our common stock outstanding immediately prior to the merger or consolidation are not exchanged for cash, securities or other property of us or another person)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any sale, transfer, lease or conveyance to another person of all or substantially all of our property and assets&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any reclassification of our common stock into securities, including securities other than our common stock&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any statutory exchange of our securities with another person (other than in connection with a merger or acquisition),</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in each case, as a result of which our common stock would be converted into, or exchanged for, stock, other securities or other property or assets (including cash or any combination thereof) (each, a &#34;Reorganization Event&#34;), each share of the Mandatory Convertible Preferred Stock outstanding immediately prior to such Reorganization Event shall, without the consent of the holders of the Mandatory Convertible Preferred Stock, become convertible into the kind of stock, other securities or other property or assets (including cash or any combination thereof) that such holder would have been entitled to receive if such holder had converted its Mandatory Convertible Preferred Stock into common stock immediately prior to such Reorganization Event (such stock, other securities or other property or assets (including cash or any combination thereof), the &#34;Exchange Property&#34;, with each &#34;Unit of Exchange Property&#34; meaning the kind and amount of Exchange Property that a holder of one share of common stock is entitled to receive).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If the transaction causes our common stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of stockholder election), the Exchange Property into which the Mandatory Convertible Preferred Stock will be convertible will be deemed to be the weighted average of the types and amounts of consideration actually received by the holders of our common stock. We will notify holders of the Mandatory Convertible Preferred Stock of the weighted average as soon as practicable after such determination is made.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The number of Units of Exchange Property we will deliver for each share of the Mandatory Convertible Preferred Stock converted following the effective date of such Reorganization Event will be determined as if references to our common stock in the description of the conversion rate applicable upon mandatory conversion, Early Conversion and Early Fundamental Change Conversion were to Units of Exchange Property (without interest thereon and without any right to dividends or distributions thereon which have a record date prior to the date such Mandatory Convertible Preferred Stock is actually converted). For the purpose of determining which bullet of the definition of conversion rate in the second paragraph under &#34;&#8212;Mandatory Conversion&#34; will apply upon mandatory conversion, and for the purpose of calculating the conversion rate if the second bullet is applicable, the value of a Unit of Exchange Property will be determined in good faith by our board of directors or an authorized committee thereof (which determination will be final), except that if a Unit of Exchange Property includes common stock or American Depositary Receipts, or &#34;ADRs&#34;, that are traded on a U.S. national securities exchange, the value of such common stock or ADRs will be the average over the 20 consecutive Trading Day period used for calculating the Applicable Market Value of the volume-weighted average prices for such common stock or ADRs, as displayed on the applicable Bloomberg screen (as determined in good faith by our board of directors or an authorized committee thereof (which determination will be final))&#59; or, if such price is not available, the average market value per share of such common stock or ADRs over such period as determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for this purpose. The provisions of this paragraph will apply to successive Reorganization Events, and the provisions summarized under &#34;&#8212;Anti-Dilution Adjustments&#34; will apply to any shares of capital stock or ADRs of us or any successor received by the holders of shares of our common stock in any such Reorganization Event.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We (or any successor to us) will, as soon as reasonably practicable (but in any event within 20 calendar days) after the occurrence of any Reorganization Event provide written notice to the holders of the Mandatory Convertible Preferred Stock of such occurrence and of the kind and amount of cash, securities or other property that constitute the Exchange Property. Failure to deliver such notice will not affect the operation of the provisions described in this section.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reservation of Shares</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will at all times reserve and keep available out of the authorized and unissued shares of common stock, solely for issuance upon conversion of the Mandatory Convertible Preferred Stock, the maximum number of shares of our common stock as shall be issuable from time to time upon the conversion of all the shares of the Mandatory Convertible Preferred Stock then outstanding.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Book-Entry, Delivery and Form</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock will be issued in global form. DTC or its nominee will be the sole registered holder of the Mandatory Convertible Preferred Stock. Ownership of beneficial interests in the Mandatory Convertible Preferred Stock in global form will be limited to persons who have accounts with DTC, or &#34;participants&#34;, or persons who hold interests through such participants. Ownership of beneficial interests in the Mandatory Convertible Preferred Stock in global form will be shown on, and the transfer of that ownership will be effected only through, records maintained by DTC or its nominee (with respect to interests of participants) and the records of participants (with respect to interests of persons other than participants).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as DTC, or its nominee, is the registered owner or holder of a global certificate representing the shares of the Mandatory Convertible Preferred Stock, DTC or such nominee, as the case may be, will be considered the sole holder of the shares of the Mandatory Convertible Preferred Stock represented by such global certificate for all purposes under the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock. No beneficial owner of an interest in the shares of the Mandatory Convertible Preferred Stock in global form will be able to transfer that interest except in accordance with the applicable procedures of DTC in addition to those provided for under the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Payments of dividends on the global certificate representing the shares of the Mandatory Convertible Preferred Stock will be made to DTC or its nominee, as the case may be, as the registered holder thereof. None of us, the transfer agent, registrar, conversion or dividend disbursing agent will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in a global certificate representing the shares of the Mandatory Convertible Preferred Stock or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We expect that DTC or its nominee, upon receipt of any payment of dividends in respect of a global certificate representing the shares of the Mandatory Convertible Preferred Stock, will credit participants' accounts with payments in amounts proportionate to their respective beneficial ownership interests in the aggregate Liquidation Preference of such global certificate representing the shares of the Mandatory Convertible Preferred Stock as shown on the records of DTC or its nominee, as the case may be. We also expect that payments by participants to owners of beneficial interests in such global certificate representing the shares of the Mandatory Convertible Preferred Stock held through such participants will be governed by standing instructions and customary practices, as is now the case with securities held for the accounts of customers registered in the names of nominees for such customers. Such payments will be the responsibility of such participants.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Transfers between participants in DTC will be effected in the ordinary way in accordance with DTC rules and will be settled in same-day funds. We understand that DTC is&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a limited purpose trust company organized under the laws of the State of New York&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a &#34;banking organization&#34; within the meaning of New York Banking Law&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a member of the Federal Reserve System&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a &#34;clearing corporation&#34; within the meaning of the Uniform Commercial Code&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a &#34;Clearing Agency&#34; registered pursuant to the provisions of Section 17A of the Exchange Act.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        DTC was created to hold securities for its participants and facilitate the clearance and settlement of securities transactions between participants through electronic book-entry changes in accounts of its participants, thereby eliminating the need for physical movement of certificates. Participants include&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">securities brokers and dealers&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">banks and trust companies&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">clearing corporations and certain other organizations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Indirect access to the DTC system is available to others such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly (indirect participants).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Although DTC is expected to follow the foregoing procedures in order to facilitate transfers of interests in a global security among its participants, it is under no obligation to perform or continue to perform such procedures, and such procedures may be discontinued at any time. None of us, the transfer agent, registrar, conversion or dividend disbursing agent will have any responsibility for the performance by DTC or its participants or indirect participants of their respective obligations under the rules and procedures governing their operations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If DTC is at any time unwilling or unable to continue as a depositary for the shares of the Mandatory Convertible Preferred Stock in global form or DTC ceases to be registered as a clearing agency under the Exchange Act, and in either case a successor depositary is not appointed by us within 90 days, we will issue certificated shares in exchange for the global securities. Holders of an interest in the Mandatory Convertible Preferred Stock in global form may receive certificated shares, at our option, in accordance with the rules and procedures of DTC in addition to those provided for under the Certificate of Designations. Beneficial interests in Mandatory Convertible Preferred Stock in global form held by any direct or indirect participant may also be exchanged for certificated shares upon request to DTC by such direct participant (for itself or on behalf of an indirect participant), to the transfer agent in accordance with their respective customary procedures.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Description of 0.625% Senior Notes due 2027</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description of our 0.625% Senior Notes due 2027 (the &#8220;notes&#8221;) is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to the form of the notes and the indenture, dated as of May 29, 2013 (the &#8220;Indenture&#8221;), between us and U.S. Bank National Association, as trustee (the &#8220;trustee&#8221;), which are both incorporated by reference as exhibits to the Annual Report on Form 10-K of which this exhibit is a part. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are traded on The New York Stock Exchange under the bond trading symbol of &#8220;BSX27.&#8221; Currently, U.S. Bank National Association is acting as transfer agent and registrar for the notes and Elavon Financial Services DAC (UK Branch) is acting as paying agent.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capitalized terms that are used but not otherwise defined herein have the meanings assigned to them in the Indenture, and those definitions are incorporated herein by reference. We encourage you to read the above referenced Indenture for additional information.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes offered were initially issued in an aggregate principal amount of &#8364;900,000,000 aggregate principal amount, which is the amount outstanding as of the date of the Annual Report on Form 10-K of which this exhibit is a part. The notes will mature on December&#160;1, 2027.  The notes will not be entitled to the benefit of a sinking fund.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes will bear interest from November 12, 2019, payable annually in arrears on December&#160;1 of each year, beginning December&#160;1, 2020, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment date. Interest on the notes will be computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes (or November&#160;12, 2019, if no interest has been paid on the notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as ACTUAL&#47;ACTUAL (ICMA) as defined in the rulebook of the International Capital Market Association. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Additional notes (the &#8220;Additional Notes&#8221;) in an unlimited amount may be issued in one or more series from time to time on the same terms and conditions, except for issue date, and in certain cases the issue price and the first interest payment, either of which may differ from the respective terms of the previously issued notes of the same series, and with the same CUSIP numbers as the notes (to the extent permissible under applicable law) without the consent of Holders of the notes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ranking</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are unsecured and rank on a parity with all of our other unsecured and unsubordinated indebtedness from time to time outstanding. The notes will rank senior to any existing and future unsecured and subordinated debt, effectively junior to our secured debt to the extent of the collateral securing such secured debt and effectively junior to liabilities of our subsidiaries, in each case as may be outstanding from time to time. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in Euro</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will pay the principal of, premium, if any, and interest on each note to the registered holder in euro in immediately available funds, provided that, if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Economic and Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted by us into U.S. dollars at the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second business day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date. Any payment in respect of the notes so made in U.S. dollars will not constitute an event of default under the notes or the indenture governing the notes.</font></div><div style="margin-top:5pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not, and will not permit any of our Subsidiaries (as defined in the Indenture) to, directly or indirectly, create, incur, assume or suffer to exist any Lien (as defined in the Indenture) upon any of our property, assets or revenues, whether now owned or hereafter acquired, except for&#58; (i)&#160;Liens for taxes not yet due or which are being contested in good faith by appropriate proceedings&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that adequate reserves with respect thereto are maintained on our or our Subsidiaries&#8217; books, as the case may be, in conformity with accounting principles generally accepted in the United States&#59; (ii)&#160;carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s or other like Liens arising in the ordinary course of business that are not overdue for a period of more than 60&#160;days or which are being contested in good faith by appropriate proceedings&#59; (iii)&#160;pledges or deposits in connection with workers&#8217; compensation, unemployment insurance and other social security legislation and deposits securing liability to insurance carriers under insurance or self-insurance arrangements&#59; (iv)&#160;deposits to secure the performance of bids, trade contracts (other than for borrowed money), leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business&#59; (v)&#160;easements, rights-of-way, restrictions and other similar encumbrances incurred in the ordinary course of business which, in the aggregate, are not substantial in amount and which do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of our business or that of a Subsidiary&#59; (vi)&#160;Liens in existence on the date of the first issuance by us of Securities (as defined in the Indenture) issued pursuant to the Indenture&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that no such Lien is spread to cover any additional property after such date and that the amount of Debt (as defined in the Indenture) secured thereby is not increased&#59; (vii)&#160;Liens securing our and our Subsidiaries&#8217; Debt incurred to finance the acquisition of fixed or capital assets&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that (A)&#160;such Liens will be created substantially simultaneously with the acquisition of such fixed or capital assets, (B)&#160;such Liens do not at any time encumber any property other than the property financed by such Debt and (C)&#160;the amount of Debt secured thereby is not increased&#59; (viii)&#160;Liens on the property or assets of a corporation that becomes a Subsidiary after the date of the Indenture&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that (A)&#160;such Liens existed at the time such corporation became a Subsidiary and were not created in anticipation thereof, (B)&#160;any such Lien is not spread to cover any property or assets of such corporation after the time such corporation becomes a Subsidiary, and (C)&#160;the amount of Debt secured thereby is not increased&#59; (ix)&#160;Liens pursuant to any Receivables Transaction (as </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">defined in the Indenture) in an aggregate principal amount not exceeding 20% of our Consolidated Tangible Assets (as defined in the Indenture)&#59; and (x)&#160;Liens (not otherwise permitted pursuant to the Indenture) (A)&#160;which secure obligations not exceeding (as to us and our Subsidiaries) the greater of (X)&#160;$250.0&#160;million or (Y)&#160;20% of our Consolidated Tangible Assets (as defined in the Indenture), in each case in an aggregate amount at any time outstanding, or (B)&#160;with respect to which we effectively provide that the Securities Outstanding (as defined in the Indenture) under the Indenture are secured equally and ratably with (or, at our option, prior to) the Debt secured by such Lien.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prior to the Par Call Date (as defined below), we may redeem the notes, in whole or in part, at our option, on at least 15&#160;days, but no more than 60&#160;days prior written notice mailed to the registered holders of the notes to be redeemed, at any time at a redemption price equal to the greater of&#58;</font></div><div style="padding-left:49.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">100% of the principal amount of the notes being redeemed, or</font></div><div style="padding-left:49.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">as determined by a Quotation Agent (as defined below), the sum of the present values of the remaining scheduled payments of principal and interest thereon to the applicable Par Call Date (not including any portion of such payments of interest accrued to the date of redemption) discounted to the redemption date on an annual basis (ACTUAL&#47;ACTUAL(ICMA)) at the Comparable Government Bond Rate (defined below), plus 20 basis points for the notes,</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">plus, in each case, accrued and unpaid interest on the notes to, but not including, the redemption date (subject to the right of holders as of the close of business on a regular record date to receive interest due on the related interest payment date).</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;At any time and from time to time on or after September&#160;1, 2027 (the date that is three months prior to the maturity date of the notes) (the &#8220;Par Call Date&#8221;), we may redeem the notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest to the redemption date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Comparable Government Bond Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, for any redemption date, the rate per annum equal to the annual equivalent yield to maturity or interpolated yield to maturity (on a day count basis), computed as the third business day immediately preceding that redemption date, of the Comparable Government Issue (as defined below), assuming a price for the Comparable Government Issue (expressed as a percentage of its principal amount) equal to the Comparable Price (as defined below) for such redemption date.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Comparable Government Issue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the euro-denominated security issued by the German federal government selected by a Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the notes to be redeemed that would be utilized (assuming that the notes matured on the applicable Par Call Date), at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Comparable Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any redemption date, (i)&#160;the average of the Reference Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Dealer Quotations, or (ii)&#160;if the trustee obtains fewer than three such Reference Dealer Quotations, the average of all such quotations.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Quotation Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Reference Dealer appointed by the trustee after consultation with us.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Reference Dealer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i)&#160;each of Barclays Bank&#160;PLC, Goldman Sachs&#160;&#38;&#160;Co.&#160;LLC and Merrill Lynch International and their respective successors&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, if any of the foregoing shall cease to be a broker or dealer of, and&#47;or a market maker in, German government bonds (a &#8220;Primary Bond Dealer&#8221;), we shall substitute therefor another Primary Bond Dealer, and (ii)&#160;any other Primary Bond Dealers selected by the trustee after consultation with us.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Reference Dealer Quotations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to each Reference Dealer and any redemption date, the average, as determined by the trustee, of the bid and ask prices for the Comparable Government Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the trustee by such Reference Dealer at 5&#58;00&#160;p.m. London time, on the third business day preceding such redemption date.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we redeem only some of the notes, the trustee shall determine by lot the notes to be redeemed or, in the case of notes held in global form, pursuant to applicable procedures of the depositary. Notice by the depositary to these participants and by participants to &#8220;street name&#8221; holders of indirect interests in the notes will be made according to arrangements among them and may be subject to statutory or regulatory requirements. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the notes or portions of the notes called for redemption.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a Change of Control Repurchase Event occurs, unless we have exercised our option to redeem the notes as described under the heading &#8220;-Optional Redemption&#8221; above, each holder of the notes will have the right to require us to purchase all or a portion (equal to &#8364;100,000 and any integral multiples of &#8364;1,000 in excess thereof) of such holder&#8217;s notes pursuant to the offer described below (a &#8220;Change of Control Offer&#8221;) at a purchase price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to, but not including, the date of repurchase (the &#8220;Change of Control Payment&#8221;), subject to the rights of holders of notes on the relevant record date to receive interest due on the relevant interest payment date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will be required to send a notice to each holder of the notes by first class mail, with a copy to the trustee, within 30&#160;days following the date upon which any Change of Control Repurchase Event occurred, or at our option, prior to any Change of Control but after the public announcement of the pending Change of Control. The notice will govern the terms of the Change of Control Offer and will describe, among other things, the transaction that constitutes or may constitute the Change of Control Repurchase Event and the purchase date. The purchase date will be at least 30&#160;days but no more than 60&#160;days from the date such notice is mailed, other than as may be required by law (a &#8220;Change of Control Payment Date&#8221;). If the notice is mailed prior to the date of consummation of the Change of Control, the notice will state that the Change of Control Offer is conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On the Change of Control Payment Date, we will, to the extent lawful&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">accept for payment all properly tendered notes or portions of notes not validly withdrawn&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">deposit with the paying agent the required payment for all properly tendered notes or portions of notes not validly withdrawn&#59; and</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">deliver or cause to be delivered to the trustee the repurchased notes, accompanied by an officers&#8217; certificate stating, among other things, the aggregate principal amount of repurchased notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will not be required to make a Change of Control Offer with respect to the notes upon the occurrence of a Change of Control Repurchase Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer made by us and the third party purchases all of the notes properly tendered and not withdrawn under its offer. In addition, we will not repurchase any notes if there has occurred and is continuing on the Change of Control Payment Date an Event of Default under the Indenture.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will comply with the requirements of Rule&#160;14e-1 under the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable, in connection with the repurchase of notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the notes, we will comply with those securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Offer provisions of the notes by virtue of any such conflict. </font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The definition of Change of Control includes a phrase relating to the direct or indirect sale, lease, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our properties or assets and those of our subsidiaries taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, lease, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For purposes of the foregoing discussion, the following definitions apply&#58;</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution of assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more series of related transactions, of all or substantially all of our assets and the assets of our subsidiaries, taken as a whole, to any &#8220;person&#8221; (as that term is used in Section&#160;13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section&#160;13(d)(3) of the Exchange Act), other than us or one of our subsidiaries, becomes the &#8220;beneficial owner&#8221; (as defined in Rule&#160;13d-3 under the Exchange Act), directly or indirectly, of more than 50% of our then outstanding Voting Stock or other Voting Stock into which our Voting Stock is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the adoption of a plan relating to our liquidation or dissolution.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a)&#160;we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(x) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (y)&#160;immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Change of Control Repurchase Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of both a Change of Control and a Rating Event.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Fitch</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Fitch,&#160;Inc. and its successors.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Investment Grade</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s), a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) and a rating of BBB- or better by Fitch (or its equivalent under any successor rating categories of Fitch)&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that we shall not be required to maintain a rating by more than two Rating Agencies at any time and if only two Rating Agencies provide a rating with respect to the notes, then &#8220;Investment Grade&#8221; shall mean the applicable rating described above of such two Rating Agencies.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Moody&#8217;s Investors Service,&#160;Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Rating Agencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means each of Moody&#8217;s, S&#38;P and Fitch, or if any of Moody&#8217;s, S&#38;P or Fitch ceases to rate the notes or fails to make a rating of the notes publicly available, any &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section&#160;3(a)(62) under the Exchange Act that is selected by us as a replacement agency for Moody&#8217;s, S&#38;P or Fitch, or each of them, as the case may be&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Company shall not be required to maintain a rating by more than two Rating Agencies at any time.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Rating Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to the notes, the rating of the notes shall be decreased by each of the Rating Agencies independently by one or more gradations during the Rating Period (as defined below). If the rating of the notes by each of the Rating Agencies is Investment Grade, then &#8220;Rating Event&#8221; will mean the rating of the notes shall be decreased by one or more gradations by each Rating Agency so that the ratings of the notes by all of the Rating Agencies fall below Investment Grade, on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the 30-day period following public notice of the occurrence of the Change of Control (the &#8220;Rating Period&#8221;) (which 30-day period shall be extended by no more than 60&#160;days from the date of the occurrence of the Change of Control if the rating of the notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies and each other Rating Agency has either downgraded, or publicly announced that it is considering downgrading, the notes). A Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed a Rating Event for purposes of the definition of &#8220;Change of Control Repurchase Event&#8221;) if each Rating Agency making the reduction in rating to which this definition would otherwise apply does not announce or publicly confirm or inform the trustee under the Indenture in writing at our request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Rating Event).</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means S&#38;P Global Ratings, a division of S&#38;P Global&#160;Inc., and its successors.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Redemption for Tax Reasons</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to a period of not less than fifteen (15)&#160;nor more than sixty (60)&#160;days&#8217; prior written notice to the registered holders of the notes to be redeemed, we may redeem the notes at any time after the issue date and prior to the maturity date, in whole, but not in part, at a redemption price equal to 100% of the aggregate principal amount of notes being redeemed, plus accrued and unpaid interest, if any, to (but not including) the redemption date, on the date determined by us for early redemption, if&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated thereunder) of a Relevant Taxing Jurisdiction (as defined below), or any change in, or amendment to, an official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment is announced or becomes effective on or after November 6, 2019, we have become or will become obligated to pay Additional Amounts (as defined below)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) any act is taken by a taxing authority of a Relevant Taxing Jurisdiction on or after November 6, 2019, whether or not such act is taken with respect to us or any of our affiliates, that results in a substantial probability that we will be required to pay Additional Amounts on the notes&#59; provided in each case that we determine, in our business judgment (determined in good faith), that the obligation to pay the Additional Amounts cannot be avoided by the use of reasonable measures available to us (including, for the avoidance of doubt, the appointment of a new paying agent where this would be reasonable and would not cause us to incur material additional out-of-pocket costs, but not including assignment of the obligation to make payment with respect to the notes).</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No redemption above may be made unless (i)&#160;we shall have received an opinion of independent counsel to the effect that any such change, amendment or act described in paragraphs&#160;(a) or (b)&#160;above results in our requirement to pay (in the case of paragraph&#160;(a)) or a substantial probability that we will be required to pay (in the case of paragraph(b)) the Additional Amounts described herein and (ii)&#160;we shall have delivered to the paying agent a certificate, signed by a duly authorized officer, stating that based on such opinion, we are entitled to redeem the notes pursuant to their terms.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Additional Amounts</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All payments of principal, premium, if any, and interest by or on behalf of us pursuant to the terms of the notes shall be made free and clear of, and without deduction or withholding for or on account of, any present or future taxes, duties, assessments or other governmental charges of whatsoever nature required to be deducted or withheld by the United States, any state thereof or the District of Columbia or any other jurisdiction through which payment on a note is made, or any political subdivision or taxing authority therein or thereof (a &#8220;Relevant Taxing Jurisdiction&#8221;), unless such withholding or deduction is required by law.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the event any withholding or deduction on payments in respect of the notes for or on account of any present or future tax, assessment or other governmental charge is required to be deducted or withheld by a Relevant Taxing Jurisdiction, we shall remit the full amount required to be deducted or withheld to </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the relevant authority in accordance with applicable law and pay such additional amounts (the &#8220;Additional Amounts&#8221;) so that every net payment of the principal of, premium, if any, and interest on the notes will result in receipt by each holder of a note of such amounts (after all such withholding or deduction, including on any additional amounts) as would have been received had no such withholding or deduction been required. We will not be required, however, to make any payment of Additional Amounts for or on account of certain situations, as set forth in the form of notes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Events of Default</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture provides that the following will be &#8220;events of default&#8221; with respect to any series of debt securities&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1) default in the payment of any interest on any debt security of that series, when it becomes due and payable, and continuance of such default for a period of 30&#160;days&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2) default in the payment of, the principal of, or premium, if any, on any debt security of that series when due at its maturity or upon acceleration&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3) default in the deposit of any sinking fund payment, when and as due by the terms of the debt securities of that series and the Indenture&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4) default in the performance, or breach, of any of our covenant or agreement in the Indenture which affects or is applicable to debt securities of such series (other than a default in the performance, or breach of a covenant or agreement that is specifically dealt with elsewhere in the Indenture), and the continuation of that default or breach for a period of 90&#160;days after the trustee has given us, or after Holders of at least 25% in aggregate principal amount of all outstanding securities of that series have given us and the trustee, written notice thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5) certain events relating to our bankruptcy, insolvency or reorganization&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6) any other event of default provided with respect to debt securities of that series.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If an event of default specified in clauses (1), (2), (3), (4) or (6) therein with respect to the notes occurs and is continuing, either the trustee or the holders of at least 25% in aggregate principal amount of the outstanding notes may declare the principal amount, plus accrued interest, if any, on all the then outstanding notes to be due and payable immediately. If an event of default specified in clause (5) therein occurs and is continuing, then the principal amount, plus accrued interest, if any, of all the notes will be due and payable immediately, without any declaration or other act on the part of the trustee or any holder. In certain cases, holders of a majority in principal amount of the outstanding notes may, on behalf of holders of all the notes, rescind and annul a declaration of acceleration.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Indenture provides that the trustee will not be liable for any action taken, suffered or omitted by it in good faith and believed by it to be authorized or within the discretion or rights or powers conferred upon it by the Indenture. The Indenture provides that no Holder may institute any proceedings, judicial or otherwise, to enforce the Indenture except in the case of failure of the trustee thereunder to act for 60&#160;days after it has received a request to enforce the Indenture by Holders of at least 25% in aggregate principal amount of the then outstanding debt securities of that series (in the case of an event of default specified in clauses&#160;(1), (2), (3), (4)&#160;or (6)&#160;above) or a request to enforce the Indenture by Holders of at least 25% in aggregate principal amount of all of the debt securities then outstanding (in the case of an event of default specified in clause&#160;(5) above), and an offer of reasonable indemnity. This provision will not prevent any </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Holder from enforcing payment of principal thereof, and premium, if any, on and interest, if any, thereon at the respective due dates.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Holders of not less than a majority in aggregate principal amount of the debt securities of any series then outstanding may direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on it with respect to debt securities of that series. The trustee may, however, refuse to follow any direction that it determines may not lawfully be taken or would be illegal or in conflict with the Indenture or involve it in personal liability or which would be unjustly prejudicial to Holders not joining in that proceeding.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Indenture provides that the trustee will, within 90&#160;days after the occurrence of a default with respect to any series of debt securities, give to Holders of debt securities of that series notice of such default if that default has not been cured or waived. Except in the case of a default in the payment of principal of, or premium, if any, on or interest on, or in the payment of any sinking fund installment in respect of, any debt securities of that series, the trustee will be protected in withholding the notice if it determines in good faith that the withholding of the notice is in the interest of Holders of the debt securities of such series.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will be required to deliver an officers' certificate to the trustee annually as to our compliance with all conditions and covenants under the terms of the Indenture.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Defeasance</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject to our defeasance option. At our option, the notes will be discharged from any and all obligations (except for certain obligations to register the transfer or exchange of notes, replace stolen, lost or mutilated notes, maintain paying agencies, and hold money for payment in trust), if we deposit with the trustee, in trust, money or Government Obligations (as defined in the Indenture) which through the payment of interest thereon and principal thereof in accordance with their terms will provide money in an amount sufficient to pay all the principal (including any mandatory sinking fund payments) of, and interest on, the notes on the dates such payments are due in accordance with the terms of the notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To exercise any such option, we are required to deliver to the trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the Holders of the notes to recognize income, gain or loss for federal income tax purposes and, in the case of a discharge pursuant to (1)&#160;above, such opinion of counsel must be based upon a ruling to such effect received by us from or published by the United States Internal Revenue Service or a change in applicable federal income tax law to such effect. We are required to deliver to the trustee an officer's certificate stating that no event of default with respect to the notes has occurred and is continuing.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Satisfaction and Discharge</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As set forth in the Indenture, and upon the occurrence of certain events, the Indenture may be subject to satisfaction and discharge with respect to the notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Modification and Waiver</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Modifications of and amendments to the Indenture may be made by us and the trustee with the consent of Holders of a majority in principal amount of the outstanding debt securities of each series issued under the Indenture that is affected by the modification or amendment&#59; provided, however, that no </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such modification or amendment may, without the consent of the Holder of each outstanding debt security affected thereby make certain changes as set forth in the Indenture.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may, with respect to any series of debt securities, omit to comply with certain restrictive provisions of the Indenture if Holders of at least a majority in principal amount of all outstanding debt securities affected waive compliance. No such waiver will extend to or affect any term, provision or condition except to the extent so expressly waived, and, until the waiver becomes effective, our obligations and the duties of the trustee to Holders of debt securities of that series in respect of the applicable term, provision or condition will remain in full force and effect.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Holders of a majority in principal amount of the outstanding debt securities of each series (in the case of an event of default specified in clauses (1), (2), (3), (4) and (6) under &#34;Events of Default&#34; above) or the Holders of a majority in principal amount of all of the debt securities then outstanding (in the case of an event of default specified in clause (5) under &#34;Events of Default&#34; above) may, on behalf of all those Holders, waive any past default under the Indenture with respect to debt securities of that series except a default in the payment of the principal of, or premium, if any, on or interest, if any, on any such debt security and except a default in respect of a covenant or provision the modification or amendment of which would require the consent of the Holder of each outstanding debt security affected.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>3
<FILENAME>exhibit21-listofsubsidiari.htm
<DESCRIPTION>EX-21 FY2021 LIST OF SUBSIDIARIES DATED JAN 31, 2022
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id602f5b322f84de0a6d702347c4787df_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:13pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%;text-decoration:underline">EXHIBIT 21</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">List of worldwide subsidiaries of Boston Scientific as of January 31, 2022</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Structure of ownership and control&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific wholly owns or has a majority interest in all of the below mentioned entities.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acurate Industria e Comercio Ltda. (Brazil) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Medical Systems Europe B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biocompatibles UK Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biocompatibles, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (Malaysia) Sdn. Bhd. (Malaysia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (South Africa) Proprietary Limited (South Africa)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (Thailand) Ltd. (Thailand)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (UK) Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific AG (Switzerland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Argentina S.A. (Argentina)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Asia Pacific Pte. Ltd. (Singapore)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Benelux NV (Belgium)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Ceska republika s.r.o. (Czech Republic)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Chile SpA (Chile)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Clonmel Limited, in liquidation (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Colombia Limitada (Colombia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Comercial de Costa Rica BSCR, S.R.L. (Costa Rica)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Cork Limited, in liquidation (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific de Costa Rica S.R.L. (Costa Rica)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific de Mexico, S.A. de C.V. (Mexico)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific del Caribe, Inc. (Puerto Rico)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific do Brasil Ltda. (Brazil)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Far East B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Gesellschaft m.b.H. (Austria)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Group plc (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Gulf for Trading (Saudi Arabia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Hellas S.A. (Greece)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Hong Kong Limited (Hong Kong)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Iberica, S.A. (Spain)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific India Private Limited (India)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International Finance Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International S.A. (France)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International Sdn. Bhd.  (Malaysia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Ireland Limited, in liquidation (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Israel Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Japan K.K. (Japan)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Korea Co., Ltd. (Korea)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific LLC (Russian Federation)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Ltd.&#47;Boston Scientifique Ltee. (Canada)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Medical Device (Malaysia) Sdn. Bhd. (Malaysia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Medical Device Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Medical Device (Canada), Inc. (Canada)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Medizintechnik GmbH (Germany)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Middle East FZ-LLC (UAE)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Middle East SAL (Offshore) (Lebanon)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Nederland B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Neuromodulation Corporation (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific New Zealand Limited (New Zealand)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Nordic AB (Sweden)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Peru S.A.C. (Peru)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Philippines, Inc. (Philippines)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Polska Sp. z o.o. (Poland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Portugal - Dispositivos Medicos, Lda (Portugal)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Pty Ltd (Australia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Romania S.R.L. (Romania)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific S.A.S. (France)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific S.p.A. (Italy)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Scimed, Inc. (Minnesota)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Technology &#38; Engineering Services Private Limited (India) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific TIP Gerecleri Limited Sirketi (Turkey)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Vietnam Company Limited (Vietnam)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bravo Bidco Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSC International Medical Trading (Shanghai) Co., Ltd. (China)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSC Medical Device Technology (Shanghai) Co., Ltd. (China)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG IM Holdings Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International (Holdings) Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Canada Inc. (Canada)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG Management Services Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiac Pacemakers, Inc. (Minnesota)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CeloNova BioSciences Germany GmbH, in liquidation (Germany)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cryterion Medical, Inc. (Delaware) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cryterion Medical Ireland, Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DeVoro Medical Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eCardio Sequoia Blocker Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EKOS LLC (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electron Acquisition Corporation (Delaware) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice GmbH, in liquidation (Germany)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice Holdings, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice Innovation Center Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice Israel Ltd. (Israel) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EP Technologies, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Farapulse, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Galil Medical Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Galil Medical Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Golden Woods Services, LLC (Texas)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidant Delaware Holding Corporation (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidant Europe NV (Belgium)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidant Puerto Rico B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong Medtech Trading Limited (Hong Kong)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laguna Holdco Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis (Australia) Pty. Ltd. (Australia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis (HK) Limited (Hong Kong)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis (Italy) S.r.l. (Italy)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis (Singapore) Pte. Ltd. (Singapore)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis (UK) Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis Holdings Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis Inc. (Massachusetts)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis India Private Limited (India)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis Japan Co. Ltd. (Japan)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis Korea Ltd. (Korea)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lumenis Medical Laser Equipment Trading (Beijing) Co. Ltd. (China)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notebook Merger Sub, Ltd. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NXT Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preventice Services, LLC  (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preventice Solutions, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preventice Technologies, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provensis Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PT Boston Scientific Indonesia (Indonesia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RMI Acquisition Corp. (California)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Robert S. Smith, M.D., Inc. (Georgia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Roxwood Medical, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sadra Medical, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNS Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Special K Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">StarMedTec GmbH, in liquidation (Germany)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stream Enterprises LLC (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Symetis SA (Switzerland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Target Therapeutics, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Veniti, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vertiflex, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Wuhan Sharplan CMLM Ltd. in liquidation (China)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zuma Investment Pty Ltd (Australia) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34 Biomedical Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9357-1867 Quebec Inc. (Canada)</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>exhibit23-2021eyconsent.htm
<DESCRIPTION>EX-23 EY CONSENT FY2021
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4e52f959d22149a188e4e0bc748b5ee8_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:13pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%;text-decoration:underline">EXHIBIT 23</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;Registration Statement (Form S-3 Nos. 333-238526, 333-223095, 333-76346, 333-61994, and 333-64991) of Boston Scientific Corporation,</font></div><div style="padding-left:27pt;padding-right:27pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)&#160;&#160;&#160;&#160;Registration Statement (Form S-4 Nos. 333-131608 and 333-22581) of Boston Scientific Corporation,</font></div><div style="padding-left:27pt;padding-right:27pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(3)&#160;&#160;&#160;&#160;Registration Statement (Form S-8 Nos. 333-25033, 333-25037, 333-36636, 333-61056, 333-61060, 333-76380, 333-98755, 333-111047, 333-131608, 333-133569, 333-134932, 333-151280, 333-174620, 333-174622, 333-188905, 333-196672, and 333-241022) of Boston Scientific Corporation&#59;</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">of our reports dated February&#160;23, 2022, with respect to the consolidated financial statements and schedule of Boston Scientific Corporation and the effectiveness of internal control over financial reporting of Boston Scientific Corporation included in this Annual Report (Form 10-K) of Boston Scientific Corporation for the year ended December&#160;31, 2021.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Boston, Massachusetts&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">February&#160;23, 2022</font></div><div><font><br></font></div><div style="margin-bottom:13pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit311-ceo302202110xk.htm
<DESCRIPTION>EX-31.1 CEO 302 CERT FY2021
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3f83476adcd64c79819429368228ab28_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael F. Mahoney, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form&#160;10-K of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:6.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 23, 2022</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit312-cfo302202110xk.htm
<DESCRIPTION>EX-31.2 CFO 302 CERT FY2021
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7e41c934e4434c359e67075cfaa6b963_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel J. Brennan, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form&#160;10-K of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:6.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 23, 2022</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321-ceo906202110xk.htm
<DESCRIPTION>EX-32.1 CEO 906 CERT FY2021
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3f196e3c372447cfa3be0f60e7066a22_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ending December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13 (a)&#160;or 15 (d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2022</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322-cfo906202110xk.htm
<DESCRIPTION>EX-32.2 CFO 906 CERT FY202
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8c69b1f011014c0c8b2378a3090db248_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ending December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13 (a)&#160;or 15 (d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2022</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>bsx-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3eeb153c-443d-4b7c-bc48-13c100a9196f,g:5aeaa418-7365-4294-a466-e7b8cf11828b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.bostonscientific.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.bostonscientific.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1001003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1002004 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetParanthetical" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical">
        <link:definition>1004006 - Statement - Consolidated Balance Sheet Paranthetical</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1006008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure">
        <link:definition>1007009 - Statement - Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSignificantAccountingPoliciesTables" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails">
        <link:definition>2404401 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestments" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments">
        <link:definition>2105102 - Disclosure - Acquisitions and Strategic Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestmentsTables" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables">
        <link:definition>2306302 - Disclosure - Acquisitions and Strategic Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails">
        <link:definition>2407402 - Disclosure - Acquisitions and Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationDetails" roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails">
        <link:definition>2408403 - Disclosure - Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails">
        <link:definition>2409404 - Disclosure - Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldforSale" roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale">
        <link:definition>2110103 - Disclosure - Assets and Liabilities Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldforSaleTables" roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables">
        <link:definition>2311303 - Disclosure - Assets and Liabilities Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldforSaleDetails" roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>2412405 - Disclosure - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2113104 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables">
        <link:definition>2314304 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails">
        <link:definition>2415406 - Disclosure - Goodwill and Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurements" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements">
        <link:definition>2116105 - Disclosure - Hedging Activities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresPolicies" roleURI="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies">
        <link:definition>2217202 - Disclosure - Fair Value Measures and Disclosures (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsTables" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables">
        <link:definition>2318305 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsDetails">
        <link:definition>2419407 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitments" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments">
        <link:definition>2120106 - Disclosure - Contractual Obligations and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsTables" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables">
        <link:definition>2321306 - Disclosure - Contractual Obligations and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsDetails" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails">
        <link:definition>2422408 - Disclosure - Contractual Obligations and Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.bostonscientific.com/role/Leases">
        <link:definition>2123107 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.bostonscientific.com/role/LeasesTables">
        <link:definition>2324307 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.bostonscientific.com/role/LeasesDetails">
        <link:definition>2425409 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRelatedActivities" roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivities">
        <link:definition>2126108 - Disclosure - Restructuring Related Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRelatedActivitiesTables" roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables">
        <link:definition>2327308 - Disclosure - Restructuring Related Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRelatedActivitiesDetails" roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails">
        <link:definition>2428410 - Disclosure - Restructuring Related Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation">
        <link:definition>2129109 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>2330309 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationDetails" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails">
        <link:definition>2431411 - Disclosure - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bostonscientific.com/role/IncomeTaxes">
        <link:definition>2132110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables">
        <link:definition>2333310 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetailsRateTable" roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable">
        <link:definition>2434412 - Disclosure - Income Taxes (Details - Rate Table)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxesDetails" roleURI="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails">
        <link:definition>2435413 - Disclosure - Income Taxes Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies">
        <link:definition>2136111 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2437414 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesPolicies" roleURI="http://www.bostonscientific.com/role/CommitmentandContingenciesPolicies">
        <link:definition>2238203 - Disclosure - Commitment and Contingencies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.bostonscientific.com/role/StockholdersEquity">
        <link:definition>2139112 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails">
        <link:definition>2440415 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockInventiveandPurchasePlans" roleURI="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans">
        <link:definition>2141113 - Disclosure - Stock Inventive and Purchase Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentiveandPurchasePlansTables" roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables">
        <link:definition>2342311 - Disclosure - Stock Incentive and Purchase Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentiveandPurchasePlansDetails" roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails">
        <link:definition>2443416 - Disclosure - Stock Incentive and Purchase Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstanding" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding">
        <link:definition>2144114 - Disclosure - Weighted Average Shares Outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingTables" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables">
        <link:definition>2345312 - Disclosure - Weighted Average Shares Outstanding (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingDetails" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails">
        <link:definition>2446417 - Disclosure - Weighted Average Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.bostonscientific.com/role/SegmentReporting">
        <link:definition>2147115 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.bostonscientific.com/role/SegmentReportingTables">
        <link:definition>2348313 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails">
        <link:definition>2449418 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.bostonscientific.com/role/Revenue">
        <link:definition>2150116 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.bostonscientific.com/role/RevenueTables">
        <link:definition>2351314 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.bostonscientific.com/role/RevenueDetails">
        <link:definition>2452419 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncome" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome">
        <link:definition>2153117 - Disclosure - Changes in Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeTables" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables">
        <link:definition>2354315 - Disclosure - Changes in Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeDetails" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails">
        <link:definition>2455420 - Disclosure - Changes in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements">
        <link:definition>2156118 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2257204 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansNotes" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes">
        <link:definition>2158119 - Disclosure - Employee Retirement Plans (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansEmployeeRetirementPlansPolicies" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies">
        <link:definition>2259205 - Disclosure - Employee Retirement Plans Employee Retirement Plans (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansTables" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables">
        <link:definition>2360316 - Disclosure - Employee Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansDetails" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails">
        <link:definition>2461421 - Disclosure - Employee Retirement Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleII" roleURI="http://www.bostonscientific.com/role/ScheduleII">
        <link:definition>2162120 - Disclosure - Schedule II</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIDetails" roleURI="http://www.bostonscientific.com/role/ScheduleIIDetails">
        <link:definition>2463422 - Disclosure - Schedule II (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_LitigationAndDebtExclusionFromEbitda" abstract="false" name="LitigationAndDebtExclusionFromEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" abstract="false" name="BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_LotusDiscontinuationMember" abstract="true" name="LotusDiscontinuationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalPeripheralInterventionsPiReportingUnitMember" abstract="true" name="GlobalPeripheralInterventionsPiReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" abstract="false" name="RangeofthetargetnumberofperformancebasedDSUsawarded" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_NetCurrencyExchangeGainLoss" abstract="false" name="NetCurrencyExchangeGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalEndoscopyEndoReportingUnitMember" abstract="true" name="GlobalEndoscopyEndoReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" abstract="false" name="NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" abstract="false" name="DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" abstract="false" name="CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" abstract="false" name="DefinedBenefitPlanPlanAssetsActuarialGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CompensationExpensePerShareBasic" abstract="false" name="CompensationExpensePerShareBasic" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bsx_BTGAcquisitionMember" abstract="true" name="BTGAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CorporateExpensesincludinghedgingactivitiesMember" abstract="true" name="CorporateExpensesincludinghedgingactivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_InternationalRetirementPlansMember" abstract="true" name="InternationalRetirementPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_MedsurgMember" abstract="true" name="MedsurgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_YenDenominatedFactoringArrangementsMember" abstract="true" name="YenDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" abstract="false" name="FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bsx_The2018FacilityDomain" abstract="true" name="The2018FacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" abstract="false" name="SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_December2027NotesMember" abstract="true" name="December2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_May2025NotesMember" abstract="true" name="May2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LatinAmericaandCanadaMember" abstract="true" name="LatinAmericaandCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_A2020TermLoanMember" abstract="true" name="A2020TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_StatementOfOperationsCaptionAxis" abstract="true" name="StatementOfOperationsCaptionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_LitigationSettlementReceivedGain" abstract="false" name="LitigationSettlementReceivedGain" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_WeightedAverageRemainingVestingPeriod" abstract="false" name="WeightedAverageRemainingVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" abstract="false" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_A2019RestructuringPlanMember" abstract="true" name="A2019RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ExecutiveRetirementPlanMember" abstract="true" name="ExecutiveRetirementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" abstract="false" name="ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_TaxRateAxis" abstract="true" name="TaxRateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RestructuringRelatedToPlanMember" abstract="true" name="RestructuringRelatedToPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_January2020NotesMember" abstract="true" name="January2020NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" abstract="false" name="TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_OptionsExpectedToVestWeightedAverageExercisePrice" abstract="false" name="OptionsExpectedToVestWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" abstract="false" name="ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_TransitionTaxPaymentRemaining" abstract="false" name="TransitionTaxPaymentRemaining" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_March2049NotesMember" abstract="true" name="March2049NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_A2016RestructuringPlanMember" abstract="true" name="A2016RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_NewAccountingPronouncementsPolicyTextBlock" abstract="false" name="NewAccountingPronouncementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" abstract="false" name="MarketBasedAwardsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" abstract="false" name="MaturitiesOfLeaseLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_PaymentsForRoyaltyRights" abstract="false" name="PaymentsForRoyaltyRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_June2030NotesMember" abstract="true" name="June2030NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_January2040NotesMember" abstract="true" name="January2040NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_February2019AggregateOfferingMember" abstract="true" name="February2019AggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_OptionsExpectedToVest" abstract="false" name="OptionsExpectedToVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bsx_TaxIncentivesInPuertoRico" abstract="false" name="TaxIncentivesInPuertoRico" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementAxis" abstract="true" name="StatementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_TwoYearDelayedDrawTermLoanMember" abstract="true" name="TwoYearDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" abstract="false" name="DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_UnrecognizedCompensationCost" abstract="false" name="UnrecognizedCompensationCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" abstract="false" name="CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LicensingArrangementLiabilitiesMember" abstract="true" name="LicensingArrangementLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DiscountRateFairValueInput" abstract="false" name="DiscountRateFairValueInput" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_PreventiceSolutionsIncMember" abstract="true" name="PreventiceSolutionsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_Paymenttonetsharesettleemployeeequityawards" abstract="false" name="Paymenttonetsharesettleemployeeequityawards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Segmentoperatingincomeaspercentageofnetsales" abstract="false" name="Segmentoperatingincomeaspercentageofnetsales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" abstract="false" name="Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" abstract="false" name="Productliabilitycasesorclaimsrelatedtomeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RevenueBasedPaymentsMember" abstract="true" name="RevenueBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" abstract="false" name="DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OperatingIncomeUnallocatedToSegment" abstract="false" name="OperatingIncomeUnallocatedToSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RenminbiDenominatedFactoringArrangementsMember" abstract="true" name="RenminbiDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" abstract="false" name="GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CanadaSettledClaims" abstract="false" name="CanadaSettledClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_DeferredTaxAssetValuationAllowanceIntraEntity" abstract="false" name="DeferredTaxAssetValuationAllowanceIntraEntity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_A2011LtipPlanMember" abstract="true" name="A2011LtipPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_IncomeTaxesAbstract" abstract="true" name="IncomeTaxesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" abstract="false" name="CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_AssetsHeldForSaleDomain" abstract="true" name="AssetsHeldForSaleDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DevoroMedicalIncMember" abstract="true" name="DevoroMedicalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_PermanentlyStayedClassActionInAustraliaMesh" abstract="false" name="PermanentlyStayedClassActionInAustraliaMesh" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_InventoryStepUpAmortization" abstract="false" name="InventoryStepUpAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Nonvestedstockawardsexerciseprice" abstract="false" name="Nonvestedstockawardsexerciseprice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bsx_ConsolidatedBalanceSheetParentheticalAbstract" abstract="true" name="ConsolidatedBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" abstract="false" name="AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_GlobalInterventionalCardiologyIcReportingUnitMember" abstract="true" name="GlobalInterventionalCardiologyIcReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" abstract="true" name="LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" abstract="false" name="OptionsExpectedToVestWeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_EuroDenominatedFactoringArrangementsMember" abstract="true" name="EuroDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_OtherOtherLongTermAssets" abstract="false" name="OtherOtherLongTermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CovenantAxis" abstract="true" name="CovenantAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_ExpenseRelatedToMatchingContributions" abstract="false" name="ExpenseRelatedToMatchingContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_A2019AcquisitionsVertiflexAndMillipedeMember" abstract="true" name="A2019AcquisitionsVertiflexAndMillipedeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RestructuringrelatedCostExpectedCost" abstract="false" name="RestructuringrelatedCostExpectedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalCrmReportingUnitMember" abstract="true" name="GlobalCrmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ChangeinDeferredTaxAssetsValuationAllowance" abstract="false" name="ChangeinDeferredTaxAssetsValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_March2029NotesMember" abstract="true" name="March2029NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_MillipedeMember" abstract="true" name="MillipedeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_Measurementperiodmarketbasedaward" abstract="false" name="Measurementperiodmarketbasedaward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" abstract="false" name="TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" abstract="true" name="RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" abstract="false" name="ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_ExclusionFromEbitdaForRestructuringCharges" abstract="false" name="ExclusionFromEbitdaForRestructuringCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Pensionbenefitobligationbenefitspaid" abstract="false" name="Pensionbenefitobligationbenefitspaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" abstract="false" name="RangeofthetargetnumberofmarketbasedDSUsawarded" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_SignificantAccountingPoliciesAbstract" abstract="true" name="SignificantAccountingPoliciesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_SpecialChargesMember" abstract="true" name="SpecialChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CompensationExpensePerShareDiluted" abstract="false" name="CompensationExpensePerShareDiluted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bsx_TransferCostsMember" abstract="true" name="TransferCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2024NotesMember" abstract="true" name="March2024NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ForeignCurrencyDenominatedInDebtMember" abstract="true" name="ForeignCurrencyDenominatedInDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" abstract="false" name="ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" abstract="false" name="ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_Fairvalueofmarketbasedawards" abstract="false" name="Fairvalueofmarketbasedawards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_November2019AggregateOfferingMember" abstract="true" name="November2019AggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" abstract="false" name="SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_OtherInternationalPlansMember" abstract="true" name="OtherInternationalPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_OtherNet" abstract="false" name="OtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" abstract="true" name="RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2026NotesMember" abstract="true" name="March2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DeferredTaxLiabilitiesDomain" abstract="true" name="DeferredTaxLiabilitiesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ContingentConsiderationLiabilityProbabilityOfPayment" abstract="false" name="ContingentConsiderationLiabilityProbabilityOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_March2028NotesMember" abstract="true" name="March2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LumenisLTDMember" abstract="true" name="LumenisLTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationAbstract" abstract="true" name="SupplementalBalanceSheetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_VotingPowerOfAllClassesOfStock" abstract="false" name="VotingPowerOfAllClassesOfStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_SpecialtyPharmaceuticalsMember" abstract="true" name="SpecialtyPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_NonCashImpactOfTransferredRoyaltyRights" abstract="false" name="NonCashImpactOfTransferredRoyaltyRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RhythmandNeuroMember" abstract="true" name="RhythmandNeuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_FederalBenefitOfUncertainTaxPositions" abstract="false" name="FederalBenefitOfUncertainTaxPositions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_EquipmentFurnitureAndFixturesGross" abstract="false" name="EquipmentFurnitureAndFixturesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StockIncentiveAndPurchasePlansAbstract" abstract="true" name="StockIncentiveAndPurchasePlansAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_BSXReportableSegmentsMember" abstract="true" name="BSXReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfifthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_April2021TermLoanMember" abstract="true" name="April2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" abstract="false" name="ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_CertifiedClassActionsInAustraliaMesh" abstract="false" name="CertifiedClassActionsInAustraliaMesh" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ActualCovenantMember" abstract="true" name="ActualCovenantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" abstract="false" name="ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_May2020NotesMember" abstract="true" name="May2020NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_TransferCosts" abstract="false" name="TransferCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationTable" abstract="true" name="ScheduleofIncomeTaxRateReconciliationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RestructuringRelatedExpenses" abstract="false" name="RestructuringRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" abstract="false" name="ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationTextualsAbstract" abstract="true" name="SupplementalBalanceSheetInformationTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_FreeTradeZoneRegimeTaxIncentive" abstract="false" name="FreeTradeZoneRegimeTaxIncentive" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" abstract="false" name="ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" abstract="true" name="ConsolidatedCashFlowSupplementalDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" abstract="false" name="PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationLineItems" abstract="true" name="ScheduleofIncomeTaxRateReconciliationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_ShareBasedCompensationNetOfTaxBenefit" abstract="false" name="ShareBasedCompensationNetOfTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_March2039NotesMember" abstract="true" name="March2039NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_AccruedRebatesCurrent" abstract="false" name="AccruedRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_A2021AcquisitionsMember" abstract="true" name="A2021AcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ConsolidatedBSXDomain" abstract="true" name="ConsolidatedBSXDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" abstract="false" name="ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_FarapulseIncMember" abstract="true" name="FarapulseIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RDRegulatoryandCommercializationbasedMilestoneMember" abstract="true" name="RDRegulatoryandCommercializationbasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_UnrecognizedCompensationCostStockOptions" abstract="false" name="UnrecognizedCompensationCostStockOptions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementOfOperationsCaptionDomain" abstract="true" name="StatementOfOperationsCaptionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" abstract="false" name="DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" abstract="true" name="RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_UnrecognizedCompensationCostNonVestedStockAwards" abstract="false" name="UnrecognizedCompensationCostNonVestedStockAwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherIntangibleAssetsTextualsAbstract" abstract="true" name="OtherIntangibleAssetsTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember" abstract="true" name="RequirementFourQuartersFollowingMaterialAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DivestitureAgreementTransferOfGlobalEmployees" abstract="false" name="DivestitureAgreementTransferOfGlobalEmployees" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_MaximumLeverageRatio" abstract="false" name="MaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_November2035NotesMember" abstract="true" name="November2035NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DeferredTaxAssetsDomain" abstract="true" name="DeferredTaxAssetsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalNeuromodulationNmReportingUnitMember" abstract="true" name="GlobalNeuromodulationNmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CumulativeRestructuringChargesIncurredToDate" abstract="false" name="CumulativeRestructuringChargesIncurredToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Annualweightedaverageforfeiturerate" abstract="false" name="Annualweightedaverageforfeiturerate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_AssertedClaimsOutsideTheUS" abstract="false" name="AssertedClaimsOutsideTheUS" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_StatementDomain" abstract="true" name="StatementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_VertiflexIncMember" abstract="true" name="VertiflexIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_EmergingMarketsTotalNumberOfCountries" abstract="false" name="EmergingMarketsTotalNumberOfCountries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" abstract="false" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_February2021TermLoanMember" abstract="true" name="February2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" abstract="true" name="RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_UKPlanMember" abstract="true" name="UKPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" abstract="false" name="ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_GoodwillTextualsAbstract" abstract="true" name="GoodwillTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_GlobalUrologyandPelvicHealthReportingUnitMember" abstract="true" name="GlobalUrologyandPelvicHealthReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LicensingArrangementAssetsMember" abstract="true" name="LicensingArrangementAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" abstract="false" name="DeferredTaxAssetsPrepaidonIntercompanyProfit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" abstract="false" name="EffectiveIncomeTaxRateReconciliationReturnToProvision" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_CovenantDomain" abstract="true" name="CovenantDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ThreeYearDelayedDrawTermLoanMember" abstract="true" name="ThreeYearDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" abstract="false" name="SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_EuroDenominatedOutstandingDebtMember" abstract="true" name="EuroDenominatedOutstandingDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_May2020SNAggregateOfferingMember" abstract="true" name="May2020SNAggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" abstract="false" name="ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_Onetimetransactiontaxpost1986EPnetpayment" abstract="false" name="Onetimetransactiontaxpost1986EPnetpayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_August2019TermLoanMember" abstract="true" name="August2019TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" abstract="false" name="DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_TaxRateDomain" abstract="true" name="TaxRateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DivestitureAgreementTransferOfFacilities" abstract="false" name="DivestitureAgreementTransferOfFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_OperatingIncomeLossAllocatedToReportableSegments" abstract="false" name="OperatingIncomeLossAllocatedToReportableSegments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" abstract="true" name="AggregateSeniorUnsecuredDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_May2022NotesMember" abstract="true" name="May2022NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_October2023NotesMember" abstract="true" name="October2023NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" abstract="false" name="AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_CumulativeRestructuringRelatedCostsIncurredToDate" abstract="false" name="CumulativeRestructuringRelatedCostsIncurredToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" abstract="false" name="FairValueOfFreeCashFlowFcfPerformanceAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSixthQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" abstract="false" name="LesseeOperatingAndFinanceLeasesOptionToExtend" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_RequirementAsOfJune302021Member" abstract="true" name="RequirementAsOfJune302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_AllOther2021AcquisitionsMember" abstract="true" name="AllOther2021AcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" abstract="false" name="TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" abstract="true" name="RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_LicensingArrangements" abstract="false" name="LicensingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CardiovascularMember" abstract="true" name="CardiovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RestructuringandRestructuringrelatedCostExpectedCost" abstract="false" name="RestructuringandRestructuringrelatedCostExpectedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_TheCARESAct" abstract="false" name="TheCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalElectrophysiologyEpReportingUnitMember" abstract="true" name="GlobalElectrophysiologyEpReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ForwardCurrencyContractsTimetoMaturity" abstract="false" name="ForwardCurrencyContractsTimetoMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_LicensingArrangementsLiability" abstract="false" name="LicensingArrangementsLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" abstract="false" name="EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" abstract="false" name="ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_June2025NotesMember" abstract="true" name="June2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherCurrentAssetsAbstract" abstract="true" name="OtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_DeemedConsolidatedEBITDA" abstract="false" name="DeemedConsolidatedEBITDA" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringPlanMember" abstract="true" name="RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" abstract="false" name="ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LicensingArrangementsAsset" abstract="false" name="LicensingArrangementsAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RequirementAsOfSeptember302021Member" abstract="true" name="RequirementAsOfSeptember302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_TotalAllocatedToReportableSegmentsMember" abstract="true" name="TotalAllocatedToReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_PercentOfFinishedGoodsAtConsignment" abstract="false" name="PercentOfFinishedGoodsAtConsignment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_RequirementAsOfMarch312021Member" abstract="true" name="RequirementAsOfMarch312021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CumulativeRestructuringChargesTableTextBlock" abstract="false" name="CumulativeRestructuringChargesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>bsx-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3eeb153c-443d-4b7c-bc48-13c100a9196f,g:5aeaa418-7365-4294-a466-e7b8cf11828b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e2df059c-f4ce-4d05-95da-ed8d68aa5c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_591b7f4f-f334-467c-8df0-d1a7d6cb6e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_e2df059c-f4ce-4d05-95da-ed8d68aa5c4a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_591b7f4f-f334-467c-8df0-d1a7d6cb6e9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6b6315b2-791d-4804-bd70-34d500aa2bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_e2df059c-f4ce-4d05-95da-ed8d68aa5c4a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6b6315b2-791d-4804-bd70-34d500aa2bb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f2ab4f69-d5cf-49e9-bab0-7846ac2fbcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f2ab4f69-d5cf-49e9-bab0-7846ac2fbcca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_323aba81-71d7-4964-bbba-02c442b1246c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_RestructuringCharges_323aba81-71d7-4964-bbba-02c442b1246c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_d0cd7570-dd7d-428c-bf93-0aaa68ffd4de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_d0cd7570-dd7d-428c-bf93-0aaa68ffd4de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_77e781e7-6bba-4fe5-89e6-ead9b3b753e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_77e781e7-6bba-4fe5-89e6-ead9b3b753e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_378d0d7f-a08e-4824-93a7-17fc9eaa6c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_378d0d7f-a08e-4824-93a7-17fc9eaa6c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1bea9c15-6e3b-420a-8b17-ce6597a91fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1bea9c15-6e3b-420a-8b17-ce6597a91fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_838eacb0-7b39-474e-ae3a-f1e9f80e7c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_RoyaltyExpense_838eacb0-7b39-474e-ae3a-f1e9f80e7c8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ca3771a2-041b-493e-8806-f62df584f45d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ca3771a2-041b-493e-8806-f62df584f45d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_6ee7a1f6-ee84-4778-af43-e47c908282b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_LitigationSettlementExpense_6ee7a1f6-ee84-4778-af43-e47c908282b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fb344a09-8f43-4d35-8c9a-213c89631c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_877193fb-bd41-4ff9-862e-9867216c5204" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fb344a09-8f43-4d35-8c9a-213c89631c4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fda4f892-c333-45a2-9112-bf4bd720f8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_31aff5e1-2dcb-4b15-a2d9-afabca4246db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fda4f892-c333-45a2-9112-bf4bd720f8b9" xlink:to="loc_us-gaap_DividendsPreferredStockStock_31aff5e1-2dcb-4b15-a2d9-afabca4246db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f2d373f1-3c6a-48b4-bf4b-18285c7d96fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fda4f892-c333-45a2-9112-bf4bd720f8b9" xlink:to="loc_us-gaap_ProfitLoss_f2d373f1-3c6a-48b4-bf4b-18285c7d96fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_730b4d1e-1c9d-42ad-85ee-0c2240876a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e9888793-d0c4-4723-bf38-cd092cf334f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_730b4d1e-1c9d-42ad-85ee-0c2240876a9e" xlink:to="loc_us-gaap_OperatingIncomeLoss_e9888793-d0c4-4723-bf38-cd092cf334f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_49e0e65f-7493-47f2-9d7e-0d03340a7a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_730b4d1e-1c9d-42ad-85ee-0c2240876a9e" xlink:to="loc_us-gaap_InterestExpense_49e0e65f-7493-47f2-9d7e-0d03340a7a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a12e2f79-9c06-4d75-935d-bef9d7e8bcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_730b4d1e-1c9d-42ad-85ee-0c2240876a9e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a12e2f79-9c06-4d75-935d-bef9d7e8bcca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_593462f2-6da8-4608-979b-be102409b2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_700bd56c-0102-455d-8e72-ee733c9947b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_593462f2-6da8-4608-979b-be102409b2ec" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_700bd56c-0102-455d-8e72-ee733c9947b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_05f46a41-8a5e-491f-8c93-a2e2f78d139d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_593462f2-6da8-4608-979b-be102409b2ec" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_05f46a41-8a5e-491f-8c93-a2e2f78d139d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_83240e64-4dc5-4381-ba0e-7e15f4db9516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f69a61ae-1b9e-4b7f-8890-d434fdf76294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_83240e64-4dc5-4381-ba0e-7e15f4db9516" xlink:to="loc_us-gaap_GrossProfit_f69a61ae-1b9e-4b7f-8890-d434fdf76294" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_58fb35dc-54d8-4596-b2c8-3e79ab27b9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_83240e64-4dc5-4381-ba0e-7e15f4db9516" xlink:to="loc_us-gaap_OperatingExpenses_58fb35dc-54d8-4596-b2c8-3e79ab27b9b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fd76c335-68e8-41da-9d9f-5d47e5dbc109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d0274e28-0b55-4c08-84d0-8cc86d181b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fd76c335-68e8-41da-9d9f-5d47e5dbc109" xlink:to="loc_us-gaap_ProfitLoss_d0274e28-0b55-4c08-84d0-8cc86d181b05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_54ee9b01-f18d-4385-88c0-51e1d034c5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fd76c335-68e8-41da-9d9f-5d47e5dbc109" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_54ee9b01-f18d-4385-88c0-51e1d034c5f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ad87e4de-71f4-4c07-bc08-f49517e15681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9c92ae5c-cd76-4a74-9bb2-0f6fdf7ffe90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ad87e4de-71f4-4c07-bc08-f49517e15681" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9c92ae5c-cd76-4a74-9bb2-0f6fdf7ffe90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a1284eeb-3199-40a0-9f65-560cd1794ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ad87e4de-71f4-4c07-bc08-f49517e15681" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a1284eeb-3199-40a0-9f65-560cd1794ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ff4239e8-7d05-4b0b-800b-5a617aeb83f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ad87e4de-71f4-4c07-bc08-f49517e15681" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ff4239e8-7d05-4b0b-800b-5a617aeb83f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0696aee0-c131-4978-90f6-6aa46d7afe69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_84562649-5780-4e0a-b61c-5502af84a686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0696aee0-c131-4978-90f6-6aa46d7afe69" xlink:to="loc_us-gaap_DebtCurrent_84562649-5780-4e0a-b61c-5502af84a686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fe4e0e18-c1f5-48ed-a784-cd14c9b54d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0696aee0-c131-4978-90f6-6aa46d7afe69" xlink:to="loc_us-gaap_AccountsPayableCurrent_fe4e0e18-c1f5-48ed-a784-cd14c9b54d25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3d4decd2-16f6-4ca4-b402-b5256a157a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0696aee0-c131-4978-90f6-6aa46d7afe69" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3d4decd2-16f6-4ca4-b402-b5256a157a86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2ccbf4a2-3c20-453d-92c9-f72248ddd52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0696aee0-c131-4978-90f6-6aa46d7afe69" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2ccbf4a2-3c20-453d-92c9-f72248ddd52c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7e0d3090-439e-42fe-b247-73bb615e7433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8327c700-f328-4c70-a31c-30e1570bd1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7e0d3090-439e-42fe-b247-73bb615e7433" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8327c700-f328-4c70-a31c-30e1570bd1fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2fc28981-b10e-47e8-8971-e080ff4e4bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7e0d3090-439e-42fe-b247-73bb615e7433" xlink:to="loc_us-gaap_Goodwill_2fc28981-b10e-47e8-8971-e080ff4e4bb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ad5f4b4a-86a6-49d0-9413-c1083825ab91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7e0d3090-439e-42fe-b247-73bb615e7433" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ad5f4b4a-86a6-49d0-9413-c1083825ab91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6ee0f659-3fc8-4a10-8bad-81f16ace5529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7e0d3090-439e-42fe-b247-73bb615e7433" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6ee0f659-3fc8-4a10-8bad-81f16ace5529" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_aabe5de4-adca-495e-9e18-c9230d1ff693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7e0d3090-439e-42fe-b247-73bb615e7433" xlink:to="loc_us-gaap_AssetsCurrent_aabe5de4-adca-495e-9e18-c9230d1ff693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_07a38aec-3ab2-4dda-8e19-b2914be757f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7e0d3090-439e-42fe-b247-73bb615e7433" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_07a38aec-3ab2-4dda-8e19-b2914be757f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_14e2d4d9-da38-4fb8-be2b-e8ecba09af33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a89bcd91-7988-45dd-8bc8-7848c2deaa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_14e2d4d9-da38-4fb8-be2b-e8ecba09af33" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a89bcd91-7988-45dd-8bc8-7848c2deaa94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_c1f5c418-8b28-47e7-97ee-5e6867e9392c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_14e2d4d9-da38-4fb8-be2b-e8ecba09af33" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_c1f5c418-8b28-47e7-97ee-5e6867e9392c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1ce4249b-65ff-4d0b-b1e9-bb4a9835322e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_14e2d4d9-da38-4fb8-be2b-e8ecba09af33" xlink:to="loc_us-gaap_InventoryNet_1ce4249b-65ff-4d0b-b1e9-bb4a9835322e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_4fcad41f-d19b-4e17-8c4f-5f792cbd2ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_14e2d4d9-da38-4fb8-be2b-e8ecba09af33" xlink:to="loc_us-gaap_PrepaidTaxes_4fcad41f-d19b-4e17-8c4f-5f792cbd2ba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_a059702e-a2f7-4a44-a6ff-a5b28466bac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_14e2d4d9-da38-4fb8-be2b-e8ecba09af33" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_a059702e-a2f7-4a44-a6ff-a5b28466bac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6ca9e6c0-7a8e-4a56-97e3-0dfe588facd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_14e2d4d9-da38-4fb8-be2b-e8ecba09af33" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6ca9e6c0-7a8e-4a56-97e3-0dfe588facd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c59d5454-fda6-4f1e-ae14-5546fab5ea10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d6187369-1c67-4c43-a333-a576a0d1c7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c59d5454-fda6-4f1e-ae14-5546fab5ea10" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d6187369-1c67-4c43-a333-a576a0d1c7a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1a5e2dd6-c452-46e1-864b-b8b27026ee80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c59d5454-fda6-4f1e-ae14-5546fab5ea10" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1a5e2dd6-c452-46e1-864b-b8b27026ee80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0cef16b8-a50a-4737-ac4f-eae6bd4ade0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c59d5454-fda6-4f1e-ae14-5546fab5ea10" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0cef16b8-a50a-4737-ac4f-eae6bd4ade0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_85560a25-6650-4d8a-8aed-b8dd071c2c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c59d5454-fda6-4f1e-ae14-5546fab5ea10" xlink:to="loc_us-gaap_LiabilitiesCurrent_85560a25-6650-4d8a-8aed-b8dd071c2c1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_dea51e96-7c8f-4557-b400-23c940dbe7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c59d5454-fda6-4f1e-ae14-5546fab5ea10" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_dea51e96-7c8f-4557-b400-23c940dbe7a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2834c6dc-8431-4cbf-b725-6783b0a19ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_PreferredStockValue_2834c6dc-8431-4cbf-b725-6783b0a19ffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_07f326b2-69de-47a2-a9d6-a6cc85909aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_CommonStockValue_07f326b2-69de-47a2-a9d6-a6cc85909aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_6ec6253d-e361-4fc5-a3c2-4bdb56c50c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_TreasuryStockValue_6ec6253d-e361-4fc5-a3c2-4bdb56c50c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_478d1990-4eb3-4e89-b9ef-1a0ad5d4169d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_478d1990-4eb3-4e89-b9ef-1a0ad5d4169d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_41ca90db-8200-4af0-92e4-f6ce64fd5f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_41ca90db-8200-4af0-92e4-f6ce64fd5f2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e2bd52b7-05a2-4d24-90d9-16965963d350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e2bd52b7-05a2-4d24-90d9-16965963d350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_87e1341b-4703-4d3b-aa5f-bc0c992f2c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_87e1341b-4703-4d3b-aa5f-bc0c992f2c3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f75bef2f-d9bb-457b-85fc-14a8677b29ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c24220a-18e6-4394-b3fb-31a0c25f2149" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f75bef2f-d9bb-457b-85fc-14a8677b29ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_005cfa2a-c0cc-4bbd-ba8a-868b3276df64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_ProfitLoss_005cfa2a-c0cc-4bbd-ba8a-868b3276df64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_d22a5fe1-e32d-4560-84fe-c2efc0f666fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_d22a5fe1-e32d-4560-84fe-c2efc0f666fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6581ec51-c77e-4b6c-8fce-3ffbba21c351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6581ec51-c77e-4b6c-8fce-3ffbba21c351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_6750c184-d505-48c6-b315-be2e9845ae52" xlink:href="bsx-20211231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_6750c184-d505-48c6-b315-be2e9845ae52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2e391bb6-6b0f-434e-bcc2-eae893e60323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_ShareBasedCompensation_2e391bb6-6b0f-434e-bcc2-eae893e60323" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_268b91ec-a140-43e3-8137-fbc0b5630048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_268b91ec-a140-43e3-8137-fbc0b5630048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_604b2927-e32d-43a9-8b11-0b03e3b401ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_GainLossOnInvestments_604b2927-e32d-43a9-8b11-0b03e3b401ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5e2f0cb2-5530-479c-920f-40d6659bb0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5e2f0cb2-5530-479c-920f-40d6659bb0ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_f9c2b525-ed6a-4181-bb64-942b8b790a43" xlink:href="bsx-20211231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_bsx_InventoryStepUpAmortization_f9c2b525-ed6a-4181-bb64-942b8b790a43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_f7aa1f21-3e11-4409-af70-c8e894b74ae3" xlink:href="bsx-20211231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_f7aa1f21-3e11-4409-af70-c8e894b74ae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_15f7f8c4-7a92-4ca3-ad27-6d28512713ad" xlink:href="bsx-20211231.xsd#bsx_OtherNet"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_bsx_OtherNet_15f7f8c4-7a92-4ca3-ad27-6d28512713ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_40fd061e-d662-4de2-b554-1d5be5076a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_40fd061e-d662-4de2-b554-1d5be5076a1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0ba4de71-ba19-4a84-a984-989a59e31dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0ba4de71-ba19-4a84-a984-989a59e31dcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f4fad66c-7dff-48c5-9c04-a0b20c8f4bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f4fad66c-7dff-48c5-9c04-a0b20c8f4bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2c88b174-254d-4925-80c6-e4305c89ea38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a74c2f29-5adf-436d-b65e-a9de6fc332e7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2c88b174-254d-4925-80c6-e4305c89ea38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_197d95e6-d283-4cc9-a907-20911507110e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_197d95e6-d283-4cc9-a907-20911507110e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_618ea77c-2e8f-49a5-ae41-dc3a65107262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_618ea77c-2e8f-49a5-ae41-dc3a65107262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c8449bd6-8d39-4437-b17d-196b7342acbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c8449bd6-8d39-4437-b17d-196b7342acbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_be331e7c-72c5-41d2-b78e-ff077df9d67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_be331e7c-72c5-41d2-b78e-ff077df9d67d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_84ed28e1-1887-41b1-9abc-fbf0aba24091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_84ed28e1-1887-41b1-9abc-fbf0aba24091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_a1748c62-bb5c-47ef-b7f4-ba7de30492ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_a1748c62-bb5c-47ef-b7f4-ba7de30492ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_13c6e71f-e718-4fe1-b5fc-63ef5d27bfbb" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9aaf0d40-8344-49a4-a803-6f4018d5d5ff" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_13c6e71f-e718-4fe1-b5fc-63ef5d27bfbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ab08b2bb-8861-492b-929a-fd6c53e63220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ab08b2bb-8861-492b-929a-fd6c53e63220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_8f465b30-027a-4500-9ec0-55c3623af7d7" xlink:href="bsx-20211231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_bsx_PaymentsForRoyaltyRights_8f465b30-027a-4500-9ec0-55c3623af7d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_2a337ec1-1e5e-48f8-b71f-6aed6cf151ec" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_2a337ec1-1e5e-48f8-b71f-6aed6cf151ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_1e1416a8-c525-4db4-a1ff-83bde87414c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_1e1416a8-c525-4db4-a1ff-83bde87414c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_837752df-2104-42e1-8bfa-3b35fed4781d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_837752df-2104-42e1-8bfa-3b35fed4781d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c45399c6-4eae-4d33-adcb-27e7a08bd675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c45399c6-4eae-4d33-adcb-27e7a08bd675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_efc2d764-3cd3-4d40-9c14-e9ae009e8d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_efc2d764-3cd3-4d40-9c14-e9ae009e8d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_74ef4202-cd99-44bf-a847-fea963161811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_74ef4202-cd99-44bf-a847-fea963161811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_b61941cc-1c81-4490-b079-b87ef307f51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_b61941cc-1c81-4490-b079-b87ef307f51a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_c44558cc-0cd1-4ae6-b3ac-6aec7de06599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_c44558cc-0cd1-4ae6-b3ac-6aec7de06599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f3889b4f-fa39-4610-a067-8936514236d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_PaymentsOfDividends_f3889b4f-fa39-4610-a067-8936514236d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_f8f86855-b68a-4bef-99a4-c03cc7fe3dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_f8f86855-b68a-4bef-99a4-c03cc7fe3dba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1dc271ca-036e-4148-bddf-be21a88671fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1dc271ca-036e-4148-bddf-be21a88671fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b6fb4c27-3f70-4d23-b1dd-4e7a92a76da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b6fb4c27-3f70-4d23-b1dd-4e7a92a76da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_3687b7a4-e353-43e1-b39d-d5ffe6b74a1b" xlink:href="bsx-20211231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_3687b7a4-e353-43e1-b39d-d5ffe6b74a1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_132ea203-90b0-4c5e-a8d8-59d143c37bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00aef9e-89f3-4b82-a450-6e41812f3c38" xlink:to="loc_us-gaap_ProceedsFromStockPlans_132ea203-90b0-4c5e-a8d8-59d143c37bd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_867c53a2-0498-4406-b2bd-beab750e2461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d4c85752-be50-4c35-ad9f-6856a9d7da78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_867c53a2-0498-4406-b2bd-beab750e2461" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d4c85752-be50-4c35-ad9f-6856a9d7da78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_07d21771-f21c-4f34-aa7b-25f50a1d5dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_867c53a2-0498-4406-b2bd-beab750e2461" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_07d21771-f21c-4f34-aa7b-25f50a1d5dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_602a49ca-f851-47b9-b6da-ee80ee730a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_867c53a2-0498-4406-b2bd-beab750e2461" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_602a49ca-f851-47b9-b6da-ee80ee730a27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8c5e722-0a13-41c2-8db6-24f72ed911ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_867c53a2-0498-4406-b2bd-beab750e2461" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8c5e722-0a13-41c2-8db6-24f72ed911ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_f20d613d-a817-4579-8ad8-5b4e586011e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_abd8ec37-3196-410a-b594-01c99c9154d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_f20d613d-a817-4579-8ad8-5b4e586011e3" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_abd8ec37-3196-410a-b594-01c99c9154d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_c2b1fb1a-f1da-4324-ad22-f911a6df066b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_f20d613d-a817-4579-8ad8-5b4e586011e3" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_c2b1fb1a-f1da-4324-ad22-f911a6df066b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_017319d0-aaca-49f8-9678-3c202ff47e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_f20d613d-a817-4579-8ad8-5b4e586011e3" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_017319d0-aaca-49f8-9678-3c202ff47e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_74970304-b309-4e8c-8e84-c3c8e0d00464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_f20d613d-a817-4579-8ad8-5b4e586011e3" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_74970304-b309-4e8c-8e84-c3c8e0d00464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_d3665e2b-e9b9-4653-af7a-1d748dc58f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_f20d613d-a817-4579-8ad8-5b4e586011e3" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_d3665e2b-e9b9-4653-af7a-1d748dc58f02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_179eeeae-ecfb-4489-840f-5328afeaf6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_f20d613d-a817-4579-8ad8-5b4e586011e3" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_179eeeae-ecfb-4489-840f-5328afeaf6be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9db709-badb-47fd-a00f-fa2b386c6626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a996e738-7bd3-4a95-a82b-0bd221eb8b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9db709-badb-47fd-a00f-fa2b386c6626" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a996e738-7bd3-4a95-a82b-0bd221eb8b8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_fde4cb89-fa4e-404e-b61b-6a905b479cee" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9db709-badb-47fd-a00f-fa2b386c6626" xlink:to="loc_bsx_LicensingArrangementsLiability_fde4cb89-fa4e-404e-b61b-6a905b479cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ec2479cf-8990-47fa-bcaa-e4a080649413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9db709-badb-47fd-a00f-fa2b386c6626" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ec2479cf-8990-47fa-bcaa-e4a080649413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_c7f84cba-1b95-43f8-9d87-9449a5c3f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9db709-badb-47fd-a00f-fa2b386c6626" xlink:to="loc_us-gaap_DeferredRevenue_c7f84cba-1b95-43f8-9d87-9449a5c3f7ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_d4cb39d6-4506-4412-bcea-07f09f030730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9db709-badb-47fd-a00f-fa2b386c6626" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_d4cb39d6-4506-4412-bcea-07f09f030730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_4cb04e8f-c6b5-41e8-a0da-c7cb2284e45d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9db709-badb-47fd-a00f-fa2b386c6626" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_4cb04e8f-c6b5-41e8-a0da-c7cb2284e45d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_d4838d35-7789-4f61-ad6b-0369f308d735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_7c7c03b3-ccf8-45ea-b3bd-06feaf3f6566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_d4838d35-7789-4f61-ad6b-0369f308d735" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_7c7c03b3-ccf8-45ea-b3bd-06feaf3f6566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_35872769-2078-4948-bc82-65ef8b0eb63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_d4838d35-7789-4f61-ad6b-0369f308d735" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_35872769-2078-4948-bc82-65ef8b0eb63a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d87249e1-bc9f-4b8d-8d61-1415e46d4585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_0942d95c-a513-4c1f-89b4-0e37676ae113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d87249e1-bc9f-4b8d-8d61-1415e46d4585" xlink:to="loc_us-gaap_Land_0942d95c-a513-4c1f-89b4-0e37676ae113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_42ae57c5-72ce-480d-8119-547b9d343ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d87249e1-bc9f-4b8d-8d61-1415e46d4585" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_42ae57c5-72ce-480d-8119-547b9d343ea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_44d78346-52f1-4a09-b0e2-b06afa18601b" xlink:href="bsx-20211231.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d87249e1-bc9f-4b8d-8d61-1415e46d4585" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_44d78346-52f1-4a09-b0e2-b06afa18601b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_2cb40382-970d-4ab6-b868-13ec82d6f06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d87249e1-bc9f-4b8d-8d61-1415e46d4585" xlink:to="loc_us-gaap_ConstructionInProgressGross_2cb40382-970d-4ab6-b868-13ec82d6f06a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_88b2e3b2-6d25-46d3-b03e-ac07cdd4b462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2f171239-9856-46b2-9519-fbe59bd202dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_88b2e3b2-6d25-46d3-b03e-ac07cdd4b462" xlink:to="loc_us-gaap_Investments_2f171239-9856-46b2-9519-fbe59bd202dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_89ec81c0-5411-49ec-be29-feb196e85b66" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_88b2e3b2-6d25-46d3-b03e-ac07cdd4b462" xlink:to="loc_bsx_LicensingArrangementsAsset_89ec81c0-5411-49ec-be29-feb196e85b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_86276c9f-09d9-4383-b79a-a15a34ab2860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_88b2e3b2-6d25-46d3-b03e-ac07cdd4b462" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_86276c9f-09d9-4383-b79a-a15a34ab2860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2da0bc69-1226-43ee-8b57-90f4e06d0ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_88b2e3b2-6d25-46d3-b03e-ac07cdd4b462" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2da0bc69-1226-43ee-8b57-90f4e06d0ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongTermAssets_9cae0cf7-69ec-4094-b315-2d30d5dd4ac8" xlink:href="bsx-20211231.xsd#bsx_OtherOtherLongTermAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_88b2e3b2-6d25-46d3-b03e-ac07cdd4b462" xlink:to="loc_bsx_OtherOtherLongTermAssets_9cae0cf7-69ec-4094-b315-2d30d5dd4ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f4858a23-f52f-4281-9a74-20cac08cb186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_88b2e3b2-6d25-46d3-b03e-ac07cdd4b462" xlink:to="loc_us-gaap_DerivativeAssets_f4858a23-f52f-4281-9a74-20cac08cb186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_19fa7162-9eb7-4b77-8fc7-2ec0dc2ba560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1084963b-3c69-482b-8bb6-153377984fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_19fa7162-9eb7-4b77-8fc7-2ec0dc2ba560" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1084963b-3c69-482b-8bb6-153377984fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c27e963b-7600-42e3-a51a-8ea00772853a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_19fa7162-9eb7-4b77-8fc7-2ec0dc2ba560" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c27e963b-7600-42e3-a51a-8ea00772853a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a53aaf64-05ef-430a-9272-500e4aedb4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_e4251ddc-b8cd-480e-84a6-ec4d737b2f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a53aaf64-05ef-430a-9272-500e4aedb4d2" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_e4251ddc-b8cd-480e-84a6-ec4d737b2f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_70f6da9b-c95e-4110-9405-9f597c1a085a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a53aaf64-05ef-430a-9272-500e4aedb4d2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_70f6da9b-c95e-4110-9405-9f597c1a085a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangements_1d4c4ed3-e127-487f-8106-fa8193b7c89f" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a53aaf64-05ef-430a-9272-500e4aedb4d2" xlink:to="loc_bsx_LicensingArrangements_1d4c4ed3-e127-487f-8106-fa8193b7c89f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_1420ef30-ef51-4368-8483-76e776060378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a53aaf64-05ef-430a-9272-500e4aedb4d2" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_1420ef30-ef51-4368-8483-76e776060378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7bbcd273-304d-45ad-9ebd-c83926c38227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_27b918f0-c185-42a7-95a0-01f3c9babb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7bbcd273-304d-45ad-9ebd-c83926c38227" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_27b918f0-c185-42a7-95a0-01f3c9babb9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e9e5a36e-2165-475f-bdbc-2e219d3e51c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7bbcd273-304d-45ad-9ebd-c83926c38227" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e9e5a36e-2165-475f-bdbc-2e219d3e51c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_9ed60d11-69d6-4182-a59e-100223949af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7bbcd273-304d-45ad-9ebd-c83926c38227" xlink:to="loc_us-gaap_LitigationReserveCurrent_9ed60d11-69d6-4182-a59e-100223949af8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bee82206-2ab3-419f-b3f4-20734e776244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7bbcd273-304d-45ad-9ebd-c83926c38227" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bee82206-2ab3-419f-b3f4-20734e776244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_ba65d134-a96a-4579-80b4-d9fab2c77bff" xlink:href="bsx-20211231.xsd#bsx_AccruedRebatesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7bbcd273-304d-45ad-9ebd-c83926c38227" xlink:to="loc_bsx_AccruedRebatesCurrent_ba65d134-a96a-4579-80b4-d9fab2c77bff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9803bf94-3243-4687-8709-0ee0be95e872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3aa4769d-b06d-465e-a3f2-f377be2b3dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9803bf94-3243-4687-8709-0ee0be95e872" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3aa4769d-b06d-465e-a3f2-f377be2b3dfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6426562-cdfd-4bad-b1ee-e261a6c928d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9803bf94-3243-4687-8709-0ee0be95e872" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6426562-cdfd-4bad-b1ee-e261a6c928d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3d73d075-d2a9-45a7-849d-22ab45cde824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e207457f-41b9-4afe-98cb-a8dcbb0fa917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3d73d075-d2a9-45a7-849d-22ab45cde824" xlink:to="loc_us-gaap_OperatingIncomeLoss_e207457f-41b9-4afe-98cb-a8dcbb0fa917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2176157e-cd7a-450b-9674-2e90015d2ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3d73d075-d2a9-45a7-849d-22ab45cde824" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2176157e-cd7a-450b-9674-2e90015d2ea6" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>bsx-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3eeb153c-443d-4b7c-bc48-13c100a9196f,g:5aeaa418-7365-4294-a466-e7b8cf11828b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Cover" xlink:type="simple" xlink:href="bsx-20211231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/Cover" xlink:type="extended" id="i1dce6a9b29c34a43842cc850e08b649b_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c370b9eb-eee9-479f-a338-81752990b56b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentType_c370b9eb-eee9-479f-a338-81752990b56b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_fb917aaf-936a-4132-93f3-85b948ae7c14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentAnnualReport_fb917aaf-936a-4132-93f3-85b948ae7c14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e9328832-dfe4-4d8d-a7b2-49827ee345ea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentPeriodEndDate_e9328832-dfe4-4d8d-a7b2-49827ee345ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d7863b76-3b4b-4766-9787-5ca4ebd6707a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentTransitionReport_d7863b76-3b4b-4766-9787-5ca4ebd6707a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5a6f5780-cf0c-4394-9ea2-251fe85e8d2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityFileNumber_5a6f5780-cf0c-4394-9ea2-251fe85e8d2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5b93a33f-93a1-4b39-b633-9619855bc15e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityRegistrantName_5b93a33f-93a1-4b39-b633-9619855bc15e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_08859152-c0c9-4d31-aa2f-4a6d51b4904c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityIncorporationStateCountryCode_08859152-c0c9-4d31-aa2f-4a6d51b4904c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c48b5304-81f5-48d8-9e54-f681e1b1e498" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityTaxIdentificationNumber_c48b5304-81f5-48d8-9e54-f681e1b1e498" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_91fa262a-658f-4548-b549-4a75b89bc984" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressAddressLine1_91fa262a-658f-4548-b549-4a75b89bc984" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2d1d56c0-cd96-455f-87f6-58361298ef70" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressCityOrTown_2d1d56c0-cd96-455f-87f6-58361298ef70" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_615ddcd3-c8fe-441b-b79c-392e96660dfb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressStateOrProvince_615ddcd3-c8fe-441b-b79c-392e96660dfb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_83e13d7e-1f72-4ce8-9241-c8e2b1051084" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressPostalZipCode_83e13d7e-1f72-4ce8-9241-c8e2b1051084" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_df049fb0-73aa-4c89-97d5-8521e58a3bfd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_CityAreaCode_df049fb0-73aa-4c89-97d5-8521e58a3bfd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ef3c2f75-9672-4391-9c8f-ef7ea02609cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_LocalPhoneNumber_ef3c2f75-9672-4391-9c8f-ef7ea02609cc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_807030ad-0d75-4d64-8ad4-f84a94c79683" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_Security12bTitle_807030ad-0d75-4d64-8ad4-f84a94c79683" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a876e6ea-56f2-4473-88e5-5a93fb002a02" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_TradingSymbol_a876e6ea-56f2-4473-88e5-5a93fb002a02" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dcf954ee-f38c-4224-ac1d-dc314a361231" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_SecurityExchangeName_dcf954ee-f38c-4224-ac1d-dc314a361231" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_95d8937f-e851-45b6-b13a-af43b1671fa9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_95d8937f-e851-45b6-b13a-af43b1671fa9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_453d2f33-3268-49e6-b13e-dddc46be7835" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityVoluntaryFilers_453d2f33-3268-49e6-b13e-dddc46be7835" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_69e60018-2080-4094-8a60-3148c16bce2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityCurrentReportingStatus_69e60018-2080-4094-8a60-3148c16bce2d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d986eb34-3641-48ce-8ca8-39f5b9c02de9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityInteractiveDataCurrent_d986eb34-3641-48ce-8ca8-39f5b9c02de9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_40314bba-3a1c-41ff-97da-28141aa90523" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityFilerCategory_40314bba-3a1c-41ff-97da-28141aa90523" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_182a7c6c-c599-4f62-a22d-738ce06f2d34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntitySmallBusiness_182a7c6c-c599-4f62-a22d-738ce06f2d34" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ffe65aef-7601-49db-92e9-c40d3137814a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityEmergingGrowthCompany_ffe65aef-7601-49db-92e9-c40d3137814a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_9c116202-fab1-4369-896c-101932c8b664" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_IcfrAuditorAttestationFlag_9c116202-fab1-4369-896c-101932c8b664" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3291876c-7843-49e7-b9fc-b1f491188c1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityShellCompany_3291876c-7843-49e7-b9fc-b1f491188c1c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_18250c2c-8f7e-4cc0-a2c3-4a95721851fa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityPublicFloat_18250c2c-8f7e-4cc0-a2c3-4a95721851fa" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_0c0c0037-cab8-4c3a-88a5-4d22a45a0add" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityListingParValuePerShare_0c0c0037-cab8-4c3a-88a5-4d22a45a0add" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_08308ed5-e450-4953-be64-8951f8308f63" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_08308ed5-e450-4953-be64-8951f8308f63" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_81c7afbd-b716-4a62-aa95-e2fddc6cdf38" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityCentralIndexKey_81c7afbd-b716-4a62-aa95-e2fddc6cdf38" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_aae50883-f061-492f-bd4f-265a8c157f77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_CurrentFiscalYearEndDate_aae50883-f061-492f-bd4f-265a8c157f77" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a1e9d75a-d1a9-4448-bdf0-e4aba1dab2cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentFiscalYearFocus_a1e9d75a-d1a9-4448-bdf0-e4aba1dab2cc" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_a9c26a2e-9ba5-4595-8797-d5c2cf64d7be" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentFiscalPeriodFocus_a9c26a2e-9ba5-4595-8797-d5c2cf64d7be" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4dc03ef6-70f9-4d95-a4e8-f112a30d3687" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_AmendmentFlag_4dc03ef6-70f9-4d95-a4e8-f112a30d3687" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_b5634c77-6c44-40d2-9ba6-89a42c503949" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntitiesTable_b5634c77-6c44-40d2-9ba6-89a42c503949" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c6145c00-4bbb-4cfd-85fc-aabaa9469243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_b5634c77-6c44-40d2-9ba6-89a42c503949" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c6145c00-4bbb-4cfd-85fc-aabaa9469243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c6145c00-4bbb-4cfd-85fc-aabaa9469243_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c6145c00-4bbb-4cfd-85fc-aabaa9469243" xlink:to="loc_us-gaap_ClassOfStockDomain_c6145c00-4bbb-4cfd-85fc-aabaa9469243_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c6145c00-4bbb-4cfd-85fc-aabaa9469243" xlink:to="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_18309ddc-764f-4d2f-81c4-5d03118a1f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:to="loc_us-gaap_CommonStockMember_18309ddc-764f-4d2f-81c4-5d03118a1f76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_f3cf6ca7-b574-475f-b922-ac094e705fda" xlink:href="bsx-20211231.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:to="loc_bsx_SeniorNotedue2027Member_f3cf6ca7-b574-475f-b922-ac094e705fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_9905c58a-f05b-4cb4-891c-e92b11944d39" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:to="loc_bsx_A550MCPSSeriesAMember_9905c58a-f05b-4cb4-891c-e92b11944d39" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i24dd5ea1cb0b4ddf85cc3c2e65ac0510_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e774fc37-7757-4a62-8239-034afda75a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e774fc37-7757-4a62-8239-034afda75a0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4af1cd49-d0eb-4a51-8658-6010187b5916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4af1cd49-d0eb-4a51-8658-6010187b5916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_43041359-7695-411a-a33e-e345a5ae591c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_GrossProfit_43041359-7695-411a-a33e-e345a5ae591c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_771b80bc-4b1e-4595-9a6b-e0aaa4b87ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_771b80bc-4b1e-4595-9a6b-e0aaa4b87ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_93f708e5-3061-4750-b8d7-a43f34e9999b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_93f708e5-3061-4750-b8d7-a43f34e9999b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_8d4febf6-edca-4dda-aca7-2fc20209d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_RoyaltyExpense_8d4febf6-edca-4dda-aca7-2fc20209d831" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_87f6df6c-ff8b-4711-8de5-5dd337813eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_87f6df6c-ff8b-4711-8de5-5dd337813eea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_295fbad5-ccd8-4a8c-9cf7-2e921e415d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_295fbad5-ccd8-4a8c-9cf7-2e921e415d99" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8da02d7f-b4ca-4696-8d31-96cdc9b6bac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8da02d7f-b4ca-4696-8d31-96cdc9b6bac7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3dde323d-af63-4a2f-8fff-ced565651376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3dde323d-af63-4a2f-8fff-ced565651376" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_750d9caf-6e3a-4843-bb41-019378d1aba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_RestructuringCharges_750d9caf-6e3a-4843-bb41-019378d1aba7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_cd11eb89-306e-45cd-ab39-2b99e8a492d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_LitigationSettlementExpense_cd11eb89-306e-45cd-ab39-2b99e8a492d1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_66f9736c-1754-4685-a98d-e44484efd3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_66f9736c-1754-4685-a98d-e44484efd3bf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ce92cc01-5ed5-44f9-97ca-220e13747779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_OperatingExpenses_ce92cc01-5ed5-44f9-97ca-220e13747779" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_20930504-2219-4a58-ac1d-9c736a851d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_OperatingIncomeLoss_20930504-2219-4a58-ac1d-9c736a851d6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_aa96ed59-933f-43cd-a8c4-286b7b685566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:to="loc_us-gaap_InterestExpense_aa96ed59-933f-43cd-a8c4-286b7b685566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b517ad30-19ae-40de-9060-409b13985030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b517ad30-19ae-40de-9060-409b13985030" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f29b2ec-22ff-4427-acbd-c2957b52cf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f29b2ec-22ff-4427-acbd-c2957b52cf7c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a5c700a1-a4ac-46cc-93fd-65a7a3f5df24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a5c700a1-a4ac-46cc-93fd-65a7a3f5df24" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_18c8afb2-b507-47bb-869f-cd64ca95be04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_ProfitLoss_18c8afb2-b507-47bb-869f-cd64ca95be04" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_6f0d3c19-868e-474c-9ce9-00e63db30df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_DividendsPreferredStockStock_6f0d3c19-868e-474c-9ce9-00e63db30df9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_54bfe5db-52b8-4f4c-9cee-4df4644bbb90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_54bfe5db-52b8-4f4c-9cee-4df4644bbb90" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fe618249-28e2-4fa9-9782-0f7348631e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_EarningsPerShareBasic_fe618249-28e2-4fa9-9782-0f7348631e25" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9e83e6b8-a5e4-4ff4-829f-0fda0918f022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9e83e6b8-a5e4-4ff4-829f-0fda0918f022" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b1cb1282-2568-4226-a31a-ee401c6db534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b1cb1282-2568-4226-a31a-ee401c6db534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b92465a4-cfca-4290-ad89-811285b4d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b92465a4-cfca-4290-ad89-811285b4d7f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9ec2adbf-6aaf-40ec-8c6f-21cdbe808692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_StatementTable_9ec2adbf-6aaf-40ec-8c6f-21cdbe808692" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8fd2b6d1-ac24-44a9-983e-44ec4741758e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9ec2adbf-6aaf-40ec-8c6f-21cdbe808692" xlink:to="loc_srt_StatementScenarioAxis_8fd2b6d1-ac24-44a9-983e-44ec4741758e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8fd2b6d1-ac24-44a9-983e-44ec4741758e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_8fd2b6d1-ac24-44a9-983e-44ec4741758e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8fd2b6d1-ac24-44a9-983e-44ec4741758e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_aaf86b55-e4f7-4210-84e9-633736c1dc84" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_8fd2b6d1-ac24-44a9-983e-44ec4741758e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_aaf86b55-e4f7-4210-84e9-633736c1dc84" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i4f84c3eb7bcc4605a8a81003029bd012_ConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_356cbbe2-0149-4c56-9eef-c7536a5b736c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:to="loc_us-gaap_ProfitLoss_356cbbe2-0149-4c56-9eef-c7536a5b736c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_29db4e45-67c1-4d0d-9930-0839e50525f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_29db4e45-67c1-4d0d-9930-0839e50525f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4d0e126a-7110-4245-a52c-6fae55b467b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4d0e126a-7110-4245-a52c-6fae55b467b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0f4821cd-51c8-4cb6-9d4d-383d2d9734f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0f4821cd-51c8-4cb6-9d4d-383d2d9734f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35be9f6f-e434-4c63-a3bb-aea0a0930ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35be9f6f-e434-4c63-a3bb-aea0a0930ec5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_37b7eb35-0401-4006-85ef-72da1bd211e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_37b7eb35-0401-4006-85ef-72da1bd211e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:to="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:to="loc_srt_StatementScenarioAxis_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c214d010-eed7-44d0-b4fb-8b669c50a5dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c214d010-eed7-44d0-b4fb-8b669c50a5dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc" xlink:to="loc_us-gaap_EquityComponentDomain_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2ab9a09e-5dcf-4496-96b7-76a51b092c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc" xlink:to="loc_us-gaap_EquityComponentDomain_2ab9a09e-5dcf-4496-96b7-76a51b092c1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_b61bb7ea-8c08-4895-a63f-9170bc08cacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2ab9a09e-5dcf-4496-96b7-76a51b092c1d" xlink:to="loc_us-gaap_PreferredStockMember_b61bb7ea-8c08-4895-a63f-9170bc08cacf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="ib1f14f6b8ed7429dacb455177de56c37_ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:to="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e420ec4d-9315-46d3-923b-fd553529e967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e420ec4d-9315-46d3-923b-fd553529e967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_0e0d0141-8ae0-4972-8eef-f0e30ea5ffa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_0e0d0141-8ae0-4972-8eef-f0e30ea5ffa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cdd4fdb0-fa19-4433-bc04-769b6fd0aef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_InventoryNet_cdd4fdb0-fa19-4433-bc04-769b6fd0aef6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_18937e16-3c93-4cd5-85a3-587be9751749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_PrepaidTaxes_18937e16-3c93-4cd5-85a3-587be9751749" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0f199e1f-9b07-47f8-956a-2fbbba1f09d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0f199e1f-9b07-47f8-956a-2fbbba1f09d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f1c05a07-4c21-496f-b0bb-d91ca9783946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f1c05a07-4c21-496f-b0bb-d91ca9783946" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7d8bc2cb-b679-4696-9dca-1c5123df9194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_AssetsCurrent_7d8bc2cb-b679-4696-9dca-1c5123df9194" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0c9c3ab1-01df-46ec-8279-ab19ea220151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0c9c3ab1-01df-46ec-8279-ab19ea220151" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d78828a0-0115-46cd-a9ae-c30dfaf1b399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_Goodwill_d78828a0-0115-46cd-a9ae-c30dfaf1b399" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_77ba5833-d78b-49c4-8f64-84fc16ec57eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_77ba5833-d78b-49c4-8f64-84fc16ec57eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_33bb63a6-4f63-4ac8-ae09-d49c5bc52080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_33bb63a6-4f63-4ac8-ae09-d49c5bc52080" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a8527528-1ace-45a6-ac43-deca6e18cb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a8527528-1ace-45a6-ac43-deca6e18cb6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1c65808d-45b7-424a-80d2-45a328c84e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_Assets_1c65808d-45b7-424a-80d2-45a328c84e60" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_358b8ea4-f3be-44bb-9936-dd2d3d2f577f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_DebtCurrent_358b8ea4-f3be-44bb-9936-dd2d3d2f577f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6fb4fa8b-c77e-4889-9a83-b8fa7ae0a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_AccountsPayableCurrent_6fb4fa8b-c77e-4889-9a83-b8fa7ae0a4b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_55a4f25d-de54-43ea-8422-22598cac917c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_55a4f25d-de54-43ea-8422-22598cac917c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6227dc32-b6d0-43b4-8958-4ffb96036bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6227dc32-b6d0-43b4-8958-4ffb96036bb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d8dd7b7e-1684-47ec-8259-96052d952b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_LiabilitiesCurrent_d8dd7b7e-1684-47ec-8259-96052d952b62" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f53777c3-9134-4b63-8377-e15a5f18bcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f53777c3-9134-4b63-8377-e15a5f18bcaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9c5cede0-2aaf-4618-8808-b1e7ac8fd804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9c5cede0-2aaf-4618-8808-b1e7ac8fd804" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_97a84633-c3e4-4a08-8cf9-d8598741a09d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_97a84633-c3e4-4a08-8cf9-d8598741a09d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_11d87463-efb6-4931-a9d1-e26aa291fb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_11d87463-efb6-4931-a9d1-e26aa291fb31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_810e40a2-3f2f-4ca8-98a9-696d7cdb579a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_810e40a2-3f2f-4ca8-98a9-696d7cdb579a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0bbc2c41-0207-435f-86e9-a28a9c2670dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_PreferredStockValue_0bbc2c41-0207-435f-86e9-a28a9c2670dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_aa7d4c88-602d-4db7-bafb-5ba8ccc48e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_CommonStockValue_aa7d4c88-602d-4db7-bafb-5ba8ccc48e5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1f2cb075-42d3-4abe-8385-d3aa4a2e810f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_TreasuryStockShares_1f2cb075-42d3-4abe-8385-d3aa4a2e810f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f3f5af13-3207-446f-a764-be7d48597e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_TreasuryStockValue_f3f5af13-3207-446f-a764-be7d48597e87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5fc7f91-6c35-46e1-bc0a-7e849833d695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5fc7f91-6c35-46e1-bc0a-7e849833d695" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a055f620-7783-4f65-96aa-d590aee2c086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a055f620-7783-4f65-96aa-d590aee2c086" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a6743f76-6831-446f-9b5e-b348b25f5d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a6743f76-6831-446f-9b5e-b348b25f5d60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_90769912-2b10-43c7-bf5c-774752d811bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_90769912-2b10-43c7-bf5c-774752d811bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f225567b-80ba-4547-9d84-fe8b0713e15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f225567b-80ba-4547-9d84-fe8b0713e15a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_148f8c36-4a91-4044-97dd-ec1dab97fd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_148f8c36-4a91-4044-97dd-ec1dab97fd17" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfb0fec7-89ab-4bc1-b889-7049f5e9a245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfb0fec7-89ab-4bc1-b889-7049f5e9a245" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_68a11ed3-aef5-43ae-a947-a9d430d74b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:to="loc_us-gaap_StatementTable_68a11ed3-aef5-43ae-a947-a9d430d74b39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_47016937-0424-4739-9581-a71da00b97c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_68a11ed3-aef5-43ae-a947-a9d430d74b39" xlink:to="loc_srt_StatementScenarioAxis_47016937-0424-4739-9581-a71da00b97c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_47016937-0424-4739-9581-a71da00b97c7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_47016937-0424-4739-9581-a71da00b97c7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_47016937-0424-4739-9581-a71da00b97c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_31f80b81-de95-4933-a231-8264b8f94560" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_47016937-0424-4739-9581-a71da00b97c7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_31f80b81-de95-4933-a231-8264b8f94560" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i5496258e58074e408c7a14d88b914b0f_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9282de63-d4f4-4622-9184-75429b51ba67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9282de63-d4f4-4622-9184-75429b51ba67" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d6d78b32-f4bf-4933-b960-5fc8e7ecfee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_SharesIssued_d6d78b32-f4bf-4933-b960-5fc8e7ecfee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4b5b0f8-a1e7-44a4-bfce-4a4aa3ebc2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4b5b0f8-a1e7-44a4-bfce-4a4aa3ebc2fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3919f721-2307-4721-92a6-fc009d31e873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3919f721-2307-4721-92a6-fc009d31e873" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_821d3b1a-9ec7-4e08-ae3a-0012594e60df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_821d3b1a-9ec7-4e08-ae3a-0012594e60df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_99d3133f-c321-448c-b431-41f329a9d962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_99d3133f-c321-448c-b431-41f329a9d962" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9d4364fe-7971-4a17-9688-1959d0c5d0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9d4364fe-7971-4a17-9688-1959d0c5d0d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_c4658aff-4a08-4554-92a6-580da62099e1" xlink:href="bsx-20211231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_c4658aff-4a08-4554-92a6-580da62099e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_dce34f8b-fc92-4664-8dac-e18768534d83" xlink:href="bsx-20211231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_dce34f8b-fc92-4664-8dac-e18768534d83" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_87bcacd5-83ce-4152-8686-87f1e504b3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_87bcacd5-83ce-4152-8686-87f1e504b3e3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ebffac3d-5925-4aed-8745-a39049ae6e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_ProfitLoss_ebffac3d-5925-4aed-8745-a39049ae6e55" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_41fa10cc-3465-4b4c-a652-141616dd8e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_41fa10cc-3465-4b4c-a652-141616dd8e71" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_cd36be41-d313-4512-8c37-3710adfbc104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_DividendsPreferredStockCash_cd36be41-d313-4512-8c37-3710adfbc104" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_c5624d51-c955-4379-a11f-8388978549c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b3daf6b1-6e81-4674-b047-757409ee04b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b3daf6b1-6e81-4674-b047-757409ee04b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_64818653-d0af-46b6-990f-1338aeef50c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_64818653-d0af-46b6-990f-1338aeef50c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f91f5faa-1eeb-47c1-95e6-4ea7a4257c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f91f5faa-1eeb-47c1-95e6-4ea7a4257c14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_39c5d8cd-534d-4ddd-acc4-c82d9550e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d8d80f7f-480c-4a09-8a2a-5df237cc718f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9282de63-d4f4-4622-9184-75429b51ba67" xlink:to="loc_us-gaap_StatementTable_d8d80f7f-480c-4a09-8a2a-5df237cc718f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1d54f1f8-6f04-46d4-8e74-d913f9fe7403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d8d80f7f-480c-4a09-8a2a-5df237cc718f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1d54f1f8-6f04-46d4-8e74-d913f9fe7403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d54f1f8-6f04-46d4-8e74-d913f9fe7403_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1d54f1f8-6f04-46d4-8e74-d913f9fe7403" xlink:to="loc_us-gaap_EquityComponentDomain_1d54f1f8-6f04-46d4-8e74-d913f9fe7403_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1d54f1f8-6f04-46d4-8e74-d913f9fe7403" xlink:to="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_bc6ed0bc-15c1-4e1a-8a53-e56e86d25735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_PreferredStockMember_bc6ed0bc-15c1-4e1a-8a53-e56e86d25735" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2a3c18e8-6793-4d59-86d2-c45373d9ee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_CommonStockMember_2a3c18e8-6793-4d59-86d2-c45373d9ee3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1d21c1f1-02d8-47c6-b9a7-31a08db67d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_TreasuryStockMember_1d21c1f1-02d8-47c6-b9a7-31a08db67d8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2c17f35a-7cba-4c66-9dce-55cf1587e4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2c17f35a-7cba-4c66-9dce-55cf1587e4a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_aff3214f-5598-4ed2-97e1-971b24172b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_RetainedEarningsMember_aff3214f-5598-4ed2-97e1-971b24172b46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1aa328f0-986d-41e6-9e8e-3663f4cdcb99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1aa328f0-986d-41e6-9e8e-3663f4cdcb99" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="ide310ddc17034259bc77f000d86c982e_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f745cc75-14cf-4741-a697-a4f41e00d165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_ProfitLoss_f745cc75-14cf-4741-a697-a4f41e00d165" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd08d5c7-a851-48e7-a7fd-4be360dbff80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd08d5c7-a851-48e7-a7fd-4be360dbff80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5f2099d5-24f2-45e2-8a6e-f221fbf135fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5f2099d5-24f2-45e2-8a6e-f221fbf135fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6545357d-a741-4116-8c21-9b8082f4b68e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6545357d-a741-4116-8c21-9b8082f4b68e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_bd70b20f-5e1d-4a10-9d7f-e3ca3b1a6011" xlink:href="bsx-20211231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_bd70b20f-5e1d-4a10-9d7f-e3ca3b1a6011" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f1a745fd-63be-4a85-98e6-ae9d4fd6d728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_ShareBasedCompensation_f1a745fd-63be-4a85-98e6-ae9d4fd6d728" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c3fc2f2f-ef11-49cf-b4c9-d60a6dbc043a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c3fc2f2f-ef11-49cf-b4c9-d60a6dbc043a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_5137abe1-d2cc-4939-b2c7-8b7f08ef28ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_GainLossOnInvestments_5137abe1-d2cc-4939-b2c7-8b7f08ef28ff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_56a98708-9af1-41a0-a543-0f435b719c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_56a98708-9af1-41a0-a543-0f435b719c8f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_3600e1fd-4b24-4c5f-abc6-f3fe6458ebf1" xlink:href="bsx-20211231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_InventoryStepUpAmortization_3600e1fd-4b24-4c5f-abc6-f3fe6458ebf1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_7740b3d8-798f-487c-bbc8-dcea1158a94d" xlink:href="bsx-20211231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_7740b3d8-798f-487c-bbc8-dcea1158a94d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_92393d6d-6d46-4bd0-95ce-ce7bc03b4e81" xlink:href="bsx-20211231.xsd#bsx_OtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_OtherNet_92393d6d-6d46-4bd0-95ce-ce7bc03b4e81" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e827c44b-e5c3-4894-8e3f-26a1457962a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e827c44b-e5c3-4894-8e3f-26a1457962a2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4b515c8-9325-4f9a-ad32-bf1e2dddf43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4b515c8-9325-4f9a-ad32-bf1e2dddf43a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b64eef8c-32b1-4a83-99c2-bb0a4f16285c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b64eef8c-32b1-4a83-99c2-bb0a4f16285c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0a6a8bbd-6c38-47b3-b424-d8c499643609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0a6a8bbd-6c38-47b3-b424-d8c499643609" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4cf7df82-6cdf-4b49-bc6e-25a683fac860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4cf7df82-6cdf-4b49-bc6e-25a683fac860" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_31de6de1-1157-4612-b0dc-719b55403bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_31de6de1-1157-4612-b0dc-719b55403bab" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7cfec563-8eac-4436-96fe-688d13de0a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7cfec563-8eac-4436-96fe-688d13de0a9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_82550b3c-de3f-455d-9a15-8f5c8d4d09a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_82550b3c-de3f-455d-9a15-8f5c8d4d09a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_88b1cff7-b506-4dc6-92d3-b92a3da1c2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_88b1cff7-b506-4dc6-92d3-b92a3da1c2d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8be43908-f9cc-44f2-9fc9-e7341a67e444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8be43908-f9cc-44f2-9fc9-e7341a67e444" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8b21e766-9a50-493a-ac5a-2289809b36a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8b21e766-9a50-493a-ac5a-2289809b36a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_aed99a73-44ef-4dd1-b090-635901f2f4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_aed99a73-44ef-4dd1-b090-635901f2f4c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_8cbfb67b-3bcf-4f90-afaf-15d52d946d1c" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_8cbfb67b-3bcf-4f90-afaf-15d52d946d1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_313cf721-8384-4852-8249-c048a95d145a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_313cf721-8384-4852-8249-c048a95d145a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_160c74d2-9f78-458c-8415-7e54c43ddfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_160c74d2-9f78-458c-8415-7e54c43ddfb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_9e0463fd-7961-40c2-850e-7559d633a992" xlink:href="bsx-20211231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_bsx_PaymentsForRoyaltyRights_9e0463fd-7961-40c2-850e-7559d633a992" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c7d06210-7a92-4970-b3bf-1b848df30b74" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c7d06210-7a92-4970-b3bf-1b848df30b74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c65ee255-eeab-4241-9853-dd5b31fd64a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c65ee255-eeab-4241-9853-dd5b31fd64a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_06a60eb1-41f5-4ae9-8db7-c91c1674f9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_06a60eb1-41f5-4ae9-8db7-c91c1674f9db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_8d7170a1-2906-4ea0-86d4-500ec6529e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_8d7170a1-2906-4ea0-86d4-500ec6529e86" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_aa01c4be-3209-404e-97fa-adc7a66987cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_aa01c4be-3209-404e-97fa-adc7a66987cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8316896c-0c07-48bf-a3f5-f75c04a548f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8316896c-0c07-48bf-a3f5-f75c04a548f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_d13cb7bf-27cf-432a-9d57-475c5423057b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_d13cb7bf-27cf-432a-9d57-475c5423057b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_13b14ee5-5435-438c-b3c1-d23d6c454102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_13b14ee5-5435-438c-b3c1-d23d6c454102" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_71cb533d-3f13-43ea-a5a8-94f60b9440fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_PaymentsOfDividends_71cb533d-3f13-43ea-a5a8-94f60b9440fd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_9d74222c-7af8-459e-8b7f-1abac761378a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_9d74222c-7af8-459e-8b7f-1abac761378a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ccaf64b9-4c59-456a-a7e2-238648eca83b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ccaf64b9-4c59-456a-a7e2-238648eca83b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c82b58fe-d2e4-43ae-9154-6153e46e7376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c82b58fe-d2e4-43ae-9154-6153e46e7376" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_8884beab-e8e5-4587-baec-03d635f79e06" xlink:href="bsx-20211231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_8884beab-e8e5-4587-baec-03d635f79e06" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_14a93805-44e9-43fa-a130-b6edf1081b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromStockPlans_14a93805-44e9-43fa-a130-b6edf1081b30" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa5b24eb-19a0-40fa-ae94-8ec021d1ba3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa5b24eb-19a0-40fa-ae94-8ec021d1ba3f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b623772e-4c2e-449d-a619-4e0e9002af1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b623772e-4c2e-449d-a619-4e0e9002af1d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5dbabcbb-7967-490f-863d-3ea738130f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5dbabcbb-7967-490f-863d-3ea738130f68" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99aa9961-84ee-474e-a370-16b37db09a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99aa9961-84ee-474e-a370-16b37db09a29" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c7b5bbb-56f8-4fc1-9315-3c2766dfa80b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_f835c9d0-58a3-4089-8700-6e9fe24f5479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_us-gaap_IncomeTaxesPaid_f835c9d0-58a3-4089-8700-6e9fe24f5479" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_abd38f01-ea60-43ee-80c5-75406a3e5d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_us-gaap_InterestPaidNet_abd38f01-ea60-43ee-80c5-75406a3e5d23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_15a0e751-fe4e-4ed2-bbd7-66ac5177ba93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_15a0e751-fe4e-4ed2-bbd7-66ac5177ba93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_84bab5a0-37c8-4f63-8708-74412f956b18" xlink:href="bsx-20211231.xsd#bsx_NonCashImpactOfTransferredRoyaltyRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_84bab5a0-37c8-4f63-8708-74412f956b18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_781411c6-1fd5-4ce4-bd8f-48df7214e4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_StatementTable_781411c6-1fd5-4ce4-bd8f-48df7214e4e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fa07bfa9-7998-42d4-8eed-6d63f6e3a029" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_781411c6-1fd5-4ce4-bd8f-48df7214e4e5" xlink:to="loc_srt_StatementScenarioAxis_fa07bfa9-7998-42d4-8eed-6d63f6e3a029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fa07bfa9-7998-42d4-8eed-6d63f6e3a029_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_fa07bfa9-7998-42d4-8eed-6d63f6e3a029" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fa07bfa9-7998-42d4-8eed-6d63f6e3a029_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d7c77ed4-3f92-4e35-8f02-209f8b2bd182" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_fa07bfa9-7998-42d4-8eed-6d63f6e3a029" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d7c77ed4-3f92-4e35-8f02-209f8b2bd182" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended" id="i8f7e15e9f3a24259bacad1286826f8d2_ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a540bc1-f33b-47af-9be8-b70ad98d676b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a540bc1-f33b-47af-9be8-b70ad98d676b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_186baa70-bf4f-49d8-8ac9-5b4792eec235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_186baa70-bf4f-49d8-8ac9-5b4792eec235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_a3cb8e59-cb7c-4f6f-a910-95a5e34d0430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_a3cb8e59-cb7c-4f6f-a910-95a5e34d0430" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7fb81fd5-34c2-4c34-a029-c37126f32ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7fb81fd5-34c2-4c34-a029-c37126f32ca4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_52bf2789-ad14-4877-acdd-4629bb15f9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_StatementTable_52bf2789-ad14-4877-acdd-4629bb15f9d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_e547d95c-0fbe-4efe-968e-b8731e3753e1" xlink:href="bsx-20211231.xsd#bsx_StatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_52bf2789-ad14-4877-acdd-4629bb15f9d5" xlink:to="loc_bsx_StatementAxis_e547d95c-0fbe-4efe-968e-b8731e3753e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_e547d95c-0fbe-4efe-968e-b8731e3753e1_default" xlink:href="bsx-20211231.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementAxis_e547d95c-0fbe-4efe-968e-b8731e3753e1" xlink:to="loc_bsx_StatementDomain_e547d95c-0fbe-4efe-968e-b8731e3753e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_d12d360d-18c9-4938-966b-61fdcf6caa23" xlink:href="bsx-20211231.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementAxis_e547d95c-0fbe-4efe-968e-b8731e3753e1" xlink:to="loc_bsx_StatementDomain_d12d360d-18c9-4938-966b-61fdcf6caa23" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="extended" id="i598f6b77e37e4e2a9ed384a6687b3a12_SignificantAccountingPoliciesSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_93e27785-82b5-4535-b48a-6e4e47836bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_93e27785-82b5-4535-b48a-6e4e47836bda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_9d1789f4-90d2-489a-8418-aa783d2199b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_9d1789f4-90d2-489a-8418-aa783d2199b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:to="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7280458a-f17d-463f-8fba-aa3d85360720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7280458a-f17d-463f-8fba-aa3d85360720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7280458a-f17d-463f-8fba-aa3d85360720_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7280458a-f17d-463f-8fba-aa3d85360720" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7280458a-f17d-463f-8fba-aa3d85360720_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f7e3288c-c0bd-4e16-a720-be9b0e7d8dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7280458a-f17d-463f-8fba-aa3d85360720" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f7e3288c-c0bd-4e16-a720-be9b0e7d8dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d732ad79-3421-48fe-85ba-9db7edaab95c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d732ad79-3421-48fe-85ba-9db7edaab95c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d732ad79-3421-48fe-85ba-9db7edaab95c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d732ad79-3421-48fe-85ba-9db7edaab95c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d732ad79-3421-48fe-85ba-9db7edaab95c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2ad311fe-6fa3-4ab9-bde1-4f399bcc441c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d732ad79-3421-48fe-85ba-9db7edaab95c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2ad311fe-6fa3-4ab9-bde1-4f399bcc441c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfeb406a-7abc-4183-819d-17ea390e3a2f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_srt_RangeAxis_cfeb406a-7abc-4183-819d-17ea390e3a2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cfeb406a-7abc-4183-819d-17ea390e3a2f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cfeb406a-7abc-4183-819d-17ea390e3a2f" xlink:to="loc_srt_RangeMember_cfeb406a-7abc-4183-819d-17ea390e3a2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cfeb406a-7abc-4183-819d-17ea390e3a2f" xlink:to="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb617fe7-816b-4965-87da-fe7fd70e674e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:to="loc_srt_MinimumMember_cb617fe7-816b-4965-87da-fe7fd70e674e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc4df719-0e1d-41ed-bd9c-1373e1ab6fd2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:to="loc_srt_MaximumMember_bc4df719-0e1d-41ed-bd9c-1373e1ab6fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239ca4ad-2c5c-42c5-ba20-b267ab33154d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239ca4ad-2c5c-42c5-ba20-b267ab33154d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_239ca4ad-2c5c-42c5-ba20-b267ab33154d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239ca4ad-2c5c-42c5-ba20-b267ab33154d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_239ca4ad-2c5c-42c5-ba20-b267ab33154d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_692f2960-172e-4a32-a2b3-097aaf9e8f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239ca4ad-2c5c-42c5-ba20-b267ab33154d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_692f2960-172e-4a32-a2b3-097aaf9e8f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_bfdb19f8-a6d7-4f5f-a4af-b7d17656acaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_692f2960-172e-4a32-a2b3-097aaf9e8f72" xlink:to="loc_us-gaap_PatentsMember_bfdb19f8-a6d7-4f5f-a4af-b7d17656acaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f07ff5f2-3a65-48c2-a682-3b7f1af52011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f07ff5f2-3a65-48c2-a682-3b7f1af52011" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f07ff5f2-3a65-48c2-a682-3b7f1af52011_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f07ff5f2-3a65-48c2-a682-3b7f1af52011" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f07ff5f2-3a65-48c2-a682-3b7f1af52011_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c94b729-d434-4a9f-8272-55d9014d095c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f07ff5f2-3a65-48c2-a682-3b7f1af52011" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c94b729-d434-4a9f-8272-55d9014d095c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_46aeb99e-b232-447d-8c46-8e68fbc04638" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_srt_ProductOrServiceAxis_46aeb99e-b232-447d-8c46-8e68fbc04638" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_46aeb99e-b232-447d-8c46-8e68fbc04638_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_46aeb99e-b232-447d-8c46-8e68fbc04638" xlink:to="loc_srt_ProductsAndServicesDomain_46aeb99e-b232-447d-8c46-8e68fbc04638_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_75b8c7f0-85ec-4f80-a463-5b463d4148c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_46aeb99e-b232-447d-8c46-8e68fbc04638" xlink:to="loc_srt_ProductsAndServicesDomain_75b8c7f0-85ec-4f80-a463-5b463d4148c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_2ec6e190-251f-422c-9089-34204a06026a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_75b8c7f0-85ec-4f80-a463-5b463d4148c6" xlink:to="loc_us-gaap_ShippingAndHandlingMember_2ec6e190-251f-422c-9089-34204a06026a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended" id="i366d911621cb47d6a7d47e55f57c209c_AcquisitionsandStrategicInvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2adff9b5-ed28-4036-968c-6d72fd24eb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2adff9b5-ed28-4036-968c-6d72fd24eb3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ce06da43-a647-4582-9a55-357a4dc7b3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ce06da43-a647-4582-9a55-357a4dc7b3ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_8794930d-d162-45da-a816-5d8d4837adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_8794930d-d162-45da-a816-5d8d4837adc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a537b39f-4b41-4dc8-b864-f794ad419cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a537b39f-4b41-4dc8-b864-f794ad419cd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a638ff5c-f5dd-422c-8ee7-125768d57fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a638ff5c-f5dd-422c-8ee7-125768d57fab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_f87fec45-f683-42b5-ab37-12a3660c7297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_f87fec45-f683-42b5-ab37-12a3660c7297" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d0ac2727-c77e-4cab-85a0-80a8710c9202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d0ac2727-c77e-4cab-85a0-80a8710c9202" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ac2727-c77e-4cab-85a0-80a8710c9202_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d0ac2727-c77e-4cab-85a0-80a8710c9202" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ac2727-c77e-4cab-85a0-80a8710c9202_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d0ac2727-c77e-4cab-85a0-80a8710c9202" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_cab0072e-6353-4ca0-9522-02261d5a7530" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_BTGAcquisitionMember_cab0072e-6353-4ca0-9522-02261d5a7530" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_f19ba240-b870-421f-aadf-6be890cade59" xlink:href="bsx-20211231.xsd#bsx_VertiflexIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_VertiflexIncMember_f19ba240-b870-421f-aadf-6be890cade59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_25bad943-af92-4d6c-b97d-d1c3a0707c18" xlink:href="bsx-20211231.xsd#bsx_MillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_MillipedeMember_25bad943-af92-4d6c-b97d-d1c3a0707c18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_76c3355d-e2be-4d8a-a51b-baed9d714f79" xlink:href="bsx-20211231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_76c3355d-e2be-4d8a-a51b-baed9d714f79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_81fbbb99-8646-4093-831e-ac082343c4c7" xlink:href="bsx-20211231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_PreventiceSolutionsIncMember_81fbbb99-8646-4093-831e-ac082343c4c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_be13b69b-a695-4e63-b1aa-2567935dafb0" xlink:href="bsx-20211231.xsd#bsx_LumenisLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_LumenisLTDMember_be13b69b-a695-4e63-b1aa-2567935dafb0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllOther2021AcquisitionsMember_276222a8-7638-4548-af69-654e4255a025" xlink:href="bsx-20211231.xsd#bsx_AllOther2021AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_AllOther2021AcquisitionsMember_276222a8-7638-4548-af69-654e4255a025" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2021AcquisitionsMember_6db5bb4c-1ef4-46e6-9382-4aa18c4b862e" xlink:href="bsx-20211231.xsd#bsx_A2021AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_A2021AcquisitionsMember_6db5bb4c-1ef4-46e6-9382-4aa18c4b862e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fcdb9116-9330-4289-a1c2-5759e31b3e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fcdb9116-9330-4289-a1c2-5759e31b3e74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fcdb9116-9330-4289-a1c2-5759e31b3e74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fcdb9116-9330-4289-a1c2-5759e31b3e74" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fcdb9116-9330-4289-a1c2-5759e31b3e74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_74f15bd7-e432-4f9c-b8c8-084d4d00dbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fcdb9116-9330-4289-a1c2-5759e31b3e74" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_74f15bd7-e432-4f9c-b8c8-084d4d00dbc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0dd6e7f8-866f-491e-9ec0-474971cd19e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_srt_OwnershipAxis_0dd6e7f8-866f-491e-9ec0-474971cd19e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_0dd6e7f8-866f-491e-9ec0-474971cd19e9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_0dd6e7f8-866f-491e-9ec0-474971cd19e9" xlink:to="loc_srt_OwnershipDomain_0dd6e7f8-866f-491e-9ec0-474971cd19e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ff9a5135-7625-4f49-a396-7ddd81bb5ec4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_0dd6e7f8-866f-491e-9ec0-474971cd19e9" xlink:to="loc_srt_OwnershipDomain_ff9a5135-7625-4f49-a396-7ddd81bb5ec4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ed778a84-e09c-44ed-9171-3246d89775c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ed778a84-e09c-44ed-9171-3246d89775c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ed778a84-e09c-44ed-9171-3246d89775c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ed778a84-e09c-44ed-9171-3246d89775c7" xlink:to="loc_us-gaap_ClassOfStockDomain_ed778a84-e09c-44ed-9171-3246d89775c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c654d550-282f-4bd7-b825-20745d80557a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ed778a84-e09c-44ed-9171-3246d89775c7" xlink:to="loc_us-gaap_ClassOfStockDomain_c654d550-282f-4bd7-b825-20745d80557a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#AcquisitionsandStrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="extended" id="icd10b5fecbd140b3a5e06a4e2dbc9476_AcquisitionsandStrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1bff959b-86dc-4659-8293-78841ee67a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1bff959b-86dc-4659-8293-78841ee67a76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_3766f359-ca08-48aa-b32b-843b8abea932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_3766f359-ca08-48aa-b32b-843b8abea932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e7265f1e-d4f4-4293-be96-5823112df19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e7265f1e-d4f4-4293-be96-5823112df19d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_5fa8eda6-248f-4ed0-b69d-4c9348dbab44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_5fa8eda6-248f-4ed0-b69d-4c9348dbab44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4fb6c88f-f0f1-4bc9-8dcc-36986408f882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4fb6c88f-f0f1-4bc9-8dcc-36986408f882" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_8b3205e7-a764-4de2-a986-58c09bf0e85c" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_8b3205e7-a764-4de2-a986-58c09bf0e85c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_bf12700e-aeaf-4f4f-9b13-a038d82bf249" xlink:href="bsx-20211231.xsd#bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_bf12700e-aeaf-4f4f-9b13-a038d82bf249" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a9f3b1e3-7ea2-4040-8406-623359b72b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a9f3b1e3-7ea2-4040-8406-623359b72b7b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_5ce83d1d-1e36-4068-ad27-de070045eeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_5ce83d1d-1e36-4068-ad27-de070045eeef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_03d7f13f-f2e3-409b-a5ff-4f108396dfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_03d7f13f-f2e3-409b-a5ff-4f108396dfd0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f6fd3119-df03-4bef-ad8d-d6b8d9a8a583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_Goodwill_f6fd3119-df03-4bef-ad8d-d6b8d9a8a583" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2c258e56-300f-4abd-90e7-2a794a8ae723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2c258e56-300f-4abd-90e7-2a794a8ae723" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_baeafc58-f7f2-42f1-945d-68ea71e0af71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_baeafc58-f7f2-42f1-945d-68ea71e0af71" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9135dd16-ee4a-4981-a7a3-65418a5440d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9135dd16-ee4a-4981-a7a3-65418a5440d5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c965cbd6-3f81-4ebc-ad60-fa14b8854335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c965cbd6-3f81-4ebc-ad60-fa14b8854335" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e507cf58-3dac-49f2-a3ca-70f9eff77678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e507cf58-3dac-49f2-a3ca-70f9eff77678" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b74b0276-153d-491a-bc4c-2da6a74bacaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b74b0276-153d-491a-bc4c-2da6a74bacaf" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_13b044a9-89e2-4261-a906-fb3ccc2bc84b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_13b044a9-89e2-4261-a906-fb3ccc2bc84b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e3b5b376-ea34-4740-ab88-21348b1b8b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e3b5b376-ea34-4740-ab88-21348b1b8b06" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_6162786b-3e96-4d5b-a01c-2033360255c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_6162786b-3e96-4d5b-a01c-2033360255c4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6887865b-229c-4a64-ba80-c6c697dfe921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6887865b-229c-4a64-ba80-c6c697dfe921" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0d22d1dd-870d-407b-a698-f6d3588325fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0d22d1dd-870d-407b-a698-f6d3588325fb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_9a06116e-d5f4-49c6-b73c-693b34d737c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_9a06116e-d5f4-49c6-b73c-693b34d737c6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_07e8d200-f009-49e2-9bb4-d1725720be83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_07e8d200-f009-49e2-9bb4-d1725720be83" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2dc66f64-1818-4bc1-8723-9a5aa94d984f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2dc66f64-1818-4bc1-8723-9a5aa94d984f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_5e6a441f-04c3-4ade-b0b6-bc05ef84ea22" xlink:href="bsx-20211231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_DiscountRateFairValueInput_5e6a441f-04c3-4ade-b0b6-bc05ef84ea22" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d994d09-bd79-4a96-986a-9eab30530587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d994d09-bd79-4a96-986a-9eab30530587" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_75b79c2e-2507-41c5-b80c-025cac781a58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_75b79c2e-2507-41c5-b80c-025cac781a58" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_84bd9f8c-0dd3-4e3f-9051-cb2f5ffe774f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_84bd9f8c-0dd3-4e3f-9051-cb2f5ffe774f" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_749578ff-b8c8-4b65-9c59-af322db3ef61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e6231d0e-3f4e-4eb9-ae12-6e17367c38df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e6231d0e-3f4e-4eb9-ae12-6e17367c38df" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_47f0e0fd-1075-4bbf-8c2f-a9b6f6b18f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_47f0e0fd-1075-4bbf-8c2f-a9b6f6b18f7c" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd60d7fe-6780-4f51-95c5-84c615985f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1620253b-256e-45f5-988a-b4db03a86a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1620253b-256e-45f5-988a-b4db03a86a1d" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_8475f1c6-e423-4ef4-a15c-ea3d1b640cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_8475f1c6-e423-4ef4-a15c-ea3d1b640cfd" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities_809f0f63-7a45-4c3d-915a-8259a528b8ac" xlink:href="bsx-20211231.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_DivestitureAgreementTransferOfFacilities_809f0f63-7a45-4c3d-915a-8259a528b8ac" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_076ab2bb-7f15-4314-b6c9-d2e8184f5af0" xlink:href="bsx-20211231.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_076ab2bb-7f15-4314-b6c9-d2e8184f5af0" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8a43bca0-043f-4a2e-b8e0-31067bc108c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8a43bca0-043f-4a2e-b8e0-31067bc108c0" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7db3c4e4-56d2-4998-91b3-19812f86e8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7db3c4e4-56d2-4998-91b3-19812f86e8e8" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_018402b3-60f7-4ed9-91dd-1146b5f2d9d2" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_018402b3-60f7-4ed9-91dd-1146b5f2d9d2" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod_ff2481f8-3f5b-48cf-b597-bf1fcecc5de6" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod_ff2481f8-3f5b-48cf-b597-bf1fcecc5de6" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_8b4e65fe-e8a7-48d6-8c75-f39f53335272" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_BTGAcquisitionMember_8b4e65fe-e8a7-48d6-8c75-f39f53335272" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_ee9f494c-f9dc-4c82-ba93-594b41b7d6e9" xlink:href="bsx-20211231.xsd#bsx_VertiflexIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_VertiflexIncMember_ee9f494c-f9dc-4c82-ba93-594b41b7d6e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_b3f6d12a-51d5-4e8f-9b2e-9d3086c68c39" xlink:href="bsx-20211231.xsd#bsx_MillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_MillipedeMember_b3f6d12a-51d5-4e8f-9b2e-9d3086c68c39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_90f94148-7d66-4456-8077-43e9594a3969" xlink:href="bsx-20211231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_90f94148-7d66-4456-8077-43e9594a3969" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_a36dfb19-1391-4b3a-98dc-9d8174c6ac2d" xlink:href="bsx-20211231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_PreventiceSolutionsIncMember_a36dfb19-1391-4b3a-98dc-9d8174c6ac2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseIncMember_378b02cd-179c-435d-a0d3-3b04e7c5becd" xlink:href="bsx-20211231.xsd#bsx_FarapulseIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_FarapulseIncMember_378b02cd-179c-435d-a0d3-3b04e7c5becd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_d047c03b-0e9d-456c-b363-10396dd93127" xlink:href="bsx-20211231.xsd#bsx_LumenisLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_LumenisLTDMember_d047c03b-0e9d-456c-b363-10396dd93127" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DevoroMedicalIncMember_02522646-6a33-4092-9830-91e1ca617eba" xlink:href="bsx-20211231.xsd#bsx_DevoroMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_DevoroMedicalIncMember_02522646-6a33-4092-9830-91e1ca617eba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllOther2021AcquisitionsMember_3cf1cb78-89ad-4f12-8a6c-b0e69a3b7161" xlink:href="bsx-20211231.xsd#bsx_AllOther2021AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_AllOther2021AcquisitionsMember_3cf1cb78-89ad-4f12-8a6c-b0e69a3b7161" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2021AcquisitionsMember_b2bdf6ef-0344-41d8-a4f8-08309736256b" xlink:href="bsx-20211231.xsd#bsx_A2021AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_A2021AcquisitionsMember_b2bdf6ef-0344-41d8-a4f8-08309736256b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be0162e9-5f4c-444e-848e-81bf513d9ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be0162e9-5f4c-444e-848e-81bf513d9ad6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_be0162e9-5f4c-444e-848e-81bf513d9ad6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be0162e9-5f4c-444e-848e-81bf513d9ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_be0162e9-5f4c-444e-848e-81bf513d9ad6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be0162e9-5f4c-444e-848e-81bf513d9ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b50ecf8b-25b6-4f01-acb7-0b884bf4375a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b50ecf8b-25b6-4f01-acb7-0b884bf4375a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_bc8bc46d-cfa8-4cf9-9424-dcd2573578ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_bc8bc46d-cfa8-4cf9-9424-dcd2573578ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_ebe6c37b-3900-4c66-b331-3c731b15b957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_ebe6c37b-3900-4c66-b331-3c731b15b957" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_511fd6be-3285-40f0-8a82-57f5019899bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_511fd6be-3285-40f0-8a82-57f5019899bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_511fd6be-3285-40f0-8a82-57f5019899bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_511fd6be-3285-40f0-8a82-57f5019899bb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_511fd6be-3285-40f0-8a82-57f5019899bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_00040e90-d0a9-4a33-9369-df74be4368c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_511fd6be-3285-40f0-8a82-57f5019899bb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_00040e90-d0a9-4a33-9369-df74be4368c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1589dee2-a260-459e-805a-6bd89427ac5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_00040e90-d0a9-4a33-9369-df74be4368c1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1589dee2-a260-459e-805a-6bd89427ac5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf842369-b898-49d5-87e8-40c859a5f58d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_srt_RangeAxis_cf842369-b898-49d5-87e8-40c859a5f58d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf842369-b898-49d5-87e8-40c859a5f58d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cf842369-b898-49d5-87e8-40c859a5f58d" xlink:to="loc_srt_RangeMember_cf842369-b898-49d5-87e8-40c859a5f58d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cf842369-b898-49d5-87e8-40c859a5f58d" xlink:to="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_28ac36a8-0869-41a1-845c-3122ebc5163d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:to="loc_srt_WeightedAverageMember_28ac36a8-0869-41a1-845c-3122ebc5163d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ddc062b0-cc04-4c7a-bbf7-b43ffde2359a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:to="loc_srt_MinimumMember_ddc062b0-cc04-4c7a-bbf7-b43ffde2359a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d933d6c3-ffef-4578-9a0e-6bb8aa28ba62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:to="loc_srt_MaximumMember_d933d6c3-ffef-4578-9a0e-6bb8aa28ba62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_66464507-77ab-44af-8bac-de47f9ed769e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_66464507-77ab-44af-8bac-de47f9ed769e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_66464507-77ab-44af-8bac-de47f9ed769e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_66464507-77ab-44af-8bac-de47f9ed769e" xlink:to="loc_us-gaap_SegmentDomain_66464507-77ab-44af-8bac-de47f9ed769e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_66464507-77ab-44af-8bac-de47f9ed769e" xlink:to="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2c4d9a85-d26a-42fc-b159-fae969289888" xlink:href="bsx-20211231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2c4d9a85-d26a-42fc-b159-fae969289888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_ceec7f95-0e95-4f12-8b81-a8e59a765cb1" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_ceec7f95-0e95-4f12-8b81-a8e59a765cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6163a93f-b90b-434a-899d-9d327cb3e30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6163a93f-b90b-434a-899d-9d327cb3e30f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6163a93f-b90b-434a-899d-9d327cb3e30f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6163a93f-b90b-434a-899d-9d327cb3e30f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6163a93f-b90b-434a-899d-9d327cb3e30f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6da20342-c5b5-435c-a6f6-25c1b46265f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6163a93f-b90b-434a-899d-9d327cb3e30f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6da20342-c5b5-435c-a6f6-25c1b46265f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3341ce61-a483-4886-9c8e-1427cb69ff24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6da20342-c5b5-435c-a6f6-25c1b46265f2" xlink:to="loc_us-gaap_SubsequentEventMember_3341ce61-a483-4886-9c8e-1427cb69ff24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3adbc7f9-e25f-4ad6-8a10-162849199a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3adbc7f9-e25f-4ad6-8a10-162849199a7d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3adbc7f9-e25f-4ad6-8a10-162849199a7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3adbc7f9-e25f-4ad6-8a10-162849199a7d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3adbc7f9-e25f-4ad6-8a10-162849199a7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3adbc7f9-e25f-4ad6-8a10-162849199a7d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ffe4ebd7-1235-4226-a70f-119344387e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ffe4ebd7-1235-4226-a70f-119344387e6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_10b6cc72-e384-409e-b9fd-d102179efaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_10b6cc72-e384-409e-b9fd-d102179efaa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_651b7781-d72c-41e0-8bce-7ca98b1f5733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_651b7781-d72c-41e0-8bce-7ca98b1f5733" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_651b7781-d72c-41e0-8bce-7ca98b1f5733_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_651b7781-d72c-41e0-8bce-7ca98b1f5733" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_651b7781-d72c-41e0-8bce-7ca98b1f5733_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79031ebc-9d77-428b-9565-4e5821d8d90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_651b7781-d72c-41e0-8bce-7ca98b1f5733" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79031ebc-9d77-428b-9565-4e5821d8d90e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_e95c0439-3292-42b2-a2d5-b6b17a176388" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79031ebc-9d77-428b-9565-4e5821d8d90e" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_e95c0439-3292-42b2-a2d5-b6b17a176388" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended" id="i37721c8c1f7444e59d8925b56f95b84d_ContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_e38afc3c-ec51-44b6-8775-f9d0ef018bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_e38afc3c-ec51-44b6-8775-f9d0ef018bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_7115bc31-2a2f-418f-9f31-02c56bf6a041" xlink:href="bsx-20211231.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:to="loc_bsx_PaymentOfContingentConsideration_7115bc31-2a2f-418f-9f31-02c56bf6a041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d3e6dce4-60ad-428e-b615-0ff8f99a0b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d3e6dce4-60ad-428e-b615-0ff8f99a0b65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3c96a4e-0517-49b9-81de-b395ba0caea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3c96a4e-0517-49b9-81de-b395ba0caea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_16deb6da-5089-4b29-b413-879ad7eec29d" xlink:href="bsx-20211231.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_16deb6da-5089-4b29-b413-879ad7eec29d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_fc2735bb-8137-4378-b65c-1b4fb88fd78c" xlink:href="bsx-20211231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:to="loc_bsx_DiscountRateFairValueInput_fc2735bb-8137-4378-b65c-1b4fb88fd78c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_709fd916-00b1-494a-b3d8-1df3da6c29e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_709fd916-00b1-494a-b3d8-1df3da6c29e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_ebf23b98-ac24-4b14-b146-76f7242aad22" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_ebf23b98-ac24-4b14-b146-76f7242aad22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_90bcae64-cc1b-4fea-94e0-407690f9a87e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_srt_RangeAxis_90bcae64-cc1b-4fea-94e0-407690f9a87e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_90bcae64-cc1b-4fea-94e0-407690f9a87e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_90bcae64-cc1b-4fea-94e0-407690f9a87e" xlink:to="loc_srt_RangeMember_90bcae64-cc1b-4fea-94e0-407690f9a87e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_90bcae64-cc1b-4fea-94e0-407690f9a87e" xlink:to="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4cf9b5a2-5183-47ea-8864-454de417dfdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:to="loc_srt_MinimumMember_4cf9b5a2-5183-47ea-8864-454de417dfdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_abc065cf-38c7-4419-b807-0613140bfafc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:to="loc_srt_MaximumMember_abc065cf-38c7-4419-b807-0613140bfafc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_6a9f8655-f37e-47aa-bda6-820d9012a892" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:to="loc_srt_WeightedAverageMember_6a9f8655-f37e-47aa-bda6-820d9012a892" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_us-gaap_ValuationTechniqueAxis_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c" xlink:to="loc_us-gaap_ValuationTechniqueDomain_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_56418b1d-eadc-492c-a6ac-2f71b7566880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c" xlink:to="loc_us-gaap_ValuationTechniqueDomain_56418b1d-eadc-492c-a6ac-2f71b7566880" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c604f6cf-8e2a-49bf-8114-28fdc0967c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56418b1d-eadc-492c-a6ac-2f71b7566880" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c604f6cf-8e2a-49bf-8114-28fdc0967c54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_804a001e-b3d5-4d6c-b470-35dfecb4ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_804a001e-b3d5-4d6c-b470-35dfecb4ac8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_804a001e-b3d5-4d6c-b470-35dfecb4ac8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_804a001e-b3d5-4d6c-b470-35dfecb4ac8a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_804a001e-b3d5-4d6c-b470-35dfecb4ac8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_804a001e-b3d5-4d6c-b470-35dfecb4ac8a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2021AcquisitionsMember_7181ca25-1c40-4695-a786-558dffc4e476" xlink:href="bsx-20211231.xsd#bsx_A2021AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:to="loc_bsx_A2021AcquisitionsMember_7181ca25-1c40-4695-a786-558dffc4e476" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseIncMember_93c271d9-bd1f-48cf-8112-a5cf35af1ab5" xlink:href="bsx-20211231.xsd#bsx_FarapulseIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:to="loc_bsx_FarapulseIncMember_93c271d9-bd1f-48cf-8112-a5cf35af1ab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_b0071676-7dcd-456b-bb39-7e5f0f382f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_b0071676-7dcd-456b-bb39-7e5f0f382f6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_b0071676-7dcd-456b-bb39-7e5f0f382f6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_b0071676-7dcd-456b-bb39-7e5f0f382f6f" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_b0071676-7dcd-456b-bb39-7e5f0f382f6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_b0071676-7dcd-456b-bb39-7e5f0f382f6f" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_5a4c9c4f-c931-4aaf-9445-e5b611c4350c" xlink:href="bsx-20211231.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_5a4c9c4f-c931-4aaf-9445-e5b611c4350c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_c4293fe3-e674-45fa-b47c-4b8449a155ba" xlink:href="bsx-20211231.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:to="loc_bsx_RevenueBasedPaymentsMember_c4293fe3-e674-45fa-b47c-4b8449a155ba" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#StrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended" id="ia58e46820d5d443d9c31da77bdf9530a_StrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_55f50724-ab0b-410c-93fb-226a1a0b005b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_55f50724-ab0b-410c-93fb-226a1a0b005b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d2be4f94-03f0-4383-86af-cec55d3daa51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquityMethodInvestments_d2be4f94-03f0-4383-86af-cec55d3daa51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1bfb0df8-27ae-4a85-8c0b-f5eb80f5eeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1bfb0df8-27ae-4a85-8c0b-f5eb80f5eeef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_8b4eccb6-5e1a-4272-9bb7-984a24a1474d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_8b4eccb6-5e1a-4272-9bb7-984a24a1474d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d8529f8e-45e0-4632-83a6-32d76d7c16a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d8529f8e-45e0-4632-83a6-32d76d7c16a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_45dbc05e-bf25-4849-9749-0217d84b71da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_Investments_45dbc05e-bf25-4849-9749-0217d84b71da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_33d22b94-4227-4f63-b256-21a647914292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_eb98d4bd-cf30-4b6c-8eda-dc8a20332aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_eb98d4bd-cf30-4b6c-8eda-dc8a20332aa9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_320a0996-29ab-4aa7-8931-566d3ab591cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_320a0996-29ab-4aa7-8931-566d3ab591cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_37b98060-135d-45c9-bdd8-972e881c5894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_320a0996-29ab-4aa7-8931-566d3ab591cb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_37b98060-135d-45c9-bdd8-972e881c5894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_37b98060-135d-45c9-bdd8-972e881c5894_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37b98060-135d-45c9-bdd8-972e881c5894" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_37b98060-135d-45c9-bdd8-972e881c5894_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9973eb52-92b0-4696-80b4-aaf333bed92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37b98060-135d-45c9-bdd8-972e881c5894" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9973eb52-92b0-4696-80b4-aaf333bed92c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_57f49461-646b-4efe-a61f-5431b24ef3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9973eb52-92b0-4696-80b4-aaf333bed92c" xlink:to="loc_us-gaap_SubsequentEventMember_57f49461-646b-4efe-a61f-5431b24ef3cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#AssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="i27f279995d70479fb9f2aacef83555d6_AssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f2b50a88-7585-4e87-a44b-94e2a3a74430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f2b50a88-7585-4e87-a44b-94e2a3a74430" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4080c601-e1e9-41a8-bae2-a6290ad6b3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4080c601-e1e9-41a8-bae2-a6290ad6b3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_fc5420a7-52fa-4e57-a8b7-46f580cf8ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_fc5420a7-52fa-4e57-a8b7-46f580cf8ada" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_609771b2-4732-42a6-a8c6-32ce169e2131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_609771b2-4732-42a6-a8c6-32ce169e2131" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_683e8195-87a4-45ea-9e0c-c6eae6420b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_683e8195-87a4-45ea-9e0c-c6eae6420b3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_ffe5f715-46da-40e1-82eb-a96559f175ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_ffe5f715-46da-40e1-82eb-a96559f175ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_d9beca9d-fabb-42e3-a6f1-f7161e60735c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_d9beca9d-fabb-42e3-a6f1-f7161e60735c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_4d38f10d-cc43-46b8-aa16-b46c3684ec99" xlink:href="bsx-20211231.xsd#bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_4d38f10d-cc43-46b8-aa16-b46c3684ec99" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_caab77e9-3934-479e-af7d-01e300b71567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_caab77e9-3934-479e-af7d-01e300b71567" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_c94ca0e3-87bb-4238-929a-46fd9333d1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_c94ca0e3-87bb-4238-929a-46fd9333d1c8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_b0b4efdf-ba47-4ff4-8c4c-731520aab342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_b0b4efdf-ba47-4ff4-8c4c-731520aab342" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_94b98ac7-334c-4aa7-9495-3328e2ff966c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_94b98ac7-334c-4aa7-9495-3328e2ff966c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8ced1598-388b-4f04-a6cb-2de076e3c5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8ced1598-388b-4f04-a6cb-2de076e3c5ac" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e22c04fc-2f9e-44e7-867b-2a91fe21995e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e22c04fc-2f9e-44e7-867b-2a91fe21995e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aa492cd4-8462-4f4e-aef1-761d07dc427d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aa492cd4-8462-4f4e-aef1-761d07dc427d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa492cd4-8462-4f4e-aef1-761d07dc427d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aa492cd4-8462-4f4e-aef1-761d07dc427d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa492cd4-8462-4f4e-aef1-761d07dc427d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_030a87ef-adfe-4424-aab4-58eb857ec5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aa492cd4-8462-4f4e-aef1-761d07dc427d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_030a87ef-adfe-4424-aab4-58eb857ec5b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_f1e0b58c-f92f-4cc9-bcb8-104c7386f08e" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_030a87ef-adfe-4424-aab4-58eb857ec5b3" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_f1e0b58c-f92f-4cc9-bcb8-104c7386f08e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4ef78b51-e43c-4cc6-ae45-1b5bee178404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4ef78b51-e43c-4cc6-ae45-1b5bee178404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4ef78b51-e43c-4cc6-ae45-1b5bee178404_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ef78b51-e43c-4cc6-ae45-1b5bee178404" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4ef78b51-e43c-4cc6-ae45-1b5bee178404_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_df449055-9137-41e3-9796-4910a8152f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ef78b51-e43c-4cc6-ae45-1b5bee178404" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_df449055-9137-41e3-9796-4910a8152f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_359973c9-455c-4b08-8ba2-d64272b75f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_df449055-9137-41e3-9796-4910a8152f03" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_359973c9-455c-4b08-8ba2-d64272b75f3e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="if23464115c294bcba1fb245cf6b62bb0_GoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f55b4f69-410b-4526-91c2-d48da543ba3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f55b4f69-410b-4526-91c2-d48da543ba3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cdb4d5bf-9347-42bb-b64f-6de86b482f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cdb4d5bf-9347-42bb-b64f-6de86b482f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_c9256ca0-9fb9-4834-b7e8-d2766316337e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_GoodwillGross_c9256ca0-9fb9-4834-b7e8-d2766316337e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_71eb30f9-7a0b-43e6-a43e-b09e2e7046e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_71eb30f9-7a0b-43e6-a43e-b09e2e7046e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9abb98d6-202e-4298-a4d2-0a9ff7eadc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9abb98d6-202e-4298-a4d2-0a9ff7eadc85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_87467427-5f3c-4baf-aaf7-00d045ddf3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_87467427-5f3c-4baf-aaf7-00d045ddf3a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:href="bsx-20211231.xsd#bsx_GoodwillTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_012ea055-ba1a-441b-b40b-1d27d9e3f2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_Goodwill_012ea055-ba1a-441b-b40b-1d27d9e3f2ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_ca452460-6ba3-40c9-9b93-1d705b63ba35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_ca452460-6ba3-40c9-9b93-1d705b63ba35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5416c064-eb6b-4a73-9754-325b5f1a8d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5416c064-eb6b-4a73-9754-325b5f1a8d64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e37ef05e-b275-41af-b7b5-34405eea7ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e37ef05e-b275-41af-b7b5-34405eea7ab6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_7e920b13-a878-44b7-970a-dae3b07deeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillTransfers_7e920b13-a878-44b7-970a-dae3b07deeb5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:href="bsx-20211231.xsd#bsx_OtherIntangibleAssetsTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7da8c583-134c-4218-a7b7-a637e709f6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7da8c583-134c-4218-a7b7-a637e709f6d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b1dc4824-0613-4fa9-b7ad-45260ca7cbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b1dc4824-0613-4fa9-b7ad-45260ca7cbe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d8a89d77-9bbc-4a59-b9f6-7e846c174398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d8a89d77-9bbc-4a59-b9f6-7e846c174398" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d2d19c2e-47c3-43aa-be11-219d0365f91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d2d19c2e-47c3-43aa-be11-219d0365f91e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ae0f61c3-d1b4-4848-ab45-a86589fe941a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ae0f61c3-d1b4-4848-ab45-a86589fe941a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dab868fb-ef0c-440d-8d23-dc9ecc8e4948" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_srt_RangeAxis_dab868fb-ef0c-440d-8d23-dc9ecc8e4948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dab868fb-ef0c-440d-8d23-dc9ecc8e4948_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dab868fb-ef0c-440d-8d23-dc9ecc8e4948" xlink:to="loc_srt_RangeMember_dab868fb-ef0c-440d-8d23-dc9ecc8e4948_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dab868fb-ef0c-440d-8d23-dc9ecc8e4948" xlink:to="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5f66b0f2-d194-4059-9503-fa1d7f06e939" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:to="loc_srt_MinimumMember_5f66b0f2-d194-4059-9503-fa1d7f06e939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_991dabee-ae0d-4ccb-b0cf-85ae15c1b2f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:to="loc_srt_MaximumMember_991dabee-ae0d-4ccb-b0cf-85ae15c1b2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec40ad03-da53-4977-b541-db16a052a0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec40ad03-da53-4977-b541-db16a052a0af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec40ad03-da53-4977-b541-db16a052a0af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec40ad03-da53-4977-b541-db16a052a0af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec40ad03-da53-4977-b541-db16a052a0af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec40ad03-da53-4977-b541-db16a052a0af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9e58ec39-2c83-4626-9183-13b166f98d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9e58ec39-2c83-4626-9183-13b166f98d53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_95644b83-f753-4cb1-bdcf-a5ce902df1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:to="loc_us-gaap_PatentsMember_95644b83-f753-4cb1-bdcf-a5ce902df1d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_049c2364-ebf1-4401-9678-2081bea4d695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_049c2364-ebf1-4401-9678-2081bea4d695" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bbe267c3-8af7-4567-aae3-982a7729978a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bbe267c3-8af7-4567-aae3-982a7729978a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_bbe267c3-8af7-4567-aae3-982a7729978a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bbe267c3-8af7-4567-aae3-982a7729978a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_bbe267c3-8af7-4567-aae3-982a7729978a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bbe267c3-8af7-4567-aae3-982a7729978a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e8b9089c-b65b-4419-8730-5a5cb6fada19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e8b9089c-b65b-4419-8730-5a5cb6fada19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_268557c6-99aa-4556-9652-7a8390293337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_268557c6-99aa-4556-9652-7a8390293337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8de50882-6bc1-4f12-8e40-ab74bb206aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8de50882-6bc1-4f12-8e40-ab74bb206aec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8de50882-6bc1-4f12-8e40-ab74bb206aec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8de50882-6bc1-4f12-8e40-ab74bb206aec" xlink:to="loc_us-gaap_SegmentDomain_8de50882-6bc1-4f12-8e40-ab74bb206aec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8de50882-6bc1-4f12-8e40-ab74bb206aec" xlink:to="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_c6e38f18-f2e5-4d5b-8cba-4d2722ba49fb" xlink:href="bsx-20211231.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_MedsurgMember_c6e38f18-f2e5-4d5b-8cba-4d2722ba49fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_f6586de4-8f03-4e1c-8e29-3435c6b7ac14" xlink:href="bsx-20211231.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_RhythmandNeuroMember_f6586de4-8f03-4e1c-8e29-3435c6b7ac14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_999e2bd5-067b-4f11-ab1b-533ab396c5f4" xlink:href="bsx-20211231.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_CardiovascularMember_999e2bd5-067b-4f11-ab1b-533ab396c5f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_f669c7f3-cda1-43ec-b849-0a276d91c315" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_f669c7f3-cda1-43ec-b849-0a276d91c315" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended" id="ib02a41ffe35944d69da07756bcf0c4ba_HedgingActivitiesandFairValueMeasurementsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_20d2fd0e-f2a0-43be-bf90-aea8a69b003c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_20d2fd0e-f2a0-43be-bf90-aea8a69b003c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3fff60ca-5577-4ae2-a571-98ca8d94cb37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3fff60ca-5577-4ae2-a571-98ca8d94cb37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4b292e3c-cc35-42a8-8c21-c16eece9211f" xlink:href="bsx-20211231.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4b292e3c-cc35-42a8-8c21-c16eece9211f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f4f3c00d-d927-4c0f-9e2c-d01e43502771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f4f3c00d-d927-4c0f-9e2c-d01e43502771" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2281fa2b-3975-47f4-84c3-fd1cc2589aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2281fa2b-3975-47f4-84c3-fd1cc2589aae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8e740395-1fc9-4637-8aa7-c635a4003baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_DerivativeTable_8e740395-1fc9-4637-8aa7-c635a4003baa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2c7679-aba5-4d95-8cae-d650058f5ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8e740395-1fc9-4637-8aa7-c635a4003baa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2c7679-aba5-4d95-8cae-d650058f5ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5b2c7679-aba5-4d95-8cae-d650058f5ddb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2c7679-aba5-4d95-8cae-d650058f5ddb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5b2c7679-aba5-4d95-8cae-d650058f5ddb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a7c9e7ef-17f2-4c44-9976-4ff845dbf56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2c7679-aba5-4d95-8cae-d650058f5ddb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a7c9e7ef-17f2-4c44-9976-4ff845dbf56f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_479c155c-db60-4c7d-a9cc-396981a72999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_72884af0-50a2-4295-8027-4f03e2b4d1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_479c155c-db60-4c7d-a9cc-396981a72999" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_72884af0-50a2-4295-8027-4f03e2b4d1e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_479c155c-db60-4c7d-a9cc-396981a72999" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f4260a98-8be2-43b3-aa4d-3f9b17505cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f4260a98-8be2-43b3-aa4d-3f9b17505cf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f4260a98-8be2-43b3-aa4d-3f9b17505cf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f4260a98-8be2-43b3-aa4d-3f9b17505cf0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f4260a98-8be2-43b3-aa4d-3f9b17505cf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0fa45293-42ed-4e39-83da-ca56834fc7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f4260a98-8be2-43b3-aa4d-3f9b17505cf0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0fa45293-42ed-4e39-83da-ca56834fc7aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea0340c9-bc57-4ca1-93e9-809c386a324e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea0340c9-bc57-4ca1-93e9-809c386a324e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ea0340c9-bc57-4ca1-93e9-809c386a324e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea0340c9-bc57-4ca1-93e9-809c386a324e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ea0340c9-bc57-4ca1-93e9-809c386a324e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7560aac-1f3f-481a-a826-cf7c178b51a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea0340c9-bc57-4ca1-93e9-809c386a324e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7560aac-1f3f-481a-a826-cf7c178b51a8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i822e8d164c2e4657aeb78b8b4d589ffb_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2278fda1-bc91-4295-9f14-8bbbdf5026e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_LongTermDebt_2278fda1-bc91-4295-9f14-8bbbdf5026e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_729d1532-117f-41f3-a92d-95bec79b09d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_729d1532-117f-41f3-a92d-95bec79b09d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_4b165c0d-b909-4860-94fb-3314e73dcee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_4b165c0d-b909-4860-94fb-3314e73dcee5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge_bc403086-7d51-4e48-aaa0-410c348f5f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeCashReceivedOnHedge_bc403086-7d51-4e48-aaa0-410c348f5f2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_7c7258c2-c623-4dd2-b599-5b2cfbcea4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_7c7258c2-c623-4dd2-b599-5b2cfbcea4ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_979a03b0-0d57-433d-88c8-7cfda3224b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_979a03b0-0d57-433d-88c8-7cfda3224b6c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_abe68c13-ce8d-4077-be45-3a1b32c1dfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeNotionalAmount_abe68c13-ce8d-4077-be45-3a1b32c1dfe6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_c24c3b24-1d01-48c6-9af3-df096b559efa" xlink:href="bsx-20211231.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_c24c3b24-1d01-48c6-9af3-df096b559efa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_43c9f075-d128-409c-81a1-cb2041b9ebc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_43c9f075-d128-409c-81a1-cb2041b9ebc3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fb5f86d4-f54f-457d-bd40-dd7db19d2a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fb5f86d4-f54f-457d-bd40-dd7db19d2a4b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_9a509e1b-b550-469a-90c3-d05e59288584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_9a509e1b-b550-469a-90c3-d05e59288584" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_088a0e6a-c879-4a3c-9ea4-853182577264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_088a0e6a-c879-4a3c-9ea4-853182577264" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c07a04a7-7021-4370-bb14-1a5569c6ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c07a04a7-7021-4370-bb14-1a5569c6ff84" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_7c56b5d1-5646-46dc-8fb2-de1fc9df8ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_7c56b5d1-5646-46dc-8fb2-de1fc9df8ff5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c7ff9b5f-3640-4026-8cca-b4beb35c473c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c7ff9b5f-3640-4026-8cca-b4beb35c473c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_68a52505-5c0c-4f93-a283-9a549f0dbe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_68a52505-5c0c-4f93-a283-9a549f0dbe3c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_927a0b7b-f0ed-4503-9fa7-c9bfabb6e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_927a0b7b-f0ed-4503-9fa7-c9bfabb6e17a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5b49eb99-f1e2-4fcf-94c8-57518cfc5e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5b49eb99-f1e2-4fcf-94c8-57518cfc5e1c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_979cddff-6dd7-4e9e-b63e-e99f84b05a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_InterestExpense_979cddff-6dd7-4e9e-b63e-e99f84b05a8b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_47f21666-7e58-4403-8b96-dc8dfddf1f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_47f21666-7e58-4403-8b96-dc8dfddf1f4a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_d3da45bd-d09c-49e5-b38f-435e8feb1d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_d3da45bd-d09c-49e5-b38f-435e8feb1d8e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_a1a6a4d4-c2e2-4edb-92c5-d2845dda201d" xlink:href="bsx-20211231.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_a1a6a4d4-c2e2-4edb-92c5-d2845dda201d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_28f9cb8d-b0e3-4842-846f-c94972393bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_28f9cb8d-b0e3-4842-846f-c94972393bd6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_51c30405-1a69-46a3-aa6a-4823d8204f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_51c30405-1a69-46a3-aa6a-4823d8204f18" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_220cc5da-b255-4800-b64a-4db82c463467" xlink:href="bsx-20211231.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_220cc5da-b255-4800-b64a-4db82c463467" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a91bfb1c-15c7-4d0d-bd26-1b80c0fce9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a91bfb1c-15c7-4d0d-bd26-1b80c0fce9b0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_dcffd58c-de49-490a-a380-3797e43c7a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_dcffd58c-de49-490a-a380-3797e43c7a41" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_83a23ef8-40d9-4ad6-9385-e9c15c96ba0f" xlink:href="bsx-20211231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_83a23ef8-40d9-4ad6-9385-e9c15c96ba0f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_7d22a639-fc4a-4aa9-a278-5860b6a70195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_7d22a639-fc4a-4aa9-a278-5860b6a70195" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_7004aa01-7d4a-44f2-a86d-3104471a3589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_7004aa01-7d4a-44f2-a86d-3104471a3589" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_639461a2-9ecc-43f9-9004-2df45c06cba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_639461a2-9ecc-43f9-9004-2df45c06cba8" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_890ed7f5-ead6-4d72-8356-b26209bb3d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_890ed7f5-ead6-4d72-8356-b26209bb3d10" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_fcf70cc0-9e6f-4f81-9a8b-bdc55fbbaf90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_fcf70cc0-9e6f-4f81-9a8b-bdc55fbbaf90" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ea751b5-1540-4d02-8c43-f66fb7cdecb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ea751b5-1540-4d02-8c43-f66fb7cdecb0" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_302dcb93-2970-4707-ba4f-84b75480cdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_edefbed0-a324-41e1-be46-6c2251a1cfa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_edefbed0-a324-41e1-be46-6c2251a1cfa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_edefbed0-a324-41e1-be46-6c2251a1cfa1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_edefbed0-a324-41e1-be46-6c2251a1cfa1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_edefbed0-a324-41e1-be46-6c2251a1cfa1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_edefbed0-a324-41e1-be46-6c2251a1cfa1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0a585ee5-a6bf-413a-bc48-2d823e26973f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:to="loc_us-gaap_CashFlowHedgingMember_0a585ee5-a6bf-413a-bc48-2d823e26973f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ad401c89-e69f-4efd-9a19-a687c0523d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ad401c89-e69f-4efd-9a19-a687c0523d28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4cbfee8d-9310-4746-92bf-85a261f82957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_HedgingDesignationAxis_4cbfee8d-9310-4746-92bf-85a261f82957" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4cbfee8d-9310-4746-92bf-85a261f82957_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_4cbfee8d-9310-4746-92bf-85a261f82957" xlink:to="loc_us-gaap_HedgingDesignationDomain_4cbfee8d-9310-4746-92bf-85a261f82957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_4cbfee8d-9310-4746-92bf-85a261f82957" xlink:to="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f12928e6-ee21-4248-aab2-1503df149350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f12928e6-ee21-4248-aab2-1503df149350" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_220e26bd-f9dc-42ce-8b3c-e35cc099ab4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:to="loc_us-gaap_NondesignatedMember_220e26bd-f9dc-42ce-8b3c-e35cc099ab4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a640adfc-72fd-45c9-8d7b-c52f3cc73a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a640adfc-72fd-45c9-8d7b-c52f3cc73a44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a640adfc-72fd-45c9-8d7b-c52f3cc73a44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a640adfc-72fd-45c9-8d7b-c52f3cc73a44" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a640adfc-72fd-45c9-8d7b-c52f3cc73a44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a640adfc-72fd-45c9-8d7b-c52f3cc73a44" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_173bc996-6bd3-4df4-ac06-09f6f04d3e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_173bc996-6bd3-4df4-ac06-09f6f04d3e59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6ee73e37-ca58-48bc-ae59-4dc7ac9a89a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6ee73e37-ca58-48bc-ae59-4dc7ac9a89a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_4742e1a5-b69e-49ae-83bc-155d3c381034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_us-gaap_InterestRateContractMember_4742e1a5-b69e-49ae-83bc-155d3c381034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeignCurrencyDenominatedInDebtMember_fb794eb6-134f-4fcb-8f5b-1ca9e494f756" xlink:href="bsx-20211231.xsd#bsx_ForeignCurrencyDenominatedInDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_bsx_ForeignCurrencyDenominatedInDebtMember_fb794eb6-134f-4fcb-8f5b-1ca9e494f756" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f32e807d-76d0-4524-804d-5d480935ccbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f32e807d-76d0-4524-804d-5d480935ccbe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32e807d-76d0-4524-804d-5d480935ccbe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f32e807d-76d0-4524-804d-5d480935ccbe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32e807d-76d0-4524-804d-5d480935ccbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d67be27-aede-4196-999d-6f6a23a7afdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f32e807d-76d0-4524-804d-5d480935ccbe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d67be27-aede-4196-999d-6f6a23a7afdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_87061174-4230-4d2f-b235-1360e3f8a3ae" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d67be27-aede-4196-999d-6f6a23a7afdf" xlink:to="loc_bsx_BTGAcquisitionMember_87061174-4230-4d2f-b235-1360e3f8a3ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_14d54041-d2c2-4b6c-aa3d-0d4f312be45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_14d54041-d2c2-4b6c-aa3d-0d4f312be45a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_14d54041-d2c2-4b6c-aa3d-0d4f312be45a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_14d54041-d2c2-4b6c-aa3d-0d4f312be45a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_14d54041-d2c2-4b6c-aa3d-0d4f312be45a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_14d54041-d2c2-4b6c-aa3d-0d4f312be45a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_358b9fab-3afe-4023-92a4-87e01cc9d0ea" xlink:href="bsx-20211231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:to="loc_bsx_November2019AggregateOfferingMember_358b9fab-3afe-4023-92a4-87e01cc9d0ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_8a2e1678-5121-4036-a1cf-7b5e6cd8c578" xlink:href="bsx-20211231.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:to="loc_bsx_December2027NotesMember_8a2e1678-5121-4036-a1cf-7b5e6cd8c578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_119f0b53-52eb-4d39-82c2-55e5e5f751b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_119f0b53-52eb-4d39-82c2-55e5e5f751b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_119f0b53-52eb-4d39-82c2-55e5e5f751b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_119f0b53-52eb-4d39-82c2-55e5e5f751b8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_119f0b53-52eb-4d39-82c2-55e5e5f751b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_119f0b53-52eb-4d39-82c2-55e5e5f751b8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_c1a9f219-7d34-43e5-a174-40a2e996cd82" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_bsx_LicensingArrangementAssetsMember_c1a9f219-7d34-43e5-a174-40a2e996cd82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_88e124e6-eb58-49fb-8b46-5cdfb7c0a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_88e124e6-eb58-49fb-8b46-5cdfb7c0a0c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_d53bb4d6-9446-4c0f-b684-9879337c1c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_d53bb4d6-9446-4c0f-b684-9879337c1c1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f2466f67-ff3a-49aa-8c4a-9a0a41e96d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f2466f67-ff3a-49aa-8c4a-9a0a41e96d8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_97243ade-fbb0-4e9f-a65b-147393d6f19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_97243ade-fbb0-4e9f-a65b-147393d6f19d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b16e42b5-4ea3-4e7d-b58c-0be72d163565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b16e42b5-4ea3-4e7d-b58c-0be72d163565" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98e1c35b-8391-4752-aab9-e03355b010e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98e1c35b-8391-4752-aab9-e03355b010e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_98e1c35b-8391-4752-aab9-e03355b010e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98e1c35b-8391-4752-aab9-e03355b010e7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_98e1c35b-8391-4752-aab9-e03355b010e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98e1c35b-8391-4752-aab9-e03355b010e7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_38c072f7-be24-4b86-aebe-2dcdc0dd63a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:to="loc_us-gaap_CostOfSalesMember_38c072f7-be24-4b86-aebe-2dcdc0dd63a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_37b4f8d7-0992-41b7-9024-5741d1cc44b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:to="loc_us-gaap_InterestExpenseMember_37b4f8d7-0992-41b7-9024-5741d1cc44b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_a8d80a14-23c4-4953-a097-1d3ec074de82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_a8d80a14-23c4-4953-a097-1d3ec074de82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_1b903886-1416-48d5-b709-8980983be855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_1b903886-1416-48d5-b709-8980983be855" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_e2249149-3bc3-490e-8b0d-b9d2014338dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_e2249149-3bc3-490e-8b0d-b9d2014338dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_1d5a1e0e-3671-40ba-9e44-fe06debde90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_DerivativeAssets_1d5a1e0e-3671-40ba-9e44-fe06debde90e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_640248f7-704a-46f6-b246-f1b85a483d2b" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_LicensingArrangementsAsset_640248f7-704a-46f6-b246-f1b85a483d2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_17e850f4-1707-4599-8048-825d3c8b10ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_17e850f4-1707-4599-8048-825d3c8b10ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a3cce438-1479-4cc5-bef4-9004076cfe30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_DerivativeLiabilities_a3cce438-1479-4cc5-bef4-9004076cfe30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93af3cec-266f-4bc2-90aa-9eea6efd858f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93af3cec-266f-4bc2-90aa-9eea6efd858f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_547e3d76-a69c-44eb-9ecb-705d5244cc2e" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_LicensingArrangementsLiability_547e3d76-a69c-44eb-9ecb-705d5244cc2e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_e073c35d-9d87-471d-885f-290505d24a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_e073c35d-9d87-471d-885f-290505d24a66" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e755160e-a576-4b93-a7cb-6a861c7060f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_e755160e-a576-4b93-a7cb-6a861c7060f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_a393aeaa-3d0a-493c-9187-ad775cbc4dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_Cash_a393aeaa-3d0a-493c-9187-ad775cbc4dd2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_334d0b5c-7808-4bfd-8087-9b3e11cfc75e" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_334d0b5c-7808-4bfd-8087-9b3e11cfc75e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_3321ff67-946e-4664-b9b2-3eb280b7c363" xlink:href="bsx-20211231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_DiscountRateFairValueInput_3321ff67-946e-4664-b9b2-3eb280b7c363" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_deb339f3-ccbf-482f-ae52-78aabaeb48b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_deb339f3-ccbf-482f-ae52-78aabaeb48b6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_48ebb64c-2819-4497-9c83-8f68258acbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_PaymentsForRoyalties_48ebb64c-2819-4497-9c83-8f68258acbcc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_abe3c1de-7dc8-4a33-a6da-02f50aa8a755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_abe3c1de-7dc8-4a33-a6da-02f50aa8a755" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9ae876a6-ea42-4310-9aec-24e245e9a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9ae876a6-ea42-4310-9aec-24e245e9a49d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a242b512-6f9b-4866-8de4-5afefc4b2079" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_srt_RangeAxis_a242b512-6f9b-4866-8de4-5afefc4b2079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a242b512-6f9b-4866-8de4-5afefc4b2079_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a242b512-6f9b-4866-8de4-5afefc4b2079" xlink:to="loc_srt_RangeMember_a242b512-6f9b-4866-8de4-5afefc4b2079_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a242b512-6f9b-4866-8de4-5afefc4b2079" xlink:to="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_2b964ce1-6cbe-43e4-b8c6-95c3143cb21a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:to="loc_srt_WeightedAverageMember_2b964ce1-6cbe-43e4-b8c6-95c3143cb21a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3fe55151-373c-44b2-bdb3-b747ad0ab426" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:to="loc_srt_MinimumMember_3fe55151-373c-44b2-bdb3-b747ad0ab426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a04119d-3221-4a66-86a0-3f3070fb5c60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:to="loc_srt_MaximumMember_8a04119d-3221-4a66-86a0-3f3070fb5c60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_78c5deb1-0d77-4984-9755-763850fe4e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_78c5deb1-0d77-4984-9755-763850fe4e8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_78c5deb1-0d77-4984-9755-763850fe4e8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_78c5deb1-0d77-4984-9755-763850fe4e8a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_78c5deb1-0d77-4984-9755-763850fe4e8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1308cbf-3b68-4cb6-a55d-ecaad94d4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_78c5deb1-0d77-4984-9755-763850fe4e8a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1308cbf-3b68-4cb6-a55d-ecaad94d4ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f3b5532c-315b-4f42-8998-a366dbb548bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1308cbf-3b68-4cb6-a55d-ecaad94d4ea0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f3b5532c-315b-4f42-8998-a366dbb548bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e85fa25b-b8bd-45a2-9edf-144f37617f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e85fa25b-b8bd-45a2-9edf-144f37617f35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e85fa25b-b8bd-45a2-9edf-144f37617f35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e85fa25b-b8bd-45a2-9edf-144f37617f35" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e85fa25b-b8bd-45a2-9edf-144f37617f35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e85fa25b-b8bd-45a2-9edf-144f37617f35" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5b8ea32a-9c27-42bd-9fea-c55b7e2f9c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5b8ea32a-9c27-42bd-9fea-c55b7e2f9c49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a3f616e8-153e-4b79-b1e3-5bf93207be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a3f616e8-153e-4b79-b1e3-5bf93207be0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_303b934c-7a77-4913-b559-31bc8e6edad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_303b934c-7a77-4913-b559-31bc8e6edad2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_20dcd3ee-0501-4806-9462-078d20ed3066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_20dcd3ee-0501-4806-9462-078d20ed3066" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20dcd3ee-0501-4806-9462-078d20ed3066_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_20dcd3ee-0501-4806-9462-078d20ed3066" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20dcd3ee-0501-4806-9462-078d20ed3066_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_20dcd3ee-0501-4806-9462-078d20ed3066" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_a402da51-31eb-4820-899d-673ad58d333c" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:to="loc_bsx_LicensingArrangementAssetsMember_a402da51-31eb-4820-899d-673ad58d333c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementLiabilitiesMember_e42c327c-0d92-4a02-bc81-523e2b1449f8" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:to="loc_bsx_LicensingArrangementLiabilitiesMember_e42c327c-0d92-4a02-bc81-523e2b1449f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedOutstandingDebtMember_fb29e984-a9ff-4c0c-8134-e33d3970afd3" xlink:href="bsx-20211231.xsd#bsx_EuroDenominatedOutstandingDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:to="loc_bsx_EuroDenominatedOutstandingDebtMember_fb29e984-a9ff-4c0c-8134-e33d3970afd3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended" id="ib88a006a76f94311bed0651b5131a8e2_ContractualObligationsandCommitmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_84aaede3-7d9c-4769-bd71-5c626e128d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_6174b155-2104-4cf7-8b5c-ab0840004978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_84aaede3-7d9c-4769-bd71-5c626e128d6b" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_6174b155-2104-4cf7-8b5c-ab0840004978" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_84aaede3-7d9c-4769-bd71-5c626e128d6b" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1df21ec3-370c-4863-8859-335d5a2aaef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1df21ec3-370c-4863-8859-335d5a2aaef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1df21ec3-370c-4863-8859-335d5a2aaef9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1df21ec3-370c-4863-8859-335d5a2aaef9" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1df21ec3-370c-4863-8859-335d5a2aaef9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ccf4a844-d6b7-41b8-9ff7-880f4648f8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1df21ec3-370c-4863-8859-335d5a2aaef9" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ccf4a844-d6b7-41b8-9ff7-880f4648f8c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_af5496d8-e36c-4dd4-8c9e-01ddb0f5d83b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ccf4a844-d6b7-41b8-9ff7-880f4648f8c7" xlink:to="loc_us-gaap_CommercialPaperMember_af5496d8-e36c-4dd4-8c9e-01ddb0f5d83b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_35ba0f82-ef25-4b7b-8ef6-25cb2c657658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:to="loc_us-gaap_DebtInstrumentAxis_35ba0f82-ef25-4b7b-8ef6-25cb2c657658" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35ba0f82-ef25-4b7b-8ef6-25cb2c657658_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_35ba0f82-ef25-4b7b-8ef6-25cb2c657658" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35ba0f82-ef25-4b7b-8ef6-25cb2c657658_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_41e2ced0-09fe-4b7b-b8cd-4c7a00e0c5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_35ba0f82-ef25-4b7b-8ef6-25cb2c657658" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_41e2ced0-09fe-4b7b-b8cd-4c7a00e0c5b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended" id="i73e5b1021c4c417785aebf172ab9a845_ContractualObligationsandCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ec34340d-f08b-4429-b1fc-03654de72ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ec34340d-f08b-4429-b1fc-03654de72ce9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_5020d181-04c4-44f9-b9fa-378ca04d7f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtCurrent_5020d181-04c4-44f9-b9fa-378ca04d7f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c2d852b-31cc-482c-afc1-f32d210d8d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c2d852b-31cc-482c-afc1-f32d210d8d88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44dca769-1ea0-44c0-893c-fb6c4167e47e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44dca769-1ea0-44c0-893c-fb6c4167e47e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d60cdf5-73f5-4f76-b909-b5534c2507db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d60cdf5-73f5-4f76-b909-b5534c2507db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_0eb84b14-6bf4-4306-8174-b58100b83c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_0eb84b14-6bf4-4306-8174-b58100b83c9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ec549f84-1ff1-4a87-bc6e-431aeee47f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_ShortTermBorrowings_ec549f84-1ff1-4a87-bc6e-431aeee47f6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4a2b5682-5083-4589-92c3-90f78270a07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_RepaymentsOfDebt_4a2b5682-5083-4589-92c3-90f78270a07f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_40d23cf1-63de-440d-ab72-ab8d378ad98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LineOfCredit_40d23cf1-63de-440d-ab72-ab8d378ad98d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_4f6b7e0b-5815-4615-8909-115b620785d3" xlink:href="bsx-20211231.xsd#bsx_MaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_MaximumLeverageRatio_4f6b7e0b-5815-4615-8909-115b620785d3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA_363a3d47-1297-4405-a49e-e08ec32d7926" xlink:href="bsx-20211231.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_DeemedConsolidatedEBITDA_363a3d47-1297-4405-a49e-e08ec32d7926" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_a354903f-6be9-4220-991e-374649a661d5" xlink:href="bsx-20211231.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_a354903f-6be9-4220-991e-374649a661d5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_b8459ec9-9b37-4977-bc01-49659bf9b954" xlink:href="bsx-20211231.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_b8459ec9-9b37-4977-bc01-49659bf9b954" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_842be70e-a831-4b97-a396-a2d1d2071f78" xlink:href="bsx-20211231.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_842be70e-a831-4b97-a396-a2d1d2071f78" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_9dd21423-b64b-4e8e-9308-d32c09c87aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_9dd21423-b64b-4e8e-9308-d32c09c87aac" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_c7277086-538a-4fed-b242-21efcc79bbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_c7277086-538a-4fed-b242-21efcc79bbc0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_6f44bfb8-9568-456f-9cf8-762486ec2b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_6f44bfb8-9568-456f-9cf8-762486ec2b53" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_57aad85a-0ab5-4ebd-ab65-525ff9c2a81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_57aad85a-0ab5-4ebd-ab65-525ff9c2a81d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ab66485e-d1ee-4cc8-962f-3be972d653f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LongTermDebt_ab66485e-d1ee-4cc8-962f-3be972d653f6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_ee26d828-9181-4288-98d2-37c24cf0ef0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_ee26d828-9181-4288-98d2-37c24cf0ef0f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_af7ba51a-dbd0-449d-8875-48ec8a2f3b47" xlink:href="bsx-20211231.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_af7ba51a-dbd0-449d-8875-48ec8a2f3b47" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c7b15e65-bbfa-4316-87b1-7e2a68d018c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c7b15e65-bbfa-4316-87b1-7e2a68d018c7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_f901c869-8d95-4ed7-96af-f418c9f5041c" xlink:href="bsx-20211231.xsd#bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_f901c869-8d95-4ed7-96af-f418c9f5041c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d3373130-fc03-477a-a22d-0aba05a63aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d3373130-fc03-477a-a22d-0aba05a63aa6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_8a558a70-a186-4b74-872a-e53fc433d280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_8a558a70-a186-4b74-872a-e53fc433d280" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_db6db740-1cbb-4a2a-bc44-c33f0e943de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_db6db740-1cbb-4a2a-bc44-c33f0e943de6" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_58296e3c-1092-4c5f-84db-27733d1c123f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_58296e3c-1092-4c5f-84db-27733d1c123f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_c9924b66-25f7-47ed-8fea-db314a0c18e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_c9924b66-25f7-47ed-8fea-db314a0c18e1" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_5b3d4e1a-fa4e-4557-a4fb-e9b3a17eb91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_5b3d4e1a-fa4e-4557-a4fb-e9b3a17eb91c" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_a137df0b-d106-4828-8176-40d939cbd6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligation_a137df0b-d106-4828-8176-40d939cbd6aa" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_70ad6b41-9b80-4d28-9e07-3c79964b3c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_70ad6b41-9b80-4d28-9e07-3c79964b3c78" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b" xlink:to="loc_us-gaap_ClassOfStockDomain_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f8830446-7b17-4d53-831d-1cfa4e43e078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b" xlink:to="loc_us-gaap_ClassOfStockDomain_f8830446-7b17-4d53-831d-1cfa4e43e078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_4961a3e1-37da-44f2-97b8-468716fbc622" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f8830446-7b17-4d53-831d-1cfa4e43e078" xlink:to="loc_bsx_A550MCPSSeriesAMember_4961a3e1-37da-44f2-97b8-468716fbc622" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_339f1bcb-1ba0-4214-8872-82e08402082d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_DebtInstrumentAxis_339f1bcb-1ba0-4214-8872-82e08402082d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_339f1bcb-1ba0-4214-8872-82e08402082d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_339f1bcb-1ba0-4214-8872-82e08402082d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_339f1bcb-1ba0-4214-8872-82e08402082d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_339f1bcb-1ba0-4214-8872-82e08402082d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember_7876366c-4db8-4099-bd36-eddae28fc4b6" xlink:href="bsx-20211231.xsd#bsx_April2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_April2021TermLoanMember_7876366c-4db8-4099-bd36-eddae28fc4b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember_74ad2053-2cd0-4070-b17f-45556ebec28c" xlink:href="bsx-20211231.xsd#bsx_A2020TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_A2020TermLoanMember_74ad2053-2cd0-4070-b17f-45556ebec28c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember_2a6d9a1f-a55c-42cd-a293-fa6644d9e0ee" xlink:href="bsx-20211231.xsd#bsx_February2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_February2021TermLoanMember_2a6d9a1f-a55c-42cd-a293-fa6644d9e0ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember_6e10b85a-7e39-45af-970b-7d7518917458" xlink:href="bsx-20211231.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_ThreeYearDelayedDrawTermLoanMember_6e10b85a-7e39-45af-970b-7d7518917458" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember_36a2e655-c237-43ff-9ccf-e6174d84c1b1" xlink:href="bsx-20211231.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_TwoYearDelayedDrawTermLoanMember_36a2e655-c237-43ff-9ccf-e6174d84c1b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_a53fbdd3-cf7d-4ffd-bc5c-272ed29984d5" xlink:href="bsx-20211231.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_a53fbdd3-cf7d-4ffd-bc5c-272ed29984d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_55a30465-7360-4be5-b262-c6b9d5b7d369" xlink:href="bsx-20211231.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_55a30465-7360-4be5-b262-c6b9d5b7d369" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_92f8b98e-36f5-43c6-b115-9be96c05e06b" xlink:href="bsx-20211231.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_92f8b98e-36f5-43c6-b115-9be96c05e06b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_75bfc1eb-af6e-4514-b04d-1bdf75a9a458" xlink:href="bsx-20211231.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_75bfc1eb-af6e-4514-b04d-1bdf75a9a458" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dfdcdc1f-d224-4108-8966-b2a644a2114f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dfdcdc1f-d224-4108-8966-b2a644a2114f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dfdcdc1f-d224-4108-8966-b2a644a2114f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dfdcdc1f-d224-4108-8966-b2a644a2114f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dfdcdc1f-d224-4108-8966-b2a644a2114f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dfdcdc1f-d224-4108-8966-b2a644a2114f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember_88107ff3-d579-4f05-8333-aeb9deba5a0e" xlink:href="bsx-20211231.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_February2019AggregateOfferingMember_88107ff3-d579-4f05-8333-aeb9deba5a0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember_e98178ba-3a16-4f83-bd31-53099deaa09e" xlink:href="bsx-20211231.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2020SNAggregateOfferingMember_e98178ba-3a16-4f83-bd31-53099deaa09e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember_7d451991-e688-4727-9f86-d85eae74ebd7" xlink:href="bsx-20211231.xsd#bsx_January2020NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_January2020NotesMember_7d451991-e688-4727-9f86-d85eae74ebd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember_15ef5505-023e-4f0e-a9fc-1b7af49207cd" xlink:href="bsx-20211231.xsd#bsx_May2020NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2020NotesMember_15ef5505-023e-4f0e-a9fc-1b7af49207cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_aa2d383c-d979-4ac1-b09b-ff890e859041" xlink:href="bsx-20211231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_November2019AggregateOfferingMember_aa2d383c-d979-4ac1-b09b-ff890e859041" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_e828aad6-c21b-4718-9e75-e2984df7f55f" xlink:href="bsx-20211231.xsd#bsx_May2022NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2022NotesMember_e828aad6-c21b-4718-9e75-e2984df7f55f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_a1ce6c0f-6bf3-4cbf-a36a-25807cc1e3d6" xlink:href="bsx-20211231.xsd#bsx_October2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_October2023NotesMember_a1ce6c0f-6bf3-4cbf-a36a-25807cc1e3d6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7e1d692d-df4a-4c62-acb6-7cbcfaa1da58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7e1d692d-df4a-4c62-acb6-7cbcfaa1da58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_1abc5cb6-e30d-43b3-9c3b-184bc2022dca" xlink:href="bsx-20211231.xsd#bsx_March2024NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2024NotesMember_1abc5cb6-e30d-43b3-9c3b-184bc2022dca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_1d3919a2-df2a-47f8-ace2-96c31fa299cc" xlink:href="bsx-20211231.xsd#bsx_May2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2025NotesMember_1d3919a2-df2a-47f8-ace2-96c31fa299cc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_9e724d33-7494-4318-aa2e-31bec79d2d89" xlink:href="bsx-20211231.xsd#bsx_June2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_June2025NotesMember_9e724d33-7494-4318-aa2e-31bec79d2d89" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_ae88dabe-f163-48df-9814-16839559fcfe" xlink:href="bsx-20211231.xsd#bsx_March2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2026NotesMember_ae88dabe-f163-48df-9814-16839559fcfe" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_81a29598-cf26-4225-9a97-dd145d6983df" xlink:href="bsx-20211231.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_December2027NotesMember_81a29598-cf26-4225-9a97-dd145d6983df" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_e383b3f8-f01b-49a7-a69c-801a4ac1d167" xlink:href="bsx-20211231.xsd#bsx_March2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2028NotesMember_e383b3f8-f01b-49a7-a69c-801a4ac1d167" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_f0ff9737-8a71-4536-a400-20c29c61064a" xlink:href="bsx-20211231.xsd#bsx_March2029NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2029NotesMember_f0ff9737-8a71-4536-a400-20c29c61064a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_c93d18b2-c2c9-431b-9393-7f233531021e" xlink:href="bsx-20211231.xsd#bsx_June2030NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_June2030NotesMember_c93d18b2-c2c9-431b-9393-7f233531021e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_12bfb8af-113a-4135-8d70-5290e0e42862" xlink:href="bsx-20211231.xsd#bsx_November2035NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_November2035NotesMember_12bfb8af-113a-4135-8d70-5290e0e42862" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_ce3dbbbf-2664-46db-8e2f-10c38eb99515" xlink:href="bsx-20211231.xsd#bsx_March2039NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2039NotesMember_ce3dbbbf-2664-46db-8e2f-10c38eb99515" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_fabbd6a0-ceb9-4012-88c1-323ed16a05a5" xlink:href="bsx-20211231.xsd#bsx_January2040NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_January2040NotesMember_fabbd6a0-ceb9-4012-88c1-323ed16a05a5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_d335b587-0e02-481d-8f74-2eb78e3835dd" xlink:href="bsx-20211231.xsd#bsx_March2049NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2049NotesMember_d335b587-0e02-481d-8f74-2eb78e3835dd" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_48784f41-5047-4a45-953b-2ce344859886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_InterestRateSwapMember_48784f41-5047-4a45-953b-2ce344859886" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_5f200599-d21c-40bc-817d-38f1b45656ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_5f200599-d21c-40bc-817d-38f1b45656ed" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_41dfb0ef-d7e5-4d62-9cf1-46f4bb1d119b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_SeniorNotesMember_41dfb0ef-d7e5-4d62-9cf1-46f4bb1d119b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_6323aa96-968b-4f80-91cb-2091d11a1386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_UnsecuredDebtMember_6323aa96-968b-4f80-91cb-2091d11a1386" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a70773-7f84-4843-afd0-6cca20fc0221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a70773-7f84-4843-afd0-6cca20fc0221" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_cff8c92a-44d8-4702-b30d-1ab50a794399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_cff8c92a-44d8-4702-b30d-1ab50a794399" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_ed3b7d03-4a09-44ee-87b5-e753ad3eacdc" xlink:href="bsx-20211231.xsd#bsx_August2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_August2019TermLoanMember_ed3b7d03-4a09-44ee-87b5-e753ad3eacdc" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e5683324-0e5c-4ec8-9b20-0b4d063eaf27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e5683324-0e5c-4ec8-9b20-0b4d063eaf27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e5683324-0e5c-4ec8-9b20-0b4d063eaf27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e5683324-0e5c-4ec8-9b20-0b4d063eaf27" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e5683324-0e5c-4ec8-9b20-0b4d063eaf27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c8cc2a63-9dbc-4953-9b91-e7ac7edb60fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e5683324-0e5c-4ec8-9b20-0b4d063eaf27" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c8cc2a63-9dbc-4953-9b91-e7ac7edb60fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_890b0240-da96-4d5f-87da-8c0a043101da" xlink:href="bsx-20211231.xsd#bsx_The2018FacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_c8cc2a63-9dbc-4953-9b91-e7ac7edb60fb" xlink:to="loc_bsx_The2018FacilityDomain_890b0240-da96-4d5f-87da-8c0a043101da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3fdf81cc-7827-4bdf-acc7-2c6654257939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_CreditFacilityAxis_3fdf81cc-7827-4bdf-acc7-2c6654257939" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3fdf81cc-7827-4bdf-acc7-2c6654257939_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_3fdf81cc-7827-4bdf-acc7-2c6654257939" xlink:to="loc_us-gaap_CreditFacilityDomain_3fdf81cc-7827-4bdf-acc7-2c6654257939_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_145e3da8-4a35-4769-9ab3-7c7c7ffaf1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_3fdf81cc-7827-4bdf-acc7-2c6654257939" xlink:to="loc_us-gaap_CreditFacilityDomain_145e3da8-4a35-4769-9ab3-7c7c7ffaf1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0ddbd6e4-e0dd-4d5b-bffb-23c93564db05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_145e3da8-4a35-4769-9ab3-7c7c7ffaf1aa" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0ddbd6e4-e0dd-4d5b-bffb-23c93564db05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_f398c964-0782-47ed-8eb5-cdb7a7c454f7" xlink:href="bsx-20211231.xsd#bsx_CovenantAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_bsx_CovenantAxis_f398c964-0782-47ed-8eb5-cdb7a7c454f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_f398c964-0782-47ed-8eb5-cdb7a7c454f7_default" xlink:href="bsx-20211231.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_CovenantAxis_f398c964-0782-47ed-8eb5-cdb7a7c454f7" xlink:to="loc_bsx_CovenantDomain_f398c964-0782-47ed-8eb5-cdb7a7c454f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:href="bsx-20211231.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_CovenantAxis_f398c964-0782-47ed-8eb5-cdb7a7c454f7" xlink:to="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_8db01390-5fe2-474f-acc0-cc6653af2238" xlink:href="bsx-20211231.xsd#bsx_ActualCovenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_ActualCovenantMember_8db01390-5fe2-474f-acc0-cc6653af2238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfMarch312021Member_9e22bcec-e236-4db9-a145-cf9faf72c82b" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfMarch312021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfMarch312021Member_9e22bcec-e236-4db9-a145-cf9faf72c82b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfJune302021Member_2b1fdcfb-45e0-46da-8a36-a3f6f71e0fec" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfJune302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfJune302021Member_2b1fdcfb-45e0-46da-8a36-a3f6f71e0fec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfSeptember302021Member_ffd8b90c-8103-4bb5-ac96-0a1209971d4c" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfSeptember302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfSeptember302021Member_ffd8b90c-8103-4bb5-ac96-0a1209971d4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_a8eb8ce2-6519-4483-b5d6-cab664d0fa26" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_a8eb8ce2-6519-4483-b5d6-cab664d0fa26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember_6abb7092-fb5c-43f1-8544-d306566bb75d" xlink:href="bsx-20211231.xsd#bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember_6abb7092-fb5c-43f1-8544-d306566bb75d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_778d618f-ea64-489d-90b7-764022ab3ea3" xlink:href="bsx-20211231.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_778d618f-ea64-489d-90b7-764022ab3ea3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_4bdcd715-6c80-46f5-8f97-877f2051f458" xlink:href="bsx-20211231.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_4bdcd715-6c80-46f5-8f97-877f2051f458" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_b58dd712-784e-46ac-be1d-814405f78f36" xlink:href="bsx-20211231.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_b58dd712-784e-46ac-be1d-814405f78f36" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember_e409d628-a035-4e3b-a8fc-19c377358f5b" xlink:href="bsx-20211231.xsd#bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember_e409d628-a035-4e3b-a8fc-19c377358f5b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_9f24890f-55b5-437e-b285-85791cf88df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_9f24890f-55b5-437e-b285-85791cf88df6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_9f24890f-55b5-437e-b285-85791cf88df6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9f24890f-55b5-437e-b285-85791cf88df6" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_9f24890f-55b5-437e-b285-85791cf88df6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9f24890f-55b5-437e-b285-85791cf88df6" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f6571c15-bee3-4917-818f-7ca1c2ff2865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:to="loc_us-gaap_CommercialPaperMember_f6571c15-bee3-4917-818f-7ca1c2ff2865" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_e7052332-d9d5-4563-8039-00496c9f4670" xlink:href="bsx-20211231.xsd#bsx_August2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:to="loc_bsx_August2019TermLoanMember_e7052332-d9d5-4563-8039-00496c9f4670" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="extended" id="i358aa6cda78646c297a73b857fa59401_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fb4fdc61-c7fb-4e38-9a6d-bfab79fd0fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fb4fdc61-c7fb-4e38-9a6d-bfab79fd0fc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_18f40b66-1ea8-4b7f-9220-92b21b66d2c2" xlink:href="bsx-20211231.xsd#bsx_LesseeOperatingAndFinanceLeasesOptionToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_18f40b66-1ea8-4b7f-9220-92b21b66d2c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ac29310-3e64-4387-b792-31579a394918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ac29310-3e64-4387-b792-31579a394918" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8721ba81-f44f-44aa-ac4c-e029f7dc447d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8721ba81-f44f-44aa-ac4c-e029f7dc447d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1b7c5ceb-377e-4b7c-b21e-f2aa1e09b892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1b7c5ceb-377e-4b7c-b21e-f2aa1e09b892" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_63c76903-98bd-4eeb-a288-e1fa1885bfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_63c76903-98bd-4eeb-a288-e1fa1885bfc9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_21a44d58-1a5c-44b5-8df0-cfd3c48369a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_21a44d58-1a5c-44b5-8df0-cfd3c48369a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cab1fdf3-dd8e-4d05-b85d-9f457415360b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cab1fdf3-dd8e-4d05-b85d-9f457415360b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_87b3f893-88e4-43eb-8427-424ae0c35fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_87b3f893-88e4-43eb-8427-424ae0c35fec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1746ecba-bb2a-4f1a-ad13-85fc74ac1907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseCost_1746ecba-bb2a-4f1a-ad13-85fc74ac1907" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_2a14b993-81a2-494d-bd6c-cef3a794caf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeasePayments_2a14b993-81a2-494d-bd6c-cef3a794caf8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d3923257-d685-4f13-b238-db897c778de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d3923257-d685-4f13-b238-db897c778de0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_8fa52ec3-a202-4ea4-ae2b-a3085882cb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_8fa52ec3-a202-4ea4-ae2b-a3085882cb91" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_4331a7b0-45ab-4050-957f-fcd914d566f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_4331a7b0-45ab-4050-957f-fcd914d566f7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_104b2555-4c7a-4be9-9ccd-a6bf8149483c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_104b2555-4c7a-4be9-9ccd-a6bf8149483c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_0a82a5e8-d3c3-4128-b560-db58335c81ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_0a82a5e8-d3c3-4128-b560-db58335c81ff" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_7445b7fa-9904-4a57-8c2a-9a14619295dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_7445b7fa-9904-4a57-8c2a-9a14619295dd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_b287caac-7b6d-4a7e-90fb-02f566c74f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_b287caac-7b6d-4a7e-90fb-02f566c74f47" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8290fdcf-4f9a-4ac3-b369-cfffa3e440fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8290fdcf-4f9a-4ac3-b369-cfffa3e440fa" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3567d3c2-05f4-4d7a-a612-09d429a193fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3567d3c2-05f4-4d7a-a612-09d429a193fa" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_31ba5550-023c-476f-bff1-5bfc13e86417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiability_31ba5550-023c-476f-bff1-5bfc13e86417" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0283ade6-0d31-4560-9043-ced562da7ff9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:to="loc_srt_RangeAxis_0283ade6-0d31-4560-9043-ced562da7ff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0283ade6-0d31-4560-9043-ced562da7ff9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0283ade6-0d31-4560-9043-ced562da7ff9" xlink:to="loc_srt_RangeMember_0283ade6-0d31-4560-9043-ced562da7ff9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0283ade6-0d31-4560-9043-ced562da7ff9" xlink:to="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab0126f1-4b22-4217-90ba-9cedafb7d847" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:to="loc_srt_MinimumMember_ab0126f1-4b22-4217-90ba-9cedafb7d847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d5fb0761-26bb-40df-b841-52dac701ab44" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:to="loc_srt_MaximumMember_d5fb0761-26bb-40df-b841-52dac701ab44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_23c9d01a-82d9-4ad7-b18d-25a0ab8a63eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_23c9d01a-82d9-4ad7-b18d-25a0ab8a63eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_6bebf345-c87a-4a41-8b64-3334b249f171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_6bebf345-c87a-4a41-8b64-3334b249f171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_74832f3c-0792-4ed7-bf1a-bd3653930fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_74832f3c-0792-4ed7-bf1a-bd3653930fa4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#RestructuringRelatedActivitiesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="extended" id="ie0f96c058f9c45d7aaa98e06401426dc_RestructuringRelatedActivitiesTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_395def4a-fd5c-4f88-84c7-8611352b1ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_395def4a-fd5c-4f88-84c7-8611352b1ec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesTableTextBlock_d2a18dcc-58c1-4b71-86c1-88f1e8db53b9" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringChargesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:to="loc_bsx_CumulativeRestructuringChargesTableTextBlock_d2a18dcc-58c1-4b71-86c1-88f1e8db53b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_5b45c095-d608-4b22-ac8b-284380364b4b" xlink:href="bsx-20211231.xsd#bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:to="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_5b45c095-d608-4b22-ac8b-284380364b4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fe937b6-1544-4413-bff7-c4344d3768f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fe937b6-1544-4413-bff7-c4344d3768f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_39a978e1-c58c-4b8a-a215-42c51486e08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fe937b6-1544-4413-bff7-c4344d3768f2" xlink:to="loc_us-gaap_RestructuringPlanAxis_39a978e1-c58c-4b8a-a215-42c51486e08d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_39a978e1-c58c-4b8a-a215-42c51486e08d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_39a978e1-c58c-4b8a-a215-42c51486e08d" xlink:to="loc_us-gaap_RestructuringPlanDomain_39a978e1-c58c-4b8a-a215-42c51486e08d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_39a978e1-c58c-4b8a-a215-42c51486e08d" xlink:to="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_6499df58-ff31-495d-93e7-324800680622" xlink:href="bsx-20211231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_A2019RestructuringPlanMember_6499df58-ff31-495d-93e7-324800680622" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_4da49b8d-efe6-4353-a62f-92a46bb41a85" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_4da49b8d-efe6-4353-a62f-92a46bb41a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_a8f262a8-2312-4c72-8f25-2027f1b9c7fb" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_RestructuringPlanMember_a8f262a8-2312-4c72-8f25-2027f1b9c7fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_feac9139-9db8-45f2-8e45-69b1d83bd5b3" xlink:href="bsx-20211231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_A2016RestructuringPlanMember_feac9139-9db8-45f2-8e45-69b1d83bd5b3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#RestructuringRelatedActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="extended" id="i33c5864a21894a45879bd55d3f8c03ee_RestructuringRelatedActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_be4c4755-ed13-4384-bd12-ab6b5f8cca49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_be4c4755-ed13-4384-bd12-ab6b5f8cca49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringrelatedCostExpectedCost_b4de06ba-bf46-4811-89df-65ef03e5e08a" xlink:href="bsx-20211231.xsd#bsx_RestructuringrelatedCostExpectedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_RestructuringrelatedCostExpectedCost_b4de06ba-bf46-4811-89df-65ef03e5e08a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_5c90f266-e036-45d2-a19c-3b363fb9caa9" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRestructuringrelatedCostExpectedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_5c90f266-e036-45d2-a19c-3b363fb9caa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount_588e96dc-8ce0-4381-bba3-237d55e6a830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_EffectOnFutureCashFlowsAmount_588e96dc-8ce0-4381-bba3-237d55e6a830" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_436a3590-872a-4cee-b2cb-d403d2d99ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_SeveranceCosts1_436a3590-872a-4cee-b2cb-d403d2d99ab8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCosts_24541b42-ee50-45e7-a934-5531fe38fd3f" xlink:href="bsx-20211231.xsd#bsx_TransferCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_TransferCosts_24541b42-ee50-45e7-a934-5531fe38fd3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_704a70cb-b407-4c0b-bfb0-1b52accc6c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_OtherRestructuringCosts_704a70cb-b407-4c0b-bfb0-1b52accc6c93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5fea327e-732f-4109-8435-53ce28316038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringCharges_5fea327e-732f-4109-8435-53ce28316038" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fc4fa3d3-9965-4669-8b3b-003c7ee81cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fc4fa3d3-9965-4669-8b3b-003c7ee81cf6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedExpenses_1fdcec95-56ec-4833-8610-1f5c7a8e204b" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_RestructuringRelatedExpenses_1fdcec95-56ec-4833-8610-1f5c7a8e204b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_3ac77a5a-aba4-4e23-8489-65cb3b099103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_InventoryWriteDown_3ac77a5a-aba4-4e23-8489-65cb3b099103" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1b477d79-1d63-4e0b-9106-e71f41621053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1b477d79-1d63-4e0b-9106-e71f41621053" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesIncurredToDate_bee09062-de43-47d7-be8c-c2a7c18a7302" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringChargesIncurredToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_CumulativeRestructuringChargesIncurredToDate_bee09062-de43-47d7-be8c-c2a7c18a7302" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_f8606fef-937d-489e-a922-e70f5e65abde" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringRelatedCostsIncurredToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_f8606fef-937d-489e-a922-e70f5e65abde" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a0eb96fc-3c5f-4d65-83df-27c7faf55f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a0eb96fc-3c5f-4d65-83df-27c7faf55f6d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_63bbf5dc-f9f9-46f4-86f2-1b678c77c292" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_63bbf5dc-f9f9-46f4-86f2-1b678c77c292" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6c1efc1b-55d8-4d2c-925d-229256ceb51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6c1efc1b-55d8-4d2c-925d-229256ceb51f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6c1efc1b-55d8-4d2c-925d-229256ceb51f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c1efc1b-55d8-4d2c-925d-229256ceb51f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6c1efc1b-55d8-4d2c-925d-229256ceb51f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c1efc1b-55d8-4d2c-925d-229256ceb51f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3d5cd39f-0064-4886-96d6-ddd6947d32a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3d5cd39f-0064-4886-96d6-ddd6947d32a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bd11248f-d34e-42a4-aa04-0ed3bc318626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:to="loc_us-gaap_CostOfSalesMember_bd11248f-d34e-42a4-aa04-0ed3bc318626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_20263855-d0ec-4326-bdaf-a5b759c2262a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_20263855-d0ec-4326-bdaf-a5b759c2262a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_020b2f52-0c0e-49a0-8978-1cae4605647d" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_020b2f52-0c0e-49a0-8978-1cae4605647d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_020b2f52-0c0e-49a0-8978-1cae4605647d_default" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_020b2f52-0c0e-49a0-8978-1cae4605647d" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_020b2f52-0c0e-49a0-8978-1cae4605647d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_020b2f52-0c0e-49a0-8978-1cae4605647d" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_12ec0485-7d42-49ae-8e04-07601e4b207f" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_12ec0485-7d42-49ae-8e04-07601e4b207f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_9ebd98ec-02f2-4d49-9382-3ee3bc0ce02a" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:to="loc_bsx_RestructuringPlanMember_9ebd98ec-02f2-4d49-9382-3ee3bc0ce02a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionAxis_72506cea-81cb-4d63-bd31-ba45e34cc8fc" xlink:href="bsx-20211231.xsd#bsx_StatementOfOperationsCaptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_bsx_StatementOfOperationsCaptionAxis_72506cea-81cb-4d63-bd31-ba45e34cc8fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain_72506cea-81cb-4d63-bd31-ba45e34cc8fc_default" xlink:href="bsx-20211231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis_72506cea-81cb-4d63-bd31-ba45e34cc8fc" xlink:to="loc_bsx_StatementOfOperationsCaptionDomain_72506cea-81cb-4d63-bd31-ba45e34cc8fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:href="bsx-20211231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis_72506cea-81cb-4d63-bd31-ba45e34cc8fc" xlink:to="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_479d0ee7-10a2-4049-801f-0851dae4239c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:to="loc_us-gaap_CostOfSalesMember_479d0ee7-10a2-4049-801f-0851dae4239c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ab4ae90c-813c-428c-aafd-9891a9010dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ab4ae90c-813c-428c-aafd-9891a9010dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_b0ae2ab2-7da9-4e98-b568-2b3a2909500e" xlink:href="bsx-20211231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_b0ae2ab2-7da9-4e98-b568-2b3a2909500e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_b0ae2ab2-7da9-4e98-b568-2b3a2909500e_default" xlink:href="bsx-20211231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_b0ae2ab2-7da9-4e98-b568-2b3a2909500e" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_b0ae2ab2-7da9-4e98-b568-2b3a2909500e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:href="bsx-20211231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_b0ae2ab2-7da9-4e98-b568-2b3a2909500e" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_7cc6ff25-8454-4c2d-98d2-30cc92ecba30" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_7cc6ff25-8454-4c2d-98d2-30cc92ecba30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_d34ecb20-c089-4dac-a155-2104d8621e4e" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:to="loc_bsx_RestructuringPlanMember_d34ecb20-c089-4dac-a155-2104d8621e4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16992baa-4922-47ac-b536-44f8eef92a10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_srt_RangeAxis_16992baa-4922-47ac-b536-44f8eef92a10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16992baa-4922-47ac-b536-44f8eef92a10_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_16992baa-4922-47ac-b536-44f8eef92a10" xlink:to="loc_srt_RangeMember_16992baa-4922-47ac-b536-44f8eef92a10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_16992baa-4922-47ac-b536-44f8eef92a10" xlink:to="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_96177db1-70ca-49d8-9928-1337f450daff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:to="loc_srt_MaximumMember_96177db1-70ca-49d8-9928-1337f450daff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_23166399-730a-4c39-b9d4-453015a8c602" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:to="loc_srt_MinimumMember_23166399-730a-4c39-b9d4-453015a8c602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_71bacbff-5786-4dfa-81af-8c6861f87847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_71bacbff-5786-4dfa-81af-8c6861f87847" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_71bacbff-5786-4dfa-81af-8c6861f87847_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_71bacbff-5786-4dfa-81af-8c6861f87847" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_71bacbff-5786-4dfa-81af-8c6861f87847_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_71bacbff-5786-4dfa-81af-8c6861f87847" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_129360a2-36a9-4d97-830b-be757da09796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_us-gaap_EmployeeSeveranceMember_129360a2-36a9-4d97-830b-be757da09796" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_7288acf4-3020-41f1-9fb1-64a56994059d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_us-gaap_OtherRestructuringMember_7288acf4-3020-41f1-9fb1-64a56994059d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCostsMember_e7aa1744-c2e8-4365-9097-b93075ae7b3a" xlink:href="bsx-20211231.xsd#bsx_TransferCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_bsx_TransferCostsMember_e7aa1744-c2e8-4365-9097-b93075ae7b3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_6fe28917-1b7f-4478-a80f-5a8392ac7970" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_6fe28917-1b7f-4478-a80f-5a8392ac7970" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8104e3ff-5242-408f-a2e7-f84a03c34345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_us-gaap_RestructuringPlanAxis_8104e3ff-5242-408f-a2e7-f84a03c34345" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8104e3ff-5242-408f-a2e7-f84a03c34345_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_8104e3ff-5242-408f-a2e7-f84a03c34345" xlink:to="loc_us-gaap_RestructuringPlanDomain_8104e3ff-5242-408f-a2e7-f84a03c34345_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_8104e3ff-5242-408f-a2e7-f84a03c34345" xlink:to="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_2f40faa9-233b-4277-be02-bc1a5231bc02" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_RestructuringPlanMember_2f40faa9-233b-4277-be02-bc1a5231bc02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_30b43696-dc5f-4153-965f-43daae73154a" xlink:href="bsx-20211231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_A2019RestructuringPlanMember_30b43696-dc5f-4153-965f-43daae73154a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_405e04a3-e766-44f3-9ba2-1223b03020f3" xlink:href="bsx-20211231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_A2016RestructuringPlanMember_405e04a3-e766-44f3-9ba2-1223b03020f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LotusDiscontinuationMember_9e99f6ea-d573-4ebe-abca-a80106665a23" xlink:href="bsx-20211231.xsd#bsx_LotusDiscontinuationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_LotusDiscontinuationMember_9e99f6ea-d573-4ebe-abca-a80106665a23" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended" id="ifc624e29ba4348a08572495feb8225bd_SupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_243310c5-5d6d-41bd-8a25-16fe687c9658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_243310c5-5d6d-41bd-8a25-16fe687c9658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_1c2ddc62-9443-41ca-9753-76352e937f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_1c2ddc62-9443-41ca-9753-76352e937f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2c2d90f1-9f17-4e9c-b999-8f135319bd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2c2d90f1-9f17-4e9c-b999-8f135319bd5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_216f9234-4fe0-4067-946a-5d5f49cf893a" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_bsx_LicensingArrangementsLiability_216f9234-4fe0-4067-946a-5d5f49cf893a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ce95bfc-6324-4c61-a04a-1c743060a48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ce95bfc-6324-4c61-a04a-1c743060a48b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_807d5213-ef64-4e03-8fdf-f570ead92d00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_807d5213-ef64-4e03-8fdf-f570ead92d00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_6937138e-851f-46f7-a0a5-f7bb7b80bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_DeferredRevenue_6937138e-851f-46f7-a0a5-f7bb7b80bfd0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4e93575b-4ec2-4e13-89e9-bbee6fed2b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4e93575b-4ec2-4e13-89e9-bbee6fed2b85" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_316afdf5-107e-48de-bbab-9fe09735c58e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_StatementTable_316afdf5-107e-48de-bbab-9fe09735c58e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_cd3023c2-e7f6-4c53-a65c-7e67125e4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_316afdf5-107e-48de-bbab-9fe09735c58e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_cd3023c2-e7f6-4c53-a65c-7e67125e4d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cd3023c2-e7f6-4c53-a65c-7e67125e4d73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cd3023c2-e7f6-4c53-a65c-7e67125e4d73" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cd3023c2-e7f6-4c53-a65c-7e67125e4d73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7ea24635-6262-4464-be9a-2c867af28942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cd3023c2-e7f6-4c53-a65c-7e67125e4d73" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7ea24635-6262-4464-be9a-2c867af28942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_892488c9-201b-4ef8-aa16-89c3fd8086e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7ea24635-6262-4464-be9a-2c867af28942" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_892488c9-201b-4ef8-aa16-89c3fd8086e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="simple" xlink:href="bsx-20211231.xsd#IncomeTaxesDetailsRateTable"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="extended" id="i75e668b19df04fdd8f948be0097ce835_IncomeTaxesDetailsRateTable">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:href="bsx-20211231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9956b809-264b-4060-b50f-abf28da02f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9956b809-264b-4060-b50f-abf28da02f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_19de698e-fefb-4bf5-a69f-5c842d69656b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_19de698e-fefb-4bf5-a69f-5c842d69656b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_e3d7f5b0-68db-4f57-b50e-a7061b281162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_e3d7f5b0-68db-4f57-b50e-a7061b281162" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6ffdfe7a-fd83-40b1-a507-d27c97b4d775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6ffdfe7a-fd83-40b1-a507-d27c97b4d775" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_ba8dc7dd-1476-4a88-b317-426d54367dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_ba8dc7dd-1476-4a88-b317-426d54367dd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_74e18570-7551-414e-b6e0-0e020ad02dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_74e18570-7551-414e-b6e0-0e020ad02dd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b53fa40d-e4f5-4562-8fe5-da8268434d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b53fa40d-e4f5-4562-8fe5-da8268434d72" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_3afbe1f3-bbd2-4fbf-a448-49a6beb71a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_3afbe1f3-bbd2-4fbf-a448-49a6beb71a1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a996ed6e-7f05-456f-ac05-93c14f176490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a996ed6e-7f05-456f-ac05-93c14f176490" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_5a50342f-9ac4-4d1e-b0df-317d67a3837a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_5a50342f-9ac4-4d1e-b0df-317d67a3837a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_3b431f82-435b-4545-b228-9ae4f29ef47b" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_3b431f82-435b-4545-b228-9ae4f29ef47b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_a8748595-b929-4213-81dd-be2584931dab" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_a8748595-b929-4213-81dd-be2584931dab" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_84856b78-a719-4d47-94f5-8fb6a4578405" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_84856b78-a719-4d47-94f5-8fb6a4578405" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_d529b275-0da6-44a9-afcc-0f74ea62be69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_d529b275-0da6-44a9-afcc-0f74ea62be69" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9b4c0ae6-247a-4f50-9dd9-cc5478321f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9b4c0ae6-247a-4f50-9dd9-cc5478321f77" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a056957d-cc0e-4583-b8e0-b46124d5e2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a056957d-cc0e-4583-b8e0-b46124d5e2c3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico_b8ad8625-8474-48d6-a6a6-ac73c4a64204" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_TaxIncentivesInPuertoRico_b8ad8625-8474-48d6-a6a6-ac73c4a64204" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_85d52926-c5d1-4504-910f-e95e0377eba3" xlink:href="bsx-20211231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_85d52926-c5d1-4504-910f-e95e0377eba3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateAxis_f4cb91f5-80bd-4290-9e6d-2cd06b95d932" xlink:href="bsx-20211231.xsd#bsx_TaxRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_85d52926-c5d1-4504-910f-e95e0377eba3" xlink:to="loc_bsx_TaxRateAxis_f4cb91f5-80bd-4290-9e6d-2cd06b95d932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain_f4cb91f5-80bd-4290-9e6d-2cd06b95d932_default" xlink:href="bsx-20211231.xsd#bsx_TaxRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_TaxRateAxis_f4cb91f5-80bd-4290-9e6d-2cd06b95d932" xlink:to="loc_bsx_TaxRateDomain_f4cb91f5-80bd-4290-9e6d-2cd06b95d932_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain_444a6caf-ad45-4950-8c55-8c78adc1c2bc" xlink:href="bsx-20211231.xsd#bsx_TaxRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_TaxRateAxis_f4cb91f5-80bd-4290-9e6d-2cd06b95d932" xlink:to="loc_bsx_TaxRateDomain_444a6caf-ad45-4950-8c55-8c78adc1c2bc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#IncomeTaxesIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="extended" id="i53335d6dd33f425f930b4ea60b027624_IncomeTaxesIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d8fee724-8cb6-4e48-bbc3-9d15039052c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d8fee724-8cb6-4e48-bbc3-9d15039052c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e5f1e1c4-bf1d-4879-bb34-66fe39c3718d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e5f1e1c4-bf1d-4879-bb34-66fe39c3718d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_704b5c07-9b0f-4e6c-a45e-5d9f06f80f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_704b5c07-9b0f-4e6c-a45e-5d9f06f80f46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21e3d3c4-5400-4318-88c8-1f5a5c56cc42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21e3d3c4-5400-4318-88c8-1f5a5c56cc42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_38717118-873c-4738-8710-9ed0133d85c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_38717118-873c-4738-8710-9ed0133d85c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c2cf8122-a0d6-4e91-9050-9e77f15c4a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c2cf8122-a0d6-4e91-9050-9e77f15c4a12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad80207f-e4ec-4cf3-b6dc-326611842fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad80207f-e4ec-4cf3-b6dc-326611842fb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b6beaf9a-9768-40d7-ace7-2959680d87a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b6beaf9a-9768-40d7-ace7-2959680d87a9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d3d17b69-3393-468b-8753-2b7a3013f285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d3d17b69-3393-468b-8753-2b7a3013f285" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0c9fbb4a-054e-4252-8216-9aa58baa3b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0c9fbb4a-054e-4252-8216-9aa58baa3b9c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6f37dfa0-b144-4c0e-b5d5-e65c67b6568a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6f37dfa0-b144-4c0e-b5d5-e65c67b6568a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0896c5dd-d268-4787-8d60-bd798802adaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0896c5dd-d268-4787-8d60-bd798802adaf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_97bb2962-ec60-44f1-b9ec-1a26ff5ca2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_97bb2962-ec60-44f1-b9ec-1a26ff5ca2bb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_908ad848-d8d0-40d5-9396-e27a2819b580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_908ad848-d8d0-40d5-9396-e27a2819b580" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_59fb05e4-7103-4a01-92fb-4c23c72e6cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_59fb05e4-7103-4a01-92fb-4c23c72e6cb0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_3f99e52a-3458-4d82-9449-8049e69ae066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_3f99e52a-3458-4d82-9449-8049e69ae066" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_8f4d58a5-8a39-4873-9727-2421bfb45719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_8f4d58a5-8a39-4873-9727-2421bfb45719" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_bd24e2c1-69df-4114-a7ab-734e5dd9841b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_bd24e2c1-69df-4114-a7ab-734e5dd9841b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_46478a06-beaf-46d0-9445-e8fbb5bff027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_46478a06-beaf-46d0-9445-e8fbb5bff027" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FederalBenefitOfUncertainTaxPositions_b5c0bef4-f090-4eca-bd24-a791099a050f" xlink:href="bsx-20211231.xsd#bsx_FederalBenefitOfUncertainTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_FederalBenefitOfUncertainTaxPositions_b5c0bef4-f090-4eca-bd24-a791099a050f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_63328344-c5fb-4574-9778-ac93154e81e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_63328344-c5fb-4574-9778-ac93154e81e6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_b5f65a71-9452-497d-9c4b-08748947ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_b5f65a71-9452-497d-9c4b-08748947ca04" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_939e7369-f37d-4957-8bbe-77428c90b19b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_939e7369-f37d-4957-8bbe-77428c90b19b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_89d243c6-f994-4f6c-91b8-d19f663c38b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_89d243c6-f994-4f6c-91b8-d19f663c38b4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_21a9f0d8-3ad0-42f6-8c6f-40f3e0087c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_21a9f0d8-3ad0-42f6-8c6f-40f3e0087c92" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3837f8f4-c123-4d45-945f-001ba31d3eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3837f8f4-c123-4d45-945f-001ba31d3eda" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_586fc24b-4d69-48e0-b8cf-7c7d2fb36ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_586fc24b-4d69-48e0-b8cf-7c7d2fb36ebe" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_dd6e0e29-5006-4f45-b883-1f812bfeb578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_dd6e0e29-5006-4f45-b883-1f812bfeb578" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_1c30a4c6-af66-4fc5-b412-4c30959445f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_1c30a4c6-af66-4fc5-b412-4c30959445f6" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_af45ea93-2c7e-4266-bb33-8e61dfa88cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_af45ea93-2c7e-4266-bb33-8e61dfa88cfe" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_736c62c6-ebae-4b3e-b4c9-4928fd6ffdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_736c62c6-ebae-4b3e-b4c9-4928fd6ffdbe" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f5110ebb-1258-4970-9cda-1b7f58328ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f5110ebb-1258-4970-9cda-1b7f58328ce9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_34a7b859-0d82-4b2e-a5a6-502aae47478c" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_34a7b859-0d82-4b2e-a5a6-502aae47478c" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_e58c880e-9d1d-4ee0-b78a-f51243d14c8b" xlink:href="bsx-20211231.xsd#bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_e58c880e-9d1d-4ee0-b78a-f51243d14c8b" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a18fefba-b839-44c3-8f2f-c73ea580a3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a18fefba-b839-44c3-8f2f-c73ea580a3a0" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_1d8810a8-e64f-4b7c-bd51-56c6c4ea9c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilities_1d8810a8-e64f-4b7c-bd51-56c6c4ea9c7a" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_a94f2ed7-b782-44a8-ae9e-a2c4a35af731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_a94f2ed7-b782-44a8-ae9e-a2c4a35af731" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_ce6e9c1d-85d0-46cd-a8b0-14d7de2666bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_ce6e9c1d-85d0-46cd-a8b0-14d7de2666bd" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_58dce618-ade9-4cd6-8274-6d82eae9bc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_58dce618-ade9-4cd6-8274-6d82eae9bc99" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_e63c0f44-ed01-4932-9406-c860d571ddc1" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetValuationAllowanceIntraEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_e63c0f44-ed01-4932-9406-c860d571ddc1" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_2ae7f1e4-f417-4446-8e53-1a3a9c25cfae" xlink:href="bsx-20211231.xsd#bsx_ChangeinDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_2ae7f1e4-f417-4446-8e53-1a3a9c25cfae" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_f6847a5d-6b26-4890-be81-a7858baca1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_f6847a5d-6b26-4890-be81-a7858baca1f8" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentive_34244ce5-08ce-43a1-bd74-5455cfa7e847" xlink:href="bsx-20211231.xsd#bsx_FreeTradeZoneRegimeTaxIncentive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_FreeTradeZoneRegimeTaxIncentive_34244ce5-08ce-43a1-bd74-5455cfa7e847" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico_a88d2d66-f3d5-407e-a548-3da3c81a3891" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TaxIncentivesInPuertoRico_a88d2d66-f3d5-407e-a548-3da3c81a3891" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b37533b9-b244-4c4c-8ccb-eac1973f589e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b37533b9-b244-4c4c-8ccb-eac1973f589e" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6a01079b-1a83-4489-82aa-c75ce453343e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6a01079b-1a83-4489-82aa-c75ce453343e" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a9d614e6-b57b-4695-a71a-bb1f03444af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a9d614e6-b57b-4695-a71a-bb1f03444af7" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_20109ecd-ed47-4e6d-9275-05f37bc9b05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_20109ecd-ed47-4e6d-9275-05f37bc9b05c" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7f81ac5d-39cf-4562-b8c8-079087eea3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7f81ac5d-39cf-4562-b8c8-079087eea3f3" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_aa4bdd11-196a-401a-a9ab-a614adbed5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_aa4bdd11-196a-401a-a9ab-a614adbed5f6" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_1e80e2f2-c8d5-42c0-b229-8aa9241fad25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_1e80e2f2-c8d5-42c0-b229-8aa9241fad25" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_ccbec320-421b-4248-8ca1-af88d803ef01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_ccbec320-421b-4248-8ca1-af88d803ef01" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d1bb3398-88ba-476e-8ab2-7002d12c32b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d1bb3398-88ba-476e-8ab2-7002d12c32b1" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8e9f4feb-a539-4c4f-8db0-800e936b9c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8e9f4feb-a539-4c4f-8db0-800e936b9c3a" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_96390c1f-b0ed-42b4-9679-6546355dfb88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_96390c1f-b0ed-42b4-9679-6546355dfb88" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_3d08ead1-33e1-4fbe-84da-21d4a1dfda1f" xlink:href="bsx-20211231.xsd#bsx_Onetimetransactiontaxpost1986EPnetpayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_3d08ead1-33e1-4fbe-84da-21d4a1dfda1f" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_64db0a10-026b-4b82-9c11-05e979f7ae26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_64db0a10-026b-4b82-9c11-05e979f7ae26" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct_8b0ab08b-ae52-4780-9f8b-827d1a77bac4" xlink:href="bsx-20211231.xsd#bsx_TheCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TheCARESAct_8b0ab08b-ae52-4780-9f8b-827d1a77bac4" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution_043470ff-72da-4e71-ba3a-b9217e355a1d" xlink:href="bsx-20211231.xsd#bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution_043470ff-72da-4e71-ba3a-b9217e355a1d" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution_8a9bf986-ac95-4d33-bbe3-1d4695f89d5d" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution_8a9bf986-ac95-4d33-bbe3-1d4695f89d5d" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransitionTaxPaymentRemaining_431ad5f8-a40d-4cf4-96f1-812130b25e7f" xlink:href="bsx-20211231.xsd#bsx_TransitionTaxPaymentRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TransitionTaxPaymentRemaining_431ad5f8-a40d-4cf4-96f1-812130b25e7f" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6f80ffe7-5093-4d1b-89f2-72aaa83ca49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6f80ffe7-5093-4d1b-89f2-72aaa83ca49f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ea0c3b4b-2946-457b-8e20-e19a3e33a75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6f80ffe7-5093-4d1b-89f2-72aaa83ca49f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ea0c3b4b-2946-457b-8e20-e19a3e33a75e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ea0c3b4b-2946-457b-8e20-e19a3e33a75e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ea0c3b4b-2946-457b-8e20-e19a3e33a75e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ea0c3b4b-2946-457b-8e20-e19a3e33a75e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ea0c3b4b-2946-457b-8e20-e19a3e33a75e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61b2332d-1c8a-4d50-85e5-bf6586d6de46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61b2332d-1c8a-4d50-85e5-bf6586d6de46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssetsHeldForSaleDomain_19e915ca-23d1-4150-b409-8a628da8f6f4" xlink:href="bsx-20211231.xsd#bsx_AssetsHeldForSaleDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_AssetsHeldForSaleDomain_19e915ca-23d1-4150-b409-8a628da8f6f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsDomain_95eed867-d8c6-450e-b65d-b181f66b919c" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_DeferredTaxAssetsDomain_95eed867-d8c6-450e-b65d-b181f66b919c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesDomain_ce9d28cc-f53e-44e0-8b37-82a1933efbe1" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_DeferredTaxLiabilitiesDomain_ce9d28cc-f53e-44e0-8b37-82a1933efbe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_25bf1b75-a8fe-4332-a4b0-5fbabe5900d5" xlink:href="bsx-20211231.xsd#bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_25bf1b75-a8fe-4332-a4b0-5fbabe5900d5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i1a3fc2a821614d44b4139408e5902733_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c5320d2e-a67c-490c-81a4-5d1a8c5a1419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c5320d2e-a67c-490c-81a4-5d1a8c5a1419" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4914f81e-04c0-4313-9bbd-7461f4f3058b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4914f81e-04c0-4313-9bbd-7461f4f3058b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_c5537209-a181-4e3e-86bc-5ad1dbc6ebd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LitigationSettlementExpense_c5537209-a181-4e3e-86bc-5ad1dbc6ebd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain_0a79734d-b11e-468c-a61f-1a37fd6a08dc" xlink:href="bsx-20211231.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_LitigationSettlementReceivedGain_0a79734d-b11e-468c-a61f-1a37fd6a08dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_076fd786-4b5d-40ec-8f60-8225cc2b6f83" xlink:href="bsx-20211231.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_076fd786-4b5d-40ec-8f60-8225cc2b6f83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_eda10e5b-679b-45f1-a49b-c70a4c0fe2a5" xlink:href="bsx-20211231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_eda10e5b-679b-45f1-a49b-c70a4c0fe2a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_c383166e-2354-4a50-b597-22ed9f4dd81f" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_c383166e-2354-4a50-b597-22ed9f4dd81f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_19a5b212-1291-45b6-a3d6-89f9ba4d1d01" xlink:href="bsx-20211231.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_19a5b212-1291-45b6-a3d6-89f9ba4d1d01" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_9d2f9084-2756-4d15-b41d-75d7f27ab49b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_9d2f9084-2756-4d15-b41d-75d7f27ab49b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_371388c9-7d62-4c0a-bf6a-1ae3ea349cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_371388c9-7d62-4c0a-bf6a-1ae3ea349cb7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssertedClaimsOutsideTheUS_ae66a39d-d6c0-4618-9403-1699d3ed255a" xlink:href="bsx-20211231.xsd#bsx_AssertedClaimsOutsideTheUS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_AssertedClaimsOutsideTheUS_ae66a39d-d6c0-4618-9403-1699d3ed255a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS_c1a43bba-c0cc-4d8c-baf6-0fae0ed5e8ed" xlink:href="bsx-20211231.xsd#bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS_c1a43bba-c0cc-4d8c-baf6-0fae0ed5e8ed" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter_b0e1b962-48b7-4e3f-a705-31747b36008e" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter_b0e1b962-48b7-4e3f-a705-31747b36008e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_57fc20e5-2d4b-4614-8b2b-d1729c47bb3c" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_57fc20e5-2d4b-4614-8b2b-d1729c47bb3c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_0ceae101-bf2b-4622-8c7a-573990bb7b0e" xlink:href="bsx-20211231.xsd#bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_0ceae101-bf2b-4622-8c7a-573990bb7b0e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CanadaSettledClaims_6885bbe4-a805-4ad6-9a39-53499262464f" xlink:href="bsx-20211231.xsd#bsx_CanadaSettledClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_CanadaSettledClaims_6885bbe4-a805-4ad6-9a39-53499262464f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh_ca76ba29-fa6d-4dd6-b9d6-c40262f3d7b0" xlink:href="bsx-20211231.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_CertifiedClassActionsInAustraliaMesh_ca76ba29-fa6d-4dd6-b9d6-c40262f3d7b0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PermanentlyStayedClassActionInAustraliaMesh_50a9c47d-f68b-4600-9699-98868f76f91f" xlink:href="bsx-20211231.xsd#bsx_PermanentlyStayedClassActionInAustraliaMesh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_PermanentlyStayedClassActionInAustraliaMesh_50a9c47d-f68b-4600-9699-98868f76f91f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_385d5ee0-338c-42ea-ae28-60410a510ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_385d5ee0-338c-42ea-ae28-60410a510ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_385d5ee0-338c-42ea-ae28-60410a510ce7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_385d5ee0-338c-42ea-ae28-60410a510ce7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_385d5ee0-338c-42ea-ae28-60410a510ce7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60307f78-0e42-4378-a154-d070340e0e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_385d5ee0-338c-42ea-ae28-60410a510ce7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60307f78-0e42-4378-a154-d070340e0e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8f89f35e-7ae0-4524-b38b-2300f30c2938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_us-gaap_LitigationStatusAxis_8f89f35e-7ae0-4524-b38b-2300f30c2938" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8f89f35e-7ae0-4524-b38b-2300f30c2938_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_8f89f35e-7ae0-4524-b38b-2300f30c2938" xlink:to="loc_us-gaap_LitigationStatusDomain_8f89f35e-7ae0-4524-b38b-2300f30c2938_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_747da116-0b41-4a05-b784-e29a57876b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_8f89f35e-7ae0-4524-b38b-2300f30c2938" xlink:to="loc_us-gaap_LitigationStatusDomain_747da116-0b41-4a05-b784-e29a57876b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_2de1cc6f-5d47-4222-8d5c-20a5647b01fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_747da116-0b41-4a05-b784-e29a57876b0c" xlink:to="loc_us-gaap_SettledLitigationMember_2de1cc6f-5d47-4222-8d5c-20a5647b01fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6184e14e-910a-4494-aa96-cc2004b49a03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_srt_LitigationCaseAxis_6184e14e-910a-4494-aa96-cc2004b49a03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6184e14e-910a-4494-aa96-cc2004b49a03_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6184e14e-910a-4494-aa96-cc2004b49a03" xlink:to="loc_srt_LitigationCaseTypeDomain_6184e14e-910a-4494-aa96-cc2004b49a03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_87599291-f60c-4a25-9abd-97afbe0b6a76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6184e14e-910a-4494-aa96-cc2004b49a03" xlink:to="loc_srt_LitigationCaseTypeDomain_87599291-f60c-4a25-9abd-97afbe0b6a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fa855631-ca57-46c9-8c68-2fe1a45ab530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fa855631-ca57-46c9-8c68-2fe1a45ab530" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fa855631-ca57-46c9-8c68-2fe1a45ab530_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa855631-ca57-46c9-8c68-2fe1a45ab530" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fa855631-ca57-46c9-8c68-2fe1a45ab530_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cbec8da1-8506-400c-ae75-fca47b57e1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa855631-ca57-46c9-8c68-2fe1a45ab530" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cbec8da1-8506-400c-ae75-fca47b57e1d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_acaeb457-bed8-42f5-a22c-f464e2aaffa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cbec8da1-8506-400c-ae75-fca47b57e1d3" xlink:to="loc_us-gaap_SubsequentEventMember_acaeb457-bed8-42f5-a22c-f464e2aaffa9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended" id="i7c3b4a88806442ac955fa0480367acd5_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b774ed2e-8263-40a6-844e-6d568e5fc023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b774ed2e-8263-40a6-844e-6d568e5fc023" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9476f5c8-7eed-4dfe-89c3-c5e89d3c9058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9476f5c8-7eed-4dfe-89c3-c5e89d3c9058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_5b42ea4c-02de-49bd-b849-0d75a6a393aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_5b42ea4c-02de-49bd-b849-0d75a6a393aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_b8bca885-9aef-47fe-8fae-d12cd01d2565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_b8bca885-9aef-47fe-8fae-d12cd01d2565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_063c3935-64a9-4ae9-8880-6d7c11788bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_063c3935-64a9-4ae9-8880-6d7c11788bc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_be42e353-f722-4384-9d33-5a64c650f0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_be42e353-f722-4384-9d33-5a64c650f0bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_39ffdb0e-cad2-4b9c-a96e-2ae8d34a6216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_39ffdb0e-cad2-4b9c-a96e-2ae8d34a6216" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_dd934003-d0ce-430b-b760-f3110bd2c55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_dd934003-d0ce-430b-b760-f3110bd2c55a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f8b81e01-b4a7-4138-b50f-8d098f880dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PaymentsOfDividends_f8b81e01-b4a7-4138-b50f-8d098f880dc4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_78e864d2-5355-4e0d-b2cd-b4848b29419c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_78e864d2-5355-4e0d-b2cd-b4848b29419c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a201680c-7ec8-47fd-9134-8648b5118ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a201680c-7ec8-47fd-9134-8648b5118ae5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61118d28-d1cf-435d-bb68-bf6533154c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61118d28-d1cf-435d-bb68-bf6533154c5f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_73ea1909-cab0-49d2-a4f8-571c46a8b414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_73ea1909-cab0-49d2-a4f8-571c46a8b414" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f8d9a868-32a3-48fb-b6ff-004decc5fe9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f8d9a868-32a3-48fb-b6ff-004decc5fe9a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ea219fe0-180e-433e-83d9-b12eaaaa5491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ea219fe0-180e-433e-83d9-b12eaaaa5491" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_a430f1aa-f5bd-4473-9315-3390b61691e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_a430f1aa-f5bd-4473-9315-3390b61691e6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09334e4c-0461-49aa-bf36-445d792f99d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09334e4c-0461-49aa-bf36-445d792f99d5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_766ed2aa-08ca-41ab-8b8b-4913864ea9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_TreasuryStockShares_766ed2aa-08ca-41ab-8b8b-4913864ea9ab" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b" xlink:to="loc_us-gaap_ClassOfStockDomain_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b" xlink:to="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_565345bb-066d-49ff-a24b-6c3dc68237f2" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:to="loc_bsx_A550MCPSSeriesAMember_565345bb-066d-49ff-a24b-6c3dc68237f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_83d93e04-edaf-47e2-92fe-2181263096c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:to="loc_us-gaap_CommonStockMember_83d93e04-edaf-47e2-92fe-2181263096c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_36bb92ef-9920-4d3c-aee9-1f2708472d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_36bb92ef-9920-4d3c-aee9-1f2708472d9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_36bb92ef-9920-4d3c-aee9-1f2708472d9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_36bb92ef-9920-4d3c-aee9-1f2708472d9d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_36bb92ef-9920-4d3c-aee9-1f2708472d9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_80814120-aa4a-4c0e-b15d-0d6e0bf1a2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_36bb92ef-9920-4d3c-aee9-1f2708472d9d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_80814120-aa4a-4c0e-b15d-0d6e0bf1a2cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d779816d-b7ab-477d-b846-523f2e09879e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_80814120-aa4a-4c0e-b15d-0d6e0bf1a2cf" xlink:to="loc_us-gaap_SubsequentEventMember_d779816d-b7ab-477d-b846-523f2e09879e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1029e42c-35a8-4c28-a86d-7ea146c6cac7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:to="loc_srt_RangeAxis_1029e42c-35a8-4c28-a86d-7ea146c6cac7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1029e42c-35a8-4c28-a86d-7ea146c6cac7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1029e42c-35a8-4c28-a86d-7ea146c6cac7" xlink:to="loc_srt_RangeMember_1029e42c-35a8-4c28-a86d-7ea146c6cac7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1029e42c-35a8-4c28-a86d-7ea146c6cac7" xlink:to="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bfef57ed-1891-43a6-bef5-444af835279f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:to="loc_srt_MinimumMember_bfef57ed-1891-43a6-bef5-444af835279f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1dcddecb-3916-4a34-b6db-d89569e06888" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:to="loc_srt_MaximumMember_1dcddecb-3916-4a34-b6db-d89569e06888" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8d1e419d-83df-4bf6-9f60-646a7704293b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_af404be5-266e-4909-b0a5-5b997b248798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3908dcf5-0fe0-49c0-8af3-169d21560d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_97191a0c-d3be-4831-bcf6-c19eba7553f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_97191a0c-d3be-4831-bcf6-c19eba7553f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_87d31a71-f4f0-43ea-9429-c35747b7badb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8b545ac2-9db9-4a35-b0c9-dfea36f08de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_dd163f22-0dd8-4cda-a17d-2fb8defd9bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_dd163f22-0dd8-4cda-a17d-2fb8defd9bc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a1eaf0d-dbf2-494a-b379-84dbdd64d737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_e82d51e1-400f-4228-9d69-ff9e2c06e130" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockIncentiveandPurchasePlansTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="extended" id="ib4ab3e2b594d4309a84acb9afd24f1bc_StockIncentiveandPurchasePlansTables">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_9e2305f3-21c0-4f68-bc65-a881603fc182" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_2d9e07fd-0442-4296-87bb-1749c2c3a3d5" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_9e2305f3-21c0-4f68-bc65-a881603fc182" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_2d9e07fd-0442-4296-87bb-1749c2c3a3d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_978adcdf-7914-4063-a5cf-d6406e8bc8db" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_9e2305f3-21c0-4f68-bc65-a881603fc182" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_978adcdf-7914-4063-a5cf-d6406e8bc8db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_09380b9b-2e10-46fa-8fee-87b5b963aa14" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_978adcdf-7914-4063-a5cf-d6406e8bc8db" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_09380b9b-2e10-46fa-8fee-87b5b963aa14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_09380b9b-2e10-46fa-8fee-87b5b963aa14_default" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_09380b9b-2e10-46fa-8fee-87b5b963aa14" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_09380b9b-2e10-46fa-8fee-87b5b963aa14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_b1245cfc-e44d-4312-9f4c-e9ee9344e836" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_09380b9b-2e10-46fa-8fee-87b5b963aa14" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_b1245cfc-e44d-4312-9f4c-e9ee9344e836" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockIncentiveandPurchasePlansDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="extended" id="ifb3a2db1e00e435d8978cbc6e33a4818_StockIncentiveandPurchasePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Fairvalueofmarketbasedawards_64bc5ba7-f29c-428d-bd23-c4713fa9026c" xlink:href="bsx-20211231.xsd#bsx_Fairvalueofmarketbasedawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Fairvalueofmarketbasedawards_64bc5ba7-f29c-428d-bd23-c4713fa9026c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_bcebe8fd-442a-4eb2-8220-3546f3d7208c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharePrice_bcebe8fd-442a-4eb2-8220-3546f3d7208c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostStockOptions_ccba8599-a475-421a-853b-9aacaa7cae9b" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCostStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_UnrecognizedCompensationCostStockOptions_ccba8599-a475-421a-853b-9aacaa7cae9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_2f2b7b70-f960-4de3-b826-6f3150f242c0" xlink:href="bsx-20211231.xsd#bsx_RangeofthetargetnumberofperformancebasedDSUsawarded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_2f2b7b70-f960-4de3-b826-6f3150f242c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cecf49f1-cf80-4e76-abd8-df237a82f32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cecf49f1-cf80-4e76-abd8-df237a82f32a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_0555496e-2625-4284-b631-dd706a659571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_0555496e-2625-4284-b631-dd706a659571" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_227cba23-573f-4c1f-9832-72b411e831be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_227cba23-573f-4c1f-9832-72b411e831be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22d90122-b9e9-496b-8856-a78763db97c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22d90122-b9e9-496b-8856-a78763db97c6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5513f7a7-4e00-4ba4-bcb1-ace8d82f6d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5513f7a7-4e00-4ba4-bcb1-ace8d82f6d19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Measurementperiodmarketbasedaward_ac1f136a-3c98-49c6-923b-0191f1c334b7" xlink:href="bsx-20211231.xsd#bsx_Measurementperiodmarketbasedaward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Measurementperiodmarketbasedaward_ac1f136a-3c98-49c6-923b-0191f1c334b7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_113a5495-9165-452b-8de0-b95691bcc764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_113a5495-9165-452b-8de0-b95691bcc764" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b092bfeb-c332-459f-acba-1912845b1702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b092bfeb-c332-459f-acba-1912845b1702" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8254a9f2-3140-48fe-9410-8ad614706b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8254a9f2-3140-48fe-9410-8ad614706b53" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_82367752-501b-4ae4-836b-252c1561baf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_82367752-501b-4ae4-836b-252c1561baf6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e00f6e53-cf15-4283-81a1-8ccccafd82f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e00f6e53-cf15-4283-81a1-8ccccafd82f0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e2083fbc-c059-48fb-95be-a4dbe171683b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e2083fbc-c059-48fb-95be-a4dbe171683b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4e58fa53-951e-4a27-ac0e-c936f29af246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4e58fa53-951e-4a27-ac0e-c936f29af246" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00eb9820-f010-4b49-bc8b-bd250491cad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00eb9820-f010-4b49-bc8b-bd250491cad4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f444cb7b-1788-4be5-a4ec-05d3d1b8dd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f444cb7b-1788-4be5-a4ec-05d3d1b8dd99" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26d49290-c3de-43e6-be2d-e78ac833fa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26d49290-c3de-43e6-be2d-e78ac833fa75" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_cbafd84d-e73b-4446-9d9a-c32691dfa575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_cbafd84d-e73b-4446-9d9a-c32691dfa575" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b67caaa-baa2-496f-b594-948405fc71b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b67caaa-baa2-496f-b594-948405fc71b3" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_472cbb2e-e452-4a20-9e10-60440eb9b170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensation_472cbb2e-e452-4a20-9e10-60440eb9b170" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4632af67-ed00-43ed-981c-feab05b5eacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4632af67-ed00-43ed-981c-feab05b5eacf" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c379b163-2919-4c02-8950-9a34d1c2feab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c379b163-2919-4c02-8950-9a34d1c2feab" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_27384fcb-7383-444e-b884-ed2cd16bccff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_27384fcb-7383-444e-b884-ed2cd16bccff" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_f9ede13d-cf35-4508-b6f0-491a70530f9b" xlink:href="bsx-20211231.xsd#bsx_ShareBasedCompensationNetOfTaxBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_f9ede13d-cf35-4508-b6f0-491a70530f9b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareBasic_0c2c286d-da40-4fa8-8a45-cbbcac6ba2b9" xlink:href="bsx-20211231.xsd#bsx_CompensationExpensePerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_CompensationExpensePerShareBasic_0c2c286d-da40-4fa8-8a45-cbbcac6ba2b9" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareDiluted_aa002813-6dee-4a44-a000-d868d71bfb6d" xlink:href="bsx-20211231.xsd#bsx_CompensationExpensePerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_CompensationExpensePerShareDiluted_aa002813-6dee-4a44-a000-d868d71bfb6d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_55ee819b-932a-48d7-b347-400270a1e0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_55ee819b-932a-48d7-b347-400270a1e0b3" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26c7bb15-b48e-4e81-9334-dd6647da6cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26c7bb15-b48e-4e81-9334-dd6647da6cca" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ce65c7b8-00ec-4620-bf66-43ea165ed87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ce65c7b8-00ec-4620-bf66-43ea165ed87f" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_81dd6e0c-2114-40ab-bc4f-5cd88eb8b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_81dd6e0c-2114-40ab-bc4f-5cd88eb8b3d8" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_67c3ff71-c5d7-4c07-ae75-16eab5c22fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_67c3ff71-c5d7-4c07-ae75-16eab5c22fe8" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b8610cf3-0c27-421c-89fa-12383f811955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b8610cf3-0c27-421c-89fa-12383f811955" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fcbd4a01-ba80-4433-875b-fa1ee730442b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fcbd4a01-ba80-4433-875b-fa1ee730442b" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_dd2acf82-c1c1-40c6-ac5e-4b61a94b5601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_dd2acf82-c1c1-40c6-ac5e-4b61a94b5601" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c971db2d-693b-431d-803c-428b888489bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c971db2d-693b-431d-803c-428b888489bc" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b7971d4e-a65a-4825-a736-50955aeadc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b7971d4e-a65a-4825-a736-50955aeadc0c" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_99f9468f-e965-4c90-a719-563034020c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_99f9468f-e965-4c90-a719-563034020c98" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_52c2b5e8-e261-4e8a-b0cf-479391e6d445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_52c2b5e8-e261-4e8a-b0cf-479391e6d445" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVest_e5bebea8-b48b-4ff2-a7f9-bce1fea95e0c" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_OptionsExpectedToVest_e5bebea8-b48b-4ff2-a7f9-bce1fea95e0c" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_1f9d8f39-36d8-43d5-83e3-98b7bdf97eea" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_1f9d8f39-36d8-43d5-83e3-98b7bdf97eea" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_c3deeaa9-c172-462d-aba0-d16ea718e4f2" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_c3deeaa9-c172-462d-aba0-d16ea718e4f2" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_c3eb431f-3e71-476c-bca7-6b411a77dc8e" xlink:href="bsx-20211231.xsd#bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_c3eb431f-3e71-476c-bca7-6b411a77dc8e" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_186a6b23-510e-419f-a9bc-d1c9e18fdcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_186a6b23-510e-419f-a9bc-d1c9e18fdcfa" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_46a12264-427d-41fd-9bed-2e4b5769e9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_46a12264-427d-41fd-9bed-2e4b5769e9b5" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_63ea0121-b8d3-4685-9aeb-2f58a94b3142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_63ea0121-b8d3-4685-9aeb-2f58a94b3142" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5e515d9f-dcef-41f9-8114-9821a0c2a8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5e515d9f-dcef-41f9-8114-9821a0c2a8da" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b373f78-363a-4e45-846a-e528bc8a9ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b373f78-363a-4e45-846a-e528bc8a9ca7" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_fe85890e-0d1e-45c0-b82a-63d861f5b67c" xlink:href="bsx-20211231.xsd#bsx_RangeofthetargetnumberofmarketbasedDSUsawarded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_fe85890e-0d1e-45c0-b82a-63d861f5b67c" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c94fbd8f-1d0a-4add-84fa-c5448d7d40c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c94fbd8f-1d0a-4add-84fa-c5448d7d40c6" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_59e9cbab-fb87-44f2-9b6b-17e745f1c562" xlink:href="bsx-20211231.xsd#bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_59e9cbab-fb87-44f2-9b6b-17e745f1c562" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4543ba1-84f3-400e-b084-1ebca89e14a0" xlink:href="bsx-20211231.xsd#bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4543ba1-84f3-400e-b084-1ebca89e14a0" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0ac5f9d7-4133-493f-b646-bf1eb5e5652a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0ac5f9d7-4133-493f-b646-bf1eb5e5652a" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_a674c0eb-a786-4c80-97b7-9adfe48d7532" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCostNonVestedStockAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_a674c0eb-a786-4c80-97b7-9adfe48d7532" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCost_6d976c95-89dd-4278-a34e-e8bc74ef0f48" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_UnrecognizedCompensationCost_6d976c95-89dd-4278-a34e-e8bc74ef0f48" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageRemainingVestingPeriod_71d1bca1-40cd-4325-86fb-85fc2bc35f1a" xlink:href="bsx-20211231.xsd#bsx_WeightedAverageRemainingVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_WeightedAverageRemainingVestingPeriod_71d1bca1-40cd-4325-86fb-85fc2bc35f1a" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Annualweightedaverageforfeiturerate_b2c29e62-6452-412b-8d2b-6273851f5146" xlink:href="bsx-20211231.xsd#bsx_Annualweightedaverageforfeiturerate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Annualweightedaverageforfeiturerate_b2c29e62-6452-412b-8d2b-6273851f5146" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VotingPowerOfAllClassesOfStock_4f63f8c2-97cc-442f-8a61-b8833ba6610e" xlink:href="bsx-20211231.xsd#bsx_VotingPowerOfAllClassesOfStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_VotingPowerOfAllClassesOfStock_4f63f8c2-97cc-442f-8a61-b8833ba6610e" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_109de6e4-ccb9-410f-bbf5-57dca04e3ae2" xlink:href="bsx-20211231.xsd#bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_109de6e4-ccb9-410f-bbf5-57dca04e3ae2" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Nonvestedstockawardsexerciseprice_d60ed5c3-4332-4a64-90cb-c0758a9fc997" xlink:href="bsx-20211231.xsd#bsx_Nonvestedstockawardsexerciseprice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Nonvestedstockawardsexerciseprice_d60ed5c3-4332-4a64-90cb-c0758a9fc997" xlink:type="arc" order="61"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_30d5d8a4-d7ef-46b6-8edf-2a4d8931f649" xlink:href="bsx-20211231.xsd#bsx_FairValueOfFreeCashFlowFcfPerformanceAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_30d5d8a4-d7ef-46b6-8edf-2a4d8931f649" xlink:type="arc" order="62"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_63dfa45c-7f4c-49b5-b2eb-3409f4a43a4e" xlink:href="bsx-20211231.xsd#bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_63dfa45c-7f4c-49b5-b2eb-3409f4a43a4e" xlink:type="arc" order="63"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_b039898f-05e3-4f99-a9df-49d2c1b66fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_b039898f-05e3-4f99-a9df-49d2c1b66fdb" xlink:type="arc" order="64"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c1ec23ee-27e1-4e6b-8240-20aee913bb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:to="loc_us-gaap_CostOfSalesMember_c1ec23ee-27e1-4e6b-8240-20aee913bb64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_898bc2bb-fe74-42e2-870b-05dead8fa9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_898bc2bb-fe74-42e2-870b-05dead8fa9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48b65150-6322-47ca-8c96-5b126fc1b8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48b65150-6322-47ca-8c96-5b126fc1b8d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_be826bd6-4954-49c6-a391-295cd7a2feb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:to="loc_us-gaap_PlanNameAxis_be826bd6-4954-49c6-a391-295cd7a2feb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_be826bd6-4954-49c6-a391-295cd7a2feb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_be826bd6-4954-49c6-a391-295cd7a2feb5" xlink:to="loc_us-gaap_PlanNameDomain_be826bd6-4954-49c6-a391-295cd7a2feb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77f96644-b0dd-4793-aa5a-15dec9950cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_be826bd6-4954-49c6-a391-295cd7a2feb5" xlink:to="loc_us-gaap_PlanNameDomain_77f96644-b0dd-4793-aa5a-15dec9950cb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2011LtipPlanMember_88f2922c-0132-4e86-8595-827dfc96ff92" xlink:href="bsx-20211231.xsd#bsx_A2011LtipPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_77f96644-b0dd-4793-aa5a-15dec9950cb4" xlink:to="loc_bsx_A2011LtipPlanMember_88f2922c-0132-4e86-8595-827dfc96ff92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5612c936-0b65-4426-9ca1-c9740bfeebfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:to="loc_srt_RangeAxis_5612c936-0b65-4426-9ca1-c9740bfeebfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5612c936-0b65-4426-9ca1-c9740bfeebfb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5612c936-0b65-4426-9ca1-c9740bfeebfb" xlink:to="loc_srt_RangeMember_5612c936-0b65-4426-9ca1-c9740bfeebfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5612c936-0b65-4426-9ca1-c9740bfeebfb" xlink:to="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_648ec843-4adf-490f-a1e4-424f72ff08be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:to="loc_srt_MinimumMember_648ec843-4adf-490f-a1e4-424f72ff08be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_157e9b17-3b26-4176-96bd-de8cee1e8a1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:to="loc_srt_MaximumMember_157e9b17-3b26-4176-96bd-de8cee1e8a1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7952c91-25de-4bc3-ab4f-b9ad48dd573b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended" id="i07710d52ea6f4dcdbf1f0c0b36061e75_WeightedAverageSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef19fbd0-c095-401a-ba29-7a9a1c460d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef19fbd0-c095-401a-ba29-7a9a1c460d3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9729ac0c-f732-4a99-86dc-776f1e54e14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9729ac0c-f732-4a99-86dc-776f1e54e14a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba75a8b0-a659-49c1-b658-fe96499ca1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba75a8b0-a659-49c1-b658-fe96499ca1fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_288d5042-c635-4daf-851c-c6dd29c2f1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_288d5042-c635-4daf-851c-c6dd29c2f1b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a65555e-cbf6-4f6a-b968-f20ce23930fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a65555e-cbf6-4f6a-b968-f20ce23930fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ab5a97d6-09a8-4e74-b28a-93c214966286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a65555e-cbf6-4f6a-b968-f20ce23930fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ab5a97d6-09a8-4e74-b28a-93c214966286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ab5a97d6-09a8-4e74-b28a-93c214966286_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ab5a97d6-09a8-4e74-b28a-93c214966286" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ab5a97d6-09a8-4e74-b28a-93c214966286_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ab5a97d6-09a8-4e74-b28a-93c214966286" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d3de298f-a958-45ac-a86c-a6aeb25dd714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d3de298f-a958-45ac-a86c-a6aeb25dd714" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_ba6f8d14-17e9-440a-9802-9ffdf956d25e" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:to="loc_bsx_A550MCPSSeriesAMember_ba6f8d14-17e9-440a-9802-9ffdf956d25e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_3ffd6039-9c63-4d9a-95fd-e3915bffe6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:to="loc_us-gaap_StockCompensationPlanMember_3ffd6039-9c63-4d9a-95fd-e3915bffe6ce" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended" id="i053fa1692842402dbddb0c4de3f5d374_SegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f84ecad4-da43-4731-b942-f9cfd080ed25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_NumberOfReportableSegments_f84ecad4-da43-4731-b942-f9cfd080ed25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe477684-5255-48ec-8561-a280b6e7ba06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe477684-5255-48ec-8561-a280b6e7ba06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_add78f49-aede-4faf-8530-b7df55b8dd35" xlink:href="bsx-20211231.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_add78f49-aede-4faf-8530-b7df55b8dd35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d578889e-756d-40cb-83d6-99695d60d375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_Depreciation_d578889e-756d-40cb-83d6-99695d60d375" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_de0bc691-f7ba-436d-b842-c302ea74ded4" xlink:href="bsx-20211231.xsd#bsx_OperatingIncomeLossAllocatedToReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_de0bc691-f7ba-436d-b842-c302ea74ded4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_70a71c01-7719-4228-a4b4-50f4c84d1d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_OperatingIncomeLoss_70a71c01-7719-4228-a4b4-50f4c84d1d40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e0c76400-fc55-4245-ba1f-b37753c8c0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e0c76400-fc55-4245-ba1f-b37753c8c0e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5721a8fc-3cce-4ec9-bae8-972531e369ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5721a8fc-3cce-4ec9-bae8-972531e369ff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00f55513-5ce5-4dee-bfd8-3b393d6e8e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00f55513-5ce5-4dee-bfd8-3b393d6e8e29" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_f4521949-523c-4ac4-9e79-16ecdd6a2e1b" xlink:href="bsx-20211231.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_f4521949-523c-4ac4-9e79-16ecdd6a2e1b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_84c95aa8-c6e5-4a4e-add6-f03f2d756ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_OtherAssets_84c95aa8-c6e5-4a4e-add6-f03f2d756ea4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43012878-611c-47dd-adcb-b14a9d6c085d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_Goodwill_43012878-611c-47dd-adcb-b14a9d6c085d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bd4abd90-238c-48e9-a3d6-922d82c52e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bd4abd90-238c-48e9-a3d6-922d82c52e0d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_41c47f5c-9609-4a0b-b371-7e977100ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_41c47f5c-9609-4a0b-b371-7e977100ed2b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_3d1ed63d-eb81-411f-bbd6-8d67bf0c5c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_NoncurrentAssets_3d1ed63d-eb81-411f-bbd6-8d67bf0c5c32" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07726165-2aa9-47a0-b50c-110a682ba57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07726165-2aa9-47a0-b50c-110a682ba57d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07726165-2aa9-47a0-b50c-110a682ba57d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07726165-2aa9-47a0-b50c-110a682ba57d" xlink:to="loc_us-gaap_SegmentDomain_07726165-2aa9-47a0-b50c-110a682ba57d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07726165-2aa9-47a0-b50c-110a682ba57d" xlink:to="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_895698a7-65a2-450e-838f-be62e4482f9c" xlink:href="bsx-20211231.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_MedsurgMember_895698a7-65a2-450e-838f-be62e4482f9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_49f0eebf-7b3d-45b1-9a34-8ee7a5a71c60" xlink:href="bsx-20211231.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_RhythmandNeuroMember_49f0eebf-7b3d-45b1-9a34-8ee7a5a71c60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_8eee5d87-85d1-4124-8c83-7ac12fc0bdeb" xlink:href="bsx-20211231.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_CardiovascularMember_8eee5d87-85d1-4124-8c83-7ac12fc0bdeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_21fba4ec-287b-4a9d-b9f4-dcd5b8a8f0db" xlink:href="bsx-20211231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_BSXReportableSegmentsMember_21fba4ec-287b-4a9d-b9f4-dcd5b8a8f0db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_fdd3f264-1896-4d81-88ad-ebef48500c79" xlink:href="bsx-20211231.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_fdd3f264-1896-4d81-88ad-ebef48500c79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_9f50faab-9cf3-4a13-b4df-58e5a3768756" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_9f50faab-9cf3-4a13-b4df-58e5a3768756" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c5abfbf6-3cce-4281-b417-e1260410f70f" xlink:href="bsx-20211231.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c5abfbf6-3cce-4281-b417-e1260410f70f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_f4f065f4-2c12-4716-ad12-776de3e9a5a0" xlink:href="bsx-20211231.xsd#bsx_SpecialChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_SpecialChargesMember_f4f065f4-2c12-4716-ad12-776de3e9a5a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_0c381ecb-cbe3-488c-b1e3-be9bd6e10890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_us-gaap_CorporateMember_0c381ecb-cbe3-488c-b1e3-be9bd6e10890" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBSXDomain_daa15043-b78e-4a24-b20c-4ad9ea3a7b6a" xlink:href="bsx-20211231.xsd#bsx_ConsolidatedBSXDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_ConsolidatedBSXDomain_daa15043-b78e-4a24-b20c-4ad9ea3a7b6a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1b36278b-e969-4d01-a574-36cae909f4a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_srt_StatementGeographicalAxis_1b36278b-e969-4d01-a574-36cae909f4a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1b36278b-e969-4d01-a574-36cae909f4a2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1b36278b-e969-4d01-a574-36cae909f4a2" xlink:to="loc_srt_SegmentGeographicalDomain_1b36278b-e969-4d01-a574-36cae909f4a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1b36278b-e969-4d01-a574-36cae909f4a2" xlink:to="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_00ed6848-c62e-4ea6-b1d7-367fd2e83813" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:to="loc_country_US_00ed6848-c62e-4ea6-b1d7-367fd2e83813" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_d29049e8-52d8-403b-9e86-deb504908e14" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:to="loc_country_IE_d29049e8-52d8-403b-9e86-deb504908e14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCountriesMember_9e4b4946-2c1b-49f0-85c5-6f7d19f68eb9" xlink:href="bsx-20211231.xsd#bsx_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:to="loc_bsx_OtherCountriesMember_9e4b4946-2c1b-49f0-85c5-6f7d19f68eb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c09cd304-af1d-419a-939d-cafefe526382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c09cd304-af1d-419a-939d-cafefe526382" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c09cd304-af1d-419a-939d-cafefe526382_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c09cd304-af1d-419a-939d-cafefe526382" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c09cd304-af1d-419a-939d-cafefe526382_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3c60af25-55db-4321-b4be-94eab49fe502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c09cd304-af1d-419a-939d-cafefe526382" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3c60af25-55db-4321-b4be-94eab49fe502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_eba46c47-4682-48f8-9d10-0de917cb13c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3c60af25-55db-4321-b4be-94eab49fe502" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_eba46c47-4682-48f8-9d10-0de917cb13c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_eb3ade68-71d7-4a2f-bd38-cdd5d517532f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_eb3ade68-71d7-4a2f-bd38-cdd5d517532f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb3ade68-71d7-4a2f-bd38-cdd5d517532f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_eb3ade68-71d7-4a2f-bd38-cdd5d517532f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb3ade68-71d7-4a2f-bd38-cdd5d517532f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9dfa302b-d561-4bda-96a5-d2441503ff5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_eb3ade68-71d7-4a2f-bd38-cdd5d517532f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9dfa302b-d561-4bda-96a5-d2441503ff5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_c27fb026-5fac-48fa-be38-972da1c13566" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9dfa302b-d561-4bda-96a5-d2441503ff5b" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_c27fb026-5fac-48fa-be38-972da1c13566" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1e5b558b-cf5c-4216-b734-f668d3d4443d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_srt_ProductOrServiceAxis_1e5b558b-cf5c-4216-b734-f668d3d4443d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e5b558b-cf5c-4216-b734-f668d3d4443d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1e5b558b-cf5c-4216-b734-f668d3d4443d" xlink:to="loc_srt_ProductsAndServicesDomain_1e5b558b-cf5c-4216-b734-f668d3d4443d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_059ed465-328b-461c-b947-4c2a722622dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1e5b558b-cf5c-4216-b734-f668d3d4443d" xlink:to="loc_srt_ProductsAndServicesDomain_059ed465-328b-461c-b947-4c2a722622dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_3793d7fc-8a40-47c7-bf50-1c1f31c64e70" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_059ed465-328b-461c-b947-4c2a722622dc" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_3793d7fc-8a40-47c7-bf50-1c1f31c64e70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1922cf4f-e8d7-4100-93fe-96591300a0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1922cf4f-e8d7-4100-93fe-96591300a0ed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1922cf4f-e8d7-4100-93fe-96591300a0ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1922cf4f-e8d7-4100-93fe-96591300a0ed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1922cf4f-e8d7-4100-93fe-96591300a0ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_14110d24-5228-45a5-97f8-594aff9a36a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1922cf4f-e8d7-4100-93fe-96591300a0ed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_14110d24-5228-45a5-97f8-594aff9a36a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_aeefc1f1-f046-44ed-8f90-58d7a1636252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_14110d24-5228-45a5-97f8-594aff9a36a7" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_aeefc1f1-f046-44ed-8f90-58d7a1636252" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended" id="i0e0dc5d3b93644ea9ea98fb30b9910b9_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsTotalNumberOfCountries_fe41ee30-31a7-4148-b028-135ec664c1df" xlink:href="bsx-20211231.xsd#bsx_EmergingMarketsTotalNumberOfCountries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:to="loc_bsx_EmergingMarketsTotalNumberOfCountries_fe41ee30-31a7-4148-b028-135ec664c1df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bafeb84-7f22-433c-8168-9be410f0048f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bafeb84-7f22-433c-8168-9be410f0048f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_38346ec7-8343-41e1-9aee-81c95f7daec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_38346ec7-8343-41e1-9aee-81c95f7daec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_38346ec7-8343-41e1-9aee-81c95f7daec2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38346ec7-8343-41e1-9aee-81c95f7daec2" xlink:to="loc_us-gaap_SegmentDomain_38346ec7-8343-41e1-9aee-81c95f7daec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fdbc94c6-fe63-4ecb-ae5d-2034e3edb169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38346ec7-8343-41e1-9aee-81c95f7daec2" xlink:to="loc_us-gaap_SegmentDomain_fdbc94c6-fe63-4ecb-ae5d-2034e3edb169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_d3778dd3-d6a5-4751-8e1a-2817ec40130d" xlink:href="bsx-20211231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fdbc94c6-fe63-4ecb-ae5d-2034e3edb169" xlink:to="loc_bsx_BSXReportableSegmentsMember_d3778dd3-d6a5-4751-8e1a-2817ec40130d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5411812c-e153-429d-bf59-18a4631e6d6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:to="loc_srt_ProductOrServiceAxis_5411812c-e153-429d-bf59-18a4631e6d6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5411812c-e153-429d-bf59-18a4631e6d6f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5411812c-e153-429d-bf59-18a4631e6d6f" xlink:to="loc_srt_ProductsAndServicesDomain_5411812c-e153-429d-bf59-18a4631e6d6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5411812c-e153-429d-bf59-18a4631e6d6f" xlink:to="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_42f5344e-f57b-400b-b44c-b6079d3bf02d" xlink:href="bsx-20211231.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_42f5344e-f57b-400b-b44c-b6079d3bf02d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_1cb116c6-79fc-4212-83b9-78d7e3fac900" xlink:href="bsx-20211231.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_1cb116c6-79fc-4212-83b9-78d7e3fac900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_59d71444-453a-4fec-9c4c-c608b6a5018a" xlink:href="bsx-20211231.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_59d71444-453a-4fec-9c4c-c608b6a5018a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_ecf49263-d0fa-40e6-8d5d-0a7d3ba1c62d" xlink:href="bsx-20211231.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_ecf49263-d0fa-40e6-8d5d-0a7d3ba1c62d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_9285ca35-6291-41fb-baea-ce22fecd3803" xlink:href="bsx-20211231.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_9285ca35-6291-41fb-baea-ce22fecd3803" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_da554e4a-e8ab-42fd-a0f5-16878972f1b7" xlink:href="bsx-20211231.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_da554e4a-e8ab-42fd-a0f5-16878972f1b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_6db06918-fe2c-4239-81d7-6d303e939979" xlink:href="bsx-20211231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_6db06918-fe2c-4239-81d7-6d303e939979" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_de3700fe-44d9-42c5-9cb0-2759656f76ba" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_de3700fe-44d9-42c5-9cb0-2759656f76ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a82d276b-2ee7-4928-a95c-98e4650a1a26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:to="loc_srt_StatementGeographicalAxis_a82d276b-2ee7-4928-a95c-98e4650a1a26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a82d276b-2ee7-4928-a95c-98e4650a1a26_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a82d276b-2ee7-4928-a95c-98e4650a1a26" xlink:to="loc_srt_SegmentGeographicalDomain_a82d276b-2ee7-4928-a95c-98e4650a1a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a82d276b-2ee7-4928-a95c-98e4650a1a26" xlink:to="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_35d30453-2b17-4cec-8925-a94b8b3607cd" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_country_US_35d30453-2b17-4cec-8925-a94b8b3607cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ab7de916-8809-4175-8fd1-6265bef16a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_us-gaap_NonUsMember_ab7de916-8809-4175-8fd1-6265bef16a0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_4ca962a0-6a1c-4be1-97f5-5d1e969a2ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_us-gaap_EMEAMember_4ca962a0-6a1c-4be1-97f5-5d1e969a2ae4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_5b767cb4-8eec-47c3-b602-70c5d0bae306" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_srt_AsiaPacificMember_5b767cb4-8eec-47c3-b602-70c5d0bae306" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_ae13c101-6d86-4806-8c90-5b9c5a685f39" xlink:href="bsx-20211231.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_bsx_LatinAmericaandCanadaMember_ae13c101-6d86-4806-8c90-5b9c5a685f39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_5b49604d-a24d-4e95-b42b-58a84d0475b3" xlink:href="bsx-20211231.xsd#bsx_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_bsx_EmergingMarketsMember_5b49604d-a24d-4e95-b42b-58a84d0475b3" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="simple" xlink:href="bsx-20211231.xsd#EmployeeRetirementPlansEmployeeRetirementPlansPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="extended" id="i3ae42b8e21524422858382f3e09f887a_EmployeeRetirementPlansEmployeeRetirementPlansPolicies">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7570b156-e903-4ad4-b13b-aa0a9774c3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_c548e2e7-a275-4833-937c-9ba244048170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7570b156-e903-4ad4-b13b-aa0a9774c3cf" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_c548e2e7-a275-4833-937c-9ba244048170" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_170fee87-1c51-472e-8d5d-c030b0d926dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7570b156-e903-4ad4-b13b-aa0a9774c3cf" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_170fee87-1c51-472e-8d5d-c030b0d926dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_170fee87-1c51-472e-8d5d-c030b0d926dc" xlink:to="loc_us-gaap_RetirementPlanNameAxis_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_a4fb858c-600f-4385-a593-6d54cfe66f74" xlink:href="bsx-20211231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_a4fb858c-600f-4385-a593-6d54cfe66f74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_886d49ab-f03e-490e-be3a-e4412176e35c" xlink:href="bsx-20211231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:to="loc_bsx_InternationalRetirementPlansMember_886d49ab-f03e-490e-be3a-e4412176e35c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#EmployeeRetirementPlansDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="extended" id="i4ce5961ebd004b36957add16d6725b7f_EmployeeRetirementPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d376d2ad-c3f4-4aad-bc19-533e8fd99636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d376d2ad-c3f4-4aad-bc19-533e8fd99636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_12575d3b-778b-4822-b860-d51129b946ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_12575d3b-778b-4822-b860-d51129b946ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6e799d39-84e9-4c2e-9ffb-fe47de60d234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6e799d39-84e9-4c2e-9ffb-fe47de60d234" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ac38a30-0a4a-4d4d-9890-44ce81d6630d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ac38a30-0a4a-4d4d-9890-44ce81d6630d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4014252a-1842-4dbb-ad04-06d505ec7af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4014252a-1842-4dbb-ad04-06d505ec7af0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fd2614ab-bff3-4dde-b8df-aafccd713e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fd2614ab-bff3-4dde-b8df-aafccd713e49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_0f68411f-dae1-45db-a99f-d5b1bc72e790" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_0f68411f-dae1-45db-a99f-d5b1bc72e790" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_aa3bb7a7-8459-4f83-82d6-fdf11df8942b" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_aa3bb7a7-8459-4f83-82d6-fdf11df8942b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_63307e3c-306b-4eb5-a9c4-89df387bf38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_63307e3c-306b-4eb5-a9c4-89df387bf38c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_3f01799e-5a29-4a6d-94dc-36ac111a6a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_3f01799e-5a29-4a6d-94dc-36ac111a6a88" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_ae8018f3-6215-41e2-8ac2-2c99270c5868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_ae8018f3-6215-41e2-8ac2-2c99270c5868" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Pensionbenefitobligationbenefitspaid_31ef8c69-e4f7-4088-b64e-2a9905fe25c3" xlink:href="bsx-20211231.xsd#bsx_Pensionbenefitobligationbenefitspaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_Pensionbenefitobligationbenefitspaid_31ef8c69-e4f7-4088-b64e-2a9905fe25c3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_5a04bb1a-67cc-4447-8dba-53eb41f836d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_5a04bb1a-67cc-4447-8dba-53eb41f836d8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d9019168-08e4-46f4-a27e-a4138a526b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d9019168-08e4-46f4-a27e-a4138a526b25" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c76a4f09-b2d2-4e97-9f3e-28c2368456e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c76a4f09-b2d2-4e97-9f3e-28c2368456e9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_834a46cf-1208-4ddd-9488-39a4defee2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_834a46cf-1208-4ddd-9488-39a4defee2f0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d07cd8e0-df75-476f-aa3c-272a2028ede5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d07cd8e0-df75-476f-aa3c-272a2028ede5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_56aa11d1-e4ab-48fa-b27c-19989c9b245d" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_56aa11d1-e4ab-48fa-b27c-19989c9b245d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a9481fe3-e2ab-4d0c-b30d-abe7952a4801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a9481fe3-e2ab-4d0c-b30d-abe7952a4801" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_efba6a9e-3f08-4216-91eb-1d5acc1d6e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_efba6a9e-3f08-4216-91eb-1d5acc1d6e2c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_2d13874f-5fda-4885-a28e-834a74657d8f" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_2d13874f-5fda-4885-a28e-834a74657d8f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExpenseRelatedToMatchingContributions_eb9cbd80-b33d-4155-877c-85f40c789cd2" xlink:href="bsx-20211231.xsd#bsx_ExpenseRelatedToMatchingContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_ExpenseRelatedToMatchingContributions_eb9cbd80-b33d-4155-877c-85f40c789cd2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1949af2e-e39a-4edb-aba1-539e90464106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1949af2e-e39a-4edb-aba1-539e90464106" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_5f57f9ad-14f8-40de-b9ae-60d404cc473a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_5f57f9ad-14f8-40de-b9ae-60d404cc473a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_4799eab5-72de-4618-bb10-2276c99df079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_4799eab5-72de-4618-bb10-2276c99df079" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1b49e057-44e2-44b2-99a5-39c91d0b56f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1b49e057-44e2-44b2-99a5-39c91d0b56f3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_f3a4d250-fb62-4f6c-af96-4511d6cee100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_f3a4d250-fb62-4f6c-af96-4511d6cee100" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_6851c3d0-f27a-482e-beab-31cdb72bfb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_6851c3d0-f27a-482e-beab-31cdb72bfb64" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_25fc38cb-4251-4516-80df-950d84246260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_25fc38cb-4251-4516-80df-950d84246260" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f3e0ffff-d5cf-4235-86c9-c7dd4d1c4857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f3e0ffff-d5cf-4235-86c9-c7dd4d1c4857" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_45b56ae7-c9b0-4ed9-a32a-cffbb571d0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_45b56ae7-c9b0-4ed9-a32a-cffbb571d0d5" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_7e372a8b-a539-44a9-9662-18308943d933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_RetirementPlanNameAxis_7e372a8b-a539-44a9-9662-18308943d933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_7e372a8b-a539-44a9-9662-18308943d933_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_7e372a8b-a539-44a9-9662-18308943d933" xlink:to="loc_us-gaap_RetirementPlanNameDomain_7e372a8b-a539-44a9-9662-18308943d933_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_7e372a8b-a539-44a9-9662-18308943d933" xlink:to="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_d90b3405-0b1b-4498-88bb-234c9be1b600" xlink:href="bsx-20211231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_d90b3405-0b1b-4498-88bb-234c9be1b600" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_dc542021-b5f2-4078-b5dc-9e48ba08fe35" xlink:href="bsx-20211231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:to="loc_bsx_InternationalRetirementPlansMember_dc542021-b5f2-4078-b5dc-9e48ba08fe35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_d3d92079-d41c-4ecf-9a3f-c451f923137a" xlink:href="bsx-20211231.xsd#bsx_UKPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:to="loc_bsx_UKPlanMember_d3d92079-d41c-4ecf-9a3f-c451f923137a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3ffab14a-790f-456c-b375-d03c967cd5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3ffab14a-790f-456c-b375-d03c967cd5a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ffab14a-790f-456c-b375-d03c967cd5a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3ffab14a-790f-456c-b375-d03c967cd5a3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ffab14a-790f-456c-b375-d03c967cd5a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22c4967d-07e0-461f-abbe-f39e2b9fd624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3ffab14a-790f-456c-b375-d03c967cd5a3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22c4967d-07e0-461f-abbe-f39e2b9fd624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_c7eadebe-5673-4b9a-a048-00a78a072e3b" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22c4967d-07e0-461f-abbe-f39e2b9fd624" xlink:to="loc_bsx_BTGAcquisitionMember_c7eadebe-5673-4b9a-a048-00a78a072e3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a1fe03d0-1656-46f9-89a3-850a9c476909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a1fe03d0-1656-46f9-89a3-850a9c476909" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_a1fe03d0-1656-46f9-89a3-850a9c476909_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a1fe03d0-1656-46f9-89a3-850a9c476909" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_a1fe03d0-1656-46f9-89a3-850a9c476909_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_8e325136-a3e6-41e1-96df-0c33ab3c003b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a1fe03d0-1656-46f9-89a3-850a9c476909" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_8e325136-a3e6-41e1-96df-0c33ab3c003b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_a500529a-236a-4f8b-89f9-1886e74cc522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_8e325136-a3e6-41e1-96df-0c33ab3c003b" xlink:to="loc_us-gaap_OtherContractMember_a500529a-236a-4f8b-89f9-1886e74cc522" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5f54674f-fb20-4011-ada7-466ed5a8a15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5f54674f-fb20-4011-ada7-466ed5a8a15a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f54674f-fb20-4011-ada7-466ed5a8a15a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5f54674f-fb20-4011-ada7-466ed5a8a15a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f54674f-fb20-4011-ada7-466ed5a8a15a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5f54674f-fb20-4011-ada7-466ed5a8a15a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0a7622ee-d88e-4951-b4ed-2abc7c4a3e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0a7622ee-d88e-4951-b4ed-2abc7c4a3e8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ddabf2a0-5baf-45fe-a77c-142c1cc98e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ddabf2a0-5baf-45fe-a77c-142c1cc98e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cc10b58a-7891-432c-819b-bcdfa0b9d8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cc10b58a-7891-432c-819b-bcdfa0b9d8b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b435cba3-d77c-4161-b9d5-526855918668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b435cba3-d77c-4161-b9d5-526855918668" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b435cba3-d77c-4161-b9d5-526855918668_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b435cba3-d77c-4161-b9d5-526855918668" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b435cba3-d77c-4161-b9d5-526855918668_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b435cba3-d77c-4161-b9d5-526855918668" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_f57f48e2-4b7a-4d70-a29e-27e04abd6a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:to="loc_us-gaap_DomesticPlanMember_f57f48e2-4b7a-4d70-a29e-27e04abd6a95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_04a51c68-b60a-47b7-b946-779a0d7b18b3" xlink:href="bsx-20211231.xsd#bsx_UKPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:to="loc_bsx_UKPlanMember_04a51c68-b60a-47b7-b946-779a0d7b18b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherInternationalPlansMember_c380cfe5-de15-4898-aec0-37abebefd697" xlink:href="bsx-20211231.xsd#bsx_OtherInternationalPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:to="loc_bsx_OtherInternationalPlansMember_c380cfe5-de15-4898-aec0-37abebefd697" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71cec395-58e0-46f3-92ef-48e64e3e4a9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_srt_RangeAxis_71cec395-58e0-46f3-92ef-48e64e3e4a9d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71cec395-58e0-46f3-92ef-48e64e3e4a9d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_71cec395-58e0-46f3-92ef-48e64e3e4a9d" xlink:to="loc_srt_RangeMember_71cec395-58e0-46f3-92ef-48e64e3e4a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_71cec395-58e0-46f3-92ef-48e64e3e4a9d" xlink:to="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7070cddc-dbdd-4bf1-813f-93d162076e12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:to="loc_srt_MaximumMember_7070cddc-dbdd-4bf1-813f-93d162076e12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b9f6b760-e42f-445e-9733-7ea4b41d5fee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:to="loc_srt_MinimumMember_b9f6b760-e42f-445e-9733-7ea4b41d5fee" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>bsx-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3eeb153c-443d-4b7c-bc48-13c100a9196f,g:5aeaa418-7365-4294-a466-e7b8cf11828b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f3c4330e-43f3-4916-a798-68800227d401_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_ee536e02-af08-45d8-a09d-3d1ff6940d85_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b1cda077-717c-487b-8ab8-3d6cb9125bc2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a90330fa-e66d-408f-99dc-b6b6b75dd887_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_14ce7c77-bb83-471e-a073-8f553c3607a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_a6cdc30e-39a2-424e-a54e-c87fb6dba8d2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_3e1836cb-4e08-4a13-b72f-d109ba479056_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_0ed6c969-e131-431d-a703-07bf0b6f2478_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_6f2d6c46-8d98-4e95-9106-31c2e9f0186d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DevoroMedicalIncMember_09ec13b5-008d-453f-9740-2056336cfe29_terseLabel_en-US" xlink:label="lab_bsx_DevoroMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devoro Medical, Inc.</link:label>
    <link:label id="lab_bsx_DevoroMedicalIncMember_label_en-US" xlink:label="lab_bsx_DevoroMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devoro Medical, Inc. [Member]</link:label>
    <link:label id="lab_bsx_DevoroMedicalIncMember_documentation_en-US" xlink:label="lab_bsx_DevoroMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devoro Medical, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DevoroMedicalIncMember" xlink:href="bsx-20211231.xsd#bsx_DevoroMedicalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DevoroMedicalIncMember" xlink:to="lab_bsx_DevoroMedicalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_39ad6496-a083-4f54-b1d7-e57ba9b8f914_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_51d6a8e4-3e0d-4456-80dc-7d42b2a50913_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_8b3a6071-3d65-4e87-8e52-b0698363dd23_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a38ca1c3-48ac-4f7b-912f-fd2359af0394_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_97240515-d25e-4f90-87ec-4cae974be4ff_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration previously established in purchase accounting</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_929e7645-11fe-4d23-9729-d4c714b1f42a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_5c98f62d-4130-4138-af02-0b67caa48cf9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_aad3bfa5-7d7f-4c28-abc1-d1bdf5f6c878_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e05cd2ca-6797-4a4b-a828-387594ef44a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_fa1ed575-3a13-4c16-9db5-2fd9cca195b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6b705415-51ca-4d77-a26f-8764fa58416d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3e34a2e-88ed-45c5-b421-05a283e15e4f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dc75a509-316d-4235-ad85-67cb07ccca19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_db08a610-a16c-4f67-9d95-5c3d3225d669_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1acce1d3-172e-4868-b1da-f924546fdbc4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_8f26bfe2-62e4-417a-89cd-f3c77919092d_terseLabel_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract" xlink:href="bsx-20211231.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCurrentAssetsAbstract" xlink:to="lab_bsx_OtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_c76e55d4-42eb-4841-8204-f09dac18d048_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5fd9beb3-8136-482e-b6ac-22301eb67b0a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember_4225cb16-2a2f-47ea-af81-5ad38b825707_terseLabel_en-US" xlink:label="lab_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four quarters following material acquisition</link:label>
    <link:label id="lab_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four quarters following material acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four quarters following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember" xlink:href="bsx-20211231.xsd#bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember" xlink:to="lab_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f3856d44-a5f4-45cc-9289-d07af21e0f06_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0be48a0e-e676-4aff-b533-1afcfa6b35f4_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_32ffc6ac-c35e-4cf5-9119-0b08a3e64db3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_db2bf71f-6536-4db1-b60c-6052af8a8ad2_terseLabel_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration" xlink:href="bsx-20211231.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentOfContingentConsideration" xlink:to="lab_bsx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_512759e8-b73e-42d4-9476-c84d2e416918_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_926a1c0d-c733-472f-94f8-611ec07679b9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_c37c9375-c8ab-4efe-a0e2-7548f5abb4b8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_c9d746b5-c01b-47ae-9679-7d9aa36f8668_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_0bda3e8d-0e4a-4ff1-a27b-4b487c3523d5_terseLabel_en-US" xlink:label="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
    <link:label id="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_label_en-US" xlink:label="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current</link:label>
    <link:label id="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_documentation_en-US" xlink:label="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:href="bsx-20211231.xsd#bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:to="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f72137ea-55e0-4933-a0b6-a04b54d69984_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ba4364db-d911-46d6-bded-9d526b1c3bc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_905193b8-812a-4171-b9c7-0c4f4141d370_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ActualCovenantMember_f3926dac-78a6-4ebb-bdb2-2a2b33a74b3a_terseLabel_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_label_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_documentation_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember" xlink:href="bsx-20211231.xsd#bsx_ActualCovenantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ActualCovenantMember" xlink:to="lab_bsx_ActualCovenantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_651098c7-9154-4c6a-82de-d984ce6fd098_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_58322c4d-fd1c-4fb0-8a95-5802dcec0fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringChargesTableTextBlock_1cca31f2-eb33-4121-99af-ff1565534bc0_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges [Text Block]</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesTableTextBlock_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges [Table Text Block]</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative restructuring charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringChargesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:to="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_6771e161-ce52-4f3c-85e8-58c4173e0cf3_terseLabel_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_label_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_documentation_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:href="bsx-20211231.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:to="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_747ff67f-af21-464a-9f67-5e26c1d0e8c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringChargesIncurredToDate_e2966f00-792d-4266-9418-a112e446a921_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesIncurredToDate_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesIncurredToDate_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringChargesIncurredToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:to="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2764dcd6-be79-499a-a29e-7f50d0f61949_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_9c23ee3f-e513-449a-8151-37e2fed91089_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_cde53b25-53f9-498e-8e7a-c8167c15b51a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_6fb35593-812c-4b93-91a7-bc79a05edbef_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d21bb777-09ab-4681-b40f-e7e84642a564_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_2eef6fcc-360e-4639-bee2-cbec4f0ecfdd_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfMarch312021Member_edd72767-8326-4c29-ac9b-8b5d4859191d_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfMarch312021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of March 31, 2021</link:label>
    <link:label id="lab_bsx_RequirementAsOfMarch312021Member_label_en-US" xlink:label="lab_bsx_RequirementAsOfMarch312021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of March 31, 2021 [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfMarch312021Member_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfMarch312021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of March 31, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfMarch312021Member" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfMarch312021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfMarch312021Member" xlink:to="lab_bsx_RequirementAsOfMarch312021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_66e29174-7ca5-4ae1-aff5-2496b4ee3a1c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_f938b9d5-8a63-4685-889e-d05edd1fb9fa_terseLabel_en-US" xlink:label="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights transfer</link:label>
    <link:label id="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_label_en-US" xlink:label="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from secured borrowings relating to royalty arrangements</link:label>
    <link:label id="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_documentation_en-US" xlink:label="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from secured borrowings relating to royalty arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:to="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TaxRateAxis_a2189f82-f217-48be-a3cd-3f10bc44e89d_terseLabel_en-US" xlink:label="lab_bsx_TaxRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Axis]</link:label>
    <link:label id="lab_bsx_TaxRateAxis_label_en-US" xlink:label="lab_bsx_TaxRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Axis]</link:label>
    <link:label id="lab_bsx_TaxRateAxis_documentation_en-US" xlink:label="lab_bsx_TaxRateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateAxis" xlink:href="bsx-20211231.xsd#bsx_TaxRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TaxRateAxis" xlink:to="lab_bsx_TaxRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5ae5b86b-a98b-4392-aed1-96c365a6bb14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_eb0515e6-fe89-4ed7-aaeb-bd996af13a64_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_ca0cb5f1-0f53-40b5-be30-693b4ab75815_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_a43b7add-083b-4d26-ab5e-761415ee93c4_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_4a7a066d-1f4d-49ea-81a2-d0dd7e07f605_terseLabel_en-US" xlink:label="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:href="bsx-20211231.xsd#bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:to="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_7ea65312-4cf2-4822-b349-f0dc6849f078_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value - authorized 50,000,000 shares; issued 10,062,500 shares as of December 31, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_c96f5c34-50c6-40a6-baa7-e4307a909924_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_f4df385e-b843-4a33-bb4c-295bf5ce5423_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_cc9b5c5f-d0bd-44ea-8cb8-094e47536952_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_cf06f547-3879-425c-80ea-4b5aafa53b27_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_e1fad347-9523-4b10-9c28-974736c35e91_terseLabel_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_label_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_documentation_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:href="bsx-20211231.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:to="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_af4c57b4-0cb7-42e5-9edc-ed7ad10b22f3_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_e6dcea14-ccc7-4bdf-866e-449e02a5a998_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:href="bsx-20211231.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_1473650b-97b6-4f82-810d-1d97a00f9278_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c97d9894-f26d-46e3-8c30-894e0f8bd463_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_49edea46-ca7a-438c-a161-92c7c67eb7a5_terseLabel_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:href="bsx-20211231.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:to="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_VertiflexIncMember_dfefde4e-add5-4902-bd1e-6bad0c5b1cf2_terseLabel_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc. [Member]</link:label>
    <link:label id="lab_bsx_VertiflexIncMember_label_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc. [Member]</link:label>
    <link:label id="lab_bsx_VertiflexIncMember_documentation_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember" xlink:href="bsx-20211231.xsd#bsx_VertiflexIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_VertiflexIncMember" xlink:to="lab_bsx_VertiflexIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_f54e5d66-01d9-4fee-b35f-8585b0de7b17_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TransitionTaxPaymentRemaining_14a359b5-34c5-4e5b-8b84-63ad2e9c26ad_terseLabel_en-US" xlink:label="lab_bsx_TransitionTaxPaymentRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">transition tax payment remaining</link:label>
    <link:label id="lab_bsx_TransitionTaxPaymentRemaining_label_en-US" xlink:label="lab_bsx_TransitionTaxPaymentRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Tax Payment Remaining</link:label>
    <link:label id="lab_bsx_TransitionTaxPaymentRemaining_documentation_en-US" xlink:label="lab_bsx_TransitionTaxPaymentRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Tax Payment Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransitionTaxPaymentRemaining" xlink:href="bsx-20211231.xsd#bsx_TransitionTaxPaymentRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TransitionTaxPaymentRemaining" xlink:to="lab_bsx_TransitionTaxPaymentRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherIntangibleAssetsTextualsAbstract_cf1d060d-3539-4f29-b9ad-c7c2040bd94f_terseLabel_en-US" xlink:label="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_OtherIntangibleAssetsTextualsAbstract_label_en-US" xlink:label="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_OtherIntangibleAssetsTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets (Textuals) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:href="bsx-20211231.xsd#bsx_OtherIntangibleAssetsTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:to="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a0f7d84-73c3-4f56-a770-aef6f3dd15ba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_fa48d5ce-367d-4046-9d04-5df5ac8363b3_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_74958bc9-266b-4124-bd3a-73e6bdf2f181_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring and Restructuring-Related Payments Made To Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring and Restructuring-Related Payments Made To Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring and Restructuring-Related Payments Made To Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:to="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_191e19b2-7683-4145-b0a6-358cdb35e8b2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_e617c28c-6510-4bd0-ba4a-50d1213805aa_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_7b16127a-7469-45e8-8f70-03d78f966a27_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_c601a2e8-f37c-4f6d-a600-30caf00b2bcb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_e90dcf17-9c13-4af4-8f6c-2c0908945f70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_faa6ce19-74d0-43c2-83f6-94ab3567bd1a_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share &#8212; basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantAxis_7df70d90-743e-425e-b8d9-b39f91755957_terseLabel_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_label_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_documentation_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis" xlink:href="bsx-20211231.xsd#bsx_CovenantAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantAxis" xlink:to="lab_bsx_CovenantAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_18153c93-31fd-4497-bd8b-d3949e4ea45b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_fbed0582-1319-4d26-8e9c-1a04e813652e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_33fed092-3626-422e-81ee-281ac0aba48d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_609c5e3e-0b82-4871-b496-17aa694c972e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028NotesMember_e5eb39a2-b827-432a-8155-4fc0f91400f7_terseLabel_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_label_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_documentation_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember" xlink:href="bsx-20211231.xsd#bsx_March2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028NotesMember" xlink:to="lab_bsx_March2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_7bf36d19-8251-4a03-99e5-cf1d94b6860c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_393e7b8d-4e1b-4322-aedd-f4a2e9dc4815_terseLabel_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_label_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_documentation_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:to="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_78328a54-49c6-4859-b15e-18260e241247_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_fa90e668-9b45-47de-bc68-328de2b02081_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c73bc394-5386-4bc4-95de-391c594dcba3_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_bea3073c-4e0e-4327-8752-ecc79587ed47_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_086f3f18-7555-4f2a-ac5e-e504d25dde22_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_143370fc-c0d6-4835-b650-c1401a17d31b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_51e956a7-d204-4262-a8fe-726d5bec9c79_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_7a89f0e4-1060-41d2-b20f-248c54b84eb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_9b1fbd68-6021-4399-8391-86751a2bdfd4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock_28fe3a6f-6956-46b4-9643-bb0734981e78_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_August2019TermLoanMember_37915e1a-fd42-4a8d-b347-3ac5c1d2be44_terseLabel_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2019TermLoanMember_label_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2019TermLoanMember_documentation_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember" xlink:href="bsx-20211231.xsd#bsx_August2019TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_August2019TermLoanMember" xlink:to="lab_bsx_August2019TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9b6c61a0-41a7-44bb-8b6e-01d35efc30ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d49332c4-ae2a-4993-9e2d-f02b29682d70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_4d7b84ab-6326-4cb2-9eba-442c3bc625aa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedOutstandingDebtMember_80d3d59a-a936-4dea-af04-2f44798a906f_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedOutstandingDebtMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedOutstandingDebtMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedOutstandingDebtMember" xlink:href="bsx-20211231.xsd#bsx_EuroDenominatedOutstandingDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedOutstandingDebtMember" xlink:to="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_33b2e305-5234-4e2d-9921-7827dc67043b_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_df38d9fc-91f8-4aa7-8184-b32104fd3bb8_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8ac3a1aa-a4dc-4cc7-b226-e2c9a429e59f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_b325a369-6ed6-4786-a1b2-ccafc73dcf21_negatedTerseLabel_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_label_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_documentation_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:href="bsx-20211231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:to="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_af0c0f7c-66fe-4eef-a246-53971d3cd422_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_a385bc1e-5ec7-4819-9a29-7c574d82e988_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8d445de-3895-4668-ab78-aa62e5d959bd_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c9852635-e86b-43ca-a11f-8ffb31cc5d5b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_dc3281c7-07eb-4d8d-84a7-633dfbed3dd2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_1760ce43-8039-40e8-b2cb-f1531824fdf7_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_label_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:href="bsx-20211231.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:to="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0fca06ca-1aa5-4044-b1aa-310e91a1927a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c3b83b7a-05ce-47f5-b3cf-99145e680ccc_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_f37aebbe-529a-406a-8121-ebb75edd145b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_6370335c-6d0d-4f43-aff5-5d55f92cc219_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0b67527f-2eec-4812-8a52-671d2022fde7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_dd472685-fcd2-4ac3-aa4d-0f20e33d36dd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_7fbc9c9b-bce3-434c-b2b9-03e8a8c531d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance (Par value)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_a1c23da3-4617-4ee0-8b6f-3d55b3f92c4b_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_a55ec146-0742-482b-8589-3aad650ee4aa_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_dddd3dbf-248b-4d7b-8c68-3e33617d3fa1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_ab35802f-acdf-4d95-85f4-8ba8480a3dbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantDomain_36092fe6-3f10-4280-b4c6-e782d1fcafa3_terseLabel_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_label_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_documentation_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain" xlink:href="bsx-20211231.xsd#bsx_CovenantDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantDomain" xlink:to="lab_bsx_CovenantDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_3a6061a2-7c14-455a-91f8-24d49ae05bcd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RhythmandNeuroMember_88584392-962a-44ef-92e3-0def5bf1ef14_terseLabel_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_label_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_documentation_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember" xlink:href="bsx-20211231.xsd#bsx_RhythmandNeuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RhythmandNeuroMember" xlink:to="lab_bsx_RhythmandNeuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_0c48251b-cf0a-4541-a342-5bcae0cb56ca_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_83ebb4fe-9c5a-4307-9141-1bcc7ddbd617_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_ddc6bcef-cd8f-4f9c-9415-47faca0854da_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_98e7ae9a-c273-4194-b55b-b59ba0446eb3_terseLabel_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest</link:label>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_label_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest</link:label>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_documentation_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:to="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NonCashImpactOfTransferredRoyaltyRights_ee26710d-0d6d-4869-a253-a1dfa730d173_terseLabel_en-US" xlink:label="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_NonCashImpactOfTransferredRoyaltyRights_label_en-US" xlink:label="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_NonCashImpactOfTransferredRoyaltyRights_documentation_en-US" xlink:label="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:href="bsx-20211231.xsd#bsx_NonCashImpactOfTransferredRoyaltyRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:to="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_6258872c-9b8a-4b9e-aef3-0d99bb1e601e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Gain on Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_cb38eafa-56c9-4b4f-8d40-ded1acf4a762_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_b102bc26-0431-4310-a0e5-d54461c350a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_950688d7-67ad-4d78-969b-359bd4c635d2_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Annualweightedaverageforfeiturerate_970a9af0-4dfb-4c18-99ba-8fd0f5e7a3cc_terseLabel_en-US" xlink:label="lab_bsx_Annualweightedaverageforfeiturerate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">annualweightedaverageforfeiturerate</link:label>
    <link:label id="lab_bsx_Annualweightedaverageforfeiturerate_label_en-US" xlink:label="lab_bsx_Annualweightedaverageforfeiturerate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">annualweightedaverageforfeiturerate</link:label>
    <link:label id="lab_bsx_Annualweightedaverageforfeiturerate_documentation_en-US" xlink:label="lab_bsx_Annualweightedaverageforfeiturerate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Weighted Average Forfeiture Rate The weighted average of estimated forfeitures for grants based on historical trends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Annualweightedaverageforfeiturerate" xlink:href="bsx-20211231.xsd#bsx_Annualweightedaverageforfeiturerate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Annualweightedaverageforfeiturerate" xlink:to="lab_bsx_Annualweightedaverageforfeiturerate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_935371a0-04b3-4caa-aeeb-ba3a3dc13532_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_14165a00-7147-47a0-b3de-a97e72eb0c0e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1c14a0dc-a165-4fd0-88da-00c8749c0352_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credits, Research</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_819a7b63-afcf-40ec-af08-27475f7b56e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ca3700a8-08a1-4d01-ad1d-ae8feef0ef87_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_c7c28ced-3bfa-4cc2-9cb4-4968b79d409f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_bf7936ad-f65e-4223-b4cc-c7a4beab0760_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_27c16c0c-a435-46b1-ac3d-05dcb25fb331_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2c2b3961-df06-48be-be18-b6bbbc12771a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_54143b84-1948-4653-9145-321e5ed1b4d5_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Measurementperiodmarketbasedaward_5d378536-f8aa-477d-bddc-0d9397b83088_terseLabel_en-US" xlink:label="lab_bsx_Measurementperiodmarketbasedaward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period - market based awards</link:label>
    <link:label id="lab_bsx_Measurementperiodmarketbasedaward_label_en-US" xlink:label="lab_bsx_Measurementperiodmarketbasedaward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period - market based award</link:label>
    <link:label id="lab_bsx_Measurementperiodmarketbasedaward_documentation_en-US" xlink:label="lab_bsx_Measurementperiodmarketbasedaward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period - market based awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Measurementperiodmarketbasedaward" xlink:href="bsx-20211231.xsd#bsx_Measurementperiodmarketbasedaward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Measurementperiodmarketbasedaward" xlink:to="lab_bsx_Measurementperiodmarketbasedaward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_fbdf773f-41ee-4196-bf34-7a8607d9fcf8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsTotalNumberOfCountries_9804691c-c03e-471f-bb6e-f05811a77cd7_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:label id="lab_bsx_EmergingMarketsTotalNumberOfCountries_label_en-US" xlink:label="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:label id="lab_bsx_EmergingMarketsTotalNumberOfCountries_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsTotalNumberOfCountries" xlink:href="bsx-20211231.xsd#bsx_EmergingMarketsTotalNumberOfCountries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsTotalNumberOfCountries" xlink:to="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_92464e14-87f0-450e-9716-9c92fce72115_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_893534b3-9756-4406-9b9a-09abf1886d69_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_ea3cc27f-342b-4403-92ee-8be20f42799d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_864acffa-e6ca-49a0-9a5c-4c5b5ac48c2d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Pensionbenefitobligationbenefitspaid_e3949bec-9abd-47ff-be35-f9236fe47942_negatedTerseLabel_en-US" xlink:label="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">pension benefit obligation, benefits paid</link:label>
    <link:label id="lab_bsx_Pensionbenefitobligationbenefitspaid_label_en-US" xlink:label="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">pension benefit obligation, benefits paid</link:label>
    <link:label id="lab_bsx_Pensionbenefitobligationbenefitspaid_documentation_en-US" xlink:label="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">pension benefit obligation, benefits paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Pensionbenefitobligationbenefitspaid" xlink:href="bsx-20211231.xsd#bsx_Pensionbenefitobligationbenefitspaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Pensionbenefitobligationbenefitspaid" xlink:to="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_58c48515-67e3-4f73-8e3f-196cf9903cdd_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_ba7fdd96-a973-44c4-b01c-f08601d519c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_55c7e5e0-02a2-4846-9cb3-35cefb403853_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock_c4df0c94-461f-46b2-b3c9-1519f2ba909d_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_4094ff80-b012-4783-8678-b8a93cde49d1_terseLabel_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average exercise price</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average exercise price</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average exercise price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:to="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_246af307-041f-4b54-94e4-53d1265a12ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_e86c630a-ea09-47a0-899c-6d81a97227ed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_f8a72a95-3b75-4dea-9652-eb4711672744_terseLabel_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_documentation_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:href="bsx-20211231.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:to="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_55092607-e0df-49a6-9bf8-31ed85431b79_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_eabb2d47-1b66-458f-839a-299631a0d29d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_24c8810e-76fe-4d5a-b739-1920921f2016_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0326bd04-7370-4d65-a8c0-15f9b12e9bd8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Balance Sheet (Parenthetical)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:href="bsx-20211231.xsd#bsx_ConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:to="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_fd9383f9-be4d-4870-bc35-630adb5dce80_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6db9abf7-a3b3-497f-85c2-4b1a4a12aef4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_fdd168fa-d65a-4c3d-87d3-407b31779d99_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_e1a5fd20-281e-4a02-a9ff-ffc9886847f8_verboseLabel_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20211231.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TransferCostsMember_38f9ce1f-1ded-44ef-8aa6-fba7065ac88e_terseLabel_en-US" xlink:label="lab_bsx_TransferCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer costs [Member]</link:label>
    <link:label id="lab_bsx_TransferCostsMember_label_en-US" xlink:label="lab_bsx_TransferCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer costs [Member]</link:label>
    <link:label id="lab_bsx_TransferCostsMember_documentation_en-US" xlink:label="lab_bsx_TransferCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer costs [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCostsMember" xlink:href="bsx-20211231.xsd#bsx_TransferCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TransferCostsMember" xlink:to="lab_bsx_TransferCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_0daab7d9-e684-4598-ab42-c09deef5b3d3_terseLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ac66c75b-48aa-4719-b702-e1edee7779ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_c4fc373f-f5d0-44b6-a82e-8cb51e082b4e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b1fd2ea4-ace9-444d-954a-0ebcf987afcd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f91d1c00-5797-4b91-8087-17af6599dfb9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_0188ea17-14ad-4604-b85e-d64f00532ad7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - authorized 2,000,000,000 shares; issued 1,688,810,052 shares as of December 31, 2021 and 1,679,911,918 shares as of December 31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4f814191-2d03-40bc-8204-45871f9213a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_16eff688-d16a-425b-80e6-2d4d9b501ddc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementOfOperationsCaptionDomain_65f814a2-fe31-430e-85b3-6a7e850b4623_terseLabel_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Domain]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionDomain_label_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Domain]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionDomain_documentation_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain" xlink:href="bsx-20211231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain" xlink:to="lab_bsx_StatementOfOperationsCaptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_83e71b71-c6e4-47c3-b468-26a6051c59b0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_ec5b93e5-4e07-4339-9100-2e8b84beb6de_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND STRATEGIC INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_ecdd1d54-b913-4029-80f2-3bfd6006d87b_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8b04d2fd-b6ac-43e8-a2bc-3056cc87c090_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2021AcquisitionsMember_d0b23662-ff2d-4d55-aa92-0a3dbdeeb12a_terseLabel_en-US" xlink:label="lab_bsx_A2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Acquisitions</link:label>
    <link:label id="lab_bsx_A2021AcquisitionsMember_label_en-US" xlink:label="lab_bsx_A2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_A2021AcquisitionsMember_documentation_en-US" xlink:label="lab_bsx_A2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2021AcquisitionsMember" xlink:href="bsx-20211231.xsd#bsx_A2021AcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2021AcquisitionsMember" xlink:to="lab_bsx_A2021AcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_dfa237a5-4cd6-432c-8c70-a2339c429ece_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_41a11bf1-7129-4568-b413-7a8655b8b92a_terseLabel_en-US" xlink:label="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</link:label>
    <link:label id="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_label_en-US" xlink:label="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</link:label>
    <link:label id="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_documentation_en-US" xlink:label="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:href="bsx-20211231.xsd#bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:to="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_cc963a99-6525-4e39-b34c-51a310f2458b_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_899100fb-5a73-429a-8ad9-c1c1c201edf3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_f51291b6-e0df-4e0b-8ac7-741b5753a98f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_efdef6a3-aaac-4d08-bd3b-f614fd34cdf4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_bbe671f7-fccc-4f02-a297-f39e67e6f9b7_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_6c153f7c-3f33-4fb1-8156-f70ba50cfb22_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_fae383ee-a526-480d-8ed6-6908d50abf2f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a053a8c1-f2fd-4094-a102-47461a54f551_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_996e6896-cfd6-494f-be2a-32acff087924_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1c694745-c7b8-43fe-a0d2-da8b5966c713_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3df12b98-4fad-4141-b743-57a88fa0469f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_08e4cf78-3fc9-452c-b11b-d4ada6b89594_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities, current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea827249-a0b1-40d6-9b51-bf0bd5a2dbde_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_23288a45-1f88-44bf-9b9b-4235c64eb63d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_6923e90e-0216-46ba-893e-a9aeb5ff835c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExpenseRelatedToMatchingContributions_8d98f2e9-1371-4306-bf91-568caf6eb375_terseLabel_en-US" xlink:label="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to matching contributions</link:label>
    <link:label id="lab_bsx_ExpenseRelatedToMatchingContributions_label_en-US" xlink:label="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to matching contributions</link:label>
    <link:label id="lab_bsx_ExpenseRelatedToMatchingContributions_documentation_en-US" xlink:label="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to matching contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExpenseRelatedToMatchingContributions" xlink:href="bsx-20211231.xsd#bsx_ExpenseRelatedToMatchingContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExpenseRelatedToMatchingContributions" xlink:to="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_6476e8d8-7d79-43a9-a639-f7f63f9c6073_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_7a98eb22-81fe-49a8-a2db-e75388b9a46b_terseLabel_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_label_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_documentation_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:href="bsx-20211231.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:to="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f84cb72a-f19c-483c-a484-3e2f3ef99db1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_8f811b87-07cc-4edf-90ab-7444920e4e01_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_60ebc51e-0869-46da-a635-ed5cc4083c61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_40beda06-c1df-48d4-95b1-e2b604c3f0ed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DiscountRateFairValueInput_884af82b-a455-4340-a417-a07314765906_terseLabel_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_label_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_documentation_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput" xlink:href="bsx-20211231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DiscountRateFairValueInput" xlink:to="lab_bsx_DiscountRateFairValueInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_e138fcc0-6368-4e23-9e4a-a83c72e9ec64_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_bc58856b-f91d-470e-8dc9-1ac95becd9d0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_59d407d3-6187-42fb-98d3-5b9312d27a44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_528fa7ad-654a-4a20-90a2-72b98e2356f9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_69180acc-dcfc-426a-a2c7-c9679ee2fdc7_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementOfOperationsCaptionAxis_297daa40-607e-4b59-baaa-398f8b851f12_terseLabel_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Axis]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionAxis_label_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Axis]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionAxis_documentation_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionAxis" xlink:href="bsx-20211231.xsd#bsx_StatementOfOperationsCaptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis" xlink:to="lab_bsx_StatementOfOperationsCaptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_b7dfad43-8876-4ae6-91d4-d216fae40573_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7a3c5345-2bca-4208-a553-38b3d7b0b561_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_79a5838e-ddd5-449b-8a86-54c55e9a461e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_262f52a6-fda0-4d88-bc97-7835d8853be8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_b2e20e10-04dd-4742-8cb0-af1f19bfcc9f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_416bc417-f9e8-40a5-b1d9-16e352576e01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_09d54d77-df71-430c-85da-93451b30c80b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_f3fc9733-87b7-43cb-a7e2-3f8ce70b8d3e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember_0da3a4f9-cad1-4932-9f47-9559d6fc3f89_terseLabel_en-US" xlink:label="lab_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter and thereafter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter and thereafter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20211231.xsd#bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_c5875d5c-435d-4a67-8efa-cacf08c036bd_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:to="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_d1b93d65-b9b7-4286-9cf4-2b08118eabf5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a53d71a-21fe-48b1-a40a-6cfe55db6c60_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_9994a322-25c3-4ef2-9683-1907f24b8369_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_ef0f6c14-f3f5-4a8a-8e68-f2ee4ba99631_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_abb777fd-7d2d-4fd8-9d15-fdb6729c0a78_terseLabel_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_label_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases [Policy Text Block]</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:to="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxAssetsDomain_f9c5e292-71c4-4a75-aeb4-06f5bdd9752e_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsDomain_label_en-US" xlink:label="lab_bsx_DeferredTaxAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsDomain_documentation_en-US" xlink:label="lab_bsx_DeferredTaxAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsDomain" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxAssetsDomain" xlink:to="lab_bsx_DeferredTaxAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c2975193-fcd5-4744-8890-5b386d6de7ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_91812d11-4274-482c-9be8-4d292f2dea33_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_675adfad-08c7-4c0f-bc5c-cc0748962913_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c090b9c8-4f1b-4bdb-bec4-d982f6ad7e5e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_4eeb8d25-c78c-4cd4-9886-af7cf12c794f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_35d74c85-7493-4c30-a780-129a36d630ea_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_d4a9615c-978e-436e-b0a9-f7c1a11875bc_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High end of range [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_62e6b9b6-e884-4d6c-a723-a5df8931a254_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b05619e4-9c4c-4877-a3d9-4b024c0c8a49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15b333e6-7285-4eaf-9021-95b71e0a2ec6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_1afb05b9-6d03-48a5-b7b0-abf74f5bec6a_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b47efc9c-5d18-4425-8532-8d93223840a1_terseLabel_en-US" xlink:label="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</link:label>
    <link:label id="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_label_en-US" xlink:label="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</link:label>
    <link:label id="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_documentation_en-US" xlink:label="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:href="bsx-20211231.xsd#bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:to="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7edc53ca-7bde-4e50-9d65-372331c9e360_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_49793dbe-d2b1-4d9c-998e-5f21a4676847_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_2f4debe7-3ee1-481a-8a0a-cd4537575763_terseLabel_en-US" xlink:label="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of employees total compensation eligible for GESOP purchase</link:label>
    <link:label id="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_label_en-US" xlink:label="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of employees total compensation eligible for GESOP purchase</link:label>
    <link:label id="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_documentation_en-US" xlink:label="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of employees total compensation eligible for GESOP purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:href="bsx-20211231.xsd#bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:to="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_d7358350-4bce-4481-aeb4-50768250ecab_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</link:label>
    <link:label id="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:to="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_d279de52-65b3-4a50-9b04-7ec02a6e4b33_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and restricted cash equivalents included in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_295b1f42-be3b-4a24-9068-d99fbdf77d37_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_ac069246-d0f6-4168-a85e-455f5c40a7bc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_65e9ea48-9702-4f12-9a9c-f5aee1319963_terseLabel_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_label_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_documentation_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Three [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:href="bsx-20211231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:to="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_537f7988-8df6-42f1-89d6-1269370df966_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b7c974f-6914-4187-9bba-c0467cf84942_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_32f47c76-621d-4be9-9080-b1cb9320b57a_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_9a2a95e3-4cf8-4115-8221-7ff93adbf961_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term borrowings and debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesDomain_e3105760-3db1-49cd-ac82-5dd0d44bb2d8_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesDomain_label_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesDomain_documentation_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesDomain" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxLiabilitiesDomain" xlink:to="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_8148dba4-bb2f-4388-a2b4-ee757fd9ec90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_c0c93d1c-777c-4151-a23e-b59abd28a0da_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_382bb42e-fcbf-4091-87a6-02c8685af196_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_21baca8e-8732-450c-82b1-3cd653d062b8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_0d4503ba-be85-47e7-9cdf-567e4f0e1eae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of businesses and assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS_08ecfb96-3c6f-4dc0-9e78-0e9aa3f26897_terseLabel_en-US" xlink:label="lab_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending cases and claims asserted in various jurisdictions in the U.S.</link:label>
    <link:label id="lab_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS_label_en-US" xlink:label="lab_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending cases and claims asserted in various jurisdictions in the U.S.</link:label>
    <link:label id="lab_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS_documentation_en-US" xlink:label="lab_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending cases and claims asserted in various jurisdictions in the U.S.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" xlink:href="bsx-20211231.xsd#bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" xlink:to="lab_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_6d815c10-09ce-4715-8333-dea28ec4e557_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_02bab611-a44c-4124-9de5-e642a0d8402c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9afc64c7-597e-46a0-8836-18ce220ff46e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PercentOfFinishedGoodsAtConsignment_d330fb7d-28fa-4f51-b404-9081300fc823_terseLabel_en-US" xlink:label="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of finished goods at consignment</link:label>
    <link:label id="lab_bsx_PercentOfFinishedGoodsAtConsignment_label_en-US" xlink:label="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of finished goods at consignment</link:label>
    <link:label id="lab_bsx_PercentOfFinishedGoodsAtConsignment_documentation_en-US" xlink:label="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of finished goods at consignment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PercentOfFinishedGoodsAtConsignment" xlink:href="bsx-20211231.xsd#bsx_PercentOfFinishedGoodsAtConsignment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PercentOfFinishedGoodsAtConsignment" xlink:to="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_ac945532-6bbe-41e7-bbf0-f9a12fbaf8ff_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_65d54973-08c2-4a4d-ba74-d179ba68c3c3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_a71ea3fc-ede8-4c7d-8096-0afe9d4da2b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized costs associated with defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c2617730-9e37-495d-a641-f27fbe1610a1_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_3a20218a-d10d-4f4d-84ce-9703400de4f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Tax Benefit from Compensation Expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_8afbff53-c5f1-44aa-8976-31b76440dfee_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_747ccaf3-90be-4c2d-baf8-7061bd9a885c_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_835840b4-128d-4202-8db1-93a63424edf0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_29cd7401-927c-490e-a366-ffbcd1b71466_terseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:href="bsx-20211231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_1f74e419-f68b-4496-843a-f3b80ab0a1d0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangements_a036bbdc-b07f-443d-902d-5c358030cc77_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_LicensingArrangements_label_en-US" xlink:label="lab_bsx_LicensingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_LicensingArrangements_documentation_en-US" xlink:label="lab_bsx_LicensingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangements" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangements" xlink:to="lab_bsx_LicensingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_e26b9602-3f6b-45a1-ab42-7d41d9de02b4_terseLabel_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20211231.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f5943568-10eb-4e7c-a9ec-9f9fdbf10ca9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_0432582e-f9e0-4102-bdcb-435152fd571f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1dee0c37-e53d-4071-9cac-fe20b12be049_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_f3414c38-3fbc-4d93-bd17-eb1d88136566_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average interest rate of de-recognized receivables</link:label>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_label_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable with Imputed Interest, Effective Yield (Interest Rate)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:to="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_b6df8392-5be1-4397-aa68-226694198d0e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_3211cd9f-fab5-4f86-9806-0793130e3114_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7b2681e9-35ee-4fb2-95cf-c3c8d6626b64_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b04f7b3f-831e-46cc-88f5-5b97078187a2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_4eea2fda-d291-4dfc-9dab-ad955f160091_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementAxis_a95e3ae5-8922-4237-b077-a7d2cc20bc2f_terseLabel_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_label_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_documentation_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis" xlink:href="bsx-20211231.xsd#bsx_StatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementAxis" xlink:to="lab_bsx_StatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9e7b84e8-2076-4715-8a7e-43c2f18b8fdf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LotusDiscontinuationMember_34e885ab-63f4-46fa-9b0b-08866dc1b7f4_terseLabel_en-US" xlink:label="lab_bsx_LotusDiscontinuationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lotus Discontinuation [Member]</link:label>
    <link:label id="lab_bsx_LotusDiscontinuationMember_label_en-US" xlink:label="lab_bsx_LotusDiscontinuationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lotus Discontinuation [Member]</link:label>
    <link:label id="lab_bsx_LotusDiscontinuationMember_documentation_en-US" xlink:label="lab_bsx_LotusDiscontinuationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lotus Discontinuation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LotusDiscontinuationMember" xlink:href="bsx-20211231.xsd#bsx_LotusDiscontinuationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LotusDiscontinuationMember" xlink:to="lab_bsx_LotusDiscontinuationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_7b8fb15f-0300-4d4e-a184-ea6d2109a92d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4a5ec536-2c14-4831-936c-732f07b0a4fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_23ab6c6b-1aa7-4331-8ca0-01811bb68973_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_bdc26c20-4fb0-4da4-88a3-13ac58fbb669_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_7db8e772-b37b-4b1f-a12a-e97890b6a0e5_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_69204ec1-bb24-4fd0-8902-94f27eebf29b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_e7a88036-989f-4f70-a598-928763fd086f_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_5e6f7499-e93f-43a6-85cc-98349a2a2fb7_terseLabel_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_label_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_documentation_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:href="bsx-20211231.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:to="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards_34243f83-e070-4b49-95d4-41ef01ee6acc_terseLabel_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Non-vested stock awards</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards_label_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Non-vested stock awards</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards_documentation_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Non-vested stock awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCostNonVestedStockAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:to="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a80c807a-2380-4a3e-b996-bd759745b92e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_efccaadf-7ed9-40e5-8501-ad4c6c0882ca_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8de66552-1845-474a-809e-2542acbf1725_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_314e7302-4bb3-42ff-bc36-bf40471575ee_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c0f002fa-8734-4b9f-8c01-3df2da6f02df_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_78fcc10e-b384-4c33-9cd8-e1bc4fc5153f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_67ad74a2-dac5-4e65-a736-2c7418d869fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_638fd209-c43d-4cce-a93e-720d2a9e0372_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_73d90243-b2d7-4aa8-b765-ac061e25334a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_WeightedAverageRemainingVestingPeriod_a044f119-b8ca-43e8-a79c-ddbe66f29495_terseLabel_en-US" xlink:label="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted average remaining vesting period</link:label>
    <link:label id="lab_bsx_WeightedAverageRemainingVestingPeriod_label_en-US" xlink:label="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted average remaining vesting period</link:label>
    <link:label id="lab_bsx_WeightedAverageRemainingVestingPeriod_documentation_en-US" xlink:label="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted average remaining vesting period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageRemainingVestingPeriod" xlink:href="bsx-20211231.xsd#bsx_WeightedAverageRemainingVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_WeightedAverageRemainingVestingPeriod" xlink:to="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_ac7b164c-444c-448b-93b2-0c967463699e_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Four Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7ac25fb6-c264-4b29-960b-bce4128b00e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_4c1a3140-37d8-405d-9355-fac267a372c7_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_a14cde79-a7f1-43e0-9345-9bcf3cd59adf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Compensation Expense</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9a19da72-0f04-4f07-a106-730154d05f8b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_790e419a-a39f-47c8-a1c5-12d479d44fb6_terseLabel_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_61a74786-7eba-454e-a2ac-a5980ead2859_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_4332a1a2-7649-4b1e-bad2-1b2b0a8e89c9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_b054cc10-adac-4da9-9633-6325ea0c8f81_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_598e57b6-ab53-48d6-826c-79e82ca0d5ae_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_556f5d7c-d26b-46da-99b0-ffbe7e81d74e_terseLabel_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_label_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_documentation_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity in Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:href="bsx-20211231.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:to="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2049NotesMember_2f59795c-1e5d-4a3e-97e5-608ef5d5201b_terseLabel_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_label_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_documentation_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember" xlink:href="bsx-20211231.xsd#bsx_March2049NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2049NotesMember" xlink:to="lab_bsx_March2049NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2039NotesMember_6679658f-e155-464a-9d78-d07bfa6abd07_terseLabel_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_label_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_documentation_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember" xlink:href="bsx-20211231.xsd#bsx_March2039NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2039NotesMember" xlink:to="lab_bsx_March2039NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3900014-6e49-4cd2-85ef-d8394f0e7bda_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_aafc76f2-876d-4c39-bdf0-0ec7db415584_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6e247017-f4f9-4c99-8335-2fc594d4ce55_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2815d88a-da72-4faa-975b-ff3b92519d80_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_095669cb-1795-411b-809a-6ab37c3f07fd_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_label_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:href="bsx-20211231.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:to="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsMember_3e2a761a-0ce0-4653-8ce5-1a203041259c_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_label_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember" xlink:href="bsx-20211231.xsd#bsx_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsMember" xlink:to="lab_bsx_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_106510d8-f6b8-434b-849e-a027ba316690_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b7ea5a4d-b847-4871-93a4-a80f5d0d666e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_196a942e-8f4d-43c4-abae-612a6085d006_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_3ef7cd98-c7fa-4525-a221-dd9ea0ed1a3a_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_2250b214-5d61-4991-9f9d-fa06a402aa49_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_b5238ce7-8980-4905-8571-bdb483a0b330_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_413ad31f-7a06-4571-aab3-43fccad99704_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_dca1c122-da13-4648-bdf5-a6e80b429cd9_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:href="bsx-20211231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_7fcc0275-6973-417a-a1a7-8d69624c3b4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_017b9b95-f48e-4b71-b44d-05596c6a3a02_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_afb913e8-6ea9-4ea7-a840-624a40b6fc1d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_c31aaa27-3c05-4441-9727-ecbc71e51b4d_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average (Member)</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_cde6fb1b-e319-4baf-b859-936a73cf60cf_terseLabel_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of performance-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_label_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of performance-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_documentation_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of performance-based DSUs awarded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:href="bsx-20211231.xsd#bsx_RangeofthetargetnumberofperformancebasedDSUsawarded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:to="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_06b0f0f1-d28e-41f2-8528-3c774d93b135_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a4b976d-724f-47f9-84cb-6b637c2c9d29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_cab1b18d-f4d6-420f-b045-d49c35e7afb6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_b2d65e60-5ad0-44e2-84b4-8260f1763a38_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ad155ddf-f2f3-49dd-bd75-4e030b38cd84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_b906d5cb-0069-48d2-9ad6-2b0ca44e758f_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_e20e2494-365c-42ae-b88f-dec070410bd2_terseLabel_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20211231.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_9f76547f-6e8d-4071-99c1-ed1f7cee85d3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_08af334d-ca14-4349-9b72-427183b47f4c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_2c77f8c2-6195-4c4c-8224-ff7e9b95070e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment for adoption of ASC 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:to="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_0b71278a-0de0-4e36-a829-88e01be613ad_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_e3e05969-0260-4aae-acff-111ee957358a_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCountriesMember_5c82bc53-1c0f-4a67-a07d-5d6d1461eab4_terseLabel_en-US" xlink:label="lab_bsx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_bsx_OtherCountriesMember_label_en-US" xlink:label="lab_bsx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_bsx_OtherCountriesMember_documentation_en-US" xlink:label="lab_bsx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCountriesMember" xlink:href="bsx-20211231.xsd#bsx_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCountriesMember" xlink:to="lab_bsx_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_3920f407-4132-4915-b03d-fba271d7ed83_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CompensationExpensePerShareDiluted_9c5dcee2-1f0a-4c36-a8f1-9eb5ec07ca9f_terseLabel_en-US" xlink:label="lab_bsx_CompensationExpensePerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - diluted</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareDiluted_label_en-US" xlink:label="lab_bsx_CompensationExpensePerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - diluted</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareDiluted_documentation_en-US" xlink:label="lab_bsx_CompensationExpensePerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareDiluted" xlink:href="bsx-20211231.xsd#bsx_CompensationExpensePerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CompensationExpensePerShareDiluted" xlink:to="lab_bsx_CompensationExpensePerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_34c5f646-42f5-4f54-be6f-3567f929395a_terseLabel_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:href="bsx-20211231.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:to="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_864fe0ff-c0b4-4add-9851-ee005571a2cb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4c2c9a5a-ae14-402c-8048-3d8a91c5f4d8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_1e237318-bf56-423d-9d01-b948a344a8cb_terseLabel_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_label_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_documentation_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Three [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:href="bsx-20211231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:to="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6820eed9-6a7b-48fc-b880-054297285b79_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d343cd61-15e1-4593-b2b6-d4c1235f8f21_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_15f25dee-b51a-4b6d-a2f2-685546904da2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_03e1d7de-5e82-4201-8b94-b5c1b5957cb1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CompensationExpensePerShareBasic_653398ce-0adb-4b43-80bd-37adc43aa03d_terseLabel_en-US" xlink:label="lab_bsx_CompensationExpensePerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - basic</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareBasic_label_en-US" xlink:label="lab_bsx_CompensationExpensePerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - basic</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareBasic_documentation_en-US" xlink:label="lab_bsx_CompensationExpensePerShareBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareBasic" xlink:href="bsx-20211231.xsd#bsx_CompensationExpensePerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CompensationExpensePerShareBasic" xlink:to="lab_bsx_CompensationExpensePerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AuditInformationAbstract_label_en-US" xlink:label="lab_bsx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_bsx_AuditInformationAbstract_documentation_en-US" xlink:label="lab_bsx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AuditInformationAbstract" xlink:href="bsx-20211231.xsd#bsx_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AuditInformationAbstract" xlink:to="lab_bsx_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a693a27a-d5b4-47a6-94a6-9789eef17d46_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_8aa0a975-39c5-4793-bee8-eaa205626b9c_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f6e5f17-c031-4de3-bf01-962b6e0cc8c7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_e0097411-1cee-44d7-b609-b7d7d5eee8fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_cc3a4417-107f-4215-967c-1effea871956_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6c415c03-ccf7-4e3d-ad62-fe28cdd518ef_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UnrecognizedCompensationCostStockOptions_e2055a76-4bff-458a-9d10-f802b2e8cd0c_terseLabel_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Stock Options</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostStockOptions_label_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Stock Options</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostStockOptions_documentation_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostStockOptions" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCostStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UnrecognizedCompensationCostStockOptions" xlink:to="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7cb28ea2-328e-4fd0-a78f-bdac14ff68bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_be9b0cb0-1958-4212-9cc0-137fc18d08aa_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_December2027NotesMember_2cb83181-ff8f-4bbc-b743-238dca5e0b1b_terseLabel_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_label_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_documentation_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember" xlink:href="bsx-20211231.xsd#bsx_December2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_December2027NotesMember" xlink:to="lab_bsx_December2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_b6392769-fc05-4ce3-a10d-f9df8c4d0282_terseLabel_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of facilities</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_label_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of facilities</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_documentation_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities" xlink:href="bsx-20211231.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DivestitureAgreementTransferOfFacilities" xlink:to="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_b3bd9dfc-ae1c-4680-a9ad-96d720b7085f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FederalBenefitOfUncertainTaxPositions_e8c1f2ab-c183-4a77-8203-79bbcbe027cf_terseLabel_en-US" xlink:label="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal benefit of uncertain tax positions</link:label>
    <link:label id="lab_bsx_FederalBenefitOfUncertainTaxPositions_label_en-US" xlink:label="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal benefit of uncertain tax positions</link:label>
    <link:label id="lab_bsx_FederalBenefitOfUncertainTaxPositions_documentation_en-US" xlink:label="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal benefit of uncertain tax positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FederalBenefitOfUncertainTaxPositions" xlink:href="bsx-20211231.xsd#bsx_FederalBenefitOfUncertainTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FederalBenefitOfUncertainTaxPositions" xlink:to="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_99e5d19a-89bf-4070-9469-5cd7cf0890ec_terseLabel_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_label_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_documentation_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:to="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_2ede2501-a37b-45a2-b2ea-e0442987fc49_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_9ffa7be4-582f-4283-8b86-3fca626708fa_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity-Wide Disclosure on Geographic Areas, Revenue from External Customers Attributed to Individual Foreign Countries [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_aee1fd63-533b-41fe-94d0-0e61f9f94b34_verboseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_808b7b6f-fdfc-4a0d-9241-aea4189cf7a5_terseLabel_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_label_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_documentation_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh" xlink:href="bsx-20211231.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CertifiedClassActionsInAustraliaMesh" xlink:to="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_29ffc9bd-22eb-4d61-9880-25cce33c185b_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a3f5e22-fdff-4fd6-890e-1bad6f67dbb2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_a75a1394-0eac-41df-aacd-5c2dc808be54_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2020TermLoanMember_e21da6f4-e731-4e8c-a863-523fd20bc378_terseLabel_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_A2020TermLoanMember_label_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_A2020TermLoanMember_documentation_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember" xlink:href="bsx-20211231.xsd#bsx_A2020TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2020TermLoanMember" xlink:to="lab_bsx_A2020TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_887c9f39-b143-4f89-ad9e-537c1c9e339d_terseLabel_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen denominated factoring arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:href="bsx-20211231.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_4ca73944-231c-4b87-b662-c8785ef946d5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_01e3df16-92d1-4559-a6c6-1228221e15eb_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_df3b0832-bb7e-4900-9997-c75364baaa6c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_69f3ad98-157e-4420-961d-c8d1300e0410_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_7c1297df-1ed9-48b1-9711-fce33f9d84ce_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Non-current deferred tax liability, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b391e11a-e2a5-49f5-9b77-580850f42f4d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_08ceaea5-274f-464a-94d5-25f7329ecd12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 263,289,848 shares as of December 31, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b1436fd4-3ce2-49ea-83fb-4deac50f1a8c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_4f947944-760a-4e36-ae41-a41fb0b182a2_terseLabel_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Text Block]</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:to="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2025NotesMember_c3634e5c-efc1-4df3-8db3-a2e85fe1e47e_terseLabel_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_label_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_documentation_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember" xlink:href="bsx-20211231.xsd#bsx_June2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2025NotesMember" xlink:to="lab_bsx_June2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_9dc72320-44b7-4791-b00e-49b54ac6d15c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_2b62f1d8-5f3d-48f1-8141-5048f9b4a24b_terseLabel_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_label_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_documentation_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims asserted related to mesh products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:href="bsx-20211231.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:to="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_d1dcba7e-2006-4a4b-a4bf-2a7238e7e015_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring net charges (credits)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_659599a1-b5c0-415e-87d1-403f19baaaf6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod_d3d0bee0-e9b8-4788-abbe-53b7433d0243_terseLabel_en-US" xlink:label="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items]</link:label>
    <link:label id="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod_label_en-US" xlink:label="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Additional Revenue Payment, period</link:label>
    <link:label id="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod_documentation_en-US" xlink:label="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" xlink:to="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8540a3f4-4649-404a-ba92-1e600c8d44e9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_d3561d0e-12fa-4368-acd4-6a8fd4a6c2c1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings on credit facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_a8e2d7e4-f760-4d78-9cf6-585f5d068572_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_c57f4c6f-dd2a-42e7-b117-83ffa3749340_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_0a1fa4f9-d70f-4e35-8a09-40db5905dc6d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_4b211ab2-6a59-4c16-b8f0-f208a52f2d01_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_678e5b6a-9a6d-4c23-acdc-0fa666d30c17_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1f4ad347-52c7-4930-b896-2f3eafe5a978_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_88c6d975-180f-4705-9dff-ce87325c0c82_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution_65183ca0-a5e3-4fa4-8b74-00d6cc8823e9_terseLabel_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution</link:label>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution_label_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution</link:label>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution_documentation_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:to="lab_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InternationalRetirementPlansMember_18d407c7-6438-40ca-8238-2ca9dd8093cd_terseLabel_en-US" xlink:label="lab_bsx_InternationalRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans [Member]</link:label>
    <link:label id="lab_bsx_InternationalRetirementPlansMember_label_en-US" xlink:label="lab_bsx_InternationalRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans [Member]</link:label>
    <link:label id="lab_bsx_InternationalRetirementPlansMember_documentation_en-US" xlink:label="lab_bsx_InternationalRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember" xlink:href="bsx-20211231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InternationalRetirementPlansMember" xlink:to="lab_bsx_InternationalRetirementPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5d599bcb-fc0b-48c9-ad17-c57891428a7d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_bc37b3bc-fe02-482a-924c-bce1a2e6d206_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e1f972da-f34a-43d8-85c8-bc2439d87590_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementsLiability_76f127ca-1fe2-4516-ace1-7634cd03656e_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_LicensingArrangementsLiability_label_en-US" xlink:label="lab_bsx_LicensingArrangementsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_LicensingArrangementsLiability_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementsLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementsLiability" xlink:to="lab_bsx_LicensingArrangementsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_b4f9b6c2-b254-4a44-8d07-8b7deca51aa1_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_fae501e8-695c-4c98-ac35-9ddbfc3c8f51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_4b4ee230-3de5-4bd1-a085-1418c8cf5a59_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TransferCosts_15d9b445-d058-4cb8-b18d-7f9cb0f798d0_terseLabel_en-US" xlink:label="lab_bsx_TransferCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Costs</link:label>
    <link:label id="lab_bsx_TransferCosts_label_en-US" xlink:label="lab_bsx_TransferCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Costs</link:label>
    <link:label id="lab_bsx_TransferCosts_documentation_en-US" xlink:label="lab_bsx_TransferCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCosts" xlink:href="bsx-20211231.xsd#bsx_TransferCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TransferCosts" xlink:to="lab_bsx_TransferCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_f4640e1b-5c53-4d3e-a232-e392b483f35c_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f71a2f1f-1e72-4b66-a400-948e458af999_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2eb5ce82-2e75-4eec-b013-de8f17cad2ee_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_860165b0-fdc1-45d4-8ec6-0ccafc68fa48_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_4f7a1850-1c5c-4537-8618-210f8cabff73_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_d0ddca4a-aae1-491a-92af-edb89eb1a6fd_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockCash" xlink:to="lab_us-gaap_DividendsPreferredStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2d570b63-81e7-4282-98d4-75ffb30f1469_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_10a1fcfb-9931-479c-a2d1-b79a4e61fe1e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_d88777d4-814b-457d-a3ac-4921aabea208_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_e995131a-2a67-4907-93a2-2a7a5dc6d132_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_6b37cc64-ba48-41ca-b720-1a358b12b374_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss (beginning balance)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_130ed3a5-005d-4e29-a860-2cf091f21152_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss (ending balance)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2016RestructuringPlanMember_3a284add-3a11-49b8-b099-739632cc60d5_terseLabel_en-US" xlink:label="lab_bsx_A2016RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2016RestructuringPlanMember_label_en-US" xlink:label="lab_bsx_A2016RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2016RestructuringPlanMember_documentation_en-US" xlink:label="lab_bsx_A2016RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember" xlink:href="bsx-20211231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2016RestructuringPlanMember" xlink:to="lab_bsx_A2016RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_20db98a6-5a3e-45ed-9f08-c7b4b990d3c4_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_0b83a5e0-206f-42dc-a7c7-33dfbcf978ef_terseLabel_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_label_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of term loan and revolving credit facility agreement compliance with debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:to="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_ed11aa0f-176e-4e50-aff2-b1aa4c12fd1a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract (Member)</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_0b7d61c9-24cd-4340-8c5f-e1f68034a7e2_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for legal matters that are probable and estimable</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c9a004ef-b363-4dcc-a78d-eb1121b5ce7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance_de4c4544-1625-412d-8ba8-9142480dfc7c_terseLabel_en-US" xlink:label="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance_documentation_en-US" xlink:label="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:href="bsx-20211231.xsd#bsx_ChangeinDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:to="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_35232db9-654d-4895-903f-9a106b85c18e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_14654620-8c65-452b-aa20-8ff702243e34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FarapulseIncMember_1163508c-be2d-44dd-99d2-be7efc416bdb_terseLabel_en-US" xlink:label="lab_bsx_FarapulseIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Farapulse, Inc.</link:label>
    <link:label id="lab_bsx_FarapulseIncMember_label_en-US" xlink:label="lab_bsx_FarapulseIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Farapulse, Inc. [Member]</link:label>
    <link:label id="lab_bsx_FarapulseIncMember_documentation_en-US" xlink:label="lab_bsx_FarapulseIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Farapulse, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseIncMember" xlink:href="bsx-20211231.xsd#bsx_FarapulseIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FarapulseIncMember" xlink:to="lab_bsx_FarapulseIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_c7251774-f9ef-41e6-83a7-2b51204504a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_c3082236-deeb-4f06-b3db-845e147d5fe8_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_dd231779-4fdd-4c27-b8de-620c4eca43ae_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_cd628f20-470e-4d08-bfa8-79baa2ad2f58_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fd60e0ee-f892-498b-b018-e0932c404268_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_d7912f7f-840d-4170-b455-9d74ef90432d_terseLabel_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:href="bsx-20211231.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:to="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_b3b88db7-2457-4814-8c08-3c9fa0f5db25_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_043702ec-80eb-4826-9912-79cc6a0b8df5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_b96c4460-d7fa-4570-b584-65bce9cf1937_terseLabel_en-US" xlink:label="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale in Other current liabilities [Domain]</link:label>
    <link:label id="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_label_en-US" xlink:label="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale in Other current liabilities [Domain]</link:label>
    <link:label id="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_documentation_en-US" xlink:label="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale in Other current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:href="bsx-20211231.xsd#bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:to="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringPlanMember_db532b07-61e5-47e6-a142-e6aeff697f40_terseLabel_en-US" xlink:label="lab_bsx_RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringPlanMember_label_en-US" xlink:label="lab_bsx_RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringPlanMember_documentation_en-US" xlink:label="lab_bsx_RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringPlanMember" xlink:to="lab_bsx_RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_68556e1f-7a16-4aa5-82bc-aab6fde7f878_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_8a8cbbac-dd88-4cd2-b49d-cd696876b37b_terseLabel_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA [Member]</link:label>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_label_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA</link:label>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_documentation_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA" xlink:href="bsx-20211231.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeemedConsolidatedEBITDA" xlink:to="lab_bsx_DeemedConsolidatedEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_ded0ebfe-b755-4477-a208-8663d05f589b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_0790f359-9754-4393-bc1e-933c8bb8e243_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_2cb0ad99-a743-4419-946e-38d58bed26d1_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Related Impairments or Charges</link:label>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_label_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Related Impairments or Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:to="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_6dff54f6-35a7-4806-939d-01b55c0acd4d_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:label id="lab_us-gaap_SharesIssued_174cbf9a-26d8-4bb0-b220-c68ec0036744_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_bb4306b6-0e5d-41c2-afc5-89f78f8c99a2_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States [Member]</link:label>
    <link:label id="lab_country_US_0462634c-7173-4a6a-bbc9-674f44265228_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_dc2c5cbb-b519-4d72-bb6c-0aa7e7530cc8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_37bd1da2-dc43-4ed7-adef-c5caf00da837_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_VotingPowerOfAllClassesOfStock_30d5775d-b148-41c5-84f4-16e851bc4e77_verboseLabel_en-US" xlink:label="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting power of all classes of stock</link:label>
    <link:label id="lab_bsx_VotingPowerOfAllClassesOfStock_label_en-US" xlink:label="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting power of all classes of stock</link:label>
    <link:label id="lab_bsx_VotingPowerOfAllClassesOfStock_documentation_en-US" xlink:label="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting power of all classes of stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VotingPowerOfAllClassesOfStock" xlink:href="bsx-20211231.xsd#bsx_VotingPowerOfAllClassesOfStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_VotingPowerOfAllClassesOfStock" xlink:to="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d5dc89ef-6db3-405c-88ce-98984b9e7323_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_db4bd20c-9bd0-41a3-b68f-33d176438f5b_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_94700300-d60a-4d8c-8612-9bb2bd0ba40e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_de2813cb-cb96-459d-b971-49bffe45a61a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_0e83d134-61a3-4452-aaa4-1259b92e6f74_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_0c27a07b-6012-43b8-a0ee-a059a3f70414_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c31c49b8-3379-478c-953a-f9cbfbc9471a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_ac276916-26f3-4a0b-bc37-69589c2dfedc_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments Due, Current</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc9aca34-d01e-4c3e-bbcb-0d84a49a5d94_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assuming dilution</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c013eaaa-f63a-4d81-9aa2-f4aaada6b16c_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9a216584-a162-4c6a-8e29-07cc8f15415d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_0ac5d971-bc71-4e74-84cf-1e394d197a1b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d5046a1f-9301-4fc0-95b0-1ea380f1d3f2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8bb9ddc9-1ddd-41fd-9cc7-1c28c79924e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution_90829ebe-b506-4d02-bb79-8fbc01009cfd_terseLabel_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution</link:label>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution_label_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution</link:label>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution_documentation_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:href="bsx-20211231.xsd#bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:to="lab_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SignificantAccountingPoliciesTable_2e56e0f4-d72e-42fc-844b-d7631a44d162_terseLabel_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesTable" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SignificantAccountingPoliciesTable" xlink:to="lab_bsx_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_0260e176-6e4c-4b70-a424-6b5786b6ed66_terseLabel_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:href="bsx-20211231.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:to="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_83636f64-0ce0-4b44-a135-c43968bdda7f_terseLabel_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:href="bsx-20211231.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:to="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e40a974e-79dc-40fd-a22d-01ad30ab7293_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_bc672583-7a9f-47e7-ab0f-28655d4f175a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_0ae64606-4709-417f-ad93-9820cda3f4ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_46ca6758-2d96-48be-a740-acf2a10c0387_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments Due</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_4119327d-2932-4dc9-b676-daee6c847f70_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_ec811867-012e-4bec-b57a-c338b1fb0a00_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_270b6bdf-c8ee-43f6-9664-a0910a3e100d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7ecaac04-6aab-42a2-8e86-5f621feefe14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRico_0c06677e-dad8-4aab-a801-c47cc76facd9_terseLabel_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRico" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico</link:label>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRico_label_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRico" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico</link:label>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRico_documentation_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRico" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TaxIncentivesInPuertoRico" xlink:to="lab_bsx_TaxIncentivesInPuertoRico" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_09dc471d-7bb3-4ac2-a660-9bd3f4609863_terseLabel_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of market-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_label_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of market-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_documentation_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of market-based DSUs awarded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:href="bsx-20211231.xsd#bsx_RangeofthetargetnumberofmarketbasedDSUsawarded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:to="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2dc3488f-0065-4873-8683-76647206436c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_bed13bfd-c9d5-44b2-8511-cb55ba16f92f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_bd72650b-f04d-40dc-bdc8-51e513dedeab_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_b3d57042-9dfb-4cd1-a41e-6bc3b45bd5f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_26eb1564-cbc8-404c-adfd-7e050d1b5aa0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2d887717-3868-41f9-909a-5a5e0ecb36fe_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_38cbabc1-ceb1-4ebc-b738-85d018621893_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_b52de455-0be2-4f2a-b8ab-7698922df403_terseLabel_en-US" xlink:label="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:label id="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities [Table Text Block]</link:label>
    <link:label id="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:to="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_c7bf82ca-2c93-4b02-b991-c5705e6673ee_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_d094d3e7-f1a8-4140-a465-b9471d621560_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_45e64325-97b6-4c9c-9c79-1935a0e43391_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3acf91c0-295a-4d5d-b247-37a8b7ee8c2b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1a83df4e-34b8-4e22-8821-04dd24af6456_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4bc1ee17-5666-47b1-a870-6fd73afdc12d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter_bd0905f5-8e2d-4ca5-a34b-830e5441a6c0_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfiled Vena Cava filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter_label_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfiled Vena Cava filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfiled Vena Cava filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" xlink:to="lab_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIncentiveAndPurchasePlansAbstract_971c9d18-649d-40c6-9bcc-1f362fad044a_terseLabel_en-US" xlink:label="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive and Ownership Plans [Abstract]</link:label>
    <link:label id="lab_bsx_StockIncentiveAndPurchasePlansAbstract_label_en-US" xlink:label="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive and Purchase Plans [Abstract]</link:label>
    <link:label id="lab_bsx_StockIncentiveAndPurchasePlansAbstract_documentation_en-US" xlink:label="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive and Purchase Plans [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:href="bsx-20211231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:to="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_1c7b453b-c396-4471-9d0b-480dd4a385e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForeignCurrencyDenominatedInDebtMember_df171dbc-18f4-4d79-b6cd-3d97cbea4b35_terseLabel_en-US" xlink:label="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeignCurrencyDenominatedInDebtMember_label_en-US" xlink:label="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeignCurrencyDenominatedInDebtMember_documentation_en-US" xlink:label="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated in debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:href="bsx-20211231.xsd#bsx_ForeignCurrencyDenominatedInDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:to="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_9bc6058d-c9c4-4fd9-94f4-2f7f4fac7f52_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_6f109efd-b915-4215-8383-9f813de41cd5_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_9f8dc29c-85f5-47f6-b6ac-b6ed7e058d32_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c976ce5f-772f-4d4d-be05-9c2029cda4b6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a3dd06c2-1d3b-45e0-aa02-13e77e0fa09c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments (Table Text Block)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_3b0cb5aa-2299-4aae-894f-cd776eda80eb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_420f031a-0f04-4aa5-aa27-fa7ba55f5498_terseLabel_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc. [Member]</link:label>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_label_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc. [Member]</link:label>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_documentation_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember" xlink:href="bsx-20211231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PreventiceSolutionsIncMember" xlink:to="lab_bsx_PreventiceSolutionsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f0c30ed0-5362-4e4e-b102-23c585942893_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_cb7c931b-e7c6-40d2-84bb-c5db59bc2d0b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_aeff0b48-a777-43e3-a542-415bffa8bf12_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_ef769f35-6627-472e-acb6-9db53b998f00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d8bda15d-5e51-4567-b43d-948114a1f85e_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_69314264-aff1-4c30-9bba-99c16d6aa05a_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_f983ae50-27b2-4cf6-addc-fd4163c2c6c9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_67ca76c9-72ae-4c4e-b85c-aa693c668752_terseLabel_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_label_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember" xlink:href="bsx-20211231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2019AggregateOfferingMember" xlink:to="lab_bsx_November2019AggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_4ed99519-5506-40bc-b09a-ff88f2d0027d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_cc5a0ef5-16a4-4ea8-a0f3-4e6815dfdd26_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_aa08b828-4b9d-4849-b448-ef887747b8fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_509ce6d7-f90c-4468-8a0d-6de8a72b071d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_bc5f489d-db35-4ed4-82ef-18c42c756715_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_e5538f77-d091-438c-abe7-2623e07b96d9_verboseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AssetsHeldForSaleDomain_13345fda-e55e-49af-9a60-a1939f181376_terseLabel_en-US" xlink:label="lab_bsx_AssetsHeldForSaleDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale [Domain]</link:label>
    <link:label id="lab_bsx_AssetsHeldForSaleDomain_label_en-US" xlink:label="lab_bsx_AssetsHeldForSaleDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale [Domain]</link:label>
    <link:label id="lab_bsx_AssetsHeldForSaleDomain_documentation_en-US" xlink:label="lab_bsx_AssetsHeldForSaleDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssetsHeldForSaleDomain" xlink:href="bsx-20211231.xsd#bsx_AssetsHeldForSaleDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AssetsHeldForSaleDomain" xlink:to="lab_bsx_AssetsHeldForSaleDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_9e35c581-62d3-402a-ad60-f2ce2fbe0f31_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7bea5489-8683-4f91-b3c8-e3cf5a928f6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Table Text Block)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_c27c77ec-fbe2-4264-9f26-70125c109045_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b82e957a-d0f9-4ac3-82db-23271260958f_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_d0088d1a-5091-47bb-be3f-2165a47acbd4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_abd3bbd2-d6d2-41a5-a5d9-9f849bc2f955_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_954d827e-53b4-4d89-969b-4d7f7800edc5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_0e8f350f-472d-4036-b3ce-ecf8d4ed4093_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e12cda9a-152a-4032-8913-d1d8ad4bb272_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_6bd584a4-c6da-4b10-a9eb-d101baeef911_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bb6add28-6a26-4d56-a10c-fbc28b345d0e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1a8087f4-180c-4c37-959d-ae13925d9c02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_2062c301-a76d-4d48-9608-33f91238fc26_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_a74efb03-2aba-4e7b-b2d6-16755da6f7b6_terseLabel_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20211231.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_b43a489f-aea7-4f5a-a63c-eeaa08038904_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions (Table Text Block)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_19dfaa45-2786-4c0f-9b0c-cc606ee12157_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_58b77970-59c4-40e8-b965-4680823b8c60_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_103232a9-4b31-4c6c-a9d5-86c1a041cd74_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_075ae02e-f0de-4c13-b037-8dbaeb846278_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3601a2da-0f2f-4d95-a8f7-47596d4260ff_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_bb6500b9-b021-46b3-9155-89e6bcd54e96_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b55710b9-9ed6-4af3-add3-4cf376e4e644_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_94e41a32-599c-4d5d-8c1f-4ee09ed8eef4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments_4561dc27-b1b6-4f25-b768-86bedaa137f1_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments_label_en-US" xlink:label="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Allocated to Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:href="bsx-20211231.xsd#bsx_OperatingIncomeLossAllocatedToReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:to="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_e2ae52ba-eb85-4756-a8ed-50958ee150b7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2011cef1-c648-4f66-85a1-4b83e6111e58_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ab7c1bcc-5fa0-414f-ab47-a65979db63c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_665cc586-6f38-406b-8fe0-c8916f5c4359_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_2be9ffc7-9a88-48d4-bc4e-28ba0a179eb6_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_9af1837c-a7f1-433a-a6fa-05a337615a25_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_ad960ddf-3a85-4a7a-943f-410de4a37e99_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e6c96af8-4c3c-4d41-8774-0abfe55b6904_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_87448222-5797-4381-9b72-36835d309562_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets (total)</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_3352d66a-d881-4e74-be1a-3dc08b5f7ba7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_13ab36eb-fcb1-4da8-8236-a49b280a1531_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_dd7316e7-765f-4a5c-add0-d4a9397723a6_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementLiabilitiesMember_76984816-7ccf-46a8-aa49-53275bc62ade_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities (Member)</link:label>
    <link:label id="lab_bsx_LicensingArrangementLiabilitiesMember_label_en-US" xlink:label="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingArrangementLiabilitiesMember_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementLiabilitiesMember" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementLiabilitiesMember" xlink:to="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_831be309-58c5-4daf-b3e2-176fbce71123_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) settlements of hedge contracts</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_18afa3f8-36b7-49a2-b139-361ae2bf8dfd_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_a564ca54-9180-4d77-b79d-dffb522ffe08_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_The2018FacilityDomain_1c2ffb1c-9f13-4ed8-87dc-8f539fc7a046_terseLabel_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_label_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_documentation_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain" xlink:href="bsx-20211231.xsd#bsx_The2018FacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_The2018FacilityDomain" xlink:to="lab_bsx_The2018FacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_766a293a-bfcb-4a9a-bfb5-8618d299ddba_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_f6bc46bd-e961-43dd-819b-4d559d191de7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:to="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b16dd55b-328e-40a7-97c4-15f3e71f3c51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_43eba620-e704-4c72-9405-26464ec6b85f_terseLabel_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_label_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_documentation_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:href="bsx-20211231.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:to="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c13bea81-5bc4-404b-9023-b93c0fa979f1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS AND LIABILITIES HELD FOR SALE</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_bdd79621-cc68-4e47-8d29-717d8f292374_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_e54b2ba6-e73d-4582-a43b-e14fc75a6c14_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_fbd77c09-b4db-48e0-bf81-ff76fda5e279_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_label_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:to="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_772b4a27-4683-4c92-b4ec-a51bbe79aae3_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_6b391d0a-c952-4c79-a4f5-b213c817226b_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_e03f40ce-bedb-4f7f-a561-9c1dd26ed7f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_dd68c1d0-47c9-4e8a-880c-326426dc2223_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_db7455e6-068a-4aaa-b3fc-6a56c2ee0dec_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_b6a41a6e-48ba-466e-9b7f-8563cac8d81d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MedsurgMember_d28ecfd1-a31e-4293-ab8a-5ecc80c284e7_terseLabel_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_label_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_documentation_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember" xlink:href="bsx-20211231.xsd#bsx_MedsurgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MedsurgMember" xlink:to="lab_bsx_MedsurgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_24cab797-a451-4584-a396-e20308d3aae1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_02812f7e-f16b-4175-b70e-9795f741caf1_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20211231.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c327d9ae-8af0-4086-bd8d-764bce6fde1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cda3c7f6-de44-4d95-869e-ace88ccb30b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_0aca98f5-8db3-4e95-ad5a-e67630141e5f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_c7659a28-3e6e-49f2-b2b0-8ad38dd4b923_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1ef64778-8618-4747-9880-ac644cff3f40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_95c5a56b-f3d7-41a0-9570-3154d30b62ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringrelatedCostExpectedCost_150da331-eaa2-4aaf-b25f-7382039418dc_terseLabel_en-US" xlink:label="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringrelatedCostExpectedCost_label_en-US" xlink:label="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringrelatedCostExpectedCost_documentation_en-US" xlink:label="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringrelatedCostExpectedCost" xlink:href="bsx-20211231.xsd#bsx_RestructuringrelatedCostExpectedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringrelatedCostExpectedCost" xlink:to="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UnrecognizedCompensationCost_b79e6d54-07ef-4336-8e6f-a58d7fdf117b_terseLabel_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCost_label_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCost_documentation_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCost" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UnrecognizedCompensationCost" xlink:to="lab_bsx_UnrecognizedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_3fa0b9c7-8aa5-4e70-ae54-0fe93672f0c3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1217f76a-9cce-4cb2-a4f0-9094b4f5ea36_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_5e1258e8-879f-44c1-88a5-c1ef67a0213d_terseLabel_en-US" xlink:label="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of depreciation by reportable segment to total [Table Text Block]</link:label>
    <link:label id="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_label_en-US" xlink:label="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of depreciation by reportable segment to total [Table Text Block]</link:label>
    <link:label id="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_documentation_en-US" xlink:label="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of depreciation by reportable segment to total [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:to="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_0c9108cc-eefe-463f-a65d-dd9a2e00bdc1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_34befb0c-96ce-4353-8c08-2761208fc3f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_8ec835a7-fcf5-48a0-8d21-50aae73194f7_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments made to prior shareholders to date</link:label>
    <link:label id="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_label_en-US" xlink:label="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments made to prior shareholders to date</link:label>
    <link:label id="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments made to prior shareholders to date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:href="bsx-20211231.xsd#bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:to="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_6a49550b-be56-4c79-8971-70332d09f811_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad222e82-f5a6-4571-8664-94cb395977cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3b750643-063d-4c75-87b1-9a12ce72dc13_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_21acc3ce-ee9e-40b8-bff9-55ac1c4fa6b1_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f65661fb-6c95-450f-b175-2f2f635e622b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiovascularMember_be734fda-5359-4ea6-9689-926cdfdf6672_terseLabel_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_label_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_documentation_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember" xlink:href="bsx-20211231.xsd#bsx_CardiovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiovascularMember" xlink:to="lab_bsx_CardiovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9a875d20-8bd8-4238-8866-44a6646d5f79_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_394d993b-d3db-42c0-b24e-f93b0edcf3ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1e76826f-f9e7-49df-bf21-99a3eeada47b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Retirement Plan Discount Rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2858fc3e-4fc0-4de0-a44d-48af8028f8e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_48adb2a4-b65c-48f5-863d-5638578bffa1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_b8c1e2fa-23e9-467e-b4a0-1f7406b6f1c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8e06830b-baf7-4b3d-9233-1dd72a54155e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_4c348512-9cdb-4072-9e20-0ff13eb83f66_terseLabel_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:href="bsx-20211231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:to="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_2de74275-ab08-452d-8a8e-b09a03e73f36_terseLabel_en-US" xlink:label="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales [Table Text Block]</link:label>
    <link:label id="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_label_en-US" xlink:label="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales [Table Text Block]</link:label>
    <link:label id="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:to="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_579a063b-ed6c-4b19-a754-a8be55ed5265_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_65483bd7-5209-43b2-9c8a-686a19e324f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_February2021TermLoanMember_429d2ff4-35b5-4171-b500-ee98316db827_terseLabel_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_February2021TermLoanMember_label_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_February2021TermLoanMember_documentation_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember" xlink:href="bsx-20211231.xsd#bsx_February2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_February2021TermLoanMember" xlink:to="lab_bsx_February2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c468e17f-6571-4f14-994b-1fcbe5767e9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9942716a-d984-439d-af31-4220e81b36b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_40dfaab8-8366-4699-9542-7554c128e1b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Segment Reporting Information By Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_fd3153be-f403-4e5b-9157-96116298f02b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2f33e63b-2ce0-4c75-b57b-2b0cf802f270_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0dd6fe68-ff7a-4b39-b4d4-41b58c06d6f5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ff9b7c4e-562e-413e-965e-e3c57e7fcbdc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_2d9a40e1-6384-42fe-9fdf-41a4ac5c1b70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c19c7a5c-8758-42c3-99b8-d8203740ba18_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3e4190a-4e98-4627-a96a-6e5c24bdc167_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite Lived Intangible Assets Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f6b08edb-096e-4097-893d-ffb773f1a065_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d3df3eb0-8ffe-4824-8ae0-822181bdd2f9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1d218b8b-7b5d-44de-96c2-0fe133a4f203_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_61ce1ef4-17fe-4a34-a4b3-32c032dc39b6_terseLabel_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_label_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_documentation_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:href="bsx-20211231.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:to="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GoodwillTextualsAbstract_f55095e2-de1b-4e3f-84a4-c49b40cda4cb_terseLabel_en-US" xlink:label="lab_bsx_GoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Roll Forward)</link:label>
    <link:label id="lab_bsx_GoodwillTextualsAbstract_label_en-US" xlink:label="lab_bsx_GoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_GoodwillTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_GoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Textuals) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GoodwillTextualsAbstract" xlink:href="bsx-20211231.xsd#bsx_GoodwillTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GoodwillTextualsAbstract" xlink:to="lab_bsx_GoodwillTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_763f5a1c-a682-4b43-a3e6-a1c4d9866be4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_f2d23f8f-7f10-4d18-a2f1-93c68883322d_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:href="bsx-20211231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_707c6897-28c2-43f9-93c5-e26ed34bf500_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_d35270ea-45b1-4a2d-8615-94a96487fee3_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Three Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b0874468-f5df-4597-b9cd-9fecc83638fe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3151d3a8-d631-4bee-9ade-ffc3bde8521f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_0a557efd-58d0-40bf-8ddf-7c9f93d3255c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_7a97ed56-454e-4c2e-8107-050194f5d46f_verboseLabel_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_label_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_documentation_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:href="bsx-20211231.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:to="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_c332fa5f-d9f6-4753-a359-d366dc3dc0a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:to="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_1a0e671d-2344-4181-a472-0ad13224a01e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ShareBasedCompensationNetOfTaxBenefit_9a5e2e95-e918-4236-b5e0-14710cc3e692_terseLabel_en-US" xlink:label="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, net of tax benefit</link:label>
    <link:label id="lab_bsx_ShareBasedCompensationNetOfTaxBenefit_label_en-US" xlink:label="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, net of tax benefit</link:label>
    <link:label id="lab_bsx_ShareBasedCompensationNetOfTaxBenefit_documentation_en-US" xlink:label="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, net of tax benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:href="bsx-20211231.xsd#bsx_ShareBasedCompensationNetOfTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:to="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_d5510a80-7858-4e82-92f0-ed54994dbe7f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">effective income tax reconciliation, compensation-related</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_e16fb4e5-c52a-4f80-a4c7-6ffc13dea6fb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_5973081c-a554-4ddb-9401-17f00a883271_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1757f204-e4e8-4db8-b746-49d492b4bfd8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_17ab88b5-3ed7-4963-91ee-daf66f5fcd0a_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (credits) charges to expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_a72358a9-dad4-4cdf-a688-b9bdd035d54f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InventoryStepUpAmortization_48a6efba-2c89-4d7d-a59f-18f63a06ecef_terseLabel_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step-up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_label_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InventoryStepUpAmortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_documentation_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Step Up Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization" xlink:href="bsx-20211231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InventoryStepUpAmortization" xlink:to="lab_bsx_InventoryStepUpAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_e08e3855-0655-4b9b-9f56-1ef274bcfc3d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_b16b13f0-0b65-4d18-8f6a-23ba37c327b9_terseLabel_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_1d843974-06a3-4c2c-ba01-e802a55f71eb_verboseLabel_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_label_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_documentation_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember" xlink:href="bsx-20211231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2019RestructuringPlanMember" xlink:to="lab_bsx_A2019RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_ccd795d9-02b7-44e8-88c0-228bde226215_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion_8d4163b0-d3a6-40cd-9ee6-4338db07c01d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Terms of Conversion</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Convertible, Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_07b7167b-a790-4374-bcc0-f510c9ca9f20_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f3b92b66-ce4a-41b7-9f21-f0488f02b949_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a2d6cca1-d1e6-47bb-a364-59cba7cb6001_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_a3d72472-0f39-4e41-b222-04263c5c7351_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MillipedeMember_8c0cbcad-68f3-43dd-907f-2bebebe9920b_terseLabel_en-US" xlink:label="lab_bsx_MillipedeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede [Member]</link:label>
    <link:label id="lab_bsx_MillipedeMember_label_en-US" xlink:label="lab_bsx_MillipedeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede [Member]</link:label>
    <link:label id="lab_bsx_MillipedeMember_documentation_en-US" xlink:label="lab_bsx_MillipedeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember" xlink:href="bsx-20211231.xsd#bsx_MillipedeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MillipedeMember" xlink:to="lab_bsx_MillipedeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9c481260-dcf8-4bf1-b4d9-5b42de949633_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_4dbe9410-b96d-4259-9a06-71fee70c5a8f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_75223146-fedc-4b5f-a5ae-9ab7811028d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_83f81450-9a6c-4c7d-8a53-952495f6c4a8_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_9db828d2-d604-41f6-a597-113f5e8b1b95_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_ae044d93-cef4-4f6e-9257-bf568fd15078_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_877c69de-3173-45e0-856d-6dc6487c6d7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2020NotesMember_93608bfd-3549-4945-af64-99508cb7350b_terseLabel_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2020NotesMember_label_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2020NotesMember_documentation_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember" xlink:href="bsx-20211231.xsd#bsx_May2020NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2020NotesMember" xlink:to="lab_bsx_May2020NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_2deee973-b2e3-457d-afda-894d8564e780_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_108096a2-70bd-4ba2-92cd-10be4fc447cc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_8fb675bc-dc35-4fe9-b414-a7785f5d31b4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_c75bf07f-d574-4ae3-8f81-42debb3636a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_cdb3e5a0-8418-4bd7-a192-67e090704c0a_terseLabel_en-US" xlink:label="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Liabilities and Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_label_en-US" xlink:label="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Assets and Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_documentation_en-US" xlink:label="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Assets and Prepaid on Intercompany Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:href="bsx-20211231.xsd#bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:to="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_217e7ec6-02cf-4e4c-840f-5e87e18669b2_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_968f3e3a-6d0d-49d0-a38d-99b369b90683_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_4c18888c-3622-4993-a1d8-af0206e5f84d_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_7793403b-f163-45f5-8df6-7200e40b25f6_terseLabel_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_label_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_documentation_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:to="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_19b75012-cf2f-4526-8b85-2225119d4115_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_3624700c-5be0-4319-8edb-8113c00959d8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3575be3c-25e8-46fa-82ba-b117650cd8bb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_8c5dbc92-bfd9-4fd9-95d7-a0d512c3aa0e_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Five Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_99dbc922-839a-40a3-a8cd-41a7a30080b0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_74a54f4e-58b4-47ab-984d-eb31b2d14b16_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_22b3b9ef-3825-48c6-8d40-c0313900ecc9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2bd1c2d9-177b-44ee-84c5-c1a87c82d7ef_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ba79b656-72d0-47da-a20a-3270c70d0578_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_0d399e61-404d-49a8-af26-50b1c15e3b5b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConsolidatedBSXDomain_eb8de699-ece9-4bd6-85a6-8052c081588e_terseLabel_en-US" xlink:label="lab_bsx_ConsolidatedBSXDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated BSX [Domain]</link:label>
    <link:label id="lab_bsx_ConsolidatedBSXDomain_label_en-US" xlink:label="lab_bsx_ConsolidatedBSXDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated BSX [Domain]</link:label>
    <link:label id="lab_bsx_ConsolidatedBSXDomain_documentation_en-US" xlink:label="lab_bsx_ConsolidatedBSXDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated BSX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBSXDomain" xlink:href="bsx-20211231.xsd#bsx_ConsolidatedBSXDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConsolidatedBSXDomain" xlink:to="lab_bsx_ConsolidatedBSXDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_d2f02e87-b3fc-4ebd-a968-0f12a0895e2d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_d5f382c1-7652-4b30-9063-d7d6ea8d98df_terseLabel_en-US" xlink:label="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Leases, Option to Extend</link:label>
    <link:label id="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_label_en-US" xlink:label="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Leases, Option to Extend</link:label>
    <link:label id="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_documentation_en-US" xlink:label="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Leases, Option to Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:href="bsx-20211231.xsd#bsx_LesseeOperatingAndFinanceLeasesOptionToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:to="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_ecab3fdf-1d05-4161-88fc-398ce9fcf8cf_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_label_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:to="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SignificantAccountingPoliciesLineItems_00dfb903-8d11-4856-95ad-590186236b15_terseLabel_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesLineItems" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems" xlink:to="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2030NotesMember_21372bc8-ef3a-4eac-a87f-6f564956f7b4_terseLabel_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_label_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_documentation_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember" xlink:href="bsx-20211231.xsd#bsx_June2030NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2030NotesMember" xlink:to="lab_bsx_June2030NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_f78ec538-bb2f-49d1-a857-bfed62e19839_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a48aabd3-6117-48ad-9088-770734d7e18c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b0f19b22-5e66-40a6-b80b-680c534c7d73_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_029f5655-1943-4a9c-a31c-7354573340be_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_791ad35d-c088-4c04-90c7-6bbe960ecdac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_d51960c0-f742-4560-853a-a31849258c03_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_2f858d99-3e7d-46de-b32e-bdb107e55798_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_64684924-e018-4f67-8279-1de7b36fe215_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_4b6cf576-1e66-4cc0-a882-cb75e0804dd7_terseLabel_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average remaining contractual life</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average remaining contractual life</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average remaining contractual life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:to="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_42825128-219d-4a83-bcc3-192f44c8cdec_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_3f27616b-f9be-47d9-80a3-b60c406a39f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_4d689ffb-31f2-48e0-b537-ec75502d43f2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_64c48a9a-699e-42b0-a064-4e230f78284b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9b1a161-4e05-4b4d-854f-3b3101a65fd9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_19869468-fd53-4638-b70c-553e58a89d9b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_7f0f15df-2541-47ab-b19c-acf58fbbf5d3_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringRelatedExpenses_efdc57f8-9310-4dac-ab52-ab7eb63b0223_terseLabel_en-US" xlink:label="lab_bsx_RestructuringRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Expenses</link:label>
    <link:label id="lab_bsx_RestructuringRelatedExpenses_label_en-US" xlink:label="lab_bsx_RestructuringRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Expenses</link:label>
    <link:label id="lab_bsx_RestructuringRelatedExpenses_documentation_en-US" xlink:label="lab_bsx_RestructuringRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring related expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedExpenses" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringRelatedExpenses" xlink:to="lab_bsx_RestructuringRelatedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_9722cfbf-0861-4145-94fb-fc5e1652de48_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_f2326bc5-56e1-492f-9576-234a92a7203d_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_835b5e0f-0a37-4e8e-9a1a-3ae7e7e15766_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3c6d4963-65e1-49bb-b835-739e75202476_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) from foreign currency transaction exposures</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherInternationalPlansMember_aaa30229-11c6-4515-b886-64526a5d653d_terseLabel_en-US" xlink:label="lab_bsx_OtherInternationalPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International Plans</link:label>
    <link:label id="lab_bsx_OtherInternationalPlansMember_label_en-US" xlink:label="lab_bsx_OtherInternationalPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International Plans [Member]</link:label>
    <link:label id="lab_bsx_OtherInternationalPlansMember_documentation_en-US" xlink:label="lab_bsx_OtherInternationalPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherInternationalPlansMember" xlink:href="bsx-20211231.xsd#bsx_OtherInternationalPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherInternationalPlansMember" xlink:to="lab_bsx_OtherInternationalPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_fc0c1e7b-84c2-45a8-b688-8a9092c408cd_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_e8732907-1911-4707-bd72-a06c2e1f64b6_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_422ce700-d5c2-4a3e-9d43-f2179916a129_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_f816ec93-23c7-42d2-8346-a47002dc3678_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e42c5e6c-4131-4355-bfce-f8827fb579ee_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f571e0b2-c2ce-4999-a242-4094b7fb5cc8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9c50d6c9-4ee0-4e2d-bc93-6e594651bfce_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_5ee56dfe-c5e8-4b6a-9a92-8da617d4de23_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_October2023NotesMember_5ad753fb-2810-4570-a065-3049e3503a4e_terseLabel_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_label_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_documentation_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember" xlink:href="bsx-20211231.xsd#bsx_October2023NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_October2023NotesMember" xlink:to="lab_bsx_October2023NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_f7a3488c-313a-4a06-9ad3-5d46d2d291bb_negatedTerseLabel_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_label_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_documentation_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights" xlink:href="bsx-20211231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentsForRoyaltyRights" xlink:to="lab_bsx_PaymentsForRoyaltyRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_6ed3ae4a-e4d4-4344-9284-5be1bd4fd021_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_9127281e-787c-4b5e-bb21-59c191c7f7f4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost_ab788724-a437-4130-9d6e-b3e63e958e22_terseLabel_en-US" xlink:label="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost_label_en-US" xlink:label="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost_documentation_en-US" xlink:label="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring-related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRestructuringrelatedCostExpectedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:to="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_9eac37a2-bd9d-4c28-9e23-995881f2bf6d_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_1a1d0b7a-4045-4cb2-b44b-9fe7babfb917_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_8931c898-0f9b-4bce-9f18-c51911465133_terseLabel_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:href="bsx-20211231.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:to="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_66a08151-c07c-440b-9e96-09312d691d32_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_caebb8fb-bffc-4991-a4d9-ae41d41b2466_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_e0ee37b9-6b27-4745-b863-3aaaaa665c4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentive_52fd6ce7-104a-4abb-af05-c1ad50ed4c44_terseLabel_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive</link:label>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentive_label_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive</link:label>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentive_documentation_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:href="bsx-20211231.xsd#bsx_FreeTradeZoneRegimeTaxIncentive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:to="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_689f51ff-a264-4d16-93e7-75c46b264494_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91bd27e4-e77c-4b44-bd6b-a28a0c0c4adc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_c4a384c0-7130-42ff-9417-2caec99fa6b1_terseLabel_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return to provision</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_label_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return to provision</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_documentation_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return to provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:to="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_347d50b2-967b-43c3-9fb2-8e83b8780ba5_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_bee621fb-59a9-4776-a1a4-229d103b0734_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_73c50776-7475-440c-a153-6a83aa3027b1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_c4ed59bf-0647-4fdc-89df-b3e351135e20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AllOther2021AcquisitionsMember_0ef79eb9-2e7b-4e18-98be-0506cd95e1c9_terseLabel_en-US" xlink:label="lab_bsx_AllOther2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other 2021 Acquisitions</link:label>
    <link:label id="lab_bsx_AllOther2021AcquisitionsMember_label_en-US" xlink:label="lab_bsx_AllOther2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other 2021 Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_AllOther2021AcquisitionsMember_documentation_en-US" xlink:label="lab_bsx_AllOther2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other 2021 Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllOther2021AcquisitionsMember" xlink:href="bsx-20211231.xsd#bsx_AllOther2021AcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AllOther2021AcquisitionsMember" xlink:to="lab_bsx_AllOther2021AcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SignificantAccountingPoliciesAbstract_006b74fb-000b-41d8-a85f-aeff921ae380_terseLabel_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesAbstract_label_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesAbstract_documentation_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesAbstract" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract" xlink:to="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_7b51225c-5d49-4335-9ba6-7b3dcdb1702a_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, PBO</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, PBO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:to="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_c8df4b52-d6bd-4ec6-85c8-a04ef14fa722_terseLabel_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember" xlink:href="bsx-20211231.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TwoYearDelayedDrawTermLoanMember" xlink:to="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_de18c942-8778-4cdd-a3ee-2d61709ceebf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_54db21fb-9452-45fc-b7f7-d445052f3d6e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Retirement Plan Rate of Compensation Increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_f259af6b-5e45-47f9-924c-cc9ce779acfc_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_f4ac3709-d4fd-4148-a94d-ae43a143e447_terseLabel_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:href="bsx-20211231.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_d3128a42-43db-4de6-8990-d5ac8b4b3e98_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_72d0fbbd-ffe9-453b-9fdb-133df3ce6c3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_07463489-9e37-490f-9e2e-4d7cbc08f3da_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligation</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsMember" xlink:to="lab_us-gaap_CapitalLeaseObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_aa2e9ad8-07c3-4c5d-950a-b9aa315ba9ea_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Two Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_53998638-1d09-454e-bddf-c0269107d8e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on preferred stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_fd7f012e-0693-4413-9c98-c5a0db303922_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_a728298b-822b-4c2a-a352-b80be307b8f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_b929aa68-b748-4a0c-8bdb-7735c67673bf_terseLabel_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_label_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_documentation_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain" xlink:href="bsx-20211231.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationSettlementReceivedGain" xlink:to="lab_bsx_LitigationSettlementReceivedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_69b3a67f-2582-4824-a53a-2b0b502debe3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_361aef7e-c1af-4328-b1d3-8715e14ec8aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_37bb9bf9-a378-429c-923c-70852f6494b5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_96e623fe-7528-4bee-95a8-3bd904d13b1c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income allocated to reportable segments</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4016f0d6-8305-43db-bfb4-2fb8f68b2823_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d0e6e123-7350-402f-9b0d-5fa2eb80c3ac_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_c008111a-5e35-451a-950d-aa2f68dcf459_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_85330c90-4ca1-4921-a6a3-8bde9dca282b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_16a30892-1490-4c5b-9f73-ae29690c37b5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8e8e095a-92ee-40da-811e-6a53a4b876f7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_9a3093ac-e7d6-428b-9adf-b02af9804ed5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e754e711-f714-4ec0-b8b5-c1ba44c7601a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ad818f93-65e0-43e4-9dc5-48a39c1a34ad_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b014748f-6ed7-4ae2-8b0b-d035bee1ba35_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_2663811f-a581-4261-82e0-32f18e578026_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_a5d805d8-d1cc-4e19-9da2-d0d279967eac_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Nonvestedstockawardsexerciseprice_96f5840c-c977-43f9-9380-9cba1b98c6d3_terseLabel_en-US" xlink:label="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified options exercise price</link:label>
    <link:label id="lab_bsx_Nonvestedstockawardsexerciseprice_label_en-US" xlink:label="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested stock awards exercise price</link:label>
    <link:label id="lab_bsx_Nonvestedstockawardsexerciseprice_documentation_en-US" xlink:label="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested stock awards exercise price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Nonvestedstockawardsexerciseprice" xlink:href="bsx-20211231.xsd#bsx_Nonvestedstockawardsexerciseprice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Nonvestedstockawardsexerciseprice" xlink:to="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_fc06d5c3-f5aa-4a50-818d-7960efe34526_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfSeptember302021Member_66e66062-9fb6-4d51-b1fc-9a1cf0b38634_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfSeptember302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of September 30, 2021</link:label>
    <link:label id="lab_bsx_RequirementAsOfSeptember302021Member_label_en-US" xlink:label="lab_bsx_RequirementAsOfSeptember302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of September 30, 2021 [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfSeptember302021Member_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfSeptember302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of September 30, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfSeptember302021Member" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfSeptember302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfSeptember302021Member" xlink:to="lab_bsx_RequirementAsOfSeptember302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_1a9cfa69-c0e0-47a9-90dd-8cd821d8b933_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Fairvalueofmarketbasedawards_9757abe3-f228-48f6-a074-7c669f010186_terseLabel_en-US" xlink:label="lab_bsx_Fairvalueofmarketbasedawards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of market based awards</link:label>
    <link:label id="lab_bsx_Fairvalueofmarketbasedawards_label_en-US" xlink:label="lab_bsx_Fairvalueofmarketbasedawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of market based awards</link:label>
    <link:label id="lab_bsx_Fairvalueofmarketbasedawards_documentation_en-US" xlink:label="lab_bsx_Fairvalueofmarketbasedawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of market based awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Fairvalueofmarketbasedawards" xlink:href="bsx-20211231.xsd#bsx_Fairvalueofmarketbasedawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Fairvalueofmarketbasedawards" xlink:to="lab_bsx_Fairvalueofmarketbasedawards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_604b7285-b76c-423d-b774-b6aa27fe102a_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due Thereafter</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4807fce1-8a0a-411a-bd4f-1fd98f572df9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_0f750371-28f4-41e5-978a-ff341ccbb81e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CanadaSettledClaims_b8585b35-939f-43a5-b18f-46833b53948d_terseLabel_en-US" xlink:label="lab_bsx_CanadaSettledClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, settled claims</link:label>
    <link:label id="lab_bsx_CanadaSettledClaims_label_en-US" xlink:label="lab_bsx_CanadaSettledClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, settled claims</link:label>
    <link:label id="lab_bsx_CanadaSettledClaims_documentation_en-US" xlink:label="lab_bsx_CanadaSettledClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, settled claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CanadaSettledClaims" xlink:href="bsx-20211231.xsd#bsx_CanadaSettledClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CanadaSettledClaims" xlink:to="lab_bsx_CanadaSettledClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ef7c9930-54f2-40e4-bf19-fb300c602811_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_edade58e-8c16-4615-a5bc-f171b42502d9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_735b4a5c-118d-468d-8157-4298e42aded6_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Valuation Allowance, Intra-entity</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_label_en-US" xlink:label="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Valuation Allowance, Intra-entity</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_documentation_en-US" xlink:label="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Valuation Allowance, Intra-entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetValuationAllowanceIntraEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:to="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_065efb17-0fbc-41d8-b893-acb0131ceda0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2011LtipPlanMember_ae314e7c-c9b8-4712-9ecc-b82d61466743_terseLabel_en-US" xlink:label="lab_bsx_A2011LtipPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP Plan [Member]</link:label>
    <link:label id="lab_bsx_A2011LtipPlanMember_label_en-US" xlink:label="lab_bsx_A2011LtipPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP Plan [Member]</link:label>
    <link:label id="lab_bsx_A2011LtipPlanMember_documentation_en-US" xlink:label="lab_bsx_A2011LtipPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2011LtipPlanMember" xlink:href="bsx-20211231.xsd#bsx_A2011LtipPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2011LtipPlanMember" xlink:to="lab_bsx_A2011LtipPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_b3546f13-91b0-49a5-9349-b0d1d199b704_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2d6972cd-9fd7-47a3-a678-84ef98a7e1d4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment and internal use software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_9b4ae4f3-cc08-4030-8c3a-655ed73beba3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_34954ea1-00d4-41e7-adae-fb08812b7acc_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_78a3f73c-7eb4-4671-9633-aea502df84cb_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_f9ab7b6e-8dcb-4510-85c3-79c585a16d89_negatedLabel_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_label_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_documentation_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:to="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_624f4395-c16b-4f9b-ad0a-8d7258e1e512_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_c97e6969-b9a8-4619-abd7-ddd671f950bc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExecutiveRetirementPlanMember_4a6c37e1-f1ad-4355-9989-485d69ea5189_terseLabel_en-US" xlink:label="lab_bsx_ExecutiveRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive retirement plan [Member]</link:label>
    <link:label id="lab_bsx_ExecutiveRetirementPlanMember_label_en-US" xlink:label="lab_bsx_ExecutiveRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive retirement plan [Member]</link:label>
    <link:label id="lab_bsx_ExecutiveRetirementPlanMember_documentation_en-US" xlink:label="lab_bsx_ExecutiveRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive retirement plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember" xlink:href="bsx-20211231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExecutiveRetirementPlanMember" xlink:to="lab_bsx_ExecutiveRetirementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_7b6175b7-8ddb-4291-95b1-b1d2c93bd935_terseLabel_en-US" xlink:label="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of the fair market value of our common stock on the date of grant</link:label>
    <link:label id="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_label_en-US" xlink:label="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of the fair market value of our common stock on the date of grant</link:label>
    <link:label id="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_documentation_en-US" xlink:label="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of the fair market value of our common stock on the date of grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:href="bsx-20211231.xsd#bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:to="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4d37c496-c88d-4afe-b834-bd2512ce5bad_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year One</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2fb5a564-9737-4692-8663-5c2e7e920656_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ed2f0541-a4d3-45d3-a69b-56bebcead1f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_41fde4c6-4593-43ab-908e-d3c42cca6672_terseLabel_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20211231.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2020NotesMember_341499af-9443-4f1f-a401-e53fc78db275_terseLabel_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2020NotesMember_label_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2020NotesMember_documentation_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember" xlink:href="bsx-20211231.xsd#bsx_January2020NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2020NotesMember" xlink:to="lab_bsx_January2020NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_87bc99d5-9697-4c74-bd41-6eb53c688f1e_terseLabel_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred and prepaid income taxes</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:href="bsx-20211231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:to="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_7b19adb6-c073-428a-ab57-35c39e11839f_terseLabel_en-US" xlink:label="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based awards, valuation assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based awards, valuation assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based awards, valuation assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:to="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_cca74470-4a4e-4b0c-a8ef-b24a65cfc65d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_069115ae-ea56-49bf-af30-a5488ba3d885_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_f804e36c-a771-4fa8-96af-da3af76dcc01_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_6526e799-2e2f-4145-8d94-1ee79e67d0a2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_514841e3-62c5-4c5c-9cfa-28db3aa015d2_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_c3dee211-b33f-46eb-90ec-8ba639472f71_terseLabel_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember" xlink:href="bsx-20211231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BSXReportableSegmentsMember" xlink:to="lab_bsx_BSXReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9929b442-9a96-47b1-911f-f8a377bcd40f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_d9c6094b-28d2-4f07-ae2f-aba814376f98_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2035NotesMember_e649798a-120d-48f8-a965-496e90aba24e_terseLabel_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_label_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_documentation_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember" xlink:href="bsx-20211231.xsd#bsx_November2035NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2035NotesMember" xlink:to="lab_bsx_November2035NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_bf680fb9-6548-464b-82b6-a198b24af722_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_9fde5eff-cd08-4c68-93f7-b91328e2b17d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1e569d59-0635-4054-aea4-cb2903f2678c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_aafedd48-bc98-49c6-93db-8e1a300d97d4_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_58a2a9e3-c76b-4eae-b1f6-0634db107bd8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_deb69f47-9512-473a-93d8-22417dc0628a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_9378ff92-92fa-4a85-ad92-ac8e0c410d33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_7f7336b8-d633-4173-a8c6-424e1b31b483_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_53397b1d-8259-4c46-9322-757351b6f0ca_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_b83a9f14-0df5-49db-ad07-203fb8d94756_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_2d7c730a-e593-4369-b113-998b145741c7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0bab7883-5afb-4da7-87fd-90e9b50b85fe_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UKPlanMember_d979ef6c-4487-4347-8696-54d9f7c42b6f_terseLabel_en-US" xlink:label="lab_bsx_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Plan</link:label>
    <link:label id="lab_bsx_UKPlanMember_label_en-US" xlink:label="lab_bsx_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Plan [Member]</link:label>
    <link:label id="lab_bsx_UKPlanMember_documentation_en-US" xlink:label="lab_bsx_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember" xlink:href="bsx-20211231.xsd#bsx_UKPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UKPlanMember" xlink:to="lab_bsx_UKPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_52856cf5-15bd-441f-a368-b542a1502294_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_c6dcd021-b766-4077-b303-377bc18b67af_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_3f277377-4ff1-4fb1-bdbd-a1bd6d91e72d_negatedTerseLabel_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gain) loss</link:label>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_b1cf88cc-78c1-48a9-9875-a6bf2934ac99_terseLabel_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gain) loss</link:label>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_label_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_documentation_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss" xlink:href="bsx-20211231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NetCurrencyExchangeGainLoss" xlink:to="lab_bsx_NetCurrencyExchangeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_38d1009a-7edd-4599-a5b3-8778ea69f2ca_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_d9d53fab-fc77-46f3-bead-a5bef8ddca21_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c4820233-a099-4d79-a7c4-a533ff9a16f6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_54cca00f-3f9a-4857-bf86-f4ff2b2ab04d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherOtherLongTermAssets_032030d4-ef24-4323-acad-e9ed4f8b498c_terseLabel_en-US" xlink:label="lab_bsx_OtherOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongTermAssets_label_en-US" xlink:label="lab_bsx_OtherOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongTermAssets_documentation_en-US" xlink:label="lab_bsx_OtherOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongTermAssets" xlink:href="bsx-20211231.xsd#bsx_OtherOtherLongTermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherOtherLongTermAssets" xlink:to="lab_bsx_OtherOtherLongTermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_2ab4c044-13a0-4f5e-a71a-667c5f330d07_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_f026cd19-e43d-4ef0-b69d-51bf61193754_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_83c789c5-9cf9-41c5-8d06-77cc158cc066_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_20f9b66a-5dce-408c-a383-da91416ad3fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) on investments and notes receivable</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_60d4cc84-42e0-46df-bf24-2f7be61b5a14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_558ffa51-b15e-42c9-bc51-598a0ba140f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_ada456b3-d262-4a30-b2d0-071148db7500_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_bb967aae-4829-4f09-b106-387b962c47db_verboseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals)</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:href="bsx-20211231.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_beea3614-7b92-4812-805f-386293a720e5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_7c4e7d94-ace5-475c-8522-983b33d45869_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_0f2305e6-7349-462d-8d88-84dec7a8a937_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5284a096-1dfe-43bc-86ec-af582f246935_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_09a50f0a-e3b1-4159-a8c4-c2a16fc597e2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bee3f032-c4f3-4542-9e99-b337ff3854af_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a4ebef2-3faf-4923-81ec-29b0b185acb3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f8faee13-41a2-41ca-aca2-f169482202ca_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c95a39e1-3472-4bb2-80c7-d83aec62c605_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5187d9e9-f82b-455b-b385-515b18433e21_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_12c021a0-000d-4250-9b77-17fa798b4ad0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b5d86229-5fa8-4540-a0c1-f45dd98055a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cc05b269-e846-4d8b-8f23-15b8a767ea95_verboseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d7d0a5aa-3d0b-463e-ae3a-518f28d0a8ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8a0d24a1-2e1f-47ba-ac7c-9100dc831b22_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_292c6ff8-f699-49d3-8eeb-89189ebfe2ad_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_037bbfff-d0d0-4b62-bb8b-8415a96cff26_terseLabel_en-US" xlink:label="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Free Cash Flow (FCF) performance awards</link:label>
    <link:label id="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_label_en-US" xlink:label="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Free Cash Flow (FCF) performance awards</link:label>
    <link:label id="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_documentation_en-US" xlink:label="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Free Cash Flow (FCF) performance awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:href="bsx-20211231.xsd#bsx_FairValueOfFreeCashFlowFcfPerformanceAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:to="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_fecb28a0-0695-4800-8cd4-3604102e86aa_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_e00ec589-c865-4ac3-8e9b-80e7076838ce_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_a0f8f840-0ebf-407e-8639-e3b359a55f2b_terseLabel_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_label_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019 Aggregate Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember" xlink:href="bsx-20211231.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_February2019AggregateOfferingMember" xlink:to="lab_bsx_February2019AggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_58fcb4f4-82af-4c38-96ed-b2c882d875d2_terseLabel_en-US" xlink:label="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Cash Flow Supplemental Disclosure [Abstract]</link:label>
    <link:label id="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_label_en-US" xlink:label="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Cash Flow Supplemental Disclosure [Abstract]</link:label>
    <link:label id="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_documentation_en-US" xlink:label="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Cash Flow Supplemental Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:href="bsx-20211231.xsd#bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:to="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a66fcf36-ee92-44f1-b42f-cca82401c086_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_45193d17-f9c7-4f3b-bde5-324043b37964_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_022a8e5a-9492-462c-8040-a90209312dbc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LumenisLTDMember_4da3b007-d968-4e15-9fd1-bc7c9ca66c90_terseLabel_en-US" xlink:label="lab_bsx_LumenisLTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis LTD</link:label>
    <link:label id="lab_bsx_LumenisLTDMember_label_en-US" xlink:label="lab_bsx_LumenisLTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis LTD [Member]</link:label>
    <link:label id="lab_bsx_LumenisLTDMember_documentation_en-US" xlink:label="lab_bsx_LumenisLTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis LTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember" xlink:href="bsx-20211231.xsd#bsx_LumenisLTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LumenisLTDMember" xlink:to="lab_bsx_LumenisLTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_792d6c92-20a6-4a07-a696-b090e03dd022_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:href="bsx-20211231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9f0adb29-afdc-4c90-ad6b-e2d38f7d74b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d375d6c4-a5e8-40b3-b6a6-3d64b0f39006_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_78e9cbcc-b6ec-4d01-9159-1d4b36c640af_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement alternative investments (1)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_e368342c-9daa-4efc-ad03-71d2f55b53a1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_2f0b55f9-b24a-49a5-9a3b-926c75bdfe67_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_4dcbdb92-55a0-4e30-bb2a-b0b052b0bfd8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_fe7b5fdf-9075-4d11-98b7-5556d0a8c933_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:to="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_6a67bdca-e148-4784-a8b3-530bbe404b0a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockStock" xlink:to="lab_us-gaap_DividendsPreferredStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_84445f10-5506-4098-8219-27255f1bbfa5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0eed278a-a07b-4637-8cd6-9dd9e173eeac_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1e8a901d-9b68-4380-b13c-37efa3841e2f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_804b42cb-c1ec-4820-9d78-8c2b192f8d34_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cash Received on Hedge</link:label>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_label_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cash Received on Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:to="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2425dd51-2471-4173-b8ac-88515cb110a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PermanentlyStayedClassActionInAustraliaMesh_0b1b4611-f96c-4422-8f63-87781574f4b8_terseLabel_en-US" xlink:label="lab_bsx_PermanentlyStayedClassActionInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanently stayed class action in Australia, Mesh</link:label>
    <link:label id="lab_bsx_PermanentlyStayedClassActionInAustraliaMesh_label_en-US" xlink:label="lab_bsx_PermanentlyStayedClassActionInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanently stayed class action in Australia, Mesh</link:label>
    <link:label id="lab_bsx_PermanentlyStayedClassActionInAustraliaMesh_documentation_en-US" xlink:label="lab_bsx_PermanentlyStayedClassActionInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanently stayed class action in Australia, Mesh</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PermanentlyStayedClassActionInAustraliaMesh" xlink:href="bsx-20211231.xsd#bsx_PermanentlyStayedClassActionInAustraliaMesh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PermanentlyStayedClassActionInAustraliaMesh" xlink:to="lab_bsx_PermanentlyStayedClassActionInAustraliaMesh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_37fdb4a7-e0b0-4e96-b549-5ac8eb522bc7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_883709e3-aa66-48d2-b236-b7c4e505c9a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_cb7c415b-21ba-4d1f-ba1f-fbde2dc48263_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_3decc942-aaa0-4e04-83cf-721c93e074b9_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_label_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:to="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_c789936c-6c28-4f0b-94f6-f8c6cf554db1_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfJune302021Member_3a8a8cc1-8f61-408f-a4d3-1b37a336c741_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfJune302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of June 30, 2021</link:label>
    <link:label id="lab_bsx_RequirementAsOfJune302021Member_label_en-US" xlink:label="lab_bsx_RequirementAsOfJune302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of June 30, 2021 [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfJune302021Member_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfJune302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of June 30, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfJune302021Member" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfJune302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfJune302021Member" xlink:to="lab_bsx_RequirementAsOfJune302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_a69cefce-a6e8-41f9-b02a-e4c3b601b782_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_292f5597-54c1-4ce2-8f68-4af35a0c1ae8_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_97cf79ac-82ff-4e5f-828b-1700522b9741_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_74ae971a-f2fe-4e02-a171-7da07ea1fcd5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_5616240a-1b68-410a-b181-a287c0b6589b_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheCARESAct_c0bfaca1-24cf-45a3-85e8-7199886b0734_terseLabel_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_label_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_documentation_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct" xlink:href="bsx-20211231.xsd#bsx_TheCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheCARESAct" xlink:to="lab_bsx_TheCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_dda16735-74c4-4bf7-97e2-2dd2bebef420_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_2ab4583d-4c25-4728-99c5-6c2e6a296e25_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_42835040-57a8-4adb-a392-59b9c721fa7b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_11930b7b-6603-4db0-b85a-c6e6ec886506_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IncomeTaxesAbstract_8f02afc7-4db0-47b7-a59a-872537dd0491_terseLabel_en-US" xlink:label="lab_bsx_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_bsx_IncomeTaxesAbstract_label_en-US" xlink:label="lab_bsx_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_bsx_IncomeTaxesAbstract_documentation_en-US" xlink:label="lab_bsx_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IncomeTaxesAbstract" xlink:href="bsx-20211231.xsd#bsx_IncomeTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IncomeTaxesAbstract" xlink:to="lab_bsx_IncomeTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5a0b6f2b-bb49-4a63-b1b4-137e831d2137_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_74b4f548-cff5-4f87-9bb3-a2ae008a61aa_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_b66e5d3b-970d-4538-b65a-c436bde8d0a1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_69243b26-2338-4611-abfe-846462e73c94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_a0a46885-9fdf-4fa6-af3d-1472121a1349_terseLabel_en-US" xlink:label="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout of Free Cash Flows (FCF) performance awards</link:label>
    <link:label id="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_label_en-US" xlink:label="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout of Free Cash Flows (FCF) performance awards</link:label>
    <link:label id="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_documentation_en-US" xlink:label="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout of Free Cash Flows (FCF) performance awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:href="bsx-20211231.xsd#bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:to="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f9505de-a331-4ee8-a5f0-205372dcb837_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_e8391b31-06d7-4d7d-8e52-ba069dbc7e05_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0eb24b6c-5c20-4515-acfa-4ac4d0234a0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_85e7564d-0afa-4504-ba93-62624e6fe9cf_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:href="bsx-20211231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_b7b65ed7-50c3-4a1b-8fd5-743848d28617_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_241626bb-f29a-4a99-872b-04a6ded1ad0b_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:href="bsx-20211231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_25487669-c766-49a2-b333-9dc4d680ad70_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_f42614d3-e607-4e6b-ab67-ad17ed1599b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_7b36e2bf-eb88-4017-a1c9-945dc8f6edfc_terseLabel_en-US" xlink:label="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Text Block]</link:label>
    <link:label id="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_label_en-US" xlink:label="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Table Text Block]</link:label>
    <link:label id="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_documentation_en-US" xlink:label="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of cash paid in the period to fully or partially settle a specified type of restructuring cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:to="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_bd634418-2bf6-4750-bc4f-0b0eb9dba8ec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2022NotesMember_d88db827-a46d-467e-bb0b-d04a5fce0756_verboseLabel_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_label_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_documentation_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember" xlink:href="bsx-20211231.xsd#bsx_May2022NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2022NotesMember" xlink:to="lab_bsx_May2022NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_bce5e292-cbc4-4a98-a887-f14f5e9bbe91_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5ac151e9-a1ba-4500-8ab7-684721d376ce_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_a41d6f39-8e40-4408-8880-918ba608e3b1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_daa12d6d-9ed0-4f2c-a757-071e1796e263_terseLabel_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_label_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:to="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_0ce9791b-cd5c-45b9-bd28-3b6043ac36eb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_c4517ba4-5fa5-4410-bee7-b13a96b66267_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_46803cd8-dd29-49bb-9d86-c22610ccf88b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_a8ef11d7-9d5b-45bd-9035-25656ef22be4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment_c455eac9-ccd2-4601-8338-f2d60bf43a16_terseLabel_en-US" xlink:label="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time transaction tax post-1986 E&amp;P - net payment</link:label>
    <link:label id="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment_label_en-US" xlink:label="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time transaction tax post-1986 E&amp;P - net payment</link:label>
    <link:label id="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment_documentation_en-US" xlink:label="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time transaction tax post-1986 E&amp;P - net payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:href="bsx-20211231.xsd#bsx_Onetimetransactiontaxpost1986EPnetpayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:to="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_3a87d95c-720c-41b4-bc27-c4cc4ba7c848_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_07816fd8-755c-4f74-abdb-58b6d58fba5d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_38318815-8885-4e0b-b96c-827a9b43a284_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_faa98771-37b7-4f28-bed9-0e54daa37ae5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_bb15efc1-37bf-4efb-b7ac-ddcae5438146_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_bed30196-9688-4352-b4db-6e2c99498544_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_dc73cc90-b71d-47c4-8aa9-3ce1f627885e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_42cc155b-742d-4d0d-98b3-b9ea7d44d720_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_171f9dcd-af12-458b-a4f5-b88819f871e6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_277270db-16a9-46a2-a7be-26e8db30857d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_41767584-a95c-4a51-8799-b651f7d667ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_d5823d0f-3167-4936-a74c-d6bea60de48d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_39dafec5-0f1c-4d54-bc7e-d6559b3a9a6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f210cf6-5b99-438e-b853-114633f0ef9b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dd0469a3-6189-42b1-86b5-ca1012f8e19b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_cc69e2e6-7793-4393-8bc1-be60af27666e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share &#8212; assuming dilution</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_66d54533-56dd-4c54-9436-4b8184b94730_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ad885097-f371-4ddc-92b2-3f378f5461dd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_9837bdd9-83a3-4bc3-98f3-fc4629f91b55_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on borrowings from credit facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1883b102-08bd-4826-bd74-009bf9be440b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_cec69af4-fef8-47bd-81e7-3832df908434_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_31aa779c-729b-46f2-9952-a94712596596_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_4110a185-f195-49f3-a353-9f67510d0f63_terseLabel_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_label_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_documentation_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:to="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TaxRateDomain_bd0a2b12-29b0-46af-ac0a-f23f1216c472_terseLabel_en-US" xlink:label="lab_bsx_TaxRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Domain]</link:label>
    <link:label id="lab_bsx_TaxRateDomain_label_en-US" xlink:label="lab_bsx_TaxRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Domain]</link:label>
    <link:label id="lab_bsx_TaxRateDomain_documentation_en-US" xlink:label="lab_bsx_TaxRateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain" xlink:href="bsx-20211231.xsd#bsx_TaxRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TaxRateDomain" xlink:to="lab_bsx_TaxRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2026NotesMember_0a09c832-24cb-4868-bc8f-b3372bb9dd37_terseLabel_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_label_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_documentation_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember" xlink:href="bsx-20211231.xsd#bsx_March2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2026NotesMember" xlink:to="lab_bsx_March2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_d305e786-d3f1-47b7-bab7-473706c426f3_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialChargesMember_85613b36-8757-4b0e-885f-8a07664e230d_terseLabel_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_label_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_documentation_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember" xlink:href="bsx-20211231.xsd#bsx_SpecialChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialChargesMember" xlink:to="lab_bsx_SpecialChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0e2ecd87-776d-42d1-aa58-88988c373498_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f9cde40d-9d92-4d38-bafe-445524b19bc0_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb213565-6b4c-4a51-8c97-45759201aa83_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_7e4f7877-5891-444a-bd43-cec7ed4c00e4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_2fa65321-e9a6-42f7-9a78-46e072664b9a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_21f8d59e-e737-4eef-9d4d-3ef76d193755_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_bf259609-4f4a-4e16-b66d-cd7e214ee5aa_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_98f0f3e9-89ec-42c3-b92c-d6b30a76f01f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_f7553fcb-b446-4eaf-b9ca-9a3397a3e654_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ad5e88f9-5823-4a37-9145-ee1561902faa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e12ebf7a-cee4-4884-be31-b23dea912d27_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4f59e0f5-e3a4-4d18-8f3f-edfe7f7a1ae6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_42eaddf2-7f87-409b-9ae4-6b2a462b6d5c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2024NotesMember_b2968479-db9d-4ef9-8483-85f48f2172d1_terseLabel_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_label_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_documentation_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember" xlink:href="bsx-20211231.xsd#bsx_March2024NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2024NotesMember" xlink:to="lab_bsx_March2024NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_c3269b45-1298-4ce2-9c05-a232cd9b8a20_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_56e249b5-7ea7-43b1-a73e-0e8c26853b2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDerivatives_1d2ceb7d-842f-405a-9828-12bbd9fc8770_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Derivatives</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDerivatives_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3528046c-9bba-4ada-a724-17e9d757dc68_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_c47ef250-82ff-42c3-93ce-5297cbab29b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_cdcf6848-c0e3-4269-9d61-39595d811291_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets (segment reporting)</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d46f0bc8-9b12-4be6-91c5-59cf7509a99c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of restructuring costs on the accompanying financial statements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_95077895-fe0c-47b9-9a29-5039c5613e9d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9b5843-a39c-4645-b29f-fa037651dbf8_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_eaf4f308-cf76-4269-a20c-b32e9dd694f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_981a33ed-c78d-4333-9972-f9e8e80d444a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8633b765-0d0e-4db9-b677-7d858f61cce2_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_ac3a0b7f-a0e4-41be-84ca-3505af08ca7b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_d4a6f579-238c-45d4-bd64-437f4a8c508e_terseLabel_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_label_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_documentation_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:href="bsx-20211231.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:to="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_3378f055-d70c-44e8-8422-3ad49032e0fa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of certain businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a23a2da9-6b99-4fa0-9547-3767a29faed3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_86ec881b-c15d-4312-bd48-81858099a172_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_39ab66a5-9338-4e82-84b0-9142b3f2b1ff_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_1c52eb02-f05c-4ff2-85ba-aa6c4e484ee7_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_81e7e7a0-967a-445e-9d58-5eb0970d2b35_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_c657034e-8497-448f-a436-6c2b99dd06a3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_446287bf-eac1-418e-8597-08590324057c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringRelatedToPlanMember_6d3b0bc8-7163-495b-9b1e-2bef423edfce_terseLabel_en-US" xlink:label="lab_bsx_RestructuringRelatedToPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related To Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringRelatedToPlanMember_label_en-US" xlink:label="lab_bsx_RestructuringRelatedToPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related To Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringRelatedToPlanMember_documentation_en-US" xlink:label="lab_bsx_RestructuringRelatedToPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related To Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringRelatedToPlanMember" xlink:to="lab_bsx_RestructuringRelatedToPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_c23494ea-3867-433f-880b-06b9342b3238_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense_8df1f237-fd1c-4487-96bc-34038490cf51_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_6d4d11eb-65ec-4cf7-9bb9-1888bf32c296_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_10c462db-fa1d-4056-808e-c479a580ac71_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_a4d47126-907d-490d-a798-c056dbc35d6a_terseLabel_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_label_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember" xlink:href="bsx-20211231.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2020SNAggregateOfferingMember" xlink:to="lab_bsx_May2020SNAggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_b505f501-aa59-4cba-9adf-33a62e3fa851_terseLabel_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_label_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_documentation_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember" xlink:href="bsx-20211231.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LatinAmericaandCanadaMember" xlink:to="lab_bsx_LatinAmericaandCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f1ad4dfc-585d-477e-b719-f58d96d21ab7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_078e1794-2ff3-4180-9891-34cd458f33d6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_88c8cf0b-7b54-4c67-bb4e-361bea6ad677_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_a8563d2d-45e7-4109-9ffd-e7753a604de8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementDomain_a6a6ed39-0ee0-42b0-a2f0-2956974226e8_terseLabel_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_label_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_documentation_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain" xlink:href="bsx-20211231.xsd#bsx_StatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementDomain" xlink:to="lab_bsx_StatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_6b37ff7e-d570-47f4-bd3a-4f860018bf6d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_076041c5-fc50-4a60-abce-6f3c98518f90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d9170a88-7433-4350-8cb1-7d461817b219_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9029a7fb-5a88-4baf-a621-b54fae82864d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b5c61e60-8628-46c9-ab6b-0c1a506e75a5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1cef80bb-dcfa-4c6a-93f8-40001ba1a87d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_d536735f-61cc-4693-8290-131bf5790f45_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_6432e04a-9fd8-419c-9c65-de99536f9b9b_terseLabel_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:href="bsx-20211231.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:to="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0fa34f04-8155-4f80-bde8-0bad24598bb8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_b861c1db-8f76-42ea-9d1a-686b587b422c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_ab1cbb91-51ac-4c21-b66b-54e2a320d313_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_20bd6ec9-b03f-4891-bf5c-96741696c6b9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementAssetsMember_26375119-d8e4-476b-9e09-b36a851f1196_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets (Member)</link:label>
    <link:label id="lab_bsx_LicensingArrangementAssetsMember_label_en-US" xlink:label="lab_bsx_LicensingArrangementAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingArrangementAssetsMember_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementAssetsMember" xlink:to="lab_bsx_LicensingArrangementAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_1ec8b8e5-8a08-48f1-aaa8-194091ccd4d1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_8e0763c8-d2b8-4b83-baec-9899abed2443_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_a87b7123-6392-4fd8-a684-943d3fed7d12_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_72f413f8-886a-4d6e-9548-8ff28ff2cb01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumLeverageRatio_63223545-1dd0-42c4-9879-f58b7bc5aa7e_terseLabel_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_label_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_documentation_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio permitted by revolving credit facility agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio" xlink:href="bsx-20211231.xsd#bsx_MaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumLeverageRatio" xlink:to="lab_bsx_MaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_28922d91-66c8-4960-a124-62adc1e7e7a3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_d30ce9fa-0567-44de-a289-48ab2d95099a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_2d744766-ae35-478f-bdb4-040ec17c4490_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_label_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:to="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_71c9b718-27a9-4497-bb36-94307845693a_terseLabel_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_label_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_documentation_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember" xlink:href="bsx-20211231.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenueBasedPaymentsMember" xlink:to="lab_bsx_RevenueBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_d88c69af-b1ec-4149-a44c-8b160889d0cf_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_930817ab-d03a-4269-885e-8c9fde372fb9_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_57678a6b-eef5-4dfd-872e-dca29eb8cfad_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_95bee889-6d95-4b60-9ea0-d1c194a9ac1a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_April2021TermLoanMember_6a6f6c44-d8c2-40ae-8244-a9f80ad881f6_terseLabel_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_April2021TermLoanMember_label_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_April2021TermLoanMember_documentation_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember" xlink:href="bsx-20211231.xsd#bsx_April2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_April2021TermLoanMember" xlink:to="lab_bsx_April2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b079d613-9a7b-477b-ad52-b48e020d503b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5d230189-66f4-459c-a006-c598242ce642_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ed06b1b-09f0-4b59-8f33-eb111e774833_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_63edf621-b5a6-454c-919c-9be98ebdd8ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_430e2701-678c-4b11-a209-d90881a78fa3_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_563ae7a6-ca88-41ac-86ae-a4f0508608af_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_cccc87da-327f-4442-b75e-994b24768f85_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_6b02a28f-680b-4d11-a831-52f776336adc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1d6d2a2e-9906-45e6-ba59-e2dbfb2149c7_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9bab17c8-7a13-4b62-9313-9c9188873ef0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_60d7b61f-3c02-4e0d-acfa-322ebfc585de_terseLabel_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember" xlink:href="bsx-20211231.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalCrmReportingUnitMember" xlink:to="lab_bsx_GlobalCrmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_cdec089b-3087-4db9-a1a9-bb489074914f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_3b2ab2e9-aacb-4e22-a567-2d813437ca1a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d6cec6f-62e9-4296-8bb9-07f83fccebf2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_4ce05df9-0ac8-4da1-82cc-c9db7d5fb0a3_terseLabel_en-US" xlink:label="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cases in final stages of resolution, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_label_en-US" xlink:label="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cases in final stages of resolution, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cases in final stages of resolution, related to Greenfield Vena Cava Filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:href="bsx-20211231.xsd#bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:to="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AssertedClaimsOutsideTheUS_c8c76b0b-e146-49fb-b9f3-00a9a419254a_terseLabel_en-US" xlink:label="lab_bsx_AssertedClaimsOutsideTheUS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asserted claims outside the U.S.</link:label>
    <link:label id="lab_bsx_AssertedClaimsOutsideTheUS_label_en-US" xlink:label="lab_bsx_AssertedClaimsOutsideTheUS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asserted claims outside the U.S.</link:label>
    <link:label id="lab_bsx_AssertedClaimsOutsideTheUS_documentation_en-US" xlink:label="lab_bsx_AssertedClaimsOutsideTheUS" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asserted claims outside the U.S.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssertedClaimsOutsideTheUS" xlink:href="bsx-20211231.xsd#bsx_AssertedClaimsOutsideTheUS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AssertedClaimsOutsideTheUS" xlink:to="lab_bsx_AssertedClaimsOutsideTheUS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_561a9727-47e0-4f65-8ef0-b8bd67b10547_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_ccd54ad3-54fc-4a54-b0fb-9d9d5917c77c_terseLabel_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_label_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_documentation_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:href="bsx-20211231.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:to="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b29412a1-233b-4e35-a10b-e50405fe4175_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1a200d91-d729-4f15-ab46-4372244d59d2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_ed9f0972-168a-4782-b697-91fd057a713d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_163c24a7-f4bd-4415-831c-ea25ec4176d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDER'S EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_8f1bb6ff-2680-45b3-b46c-0f1998079e9b_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_5f09b48f-2fd1-4e11-a1c4-8ab404f441df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_e76204e8-064b-457e-9607-94c50d430232_terseLabel_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:href="bsx-20211231.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:to="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_187af12f-649e-4831-9208-f24f28810fe7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_4777fc27-ef35-4ace-a690-a9f708805a12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_1b4ca223-9b3d-46d0-9385-1b70e7d1cb66_terseLabel_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_label_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases [Table Text Block]</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:href="bsx-20211231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_29fe1e41-3150-466f-b0d8-b3034cf1e048_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_af795a20-d56b-4a24-a6c8-c8728df6d60f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_de7d9b2e-f69c-4ce0-bfef-2d90492652c6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_e93be2b5-6ed3-4425-937c-2f1ef6fdedbe_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AccruedRebatesCurrent_0d0b0980-48fb-4640-920c-d4d047c2c63c_terseLabel_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_label_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_documentation_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent" xlink:href="bsx-20211231.xsd#bsx_AccruedRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AccruedRebatesCurrent" xlink:to="lab_bsx_AccruedRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5aa48b1-749e-4097-8649-3dd6bfc8d0b4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_7e4d242e-8c44-4da2-8bb1-5f7f5e3b7c2c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1d264319-5d07-489a-9579-88ecdf9b0583_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_92ecfd81-b908-4bdb-a184-5deb9645838f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherNet_7e360d30-f222-49af-b968-273c88458a98_terseLabel_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_label_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_documentation_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet" xlink:href="bsx-20211231.xsd#bsx_OtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherNet" xlink:to="lab_bsx_OtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_04e4aa38-7960-42d0-bed8-8563d2db823d_terseLabel_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_label_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_documentation_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:to="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2029NotesMember_d57eb3b6-5c67-4156-bf34-d5c0014bbc1f_terseLabel_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_label_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_documentation_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember" xlink:href="bsx-20211231.xsd#bsx_March2029NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2029NotesMember" xlink:to="lab_bsx_March2029NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingParValuePerShare_e1c1809b-2d44-4016-b6b3-c731f04da44a_terseLabel_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:label id="lab_dei_EntityListingParValuePerShare_label_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingParValuePerShare" xlink:to="lab_dei_EntityListingParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_58c047b0-3436-4e9e-86a8-915b7d9da4fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_2f7abf54-f94a-4dc4-969a-e815e134956e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_23247061-30dc-4c5a-bf93-0c92aa4e7c82_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, actuarial gain loss</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, actuarial gain loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:to="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_06f833c2-d1c5-4cc8-93f3-54df66e03040_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_f8d3cc8f-f6c3-4009-ad27-b79796500120_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_6f5f9db1-f0f9-4a53-9236-b413209322b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_9dde13d0-708f-4664-8b47-54e0da00397f_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a318a003-7686-4986-ab46-bd1f1c4ac77a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BTGAcquisitionMember_ea1e7d63-bf06-469f-9719-635d17d74549_terseLabel_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_BTGAcquisitionMember_label_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_BTGAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BTGAcquisitionMember" xlink:to="lab_bsx_BTGAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_2336a02d-a81f-4e8b-acce-69834ed491c6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_fe3eb2eb-b542-4878-a188-4b0b26089fa2_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_68e257b2-fc6d-42b0-a396-e836122f8654_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2d190c68-a441-4af9-b283-1791cf5bf8d2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_435ad1d4-18b0-445a-953c-00d0feec4ab1_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_99c3d45c-4ea2-4dd5-ac50-366425c60d87_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_f19ad1ef-7336-42a0-9cc5-7eb78c204fe9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_5c8ff01c-71fc-433b-baa4-a09c95a7daaa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e740e211-67de-46ff-a5f2-6806efb77727_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_ce79aeab-047b-4fae-a77f-2359a55ea7a3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_1d96129b-8470-4e20-92e5-fe41b7245294_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OptionsExpectedToVest_af4f242a-bdaf-4b87-ab53-f431141a5046_terseLabel_en-US" xlink:label="lab_bsx_OptionsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVest_label_en-US" xlink:label="lab_bsx_OptionsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVest_documentation_en-US" xlink:label="lab_bsx_OptionsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVest" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OptionsExpectedToVest" xlink:to="lab_bsx_OptionsExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_287461f2-1ced-4ba6-98f1-ef942b9b804c_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_label_en-US" xlink:label="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_documentation_en-US" xlink:label="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Prepaid on Intercompany Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:to="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_242eb4b5-f906-4dd5-a024-57170d1f0140_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1f221442-f821-4754-a9df-4d41b461ee2d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_926ff63e-f026-4cad-b086-82d6ff8673da_terseLabel_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede)</link:label>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_label_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede) [Member]</link:label>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_documentation_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:href="bsx-20211231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:to="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_bdafc8f7-0000-45d2-b422-c96752bd0a11_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring-related Costs Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring-related Costs Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring-related Costs Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringRelatedCostsIncurredToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:to="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_13762aa0-bd0d-4dc6-abcc-56790e21855e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_2e8c27a6-652f-4338-9a9d-faed4e98f75e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0b1c7782-fe7e-4ef6-a9ee-97dcf386ec8b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_36c22a12-bf8a-413c-94ec-5cc530947d9b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2040NotesMember_bb4fc947-e899-49ec-9517-74864ab02f35_terseLabel_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_label_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_documentation_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember" xlink:href="bsx-20211231.xsd#bsx_January2040NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2040NotesMember" xlink:to="lab_bsx_January2040NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_e4037091-67c8-4f48-8b17-8dc87cf97e61_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_81c7ae84-779e-4b7c-8aff-ed1614a70416_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c12ac2bd-44ba-4ad0-81c0-27aa50ba0541_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_90539d9c-4e10-491b-9fa1-cc3d5de52271_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_bd448e21-46f6-45a6-b196-4adf593342ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_621d2015-7f53-4bd8-8ae7-44cab6f969cb_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_9833f040-576c-4d7c-9f53-e8a89889de39_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_ca9f466d-72f2-4f12-88ee-dc43b9ae59dd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_bacfc12c-a8a1-46e0-86cc-1a7eaf196c57_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2025NotesMember_578dee47-df97-497a-a69f-ab7ec1cc0aca_terseLabel_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_label_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_documentation_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember" xlink:href="bsx-20211231.xsd#bsx_May2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2025NotesMember" xlink:to="lab_bsx_May2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_122ad4a6-5192-4f58-989a-977b82d6ee30_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementsAsset_d4da86b0-5bc8-4163-b279-318d8ea7fab0_negatedTerseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementsAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAsset_ba110cb5-a90d-4288-9b50-41d05df18dc2_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementsAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAsset_label_en-US" xlink:label="lab_bsx_LicensingArrangementsAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAsset_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementsAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementsAsset" xlink:to="lab_bsx_LicensingArrangementsAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_3a25233c-61a1-493b-a14e-5a5d8321d170_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>bsx-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3eeb153c-443d-4b7c-bc48-13c100a9196f,g:5aeaa418-7365-4294-a466-e7b8cf11828b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Cover" xlink:type="simple" xlink:href="bsx-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cb4f8593-a1e6-4e81-91b2-5005b048f596" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_b5634c77-6c44-40d2-9ba6-89a42c503949" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb4f8593-a1e6-4e81-91b2-5005b048f596" xlink:to="loc_dei_EntitiesTable_b5634c77-6c44-40d2-9ba6-89a42c503949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c6145c00-4bbb-4cfd-85fc-aabaa9469243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b5634c77-6c44-40d2-9ba6-89a42c503949" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c6145c00-4bbb-4cfd-85fc-aabaa9469243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c6145c00-4bbb-4cfd-85fc-aabaa9469243" xlink:to="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_18309ddc-764f-4d2f-81c4-5d03118a1f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:to="loc_us-gaap_CommonStockMember_18309ddc-764f-4d2f-81c4-5d03118a1f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_f3cf6ca7-b574-475f-b922-ac094e705fda" xlink:href="bsx-20211231.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:to="loc_bsx_SeniorNotedue2027Member_f3cf6ca7-b574-475f-b922-ac094e705fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_9905c58a-f05b-4cb4-891c-e92b11944d39" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a1e0dfa8-c497-4d04-97a6-88b7db748200" xlink:to="loc_bsx_A550MCPSSeriesAMember_9905c58a-f05b-4cb4-891c-e92b11944d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b5634c77-6c44-40d2-9ba6-89a42c503949" xlink:to="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c370b9eb-eee9-479f-a338-81752990b56b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentType_c370b9eb-eee9-479f-a338-81752990b56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_fb917aaf-936a-4132-93f3-85b948ae7c14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentAnnualReport_fb917aaf-936a-4132-93f3-85b948ae7c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e9328832-dfe4-4d8d-a7b2-49827ee345ea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentPeriodEndDate_e9328832-dfe4-4d8d-a7b2-49827ee345ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d7863b76-3b4b-4766-9787-5ca4ebd6707a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentTransitionReport_d7863b76-3b4b-4766-9787-5ca4ebd6707a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5a6f5780-cf0c-4394-9ea2-251fe85e8d2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityFileNumber_5a6f5780-cf0c-4394-9ea2-251fe85e8d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5b93a33f-93a1-4b39-b633-9619855bc15e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityRegistrantName_5b93a33f-93a1-4b39-b633-9619855bc15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_08859152-c0c9-4d31-aa2f-4a6d51b4904c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityIncorporationStateCountryCode_08859152-c0c9-4d31-aa2f-4a6d51b4904c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c48b5304-81f5-48d8-9e54-f681e1b1e498" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityTaxIdentificationNumber_c48b5304-81f5-48d8-9e54-f681e1b1e498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_91fa262a-658f-4548-b549-4a75b89bc984" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressAddressLine1_91fa262a-658f-4548-b549-4a75b89bc984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2d1d56c0-cd96-455f-87f6-58361298ef70" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressCityOrTown_2d1d56c0-cd96-455f-87f6-58361298ef70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_615ddcd3-c8fe-441b-b79c-392e96660dfb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressStateOrProvince_615ddcd3-c8fe-441b-b79c-392e96660dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_83e13d7e-1f72-4ce8-9241-c8e2b1051084" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityAddressPostalZipCode_83e13d7e-1f72-4ce8-9241-c8e2b1051084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_df049fb0-73aa-4c89-97d5-8521e58a3bfd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_CityAreaCode_df049fb0-73aa-4c89-97d5-8521e58a3bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ef3c2f75-9672-4391-9c8f-ef7ea02609cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_LocalPhoneNumber_ef3c2f75-9672-4391-9c8f-ef7ea02609cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_807030ad-0d75-4d64-8ad4-f84a94c79683" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_Security12bTitle_807030ad-0d75-4d64-8ad4-f84a94c79683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a876e6ea-56f2-4473-88e5-5a93fb002a02" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_TradingSymbol_a876e6ea-56f2-4473-88e5-5a93fb002a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dcf954ee-f38c-4224-ac1d-dc314a361231" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_SecurityExchangeName_dcf954ee-f38c-4224-ac1d-dc314a361231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_95d8937f-e851-45b6-b13a-af43b1671fa9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_95d8937f-e851-45b6-b13a-af43b1671fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_453d2f33-3268-49e6-b13e-dddc46be7835" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityVoluntaryFilers_453d2f33-3268-49e6-b13e-dddc46be7835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_69e60018-2080-4094-8a60-3148c16bce2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityCurrentReportingStatus_69e60018-2080-4094-8a60-3148c16bce2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d986eb34-3641-48ce-8ca8-39f5b9c02de9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityInteractiveDataCurrent_d986eb34-3641-48ce-8ca8-39f5b9c02de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_40314bba-3a1c-41ff-97da-28141aa90523" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityFilerCategory_40314bba-3a1c-41ff-97da-28141aa90523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_182a7c6c-c599-4f62-a22d-738ce06f2d34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntitySmallBusiness_182a7c6c-c599-4f62-a22d-738ce06f2d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ffe65aef-7601-49db-92e9-c40d3137814a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityEmergingGrowthCompany_ffe65aef-7601-49db-92e9-c40d3137814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_9c116202-fab1-4369-896c-101932c8b664" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_IcfrAuditorAttestationFlag_9c116202-fab1-4369-896c-101932c8b664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3291876c-7843-49e7-b9fc-b1f491188c1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityShellCompany_3291876c-7843-49e7-b9fc-b1f491188c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_18250c2c-8f7e-4cc0-a2c3-4a95721851fa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityPublicFloat_18250c2c-8f7e-4cc0-a2c3-4a95721851fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_0c0c0037-cab8-4c3a-88a5-4d22a45a0add" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingParValuePerShare"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityListingParValuePerShare_0c0c0037-cab8-4c3a-88a5-4d22a45a0add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_08308ed5-e450-4953-be64-8951f8308f63" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_08308ed5-e450-4953-be64-8951f8308f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_81c7afbd-b716-4a62-aa95-e2fddc6cdf38" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_EntityCentralIndexKey_81c7afbd-b716-4a62-aa95-e2fddc6cdf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_aae50883-f061-492f-bd4f-265a8c157f77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_CurrentFiscalYearEndDate_aae50883-f061-492f-bd4f-265a8c157f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a1e9d75a-d1a9-4448-bdf0-e4aba1dab2cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentFiscalYearFocus_a1e9d75a-d1a9-4448-bdf0-e4aba1dab2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_a9c26a2e-9ba5-4595-8797-d5c2cf64d7be" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_DocumentFiscalPeriodFocus_a9c26a2e-9ba5-4595-8797-d5c2cf64d7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4dc03ef6-70f9-4d95-a4e8-f112a30d3687" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_6be5509a-37be-438d-b1cb-95e0bda57292" xlink:to="loc_dei_AmendmentFlag_4dc03ef6-70f9-4d95-a4e8-f112a30d3687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AuditInformation" xlink:type="simple" xlink:href="bsx-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AuditInformationAbstract_8a03909d-c1a2-4393-b9ba-0f26cff6b85f" xlink:href="bsx-20211231.xsd#bsx_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_0ff8a85c-2878-4211-be6a-c9f508364f9c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_AuditInformationAbstract_8a03909d-c1a2-4393-b9ba-0f26cff6b85f" xlink:to="loc_dei_AuditorName_0ff8a85c-2878-4211-be6a-c9f508364f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_92d961a2-be8d-4ad7-846b-51aa04b71b41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_AuditInformationAbstract_8a03909d-c1a2-4393-b9ba-0f26cff6b85f" xlink:to="loc_dei_AuditorFirmId_92d961a2-be8d-4ad7-846b-51aa04b71b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_0a8bad48-87a3-4ca6-89a8-29b8dc398f5b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_AuditInformationAbstract_8a03909d-c1a2-4393-b9ba-0f26cff6b85f" xlink:to="loc_dei_AuditorLocation_0a8bad48-87a3-4ca6-89a8-29b8dc398f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f85d9007-5629-42b4-8f23-0e9328aac0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9ec2adbf-6aaf-40ec-8c6f-21cdbe808692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f85d9007-5629-42b4-8f23-0e9328aac0aa" xlink:to="loc_us-gaap_StatementTable_9ec2adbf-6aaf-40ec-8c6f-21cdbe808692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8fd2b6d1-ac24-44a9-983e-44ec4741758e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ec2adbf-6aaf-40ec-8c6f-21cdbe808692" xlink:to="loc_srt_StatementScenarioAxis_8fd2b6d1-ac24-44a9-983e-44ec4741758e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_aaf86b55-e4f7-4210-84e9-633736c1dc84" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_8fd2b6d1-ac24-44a9-983e-44ec4741758e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_aaf86b55-e4f7-4210-84e9-633736c1dc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ec2adbf-6aaf-40ec-8c6f-21cdbe808692" xlink:to="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e774fc37-7757-4a62-8239-034afda75a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e774fc37-7757-4a62-8239-034afda75a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4af1cd49-d0eb-4a51-8658-6010187b5916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4af1cd49-d0eb-4a51-8658-6010187b5916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_43041359-7695-411a-a33e-e345a5ae591c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_GrossProfit_43041359-7695-411a-a33e-e345a5ae591c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_771b80bc-4b1e-4595-9a6b-e0aaa4b87ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_771b80bc-4b1e-4595-9a6b-e0aaa4b87ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_93f708e5-3061-4750-b8d7-a43f34e9999b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_93f708e5-3061-4750-b8d7-a43f34e9999b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_8d4febf6-edca-4dda-aca7-2fc20209d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_RoyaltyExpense_8d4febf6-edca-4dda-aca7-2fc20209d831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_87f6df6c-ff8b-4711-8de5-5dd337813eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_87f6df6c-ff8b-4711-8de5-5dd337813eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_295fbad5-ccd8-4a8c-9cf7-2e921e415d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_295fbad5-ccd8-4a8c-9cf7-2e921e415d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8da02d7f-b4ca-4696-8d31-96cdc9b6bac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8da02d7f-b4ca-4696-8d31-96cdc9b6bac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3dde323d-af63-4a2f-8fff-ced565651376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3dde323d-af63-4a2f-8fff-ced565651376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_750d9caf-6e3a-4843-bb41-019378d1aba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_RestructuringCharges_750d9caf-6e3a-4843-bb41-019378d1aba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_cd11eb89-306e-45cd-ab39-2b99e8a492d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_LitigationSettlementExpense_cd11eb89-306e-45cd-ab39-2b99e8a492d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_66f9736c-1754-4685-a98d-e44484efd3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_66f9736c-1754-4685-a98d-e44484efd3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ce92cc01-5ed5-44f9-97ca-220e13747779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60f19641-1bf0-412d-9924-01173c80aec7" xlink:to="loc_us-gaap_OperatingExpenses_ce92cc01-5ed5-44f9-97ca-220e13747779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_20930504-2219-4a58-ac1d-9c736a851d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_OperatingIncomeLoss_20930504-2219-4a58-ac1d-9c736a851d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_aa96ed59-933f-43cd-a8c4-286b7b685566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:to="loc_us-gaap_InterestExpense_aa96ed59-933f-43cd-a8c4-286b7b685566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b517ad30-19ae-40de-9060-409b13985030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2c3d1442-cf7f-421d-b7b2-0721ca5d5151" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b517ad30-19ae-40de-9060-409b13985030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f29b2ec-22ff-4427-acbd-c2957b52cf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f29b2ec-22ff-4427-acbd-c2957b52cf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a5c700a1-a4ac-46cc-93fd-65a7a3f5df24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a5c700a1-a4ac-46cc-93fd-65a7a3f5df24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_18c8afb2-b507-47bb-869f-cd64ca95be04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_ProfitLoss_18c8afb2-b507-47bb-869f-cd64ca95be04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_6f0d3c19-868e-474c-9ce9-00e63db30df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_DividendsPreferredStockStock_6f0d3c19-868e-474c-9ce9-00e63db30df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_54bfe5db-52b8-4f4c-9cee-4df4644bbb90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_54bfe5db-52b8-4f4c-9cee-4df4644bbb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fe618249-28e2-4fa9-9782-0f7348631e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_EarningsPerShareBasic_fe618249-28e2-4fa9-9782-0f7348631e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9e83e6b8-a5e4-4ff4-829f-0fda0918f022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9e83e6b8-a5e4-4ff4-829f-0fda0918f022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96e09938-7eac-41d3-9bdf-307dc741cf19" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b1cb1282-2568-4226-a31a-ee401c6db534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b1cb1282-2568-4226-a31a-ee401c6db534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b92465a4-cfca-4290-ad89-811285b4d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f5bbec64-725d-4b8c-be41-424700b1ef62" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b92465a4-cfca-4290-ad89-811285b4d7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d347f0a5-faf9-4dc6-adb9-ba27605aa5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d347f0a5-faf9-4dc6-adb9-ba27605aa5bc" xlink:to="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:to="loc_srt_StatementScenarioAxis_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c214d010-eed7-44d0-b4fb-8b669c50a5dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_2a8b4ba1-2a8f-4a04-b989-a6b7a13b54bb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c214d010-eed7-44d0-b4fb-8b669c50a5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2ab9a09e-5dcf-4496-96b7-76a51b092c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ed6c75a0-78f0-4d7c-b4f3-9724d53a68bc" xlink:to="loc_us-gaap_EquityComponentDomain_2ab9a09e-5dcf-4496-96b7-76a51b092c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_b61bb7ea-8c08-4895-a63f-9170bc08cacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2ab9a09e-5dcf-4496-96b7-76a51b092c1d" xlink:to="loc_us-gaap_PreferredStockMember_b61bb7ea-8c08-4895-a63f-9170bc08cacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_167276f6-b773-4e18-9008-0ca29ac83770" xlink:to="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_356cbbe2-0149-4c56-9eef-c7536a5b736c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:to="loc_us-gaap_ProfitLoss_356cbbe2-0149-4c56-9eef-c7536a5b736c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_29db4e45-67c1-4d0d-9930-0839e50525f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_29db4e45-67c1-4d0d-9930-0839e50525f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4d0e126a-7110-4245-a52c-6fae55b467b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4d0e126a-7110-4245-a52c-6fae55b467b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0f4821cd-51c8-4cb6-9d4d-383d2d9734f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0f4821cd-51c8-4cb6-9d4d-383d2d9734f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35be9f6f-e434-4c63-a3bb-aea0a0930ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_77213331-dd15-4af8-a676-a7b8948f6b43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35be9f6f-e434-4c63-a3bb-aea0a0930ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_37b7eb35-0401-4006-85ef-72da1bd211e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_38fe2345-155b-419c-893b-92632e842a3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_37b7eb35-0401-4006-85ef-72da1bd211e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2ab9f337-336b-4d7f-96b9-e1f1edde5709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_68a11ed3-aef5-43ae-a947-a9d430d74b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2ab9f337-336b-4d7f-96b9-e1f1edde5709" xlink:to="loc_us-gaap_StatementTable_68a11ed3-aef5-43ae-a947-a9d430d74b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_47016937-0424-4739-9581-a71da00b97c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_68a11ed3-aef5-43ae-a947-a9d430d74b39" xlink:to="loc_srt_StatementScenarioAxis_47016937-0424-4739-9581-a71da00b97c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_31f80b81-de95-4933-a231-8264b8f94560" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_47016937-0424-4739-9581-a71da00b97c7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_31f80b81-de95-4933-a231-8264b8f94560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_68a11ed3-aef5-43ae-a947-a9d430d74b39" xlink:to="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:to="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e420ec4d-9315-46d3-923b-fd553529e967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e420ec4d-9315-46d3-923b-fd553529e967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_0e0d0141-8ae0-4972-8eef-f0e30ea5ffa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_0e0d0141-8ae0-4972-8eef-f0e30ea5ffa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cdd4fdb0-fa19-4433-bc04-769b6fd0aef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_InventoryNet_cdd4fdb0-fa19-4433-bc04-769b6fd0aef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_18937e16-3c93-4cd5-85a3-587be9751749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_PrepaidTaxes_18937e16-3c93-4cd5-85a3-587be9751749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0f199e1f-9b07-47f8-956a-2fbbba1f09d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0f199e1f-9b07-47f8-956a-2fbbba1f09d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f1c05a07-4c21-496f-b0bb-d91ca9783946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f1c05a07-4c21-496f-b0bb-d91ca9783946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7d8bc2cb-b679-4696-9dca-1c5123df9194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4edd77c6-f336-4115-9c2d-42f885b99b2c" xlink:to="loc_us-gaap_AssetsCurrent_7d8bc2cb-b679-4696-9dca-1c5123df9194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0c9c3ab1-01df-46ec-8279-ab19ea220151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0c9c3ab1-01df-46ec-8279-ab19ea220151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d78828a0-0115-46cd-a9ae-c30dfaf1b399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_Goodwill_d78828a0-0115-46cd-a9ae-c30dfaf1b399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_77ba5833-d78b-49c4-8f64-84fc16ec57eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_77ba5833-d78b-49c4-8f64-84fc16ec57eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_33bb63a6-4f63-4ac8-ae09-d49c5bc52080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_33bb63a6-4f63-4ac8-ae09-d49c5bc52080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a8527528-1ace-45a6-ac43-deca6e18cb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a8527528-1ace-45a6-ac43-deca6e18cb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1c65808d-45b7-424a-80d2-45a328c84e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4461cfbf-ad7d-4dec-b800-67447f2eaff7" xlink:to="loc_us-gaap_Assets_1c65808d-45b7-424a-80d2-45a328c84e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bddd2a6c-ae2b-4914-974b-9a99c62801d3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_358b8ea4-f3be-44bb-9936-dd2d3d2f577f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_DebtCurrent_358b8ea4-f3be-44bb-9936-dd2d3d2f577f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6fb4fa8b-c77e-4889-9a83-b8fa7ae0a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_AccountsPayableCurrent_6fb4fa8b-c77e-4889-9a83-b8fa7ae0a4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_55a4f25d-de54-43ea-8422-22598cac917c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_55a4f25d-de54-43ea-8422-22598cac917c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6227dc32-b6d0-43b4-8958-4ffb96036bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6227dc32-b6d0-43b4-8958-4ffb96036bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d8dd7b7e-1684-47ec-8259-96052d952b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c415ac9b-7651-4d39-8966-044c7ec2f171" xlink:to="loc_us-gaap_LiabilitiesCurrent_d8dd7b7e-1684-47ec-8259-96052d952b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f53777c3-9134-4b63-8377-e15a5f18bcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f53777c3-9134-4b63-8377-e15a5f18bcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9c5cede0-2aaf-4618-8808-b1e7ac8fd804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9c5cede0-2aaf-4618-8808-b1e7ac8fd804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_97a84633-c3e4-4a08-8cf9-d8598741a09d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_97a84633-c3e4-4a08-8cf9-d8598741a09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_11d87463-efb6-4931-a9d1-e26aa291fb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_11d87463-efb6-4931-a9d1-e26aa291fb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_810e40a2-3f2f-4ca8-98a9-696d7cdb579a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_810e40a2-3f2f-4ca8-98a9-696d7cdb579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0bbc2c41-0207-435f-86e9-a28a9c2670dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_PreferredStockValue_0bbc2c41-0207-435f-86e9-a28a9c2670dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_aa7d4c88-602d-4db7-bafb-5ba8ccc48e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_CommonStockValue_aa7d4c88-602d-4db7-bafb-5ba8ccc48e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1f2cb075-42d3-4abe-8385-d3aa4a2e810f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_TreasuryStockShares_1f2cb075-42d3-4abe-8385-d3aa4a2e810f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f3f5af13-3207-446f-a764-be7d48597e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_TreasuryStockValue_f3f5af13-3207-446f-a764-be7d48597e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5fc7f91-6c35-46e1-bc0a-7e849833d695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5fc7f91-6c35-46e1-bc0a-7e849833d695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a055f620-7783-4f65-96aa-d590aee2c086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a055f620-7783-4f65-96aa-d590aee2c086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a6743f76-6831-446f-9b5e-b348b25f5d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a6743f76-6831-446f-9b5e-b348b25f5d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_90769912-2b10-43c7-bf5c-774752d811bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_90769912-2b10-43c7-bf5c-774752d811bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f225567b-80ba-4547-9d84-fe8b0713e15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f513f724-e58d-41ae-8290-f2ee9519228b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f225567b-80ba-4547-9d84-fe8b0713e15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_148f8c36-4a91-4044-97dd-ec1dab97fd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2b22a9dc-3372-4dc5-9fb8-02d17dd0b3d2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_148f8c36-4a91-4044-97dd-ec1dab97fd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfb0fec7-89ab-4bc1-b889-7049f5e9a245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d56d98-d7e8-46d4-abbb-4d4c2b609d2c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfb0fec7-89ab-4bc1-b889-7049f5e9a245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedBalanceSheetParanthetical"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:href="bsx-20211231.xsd#bsx_ConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4e31bc69-f59f-48cd-bccc-4af05d999def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4e31bc69-f59f-48cd-bccc-4af05d999def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_809a2948-94d4-405c-9785-1227a48291e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_809a2948-94d4-405c-9785-1227a48291e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_8b65e22a-e19c-4b33-a431-48a9f376e6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_8b65e22a-e19c-4b33-a431-48a9f376e6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_09f86924-940f-41ba-a8b3-80057a913854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_09f86924-940f-41ba-a8b3-80057a913854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9bf629b5-990f-4d4b-a972-c1aadd21ed43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9bf629b5-990f-4d4b-a972-c1aadd21ed43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c0fb22d6-0a97-4093-b952-f15437b8ca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:to="loc_us-gaap_CommonStockSharesIssued_c0fb22d6-0a97-4093-b952-f15437b8ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_9940bac0-53dc-4b71-a901-a40a729d6bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_a383c97c-3c63-42b9-a716-b94118c7e6a9" xlink:to="loc_us-gaap_TreasuryStockShares_9940bac0-53dc-4b71-a901-a40a729d6bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5ac1b1c6-9d87-46eb-b18f-3af94287e26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d8d80f7f-480c-4a09-8a2a-5df237cc718f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5ac1b1c6-9d87-46eb-b18f-3af94287e26f" xlink:to="loc_us-gaap_StatementTable_d8d80f7f-480c-4a09-8a2a-5df237cc718f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1d54f1f8-6f04-46d4-8e74-d913f9fe7403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d8d80f7f-480c-4a09-8a2a-5df237cc718f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1d54f1f8-6f04-46d4-8e74-d913f9fe7403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1d54f1f8-6f04-46d4-8e74-d913f9fe7403" xlink:to="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_bc6ed0bc-15c1-4e1a-8a53-e56e86d25735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_PreferredStockMember_bc6ed0bc-15c1-4e1a-8a53-e56e86d25735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2a3c18e8-6793-4d59-86d2-c45373d9ee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_CommonStockMember_2a3c18e8-6793-4d59-86d2-c45373d9ee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1d21c1f1-02d8-47c6-b9a7-31a08db67d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_TreasuryStockMember_1d21c1f1-02d8-47c6-b9a7-31a08db67d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2c17f35a-7cba-4c66-9dce-55cf1587e4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2c17f35a-7cba-4c66-9dce-55cf1587e4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_aff3214f-5598-4ed2-97e1-971b24172b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_RetainedEarningsMember_aff3214f-5598-4ed2-97e1-971b24172b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1aa328f0-986d-41e6-9e8e-3663f4cdcb99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_97d5d7b5-fd98-4d47-8d60-ff1ea8cacac9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1aa328f0-986d-41e6-9e8e-3663f4cdcb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9282de63-d4f4-4622-9184-75429b51ba67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d8d80f7f-480c-4a09-8a2a-5df237cc718f" xlink:to="loc_us-gaap_StatementLineItems_9282de63-d4f4-4622-9184-75429b51ba67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9282de63-d4f4-4622-9184-75429b51ba67" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d6d78b32-f4bf-4933-b960-5fc8e7ecfee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_SharesIssued_d6d78b32-f4bf-4933-b960-5fc8e7ecfee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4b5b0f8-a1e7-44a4-bfce-4a4aa3ebc2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4b5b0f8-a1e7-44a4-bfce-4a4aa3ebc2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3919f721-2307-4721-92a6-fc009d31e873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3919f721-2307-4721-92a6-fc009d31e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_821d3b1a-9ec7-4e08-ae3a-0012594e60df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_821d3b1a-9ec7-4e08-ae3a-0012594e60df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_99d3133f-c321-448c-b431-41f329a9d962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_99d3133f-c321-448c-b431-41f329a9d962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9d4364fe-7971-4a17-9688-1959d0c5d0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9d4364fe-7971-4a17-9688-1959d0c5d0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_c4658aff-4a08-4554-92a6-580da62099e1" xlink:href="bsx-20211231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_c4658aff-4a08-4554-92a6-580da62099e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_dce34f8b-fc92-4664-8dac-e18768534d83" xlink:href="bsx-20211231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_dce34f8b-fc92-4664-8dac-e18768534d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_87bcacd5-83ce-4152-8686-87f1e504b3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_87bcacd5-83ce-4152-8686-87f1e504b3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ebffac3d-5925-4aed-8745-a39049ae6e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_ProfitLoss_ebffac3d-5925-4aed-8745-a39049ae6e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_41fa10cc-3465-4b4c-a652-141616dd8e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_41fa10cc-3465-4b4c-a652-141616dd8e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_cd36be41-d313-4512-8c37-3710adfbc104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_DividendsPreferredStockCash_cd36be41-d313-4512-8c37-3710adfbc104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_c5624d51-c955-4379-a11f-8388978549c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_SharesIssued_c5624d51-c955-4379-a11f-8388978549c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b3daf6b1-6e81-4674-b047-757409ee04b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b3daf6b1-6e81-4674-b047-757409ee04b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_64818653-d0af-46b6-990f-1338aeef50c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_64818653-d0af-46b6-990f-1338aeef50c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f91f5faa-1eeb-47c1-95e6-4ea7a4257c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ce716ec-9ec4-41dc-8b6a-1fc550ea16b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f91f5faa-1eeb-47c1-95e6-4ea7a4257c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_39c5d8cd-534d-4ddd-acc4-c82d9550e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16a4477-9534-446c-b9c1-ac5a090b4be0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_39c5d8cd-534d-4ddd-acc4-c82d9550e2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a850d841-dfef-4578-aff2-4a06390d8c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_781411c6-1fd5-4ce4-bd8f-48df7214e4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a850d841-dfef-4578-aff2-4a06390d8c23" xlink:to="loc_us-gaap_StatementTable_781411c6-1fd5-4ce4-bd8f-48df7214e4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fa07bfa9-7998-42d4-8eed-6d63f6e3a029" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_781411c6-1fd5-4ce4-bd8f-48df7214e4e5" xlink:to="loc_srt_StatementScenarioAxis_fa07bfa9-7998-42d4-8eed-6d63f6e3a029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d7c77ed4-3f92-4e35-8f02-209f8b2bd182" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_fa07bfa9-7998-42d4-8eed-6d63f6e3a029" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d7c77ed4-3f92-4e35-8f02-209f8b2bd182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_781411c6-1fd5-4ce4-bd8f-48df7214e4e5" xlink:to="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f745cc75-14cf-4741-a697-a4f41e00d165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_ProfitLoss_f745cc75-14cf-4741-a697-a4f41e00d165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd08d5c7-a851-48e7-a7fd-4be360dbff80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd08d5c7-a851-48e7-a7fd-4be360dbff80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5f2099d5-24f2-45e2-8a6e-f221fbf135fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5f2099d5-24f2-45e2-8a6e-f221fbf135fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6545357d-a741-4116-8c21-9b8082f4b68e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6545357d-a741-4116-8c21-9b8082f4b68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_bd70b20f-5e1d-4a10-9d7f-e3ca3b1a6011" xlink:href="bsx-20211231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_bd70b20f-5e1d-4a10-9d7f-e3ca3b1a6011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f1a745fd-63be-4a85-98e6-ae9d4fd6d728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_ShareBasedCompensation_f1a745fd-63be-4a85-98e6-ae9d4fd6d728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c3fc2f2f-ef11-49cf-b4c9-d60a6dbc043a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c3fc2f2f-ef11-49cf-b4c9-d60a6dbc043a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_5137abe1-d2cc-4939-b2c7-8b7f08ef28ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_GainLossOnInvestments_5137abe1-d2cc-4939-b2c7-8b7f08ef28ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_56a98708-9af1-41a0-a543-0f435b719c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_56a98708-9af1-41a0-a543-0f435b719c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_3600e1fd-4b24-4c5f-abc6-f3fe6458ebf1" xlink:href="bsx-20211231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_InventoryStepUpAmortization_3600e1fd-4b24-4c5f-abc6-f3fe6458ebf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_7740b3d8-798f-487c-bbc8-dcea1158a94d" xlink:href="bsx-20211231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_7740b3d8-798f-487c-bbc8-dcea1158a94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_92393d6d-6d46-4bd0-95ce-ce7bc03b4e81" xlink:href="bsx-20211231.xsd#bsx_OtherNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_bsx_OtherNet_92393d6d-6d46-4bd0-95ce-ce7bc03b4e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e827c44b-e5c3-4894-8e3f-26a1457962a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e827c44b-e5c3-4894-8e3f-26a1457962a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4b515c8-9325-4f9a-ad32-bf1e2dddf43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4b515c8-9325-4f9a-ad32-bf1e2dddf43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b64eef8c-32b1-4a83-99c2-bb0a4f16285c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b64eef8c-32b1-4a83-99c2-bb0a4f16285c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0a6a8bbd-6c38-47b3-b424-d8c499643609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0a6a8bbd-6c38-47b3-b424-d8c499643609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4cf7df82-6cdf-4b49-bc6e-25a683fac860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4cf7df82-6cdf-4b49-bc6e-25a683fac860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_31de6de1-1157-4612-b0dc-719b55403bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_31de6de1-1157-4612-b0dc-719b55403bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7cfec563-8eac-4436-96fe-688d13de0a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7cfec563-8eac-4436-96fe-688d13de0a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_82550b3c-de3f-455d-9a15-8f5c8d4d09a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_82550b3c-de3f-455d-9a15-8f5c8d4d09a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_88b1cff7-b506-4dc6-92d3-b92a3da1c2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_88b1cff7-b506-4dc6-92d3-b92a3da1c2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8be43908-f9cc-44f2-9fc9-e7341a67e444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8be43908-f9cc-44f2-9fc9-e7341a67e444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8b21e766-9a50-493a-ac5a-2289809b36a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8b21e766-9a50-493a-ac5a-2289809b36a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_aed99a73-44ef-4dd1-b090-635901f2f4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities_aed99a73-44ef-4dd1-b090-635901f2f4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_8cbfb67b-3bcf-4f90-afaf-15d52d946d1c" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_8cbfb67b-3bcf-4f90-afaf-15d52d946d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_313cf721-8384-4852-8249-c048a95d145a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dafad694-a8fe-4f2c-8164-e89db67ccc92" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_313cf721-8384-4852-8249-c048a95d145a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_160c74d2-9f78-458c-8415-7e54c43ddfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_160c74d2-9f78-458c-8415-7e54c43ddfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_9e0463fd-7961-40c2-850e-7559d633a992" xlink:href="bsx-20211231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_bsx_PaymentsForRoyaltyRights_9e0463fd-7961-40c2-850e-7559d633a992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c7d06210-7a92-4970-b3bf-1b848df30b74" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c7d06210-7a92-4970-b3bf-1b848df30b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c65ee255-eeab-4241-9853-dd5b31fd64a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c65ee255-eeab-4241-9853-dd5b31fd64a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_06a60eb1-41f5-4ae9-8db7-c91c1674f9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_06a60eb1-41f5-4ae9-8db7-c91c1674f9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_8d7170a1-2906-4ea0-86d4-500ec6529e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_8d7170a1-2906-4ea0-86d4-500ec6529e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_aa01c4be-3209-404e-97fa-adc7a66987cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_aa01c4be-3209-404e-97fa-adc7a66987cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8316896c-0c07-48bf-a3f5-f75c04a548f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8316896c-0c07-48bf-a3f5-f75c04a548f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_d13cb7bf-27cf-432a-9d57-475c5423057b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_d13cb7bf-27cf-432a-9d57-475c5423057b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_13b14ee5-5435-438c-b3c1-d23d6c454102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_13b14ee5-5435-438c-b3c1-d23d6c454102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_71cb533d-3f13-43ea-a5a8-94f60b9440fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_PaymentsOfDividends_71cb533d-3f13-43ea-a5a8-94f60b9440fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_9d74222c-7af8-459e-8b7f-1abac761378a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_9d74222c-7af8-459e-8b7f-1abac761378a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ccaf64b9-4c59-456a-a7e2-238648eca83b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ccaf64b9-4c59-456a-a7e2-238648eca83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c82b58fe-d2e4-43ae-9154-6153e46e7376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c82b58fe-d2e4-43ae-9154-6153e46e7376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_8884beab-e8e5-4587-baec-03d635f79e06" xlink:href="bsx-20211231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_8884beab-e8e5-4587-baec-03d635f79e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_14a93805-44e9-43fa-a130-b6edf1081b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_ProceedsFromStockPlans_14a93805-44e9-43fa-a130-b6edf1081b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa5b24eb-19a0-40fa-ae94-8ec021d1ba3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b78277a0-e439-439f-9682-814c567c11af" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa5b24eb-19a0-40fa-ae94-8ec021d1ba3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b623772e-4c2e-449d-a619-4e0e9002af1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b623772e-4c2e-449d-a619-4e0e9002af1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5dbabcbb-7967-490f-863d-3ea738130f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5dbabcbb-7967-490f-863d-3ea738130f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99aa9961-84ee-474e-a370-16b37db09a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99aa9961-84ee-474e-a370-16b37db09a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c7b5bbb-56f8-4fc1-9315-3c2766dfa80b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c7b5bbb-56f8-4fc1-9315-3c2766dfa80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c8f7955-bda7-4bd2-af98-157ab248185b" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_f835c9d0-58a3-4089-8700-6e9fe24f5479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_us-gaap_IncomeTaxesPaid_f835c9d0-58a3-4089-8700-6e9fe24f5479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_abd38f01-ea60-43ee-80c5-75406a3e5d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_us-gaap_InterestPaidNet_abd38f01-ea60-43ee-80c5-75406a3e5d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_15a0e751-fe4e-4ed2-bbd7-66ac5177ba93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_15a0e751-fe4e-4ed2-bbd7-66ac5177ba93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_84bab5a0-37c8-4f63-8708-74412f956b18" xlink:href="bsx-20211231.xsd#bsx_NonCashImpactOfTransferredRoyaltyRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_62396b07-e45d-4907-b693-01293cf13b83" xlink:to="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_84bab5a0-37c8-4f63-8708-74412f956b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20211231.xsd#ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_242fb3b8-a30b-44d9-991d-d80a4136ed74" xlink:href="bsx-20211231.xsd#bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_52bf2789-ad14-4877-acdd-4629bb15f9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_242fb3b8-a30b-44d9-991d-d80a4136ed74" xlink:to="loc_us-gaap_StatementTable_52bf2789-ad14-4877-acdd-4629bb15f9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_e547d95c-0fbe-4efe-968e-b8731e3753e1" xlink:href="bsx-20211231.xsd#bsx_StatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_52bf2789-ad14-4877-acdd-4629bb15f9d5" xlink:to="loc_bsx_StatementAxis_e547d95c-0fbe-4efe-968e-b8731e3753e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_d12d360d-18c9-4938-966b-61fdcf6caa23" xlink:href="bsx-20211231.xsd#bsx_StatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementAxis_e547d95c-0fbe-4efe-968e-b8731e3753e1" xlink:to="loc_bsx_StatementDomain_d12d360d-18c9-4938-966b-61fdcf6caa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_52bf2789-ad14-4877-acdd-4629bb15f9d5" xlink:to="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a540bc1-f33b-47af-9be8-b70ad98d676b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a540bc1-f33b-47af-9be8-b70ad98d676b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_186baa70-bf4f-49d8-8ac9-5b4792eec235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_186baa70-bf4f-49d8-8ac9-5b4792eec235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_a3cb8e59-cb7c-4f6f-a910-95a5e34d0430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_a3cb8e59-cb7c-4f6f-a910-95a5e34d0430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7fb81fd5-34c2-4c34-a029-c37126f32ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_99001133-b4c4-4db4-b949-4410befe718b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7fb81fd5-34c2-4c34-a029-c37126f32ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="bsx-20211231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1df14d5f-3de7-4fd0-9811-3e7ff866e877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_859e4bb5-94dc-4b14-8392-e398fb478dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1df14d5f-3de7-4fd0-9811-3e7ff866e877" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_859e4bb5-94dc-4b14-8392-e398fb478dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="bsx-20211231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7f253a66-c369-4ab7-b016-18c53035e66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7f253a66-c369-4ab7-b016-18c53035e66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_d1397efc-a5b0-4ed7-bf0b-1e1f11e6fee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_d1397efc-a5b0-4ed7-bf0b-1e1f11e6fee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_87771b84-25a4-48ac-8c60-b943305278db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_UseOfEstimates_87771b84-25a4-48ac-8c60-b943305278db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5efc2500-91d2-4d5d-a221-ea18bda5affa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5efc2500-91d2-4d5d-a221-ea18bda5affa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_ce62b808-9696-4ad8-9702-af4bad886bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_ce62b808-9696-4ad8-9702-af4bad886bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_71d1aa10-3b67-4055-ae1e-f581010d5ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_71d1aa10-3b67-4055-ae1e-f581010d5ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_2ed1402a-a581-48bb-86cf-d22e68f668e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_2ed1402a-a581-48bb-86cf-d22e68f668e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_db5450f5-3807-42f8-8bd2-88cb25173c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_db5450f5-3807-42f8-8bd2-88cb25173c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_b1471367-5fce-453f-bdb8-6d357be14354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_b1471367-5fce-453f-bdb8-6d357be14354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_ac052950-206c-43c9-8d82-ea9f0300ece0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_ac052950-206c-43c9-8d82-ea9f0300ece0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_c6e955dd-88e5-4c48-8cda-570e3f7f3a50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_c6e955dd-88e5-4c48-8cda-570e3f7f3a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_23a66382-c0a2-47ff-926c-321091fc9a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_23a66382-c0a2-47ff-926c-321091fc9a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_164ad5af-9ee0-45cb-a4a1-36ca31232bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_164ad5af-9ee0-45cb-a4a1-36ca31232bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_121e06f3-826d-49da-975c-81593bda4fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_121e06f3-826d-49da-975c-81593bda4fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_d289c204-63f9-49f4-b2b4-faedb380fda1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_d289c204-63f9-49f4-b2b4-faedb380fda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1e195f92-4915-4ec9-8858-3768f0a34872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1e195f92-4915-4ec9-8858-3768f0a34872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_5179385f-3a0e-4ed4-924f-add661b0b4bd" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_5179385f-3a0e-4ed4-924f-add661b0b4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_70e3dff6-d64d-4197-927c-a0e573f3aff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_70e3dff6-d64d-4197-927c-a0e573f3aff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_339a6da0-ab4e-4719-a90f-4c64d4e0ab42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_339a6da0-ab4e-4719-a90f-4c64d4e0ab42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_45678fbf-110a-4a14-87d3-604db0edfc76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_45678fbf-110a-4a14-87d3-604db0edfc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_59f72f19-014d-4723-a371-b55f26dbdab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_30a600c3-3a42-412c-939f-95a526cd24e1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_59f72f19-014d-4723-a371-b55f26dbdab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesAbstract_7e695ba8-4512-4f1f-8493-fab72989c09a" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_7e695ba8-4512-4f1f-8493-fab72989c09a" xlink:to="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7280458a-f17d-463f-8fba-aa3d85360720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7280458a-f17d-463f-8fba-aa3d85360720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f7e3288c-c0bd-4e16-a720-be9b0e7d8dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7280458a-f17d-463f-8fba-aa3d85360720" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f7e3288c-c0bd-4e16-a720-be9b0e7d8dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d732ad79-3421-48fe-85ba-9db7edaab95c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d732ad79-3421-48fe-85ba-9db7edaab95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2ad311fe-6fa3-4ab9-bde1-4f399bcc441c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d732ad79-3421-48fe-85ba-9db7edaab95c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2ad311fe-6fa3-4ab9-bde1-4f399bcc441c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfeb406a-7abc-4183-819d-17ea390e3a2f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_srt_RangeAxis_cfeb406a-7abc-4183-819d-17ea390e3a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cfeb406a-7abc-4183-819d-17ea390e3a2f" xlink:to="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb617fe7-816b-4965-87da-fe7fd70e674e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:to="loc_srt_MinimumMember_cb617fe7-816b-4965-87da-fe7fd70e674e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc4df719-0e1d-41ed-bd9c-1373e1ab6fd2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4e113b51-b289-4f30-96c8-86c76ee7dbcf" xlink:to="loc_srt_MaximumMember_bc4df719-0e1d-41ed-bd9c-1373e1ab6fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239ca4ad-2c5c-42c5-ba20-b267ab33154d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239ca4ad-2c5c-42c5-ba20-b267ab33154d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_692f2960-172e-4a32-a2b3-097aaf9e8f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_239ca4ad-2c5c-42c5-ba20-b267ab33154d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_692f2960-172e-4a32-a2b3-097aaf9e8f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_bfdb19f8-a6d7-4f5f-a4af-b7d17656acaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_692f2960-172e-4a32-a2b3-097aaf9e8f72" xlink:to="loc_us-gaap_PatentsMember_bfdb19f8-a6d7-4f5f-a4af-b7d17656acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f07ff5f2-3a65-48c2-a682-3b7f1af52011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f07ff5f2-3a65-48c2-a682-3b7f1af52011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c94b729-d434-4a9f-8272-55d9014d095c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f07ff5f2-3a65-48c2-a682-3b7f1af52011" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c94b729-d434-4a9f-8272-55d9014d095c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_46aeb99e-b232-447d-8c46-8e68fbc04638" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_srt_ProductOrServiceAxis_46aeb99e-b232-447d-8c46-8e68fbc04638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_75b8c7f0-85ec-4f80-a463-5b463d4148c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_46aeb99e-b232-447d-8c46-8e68fbc04638" xlink:to="loc_srt_ProductsAndServicesDomain_75b8c7f0-85ec-4f80-a463-5b463d4148c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_2ec6e190-251f-422c-9089-34204a06026a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_75b8c7f0-85ec-4f80-a463-5b463d4148c6" xlink:to="loc_us-gaap_ShippingAndHandlingMember_2ec6e190-251f-422c-9089-34204a06026a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:href="bsx-20211231.xsd#bsx_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_f52f71b5-c2ef-4f26-a9f1-f19514cda525" xlink:to="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_93e27785-82b5-4535-b48a-6e4e47836bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_93e27785-82b5-4535-b48a-6e4e47836bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_9d1789f4-90d2-489a-8418-aa783d2199b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_5af69c09-99ef-456c-9396-df37d4771473" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_9d1789f4-90d2-489a-8418-aa783d2199b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20211231.xsd#AcquisitionsandStrategicInvestments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_fff3edf9-1dee-462e-a532-3b0447b92d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_ff6fad70-d1d7-4bd9-b1c1-e2440d14d432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fff3edf9-1dee-462e-a532-3b0447b92d8c" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_ff6fad70-d1d7-4bd9-b1c1-e2440d14d432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_263414bb-889a-47f7-814a-260b48d51b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_263414bb-889a-47f7-814a-260b48d51b95" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d0ac2727-c77e-4cab-85a0-80a8710c9202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d0ac2727-c77e-4cab-85a0-80a8710c9202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d0ac2727-c77e-4cab-85a0-80a8710c9202" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_cab0072e-6353-4ca0-9522-02261d5a7530" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_BTGAcquisitionMember_cab0072e-6353-4ca0-9522-02261d5a7530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_f19ba240-b870-421f-aadf-6be890cade59" xlink:href="bsx-20211231.xsd#bsx_VertiflexIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_VertiflexIncMember_f19ba240-b870-421f-aadf-6be890cade59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_25bad943-af92-4d6c-b97d-d1c3a0707c18" xlink:href="bsx-20211231.xsd#bsx_MillipedeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_MillipedeMember_25bad943-af92-4d6c-b97d-d1c3a0707c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_76c3355d-e2be-4d8a-a51b-baed9d714f79" xlink:href="bsx-20211231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_76c3355d-e2be-4d8a-a51b-baed9d714f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_81fbbb99-8646-4093-831e-ac082343c4c7" xlink:href="bsx-20211231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_PreventiceSolutionsIncMember_81fbbb99-8646-4093-831e-ac082343c4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_be13b69b-a695-4e63-b1aa-2567935dafb0" xlink:href="bsx-20211231.xsd#bsx_LumenisLTDMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_LumenisLTDMember_be13b69b-a695-4e63-b1aa-2567935dafb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllOther2021AcquisitionsMember_276222a8-7638-4548-af69-654e4255a025" xlink:href="bsx-20211231.xsd#bsx_AllOther2021AcquisitionsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_AllOther2021AcquisitionsMember_276222a8-7638-4548-af69-654e4255a025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2021AcquisitionsMember_6db5bb4c-1ef4-46e6-9382-4aa18c4b862e" xlink:href="bsx-20211231.xsd#bsx_A2021AcquisitionsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff9ab9d4-2452-4cbb-bcb8-e97c284145bf" xlink:to="loc_bsx_A2021AcquisitionsMember_6db5bb4c-1ef4-46e6-9382-4aa18c4b862e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fcdb9116-9330-4289-a1c2-5759e31b3e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fcdb9116-9330-4289-a1c2-5759e31b3e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_74f15bd7-e432-4f9c-b8c8-084d4d00dbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fcdb9116-9330-4289-a1c2-5759e31b3e74" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_74f15bd7-e432-4f9c-b8c8-084d4d00dbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0dd6e7f8-866f-491e-9ec0-474971cd19e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_srt_OwnershipAxis_0dd6e7f8-866f-491e-9ec0-474971cd19e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ff9a5135-7625-4f49-a396-7ddd81bb5ec4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_0dd6e7f8-866f-491e-9ec0-474971cd19e9" xlink:to="loc_srt_OwnershipDomain_ff9a5135-7625-4f49-a396-7ddd81bb5ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ed778a84-e09c-44ed-9171-3246d89775c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ed778a84-e09c-44ed-9171-3246d89775c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c654d550-282f-4bd7-b825-20745d80557a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ed778a84-e09c-44ed-9171-3246d89775c7" xlink:to="loc_us-gaap_ClassOfStockDomain_c654d550-282f-4bd7-b825-20745d80557a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21652ab2-4536-4849-8b73-27bd675bc746" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2adff9b5-ed28-4036-968c-6d72fd24eb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2adff9b5-ed28-4036-968c-6d72fd24eb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ce06da43-a647-4582-9a55-357a4dc7b3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ce06da43-a647-4582-9a55-357a4dc7b3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_8794930d-d162-45da-a816-5d8d4837adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_8794930d-d162-45da-a816-5d8d4837adc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a537b39f-4b41-4dc8-b864-f794ad419cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a537b39f-4b41-4dc8-b864-f794ad419cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a638ff5c-f5dd-422c-8ee7-125768d57fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a638ff5c-f5dd-422c-8ee7-125768d57fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_f87fec45-f683-42b5-ab37-12a3660c7297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6d463df3-2260-4fa7-85d1-bbc5e8b8ad5a" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_f87fec45-f683-42b5-ab37-12a3660c7297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#AcquisitionsandStrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_05ab40c4-2c54-4768-b153-9d567893a56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_05ab40c4-2c54-4768-b153-9d567893a56c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5a7b1448-61bc-4bc4-96b5-c8b40a0a2191" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_8b4e65fe-e8a7-48d6-8c75-f39f53335272" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_BTGAcquisitionMember_8b4e65fe-e8a7-48d6-8c75-f39f53335272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_ee9f494c-f9dc-4c82-ba93-594b41b7d6e9" xlink:href="bsx-20211231.xsd#bsx_VertiflexIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_VertiflexIncMember_ee9f494c-f9dc-4c82-ba93-594b41b7d6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_b3f6d12a-51d5-4e8f-9b2e-9d3086c68c39" xlink:href="bsx-20211231.xsd#bsx_MillipedeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_MillipedeMember_b3f6d12a-51d5-4e8f-9b2e-9d3086c68c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_90f94148-7d66-4456-8077-43e9594a3969" xlink:href="bsx-20211231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_90f94148-7d66-4456-8077-43e9594a3969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_a36dfb19-1391-4b3a-98dc-9d8174c6ac2d" xlink:href="bsx-20211231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_PreventiceSolutionsIncMember_a36dfb19-1391-4b3a-98dc-9d8174c6ac2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseIncMember_378b02cd-179c-435d-a0d3-3b04e7c5becd" xlink:href="bsx-20211231.xsd#bsx_FarapulseIncMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_FarapulseIncMember_378b02cd-179c-435d-a0d3-3b04e7c5becd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_d047c03b-0e9d-456c-b363-10396dd93127" xlink:href="bsx-20211231.xsd#bsx_LumenisLTDMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_LumenisLTDMember_d047c03b-0e9d-456c-b363-10396dd93127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DevoroMedicalIncMember_02522646-6a33-4092-9830-91e1ca617eba" xlink:href="bsx-20211231.xsd#bsx_DevoroMedicalIncMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_DevoroMedicalIncMember_02522646-6a33-4092-9830-91e1ca617eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllOther2021AcquisitionsMember_3cf1cb78-89ad-4f12-8a6c-b0e69a3b7161" xlink:href="bsx-20211231.xsd#bsx_AllOther2021AcquisitionsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_AllOther2021AcquisitionsMember_3cf1cb78-89ad-4f12-8a6c-b0e69a3b7161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2021AcquisitionsMember_b2bdf6ef-0344-41d8-a4f8-08309736256b" xlink:href="bsx-20211231.xsd#bsx_A2021AcquisitionsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92367715-6847-472a-b09e-5bf9010e1a30" xlink:to="loc_bsx_A2021AcquisitionsMember_b2bdf6ef-0344-41d8-a4f8-08309736256b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be0162e9-5f4c-444e-848e-81bf513d9ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be0162e9-5f4c-444e-848e-81bf513d9ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be0162e9-5f4c-444e-848e-81bf513d9ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b50ecf8b-25b6-4f01-acb7-0b884bf4375a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b50ecf8b-25b6-4f01-acb7-0b884bf4375a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_bc8bc46d-cfa8-4cf9-9424-dcd2573578ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_bc8bc46d-cfa8-4cf9-9424-dcd2573578ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_ebe6c37b-3900-4c66-b331-3c731b15b957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aeb49a5-176c-4ca1-a134-445159bef31d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_ebe6c37b-3900-4c66-b331-3c731b15b957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_511fd6be-3285-40f0-8a82-57f5019899bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_511fd6be-3285-40f0-8a82-57f5019899bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_00040e90-d0a9-4a33-9369-df74be4368c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_511fd6be-3285-40f0-8a82-57f5019899bb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_00040e90-d0a9-4a33-9369-df74be4368c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1589dee2-a260-459e-805a-6bd89427ac5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_00040e90-d0a9-4a33-9369-df74be4368c1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1589dee2-a260-459e-805a-6bd89427ac5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf842369-b898-49d5-87e8-40c859a5f58d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_srt_RangeAxis_cf842369-b898-49d5-87e8-40c859a5f58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cf842369-b898-49d5-87e8-40c859a5f58d" xlink:to="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_28ac36a8-0869-41a1-845c-3122ebc5163d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:to="loc_srt_WeightedAverageMember_28ac36a8-0869-41a1-845c-3122ebc5163d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ddc062b0-cc04-4c7a-bbf7-b43ffde2359a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:to="loc_srt_MinimumMember_ddc062b0-cc04-4c7a-bbf7-b43ffde2359a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d933d6c3-ffef-4578-9a0e-6bb8aa28ba62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ac6f1711-dd08-428e-a5bc-15eaf4b3e065" xlink:to="loc_srt_MaximumMember_d933d6c3-ffef-4578-9a0e-6bb8aa28ba62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_66464507-77ab-44af-8bac-de47f9ed769e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_66464507-77ab-44af-8bac-de47f9ed769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_66464507-77ab-44af-8bac-de47f9ed769e" xlink:to="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2c4d9a85-d26a-42fc-b159-fae969289888" xlink:href="bsx-20211231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2c4d9a85-d26a-42fc-b159-fae969289888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_ceec7f95-0e95-4f12-8b81-a8e59a765cb1" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3268acb-d19f-4479-a357-418582779e5f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_ceec7f95-0e95-4f12-8b81-a8e59a765cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6163a93f-b90b-434a-899d-9d327cb3e30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6163a93f-b90b-434a-899d-9d327cb3e30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6da20342-c5b5-435c-a6f6-25c1b46265f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6163a93f-b90b-434a-899d-9d327cb3e30f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6da20342-c5b5-435c-a6f6-25c1b46265f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3341ce61-a483-4886-9c8e-1427cb69ff24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6da20342-c5b5-435c-a6f6-25c1b46265f2" xlink:to="loc_us-gaap_SubsequentEventMember_3341ce61-a483-4886-9c8e-1427cb69ff24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3adbc7f9-e25f-4ad6-8a10-162849199a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3adbc7f9-e25f-4ad6-8a10-162849199a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3adbc7f9-e25f-4ad6-8a10-162849199a7d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ffe4ebd7-1235-4226-a70f-119344387e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ffe4ebd7-1235-4226-a70f-119344387e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_10b6cc72-e384-409e-b9fd-d102179efaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c1698c74-693a-421f-b193-7e573fe2aebd" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_10b6cc72-e384-409e-b9fd-d102179efaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_651b7781-d72c-41e0-8bce-7ca98b1f5733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_651b7781-d72c-41e0-8bce-7ca98b1f5733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79031ebc-9d77-428b-9565-4e5821d8d90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_651b7781-d72c-41e0-8bce-7ca98b1f5733" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79031ebc-9d77-428b-9565-4e5821d8d90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_e95c0439-3292-42b2-a2d5-b6b17a176388" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79031ebc-9d77-428b-9565-4e5821d8d90e" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_e95c0439-3292-42b2-a2d5-b6b17a176388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f90c532-4690-4be6-9dc0-9a5116373a81" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1bff959b-86dc-4659-8293-78841ee67a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1bff959b-86dc-4659-8293-78841ee67a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_3766f359-ca08-48aa-b32b-843b8abea932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_3766f359-ca08-48aa-b32b-843b8abea932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e7265f1e-d4f4-4293-be96-5823112df19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e7265f1e-d4f4-4293-be96-5823112df19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_5fa8eda6-248f-4ed0-b69d-4c9348dbab44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_5fa8eda6-248f-4ed0-b69d-4c9348dbab44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4fb6c88f-f0f1-4bc9-8dcc-36986408f882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4fb6c88f-f0f1-4bc9-8dcc-36986408f882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_8b3205e7-a764-4de2-a986-58c09bf0e85c" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_8b3205e7-a764-4de2-a986-58c09bf0e85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_bf12700e-aeaf-4f4f-9b13-a038d82bf249" xlink:href="bsx-20211231.xsd#bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_bf12700e-aeaf-4f4f-9b13-a038d82bf249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a9f3b1e3-7ea2-4040-8406-623359b72b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a9f3b1e3-7ea2-4040-8406-623359b72b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_5ce83d1d-1e36-4068-ad27-de070045eeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_5ce83d1d-1e36-4068-ad27-de070045eeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_03d7f13f-f2e3-409b-a5ff-4f108396dfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_03d7f13f-f2e3-409b-a5ff-4f108396dfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f6fd3119-df03-4bef-ad8d-d6b8d9a8a583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_Goodwill_f6fd3119-df03-4bef-ad8d-d6b8d9a8a583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2c258e56-300f-4abd-90e7-2a794a8ae723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2c258e56-300f-4abd-90e7-2a794a8ae723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_baeafc58-f7f2-42f1-945d-68ea71e0af71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_baeafc58-f7f2-42f1-945d-68ea71e0af71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9135dd16-ee4a-4981-a7a3-65418a5440d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9135dd16-ee4a-4981-a7a3-65418a5440d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c965cbd6-3f81-4ebc-ad60-fa14b8854335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c965cbd6-3f81-4ebc-ad60-fa14b8854335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e507cf58-3dac-49f2-a3ca-70f9eff77678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e507cf58-3dac-49f2-a3ca-70f9eff77678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b74b0276-153d-491a-bc4c-2da6a74bacaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b74b0276-153d-491a-bc4c-2da6a74bacaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_13b044a9-89e2-4261-a906-fb3ccc2bc84b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_13b044a9-89e2-4261-a906-fb3ccc2bc84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e3b5b376-ea34-4740-ab88-21348b1b8b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e3b5b376-ea34-4740-ab88-21348b1b8b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_6162786b-3e96-4d5b-a01c-2033360255c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_6162786b-3e96-4d5b-a01c-2033360255c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6887865b-229c-4a64-ba80-c6c697dfe921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6887865b-229c-4a64-ba80-c6c697dfe921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0d22d1dd-870d-407b-a698-f6d3588325fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0d22d1dd-870d-407b-a698-f6d3588325fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_9a06116e-d5f4-49c6-b73c-693b34d737c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_9a06116e-d5f4-49c6-b73c-693b34d737c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_07e8d200-f009-49e2-9bb4-d1725720be83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_07e8d200-f009-49e2-9bb4-d1725720be83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2dc66f64-1818-4bc1-8723-9a5aa94d984f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2dc66f64-1818-4bc1-8723-9a5aa94d984f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_5e6a441f-04c3-4ade-b0b6-bc05ef84ea22" xlink:href="bsx-20211231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_DiscountRateFairValueInput_5e6a441f-04c3-4ade-b0b6-bc05ef84ea22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d994d09-bd79-4a96-986a-9eab30530587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d994d09-bd79-4a96-986a-9eab30530587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_75b79c2e-2507-41c5-b80c-025cac781a58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_75b79c2e-2507-41c5-b80c-025cac781a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_84bd9f8c-0dd3-4e3f-9051-cb2f5ffe774f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_84bd9f8c-0dd3-4e3f-9051-cb2f5ffe774f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_749578ff-b8c8-4b65-9c59-af322db3ef61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e6231d0e-3f4e-4eb9-ae12-6e17367c38df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e6231d0e-3f4e-4eb9-ae12-6e17367c38df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_47f0e0fd-1075-4bbf-8c2f-a9b6f6b18f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_47f0e0fd-1075-4bbf-8c2f-a9b6f6b18f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd60d7fe-6780-4f51-95c5-84c615985f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd60d7fe-6780-4f51-95c5-84c615985f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1620253b-256e-45f5-988a-b4db03a86a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1620253b-256e-45f5-988a-b4db03a86a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_8475f1c6-e423-4ef4-a15c-ea3d1b640cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_8475f1c6-e423-4ef4-a15c-ea3d1b640cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities_809f0f63-7a45-4c3d-915a-8259a528b8ac" xlink:href="bsx-20211231.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_DivestitureAgreementTransferOfFacilities_809f0f63-7a45-4c3d-915a-8259a528b8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_076ab2bb-7f15-4314-b6c9-d2e8184f5af0" xlink:href="bsx-20211231.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_076ab2bb-7f15-4314-b6c9-d2e8184f5af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8a43bca0-043f-4a2e-b8e0-31067bc108c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8a43bca0-043f-4a2e-b8e0-31067bc108c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7db3c4e4-56d2-4998-91b3-19812f86e8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7db3c4e4-56d2-4998-91b3-19812f86e8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_018402b3-60f7-4ed9-91dd-1146b5f2d9d2" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_018402b3-60f7-4ed9-91dd-1146b5f2d9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod_ff2481f8-3f5b-48cf-b597-bf1fcecc5de6" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdadece7-2b30-4bf6-9513-a92a4f26885d" xlink:to="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod_ff2481f8-3f5b-48cf-b597-bf1fcecc5de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_516a3b9b-5120-491d-9da2-f7cb1421dcf0" xlink:href="bsx-20211231.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_05ab40c4-2c54-4768-b153-9d567893a56c" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_516a3b9b-5120-491d-9da2-f7cb1421dcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5c7cf602-0115-4f81-a54c-f6817fb644d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5c7cf602-0115-4f81-a54c-f6817fb644d1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_90bcae64-cc1b-4fea-94e0-407690f9a87e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_srt_RangeAxis_90bcae64-cc1b-4fea-94e0-407690f9a87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_90bcae64-cc1b-4fea-94e0-407690f9a87e" xlink:to="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4cf9b5a2-5183-47ea-8864-454de417dfdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:to="loc_srt_MinimumMember_4cf9b5a2-5183-47ea-8864-454de417dfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_abc065cf-38c7-4419-b807-0613140bfafc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:to="loc_srt_MaximumMember_abc065cf-38c7-4419-b807-0613140bfafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_6a9f8655-f37e-47aa-bda6-820d9012a892" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_58ced645-7180-40ba-b77a-7601b3767fd2" xlink:to="loc_srt_WeightedAverageMember_6a9f8655-f37e-47aa-bda6-820d9012a892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_us-gaap_ValuationTechniqueAxis_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_56418b1d-eadc-492c-a6ac-2f71b7566880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_1b55b96d-4a42-4fd6-b9d3-122e603b5e3c" xlink:to="loc_us-gaap_ValuationTechniqueDomain_56418b1d-eadc-492c-a6ac-2f71b7566880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c604f6cf-8e2a-49bf-8114-28fdc0967c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56418b1d-eadc-492c-a6ac-2f71b7566880" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c604f6cf-8e2a-49bf-8114-28fdc0967c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_804a001e-b3d5-4d6c-b470-35dfecb4ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_804a001e-b3d5-4d6c-b470-35dfecb4ac8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_804a001e-b3d5-4d6c-b470-35dfecb4ac8a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2021AcquisitionsMember_7181ca25-1c40-4695-a786-558dffc4e476" xlink:href="bsx-20211231.xsd#bsx_A2021AcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:to="loc_bsx_A2021AcquisitionsMember_7181ca25-1c40-4695-a786-558dffc4e476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseIncMember_93c271d9-bd1f-48cf-8112-a5cf35af1ab5" xlink:href="bsx-20211231.xsd#bsx_FarapulseIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b3dd36-4eb1-4c82-953c-e7f8d78d2404" xlink:to="loc_bsx_FarapulseIncMember_93c271d9-bd1f-48cf-8112-a5cf35af1ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_b0071676-7dcd-456b-bb39-7e5f0f382f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_b0071676-7dcd-456b-bb39-7e5f0f382f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_b0071676-7dcd-456b-bb39-7e5f0f382f6f" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_5a4c9c4f-c931-4aaf-9445-e5b611c4350c" xlink:href="bsx-20211231.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_5a4c9c4f-c931-4aaf-9445-e5b611c4350c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_c4293fe3-e674-45fa-b47c-4b8449a155ba" xlink:href="bsx-20211231.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3a3e2142-13af-4675-b300-a44ff2bb35f2" xlink:to="loc_bsx_RevenueBasedPaymentsMember_c4293fe3-e674-45fa-b47c-4b8449a155ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b97868a7-54d8-4215-8a56-64633b5d8901" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_e38afc3c-ec51-44b6-8775-f9d0ef018bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_e38afc3c-ec51-44b6-8775-f9d0ef018bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_7115bc31-2a2f-418f-9f31-02c56bf6a041" xlink:href="bsx-20211231.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:to="loc_bsx_PaymentOfContingentConsideration_7115bc31-2a2f-418f-9f31-02c56bf6a041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d3e6dce4-60ad-428e-b615-0ff8f99a0b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_bdc531f6-f621-45d9-8669-ef71cc525a72" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d3e6dce4-60ad-428e-b615-0ff8f99a0b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3c96a4e-0517-49b9-81de-b395ba0caea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3c96a4e-0517-49b9-81de-b395ba0caea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_16524f89-b290-4f8e-89c8-bce30c4aab0a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_16deb6da-5089-4b29-b413-879ad7eec29d" xlink:href="bsx-20211231.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_16deb6da-5089-4b29-b413-879ad7eec29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_fc2735bb-8137-4378-b65c-1b4fb88fd78c" xlink:href="bsx-20211231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:to="loc_bsx_DiscountRateFairValueInput_fc2735bb-8137-4378-b65c-1b4fb88fd78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_709fd916-00b1-494a-b3d8-1df3da6c29e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_364b68f4-51df-4102-b5fa-8a336c40b69d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_709fd916-00b1-494a-b3d8-1df3da6c29e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_ebf23b98-ac24-4b14-b146-76f7242aad22" xlink:href="bsx-20211231.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7cbc5318-951f-4310-8252-457221951ae1" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_ebf23b98-ac24-4b14-b146-76f7242aad22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#StrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_f333871d-e5a7-4e87-afbd-8b60a6ac2a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_320a0996-29ab-4aa7-8931-566d3ab591cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f333871d-e5a7-4e87-afbd-8b60a6ac2a8e" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_320a0996-29ab-4aa7-8931-566d3ab591cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_37b98060-135d-45c9-bdd8-972e881c5894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_320a0996-29ab-4aa7-8931-566d3ab591cb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_37b98060-135d-45c9-bdd8-972e881c5894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9973eb52-92b0-4696-80b4-aaf333bed92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37b98060-135d-45c9-bdd8-972e881c5894" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9973eb52-92b0-4696-80b4-aaf333bed92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_57f49461-646b-4efe-a61f-5431b24ef3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9973eb52-92b0-4696-80b4-aaf333bed92c" xlink:to="loc_us-gaap_SubsequentEventMember_57f49461-646b-4efe-a61f-5431b24ef3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_320a0996-29ab-4aa7-8931-566d3ab591cb" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_55f50724-ab0b-410c-93fb-226a1a0b005b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_55f50724-ab0b-410c-93fb-226a1a0b005b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d2be4f94-03f0-4383-86af-cec55d3daa51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquityMethodInvestments_d2be4f94-03f0-4383-86af-cec55d3daa51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1bfb0df8-27ae-4a85-8c0b-f5eb80f5eeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1bfb0df8-27ae-4a85-8c0b-f5eb80f5eeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_8b4eccb6-5e1a-4272-9bb7-984a24a1474d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_8b4eccb6-5e1a-4272-9bb7-984a24a1474d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d8529f8e-45e0-4632-83a6-32d76d7c16a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d8529f8e-45e0-4632-83a6-32d76d7c16a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_45dbc05e-bf25-4849-9749-0217d84b71da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_Investments_45dbc05e-bf25-4849-9749-0217d84b71da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_33d22b94-4227-4f63-b256-21a647914292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_eb98d4bd-cf30-4b6c-8eda-dc8a20332aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c4bdb35-a767-4041-a095-80e72ad4cbc2" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_eb98d4bd-cf30-4b6c-8eda-dc8a20332aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="simple" xlink:href="bsx-20211231.xsd#AssetsandLiabilitiesHeldforSale"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0456deb4-4d8b-41e3-9f0d-ef72256d8214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f7cee5f3-e635-4a44-bcc1-baafccd18c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0456deb4-4d8b-41e3-9f0d-ef72256d8214" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f7cee5f3-e635-4a44-bcc1-baafccd18c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#AssetsandLiabilitiesHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c60e3a8a-8d25-4271-8347-0f531641c48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_a952c4c1-7bf9-4741-aed3-69dd48912c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c60e3a8a-8d25-4271-8347-0f531641c48c" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_a952c4c1-7bf9-4741-aed3-69dd48912c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#AssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a5e89345-7c55-4a7b-af05-bae248cc9d16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a5e89345-7c55-4a7b-af05-bae248cc9d16" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aa492cd4-8462-4f4e-aef1-761d07dc427d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aa492cd4-8462-4f4e-aef1-761d07dc427d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_030a87ef-adfe-4424-aab4-58eb857ec5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aa492cd4-8462-4f4e-aef1-761d07dc427d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_030a87ef-adfe-4424-aab4-58eb857ec5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_f1e0b58c-f92f-4cc9-bcb8-104c7386f08e" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_030a87ef-adfe-4424-aab4-58eb857ec5b3" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_f1e0b58c-f92f-4cc9-bcb8-104c7386f08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4ef78b51-e43c-4cc6-ae45-1b5bee178404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4ef78b51-e43c-4cc6-ae45-1b5bee178404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_df449055-9137-41e3-9796-4910a8152f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ef78b51-e43c-4cc6-ae45-1b5bee178404" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_df449055-9137-41e3-9796-4910a8152f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_359973c9-455c-4b08-8ba2-d64272b75f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_df449055-9137-41e3-9796-4910a8152f03" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_359973c9-455c-4b08-8ba2-d64272b75f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_86776ed3-f64a-43a5-9705-6888503ee9b8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f2b50a88-7585-4e87-a44b-94e2a3a74430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f2b50a88-7585-4e87-a44b-94e2a3a74430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4080c601-e1e9-41a8-bae2-a6290ad6b3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4080c601-e1e9-41a8-bae2-a6290ad6b3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_fc5420a7-52fa-4e57-a8b7-46f580cf8ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_fc5420a7-52fa-4e57-a8b7-46f580cf8ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_609771b2-4732-42a6-a8c6-32ce169e2131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_609771b2-4732-42a6-a8c6-32ce169e2131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_683e8195-87a4-45ea-9e0c-c6eae6420b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_683e8195-87a4-45ea-9e0c-c6eae6420b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_ffe5f715-46da-40e1-82eb-a96559f175ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_ffe5f715-46da-40e1-82eb-a96559f175ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_d9beca9d-fabb-42e3-a6f1-f7161e60735c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_d9beca9d-fabb-42e3-a6f1-f7161e60735c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_4d38f10d-cc43-46b8-aa16-b46c3684ec99" xlink:href="bsx-20211231.xsd#bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_4d38f10d-cc43-46b8-aa16-b46c3684ec99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_caab77e9-3934-479e-af7d-01e300b71567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_caab77e9-3934-479e-af7d-01e300b71567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_c94ca0e3-87bb-4238-929a-46fd9333d1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_c94ca0e3-87bb-4238-929a-46fd9333d1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_b0b4efdf-ba47-4ff4-8c4c-731520aab342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_b0b4efdf-ba47-4ff4-8c4c-731520aab342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_94b98ac7-334c-4aa7-9495-3328e2ff966c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_94b98ac7-334c-4aa7-9495-3328e2ff966c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8ced1598-388b-4f04-a6cb-2de076e3c5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8ced1598-388b-4f04-a6cb-2de076e3c5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e22c04fc-2f9e-44e7-867b-2a91fe21995e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd3b86cd-6994-44ee-b2c6-869013606684" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e22c04fc-2f9e-44e7-867b-2a91fe21995e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20211231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_158c2c59-9d1a-4419-af71-f0e8f020ed53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8a8202f4-e020-4ae9-af76-59ccb51aa979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_158c2c59-9d1a-4419-af71-f0e8f020ed53" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8a8202f4-e020-4ae9-af76-59ccb51aa979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b295e92-eca5-4bb9-ac3a-70b16b9da937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_467d3684-8370-4663-a52a-8137d262d134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b295e92-eca5-4bb9-ac3a-70b16b9da937" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_467d3684-8370-4663-a52a-8137d262d134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_0534f11b-2323-4b5b-8099-cb7a10d376fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b295e92-eca5-4bb9-ac3a-70b16b9da937" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_0534f11b-2323-4b5b-8099-cb7a10d376fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_93cd257f-78c5-4248-bee7-ec238efcc377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b295e92-eca5-4bb9-ac3a-70b16b9da937" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_93cd257f-78c5-4248-bee7-ec238efcc377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_818b5c71-5c75-4090-9208-9df499b31d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_818b5c71-5c75-4090-9208-9df499b31d03" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dab868fb-ef0c-440d-8d23-dc9ecc8e4948" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_srt_RangeAxis_dab868fb-ef0c-440d-8d23-dc9ecc8e4948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dab868fb-ef0c-440d-8d23-dc9ecc8e4948" xlink:to="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5f66b0f2-d194-4059-9503-fa1d7f06e939" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:to="loc_srt_MinimumMember_5f66b0f2-d194-4059-9503-fa1d7f06e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_991dabee-ae0d-4ccb-b0cf-85ae15c1b2f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f7708674-84f3-49c5-82bc-6a23b6099dfb" xlink:to="loc_srt_MaximumMember_991dabee-ae0d-4ccb-b0cf-85ae15c1b2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec40ad03-da53-4977-b541-db16a052a0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec40ad03-da53-4977-b541-db16a052a0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec40ad03-da53-4977-b541-db16a052a0af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9e58ec39-2c83-4626-9183-13b166f98d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9e58ec39-2c83-4626-9183-13b166f98d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_95644b83-f753-4cb1-bdcf-a5ce902df1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:to="loc_us-gaap_PatentsMember_95644b83-f753-4cb1-bdcf-a5ce902df1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_049c2364-ebf1-4401-9678-2081bea4d695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b937911c-13b5-4870-b5d5-24ce392c7d19" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_049c2364-ebf1-4401-9678-2081bea4d695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bbe267c3-8af7-4567-aae3-982a7729978a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bbe267c3-8af7-4567-aae3-982a7729978a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bbe267c3-8af7-4567-aae3-982a7729978a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e8b9089c-b65b-4419-8730-5a5cb6fada19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e8b9089c-b65b-4419-8730-5a5cb6fada19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_268557c6-99aa-4556-9652-7a8390293337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_32d94804-b020-4735-90e8-0fbcc100c9bd" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_268557c6-99aa-4556-9652-7a8390293337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8de50882-6bc1-4f12-8e40-ab74bb206aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8de50882-6bc1-4f12-8e40-ab74bb206aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8de50882-6bc1-4f12-8e40-ab74bb206aec" xlink:to="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_c6e38f18-f2e5-4d5b-8cba-4d2722ba49fb" xlink:href="bsx-20211231.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_MedsurgMember_c6e38f18-f2e5-4d5b-8cba-4d2722ba49fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_f6586de4-8f03-4e1c-8e29-3435c6b7ac14" xlink:href="bsx-20211231.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_RhythmandNeuroMember_f6586de4-8f03-4e1c-8e29-3435c6b7ac14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_999e2bd5-067b-4f11-ab1b-533ab396c5f4" xlink:href="bsx-20211231.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_CardiovascularMember_999e2bd5-067b-4f11-ab1b-533ab396c5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_f669c7f3-cda1-43ec-b849-0a276d91c315" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8543d614-7dd7-44d8-8a7a-7254514d6730" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_f669c7f3-cda1-43ec-b849-0a276d91c315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0874f26a-d422-4d63-ae99-952d6db060f1" xlink:to="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f55b4f69-410b-4526-91c2-d48da543ba3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f55b4f69-410b-4526-91c2-d48da543ba3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cdb4d5bf-9347-42bb-b64f-6de86b482f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cdb4d5bf-9347-42bb-b64f-6de86b482f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_c9256ca0-9fb9-4834-b7e8-d2766316337e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_GoodwillGross_c9256ca0-9fb9-4834-b7e8-d2766316337e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_71eb30f9-7a0b-43e6-a43e-b09e2e7046e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_71eb30f9-7a0b-43e6-a43e-b09e2e7046e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9abb98d6-202e-4298-a4d2-0a9ff7eadc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9abb98d6-202e-4298-a4d2-0a9ff7eadc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_87467427-5f3c-4baf-aaf7-00d045ddf3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_87467427-5f3c-4baf-aaf7-00d045ddf3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:href="bsx-20211231.xsd#bsx_GoodwillTextualsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_012ea055-ba1a-441b-b40b-1d27d9e3f2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_Goodwill_012ea055-ba1a-441b-b40b-1d27d9e3f2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_ca452460-6ba3-40c9-9b93-1d705b63ba35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_ca452460-6ba3-40c9-9b93-1d705b63ba35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5416c064-eb6b-4a73-9754-325b5f1a8d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5416c064-eb6b-4a73-9754-325b5f1a8d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e37ef05e-b275-41af-b7b5-34405eea7ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e37ef05e-b275-41af-b7b5-34405eea7ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_7e920b13-a878-44b7-970a-dae3b07deeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_ec6f5055-8c91-4ea9-868f-9933122384dc" xlink:to="loc_us-gaap_GoodwillTransfers_7e920b13-a878-44b7-970a-dae3b07deeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:href="bsx-20211231.xsd#bsx_OtherIntangibleAssetsTextualsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2daf7956-aaa8-488d-80da-d711da5adb43" xlink:to="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7da8c583-134c-4218-a7b7-a637e709f6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7da8c583-134c-4218-a7b7-a637e709f6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b1dc4824-0613-4fa9-b7ad-45260ca7cbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b1dc4824-0613-4fa9-b7ad-45260ca7cbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d8a89d77-9bbc-4a59-b9f6-7e846c174398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d8a89d77-9bbc-4a59-b9f6-7e846c174398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d2d19c2e-47c3-43aa-be11-219d0365f91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d2d19c2e-47c3-43aa-be11-219d0365f91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ae0f61c3-d1b4-4848-ab45-a86589fe941a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_8aa8996d-79cc-4a50-9bac-3ef949ae5cb6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ae0f61c3-d1b4-4848-ab45-a86589fe941a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20211231.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a44ff23a-79e0-4a16-8bfc-cf62a989c11b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d0f60db3-0f43-47b6-9958-56964c5f73d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a44ff23a-79e0-4a16-8bfc-cf62a989c11b" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_d0f60db3-0f43-47b6-9958-56964c5f73d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_61491469-b58e-4760-a18e-461c75b15a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d0f60db3-0f43-47b6-9958-56964c5f73d9" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_61491469-b58e-4760-a18e-461c75b15a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="simple" xlink:href="bsx-20211231.xsd#FairValueMeasuresandDisclosuresPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c4cbe5b0-ccf6-4a2c-84bc-2063ef780890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_8072bae8-eb3b-4a6b-9a94-d4c0e419de17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c4cbe5b0-ccf6-4a2c-84bc-2063ef780890" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_8072bae8-eb3b-4a6b-9a94-d4c0e419de17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_00f128f9-df81-4c3f-9b58-dbbc2754f599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c4cbe5b0-ccf6-4a2c-84bc-2063ef780890" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_00f128f9-df81-4c3f-9b58-dbbc2754f599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8d893cb0-3142-4702-aafa-c98231686132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8e740395-1fc9-4637-8aa7-c635a4003baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8d893cb0-3142-4702-aafa-c98231686132" xlink:to="loc_us-gaap_DerivativeTable_8e740395-1fc9-4637-8aa7-c635a4003baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2c7679-aba5-4d95-8cae-d650058f5ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8e740395-1fc9-4637-8aa7-c635a4003baa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2c7679-aba5-4d95-8cae-d650058f5ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a7c9e7ef-17f2-4c44-9976-4ff845dbf56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5b2c7679-aba5-4d95-8cae-d650058f5ddb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a7c9e7ef-17f2-4c44-9976-4ff845dbf56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8e740395-1fc9-4637-8aa7-c635a4003baa" xlink:to="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_20d2fd0e-f2a0-43be-bf90-aea8a69b003c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_20d2fd0e-f2a0-43be-bf90-aea8a69b003c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3fff60ca-5577-4ae2-a571-98ca8d94cb37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3fff60ca-5577-4ae2-a571-98ca8d94cb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4b292e3c-cc35-42a8-8c21-c16eece9211f" xlink:href="bsx-20211231.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4b292e3c-cc35-42a8-8c21-c16eece9211f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f4f3c00d-d927-4c0f-9e2c-d01e43502771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f4f3c00d-d927-4c0f-9e2c-d01e43502771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2281fa2b-3975-47f4-84c3-fd1cc2589aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5692fbee-c923-4035-ac08-d0db66134af3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2281fa2b-3975-47f4-84c3-fd1cc2589aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_565e0511-bf80-4325-8bf9-c291f426df9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8d893cb0-3142-4702-aafa-c98231686132" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_565e0511-bf80-4325-8bf9-c291f426df9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_565e0511-bf80-4325-8bf9-c291f426df9e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f4260a98-8be2-43b3-aa4d-3f9b17505cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f4260a98-8be2-43b3-aa4d-3f9b17505cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0fa45293-42ed-4e39-83da-ca56834fc7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f4260a98-8be2-43b3-aa4d-3f9b17505cf0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0fa45293-42ed-4e39-83da-ca56834fc7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea0340c9-bc57-4ca1-93e9-809c386a324e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea0340c9-bc57-4ca1-93e9-809c386a324e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7560aac-1f3f-481a-a826-cf7c178b51a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea0340c9-bc57-4ca1-93e9-809c386a324e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7560aac-1f3f-481a-a826-cf7c178b51a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_479c155c-db60-4c7d-a9cc-396981a72999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f95c8b12-1e2c-474a-865e-9bb5daa94fe6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_479c155c-db60-4c7d-a9cc-396981a72999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_72884af0-50a2-4295-8027-4f03e2b4d1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_479c155c-db60-4c7d-a9cc-396981a72999" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_72884af0-50a2-4295-8027-4f03e2b4d1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_04610f1b-7cf3-42bf-8088-d0ab928e726e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_04610f1b-7cf3-42bf-8088-d0ab928e726e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_edefbed0-a324-41e1-be46-6c2251a1cfa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_edefbed0-a324-41e1-be46-6c2251a1cfa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_edefbed0-a324-41e1-be46-6c2251a1cfa1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0a585ee5-a6bf-413a-bc48-2d823e26973f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:to="loc_us-gaap_CashFlowHedgingMember_0a585ee5-a6bf-413a-bc48-2d823e26973f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ad401c89-e69f-4efd-9a19-a687c0523d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bb2361f5-bbe7-46ab-84b5-bbe2e9d176a3" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ad401c89-e69f-4efd-9a19-a687c0523d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4cbfee8d-9310-4746-92bf-85a261f82957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_HedgingDesignationAxis_4cbfee8d-9310-4746-92bf-85a261f82957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_4cbfee8d-9310-4746-92bf-85a261f82957" xlink:to="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f12928e6-ee21-4248-aab2-1503df149350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f12928e6-ee21-4248-aab2-1503df149350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_220e26bd-f9dc-42ce-8b3c-e35cc099ab4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5ef139ab-6867-49c5-a724-60f7fadae1e8" xlink:to="loc_us-gaap_NondesignatedMember_220e26bd-f9dc-42ce-8b3c-e35cc099ab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a640adfc-72fd-45c9-8d7b-c52f3cc73a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a640adfc-72fd-45c9-8d7b-c52f3cc73a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a640adfc-72fd-45c9-8d7b-c52f3cc73a44" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_173bc996-6bd3-4df4-ac06-09f6f04d3e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_173bc996-6bd3-4df4-ac06-09f6f04d3e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6ee73e37-ca58-48bc-ae59-4dc7ac9a89a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6ee73e37-ca58-48bc-ae59-4dc7ac9a89a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_4742e1a5-b69e-49ae-83bc-155d3c381034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_us-gaap_InterestRateContractMember_4742e1a5-b69e-49ae-83bc-155d3c381034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeignCurrencyDenominatedInDebtMember_fb794eb6-134f-4fcb-8f5b-1ca9e494f756" xlink:href="bsx-20211231.xsd#bsx_ForeignCurrencyDenominatedInDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c3a0fe-e519-4bf2-ad36-968fa1e7f797" xlink:to="loc_bsx_ForeignCurrencyDenominatedInDebtMember_fb794eb6-134f-4fcb-8f5b-1ca9e494f756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f32e807d-76d0-4524-804d-5d480935ccbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f32e807d-76d0-4524-804d-5d480935ccbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d67be27-aede-4196-999d-6f6a23a7afdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f32e807d-76d0-4524-804d-5d480935ccbe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d67be27-aede-4196-999d-6f6a23a7afdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_87061174-4230-4d2f-b235-1360e3f8a3ae" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d67be27-aede-4196-999d-6f6a23a7afdf" xlink:to="loc_bsx_BTGAcquisitionMember_87061174-4230-4d2f-b235-1360e3f8a3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_14d54041-d2c2-4b6c-aa3d-0d4f312be45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_14d54041-d2c2-4b6c-aa3d-0d4f312be45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_14d54041-d2c2-4b6c-aa3d-0d4f312be45a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_358b9fab-3afe-4023-92a4-87e01cc9d0ea" xlink:href="bsx-20211231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:to="loc_bsx_November2019AggregateOfferingMember_358b9fab-3afe-4023-92a4-87e01cc9d0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_8a2e1678-5121-4036-a1cf-7b5e6cd8c578" xlink:href="bsx-20211231.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7bf80675-b417-49d9-a574-dc32dd79f346" xlink:to="loc_bsx_December2027NotesMember_8a2e1678-5121-4036-a1cf-7b5e6cd8c578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_119f0b53-52eb-4d39-82c2-55e5e5f751b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_119f0b53-52eb-4d39-82c2-55e5e5f751b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_119f0b53-52eb-4d39-82c2-55e5e5f751b8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_c1a9f219-7d34-43e5-a174-40a2e996cd82" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_bsx_LicensingArrangementAssetsMember_c1a9f219-7d34-43e5-a174-40a2e996cd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_88e124e6-eb58-49fb-8b46-5cdfb7c0a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_88e124e6-eb58-49fb-8b46-5cdfb7c0a0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_d53bb4d6-9446-4c0f-b684-9879337c1c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_d53bb4d6-9446-4c0f-b684-9879337c1c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f2466f67-ff3a-49aa-8c4a-9a0a41e96d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f2466f67-ff3a-49aa-8c4a-9a0a41e96d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_97243ade-fbb0-4e9f-a65b-147393d6f19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_97243ade-fbb0-4e9f-a65b-147393d6f19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b16e42b5-4ea3-4e7d-b58c-0be72d163565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5ead5948-3ea2-4638-9142-cf86aa2c1243" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b16e42b5-4ea3-4e7d-b58c-0be72d163565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98e1c35b-8391-4752-aab9-e03355b010e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98e1c35b-8391-4752-aab9-e03355b010e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98e1c35b-8391-4752-aab9-e03355b010e7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_38c072f7-be24-4b86-aebe-2dcdc0dd63a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:to="loc_us-gaap_CostOfSalesMember_38c072f7-be24-4b86-aebe-2dcdc0dd63a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_37b4f8d7-0992-41b7-9024-5741d1cc44b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:to="loc_us-gaap_InterestExpenseMember_37b4f8d7-0992-41b7-9024-5741d1cc44b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_a8d80a14-23c4-4953-a097-1d3ec074de82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ec7fd64-972c-4c02-b7d8-94f778477883" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_a8d80a14-23c4-4953-a097-1d3ec074de82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ad6bbb6-30eb-4b20-b0a7-d7581f337de6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2278fda1-bc91-4295-9f14-8bbbdf5026e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_LongTermDebt_2278fda1-bc91-4295-9f14-8bbbdf5026e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_729d1532-117f-41f3-a92d-95bec79b09d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_729d1532-117f-41f3-a92d-95bec79b09d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_4b165c0d-b909-4860-94fb-3314e73dcee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_4b165c0d-b909-4860-94fb-3314e73dcee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge_bc403086-7d51-4e48-aaa0-410c348f5f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeCashReceivedOnHedge_bc403086-7d51-4e48-aaa0-410c348f5f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_7c7258c2-c623-4dd2-b599-5b2cfbcea4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_7c7258c2-c623-4dd2-b599-5b2cfbcea4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_979a03b0-0d57-433d-88c8-7cfda3224b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_979a03b0-0d57-433d-88c8-7cfda3224b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_abe68c13-ce8d-4077-be45-3a1b32c1dfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeNotionalAmount_abe68c13-ce8d-4077-be45-3a1b32c1dfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_c24c3b24-1d01-48c6-9af3-df096b559efa" xlink:href="bsx-20211231.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_c24c3b24-1d01-48c6-9af3-df096b559efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_43c9f075-d128-409c-81a1-cb2041b9ebc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_43c9f075-d128-409c-81a1-cb2041b9ebc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fb5f86d4-f54f-457d-bd40-dd7db19d2a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fb5f86d4-f54f-457d-bd40-dd7db19d2a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_9a509e1b-b550-469a-90c3-d05e59288584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_9a509e1b-b550-469a-90c3-d05e59288584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_088a0e6a-c879-4a3c-9ea4-853182577264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_088a0e6a-c879-4a3c-9ea4-853182577264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c07a04a7-7021-4370-bb14-1a5569c6ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c07a04a7-7021-4370-bb14-1a5569c6ff84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_7c56b5d1-5646-46dc-8fb2-de1fc9df8ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_7c56b5d1-5646-46dc-8fb2-de1fc9df8ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c7ff9b5f-3640-4026-8cca-b4beb35c473c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c7ff9b5f-3640-4026-8cca-b4beb35c473c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_68a52505-5c0c-4f93-a283-9a549f0dbe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_68a52505-5c0c-4f93-a283-9a549f0dbe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_927a0b7b-f0ed-4503-9fa7-c9bfabb6e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_927a0b7b-f0ed-4503-9fa7-c9bfabb6e17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5b49eb99-f1e2-4fcf-94c8-57518cfc5e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5b49eb99-f1e2-4fcf-94c8-57518cfc5e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_979cddff-6dd7-4e9e-b63e-e99f84b05a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_InterestExpense_979cddff-6dd7-4e9e-b63e-e99f84b05a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_47f21666-7e58-4403-8b96-dc8dfddf1f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_47f21666-7e58-4403-8b96-dc8dfddf1f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_d3da45bd-d09c-49e5-b38f-435e8feb1d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_d3da45bd-d09c-49e5-b38f-435e8feb1d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_a1a6a4d4-c2e2-4edb-92c5-d2845dda201d" xlink:href="bsx-20211231.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_a1a6a4d4-c2e2-4edb-92c5-d2845dda201d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_28f9cb8d-b0e3-4842-846f-c94972393bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_28f9cb8d-b0e3-4842-846f-c94972393bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_51c30405-1a69-46a3-aa6a-4823d8204f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_51c30405-1a69-46a3-aa6a-4823d8204f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_220cc5da-b255-4800-b64a-4db82c463467" xlink:href="bsx-20211231.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_220cc5da-b255-4800-b64a-4db82c463467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a91bfb1c-15c7-4d0d-bd26-1b80c0fce9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a91bfb1c-15c7-4d0d-bd26-1b80c0fce9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_dcffd58c-de49-490a-a380-3797e43c7a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_dcffd58c-de49-490a-a380-3797e43c7a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_83a23ef8-40d9-4ad6-9385-e9c15c96ba0f" xlink:href="bsx-20211231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_83a23ef8-40d9-4ad6-9385-e9c15c96ba0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_7d22a639-fc4a-4aa9-a278-5860b6a70195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_7d22a639-fc4a-4aa9-a278-5860b6a70195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_7004aa01-7d4a-44f2-a86d-3104471a3589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_7004aa01-7d4a-44f2-a86d-3104471a3589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_639461a2-9ecc-43f9-9004-2df45c06cba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_639461a2-9ecc-43f9-9004-2df45c06cba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_890ed7f5-ead6-4d72-8356-b26209bb3d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_890ed7f5-ead6-4d72-8356-b26209bb3d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_fcf70cc0-9e6f-4f81-9a8b-bdc55fbbaf90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_fcf70cc0-9e6f-4f81-9a8b-bdc55fbbaf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ea751b5-1540-4d02-8c43-f66fb7cdecb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ea751b5-1540-4d02-8c43-f66fb7cdecb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_302dcb93-2970-4707-ba4f-84b75480cdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3953ac11-2814-4a32-8548-ccfc58119a87" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_302dcb93-2970-4707-ba4f-84b75480cdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_04610f1b-7cf3-42bf-8088-d0ab928e726e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a242b512-6f9b-4866-8de4-5afefc4b2079" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_srt_RangeAxis_a242b512-6f9b-4866-8de4-5afefc4b2079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a242b512-6f9b-4866-8de4-5afefc4b2079" xlink:to="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_2b964ce1-6cbe-43e4-b8c6-95c3143cb21a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:to="loc_srt_WeightedAverageMember_2b964ce1-6cbe-43e4-b8c6-95c3143cb21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3fe55151-373c-44b2-bdb3-b747ad0ab426" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:to="loc_srt_MinimumMember_3fe55151-373c-44b2-bdb3-b747ad0ab426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a04119d-3221-4a66-86a0-3f3070fb5c60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd8deca5-4a32-464f-8e57-084352ef9254" xlink:to="loc_srt_MaximumMember_8a04119d-3221-4a66-86a0-3f3070fb5c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_78c5deb1-0d77-4984-9755-763850fe4e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_78c5deb1-0d77-4984-9755-763850fe4e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1308cbf-3b68-4cb6-a55d-ecaad94d4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_78c5deb1-0d77-4984-9755-763850fe4e8a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1308cbf-3b68-4cb6-a55d-ecaad94d4ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f3b5532c-315b-4f42-8998-a366dbb548bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1308cbf-3b68-4cb6-a55d-ecaad94d4ea0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f3b5532c-315b-4f42-8998-a366dbb548bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e85fa25b-b8bd-45a2-9edf-144f37617f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e85fa25b-b8bd-45a2-9edf-144f37617f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e85fa25b-b8bd-45a2-9edf-144f37617f35" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5b8ea32a-9c27-42bd-9fea-c55b7e2f9c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5b8ea32a-9c27-42bd-9fea-c55b7e2f9c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a3f616e8-153e-4b79-b1e3-5bf93207be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a3f616e8-153e-4b79-b1e3-5bf93207be0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_303b934c-7a77-4913-b559-31bc8e6edad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e845dcf-470a-4913-987e-f189f8407b42" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_303b934c-7a77-4913-b559-31bc8e6edad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_20dcd3ee-0501-4806-9462-078d20ed3066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_20dcd3ee-0501-4806-9462-078d20ed3066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_20dcd3ee-0501-4806-9462-078d20ed3066" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_a402da51-31eb-4820-899d-673ad58d333c" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:to="loc_bsx_LicensingArrangementAssetsMember_a402da51-31eb-4820-899d-673ad58d333c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementLiabilitiesMember_e42c327c-0d92-4a02-bc81-523e2b1449f8" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:to="loc_bsx_LicensingArrangementLiabilitiesMember_e42c327c-0d92-4a02-bc81-523e2b1449f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedOutstandingDebtMember_fb29e984-a9ff-4c0c-8134-e33d3970afd3" xlink:href="bsx-20211231.xsd#bsx_EuroDenominatedOutstandingDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb2b75c1-ef24-4b6f-8ce5-2613d5657b07" xlink:to="loc_bsx_EuroDenominatedOutstandingDebtMember_fb29e984-a9ff-4c0c-8134-e33d3970afd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34a1a4ff-dbb5-44cc-95b6-68f0eebf47f2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_1b903886-1416-48d5-b709-8980983be855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_1b903886-1416-48d5-b709-8980983be855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_e2249149-3bc3-490e-8b0d-b9d2014338dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_e2249149-3bc3-490e-8b0d-b9d2014338dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_1d5a1e0e-3671-40ba-9e44-fe06debde90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_DerivativeAssets_1d5a1e0e-3671-40ba-9e44-fe06debde90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_640248f7-704a-46f6-b246-f1b85a483d2b" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_LicensingArrangementsAsset_640248f7-704a-46f6-b246-f1b85a483d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_17e850f4-1707-4599-8048-825d3c8b10ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_17e850f4-1707-4599-8048-825d3c8b10ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a3cce438-1479-4cc5-bef4-9004076cfe30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_DerivativeLiabilities_a3cce438-1479-4cc5-bef4-9004076cfe30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93af3cec-266f-4bc2-90aa-9eea6efd858f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93af3cec-266f-4bc2-90aa-9eea6efd858f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_547e3d76-a69c-44eb-9ecb-705d5244cc2e" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_LicensingArrangementsLiability_547e3d76-a69c-44eb-9ecb-705d5244cc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_e073c35d-9d87-471d-885f-290505d24a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_e073c35d-9d87-471d-885f-290505d24a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e755160e-a576-4b93-a7cb-6a861c7060f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_e755160e-a576-4b93-a7cb-6a861c7060f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_a393aeaa-3d0a-493c-9187-ad775cbc4dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_Cash_a393aeaa-3d0a-493c-9187-ad775cbc4dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_334d0b5c-7808-4bfd-8087-9b3e11cfc75e" xlink:href="bsx-20211231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_334d0b5c-7808-4bfd-8087-9b3e11cfc75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_3321ff67-946e-4664-b9b2-3eb280b7c363" xlink:href="bsx-20211231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_bsx_DiscountRateFairValueInput_3321ff67-946e-4664-b9b2-3eb280b7c363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_deb339f3-ccbf-482f-ae52-78aabaeb48b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_deb339f3-ccbf-482f-ae52-78aabaeb48b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_48ebb64c-2819-4497-9c83-8f68258acbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_PaymentsForRoyalties_48ebb64c-2819-4497-9c83-8f68258acbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_abe3c1de-7dc8-4a33-a6da-02f50aa8a755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_abe3c1de-7dc8-4a33-a6da-02f50aa8a755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9ae876a6-ea42-4310-9aec-24e245e9a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f44f27f-8e9a-4ed3-87d0-b7f6552740d0" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9ae876a6-ea42-4310-9aec-24e245e9a49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContractualObligationsandCommitments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_60476294-b650-4cdf-ab63-20718ecdc09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_98227fae-2dd0-434e-a4f8-2ba6bae9d208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_60476294-b650-4cdf-ab63-20718ecdc09c" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_98227fae-2dd0-434e-a4f8-2ba6bae9d208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bedd4502-8bcb-417a-9472-7ca472910d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bedd4502-8bcb-417a-9472-7ca472910d26" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1df21ec3-370c-4863-8859-335d5a2aaef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1df21ec3-370c-4863-8859-335d5a2aaef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ccf4a844-d6b7-41b8-9ff7-880f4648f8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1df21ec3-370c-4863-8859-335d5a2aaef9" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ccf4a844-d6b7-41b8-9ff7-880f4648f8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_af5496d8-e36c-4dd4-8c9e-01ddb0f5d83b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ccf4a844-d6b7-41b8-9ff7-880f4648f8c7" xlink:to="loc_us-gaap_CommercialPaperMember_af5496d8-e36c-4dd4-8c9e-01ddb0f5d83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_35ba0f82-ef25-4b7b-8ef6-25cb2c657658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:to="loc_us-gaap_DebtInstrumentAxis_35ba0f82-ef25-4b7b-8ef6-25cb2c657658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_41e2ced0-09fe-4b7b-b8cd-4c7a00e0c5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_35ba0f82-ef25-4b7b-8ef6-25cb2c657658" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_41e2ced0-09fe-4b7b-b8cd-4c7a00e0c5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_84aaede3-7d9c-4769-bd71-5c626e128d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_f775482b-b35c-4dda-866a-5b533a9f539f" xlink:to="loc_us-gaap_ShortTermDebtLineItems_84aaede3-7d9c-4769-bd71-5c626e128d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_6174b155-2104-4cf7-8b5c-ab0840004978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_84aaede3-7d9c-4769-bd71-5c626e128d6b" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_6174b155-2104-4cf7-8b5c-ab0840004978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_262cef37-d450-4b69-949f-abfce7c9d001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bedd4502-8bcb-417a-9472-7ca472910d26" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_262cef37-d450-4b69-949f-abfce7c9d001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_8abed623-5759-4ef7-be09-312ae52ebcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bedd4502-8bcb-417a-9472-7ca472910d26" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_8abed623-5759-4ef7-be09-312ae52ebcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_6d603dc3-de55-4592-ab0f-37a2e872c16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bedd4502-8bcb-417a-9472-7ca472910d26" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_6d603dc3-de55-4592-ab0f-37a2e872c16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_14f4a075-afb0-4eea-ad63-b69419645b2d" xlink:href="bsx-20211231.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bedd4502-8bcb-417a-9472-7ca472910d26" xlink:to="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_14f4a075-afb0-4eea-ad63-b69419645b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_95bab8d3-a626-43f1-bba1-ef0f634a6c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95bab8d3-a626-43f1-bba1-ef0f634a6c0a" xlink:to="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f8830446-7b17-4d53-831d-1cfa4e43e078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b13a6dc3-1f02-45c5-85e0-7ddd895dc25b" xlink:to="loc_us-gaap_ClassOfStockDomain_f8830446-7b17-4d53-831d-1cfa4e43e078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_4961a3e1-37da-44f2-97b8-468716fbc622" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f8830446-7b17-4d53-831d-1cfa4e43e078" xlink:to="loc_bsx_A550MCPSSeriesAMember_4961a3e1-37da-44f2-97b8-468716fbc622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_339f1bcb-1ba0-4214-8872-82e08402082d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_DebtInstrumentAxis_339f1bcb-1ba0-4214-8872-82e08402082d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_339f1bcb-1ba0-4214-8872-82e08402082d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember_7876366c-4db8-4099-bd36-eddae28fc4b6" xlink:href="bsx-20211231.xsd#bsx_April2021TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_April2021TermLoanMember_7876366c-4db8-4099-bd36-eddae28fc4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember_74ad2053-2cd0-4070-b17f-45556ebec28c" xlink:href="bsx-20211231.xsd#bsx_A2020TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_A2020TermLoanMember_74ad2053-2cd0-4070-b17f-45556ebec28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember_2a6d9a1f-a55c-42cd-a293-fa6644d9e0ee" xlink:href="bsx-20211231.xsd#bsx_February2021TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_February2021TermLoanMember_2a6d9a1f-a55c-42cd-a293-fa6644d9e0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember_6e10b85a-7e39-45af-970b-7d7518917458" xlink:href="bsx-20211231.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_ThreeYearDelayedDrawTermLoanMember_6e10b85a-7e39-45af-970b-7d7518917458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember_36a2e655-c237-43ff-9ccf-e6174d84c1b1" xlink:href="bsx-20211231.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_TwoYearDelayedDrawTermLoanMember_36a2e655-c237-43ff-9ccf-e6174d84c1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_a53fbdd3-cf7d-4ffd-bc5c-272ed29984d5" xlink:href="bsx-20211231.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_a53fbdd3-cf7d-4ffd-bc5c-272ed29984d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_55a30465-7360-4be5-b262-c6b9d5b7d369" xlink:href="bsx-20211231.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_55a30465-7360-4be5-b262-c6b9d5b7d369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_92f8b98e-36f5-43c6-b115-9be96c05e06b" xlink:href="bsx-20211231.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_92f8b98e-36f5-43c6-b115-9be96c05e06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_75bfc1eb-af6e-4514-b04d-1bdf75a9a458" xlink:href="bsx-20211231.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_165bf47c-f6ee-442f-ace6-f7b806bc8fb0" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_75bfc1eb-af6e-4514-b04d-1bdf75a9a458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dfdcdc1f-d224-4108-8966-b2a644a2114f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dfdcdc1f-d224-4108-8966-b2a644a2114f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dfdcdc1f-d224-4108-8966-b2a644a2114f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember_88107ff3-d579-4f05-8333-aeb9deba5a0e" xlink:href="bsx-20211231.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_February2019AggregateOfferingMember_88107ff3-d579-4f05-8333-aeb9deba5a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember_e98178ba-3a16-4f83-bd31-53099deaa09e" xlink:href="bsx-20211231.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2020SNAggregateOfferingMember_e98178ba-3a16-4f83-bd31-53099deaa09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember_7d451991-e688-4727-9f86-d85eae74ebd7" xlink:href="bsx-20211231.xsd#bsx_January2020NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_January2020NotesMember_7d451991-e688-4727-9f86-d85eae74ebd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember_15ef5505-023e-4f0e-a9fc-1b7af49207cd" xlink:href="bsx-20211231.xsd#bsx_May2020NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2020NotesMember_15ef5505-023e-4f0e-a9fc-1b7af49207cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_aa2d383c-d979-4ac1-b09b-ff890e859041" xlink:href="bsx-20211231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_November2019AggregateOfferingMember_aa2d383c-d979-4ac1-b09b-ff890e859041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_e828aad6-c21b-4718-9e75-e2984df7f55f" xlink:href="bsx-20211231.xsd#bsx_May2022NotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2022NotesMember_e828aad6-c21b-4718-9e75-e2984df7f55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_a1ce6c0f-6bf3-4cbf-a36a-25807cc1e3d6" xlink:href="bsx-20211231.xsd#bsx_October2023NotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_October2023NotesMember_a1ce6c0f-6bf3-4cbf-a36a-25807cc1e3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7e1d692d-df4a-4c62-acb6-7cbcfaa1da58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7e1d692d-df4a-4c62-acb6-7cbcfaa1da58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_1abc5cb6-e30d-43b3-9c3b-184bc2022dca" xlink:href="bsx-20211231.xsd#bsx_March2024NotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2024NotesMember_1abc5cb6-e30d-43b3-9c3b-184bc2022dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_1d3919a2-df2a-47f8-ace2-96c31fa299cc" xlink:href="bsx-20211231.xsd#bsx_May2025NotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_May2025NotesMember_1d3919a2-df2a-47f8-ace2-96c31fa299cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_9e724d33-7494-4318-aa2e-31bec79d2d89" xlink:href="bsx-20211231.xsd#bsx_June2025NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_June2025NotesMember_9e724d33-7494-4318-aa2e-31bec79d2d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_ae88dabe-f163-48df-9814-16839559fcfe" xlink:href="bsx-20211231.xsd#bsx_March2026NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2026NotesMember_ae88dabe-f163-48df-9814-16839559fcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_81a29598-cf26-4225-9a97-dd145d6983df" xlink:href="bsx-20211231.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_December2027NotesMember_81a29598-cf26-4225-9a97-dd145d6983df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_e383b3f8-f01b-49a7-a69c-801a4ac1d167" xlink:href="bsx-20211231.xsd#bsx_March2028NotesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2028NotesMember_e383b3f8-f01b-49a7-a69c-801a4ac1d167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_f0ff9737-8a71-4536-a400-20c29c61064a" xlink:href="bsx-20211231.xsd#bsx_March2029NotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2029NotesMember_f0ff9737-8a71-4536-a400-20c29c61064a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_c93d18b2-c2c9-431b-9393-7f233531021e" xlink:href="bsx-20211231.xsd#bsx_June2030NotesMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_June2030NotesMember_c93d18b2-c2c9-431b-9393-7f233531021e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_12bfb8af-113a-4135-8d70-5290e0e42862" xlink:href="bsx-20211231.xsd#bsx_November2035NotesMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_November2035NotesMember_12bfb8af-113a-4135-8d70-5290e0e42862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_ce3dbbbf-2664-46db-8e2f-10c38eb99515" xlink:href="bsx-20211231.xsd#bsx_March2039NotesMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2039NotesMember_ce3dbbbf-2664-46db-8e2f-10c38eb99515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_fabbd6a0-ceb9-4012-88c1-323ed16a05a5" xlink:href="bsx-20211231.xsd#bsx_January2040NotesMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_January2040NotesMember_fabbd6a0-ceb9-4012-88c1-323ed16a05a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_d335b587-0e02-481d-8f74-2eb78e3835dd" xlink:href="bsx-20211231.xsd#bsx_March2049NotesMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_March2049NotesMember_d335b587-0e02-481d-8f74-2eb78e3835dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_48784f41-5047-4a45-953b-2ce344859886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_InterestRateSwapMember_48784f41-5047-4a45-953b-2ce344859886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_5f200599-d21c-40bc-817d-38f1b45656ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_5f200599-d21c-40bc-817d-38f1b45656ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_41dfb0ef-d7e5-4d62-9cf1-46f4bb1d119b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_SeniorNotesMember_41dfb0ef-d7e5-4d62-9cf1-46f4bb1d119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_6323aa96-968b-4f80-91cb-2091d11a1386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_UnsecuredDebtMember_6323aa96-968b-4f80-91cb-2091d11a1386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a70773-7f84-4843-afd0-6cca20fc0221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a70773-7f84-4843-afd0-6cca20fc0221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_cff8c92a-44d8-4702-b30d-1ab50a794399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_cff8c92a-44d8-4702-b30d-1ab50a794399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_ed3b7d03-4a09-44ee-87b5-e753ad3eacdc" xlink:href="bsx-20211231.xsd#bsx_August2019TermLoanMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b611ed1-e55b-49e4-b4ed-ee3787e80ad3" xlink:to="loc_bsx_August2019TermLoanMember_ed3b7d03-4a09-44ee-87b5-e753ad3eacdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e5683324-0e5c-4ec8-9b20-0b4d063eaf27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e5683324-0e5c-4ec8-9b20-0b4d063eaf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c8cc2a63-9dbc-4953-9b91-e7ac7edb60fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e5683324-0e5c-4ec8-9b20-0b4d063eaf27" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c8cc2a63-9dbc-4953-9b91-e7ac7edb60fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_890b0240-da96-4d5f-87da-8c0a043101da" xlink:href="bsx-20211231.xsd#bsx_The2018FacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_c8cc2a63-9dbc-4953-9b91-e7ac7edb60fb" xlink:to="loc_bsx_The2018FacilityDomain_890b0240-da96-4d5f-87da-8c0a043101da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3fdf81cc-7827-4bdf-acc7-2c6654257939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_CreditFacilityAxis_3fdf81cc-7827-4bdf-acc7-2c6654257939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_145e3da8-4a35-4769-9ab3-7c7c7ffaf1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_3fdf81cc-7827-4bdf-acc7-2c6654257939" xlink:to="loc_us-gaap_CreditFacilityDomain_145e3da8-4a35-4769-9ab3-7c7c7ffaf1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0ddbd6e4-e0dd-4d5b-bffb-23c93564db05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_145e3da8-4a35-4769-9ab3-7c7c7ffaf1aa" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0ddbd6e4-e0dd-4d5b-bffb-23c93564db05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_f398c964-0782-47ed-8eb5-cdb7a7c454f7" xlink:href="bsx-20211231.xsd#bsx_CovenantAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_bsx_CovenantAxis_f398c964-0782-47ed-8eb5-cdb7a7c454f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:href="bsx-20211231.xsd#bsx_CovenantDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantAxis_f398c964-0782-47ed-8eb5-cdb7a7c454f7" xlink:to="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_8db01390-5fe2-474f-acc0-cc6653af2238" xlink:href="bsx-20211231.xsd#bsx_ActualCovenantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_ActualCovenantMember_8db01390-5fe2-474f-acc0-cc6653af2238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfMarch312021Member_9e22bcec-e236-4db9-a145-cf9faf72c82b" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfMarch312021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfMarch312021Member_9e22bcec-e236-4db9-a145-cf9faf72c82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfJune302021Member_2b1fdcfb-45e0-46da-8a36-a3f6f71e0fec" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfJune302021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfJune302021Member_2b1fdcfb-45e0-46da-8a36-a3f6f71e0fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfSeptember302021Member_ffd8b90c-8103-4bb5-ac96-0a1209971d4c" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfSeptember302021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfSeptember302021Member_ffd8b90c-8103-4bb5-ac96-0a1209971d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_a8eb8ce2-6519-4483-b5d6-cab664d0fa26" xlink:href="bsx-20211231.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_a8eb8ce2-6519-4483-b5d6-cab664d0fa26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember_6abb7092-fb5c-43f1-8544-d306566bb75d" xlink:href="bsx-20211231.xsd#bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember_6abb7092-fb5c-43f1-8544-d306566bb75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_778d618f-ea64-489d-90b7-764022ab3ea3" xlink:href="bsx-20211231.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_778d618f-ea64-489d-90b7-764022ab3ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_4bdcd715-6c80-46f5-8f97-877f2051f458" xlink:href="bsx-20211231.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_4bdcd715-6c80-46f5-8f97-877f2051f458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_b58dd712-784e-46ac-be1d-814405f78f36" xlink:href="bsx-20211231.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_b58dd712-784e-46ac-be1d-814405f78f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember_e409d628-a035-4e3b-a8fc-19c377358f5b" xlink:href="bsx-20211231.xsd#bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_226eefba-d04e-49b9-9e2f-cacf7ccee10e" xlink:to="loc_bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember_e409d628-a035-4e3b-a8fc-19c377358f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_9f24890f-55b5-437e-b285-85791cf88df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_9f24890f-55b5-437e-b285-85791cf88df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9f24890f-55b5-437e-b285-85791cf88df6" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f6571c15-bee3-4917-818f-7ca1c2ff2865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:to="loc_us-gaap_CommercialPaperMember_f6571c15-bee3-4917-818f-7ca1c2ff2865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_e7052332-d9d5-4563-8039-00496c9f4670" xlink:href="bsx-20211231.xsd#bsx_August2019TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4562d197-3492-444d-bf1a-6637fca2eb4c" xlink:to="loc_bsx_August2019TermLoanMember_e7052332-d9d5-4563-8039-00496c9f4670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f4d7f28-7399-49db-bc60-82e2dd4c5faf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ec34340d-f08b-4429-b1fc-03654de72ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ec34340d-f08b-4429-b1fc-03654de72ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_5020d181-04c4-44f9-b9fa-378ca04d7f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtCurrent_5020d181-04c4-44f9-b9fa-378ca04d7f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c2d852b-31cc-482c-afc1-f32d210d8d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c2d852b-31cc-482c-afc1-f32d210d8d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44dca769-1ea0-44c0-893c-fb6c4167e47e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44dca769-1ea0-44c0-893c-fb6c4167e47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d60cdf5-73f5-4f76-b909-b5534c2507db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d60cdf5-73f5-4f76-b909-b5534c2507db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_0eb84b14-6bf4-4306-8174-b58100b83c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_0eb84b14-6bf4-4306-8174-b58100b83c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ec549f84-1ff1-4a87-bc6e-431aeee47f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_ShortTermBorrowings_ec549f84-1ff1-4a87-bc6e-431aeee47f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4a2b5682-5083-4589-92c3-90f78270a07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_RepaymentsOfDebt_4a2b5682-5083-4589-92c3-90f78270a07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_40d23cf1-63de-440d-ab72-ab8d378ad98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LineOfCredit_40d23cf1-63de-440d-ab72-ab8d378ad98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_4f6b7e0b-5815-4615-8909-115b620785d3" xlink:href="bsx-20211231.xsd#bsx_MaximumLeverageRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_MaximumLeverageRatio_4f6b7e0b-5815-4615-8909-115b620785d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA_363a3d47-1297-4405-a49e-e08ec32d7926" xlink:href="bsx-20211231.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_DeemedConsolidatedEBITDA_363a3d47-1297-4405-a49e-e08ec32d7926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_a354903f-6be9-4220-991e-374649a661d5" xlink:href="bsx-20211231.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_a354903f-6be9-4220-991e-374649a661d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_b8459ec9-9b37-4977-bc01-49659bf9b954" xlink:href="bsx-20211231.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_b8459ec9-9b37-4977-bc01-49659bf9b954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_842be70e-a831-4b97-a396-a2d1d2071f78" xlink:href="bsx-20211231.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_842be70e-a831-4b97-a396-a2d1d2071f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_9dd21423-b64b-4e8e-9308-d32c09c87aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_9dd21423-b64b-4e8e-9308-d32c09c87aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_c7277086-538a-4fed-b242-21efcc79bbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_c7277086-538a-4fed-b242-21efcc79bbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_6f44bfb8-9568-456f-9cf8-762486ec2b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_6f44bfb8-9568-456f-9cf8-762486ec2b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_57aad85a-0ab5-4ebd-ab65-525ff9c2a81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_57aad85a-0ab5-4ebd-ab65-525ff9c2a81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ab66485e-d1ee-4cc8-962f-3be972d653f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LongTermDebt_ab66485e-d1ee-4cc8-962f-3be972d653f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_ee26d828-9181-4288-98d2-37c24cf0ef0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_ee26d828-9181-4288-98d2-37c24cf0ef0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_af7ba51a-dbd0-449d-8875-48ec8a2f3b47" xlink:href="bsx-20211231.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_af7ba51a-dbd0-449d-8875-48ec8a2f3b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c7b15e65-bbfa-4316-87b1-7e2a68d018c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c7b15e65-bbfa-4316-87b1-7e2a68d018c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_f901c869-8d95-4ed7-96af-f418c9f5041c" xlink:href="bsx-20211231.xsd#bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_f901c869-8d95-4ed7-96af-f418c9f5041c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d3373130-fc03-477a-a22d-0aba05a63aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d3373130-fc03-477a-a22d-0aba05a63aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_8a558a70-a186-4b74-872a-e53fc433d280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_8a558a70-a186-4b74-872a-e53fc433d280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_db6db740-1cbb-4a2a-bc44-c33f0e943de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_db6db740-1cbb-4a2a-bc44-c33f0e943de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_58296e3c-1092-4c5f-84db-27733d1c123f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_58296e3c-1092-4c5f-84db-27733d1c123f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_c9924b66-25f7-47ed-8fea-db314a0c18e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_c9924b66-25f7-47ed-8fea-db314a0c18e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_5b3d4e1a-fa4e-4557-a4fb-e9b3a17eb91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_5b3d4e1a-fa4e-4557-a4fb-e9b3a17eb91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_a137df0b-d106-4828-8176-40d939cbd6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_PurchaseObligation_a137df0b-d106-4828-8176-40d939cbd6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_70ad6b41-9b80-4d28-9e07-3c79964b3c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_78cbf7e5-b8d5-4125-862b-42bc99f845e6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_70ad6b41-9b80-4d28-9e07-3c79964b3c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Leases" xlink:type="simple" xlink:href="bsx-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_652e05a2-dbe9-47a9-8467-946441ebc0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_d2663a2b-63e1-4d30-9821-c6aec28734f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_652e05a2-dbe9-47a9-8467-946441ebc0f2" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_d2663a2b-63e1-4d30-9821-c6aec28734f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b1b68e7b-5e1e-4426-a1ac-706c64a77404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_4ae627bd-e461-4e69-85b1-c2eca0f9b989" xlink:href="bsx-20211231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b1b68e7b-5e1e-4426-a1ac-706c64a77404" xlink:to="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_4ae627bd-e461-4e69-85b1-c2eca0f9b989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_0e36ec24-2ecc-4e3d-8211-799c641ef091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b1b68e7b-5e1e-4426-a1ac-706c64a77404" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_0e36ec24-2ecc-4e3d-8211-799c641ef091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_dee8bb22-024e-4077-a19f-00cb43775b41" xlink:href="bsx-20211231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b1b68e7b-5e1e-4426-a1ac-706c64a77404" xlink:to="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_dee8bb22-024e-4077-a19f-00cb43775b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_0106b760-b695-4307-9b82-2b0b7a075eb0" xlink:href="bsx-20211231.xsd#bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b1b68e7b-5e1e-4426-a1ac-706c64a77404" xlink:to="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_0106b760-b695-4307-9b82-2b0b7a075eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eb9e15be-750c-4abe-b281-1f5534c75fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9e15be-750c-4abe-b281-1f5534c75fd6" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0283ade6-0d31-4560-9043-ced562da7ff9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:to="loc_srt_RangeAxis_0283ade6-0d31-4560-9043-ced562da7ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0283ade6-0d31-4560-9043-ced562da7ff9" xlink:to="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab0126f1-4b22-4217-90ba-9cedafb7d847" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:to="loc_srt_MinimumMember_ab0126f1-4b22-4217-90ba-9cedafb7d847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d5fb0761-26bb-40df-b841-52dac701ab44" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_225ac45e-3df5-4125-aa4d-bd40bebce6e5" xlink:to="loc_srt_MaximumMember_d5fb0761-26bb-40df-b841-52dac701ab44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ad795d9-3019-4c27-b87c-6f2a33d3ad8e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_23c9d01a-82d9-4ad7-b18d-25a0ab8a63eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_23c9d01a-82d9-4ad7-b18d-25a0ab8a63eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_6bebf345-c87a-4a41-8b64-3334b249f171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_6bebf345-c87a-4a41-8b64-3334b249f171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_74832f3c-0792-4ed7-bf1a-bd3653930fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91423d7e-7b7c-40e3-99fa-7395ccf982af" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_74832f3c-0792-4ed7-bf1a-bd3653930fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b95733f1-a294-4b52-92a0-aca8f55fb62b" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fb4fdc61-c7fb-4e38-9a6d-bfab79fd0fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fb4fdc61-c7fb-4e38-9a6d-bfab79fd0fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_18f40b66-1ea8-4b7f-9220-92b21b66d2c2" xlink:href="bsx-20211231.xsd#bsx_LesseeOperatingAndFinanceLeasesOptionToExtend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_18f40b66-1ea8-4b7f-9220-92b21b66d2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ac29310-3e64-4387-b792-31579a394918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ac29310-3e64-4387-b792-31579a394918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8721ba81-f44f-44aa-ac4c-e029f7dc447d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8721ba81-f44f-44aa-ac4c-e029f7dc447d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1b7c5ceb-377e-4b7c-b21e-f2aa1e09b892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1b7c5ceb-377e-4b7c-b21e-f2aa1e09b892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_63c76903-98bd-4eeb-a288-e1fa1885bfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_63c76903-98bd-4eeb-a288-e1fa1885bfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_21a44d58-1a5c-44b5-8df0-cfd3c48369a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_21a44d58-1a5c-44b5-8df0-cfd3c48369a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cab1fdf3-dd8e-4d05-b85d-9f457415360b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cab1fdf3-dd8e-4d05-b85d-9f457415360b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_87b3f893-88e4-43eb-8427-424ae0c35fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_87b3f893-88e4-43eb-8427-424ae0c35fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1746ecba-bb2a-4f1a-ad13-85fc74ac1907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseCost_1746ecba-bb2a-4f1a-ad13-85fc74ac1907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_2a14b993-81a2-494d-bd6c-cef3a794caf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeasePayments_2a14b993-81a2-494d-bd6c-cef3a794caf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d3923257-d685-4f13-b238-db897c778de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d3923257-d685-4f13-b238-db897c778de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_8fa52ec3-a202-4ea4-ae2b-a3085882cb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_8fa52ec3-a202-4ea4-ae2b-a3085882cb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_4331a7b0-45ab-4050-957f-fcd914d566f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_4331a7b0-45ab-4050-957f-fcd914d566f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_104b2555-4c7a-4be9-9ccd-a6bf8149483c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_104b2555-4c7a-4be9-9ccd-a6bf8149483c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_0a82a5e8-d3c3-4128-b560-db58335c81ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_0a82a5e8-d3c3-4128-b560-db58335c81ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_7445b7fa-9904-4a57-8c2a-9a14619295dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_7445b7fa-9904-4a57-8c2a-9a14619295dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_b287caac-7b6d-4a7e-90fb-02f566c74f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_b287caac-7b6d-4a7e-90fb-02f566c74f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8290fdcf-4f9a-4ac3-b369-cfffa3e440fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8290fdcf-4f9a-4ac3-b369-cfffa3e440fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3567d3c2-05f4-4d7a-a612-09d429a193fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3567d3c2-05f4-4d7a-a612-09d429a193fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_31ba5550-023c-476f-bff1-5bfc13e86417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_cc537852-871e-468e-a7a2-339d613b2d1d" xlink:to="loc_us-gaap_OperatingLeaseLiability_31ba5550-023c-476f-bff1-5bfc13e86417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="simple" xlink:href="bsx-20211231.xsd#RestructuringRelatedActivities"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4fb3b07b-3ddc-470a-9d90-7056f6269bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_7e1f1ddb-04a1-4430-b24a-1c01b010321a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4fb3b07b-3ddc-470a-9d90-7056f6269bd4" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_7e1f1ddb-04a1-4430-b24a-1c01b010321a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#RestructuringRelatedActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7058303a-aaec-4a97-81de-f204f35d1c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fe937b6-1544-4413-bff7-c4344d3768f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7058303a-aaec-4a97-81de-f204f35d1c83" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fe937b6-1544-4413-bff7-c4344d3768f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_39a978e1-c58c-4b8a-a215-42c51486e08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fe937b6-1544-4413-bff7-c4344d3768f2" xlink:to="loc_us-gaap_RestructuringPlanAxis_39a978e1-c58c-4b8a-a215-42c51486e08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_39a978e1-c58c-4b8a-a215-42c51486e08d" xlink:to="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_6499df58-ff31-495d-93e7-324800680622" xlink:href="bsx-20211231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_A2019RestructuringPlanMember_6499df58-ff31-495d-93e7-324800680622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_4da49b8d-efe6-4353-a62f-92a46bb41a85" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_4da49b8d-efe6-4353-a62f-92a46bb41a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_a8f262a8-2312-4c72-8f25-2027f1b9c7fb" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_RestructuringPlanMember_a8f262a8-2312-4c72-8f25-2027f1b9c7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_feac9139-9db8-45f2-8e45-69b1d83bd5b3" xlink:href="bsx-20211231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cbb23bb4-45cf-4ca8-a835-fe94d74a2a2b" xlink:to="loc_bsx_A2016RestructuringPlanMember_feac9139-9db8-45f2-8e45-69b1d83bd5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fe937b6-1544-4413-bff7-c4344d3768f2" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_395def4a-fd5c-4f88-84c7-8611352b1ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_395def4a-fd5c-4f88-84c7-8611352b1ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesTableTextBlock_d2a18dcc-58c1-4b71-86c1-88f1e8db53b9" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringChargesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:to="loc_bsx_CumulativeRestructuringChargesTableTextBlock_d2a18dcc-58c1-4b71-86c1-88f1e8db53b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_5b45c095-d608-4b22-ac8b-284380364b4b" xlink:href="bsx-20211231.xsd#bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_700673c5-dc61-4df4-85a5-e24092ff2839" xlink:to="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_5b45c095-d608-4b22-ac8b-284380364b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#RestructuringRelatedActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_02279a3e-5dd1-4f7a-9047-b8c68dcd6cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_02279a3e-5dd1-4f7a-9047-b8c68dcd6cba" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6c1efc1b-55d8-4d2c-925d-229256ceb51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6c1efc1b-55d8-4d2c-925d-229256ceb51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6c1efc1b-55d8-4d2c-925d-229256ceb51f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3d5cd39f-0064-4886-96d6-ddd6947d32a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3d5cd39f-0064-4886-96d6-ddd6947d32a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bd11248f-d34e-42a4-aa04-0ed3bc318626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:to="loc_us-gaap_CostOfSalesMember_bd11248f-d34e-42a4-aa04-0ed3bc318626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_20263855-d0ec-4326-bdaf-a5b759c2262a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dbdb2935-ebf8-4f28-8417-6c94b96e8e33" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_20263855-d0ec-4326-bdaf-a5b759c2262a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_020b2f52-0c0e-49a0-8978-1cae4605647d" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_020b2f52-0c0e-49a0-8978-1cae4605647d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_020b2f52-0c0e-49a0-8978-1cae4605647d" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_12ec0485-7d42-49ae-8e04-07601e4b207f" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_12ec0485-7d42-49ae-8e04-07601e4b207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_9ebd98ec-02f2-4d49-9382-3ee3bc0ce02a" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_f72bc7da-60e6-47c3-a85f-0a9e8a61824a" xlink:to="loc_bsx_RestructuringPlanMember_9ebd98ec-02f2-4d49-9382-3ee3bc0ce02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionAxis_72506cea-81cb-4d63-bd31-ba45e34cc8fc" xlink:href="bsx-20211231.xsd#bsx_StatementOfOperationsCaptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_bsx_StatementOfOperationsCaptionAxis_72506cea-81cb-4d63-bd31-ba45e34cc8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:href="bsx-20211231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis_72506cea-81cb-4d63-bd31-ba45e34cc8fc" xlink:to="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_479d0ee7-10a2-4049-801f-0851dae4239c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:to="loc_us-gaap_CostOfSalesMember_479d0ee7-10a2-4049-801f-0851dae4239c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ab4ae90c-813c-428c-aafd-9891a9010dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_d3361372-15e6-454c-a577-8dfb07dc4d21" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ab4ae90c-813c-428c-aafd-9891a9010dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_b0ae2ab2-7da9-4e98-b568-2b3a2909500e" xlink:href="bsx-20211231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_b0ae2ab2-7da9-4e98-b568-2b3a2909500e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:href="bsx-20211231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_b0ae2ab2-7da9-4e98-b568-2b3a2909500e" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_7cc6ff25-8454-4c2d-98d2-30cc92ecba30" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_7cc6ff25-8454-4c2d-98d2-30cc92ecba30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_d34ecb20-c089-4dac-a155-2104d8621e4e" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_46dd3ee8-936d-456d-af1f-5cf078f3fd21" xlink:to="loc_bsx_RestructuringPlanMember_d34ecb20-c089-4dac-a155-2104d8621e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16992baa-4922-47ac-b536-44f8eef92a10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_srt_RangeAxis_16992baa-4922-47ac-b536-44f8eef92a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_16992baa-4922-47ac-b536-44f8eef92a10" xlink:to="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_96177db1-70ca-49d8-9928-1337f450daff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:to="loc_srt_MaximumMember_96177db1-70ca-49d8-9928-1337f450daff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_23166399-730a-4c39-b9d4-453015a8c602" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ded74570-f8c0-4272-b139-984537e8ee9d" xlink:to="loc_srt_MinimumMember_23166399-730a-4c39-b9d4-453015a8c602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_71bacbff-5786-4dfa-81af-8c6861f87847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_71bacbff-5786-4dfa-81af-8c6861f87847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_71bacbff-5786-4dfa-81af-8c6861f87847" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_129360a2-36a9-4d97-830b-be757da09796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_us-gaap_EmployeeSeveranceMember_129360a2-36a9-4d97-830b-be757da09796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_7288acf4-3020-41f1-9fb1-64a56994059d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_us-gaap_OtherRestructuringMember_7288acf4-3020-41f1-9fb1-64a56994059d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCostsMember_e7aa1744-c2e8-4365-9097-b93075ae7b3a" xlink:href="bsx-20211231.xsd#bsx_TransferCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_bsx_TransferCostsMember_e7aa1744-c2e8-4365-9097-b93075ae7b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_6fe28917-1b7f-4478-a80f-5a8392ac7970" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_063830a6-6f68-4ec5-885f-d4a83691cb03" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_6fe28917-1b7f-4478-a80f-5a8392ac7970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8104e3ff-5242-408f-a2e7-f84a03c34345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_us-gaap_RestructuringPlanAxis_8104e3ff-5242-408f-a2e7-f84a03c34345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_8104e3ff-5242-408f-a2e7-f84a03c34345" xlink:to="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_2f40faa9-233b-4277-be02-bc1a5231bc02" xlink:href="bsx-20211231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_RestructuringPlanMember_2f40faa9-233b-4277-be02-bc1a5231bc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_30b43696-dc5f-4153-965f-43daae73154a" xlink:href="bsx-20211231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_A2019RestructuringPlanMember_30b43696-dc5f-4153-965f-43daae73154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_405e04a3-e766-44f3-9ba2-1223b03020f3" xlink:href="bsx-20211231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_A2016RestructuringPlanMember_405e04a3-e766-44f3-9ba2-1223b03020f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LotusDiscontinuationMember_9e99f6ea-d573-4ebe-abca-a80106665a23" xlink:href="bsx-20211231.xsd#bsx_LotusDiscontinuationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb89d8da-f00c-42f8-8bb9-3d3f52acde91" xlink:to="loc_bsx_LotusDiscontinuationMember_9e99f6ea-d573-4ebe-abca-a80106665a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a83ccafc-0b25-44d5-883a-299772b7222f" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_be4c4755-ed13-4384-bd12-ab6b5f8cca49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_be4c4755-ed13-4384-bd12-ab6b5f8cca49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringrelatedCostExpectedCost_b4de06ba-bf46-4811-89df-65ef03e5e08a" xlink:href="bsx-20211231.xsd#bsx_RestructuringrelatedCostExpectedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_RestructuringrelatedCostExpectedCost_b4de06ba-bf46-4811-89df-65ef03e5e08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_5c90f266-e036-45d2-a19c-3b363fb9caa9" xlink:href="bsx-20211231.xsd#bsx_RestructuringandRestructuringrelatedCostExpectedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_5c90f266-e036-45d2-a19c-3b363fb9caa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount_588e96dc-8ce0-4381-bba3-237d55e6a830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_EffectOnFutureCashFlowsAmount_588e96dc-8ce0-4381-bba3-237d55e6a830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_436a3590-872a-4cee-b2cb-d403d2d99ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_SeveranceCosts1_436a3590-872a-4cee-b2cb-d403d2d99ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCosts_24541b42-ee50-45e7-a934-5531fe38fd3f" xlink:href="bsx-20211231.xsd#bsx_TransferCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_TransferCosts_24541b42-ee50-45e7-a934-5531fe38fd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_704a70cb-b407-4c0b-bfb0-1b52accc6c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_OtherRestructuringCosts_704a70cb-b407-4c0b-bfb0-1b52accc6c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5fea327e-732f-4109-8435-53ce28316038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringCharges_5fea327e-732f-4109-8435-53ce28316038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fc4fa3d3-9965-4669-8b3b-003c7ee81cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fc4fa3d3-9965-4669-8b3b-003c7ee81cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedExpenses_1fdcec95-56ec-4833-8610-1f5c7a8e204b" xlink:href="bsx-20211231.xsd#bsx_RestructuringRelatedExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_RestructuringRelatedExpenses_1fdcec95-56ec-4833-8610-1f5c7a8e204b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_3ac77a5a-aba4-4e23-8489-65cb3b099103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_InventoryWriteDown_3ac77a5a-aba4-4e23-8489-65cb3b099103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1b477d79-1d63-4e0b-9106-e71f41621053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1b477d79-1d63-4e0b-9106-e71f41621053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesIncurredToDate_bee09062-de43-47d7-be8c-c2a7c18a7302" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringChargesIncurredToDate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_CumulativeRestructuringChargesIncurredToDate_bee09062-de43-47d7-be8c-c2a7c18a7302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_f8606fef-937d-489e-a922-e70f5e65abde" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringRelatedCostsIncurredToDate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_f8606fef-937d-489e-a922-e70f5e65abde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a0eb96fc-3c5f-4d65-83df-27c7faf55f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a0eb96fc-3c5f-4d65-83df-27c7faf55f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_63bbf5dc-f9f9-46f4-86f2-1b678c77c292" xlink:href="bsx-20211231.xsd#bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cfd59626-f9de-403d-874d-a03845f65d9d" xlink:to="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_63bbf5dc-f9f9-46f4-86f2-1b678c77c292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20211231.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_8baa2010-c088-4722-a817-bc9a0156347d" xlink:href="bsx-20211231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_9850d1a3-ff61-4c75-ad0d-dc8b101b8912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8baa2010-c088-4722-a817-bc9a0156347d" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_9850d1a3-ff61-4c75-ad0d-dc8b101b8912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:href="bsx-20211231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e254847a-84b2-4412-974a-0d80aaa9d7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e254847a-84b2-4412-974a-0d80aaa9d7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_60a18658-f672-47fe-adb4-456a66ff7318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_60a18658-f672-47fe-adb4-456a66ff7318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_7e716b0e-b402-40be-9f2c-5a951c780793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_7e716b0e-b402-40be-9f2c-5a951c780793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9693cfa7-b6bf-4e71-81c9-3ff64d97c735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9693cfa7-b6bf-4e71-81c9-3ff64d97c735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_5cf00b9c-16bd-4758-b9d7-37239646b939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_5cf00b9c-16bd-4758-b9d7-37239646b939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_94b85652-d696-41d7-ab52-7e0387d31c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_94b85652-d696-41d7-ab52-7e0387d31c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_99af566a-0737-4e9c-965d-4ef186a8c644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_99af566a-0737-4e9c-965d-4ef186a8c644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_e1541461-950e-4436-a51f-64719f520c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_9a1f97b1-3d45-4428-a30f-0d6edc359c8d" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_e1541461-950e-4436-a51f-64719f520c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:href="bsx-20211231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract_94278d90-a07d-4323-82ad-1c92d8688f2c" xlink:href="bsx-20211231.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_bsx_OtherCurrentAssetsAbstract_94278d90-a07d-4323-82ad-1c92d8688f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_78962ced-ebab-4978-8470-f9fed6aed8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_94278d90-a07d-4323-82ad-1c92d8688f2c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_78962ced-ebab-4978-8470-f9fed6aed8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_be5f1919-25ef-4550-9494-bd9b9910aa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_94278d90-a07d-4323-82ad-1c92d8688f2c" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_be5f1919-25ef-4550-9494-bd9b9910aa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangements_a3f02f00-cb12-4041-a56a-9af2866efcbc" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_94278d90-a07d-4323-82ad-1c92d8688f2c" xlink:to="loc_bsx_LicensingArrangements_a3f02f00-cb12-4041-a56a-9af2866efcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_d8dc7e86-f8c1-4a8c-9df0-1c6088028c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_94278d90-a07d-4323-82ad-1c92d8688f2c" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_d8dc7e86-f8c1-4a8c-9df0-1c6088028c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_9e946d62-7074-438d-a45d-9fe657855a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_94278d90-a07d-4323-82ad-1c92d8688f2c" xlink:to="loc_us-gaap_OtherAssetsCurrent_9e946d62-7074-438d-a45d-9fe657855a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_9246ae97-ebaa-4830-ba87-c8f24e8b2d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_9246ae97-ebaa-4830-ba87-c8f24e8b2d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_cfa43cd3-2512-4b5d-9ffc-f0df2c72d1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_9246ae97-ebaa-4830-ba87-c8f24e8b2d6a" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_cfa43cd3-2512-4b5d-9ffc-f0df2c72d1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_65698ef0-4bd0-47c8-907e-3138bebc123f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_9246ae97-ebaa-4830-ba87-c8f24e8b2d6a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_65698ef0-4bd0-47c8-907e-3138bebc123f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_d2af4392-4664-4629-9252-b6ba2e217e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_9246ae97-ebaa-4830-ba87-c8f24e8b2d6a" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_d2af4392-4664-4629-9252-b6ba2e217e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec12e331-a92e-404a-b543-0007b644bea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec12e331-a92e-404a-b543-0007b644bea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_07f8798d-2a3b-4421-846b-cc621680023f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec12e331-a92e-404a-b543-0007b644bea2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_07f8798d-2a3b-4421-846b-cc621680023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c5ce68c4-37f8-479e-8783-449cefd688ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec12e331-a92e-404a-b543-0007b644bea2" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c5ce68c4-37f8-479e-8783-449cefd688ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1f317941-8a6b-47f0-a105-e5559bc69e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec12e331-a92e-404a-b543-0007b644bea2" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1f317941-8a6b-47f0-a105-e5559bc69e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_1e08338b-f0fc-4a49-86fd-9a776950fb52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec12e331-a92e-404a-b543-0007b644bea2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_1e08338b-f0fc-4a49-86fd-9a776950fb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_67659182-7b20-4158-8412-ed696b240d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec12e331-a92e-404a-b543-0007b644bea2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_67659182-7b20-4158-8412-ed696b240d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_c0a826fe-2770-4cbc-af1c-4a8d3c54e114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_InventoryNetAbstract_c0a826fe-2770-4cbc-af1c-4a8d3c54e114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a3f3a9c9-3ce5-43d6-9538-606451d66404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_c0a826fe-2770-4cbc-af1c-4a8d3c54e114" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a3f3a9c9-3ce5-43d6-9538-606451d66404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bfe40502-ea1f-47bf-b5ea-cd523767b6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_c0a826fe-2770-4cbc-af1c-4a8d3c54e114" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bfe40502-ea1f-47bf-b5ea-cd523767b6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1d5218c4-1918-426d-bdf2-2d7d05c5bda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_c0a826fe-2770-4cbc-af1c-4a8d3c54e114" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1d5218c4-1918-426d-bdf2-2d7d05c5bda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b7d6f3ee-254b-47b3-82bf-65d39f6cf630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_c0a826fe-2770-4cbc-af1c-4a8d3c54e114" xlink:to="loc_us-gaap_InventoryNet_b7d6f3ee-254b-47b3-82bf-65d39f6cf630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e65b41ba-10dd-4281-8a97-bd2e0524d7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:to="loc_us-gaap_Land_e65b41ba-10dd-4281-8a97-bd2e0524d7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_89817515-71f0-444d-932e-2c66c515878e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_89817515-71f0-444d-932e-2c66c515878e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_b1e6bae5-7031-490f-8924-bc532c70c35c" xlink:href="bsx-20211231.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_b1e6bae5-7031-490f-8924-bc532c70c35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_df5b0b64-d9b7-4f0c-b3cb-0f75fe7cb2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:to="loc_us-gaap_ConstructionInProgressGross_df5b0b64-d9b7-4f0c-b3cb-0f75fe7cb2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_12898f6a-4a3e-4ca3-bc32-4dab63f4d367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_12898f6a-4a3e-4ca3-bc32-4dab63f4d367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cbc72156-20a0-4298-8194-2962337960b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cbc72156-20a0-4298-8194-2962337960b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5f9e2671-ed49-4c37-b9ee-80710448d40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_34cbd91d-c31e-4fc6-af4c-3220b29cf489" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5f9e2671-ed49-4c37-b9ee-80710448d40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_1d623cd4-04f8-4548-a463-e8a65cc2ae54" xlink:href="bsx-20211231.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_1d623cd4-04f8-4548-a463-e8a65cc2ae54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PercentOfFinishedGoodsAtConsignment_389001fb-ae28-453d-a1ba-c41406451f91" xlink:href="bsx-20211231.xsd#bsx_PercentOfFinishedGoodsAtConsignment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_1d623cd4-04f8-4548-a463-e8a65cc2ae54" xlink:to="loc_bsx_PercentOfFinishedGoodsAtConsignment_389001fb-ae28-453d-a1ba-c41406451f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b34c5ff1-56cd-42c5-8797-b74ee47323b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_1d623cd4-04f8-4548-a463-e8a65cc2ae54" xlink:to="loc_us-gaap_Depreciation_b34c5ff1-56cd-42c5-8797-b74ee47323b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_022ffc89-b4be-46a0-9e78-e808f6c30241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_022ffc89-b4be-46a0-9e78-e808f6c30241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fac63af6-dcb4-4cf5-b1a0-63e623f642b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fac63af6-dcb4-4cf5-b1a0-63e623f642b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_ba5c979c-93fd-4c72-b33d-58adce24dd94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:to="loc_us-gaap_DerivativeAssets_ba5c979c-93fd-4c72-b33d-58adce24dd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_01c561b4-7b6c-425e-8015-b70d6616b5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:to="loc_us-gaap_Investments_01c561b4-7b6c-425e-8015-b70d6616b5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_4c487700-1487-4859-ad8f-1ce0d0d7a293" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:to="loc_bsx_LicensingArrangementsAsset_4c487700-1487-4859-ad8f-1ce0d0d7a293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongTermAssets_0d21d5da-1984-4699-af44-c506308c0668" xlink:href="bsx-20211231.xsd#bsx_OtherOtherLongTermAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:to="loc_bsx_OtherOtherLongTermAssets_0d21d5da-1984-4699-af44-c506308c0668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2a2ea888-ce88-4ceb-8364-da62ccfbee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a04e785d-38e0-4c05-8303-d6a847857e06" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2a2ea888-ce88-4ceb-8364-da62ccfbee7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_4a68eecc-9d72-4b32-a9a2-8b6630127f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:to="loc_us-gaap_LitigationReserveCurrent_4a68eecc-9d72-4b32-a9a2-8b6630127f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a201d147-8b59-4fa8-9fe3-9283a4f2bb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a201d147-8b59-4fa8-9fe3-9283a4f2bb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_cfaad947-0bae-47b9-a063-1993388af588" xlink:href="bsx-20211231.xsd#bsx_AccruedRebatesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:to="loc_bsx_AccruedRebatesCurrent_cfaad947-0bae-47b9-a063-1993388af588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b4d56bcd-3069-40cd-9121-f6ad8d16df75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b4d56bcd-3069-40cd-9121-f6ad8d16df75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5d0e607b-68cb-4ada-87db-b75d576243e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5d0e607b-68cb-4ada-87db-b75d576243e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_827da90f-9e62-4e59-8d2d-d0371f3b2707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2071bdf7-fe9a-4480-8cab-f8103fb0d5fe" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_827da90f-9e62-4e59-8d2d-d0371f3b2707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_7de824f6-e228-42df-9230-8ebb5832e870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:to="loc_us-gaap_DeferredRevenueCurrent_7de824f6-e228-42df-9230-8ebb5832e870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_7126084c-5442-4a04-a130-36a5df44b6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_7126084c-5442-4a04-a130-36a5df44b6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_a3a51908-f27b-4011-bf74-2730f57cf49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:to="loc_us-gaap_TaxesPayableCurrent_a3a51908-f27b-4011-bf74-2730f57cf49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5cf70272-9834-41f6-95ea-0a79211a4bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5cf70272-9834-41f6-95ea-0a79211a4bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_8f255f56-cc6d-4b43-b4ec-20ac75000035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_8f255f56-cc6d-4b43-b4ec-20ac75000035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3735ce4d-8633-49f7-a585-f31f584badc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_fc78ce95-99b1-43a6-946f-d394b9e5cf95" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3735ce4d-8633-49f7-a585-f31f584badc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a4f9f193-c68d-48bc-b438-0d407aeb006a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a4f9f193-c68d-48bc-b438-0d407aeb006a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_a07d6b10-4ed2-408b-a778-c209cbfca0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_a07d6b10-4ed2-408b-a778-c209cbfca0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_775213d5-db27-4127-904b-141eeaf7827e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_775213d5-db27-4127-904b-141eeaf7827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_e131c824-e9ff-43ac-a895-2e6c6406e84c" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_bsx_LicensingArrangementsLiability_e131c824-e9ff-43ac-a895-2e6c6406e84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_36ea786e-fddc-422b-9cc5-b18774dda987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_36ea786e-fddc-422b-9cc5-b18774dda987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_8727d146-12c5-4ba5-966c-947598235c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_8727d146-12c5-4ba5-966c-947598235c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_d93cb4c9-e4d9-4dc3-92af-4267f32e4817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_DeferredRevenue_d93cb4c9-e4d9-4dc3-92af-4267f32e4817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a4954b37-6a42-4068-bc40-c933605648cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a4954b37-6a42-4068-bc40-c933605648cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_16d8efe3-caa4-4fec-869b-b284e23b8d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_d6c08896-b965-446e-8506-cb416b0bc6c4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_16d8efe3-caa4-4fec-869b-b284e23b8d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_316afdf5-107e-48de-bbab-9fe09735c58e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_31f564a6-a0ee-4b11-b8f7-1833b14ba79c" xlink:to="loc_us-gaap_StatementTable_316afdf5-107e-48de-bbab-9fe09735c58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_cd3023c2-e7f6-4c53-a65c-7e67125e4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_316afdf5-107e-48de-bbab-9fe09735c58e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_cd3023c2-e7f6-4c53-a65c-7e67125e4d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7ea24635-6262-4464-be9a-2c867af28942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cd3023c2-e7f6-4c53-a65c-7e67125e4d73" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7ea24635-6262-4464-be9a-2c867af28942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_892488c9-201b-4ef8-aa16-89c3fd8086e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7ea24635-6262-4464-be9a-2c867af28942" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_892488c9-201b-4ef8-aa16-89c3fd8086e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_316afdf5-107e-48de-bbab-9fe09735c58e" xlink:to="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_243310c5-5d6d-41bd-8a25-16fe687c9658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_243310c5-5d6d-41bd-8a25-16fe687c9658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_1c2ddc62-9443-41ca-9753-76352e937f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_1c2ddc62-9443-41ca-9753-76352e937f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2c2d90f1-9f17-4e9c-b999-8f135319bd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2c2d90f1-9f17-4e9c-b999-8f135319bd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_216f9234-4fe0-4067-946a-5d5f49cf893a" xlink:href="bsx-20211231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_bsx_LicensingArrangementsLiability_216f9234-4fe0-4067-946a-5d5f49cf893a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ce95bfc-6324-4c61-a04a-1c743060a48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ce95bfc-6324-4c61-a04a-1c743060a48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_807d5213-ef64-4e03-8fdf-f570ead92d00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_807d5213-ef64-4e03-8fdf-f570ead92d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_6937138e-851f-46f7-a0a5-f7bb7b80bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_DeferredRevenue_6937138e-851f-46f7-a0a5-f7bb7b80bfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4e93575b-4ec2-4e13-89e9-bbee6fed2b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_379c6e7d-c5a7-4842-a214-058d6e205722" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4e93575b-4ec2-4e13-89e9-bbee6fed2b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0302b1b2-edb4-469b-81e3-baf5c54bf5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_851f3aa8-1e26-41a0-ab6a-783672fafdaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0302b1b2-edb4-469b-81e3-baf5c54bf5fa" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_851f3aa8-1e26-41a0-ab6a-783672fafdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2799f705-2abe-41bb-8061-bfc4b6edacd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0533faca-c1ab-4602-8bbf-2d8c036a8e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2799f705-2abe-41bb-8061-bfc4b6edacd4" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0533faca-c1ab-4602-8bbf-2d8c036a8e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_0d40dc8b-ad28-4571-9ded-9f536721cbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2799f705-2abe-41bb-8061-bfc4b6edacd4" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_0d40dc8b-ad28-4571-9ded-9f536721cbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_eebfaf03-9993-4290-8ecf-aa8e90ec4942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2799f705-2abe-41bb-8061-bfc4b6edacd4" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_eebfaf03-9993-4290-8ecf-aa8e90ec4942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_2349b611-0af7-446e-89fd-9d1279b75c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2799f705-2abe-41bb-8061-bfc4b6edacd4" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_2349b611-0af7-446e-89fd-9d1279b75c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_594fe26a-65e5-4327-88a6-903101fe0889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2799f705-2abe-41bb-8061-bfc4b6edacd4" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_594fe26a-65e5-4327-88a6-903101fe0889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="simple" xlink:href="bsx-20211231.xsd#IncomeTaxesDetailsRateTable"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IncomeTaxesAbstract_a30e86d8-0733-4906-bbd6-eb63c1c8cfaa" xlink:href="bsx-20211231.xsd#bsx_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_85d52926-c5d1-4504-910f-e95e0377eba3" xlink:href="bsx-20211231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IncomeTaxesAbstract_a30e86d8-0733-4906-bbd6-eb63c1c8cfaa" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_85d52926-c5d1-4504-910f-e95e0377eba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateAxis_f4cb91f5-80bd-4290-9e6d-2cd06b95d932" xlink:href="bsx-20211231.xsd#bsx_TaxRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_85d52926-c5d1-4504-910f-e95e0377eba3" xlink:to="loc_bsx_TaxRateAxis_f4cb91f5-80bd-4290-9e6d-2cd06b95d932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain_444a6caf-ad45-4950-8c55-8c78adc1c2bc" xlink:href="bsx-20211231.xsd#bsx_TaxRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_TaxRateAxis_f4cb91f5-80bd-4290-9e6d-2cd06b95d932" xlink:to="loc_bsx_TaxRateDomain_444a6caf-ad45-4950-8c55-8c78adc1c2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:href="bsx-20211231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_85d52926-c5d1-4504-910f-e95e0377eba3" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9956b809-264b-4060-b50f-abf28da02f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9956b809-264b-4060-b50f-abf28da02f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_19de698e-fefb-4bf5-a69f-5c842d69656b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_19de698e-fefb-4bf5-a69f-5c842d69656b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_e3d7f5b0-68db-4f57-b50e-a7061b281162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_e3d7f5b0-68db-4f57-b50e-a7061b281162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6ffdfe7a-fd83-40b1-a507-d27c97b4d775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6ffdfe7a-fd83-40b1-a507-d27c97b4d775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_ba8dc7dd-1476-4a88-b317-426d54367dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_ba8dc7dd-1476-4a88-b317-426d54367dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_74e18570-7551-414e-b6e0-0e020ad02dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_74e18570-7551-414e-b6e0-0e020ad02dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b53fa40d-e4f5-4562-8fe5-da8268434d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b53fa40d-e4f5-4562-8fe5-da8268434d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_3afbe1f3-bbd2-4fbf-a448-49a6beb71a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_3afbe1f3-bbd2-4fbf-a448-49a6beb71a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a996ed6e-7f05-456f-ac05-93c14f176490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a996ed6e-7f05-456f-ac05-93c14f176490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_5a50342f-9ac4-4d1e-b0df-317d67a3837a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_5a50342f-9ac4-4d1e-b0df-317d67a3837a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_3b431f82-435b-4545-b228-9ae4f29ef47b" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_3b431f82-435b-4545-b228-9ae4f29ef47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_a8748595-b929-4213-81dd-be2584931dab" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_a8748595-b929-4213-81dd-be2584931dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_84856b78-a719-4d47-94f5-8fb6a4578405" xlink:href="bsx-20211231.xsd#bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_84856b78-a719-4d47-94f5-8fb6a4578405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_d529b275-0da6-44a9-afcc-0f74ea62be69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_d529b275-0da6-44a9-afcc-0f74ea62be69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9b4c0ae6-247a-4f50-9dd9-cc5478321f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9b4c0ae6-247a-4f50-9dd9-cc5478321f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a056957d-cc0e-4583-b8e0-b46124d5e2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a056957d-cc0e-4583-b8e0-b46124d5e2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico_b8ad8625-8474-48d6-a6a6-ac73c4a64204" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e1ce2266-3905-4672-a63a-7feb2a48c060" xlink:to="loc_bsx_TaxIncentivesInPuertoRico_b8ad8625-8474-48d6-a6a6-ac73c4a64204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#IncomeTaxesIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IncomeTaxesAbstract_b89d7bb1-8324-4af0-bb35-4d864a919044" xlink:href="bsx-20211231.xsd#bsx_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6f80ffe7-5093-4d1b-89f2-72aaa83ca49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IncomeTaxesAbstract_b89d7bb1-8324-4af0-bb35-4d864a919044" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6f80ffe7-5093-4d1b-89f2-72aaa83ca49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ea0c3b4b-2946-457b-8e20-e19a3e33a75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6f80ffe7-5093-4d1b-89f2-72aaa83ca49f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ea0c3b4b-2946-457b-8e20-e19a3e33a75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ea0c3b4b-2946-457b-8e20-e19a3e33a75e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61b2332d-1c8a-4d50-85e5-bf6586d6de46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61b2332d-1c8a-4d50-85e5-bf6586d6de46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssetsHeldForSaleDomain_19e915ca-23d1-4150-b409-8a628da8f6f4" xlink:href="bsx-20211231.xsd#bsx_AssetsHeldForSaleDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_AssetsHeldForSaleDomain_19e915ca-23d1-4150-b409-8a628da8f6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsDomain_95eed867-d8c6-450e-b65d-b181f66b919c" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetsDomain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_DeferredTaxAssetsDomain_95eed867-d8c6-450e-b65d-b181f66b919c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesDomain_ce9d28cc-f53e-44e0-8b37-82a1933efbe1" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxLiabilitiesDomain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_DeferredTaxLiabilitiesDomain_ce9d28cc-f53e-44e0-8b37-82a1933efbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_25bf1b75-a8fe-4332-a4b0-5fbabe5900d5" xlink:href="bsx-20211231.xsd#bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b17c961-797e-45c1-83ef-c63de5a7d4d8" xlink:to="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_25bf1b75-a8fe-4332-a4b0-5fbabe5900d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6f80ffe7-5093-4d1b-89f2-72aaa83ca49f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d8fee724-8cb6-4e48-bbc3-9d15039052c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d8fee724-8cb6-4e48-bbc3-9d15039052c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e5f1e1c4-bf1d-4879-bb34-66fe39c3718d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e5f1e1c4-bf1d-4879-bb34-66fe39c3718d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_704b5c07-9b0f-4e6c-a45e-5d9f06f80f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_704b5c07-9b0f-4e6c-a45e-5d9f06f80f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21e3d3c4-5400-4318-88c8-1f5a5c56cc42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21e3d3c4-5400-4318-88c8-1f5a5c56cc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_38717118-873c-4738-8710-9ed0133d85c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_38717118-873c-4738-8710-9ed0133d85c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c2cf8122-a0d6-4e91-9050-9e77f15c4a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c2cf8122-a0d6-4e91-9050-9e77f15c4a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad80207f-e4ec-4cf3-b6dc-326611842fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad80207f-e4ec-4cf3-b6dc-326611842fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b6beaf9a-9768-40d7-ace7-2959680d87a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b6beaf9a-9768-40d7-ace7-2959680d87a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d3d17b69-3393-468b-8753-2b7a3013f285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d3d17b69-3393-468b-8753-2b7a3013f285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0c9fbb4a-054e-4252-8216-9aa58baa3b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0c9fbb4a-054e-4252-8216-9aa58baa3b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6f37dfa0-b144-4c0e-b5d5-e65c67b6568a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6f37dfa0-b144-4c0e-b5d5-e65c67b6568a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0896c5dd-d268-4787-8d60-bd798802adaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0896c5dd-d268-4787-8d60-bd798802adaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_97bb2962-ec60-44f1-b9ec-1a26ff5ca2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_97bb2962-ec60-44f1-b9ec-1a26ff5ca2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_908ad848-d8d0-40d5-9396-e27a2819b580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_908ad848-d8d0-40d5-9396-e27a2819b580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_59fb05e4-7103-4a01-92fb-4c23c72e6cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_59fb05e4-7103-4a01-92fb-4c23c72e6cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_3f99e52a-3458-4d82-9449-8049e69ae066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_3f99e52a-3458-4d82-9449-8049e69ae066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_8f4d58a5-8a39-4873-9727-2421bfb45719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_8f4d58a5-8a39-4873-9727-2421bfb45719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_bd24e2c1-69df-4114-a7ab-734e5dd9841b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_bd24e2c1-69df-4114-a7ab-734e5dd9841b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_46478a06-beaf-46d0-9445-e8fbb5bff027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_46478a06-beaf-46d0-9445-e8fbb5bff027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FederalBenefitOfUncertainTaxPositions_b5c0bef4-f090-4eca-bd24-a791099a050f" xlink:href="bsx-20211231.xsd#bsx_FederalBenefitOfUncertainTaxPositions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_FederalBenefitOfUncertainTaxPositions_b5c0bef4-f090-4eca-bd24-a791099a050f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_63328344-c5fb-4574-9778-ac93154e81e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_63328344-c5fb-4574-9778-ac93154e81e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_b5f65a71-9452-497d-9c4b-08748947ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_b5f65a71-9452-497d-9c4b-08748947ca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_939e7369-f37d-4957-8bbe-77428c90b19b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_939e7369-f37d-4957-8bbe-77428c90b19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_89d243c6-f994-4f6c-91b8-d19f663c38b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_89d243c6-f994-4f6c-91b8-d19f663c38b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_21a9f0d8-3ad0-42f6-8c6f-40f3e0087c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_21a9f0d8-3ad0-42f6-8c6f-40f3e0087c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3837f8f4-c123-4d45-945f-001ba31d3eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3837f8f4-c123-4d45-945f-001ba31d3eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_586fc24b-4d69-48e0-b8cf-7c7d2fb36ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_586fc24b-4d69-48e0-b8cf-7c7d2fb36ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_dd6e0e29-5006-4f45-b883-1f812bfeb578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_dd6e0e29-5006-4f45-b883-1f812bfeb578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_1c30a4c6-af66-4fc5-b412-4c30959445f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_1c30a4c6-af66-4fc5-b412-4c30959445f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_af45ea93-2c7e-4266-bb33-8e61dfa88cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_af45ea93-2c7e-4266-bb33-8e61dfa88cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_736c62c6-ebae-4b3e-b4c9-4928fd6ffdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_736c62c6-ebae-4b3e-b4c9-4928fd6ffdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f5110ebb-1258-4970-9cda-1b7f58328ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f5110ebb-1258-4970-9cda-1b7f58328ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_34a7b859-0d82-4b2e-a5a6-502aae47478c" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_34a7b859-0d82-4b2e-a5a6-502aae47478c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_e58c880e-9d1d-4ee0-b78a-f51243d14c8b" xlink:href="bsx-20211231.xsd#bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_e58c880e-9d1d-4ee0-b78a-f51243d14c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a18fefba-b839-44c3-8f2f-c73ea580a3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a18fefba-b839-44c3-8f2f-c73ea580a3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_1d8810a8-e64f-4b7c-bd51-56c6c4ea9c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxLiabilities_1d8810a8-e64f-4b7c-bd51-56c6c4ea9c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_a94f2ed7-b782-44a8-ae9e-a2c4a35af731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_a94f2ed7-b782-44a8-ae9e-a2c4a35af731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_ce6e9c1d-85d0-46cd-a8b0-14d7de2666bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_ce6e9c1d-85d0-46cd-a8b0-14d7de2666bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_58dce618-ade9-4cd6-8274-6d82eae9bc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_58dce618-ade9-4cd6-8274-6d82eae9bc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_e63c0f44-ed01-4932-9406-c860d571ddc1" xlink:href="bsx-20211231.xsd#bsx_DeferredTaxAssetValuationAllowanceIntraEntity"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_e63c0f44-ed01-4932-9406-c860d571ddc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_2ae7f1e4-f417-4446-8e53-1a3a9c25cfae" xlink:href="bsx-20211231.xsd#bsx_ChangeinDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_2ae7f1e4-f417-4446-8e53-1a3a9c25cfae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_f6847a5d-6b26-4890-be81-a7858baca1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_f6847a5d-6b26-4890-be81-a7858baca1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentive_34244ce5-08ce-43a1-bd74-5455cfa7e847" xlink:href="bsx-20211231.xsd#bsx_FreeTradeZoneRegimeTaxIncentive"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_FreeTradeZoneRegimeTaxIncentive_34244ce5-08ce-43a1-bd74-5455cfa7e847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico_a88d2d66-f3d5-407e-a548-3da3c81a3891" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TaxIncentivesInPuertoRico_a88d2d66-f3d5-407e-a548-3da3c81a3891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b37533b9-b244-4c4c-8ccb-eac1973f589e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b37533b9-b244-4c4c-8ccb-eac1973f589e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6a01079b-1a83-4489-82aa-c75ce453343e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6a01079b-1a83-4489-82aa-c75ce453343e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a9d614e6-b57b-4695-a71a-bb1f03444af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a9d614e6-b57b-4695-a71a-bb1f03444af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_20109ecd-ed47-4e6d-9275-05f37bc9b05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_20109ecd-ed47-4e6d-9275-05f37bc9b05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7f81ac5d-39cf-4562-b8c8-079087eea3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7f81ac5d-39cf-4562-b8c8-079087eea3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_aa4bdd11-196a-401a-a9ab-a614adbed5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_aa4bdd11-196a-401a-a9ab-a614adbed5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_1e80e2f2-c8d5-42c0-b229-8aa9241fad25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_1e80e2f2-c8d5-42c0-b229-8aa9241fad25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_ccbec320-421b-4248-8ca1-af88d803ef01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_ccbec320-421b-4248-8ca1-af88d803ef01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d1bb3398-88ba-476e-8ab2-7002d12c32b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d1bb3398-88ba-476e-8ab2-7002d12c32b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8e9f4feb-a539-4c4f-8db0-800e936b9c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8e9f4feb-a539-4c4f-8db0-800e936b9c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_96390c1f-b0ed-42b4-9679-6546355dfb88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_96390c1f-b0ed-42b4-9679-6546355dfb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_3d08ead1-33e1-4fbe-84da-21d4a1dfda1f" xlink:href="bsx-20211231.xsd#bsx_Onetimetransactiontaxpost1986EPnetpayment"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_3d08ead1-33e1-4fbe-84da-21d4a1dfda1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_64db0a10-026b-4b82-9c11-05e979f7ae26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_64db0a10-026b-4b82-9c11-05e979f7ae26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct_8b0ab08b-ae52-4780-9f8b-827d1a77bac4" xlink:href="bsx-20211231.xsd#bsx_TheCARESAct"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TheCARESAct_8b0ab08b-ae52-4780-9f8b-827d1a77bac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution_043470ff-72da-4e71-ba3a-b9217e355a1d" xlink:href="bsx-20211231.xsd#bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution_043470ff-72da-4e71-ba3a-b9217e355a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution_8a9bf986-ac95-4d33-bbe3-1d4695f89d5d" xlink:href="bsx-20211231.xsd#bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution_8a9bf986-ac95-4d33-bbe3-1d4695f89d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransitionTaxPaymentRemaining_431ad5f8-a40d-4cf4-96f1-812130b25e7f" xlink:href="bsx-20211231.xsd#bsx_TransitionTaxPaymentRemaining"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_757cf52d-607f-44b5-b389-6eefe5a8ab1d" xlink:to="loc_bsx_TransitionTaxPaymentRemaining_431ad5f8-a40d-4cf4-96f1-812130b25e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3bfe272b-0f85-432e-8f1c-3314beaf5833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_541c9010-a144-44d8-9433-f11440daa7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3bfe272b-0f85-432e-8f1c-3314beaf5833" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_541c9010-a144-44d8-9433-f11440daa7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a14812e7-8503-4d2b-9414-5541b32659c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a14812e7-8503-4d2b-9414-5541b32659c2" xlink:to="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_385d5ee0-338c-42ea-ae28-60410a510ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_385d5ee0-338c-42ea-ae28-60410a510ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60307f78-0e42-4378-a154-d070340e0e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_385d5ee0-338c-42ea-ae28-60410a510ce7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60307f78-0e42-4378-a154-d070340e0e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8f89f35e-7ae0-4524-b38b-2300f30c2938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_us-gaap_LitigationStatusAxis_8f89f35e-7ae0-4524-b38b-2300f30c2938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_747da116-0b41-4a05-b784-e29a57876b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_8f89f35e-7ae0-4524-b38b-2300f30c2938" xlink:to="loc_us-gaap_LitigationStatusDomain_747da116-0b41-4a05-b784-e29a57876b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_2de1cc6f-5d47-4222-8d5c-20a5647b01fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_747da116-0b41-4a05-b784-e29a57876b0c" xlink:to="loc_us-gaap_SettledLitigationMember_2de1cc6f-5d47-4222-8d5c-20a5647b01fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6184e14e-910a-4494-aa96-cc2004b49a03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_srt_LitigationCaseAxis_6184e14e-910a-4494-aa96-cc2004b49a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_87599291-f60c-4a25-9abd-97afbe0b6a76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6184e14e-910a-4494-aa96-cc2004b49a03" xlink:to="loc_srt_LitigationCaseTypeDomain_87599291-f60c-4a25-9abd-97afbe0b6a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fa855631-ca57-46c9-8c68-2fe1a45ab530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fa855631-ca57-46c9-8c68-2fe1a45ab530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cbec8da1-8506-400c-ae75-fca47b57e1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa855631-ca57-46c9-8c68-2fe1a45ab530" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cbec8da1-8506-400c-ae75-fca47b57e1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_acaeb457-bed8-42f5-a22c-f464e2aaffa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cbec8da1-8506-400c-ae75-fca47b57e1d3" xlink:to="loc_us-gaap_SubsequentEventMember_acaeb457-bed8-42f5-a22c-f464e2aaffa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_219c46d5-7721-4dc0-b550-1fddc55456d0" xlink:to="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c5320d2e-a67c-490c-81a4-5d1a8c5a1419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c5320d2e-a67c-490c-81a4-5d1a8c5a1419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4914f81e-04c0-4313-9bbd-7461f4f3058b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4914f81e-04c0-4313-9bbd-7461f4f3058b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_c5537209-a181-4e3e-86bc-5ad1dbc6ebd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LitigationSettlementExpense_c5537209-a181-4e3e-86bc-5ad1dbc6ebd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain_0a79734d-b11e-468c-a61f-1a37fd6a08dc" xlink:href="bsx-20211231.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_LitigationSettlementReceivedGain_0a79734d-b11e-468c-a61f-1a37fd6a08dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_076fd786-4b5d-40ec-8f60-8225cc2b6f83" xlink:href="bsx-20211231.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_076fd786-4b5d-40ec-8f60-8225cc2b6f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_eda10e5b-679b-45f1-a49b-c70a4c0fe2a5" xlink:href="bsx-20211231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_eda10e5b-679b-45f1-a49b-c70a4c0fe2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_c383166e-2354-4a50-b597-22ed9f4dd81f" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_c383166e-2354-4a50-b597-22ed9f4dd81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_19a5b212-1291-45b6-a3d6-89f9ba4d1d01" xlink:href="bsx-20211231.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_19a5b212-1291-45b6-a3d6-89f9ba4d1d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_9d2f9084-2756-4d15-b41d-75d7f27ab49b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_9d2f9084-2756-4d15-b41d-75d7f27ab49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_371388c9-7d62-4c0a-bf6a-1ae3ea349cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_371388c9-7d62-4c0a-bf6a-1ae3ea349cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssertedClaimsOutsideTheUS_ae66a39d-d6c0-4618-9403-1699d3ed255a" xlink:href="bsx-20211231.xsd#bsx_AssertedClaimsOutsideTheUS"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_AssertedClaimsOutsideTheUS_ae66a39d-d6c0-4618-9403-1699d3ed255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS_c1a43bba-c0cc-4d8c-baf6-0fae0ed5e8ed" xlink:href="bsx-20211231.xsd#bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS_c1a43bba-c0cc-4d8c-baf6-0fae0ed5e8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter_b0e1b962-48b7-4e3f-a705-31747b36008e" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter_b0e1b962-48b7-4e3f-a705-31747b36008e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_57fc20e5-2d4b-4614-8b2b-d1729c47bb3c" xlink:href="bsx-20211231.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_57fc20e5-2d4b-4614-8b2b-d1729c47bb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_0ceae101-bf2b-4622-8c7a-573990bb7b0e" xlink:href="bsx-20211231.xsd#bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_0ceae101-bf2b-4622-8c7a-573990bb7b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CanadaSettledClaims_6885bbe4-a805-4ad6-9a39-53499262464f" xlink:href="bsx-20211231.xsd#bsx_CanadaSettledClaims"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_CanadaSettledClaims_6885bbe4-a805-4ad6-9a39-53499262464f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh_ca76ba29-fa6d-4dd6-b9d6-c40262f3d7b0" xlink:href="bsx-20211231.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_CertifiedClassActionsInAustraliaMesh_ca76ba29-fa6d-4dd6-b9d6-c40262f3d7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PermanentlyStayedClassActionInAustraliaMesh_50a9c47d-f68b-4600-9699-98868f76f91f" xlink:href="bsx-20211231.xsd#bsx_PermanentlyStayedClassActionInAustraliaMesh"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_db25ffc5-6f7a-498a-904e-44c0396362f4" xlink:to="loc_bsx_PermanentlyStayedClassActionInAustraliaMesh_50a9c47d-f68b-4600-9699-98868f76f91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentandContingenciesPolicies" xlink:type="simple" xlink:href="bsx-20211231.xsd#CommitmentandContingenciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentandContingenciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a057a97a-b4d3-47e7-b0e8-ff33f595f39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_1ad4a7dc-74b8-4ed3-b134-7e570e8daf4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a057a97a-b4d3-47e7-b0e8-ff33f595f39c" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_1ad4a7dc-74b8-4ed3-b134-7e570e8daf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_fcef2b01-5269-4290-8f97-846a68c3e5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_24c1c849-034e-4b41-aee6-6c40f55d2f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fcef2b01-5269-4290-8f97-846a68c3e5c2" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_24c1c849-034e-4b41-aee6-6c40f55d2f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_118e7740-86ac-4fbd-84e3-91ebe9d0e6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract_7d0135f4-0089-4b69-89a1-3e0a102c3630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_118e7740-86ac-4fbd-84e3-91ebe9d0e6af" xlink:to="loc_us-gaap_ClassOfStockDisclosuresAbstract_7d0135f4-0089-4b69-89a1-3e0a102c3630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract_7d0135f4-0089-4b69-89a1-3e0a102c3630" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f8066b88-f2c9-4390-bb4a-e6a6c4456a6b" xlink:to="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_565345bb-066d-49ff-a24b-6c3dc68237f2" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:to="loc_bsx_A550MCPSSeriesAMember_565345bb-066d-49ff-a24b-6c3dc68237f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_83d93e04-edaf-47e2-92fe-2181263096c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_395de734-7e3b-4b78-a77d-afb790ea0cf9" xlink:to="loc_us-gaap_CommonStockMember_83d93e04-edaf-47e2-92fe-2181263096c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_36bb92ef-9920-4d3c-aee9-1f2708472d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_36bb92ef-9920-4d3c-aee9-1f2708472d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_80814120-aa4a-4c0e-b15d-0d6e0bf1a2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_36bb92ef-9920-4d3c-aee9-1f2708472d9d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_80814120-aa4a-4c0e-b15d-0d6e0bf1a2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d779816d-b7ab-477d-b846-523f2e09879e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_80814120-aa4a-4c0e-b15d-0d6e0bf1a2cf" xlink:to="loc_us-gaap_SubsequentEventMember_d779816d-b7ab-477d-b846-523f2e09879e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1029e42c-35a8-4c28-a86d-7ea146c6cac7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:to="loc_srt_RangeAxis_1029e42c-35a8-4c28-a86d-7ea146c6cac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1029e42c-35a8-4c28-a86d-7ea146c6cac7" xlink:to="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bfef57ed-1891-43a6-bef5-444af835279f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:to="loc_srt_MinimumMember_bfef57ed-1891-43a6-bef5-444af835279f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1dcddecb-3916-4a34-b6db-d89569e06888" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_174670ed-a522-4f0e-9f50-79a0d2a6a14a" xlink:to="loc_srt_MaximumMember_1dcddecb-3916-4a34-b6db-d89569e06888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5592e326-693d-42ad-a6c0-2f66e01b07f5" xlink:to="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b774ed2e-8263-40a6-844e-6d568e5fc023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b774ed2e-8263-40a6-844e-6d568e5fc023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9476f5c8-7eed-4dfe-89c3-c5e89d3c9058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9476f5c8-7eed-4dfe-89c3-c5e89d3c9058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_5b42ea4c-02de-49bd-b849-0d75a6a393aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_5b42ea4c-02de-49bd-b849-0d75a6a393aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_b8bca885-9aef-47fe-8fae-d12cd01d2565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_b8bca885-9aef-47fe-8fae-d12cd01d2565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_063c3935-64a9-4ae9-8880-6d7c11788bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_063c3935-64a9-4ae9-8880-6d7c11788bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_be42e353-f722-4384-9d33-5a64c650f0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_be42e353-f722-4384-9d33-5a64c650f0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_39ffdb0e-cad2-4b9c-a96e-2ae8d34a6216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_39ffdb0e-cad2-4b9c-a96e-2ae8d34a6216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_dd934003-d0ce-430b-b760-f3110bd2c55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_dd934003-d0ce-430b-b760-f3110bd2c55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f8b81e01-b4a7-4138-b50f-8d098f880dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PaymentsOfDividends_f8b81e01-b4a7-4138-b50f-8d098f880dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_78e864d2-5355-4e0d-b2cd-b4848b29419c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_78e864d2-5355-4e0d-b2cd-b4848b29419c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a201680c-7ec8-47fd-9134-8648b5118ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a201680c-7ec8-47fd-9134-8648b5118ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61118d28-d1cf-435d-bb68-bf6533154c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61118d28-d1cf-435d-bb68-bf6533154c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_73ea1909-cab0-49d2-a4f8-571c46a8b414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_73ea1909-cab0-49d2-a4f8-571c46a8b414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f8d9a868-32a3-48fb-b6ff-004decc5fe9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f8d9a868-32a3-48fb-b6ff-004decc5fe9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ea219fe0-180e-433e-83d9-b12eaaaa5491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ea219fe0-180e-433e-83d9-b12eaaaa5491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_a430f1aa-f5bd-4473-9315-3390b61691e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_a430f1aa-f5bd-4473-9315-3390b61691e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09334e4c-0461-49aa-bf36-445d792f99d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09334e4c-0461-49aa-bf36-445d792f99d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_766ed2aa-08ca-41ab-8b8b-4913864ea9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a196dad5-4fe4-42fb-90e6-e9db7cc01cf5" xlink:to="loc_us-gaap_TreasuryStockShares_766ed2aa-08ca-41ab-8b8b-4913864ea9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3908dcf5-0fe0-49c0-8af3-169d21560d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_118e7740-86ac-4fbd-84e3-91ebe9d0e6af" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_3908dcf5-0fe0-49c0-8af3-169d21560d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_97191a0c-d3be-4831-bcf6-c19eba7553f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_87d31a71-f4f0-43ea-9429-c35747b7badb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8b545ac2-9db9-4a35-b0c9-dfea36f08de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_dd163f22-0dd8-4cda-a17d-2fb8defd9bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a1eaf0d-dbf2-494a-b379-84dbdd64d737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_e82d51e1-400f-4228-9d69-ff9e2c06e130" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8d1e419d-83df-4bf6-9f60-646a7704293b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_af404be5-266e-4909-b0a5-5b997b248798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockInventiveandPurchasePlans"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract_11c3ff1a-94d1-4697-bb01-0e1c45798948" xlink:href="bsx-20211231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a51d0ada-f7d6-4ed9-883b-298837bcfd76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_11c3ff1a-94d1-4697-bb01-0e1c45798948" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a51d0ada-f7d6-4ed9-883b-298837bcfd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockIncentiveandPurchasePlansTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:href="bsx-20211231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_978adcdf-7914-4063-a5cf-d6406e8bc8db" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_978adcdf-7914-4063-a5cf-d6406e8bc8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_09380b9b-2e10-46fa-8fee-87b5b963aa14" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_978adcdf-7914-4063-a5cf-d6406e8bc8db" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_09380b9b-2e10-46fa-8fee-87b5b963aa14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_b1245cfc-e44d-4312-9f4c-e9ee9344e836" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_09380b9b-2e10-46fa-8fee-87b5b963aa14" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_b1245cfc-e44d-4312-9f4c-e9ee9344e836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_9e2305f3-21c0-4f68-bc65-a881603fc182" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_978adcdf-7914-4063-a5cf-d6406e8bc8db" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_9e2305f3-21c0-4f68-bc65-a881603fc182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_2d9e07fd-0442-4296-87bb-1749c2c3a3d5" xlink:href="bsx-20211231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_9e2305f3-21c0-4f68-bc65-a881603fc182" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_2d9e07fd-0442-4296-87bb-1749c2c3a3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6725c5c7-d6af-4e8e-a4db-a2876ad2701f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6725c5c7-d6af-4e8e-a4db-a2876ad2701f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c08fb313-6dec-425b-93f2-e716fe1ada56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c08fb313-6dec-425b-93f2-e716fe1ada56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_e5db86c4-72df-4458-84c1-9fdc0d5ac89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_e5db86c4-72df-4458-84c1-9fdc0d5ac89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_e531afe6-db9f-4fa3-bd39-ad040559fe40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_e531afe6-db9f-4fa3-bd39-ad040559fe40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_87211bec-658b-4cb3-8cf7-3b3a22f533b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_87211bec-658b-4cb3-8cf7-3b3a22f533b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_3f275232-7948-477a-909d-4f812f074f4c" xlink:href="bsx-20211231.xsd#bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_3f275232-7948-477a-909d-4f812f074f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_577b2505-217f-4456-bc72-2bdbe675c2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_55428079-df6a-4413-b407-a4aac42613b8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_577b2505-217f-4456-bc72-2bdbe675c2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#StockIncentiveandPurchasePlansDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract_6139186b-f9a4-4e81-a874-5fa004789b5b" xlink:href="bsx-20211231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_6139186b-f9a4-4e81-a874-5fa004789b5b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b908cc18-8c59-4e7b-a4e3-9b9f814e0f78" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c1ec23ee-27e1-4e6b-8240-20aee913bb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:to="loc_us-gaap_CostOfSalesMember_c1ec23ee-27e1-4e6b-8240-20aee913bb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_898bc2bb-fe74-42e2-870b-05dead8fa9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_898bc2bb-fe74-42e2-870b-05dead8fa9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48b65150-6322-47ca-8c96-5b126fc1b8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14ce2547-10cb-4779-8980-885b2ac8103d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48b65150-6322-47ca-8c96-5b126fc1b8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_be826bd6-4954-49c6-a391-295cd7a2feb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:to="loc_us-gaap_PlanNameAxis_be826bd6-4954-49c6-a391-295cd7a2feb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77f96644-b0dd-4793-aa5a-15dec9950cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_be826bd6-4954-49c6-a391-295cd7a2feb5" xlink:to="loc_us-gaap_PlanNameDomain_77f96644-b0dd-4793-aa5a-15dec9950cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2011LtipPlanMember_88f2922c-0132-4e86-8595-827dfc96ff92" xlink:href="bsx-20211231.xsd#bsx_A2011LtipPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77f96644-b0dd-4793-aa5a-15dec9950cb4" xlink:to="loc_bsx_A2011LtipPlanMember_88f2922c-0132-4e86-8595-827dfc96ff92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5612c936-0b65-4426-9ca1-c9740bfeebfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:to="loc_srt_RangeAxis_5612c936-0b65-4426-9ca1-c9740bfeebfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5612c936-0b65-4426-9ca1-c9740bfeebfb" xlink:to="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_648ec843-4adf-490f-a1e4-424f72ff08be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:to="loc_srt_MinimumMember_648ec843-4adf-490f-a1e4-424f72ff08be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_157e9b17-3b26-4176-96bd-de8cee1e8a1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:to="loc_srt_MaximumMember_157e9b17-3b26-4176-96bd-de8cee1e8a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7952c91-25de-4bc3-ab4f-b9ad48dd573b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a2e8c063-811d-4086-9548-d9d75c37c156" xlink:to="loc_srt_MaximumMember_b7952c91-25de-4bc3-ab4f-b9ad48dd573b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0d92f50-e089-4ac4-a643-b31e20058bcf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Fairvalueofmarketbasedawards_64bc5ba7-f29c-428d-bd23-c4713fa9026c" xlink:href="bsx-20211231.xsd#bsx_Fairvalueofmarketbasedawards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Fairvalueofmarketbasedawards_64bc5ba7-f29c-428d-bd23-c4713fa9026c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_bcebe8fd-442a-4eb2-8220-3546f3d7208c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharePrice_bcebe8fd-442a-4eb2-8220-3546f3d7208c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostStockOptions_ccba8599-a475-421a-853b-9aacaa7cae9b" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCostStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_UnrecognizedCompensationCostStockOptions_ccba8599-a475-421a-853b-9aacaa7cae9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_2f2b7b70-f960-4de3-b826-6f3150f242c0" xlink:href="bsx-20211231.xsd#bsx_RangeofthetargetnumberofperformancebasedDSUsawarded"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_2f2b7b70-f960-4de3-b826-6f3150f242c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cecf49f1-cf80-4e76-abd8-df237a82f32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cecf49f1-cf80-4e76-abd8-df237a82f32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_0555496e-2625-4284-b631-dd706a659571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_0555496e-2625-4284-b631-dd706a659571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_227cba23-573f-4c1f-9832-72b411e831be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_227cba23-573f-4c1f-9832-72b411e831be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22d90122-b9e9-496b-8856-a78763db97c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22d90122-b9e9-496b-8856-a78763db97c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5513f7a7-4e00-4ba4-bcb1-ace8d82f6d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5513f7a7-4e00-4ba4-bcb1-ace8d82f6d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Measurementperiodmarketbasedaward_ac1f136a-3c98-49c6-923b-0191f1c334b7" xlink:href="bsx-20211231.xsd#bsx_Measurementperiodmarketbasedaward"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Measurementperiodmarketbasedaward_ac1f136a-3c98-49c6-923b-0191f1c334b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_113a5495-9165-452b-8de0-b95691bcc764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_113a5495-9165-452b-8de0-b95691bcc764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b092bfeb-c332-459f-acba-1912845b1702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b092bfeb-c332-459f-acba-1912845b1702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8254a9f2-3140-48fe-9410-8ad614706b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8254a9f2-3140-48fe-9410-8ad614706b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_82367752-501b-4ae4-836b-252c1561baf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_82367752-501b-4ae4-836b-252c1561baf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e00f6e53-cf15-4283-81a1-8ccccafd82f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e00f6e53-cf15-4283-81a1-8ccccafd82f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e2083fbc-c059-48fb-95be-a4dbe171683b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e2083fbc-c059-48fb-95be-a4dbe171683b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4e58fa53-951e-4a27-ac0e-c936f29af246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4e58fa53-951e-4a27-ac0e-c936f29af246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00eb9820-f010-4b49-bc8b-bd250491cad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00eb9820-f010-4b49-bc8b-bd250491cad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f444cb7b-1788-4be5-a4ec-05d3d1b8dd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f444cb7b-1788-4be5-a4ec-05d3d1b8dd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26d49290-c3de-43e6-be2d-e78ac833fa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26d49290-c3de-43e6-be2d-e78ac833fa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_cbafd84d-e73b-4446-9d9a-c32691dfa575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_cbafd84d-e73b-4446-9d9a-c32691dfa575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b67caaa-baa2-496f-b594-948405fc71b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b67caaa-baa2-496f-b594-948405fc71b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_472cbb2e-e452-4a20-9e10-60440eb9b170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensation_472cbb2e-e452-4a20-9e10-60440eb9b170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4632af67-ed00-43ed-981c-feab05b5eacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4632af67-ed00-43ed-981c-feab05b5eacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c379b163-2919-4c02-8950-9a34d1c2feab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c379b163-2919-4c02-8950-9a34d1c2feab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_27384fcb-7383-444e-b884-ed2cd16bccff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_27384fcb-7383-444e-b884-ed2cd16bccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_f9ede13d-cf35-4508-b6f0-491a70530f9b" xlink:href="bsx-20211231.xsd#bsx_ShareBasedCompensationNetOfTaxBenefit"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_f9ede13d-cf35-4508-b6f0-491a70530f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareBasic_0c2c286d-da40-4fa8-8a45-cbbcac6ba2b9" xlink:href="bsx-20211231.xsd#bsx_CompensationExpensePerShareBasic"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_CompensationExpensePerShareBasic_0c2c286d-da40-4fa8-8a45-cbbcac6ba2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareDiluted_aa002813-6dee-4a44-a000-d868d71bfb6d" xlink:href="bsx-20211231.xsd#bsx_CompensationExpensePerShareDiluted"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_CompensationExpensePerShareDiluted_aa002813-6dee-4a44-a000-d868d71bfb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_55ee819b-932a-48d7-b347-400270a1e0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_55ee819b-932a-48d7-b347-400270a1e0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26c7bb15-b48e-4e81-9334-dd6647da6cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26c7bb15-b48e-4e81-9334-dd6647da6cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ce65c7b8-00ec-4620-bf66-43ea165ed87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ce65c7b8-00ec-4620-bf66-43ea165ed87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_81dd6e0c-2114-40ab-bc4f-5cd88eb8b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_81dd6e0c-2114-40ab-bc4f-5cd88eb8b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_67c3ff71-c5d7-4c07-ae75-16eab5c22fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_67c3ff71-c5d7-4c07-ae75-16eab5c22fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b8610cf3-0c27-421c-89fa-12383f811955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b8610cf3-0c27-421c-89fa-12383f811955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fcbd4a01-ba80-4433-875b-fa1ee730442b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fcbd4a01-ba80-4433-875b-fa1ee730442b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_dd2acf82-c1c1-40c6-ac5e-4b61a94b5601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_dd2acf82-c1c1-40c6-ac5e-4b61a94b5601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c971db2d-693b-431d-803c-428b888489bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c971db2d-693b-431d-803c-428b888489bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b7971d4e-a65a-4825-a736-50955aeadc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b7971d4e-a65a-4825-a736-50955aeadc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_99f9468f-e965-4c90-a719-563034020c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_99f9468f-e965-4c90-a719-563034020c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_52c2b5e8-e261-4e8a-b0cf-479391e6d445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_52c2b5e8-e261-4e8a-b0cf-479391e6d445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVest_e5bebea8-b48b-4ff2-a7f9-bce1fea95e0c" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVest"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_OptionsExpectedToVest_e5bebea8-b48b-4ff2-a7f9-bce1fea95e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_1f9d8f39-36d8-43d5-83e3-98b7bdf97eea" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_1f9d8f39-36d8-43d5-83e3-98b7bdf97eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_c3deeaa9-c172-462d-aba0-d16ea718e4f2" xlink:href="bsx-20211231.xsd#bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_c3deeaa9-c172-462d-aba0-d16ea718e4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_c3eb431f-3e71-476c-bca7-6b411a77dc8e" xlink:href="bsx-20211231.xsd#bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_c3eb431f-3e71-476c-bca7-6b411a77dc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_186a6b23-510e-419f-a9bc-d1c9e18fdcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_186a6b23-510e-419f-a9bc-d1c9e18fdcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_46a12264-427d-41fd-9bed-2e4b5769e9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_46a12264-427d-41fd-9bed-2e4b5769e9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_63ea0121-b8d3-4685-9aeb-2f58a94b3142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_63ea0121-b8d3-4685-9aeb-2f58a94b3142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5e515d9f-dcef-41f9-8114-9821a0c2a8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5e515d9f-dcef-41f9-8114-9821a0c2a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b373f78-363a-4e45-846a-e528bc8a9ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b373f78-363a-4e45-846a-e528bc8a9ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_fe85890e-0d1e-45c0-b82a-63d861f5b67c" xlink:href="bsx-20211231.xsd#bsx_RangeofthetargetnumberofmarketbasedDSUsawarded"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_fe85890e-0d1e-45c0-b82a-63d861f5b67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c94fbd8f-1d0a-4add-84fa-c5448d7d40c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c94fbd8f-1d0a-4add-84fa-c5448d7d40c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_59e9cbab-fb87-44f2-9b6b-17e745f1c562" xlink:href="bsx-20211231.xsd#bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_59e9cbab-fb87-44f2-9b6b-17e745f1c562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4543ba1-84f3-400e-b084-1ebca89e14a0" xlink:href="bsx-20211231.xsd#bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4543ba1-84f3-400e-b084-1ebca89e14a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0ac5f9d7-4133-493f-b646-bf1eb5e5652a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0ac5f9d7-4133-493f-b646-bf1eb5e5652a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_a674c0eb-a786-4c80-97b7-9adfe48d7532" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCostNonVestedStockAwards"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_a674c0eb-a786-4c80-97b7-9adfe48d7532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCost_6d976c95-89dd-4278-a34e-e8bc74ef0f48" xlink:href="bsx-20211231.xsd#bsx_UnrecognizedCompensationCost"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_UnrecognizedCompensationCost_6d976c95-89dd-4278-a34e-e8bc74ef0f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageRemainingVestingPeriod_71d1bca1-40cd-4325-86fb-85fc2bc35f1a" xlink:href="bsx-20211231.xsd#bsx_WeightedAverageRemainingVestingPeriod"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_WeightedAverageRemainingVestingPeriod_71d1bca1-40cd-4325-86fb-85fc2bc35f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Annualweightedaverageforfeiturerate_b2c29e62-6452-412b-8d2b-6273851f5146" xlink:href="bsx-20211231.xsd#bsx_Annualweightedaverageforfeiturerate"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Annualweightedaverageforfeiturerate_b2c29e62-6452-412b-8d2b-6273851f5146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VotingPowerOfAllClassesOfStock_4f63f8c2-97cc-442f-8a61-b8833ba6610e" xlink:href="bsx-20211231.xsd#bsx_VotingPowerOfAllClassesOfStock"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_VotingPowerOfAllClassesOfStock_4f63f8c2-97cc-442f-8a61-b8833ba6610e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_109de6e4-ccb9-410f-bbf5-57dca04e3ae2" xlink:href="bsx-20211231.xsd#bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_109de6e4-ccb9-410f-bbf5-57dca04e3ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Nonvestedstockawardsexerciseprice_d60ed5c3-4332-4a64-90cb-c0758a9fc997" xlink:href="bsx-20211231.xsd#bsx_Nonvestedstockawardsexerciseprice"/>
    <link:presentationArc order="62" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_Nonvestedstockawardsexerciseprice_d60ed5c3-4332-4a64-90cb-c0758a9fc997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_30d5d8a4-d7ef-46b6-8edf-2a4d8931f649" xlink:href="bsx-20211231.xsd#bsx_FairValueOfFreeCashFlowFcfPerformanceAwards"/>
    <link:presentationArc order="63" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_30d5d8a4-d7ef-46b6-8edf-2a4d8931f649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_63dfa45c-7f4c-49b5-b2eb-3409f4a43a4e" xlink:href="bsx-20211231.xsd#bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards"/>
    <link:presentationArc order="64" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_63dfa45c-7f4c-49b5-b2eb-3409f4a43a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_b039898f-05e3-4f99-a9df-49d2c1b66fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:presentationArc order="65" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2600fecc-6f3b-4ae3-bfc2-008377848e5e" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_b039898f-05e3-4f99-a9df-49d2c1b66fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20211231.xsd#WeightedAverageSharesOutstanding"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3c9afaa0-68fb-4e60-889b-fd6e5aced8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_71f7b85b-4510-4999-b9df-c28c6b711bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c9afaa0-68fb-4e60-889b-fd6e5aced8eb" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_71f7b85b-4510-4999-b9df-c28c6b711bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_01f28516-7767-4b8a-82ad-cf207428316a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6ca77178-badf-4916-b153-997360181bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_01f28516-7767-4b8a-82ad-cf207428316a" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6ca77178-badf-4916-b153-997360181bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_fda6f1a2-e472-4f50-baf7-469108453f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_01f28516-7767-4b8a-82ad-cf207428316a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_fda6f1a2-e472-4f50-baf7-469108453f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f4fdaf77-9752-4ecd-9f14-b56946dffa78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a65555e-cbf6-4f6a-b968-f20ce23930fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4fdaf77-9752-4ecd-9f14-b56946dffa78" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a65555e-cbf6-4f6a-b968-f20ce23930fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ab5a97d6-09a8-4e74-b28a-93c214966286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a65555e-cbf6-4f6a-b968-f20ce23930fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ab5a97d6-09a8-4e74-b28a-93c214966286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ab5a97d6-09a8-4e74-b28a-93c214966286" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d3de298f-a958-45ac-a86c-a6aeb25dd714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d3de298f-a958-45ac-a86c-a6aeb25dd714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_ba6f8d14-17e9-440a-9802-9ffdf956d25e" xlink:href="bsx-20211231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:to="loc_bsx_A550MCPSSeriesAMember_ba6f8d14-17e9-440a-9802-9ffdf956d25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_3ffd6039-9c63-4d9a-95fd-e3915bffe6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_931d5c53-5d32-41cf-bdd5-0bf7b35b74b8" xlink:to="loc_us-gaap_StockCompensationPlanMember_3ffd6039-9c63-4d9a-95fd-e3915bffe6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a65555e-cbf6-4f6a-b968-f20ce23930fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef19fbd0-c095-401a-ba29-7a9a1c460d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef19fbd0-c095-401a-ba29-7a9a1c460d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9729ac0c-f732-4a99-86dc-776f1e54e14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9729ac0c-f732-4a99-86dc-776f1e54e14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba75a8b0-a659-49c1-b658-fe96499ca1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba75a8b0-a659-49c1-b658-fe96499ca1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_288d5042-c635-4daf-851c-c6dd29c2f1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f313aeac-bc01-4a2d-9d76-fd1e5b400522" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_288d5042-c635-4daf-851c-c6dd29c2f1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20211231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bad434bc-5583-4f2d-87a4-68a13379de89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f92e49ea-165a-47e4-835a-088baabca4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bad434bc-5583-4f2d-87a4-68a13379de89" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f92e49ea-165a-47e4-835a-088baabca4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c22bf547-687a-43e1-8a28-fe736d2e8a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_fdbddb3d-30b6-4184-9c18-eca38035c719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c22bf547-687a-43e1-8a28-fe736d2e8a2f" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_fdbddb3d-30b6-4184-9c18-eca38035c719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_b095e9b0-a859-4f45-aa0e-78e1981f6b48" xlink:href="bsx-20211231.xsd#bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c22bf547-687a-43e1-8a28-fe736d2e8a2f" xlink:to="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_b095e9b0-a859-4f45-aa0e-78e1981f6b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_a662cdba-c58c-46d3-976c-4079f455a098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c22bf547-687a-43e1-8a28-fe736d2e8a2f" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_a662cdba-c58c-46d3-976c-4079f455a098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_a3f9f117-3aff-4f1e-8909-b65f4e177e9f" xlink:href="bsx-20211231.xsd#bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c22bf547-687a-43e1-8a28-fe736d2e8a2f" xlink:to="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_a3f9f117-3aff-4f1e-8909-b65f4e177e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_968f2b17-57fa-44bb-99ad-fc222eb0a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c22bf547-687a-43e1-8a28-fe736d2e8a2f" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_968f2b17-57fa-44bb-99ad-fc222eb0a4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_68ef49fd-c7b1-4ed5-9ebc-4f2ee403cf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c22bf547-687a-43e1-8a28-fe736d2e8a2f" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_68ef49fd-c7b1-4ed5-9ebc-4f2ee403cf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_38d2d3ed-ecb2-448c-a5ab-e5269627a86d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_38d2d3ed-ecb2-448c-a5ab-e5269627a86d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07726165-2aa9-47a0-b50c-110a682ba57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07726165-2aa9-47a0-b50c-110a682ba57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07726165-2aa9-47a0-b50c-110a682ba57d" xlink:to="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_895698a7-65a2-450e-838f-be62e4482f9c" xlink:href="bsx-20211231.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_MedsurgMember_895698a7-65a2-450e-838f-be62e4482f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_49f0eebf-7b3d-45b1-9a34-8ee7a5a71c60" xlink:href="bsx-20211231.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_RhythmandNeuroMember_49f0eebf-7b3d-45b1-9a34-8ee7a5a71c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_8eee5d87-85d1-4124-8c83-7ac12fc0bdeb" xlink:href="bsx-20211231.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_CardiovascularMember_8eee5d87-85d1-4124-8c83-7ac12fc0bdeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_21fba4ec-287b-4a9d-b9f4-dcd5b8a8f0db" xlink:href="bsx-20211231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_BSXReportableSegmentsMember_21fba4ec-287b-4a9d-b9f4-dcd5b8a8f0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_fdd3f264-1896-4d81-88ad-ebef48500c79" xlink:href="bsx-20211231.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_fdd3f264-1896-4d81-88ad-ebef48500c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_9f50faab-9cf3-4a13-b4df-58e5a3768756" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_9f50faab-9cf3-4a13-b4df-58e5a3768756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c5abfbf6-3cce-4281-b417-e1260410f70f" xlink:href="bsx-20211231.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c5abfbf6-3cce-4281-b417-e1260410f70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_f4f065f4-2c12-4716-ad12-776de3e9a5a0" xlink:href="bsx-20211231.xsd#bsx_SpecialChargesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_SpecialChargesMember_f4f065f4-2c12-4716-ad12-776de3e9a5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_0c381ecb-cbe3-488c-b1e3-be9bd6e10890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_us-gaap_CorporateMember_0c381ecb-cbe3-488c-b1e3-be9bd6e10890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBSXDomain_daa15043-b78e-4a24-b20c-4ad9ea3a7b6a" xlink:href="bsx-20211231.xsd#bsx_ConsolidatedBSXDomain"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c8d66747-9959-40d6-b028-1e5c841b0b34" xlink:to="loc_bsx_ConsolidatedBSXDomain_daa15043-b78e-4a24-b20c-4ad9ea3a7b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1b36278b-e969-4d01-a574-36cae909f4a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_srt_StatementGeographicalAxis_1b36278b-e969-4d01-a574-36cae909f4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1b36278b-e969-4d01-a574-36cae909f4a2" xlink:to="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_00ed6848-c62e-4ea6-b1d7-367fd2e83813" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:to="loc_country_US_00ed6848-c62e-4ea6-b1d7-367fd2e83813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_d29049e8-52d8-403b-9e86-deb504908e14" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:to="loc_country_IE_d29049e8-52d8-403b-9e86-deb504908e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCountriesMember_9e4b4946-2c1b-49f0-85c5-6f7d19f68eb9" xlink:href="bsx-20211231.xsd#bsx_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_80e19d13-2bef-43da-b280-05fc342b58c4" xlink:to="loc_bsx_OtherCountriesMember_9e4b4946-2c1b-49f0-85c5-6f7d19f68eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c09cd304-af1d-419a-939d-cafefe526382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c09cd304-af1d-419a-939d-cafefe526382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3c60af25-55db-4321-b4be-94eab49fe502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c09cd304-af1d-419a-939d-cafefe526382" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3c60af25-55db-4321-b4be-94eab49fe502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_eba46c47-4682-48f8-9d10-0de917cb13c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3c60af25-55db-4321-b4be-94eab49fe502" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_eba46c47-4682-48f8-9d10-0de917cb13c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_eb3ade68-71d7-4a2f-bd38-cdd5d517532f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_eb3ade68-71d7-4a2f-bd38-cdd5d517532f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9dfa302b-d561-4bda-96a5-d2441503ff5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_eb3ade68-71d7-4a2f-bd38-cdd5d517532f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9dfa302b-d561-4bda-96a5-d2441503ff5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_c27fb026-5fac-48fa-be38-972da1c13566" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9dfa302b-d561-4bda-96a5-d2441503ff5b" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_c27fb026-5fac-48fa-be38-972da1c13566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1e5b558b-cf5c-4216-b734-f668d3d4443d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_srt_ProductOrServiceAxis_1e5b558b-cf5c-4216-b734-f668d3d4443d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_059ed465-328b-461c-b947-4c2a722622dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1e5b558b-cf5c-4216-b734-f668d3d4443d" xlink:to="loc_srt_ProductsAndServicesDomain_059ed465-328b-461c-b947-4c2a722622dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_3793d7fc-8a40-47c7-bf50-1c1f31c64e70" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_059ed465-328b-461c-b947-4c2a722622dc" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_3793d7fc-8a40-47c7-bf50-1c1f31c64e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1922cf4f-e8d7-4100-93fe-96591300a0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1922cf4f-e8d7-4100-93fe-96591300a0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_14110d24-5228-45a5-97f8-594aff9a36a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1922cf4f-e8d7-4100-93fe-96591300a0ed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_14110d24-5228-45a5-97f8-594aff9a36a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_aeefc1f1-f046-44ed-8f90-58d7a1636252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_14110d24-5228-45a5-97f8-594aff9a36a7" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_aeefc1f1-f046-44ed-8f90-58d7a1636252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f1f58c74-c9a3-4a4b-b807-c167e5dd9048" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f84ecad4-da43-4731-b942-f9cfd080ed25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_NumberOfReportableSegments_f84ecad4-da43-4731-b942-f9cfd080ed25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe477684-5255-48ec-8561-a280b6e7ba06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe477684-5255-48ec-8561-a280b6e7ba06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_add78f49-aede-4faf-8530-b7df55b8dd35" xlink:href="bsx-20211231.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_add78f49-aede-4faf-8530-b7df55b8dd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d578889e-756d-40cb-83d6-99695d60d375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_Depreciation_d578889e-756d-40cb-83d6-99695d60d375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_de0bc691-f7ba-436d-b842-c302ea74ded4" xlink:href="bsx-20211231.xsd#bsx_OperatingIncomeLossAllocatedToReportableSegments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_de0bc691-f7ba-436d-b842-c302ea74ded4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_70a71c01-7719-4228-a4b4-50f4c84d1d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_OperatingIncomeLoss_70a71c01-7719-4228-a4b4-50f4c84d1d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e0c76400-fc55-4245-ba1f-b37753c8c0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e0c76400-fc55-4245-ba1f-b37753c8c0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5721a8fc-3cce-4ec9-bae8-972531e369ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5721a8fc-3cce-4ec9-bae8-972531e369ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00f55513-5ce5-4dee-bfd8-3b393d6e8e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00f55513-5ce5-4dee-bfd8-3b393d6e8e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_f4521949-523c-4ac4-9e79-16ecdd6a2e1b" xlink:href="bsx-20211231.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_f4521949-523c-4ac4-9e79-16ecdd6a2e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_84c95aa8-c6e5-4a4e-add6-f03f2d756ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_OtherAssets_84c95aa8-c6e5-4a4e-add6-f03f2d756ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43012878-611c-47dd-adcb-b14a9d6c085d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_Goodwill_43012878-611c-47dd-adcb-b14a9d6c085d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bd4abd90-238c-48e9-a3d6-922d82c52e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bd4abd90-238c-48e9-a3d6-922d82c52e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_41c47f5c-9609-4a0b-b371-7e977100ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_41c47f5c-9609-4a0b-b371-7e977100ed2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_3d1ed63d-eb81-411f-bbd6-8d67bf0c5c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_26b2eb27-ba2b-4584-a3f0-414e5ef8966f" xlink:to="loc_us-gaap_NoncurrentAssets_3d1ed63d-eb81-411f-bbd6-8d67bf0c5c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20211231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e1544b5-3f55-4d42-881c-7611dac05ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_3be63d26-57e2-48b5-9cdc-a5d73dc93abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e1544b5-3f55-4d42-881c-7611dac05ee2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_3be63d26-57e2-48b5-9cdc-a5d73dc93abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3e481e17-f040-495c-8c07-9a419d3a6fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_96fb91e4-fd18-46b8-b772-7c3d8f9f5036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3e481e17-f040-495c-8c07-9a419d3a6fd9" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_96fb91e4-fd18-46b8-b772-7c3d8f9f5036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_9e44294d-739f-4cea-9d1b-fd9e05989d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_96fb91e4-fd18-46b8-b772-7c3d8f9f5036" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_9e44294d-739f-4cea-9d1b-fd9e05989d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_903344d9-6168-4d80-a771-c36b361cf29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_903344d9-6168-4d80-a771-c36b361cf29b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_38346ec7-8343-41e1-9aee-81c95f7daec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_38346ec7-8343-41e1-9aee-81c95f7daec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fdbc94c6-fe63-4ecb-ae5d-2034e3edb169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38346ec7-8343-41e1-9aee-81c95f7daec2" xlink:to="loc_us-gaap_SegmentDomain_fdbc94c6-fe63-4ecb-ae5d-2034e3edb169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_d3778dd3-d6a5-4751-8e1a-2817ec40130d" xlink:href="bsx-20211231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fdbc94c6-fe63-4ecb-ae5d-2034e3edb169" xlink:to="loc_bsx_BSXReportableSegmentsMember_d3778dd3-d6a5-4751-8e1a-2817ec40130d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5411812c-e153-429d-bf59-18a4631e6d6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:to="loc_srt_ProductOrServiceAxis_5411812c-e153-429d-bf59-18a4631e6d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5411812c-e153-429d-bf59-18a4631e6d6f" xlink:to="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_42f5344e-f57b-400b-b44c-b6079d3bf02d" xlink:href="bsx-20211231.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_42f5344e-f57b-400b-b44c-b6079d3bf02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_1cb116c6-79fc-4212-83b9-78d7e3fac900" xlink:href="bsx-20211231.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_1cb116c6-79fc-4212-83b9-78d7e3fac900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_59d71444-453a-4fec-9c4c-c608b6a5018a" xlink:href="bsx-20211231.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_59d71444-453a-4fec-9c4c-c608b6a5018a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_ecf49263-d0fa-40e6-8d5d-0a7d3ba1c62d" xlink:href="bsx-20211231.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_ecf49263-d0fa-40e6-8d5d-0a7d3ba1c62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_9285ca35-6291-41fb-baea-ce22fecd3803" xlink:href="bsx-20211231.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_9285ca35-6291-41fb-baea-ce22fecd3803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_da554e4a-e8ab-42fd-a0f5-16878972f1b7" xlink:href="bsx-20211231.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_da554e4a-e8ab-42fd-a0f5-16878972f1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_6db06918-fe2c-4239-81d7-6d303e939979" xlink:href="bsx-20211231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_6db06918-fe2c-4239-81d7-6d303e939979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_de3700fe-44d9-42c5-9cb0-2759656f76ba" xlink:href="bsx-20211231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5cb751a-44e1-4664-8a45-0bb1b04aa3e2" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_de3700fe-44d9-42c5-9cb0-2759656f76ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a82d276b-2ee7-4928-a95c-98e4650a1a26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:to="loc_srt_StatementGeographicalAxis_a82d276b-2ee7-4928-a95c-98e4650a1a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a82d276b-2ee7-4928-a95c-98e4650a1a26" xlink:to="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_35d30453-2b17-4cec-8925-a94b8b3607cd" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_country_US_35d30453-2b17-4cec-8925-a94b8b3607cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ab7de916-8809-4175-8fd1-6265bef16a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_us-gaap_NonUsMember_ab7de916-8809-4175-8fd1-6265bef16a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_4ca962a0-6a1c-4be1-97f5-5d1e969a2ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_us-gaap_EMEAMember_4ca962a0-6a1c-4be1-97f5-5d1e969a2ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_5b767cb4-8eec-47c3-b602-70c5d0bae306" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_srt_AsiaPacificMember_5b767cb4-8eec-47c3-b602-70c5d0bae306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_ae13c101-6d86-4806-8c90-5b9c5a685f39" xlink:href="bsx-20211231.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_bsx_LatinAmericaandCanadaMember_ae13c101-6d86-4806-8c90-5b9c5a685f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_5b49604d-a24d-4e95-b42b-58a84d0475b3" xlink:href="bsx-20211231.xsd#bsx_EmergingMarketsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65dc743-6588-4283-97e4-abb89f6bb51b" xlink:to="loc_bsx_EmergingMarketsMember_5b49604d-a24d-4e95-b42b-58a84d0475b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_38f0d7f7-8d2f-4a86-978c-8380e311d6be" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsTotalNumberOfCountries_fe41ee30-31a7-4148-b028-135ec664c1df" xlink:href="bsx-20211231.xsd#bsx_EmergingMarketsTotalNumberOfCountries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:to="loc_bsx_EmergingMarketsTotalNumberOfCountries_fe41ee30-31a7-4148-b028-135ec664c1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bafeb84-7f22-433c-8168-9be410f0048f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e1f0629b-0b00-474a-8360-a1e7be4db1d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bafeb84-7f22-433c-8168-9be410f0048f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_97f452f3-d13f-4851-bfb0-9e0de895ef76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_903344d9-6168-4d80-a771-c36b361cf29b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_97f452f3-d13f-4851-bfb0-9e0de895ef76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_09972bd5-8aa8-4ffa-846e-06b871c66e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_97f452f3-d13f-4851-bfb0-9e0de895ef76" xlink:to="loc_us-gaap_ContractWithCustomerLiability_09972bd5-8aa8-4ffa-846e-06b871c66e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8ef75483-edd2-4a5d-9aa5-010335611362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_903344d9-6168-4d80-a771-c36b361cf29b" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8ef75483-edd2-4a5d-9aa5-010335611362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_4ae13561-c2ed-4205-b357-48934e553bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8ef75483-edd2-4a5d-9aa5-010335611362" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_4ae13561-c2ed-4205-b357-48934e553bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_383e1115-6622-485f-a101-1229db9531d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8ef75483-edd2-4a5d-9aa5-010335611362" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_383e1115-6622-485f-a101-1229db9531d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20211231.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_83a57d61-3d3b-4e72-bfd3-c66fb60f922b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ffc64abf-61dd-4177-933e-a4ca19059e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_83a57d61-3d3b-4e72-bfd3-c66fb60f922b" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ffc64abf-61dd-4177-933e-a4ca19059e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_ab1891c0-0091-49ca-8289-90c2d61dbfee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2d59dae8-79c5-406d-903e-c1981d83519a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_ab1891c0-0091-49ca-8289-90c2d61dbfee" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2d59dae8-79c5-406d-903e-c1981d83519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_f6c01e74-1b6d-40d3-af66-c860dfa5dec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_f6c01e74-1b6d-40d3-af66-c860dfa5dec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_4785cd78-9f74-43e0-bb61-d6a8f94cf3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_4785cd78-9f74-43e0-bb61-d6a8f94cf3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_a6f5f2e5-b687-4810-994b-ea7fffdd1de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_a6f5f2e5-b687-4810-994b-ea7fffdd1de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d6f3b856-5afb-461e-acca-5fff256bbf14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d6f3b856-5afb-461e-acca-5fff256bbf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2501a182-4cef-4da1-b5bb-8baf09412976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2501a182-4cef-4da1-b5bb-8baf09412976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cb36f02a-cf51-4b63-bf5e-583ac1850009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cb36f02a-cf51-4b63-bf5e-583ac1850009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1136ecba-362b-454c-a7a6-c0dccf324ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1136ecba-362b-454c-a7a6-c0dccf324ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b51148d1-73a8-4025-a809-187bea7a1444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b51148d1-73a8-4025-a809-187bea7a1444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_c6ca9942-1898-475a-9187-6602f7cd828e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_c6ca9942-1898-475a-9187-6602f7cd828e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_f329f1d9-222b-403c-9ecd-c0e866395f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_f329f1d9-222b-403c-9ecd-c0e866395f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_92ac21c4-1d74-4c41-9510-8837e6be36e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_92ac21c4-1d74-4c41-9510-8837e6be36e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e8050bf0-8c55-44cb-85fe-84908ce5952f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e8050bf0-8c55-44cb-85fe-84908ce5952f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76376db3-0f96-4457-84a3-c6783cc0bf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76376db3-0f96-4457-84a3-c6783cc0bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2f64a363-39fe-4050-9adf-09408a7db1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2f64a363-39fe-4050-9adf-09408a7db1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b74de747-c509-4b53-8836-9b45e2ef42ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b74de747-c509-4b53-8836-9b45e2ef42ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1e3fa6bb-28d7-4b4f-9f5e-23a880775c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc6a8358-35cc-4b03-a1ce-5709b92c4dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1e3fa6bb-28d7-4b4f-9f5e-23a880775c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20211231.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8853950f-d777-4979-a150-05a293f9bac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_484d8dee-e071-47cb-88aa-1ecfc4b8591b" xlink:href="bsx-20211231.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_8853950f-d777-4979-a150-05a293f9bac7" xlink:to="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_484d8dee-e071-47cb-88aa-1ecfc4b8591b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20211231.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_bb4d1716-c91e-4d5f-ac77-c774708004b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock_1327ac2f-9077-4562-a909-b37c0a70bc0b" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_bb4d1716-c91e-4d5f-ac77-c774708004b7" xlink:to="loc_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock_1327ac2f-9077-4562-a909-b37c0a70bc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_2a9b3f63-fef3-49b9-af88-a675b35a03f7" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_bb4d1716-c91e-4d5f-ac77-c774708004b7" xlink:to="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_2a9b3f63-fef3-49b9-af88-a675b35a03f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_b2e0d082-9f47-41fb-a507-cfc03e8fbf7e" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_bb4d1716-c91e-4d5f-ac77-c774708004b7" xlink:to="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_b2e0d082-9f47-41fb-a507-cfc03e8fbf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_4663191d-c810-4e85-8922-70d45840eb7c" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_bb4d1716-c91e-4d5f-ac77-c774708004b7" xlink:to="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_4663191d-c810-4e85-8922-70d45840eb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock_13b68b23-ead8-4767-aa79-4364f2150983" xlink:href="bsx-20211231.xsd#bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_bb4d1716-c91e-4d5f-ac77-c774708004b7" xlink:to="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock_13b68b23-ead8-4767-aa79-4364f2150983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="simple" xlink:href="bsx-20211231.xsd#EmployeeRetirementPlansNotes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f4dbc5dc-a1d1-47e5-b296-80cfe0c27541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_b39c2bb5-0a4f-4c7d-98b5-f3df20e7e3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f4dbc5dc-a1d1-47e5-b296-80cfe0c27541" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_b39c2bb5-0a4f-4c7d-98b5-f3df20e7e3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="simple" xlink:href="bsx-20211231.xsd#EmployeeRetirementPlansEmployeeRetirementPlansPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_771fc06c-8410-4183-a247-8e4a7d418dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_170fee87-1c51-472e-8d5d-c030b0d926dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_771fc06c-8410-4183-a247-8e4a7d418dbd" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_170fee87-1c51-472e-8d5d-c030b0d926dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_170fee87-1c51-472e-8d5d-c030b0d926dc" xlink:to="loc_us-gaap_RetirementPlanNameAxis_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_ffb0b6c6-cbbb-4e57-af81-20338d85aa6b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_a4fb858c-600f-4385-a593-6d54cfe66f74" xlink:href="bsx-20211231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_a4fb858c-600f-4385-a593-6d54cfe66f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_886d49ab-f03e-490e-be3a-e4412176e35c" xlink:href="bsx-20211231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_243adb9f-0934-4a26-bf43-92b744eececa" xlink:to="loc_bsx_InternationalRetirementPlansMember_886d49ab-f03e-490e-be3a-e4412176e35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7570b156-e903-4ad4-b13b-aa0a9774c3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_170fee87-1c51-472e-8d5d-c030b0d926dc" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7570b156-e903-4ad4-b13b-aa0a9774c3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_c548e2e7-a275-4833-937c-9ba244048170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7570b156-e903-4ad4-b13b-aa0a9774c3cf" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_c548e2e7-a275-4833-937c-9ba244048170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="bsx-20211231.xsd#EmployeeRetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_e2d5c25d-dc84-4762-af90-e5c9a5de4a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_e2d5c25d-dc84-4762-af90-e5c9a5de4a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_797d33d8-799e-4fd5-9cc6-49417fd78778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_797d33d8-799e-4fd5-9cc6-49417fd78778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_a77e248f-ac3c-4f3a-9255-b722644fdbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_a77e248f-ac3c-4f3a-9255-b722644fdbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_7a0c15d0-3418-4b2c-a587-3cdc5c03c6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_7a0c15d0-3418-4b2c-a587-3cdc5c03c6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ba2edad2-8a69-4c5b-a20e-31d6cbfe65ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ba2edad2-8a69-4c5b-a20e-31d6cbfe65ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_a564fca2-141d-441b-8631-bfe265dd0694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_a564fca2-141d-441b-8631-bfe265dd0694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_75115449-a55d-4f3e-99fb-9b536f06515e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_fcc40081-ee0a-44dd-98d6-3bc1b53ad336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4eeb5ec2-ea07-4bad-bf16-55ce11af8b27" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_fcc40081-ee0a-44dd-98d6-3bc1b53ad336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#EmployeeRetirementPlansDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5719e193-af78-45f9-a396-c2b0a9700c04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5719e193-af78-45f9-a396-c2b0a9700c04" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_7e372a8b-a539-44a9-9662-18308943d933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_RetirementPlanNameAxis_7e372a8b-a539-44a9-9662-18308943d933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_7e372a8b-a539-44a9-9662-18308943d933" xlink:to="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_d90b3405-0b1b-4498-88bb-234c9be1b600" xlink:href="bsx-20211231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_d90b3405-0b1b-4498-88bb-234c9be1b600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_dc542021-b5f2-4078-b5dc-9e48ba08fe35" xlink:href="bsx-20211231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:to="loc_bsx_InternationalRetirementPlansMember_dc542021-b5f2-4078-b5dc-9e48ba08fe35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_d3d92079-d41c-4ecf-9a3f-c451f923137a" xlink:href="bsx-20211231.xsd#bsx_UKPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_44e4a674-5a7d-4f45-915f-bcac657fe963" xlink:to="loc_bsx_UKPlanMember_d3d92079-d41c-4ecf-9a3f-c451f923137a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3ffab14a-790f-456c-b375-d03c967cd5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3ffab14a-790f-456c-b375-d03c967cd5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22c4967d-07e0-461f-abbe-f39e2b9fd624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3ffab14a-790f-456c-b375-d03c967cd5a3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22c4967d-07e0-461f-abbe-f39e2b9fd624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_c7eadebe-5673-4b9a-a048-00a78a072e3b" xlink:href="bsx-20211231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22c4967d-07e0-461f-abbe-f39e2b9fd624" xlink:to="loc_bsx_BTGAcquisitionMember_c7eadebe-5673-4b9a-a048-00a78a072e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a1fe03d0-1656-46f9-89a3-850a9c476909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a1fe03d0-1656-46f9-89a3-850a9c476909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_8e325136-a3e6-41e1-96df-0c33ab3c003b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a1fe03d0-1656-46f9-89a3-850a9c476909" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_8e325136-a3e6-41e1-96df-0c33ab3c003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_a500529a-236a-4f8b-89f9-1886e74cc522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_8e325136-a3e6-41e1-96df-0c33ab3c003b" xlink:to="loc_us-gaap_OtherContractMember_a500529a-236a-4f8b-89f9-1886e74cc522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5f54674f-fb20-4011-ada7-466ed5a8a15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5f54674f-fb20-4011-ada7-466ed5a8a15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5f54674f-fb20-4011-ada7-466ed5a8a15a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0a7622ee-d88e-4951-b4ed-2abc7c4a3e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0a7622ee-d88e-4951-b4ed-2abc7c4a3e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ddabf2a0-5baf-45fe-a77c-142c1cc98e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ddabf2a0-5baf-45fe-a77c-142c1cc98e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cc10b58a-7891-432c-819b-bcdfa0b9d8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a531ffd2-360e-4424-94bf-86f3abda0a81" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cc10b58a-7891-432c-819b-bcdfa0b9d8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b435cba3-d77c-4161-b9d5-526855918668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b435cba3-d77c-4161-b9d5-526855918668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b435cba3-d77c-4161-b9d5-526855918668" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_f57f48e2-4b7a-4d70-a29e-27e04abd6a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:to="loc_us-gaap_DomesticPlanMember_f57f48e2-4b7a-4d70-a29e-27e04abd6a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_04a51c68-b60a-47b7-b946-779a0d7b18b3" xlink:href="bsx-20211231.xsd#bsx_UKPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:to="loc_bsx_UKPlanMember_04a51c68-b60a-47b7-b946-779a0d7b18b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherInternationalPlansMember_c380cfe5-de15-4898-aec0-37abebefd697" xlink:href="bsx-20211231.xsd#bsx_OtherInternationalPlansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0eb4628a-ac49-47c3-8444-d322a1dd7569" xlink:to="loc_bsx_OtherInternationalPlansMember_c380cfe5-de15-4898-aec0-37abebefd697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71cec395-58e0-46f3-92ef-48e64e3e4a9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_srt_RangeAxis_71cec395-58e0-46f3-92ef-48e64e3e4a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_71cec395-58e0-46f3-92ef-48e64e3e4a9d" xlink:to="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7070cddc-dbdd-4bf1-813f-93d162076e12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:to="loc_srt_MaximumMember_7070cddc-dbdd-4bf1-813f-93d162076e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b9f6b760-e42f-445e-9733-7ea4b41d5fee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eb004931-57b5-4e45-b383-179afe8df40b" xlink:to="loc_srt_MinimumMember_b9f6b760-e42f-445e-9733-7ea4b41d5fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_77abb88f-8a90-4a42-abe7-aff618a307b2" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d376d2ad-c3f4-4aad-bc19-533e8fd99636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d376d2ad-c3f4-4aad-bc19-533e8fd99636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_12575d3b-778b-4822-b860-d51129b946ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_12575d3b-778b-4822-b860-d51129b946ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6e799d39-84e9-4c2e-9ffb-fe47de60d234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6e799d39-84e9-4c2e-9ffb-fe47de60d234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ac38a30-0a4a-4d4d-9890-44ce81d6630d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ac38a30-0a4a-4d4d-9890-44ce81d6630d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4014252a-1842-4dbb-ad04-06d505ec7af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4014252a-1842-4dbb-ad04-06d505ec7af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fd2614ab-bff3-4dde-b8df-aafccd713e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fd2614ab-bff3-4dde-b8df-aafccd713e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_0f68411f-dae1-45db-a99f-d5b1bc72e790" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_0f68411f-dae1-45db-a99f-d5b1bc72e790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_aa3bb7a7-8459-4f83-82d6-fdf11df8942b" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_aa3bb7a7-8459-4f83-82d6-fdf11df8942b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_63307e3c-306b-4eb5-a9c4-89df387bf38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_63307e3c-306b-4eb5-a9c4-89df387bf38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_3f01799e-5a29-4a6d-94dc-36ac111a6a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_3f01799e-5a29-4a6d-94dc-36ac111a6a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_ae8018f3-6215-41e2-8ac2-2c99270c5868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_ae8018f3-6215-41e2-8ac2-2c99270c5868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Pensionbenefitobligationbenefitspaid_31ef8c69-e4f7-4088-b64e-2a9905fe25c3" xlink:href="bsx-20211231.xsd#bsx_Pensionbenefitobligationbenefitspaid"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_Pensionbenefitobligationbenefitspaid_31ef8c69-e4f7-4088-b64e-2a9905fe25c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_5a04bb1a-67cc-4447-8dba-53eb41f836d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_5a04bb1a-67cc-4447-8dba-53eb41f836d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d9019168-08e4-46f4-a27e-a4138a526b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d9019168-08e4-46f4-a27e-a4138a526b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c76a4f09-b2d2-4e97-9f3e-28c2368456e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c76a4f09-b2d2-4e97-9f3e-28c2368456e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_834a46cf-1208-4ddd-9488-39a4defee2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_834a46cf-1208-4ddd-9488-39a4defee2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d07cd8e0-df75-476f-aa3c-272a2028ede5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d07cd8e0-df75-476f-aa3c-272a2028ede5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_56aa11d1-e4ab-48fa-b27c-19989c9b245d" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_56aa11d1-e4ab-48fa-b27c-19989c9b245d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a9481fe3-e2ab-4d0c-b30d-abe7952a4801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a9481fe3-e2ab-4d0c-b30d-abe7952a4801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_efba6a9e-3f08-4216-91eb-1d5acc1d6e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_efba6a9e-3f08-4216-91eb-1d5acc1d6e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_2d13874f-5fda-4885-a28e-834a74657d8f" xlink:href="bsx-20211231.xsd#bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_2d13874f-5fda-4885-a28e-834a74657d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExpenseRelatedToMatchingContributions_eb9cbd80-b33d-4155-877c-85f40c789cd2" xlink:href="bsx-20211231.xsd#bsx_ExpenseRelatedToMatchingContributions"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_bsx_ExpenseRelatedToMatchingContributions_eb9cbd80-b33d-4155-877c-85f40c789cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1949af2e-e39a-4edb-aba1-539e90464106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1949af2e-e39a-4edb-aba1-539e90464106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_5f57f9ad-14f8-40de-b9ae-60d404cc473a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_5f57f9ad-14f8-40de-b9ae-60d404cc473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_4799eab5-72de-4618-bb10-2276c99df079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_4799eab5-72de-4618-bb10-2276c99df079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1b49e057-44e2-44b2-99a5-39c91d0b56f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1b49e057-44e2-44b2-99a5-39c91d0b56f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_f3a4d250-fb62-4f6c-af96-4511d6cee100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_f3a4d250-fb62-4f6c-af96-4511d6cee100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_6851c3d0-f27a-482e-beab-31cdb72bfb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_6851c3d0-f27a-482e-beab-31cdb72bfb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_25fc38cb-4251-4516-80df-950d84246260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_25fc38cb-4251-4516-80df-950d84246260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f3e0ffff-d5cf-4235-86c9-c7dd4d1c4857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f3e0ffff-d5cf-4235-86c9-c7dd4d1c4857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_45b56ae7-c9b0-4ed9-a32a-cffbb571d0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_3bd0ac92-24d1-46de-a0f8-bfcc8b2f28c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_45b56ae7-c9b0-4ed9-a32a-cffbb571d0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleII" xlink:type="simple" xlink:href="bsx-20211231.xsd#ScheduleII"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ScheduleII" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_89510dc4-c7a8-48f5-abe9-63f5251e9724" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_dbc613b8-60cf-49ac-82ae-338b31a05321" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_89510dc4-c7a8-48f5-abe9-63f5251e9724" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_dbc613b8-60cf-49ac-82ae-338b31a05321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="bsx-20211231.xsd#ScheduleIIDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_4be2f47b-8d94-4ae3-803b-7f5525050fa2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_04641e66-2889-4cd1-a0f0-2075957cbc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4be2f47b-8d94-4ae3-803b-7f5525050fa2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_04641e66-2889-4cd1-a0f0-2075957cbc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_2df71f93-e2ed-41d9-a19f-1aa665db32f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4be2f47b-8d94-4ae3-803b-7f5525050fa2" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_2df71f93-e2ed-41d9-a19f-1aa665db32f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_56cb90e3-0e2e-4df0-8361-b08635030f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4be2f47b-8d94-4ae3-803b-7f5525050fa2" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_56cb90e3-0e2e-4df0-8361-b08635030f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_9cd5ab28-3d86-4802-ab8a-c395c706783a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4be2f47b-8d94-4ae3-803b-7f5525050fa2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_9cd5ab28-3d86-4802-ab8a-c395c706783a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ecf2449c-2f20-4d31-acda-b1d70ef705ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4be2f47b-8d94-4ae3-803b-7f5525050fa2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ecf2449c-2f20-4d31-acda-b1d70ef705ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_ee78a52d-25fb-4b26-821e-db288801b4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4be2f47b-8d94-4ae3-803b-7f5525050fa2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_ee78a52d-25fb-4b26-821e-db288801b4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>bsx-20211231_g1.jpg
<TEXT>
begin 644 bsx-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %=I=&MO=W-K
M:2P@06UA;F1A   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,R
M,0  DI(  @    ,R,0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M[W:T<KQ+)F)"F)$570EBRGDX4XYY.'XTV=EH^ER7@M6)TZTN[TWNJ1173"8
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MQ.4M)D='6VNDC1,&)#N!8HIW $#<P);Y #2L_ _Q$@7RKGXI"YM_)>(0GP_
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MOHH&E&I-I\:C#-^]N55FB3Y,97!)*KG#&@!9_A[;W$UZDFN:M_9U_>?;+G3
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MU ^9=VK7";?W&1M61#GWW?A7#27NKZ;;:FEY?6RV\GBV=-3NTO)=*@(^RQE
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MT2299?D5RQBD*D,Q +/@<YJRGPQTQK<1WFIZK>O&+5(9KB:,O#%;RK+'$N$
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MS%=NT+N( "\5MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!3_LJR&MG
M5_)_TXVXM3+O;_5!MVW&<=3G.,U->V<&H6%Q97B>9;W,312IDC<C#!&1R.#V
MJ:B@"*UM8;*SAM;5-D,$:QQKDG:JC &3ST%2T44 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT >GT5G:NT\"P7$%U)&!<0QM$%0JX>55.<J3T8]"*T: "BBB@ HHHH ****
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4453U75K+1;!KS4YQ!
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MOR@$<$ >CVUO':6L5O#N\N) B[W+M@# RS$DGW)S4E% !1110 4444 %%%%
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M&>O%9/\ 8_B?4!_Q,_$<=@A_Y9:1:*K >ADEWY^H5:Z6B@"G)I5G<Z?#9ZA
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M%=/10!G:Y_R#XO\ K\M?_1\=:-9VN?\ (/B_Z_+7_P!'QUHT %%%% !1110
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M_D'Q?]?EK_Z/CK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/3Y;Z>T;3]&_M#[$\+L9I_M<XE/F*5 38 1PS9Z\=* .QUS_ )!\7_7Y:_\
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M97UB9;66(I%;10QKY1( W[R"21R1VYY!K,W>.+KI'H&E@]R\UZ1^&(?YT?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 8GC*QM]3\$ZQ97MI>WEO<6DB206&W[0X*_\ +/<0"W<
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9VN?\
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MT>[MB9E*[4_?IUR<_D#6M0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %9VMZ!I/B33_ +#K^G6^H6N\2"*XC# ,.A'H
M>2/H2.]:-% &;)X;T.:_M+Z;1M/DN[)%2UN&M4,D"KT5&QE0,G &.M2VFBZ7
M8:A<W]CIMG;7EV<W-Q# J23'_;8#+?C5VB@#.US_ )!\7_7Y:_\ H^.M&L[7
M/^0?%_U^6O\ Z/CK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH SM<_Y!\7_ %^6O_H^.M&L[7/^0?%_
MU^6O_H^.M&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%[#_ ,"4_P :T:* ,[_A(=%_Z"]A_P"!*?XT?\)#HO\ T%[#_P "4_QK1HH
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M -!>P_\  E/\:T:* ,[_ (2'1?\ H+V'_@2G^-16WB?1YXB[:E9Q$2.FU[E
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M?XUHT4 9W_"0Z+_T%[#_ ,"4_P :/^$AT7_H+V'_ ($I_C6C10!G?\)#HO\
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M/NU% ''?"3_DD'AC_L'1?RKL:** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSY22>A.1D>_-6?BUX3NO$_V1K#P_?75[:0226&KZ7J,5O<V5QD%599&0&-L
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MO2:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4EF96VJ5P:U9OB*MWK^D66A64TUC=ZK]@EU&6,>3)BVDE81$/NW J@RR[?O
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M#@@,<%L<T =S17$ZE\5_#VFV,-V_G20SPVTD,F^&))#.KNB;Y)%0,$C9CN8
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M1*L?FG]V$#DCS,CRW&3@$Q/\31+-I,=A93O;S7T-I>:C- %@#-!YK(H$A8,
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MF:7XUTKQ'HUA?:AJ2O90Z=!;K;V5Q/;RQ+$JS^9(LRVZ_.)0QD5I,;2F3M%
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MI=OIDYSVA3X::7'=PLNH:E]CBN!=?V>9(_(>;R?*+M\F_E>JA@N>0 378T4
M<C!\/+2/3TT^ZUK6+[3T$,8LKJ:-H3!$25@91&-R$[=Q;+L%"LQ4LIU]%T>X
MT8K:IJ$]SIT,"QP1W#*[J=['[P4$@*449))"\\Y+:]% '''X9:,;"_M/M-]Y
M=_;36TI\Q,A9;B2X8CY.N^5@,YX ZGDON_AU8WC7T;ZMJT=A>2R3G3XYD6".
M5Y%D=P-FXDLI.'9E!=B #C'744 <3+\+-&N)[C[5>ZE-:RF[,=FTJ+' ;EMT
MI0J@?);# LS;2.,#(*3?"[3KQ[F74]9U>^N;D2"6>:2$,=]LUMP%C"C".<8
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MM@QL(W4_4I]6T?P/I?BA/$OE:GJT%K]ON;M[>V5T6*:411.T+11$O)@&48(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
544 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>mcps202010-k.jpg
<TEXT>
begin 644 mcps202010-k.jpg
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M /X65S_\@T?\)E^THO7X8> !]?&5S_\ (-+_ ,)C^TIU_P"%8> ,?]CE<_\
MR#2?\)I^TI_T3'X?_P#A97/_ ,@TO_":?M*?]$Q^'_\ X65S_P#(-'_":?M*
M?]$Q^'__ (65S_\ (-'_  FG[2G_ $3'X?\ _A97/_R#70> ?$WQOU#Q78V_
MB_P+X/T;P\V_[3>Z7XEGN[B/",4VQ-:H&RVT'+# )/.,5[#1111111111111
M11111111117@/[;/Q%U_X>_!JW'AK4)-$U+7M=TWP_\ VS" 7TZ*ZG$<DZD\
M*P3(#'H6![5POQV\/Q?LQZC\)?$W@&XU2TGU#QEIOAG5[";4+B[36+2Z+QL9
MEE=M]PI4.LWW\Y!)!(KS73FN?!/QBTK2/BG'X@TO6]5\<1WWA[XH:?J4]SI&
MOPF[WP:9<HDFR F/]RD3+L!0,.A9O1_A#^T)XR\3>,?A7K.J7WFZ'\2=5\1Z
M;'H36\:II<=B9FM'C<*)"YCM9!+YC'+2C"IMQ7UW11111111111111111111
M11111117,_$CX=>'_BSX)U7PIXHL%U+0]2C$<]N79#PP975E(*NK*K*P((*@
MBN)TG]G>P_X2;PUK7B?Q7XC\=S>&CYFBV_B":W,5G-M*?:"L,,?G3A"5$DI<
MC)(PQ+''TC]D_1M/L=#TBZ\7^*=8\*Z/JZ:W:^'K^XMVM_M4<S3Q;I%@68Q)
M*0ZQ>9L!51@J-M=!X5_9Q\)>$?&MEXBLS?R-IMQJ=WI>G3S*;339K^027DD*
4A0P,C;N&9@HD<*%#8KU2BBBO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>mcps202010-k2.jpg
<TEXT>
begin 644 mcps202010-k2.jpg
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M"A4G?_9-NK7X6O\ $3P'X^AFA^)JW]SJVM^(;Q97M_$T#1[H[^%V&Q5$0"-
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mcps202010-k3.jpg
<TEXT>
begin 644 mcps202010-k3.jpg
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6^I+W_DXS0?\ L5-1_P#2RRKTJBO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mcps202010-k4.jpg
<TEXT>
begin 644 mcps202010-k4.jpg
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H-\(%EM895O-PN0\8(G^SR&:WW\?-Y4I,B9^XQ++@\U]-CI2T45__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>mcps202010-k5.jpg
<TEXT>
begin 644 mcps202010-k5.jpg
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:4R,MWI^FPP2(9,^8595&TMDYQUR<UVE?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>mcps202010-k6.jpg
<TEXT>
begin 644 mcps202010-k6.jpg
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M9M&ET;7;[0IK>>9)6:2VD\MGRG&&/(&3CUKO:****************:RB12K
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*IZ$\^M=W117_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168573301192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,426,724,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168579407720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168574120872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 11,888<span></span>
</td>
<td class="nump">$ 9,913<span></span>
</td>
<td class="nump">$ 10,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,465<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">8,177<span></span>
</td>
<td class="nump">6,448<span></span>
</td>
<td class="nump">7,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">4,359<span></span>
</td>
<td class="nump">3,787<span></span>
</td>
<td class="nump">3,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expenses</a></td>
<td class="nump">1,204<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">741<span></span>
</td>
<td class="nump">789<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring net charges (credits)</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits)</a></td>
<td class="nump">430<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Assets</a></td>
<td class="num">(78)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">6,978<span></span>
</td>
<td class="nump">6,528<span></span>
</td>
<td class="nump">6,102<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(341)<span></span>
</td>
<td class="num">(361)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="num">(358)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4,013)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,041<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Preferred stock dividends</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) available to common stockholders</a></td>
<td class="nump">$ 985<span></span>
</td>
<td class="num">$ (115)<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per common share &#8212; basic</a></td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 3.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per common share &#8212; assuming dilution</a></td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">1,422,300<span></span>
</td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,391,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Assuming dilution</a></td>
<td class="nump">1,433,800<span></span>
</td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,410,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581709080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,041<span></span>
</td>
<td class="num">$ (82)<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(125)<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="nump">170<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">56<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="nump">$ 1,096<span></span>
</td>
<td class="num">$ (145)<span></span>
</td>
<td class="nump">$ 4,937<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168574456760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,925<span></span>
</td>
<td class="nump">$ 1,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">1,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">751<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,317<span></span>
</td>
<td class="nump">6,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,252<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">11,988<span></span>
</td>
<td class="nump">9,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,121<span></span>
</td>
<td class="nump">5,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,142<span></span>
</td>
<td class="nump">4,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">32,229<span></span>
</td>
<td class="nump">30,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">794<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,436<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">783<span></span>
</td>
<td class="nump">958<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,274<span></span>
</td>
<td class="nump">3,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,804<span></span>
</td>
<td class="nump">9,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,220<span></span>
</td>
<td class="nump">2,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value - authorized 50,000,000 shares; issued 10,062,500 shares as of December 31, 2021 and December 31, 2020</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - authorized 2,000,000,000 shares; issued 1,688,810,052 shares as of December 31, 2021 and 1,679,911,918 shares as of December 31, 2020</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 263,289,848 shares as of December 31, 2021 and December 31, 2020</a></td>
<td class="num">$ (2,251)<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">19,986<span></span>
</td>
<td class="nump">19,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,392)<span></span>
</td>
<td class="num">(2,378)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Unrealized costs associated with defined benefit pensions and other items</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">16,622<span></span>
</td>
<td class="nump">15,326<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 32,229<span></span>
</td>
<td class="nump">$ 30,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168574454872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Paranthetical - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ConsolidatedBalanceSheetParentheticalAbstract', window );"><strong>Consolidated Balance Sheet (Parenthetical) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,688,810,052<span></span>
</td>
<td class="nump">1,679,911,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ConsolidatedBalanceSheetParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consolidated Balance Sheet (Parenthetical)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ConsolidatedBalanceSheetParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570746152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,632,148,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders' Equity at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (1,717)<span></span>
</td>
<td class="nump">$ 17,346<span></span>
</td>
<td class="num">$ (6,953)<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issuance (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,340,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock Issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock', window );">Preferred stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock', window );">Common stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Dec. 31, 2019</a></td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,561<span></span>
</td>
<td class="num">(2,253)<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issuance (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">29,382,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,040,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock Issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock', window );">Preferred stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock', window );">Common stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,911,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="num">(137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Dec. 31, 2020</a></td>
<td class="nump">15,326<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,732<span></span>
</td>
<td class="num">(2,378)<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issuance (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,898,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock Issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock', window );">Preferred stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock', window );">Common stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,688,810,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Dec. 31, 2021</a></td>
<td class="nump">$ 16,622<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
<td class="nump">$ 19,986<span></span>
</td>
<td class="num">$ (1,392)<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Common stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Preferred stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121321822&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121323062&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168573680264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,041,000,000<span></span>
</td>
<td class="num">$ (82,000,000)<span></span>
</td>
<td class="nump">$ 4,700,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on disposal of businesses and assets</a></td>
<td class="num">(78,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,093,000,000<span></span>
</td>
<td class="nump">1,123,000,000<span></span>
</td>
<td class="nump">1,011,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit', window );">Deferred and prepaid income taxes</a></td>
<td class="num">(124,000,000)<span></span>
</td>
<td class="num">(82,000,000)<span></span>
</td>
<td class="num">(4,301,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">194,000,000<span></span>
</td>
<td class="nump">170,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Goodwill and other intangible asset impairment charges</a></td>
<td class="nump">370,000,000<span></span>
</td>
<td class="nump">533,000,000<span></span>
</td>
<td class="nump">105,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net loss (gain) on investments and notes receivable</a></td>
<td class="num">(250,000,000)<span></span>
</td>
<td class="num">(333,000,000)<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(136,000,000)<span></span>
</td>
<td class="num">(100,000,000)<span></span>
</td>
<td class="num">(35,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_InventoryStepUpAmortization', window );">Inventory step-up amortization</a></td>
<td class="nump">34,000,000<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
<td class="nump">46,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetCurrencyExchangeGainLoss', window );">Foreign exchange (gain) loss</a></td>
<td class="nump">27,000,000<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="nump">358,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherNet', window );">Other, net</a></td>
<td class="nump">51,000,000<span></span>
</td>
<td class="nump">213,000,000<span></span>
</td>
<td class="nump">63,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="num">(279,000,000)<span></span>
</td>
<td class="nump">335,000,000<span></span>
</td>
<td class="num">(130,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(346,000,000)<span></span>
</td>
<td class="num">(65,000,000)<span></span>
</td>
<td class="num">(290,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(134,000,000)<span></span>
</td>
<td class="num">(265,000,000)<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">408,000,000<span></span>
</td>
<td class="num">(28,000,000)<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash provided by (used for) operating activities</a></td>
<td class="nump">1,870,000,000<span></span>
</td>
<td class="nump">1,508,000,000<span></span>
</td>
<td class="nump">1,836,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment and internal use software</a></td>
<td class="num">(554,000,000)<span></span>
</td>
<td class="num">(376,000,000)<span></span>
</td>
<td class="num">(461,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(2,258,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(4,382,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of certain businesses</a></td>
<td class="nump">826,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">82,000,000<span></span>
</td>
<td class="nump">87,000,000<span></span>
</td>
<td class="nump">52,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities', window );">Proceeds from (payments for) settlements of hedge contracts</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(199,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies', window );">Proceeds from (payments for) investments and acquisitions of certain technologies</a></td>
<td class="nump">279,000,000<span></span>
</td>
<td class="num">(146,000,000)<span></span>
</td>
<td class="num">(149,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash provided by (used for) investing activities</a></td>
<td class="num">(1,597,000,000)<span></span>
</td>
<td class="num">(411,000,000)<span></span>
</td>
<td class="num">(5,041,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration previously established in purchase accounting</a></td>
<td class="num">(15,000,000)<span></span>
</td>
<td class="num">(49,000,000)<span></span>
</td>
<td class="num">(66,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentsForRoyaltyRights', window );">Payments for royalty rights</a></td>
<td class="num">(85,000,000)<span></span>
</td>
<td class="num">(97,000,000)<span></span>
</td>
<td class="num">(69,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">256,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Payments on short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,950,000,000)<span></span>
</td>
<td class="num">(1,000,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings, net of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,245,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Net increase (decrease) in commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(714,000,000)<span></span>
</td>
<td class="num">(575,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on borrowings from credit facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,919,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from borrowings on credit facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,916,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on long-term borrowings and debt extinguishment costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,260,000,000)<span></span>
</td>
<td class="num">(3,560,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from long-term borrowings, net of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,683,000,000<span></span>
</td>
<td class="nump">7,229,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid on preferred stock</a></td>
<td class="num">(55,000,000)<span></span>
</td>
<td class="num">(28,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">975,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">975,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(535,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Paymenttonetsharesettleemployeeequityawards', window );">Cash used to net share settle employee equity awards</a></td>
<td class="num">(50,000,000)<span></span>
</td>
<td class="num">(59,000,000)<span></span>
</td>
<td class="num">(65,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</a></td>
<td class="nump">110,000,000<span></span>
</td>
<td class="nump">111,000,000<span></span>
</td>
<td class="nump">123,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided by (used for) financing activities</a></td>
<td class="num">(95,000,000)<span></span>
</td>
<td class="nump">293,000,000<span></span>
</td>
<td class="nump">2,973,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash</a></td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">173,000,000<span></span>
</td>
<td class="nump">1,388,000,000<span></span>
</td>
<td class="num">(222,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</a></td>
<td class="nump">1,995,000,000<span></span>
</td>
<td class="nump">607,000,000<span></span>
</td>
<td class="nump">829,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</a></td>
<td class="nump">2,168,000,000<span></span>
</td>
<td class="nump">1,995,000,000<span></span>
</td>
<td class="nump">607,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="nump">302,000,000<span></span>
</td>
<td class="nump">207,000,000<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest Paid, Excluding Capitalized Interest, Operating Activities</a></td>
<td class="nump">338,000,000<span></span>
</td>
<td class="nump">359,000,000<span></span>
</td>
<td class="nump">449,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</a></td>
<td class="nump">440,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NonCashImpactOfTransferredRoyaltyRights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">$ (82,000,000)<span></span>
</td>
<td class="num">$ (87,000,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash flow impact of deferred income tax expense (benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_InventoryStepUpAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory Step Up Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_InventoryStepUpAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetCurrencyExchangeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetCurrencyExchangeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NonCashImpactOfTransferredRoyaltyRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NonCashImpactOfTransferredRoyaltyRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentsForRoyaltyRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentsForRoyaltyRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Paymenttonetsharesettleemployeeequityawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment to net share settle employee equity awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Paymenttonetsharesettleemployeeequityawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from (payments for) investments and acquisitions of certain technologies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from secured borrowings relating to royalty arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow or inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168573669512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,925,000,000<span></span>
</td>
<td class="nump">$ 1,734,000,000<span></span>
</td>
<td class="nump">$ 217,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">188,000,000<span></span>
</td>
<td class="nump">208,000,000<span></span>
</td>
<td class="nump">346,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">52,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">$ 2,168,000,000<span></span>
</td>
<td class="nump">$ 1,995,000,000<span></span>
</td>
<td class="nump">$ 607,000,000<span></span>
</td>
<td class="nump">$ 829,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581470712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; SIGNIFICANT ACCOUNTING POLICIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#8217;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2021, 2020 or 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note O &#8211; Segment Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for further discussion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets are related to deferred compensation plans. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We write-off amounts determined to be uncollectible against this reserve. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2021, 2020 and 2019; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes in the U.S. toward non-hospital settings, particularly ambulatory surgery centers and office-based labs. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is adequate as of December&#160;31, 2021; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a contract with a customer that creates enforceable rights and obligations,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Promised products or services are identified,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The transaction price, or the amount we expect to receive, is determinable and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have transferred control of the promised items to the customer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management (CRM) product offerings combine the sale of a device with our LATITUDE&#8482; Patient Management System, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers, where necessary, to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these services at the time the devices are sold. We record these costs to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2021 or 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Business Combinations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where we acquire a company in which we previously held an equity stake, we attribute a portion of the purchase price to the previously-held equity interest, which is implied based on the total purchase consideration allocable to each of the shareholders, including Boston Scientific, according to priority of equity interests. We record a gain or loss in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equal to the difference between the implied fair value of our prior ownership and the book value immediately prior to the acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration net expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived Intangibles and IPR&amp;D </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which are foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, as well as IPR&amp;D intangible assets acquired in a business combination. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;D intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the income approach to determine the fair values of our IPR&amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#8217; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to indefinite-lived intangibles, including IPR&amp;D.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization and Impairment of Intangible Assets </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to impairments of intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Valuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2021 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. For purposes of the goodwill impairment test, we aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the second quarter of&#160;2021, we performed our annual goodwill impairment test utilizing the quantitative assessment approach to test all of our reporting units. We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Publicly Traded and Privately-Held Entities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities for which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Investments - Debt and Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details on our investment balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#8217;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment is impaired and we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses and impairments associated with our investment portfolio are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Product Liability Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities and product liability litigation. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of our individual material legal proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record employee termination costs in accordance with FASB ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. We record such costs into expense over the employee&#8217;s future service period, if any. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information and discussion of our restructuring plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currency</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency transaction gains and losses are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our hedging instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not bill customers for shipping and handling of our products. We treat shipping costs incurred after a customer obtains control of the good as a fulfillment cost and record in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated statements of operations. Shipping costs were $194 million in 2021, $146 million in 2020 and $144 million in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development (R&amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Indefinite-lived Intangibles and IPR&amp;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for our policy regarding R&amp;D projects acquired in connection with our business combinations and asset purchases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575305944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments<br></strong></div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND STRATEGIC INVESTMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS AND STRATEGIC INVESTMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed four acquisitions and one divestiture in 2021 and did not complete any material acquisitions during 2020. We have not presented supplemental pro forma financial information for any of our recent acquisitions given their results are not material to our consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which has developed the radiofrequency (RF) NRG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and VersaCross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which will expand our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment using cash on hand of $1.750 billion subject to closing adjustments. We plan to integrate the Baylis Medical business into our Electrophysiology division, supported by our structural heart sales force.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed our acquisition of the remaining shares of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $925 million and up to an additional $300 million in a potential commercial milestone payment. We had been an investor in Preventice since 2015 and held an equity stake of approximately 22 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $196 million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction price for the remaining stake consisted of an upfront cash payment of $706 million, net of cash acquired, and up to approximately $230 million in future milestone payments. The Preventice business is being managed by our Cardiac Rhythm Management division. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse, Inc. (Farapulse), a privately-held company that has developed a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. The transaction consisted of an upfront cash payment of $450 million, up to $125 million upon achievement of certain clinical and regulatory milestones and additional revenue-based payments over the next three years. We had been an investor in Farapulse since 2014 and held an equity stake of approximately 27 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests which resulted in a $222 million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction price for the remaining stake consisted of an upfront cash payment of $268 million, net of cash acquired, and up to approximately $92 million in future milestone payments. The Farapulse business is being integrated into our Electrophysiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2021, we completed our acquisition of the global surgical business of Lumenis LTD. (Lumenis), a privately-held company that develops and commercializes energy-based medical solutions, including innovative laser systems, fibers and accessories used for urology and otolaryngology procedures. The transaction consisted of an upfront cash payment of $1.032 billion, net of cash acquired. The Lumenis business is being integrated into our Urology and Pelvic Health division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2021, we completed our acquisition of the remaining shares of Devoro Medical, Inc. (Devoro Medical), a privately-held company which has developed the WOLF Thrombectomy&#174; Platform, a non-console and lytic-free platform designed to rapidly capture and extract blood clots in arterial, venous and pulmonary embolism procedures. The transaction consisted of an upfront cash payment of $320 million and up to $80 million upon achievement of certain clinical and regulatory milestones. We had been an investor in Devoro Medical since 2019 and held an equity stake of approximately 16 percent. We remeasured the fair value of our previously held investment based on the allocation of the purchase price according to priority of equity interests which resulted in a $57 million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction price for the remaining stake consisted of an upfront cash payment of $251 million, net of cash acquired, and up to approximately $67 million in future milestone payments. The Devoro Medical business is being integrated into our Peripheral Interventions division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price for the acquisitions completed during 2021 were comprised of the components presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preventice</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lumenis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,032</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation for these acquisitions was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preventice</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lumenis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,032</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Preventice:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lumenis:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">492</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">All Other:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $800 million. The agreement included the transfer of five facilities and approximately 280 employees globally. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheet as of December 31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BTG plc</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;19, 2019, we completed our acquisition of BTG plc (BTG), a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we integrated BTG's Interventional Medicine business into our Peripheral Interventions division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Interventional Medicine product lines, the BTG portfolio also included the Specialty Pharmaceuticals business, comprised of acute care antidotes to treat overexposure to certain medications and toxins. On March 1, 2021, we completed the divestiture of Specialty Pharmaceuticals for a purchase price of approximately $800 million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BTG portfolio further included a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. In connection with the acquisition, we acquired rights to future royalties associated with the Zytiga&#8482; Drug used to treat certain forms of prostate cancer. In the fourth quarter of 2019, we sold our rights to these royalties for $256 million in cash, included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price for the acquisition of BTG consisted of upfront cash in the aggregate amount of &#163;3.312 billion (or $4.023 billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received 840 pence (or $10.20 based on the exchange rate at closing) in cash for each BTG share. The transaction price included $404 million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#160;Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase price allocation was comprised of the following components:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized goodwill of $1.635 billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. We allocated $1.399 billion to our Peripheral Interventions reporting unit and $236 million to the Specialty Pharmaceuticals reporting unit. In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of  $73 million related to the execution of a definitive agreement to sell our Specialty Pharmaceuticals business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vertiflex, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2019, we completed our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#8482; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $465 million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of zero to $100 million; however, the payments are uncapped over the three year earn-out period. Through December&#160;31, 2021, we have made incremental payments of $20 million to the prior shareholders of Vertiflex in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Millipede, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we completed our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $90 million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately 20 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $325 million and up to an additional $125 million payment upon achievement of a commercial milestone. During 2021, we cancelled the Millipede mitral valve IPR&amp;D program, recording intangible asset impairment charges of $242 million, and a contingent consideration benefit of $104 million for milestones that would not be achieved due to the cancellation of the program due to the time and financial investment required to commercialize the platform.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies. The goodwill recorded relating to our acquisitions is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">486</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $986 million, which includes amounts related to our recently completed acquisitions of Preventice, Farapulse and Devoro Medical.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net benefits of $136 million and $100 million recorded in 2021 and 2020, respectively, related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or, in the case of Millipede and nVision, for milestones that would not be achieved due to management's discontinuation of the associated R&amp;D program.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$143 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$343 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to our R&amp;D, regulatory and commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a $178 million loss in 2021 and a $363 million gain in 2020 on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span> associated with the remeasurement of our investment during the period to fair value based on observable market prices, as well as the disposition of our remaining ownership during 2021. As of December&#160;31, 2021, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $289 million, which represents amortizable intangible assets, IPR&amp;D, goodwill and deferred tax liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168672384248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets and Liabilities Held for Sale<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">ASSETS AND LIABILITIES HELD FOR SALE</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; ASSETS AND LIABILITIES HELD FOR SALE</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group. On March 1, 2021, we completed the divestiture for a purchase price of approximately $800 million, which was subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of five facilities and approximately 280 employees globally. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheet as of December 31, 2020.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other current liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of December 31, 2020, we had foreign currency translation adjustments of $107 million contained within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span> attributable to the Specialty Pharmaceuticals business that were released upon the closing of the transaction.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581399448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization/Write-offs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,476)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,973)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">377</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $370 million in 2021, $460 million in 2020 and $105 million in 2019. The impairment charges recorded in 2021 were primarily associated with intangible assets established in connection with our acquisition of Millipede, Inc. and VENITI, Inc. The impairment charges recorded in 2020 were primarily associated with intangible assets established in connection with our acquisitions of Sadra Medical, Inc., Apama Medical Inc. and nVision Medical Corporation (nVision). Each of these impairment charges were recorded following management&#8217;s decision to cancel </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the programs due to the length of time, and remaining cost to complete and commercialize the technology, the cost to remediate quality issues or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current assets held for sale</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,887</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $73&#160;million related to our Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. We did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of our goodwill and intangible asset impairment testing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2021 is as follows (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:83.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.127%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581569848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecasted. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. For these derivative instruments, we elected to use the spot method to assess hedge effectiveness. We also elected to exclude the spot-forward difference, referred to as the excluded component, from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. As such, we defer recognition of foreign currency gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we reclassify amortization of the excluded component from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of December 31, 2021 and 2020, we designated as a net investment hedge a portion of our &#8364;900 million in aggregate principal amount of 0.625% senior notes issued in November 2019 and due in 2027. For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains and losses within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In 2019, we settled all outstanding contracts, for $294 million, which is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for settlements of hedge contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Upon settlement in 2019, we received &#163;3.312 billion of cash to fund our acquisition of BTG, which translated into $4.303 billion based on hedged currency exchange rates. We recognized a $323 million loss in 2019  in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to changes in fair value of the contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar and euro-denominated borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of December&#160;31, 2021 and December&#160;31, 2020. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $24 million loss as of December&#160;31, 2021 and a $29 million loss as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as fair value hedges outstanding as of December&#160;31, 2021 and December&#160;31, 2020. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal designated as a net investment hedge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of December&#160;31, 2021 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next year. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note Q &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:30.564%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.727%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:41.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.035%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.559%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:31.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,998</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">767</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $1.632 billion invested in money market funds and time deposits as of December&#160;31, 2021 and $1.584 billion as of December&#160;31, 2020, we held $293 million in interest-bearing and non-interest-bearing bank accounts as of December&#160;31, 2021 and $150 million as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We recognized a financial asset and associated liability for our licensing arrangements at fair value in our consolidated balance sheets using the fair value option in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own the contractual right to receive 50 percent of the future Zytiga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Drug royalty payments from the licensee and remit such payments to the inventors associated with the intellectual property. Royalty payments we receive reduce the fair value of the financial asset and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and payments we remit to inventors reduce the fair value of the financial liability and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of cash flows. We sold our right to receive and retain the other 50 percent of the future royalty payments in 2019 for an upfront cash payment, which we accounted for as a secured borrowing in accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Although we sold these rights, we continue to recognize at fair value the future royalty payments as a financial asset and associated liability. Royalty payments associated with the rights we sold no longer impact our cash flows, and we present this activity as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-cash impact of transferred royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the supplemental information to our consolidated statements of cash flows. We reduce the fair value of the financial asset and associated liability when such non-cash activity occurs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded the fair value of the financial asset and associated liability using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of December&#160;31, 2021. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains and losses from the licensing arrangement. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2021 include the following significant unobservable inputs:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$246 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$281 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">281</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $10.196 billion as of December&#160;31, 2021, including $1.020 billion relating to our euro-denominated December 2027 Notes, and $10.774 billion as of December&#160;31, 2020, including $1.118 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581485160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $9.065 billion as of December&#160;31, 2021 and $9.143 billion as of December&#160;31, 2020, with current maturities of $261 million as of December&#160;31, 2021 and $13 million as of December&#160;31, 2020. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.750%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the December 2027 Notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective November 15, 2021, the interest rate payable decreased by 0.25 percent and began accruing at a rate of 6.75 percent following recent upgrades to our credit ratings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)  As of December&#160;31, 2021 the outstanding balance is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated balance sheet. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;The December 2027 notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of December&#160;31, 2021 or December&#160;31, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $1.250 billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the 2018 Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $500 million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our Mandatory Convertible Preferred Stock (MCPS) and common stock offerings to repay in full the remaining $750 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, we entered into a $1.000 billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding on the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of 0.85%. The credit agreement is subject to a financial covenant described below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $750 million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $250 million and terminated the February 2021 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, we entered into a $700 million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December 31, 2019, we had $700 million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $300 million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into a $2.000 billion senior unsecured delayed-draw term loan facility consisting of a $1.000 billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $1.000 billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August 19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $1.000 billion under the Two-Year Delayed Draw Term Loan and $1.000 billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, the December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $1.000 billion outstanding under the Three-Year Delayed Draw Term Loan. In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of December&#160;31, 2021, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through December&#160;31, 2021, we were in compliance with the financial covenant required by our credit facilities described above. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.047%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement<br/>as of December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual<br/>as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71 times</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the following financial covenant requirement for all of our credit arrangements (i) maintain the maximum permitted leverage ratio of 4.50 times for the first quarter of 2021, with a step-down for each succeeding fiscal quarter end to 4.25 times, 4.00 times, and ultimately 3.75 times for the fourth quarter of 2021 and through the remaining term of the 2021 Revolving Credit Facility. The agreement provides for higher leverage ratios for the period following a qualified acquisition, at our election, for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">leverage ratio is 4.75 times. It steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreement, through maturity, of any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of December&#160;31, 2021, we had $376 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $1.455 billion in the aggregate. As of December&#160;31, 2021, we had $1.122 billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to further renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $9.121 billion as of December&#160;31, 2021 and $9.205 billion as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2020, we redeemed $250 million of our $500 million 3.375% senior notes due 2022 (May 2022 Notes) at a redemption price calculated in accordance with the terms of the May 2022 Notes and its indenture, plus accrued and unpaid interest through, but excluding, the date of redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $1.700 billion in aggregate principal amount of senior notes comprised of $500 million of 1.900% senior notes due June 2025 and $1.200 billion of 2.650% senior notes due June 2030. We used the net proceeds from the offering to refinance $450 million of amounts outstanding under the 2018 Revolving Credit Facility, prepay $750 million of amounts outstanding under the $1.000 billion February 2021 Term Loan, prepay $500 million of amounts outstanding under the $1.250 billion April 2021 Term Loan and pay related fees, expenses and premiums.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $206 million of our $450 million 4.125% senior notes due 2023, $566 million of our $1.000 billion 4.000% senior notes due 2028 and $227 million of our $750 million 3.850% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in connection with the transaction. In 2019, we incurred associated debt extinguishment charges of $86 million presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we completed an offering of $4.300 billion in aggregate principal amount of senior notes comprised of $850 million of 3.450% senior notes due March 2024, $850 million of 3.750% senior notes due March 2026, $850 million of 4.000% senior notes due March 2029, $750 million of 4.550% senior notes due March 2039 and $1.000 billion of 4.700% senior notes due March 2049. We used a portion of the net proceeds from the offering to repay the $850 million plus accrued interest and premium of our 6.000% senior notes due in January 2020, the $600 million plus accrued interest and premium of our 2.850% senior notes due in May 2020 and the $1.000 billion plus accrued interest of our August 2019 Term Loan. In 2019, the remaining proceeds were used to finance a portion of our acquisition of BTG.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our senior notes contain a change-in-control provision, which provides that each holder of the senior notes may require us to repurchase all or a portion of the notes at a price equal to 101 percent of the aggregate repurchased principal, plus accrued and unpaid interest, if a rating event, as defined in the indenture, occurs as a result of a change-in-control, as defined in the indenture. Any other credit rating changes may impact our borrowing cost, but do not require us to repay any borrowings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renminbi denominated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $134 million as of December&#160;31, 2021 and $124 million as of December&#160;31, 2020, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of December&#160;31, 2021 and December&#160;31, 2020, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our consolidated balance sheets as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum purchase obligations, relating primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business, were as of December&#160;31, 2021 (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecorded Purchase Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">812</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581415416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; LEASES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance leases for real estate including corporate offices, land, warehouse space, and vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet, unless the arrangement includes an option to purchase the underlying asset, or an option to renew the arrangement, that we are reasonably certain to exercise (short-term leases). We recognize lease expense on a straight-line basis over the lease term for short-term leases that we do not record on our balance sheet. If there is a change in our assessment of the lease term and, as a result, the remaining lease term extends more than 12 months from the end of the previously determined lease term, or we subsequently become reasonably certain that we will exercise an option to purchase the underlying asset, the lease no longer meets the definition of a short-term lease and is accounted for as either an operating or finance lease and recognized on the balance sheet. In accordance with FASB ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we account for the lease components and the non-lease components as a single lease component, with the exception of our warehouse leases. Our leases have remaining lease terms of less than 1 year to approximately 55 years, some of which may include options to extend the leases for up to 15 years. If we are reasonably certain we will exercise an option to extend the lease, the time period covered by the extension option is included in the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of the arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, we utilize the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease right-of-use assets are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and corresponding liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated balance sheets. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information regarding our finance leases. The following table presents supplemental balance sheet information related to our operating leases:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_5c57a388-4a11-402a-ac98-8db5289b32b1">71</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_02fd6496-c14e-4d01-8da6-bd43092a2153">70</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_2643a84a-4741-454c-9f77-8a94ad26cb86">389</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_18293d37-bb2b-40b9-aa4f-ac327a0961c8">401</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease cost under FASB ASC Topic 842 was $90 million in 2021, $92&#160;million in 2020 and $80&#160;million in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for operating lease obligations were $68 million as of December 31, 2021 and $202 million as of December 31, 2020.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2021 (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">528</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">460</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168574426456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Related Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE H &#8211; RESTRUCTURING-RELATED ACTIVITIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2018, our Board of Directors approved, and we committed to a global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan is intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, our Board of Directors approved an extension and expansion of the 2019 Restructuring Plan to include additional cost optimization activities, including the centralization of certain functional capabilities within the international regions in which we operate, and a one-year extension of the program to complete these activities along with certain other initiatives that were delayed in 2020 due to restrictions related to the COVID-19 pandemic. In addition, on February 22, 2022, we increased and our Board of Directors approved cost estimates to complete additional activities identified under the program. We continue to expect the majority of activity associated with our 2019 Restructuring Plan, including the recent expansion, to be substantially complete by the end of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, by major type of cost, of which approximately $375 million to $475 million are expected to result in cash outlays:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Estimated Amount Expected to be Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$75</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$425</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$525 </span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2016, our Board of Directors approved, and we committed to a restructuring initiative (the 2016 Restructuring Plan). The 2016 Restructuring Plan was intended to&#160;develop global commercialization, technology and manufacturing capabilities in key growth markets, build on our Plant Network Optimization (PNO) strategy which is intended to simplify our manufacturing plant structure by transferring certain production lines among facilities and expand operational efficiencies in support of our operating income margin goals. Key activities under the 2016 Restructuring Plan included strengthening global infrastructure through evolving global real estate assets and workplaces, developing global commercial and technical competencies, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enhancing manufacturing and distribution expertise in certain regions and continuing implementation of our PNO strategy. These activities were initiated in the second quarter of 2016 and substantially completed in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2021, related to our ongoing Restructuring Plans by major type: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">622</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LOTUS Discontinuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS&#8482; Valve platform. We recorded restructuring and restructuring-related net charges associated with the product discontinuation of $20 million in 2021 and $55 million in 2020, which are included in the tables above for the year ended December 31, 2021 and December 31, 2020. The restructuring activities were completed in 2021 and resulted in total pre-tax restructuring and restructuring-related net charges of approximately $80 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2020 we recorded $119 million of inventory charges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and $8 million of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> associated with the product discontinuation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581458952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET INFORMATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying consolidated balance sheets are as follows:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,610</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 30 percent of our finished goods inventory as of December&#160;31, 2021 and approximately 33 percent as of December 31, 2020 was at customer locations pursuant to consignment arrangements or held by sales representatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,084</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $352 million in 2021, $333 million in 2020 and $311 million in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">783</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_1ed815c9-5da2-4587-b032-4aa6994bd099">389</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_bbf05a7c-f990-4fcb-b0f0-f7abb412ae4f">401</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581569848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related expense (benefit) for income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,288)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,013)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic taxes on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intra-entity asset transfers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(584.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:70.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.729%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit of net operating losses and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and product liability reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal benefit of uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses on derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,038</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional deferred items in 2021, we have reclassified select items in prior years to align with the new categories disclosed in the current year.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Component</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,038</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $560 million. As of December&#160;31, 2020, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $474 million. In addition, we had foreign tax net operating loss carryforwards and tax </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">credits, the tax effect of which was $60 million as of December&#160;31, 2021, as compared to $83 million as of December&#160;31, 2020. These tax attributes expire periodically beginning in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, we completed intra-entity asset transfers of certain intellectual property rights among various wholly owned subsidiaries. These transactions occurred to more closely align the global economic ownership of our intellectual property rights with our current and future business operations. These transactions did not result in a taxable gain in any jurisdiction, however, some of the transactions did create a step-up in the tax-deductible basis in the transferred intellectual property rights in certain jurisdictions. As a result, we recorded deferred tax assets in the amount of $4.102 billion, which represents the book and tax basis differences measured at applicable statutory tax rates, net of a valuation allowance of $542 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After consideration of all positive and negative evidence, we believe that it is more likely than not that a portion of our deferred tax assets will not be realized. As a result, we recorded a valuation allowance of $1,014 million as of December&#160;31, 2021 and $887 million as of December&#160;31, 2020, representing an increase of $127 million. The increase in the valuation allowance as of December&#160;31, 2021, as compared to December&#160;31, 2020, is primarily due to an increase of US state loss carryforwards and the concurrent build of the related valuation allowance. The income tax impact of the unrealized gain or loss component of other comprehensive income and stockholders' equity was a charge of $81 million in 2021, a benefit of $78 million in 2020 and a charge of $13 million in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain tax incentives through Free Trade Zone Regime offered in Costa Rica which allows 100.0 percent exemption from income tax in the first eight years of operations and 50.0 percent exemption in the following four years. This tax incentive resulted in income tax savings of $149 million for 2021, $64 million for 2020 and $173 million for 2019. The tax incentive for 100.0 percent exemption from income tax was renewed during 2019 and is expected to expire in 2027. The impact on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $0.10 for 2021, $0.04 for 2020 and $0.12 for 2019. Additionally, we benefit from tax incentives in Puerto Rico resulting in income tax savings of $27 million for 2021, $30 million for 2020 and immaterial amounts for 2019. The impact on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $0.02 for 2021 and 2020, and less than $0.01 for 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $255 million of gross unrecognized tax benefits, of which a net $177 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2020, we had $261 million of gross unrecognized tax benefits, of which a net $183 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $455 million of gross unrecognized tax benefits, of which a net $355 million, if recognized, would affect our effective tax rate. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation expirations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. Federal income tax as well as income tax of multiple state and foreign jurisdictions. We have concluded all U.S. federal income tax matters through 2016 and substantially all material state and local income tax matters through 2010. We have concluded all foreign income tax matters through 2013, with the exception of issues for Italy, which have concluded through 2002.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91&#160;million to release the reserves related to these years. We received a refund of $62&#160;million from the IRS reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to income taxes as a component of income tax expense. We had $43 million accrued for gross interest and penalties as of December&#160;31, 2021 and $41 million as of December&#160;31, 2020. Net tax expense related to interest and penalties was immaterial in 2021, 2020 and 2019. The increase in our net tax expense related to interest and penalties as of December&#160;31, 2021, as compared to December&#160;31, 2020, is related to reaching settlements with the taxing authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12&#160;months we will resolve transactional-related issues with foreign and state taxing authorities, in which case we could record a reduction in our balance of unrecognized tax benefits of up to approximately $54 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2017, we were required under the TCJA to calculate a one-time transition tax based on our total post-1986 foreign subsidiaries' earnings and profits (E&amp;P) that we previously deferred from U.S. income taxes. As a result of various audit activities, the revised amount of transition tax was approximately $938 million as of December 31, 2021 as compared to $939 million as of December 31, 2020. We anticipate offsetting this liability against existing tax attributes reducing the required payment to approximately $590 million, which will be remitted over an eight-year period. We have begun remitting the required installment payments, with a balance remaining of $430 million as of December&#160;31, 2021. In addition, we have provided for U.S. state income taxes of $19 million on all U.S. dollar-denominated E&amp;P accumulated through December 31, 2017, which constitutes the preponderance of our foreign subsidiaries' accumulated E&amp;P through December 31, 2017. We intend to indefinitely reinvest the unremitted foreign earnings of all other subsidiaries as of December 31, 2017, as well as all subsequent earnings generated by all of our foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings and additional outside basis difference in these entities is not practicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a territorial tax system under the TCJA, in which we are required to provide for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have established an accounting policy election to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we did not apply for government loans, we took advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581408840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $548 million as of December&#160;31, 2021 and $569 million as of December&#160;31, 2020 and includes certain estimated costs of settlement, damages and defense. We recorded litigation-related net charges of $430 million in 2021, primarily related to ongoing litigation associated with our transvaginal surgical mesh products principally in the U.S. and Australia, as well as anticipated legal fees to defend certain other legal matters. We increased the accrual associated with transvaginal mesh claims to account for increased settlement and litigation activity related to the remaining cases and claims we face, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity and changes to our expectations regarding the rate of incoming cases and claims. These increases were partially offset by settlement payments, primarily associated with a coalition of state attorneys general. A portion of our legal accrual for transvaginal surgical mesh product claims is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $188 million as of December&#160;31, 2021 and $208 million as of December&#160;31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $278 million in 2020, primarily related to transvaginal surgical mesh product litigation, inclusive of a reserve related to claims made by a coalition of state attorneys general, which has since been settled. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $115 million in 2019, which included a net charge of $223 million, primarily related to litigation with Channel Medsystems, Inc., net charges of $40 million primarily related to transvaginal surgical mesh product liability litigation, and a gain of $148 million, which represents a portion of the total $180 million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from this settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant. In management's opinion, we are not currently involved in any legal proceedings other than those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against the four asserted patents. All IPRs have concluded, and Cook and the Company both appealed the Patent Office&#8217;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Company's patents remain valid, remanding two of the patents for further review by the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USPTO's Patent Trial and Appeal Board. In November 2020, the Patent Office issued remand rulings invalidating several additional claims. The district court stayed the case pending the appeals court decision on </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the IPRs, which is now complete. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in February 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro Corp. (Nevro) in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro's Senza&#8482; Spinal Cord Stimulation (SCS) System. The company seeks lost profits, a reasonable royalty and a permanent injunction. At a trial held in October and November 2021 regarding six of Boston Scientific's originally asserted patent claims, a jury granted Boston Scientific a monetary award, finding that each asserted claim is valid, that four of the six claims are infringed by Nevro, and that two of the claims are willfully infringed by Nevro. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#8217;s Senza&#8482; I and Senza&#8482; II SCS Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our SCS systems infringe five Nevro patents. Nevro seeks lost profits, a reasonable royalty and a permanent injunction.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial date has been set for the theft of trade secrets and patent counterclaims. The patent infringement claims from case 18-cv-664 were stayed pending IPRs. On January 6, 2021, the court stayed one of the patent infringement claims from case 16-cv-1163, such that it will proceed with the stayed patent infringement claims from case 18-cv-664.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, Nevro filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#8217;s spinal cord stimulation systems. Nevro seeks lost profits, a reasonable royalty and a permanent injunction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2017, The Board of Regents, University of Texas System (UT) and TissueGen. Inc., served a lawsuit against us in the Western District of Texas. The complaint against us alleges patent infringement of two U.S. patents owned by UT, relating to &#8220;Drug Releasing Biodegradable Fiber Implant&#8221; and &#8220;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#8221; and affects the manufacture, use and sale of our Synergy&#8482; Stent System. UT seeks a reasonable royalty. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the UT&#8217;s Petition for Certiorari. UT is proceeding with its case against BSC in Delaware. Trial is scheduled for November 14, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 26, 2022, in the United States, approximately 54,500 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. Outside the United States, approximately 2,700 cases or claims have been asserted, predominantly in Canada, the United Kingdom, Ireland and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 26, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately&#160;52,500&#160;cases and claims in the United States, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,500 cases and claims, approximately 51,000 have met the conditions of the settlement and are final. In Canada, we have settled approximately 300 claims. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 26, 2022, the company is facing fewer than 300 pending cases and claims asserted in various jurisdictions in the United States. Outside the United States, the company is facing fewer than 90 cases and claims in the United Kingdom, Ireland and Canada. In Australia, two class actions were filed against the Company in in the first quarter of 2021. In the second quarter of 2021, one of these class actions was permanently stayed, while the other was allowed to proceed. The registration process for this Australian action closed on January 28, 2022. Complete registration information is not yet available but preliminary </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information indicates that approximately 2,250 women have completed registration forms alleging they received and were injured by Boston Scientific implants in Australia. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In February 2021, the Multi-District Litigation (MDL) established in February 2012 by the United States Federal Courts was closed after all pending cases were dismissed or remanded to courts of primary jurisdiction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle, and expect that more cases will go to trial through 2023. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in 67 filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and actively selling in the fourth quarter of 2018. The plaintiffs assert they are entitled to monetary damages related to alleged injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 377 claims, none of which have been filed. As of January 26, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering with certain plaintiffs' counsel to resolve approximately 200 cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#8217;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. The full Commission is considering this recommendation but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#8217;s decision.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments are due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents. Labcoat seeks monetary damages related to an earn-out provision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all others similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. Under the terms of the Court-approved Scheduling Order, Counsel for Mr. Errichiello was required to file an Amended Complaint on or before June 4, 2021, which they did. The Amended Complaint seeks unspecified compensatory damages in favor of the alleged class as well as unspecified equitable relief. In response, the Company brought a Motion to Dismiss the Amended Complaint which it filed on July 19, 2021, and argued on November 19, 2021. On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#8217;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company cooperated fully with the requests, and on January 3, 2022, the SEC informed us that it was concluding its investigation and that it did not intend to recommend an enforcement action. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above. The Company received letters on behalf of the Union Excavators Local 731 Pension Fund and Diane Nachbaur, two stockholders of the Company, on July 26, 2021, and July 29, 2021, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for Boston Scientific and three of its employees, as well as numerous other defendants charged in criminal proceedings. The charges arose from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials. A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Boston Scientific employee but acquitted two others and levied a fine of &#8364;245 thousand against us and imposed joint and several civil damages of &#8364;620 thousand on all defendants. We continued to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against Boston Scientific and its employee and acquitted them of all charges. This judgment of acquittal became final as to the Company and its employee on April 15, 2021 when the prosecution chose not to appeal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general regarding our transvaginal surgical mesh products and related alleged violations of states&#8217; consumer protection statutes. On December 12, 2019, the Mississippi Attorney General filed suit against us in a Mississippi state court alleging violations of the Mississippi Consumer Protection Act. In the fourth quarter of 2020 and the first quarter of 2021, we reached settlements with 48 states, including Mississippi, and the District of Columbia. These settlements were finalized in March of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. On April 8, 2021, the parties settled the dispute, and, on April 12, 2021, the parties filed stipulations with the court to dismiss the remaining legal proceedings. The settlement did not result in any material benefit or liability to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena sought information related to the launch of the Cognis&#8482; CRT-D and Teligen&#8482; ICD line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of our Physician Guided Learning Program. We cooperated with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. federal government and the State of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to our Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint. We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018. In February 2021, we filed a motion for summary judgment, which the relator opposed, and on August 13, 2021, the Court granted the motion in its entirety. Subsequently, the parties resolved the matter, effective October 4, 2021, and the matter is now concluded. The resolution did not result in any material liability to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, Koninklijke Philips N.V. and IP2IPO Innovations, Ltd. (Philips) served a complaint against the Company in the United States District Court for the District of Delaware. The complaint alleged that certain BSC cardiovascular diagnostic devices infringed six Philips patents. The parties have settled the dispute through a confidential settlement agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc., alleged indirect purchasers of ZYTIGA&#8482;, filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia. The complaint alleges that the defendants violated the Sherman Act and the antitrust and consumer protections laws of several states by pursuing patent litigation relating to ZYTIGA&#8482; in order to delay generic entry. On June 21, 2019, the case was transferred to the United States District Court for the District of New Jersey and has been consolidated with similar complaints.</span><span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 27, 2021, the court granted BTG and Janssen's motion to dismiss all claims in the indirect purchaser action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2017, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed on behalf of the United States, 29 states, and the District of Columbia. The complaint, which was filed in the United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA to the government in connection with direct government sales and government-funded drug reimbursement programs. The case has been transferred to United States District Court for the District of New Jersey. On June 20, 2019, the complaint was amended to include BTG International Limited as a defendant. In May 2020, a class action complaint was filed in New Jersey federal court against Janssen and BTG by a direct purchaser of Zytiga on behalf of similarly situated entities. The complaint was amended in February 2021 and alleges that BTG and Janssen violated antitrust laws by attempting to enforce certain patents against potential generic competitors. On October 12, 2021, the court granted BTG and Janssen&#8217;s motion to compel arbitration in the direct purchaser action and stayed all direct purchaser proceedings. On December 17, 2021, the court granted BTG&#8217;s motion to dismiss the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> action. On January 10, 2022, the court granted the parties&#8217; stipulation of dismissal with prejudice as to the claims of the direct purchaser plaintiff, whose claims had been stayed in the October 12, 2021, order compelling arbitration.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575317336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDER'S EQUITY</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; STOCKHOLDERS' EQUITY </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. As of December&#160;31, 2021, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared and we paid quarterly cash dividends of $1.3750 per MCPS share to holders, representing dividend periods through November 2021. On February 1, 2022, the Committee declared a cash dividend of $1.3750 per MCPS share to holders of our MCPS as of February 15, 2022, representing a dividend period from December 2021 through February 2022. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets as of December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 2.000 billion shares of common stock, $0.01 par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remaining proceeds were used for general corporate purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $535 million in cash, which represented the full amount remaining under that authorization. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program) and as of December&#160;31, 2021, we had the full amount remaining available under the 2020 share repurchase program. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during 2021. There were approximately 263 million shares in treasury as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581430120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Inventive and Purchase Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIncentiveAndPurchasePlansAbstract', window );"><strong>Stock Incentive and Purchase Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; STOCK INCENTIVE AND PURCHASE PLANS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Director Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Board of Directors and stockholders approved amendments to our 2011 Long-Term Incentive Plan effective October 1, 2020 (Amended and Restated 2011 LTIP), authorizing for issuance up to 171 million shares of our common stock. The Amended and Restated 2011 LTIP covers officers, directors, employees and consultants and provides for the grant of restricted or unrestricted common stock, restricted stock units (RSUs), options to acquire our common stock, stock appreciation rights, performance awards (market-based and performance-based RSUs) and other stock and non-stock awards. Shares reserved under our current and former stock incentive plans totaled approximately 180 million as of December&#160;31, 2021. The Executive Compensation and Human Resources Committee (the Committee) of the Board of Directors, consisting of independent, non-employee directors may authorize the issuance of common stock and cash awards under the Amended and Restated 2011 LTIP in recognition of the achievement of long-term performance objectives established by the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-qualified options issued to employees are generally granted with an exercise price equal to the market price of our stock on the grant date, vest over a four-year service period and have a ten-year contractual life. In the case of qualified options, if the recipient owns more than ten percent of the voting power of all classes of stock, the option granted will be at an exercise price of 110 percent&#160;of the fair market value of our common stock on the date of grant and will expire over a period not to exceed five years. Non-vested stock awards, including restricted stock awards (RSAs), RSUs and deferred stock units (DSUs) issued to employees are generally granted with an exercise price of zero and typically vest in four or five equal annual installments. These awards represent our commitment to issue shares to recipients after the vesting period. Upon each vesting date, such awards are no longer subject to risk of forfeiture and we issue shares of our common stock to the recipient.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the impact of stock-based compensation on our consolidated statements of operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Black-Scholes Assumptions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years, weighted)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Volatility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our historical volatility and implied volatility as a basis to estimate expected volatility in our valuation of stock options.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Term</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the expected term of options using historical exercise and forfeiture data. We believe that this historical data provides the best estimate of the expected term of new option grants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk-Free Interest Rate</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use yield rates on U.S. Treasury securities for a period approximating the expected term of the award to estimate the risk-free interest rate in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Dividend Yield</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not historically paid cash dividends on our common stock and currently we do not intend to pay cash dividends on our common stock. Therefore, we have assumed an expected dividend yield of zero in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to stock options under stock incentive plans are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:49.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.815%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,096)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,796)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,448</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,248&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total vested and expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $137 million in 2021, $84 million in 2020 and $140 million in 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Vested Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value RSAs, RSUs and DSUs based on the closing trading value of our shares on the date of grant. Information related to non-vested stock awards is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Award Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,683</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,811)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.43pt">The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of shares that vested was approximately $148 million in 2021, $172 million in 2020 and $193 million in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market-based RSU and DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we granted market-based RSU awards, and in 2020 and 2019, we granted market-based DSU awards to certain members of our senior management team. The number of shares ultimately issued to the recipient is based on the total stockholder return (TSR) of our common stock as compared to the TSR of the common stock of the other companies in the S&amp;P 500 Healthcare Index over a three-year performance period. The number of RSUs and DSUs ultimately granted under this program range from 0 percent to 200 percent of the target number awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout the three-year performance period to attain the full amount of the market-based RSU's and DSUs that satisfied the market performance criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the market-based RSU and DSU awards to be approximately $11 million for 2021, $8 million for 2020 and $10 million for 2019. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price on date of grant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> (in years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations on a straight-line basis over the three-year measurement period.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow Performance-based RSU and DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2021, we granted free-cash flow performance-based RSU awards, and in 2020 and 2019, we granted free-cash flow performance-based DSU awards to certain members of our senior management team. The attainment of these performance-based RSUs and DSUs is based on our adjusted free cash flow (AFCF) measured against our goal set by the Executive Compensation and Human Resources Committees of our Board, based on our internal annual financial plan performance for AFCF. AFCF is measured over a one-year performance period beginning January 1st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of each year and ending December 31st. The number of RSUs and DSUs ultimately granted under this program range from 0 percent to 150 percent of the target number of performance-based RSUs and DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout a three-year service period (inclusive of the one-year performance period) to attain the full amount of the performance-based RSUs and DSUs that satisfied the performance criteria. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 AFCF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, net of forfeitures to date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achievement of target payout</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end stock price used in determining fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations over the vesting period which is three years after the date of grant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expense Attribution</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize compensation expense for our stock incentive plan using a straight-line method over the substantive vesting period. Most of our stock awards provide for immediate vesting upon death or disability of the participant. In addition, our stock grants to employees provide for accelerated vesting of our stock-based awards, other than performance-based and market-based awards, upon retirement, if the stock award has been held for at least one year by the recipient. In accordance with the terms of our stock grants, for employees who will become retirement eligible prior to the vest date we expense stock-based awards, other than performance-based and market-based awards, over the greater of one year or the period between grant date and retirement-eligibility. The performance-based and market-based awards discussed above do not contain provisions that would accelerate the full vesting of the awards upon retirement-eligibility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation expense for the value of the portion of awards that are ultimately expected to vest. FASB ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allows forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term &#8220;forfeitures&#8221; is distinct from &#8220;cancellations&#8221; or &#8220;expirations&#8221; and represents only the unvested portion of the surrendered stock-based award. We have applied, based on an analysis of our historical forfeitures, a weighted-average annual forfeiture rate of approximately five percent to all unvested stock-based awards as of December&#160;31, 2021, which represents the portion that we expect will be forfeited each year over the vesting period. We re-evaluate this analysis annually or more frequently if there are significant changes in circumstances and adjust the forfeiture rate as necessary. Ultimately, we will only recognize expense for those shares that vest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Compensation Cost</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Cost</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">214</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Amounts presented represent compensation cost, net of estimated forfeitures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global employee stock purchase plan provides for the granting of options to purchase up to 50 million shares of our common stock to all eligible employees. Under the global employee stock purchase plan, we grant each eligible employee, at the beginning of each six-month offering period, an option to purchase shares of our common stock equal to not more than ten percent of the employee&#8217;s eligible compensation or the statutory limit under the U.S. Internal Revenue Code. Such options may be exercised only to the extent of accumulated payroll deductions at the end of the offering period, at a purchase price equal to 85 percent of the fair market value of our common stock at the beginning or end of each offering period, whichever is less. As of December&#160;31, 2021, there were approximately 4 million shares available for future issuance under the employee stock purchase plan. We temporarily suspended our global employee stock purchase plan for the offering period for the second half of 2020 due to cost-savings initiatives in response to the COVID-19 pandemic and resumed the plan beginning with the offering period for the first half of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:51.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued or to be issued&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Range of purchase prices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.29</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.47</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recognized&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of shares issued under the employee stock purchase plan. We recognize expense related to shares purchased through the employee stock purchase plan ratably over the offering period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIncentiveAndPurchasePlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Incentive and Purchase Plans [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIncentiveAndPurchasePlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581800696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text"><div style="margin-top:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,433.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,416.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in this period.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021 and 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented in our consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) available to common stockholders</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581797112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE O &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), certain investment portfolio net losses (gains) and EU Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations and are included in the reconciliation below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we are reorganizing our operational structure in order to strengthen our category leadership in the markets we serve, and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we will aggregate our core businesses into two reportable segments: MedSurg and Cardiovascular.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated depreciation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">352</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,595&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the announcement of our plan to sell our Specialty Pharmaceuticals business, as of December 31, 2020, we classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet at their respective carrying values, which approximated fair value, less costs to sell. Accordingly, the total assets of the Specialty Pharmaceuticals business as of December 31, 2020 reflected above include goodwill and intangible assets attributable to the disposal group that were not previously allocated to our reportable segments.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,477</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581825304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE P &#8211; REVENUE </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,911</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,978</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,701</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,212</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,875</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,694</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying consolidated balance sheets. Our deferred revenue balance was $484 million as of December&#160;31, 2021 and $395 million as of December&#160;31, 2020. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiac Rhythm Management (CRM) business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $159 million in 2021 that was included in the above contract liability balance as of December&#160;31, 2020. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales force commissions related to contracts with customers when the associated revenue is expected to be earned over a period that exceeds one year. Deferred commissions are primarily related to the sale of devices enabled with our LATITUDE&#8482; Patient Management System. We have elected to expense commission costs when incurred for contracts with an expected duration of one year or less. Capitalized commission fees are amortized over the period the associated products or services are transferred. Similarly, we capitalize certain recoverable costs related to the delivery of the LATITUDE&#8482; Remote Monitoring Service. These fulfillment costs are amortized over the average service period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received FDA approval in mid-2020 and began the U.S. launch of our next generation WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#8482; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In 2020, we recorded $179 million in revenue reserves primarily related to our conversion to a consignment commercial model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. In connection with the conversion, we repurchased customer-owned inventory and will recognize revenue for consigned units as they are consumed by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our accounting policies relating to revenue recognition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581818936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income (Loss) Note [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE Q &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span> were reduced by immaterial income tax impacts in 2021 and in 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581430680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NewAccountingPronouncementsPolicyTextBlock', window );">New Accounting Pronouncements, Policy</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE R &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Standards Implemented in 2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-08</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASC Update No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in Update No. 2021-08 improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Update No. 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2021-08 in the fourth quarter of 2021. We applied the amendments retroactively to all business combinations that we completed during 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. We adopted Update No. 2020-10 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. We adopted Update No. 2020-06 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. We adopted Update No. 2019-12 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively. The adoption did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements, issued or effective, during the period had, or is expected to have, a material impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NewAccountingPronouncementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New Accounting Pronouncements, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NewAccountingPronouncementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575330296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Compensation and Employee Benefit Plans [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE S &#8211; EMPLOYEE RETIREMENT PLANS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Domestic Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our 2006 acquisition of Guidant, we assumed the Guidant Supplemental Retirement Plan, a frozen, non-qualified defined benefit plan for certain former officers and employees of Guidant. The Guidant Supplemental Retirement Plan was partially funded through a Rabbi Trust that contains segregated company assets within restricted cash used to pay the benefit obligations related to the plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain an Executive Retirement Plan, a defined benefit plan covering executive officers and other key contributors. Participants may retire with benefits once retirement conditions have been satisfied. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.K. Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our acquisition of BTG, we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom (U.K.) employees (U.K. Plan). The U.K. Plan was closed to new entrants as of June 1, 2004. Prior to the acquisition close date of August&#160;19, 2019, the Trustees of the U.K. Plan executed buy-in arrangements (Buy-in Contracts), which effectively, as structured under the Buy-in Contracts, are intended to provide payments designed to equal all future designated contractual benefit payments to covered participants. The benefit obligation of the pension plan is not transferred to the insurers, and we remain responsible for paying pension benefits. We do not anticipate any additional material contributions or payments to the U.K. Plan or the insurer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the final purchase price allocation of BTG, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rate of Compensation Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the measurement date of August&#160;19, 2019, the funded status was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:84.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the U.K. Plan presented below is as of the December 31, 2021 and 2020 measurement dates.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other International Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we maintain retirement plans covering certain international employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of December 31, 2021 and 2020, the funded status of our plans were unfunded or underfunded in aggregate. The outstanding obligation is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded<br/>PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">336</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">166</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the PBO for our retirement plans is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments and assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending obligation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2021 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:45.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.083%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2020 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="padding-left:36pt;text-indent:-13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">336</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our defined benefit plans excluding our U.K. Plan, we base our discount rate on the rates of return available on high-quality bonds with maturities approximating the expected period over which benefits will be paid. The rate of compensation increase is based on historical and expected rate increases. We base our rate of expected return on plan assets on historical experience, our investment guidelines and expectations for long-term rates of return. Our assets are invested in a variety of securities, primarily equity securities and government bonds. These securities are considered Level 1 and Level 2 investments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our U.K. Plan, we utilize the insurance buy-in methodology and base our discount rate on a yield curve reflective of the market pricing obtained in the most recent buy-in transaction, which occurred prior to the acquisition of BTG, and movements in market-observed buy-in pricing as of December&#160;31, 2021. We believe this is a reasonable proxy for an effective settlement rate of the buy-in assets. The discount rate is calculated as the single equivalent assumption that gives the same value of the liabilities as if the figures were calculated using the full yield curve. We assume that all pension increases will continue to be linked to the Retail Price Inflation (RPI), both before and after retirement, for all members, with the exception of post-88 Guaranteed Minimum Pensions (GMP), which will be based on Consumer Price Inflation (CPI). We base our rate of expected return on plan assets as equal to the discount rate used to value the buy-in assets. The U.K. Plan assets' investment policy is to invest in fully matching assets. This has been achieved through the purchase of two buy-in policies (Buy-in contracts), which provide payments designed to equal all future benefit payments due from the fund. As of December&#160;31, 2021, the Buy-in contracts represented 100 percent of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. As of December 31, 2020, the Buy-in contracts represented 100 percent of the total plan assets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2021: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the U.K. Plan Level 3 assets were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Buy-in Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out for benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments are estimated based on the same assumptions used in determining our benefit obligation as of December&#160;31, 2021. Actual benefit payments will depend on future employment and compensation, average years employed and average life spans, in addition to other factors. Changes in any of these factors could significantly impact these estimated future benefit payments. Benefit payments expected to be paid during the next ten years for our Domestic Retirement Plans, our U.K. Plan and our Other International Retirement Plans are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post Retirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $118 million in 2021, $102 million in 2020 and $98 million in 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575303256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.988%"><tr><td style="width:1.0%"/><td style="width:27.639%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.640%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.517%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/>&#160;Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13 (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Credit loss exposure (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Write-offs (c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for credit losses (b)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for uncollectible accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:20pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Following the adoption of FASB ASC Topic 326 as of January 1, 2020, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> account. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Amounts shown within credit loss exposure above were established through selling, general and administrative expense. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Beginning in 2020, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for uncollectible accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Represents actual write-offs of uncollectible accounts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570656856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SignificantAccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#8217;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2021, 2020 or 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note O &#8211; Segment Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for further discussion.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash Equivalents</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets </span>caption within our consolidated balance sheets are related to deferred compensation plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration Risk Disclosure [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We write-off amounts determined to be uncollectible against this reserve. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2021, 2020 and 2019; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes in the U.S. toward non-hospital settings, particularly ambulatory surgery centers and office-based labs. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span> is adequate as of December&#160;31, 2021; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a contract with a customer that creates enforceable rights and obligations,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Promised products or services are identified,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The transaction price, or the amount we expect to receive, is determinable and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have transferred control of the promised items to the customer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management (CRM) product offerings combine the sale of a device with our LATITUDE&#8482; Patient Management System, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers, where necessary, to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these services at the time the devices are sold. We record these costs to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2021 or 2019.</span></div>We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Business Combinations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where we acquire a company in which we previously held an equity stake, we attribute a portion of the purchase price to the previously-held equity interest, which is implied based on the total purchase consideration allocable to each of the shareholders, including Boston Scientific, according to priority of equity interests. We record a gain or loss in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equal to the difference between the implied fair value of our prior ownership and the book value immediately prior to the acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration net expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">In Process Research and Development, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived Intangibles and IPR&amp;D </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which are foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, as well as IPR&amp;D intangible assets acquired in a business combination. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;D intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the income approach to determine the fair values of our IPR&amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#8217; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to indefinite-lived intangibles, including IPR&amp;D.</span></div>For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization and Impairment of Intangible Assets </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to impairments of intangible assets.</span></div>For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Valuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2021 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. For purposes of the goodwill impairment test, we aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>In the second quarter of&#160;2021, we performed our annual goodwill impairment test utilizing the quantitative assessment approach to test all of our reporting units. We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span> for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span><span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Product Liability Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities and product liability litigation. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of our individual material legal proceedings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy', window );">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record employee termination costs in accordance with FASB ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. We record such costs into expense over the employee&#8217;s future service period, if any. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information and discussion of our restructuring plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currency</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency transaction gains and losses are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span>in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock', window );">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development (R&amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Indefinite-lived Intangibles and IPR&amp;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for our policy regarding R&amp;D projects acquired in connection with our business combinations and asset purchases.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Publicly Traded and Privately-Held Entities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities for which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Investments - Debt and Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details on our investment balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#8217;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment is impaired and we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses and impairments associated with our investment portfolio are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span>in our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Standard Product Warranty, Policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a </span></div>liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General and Administrative Expenses, Policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Shipping and Handling Costs<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not bill customers for shipping and handling of our products. We treat shipping costs incurred after a customer obtains control of the good as a fulfillment cost and record in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span>within our consolidated statements of operations. Shipping costs were $194 million in 2021, $146 million in 2020 and $144 million in 2019<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581818936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our hedging instruments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span>, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581560664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span><span></span>
</td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Product Liability Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities and product liability litigation. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of our individual material legal proceedings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168577923880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock', window );">ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-08</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASC Update No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in Update No. 2021-08 improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Update No. 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2021-08 in the fourth quarter of 2021. We applied the amendments retroactively to all business combinations that we completed during 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock', window );">ASC Update No. 2020-10 Codification Improvements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. We adopted Update No. 2020-10 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock', window );">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. We adopted Update No. 2020-06 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock', window );">ASC Update No. 2019-12, Income Taxes (Topic 740)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. We adopted Update No. 2019-12 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock', window );">ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively. The adoption did not have a material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2019-12, Income Taxes (Topic 740)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-10 Codification Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581432360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans Employee Retirement Plans (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy', window );">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168573691768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Preventice:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lumenis:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">492</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">All Other:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">486</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$143 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$343 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Investment [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text">The final purchase price was comprised of the following components:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase price allocation was comprised of the following components:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text">The final purchase prices were comprised of the following components:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember', window );">2021 Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text">The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preventice</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lumenis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,032</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation for these acquisitions was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preventice</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lumenis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,032</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581461240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets and Liabilities Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other current liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581526472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization/Write-offs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,476)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,973)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">377</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of December 31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current assets held for sale</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,887</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Expected Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2021 is as follows (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:83.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.127%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168576197016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions (Table Text Block)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note Q &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock', window );">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:30.564%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.727%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments (Table Text Block)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:41.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.035%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Table Text Block)</a></td>
<td class="text">The following are the balances of our derivative and nonderivative assets and liabilities:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.559%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:31.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,998</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">767</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2021 include the following significant unobservable inputs:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$246 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$281 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">281</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168578454008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.750%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the December 2027 Notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective November 15, 2021, the interest rate payable decreased by 0.25 percent and began accruing at a rate of 6.75 percent following recent upgrades to our credit ratings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)  As of December&#160;31, 2021 the outstanding balance is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated balance sheet. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;The December 2027 notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</a></td>
<td class="text">Amounts de-recognized for accounts and notes receivable, which are excluded from <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renminbi denominated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentTextBlock', window );">Long-term Purchase Commitment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecorded Purchase Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">812</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock', window );">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through December&#160;31, 2021, we were in compliance with the financial covenant required by our credit facilities described above. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.047%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement<br/>as of December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual<br/>as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71 times</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of term loan and revolving credit facility agreement compliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168578629528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock', window );">Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text">The following table presents supplemental balance sheet information related to our operating leases:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_5c57a388-4a11-402a-ac98-8db5289b32b1">71</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_02fd6496-c14e-4d01-8da6-bd43092a2153">70</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_2643a84a-4741-454c-9f77-8a94ad26cb86">389</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_18293d37-bb2b-40b9-aa4f-ac327a0961c8">401</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock', window );">Maturities of Lease Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2021 (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">528</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">460</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maturities of Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Cash Flow Information Related to Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Cash Flow Information Related to Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168577928904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Related Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring and Related Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Impact of restructuring costs on the accompanying financial statements</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesTableTextBlock', window );">Cumulative Restructuring Charges [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2021, related to our ongoing Restructuring Plans by major type: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">622</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock', window );">Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LOTUS Discontinuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS&#8482; Valve platform. We recorded restructuring and restructuring-related net charges associated with the product discontinuation of $20 million in 2021 and $55 million in 2020, which are included in the tables above for the year ended December 31, 2021 and December 31, 2020. The restructuring activities were completed in 2021 and resulted in total pre-tax restructuring and restructuring-related net charges of approximately $80 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2020 we recorded $119 million of inventory charges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and $8 million of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> associated with the product discontinuation.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember', window );">2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring and Related Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Impact of restructuring costs on the accompanying financial statements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, by major type of cost, of which approximately $375 million to $475 million are expected to result in cash outlays:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Estimated Amount Expected to be Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$75</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$425</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$525 </span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember', window );">2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring and Related Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Impact of restructuring costs on the accompanying financial statements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div>(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid in the period to fully or partially settle a specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringChargesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringChargesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168578218248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade accounts receivable, net [Table Text Block]</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 310</span>.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,610</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment, net [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,084</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">783</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other long-term liabilities [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_1ed815c9-5da2-4587-b032-4aa6994bd099">389</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_bbf05a7c-f990-4fcb-b0f0-f7abb412ae4f">401</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581425672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Tax rate</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic taxes on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intra-entity asset transfers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(584.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Summary of Income Tax Contingencies [Table Text Block]</a></td>
<td class="text">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation expirations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:70.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.729%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit of net operating losses and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and product liability reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal benefit of uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses on derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,038</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Component</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,038</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related expense (benefit) for income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,288)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,013)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168578192328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive and Purchase Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems', window );"><strong>Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock', window );">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 AFCF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, net of forfeitures to date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achievement of target payout</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end stock price used in determining fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the impact of stock-based compensation on our consolidated statements of operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Black-Scholes Assumptions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years, weighted)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]</a></td>
<td class="text">Information related to non-vested stock awards is as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Award Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,683</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,811)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.43pt">The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock', window );">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:51.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued or to be issued&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Range of purchase prices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.29</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.47</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recognized&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Cost</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">214</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Amounts presented represent compensation cost, net of estimated forfeitures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock', window );">Market-based awards, valuation assumptions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the market-based RSU and DSU awards to be approximately $11 million for 2021, $8 million for 2020 and $10 million for 2019. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price on date of grant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> (in years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to stock options under stock incentive plans are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:49.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.815%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,096)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,796)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,448</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,248&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total vested and expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Market-based awards, valuation assumptions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of employee stock purchase plan activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575325656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,433.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,416.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in this period.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168578066424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock', window );">Reconciliation of depreciation by reportable segment to total [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated depreciation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">352</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock', window );">Segment operating income as percentage of net sales [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,595&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,477</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of depreciation by reportable segment to total [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment operating income as percentage of net sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581460680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): <div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,911</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,978</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,701</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,212</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,875</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,694</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168581541784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570647992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension and Other Postretirement Plans, Policy [Policy Text Block]</a></td>
<td class="text">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $118 million in 2021, $102 million in 2020 and $98 million in 2019.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]</a></td>
<td class="text">The outstanding obligation is as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded<br/>PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">336</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">166</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the PBO for our retirement plans is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments and assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending obligation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</a></td>
<td class="text">The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rate of Compensation Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the measurement date of August&#160;19, 2019, the funded status was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:84.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2021 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:45.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.083%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2020 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2021: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">336</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the U.K. Plan Level 3 assets were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Buy-in Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out for benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text">Benefit payments expected to be paid during the next ten years for our Domestic Retirement Plans, our U.K. Plan and our Other International Retirement Plans are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post Retirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168578124296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 4,359<span></span>
</td>
<td class="nump">$ 3,787<span></span>
</td>
<td class="nump">$ 3,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Production Related Impairments or Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionRelatedImpairmentsOrCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionRelatedImpairmentsOrCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168554162008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments (Details)<br> &#163; / shares in Units, $ / shares in Units, &#163; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 14, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 08, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>GBP (&#163;) </div>
<div>&#163; / shares</div>
</th>
<th class="th">
<div>Jun. 11, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of certain businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 826,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">256,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,000,000<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="nump">354,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,988,000,000<span></span>
</td>
<td class="nump">9,951,000,000<span></span>
</td>
<td class="nump">10,176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,258,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">4,382,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(486,000,000)<span></span>
</td>
<td class="num">(196,000,000)<span></span>
</td>
<td class="num">(354,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000,000<span></span>
</td>
<td class="nump">460,000,000<span></span>
</td>
<td class="nump">105,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,000,000)<span></span>
</td>
<td class="num">(100,000,000)<span></span>
</td>
<td class="num">(35,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DivestitureAgreementTransferOfFacilities', window );">Divestiture, agreement, transfer of facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DivestitureAgreementTransferOfGlobalEmployees', window );">Divestiture, agreement, transfer of global employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">247,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,023,000,000.000<span></span>
</td>
<td class="nump">&#163; 3,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash Acquired from Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 404,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,635,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,785,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(308,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(349,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,619,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,619,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Global Peripheral Interventions (PI) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,399,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,709,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember', window );">Vertiflex, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate', window );">Contingent consideration payments made to prior shareholders to date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_MillipedeMember', window );">Millipede [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">763,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(127,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | In Process Research and Development [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Technology-Based Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Other Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice Solutions, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,197,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 925,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268,000,000<span></span>
</td>
<td class="nump">706,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">706,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(221,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice Solutions, Inc. [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice Solutions, Inc. [Member] | Technology-Based Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice Solutions, Inc. [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice Solutions, Inc. [Member] | Other Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_FarapulseIncMember', window );">Farapulse, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod', window );">Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">544,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,032,000,000.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD | In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD | In Process Research and Development [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 388,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD | Technology-Based Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD | Other Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_DevoroMedicalIncMember', window );">Devoro Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember', window );">All Other 2021 Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,025,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">594,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember', window );">All Other 2021 Acquisitions | In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember', window );">All Other 2021 Acquisitions | In Process Research and Development [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember', window );">All Other 2021 Acquisitions | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember', window );">All Other 2021 Acquisitions | Technology-Based Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember', window );">All Other 2021 Acquisitions | Technology-Based Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember', window );">2021 Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,254,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,064,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(144,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">986,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,258,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (440,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration payments made to prior shareholders to date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DivestitureAgreementTransferOfFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture, agreement, transfer of facilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DivestitureAgreementTransferOfFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DivestitureAgreementTransferOfGlobalEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture, agreement, transfer of global employees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DivestitureAgreementTransferOfGlobalEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from secured borrowings relating to royalty arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_MillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_MillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_FarapulseIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_FarapulseIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_DevoroMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_DevoroMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575683608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</a></td>
<td class="nump">$ 440<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">486<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember', window );">2021 Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_FarapulseIncMember', window );">Farapulse, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">92.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration liability, probability of payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationLiabilityProbabilityOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_FarapulseIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_FarapulseIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168567804008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</a></td>
<td class="nump">$ 289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Measurement alternative investments (1)</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized Gain (Loss) on Investments</a></td>
<td class="num">$ (178)<span></span>
</td>
<td class="nump">$ 363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168573444792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets and Liabilities Held for Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Disposal Group, Including Discontinued Operation, Inventory, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Disposal Group, Including Discontinued Operation, Other Assets, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent', window );">Disposal Group, Including Discontinued Operation, Goodwill, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent', window );">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent', window );">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent', window );">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable', window );">Disposal Group, Including Discontinued Operation, Non-current deferred tax liability, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as income tax obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570483368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 14,351<span></span>
</td>
<td class="nump">$ 13,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(8,476)<span></span>
</td>
<td class="num">(7,806)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, Gross</a></td>
<td class="nump">21,888<span></span>
</td>
<td class="nump">19,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">(9,900)<span></span>
</td>
<td class="num">(9,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">11,988<span></span>
</td>
<td class="nump">9,951<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">2,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherIntangibleAssetsTextualsAbstract', window );"><strong>Other Intangible Assets (Textuals) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Future Amortization Expense, Year One</a></td>
<td class="nump">752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Future Amortization Expense, Year Two</a></td>
<td class="nump">738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Future Amortization Expense, Year Three</a></td>
<td class="nump">703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Future Amortization Expense, Year Four</a></td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Future Amortization Expense, Year Five</a></td>
<td class="nump">620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,598<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,503<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">2,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,887<span></span>
</td>
<td class="nump">5,697<span></span>
</td>
<td class="nump">5,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">11,957<span></span>
</td>
<td class="nump">11,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(6,754)<span></span>
</td>
<td class="num">(6,179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(398)<span></span>
</td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">1,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (1,325)<span></span>
</td>
<td class="num">$ (1,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_GoodwillTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill (Textuals) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_GoodwillTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherIntangibleAssetsTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Intangible Assets (Textuals) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherIntangibleAssetsTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168562402200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet', window );">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,378<span></span>
</td>
<td class="nump">11,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(208)<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,465<span></span>
</td>
<td class="nump">$ 3,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other Operating Income (Expense), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetCurrencyExchangeGainLoss', window );">Foreign exchange (gain) loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liability, Fair Value, Gross Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,196<span></span>
</td>
<td class="nump">10,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember', window );">November 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementAssetsMember', window );">Licensing arrangement assets (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_EuroDenominatedOutstandingDebtMember', window );">Euro-denominated outstanding debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,020<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,632<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(246)<span></span>
</td>
<td class="num">(365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,282<span></span>
</td>
<td class="nump">2,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,838<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,632<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,642<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(246)<span></span>
</td>
<td class="num">(365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">767<span></span>
</td>
<td class="nump">603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Licensing arrangement assets (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair Value of Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair Value of Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,011<span></span>
</td>
<td class="nump">1,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ForwardCurrencyContractsTimetoMaturity', window );">Forward Currency Contracts, Time to Maturity | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="num">(343)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetCurrencyExchangeGainLoss', window );">Foreign exchange (gain) loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Net gain (loss) from foreign currency transaction exposures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payments for Hedge, Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | BTG Acquisition [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(323)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,892<span></span>
</td>
<td class="nump">4,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCashReceivedOnHedge', window );">Derivative, Cash Received on Hedge</a></td>
<td class="nump">$ 4,303<span></span>
</td>
<td class="nump">&#163; 3,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Licensing arrangement assets (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Foreign Exchange Contract (Member) | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,996<span></span>
</td>
<td class="nump">4,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(208)<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Foreign Exchange Contract (Member) | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet', window );">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign currency denominated in debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign currency denominated in debt [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ForwardCurrencyContractsTimetoMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forward Currency Contracts, Time to Maturity in Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ForwardCurrencyContractsTimetoMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetCurrencyExchangeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetCurrencyExchangeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from secured borrowings relating to royalty arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCashReceivedOnHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period on settlement of a hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCashReceivedOnHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_EuroDenominatedOutstandingDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_EuroDenominatedOutstandingDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeignCurrencyDenominatedInDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeignCurrencyDenominatedInDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168557295352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 18, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 10, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 19, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,065<span></span>
</td>
<td class="nump">$ 9,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Capital Lease Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,804<span></span>
</td>
<td class="nump">9,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeemedConsolidatedEBITDA', window );">Deemed Consolidated EBITDA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ExclusionFromEbitdaForRestructuringCharges', window );">Exclusion from EBITDA for Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationAndDebtExclusionFromEbitda', window );">Litigation and Debt Exclusion from EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Legal payments remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest', window );">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Purchase Obligations, Future Minimum Payments Due, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Purchase Obligations, Future Minimum Payments, Due in Two Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Purchase Obligations, Future Minimum Payments, Due in Three Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Purchase Obligations, Future Minimum Payments, Due in Four Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">Purchase Obligations, Future Minimum Payments, Due in Five Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueAfterFifthYear', window );">Purchase Obligations, Future Minimum Payments, Due Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase Obligations, Future Minimum Payments Due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_ActualCovenantMember', window );">Actual, Covenant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfMarch312021Member', window );">Requirement, as of March 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfJune302021Member', window );">Requirement, as of June 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfSeptember302021Member', window );">Requirement, as of September 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember', window );">Requirement, as of December 31, 2021 and through remaining term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember', window );">Requirement, four quarters following material acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fifth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, seventh quarter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember', window );">Requirement, eighth quarter and thereafter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain', window );">the 2018 Facility [Domain] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember', window );">February 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember', window );">May 2020 SN Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember', window );">January 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember', window );">May 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.85%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember', window );">November 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember', window );">May 2022 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.375%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember', window );">October 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.125%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember', window );">March 2024 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.45%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember', window );">May 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.85%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember', window );">June 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember', window );">March 2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.75%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.625%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember', window );">March 2028 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember', window );">March 2029 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember', window );">June 2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.65%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember', window );">November 2035 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.75%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember', window );">March 2039 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.55%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember', window );">January 2040 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.375%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember', window );">March 2049 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember', window );">Unamortized Gain on Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Finance Lease Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,121<span></span>
</td>
<td class="nump">9,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_August2019TermLoanMember', window );">August 2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember', window );">April 2021 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember', window );">2020 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember', window );">February 2021 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.85%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember', window );">Three-Year Delayed Draw Term Loan [Member] | Debt Instrument, Redemption, Period Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember', window );">Two-Year Delayed Draw Term Loan [Member] | Debt Instrument, Redemption, Period Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember', window );">Aggregate Senior Unsecured Delayed Draw Term Loan [Member] | Unsecured Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember', window );">Euro Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember', window );">Yen Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember', window );">Renminbi Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeemedConsolidatedEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed Consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeemedConsolidatedEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExclusionFromEbitdaForRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion from EBITDA for Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExclusionFromEbitdaForRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal payments remaining to be excluded from calculation of consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationAndDebtExclusionFromEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationAndDebtExclusionFromEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio permitted by revolving credit facility agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_ActualCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_ActualCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfMarch312021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfMarch312021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfJune302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfJune302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfSeptember302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfSeptember302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_August2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_August2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168557225672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 435<span></span>
</td>
<td class="nump">$ 458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 389<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</a></td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, to be Paid</a></td>
<td class="nump">528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 389<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">55 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend', window );">Lessee, Operating and Finance Leases, Option to Extend</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Leases, Option to Extend</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LesseeOperatingAndFinanceLeasesOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168553207512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Related Activities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember', window );">2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember', window );">2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_LotusDiscontinuationMember', window );">Lotus Discontinuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member] | 2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other Restructuring Costs</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring [Member] | 2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember', window );">Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TransferCosts', window );">Transfer Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember', window );">Transfer costs [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember', window );">Transfer costs [Member] | 2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost', window );">Restructuring and Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureCashFlowsAmount', window );">Effect on Future Cash Flows, Amount</a></td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost', window );">Restructuring and Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureCashFlowsAmount', window );">Effect on Future Cash Flows, Amount</a></td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Lotus Discontinuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost', window );">Restructuring and Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember', window );">Restructuring Related To Plan [Member] | Maximum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringrelatedCostExpectedCost', window );">Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember', window );">Restructuring Related To Plan [Member] | Minimum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringrelatedCostExpectedCost', window );">Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Maximum [Member] | Employee Severance [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Maximum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Minimum [Member] | Employee Severance [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Minimum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Lotus Discontinuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Restructuring and Restructuring-Related Payments Made To Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringChargesIncurredToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Restructuring Charges Incurred to Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringChargesIncurredToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Restructuring-related Costs Incurred to Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringRelatedCostsIncurredToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring related expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Restructuring-related Cost, Expected Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringandRestructuringrelatedCostExpectedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringrelatedCostExpectedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring-related Cost, Expected Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringrelatedCostExpectedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TransferCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfer Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TransferCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOnFutureCashFlowsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The quantified amount of the future effect on cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOnFutureCashFlowsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_LotusDiscontinuationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_LotusDiscontinuationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570372184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherCurrentAssetsAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangements', window );">Licensing arrangements</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other Assets, Miscellaneous, Current</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Trade accounts receivable, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Trade accounts receivable</a></td>
<td class="nump">1,886<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">1,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Allowance for doubtful accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (beginning balance)</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Net (credits) charges to expenses</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Utilization of allowances</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (ending balance)</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">1,335<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EquipmentFurnitureAndFixturesGross', window );">Equipment, furniture and fixtures</a></td>
<td class="nump">3,475<span></span>
</td>
<td class="nump">3,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Capital in progress</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">5,525<span></span>
</td>
<td class="nump">5,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="nump">3,273<span></span>
</td>
<td class="nump">3,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 2,252<span></span>
</td>
<td class="nump">$ 2,084<span></span>
</td>
<td class="nump">2,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract', window );"><strong>Supplemental Balance Sheet Information (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PercentOfFinishedGoodsAtConsignment', window );">Percent of finished goods at consignment</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 333<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted Cash Equivalents included in Other long-term assets</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherOtherLongTermAssets', window );">Other, Other Long-term Assets</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets (total)</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal reserves</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related liabilities</a></td>
<td class="nump">848<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AccruedRebatesCurrent', window );">Accrued Rebates, Current</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities, current</a></td>
<td class="nump">2,436<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued Royalties, Current</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes Payable, Current</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other Sundry Liabilities, Current</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">783<span></span>
</td>
<td class="nump">958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 389<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 2,220<span></span>
</td>
<td class="nump">$ 2,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 389<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued Income Taxes, Noncurrent</a></td>
<td class="nump">$ 442<span></span>
</td>
<td class="nump">$ 547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued Income Taxes, Noncurrent</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">$ 489<span></span>
</td>
<td class="nump">$ 615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AccruedRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AccruedRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EquipmentFurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equipment, furniture and fixtures Gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EquipmentFurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherOtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, Other Long-term Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherOtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PercentOfFinishedGoodsAtConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of finished goods at consignment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PercentOfFinishedGoodsAtConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information (Textuals)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168557244776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details - Rate Table) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems', window );"><strong>Schedule of Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate</a></td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">Effective Income Tax Rate Reconciliation, State and Local Income Taxes</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">16.60%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="nump">155.40%<span></span>
</td>
<td class="nump">21.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential</a></td>
<td class="num">(14.30%)<span></span>
</td>
<td class="num">(40.70%)<span></span>
</td>
<td class="num">(47.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense</a></td>
<td class="num">(8.10%)<span></span>
</td>
<td class="nump">16.70%<span></span>
</td>
<td class="num">(12.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Effective Income Tax Rate Reconciliation, Tax Credits, Research</a></td>
<td class="num">(3.00%)<span></span>
</td>
<td class="num">(43.00%)<span></span>
</td>
<td class="num">(4.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="num">(42.00%)<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">effective income tax reconciliation, compensation-related</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(7.70%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">64.40%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions', window );">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="num">(96.80%)<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers', window );">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
<td class="num">(597.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision', window );">Effective Income Tax Rate Reconciliation, Return to provision</a></td>
<td class="num">(5.70%)<span></span>
</td>
<td class="num">(37.30%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">51.80%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Effective Income Tax Rate Reconciliation, Other Adjustments</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported tax rate</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="num">(584.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TaxIncentivesInPuertoRico', window );">Tax Incentives in Puerto Rico</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Return to provision</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TaxIncentivesInPuertoRico">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Incentives in Puerto Rico</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TaxIncentivesInPuertoRico</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168569878344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income Taxes (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (Loss) from Continuing Operations before Income Taxes, Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (648)<span></span>
</td>
<td class="num">$ (660)<span></span>
</td>
<td class="num">$ (1,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income (Loss) from Continuing Operations before Income Taxes, Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,724<span></span>
</td>
<td class="nump">581<span></span>
</td>
<td class="nump">1,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current Federal Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current State and Local Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current Foreign Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred Federal Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(256)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred State and Local Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(4,124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(4,288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Deferred Tax Assets, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Deferred Tax Assets, Operating Loss Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">620<span></span>
</td>
<td class="nump">557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FederalBenefitOfUncertainTaxPositions', window );">Federal benefit of uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Deferred Tax Assets, Goodwill and Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,546<span></span>
</td>
<td class="nump">3,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Deferred Tax Assets, in Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Deferred Tax Assets, Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Deferred Tax Assets, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Deferred Tax Assets, Tax Deferred Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,926<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,014)<span></span>
</td>
<td class="num">(887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred Tax Assets, Net of Valuation Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,912<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Deferred Tax Liabilities, Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDerivatives', window );">Deferred Tax Liabilities, Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred Tax Liabilities, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,833<span></span>
</td>
<td class="nump">3,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit', window );">Deferred Tax Assets, Prepaid on Intercompany Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit', window );">Net Deferred Tax Liabilities and Prepaid on Intercompany Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,038<span></span>
</td>
<td class="nump">3,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,348<span></span>
</td>
<td class="nump">4,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory', window );">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeferredTaxAssetValuationAllowanceIntraEntity', window );">Deferred Tax Asset, Valuation Allowance, Intra-entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ChangeinDeferredTaxAssetsValuationAllowance', window );">Change in Deferred Tax Assets, Valuation Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other Comprehensive Income (Loss), Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeTradeZoneRegimeTaxIncentive', window );">Free Trade Zone Regime Tax Incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TaxIncentivesInPuertoRico', window );">Tax Incentives in Puerto Rico</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Tax Adjustments, Settlements, and Unusual Provisions</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Income Tax Examination, Penalties and Interest Accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability', window );">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="nump">$ 939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Onetimetransactiontaxpost1986EPnetpayment', window );">One-time transaction tax post-1986 E&amp;P - net payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense', window );">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TheCARESAct', window );">The CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution', window );">Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution', window );">Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TransitionTaxPaymentRemaining', window );">transition tax payment remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_AssetsHeldForSaleDomain', window );">Assets held for sale [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxAssetsDomain', window );">Deferred tax assets [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142<span></span>
</td>
<td class="nump">4,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxLiabilitiesDomain', window );">Deferred tax liabilities [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain', window );">Liabilities held for sale in Other current liabilities [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ChangeinDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Deferred Tax Assets, Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ChangeinDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeferredTaxAssetValuationAllowanceIntraEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Valuation Allowance, Intra-entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeferredTaxAssetValuationAllowanceIntraEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Prepaid on Intercompany Profit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FederalBenefitOfUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal benefit of uncertain tax positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FederalBenefitOfUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeTradeZoneRegimeTaxIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Free Trade Zone Regime Tax Incentive</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeTradeZoneRegimeTaxIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Deferred Tax Assets and Prepaid on Intercompany Profit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Onetimetransactiontaxpost1986EPnetpayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>One-time transaction tax post-1986 E&amp;P - net payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Onetimetransactiontaxpost1986EPnetpayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TaxIncentivesInPuertoRico">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Incentives in Puerto Rico</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TaxIncentivesInPuertoRico</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TheCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TheCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TransitionTaxPaymentRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transition Tax Payment Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TransitionTaxPaymentRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from contingent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123452999&amp;loc=d3e28511-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123452999&amp;loc=d3e28446-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_AssetsHeldForSaleDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_AssetsHeldForSaleDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxAssetsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxAssetsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxLiabilitiesDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxLiabilitiesDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570401512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 10, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>claims</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 26, 2022 </div>
<div>claims </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>claims</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>claims</div>
</th>
<th class="th">
<div>Jan. 15, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for legal matters that are probable and estimable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 569,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548,000,000<span></span>
</td>
<td class="nump">$ 569,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,000,000<span></span>
</td>
<td class="nump">208,000,000<span></span>
</td>
<td class="nump">$ 346,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,000,000<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="num">$ (148,000,000)<span></span>
</td>
<td class="nump">$ 430,000,000<span></span>
</td>
<td class="nump">$ 278,000,000<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationSettlementReceivedGain', window );">Litigation Settlement Received, Gain | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Loss Contingency, Damages Paid, Value | &#8364;</a></td>
<td class="nump">&#8364; 620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss Contingency, Damages Awarded, Value | &#8364;</a></td>
<td class="nump">&#8364; 245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter', window );">Product liability cases related to Greenfiled Vena Cava filter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter', window );">Product liability claims, not filed, related to Greenfield Vena Cava Filter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CertifiedClassActionsInAustraliaMesh', window );">Certified class actions in Australia, Mesh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PermanentlyStayedClassActionInAustraliaMesh', window );">Permanently stayed class action in Australia, Mesh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom', window );">Product liability cases or claims related to mesh product - United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia', window );">Product liability cases or claims related to mesh product - Australia | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AssertedClaimsOutsideTheUS', window );">Asserted claims outside the U.S. | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS', window );">Pending cases and claims asserted in various jurisdictions in the U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter', window );">Cases in final stages of resolution, related to Greenfield Vena Cava Filter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CanadaSettledClaims', window );">Canada, settled claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct', window );">Total Product liability cases and claims settled related to Mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AssertedClaimsOutsideTheUS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asserted claims outside the U.S.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AssertedClaimsOutsideTheUS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CanadaSettledClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Canada, settled claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CanadaSettledClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cases in final stages of resolution, related to Greenfield Vena Cava Filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CertifiedClassActionsInAustraliaMesh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Certified class actions in Australia, Mesh</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CertifiedClassActionsInAustraliaMesh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationSettlementReceivedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement Received, Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationSettlementReceivedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pending cases and claims asserted in various jurisdictions in the U.S.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PermanentlyStayedClassActionInAustraliaMesh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Permanently stayed class action in Australia, Mesh</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PermanentlyStayedClassActionInAustraliaMesh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - Australia</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases related to Greenfiled Vena Cava filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability claims, not filed, related to Greenfield Vena Cava Filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims asserted related to mesh products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Productliabilitycasesorclaimsrelatedtomeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - United Kingdom</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Product liability cases and claims settled related to Mesh product</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570423992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2022</div></th>
<th class="th"><div>May 27, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 14, 2020</div></th>
<th class="th"><div>Jan. 25, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 535<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred Stock, Liquidation Preference, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible Preferred Stock, Terms of Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2.3834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible Preferred Stock, Terms of Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2.9197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid</a></td>
<td class="nump">$ 1.3750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,382,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockTermsOfConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of conversion terms for preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockTermsOfConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168562030360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive and Purchase Plans (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 17, 2021</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
<th class="th"><div>Feb. 18, 2020</div></th>
<th class="th"><div>Feb. 21, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Fairvalueofmarketbasedawards', window );">Fair value of market based awards</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 42.48<span></span>
</td>
<td class="nump">$ 35.95<span></span>
</td>
<td class="nump">$ 45.22<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.16<span></span>
</td>
<td class="nump">$ 40.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_UnrecognizedCompensationCostStockOptions', window );">Unrecognized Compensation Cost - Stock Options</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock Issued During Period, Shares, Employee Stock Purchase Plans</a></td>
<td class="nump">2,578,000<span></span>
</td>
<td class="nump">1,387,000<span></span>
</td>
<td class="nump">2,196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased', window );">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</a></td>
<td class="nump">$ 29.98<span></span>
</td>
<td class="nump">$ 29.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">9,745,000<span></span>
</td>
<td class="nump">9,987,000<span></span>
</td>
<td class="nump">11,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,683,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">4,240,000<span></span>
</td>
<td class="nump">3,609,000<span></span>
</td>
<td class="nump">3,656,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Measurementperiodmarketbasedaward', window );">Measurement period - market based awards</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.37%<span></span>
</td>
<td class="nump">2.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="num">(3,823,000)<span></span>
</td>
<td class="num">(4,147,000)<span></span>
</td>
<td class="num">(4,811,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="num">(658,000)<span></span>
</td>
<td class="num">(554,000)<span></span>
</td>
<td class="num">(449,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">21,448,000<span></span>
</td>
<td class="nump">23,122,000<span></span>
</td>
<td class="nump">23,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,304,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">3,822,000<span></span>
</td>
<td class="nump">3,819,000<span></span>
</td>
<td class="nump">2,992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(4,796,000)<span></span>
</td>
<td class="num">(3,096,000)<span></span>
</td>
<td class="num">(4,872,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</a></td>
<td class="num">(699,000)<span></span>
</td>
<td class="num">(666,000)<span></span>
</td>
<td class="num">(359,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Employee Service Share-based Compensation, Tax Benefit from Compensation Expense</a></td>
<td class="num">$ (29)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ShareBasedCompensationNetOfTaxBenefit', window );">Share-based compensation, net of tax benefit</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CompensationExpensePerShareBasic', window );">compensation expense, per share - basic</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CompensationExpensePerShareDiluted', window );">compensation expense, per share - diluted</a></td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.10<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="nump">37.69<span></span>
</td>
<td class="nump">41.79<span></span>
</td>
<td class="nump">40.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 10.77<span></span>
</td>
<td class="nump">$ 10.44<span></span>
</td>
<td class="nump">$ 11.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</a></td>
<td class="nump">$ 296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">13,248,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</a></td>
<td class="nump">$ 263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OptionsExpectedToVest', window );">Options expected to vest</a></td>
<td class="nump">7,893,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OptionsExpectedToVestWeightedAverageExercisePrice', window );">Options expected to vest, weighted average exercise price</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife', window );">Options expected to vest, weighted average remaining contractual life</a></td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</a></td>
<td class="nump">21,141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase', window );">Amount of employees total compensation eligible for GESOP purchase</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless', window );">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_UnrecognizedCompensationCostNonVestedStockAwards', window );">Unrecognized Compensation Cost - Non-vested stock awards</a></td>
<td class="nump">$ 178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_UnrecognizedCompensationCost', window );">Unrecognized Compensation Cost</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_WeightedAverageRemainingVestingPeriod', window );">weighted average remaining vesting period</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Annualweightedaverageforfeiturerate', window );">annualweightedaverageforfeiturerate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_VotingPowerOfAllClassesOfStock', window );">Voting power of all classes of stock</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant', window );">Exercise price of the fair market value of our common stock on the date of grant</a></td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Nonvestedstockawardsexerciseprice', window );">Qualified options exercise price</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards', window );">Fair value of the Free Cash Flow (FCF) performance awards</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards', window );">Target payout of Free Cash Flows (FCF) performance awards</a></td>
<td class="nump">131.00%<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Employee Stock Ownership Plan (ESOP), Compensation Expense</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded', window );">Range of the target number of performance-based DSUs awarded</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased', window );">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">0.66%<span></span>
</td>
<td class="nump">0.27%<span></span>
</td>
<td class="nump">1.38%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded', window );">Range of the target number of market-based DSUs awarded</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">High end of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded', window );">Range of the target number of performance-based DSUs awarded</a></td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased', window );">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</a></td>
<td class="nump">$ 36.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.72%<span></span>
</td>
<td class="nump">2.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded', window );">Range of the target number of market-based DSUs awarded</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=bsx_A2011LtipPlanMember', window );">2011 LTIP Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of employees total compensation eligible for GESOP purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Annualweightedaverageforfeiturerate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Weighted Average Forfeiture Rate The weighted average of estimated forfeitures for grants based on historical trends</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Annualweightedaverageforfeiturerate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CompensationExpensePerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>compensation expense, per share - basic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CompensationExpensePerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CompensationExpensePerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>compensation expense, per share - diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CompensationExpensePerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price of the fair market value of our common stock on the date of grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the Free Cash Flow (FCF) performance awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FairValueOfFreeCashFlowFcfPerformanceAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Fairvalueofmarketbasedawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of market based awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Fairvalueofmarketbasedawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Measurementperiodmarketbasedaward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measurement period - market based awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Measurementperiodmarketbasedaward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Nonvestedstockawardsexerciseprice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-vested stock awards exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Nonvestedstockawardsexerciseprice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OptionsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OptionsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OptionsExpectedToVestWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options expected to vest, weighted average exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OptionsExpectedToVestWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options expected to vest, weighted average remaining contractual life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Range of the target number of market-based DSUs awarded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RangeofthetargetnumberofmarketbasedDSUsawarded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Range of the target number of performance-based DSUs awarded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RangeofthetargetnumberofperformancebasedDSUsawarded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ShareBasedCompensationNetOfTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation, net of tax benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ShareBasedCompensationNetOfTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Target payout of Free Cash Flows (FCF) performance awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_UnrecognizedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Compensation Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_UnrecognizedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_UnrecognizedCompensationCostNonVestedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Compensation Cost - Non-vested stock awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_UnrecognizedCompensationCostNonVestedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_UnrecognizedCompensationCostStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Compensation Cost - Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_UnrecognizedCompensationCostStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_VotingPowerOfAllClassesOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voting power of all classes of stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_VotingPowerOfAllClassesOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_WeightedAverageRemainingVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>weighted average remaining vesting period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_WeightedAverageRemainingVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of plan compensation cost recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average purchase price of capital shares purchased through an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=bsx_A2011LtipPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=bsx_A2011LtipPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168577598952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">1,422,300<span></span>
</td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,391,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">11,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">1,433,800<span></span>
</td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,410,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Payment Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575513832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>reportablesegments</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 11,888<span></span>
</td>
<td class="nump">$ 9,913<span></span>
</td>
<td class="nump">$ 10,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income allocated to reportable segments</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="num">(741)<span></span>
</td>
<td class="num">(789)<span></span>
</td>
<td class="num">(699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(123)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(831)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">11,988<span></span>
</td>
<td class="nump">9,951<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">6,121<span></span>
</td>
<td class="nump">5,917<span></span>
</td>
<td class="nump">7,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">20,795<span></span>
</td>
<td class="nump">18,409<span></span>
</td>
<td class="nump">20,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">6,911<span></span>
</td>
<td class="nump">5,701<span></span>
</td>
<td class="nump">6,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member] | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">IRELAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_OtherCountriesMember', window );">Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,724<span></span>
</td>
<td class="nump">3,066<span></span>
</td>
<td class="nump">3,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeLossAllocatedToReportableSegments', window );">Operating Income (Loss) Allocated to Reportable Segments</a></td>
<td class="nump">$ 1,399<span></span>
</td>
<td class="nump">$ 1,079<span></span>
</td>
<td class="nump">$ 1,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">37.60%<span></span>
</td>
<td class="nump">35.20%<span></span>
</td>
<td class="nump">36.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="nump">$ 1,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,598<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">$ 2,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,293<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">3,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeLossAllocatedToReportableSegments', window );">Operating Income (Loss) Allocated to Reportable Segments</a></td>
<td class="nump">$ 607<span></span>
</td>
<td class="nump">$ 439<span></span>
</td>
<td class="nump">$ 666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">18.40%<span></span>
</td>
<td class="nump">15.90%<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 1,981<span></span>
</td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,503<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">$ 2,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,858<span></span>
</td>
<td class="nump">3,876<span></span>
</td>
<td class="nump">4,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeLossAllocatedToReportableSegments', window );">Operating Income (Loss) Allocated to Reportable Segments</a></td>
<td class="nump">$ 1,448<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
<td class="nump">$ 1,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">29.80%<span></span>
</td>
<td class="nump">17.10%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 2,821<span></span>
</td>
<td class="nump">$ 2,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,887<span></span>
</td>
<td class="nump">5,697<span></span>
</td>
<td class="nump">$ 5,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">11,875<span></span>
</td>
<td class="nump">9,694<span></span>
</td>
<td class="nump">10,654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">6,901<span></span>
</td>
<td class="nump">5,508<span></span>
</td>
<td class="nump">6,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember', window );">Total allocated to reportable segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income allocated to reportable segments</a></td>
<td class="nump">3,454<span></span>
</td>
<td class="nump">2,179<span></span>
</td>
<td class="nump">3,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">6,595<span></span>
</td>
<td class="nump">5,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income allocated to reportable segments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember', window );">Corporate Expenses including hedging activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(405)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember', window );">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">(1,070)<span></span>
</td>
<td class="num">(1,208)<span></span>
</td>
<td class="num">$ (582)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">7,525<span></span>
</td>
<td class="nump">7,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_ConsolidatedBSXDomain', window );">Consolidated BSX [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 32,229<span></span>
</td>
<td class="nump">$ 30,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeLossAllocatedToReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Allocated to Reportable Segments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeLossAllocatedToReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeUnallocatedToSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Unallocated to Segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeUnallocatedToSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Segmentoperatingincomeaspercentageofnetsales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment operating income as percentage of net sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Segmentoperatingincomeaspercentageofnetsales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_ConsolidatedBSXDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_ConsolidatedBSXDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168575435432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>countries</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EmergingMarketsTotalNumberOfCountries', window );">Emerging Markets total number of countries | countries</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 11,888<span></span>
</td>
<td class="nump">$ 9,913<span></span>
</td>
<td class="nump">$ 10,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">6,911<span></span>
</td>
<td class="nump">5,701<span></span>
</td>
<td class="nump">6,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,978<span></span>
</td>
<td class="nump">4,212<span></span>
</td>
<td class="nump">4,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember', window );">Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">1,780<span></span>
</td>
<td class="nump">1,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">919<span></span>
</td>
<td class="nump">780<span></span>
</td>
<td class="nump">814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology and Pelvic Health Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,583<span></span>
</td>
<td class="nump">1,286<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology and Pelvic Health Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology and Pelvic Health Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,019<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">992<span></span>
</td>
<td class="nump">1,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="nump">804<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">909<span></span>
</td>
<td class="nump">761<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">713<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,038<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">2,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,508<span></span>
</td>
<td class="nump">981<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,530<span></span>
</td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">888<span></span>
</td>
<td class="nump">741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">824<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">11,875<span></span>
</td>
<td class="nump">9,694<span></span>
</td>
<td class="nump">10,654<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">6,901<span></span>
</td>
<td class="nump">5,508<span></span>
</td>
<td class="nump">6,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,518<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | APAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
<td class="nump">1,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | Latin America and Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 386<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EmergingMarketsTotalNumberOfCountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Markets total number of countries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EmergingMarketsTotalNumberOfCountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168570681576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">208<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="num">(137)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(173)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="num">(125)<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="nump">170<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="num">$ (63)<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168569370152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 19, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 478<span></span>
</td>
<td class="nump">$ 506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(502)<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="num">$ (488)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets', window );">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO', window );">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Defined Benefit Plan, Service Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Pensionbenefitobligationbenefitspaid', window );">pension benefit obligation, benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan, Plan Assets, Contributions by Employer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss', window );">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ExpenseRelatedToMatchingContributions', window );">Expense related to matching contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Executive Retirement Plan Rate of Compensation Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=bsx_UKPlanMember', window );">U.K. Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn', window );">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=bsx_OtherInternationalPlansMember', window );">Other International Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn', window );">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.16%<span></span>
</td>
<td class="nump">1.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.82%<span></span>
</td>
<td class="nump">0.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Executive Retirement Plan Rate of Compensation Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_ExecutiveRetirementPlanMember', window );">Executive retirement plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_InternationalRetirementPlansMember', window );">International retirement plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(234)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Assets for Plan Benefits, Defined Benefit Plan</a></td>
<td class="nump">$ 213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="num">(216)<span></span>
</td>
<td class="num">(209)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Executive Retirement Plan Rate of Compensation Increase</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Acquired and Established Plan Changes, PBO</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plan, plan assets, actuarial gain loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExpenseRelatedToMatchingContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expense related to matching contributions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExpenseRelatedToMatchingContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Pensionbenefitobligationbenefitspaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>pension benefit obligation, benefits paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Pensionbenefitobligationbenefitspaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=bsx_UKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=bsx_UKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=bsx_OtherInternationalPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=bsx_OtherInternationalPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=bsx_ExecutiveRetirementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=bsx_ExecutiveRetirementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=bsx_InternationalRetirementPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=bsx_InternationalRetirementPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140168574317704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (beginning balance)</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Net (credits) charges to expenses</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Utilization of allowances</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (ending balance)</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>bsx-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bsx-20211231.xsd" xlink:type="simple"/>
    <context id="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i68f3333d6cce460dbc252aac2c3a29cb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6094d98b0e484f6ab786282879ded28e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i88982097e17e4e148f4e0e1928230864_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i17733ef333a04949b7d70a7bfa14f475_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i28a14163a2a74f7b8d354e3243028f49_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifcacc25eca514356a1de06415cfc5492_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i55c9f4684ac746bda57f532f6a87f684_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1bb4626ce5af43629527f19d1f2b8d8f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i86d1794a80bb4fe2a6e1462adf2ed270_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a5ab205543a48ddb58369506f4258e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i23a174508ba44dd89de3efafe40cfb80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbc589c795204965a3cc585ab55e4724_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i47fffe98c44745d5abab2aa20b5ce269_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie22723d6721640b7a59646827025bd5f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7a72129993b9407296d812a52123d5e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i621567053d2744019f158e373637541a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4747802c7e754ca399dcd04b1ba8d7fb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ief44305703574f549e1b0deefa30aa9b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic842d867786b4ccea9cfa96a40cf30df_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic81c4f4cfd734a44bbbfbc03be7529de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4703f4563ef24622b191ace91b7046bb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i50e1494b00924399b0198cf1908c6eac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d7cdad179c64659939a57d640d0398e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d65743aa83c4feba194be59d23ff5b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7a84911e7b44222a521b4865d0ca338_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2aa6d669fbe84dada7c5bed68a7bab52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief259e9b815d43c6b3e7f2b9f85ad45e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e19129d2b6b49af9f944cde90d53a9c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifcaaf4e1347a49e2be525edf65b64c63_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8acaf977546b4524b2309e825920c392_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i11e39577dbf144d782e2e16d4feea22d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f487090abb844d5b6124d5eab360ef6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42c0c9a4fac74bfb842c3bdb6adfa49b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3423ba3a4510459d9315c471a11407a9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if652d38406174006a7b4700327ea9b78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icea25cb690174465b8215ce1c263a42a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i80c252fab7084dbaa7b52601cb17955e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i09fba96124454331976d8e4961c807b5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58e8f5b2e3704a63ba7c4e8c062839c7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7862dc97bbe245dc92c012be4bc24ff9_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="ia4c1e55cd1e444d88c6ef56f87ecf676_D20220214-20220214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-14</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i43a1b72be8d74d5eb954a3448a0598e7_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i07946074b2524113bd25ea3602907bae_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="i27aafceb9a8241bb8a7b5487131b9106_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i0930e389c7ed4a8a9b076aa4c40709ee_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="i30d60e95a9ad4691b3c08057fb408f2c_D20210901-20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DevoroMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-08</startDate>
            <endDate>2021-11-08</endDate>
        </period>
    </context>
    <context id="i9d817719bd624f91ba936d54cd189dd0_I20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DevoroMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-08</instant>
        </period>
    </context>
    <context id="i2e35130934fd4a358eacac841a7a82fb_I20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-08</instant>
        </period>
    </context>
    <context id="i25282a1ba939439980c46921de6f92f4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2021AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i375363a8a82747f993aef5796e14a72c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i977a60dd4a094b4badc4cc6074972559_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied21f3ab578a46919e7241d90ab45962_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib5890dc3bad44013810b2e4b67e759c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8960237fdb4c4623ae9438f6a20ff081_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2021AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c4c18e74ac94029b4ed8c497c643638_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2bd7513127242f78e881962dac45e4b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1a2eb59807f4fa98038488a67c899d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72d131180c20411ba4a7c16e8fbe7351_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56df3da0ec92473699d19c087728742d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24bd565b73f44fe7aea51a237868fa51_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ca66a6bcf654c779a82ae88dfb8e058_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf5c1ca1458c4c31b1e096eda7cca942_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia67dafbfe3fe4b0bb926c4c9c35b4c4d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i401803de34c347149bdb6b113441fe31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9051905a0e9457a9c8249141096c7af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic188f63db33d43519ebe846287701578_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if1005dbdd4f84094bb2b629f0c0ad6f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8442535b691b4124862b82abe60ed41b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea9cf6036d3a467d98b57608db9b9c7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3f2a730fb2840249b185833474b5453_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i54b7493616504921a135abba92ddaa2e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i14ccc97c93104644b760b49a50825d0f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd2558040a1a42e4bd8cc29eb78555e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe24aea88d3d42d5b34c3e42f204cbb6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllOther2021AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6132cb03cef491d949660bfc42e7b5c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-19</startDate>
            <endDate>2019-08-19</endDate>
        </period>
    </context>
    <context id="ic42ef98edc4741318f57c64a9bfb2735_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id69301cd870d43dd80ea71d12d42a76b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7b4ebd9d21548d3b495be941b489706_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i326847b5c1684d50bd21f2c964e25e95_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i031288d26dbe4dad9111cf8a737a815e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4831b01bd4334a1abd79911b16ed4c3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13cb159d3e45462a9c50314d05440d78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia6f4b506c8c24f178b63a4f53ff627dd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f53f48683c54762a784b30fca510244_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id35802ead11946739ec96eb588e199b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7059a74267434518bbc0ed0077d56f7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i236d0e3aac6448faa715c3f08ec819a6_D20190611-20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-11</startDate>
            <endDate>2019-06-11</endDate>
        </period>
    </context>
    <context id="i60e5a145ef214a48b006713d03a06923_I20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-11</instant>
        </period>
    </context>
    <context id="i8efe8988e2544797a55f44fb65e85f88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0136ac01ee9747ddbfdbac14e429ec42_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="i2b58c1611a834f2ca3ba6c6410d7b13e_I20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-29</instant>
        </period>
    </context>
    <context id="i0fffb8b77bc043679725e5bc32404c66_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2ddb1f3b42b943b98458f1def7473e27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia220fba2afe640c5b10959e748bdc0f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e6697aaff074326a490c1c4df961df1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0222b251d46f4b5b9adba6a70f6ca5b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc5e6407019d4c5ba9239b2dc0326dc9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63e20a416e72492f8ea6b11da4fca76d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i934dc3da23a444f68c5411629abd5c05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b6cfcec597e408b9a5fd82f4348c035_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia390ec0e6c2945b8ac3c143bec1f4d48_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b52c801fa3443fba640800528e27d89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i286ca5ae382c4a2c8eb259f86f360abc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2ada5aeb391411cb94688ce1c7bf045_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1679fab0c33040bea869e31b477d8218_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i240029b128a642eb92a242ba01b28e5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87fc5a1a4adc4ccfa36556f49b411e45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5279e9ef42dd4b35a8efebed33d86874_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c6aab66b44f4082a6966e817d9f00ca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i44e14e1f91774b6ca60421226afdf115_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3cff2f3a775c477eb7e3299584301fe4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib2deb61987c348f792b6cc878f078498_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief5124b672194097aa937d5abf34195e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9eaa1423fdfa4907a958a048b0c0d9d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79008fc3f7c7470e85ee26a22fb45478_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32a03dfab4d54a0eb2135b969c2e72db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia490ede05d664ada928496a145ece1b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b1c6c4cd7c54799b4fa99f477778cb0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f8b467de7e3474592af98d693a17cc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i893db808ea6d4f7ead3577ea17638692_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd5942d7cff84bfcb443a0b4ee20e405_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e92b1090f6e4a34bdde827d0faa1850_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i341295b5472d4fd5adb9a8a46d925465_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i297b6847ff994bb0832cc1355bf182cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ed6b73fff7f49ae9d9bbaf6f9c9bd80_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id527155f2d674c79ab6ae71c08673835_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic4f44a484dff44c3b6ed7ba7f19327d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i246516f377cc4e69991858548b75cc3a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idac6c44071294ea9849175fac9191b7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4143ca6110b349138f60bc19e3247ec2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7ac69cebdf54652867c133c8113b7f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7df2e64a9b0450b929459426005d498_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71634376771a4713b50f023688e510ea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57688279666042d3a293e8a1628747b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic90da61ebdeb44219dc8a12648b8a069_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82aece15df8345618f0e67a8da516a4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f668b88714f457e8c79337cd7f50e8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc2a9aaec8d24401867d89d8e7f12627_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2019AggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89b2d96f4b3f4582940e4f6463a44151_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i782d01afd07e478a931537d96fdb53e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i626ff39017e34162b100364f2724ec05_D20190819-20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-19</startDate>
            <endDate>2019-08-19</endDate>
        </period>
    </context>
    <context id="i0a660eb1a9ef41b289c2fd72520e03d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib9531280867949db9464c43e67215202_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55bdce8f6e9a4122a9891e58c6011e24_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i812f08c4fbcb4aff9a4d22c42cf9c6b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife7facfda412415a861148c501e1b519_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87edfb08cbb845159b6b5e6f1d4f21b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76233e3f8eda4f81b4c34b9f8f97cec6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c84f93b28ad41b9b47b5c208f7efc54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ed12a7015134ea4942cb2107d893933_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib55f19bd5c9d4d2daf3efa38fdb0d083_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59bf5213305c406f8aae709bc179528e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieef9394ae96e42548978301b4001ac22_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i097a22a349ff4abea29f95badcb8b81d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12c5ecd8e9d04fb5bfb0c044ab0e9c6d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c4da7805cf34686993ec3f55d35e90c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id80ca8f87e8c4cb484a3d263b3bb637e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idda6065f68154a37934825525972e22e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief10444ff3084ac7bc054c27341e827b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i109998db04ff4f648674392ae1a723c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2731c2a351fe4a4f840aa3d75204b39a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0d8505202864b7385a6cea691031d04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd4847b37d67457bab88ed655a398e6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87f4b0d184cc492b8a1c645c1eb819da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3c7842f764a4d47946a0b5c9fc60c6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd00d55e3da24a278600f1257c6a759f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i725a0c2c245d477a866680ee271fef5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9da8aea23bd441c979d30b5eca1589d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3918eea06dc645afa81bf6b59e512ffc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5cd80680db2415fa27296f65f1a788c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i134d607092fd4a008581e04dfcac820e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48ae77b262464a3faa59c2a3cd00d12e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57785f8465894b2daed454aefed9a6ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5cc3f8952c054ec69239a226f72abbe5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idc26837a45614b51bb4eed0c541ba0df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65b9acc5b0d846c29779b6e5a0529569_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88b6427b107a4b6893f3bce6a59d182f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5080b79d26164c5da882a84779417883_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5ac76f7fccd4691a0a4ef3f2d0fcf1b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i80725583ad834079902d53e2aadcf36e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74d5a471f86e4b9f9ffbc69b60fdba65_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic2567fd9e6c448c6bd8df0511e4e2148_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib369619c4f02462baf6c43cb80f23d68_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i159eed8645cb401f99a8d7dc6909d9ff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i313491a2c13d4ea18bb58480b90499ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i969bdf20fd234556a472ac3c3bd91a4e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d55e0941456418590fcc0b66bb0dae8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie093a7adfb86426a9b678f6d156bac3b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5e36a30cc5194c4fb5b6a7caf9030f5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i407f649729a04a849ad43194e1cb4088_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic347736243d746bda91e919b3077d630_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73cc4ab1dd684ec58982d5866047dbdf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40cd8405c4eb41baa85544a9136ba611_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8b35b770901410ca52fdc805a2e9579_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f4593a60912482fab2688cbdaa05100_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99294feafedf4ee49fa109e2229c4b49_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29e6c70077d8421abaf6a0195ae09d2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69988c85621b476fa63c489ced0e8284_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f20c3d1ba7a4b9393b313eeabdf8773_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a45203f1a3447988e6706b1059e3a29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7bcc19872444969a853a9139102340a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d7f3635455746f3b28295c2ea994f38_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0f97fadb3df48bda0decc6fefc848f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if320e56a752a41e88cfb08c43d245e51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b460c38790240a9aa867c6fed4202a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0ce36bb88f54225ab4c1a3a6ffe1e0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3977734d09ce4c1ab17af6a4ee2899d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99deafdf2a70460e9d8c50f4d6973f0e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if741aa50339b4ba18fff942b2ac8318a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9f6423b1ae248ea89c9e621bfea9ed0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie81e19c0a1fc4ab48f45f7fa43d479fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90d2c756a94c45ae93fcd4c66aefc816_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37d082b275694367bb539a8515b1a5af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie054bf7025744c0e8874ea68a52321e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a267278831c49c780031fe1e50cd725_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b8a56164792489dafeb7028a867339e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3d831f9c48348a68d8597ce5baaaf5e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c6e285fb891405ebda3f5864aefc402_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idda6217ac6554ef59c1b054231dd5711_I20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-10</instant>
        </period>
    </context>
    <context id="ic538cbc1ea4a4e6482d96eb75deaeea9_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="i9e7ecae3134a4534a02c0c55e5ca169a_D20200518-20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-18</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <context id="ie3c94b7687874bd48df338dc146a6811_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i5e2c1e2b027e497dbd0261bab6602a47_I20200227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="i1c914099e6904d71a94dc97f6783d3fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id2f4f8def2974bd3ad9e71fd663edb3d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i197c21f8e68c4cc2ae4d6604948b055c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica6d67210a5b40639571e17472201a15_I20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-05</instant>
        </period>
    </context>
    <context id="ie47d736dd834426ab929b497f1361581_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7abc3bd638524e8bbfed8a8d71278d8b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic1b3fc2a867647d786b7994f29b2db88_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:AggregateSeniorUnsecuredDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i7686ee5deffa4dbd9d2a8c5eaf9db505_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i15a93de21f3f486280e4d2a80f4564b7_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i2174cbca29474ac7a29b9341a392c4c4_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i94a8abe8b67a41ecae72f9a4a146bf9d_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i4c0adf6547af4ea1bf69150f334d3a2d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie936008df8bc47b7bb4819618486c3bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8fc502671304865bc79e37327645508_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i444a310bc0c4448b9123ec72d5545a72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfMarch312021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70271503dce14eb097b21a37884cad0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfJune302021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ec855f40caa42989882af458e570454_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfSeptember302021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i308b229a078349f4a6b8fa547142e74e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourQuartersFollowingMaterialAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie61164ba53424b53a89a01bcfc962d28_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5411c3c5e25b4c5390bd6cd699a689af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93ab540e0baa4ea8b3e7d94197263283_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia398c25f0ce342b09028c1fce6e28c7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia17445cfa0b9425d9591416f99eabbb5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1eb9666c9b5d47758f0f329b195d28fd_D20201229-20201229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-29</startDate>
            <endDate>2020-12-29</endDate>
        </period>
    </context>
    <context id="i97e680c0ff1f4c26929f74c3434a3c3b_I20201229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-29</instant>
        </period>
    </context>
    <context id="icae6cce43b414bfb9f7507f8a47db081_I20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020SNAggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-18</instant>
        </period>
    </context>
    <context id="ie3a666428edd40358c27d96bac0e5b06_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4db5d14246b341c3b63536f6f5b51606_D20200518-20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-18</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <context id="i0464d11ab42f4a12b77d118c34369f89_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i19e347625da0413196bed00d6571b0aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e308f2a8c574f68b80ca9eb8be35b85_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib447fd8998e74765b84c8b606bde736d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib44c6e8af734489b858d59c23974cbb2_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6709a77d8fee4017926528030492bcbd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3cf03c18e48745718c15c78dddd26e7d_I20190225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:February2019AggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-25</instant>
        </period>
    </context>
    <context id="i8225f5ac9e2d4a35b19f518f7b34a8cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib21d26613df8433b90b18e4269afc46c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50090a44ed3648b09d9a32e978a34b4d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d747a9536d94fb7b60a93be1cbd161c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4bf916bbcc84dc4825df5c3ccaa8aae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2019TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6c464c8023048e696d029db1389bebd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9fce21be2de4c2485cc6ac5d19a3d23_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24e961c1a10f4c2c92f033e86ef7a70c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bc579bbe1d5474b81205d71f15e00f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07e0816ac73d4823bbb1284d2da621ac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i485f0a72de344efcb418b11eeb6678cb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic77ad771abd648f3a41ae116c98b285d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63949649e58e46738f2ae4a1fa93fc28_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iba5a4c30a3134fd9bb5496536fd667f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2af204e5236d4e009be09c240fec1f8c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0444bfe732324384a1a99c91c94db100_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88fa01f8ca884ebd86e9a4890726f80d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i048f5701adc84d0daa997ae6c06ef6ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i617fc320c955455ab7389624fb17f118_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie4b63f2e0707444f8d067bcb2fe459f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98488b74746f4325a718729aa016bf1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59918f0ebd684c1d8379289da4defc20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i579de7aa53774d52a5d838a68bce863a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2af2c7ed77b498eb719fa78d5da83ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica411c80fdf24d109ac19137eaa6f96e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if1252f564c6d428c98f594fc337b97b7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd865108013d4bcca24cc4a6e429770d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i050247ca3e5f4d8792f99eed4db2251f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9881105cc7c458785ea4390c09d5c34_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc33409cd1684f7c94717750ee9c914f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa5fab8b1c884ba48ab6fe7638fedd7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80ab67bc08d646feb8bcd26b4e7f25d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbc81bf26f074c4781cd0bbddfe60c72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ea968104af64d01994c09ee3b458889_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i764b1d4f04ed46a6948921a252c5d8a3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i789a5ae0df854c6e9c37f4a337dcc452_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33c2d5faf95f49dc9254955b9429d578_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ebacdb932654dc8a1cdfd75fbdd467c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7bc828b5a044f45b01faf25a60e9c78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i96e07352147f42009d9cd8b62d7b1df6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib5a809506747427492eaf2ed10add804_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id117a9767e20473d910b25f606a1e323_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c56158760a14fc7b71e8385501fece8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9348686cc963447c935d4482b79d2c75_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63979d9af7f74e27b56796a2814939d0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d63013b85484f03ad0cce1d4df4bc84_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id8259fbfc86d41e2b865f4365a602b30_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93f2550ce37a400e84700479f1651ade_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iee11ea97704a4ea8a16e4725ab7a428a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5803b285b4d846bea82279aeafe39223_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5a55a21282ed4611a789274532e46db2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib86edd9c6f8940f09b7cb40123e5cf7e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i356a0c4641ce409d99e92a91a23e56f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3ea22f9173a842c3a6a6aa67253d4913_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i335029b57a154f92b77a7911aeddac43_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8e3e16a28194313a0ad082eb5bb8785_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id412cfa512b949ec907ca18d0cd1c46b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id57a42ba8f784b46a76bcdd531d63e18_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3645a52d5198438e9a8689f203c0cf54_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iba2692c4ecf242c1b4befbf697da23d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90551e630dbe44ad87da029f9c03ab34_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f1bd6c6a8a9457c865b6f6d2377b05f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4ba129a320747d88fecf483bb2dc190_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i670166b7b500445f9d43034e4175db7b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b35f447b40b455ead67f66c9f4bfa5b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id7264ea4939f4943af5a24c4278c439f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ace6dde67bd4f898df25357d3c29937_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i244bfd1f3457405c99a68939b39f1e1c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i87e1cea449b84a3abb1aa082d8446440_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied974547e60f42538926f26d479f2cd4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0ad73371f1eb4bf5b2448c9cc099490a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i17d2f64bd733453ab060f8ba6b991f03_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i10777e0a13844245a66a3a04333ca671_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia32581cb18484982a8776dc9b9f8eea2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1785b428f97549d8ae81b21532bc254f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i379c2756c93a4bf38d84777eb83466fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fad2ab117924655ba224551660eddab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02efe013a1cb40fa9325d57e55e78b92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1626115a196044c7964d18ab75d20b9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9eb67a96dc904adf81eb688fc53e83cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0df90b8ebd7c4c70bb72f12619218a79_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f8abbaa26ce4c349b56fdf51f523b44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0683bdec183a43d1af27f889bfe2f888_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4119e3f71c984843b6e8313e74d94802_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id80ded4802ba46d3832724842de8285c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fed35511829459da5a38d83c0ca798b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id02c5663b02141118d004b9caa3424ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61ba8102128e4d5ca7ba5fd85188b839_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i193a2e3116b8454aa87e65f1058e0278_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb74a863f3154f8db49c64618640bd85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c897d04f2364feeb5c3c6a2fa36d797_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b55c014808f40fa88ef1b3f959db8d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93bd60f6d70c420a9bc09e7c7bf6fc5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib8d817c2bd28479980edad681c6a2071_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb1d6977085e41d8b212c9975e19b482_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dbe26c3626844cc8fca8bfbd336dd73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6419e203999942329c84202801da4c46_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i46f8fa0b6c8c432d9384623e2768c3a3_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9a23f29987844bacb827e4e0bf7ebd5b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6c9e3d1c87f245508ec3d21cac73b819_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iaa4713eca034411386bd8958667ff155_I20190115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-01-15</instant>
        </period>
    </context>
    <context id="i30b040b90f0b41758b9ded39e98a67e1_I20220126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-26</instant>
        </period>
    </context>
    <context id="i3a44a33716c34232840446222d515685_I20220126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-26</instant>
        </period>
    </context>
    <context id="if82ad8d4e79140ae9ff32488143d6d7b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i66f21ac1ac454c5d80b0c27572fa871f_D20171110-20171110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2017-11-10</startDate>
            <endDate>2017-11-10</endDate>
        </period>
    </context>
    <context id="ia1b7da4d442341ae9e6ed840e1f4cd33_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c11391a90f343a8a29ca5a651461834_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0157a31857394755b58f1cb928f3509e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5bb7cb06378a4432bb97c143cc5f5952_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="id85bcc6a4b684d52a383187a1856dd57_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i419713e280d4402f8c14fa84298a0ccd_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="i72aa8f882331458e90a94bf23ae61e59_I20130125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2013-01-25</instant>
        </period>
    </context>
    <context id="i76d5c1eb8c3c498e932fff915c09dd38_I20201214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-14</instant>
        </period>
    </context>
    <context id="id9728f3b38444f35b64ff2f079ea4b3d_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bsx:A2011LtipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="if59bff74575c44e3a5039251cf9b8592_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51e61128384f479281522b42f68d88de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d964f1e8fde4f869b9572107e4cd663_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3a649302b88643399da73bbaa811ad27_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03336283c2ff4b398efa41236e67a2d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b7e7bf22b2b40ce8673e049908bce94_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0db9ac2d795d4e17aee7151bfb6ee932_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ae1671df59943f7acd666541a997122_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92048bcac2e04d9983b5f962b19cad96_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie188534f742842feac06df7e1c74aa45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0aae52091d8944baa48514791518f001_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18d0f7d58dbe4881a08e6c6c4d798dc7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28b5c1f16ae04ad0863e335580139350_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7bc526be42e743bb9a8a6576a16447ee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2aad1bab8c3f42188e8caee5487fc161_I20210217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-02-17</instant>
        </period>
    </context>
    <context id="i58d60bf54d9b477b9441568e22f085d1_I20200218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-02-18</instant>
        </period>
    </context>
    <context id="i9292f58cc599475cbe04d0e8c11e9935_I20190221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-02-21</instant>
        </period>
    </context>
    <context id="i56d2063406334ffa9e99fa12a46b4055_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57fa53402a1e4d61946e5928f0177f07_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69bc7b2173af4ec4be135c607f06064b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3dcc1d9f587e4bdf84dc58e0c744f18f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibcc7a0cac76948efb6e5fa18d4642442_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i979c7d5f5f30414bb30ba5f9f9d3c752_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i04991ed25715473bae686eada34ce8e3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib3595f016be44152b0810b7941073c20_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icfdac215247a41d5a190631edb467695_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i998fc4c852bb4712a6ac361d50f1addb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5c616e504e944e48bc57a78d5f0bcc4f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6cd23720dcf441b893aa13e8563d15ef_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib6d4db93b38040f2a515f954395082f3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3af6a1df22a242a4b23b635ddeb5a981_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i88f0a448c20c42a59fc6c0a04e829f95_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibb04350660a44a988ce323d0808bb5a2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibb392f0b52d04562bbafef2c2e3bd024_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d2aee8e67d5473ca756655b97f76be1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id43b6011336d44cda836897ad0a99eef_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i248c898d732b4314b0a88247e5686fb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1917903eab064ebd8f9b5c4561e2f754_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25175389829c4c00b8fd64f6b1b9bf50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb9ed43167d04cf5a5e8be0581a2d3c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib195a39da918458daa4a2a7c922e5626_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia58f50b0109e41fd8e438c82c71e3141_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7af8a989c1284f24a421723a037abca7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a5ed8dbde274fb797a84e2782bb541f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id384c54f72144cdf8fee9a2d43b64754_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a97fc47966f4c888c420993a4ecc84c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4883d6ab73714fa080e66ddc8068d9e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id679dd594dfe40169b0716db7018f794_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3a0e6b8dba74575aee5f5f86c271bbb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8968316c251443599b1cc42fc078d2fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee1badc1b55e4c3580f690a018638da5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ca302daf1c74047b3c5899ea8e0aca6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i411673321b714ce89c57299921fae970_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0381e81002ea48aea3c5b8276a4bdfe2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib323af1d123f4f288409892c6d582c3a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i492788538a3b4d079d5f2e01ce834568_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i83749835aad04c27823ee7e3e441d8d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieebda7efcc984eaaa323a3965ae8afc2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice8b818c14fa4356b602a04c1ab17b68_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ief070d59a8a74c6883609bd434bfbfdd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i19e08cc88e42477f8b204d52aefeefae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4226949d0cdc471da19b2ef5376d32b7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i296c600288ba4126abba2c8e6654d659_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7877e3175114481298066be0fb237a24_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46048892559447039913345bc4184710_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3d0a46f763a34fcfbb98da18cb232850_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98c2a656422d4982be4f1876ef15fbd7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i05500613984e4170ae63706134751f68_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia7e6f6584f284ab5b2bbf59c9911ab30_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8d69f6e362124b848580bbf31ad6ad84_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if1fb275aaa7347e884e5e734e95e6439_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0296cee599414719bd3d27b8e535a348_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i47108644abed4ca48d40f6618e8766e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66be153aa8a64bd3a8549033c030d988_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d91f24a77dd4e05a3909ceb50bdb176_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i139438da5f5c43439b7f6cb237aefe53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5414046eeaee4c90baf8f05d81103cf9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1028c0ccdd44e579fc1a7e93e864c8e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5e624f8fff1b4416a9d5d3cd9c9a3a8c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5e89d505d51c40cf9c9b06a4a255d695_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0559f366b4db4027814a50efc3811d7c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i792d16e027b94051b1350ad706ae61b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iffbec07d746b4648b462392b1200914a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id7a8d5dfc7cc449b8eaea3d0a207bca7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id1f761ed299c43aaba3aeb4c183b4bb1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie15626b1bdc1459ebc740a7d9123e3a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3ee6b1033014d9e89c4ef9c0d696921_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i46e7887ed9b64aaa828480abdd1350e3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib7f200406b1741da8d29e0597b3ef799_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib6ac600b424e4c36ae326ac78fc6acb0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b2d57381d214a61974a25af56e0fe97_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b7c862ab83b44a6823252694cfedafa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8b9a583488948c3ac09adffaa7c62b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61903be42d074c65b668c3852b09debb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8fc90b63ec344bb382c1ac4ac757ec55_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2950edca24e646cf92832d6acc6da711_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7ecfae37eff349aabd3cffa238c04a7a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i448b76a8a955443b853399bdede98723_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib0ed2f4d1bd545449a2f19715b187d67_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3c8df2ca0184543adf70bfad9cb539d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6851f3461e914845861fc25f808129ff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11b6ff9b41f34af7bf8811c4d7d9280c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7448b8ca366f4827bc4f258c57c93261_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibcb61ff1feec4e518decbdf1ca114591_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i969834eefc47426fa7387f6ee8b1085b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4178008f18a6432bb79c295f035843c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5edb697c55bc4cf4b947643bcd30a7fd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i363f7457787448d5a0978accd8392066_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i990fcdb4d4d64102a6e2a01d782d3da7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i219bdc71c5134494a8e8468f8d87edbf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i77a4631fadd7470dbdb228646d0d1e64_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id47b9b05ad00409f8e34ab200b239f73_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f59541845b541a398a1c956947b253e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia608cda32d2c4a75acba41461285ef9f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iddebf93ed35b4294bfc7d57c147f14a0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i230686786fb8479c8e8b3aa250c6294a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5daeb0eea7624d95bd33a61b6630acf1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if745267c77af430eb139ec47097f83b4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ce9f4d10e55459c9da61e0b45861feb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic65e05bd72794ad69c38ad937bbdd8c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic11feaaacdaf46dbbaad088de02198bb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0798aac718394b2e885e3eec15b7a1b7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i29e3a0a6440d4892b49e46f886fbcb2a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7510a4849a314540abc54995d58f29a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1ba9db017ca54a60b7e7c1ea9f933ffd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6afa1156f16c40a9bfe1aaca76cb5002_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3aa17098a29b48e894a6b05f541a6034_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2e61f5e37fc74a6f81ea7c5928a92766_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i37d5ca208074462f876fe31f23b1fed5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3934f348ffb740b0af4a20a77601e650_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbd3c076197c4394a0b5a998e05dbd49_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia58a0bdc221345bfbf3c6181a5c06176_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic9c7d84961bb4190a76e256fa88277af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia85ece485aa444be8199976328f65690_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i38022f0994a44701b3f50846a6fd4016_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i240079c64e2b40068b8e05779f120de1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97644286dfd2411eb21e3c030a24a491_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib93b9e8e344744818491704b2f2d822e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie419b41857fe446fb2fd54d0467e3cc3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if99c383051264d1c8e894654e1c8eea9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i876002865abc4f97ba83a0ef52267bbf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b08a70a845343069de514f02498dcd4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i093d7ccd7bf04c0db289d031e28a2247_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idd2a04e716dc4d76ada198ae8de3512c_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i9677d942cddf415f979a5572240cb314_D20190819-20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-19</startDate>
            <endDate>2019-08-19</endDate>
        </period>
    </context>
    <context id="if2959d13185e44b0b5c23911f7e0c9b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96369c0f230346708d64ca28018edad7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1704cd4a6e4d4195bd594fd45e78d251_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9ba8f98eb3545039f395219720cc097_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2233b84039de4a86bf1e039d4ebd672b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84912b2290e843e7ba4e06ea51b35268_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25ddf18419df442eb0b2829d76375ae3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f13d53946094d0597052e0d0c1fed72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98b179ab6b284836b5b7e104d9b796fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibadf8b569527469ab651f550d716b4c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if28e5bd9680c4874b621bceaa941ea18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c99c0d845c344c2aaaa4f9075b3cc36_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f7c5cd724b943808b5b4a790359037e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9107422a10134aa88c15d6264e4b0a15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32babe1b5a2d4787946bcd2130f04a6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i479839a4abc848c0822e4fc438e2f790_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22e137b5ac4e443db82fce619d7addda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieed3b64471e4431396082d1b7661d187_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id4fe210a6ecd4082b33c83f96d710db0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57226788691947098831b210f4d9e6f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7387bc40a28d42d3a310a107abc8db02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5cd235ef6f2496e8f2b3c361e6c2083_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia22158488b3a459c88e0b1f6a927db8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc049394c7014a64935dbc97f6fdef13_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i699d1eb2cebb41f1bfb906a93a9f96f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51845faa20174064ac84a92ea5ff121a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="gbpPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:GBP</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="units">
        <measure>bsx:units</measure>
    </unit>
    <unit id="claims">
        <measure>bsx:claims</measure>
    </unit>
    <unit id="reportablesegments">
        <measure>bsx:reportablesegments</measure>
    </unit>
    <unit id="countries">
        <measure>bsx:countries</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV8zLTEtMS0xLTA_80ff7d57-bda2-44e9-a159-29b36545942c">0000885725</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV80LTEtMS0xLTA_66c6aa69-8aac-4bf4-93bc-7b5550de5989">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV81LTEtMS0xLTA_60cf21a2-3c03-4ae2-8bcb-c23d11f81bdd">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV82LTEtMS0xLTA_54327b3e-f064-42fc-ad5b-15b35facb9fd">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN180L2ZyYWc6ZTZlZDZkOTBjZjRjNDY4OGI1YjJhMzU5MjZhMTg1YjYvdGFibGU6YjkyYWZkZWNlMzczNDFmNDk5NDUxMTFkNTc4NzVlYWEvdGFibGVyYW5nZTpiOTJhZmRlY2UzNzM0MWY0OTk0NTExMWQ1Nzg3NWVhYV83LTEtMS0xLTA_905f2a62-22d8-47b0-8e92-abf58f4922d1">false</dei:AmendmentFlag>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_5c57a388-4a11-402a-ac98-8db5289b32b1">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_02fd6496-c14e-4d01-8da6-bd43092a2153">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_2643a84a-4741-454c-9f77-8a94ad26cb86">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_18293d37-bb2b-40b9-aa4f-ac327a0961c8">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_1ed815c9-5da2-4587-b032-4aa6994bd099">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_bbf05a7c-f990-4fcb-b0f0-f7abb412ae4f">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjA4_270b3357-e3db-4087-ba7e-1770a84f57d1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6YWRhMmUyNmMzYmEyNGI4YThiMThiZWViMGViZjcwOTcvdGFibGVyYW5nZTphZGEyZTI2YzNiYTI0YjhhOGIxOGJlZWIwZWJmNzA5N18wLTAtMS0xLTA_815f4cca-0cc6-4675-af1e-5d018e1ff59e">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18xMTU_c992284f-bd5b-4656-95e3-dabe95642e17">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NjlkNjhkNGY5NjE1NDYzOWE0NjEyNDgzNzU4Nzk4MjIvdGFibGVyYW5nZTo2OWQ2OGQ0Zjk2MTU0NjM5YTQ2MTI0ODM3NTg3OTgyMl8wLTAtMS0xLTA_c62a52d3-fca6-4d10-9cc2-f1aae7196773">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjA5_dd392202-e8d5-442f-8ac1-9c4d0efce2c1">1-11083</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjEz_666274be-67f7-400f-9ea9-ef1acc5e3cb6">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6YWI4OTMzMGE4YmIxNDM1YzgyNmIwMGUwNTkxZDMwZTEvdGFibGVyYW5nZTphYjg5MzMwYThiYjE0MzVjODI2YjAwZTA1OTFkMzBlMV8wLTAtMS0xLTA_e1f41603-faf6-437b-bb07-9ef8f2e1f50e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6YWI4OTMzMGE4YmIxNDM1YzgyNmIwMGUwNTkxZDMwZTEvdGFibGVyYW5nZTphYjg5MzMwYThiYjE0MzVjODI2YjAwZTA1OTFkMzBlMV8wLTItMS0xLTA_b7a1b416-edaf-4c70-9b3d-d3f3f308f4db">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE5_0df64919-ffe3-4a20-9298-26f9e17ded67">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE0_d2d93b3c-a361-4874-8e5f-903fc31c3241">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIx_a721e49f-24ec-4faa-b1e1-c9cc84ec426e">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE1_3826213e-3c74-4908-bade-c92946ef9118">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE2_72778211-b960-4eb8-8fe1-803151cfe4fb">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjE3_cdd7b4f0-0324-45ed-9c72-dd08d7bd8afc">683-4000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18xLTAtMS0xLTA_5cc737b3-4a5a-401a-9bad-08dea9b07e0b">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18xLTItMS0xLTA_fe2da0e2-242f-47fa-9a1a-44b4e302fe3f">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9e38a5d922634f5ebbfb9f80ac92409f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18xLTQtMS0xLTA_9175ba26-cb52-4f64-bd32-58adf0c1bd09">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18yLTAtMS0xLTA_87954fde-c8c6-46a8-85cc-d279ab0c5796">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18yLTItMS0xLTA_0a44aae3-5f19-4393-9e0e-043f8549b9fa">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9371cf3a708b4714b3851137a49faa3a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18yLTQtMS0xLTA_79b5ca0d-f706-4f1d-832e-61409e699b96">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18zLTAtMS0xLTA_496435d2-d883-4ec5-9946-6da16d16437f">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18zLTItMS0xLTA_db91ab3b-8daf-4fe6-b0d5-22742d9b9a9a">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6ZDU5YzU1NTM2ZWM4NDUxYzg3MmFhZmYyNjc1NDgxNTcvdGFibGVyYW5nZTpkNTljNTU1MzZlYzg0NTFjODcyYWFmZjI2NzU0ODE1N18zLTQtMS0xLTA_41d35995-dd39-4870-b041-f866bceb4d3a">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIy_c74cd557-4390-481d-8472-0f522b256f9f">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIw_0db1aade-58f4-4ad6-a02e-33e08b9b34e0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjIz_5e7a44fd-4a5b-4cf9-8194-29cbe7de1e5c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjEw_740a008b-2d68-4232-9e10-76198b8b0898">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NDZmMzVmYTVkZjJlNGZiOWEwN2UxMDgyNGRlMjI0YjEvdGFibGVyYW5nZTo0NmYzNWZhNWRmMmU0ZmI5YTA3ZTEwODI0ZGUyMjRiMV8wLTAtMS0xLTA_7782f291-b3cc-4d84-aea9-1f9ad2916723">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NDZmMzVmYTVkZjJlNGZiOWEwN2UxMDgyNGRlMjI0YjEvdGFibGVyYW5nZTo0NmYzNWZhNWRmMmU0ZmI5YTA3ZTEwODI0ZGUyMjRiMV8xLTMtMS0xLTA_d87d9637-acc5-482c-ac8f-2a4d7451756e">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGFibGU6NDZmMzVmYTVkZjJlNGZiOWEwN2UxMDgyNGRlMjI0YjEvdGFibGVyYW5nZTo0NmYzNWZhNWRmMmU0ZmI5YTA3ZTEwODI0ZGUyMjRiMV8yLTMtMS0xLTA_7043a743-d677-4ddb-9a56-3e0ea512f32c">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjEx_c45301f8-f03c-42a2-87cd-c65342e4a3c1">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zNjI0_0f1689c6-547d-47e1-8b5c-ebfdcc92446b">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i68f3333d6cce460dbc252aac2c3a29cb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18yNjcx_2fc59f0c-cbc0-4b6e-853b-40d3fd937e74"
      unitRef="usd">60600000000</dei:EntityPublicFloat>
    <dei:EntityListingParValuePerShare
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zMjY1_2c9c7b16-28ca-4b6a-a372-f6cd3700aaa8"
      unitRef="usdPerShare">0.01</dei:EntityListingParValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6094d98b0e484f6ab786282879ded28e_I20220131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xL2ZyYWc6NWU1NmI5OTk1NTY2NGYxOGIzNjY2NDYzZWNkYTI3ZDMvdGV4dHJlZ2lvbjo1ZTU2Yjk5OTU1NjY0ZjE4YjM2NjY0NjNlY2RhMjdkM18zMzE2_be298712-d567-44ef-9584-bddc4b346601"
      unitRef="shares">1426724712</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183MC9mcmFnOmM2OTM3ZTk5NGNkODRjMGI4Y2ZkYzcyMzk2OTMzMTJjL3RleHRyZWdpb246YzY5MzdlOTk0Y2Q4NGMwYjhjZmRjNzIzOTY5MzMxMmNfMjE5OTAyMzI3NzkyNA_027a1f36-8627-42b8-8f99-78215fad42ec">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183MC9mcmFnOmM2OTM3ZTk5NGNkODRjMGI4Y2ZkYzcyMzk2OTMzMTJjL3RleHRyZWdpb246YzY5MzdlOTk0Y2Q4NGMwYjhjZmRjNzIzOTY5MzMxMmNfMjE5OTAyMzI3NzkyNg_cca8ebcd-0f7a-4684-9a8c-3c0363cd95e9">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMy0xLTEtMS0w_537a8d2a-beb7-4fe1-96c1-41595999d3e5"
      unitRef="usd">11888000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMy0zLTEtMS0w_f746b2f8-3b53-47f0-9cb1-04730c02201c"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMy01LTEtMS0w_6d926400-ade9-472e-a416-1a70820f3fc9"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNC0xLTEtMS0w_a725d8b1-a6ae-4826-95b1-08fe723cae5c"
      unitRef="usd">3711000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNC0zLTEtMS0w_abe2d9ff-cbfe-43ed-aff5-16b877a63b7d"
      unitRef="usd">3465000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNC01LTEtMS0w_7539f9f1-d01d-44f8-8eec-e539eda39562"
      unitRef="usd">3116000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNS0xLTEtMS0w_7bfb102c-0710-4097-950b-688f3b8052e1"
      unitRef="usd">8177000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNS0zLTEtMS0w_a16d0d3a-945e-437a-a31e-fb045487f8b4"
      unitRef="usd">6448000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfNS01LTEtMS0w_5518e448-5734-41b4-8837-c22221af39b5"
      unitRef="usd">7620000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOC0xLTEtMS0w_0c282c1c-1c6f-450c-b47d-38507c49ae87"
      unitRef="usd">4359000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOC0zLTEtMS0w_7475ecdf-987d-4ccc-9ab5-d5008397a97d"
      unitRef="usd">3787000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOC01LTEtMS0w_f5557baf-e3f8-4108-b651-a6f4df84b7d1"
      unitRef="usd">3941000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOS0xLTEtMS0w_8580b271-473b-4819-ad41-8ee805543883"
      unitRef="usd">1204000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOS0zLTEtMS0w_aceda4bf-5599-4be2-ae67-074c083609ad"
      unitRef="usd">1143000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfOS01LTEtMS0w_e8f808c5-2215-4afd-97c2-cde308fa4c1e"
      unitRef="usd">1174000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:RoyaltyExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTAtMS0xLTEtMA_a33820df-58f1-4d58-8b44-0bb610add402"
      unitRef="usd">49000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTAtMy0xLTEtMA_82f38be3-c9ea-4de8-94d3-0e525020e830"
      unitRef="usd">45000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTAtNS0xLTEtMA_a519446e-9b0a-42ab-9376-f1c1e589b7ae"
      unitRef="usd">65000000</us-gaap:RoyaltyExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTEtMS0xLTEtMA_43192cde-a409-4109-ae32-df8c0ba28450"
      unitRef="usd">741000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTEtMy0xLTEtMA_5231a5e0-e5c9-4974-a9e6-1cda483f3a85"
      unitRef="usd">789000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTEtNS0xLTEtMA_10e798d6-9c86-44d0-b09b-ec731329fe08"
      unitRef="usd">699000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTItMS0xLTEtMA_6ce0a0ac-4b56-4fb3-a55b-93dbddd94fe4"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTItMy0xLTEtMA_781d2c58-31be-4ea1-bec9-c377fa96c674"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTItNS0xLTEtMA_15dde5b7-21d3-453a-8dc1-640e9e9fe394"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTMtMS0xLTEtMA_0a71ea9d-7ac9-4ff1-8a0c-aa506615aea8"
      unitRef="usd">370000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTMtMy0xLTEtMA_0f1da7b9-49f0-470c-82a5-3ae931f03230"
      unitRef="usd">460000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTMtNS0xLTEtMA_9743aa41-97da-4386-92fa-3d2bbb535be9"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTQtMS0xLTEtMA_0aec8765-7c08-4fc0-8343-8c7e97bb1dd2"
      unitRef="usd">-136000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTQtMy0xLTEtMA_72f179b4-da98-48b2-b894-d6f1c9041894"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTQtNS0xLTEtMA_2bf3002d-3a0d-48e5-bcc5-e0cd457f254e"
      unitRef="usd">-35000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:RestructuringCharges
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTUtMS0xLTEtMA_88dba87d-2809-49f3-be74-5f83f0fa7335"
      unitRef="usd">40000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTUtMy0xLTEtMA_d3644e77-11aa-4335-a924-94cbc2ae3ffc"
      unitRef="usd">52000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTUtNS0xLTEtMA_0b0ee396-070f-430b-a0cf-9683d78d2f7d"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTYtMS0xLTEtMA_44b6b3bc-f400-49db-bc76-ade645239fe0"
      unitRef="usd">430000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTYtMy0xLTEtMA_6ffa83c5-7487-4d92-bd4c-afd08eec32b8"
      unitRef="usd">278000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTYtNS0xLTEtMA_eebac84a-d848-4205-bfd7-73ba6e1f8a3b"
      unitRef="usd">115000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTctMS0xLTEtMA_b81c9f8f-00ff-4ebf-9c37-f75492a9e7a2"
      unitRef="usd">78000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTctMy0xLTEtMA_866f150c-ec79-41e1-8f27-18ca74c5e2af"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTctNS0xLTEtMA_a4997dd5-7a75-4538-8890-7f130613e7da"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OperatingExpenses
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTgtMS0xLTEtMA_e0d32333-b5f4-4f4c-b239-c09af7c563d5"
      unitRef="usd">6978000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTgtMy0xLTEtMA_a8e3dfe4-2221-46c2-9346-e89aa185a88d"
      unitRef="usd">6528000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTgtNS0xLTEtMA_f729d63b-5546-464f-b881-d91341526e26"
      unitRef="usd">6102000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTktMS0xLTEtMA_3b05d976-32d9-4a74-8ba7-3d1c4896ae7b"
      unitRef="usd">1199000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTktMy0xLTEtMA_61b9e62d-3f69-440b-968b-174f858c4418"
      unitRef="usd">-80000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMTktNS0xLTEtMA_022040ed-e817-4721-8819-800b34d96635"
      unitRef="usd">1518000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjItMS0xLTEtMA_f3831a3a-9b1e-4a63-9568-de19f061eb7d"
      unitRef="usd">341000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjItMy0xLTEtMA_4d1f9aa8-07f3-41e2-b2a0-b0c88fa14599"
      unitRef="usd">361000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjItNS0xLTEtMA_0d411b56-35dd-4f59-812e-91473c81912a"
      unitRef="usd">473000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjMtMS0xLTEtMA_2696627f-9bbb-465d-832e-56afc65cde99"
      unitRef="usd">218000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjMtMy0xLTEtMA_47ebab64-f222-4708-ac2d-d7360fc30f22"
      unitRef="usd">362000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjMtNS0xLTEtMA_7136146b-fba6-48cb-830d-20c4390db7ab"
      unitRef="usd">-358000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjQtMS0xLTEtMA_4f9fb957-d8d9-416c-b9b1-1261c017aab8"
      unitRef="usd">1076000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjQtMy0xLTEtMA_9770da8c-5dcb-4ec5-8fe3-ab11f89b16e2"
      unitRef="usd">-79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjQtNS0xLTEtMA_4e8f5bcd-4eaf-4aa7-afb2-e804b08044e7"
      unitRef="usd">687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjUtMS0xLTEtMA_5d41bb8f-aeb4-4bd1-bf03-7c877d7731c6"
      unitRef="usd">36000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjUtMy0xLTEtMA_01389e8f-cabf-4c98-836c-c15604d256bd"
      unitRef="usd">2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjUtNS0xLTEtMA_4c2dcc4c-a962-4e53-9d3d-ff3f3b163f3f"
      unitRef="usd">-4013000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjYtMS0xLTEtMA_409623b3-002c-4ac4-8223-d9741a77119d"
      unitRef="usd">1041000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjYtMy0xLTEtMA_2a31a583-dc08-4370-962a-89e7c5e3827c"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjYtNS0xLTEtMA_01e7dde7-bbe5-4d24-9a8b-90d97710e24c"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjctMS0xLTEtMA_3a148871-5709-415a-ac05-30ccd1c1069b"
      unitRef="usd">55000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjctMy0xLTEtMA_3fcc4c82-0463-4c77-88a1-0cc62df021db"
      unitRef="usd">33000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjctNS0xLTEtMA_7b2cb90f-18c4-4630-af68-1bc65da92eaf"
      unitRef="usd">0</us-gaap:DividendsPreferredStockStock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjgtMS0xLTEtMA_7f219dd1-78ba-4f53-a888-c9ffc89bb90e"
      unitRef="usd">985000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjgtMy0xLTEtMA_5f66d964-d0b4-459c-8d66-5d93fcbea596"
      unitRef="usd">-115000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMjgtNS0xLTEtMA_27b85515-6d11-486d-8b20-cea11d89af25"
      unitRef="usd">4700000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzAtMS0xLTEtMA_11228891-119b-4aef-892a-e21322bdae1a"
      unitRef="usdPerShare">0.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzAtMy0xLTEtMA_580ef798-ccc1-4e9e-83b8-94e32173078b"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzAtNS0xLTEtMA_f0ec209a-02e0-4e02-8ccc-a440a11f6309"
      unitRef="usdPerShare">3.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzEtMS0xLTEtMA_55c529e9-b432-4985-b7c0-2aac3a29c443"
      unitRef="usdPerShare">0.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzEtMy0xLTEtMA_ca5134ec-60d8-4428-abd7-ac7e94328273"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzEtNS0xLTEtMA_a61226e7-f514-4574-a967-776d2a0b0a06"
      unitRef="usdPerShare">3.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzQtMS0xLTEtMA_9d179421-772a-49df-9f0b-724eecc6df3b"
      unitRef="shares">1422300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzQtMy0xLTEtMA_d08e578e-6377-4d79-b528-532fb3d8a5b1"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzQtNS0xLTEtMA_5c4231f3-226a-4215-ba1b-0898fdc7b3b0"
      unitRef="shares">1391500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzUtMS0xLTEtMA_a94e6c5f-bb62-4b76-9704-09dffa0a9fbb"
      unitRef="shares">1433800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzUtMy0xLTEtMA_8b21447a-9f89-4d98-be9c-4d8ba5e1ca04"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183Ni9mcmFnOjZlY2RlZTc0ZGJiZDRhM2FhNWYzZGVhZDcwZjdkNzE2L3RhYmxlOjkzZGQ0NjFmNDI4MTQ3OWQ5YTczYTYzNjkxNGI1Yjk5L3RhYmxlcmFuZ2U6OTNkZDQ2MWY0MjgxNDc5ZDlhNzNhNjM2OTE0YjViOTlfMzUtNS0xLTEtMA_8e338b1d-f69c-4d57-812d-e68fc608a5e2"
      unitRef="shares">1410600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfMi0xLTEtMS0w_409623b3-002c-4ac4-8223-d9741a77119d"
      unitRef="usd">1041000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfMi0zLTEtMS0w_2a31a583-dc08-4370-962a-89e7c5e3827c"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfMi01LTEtMS0w_01e7dde7-bbe5-4d24-9a8b-90d97710e24c"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNC0xLTEtMS0w_b44d4e4a-887b-465d-bc34-1f2ce07551c9"
      unitRef="usd">-125000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNC0zLTEtMS0w_13017434-f635-4505-af00-980a3069e6fd"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNC01LTEtMS0w_024bfb53-26f6-44c4-bbaf-e17f01ef50a8"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNS0xLTEtMS0w_3560ed04-c7a4-43d7-90ea-b51d9f897e8e"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNS0zLTEtMS0w_7287c84e-06b4-43b3-aa8f-b5f666dd5baa"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNS01LTEtMS0w_e5041cf2-a3ff-4a25-9f4c-6a1bf05652e8"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNy0xLTEtMS0w_14f25da8-2cdf-4de2-bfde-264f4e75ff49"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNy0zLTEtMS0w_ca3efc00-fc79-4455-93b0-818ee6e218e5"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfNy01LTEtMS0w_ea88118c-f492-4cda-86fe-3b5676cc9ae1"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOC0xLTEtMS0w_d9b1fd6c-c4d9-4856-8b37-5ef4c1019cf1"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOC0zLTEtMS0w_1c6c3f35-b8de-4aea-9419-9b8ccf285583"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOC01LTEtMS0w_a5538da3-f58a-47f5-85b6-a6ae00744ebb"
      unitRef="usd">237000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOS0xLTEtMS0w_8d990b67-a91d-4ecf-a13f-74d6412b0ef8"
      unitRef="usd">1096000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOS0zLTEtMS0w_d0610484-9201-422b-a1f3-3f75253c1e8a"
      unitRef="usd">-145000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN183OS9mcmFnOjhmMGQ4ZWVjZTVkZTQ4ZWI4ZDRjMWZlYzk1NmQzN2IyL3RhYmxlOmYzMzk5YTUzYjM3ZTRlYzI5ZmMwYTJmZDcwNTE0NDEwL3RhYmxlcmFuZ2U6ZjMzOTlhNTNiMzdlNGVjMjlmYzBhMmZkNzA1MTQ0MTBfOS01LTEtMS0w_41abff15-dfa9-46ab-afb0-5093e380db60"
      unitRef="usd">4937000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNC0xLTEtMS0w_9cc55fe9-0863-4471-b85b-5002e6c3eba4"
      unitRef="usd">1925000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNC0zLTEtMS0w_af9cb53c-a0c5-4f71-8942-baef1d9bb646"
      unitRef="usd">1734000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNS0xLTEtMS0w_31ca29ab-b094-4694-a0ba-592a7f5a3d96"
      unitRef="usd">1778000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNS0zLTEtMS0w_f04dd21d-b489-4aa1-b3a9-9433d7a495cb"
      unitRef="usd">1531000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNi0xLTEtMS0w_d81045b2-3bd6-4f66-a037-78368a694316"
      unitRef="usd">1610000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNi0zLTEtMS0w_51e6c901-96d2-4ae1-a426-caa3f38ea0df"
      unitRef="usd">1351000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNy0xLTEtMS0w_3fe4ec01-e1e9-46b9-84c0-819cad7b4dd0"
      unitRef="usd">205000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNy0zLTEtMS0w_39aa3c44-250e-4daf-998b-88a722848c8f"
      unitRef="usd">194000000</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOC0xLTEtMS0w_49a65c93-cc6d-4525-be23-f89d606a0759"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOC0zLTEtMS0w_cac68737-2c66-4423-9d53-90285ac35a6e"
      unitRef="usd">1133000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOS0xLTEtMS0w_ff914c79-4ef4-476a-96e0-d30815dde453"
      unitRef="usd">799000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfOS0zLTEtMS0w_d6076ce2-ea56-4681-88cd-cc52dbfdf1a7"
      unitRef="usd">751000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTAtMS0xLTEtMA_c00354a6-e562-4b5e-9ed1-1bb0b107362b"
      unitRef="usd">6317000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTAtMy0xLTEtMA_53656906-f0af-43f9-8df8-ac74ccca980c"
      unitRef="usd">6694000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTEtMS0xLTEtMA_75402024-2eb8-4d08-982c-fee92516c59d"
      unitRef="usd">2252000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTEtMy0xLTEtMA_040c97ee-a3d4-46f4-a4d6-f5555087db68"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTItMS0xLTEtMA_4e76c49e-a4cd-4128-9b97-d35ce1893863"
      unitRef="usd">11988000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTItMy0xLTEtMA_a3088370-fca3-4a36-9d7e-ec4a8df41e89"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTMtMS0xLTEtMA_5c52718c-7822-4f24-ac06-4d6f5bf062f9"
      unitRef="usd">6121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTMtMy0xLTEtMA_8267de7a-3467-4c60-98cd-09558539f448"
      unitRef="usd">5917000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTQtMS0xLTEtMA_d7682f57-7d7f-49a8-9a0a-03b0bf510807"
      unitRef="usd">4142000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTQtMy0xLTEtMA_9c6dbbb6-7a32-496d-8e5b-ecfbf62d1512"
      unitRef="usd">4210000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTUtMS0xLTEtMA_cffd3252-9f38-4b08-8c04-24227e71a37f"
      unitRef="usd">1410000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTUtMy0xLTEtMA_f0375f0a-854d-4321-bb1b-49c755363b56"
      unitRef="usd">1921000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTYtMS0xLTEtMA_0c1858d0-1182-46bf-ba53-39b80e271fe8"
      unitRef="usd">32229000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMTYtMy0xLTEtMA_96910ff1-86fc-4a22-bb33-47d53daa1d5b"
      unitRef="usd">30777000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjAtMS0xLTEtMA_b44b8d9d-5a0f-4f30-8b98-a8a554065768"
      unitRef="usd">261000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjAtMy0xLTEtMA_7eb550aa-731a-47aa-a4d1-705e803139dc"
      unitRef="usd">13000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjEtMS0xLTEtMA_a72541dd-970f-4aab-aba2-8fb01e0035cd"
      unitRef="usd">794000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjEtMy0xLTEtMA_04802a11-8d47-49c8-9598-b06233343715"
      unitRef="usd">513000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjItMS0xLTEtMA_e1a806c0-f054-42b4-94f8-3bf3f44a6a36"
      unitRef="usd">2436000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjItMy0xLTEtMA_328cd582-5b2f-4bd7-b294-33161e2678a1"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjMtMS0xLTEtMA_13b5f27a-18e2-432f-b1c6-204bc85f498d"
      unitRef="usd">783000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjMtMy0xLTEtMA_0631e340-79ab-4c7d-a600-f7fa37f353c1"
      unitRef="usd">958000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjQtMS0xLTEtMA_6b524fca-3cd1-4df6-af6d-8c88e4b0bc5f"
      unitRef="usd">4274000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjQtMy0xLTEtMA_a6890b19-ac3c-4ff0-a222-09604fb57c75"
      unitRef="usd">3681000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjUtMS0xLTEtMA_b9e9f9ab-5822-409d-b297-931748f80e67"
      unitRef="usd">8804000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjUtMy0xLTEtMA_c42903f0-8b3a-4883-bbe3-ce917f38a05a"
      unitRef="usd">9130000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjYtMS0xLTEtMA_e11d2269-55aa-43e6-b6f6-618c06b055df"
      unitRef="usd">310000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjYtMy0xLTEtMA_97fc6b99-d6d5-461f-8c29-09825b73032e"
      unitRef="usd">330000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjctMS0xLTEtMA_9ee60578-b483-442a-af73-595aa3e11695"
      unitRef="usd">2220000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjctMy0xLTEtMA_a75181b7-9601-4b58-972e-c0ba8d2037df"
      unitRef="usd">2309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjktMS0xLTEtMA_d826aa58-b3f4-4d17-9276-7e4aa86f9e41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMjktMy0xLTEtMA_e26de844-285a-4c7d-a830-34e1997568c3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzIx_22567360-ad6d-4b0c-ac91-d91cad508ace"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzIx_c7abce91-aa08-4d0d-8e7e-37a2925f0fd0"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzQ3_5b084393-0366-477d-a1df-3a10f8e6632f"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzQ3_b8201cd6-fb9f-44b7-8c39-ef6685cb71bf"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzY2_dd29c944-1260-4c37-9fb7-148c70ed8a15"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjczZTRhZjAxOGM4MzQ0OGRhYjhjOWZhZGJjNWZkNTlmXzY2_ffeef025-010b-4a8f-a296-4fe6d02db977"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMS0xLTEtMA_e39bffff-66b9-4cce-b169-669105ba90cb"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzItMy0xLTEtMA_e08ac0ba-28cb-4ea9-80e0-fc09f1ebcdb0"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzE4_91bb6a8e-7a0d-4293-978c-2e2c41608809"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzE4_dc479340-c26b-4602-8c51-d5e089f3a217"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzQ0_3da4e1c7-7eef-4ec2-85e5-234b321e081b"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzQ0_42afa559-5e15-472c-93c9-7fc25385f296"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzYy_c864c0cb-bd69-4698-b940-5f79ae19f0c1"
      unitRef="shares">1688810052</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmNmNWJhNDc2ZGU5NzRjOTI5NWM1NGUyNWRiNzEwYTJlXzEwMA_72623022-7d5b-4e88-9364-cb7864f5d88b"
      unitRef="shares">1679911918</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMS0xLTEtMA_a246c932-5d72-4025-875d-c3c9b85dfc4f"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzMtMy0xLTEtMA_6601d3c5-5384-480e-958c-7c70c4e015e4"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmU1M2RiMWYwMzkyMDQ1MGI4YzQzYzY2NzA1OTQzMWQzXzMw_29535674-2840-47ab-82f4-f178ab55e767"
      unitRef="shares">263289848</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmU1M2RiMWYwMzkyMDQ1MGI4YzQzYzY2NzA1OTQzMWQzXzMw_50628e7f-b70a-46f1-b685-0a43afeac69f"
      unitRef="shares">263289848</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMS0xLTEtMA_7d1b1b76-d045-4e7d-87a3-d06b6ea74cb5"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzQtMy0xLTEtMA_9d56dbc2-8510-4439-b1da-244c2a159ac6"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzUtMS0xLTEtMA_b7e84e8d-419c-4893-a8df-771d66858d7d"
      unitRef="usd">19986000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzUtMy0xLTEtMA_83a26968-991b-4f3d-a24e-aef5e49878b1"
      unitRef="usd">19732000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzYtMS0xLTEtMA_64b29961-da46-4c72-9187-a19d907584ad"
      unitRef="usd">-1392000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzYtMy0xLTEtMA_42ccae92-e401-4419-8e57-35dbaaede052"
      unitRef="usd">-2378000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzgtMS0xLTEtMA_40d3fb68-3169-4e5e-ae76-54bda6a71b5d"
      unitRef="usd">93000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzgtMy0xLTEtMA_7656cbda-fcfb-49fb-b7aa-5fe789737f86"
      unitRef="usd">218000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzktMS0xLTEtMA_d1f159f2-a6b7-43d4-90f5-d79988da2841"
      unitRef="usd">206000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfMzktMy0xLTEtMA_fef294af-5e72-44b0-8bb8-1ba4367f71bc"
      unitRef="usd">36000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDEtMS0xLTEtMA_0c363137-87cb-4c29-84ec-8f6f8129e6b5"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDEtMy0xLTEtMA_713913d9-c35b-4c17-a6f5-40af81acfaa2"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDItMS0xLTEtMA_ce4c7f01-964b-412b-ab13-29d592afd625"
      unitRef="usd">16622000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDItMy0xLTEtMA_38d22967-151d-434b-ae57-ce8633e40218"
      unitRef="usd">15326000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDMtMS0xLTEtMA_5a9daae0-bff5-4ec0-aa3a-8135d3dc9aa7"
      unitRef="usd">32229000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184Mi9mcmFnOjM0NjI4NWU1MTdiMzQ4NjQ4M2Y4ZjFmYzcwN2NhZDRmL3RhYmxlOjQzNWVkODY3ZTNmNDRlZTA4ZmNmZmVmNTRjNTdkOWFiL3RhYmxlcmFuZ2U6NDM1ZWQ4NjdlM2Y0NGVlMDhmY2ZmZWY1NGM1N2Q5YWJfNDMtMy0xLTEtMA_b54a9f1c-389a-4f07-8069-3a283aefbcde"
      unitRef="usd">30777000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMy0xLTEtMS00MTI2NQ_08168746-b9ac-43a2-9b7a-65e7b95db899"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMy0zLTEtMS00MTI2NQ_069a5815-e212-47f8-9aef-bfc82295337f"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i55c9f4684ac746bda57f532f6a87f684_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMy01LTEtMS00MTI2NQ_d262d026-c4bf-480a-b9d1-d3e6132a72fb"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i1bb4626ce5af43629527f19d1f2b8d8f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNC0xLTEtMS02ODczNw_b0fc4233-0021-4825-948c-be478283ed2c"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i86d1794a80bb4fe2a6e1462adf2ed270_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNC0zLTEtMS00MTcxNA_769ef740-fb1e-452f-ae52-c3609c915f4d"
      unitRef="shares">10062500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0a5ab205543a48ddb58369506f4258e1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNC01LTEtMS00MTgwOA_c2682310-d68e-424c-b1d5-a27f08fe68ba"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssued
      contextRef="i23a174508ba44dd89de3efafe40cfb80_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNS0xLTEtMS00MTI2NQ_a0fc3146-9b86-4676-8643-0838af4fd9e9"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNS0zLTEtMS00MTI2NQ_08168746-b9ac-43a2-9b7a-65e7b95db899"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNS01LTEtMS00MTI2NQ_069a5815-e212-47f8-9aef-bfc82295337f"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNy0xLTEtMS00MTI2NQ_781cc470-482f-40f7-9fb7-9aaa7c6c335e"
      unitRef="shares">1679911918</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNy0zLTEtMS00MTI2NQ_8fcd52eb-f0a1-4174-9bea-3fd901c3f71e"
      unitRef="shares">1642488911</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i47fffe98c44745d5abab2aa20b5ce269_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNy01LTEtMS00MTI2NQ_7b1918cb-3283-4c8d-af1c-bc22a47f7eae"
      unitRef="shares">1632148030</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOC0xLTEtMS02ODczOQ_4c12a200-fed6-4e08-8c9a-b7216e190e30"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOC0zLTEtMS00MTcxNA_fc372eb9-04ec-46f3-a481-5972780f7826"
      unitRef="shares">29382500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOC01LTEtMS00MTI2NQ_1714178e-8082-4d28-a870-750388435946"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOS0xLTEtMS00MTI2NQ_8ff16dc0-47a2-47d0-a573-b46de3e7301b"
      unitRef="shares">8898134</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOS0zLTEtMS00MTI2NQ_8e20b773-ac46-4621-865f-5ad365fd6622"
      unitRef="shares">8040507</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfOS01LTEtMS00MTI2NQ_020a502e-39f8-4d1f-9429-32545791067f"
      unitRef="shares">10340881</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:SharesIssued
      contextRef="i7a72129993b9407296d812a52123d5e9_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTAtMS0xLTEtNDEyNjU_86b13e1d-8e11-426f-8d09-24c7843f7116"
      unitRef="shares">1688810052</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTAtMy0xLTEtNDEyNjU_781cc470-482f-40f7-9fb7-9aaa7c6c335e"
      unitRef="shares">1679911918</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTAtNS0xLTEtNDEyNjU_8fcd52eb-f0a1-4174-9bea-3fd901c3f71e"
      unitRef="shares">1642488911</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTMtMS0xLTEtNDEyNjU_d82fa1c7-3e69-4ee7-8888-b710749979cf"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTMtMy0xLTEtNDEyNjU_ce7093ef-a38c-4eec-b7e0-314c9ad2e38f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55c9f4684ac746bda57f532f6a87f684_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTMtNS0xLTEtNDEyNjU_0bb43fe3-c549-455f-a45c-20c4756a210b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i1bb4626ce5af43629527f19d1f2b8d8f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTQtMS0xLTEtNjg3NDU_3251f6d3-9ad1-44b8-85ad-f7eed6f89f9c"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i86d1794a80bb4fe2a6e1462adf2ed270_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTQtMy0xLTEtNjg3NDk_f6b23fdc-7976-46f4-8b79-2ed10e5932a4"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i0a5ab205543a48ddb58369506f4258e1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTQtNS0xLTEtNjg3NTE_f3485091-40a8-47d8-9aff-9f01d81fa992"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23a174508ba44dd89de3efafe40cfb80_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTUtMS0xLTEtNDEyNjU_89090d17-2446-45c6-b191-e53eb00e65b3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcacc25eca514356a1de06415cfc5492_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTUtMy0xLTEtNDEyNjU_d82fa1c7-3e69-4ee7-8888-b710749979cf"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb6e8a3df9be40559b5baf53e674d8f2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTUtNS0xLTEtNDEyNjU_ce7093ef-a38c-4eec-b7e0-314c9ad2e38f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTctMS0xLTEtNDEyNjU_fd13a044-4f79-4e51-85cb-5f794b41c1f0"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTctMy0xLTEtNDEyNjU_6703ca0e-2371-427b-98a2-4dbabac3bda6"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i47fffe98c44745d5abab2aa20b5ce269_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTctNS0xLTEtNDEyNjU_5ab7ce08-2dcc-4413-aab4-9b5c19c46480"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTgtMS0xLTEtNjg3NTQ_15dd8a91-44de-4f68-8f68-9175fb851eb1"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTgtMy0xLTEtNDE3MjY_59a3d736-099e-440e-8b8f-e35829a612b9"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTgtNS0xLTEtNjg3NTc_dbf7ae0b-ca9b-46e9-b763-1bd56de57893"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i1942f6934f2d45abaafaef48cef16577_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTktMS0xLTEtNjg3NjA_c08347a2-5bca-47cd-b134-337a3a4cdf94"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ie22723d6721640b7a59646827025bd5f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTktMy0xLTEtNjg3NjM_2166de55-daf7-4db7-bbd9-1148300bd8dc"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ic93e3863b7734c22962cb39a8ddd492c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMTktNS0xLTEtNjg3NjY_ad3202be-05f7-49a3-b7dd-8882e7508713"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a72129993b9407296d812a52123d5e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjAtMS0xLTEtNDEyNjU_eb805ece-f612-481e-b8b4-875b1f76e789"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e7eea3f940f4889a21ed7f84d8a06cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjAtMy0xLTEtNDEyNjU_fd13a044-4f79-4e51-85cb-5f794b41c1f0"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbc589c795204965a3cc585ab55e4724_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjAtNS0xLTEtNDEyNjU_6703ca0e-2371-427b-98a2-4dbabac3bda6"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i621567053d2744019f158e373637541a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjItMS0xLTEtNDEyNjU_5bec2caa-0a7e-4241-9d76-35d067af51f3"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4747802c7e754ca399dcd04b1ba8d7fb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjItMy0xLTEtNDEyNjU_0bee1a62-e14e-48d3-a9e2-1257bf9d6c25"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief44305703574f549e1b0deefa30aa9b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjItNS0xLTEtNDEyNjU_c43c3d9d-1aee-4cf3-b108-ac13d21bb7c0"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic842d867786b4ccea9cfa96a40cf30df_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjMtMS0xLTEtNDE3Mjk_eb516fc4-cd52-4690-aa68-b628346bc6cf"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic81c4f4cfd734a44bbbfbc03be7529de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjMtMy0xLTEtNDE3Mjk_e889b7c7-0f5d-4745-a7c6-3f1d877da8b4"
      unitRef="usd">-535000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4703f4563ef24622b191ace91b7046bb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjMtNS0xLTEtNDEyNjU_f7c8599f-50e8-47c2-98ec-7772893f374b"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50e1494b00924399b0198cf1908c6eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjQtMS0xLTEtNDEyNjU_6b14171f-3b1e-402e-8478-0c53f7fbd37b"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i621567053d2744019f158e373637541a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjQtMy0xLTEtNDEyNjU_5bec2caa-0a7e-4241-9d76-35d067af51f3"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4747802c7e754ca399dcd04b1ba8d7fb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjQtNS0xLTEtNDEyNjU_0bee1a62-e14e-48d3-a9e2-1257bf9d6c25"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d7cdad179c64659939a57d640d0398e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjYtMS0xLTEtNDEyNjU_3036b4f2-0f87-4a04-83b4-8db08d04fb78"
      unitRef="usd">19732000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d65743aa83c4feba194be59d23ff5b6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjYtMy0xLTEtNDEyNjU_74c26478-53dd-4a87-a650-beea97256f45"
      unitRef="usd">17561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7a84911e7b44222a521b4865d0ca338_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjYtNS0xLTEtNDEyNjU_c48c197c-4260-4eec-81da-8e1410f396fe"
      unitRef="usd">17346000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock
      contextRef="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjctMS0xLTEtNjg3Nzc_8f5ed86b-6874-4e32-accd-2025f9e53aeb"
      unitRef="usd">0</bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock>
    <bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock
      contextRef="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjctMy0xLTEtNDE3Mzc_0684f755-6f63-4edf-ba21-f9e77d025e8d"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock>
    <bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock
      contextRef="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjctNS0xLTEtNDEyNjU_7b917cb4-7df8-420a-a8f8-e37da742a47e"
      unitRef="usd">0</bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock>
    <bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock
      contextRef="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjgtMS0xLTEtNjg3Nzc_1e34a299-0163-4c89-80ae-751ad24ae624"
      unitRef="usd">0</bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock>
    <bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock
      contextRef="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjgtMy0xLTEtNDE3Mzc_77eadfd5-8450-4687-a8ba-ca3d9410a57c"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock>
    <bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock
      contextRef="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjgtNS0xLTEtNDEyNjU_4398ce82-a60a-4dd5-acae-42192fa63096"
      unitRef="usd">0</bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i0f52d256643c47b1b03397f849cab3ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjktMS0xLTEtNDEyNjU_0d041e98-6c05-442f-bbc9-93d25bfe31b8"
      unitRef="usd">254000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="if461c582fd3a44c0b5e9a6cbca21ea6e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjktMy0xLTEtNDEyNjU_202e6855-a84e-4f73-9fe9-d193b7c35bef"
      unitRef="usd">221000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ie868b8a705494d94ac1111f6bae45776_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMjktNS0xLTEtNDEyNjU_07a2f3ac-d647-4ea2-b537-642334e7bd0a"
      unitRef="usd">215000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2aa6d669fbe84dada7c5bed68a7bab52_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzAtMS0xLTEtNDEyNjU_641b0d18-535c-481f-be5a-b22ec1750d6e"
      unitRef="usd">19986000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d7cdad179c64659939a57d640d0398e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzAtMy0xLTEtNDEyNjU_3036b4f2-0f87-4a04-83b4-8db08d04fb78"
      unitRef="usd">19732000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d65743aa83c4feba194be59d23ff5b6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzAtNS0xLTEtNDEyNjU_74c26478-53dd-4a87-a650-beea97256f45"
      unitRef="usd">17561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief259e9b815d43c6b3e7f2b9f85ad45e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzItMS0xLTEtNDEyNjU_270f5079-0ef6-48a1-b115-070f5a70753a"
      unitRef="usd">-2378000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e19129d2b6b49af9f944cde90d53a9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzItMy0xLTEtNDEyNjU_f2a2d5bd-0c3f-4e21-b2fd-b1acc8d32d5a"
      unitRef="usd">-2253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcaaf4e1347a49e2be525edf65b64c63_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzItNS0xLTEtNDEyNjU_acdc307c-93fb-476b-9264-37b0f8ba4447"
      unitRef="usd">-6953000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzMtMS0xLTEtNDEyNjU_26ebaa57-16e4-40ae-b58b-ce8280431da5"
      unitRef="usd">1041000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzMtMy0xLTEtNDEyNjU_fbc31275-7238-4616-9a56-e0acceac28fb"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8acaf977546b4524b2309e825920c392_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzMtNS0xLTEtNDEyNjU_60442249-927f-4d12-a91b-fc32c21aec75"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzQtMS0xLTEtNDE3NDI_1cce2415-6024-4598-8ed4-ae919fd4c646"
      unitRef="usd">0</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzQtMy0xLTEtNDE3NDI_734ac306-34a8-47a8-ac6e-6c6291219ff6"
      unitRef="usd">-10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="i8acaf977546b4524b2309e825920c392_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzQtNS0xLTEtNDEyNjU_de99ba89-1ff5-433b-9661-e77113b8678f"
      unitRef="usd">0</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i69ba029b9ba646e2915c2e4e553b2720_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzUtMS0xLTEtNDEyNjU_d5ae8b3f-dcbc-4f31-80a2-ab4b9321d3e8"
      unitRef="usd">-55000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i144453d77a0a453eb2c8e23442ca25f6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzUtMy0xLTEtNDEyNjU_7d104350-feed-404f-bd31-306944402c6d"
      unitRef="usd">-33000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i8acaf977546b4524b2309e825920c392_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzUtNS0xLTEtNDEyNjU_f8c845fb-9ba0-49f9-a364-253d831d641c"
      unitRef="usd">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i11e39577dbf144d782e2e16d4feea22d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzYtMS0xLTEtNDEyNjU_5a7ca6c7-fdda-4a5a-a95d-0d00f588d828"
      unitRef="usd">-1392000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief259e9b815d43c6b3e7f2b9f85ad45e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzYtMy0xLTEtNDEyNjU_270f5079-0ef6-48a1-b115-070f5a70753a"
      unitRef="usd">-2378000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e19129d2b6b49af9f944cde90d53a9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzYtNS0xLTEtNDEyNjU_f2a2d5bd-0c3f-4e21-b2fd-b1acc8d32d5a"
      unitRef="usd">-2253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f487090abb844d5b6124d5eab360ef6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzgtMS0xLTEtNDEyNjU_d13a275c-c71e-44ac-a484-b1a43db3565f"
      unitRef="usd">207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42c0c9a4fac74bfb842c3bdb6adfa49b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzgtMy0xLTEtNDEyNjU_9ef11585-e59c-4ea0-ab51-256892978c09"
      unitRef="usd">270000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3423ba3a4510459d9315c471a11407a9_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfMzgtNS0xLTEtNDEyNjU_25ba0551-c8a1-451d-951f-fd86f9fb69b8"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMS0xLTEtNDE3ODE_79a662a9-99d4-4105-9428-632f401ecc42"
      unitRef="usd">-125000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMy0xLTEtNDE3ODE_30897712-9289-453b-b600-c2f0aa042fce"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtNS0xLTEtNDE3ODE_6a1bf73c-4170-4ad7-a0f6-589fe0810b84"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMS0xLTEtNDE3ODE_89b4a817-76a3-4b34-9e49-3e7bed311be3"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMy0xLTEtNDE3ODE_e84a9d4e-7f66-4e46-8040-e94054b10409"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtNS0xLTEtNDE3ODE_0219d497-e7e0-4993-894d-8bf438b667ab"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i63ef5d19b22a42089fb132a9ccb00240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDItMS0xLTEtNDE3ODE_73ca48bf-a785-4285-9614-1b4436fe7019"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib8485287f21d40e0a60203ef0929b331_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDItMy0xLTEtNDE3ODE_cbe42362-3d74-48cc-85df-2947e5d356cd"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i18eb629d66b04e9ca4c8d3b18b4ff252_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDItNS0xLTEtNDE3ODE_c218f36a-5e5a-4924-beeb-7c9f01600a13"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if652d38406174006a7b4700327ea9b78_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMS0xLTEtNDEyNjU_c2f30fd6-d6dd-477d-9602-a3c01e8c3672"
      unitRef="usd">263000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f487090abb844d5b6124d5eab360ef6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtMy0xLTEtNDEyNjU_d13a275c-c71e-44ac-a484-b1a43db3565f"
      unitRef="usd">207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42c0c9a4fac74bfb842c3bdb6adfa49b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDAtNS0xLTEtNDEyNjU_9ef11585-e59c-4ea0-ab51-256892978c09"
      unitRef="usd">270000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMS0xLTEtNDEyNjU_7346dbfd-42f3-412b-b3d9-a5884f59187b"
      unitRef="usd">16622000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtMy0xLTEtNDEyNjU_921ec559-596f-4208-90d9-c94743c344a8"
      unitRef="usd">15326000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184NS9mcmFnOmUzY2RlYTQ5ODc0MzQ3ZjI4OTljNjVjMjI0M2EzYmFjL3RhYmxlOjcwYzI0OWMzY2QzZjQzMDU5ZDMzNDY5OTc0OGQ1NzI2L3RhYmxlcmFuZ2U6NzBjMjQ5YzNjZDNmNDMwNTlkMzM0Njk5NzQ4ZDU3MjZfNDEtNS0xLTEtNDEyNjU_014f5f58-471e-4bd2-8ef3-4844bc439800"
      unitRef="usd">13877000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMy0xLTEtMS0w_f2057220-5916-4f1f-a271-0ff78b7e91e3"
      unitRef="usd">1041000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMy0zLTEtMS0w_09e5300f-7883-4905-9ec9-5894b60aa19e"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMy01LTEtMS0w_38a01ddd-dad0-4212-bf47-eb25822d562e"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNS0xLTEtMS0w_60daecee-6b56-4b36-8d8e-dfdf09eedaab"
      unitRef="usd">78000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNS0zLTEtMS0w_9d6a4dc7-05c6-4f18-b640-8ddf05d7c73e"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNS01LTEtMS0w_f47c1eff-02c9-49e9-99e7-486b44b2419b"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNy0xLTEtMS0w_b60302ad-2b6c-4b62-9bdf-345f0853d447"
      unitRef="usd">1093000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNy0zLTEtMS0w_d36a5e4a-3271-434f-9648-5abab42172e9"
      unitRef="usd">1123000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNy01LTEtMS0w_9405ad2f-a806-43de-8eec-43f84300a7f0"
      unitRef="usd">1011000000</us-gaap:DepreciationDepletionAndAmortization>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOC0xLTEtMS0w_693f13b3-f715-4fad-99fc-3dcdb61623f8"
      unitRef="usd">-124000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOC0zLTEtMS0w_4ef8e7e0-9658-4cda-9201-7c1b84d18bc4"
      unitRef="usd">-82000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOC01LTEtMS0w_b17b118a-cba9-4645-a99b-6ed2219a82f5"
      unitRef="usd">-4301000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOS0xLTEtMS0w_ed06ff94-67cb-4f54-9a13-0450de42468d"
      unitRef="usd">194000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOS0zLTEtMS0w_9a61a3f9-33df-4756-adf3-681f63d8bb83"
      unitRef="usd">170000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfOS01LTEtMS0w_c565a49d-e1cd-4f73-ae00-c4f2c9327262"
      unitRef="usd">157000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTEtMS0xLTEtMA_68da4daa-19ac-49a8-916f-42d0fe680343"
      unitRef="usd">370000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTEtMy0xLTEtMA_1948ec71-0e09-4dba-9c13-68751659e6c5"
      unitRef="usd">533000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTEtNS0xLTEtMA_0cba274f-17aa-4260-8652-19fff04068b2"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:GainLossOnInvestments
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTItMS0xLTEtMA_6d4b7ba7-97d1-4efa-a089-c3850df89290"
      unitRef="usd">250000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTItMy0xLTEtMA_c152e95a-a052-4893-bdd4-6c63ac461f9c"
      unitRef="usd">333000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTItNS0xLTEtMA_cdcff114-e138-4e26-bde0-60665a7951ed"
      unitRef="usd">-30000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTMtMS0xLTEtMA_7f63e4c8-03ab-4006-95f3-8f2be829b705"
      unitRef="usd">-136000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTMtMy0xLTEtMA_9f34fe3b-73b7-4c86-a268-18dab5d7f6ba"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTMtNS0xLTEtMA_34bb2b33-6564-4e9e-8d85-7dd2ac68bc57"
      unitRef="usd">-35000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:InventoryStepUpAmortization
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTUtMS0xLTEtMA_ce7f8ed8-cd93-471d-ba1c-8217fb189e0a"
      unitRef="usd">34000000</bsx:InventoryStepUpAmortization>
    <bsx:InventoryStepUpAmortization
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTUtMy0xLTEtMA_b2e0c563-0287-40d8-a45c-6f546c0e4056"
      unitRef="usd">58000000</bsx:InventoryStepUpAmortization>
    <bsx:InventoryStepUpAmortization
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTUtNS0xLTEtMA_80727fd0-5e9a-40ea-85dc-7d2b2f3e1946"
      unitRef="usd">46000000</bsx:InventoryStepUpAmortization>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTYtMS0xLTEtMA_c241140f-db7d-4c78-bf62-84ce67f512f3"
      unitRef="usd">-27000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTYtMy0xLTEtMA_7edc1ab0-328d-488f-b875-9fb2344f83ec"
      unitRef="usd">-32000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTYtNS0xLTEtMA_273258d7-22a1-4237-a48d-4d343e7533a4"
      unitRef="usd">-358000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:OtherNet
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTctMS0xLTEtMA_3ada8dfb-a94f-4aac-81f0-97a00b9df9e1"
      unitRef="usd">51000000</bsx:OtherNet>
    <bsx:OtherNet
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTctMy0xLTEtMA_4a5b401e-398d-4450-a466-a29b04b2735d"
      unitRef="usd">213000000</bsx:OtherNet>
    <bsx:OtherNet
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTctNS0xLTEtMA_e915e322-65b8-4ed6-8a25-aba1df7ad102"
      unitRef="usd">63000000</bsx:OtherNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTktMS0xLTEtMA_d6023ac5-7592-4e59-8fcc-cb57da461177"
      unitRef="usd">279000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTktMy0xLTEtMA_dd0b19b8-e197-4b5b-bca5-43da29a49a37"
      unitRef="usd">-335000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMTktNS0xLTEtMA_dc5fab9c-4387-4d65-a29d-2a4bd7848f4a"
      unitRef="usd">130000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjAtMS0xLTEtMA_7e54f427-cb3a-4a81-8138-a62d2f640a61"
      unitRef="usd">346000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjAtMy0xLTEtMA_8d1b76f2-66db-423e-8b91-371c2b66f924"
      unitRef="usd">65000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjAtNS0xLTEtMA_3935c8b6-e427-46eb-85d2-4a149b4426fe"
      unitRef="usd">290000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjEtMS0xLTEtMA_9cb470ff-e8d5-45b5-9c53-3a8ebfe37735"
      unitRef="usd">134000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjEtMy0xLTEtMA_792300a8-0683-4fab-9df9-6a2c3c0269a2"
      unitRef="usd">265000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjEtNS0xLTEtMA_b4dd0097-a4d3-45ce-b3fa-df7799a48fd0"
      unitRef="usd">-45000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjItMS0xLTEtMA_9b9c7ad6-8e69-47c2-8253-94fd06ce2d2b"
      unitRef="usd">408000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjItMy0xLTEtMA_b66d8fde-05e7-4308-a10a-de8f26f381b2"
      unitRef="usd">-28000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjItNS0xLTEtMA_5457073c-a742-4f4d-af1a-3244e0966d06"
      unitRef="usd">79000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjQtMS0xLTEtMA_17bba986-636d-422f-979c-25c6f47a4d42"
      unitRef="usd">1870000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjQtMy0xLTEtMA_b60f9e5b-1ec7-4d2e-9e41-ef0647acc783"
      unitRef="usd">1508000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjQtNS0xLTEtMA_c688f698-f718-41fd-8f7c-5abe6cc4b3b0"
      unitRef="usd">1836000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjYtMS0xLTEtMA_ae86d499-8ee9-401e-9825-28a94c70ab99"
      unitRef="usd">554000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjYtMy0xLTEtMA_a7b97756-99a2-46d9-b620-1e07b1cfa885"
      unitRef="usd">376000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjYtNS0xLTEtMA_b038de4e-4124-435f-b5d0-4af2dcedbf0f"
      unitRef="usd">461000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjctMS0xLTEtMA_719b0146-3aa0-4e39-a294-26c78597dd0f"
      unitRef="usd">14000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjctMy0xLTEtMA_40921d94-e357-4210-80ec-85a3b58a14fc"
      unitRef="usd">12000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjctNS0xLTEtMA_d5cbd677-3591-4b06-bcee-e37d84e2e66b"
      unitRef="usd">7000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjgtMS0xLTEtMA_0ef2ed5e-311c-4e71-bf11-dcc45a55419a"
      unitRef="usd">2258000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjgtMy0xLTEtMA_4141c699-174e-4fa3-b0ed-aa0632618095"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjgtNS0xLTEtMA_06f7ed9b-0e14-4679-ae67-342cdd1d4eda"
      unitRef="usd">4382000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjktMS0xLTEtMA_37ad0bcb-6dff-4eac-87cf-6562a83f2a41"
      unitRef="usd">826000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjktMy0xLTEtMA_f8a03dc3-9afb-4c9c-968d-c25b28c338d9"
      unitRef="usd">15000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMjktNS0xLTEtMA_3ce3edce-4a81-49da-8348-04c64293f1b2"
      unitRef="usd">90000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzAtMS0xLTEtMA_1e2a0338-ac83-47c4-93cc-283dd22fe913"
      unitRef="usd">-82000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzAtMy0xLTEtMA_fa97fbdb-fc53-461c-8e6c-4e5c52872609"
      unitRef="usd">-87000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzAtNS0xLTEtMA_0cab727d-cb99-4cc4-b3a1-e604fb95605f"
      unitRef="usd">-52000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeInvestingActivities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzEtMS0xLTEtMA_16f7c90a-dead-44c8-94d6-e595f1fce556"
      unitRef="usd">-15000000</us-gaap:PaymentsForProceedsFromHedgeInvestingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeInvestingActivities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzEtMy0xLTEtMA_97d3aa3f-1cd9-4cb4-aef9-1bd849d158b9"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromHedgeInvestingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeInvestingActivities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzEtNS0xLTEtMA_de4b91d3-7f42-4865-898d-cbd9e5f135df"
      unitRef="usd">199000000</us-gaap:PaymentsForProceedsFromHedgeInvestingActivities>
    <bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzItMS0xLTEtMA_2a18bc28-909c-47bc-8404-35c7623c2564"
      unitRef="usd">-279000000</bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies>
    <bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzItMy0xLTEtMA_8ec1bdf5-241b-4159-832a-6acb46d354f7"
      unitRef="usd">146000000</bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies>
    <bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzItNS0xLTEtMA_b2f10c19-1c5a-411d-b0a2-850fa8d3cd9c"
      unitRef="usd">149000000</bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzQtMS0xLTEtMA_52f65ed9-bc98-453d-80e3-b587ac521c08"
      unitRef="usd">-1597000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzQtMy0xLTEtMA_456ab3c4-1a33-4dd8-b834-e84c5ce9978b"
      unitRef="usd">-411000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzQtNS0xLTEtMA_e4b42926-275e-4df8-ad81-39c0fafd2cf8"
      unitRef="usd">-5041000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzYtMS0xLTEtMA_3356f252-ebd5-414b-902e-e4109bdb42e4"
      unitRef="usd">15000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzYtMy0xLTEtMA_5bc75417-d4cc-4541-ae9a-3f9d7330926d"
      unitRef="usd">49000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzYtNS0xLTEtMA_f2386aec-90a3-49f8-b4f4-36472699dcd6"
      unitRef="usd">66000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzctMS0xLTEtMA_7a1ada5b-5896-432a-af35-902bf3fc6919"
      unitRef="usd">85000000</bsx:PaymentsForRoyaltyRights>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzctMy0xLTEtMA_9772cb62-69de-4a67-9986-4d488986c5e7"
      unitRef="usd">97000000</bsx:PaymentsForRoyaltyRights>
    <bsx:PaymentsForRoyaltyRights
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzctNS0xLTEtMA_57f6ead5-0ef6-4e29-94ac-6bcb73f2ad93"
      unitRef="usd">69000000</bsx:PaymentsForRoyaltyRights>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzgtMS0xLTEtMA_b0fecd73-b330-48aa-9278-a72c4d9e3a4d"
      unitRef="usd">0</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzgtMy0xLTEtMA_ff6caccc-4d7d-4c4e-9fea-f8e28b70ea99"
      unitRef="usd">0</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzgtNS0xLTEtMA_85fa2a98-e0fb-4394-9de0-2a653cb02e1a"
      unitRef="usd">256000000</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzktMS0xLTEtMA_70b7e4bf-c79f-40b5-b57e-fcd9cfd4ede6"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzktMy0xLTEtMA_b461aa91-ba2d-45f3-be67-bec1be94163f"
      unitRef="usd">2950000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfMzktNS0xLTEtMA_5f94afa7-38f4-48bb-8483-6ff7e936f39b"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDAtMS0xLTEtMA_da440046-fca1-4895-91f7-aa65ddd9186b"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDAtMy0xLTEtMA_8f68f969-77cd-4899-86aa-7ba2d3c848cd"
      unitRef="usd">2245000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDAtNS0xLTEtMA_3af208ce-e8af-49cc-a67e-e528a61f9cae"
      unitRef="usd">700000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDEtMS0xLTEtMA_e9663614-3224-4435-9604-9245ba6b1df0"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDEtMy0xLTEtMA_35f95917-f9b9-4e5e-aecc-23749f652e4d"
      unitRef="usd">-714000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDEtNS0xLTEtMA_239a8620-eb97-46c8-9b8c-3572fba6e399"
      unitRef="usd">-575000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDItMS0xLTEtMA_9a1b261e-4a08-4c5b-8359-d953edfc4dea"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDItMy0xLTEtMA_7a628640-123d-4f82-973c-d23add3a8b4a"
      unitRef="usd">1919000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDItNS0xLTEtMA_92e283f7-9136-4a71-9dab-435bfb3d2c0f"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDMtMS0xLTEtMA_398f9886-4a5b-4396-912e-2c3434740105"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDMtMy0xLTEtMA_65faf017-daf7-4835-a9f3-d8b6aa9037ad"
      unitRef="usd">1916000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDMtNS0xLTEtMA_39d46aad-f97c-4f90-be58-24d3b8152a77"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDQtMS0xLTEtMA_c5451a74-855f-4732-8892-69ea1c5d6d04"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDQtMy0xLTEtMA_15236290-9806-4fce-b668-e6dec9261230"
      unitRef="usd">1260000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDQtNS0xLTEtMA_3eb65c33-95a8-4d61-9b06-a77790642dda"
      unitRef="usd">3560000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDUtMS0xLTEtMA_26ec5b40-e2d3-4367-a70a-694c2d8e26d3"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDUtMy0xLTEtMA_465fa66a-8437-4e9c-89e9-95563a53d284"
      unitRef="usd">1683000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDUtNS0xLTEtMA_fa169d7d-c618-4e91-a39b-b85d700329ec"
      unitRef="usd">7229000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDYtMS0xLTEtMA_3a81b480-addf-4fc8-81dc-66d126692b48"
      unitRef="usd">55000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDYtMy0xLTEtMA_d464b69f-c821-495b-8363-1eaffc8fc8db"
      unitRef="usd">28000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDYtNS0xLTEtMA_6fc647f2-330f-40b4-afd3-e29aa6b2f71f"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDctMS0xLTEtMA_feaa166b-3542-46fe-af37-664fab2054e4"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDctMy0xLTEtMA_0ab32628-0176-45ce-bda6-181a253984df"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDctNS0xLTEtMA_aa3bb86f-c492-4d1f-856f-c4ff9c101e26"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDgtMS0xLTEtMA_1f50b1ce-1bb3-47f4-a67e-ddf5951f4a4c"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDgtMy0xLTEtMA_09403b9b-485f-4a84-86c5-2703f8f1ba3c"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDgtNS0xLTEtMA_7bea5ad5-a426-4654-b538-e921ca2e25c5"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDktMS0xLTEtMA_661f83d8-aa46-4574-8882-6aad8d833696"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDktMy0xLTEtMA_195d8527-f011-4ba5-b4a0-2ee30da732be"
      unitRef="usd">535000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNDktNS0xLTEtMA_b5582c5a-89bd-4d90-8f63-bf201a26268a"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTAtMS0xLTEtMA_c1a0ddd9-7d73-4d33-9886-74e38b24e91f"
      unitRef="usd">50000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTAtMy0xLTEtMA_7a22760c-96eb-4388-b2fa-e27ceb9254b8"
      unitRef="usd">59000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTAtNS0xLTEtMA_3fa344ba-fd0b-4511-96dc-6eb379a46cd4"
      unitRef="usd">65000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTEtMS0xLTEtMA_598b6817-1265-477c-95e7-ab5970e11088"
      unitRef="usd">110000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTEtMy0xLTEtMA_9335a649-1e15-4d9b-ad6b-9198a9c99a6e"
      unitRef="usd">111000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTEtNS0xLTEtMA_27fa3a6f-a682-43cd-8631-285f5bab06a3"
      unitRef="usd">123000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTItMS0xLTEtMA_ae1250f0-7d16-4237-b2bb-79d219d50455"
      unitRef="usd">-95000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTItMy0xLTEtMA_1cbead08-8cb8-4f22-b6bf-87838ddabe51"
      unitRef="usd">293000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTItNS0xLTEtMA_81edd036-1a3d-4ceb-a628-22c6b0d8aadb"
      unitRef="usd">2973000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTMtMS0xLTEtMA_7908214f-b174-4ffc-9fa9-1f9c58544de5"
      unitRef="usd">-6000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTMtMy0xLTEtMA_14d17baa-b766-48b6-ac43-2bc4d4f1a9d0"
      unitRef="usd">-2000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTMtNS0xLTEtMA_6624364a-e41a-4c2e-8225-8dd8525b8e20"
      unitRef="usd">10000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTQtMS0xLTEtMA_7691bdb6-6bae-4990-add2-b684ab05dc69"
      unitRef="usd">173000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTQtMy0xLTEtMA_8904d060-9837-4ab3-845c-99ec1fe80d56"
      unitRef="usd">1388000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTQtNS0xLTEtMA_0f2926fc-60fe-44e1-8850-b8e22ccbc94d"
      unitRef="usd">-222000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTUtMS0xLTEtMA_0375b3ff-9e3b-4a5e-8850-c158d2c4ba6e"
      unitRef="usd">1995000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTUtMy0xLTEtMA_d4d0528a-cee5-4d62-be37-6118e83cc53b"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTUtNS0xLTEtMA_db768a5f-9c82-4fe9-8417-e48e96e4a160"
      unitRef="usd">829000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTYtMS0xLTEtMA_3b7e0551-44e9-4229-a7e3-06fc7e7c2802"
      unitRef="usd">2168000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTYtMy0xLTEtMA_7bdece91-b304-437d-b799-a01db1371a12"
      unitRef="usd">1995000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOjRmNTU1MzNlMDAxNDRmZDI4NzQ3OTQ2NzE2ODVkNzQ0L3RhYmxlcmFuZ2U6NGY1NTUzM2UwMDE0NGZkMjg3NDc5NDY3MTY4NWQ3NDRfNTYtNS0xLTEtMA_4076f759-358a-4752-8337-515a5fd053ec"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMy0xLTEtMS0w_2e4df21e-457c-4c0d-a2de-1bb3e6a2d927"
      unitRef="usd">302000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMy0zLTEtMS0w_5d6c5a3b-1105-47f5-a236-d0c31f1c061c"
      unitRef="usd">207000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMy01LTEtMS0w_6ce81610-0363-4151-943a-712ad74605a9"
      unitRef="usd">242000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNC0xLTEtMS0w_3ffdf567-ab47-4f34-83b2-704fb9d021ae"
      unitRef="usd">338000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNC0zLTEtMS0w_321e5860-73f5-4da6-8e5d-dd8b6784f6dd"
      unitRef="usd">359000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNC01LTEtMS0w_94ccb1e0-6820-4190-a758-8c054aa5cbad"
      unitRef="usd">449000000</us-gaap:InterestPaidNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNS0xLTEtMS0w_f495e3bc-8ca9-4a89-a0ea-8f21af21b6b3"
      unitRef="usd">440000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNS0zLTEtMS0w_b1258929-ea23-4dc3-baf5-52ae74459e36"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNS01LTEtMS0w_eb1d2e38-a2b4-4f14-9040-248ed162e07c"
      unitRef="usd">127000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <bsx:NonCashImpactOfTransferredRoyaltyRights
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNi0xLTEtMS0w_437a5c6f-9036-4f93-be67-a2e4b18e338a"
      unitRef="usd">-82000000</bsx:NonCashImpactOfTransferredRoyaltyRights>
    <bsx:NonCashImpactOfTransferredRoyaltyRights
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNi0zLTEtMS0w_11fb8864-6089-423f-9437-aa01c5a53d8a"
      unitRef="usd">-87000000</bsx:NonCashImpactOfTransferredRoyaltyRights>
    <bsx:NonCashImpactOfTransferredRoyaltyRights
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfNi01LTEtMS0w_34419848-ca87-4716-9d41-4a6c57e7200b"
      unitRef="usd">0</bsx:NonCashImpactOfTransferredRoyaltyRights>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTEtMS0xLTEtMA_b82f3703-3870-4b0b-96cd-c3a57575ea89"
      unitRef="usd">1925000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTEtMy0xLTEtMA_a805072c-001b-441e-a078-8b99995841fd"
      unitRef="usd">1734000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTEtNS0xLTEtMA_6b2c6851-e299-40fa-a5c6-732badae452c"
      unitRef="usd">217000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTItMS0xLTEtMA_aac0ba3f-c1fc-44d8-b5b6-1379e120b8bd"
      unitRef="usd">188000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTItMy0xLTEtMA_3f0251d4-3940-4b17-9228-11696ebdc429"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTItNS0xLTEtMA_f0905ac9-7e93-4a6e-9f28-a6721a227a23"
      unitRef="usd">346000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTMtMS0xLTEtMA_0e6b7fcf-bdf6-4e27-b77b-70f8f6734403"
      unitRef="usd">55000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTMtMy0xLTEtMA_6c42cca0-df00-4486-b96e-b6cc7183ac1e"
      unitRef="usd">52000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTMtNS0xLTEtMA_78a80c7c-991b-4a20-902f-b51703aef8ad"
      unitRef="usd">43000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTQtMS0xLTEtMA_c275a0ab-3d27-4803-bc60-33d590dd8c0b"
      unitRef="usd">2168000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTQtMy0xLTEtMA_9e097783-5fad-442c-846e-b3e52207dff0"
      unitRef="usd">1995000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN184OC9mcmFnOmE3MmNjYTNjODcxNDRmZjZiMmRmZjBmZmJlY2I5YzI5L3RhYmxlOmU1NmYxODczZWY1ODQ4NzBiOThjYjI2OTI1MzYyNTE0L3RhYmxlcmFuZ2U6ZTU2ZjE4NzNlZjU4NDg3MGI5OGNiMjY5MjUzNjI1MTRfMTQtNS0xLTEtMA_7fde62d4-6145-445f-a462-f90a0cecaf67"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyMTM_5bb85086-fb6b-4958-b8c9-5f1b10760075">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE A &#x2013; SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#x2019;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note O &#x2013; Segment Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets are related to deferred compensation plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We write-off amounts determined to be uncollectible against this reserve. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2021, 2020 and 2019; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes in the U.S. toward non-hospital settings, particularly ambulatory surgery centers and office-based labs. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is adequate as of December&#160;31, 2021; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have a contract with a customer that creates enforceable rights and obligations,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Promised products or services are identified,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The transaction price, or the amount we expect to receive, is determinable and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have transferred control of the promised items to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management (CRM) product offerings combine the sale of a device with our LATITUDE&#x2122; Patient Management System, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Post-Implant Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide non-contractual services to customers, where necessary, to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these services at the time the devices are sold. We record these costs to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2021 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation of Business Combinations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#x2019;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In cases where we acquire a company in which we previously held an equity stake, we attribute a portion of the purchase price to the previously-held equity interest, which is implied based on the total purchase consideration allocable to each of the shareholders, including Boston Scientific, according to priority of equity interests. We record a gain or loss in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;equal to the difference between the implied fair value of our prior ownership and the book value immediately prior to the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangibles and IPR&amp;amp;D &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which are foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, as well as IPR&amp;amp;D intangible assets acquired in a business combination. Our IPR&amp;amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;amp;D intangible asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the income approach to determine the fair values of our IPR&amp;amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#x2019; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to indefinite-lived intangibles, including IPR&amp;amp;D.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization and Impairment of Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to impairments of intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2021 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. For purposes of the goodwill impairment test, we aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the second quarter of&#160;2021, we performed our annual goodwill impairment test utilizing the quantitative assessment approach to test all of our reporting units. We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Publicly Traded and Privately-Held Entities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities for which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Method and Joint Ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Investments - Debt and Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional details on our investment balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#x2019;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment is impaired and we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses and impairments associated with our investment portfolio are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note J &#x2013; Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal and Product Liability Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities and product liability litigation. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for discussion of our individual material legal proceedings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Costs Associated with Exit Activities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record employee termination costs in accordance with FASB ASC Topic 712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Nonretirement and Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit or Disposal Cost Obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. We record such costs into expense over the employee&#x2019;s future service period, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further information and discussion of our restructuring plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Translation of Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency transaction gains and losses are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on our hedging instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not bill customers for shipping and handling of our products. We treat shipping costs incurred after a customer obtains control of the good as a fulfillment cost and record in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our consolidated statements of operations. Shipping costs were $194 million in 2021, $146 million in 2020 and $144 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense research and development (R&amp;amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Indefinite-lived Intangibles and IPR&amp;amp;D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for our policy regarding R&amp;amp;D projects acquired in connection with our business combinations and asset purchases.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNDk_091055c5-02ce-40a9-8238-b933be0b06ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#x2019;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyMDg_d9f58d19-d6dd-45a6-9a2d-d21934366aa3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note O &#x2013; Segment Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTQ_58166162-1cb1-4d8e-8c38-4a6064142bc1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxNzc_df95f8d3-2fbc-442e-9d2b-99234231bae5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets &lt;/span&gt;caption within our consolidated balance sheets are related to deferred compensation plans.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxOTc_6a80a50d-5576-4962-b07f-61fa7e48cae9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We write-off amounts determined to be uncollectible against this reserve. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2021, 2020 and 2019; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes in the U.S. toward non-hospital settings, particularly ambulatory surgery centers and office-based labs. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt; is adequate as of December&#160;31, 2021; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase.</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxNjM_ed25a185-364d-4cb7-8f86-3b81ceb8c12e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have a contract with a customer that creates enforceable rights and obligations,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Promised products or services are identified,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The transaction price, or the amount we expect to receive, is determinable and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have transferred control of the promised items to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management (CRM) product offerings combine the sale of a device with our LATITUDE&#x2122; Patient Management System, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Post-Implant Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide non-contractual services to customers, where necessary, to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these services at the time the devices are sold. We record these costs to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczNDU_61ecc4cb-3ace-4323-bc27-247c3abfb52b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a &lt;/span&gt;&lt;/div&gt;liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczODU_830ae477-2ebc-4962-9502-891742bf16ac">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2021 or 2019.&lt;/span&gt;&lt;/div&gt;We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzg0ODI5MDczNjYyNg_7ac2255e-bb24-4ffb-b352-c2768ac35940"
      unitRef="usd">149000000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMDg_e0f020e0-819e-43c0-b6a9-4adcb17a356c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNjk_3a096eea-46cd-45ab-8c90-82a38ace1e24">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation of Business Combinations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#x2019;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In cases where we acquire a company in which we previously held an equity stake, we attribute a portion of the purchase price to the previously-held equity interest, which is implied based on the total purchase consideration allocable to each of the shareholders, including Boston Scientific, according to priority of equity interests. We record a gain or loss in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;equal to the difference between the implied fair value of our prior ownership and the book value immediately prior to the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTE_5584475c-7c76-4ba3-9650-698852bc256c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangibles and IPR&amp;amp;D &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which are foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, as well as IPR&amp;amp;D intangible assets acquired in a business combination. Our IPR&amp;amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;amp;D intangible asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the income approach to determine the fair values of our IPR&amp;amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#x2019; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to indefinite-lived intangibles, including IPR&amp;amp;D.&lt;/span&gt;&lt;/div&gt;For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date.</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczNjQ_8b92fd05-1118-4432-aaaf-2713e65746b4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization and Impairment of Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to impairments of intangible assets.&lt;/span&gt;&lt;/div&gt;For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNzA_f10269a4-3697-459e-82ea-947f2698fb8b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2021 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. For purposes of the goodwill impairment test, we aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;In the second quarter of&#160;2021, we performed our annual goodwill impairment test utilizing the quantitative assessment approach to test all of our reporting units. We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTI_13181b69-58bf-47e6-af2e-f8c4e60d5e8d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Publicly Traded and Privately-Held Entities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities for which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Method and Joint Ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Investments - Debt and Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional details on our investment balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#x2019;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment is impaired and we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses and impairments associated with our investment portfolio are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;in our consolidated statements of operations.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMzQ_022529a9-b44a-430b-a2a4-6afd70f8e036">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note J &#x2013; Income Taxes&lt;/span&gt; for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMTA_f8616ea1-79ae-4952-9dad-30057cc39bed">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal and Product Liability Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities and product liability litigation. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for discussion of our individual material legal proceedings.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMjg_e7f1c4c0-17b5-46ab-80e6-9d30280468d3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Costs Associated with Exit Activities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record employee termination costs in accordance with FASB ASC Topic 712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Nonretirement and Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit or Disposal Cost Obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. We record such costs into expense over the employee&#x2019;s future service period, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further information and discussion of our restructuring plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczNTA_7d040f05-6b96-45f0-8a40-96f4b3b55a54">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Translation of Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency transaction gains and losses are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyOTM_0b44e97f-6fc6-45cb-84a6-25875bb2df90">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on our hedging instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <bsx:ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcxNjg_951b35b3-f878-4a8b-9941-d1ed88194c65"
      xsi:nil="true"/>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzczMTU_c87eba7d-8963-46b0-ba59-8c07cf45728d">Shipping and Handling Costs&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not bill customers for shipping and handling of our products. We treat shipping costs incurred after a customer obtains control of the good as a fulfillment cost and record in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;within our consolidated statements of operations. Shipping costs were $194 million in 2021, $146 million in 2020 and $144 million in 2019</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i80c252fab7084dbaa7b52601cb17955e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzY3ODY_da8e1bbe-c44f-426e-93d5-818944b6abdd"
      unitRef="usd">194000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i09fba96124454331976d8e4961c807b5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzY3OTY_ba277019-dfb2-4222-adfe-5621252e049d"
      unitRef="usd">146000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i58e8f5b2e3704a63ba7c4e8c062839c7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzY4MDk_a2339be3-51fd-4535-bf5b-57ebb179cd4b"
      unitRef="usd">144000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185NC9mcmFnOjhkOWZjMzhhNDU3ZDRjYjViYjRjMWM5YThhZTljYjIzL3RleHRyZWdpb246OGQ5ZmMzOGE0NTdkNGNiNWJiNGMxYzlhOGFlOWNiMjNfMzcyNDM_f48b3348-c4a1-497f-bf83-204f7386e64a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense research and development (R&amp;amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Indefinite-lived Intangibles and IPR&amp;amp;D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for our policy regarding R&amp;amp;D projects acquired in connection with our business combinations and asset purchases.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i7862dc97bbe245dc92c012be4bc24ff9_D20210806-20210806"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwNzE_e89db4b3-43e9-45d3-911b-7555bee97a89">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE B &#x2013; ACQUISITIONS AND STRATEGIC INVESTMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed four acquisitions and one divestiture in 2021 and did not complete any material acquisitions during 2020. We have not presented supplemental pro forma financial information for any of our recent acquisitions given their results are not material to our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which has developed the radiofrequency (RF) NRG&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and VersaCross&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which will expand our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment using cash on hand of $1.750 billion subject to closing adjustments. We plan to integrate the Baylis Medical business into our Electrophysiology division, supported by our structural heart sales force.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed our acquisition of the remaining shares of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $925 million and up to an additional $300 million in a potential commercial milestone payment. We had been an investor in Preventice since 2015 and held an equity stake of approximately 22 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $196 million gain recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The transaction price for the remaining stake consisted of an upfront cash payment of $706 million, net of cash acquired, and up to approximately $230 million in future milestone payments. The Preventice business is being managed by our Cardiac Rhythm Management division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse, Inc. (Farapulse), a privately-held company that has developed a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. The transaction consisted of an upfront cash payment of $450 million, up to $125 million upon achievement of certain clinical and regulatory milestones and additional revenue-based payments over the next three years. We had been an investor in Farapulse since 2014 and held an equity stake of approximately 27 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests which resulted in a $222 million gain recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The transaction price for the remaining stake consisted of an upfront cash payment of $268 million, net of cash acquired, and up to approximately $92 million in future milestone payments. The Farapulse business is being integrated into our Electrophysiology division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 1, 2021, we completed our acquisition of the global surgical business of Lumenis LTD. (Lumenis), a privately-held company that develops and commercializes energy-based medical solutions, including innovative laser systems, fibers and accessories used for urology and otolaryngology procedures. The transaction consisted of an upfront cash payment of $1.032 billion, net of cash acquired. The Lumenis business is being integrated into our Urology and Pelvic Health division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 8, 2021, we completed our acquisition of the remaining shares of Devoro Medical, Inc. (Devoro Medical), a privately-held company which has developed the WOLF Thrombectomy&#xae; Platform, a non-console and lytic-free platform designed to rapidly capture and extract blood clots in arterial, venous and pulmonary embolism procedures. The transaction consisted of an upfront cash payment of $320 million and up to $80 million upon achievement of certain clinical and regulatory milestones. We had been an investor in Devoro Medical since 2019 and held an equity stake of approximately 16 percent. We remeasured the fair value of our previously held investment based on the allocation of the purchase price according to priority of equity interests which resulted in a $57 million gain recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The transaction price for the remaining stake consisted of an upfront cash payment of $251 million, net of cash acquired, and up to approximately $67 million in future milestone payments. The Devoro Medical business is being integrated into our Peripheral Interventions division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price for the acquisitions completed during 2021 were comprised of the components presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preventice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lumenis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,032&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price allocation for these acquisitions was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preventice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lumenis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,032&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Preventice:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lumenis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;All Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;508&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $800 million. The agreement included the transfer of five facilities and approximately 280 employees globally. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and liabilities are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our consolidated balance sheet as of December 31, 2020. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Assets and Liabilities Held for Sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;BTG plc&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;19, 2019, we completed our acquisition of BTG plc (BTG), a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we integrated BTG's Interventional Medicine business into our Peripheral Interventions division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the Interventional Medicine product lines, the BTG portfolio also included the Specialty Pharmaceuticals business, comprised of acute care antidotes to treat overexposure to certain medications and toxins. On March 1, 2021, we completed the divestiture of Specialty Pharmaceuticals for a purchase price of approximately $800 million. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The BTG portfolio further included a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. In connection with the acquisition, we acquired rights to future royalties associated with the Zytiga&#x2122; Drug used to treat certain forms of prostate cancer. In the fourth quarter of 2019, we sold our rights to these royalties for $256 million in cash, included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proceeds from royalty rights transfer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of cash flows. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price for the acquisition of BTG consisted of upfront cash in the aggregate amount of &#xa3;3.312 billion (or $4.023 billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received 840 pence (or $10.20 based on the exchange rate at closing) in cash for each BTG share. The transaction price included $404 million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&#160;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized goodwill of $1.635 billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. We allocated $1.399 billion to our Peripheral Interventions reporting unit and $236 million to the Specialty Pharmaceuticals reporting unit. In 2020, we recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of  $73 million related to the execution of a definitive agreement to sell our Specialty Pharmaceuticals business. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Vertiflex, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 11, 2019, we completed our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#x2122; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $465 million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of zero to $100 million; however, the payments are uncapped over the three year earn-out period. Through December&#160;31, 2021, we have made incremental payments of $20 million to the prior shareholders of Vertiflex in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Millipede, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2019, we completed our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $90 million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately 20 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $325 million and up to an additional $125 million payment upon achievement of a commercial milestone. During 2021, we cancelled the Millipede mitral valve IPR&amp;amp;D program, recording intangible asset impairment charges of $242 million, and a contingent consideration benefit of $104 million for milestones that would not be achieved due to the cancellation of the program due to the time and financial investment required to commercialize the platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final combined purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies. The goodwill recorded relating to our acquisitions is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded related to current year acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $986 million, which includes amounts related to our recently completed acquisitions of Preventice, Farapulse and Devoro Medical.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net benefits of $136 million and $100 million recorded in 2021 and 2020, respectively, related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or, in the case of Millipede and nVision, for milestones that would not be achieved due to management's discontinuation of the associated R&amp;amp;D program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$143 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$343 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected contingent payment amounts related to our R&amp;amp;D, regulatory and commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded a $178 million loss in 2021 and a $363 million gain in 2020 on our investment in Pulmonx Corporation presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt; associated with the remeasurement of our investment during the period to fair value based on observable market prices, as well as the disposition of our remaining ownership during 2021. As of December&#160;31, 2021, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $289 million, which represents amortizable intangible assets, IPR&amp;amp;D, goodwill and deferred tax liabilities.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia4c1e55cd1e444d88c6ef56f87ecf676_D20220214-20220214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzExOQ_45e7b7f8-cf3c-40c2-bda0-e2d592ef05a3"
      unitRef="usd">1750000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODI4Nw_e42660a7-da36-4fd7-85a1-7610985bdd35"
      unitRef="usd">925000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest
      contextRef="i43a1b72be8d74d5eb954a3448a0598e7_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODI5NQ_73c39128-9dae-49a6-a79d-895bc387da0b"
      unitRef="usd">300000000</bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i43a1b72be8d74d5eb954a3448a0598e7_I20210301"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMwMQ_f9fdeed0-71f0-4f72-a5d7-cf2da122a454"
      unitRef="number">0.22</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMwOA_ad5b2872-c3d3-4ec7-8798-7fd65ec887e0"
      unitRef="usd">196000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6a450061a2c34ef4a3c8adacadf0cc55_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMxNQ_8f7b242a-785c-46ab-bf83-8538dc98a7d0"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i43a1b72be8d74d5eb954a3448a0598e7_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODMyNg_b267b9a4-0fa6-4808-b086-8de33d490b9e"
      unitRef="usd">230000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i07946074b2524113bd25ea3602907bae_D20210806-20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODg4OA_bc500af3-4864-4b0f-8d2b-83a07df97aa8"
      unitRef="usd">450000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest
      contextRef="i27aafceb9a8241bb8a7b5487131b9106_I20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODg5OQ_236831bf-3ad5-4be4-9ebc-ccf128541adc"
      unitRef="usd">125000000</bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest>
    <bsx:BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod
      contextRef="i07946074b2524113bd25ea3602907bae_D20210806-20210806"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkxNg_9e86f45b-b97c-429b-abd3-0f1ba8f77510">P3Y</bsx:BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i27aafceb9a8241bb8a7b5487131b9106_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkxOQ_7f93b43a-af02-472b-bc09-52cf465ab638"
      unitRef="number">0.27</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i07946074b2524113bd25ea3602907bae_D20210806-20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkyNg_0beb0c7e-b4d4-4cad-9f97-c823e0e9f739"
      unitRef="usd">222000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0930e389c7ed4a8a9b076aa4c40709ee_D20210806-20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODkzNg_97fecd1a-beaa-40b7-a84b-d064d1835137"
      unitRef="usd">268000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i27aafceb9a8241bb8a7b5487131b9106_I20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODk0Mw_4ca11cd0-ccc3-48dd-b9bd-447ff4e640e9"
      unitRef="usd">92000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i30d60e95a9ad4691b3c08057fb408f2c_D20210901-20210901"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI4ODk0OQ_60c750e2-0070-44eb-adb1-e55b6f6c6c5a"
      unitRef="usd">1032000000.000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTMxOTQxMzk1ODQxNjM_814defa1-de29-43d2-a8ec-6008fea172c4"
      unitRef="usd">320000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest
      contextRef="i9d817719bd624f91ba936d54cd189dd0_I20211108"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTMxOTQxMzk1ODQxOTk_e8ad2d4a-2a05-4ce9-baf2-992f6fcad12d"
      unitRef="usd">80000000</bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i2e35130934fd4a358eacac841a7a82fb_I20211108"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MTEzNw_bb5fa2e5-85d8-48aa-9f3c-c91d23706b43"
      unitRef="number">0.16</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTA5OTUxMTY3MDc4MQ_2f133948-ad74-487b-94ed-83ee8f8c7f6d"
      unitRef="usd">57000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia5947dbcc10d45a7a0b389559ad0eb70_D20211108-20211108"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwOTI3Mw_8b0a2a82-fefe-4d78-ae20-804d5aa6a846"
      unitRef="usd">251000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i9d817719bd624f91ba936d54cd189dd0_I20211108"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwOTI5MA_b58b0730-9e16-4148-9839-eeb50e5c6ea4"
      unitRef="usd">67000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwODg0Mg_edb0c580-aed2-4832-a70b-4c537f93de52">The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preventice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lumenis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,032&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i375363a8a82747f993aef5796e14a72c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS0xLTEtMS00MzA5Ng_15702b9c-40c7-4c1d-a5e4-8e2abedf146e"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i977a60dd4a094b4badc4cc6074972559_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS0zLTEtMS00MzA5Ng_3a5e653c-aa25-4280-9a49-befae9da6c60"
      unitRef="usd">1032000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ied21f3ab578a46919e7241d90ab45962_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS01LTEtMS00MzA5Ng_36daa52f-019c-49b3-8c14-7ea43e4c668c"
      unitRef="usd">519000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMS02LTEtMS00MzA5Ng_6182a9a2-a5ce-4188-bf5e-ae134fa8ff48"
      unitRef="usd">2258000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi0xLTEtMS00MzA5Ng_818c68c0-e855-4897-af04-dd157d0a58a1"
      unitRef="usd">221000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi0zLTEtMS00MzA5Ng_92c4aeea-3494-43e4-b284-2b706e783b7e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi01LTEtMS00MzA5Ng_f9cf56c6-ce5d-47fa-8b7f-a5b3f1d48d2c"
      unitRef="usd">218000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMi02LTEtMS00MzA5Ng_ac728c84-f77e-4321-8784-f73257ccd9db"
      unitRef="usd">440000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i375363a8a82747f993aef5796e14a72c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy0xLTEtMS00MzA5Ng_66d46d3c-93bf-43e5-8a43-e6f6c98365f5"
      unitRef="usd">269000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i977a60dd4a094b4badc4cc6074972559_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy0zLTEtMS00MzA5Ng_c7130142-ae67-411b-86bb-a5c385475be4"
      unitRef="usd">0</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="ied21f3ab578a46919e7241d90ab45962_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy01LTEtMS00MzA5Ng_cba41e9b-1824-46cb-8e9d-892fbd37010a"
      unitRef="usd">287000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfMy02LTEtMS00MzA5Ng_f16c57be-9281-4572-afea-05548a873495"
      unitRef="usd">556000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC0xLTEtMS00MzA5Ng_936aaa2d-5413-4ccc-9941-da022144dacd"
      unitRef="usd">1197000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC0zLTEtMS00MzA5Ng_ee759ca6-daa0-4d16-a02e-2a1bd5004c6b"
      unitRef="usd">1032000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC01LTEtMS00MzA5Ng_6a85ffbe-13db-4d60-aa00-0d4e0ac56377"
      unitRef="usd">1025000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjEyMDJkYzAwMjBjMDQ1MDhiMzdhMWM2YTNiMThmNjIyL3RhYmxlcmFuZ2U6MTIwMmRjMDAyMGMwNDUwOGIzN2ExYzZhM2IxOGY2MjJfNC02LTEtMS00MzA5Ng_93069b01-2927-4626-980a-fc3d563717b8"
      unitRef="usd">3254000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i25282a1ba939439980c46921de6f92f4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwODg0NA_33cdca37-4aef-4aea-a378-a8ddcd8c47ef">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price allocation for these acquisitions was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preventice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lumenis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,032&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS0xLTEtMS00MzA5Ng_8a0f1e56-40dd-47f5-878e-c42817ab42d2"
      unitRef="usd">926000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS0zLTEtMS00MzA5Ng_5f5f4d34-4072-4615-8715-944486b23bc3"
      unitRef="usd">544000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS01LTEtMS00MzA5Ng_44ee3187-a069-4b9f-9a33-a27969d4c603"
      unitRef="usd">594000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMS02LTEtMS00MzA5Ng_6f37ffe3-720d-4fa5-b8d6-7b0bcea83af9"
      unitRef="usd">2064000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi0xLTEtMS00MzA5Ng_7e7c5281-8c39-4bac-974b-09c3dcd31f71"
      unitRef="usd">237000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi0zLTEtMS00MzA5Ng_9edcf485-33fa-4045-ac16-559bee538532"
      unitRef="usd">423000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi01LTEtMS00MzA5Ng_9e9090c6-a22c-4a66-9444-001898b5f16c"
      unitRef="usd">465000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMi02LTEtMS00MzA5Ng_cc2880b2-add3-44ce-81c8-9b94ea466736"
      unitRef="usd">1125000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy0xLTEtMS00MzA5Ng_479c15ef-8bf1-457f-865a-b2b9a7e0b912"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy0zLTEtMS00MzA5Ng_53b10272-bbef-4d3b-af97-e315cfd71408"
      unitRef="usd">69000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy01LTEtMS00MzA5Ng_c3b4ac7c-1413-4bc5-8d45-c401fc5caaf1"
      unitRef="usd">43000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfMy02LTEtMS00MzA5Ng_d1c7aa15-ec48-4c75-b3ed-68a47f7c983d"
      unitRef="usd">112000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC0xLTEtMS00MzA5Ng_dac11ed8-7ba1-493c-a1fe-7772afb63a38"
      unitRef="usd">65000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC0zLTEtMS00MzA5Ng_3429dac1-73d9-4d0b-ad97-58f37625b3a9"
      unitRef="usd">115000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC01LTEtMS00MzA5Ng_b2415e58-1268-4a4b-a763-a0e0fe611936"
      unitRef="usd">9000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNC02LTEtMS00MzA5Ng_7f31ec85-8ba9-4582-82c7-2efb0ff98b8f"
      unitRef="usd">190000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi0xLTEtMS00MzA5Ng_a56e41a1-068c-4785-a635-2cf7a2b44b5c"
      unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi0zLTEtMS00MzA5Ng_5f7115f7-6293-434e-bc68-18b50f8a2d95"
      unitRef="usd">101000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi01LTEtMS00MzA5Ng_2410158a-05a7-4827-91db-c60c25f5c73a"
      unitRef="usd">11000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNi02LTEtMS00MzA5Ng_bca2b0ec-8838-444e-a73d-b158927bd3aa"
      unitRef="usd">144000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy0xLTEtMS00MzA5Ng_86578dfe-d5ce-4457-9553-5d63327838bb"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy0zLTEtMS00MzA5Ng_58be5d95-80f6-48d9-9e61-002b59cfa355"
      unitRef="usd">18000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy01LTEtMS00MzA5Ng_d6717bd3-d6b6-4bde-97e3-1352f985c643"
      unitRef="usd">75000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfNy02LTEtMS01NzYwNg_7c979715-a011-46bd-bd6f-331d0f46cb13"
      unitRef="usd">93000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC0xLTEtMS00MzA5Ng_25efbe36-2d38-49e0-b11e-db9a37975e58"
      unitRef="usd">1197000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC0zLTEtMS00MzA5Ng_6003a6e1-ddbb-4f51-81a4-566d75c15f13"
      unitRef="usd">1032000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC01LTEtMS00MzA5Ng_d5d564e0-b2bd-456b-9bf9-6eb7992a6816"
      unitRef="usd">1025000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjQ0ODUwMDVjYTc3YTRlNWZhN2IwYWY0NjZmMDgxNGU1L3RhYmxlcmFuZ2U6NDQ4NTAwNWNhNzdhNGU1ZmE3YjBhZjQ2NmYwODE0ZTVfOC02LTEtMS00MzA5Ng_b441d6f8-d0aa-4411-8ea3-06b21dfaa9f9"
      unitRef="usd">3254000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwODg0NQ_aee52995-1fe6-4ae2-b05f-b1a1627efbe0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Preventice:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lumenis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;All Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;508&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2c4c18e74ac94029b4ed8c497c643638_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMy0xLTEtMS00MzA5Ng_cc1518dd-80b6-4ca7-881e-cc41261aece8"
      unitRef="usd">215000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if2bd7513127242f78e881962dac45e4b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMy0zLTEtMS00MzA5Ng_1bdf7a1b-ec4c-4a41-9d44-4d2935b3d560">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="ic1a2eb59807f4fa98038488a67c899d4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMy01LTEtMS00MzA5Ng_dd4b2351-ae9a-473c-b67c-0499e81e942d"
      unitRef="number">0.10</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i72d131180c20411ba4a7c16e8fbe7351_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfNS0xLTEtMS00MzA5Ng_46dc796f-3bf1-4bc6-86fc-5f3f2a47b232"
      unitRef="usd">22000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i56df3da0ec92473699d19c087728742d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfNS0zLTEtMS00MzA5Ng_53f57919-8da8-48ed-aa8d-5567af28a4ba">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i24bd565b73f44fe7aea51a237868fa51_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfNS01LTEtMS00MzA5Ng_247dc64d-5706-449d-b36d-9568de7fb891"
      unitRef="number">0.10</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ib5890dc3bad44013810b2e4b67e759c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfOC0xLTEtMS00MzA5Ng_43ebcb2a-64d7-4684-b884-c6562863863c"
      unitRef="usd">237000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4ca66a6bcf654c779a82ae88dfb8e058_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTEtMS0xLTEtNDMwOTY_cf181ff3-fd71-4719-9b52-433fddfefc15"
      unitRef="usd">388000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="idf5c1ca1458c4c31b1e096eda7cca942_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTEtMy0xLTEtNDMwOTY_85276785-96a8-4665-95a2-a2d8d61a7cde">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="ia67dafbfe3fe4b0bb926c4c9c35b4c4d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTEtNS0xLTMtNjc4Mzk_1290670d-0368-40f3-9c14-82d879b3e63d"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i401803de34c347149bdb6b113441fe31_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTMtMS0xLTEtNDMwOTY_3ab9797c-d96b-4161-8127-45bba9d717af"
      unitRef="usd">35000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if9051905a0e9457a9c8249141096c7af_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTMtMy0xLTEtNDMwOTY_1626b262-6b08-4572-acb5-1cd75c3dd302">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="ic188f63db33d43519ebe846287701578_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTMtNS0xLTMtNjc4Mzk_6d0708f1-78ab-4539-aeb3-1a37842711be"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if1005dbdd4f84094bb2b629f0c0ad6f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTUtMS0xLTEtNDMwOTY_4c109b1a-c79c-4241-b67e-efc399370365"
      unitRef="usd">69000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <bsx:DiscountRateFairValueInput
      contextRef="i8442535b691b4124862b82abe60ed41b_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTUtNS0xLTEtNDMwOTY_2285726d-c0ec-47e1-8ccd-5d6dab63711d"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i8960237fdb4c4623ae9438f6a20ff081_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTYtMS0xLTEtNDMwOTY_6e2001d0-4c80-47d1-afbe-0607e9d65319"
      unitRef="usd">492000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iea9cf6036d3a467d98b57608db9b9c7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktMS0xLTEtNDMwOTY_b0ade060-1ff1-4c2c-8b95-7d178801ae5b"
      unitRef="usd">465000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic3f2a730fb2840249b185833474b5453_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktMy0xLTEtNDMwOTY_9c15ac38-552e-48f1-881c-2095be2c8b18">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i54b7493616504921a135abba92ddaa2e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktNS0xLTEtNDMwOTY_55c26a4a-a641-4c40-8ab5-4241c30cf122"
      unitRef="number">0.16</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i14ccc97c93104644b760b49a50825d0f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMTktNy0xLTEtNTc4ODA_0b137853-d016-4eb4-993f-532f792f79f6"
      unitRef="number">0.17</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="idd2558040a1a42e4bd8cc29eb78555e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMjMtMS0xLTEtNDMwOTY_e8da4a57-2f3b-4166-8812-4af16efed5c2"
      unitRef="usd">43000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <bsx:DiscountRateFairValueInput
      contextRef="ibe24aea88d3d42d5b34c3e42f204cbb6_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMjMtNS0xLTEtNDMwOTY_5e689c00-d8f2-472e-b755-1fde7b2d40c1"
      unitRef="number">0.17</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i89e23228f2de4a7bb6d366fe1446b3c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjZhYjVlYjg2YjRhOTQ5MWJiZWIxYTNhNDVmNTg4NTJlL3RhYmxlcmFuZ2U6NmFiNWViODZiNGE5NDkxYmJlYjFhM2E0NWY1ODg1MmVfMjQtMS0xLTEtNDMwOTY_3de6f5b4-d9d5-47a1-9c81-51f588e018b6"
      unitRef="usd">508000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzEzNw_8da66411-7af9-4c2b-ad3f-ef91c437d590"
      unitRef="usd">800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <bsx:DivestitureAgreementTransferOfFacilities
      contextRef="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzE2MQ_ac61593d-374e-4272-a3ee-bf6a154d9777"
      unitRef="usd">5</bsx:DivestitureAgreementTransferOfFacilities>
    <bsx:DivestitureAgreementTransferOfGlobalEmployees
      contextRef="i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5MzE2OQ_90035ea7-d494-4e7c-94c1-752048355c4e"
      unitRef="usd">280</bsx:DivestitureAgreementTransferOfGlobalEmployees>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjQyNw_98999cdd-4e00-4d40-a269-654a34634e5f"
      unitRef="usd">800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="id6132cb03cef491d949660bfc42e7b5c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjg4Ng_9aad64fc-e622-413e-bd6a-e8e3f5e38219"
      unitRef="usd">256000000</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzA2Nw_ef068c32-13c9-423a-a51a-358db1d63a32"
      unitRef="gbp">3312000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzA3NA_8851c2bc-6839-4817-a951-85bf8cbb0df7"
      unitRef="usd">4023000000.000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ic42ef98edc4741318f57c64a9bfb2735_I20190819"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzIyMg_efc7a49b-d3df-4478-aefa-cfc2bd51b85e"
      unitRef="gbpPerShare">8.40</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ic42ef98edc4741318f57c64a9bfb2735_I20190819"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzIyOQ_6dba3adb-c97e-41f5-8863-438e8e0f319d"
      unitRef="usdPerShare">10.20</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i8f1a18bdf3834f97ba7722d542f4d3be_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMzMzMA_5df4ee44-ada4-427f-9293-e4757fdec1a5"
      unitRef="usd">404000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMjI_f31d293a-7da8-4ec0-bbb4-00b8b9d3894d">The final purchase price was comprised of the following components:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="id6132cb03cef491d949660bfc42e7b5c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmFhOTQ4NmUwOWYzNzQ1MmY5MTU3ZGRhMmZiODg4ODY1L3RhYmxlcmFuZ2U6YWE5NDg2ZTA5ZjM3NDUyZjkxNTdkZGEyZmI4ODg4NjVfMS0xLTEtMS0w_81c8bb1e-3269-402b-858b-7ac5cc3c5d3c"
      unitRef="usd">3619000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMjA_d5773b9a-006d-45ca-bd6a-7c0c53c80237">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMS0xLTEtMS0w_e4fa88c4-a8bb-4da9-b0f0-607fec596559"
      unitRef="usd">1635000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMy0xLTEtMS0w_e2736c1a-90c0-4e4e-b0d4-cc2e5851b9f0"
      unitRef="usd">108000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNC0xLTEtMS0w_acec2c35-953f-48cb-ad04-9b4d8304e65a"
      unitRef="usd">232000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNS0xLTEtMS0w_9ed39eab-0848-4ba4-99b2-9b2e7ac41099"
      unitRef="usd">252000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNi0xLTEtMS0w_c2b460fb-a1ac-47a4-b167-96b92c7e7819"
      unitRef="usd">1785000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfNy0xLTEtMS0w_6a657afb-9a7c-4698-9715-2cd8f3733b9c"
      unitRef="usd">538000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfOC0xLTEtMS0w_3294646a-8b20-4e35-a897-152f66061ac5"
      unitRef="usd">308000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfOS0xLTEtMS0w_81fec69c-d490-463b-abff-845d37de334b"
      unitRef="usd">274000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMTAtMS0xLTEtMA_7989848b-3e3f-4b8e-9ed4-d64b27802320"
      unitRef="usd">349000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjNhNTRhNWFjNzg5YTQxNzJhZWI2YTU4OWJiYWQ1NDMxL3RhYmxlcmFuZ2U6M2E1NGE1YWM3ODlhNDE3MmFlYjZhNTg5YmJhZDU0MzFfMTEtMS0xLTEtMA_738dc3ea-9f0b-461a-9d9e-e889fc55b7d8"
      unitRef="usd">3619000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="ib894b68b57594ff99eb398f77ed5abcd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwNzM_c3fab591-bb76-4449-9473-daf93720860e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if7b4ebd9d21548d3b495be941b489706_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi0xLTEtMS0w_7eb2b649-756b-4d75-bac2-e98a6e73d08f"
      unitRef="usd">1709000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i326847b5c1684d50bd21f2c964e25e95_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi0zLTEtMS0w_21c64df7-c12e-4a61-a9ee-8e5973deedf6">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i031288d26dbe4dad9111cf8a737a815e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi01LTEtMS0w_0451346b-a9da-4621-9346-7bf30fe14ee2">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i326847b5c1684d50bd21f2c964e25e95_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi03LTEtMS0w_4883740e-6305-47f9-8d10-c6da1d07a088"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i031288d26dbe4dad9111cf8a737a815e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfMi05LTEtMS0w_ea679ebd-1437-4138-9b59-c67c9c20e2f1"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4831b01bd4334a1abd79911b16ed4c3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS0xLTEtMS0w_bf1ff931-580f-441f-ab83-68b82fc9b8d5"
      unitRef="usd">75000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i13cb159d3e45462a9c50314d05440d78_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS0zLTEtMS0w_586b3521-e245-458b-af7c-0ac19b0297a4">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia6f4b506c8c24f178b63a4f53ff627dd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS01LTEtMS0w_e019f7f6-a9c1-4867-82f7-a8489fd811e8">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i3f53f48683c54762a784b30fca510244_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfNS03LTEtMS0w_b5157859-721d-41e8-a873-57887e10cbf9"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmU1MWYxYjkzZDZiNjQ1ZGNiNzQyNjczNzhhMWUxODQ2L3RhYmxlcmFuZ2U6ZTUxZjFiOTNkNmI2NDVkY2I3NDI2NzM3OGExZTE4NDZfOC0xLTEtMS0w_52d4be18-b14d-4a8e-81e1-ba16afbeffea"
      unitRef="usd">1785000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="id69301cd870d43dd80ea71d12d42a76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNDA1Nw_e4fa88c4-a8bb-4da9-b0f0-607fec596559"
      unitRef="usd">1635000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id35802ead11946739ec96eb588e199b4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNDIyNw_07c7d02d-108a-4e85-9a13-2ce49fddea43"
      unitRef="usd">1399000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7059a74267434518bbc0ed0077d56f7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNDI4MQ_cee5f3c9-f345-46fe-bcc4-8e10b34dbd2f"
      unitRef="usd">236000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NDEzOA_781d2c58-31be-4ea1-bec9-c377fa96c674"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i236d0e3aac6448faa715c3f08ec819a6_D20190611-20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjAyOA_a3acf473-ea5d-4f04-8e83-f5bf1d0eebc5"
      unitRef="usd">465000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
      contextRef="i60e5a145ef214a48b006713d03a06923_I20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjI2Nw_eec07331-c302-401c-a26b-a37857ac3ab8"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i60e5a145ef214a48b006713d03a06923_I20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjI3Mw_68172cce-0e58-4909-9367-8d407d0e0e8b"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate
      contextRef="i8efe8988e2544797a55f44fb65e85f88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNjM5OA_7df924a1-a2fb-49fa-8f02-2ca0e497ee48"
      unitRef="usd">20000000</bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0136ac01ee9747ddbfdbac14e429ec42_D20190129-20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzEzMg_fe8433e4-0456-44f9-8ceb-2607cb23a93c"
      unitRef="usd">90000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i2b58c1611a834f2ca3ba6c6410d7b13e_I20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzM0MQ_9cb65d45-5eac-4473-9fd4-ec8759d8ed4c"
      unitRef="number">0.20</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i0136ac01ee9747ddbfdbac14e429ec42_D20190129-20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzY2NA_02cb6d6e-bacc-4745-940c-2f39bd73cad4"
      unitRef="usd">325000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i2b58c1611a834f2ca3ba6c6410d7b13e_I20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfNzY5MQ_1143bdfd-2249-4ec4-9b71-470c4277312a"
      unitRef="usd">125000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i0fffb8b77bc043679725e5bc32404c66_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTA5OTUxMTY4MDUxNg_7310086d-74e4-4314-b855-f0a86fb8e9b8"
      unitRef="usd">242000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0fffb8b77bc043679725e5bc32404c66_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzMwMzczMw_0a3feb90-9388-4af6-b8dc-cfe2a3e39692"
      unitRef="usd">104000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwODA_8ff14a44-bffe-44e2-9ae5-2ead161a62ee">The final purchase prices were comprised of the following components:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfMS0xLTEtMS0w_0cbe42b1-5025-41d2-ba35-0ec8fc8754fe"
      unitRef="usd">763000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfMi0xLTEtMS0w_194a2dcd-3884-4ab5-9388-3e2e01804d81"
      unitRef="usd">127000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfMy0xLTEtMS0w_cf49ee35-b38f-4599-a54c-f8bc08300a2f"
      unitRef="usd">102000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmEwODI3NTllNGQyZjRjODY5ZjVhYjVjNWM0ZjM4MjUzL3RhYmxlcmFuZ2U6YTA4Mjc1OWU0ZDJmNGM4NjlmNWFiNWM1YzRmMzgyNTNfNC0xLTEtMS0w_02e867b9-c75e-409b-a2c4-0c81706e635e"
      unitRef="usd">992000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMDI_8c9f0181-902b-4d4e-b69d-142447b6372e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final combined purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfMS0xLTEtMS0w_69584f3a-4d3c-4c76-91de-d4d8e94fbfce"
      unitRef="usd">577000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfMi0xLTEtMS0w_3bfebd14-4556-42a9-803a-284ec51bb029"
      unitRef="usd">220000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfMy0xLTEtMS0w_94ccaec0-da62-472d-a062-6d423e95a501"
      unitRef="usd">240000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNC0xLTEtMS0w_a141c05b-c367-4aa2-bdbc-81bd4d9bc912"
      unitRef="usd">24000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNS0xLTEtMS0w_4d70c28e-6bba-4057-bbb3-07382a0ce9b1"
      unitRef="usd">12000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNi0xLTEtMS0w_a026775b-042a-4c29-ad4e-67d54c24ce99"
      unitRef="usd">58000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmYzMTQ2MWY0ZTlmMzQ1NmVhNzRhNzNjZGU0ZTg2NTAxL3RhYmxlcmFuZ2U6ZjMxNDYxZjRlOWYzNDU2ZWE3NGE3M2NkZTRlODY1MDFfNy0xLTEtMS0w_aae31627-104e-41ad-b352-30e1875d99b3"
      unitRef="usd">992000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="ib01e4f0b0e3f4c68a79e79dae75b4ec1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMTQ_b6646816-20a7-440e-8acd-a256cf77353e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia220fba2afe640c5b10959e748bdc0f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfMi0xLTEtMS0w_7138d518-5ded-4f5b-9de4-ef426608804a"
      unitRef="usd">210000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9e6697aaff074326a490c1c4df961df1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfMi0zLTEtMS0w_a675a33f-1663-4ca7-87d3-007684dd13b4">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i9e6697aaff074326a490c1c4df961df1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfMi03LTEtMS0w_bdf5d8c3-76f5-4991-965c-aa1f3a7216e5"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0222b251d46f4b5b9adba6a70f6ca5b4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNC0xLTEtMS0w_68084c11-b778-429c-9097-35c4c8e60798"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icc5e6407019d4c5ba9239b2dc0326dc9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNC0zLTEtMS0w_f36f2f07-4f8d-4222-b827-e4d7c70e62e6">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="icc5e6407019d4c5ba9239b2dc0326dc9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNC03LTEtMS0w_7dd47fa5-86c8-482b-a258-a65f34d3f0e7"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i63e20a416e72492f8ea6b11da4fca76d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNi0xLTEtMS0w_3ab52442-84f6-4668-a44b-e3f32d42e1bf"
      unitRef="usd">240000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <bsx:DiscountRateFairValueInput
      contextRef="i934dc3da23a444f68c5411629abd5c05_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNi03LTEtMS0w_da48d9a4-be6a-4949-bb38-d58c23253e5e"
      unitRef="number">0.19</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i2ddb1f3b42b943b98458f1def7473e27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjkzYjI0YWEwMDM3MDQyOWY5MjIzNWQ5YTgwZGU0Y2QyL3RhYmxlcmFuZ2U6OTNiMjRhYTAwMzcwNDI5ZjkyMjM1ZDlhODBkZTRjZDJfNy0xLTEtMS0w_6f7cadde-4f89-49bb-a177-2620586908ae"
      unitRef="usd">461000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMDQ_b487d601-07a9-42c7-8fe5-b3d4f182f391">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded related to current year acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMS0xLTEtMS0w_3de42c7e-5c06-4e25-9781-e3c0288993ff"
      unitRef="usd">354000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNS0xLTEtMS0w_94884c9f-3438-4ac8-8f6f-d18a08da2359"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNi0xLTEtMS0w_e17d1430-c446-4853-9308-49ceefe42795"
      unitRef="usd">58000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNy0xLTEtMS0w_69efde8e-4063-4ef0-860a-814c34d7b68d"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfNS0xLTEtMS00NzUyMA_64943492-eb44-4303-bd5a-ff2c8c16bbad"
      unitRef="usd">440000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMTAtMS0xLTEtMA_08b212c8-5610-42e9-8c22-043a7135385a"
      unitRef="usd">-136000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMTEtMS0xLTEtMA_7210e115-c40b-4452-ae37-6e08cdb2cb0a"
      unitRef="usd">15000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOmUwZTFlODQ0ODk4MjQ3Zjg4YTk4YmM0Y2FmZTI0ODlmL3RhYmxlcmFuZ2U6ZTBlMWU4NDQ4OTgyNDdmODhhOThiYzRjYWZlMjQ4OWZfMTItMS0xLTEtMA_be53adc6-fbbd-45ca-9dc6-d731a5bb4c22"
      unitRef="usd">486000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i6ba23d93e9ec4f15bb0a4f81277429a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTQ3MjM_f6a69ab9-4c88-456f-8da8-a70000afd713"
      unitRef="usd">986000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NTA5OQ_0aec8765-7c08-4fc0-8343-8c7e97bb1dd2"
      unitRef="usd">-136000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NTE1MQ_72f179b4-da98-48b2-b894-d6f1c9041894"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcwOTQ_599ce76b-a7d7-4874-a5dc-107e6e3d5a7b">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$143 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$343 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2b6cfcec597e408b9a5fd82f4348c035_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS0xLTEtMS0w_7ba12383-37ac-4e55-9a77-ed9d2e4aa65a"
      unitRef="usd">143000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="ia390ec0e6c2945b8ac3c143bec1f4d48_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS00LTEtMS0w_be714cdf-dde9-4e74-8657-73c0a010834e"
      unitRef="number">0.01</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i5b52c801fa3443fba640800528e27d89_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS02LTEtMS01MjkxMg_9acc325e-5e3f-40e7-85ea-e7bb1a2b8cad"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i286ca5ae382c4a2c8eb259f86f360abc_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMS03LTEtMS0w_3cf955ce-4c02-4ba1-9a77-f070d330d014"
      unitRef="number">0.01</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="id2ada5aeb391411cb94688ce1c7bf045_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMi00LTEtMS0w_9943256f-c18f-4753-9b89-1542eeceed6f"
      unitRef="number">0.80</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i1679fab0c33040bea869e31b477d8218_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMi02LTEtMS01MjkxOQ_c502af2f-9443-4005-ba55-60eba24635f8"
      unitRef="number">0.95</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i240029b128a642eb92a242ba01b28e5b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfMi03LTEtMS0w_f3e23d09-b4e9-4e18-a858-da5c0ef53349"
      unitRef="number">0.92</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i87fc5a1a4adc4ccfa36556f49b411e45_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC0xLTEtMS0w_b2b5f955-bf60-42b2-8fd4-7f5c647e5be2"
      unitRef="usd">343000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i5279e9ef42dd4b35a8efebed33d86874_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC00LTEtMS0w_1c845bfa-d8a8-4574-b690-e66d1c70c84a"
      unitRef="number">0.04</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i5c6aab66b44f4082a6966e817d9f00ca_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC02LTEtMS0w_44070146-4563-48df-907b-1be1301de05b"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i44e14e1f91774b6ca60421226afdf115_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNC03LTEtMS0w_403a8162-7369-4567-b83f-16f4e743da24"
      unitRef="number">0.06</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i3cff2f3a775c477eb7e3299584301fe4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNS00LTEtMS0w_f4a82f76-0406-47fa-8592-cd908529cf50"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="ib2deb61987c348f792b6cc878f078498_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNS02LTEtMS0w_96ca9c16-f555-4b78-9041-99a77bbea8d1"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="ief5124b672194097aa937d5abf34195e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjAyMTA1MzcyNjFlODQ3Yzk4MGRhNGM4OTUyMmQ0YjZlL3RhYmxlcmFuZ2U6MDIxMDUzNzI2MWU4NDdjOTgwZGE0Yzg5NTIyZDRiNmVfNS03LTEtMS0w_04f43b18-a584-40d5-80fa-892e6f85bf5f"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTcxMTA_8ff0850e-cd0e-4907-be5d-02e20578db31">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMi0xLTEtMS0w_47bf4340-0df9-4737-aceb-9174d03d1314"
      unitRef="usd">259000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMi0zLTEtMS0w_5ed40041-718f-47fb-8917-2c2ee26304c3"
      unitRef="usd">319000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMy0xLTEtMS0w_8c1753f8-0b86-40e6-a546-1d6e0beb30a6"
      unitRef="usd">142000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfMy0zLTEtMS0w_db22d08b-0801-476c-8068-61960d06d265"
      unitRef="usd">183000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNC0xLTEtMS0w_d76a1f8d-b3de-489d-9fb7-ec6fa80420ee"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNC0zLTEtMS0w_05ec7278-4441-4f50-ac2b-919b8b1aebf4"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNS0xLTEtMS0w_486b9241-cd9a-4db3-8d3c-e21c54c371ff"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNS0zLTEtMS0w_ac60d9c4-d429-4994-8a50-6d9ff2b24edc"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:Investments
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNi0xLTEtMS0w_33c880ae-77e1-491e-b4b4-0c4086e94d8e"
      unitRef="usd">412000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RhYmxlOjBiMDEzMTMwOGUwNTQ1OTI4YzEzYTg0MTFkODdiOTI3L3RhYmxlcmFuZ2U6MGIwMTMxMzA4ZTA1NDU5MjhjMTNhODQxMWQ4N2I5MjdfNi0zLTEtMS0w_2a40fc78-779f-4a92-87f9-1e60a8e9514d"
      unitRef="usd">918000000</us-gaap:Investments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NjMwOQ_61b51125-929c-4d21-adc8-ed5eff565df2"
      unitRef="usd">-178000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMjE5OTAyMzI5NjMxMw_5479c258-1258-4fb4-bc27-aa66740db691"
      unitRef="usd">363000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN185Ny9mcmFnOjNlNWIzMDQ3NDgwMjQyNzI5Njk1NDZjNDJiMTIwZGU2L3RleHRyZWdpb246M2U1YjMwNDc0ODAyNDI3Mjk2OTU0NmM0MmIxMjBkZTZfMTY5NTc_d1bef803-ba40-4efa-ac29-6e242bd5ad43"
      unitRef="usd">289000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzE0NTE_1079b178-49a7-484f-b076-cfb3436c26fc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE C &#x2013; ASSETS AND LIABILITIES HELD FOR SALE&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group. On March 1, 2021, we completed the divestiture for a purchase price of approximately $800 million, which was subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of five facilities and approximately 280 employees globally. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and liabilities are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our consolidated balance sheet as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities held for sale included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as of December 31, 2020, we had foreign currency translation adjustments of $107 million contained within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt; attributable to the Specialty Pharmaceuticals business that were released upon the closing of the transaction.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzI5Ng_98999cdd-4e00-4d40-a269-654a34634e5f"
      unitRef="usd">800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <bsx:DivestitureAgreementTransferOfFacilities
      contextRef="i9eaa1423fdfa4907a958a048b0c0d9d3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzIxOTkwMjMyNTc3OTQ_0ff6b1d3-a799-48cd-8020-219e2705823a"
      unitRef="usd">5</bsx:DivestitureAgreementTransferOfFacilities>
    <bsx:DivestitureAgreementTransferOfGlobalEmployees
      contextRef="i9eaa1423fdfa4907a958a048b0c0d9d3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzIxOTkwMjMyNTc4MDc_10509744-117c-4010-bfc7-d22226bb05e7"
      unitRef="usd">280</bsx:DivestitureAgreementTransferOfGlobalEmployees>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzE0NTM_09cea33f-cbec-41fb-9c0f-82b4c7ef7146">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities held for sale included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEtMS0xLTEtMA_d7ad5ce2-5981-4b45-ba2a-7a8bdb62acd9"
      unitRef="usd">37000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzItMS0xLTEtMA_962a635a-719f-499c-a9a9-6c47ba6373bd"
      unitRef="usd">24000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzMtMS0xLTEtMA_ff6a13ba-114e-43fa-8f88-8918bb80f1e4"
      unitRef="usd">79000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzQtMS0xLTEtMA_bcdb4eab-3064-489a-a67e-743ad1c9ebb8"
      unitRef="usd">17000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzUtMS0xLTEtMA_d7e4e52e-114a-4a8a-9cb2-d54c6c607adb"
      unitRef="usd">175000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzYtMS0xLTEtMA_c9776d16-d1da-4448-a0d0-9fbbda8c9eaa"
      unitRef="usd">758000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent>
    <bsx:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzctMS0xLTEtMA_8480e8b7-004d-475e-80d4-faf1a2cf2643"
      unitRef="usd">45000000</bsx:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzgtMS0xLTEtMA_5106d95a-9309-47ae-80f0-5e47c40c00f1"
      unitRef="usd">1133000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEwLTEtMS0xLTA_bbe6d3d1-f4e8-4342-95bc-14671d4957db"
      unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzExLTEtMS0xLTA_60ce901f-909e-4e21-a591-02e913cb6977"
      unitRef="usd">27000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEyLTEtMS0xLTA_42d99e4f-7f73-4478-89f5-2c4319d85fea"
      unitRef="usd">148000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90YWJsZTowZDc2NDg1ZTBhZjc0M2FiYTIwYjkyNjk5NDQwODI2MC90YWJsZXJhbmdlOjBkNzY0ODVlMGFmNzQzYWJhMjBiOTI2OTk0NDA4MjYwXzEzLTEtMS0xLTA_343c9f56-44d2-472f-bba8-8386df4d50e6"
      unitRef="usd">200000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i08b0dfa99eed4161a4a7fe92ff91c858_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDAvZnJhZzoxMDYzZTlhZGZjMjA0NWIxYjVmOTU3MWMxOGUzYWUxMy90ZXh0cmVnaW9uOjEwNjNlOWFkZmMyMDQ1YjFiNWY5NTcxYzE4ZTNhZTEzXzEyNjc_781e269a-e092-4cfe-ae73-d2436dd8e98e"
      unitRef="usd">107000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NzA_ea66e7f3-bd0c-41d4-adb1-801371f941fd">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE D &#x2013; GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization/Write-offs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization/Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; were $370 million in 2021, $460 million in 2020 and $105 million in 2019. The impairment charges recorded in 2021 were primarily associated with intangible assets established in connection with our acquisition of Millipede, Inc. and VENITI, Inc. The impairment charges recorded in 2020 were primarily associated with intangible assets established in connection with our acquisitions of Sadra Medical, Inc., Apama Medical Inc. and nVision Medical Corporation (nVision). Each of these impairment charges were recorded following management&#x2019;s decision to cancel &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the programs due to the length of time, and remaining cost to complete and commercialize the technology, the cost to remediate quality issues or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill reclassified to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Current assets held for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,503&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,887&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, we did not record any &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill impairment charges.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In 2020, we recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $73&#160;million related to our Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. We did not record any &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in 2019. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion of our goodwill and intangible asset impairment testing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2021 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.127%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NzE_a85fc0eb-f6e1-4a3f-a14d-4a7bf5882311">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization/Write-offs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization/Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i79008fc3f7c7470e85ee26a22fb45478_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItMS0xLTEtMA_ebb0b81a-9762-43c6-8481-f24f6c2315c2"
      unitRef="usd">11957000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i79008fc3f7c7470e85ee26a22fb45478_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItMy0xLTEtMA_78ab737e-de63-46da-8c67-52d59f0c0812"
      unitRef="usd">6754000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i32a03dfab4d54a0eb2135b969c2e72db_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItNS0xLTEtMA_e9b22748-7e1c-409d-91e6-9cce4965d99d"
      unitRef="usd">11059000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i32a03dfab4d54a0eb2135b969c2e72db_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzItNy0xLTEtMA_f844a07c-da22-4af1-a892-3a927f88c24a"
      unitRef="usd">6179000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia490ede05d664ada928496a145ece1b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtMS0xLTEtMA_5f30e4ac-1f16-4a5a-9842-f6dd62960740"
      unitRef="usd">494000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia490ede05d664ada928496a145ece1b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtMy0xLTEtMA_c5a62daa-edc5-40e6-8f57-02ba9ec8d877"
      unitRef="usd">398000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7b1c6c4cd7c54799b4fa99f477778cb0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtNS0xLTEtMA_b597a059-20d6-42c7-927e-1e862e576ca1"
      unitRef="usd">511000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7b1c6c4cd7c54799b4fa99f477778cb0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzMtNy0xLTEtMA_67766ecc-a381-42f7-9573-73b95aa69da3"
      unitRef="usd">407000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4f8b467de7e3474592af98d693a17cc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtMS0xLTEtMA_f07dd9b5-788d-4d5e-8830-c7c37b07be27"
      unitRef="usd">1900000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4f8b467de7e3474592af98d693a17cc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtMy0xLTEtMA_4d82d778-bb09-4200-b61b-f8705d570de5"
      unitRef="usd">1325000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i893db808ea6d4f7ead3577ea17638692_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtNS0xLTEtMA_1388b02a-812e-43f5-b892-509cf7e3bd07"
      unitRef="usd">1775000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i893db808ea6d4f7ead3577ea17638692_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzQtNy0xLTEtMA_a4a553f2-e12d-4b18-8185-18621a5341df"
      unitRef="usd">1220000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtMS0xLTEtMA_51c78816-f327-45d2-92cb-df9fe462fa2a"
      unitRef="usd">14351000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtMy0xLTEtMA_7ae2c8b0-99e4-4351-be37-f2a60a5a6466"
      unitRef="usd">8476000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtNS0xLTEtMA_09a3f3eb-8bc3-47c3-b6d5-8726f6576e55"
      unitRef="usd">13345000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzUtNy0xLTEtMA_94d74551-1afb-428f-a594-2bc7849cb019"
      unitRef="usd">7806000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:GoodwillGross
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctMS0xLTEtMA_78bc23c6-dbcd-4fa4-b0ea-5a8eda698cc0"
      unitRef="usd">21888000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctMy0xLTEtMA_3039b996-9138-4dfb-9c74-939676f67577"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctNS0xLTEtMA_245f2857-8c5c-460d-b2b5-1721710e6fca"
      unitRef="usd">19924000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzctNy0xLTEtMA_aa8ab595-8447-48e3-b712-7746962f764e"
      unitRef="usd">9973000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibd5942d7cff84bfcb443a0b4ee20e405_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzktMS0xLTEtMA_5fe51801-1e62-4157-bcf2-ab11a3c34fc9"
      unitRef="usd">126000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6e92b1090f6e4a34bdde827d0faa1850_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzktNS0xLTEtMA_6c5f3202-baf3-4c15-ac07-552c060f07ce"
      unitRef="usd">257000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i341295b5472d4fd5adb9a8a46d925465_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzEwLTEtMS0xLTA_f9c0362c-e365-4d87-bf55-6e00b8f3bef5"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i297b6847ff994bb0832cc1355bf182cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzEwLTUtMS0xLTA_f4bc35d4-f1fd-4933-93b3-248ef98a0623"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzExLTEtMS0xLTA_8809962a-a8ae-49f5-8ead-40930548bc7c"
      unitRef="usd">246000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZToyMDc4OTM4Y2M0MzQ0Y2NiOGY4NGQ2ZTM1MmE3NjExOC90YWJsZXJhbmdlOjIwNzg5MzhjYzQzNDRjY2I4Zjg0ZDZlMzUyYTc2MTE4XzExLTUtMS0xLTA_51a62d0c-d4ed-4e2c-90e1-9a3a99df82ae"
      unitRef="usd">377000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzIxOTkwMjMyNTgwODA_5336355d-484f-4bd3-915d-52c49c7c2538"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzIxOTkwMjMyNTgwOTQ_5336355d-484f-4bd3-915d-52c49c7c2538"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzQ5NA_0a71ea9d-7ac9-4ff1-8a0c-aa506615aea8"
      unitRef="usd">370000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzUwNA_0f1da7b9-49f0-470c-82a5-3ae931f03230"
      unitRef="usd">460000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzUxNw_9743aa41-97da-4386-92fa-3d2bbb535be9"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NzM_66a21c45-1d38-40b9-a4e5-9278f9cafa16">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill reclassified to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Current assets held for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,503&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,887&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i9ed6b73fff7f49ae9d9bbaf6f9c9bd80_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtMS0xLTEtMA_2fcffc93-8ae0-4143-b1fd-c6a27310feda"
      unitRef="usd">2061000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id527155f2d674c79ab6ae71c08673835_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtMy0xLTEtMA_04268ed0-9a94-4967-915a-dd77ac73d4e7"
      unitRef="usd">2192000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic4f44a484dff44c3b6ed7ba7f19327d1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtNS0xLTEtMA_8c5f4196-0090-4faa-aeac-dd1c1f637779"
      unitRef="usd">5676000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i246516f377cc4e69991858548b75cc3a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtNy0xLTEtMA_c90e3eb6-e334-4a50-8a8f-41e87bc7e5e1"
      unitRef="usd">247000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEtOS0xLTEtMA_2ca8e45c-008a-4054-a191-56b23d1eb3ef"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtMS0xLTEtMA_9c9d4203-780d-4fe7-bad1-83c6f1f6f020"
      unitRef="usd">-2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtMy0xLTEtMA_4ab9284b-6587-4039-ae5d-b5aa7711106b"
      unitRef="usd">3000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtNS0xLTEtMA_7affa332-ef65-4eb3-a33e-8ff553f11de0"
      unitRef="usd">22000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtNy0xLTEtMA_38759aba-d9d3-4075-a037-14c95868dd1c"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzMtOS0xLTEtMA_144de141-a2d9-43fc-8ab0-8139f9772a1f"
      unitRef="usd">22000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtMS0xLTEtNjg3ODU_f5cd80fd-5109-4e2f-ad6a-bd68101af9c8"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtMy0xLTEtNjg3ODE_3c55aebd-f0f7-4612-990d-a74ff473f9f3"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtNS0xLTEtNjg3NzQ_98dc12ce-5a16-436b-8fe8-fe7d9f3ca8ba"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtNy0xLTEtMTM0_434ac5cc-4f74-4f59-9206-d8fbf76f71f8"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzQtOS0xLTEtMTQw_1406e8e8-2435-4379-99c4-156d7dc73df8"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTransfers
      contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtMS0xLTEtNjg3ODU_7bc78831-bf7a-4f6f-82b4-92d4e1d9b118"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtMy0xLTEtNjg3ODE_b80e1946-eeca-482b-8daf-dbd517362665"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtNS0xLTEtNjg3NzQ_4a10b191-ee23-4aec-b0fa-2e96e0cfb2c8"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtNy0xLTEtMTA2_658463f3-021b-415e-a330-73b34ba4adc7"
      unitRef="usd">-175000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzUtOS0xLTEtMTA5_88d0bcc2-69c2-41c0-947b-4c2ecdab9fd6"
      unitRef="usd">-175000000</us-gaap:GoodwillTransfers>
    <us-gaap:Goodwill
      contextRef="idac6c44071294ea9849175fac9191b7e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtMS0xLTEtMA_a00ccb73-8f4f-44ed-a7ba-823d77fdd350"
      unitRef="usd">2059000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4143ca6110b349138f60bc19e3247ec2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtMy0xLTEtMA_e6812696-55ce-4fb1-bb45-e739e594b5ef"
      unitRef="usd">2194000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia7ac69cebdf54652867c133c8113b7f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtNS0xLTEtMA_e871d16f-aab4-4f9a-9499-9f17dddf0c37"
      unitRef="usd">5697000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id7df2e64a9b0450b929459426005d498_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtNy0xLTEtMA_a310473b-473e-4dc0-8386-c8dbf6744fad"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzYtOS0xLTEtMA_1b01da17-7489-411e-ae67-042170ec4647"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtMS0xLTEtMA_e73616a6-444c-46b0-9bbf-51e24285f7e4"
      unitRef="usd">-5000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtMy0xLTEtMA_1ef9dea1-c4ce-48c6-9022-f575bf5d4a51"
      unitRef="usd">-1000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtNS0xLTEtMA_d542f3c0-eee3-46bc-9dcb-ff0d9f77818e"
      unitRef="usd">-21000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtNy0xLTEtMA_f7b3804a-70da-4af7-96e7-94d7217efcb9"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzgtOS0xLTEtMA_e2d076a7-baee-4af3-af0f-bc050ffdbfcd"
      unitRef="usd">-27000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktMS0xLTEtMA_98c20cb3-3b28-474b-aff5-07d2fb6e5d65"
      unitRef="usd">544000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktMy0xLTEtMA_39459c6d-9f2e-4ecf-8de0-3db95ed9bf48"
      unitRef="usd">1309000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktNS0xLTEtMA_a6d7a815-1b54-40cd-8658-674ff273c794"
      unitRef="usd">210000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktNy0xLTEtMA_ec065608-bad0-4442-8aa8-25612f6066f8"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzktOS0xLTEtMA_c53d885f-68f2-4c6a-80a5-3ea94790f5b0"
      unitRef="usd">2064000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i57688279666042d3a293e8a1628747b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTEtMS0xLTA_d2a75757-3e7e-4c02-85b7-198a8507f756"
      unitRef="usd">2598000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic90da61ebdeb44219dc8a12648b8a069_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTMtMS0xLTA_33949560-6a36-4550-9ba0-b30ca058b425"
      unitRef="usd">3503000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i82aece15df8345618f0e67a8da516a4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTUtMS0xLTA_d4b10b99-58bb-4a00-a81f-bc7f8df50447"
      unitRef="usd">5887000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1f668b88714f457e8c79337cd7f50e8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTctMS0xLTA_b6ef00e2-932d-4298-ade9-1f7176ee6261"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTphYmM4NjI0OThlMmE0NzQ0Yjk5M2M2MWNlNWE1M2Q0Yi90YWJsZXJhbmdlOmFiYzg2MjQ5OGUyYTQ3NDRiOTkzYzYxY2U1YTUzZDRiXzEzLTktMS0xLTA_749eff53-3fda-4ef3-a1a8-29a11f98d8a2"
      unitRef="usd">11988000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzIxOTkwMjMyNTkwNTM_dbb06548-0815-4774-b434-879536a8f811"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90ZXh0cmVnaW9uOjYyMmZkMGIyZGI1ZTQ1YWI4MDA4ZTE4MGMyYTk1OTA2XzE3NjQ_21549510-742c-45e7-b9c7-a55c778e39d4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2021 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.127%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzItMS0xLTEtMA_47e77264-7b8e-4384-9bf1-27a340e62b04"
      unitRef="usd">752000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzMtMS0xLTEtMA_428e9278-e6ba-4b1a-bced-90eeb30cca6b"
      unitRef="usd">738000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzQtMS0xLTEtMA_a6a951bf-fa36-4e22-b045-a0d7f0b55eab"
      unitRef="usd">703000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzUtMS0xLTEtMA_d028dfdc-180f-46e5-a0ee-ace05f4e960c"
      unitRef="usd">644000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDMvZnJhZzo2MjJmZDBiMmRiNWU0NWFiODAwOGUxODBjMmE5NTkwNi90YWJsZTowOGFkOWQwYTEyODE0ODVmOGI3ZTc1MzVjYWViZDgzNC90YWJsZXJhbmdlOjA4YWQ5ZDBhMTI4MTQ4NWY4YjdlNzUzNWNhZWJkODM0XzYtMS0xLTEtMA_42bf459a-eaa2-4831-bf48-cae669151bbc"
      unitRef="usd">620000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjU0_e2d3e168-f6f3-4e56-85e2-705b80281f38">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE E &#x2013; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Currency Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecasted. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax (OCI)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. For these derivative instruments, we elected to use the spot method to assess hedge effectiveness. We also elected to exclude the spot-forward difference, referred to as the excluded component, from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. As such, we defer recognition of foreign currency gains and losses within the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and we reclassify amortization of the excluded component from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to current period earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of December 31, 2021 and 2020, we designated as a net investment hedge a portion of our &#x20ac;900 million in aggregate principal amount of 0.625% senior notes issued in November 2019 and due in 2027. For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains and losses within the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We reclassify these gains and losses to current period earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In 2019, we settled all outstanding contracts, for $294 million, which is presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Payments for settlements of hedge contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of cash flows. Upon settlement in 2019, we received &#xa3;3.312 billion of cash to fund our acquisition of BTG, which translated into $4.303 billion based on hedged currency exchange rates. We recognized a $323 million loss in 2019  in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; due to changes in fair value of the contracts.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest Rate Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our interest rate risk relates primarily to U.S. dollar and euro-denominated borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as cash flow hedges outstanding as of December&#160;31, 2021 and December&#160;31, 2020. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was a $24 million loss as of December&#160;31, 2021 and a $29 million loss as of December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as fair value hedges outstanding as of December&#160;31, 2021 and December&#160;31, 2020. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated balance sheets into earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which generally offset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining time to maturity as of December&#160;31, 2021 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next year. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note Q &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $1.632 billion invested in money market funds and time deposits as of December&#160;31, 2021 and $1.584 billion as of December&#160;31, 2020, we held $293 million in interest-bearing and non-interest-bearing bank accounts as of December&#160;31, 2021 and $150 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#x2122; Drug. We recognized a financial asset and associated liability for our licensing arrangements at fair value in our consolidated balance sheets using the fair value option in accordance with FASB ASC Topic 825, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We own the contractual right to receive 50 percent of the future Zytiga&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Drug royalty payments from the licensee and remit such payments to the inventors associated with the intellectual property. Royalty payments we receive reduce the fair value of the financial asset and are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proceeds from royalty rights,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and payments we remit to inventors reduce the fair value of the financial liability and are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Payments for royalty rights&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of cash flows. We sold our right to receive and retain the other 50 percent of the future royalty payments in 2019 for an upfront cash payment, which we accounted for as a secured borrowing in accordance with FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Although we sold these rights, we continue to recognize at fair value the future royalty payments as a financial asset and associated liability. Royalty payments associated with the rights we sold no longer impact our cash flows, and we present this activity as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-cash impact of transferred royalty rights&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the supplemental information to our consolidated statements of cash flows. We reduce the fair value of the financial asset and associated liability when such non-cash activity occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have recorded the fair value of the financial asset and associated liability using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of December&#160;31, 2021. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains and losses from the licensing arrangement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2021 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$246 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$281 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Non-Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our strategic investments and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the fair values of our intangible assets including goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our outstanding debt obligations was $10.196 billion as of December&#160;31, 2021, including $1.020 billion relating to our euro-denominated December 2027 Notes, and $10.774 billion as of December&#160;31, 2020, including $1.118 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzQ2MDg_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzQ2MzE_26f223d7-3e89-42f5-9029-24c13e9d9bb6"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="i782d01afd07e478a931537d96fdb53e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU1MDk_993dfa3b-be7e-4f15-84a7-c4f75b4e6df6"
      unitRef="usd">294000000</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:DerivativeCashReceivedOnHedge
      contextRef="i626ff39017e34162b100364f2724ec05_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU2MzE_4b10e2df-3db3-4ee9-837a-657ee95873c2"
      unitRef="gbp">3312000000</us-gaap:DerivativeCashReceivedOnHedge>
    <us-gaap:DerivativeCashReceivedOnHedge
      contextRef="i626ff39017e34162b100364f2724ec05_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU2OTY_3a824ca1-5f09-42f6-aed8-7d0e7c7a6a64"
      unitRef="usd">4303000000</us-gaap:DerivativeCashReceivedOnHedge>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i0a660eb1a9ef41b289c2fd72520e03d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzU3NTY_d137dfdd-5d39-4fcb-a0d5-93d33c271df9"
      unitRef="usd">-323000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzc1NTE_d1329da1-5109-4e1d-b69c-831a12606d95"
      unitRef="usd">24000000</us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet>
    <us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzc1NzQ_80962ef5-be09-4a24-80c5-7e372c80831d"
      unitRef="usd">29000000</us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4Njky_d5de3367-f714-420a-af18-963595cc8ebe">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib9531280867949db9464c43e67215202_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzItNC0xLTEtMA_b815d6a1-60ba-4bef-aa24-0f8419bb2ab5"
      unitRef="usd">3996000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i55bdce8f6e9a4122a9891e58c6011e24_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzItNi0xLTEtMA_8c1ad47b-edc0-4e83-848e-62cc3d33e42d"
      unitRef="usd">4531000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i812f08c4fbcb4aff9a4d22c42cf9c6b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzMtNC0xLTEtMA_39286d1f-3d53-487a-8628-0a7be7706d60"
      unitRef="usd">493000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife7facfda412415a861148c501e1b519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzMtNi0xLTEtMA_0f17c998-f70c-4602-be5c-41337d23517f"
      unitRef="usd">1004000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i87edfb08cbb845159b6b5e6f1d4f21b4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzQtNC0xLTEtMA_f0540ac5-be20-45f6-92c2-799af50fc38a"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i76233e3f8eda4f81b4c34b9f8f97cec6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzQtNi0xLTEtMA_78c15c7e-b20b-4028-91b0-2e663c5fb69c"
      unitRef="usd">868000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9c84f93b28ad41b9b47b5c208f7efc54_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzUtNC0xLTEtMA_8b3762e0-dbe1-4907-bd76-17a6fa108e15"
      unitRef="usd">3892000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6ed12a7015134ea4942cb2107d893933_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzUtNi0xLTEtMA_7afc8fba-3e02-4f64-8acb-132e140bf2fb"
      unitRef="usd">4946000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzctNC0xLTEtMA_8ce75c1b-68f4-4ca3-9547-e300e2f138ed"
      unitRef="usd">9378000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjMzc4YWUyNThkYjA0M2YzYmVhOGU0NzcxODM5ZjQ3MS90YWJsZXJhbmdlOmMzNzhhZTI1OGRiMDQzZjNiZWE4ZTQ3NzE4MzlmNDcxXzctNi0xLTEtMA_7c2a193e-e0ba-4154-a0c7-599613157862"
      unitRef="usd">11349000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzg5MTc_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <bsx:ForwardCurrencyContractsTimetoMaturity
      contextRef="ib55f19bd5c9d4d2daf3efa38fdb0d083_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzkyMDc_68d6a0c7-35d9-48ae-bc0a-9b660cbadb75"
      unitRef="units">60</bsx:ForwardCurrencyContractsTimetoMaturity>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjY0_26a371bc-d3ad-4832-9f55-9f47340597e9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note Q &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMS0xLTEtMA_969ab18c-2f4b-45da-9bcd-3df04aebb71c"
      unitRef="usd">268000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMi0xLTEtMA_95be04d2-da96-45fb-9da8-7311938ebcfb"
      unitRef="usd">-60000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMy0xLTEtMA_d64eb835-6527-447b-ab52-d524a9e8cd18"
      unitRef="usd">208000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtNi0xLTEtMA_a725d8b1-a6ae-4826-95b1-08fe723cae5c"
      unitRef="usd">3711000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtOC0xLTEtMA_a3250867-cecd-4225-8259-99d1a34d00a2"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtOS0xLTEtMA_fa4e5b88-7078-492a-b522-9ced343c4c56"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i59bf5213305c406f8aae709bc179528e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzUtMTAtMS0xLTA_6ed743cb-cb7a-47e7-ad46-4056a82ed6dd"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMS0xLTEtMA_1a6fd16d-aad9-4869-bd06-5be81efb017a"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMi0xLTEtMA_6770cbea-ac5f-404f-8568-0381ef3e199d"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMy0xLTEtMA_791d0fa7-85b6-4b7a-8ae0-e03a3af2efbe"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtNi0xLTEtMA_6fc08023-851c-4a0c-b7f6-c99f2a4f6159"
      unitRef="usd">341000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtOC0xLTEtMA_12b9d8f6-ff85-4777-bb77-6b91bcf3364c"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtOS0xLTEtMA_1ab4229f-0349-42ce-8b3c-9b54e1fc176d"
      unitRef="usd">3000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i61120d0e898a41bf8350151f63eb6a6a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzYtMTAtMS0xLTA_539f925b-54d2-48d8-9d10-7a79d9094ea6"
      unitRef="usd">10000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMS0xLTEtMA_6e5c3072-4571-4269-8fd1-3be872543cf1"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMi0xLTEtMA_199c853d-e57c-473f-96f8-265fbd05221d"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMy0xLTEtMA_b24a0c57-aa71-4cdd-96ed-e3a7bc8ed5f7"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtNi0xLTEtMA_bfe9f675-646f-4780-9ca0-eb307411d46b"
      unitRef="usd">-218000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtOC0xLTEtMA_dd1ad90e-35b5-4ad4-91eb-ee21a58657d5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtOS0xLTEtMA_e6555b6d-5e6b-431d-8b61-d3bf61407e6d"
      unitRef="usd">0</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="ied94405573f54864b56ad4894ecc90e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzgtMTAtMS0xLTA_c2372858-fe6a-4f9a-9c7d-7e7d96e44739"
      unitRef="usd">0</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTEtMS0xLTA_2f05d65c-6e75-4703-b83a-ab689cba64cf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTItMS0xLTA_3db09e97-6ee8-4307-88bf-9038053a0161"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTMtMS0xLTA_307e9e89-d21c-4224-98d5-6dd81e7ab995"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTYtMS0xLTA_6fc08023-851c-4a0c-b7f6-c99f2a4f6159"
      unitRef="usd">341000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTgtMS0xLTA_cd0edb4c-f288-47b2-bf39-b908e1686046"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTktMS0xLTA_d852d5af-879b-408b-aded-550dbf23de9b"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ife13877f1409434e9eda065c8ddaa381_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEwLTEwLTEtMS0w_3f4d61e7-3561-4026-a99b-f3a6eba8e920"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTEtMS0xLTA_7997e98c-43d6-46ed-ab1b-a264f69a0702"
      unitRef="usd">-99000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTItMS0xLTA_c777d138-0cd4-4cae-a2a4-c04108d8ac22"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTMtMS0xLTA_f2f52276-995b-43dd-8654-147d7492983b"
      unitRef="usd">-77000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTYtMS0xLTA_abe2d9ff-cbfe-43ed-aff5-16b877a63b7d"
      unitRef="usd">3465000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTgtMS0xLTA_313be5a7-5b36-451e-8b37-719a8da9b02d"
      unitRef="usd">-83000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTktMS0xLTA_e2fe56a5-2106-45aa-956f-d8870ad838a0"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ieef9394ae96e42548978301b4001ac22_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzEzLTEwLTEtMS0w_671d7492-46a7-49b8-9712-f216819a00ab"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTEtMS0xLTA_fa520193-7a88-402e-a246-61514c010d5d"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTItMS0xLTA_204eb553-46a8-4d8e-85fc-a29974a6b7fb"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTMtMS0xLTA_5aa29678-54ca-4036-a914-022650316210"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTYtMS0xLTA_9f41421d-10c2-44d4-b29a-130a206d4fa8"
      unitRef="usd">361000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTgtMS0xLTA_f98f0a14-6b83-42c3-9136-9224f2955c4c"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTktMS0xLTA_33d32d61-3d8c-42be-996a-88d2347ad711"
      unitRef="usd">5000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i837f059ae5ab4ce0b78da522ec069a94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE0LTEwLTEtMS0w_49c1ab5e-4d34-4cc2-837a-8fcd9f475430"
      unitRef="usd">-19000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTEtMS0xLTA_c00f5d56-c828-47c0-a1e7-10014bd59049"
      unitRef="usd">-89000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTItMS0xLTA_bd5ed852-29ae-4765-83ee-6f92d1efed96"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTMtMS0xLTA_1a7471f1-7a2c-4b18-963a-ca2476b164d4"
      unitRef="usd">-68000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTYtMS0xLTA_b19c2879-db30-426c-8675-b07bb3558f83"
      unitRef="usd">-362000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTgtMS0xLTA_30f140e3-c17d-43f7-a0cb-b0fe23fe0785"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTktMS0xLTA_189864fd-6127-4e30-8a27-efd87b95f4e1"
      unitRef="usd">0</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="ie342c2911db0411ebfc0284b256abb48_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE2LTEwLTEtMS0w_96395a8b-0077-41e5-b1f3-bf5adf9d0732"
      unitRef="usd">0</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTEtMS0xLTA_d13bc4b3-3598-4397-95d4-1445cc953a63"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTItMS0xLTA_9f4554d8-a8fd-4bab-9d11-5139ad9b5a66"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTMtMS0xLTA_3cc360bd-5144-49a8-87b6-66f0097619b8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTYtMS0xLTA_9f41421d-10c2-44d4-b29a-130a206d4fa8"
      unitRef="usd">361000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTgtMS0xLTA_059ae571-e061-4b77-9d64-d59afdb17b3c"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTktMS0xLTA_2b9337bb-3192-4b0f-af3e-b1ee3c0ee323"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i49fa4cd0997b482d909cf65c420105ec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzE4LTEwLTEtMS0w_4768d6b9-408e-4f10-bdc1-3c2f43bf3d08"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTEtMS0xLTA_310c7069-3183-4ac4-8637-c36dd5818105"
      unitRef="usd">150000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTItMS0xLTA_911272ca-bc31-44ce-ac6b-6be5aa0ba8ac"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTMtMS0xLTA_5d17acc9-6285-4f96-8d9c-4fe681e0bcf5"
      unitRef="usd">117000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTYtMS0xLTA_7539f9f1-d01d-44f8-8eec-e539eda39562"
      unitRef="usd">3116000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTgtMS0xLTA_2f3e43b7-4c60-4384-9067-7a3722d26c8a"
      unitRef="usd">-73000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTktMS0xLTA_bb4dd928-2292-454d-a96a-e1b51709e94d"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3bb5cba4c67842329a24b38b2cee9258_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIxLTEwLTEtMS0w_157dad1a-83b1-415f-bf69-8e379ebbfa6d"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTEtMS0xLTA_a196392c-7e7a-4ec7-baaf-265e45a2d411"
      unitRef="usd">-68000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTItMS0xLTA_6775824e-dedd-4a1d-9ba8-4efdd6778c50"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTMtMS0xLTA_f4acbd83-82be-478e-ba62-d119b91e5b88"
      unitRef="usd">-53000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTYtMS0xLTA_be80fb9c-976d-4176-a7d0-21195ee5a6b8"
      unitRef="usd">473000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTgtMS0xLTA_8ba68c13-bbab-45c8-b975-4bee203f287d"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTktMS0xLTA_f96fd10b-d590-485d-9441-5e9193033678"
      unitRef="usd">10000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="iba24047ab9634b0fba02c8048e5629d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzIyLTEwLTEtMS0w_3410117e-4f6d-4612-88bc-b001945edd24"
      unitRef="usd">-33000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEtMS0xLTQ4MjM2_1753ea5a-036c-4d5f-ba21-36973540952d"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTItMS0xLTQ4MjQ0_7a99f66d-fcce-44ef-8212-3ac0fe9022ac"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTMtMS0xLTQ4MjUy_aff56438-a862-4a54-8100-1b4456ec7b75"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTYtMS0xLTQ4MjYy_57d29d43-297f-4e08-971f-200dee82e476"
      unitRef="usd">-358000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTgtMS0xLTQ4Mjcw_4c3d8d94-f270-40d2-9242-3dc2e013328d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTktMS0xLTQ4Mjc3_703ce884-1454-4e32-b9e2-a4896ba576e0"
      unitRef="usd">0</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i0a1af9b4e47246a0bc0af230728dd692_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEwLTEtMS00ODI4NA_53ca14b2-550b-41af-9fca-0b93664a0559"
      unitRef="usd">0</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEtMS0xLTA_f1640050-5184-4d18-bced-7f793eb19c90"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTItMS0xLTA_c1bca3c3-6358-4f4d-a0c0-e9cd603ca3b2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTMtMS0xLTA_538e4ec0-9feb-4518-a516-d268c27d19e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTYtMS0xLTA_be80fb9c-976d-4176-a7d0-21195ee5a6b8"
      unitRef="usd">473000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTgtMS0xLTA_6003ea0d-2f72-4dd5-a70f-d87cda13da76"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTktMS0xLTA_9a1d9831-9ade-4edc-8f3c-ca355e1cc7ea"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i273082e62ab44a87b7b8654ef40613a9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozZTJmYjNjNmQ3ZTI0ODA3OWIzM2MzMDM5NTA5ODMzMS90YWJsZXJhbmdlOjNlMmZiM2M2ZDdlMjQ4MDc5YjMzYzMwMzk1MDk4MzMxXzI0LTEwLTEtMS0w_b4931efb-8d63-4473-88d8-5798564b9924"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjMy_74bf0e90-7bfd-4261-9ec5-1be6e919df32">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i097a22a349ff4abea29f95badcb8b81d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozOTNjYjU2ZWJmYjA0Y2I2YmY1YjliOWE0YjliNTBlYy90YWJsZXJhbmdlOjM5M2NiNTZlYmZiMDRjYjZiZjViOWI5YTRiOWI1MGVjXzEtNi0xLTEtMA_89b53a31-2991-476d-b133-157c88ad84c8"
      unitRef="usd">127000000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet
      contextRef="i12c5ecd8e9d04fb5bfb0c044ab0e9c6d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozOTNjYjU2ZWJmYjA0Y2I2YmY1YjliOWE0YjliNTBlYy90YWJsZXJhbmdlOjM5M2NiNTZlYmZiMDRjYjZiZjViOWI5YTRiOWI1MGVjXzItNi0xLTEtMA_dfaf2324-f64e-4593-9967-7efbeeb9550e"
      unitRef="usd">3000000</bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i5c4da7805cf34686993ec3f55d35e90c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozOTNjYjU2ZWJmYjA0Y2I2YmY1YjliOWE0YjliNTBlYy90YWJsZXJhbmdlOjM5M2NiNTZlYmZiMDRjYjZiZjViOWI5YTRiOWI1MGVjXzMtNi0xLTEtMA_91ff3199-950e-4f12-b638-35b3a0c92b00"
      unitRef="usd">-5000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4Njg0_0f2bfbd1-ef55-41a9-a7f5-6b317ec0e073">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzItNC0xLTEtMA_52a44406-405c-4710-ae65-b8e9e08d9259"
      unitRef="usd">-16000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzItNi0xLTEtMA_860309a3-3f93-41bc-8512-7804b3bdd217"
      unitRef="usd">73000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzItOC0xLTEtMA_0cf68b25-4f8b-46a7-bce6-96b37c3dfbfa"
      unitRef="usd">-343000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzMtNC0xLTEtMA_2be37e02-0c37-422d-8034-b4611977af31"
      unitRef="usd">-12000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzMtNi0xLTEtMA_27495d6b-e1d4-48fd-a683-f070956f61f8"
      unitRef="usd">-105000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzMtOC0xLTEtMA_b6d5cb95-6ab2-4f16-9085-29f480711baa"
      unitRef="usd">-15000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i236dc457d4c44d0fb4060bfd45fd4d35_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzQtNC0xLTEtMA_c3695f1d-112f-4a89-b062-93fee7b380d5"
      unitRef="usd">-27000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i30b2277c6ee74e83b8f3b1b5acc41163_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzQtNi0xLTEtMA_40032b1b-9b89-4f57-bc0c-9b36159f043b"
      unitRef="usd">-32000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i97e368e810c940b4bb3181d5b340de88_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpjOWEwYzNiYjZjZTA0NzQ3YWFkM2UwZDllYzU0M2I4OC90YWJsZXJhbmdlOmM5YTBjM2JiNmNlMDQ3NDdhYWQzZTBkOWVjNTQzYjg4XzQtOC0xLTEtMA_8227e904-1fcb-4def-bb18-5563b50cc849"
      unitRef="usd">-358000000</bsx:NetCurrencyExchangeGainLoss>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NzA2_7b28efc6-039c-408b-8ea1-98d3a42141b6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means.</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjQ2_5bfe5cf9-64b1-4708-8ad0-b77bf0c0d570">The following are the balances of our derivative and nonderivative assets and liabilities:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="id80ca8f87e8c4cb484a3d263b3bb637e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzQtNC0xLTEtMA_fb90fea3-ca5b-4979-876a-ff4716f7689b"
      unitRef="usd">183000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="idda6065f68154a37934825525972e22e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzQtNi0xLTEtMA_765f75b3-cba0-4e0d-889c-414122bc2ad3"
      unitRef="usd">53000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ief10444ff3084ac7bc054c27341e827b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzUtNC0xLTEtMA_bee9a3e0-412a-45dd-987d-fe2dd4841905"
      unitRef="usd">169000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i109998db04ff4f648674392ae1a723c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzUtNi0xLTEtMA_7dc5f9e9-15a8-4e15-a66d-fa559f0776f3"
      unitRef="usd">109000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i2731c2a351fe4a4f840aa3d75204b39a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzYtNC0xLTEtMA_3d9c7270-18e7-4daa-b010-aebf734d8f9b"
      unitRef="usd">352000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ib0d8505202864b7385a6cea691031d04_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzYtNi0xLTEtMA_2048bf86-1622-46ac-a631-9b4f2f65a049"
      unitRef="usd">162000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="idd4847b37d67457bab88ed655a398e6b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzgtNC0xLTEtMA_970a1b34-e23b-4324-9dfd-7e575a32237d"
      unitRef="usd">42000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i87f4b0d184cc492b8a1c645c1eb819da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzgtNi0xLTEtMA_c110188a-2ba7-42c1-9693-28b8026a8e5d"
      unitRef="usd">79000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzktNC0xLTEtMA_a71e29e8-b13a-4295-815b-a5a1dbfb418b"
      unitRef="usd">394000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzktNi0xLTEtMA_2fc60b70-19ae-4ec6-96df-939ef080fb58"
      unitRef="usd">242000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="if3c7842f764a4d47946a0b5c9fc60c6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzEzLTQtMS0xLTA_eb74e3fe-5256-42a2-99ed-678b317bed09"
      unitRef="usd">32000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ibd00d55e3da24a278600f1257c6a759f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzEzLTYtMS0xLTA_f0b8fbfa-0b54-4ff9-b886-06f7bc94f6fc"
      unitRef="usd">44000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i725a0c2c245d477a866680ee271fef5b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE0LTQtMS0xLTA_de6abb7d-fcac-4c61-a5f4-c5c06ece10aa"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ic9da8aea23bd441c979d30b5eca1589d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE0LTYtMS0xLTA_e8182a00-832e-4b12-a4bc-b3d9fd953746"
      unitRef="usd">54000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i3918eea06dc645afa81bf6b59e512ffc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE1LTQtMS0xLTA_ca4f8200-2378-4d18-9ab9-e2ce2f89c8ef"
      unitRef="usd">1011000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ie5cd80680db2415fa27296f65f1a788c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE1LTYtMS0xLTA_533132e8-de71-40f9-86bb-8b27f8a6bbf1"
      unitRef="usd">1094000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i2731c2a351fe4a4f840aa3d75204b39a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE3LTQtMS0xLTA_d2af1357-b930-4d45-8737-19c93e353da9"
      unitRef="usd">1049000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ib0d8505202864b7385a6cea691031d04_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE3LTYtMS0xLTA_541001ef-dbcb-410a-8c59-9ca2ddad7fe6"
      unitRef="usd">1191000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i134d607092fd4a008581e04dfcac820e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE5LTQtMS0xLTA_7d5870ed-f458-4e1f-8c7a-39c8021fb469"
      unitRef="usd">22000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i48ae77b262464a3faa59c2a3cd00d12e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzE5LTYtMS0xLTA_787a1593-efe1-42c7-af79-00d4f59ef07f"
      unitRef="usd">71000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzIwLTQtMS0xLTA_f540c11c-8021-4fda-979b-1cb422da5176"
      unitRef="usd">1071000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTozODNjOTM3NmQwNDk0MDk3YmY5MzY2NTgyNWJhY2VkNS90YWJsZXJhbmdlOjM4M2M5Mzc2ZDA0OTQwOTdiZjkzNjY1ODI1YmFjZWQ1XzIwLTYtMS0xLTA_8e21c86c-db8d-4399-8b9d-4bf2916b3a80"
      unitRef="usd">1262000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LongTermDebt
      contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzEyNzgz_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4NjQ3_2b3be7b0-d0a7-4c92-bff0-53da9023bb40">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2021 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$246 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$281 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMS0xLTEtMA_31e8be6c-69c7-4b69-aee4-e9deef852856"
      unitRef="usd">1632000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMy0xLTEtMA_68f604ef-085e-4f2f-8a5e-c900b6344806"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtNS0xLTEtMA_2f88a280-1bd5-4546-95ca-6fc0b6c648bd"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtNy0xLTEtMA_a5e3a88f-870c-4d46-b626-b45dab8a0a3e"
      unitRef="usd">1632000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtOS0xLTEtMA_7a8e8a90-5d30-4f6e-81f5-c6d86709e841"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMTEtMS0xLTA_d6d362f5-c876-4a04-a4fd-dcff9dd1a1ba"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMTMtMS0xLTA_131cd7f8-e214-48fa-9cbe-0bcffe1558de"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzQtMTUtMS0xLTA_5f5e0b79-c648-4406-a3ec-4a38bba8568c"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMS0xLTEtMA_78535792-5450-4cc4-a2bd-8a6ddc487e0c"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMy0xLTEtMA_f1ef0c4e-e3ed-478b-a699-e02fa2110fec"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtNS0xLTEtMA_df3d1a4b-f081-43cc-a782-6977fdd45c44"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtNy0xLTEtMA_2957a7a6-5809-4d37-b21a-34a12a979775"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtOS0xLTEtMA_8a72e839-bfe3-43dc-aefa-0c5e5a9e4dfc"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMTEtMS0xLTA_81f54893-07fc-4e53-b2f1-c0fa1661cac0"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMTMtMS0xLTA_4b98f9c6-40b8-48ca-96da-81b6237e085c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzUtMTUtMS0xLTA_67c1e0aa-9570-497d-8af4-013ac42c3c5a"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMS0xLTEtMA_28ea88de-14ef-400a-81ef-fb8c19b73c3c"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMy0xLTEtMA_0817a00c-cd43-4a3b-befb-f3ceaca2de7d"
      unitRef="usd">394000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtNS0xLTEtMA_dc1958c8-0aba-4f0e-a45a-145853f38b91"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtNy0xLTEtMA_b0e8689a-a493-48a4-a9fb-8d6702834596"
      unitRef="usd">394000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtOS0xLTEtMA_00f12fc0-c696-49cd-b295-d608d04643b5"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMTEtMS0xLTA_dfd1dce7-c894-4e03-aa61-f90497f29d1b"
      unitRef="usd">242000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMTMtMS0xLTA_739d2d9e-38d7-4f04-8b88-7c695922911f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzYtMTUtMS0xLTA_ac7a489f-4bbf-420d-a7bd-41b24002c866"
      unitRef="usd">242000000</us-gaap:DerivativeAssets>
    <bsx:LicensingArrangementsAsset
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMS0xLTEtMA_26f60b80-6fae-448d-8576-c6c9c66be458"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMy0xLTEtMA_4242010d-eb2f-4279-a217-a4a1abdf2635"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctNS0xLTEtMA_64df3dd5-792d-4d0b-b7f1-f8a95639b81b"
      unitRef="usd">246000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctNy0xLTEtMA_81ca8ddc-1455-45ea-803d-d08194ba61a7"
      unitRef="usd">246000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctOS0xLTEtMA_326a878c-440a-4310-8d5f-6e712935330f"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMTEtMS0xLTA_cca70296-ddb0-4de5-abc6-22d3f3264540"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMTMtMS0xLTA_3d399070-ac8b-4858-824f-783c75df5767"
      unitRef="usd">365000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzctMTUtMS0xLTA_49d73988-08d5-4cc4-84e8-4005479a60a6"
      unitRef="usd">365000000</bsx:LicensingArrangementsAsset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMS0xLTEtMA_676e2f07-a1ee-4a5a-833c-330f46d029b2"
      unitRef="usd">1642000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMy0xLTEtMA_37295675-7450-4596-85fe-1a3ba2d21673"
      unitRef="usd">394000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtNS0xLTEtMA_1024a292-5118-4355-b114-535632a45204"
      unitRef="usd">246000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtNy0xLTEtMA_11a97873-b1cb-408e-8e53-a2b7a0126c00"
      unitRef="usd">2282000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtOS0xLTEtMA_04c484b1-7437-480d-bd27-d7ed6bbb9d85"
      unitRef="usd">1998000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMTEtMS0xLTA_2ea478ba-1424-4e55-9272-8ffa1a16b4a7"
      unitRef="usd">242000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMTMtMS0xLTA_b2774155-7b1e-426a-a2b5-3705e6497d22"
      unitRef="usd">365000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzgtMTUtMS0xLTA_f2711c31-41d3-4354-bde7-87e4dc4cba6a"
      unitRef="usd">2605000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTEtMS0xLTA_f86c7381-c476-49e9-858b-ec64251ec1b8"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTMtMS0xLTA_b5d42db8-3ffd-41b9-8524-9fed5e5e198c"
      unitRef="usd">1071000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTUtMS0xLTA_b4c24411-9fe1-4160-9ac7-29151d532ea5"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTctMS0xLTA_377ba2f2-1079-475f-a21b-57dd81450311"
      unitRef="usd">1071000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTktMS0xLTA_bbe1cb54-db3b-45d9-a6df-accb3217b539"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTExLTEtMS0w_3b0821ef-dcf8-4e39-bfcb-039968a38eaa"
      unitRef="usd">1262000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTEzLTEtMS0w_fc17e472-20f2-42c8-b52c-7137711b5fbe"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEwLTE1LTEtMS0w_515d99c4-735c-4425-a09b-f2973a4bbe91"
      unitRef="usd">1262000000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTEtMS0xLTA_b697b19a-5d1f-46e3-97e5-49ec4de2e6e3"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTMtMS0xLTA_c0870f4c-576e-4798-b19a-c78a3e6ae8fb"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTUtMS0xLTA_3ed73b25-add0-4ea2-b9b1-9719425be463"
      unitRef="usd">486000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTctMS0xLTA_1f34dfab-762c-4f4a-a67f-e92dba94c36d"
      unitRef="usd">486000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTktMS0xLTA_52b89569-c349-4814-bbf1-5b43406c5209"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTExLTEtMS0w_a0946feb-88bf-431a-ac18-7d8f47153a30"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTEzLTEtMS0w_ea47e7ce-6c23-4039-a7ac-b9bbf6508baa"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzExLTE1LTEtMS0w_85d6eca1-4435-4e32-a1f8-132e439a895e"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTEtMS0xLTA_5bed72e1-48e2-4c53-8ee9-16c4a79746d1"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTMtMS0xLTA_93f33ba9-a1a5-4b90-9b88-1713a9ac8f97"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTUtMS0xLTA_492afbbe-e2e1-44d3-9037-def531e889ae"
      unitRef="usd">281000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTctMS0xLTA_85734b02-e39d-43e9-80e9-563365a876fa"
      unitRef="usd">281000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTktMS0xLTA_52334892-2fed-46ec-9cb2-2bdb1aaa52cc"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTExLTEtMS0w_0f619879-065f-492c-a2fc-b1ca7ded87f5"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTEzLTEtMS0w_4a34dddc-1c36-4718-844e-194fcf4d27df"
      unitRef="usd">407000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEyLTE1LTEtMS0w_24b4d286-fc0b-4d41-9c9a-95c0e7512cd9"
      unitRef="usd">407000000</bsx:LicensingArrangementsLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTEtMS0xLTA_635bda0a-dc4e-4a47-a6ca-c8f8986b93e2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i57785f8465894b2daed454aefed9a6ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTMtMS0xLTA_21d56f56-332d-44b3-ab15-77d0c9458e0d"
      unitRef="usd">1071000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5cc3f8952c054ec69239a226f72abbe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTUtMS0xLTA_a8fd222f-ecb3-4cf1-accb-15256338c508"
      unitRef="usd">767000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idc26837a45614b51bb4eed0c541ba0df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTctMS0xLTA_088381ff-9d9b-4ed3-b75f-11c032fb6a66"
      unitRef="usd">1838000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTktMS0xLTA_4efa43ae-fad0-44da-9794-092553379cf0"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i88b6427b107a4b6893f3bce6a59d182f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTExLTEtMS0w_34f779c4-7429-4972-9f65-3e33e5a0b54f"
      unitRef="usd">1262000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib95bc373f5b8475d91c13ee889dbdaf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTEzLTEtMS0w_4c5b67f2-26d4-486d-be8c-1919c8875dfc"
      unitRef="usd">603000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib54d7880b0f14060b36dc8a02d2bbf4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo4NTVhYzY4NDI1YTc0OTQ3OWQ2ZDMzZWQ4ZjliYWMzMi90YWJsZXJhbmdlOjg1NWFjNjg0MjVhNzQ5NDc5ZDZkMzNlZDhmOWJhYzMyXzEzLTE1LTEtMS0w_ad1d6b57-6afd-486f-aa54-bcf1395b9252"
      unitRef="usd">1865000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i6c14ffbf1a2c42ccb31bc02eb619a2e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0NTk0_31e8be6c-69c7-4b69-aee4-e9deef852856"
      unitRef="usd">1632000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i65b9acc5b0d846c29779b6e5a0529569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0NjU5_7a8e8a90-5d30-4f6e-81f5-c6d86709e841"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:Cash
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0Njgw_fe600458-cafb-42e5-9a07-da9e316317db"
      unitRef="usd">293000000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE0NzU1_12c903de-50ab-4bbb-a13b-8c13e893f2d9"
      unitRef="usd">150000000</us-gaap:Cash>
    <bsx:LicensingArrangementsAsset
      contextRef="i5080b79d26164c5da882a84779417883_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzEtMS0xLTEtMA_7a61cf7a-c113-455b-8fea-9713fedbe832"
      unitRef="usd">246000000</bsx:LicensingArrangementsAsset>
    <bsx:DiscountRateFairValueInput
      contextRef="ic5ac76f7fccd4691a0a4ef3f2d0fcf1b_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzEtNC0xLTEtMA_965b21ae-773a-43f2-b7a7-511ef5006107"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i80725583ad834079902d53e2aadcf36e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzEtNy0xLTEtMA_baa1b54f-cbd7-4c42-b5d3-73ae94e928b9"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:LicensingArrangementsLiability
      contextRef="i5080b79d26164c5da882a84779417883_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtMS0xLTEtMA_0fa72080-589e-41c8-83b0-128efc9e1edd"
      unitRef="usd">281000000</bsx:LicensingArrangementsLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i74d5a471f86e4b9f9ffbc69b60fdba65_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtNC0xLTEtMA_3b1189b7-b4e6-4e49-96d3-631239a00165"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ic2567fd9e6c448c6bd8df0511e4e2148_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtNi0xLTEtMA_4b2f2ba1-44fb-4b67-ac0e-b73316674377"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ib369619c4f02462baf6c43cb80f23d68_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTo5NTMxNThmOTA0N2Q0MGE3OTYyYjdhMzQ2ZmRmNjYyMi90YWJsZXJhbmdlOjk1MzE1OGY5MDQ3ZDQwYTc5NjJiN2EzNDZmZGY2NjIyXzQtNy0xLTEtMA_a8dac5fc-c6cc-4261-a097-fcce33fefecc"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:LicensingArrangementsAsset
      contextRef="i159eed8645cb401f99a8d7dc6909d9ff_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzEtMS0xLTEtMA_12d8f98e-b44b-4136-a818-e028410c7486"
      unitRef="usd">518000000</bsx:LicensingArrangementsAsset>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzItMS0xLTEtMA_69156576-032b-47c7-918e-c4191b832fa0"
      unitRef="usd">175000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzMtMS0xLTEtMA_2dc68690-261d-4c4c-9809-44ad4b8de590"
      unitRef="usd">22000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i025ca3c48ee74d04b6b542e96b93ba50_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzQtMS0xLTEtMA_c262adf5-fac5-446c-bbf9-c3d2b0c48710"
      unitRef="usd">365000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:LicensingArrangementsAsset
      contextRef="i313491a2c13d4ea18bb58480b90499ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzUtMS0xLTEtMA_12c11b75-ce53-4b9a-b72c-37087eb96819"
      unitRef="usd">163000000</bsx:LicensingArrangementsAsset>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i969bdf20fd234556a472ac3c3bd91a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzYtMS0xLTEtMA_e3fd6180-9a64-4b60-9f69-257301c88747"
      unitRef="usd">44000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i969bdf20fd234556a472ac3c3bd91a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZToxYzVhY2FjZmM3ODU0MjVlODkxMmFhMTJiZTk2NjU0Ny90YWJsZXJhbmdlOjFjNWFjYWNmYzc4NTQyNWU4OTEyYWExMmJlOTY2NTQ3XzctMS0xLTEtMA_2493c501-5c21-4424-9aa4-d822221feb4e"
      unitRef="usd">246000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:LicensingArrangementsLiability
      contextRef="i9d55e0941456418590fcc0b66bb0dae8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzEtMS0xLTEtMA_35030659-ff7b-489a-a58c-72a901be966b"
      unitRef="usd">571000000</bsx:LicensingArrangementsLiability>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ie093a7adfb86426a9b678f6d156bac3b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzItMS0xLTEtMA_8f43552c-4eb0-4272-a832-978510d8a4c0"
      unitRef="usd">186000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="ie093a7adfb86426a9b678f6d156bac3b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzMtMS0xLTEtMA_47071a83-5409-4aa3-bdde-a9bd0f3a36ea"
      unitRef="usd">22000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <bsx:LicensingArrangementsLiability
      contextRef="i5e36a30cc5194c4fb5b6a7caf9030f5f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzQtMS0xLTEtMA_949cf314-bbee-4a94-8af2-48c56c89360c"
      unitRef="usd">407000000</bsx:LicensingArrangementsLiability>
    <us-gaap:PaymentsForRoyalties
      contextRef="i407f649729a04a849ad43194e1cb4088_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzUtMS0xLTEtMA_1603d6c2-0a91-4ebe-a616-ca3d908228ca"
      unitRef="usd">166000000</us-gaap:PaymentsForRoyalties>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i407f649729a04a849ad43194e1cb4088_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzYtMS0xLTEtMA_a028e42f-ebed-43a8-88e5-a6f7c82c06dc"
      unitRef="usd">41000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:LicensingArrangementsLiability
      contextRef="ic347736243d746bda91e919b3077d630_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90YWJsZTpkMjU3MDczZDRmMjg0MDBhYmQ4MjQyMjJiYTM1N2ZjMS90YWJsZXJhbmdlOmQyNTcwNzNkNGYyODQwMGFiZDgyNDIyMmJhMzU3ZmMxXzctMS0xLTEtMA_e3029b07-96ec-4514-9d4b-b2a76cc9c43d"
      unitRef="usd">281000000</bsx:LicensingArrangementsLiability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4MTg5_7539bfce-7e30-4ccd-876e-1b2aad55cd2f"
      unitRef="usd">10196000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i73cc4ab1dd684ec58982d5866047dbdf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4MjEy_04db13a2-f9f7-431f-bee9-80f75d58df97"
      unitRef="usd">1020000000.00</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4MjU2_29fadc6d-9adc-4dd6-820e-b3610649d9c6"
      unitRef="usd">10774000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i40cd8405c4eb41baa85544a9136ba611_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDYvZnJhZzoxYTk3NTMxZDA5Nzk0Y2E5YWQ2YTkxYTcwZDkxYmM0Yi90ZXh0cmVnaW9uOjFhOTc1MzFkMDk3OTRjYTlhZDZhOTFhNzBkOTFiYzRiXzE4Mjc5_fe8783b0-1378-4b3c-9566-45bb61034cbd"
      unitRef="usd">1118000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NDky_993dd6e8-a2ec-4092-adbe-6745db1a65d0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE F &#x2013; CONTRACTUAL OBLIGATIONS AND COMMITMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Borrowings and Credit Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had total debt outstanding of $9.065 billion as of December&#160;31, 2021 and $9.143 billion as of December&#160;31, 2020, with current maturities of $261 million as of December&#160;31, 2021 and $13 million as of December&#160;31, 2020. The debt maturity schedule for our long-term debt obligations is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the December 2027 Notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective November 15, 2021, the interest rate payable decreased by 0.25 percent and began accruing at a rate of 6.75 percent following recent upgrades to our credit ratings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)  As of December&#160;31, 2021 the outstanding balance is presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Debt Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&#160;&#160;&#160;&#160;The December 2027 notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 10, 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of December&#160;31, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Term Loans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $1.250 billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the 2018 Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $500 million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our Mandatory Convertible Preferred Stock (MCPS) and common stock offerings to repay in full the remaining $750 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 27, 2020, we entered into a $1.000 billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding on the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of 0.85%. The credit agreement is subject to a financial covenant described below under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $750 million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $250 million and terminated the February 2021 Term Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 5, 2019, we entered into a $700 million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December 31, 2019, we had $700 million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $300 million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 19, 2018, we entered into a $2.000 billion senior unsecured delayed-draw term loan facility consisting of a $1.000 billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $1.000 billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August 19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $1.000 billion under the Two-Year Delayed Draw Term Loan and $1.000 billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, the December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $1.000 billion outstanding under the Three-Year Delayed Draw Term Loan. In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of December&#160;31, 2021, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of and through December&#160;31, 2021, we were in compliance with the financial covenant required by our credit facilities described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;br/&gt;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;br/&gt;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Revolving Credit Facility includes the following financial covenant requirement for all of our credit arrangements (i) maintain the maximum permitted leverage ratio of 4.50 times for the first quarter of 2021, with a step-down for each succeeding fiscal quarter end to 4.25 times, 4.00 times, and ultimately 3.75 times for the fourth quarter of 2021 and through the remaining term of the 2021 Revolving Credit Facility. The agreement provides for higher leverage ratios for the period following a qualified acquisition, at our election, for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;leverage ratio is 4.75 times. It steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreement, through maturity, of any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of December&#160;31, 2021, we had $376 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $1.455 billion in the aggregate. As of December&#160;31, 2021, we had $1.122 billion of the litigation exclusion remaining.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any inability to maintain compliance with this covenant could require us to seek to further renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable&lt;/span&gt;&lt;span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had senior notes outstanding of $9.121 billion as of December&#160;31, 2021 and $9.205 billion as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2020, we redeemed $250 million of our $500 million 3.375% senior notes due 2022 (May 2022 Notes) at a redemption price calculated in accordance with the terms of the May 2022 Notes and its indenture, plus accrued and unpaid interest through, but excluding, the date of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we completed an offering of $1.700 billion in aggregate principal amount of senior notes comprised of $500 million of 1.900% senior notes due June 2025 and $1.200 billion of 2.650% senior notes due June 2030. We used the net proceeds from the offering to refinance $450 million of amounts outstanding under the 2018 Revolving Credit Facility, prepay $750 million of amounts outstanding under the $1.000 billion February 2021 Term Loan, prepay $500 million of amounts outstanding under the $1.250 billion April 2021 Term Loan and pay related fees, expenses and premiums.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we completed an offering of &#x20ac;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $206 million of our $450 million 4.125% senior notes due 2023, $566 million of our $1.000 billion 4.000% senior notes due 2028 and $227 million of our $750 million 3.850% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in connection with the transaction. In 2019, we incurred associated debt extinguishment charges of $86 million presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, we completed an offering of $4.300 billion in aggregate principal amount of senior notes comprised of $850 million of 3.450% senior notes due March 2024, $850 million of 3.750% senior notes due March 2026, $850 million of 4.000% senior notes due March 2029, $750 million of 4.550% senior notes due March 2039 and $1.000 billion of 4.700% senior notes due March 2049. We used a portion of the net proceeds from the offering to repay the $850 million plus accrued interest and premium of our 6.000% senior notes due in January 2020, the $600 million plus accrued interest and premium of our 2.850% senior notes due in May 2020 and the $1.000 billion plus accrued interest of our August 2019 Term Loan. In 2019, the remaining proceeds were used to finance a portion of our acquisition of BTG.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Other Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our senior notes contain a change-in-control provision, which provides that each holder of the senior notes may require us to repurchase all or a portion of the notes at a price equal to 101 percent of the aggregate repurchased principal, plus accrued and unpaid interest, if a rating event, as defined in the indenture, occurs as a result of a change-in-control, as defined in the indenture. Any other credit rating changes may impact our borrowing cost, but do not require us to repay any borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Renminbi denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had outstanding letters of credit of $134 million as of December&#160;31, 2021 and $124 million as of December&#160;31, 2020, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of December&#160;31, 2021 and December&#160;31, 2020, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our consolidated balance sheets as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum purchase obligations, relating primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business, were as of December&#160;31, 2021 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecorded Purchase Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;812&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzgw_85c2724f-7297-408e-8d62-304d2afe3528"
      unitRef="usd">9065000000.000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk2_bc0ce16d-d278-4695-a8cd-e294c93f90fd"
      unitRef="usd">9143000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEzNg_b44b8d9d-5a0f-4f30-8b98-a8a554065768"
      unitRef="usd">261000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE1Mg_7eb550aa-731a-47aa-a4d1-705e803139dc"
      unitRef="usd">13000000</us-gaap:DebtCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NDk2_14d2ba2e-2250-4567-93d0-27c23e4c3c7d">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the December 2027 Notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective November 15, 2021, the interest rate payable decreased by 0.25 percent and began accruing at a rate of 6.75 percent following recent upgrades to our credit ratings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)  As of December&#160;31, 2021 the outstanding balance is presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Debt Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&#160;&#160;&#160;&#160;The December 2027 notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ib8b35b770901410ca52fdc805a2e9579_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzItNi0xLTEtMA_32c65e4d-db48-4d89-8550-f47433a92fb0"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4f4593a60912482fab2688cbdaa05100_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzItOC0xLTEtMA_59b0cb4e-5949-4a43-93ba-c812860f2693"
      unitRef="usd">250000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8b35b770901410ca52fdc805a2e9579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzItMTAtMS0xLTA_35c1f010-3a79-4304-b574-cd15bd507f62"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzMtNi0xLTEtMA_51978594-7987-43c3-b559-88e8b30a6761"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i99294feafedf4ee49fa109e2229c4b49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzMtOC0xLTEtMA_899a0222-e15d-4d9f-84ba-4cbb55a82d6d"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzMtMTAtMS0xLTA_b8bf0d8a-7374-44ac-b4ed-7569ff0ccfa1"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzQtNi0xLTEtMA_dcbce02b-b52d-40de-892c-19ce49f67567"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzQtOC0xLTEtMA_86dcc10c-6750-4616-b69d-09c40a892b89"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzQtMTAtMS0xLTA_ddbcc015-5654-47f5-8d66-ae3501d20ce2"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i69988c85621b476fa63c489ced0e8284_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzUtNi0xLTEtMA_66e2f7eb-2cfb-47e7-b498-230a6be1220e"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6f20c3d1ba7a4b9393b313eeabdf8773_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzUtOC0xLTEtMA_c2a6c461-f280-461c-ba7d-6dc45e04d4c9"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69988c85621b476fa63c489ced0e8284_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzUtMTAtMS0xLTA_ae1d191d-0049-4bf2-984e-6f4598550b4b"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2a45203f1a3447988e6706b1059e3a29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzYtNi0xLTEtMA_067f02e1-e2e4-487a-83c0-95032d4287a7"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic7bcc19872444969a853a9139102340a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzYtOC0xLTEtMA_afe6a776-6767-41d6-b2bf-c267ef177f33"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a45203f1a3447988e6706b1059e3a29_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzYtMTAtMS0xLTA_8a43aa38-d86a-446a-91e0-75ec53094aaf"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzctNi0xLTEtMA_3e07ab2f-e35e-434a-8947-2eb80392c058"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzctOC0xLTEtMA_6d2383cb-0b09-4c49-9e02-9c4ebb1f811f"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzctMTAtMS0xLTA_80a50ad3-3b9d-4cc1-a9ef-1a412127d046"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzgtNi0xLTEtMA_a663c383-b7b2-4837-a5e5-6c8ab5091ef8"
      unitRef="usd">1021000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7d7f3635455746f3b28295c2ea994f38_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzgtOC0xLTEtMA_4bacb529-00d6-4b40-bc08-1e42132b716e"
      unitRef="usd">1105000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzgtMTAtMS0xLTA_26f223d7-3e89-42f5-9029-24c13e9d9bb6"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzktNi0xLTEtMA_18edc6b3-6248-4f82-8302-553221e02863"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if0f97fadb3df48bda0decc6fefc848f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzktOC0xLTEtMA_ee7c4df3-bf91-47e7-9380-b7ca09331c67"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzktMTAtMS0xLTA_606cf94a-d037-47b3-be03-2711b4bca1d7"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEwLTYtMS0xLTA_836fdaf0-47ad-427f-96db-2f1f745aa262"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEwLTgtMS0xLTA_91bc44e1-212f-494f-b0e9-7688c4766f0e"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEwLTEwLTEtMS0w_77453287-5689-4b92-834b-613f144d92a0"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7b460c38790240a9aa867c6fed4202a6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzExLTYtMS0xLTA_160a2957-5dc9-4132-bac6-873f3921f3d4"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib0ce36bb88f54225ab4c1a3a6ffe1e0d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzExLTgtMS0xLTA_7433d6f3-9588-446d-803e-a320da33e520"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7b460c38790240a9aa867c6fed4202a6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzExLTEwLTEtMS0w_86d3a01a-1228-4fd2-ac22-d9970d2207a3"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3977734d09ce4c1ab17af6a4ee2899d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEyLTYtMS0xLTA_bcb11ed9-5e99-4a33-a614-898d5780484c"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i99deafdf2a70460e9d8c50f4d6973f0e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEyLTgtMS0xLTA_96abe131-c821-48c7-b0b3-f315995e2635"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3977734d09ce4c1ab17af6a4ee2899d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEyLTEwLTEtMS0w_e95ce8ff-bd56-44e8-b3c1-4147b764c7f6"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEzLTYtMS0xLTA_98e99c36-bc2e-4fb0-9186-bb0cc748373d"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEzLTgtMS0xLTA_14c57938-7089-47b3-88c3-3d7827808298"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzEzLTEwLTEtMS0w_a95580fd-b9a7-4017-a39e-a972e6cedad2"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if9f6423b1ae248ea89c9e621bfea9ed0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE0LTYtMS0xLTA_ce5f4dc4-10e1-464b-b758-7722d87a4797"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie81e19c0a1fc4ab48f45f7fa43d479fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE0LTgtMS0xLTA_d2c1defd-ea97-4f58-8228-b7fecd590e2d"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if9f6423b1ae248ea89c9e621bfea9ed0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE0LTEwLTEtMS0w_227661b9-64ae-41b0-aa64-17a3974d4942"
      unitRef="number">0.07375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE1LTYtMS0xLTA_20f55312-f196-42b9-98e5-9201b457887a"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE1LTgtMS0xLTA_9529c35e-5b8b-4eef-b929-d6f0561293b1"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE1LTEwLTEtMS0w_c74c30c9-cf0f-49fe-b7c7-af99f2658162"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i37d082b275694367bb539a8515b1a5af_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE3LTYtMS0xLTA_f28babbc-02ff-4efa-9737-891d4f73139a"
      unitRef="usd">76000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ie054bf7025744c0e8874ea68a52321e2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE3LTgtMS0xLTA_bbcbf5bf-6c0a-4eac-b97c-d34c541153b4"
      unitRef="usd">88000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i1a267278831c49c780031fe1e50cd725_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE4LTYtMS0xLTA_90b34b4e-408b-4673-be4a-2d39aaa6104e"
      unitRef="usd">3000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2b8a56164792489dafeb7028a867339e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE4LTgtMS0xLTA_d9da4cd5-6953-43ee-8cc3-cc465df8b59d"
      unitRef="usd">5000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie3d831f9c48348a68d8597ce5baaaf5e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE5LTYtMS0xLTA_cb8ab5c9-4376-4df2-b359-a8ca4e9b4c66"
      unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7c6e285fb891405ebda3f5864aefc402_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzE5LTgtMS0xLTA_12e743a6-3321-49b4-be5c-1564d50dd211"
      unitRef="usd">7000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzIwLTYtMS0xLTA_75fe22b9-e35b-44ae-8dcb-c4f28d33cf4e"
      unitRef="usd">8804000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTo3NzM3YmFmYjAzMzQ0YjViYjFiYmM0ZmI2OWYzOGY5MC90YWJsZXJhbmdlOjc3MzdiYWZiMDMzNDRiNWJiMWJiYzRmYjY5ZjM4ZjkwXzIwLTgtMS0xLTA_9569486f-bf98-4c8a-a227-e1b2b23d6313"
      unitRef="usd">9130000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="idda6217ac6554ef59c1b054231dd5711_I20210510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk5Nw_a2b3ea25-a69c-48b5-9217-66b57b9dcd5b"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ShortTermBorrowings
      contextRef="ic538cbc1ea4a4e6482d96eb75deaeea9_I20200421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODM4NTc_2a34571a-19a5-4925-9bb9-ad0841ce1fe5"
      unitRef="usd">1250000000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i9e7ecae3134a4534a02c0c55e5ca169a_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODM4NjM_59ae0d2f-4465-4809-b2f3-a67c054103c8"
      unitRef="usd">500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ie3c94b7687874bd48df338dc146a6811_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODQwMzc_3fa6b1bb-d549-474b-962e-7497cf3ef2c5"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i5e2c1e2b027e497dbd0261bab6602a47_I20200227"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODQyMDQ_44e1e518-afe6-4c8b-a2c5-aad5f6c4b6e4"
      unitRef="usd">1000000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1c914099e6904d71a94dc97f6783d3fb_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODQ4Njg_d341100a-85ca-46a0-8ad2-9a7bd0ad2651"
      unitRef="number">0.0085</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="id2f4f8def2974bd3ad9e71fd663edb3d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODUxODk_e742f829-9b39-449d-9e8f-14bdc85befc8"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i197c21f8e68c4cc2ae4d6604948b055c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODUzMzY_1ee3d4f3-98a8-4072-a8c0-92c5a8ccda17"
      unitRef="usd">250000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="ica6d67210a5b40639571e17472201a15_I20191205"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODU0MjU_8c371c20-f37c-49d9-bce7-06fde5fb460f"
      unitRef="usd">700000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ie47d736dd834426ab929b497f1361581_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODU1NTI_b081a324-9cef-44e3-af64-b510a50e9cfe"
      unitRef="usd">700000000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i7abc3bd638524e8bbfed8a8d71278d8b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODU3MzE_edf57951-505a-4cda-bae7-3ba22d2c795e"
      unitRef="usd">300000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="ic1b3fc2a867647d786b7994f29b2db88_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODYwNzA_d29c3712-da82-4ca4-8be1-329075e58ec5"
      unitRef="usd">2000000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCredit
      contextRef="i7686ee5deffa4dbd9d2a8c5eaf9db505_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODYxMzk_7d88243e-b7f7-418f-9fb3-9af4cc9345c3"
      unitRef="usd">1000000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i15a93de21f3f486280e4d2a80f4564b7_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODYzMDg_30cf1365-e1c2-4fc4-9249-8d86a32c5241"
      unitRef="usd">1000000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i2174cbca29474ac7a29b9341a392c4c4_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODY1NjE_a89d759b-2c0c-491d-8f17-742b6b9d4a36"
      unitRef="usd">1000000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i94a8abe8b67a41ecae72f9a4a146bf9d_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODY2MTE_a9a1639c-5cf1-412e-be0d-38de3db9ecd5"
      unitRef="usd">1000000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i4c0adf6547af4ea1bf69150f334d3a2d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODY5MDc_67944624-e8d3-4395-950f-7e8b91432af3"
      unitRef="usd">1000000000</us-gaap:LineOfCredit>
    <bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzkzNDU4NDg4Njk2NzI_db3be93d-5b85-431c-a1f1-335ac4c0f044">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of and through December&#160;31, 2021, we were in compliance with the financial covenant required by our credit facilities described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;br/&gt;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;br/&gt;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;</bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock>
    <bsx:MaximumLeverageRatio
      contextRef="ie936008df8bc47b7bb4819618486c3bb_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpmYmQ1ZGM5NzY2ZTM0MWJhYWQyNGNhNDZlYzJkODExNi90YWJsZXJhbmdlOmZiZDVkYzk3NjZlMzQxYmFhZDI0Y2E0NmVjMmQ4MTE2XzEtMS0xLTEtNDQ1NzI_c4a324bb-6eb3-49f7-94a0-2db72b1b9369"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ic8fc502671304865bc79e37327645508_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpmYmQ1ZGM5NzY2ZTM0MWJhYWQyNGNhNDZlYzJkODExNi90YWJsZXJhbmdlOmZiZDVkYzk3NjZlMzQxYmFhZDI0Y2E0NmVjMmQ4MTE2XzEtMy0xLTEtNDQ1NzI_aac14817-7acd-409f-8fd8-fb26884a966e"
      unitRef="number">2.71</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i444a310bc0c4448b9123ec72d5545a72_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA3MTc_1c4c5d23-b6de-49f6-911c-70554872f2f5"
      unitRef="number">4.50</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i70271503dce14eb097b21a37884cad0e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA3OTE_699e8bcb-8451-4e39-8b49-4717c9d1e68a"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i7ec855f40caa42989882af458e570454_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1NTY_36580630-8274-4a04-b761-5087f0fe223c"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ie936008df8bc47b7bb4819618486c3bb_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1NjA_c4a324bb-6eb3-49f7-94a0-2db72b1b9369"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:DeemedConsolidatedEBITDA
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1Nzc_2f14885b-f4f2-4580-886d-fb78dd9f663d"
      unitRef="usd">1000000000</bsx:DeemedConsolidatedEBITDA>
    <bsx:MaximumLeverageRatio
      contextRef="i308b229a078349f4a6b8fa547142e74e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA1OTM_572c2658-c54a-44c1-9c49-214b72bcb6ad"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ie61164ba53424b53a89a01bcfc962d28_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2MDY_9a30d4cc-a7df-4835-aced-dabdfccdf075"
      unitRef="number">4.50</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i5411c3c5e25b4c5390bd6cd699a689af_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2MTk_5c140d37-61bb-49d6-91c3-92c4bee4edff"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i93ab540e0baa4ea8b3e7d94197263283_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2MzI_14d89614-0091-4d66-af15-d5b46dfc8cb1"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ia398c25f0ce342b09028c1fce6e28c7a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODA2NDY_5a61ebf2-e02c-433d-938d-1f64852dcdc8"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:ExclusionFromEbitdaForRestructuringCharges
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzE4NzY_69f76a19-22f4-47e2-a23e-4ca9d06aff0c"
      unitRef="usd">500000000</bsx:ExclusionFromEbitdaForRestructuringCharges>
    <bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzIwMDc_1cd3c276-1aad-4620-8696-49f816d52b40"
      unitRef="usd">376000000</bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <bsx:LitigationAndDebtExclusionFromEbitda
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzIzNDU_562b8210-1889-4748-9c26-656bd04807dd"
      unitRef="usd">1455000000</bsx:LitigationAndDebtExclusionFromEbitda>
    <bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyNzIzODU_ac18d000-f619-4607-9918-21af9fad74ed"
      unitRef="usd">1122000000</bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="ia17445cfa0b9425d9591416f99eabbb5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NDg1_360e6875-a6b0-45fc-9875-b29b6a3dd9e4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i37d082b275694367bb539a8515b1a5af_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3MTE_643ad2a0-8149-4c3f-b34c-0a51c3766c7e"
      unitRef="usd">9121000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie054bf7025744c0e8874ea68a52321e2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzIxOTkwMjMyODM1Njk_b96cb792-69c9-4fb2-9d2f-b9018a158078"
      unitRef="usd">9205000000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i1eb9666c9b5d47758f0f329b195d28fd_D20201229-20201229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3NzU_93f6d4ba-9073-445d-bcd3-21498dfe7422"
      unitRef="usd">250000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i97e680c0ff1f4c26929f74c3434a3c3b_I20201229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3ODU_73f8df89-ebd0-4fc1-a6a3-141901d1b587"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8b35b770901410ca52fdc805a2e9579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzk3ODg_35c1f010-3a79-4304-b574-cd15bd507f62"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icae6cce43b414bfb9f7507f8a47db081_I20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMDMy_381fe647-853b-4095-86fc-0932c735928d"
      unitRef="usd">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic7bcc19872444969a853a9139102340a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMDk0_f72f1a1f-083c-41b8-b6af-12e69eee2a7a"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a45203f1a3447988e6706b1059e3a29_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMTAw_8a43aa38-d86a-446a-91e0-75ec53094aaf"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib0ce36bb88f54225ab4c1a3a6ffe1e0d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMTM0_61271a49-2f0d-4685-8f7b-75b6f1c90f2e"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7b460c38790240a9aa867c6fed4202a6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMTQw_86d3a01a-1228-4fd2-ac22-d9970d2207a3"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ie3a666428edd40358c27d96bac0e5b06_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMjI3_31e5af92-88bf-432c-8650-f6656a707de6"
      unitRef="usd">450000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfDebt
      contextRef="i4db5d14246b341c3b63536f6f5b51606_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMjk3_069ecadd-93db-4318-8a94-3b81a494041a"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i5e2c1e2b027e497dbd0261bab6602a47_I20200227"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMzMz_44e1e518-afe6-4c8b-a2c5-aad5f6c4b6e4"
      unitRef="usd">1000000000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i9e7ecae3134a4534a02c0c55e5ca169a_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwMzY4_13ef10e3-17d8-42da-acae-95f1866e0c60"
      unitRef="usd">500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="ic538cbc1ea4a4e6482d96eb75deaeea9_I20200421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNDA0_2a34571a-19a5-4925-9bb9-ad0841ce1fe5"
      unitRef="usd">1250000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebt
      contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNTIw_0f08ae05-4aa6-46b7-bdaa-f4442ce06a55"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibc2a9aaec8d24401867d89d8e7f12627_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNTM4_a232b853-d585-4ef2-af0e-afcf6ad69721"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i89b2d96f4b3f4582940e4f6463a44151_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwNTc1_26f223d7-3e89-42f5-9029-24c13e9d9bb6"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i0464d11ab42f4a12b77d118c34369f89_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk2_cbbf79b0-0d87-4fb3-ab4b-4b55eda26454"
      unitRef="usd">206000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i19e347625da0413196bed00d6571b0aa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDA2_a6406229-bd38-4964-aa6b-5de244a13e1b"
      unitRef="usd">450000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e9f34b82c4742f3bf5e2e7c5567b377_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDA5_b8bf0d8a-7374-44ac-b4ed-7569ff0ccfa1"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i8e308f2a8c574f68b80ca9eb8be35b85_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDM1_3f049a3f-4f54-4732-b659-451106302200"
      unitRef="usd">566000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="ib447fd8998e74765b84c8b606bde736d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDQ1_796f4cb4-fbb7-446a-87aa-6d814381c1b4"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2f78bc3a32f34fc9a636c88f8e2e7caa_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDQ4_606cf94a-d037-47b3-be03-2711b4bca1d7"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="ib44c6e8af734489b858d59c23974cbb2_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDc3_aa4f2662-87d0-46ce-812f-d5e456ecd04c"
      unitRef="usd">227000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i6709a77d8fee4017926528030492bcbd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDg3_9910c032-99d5-426c-9422-10891b1e2a5e"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69988c85621b476fa63c489ced0e8284_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMDkw_ae1d191d-0049-4bf2-984e-6f4598550b4b"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMjc5_05fea6a9-d72c-4b06-9624-a8139282b4f6"
      unitRef="usd">86000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i3cf03c18e48745718c15c78dddd26e7d_I20190225"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExMzcw_f2fc43c7-ff4c-497c-a97b-5f3476056afa"
      unitRef="usd">4300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0MTY_86dcc10c-6750-4616-b69d-09c40a892b89"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i29e6c70077d8421abaf6a0195ae09d2d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNDM4_ddbcc015-5654-47f5-8d66-ae3501d20ce2"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0MjI_6d2383cb-0b09-4c49-9e02-9c4ebb1f811f"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6e48ed4587ab4b3bbcd5798a947274ec_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNDc2_80a50ad3-3b9d-4cc1-a9ef-1a412127d046"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0Mjg_91bc44e1-212f-494f-b0e9-7688c4766f0e"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if320e56a752a41e88cfb08c43d245e51_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNTE0_77453287-5689-4b92-834b-613f144d92a0"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0MzQ_14c57938-7089-47b3-88c3-3d7827808298"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if741aa50339b4ba18fff942b2ac8318a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNTUy_a95580fd-b9a7-4017-a39e-a972e6cedad2"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0NDA_9529c35e-5b8b-4eef-b929-d6f0561293b1"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i90d2c756a94c45ae93fcd4c66aefc816_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNTkz_c74c30c9-cf0f-49fe-b7c7-af99f2658162"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i8225f5ac9e2d4a35b19f518f7b34a8cd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNjk0_654277ab-c02b-4ed4-950f-2f434a2e8831"
      unitRef="usd">850000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib21d26613df8433b90b18e4269afc46c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0NDc_bd92a78d-95e4-4942-8b44-9648ef43e8d6"
      unitRef="number">0.06000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i50090a44ed3648b09d9a32e978a34b4d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExNzc5_64049141-1c24-4221-8bf4-b0aec9e39626"
      unitRef="usd">600000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0d747a9536d94fb7b60a93be1cbd161c_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEwOTk1MTE2NjA0NTQ_eac02200-dbe4-4b91-b511-539df0d6a095"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie4bf916bbcc84dc4825df5c3ccaa8aae_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzExODYz_bff2885a-7ef2-4155-b1db-915965fd94ef"
      unitRef="usd">1000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <bsx:ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEyNTgx_f9462ab5-52fb-41fa-a2bb-051ff012e307"
      unitRef="number">1.01</bsx:ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NTYz_f1806162-5595-42a9-a988-893872f1817d">Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Renminbi denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="if6c464c8023048e696d029db1389bebd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItMS0xLTEtMA_bb38a0c3-280f-4be6-86f1-0e45e37c6950"
      unitRef="usd">141000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="ic9fce21be2de4c2485cc6ac5d19a3d23_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItMy0xLTEtMA_b4910fd8-f068-433a-bb76-f695d2d62612"
      unitRef="number">0.021</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i24e961c1a10f4c2c92f033e86ef7a70c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItNS0xLTEtMA_c8250da5-00df-47e2-91c4-424d81d0b8d8"
      unitRef="usd">148000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i5bc579bbe1d5474b81205d71f15e00f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzItNy0xLTEtMA_8901385f-2cdb-45b1-8db3-1663d0149f44"
      unitRef="number">0.019</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i07e0816ac73d4823bbb1284d2da621ac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtMS0xLTEtMA_6ec3b964-efa1-4900-b7a6-57cebffbeae5"
      unitRef="usd">223000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i485f0a72de344efcb418b11eeb6678cb_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtMy0xLTEtMA_5a7663e0-a55d-4857-8dd6-b49ef225e7a5"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ic77ad771abd648f3a41ae116c98b285d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtNS0xLTEtMA_e044c9b3-ede7-456d-8caa-67bdcb32112a"
      unitRef="usd">240000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i63949649e58e46738f2ae4a1fa93fc28_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzMtNy0xLTEtMA_e55b696f-ff62-4bc7-923d-8a93a8add0c6"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="iba5a4c30a3134fd9bb5496536fd667f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtMS0xLTEtMA_825fc6c5-bf86-43d8-be9b-f4b1646d8dd9"
      unitRef="usd">0</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i2af204e5236d4e009be09c240fec1f8c_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtMy0xLTEtMA_9b3bcff9-f2cf-4ba9-a0f5-fd623ffc8390"
      unitRef="number">0.032</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i0444bfe732324384a1a99c91c94db100_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtNS0xLTEtMjg4_5a5e19a9-c8e2-4d20-8137-08ebb194b62d"
      unitRef="usd">0</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i88fa01f8ca884ebd86e9a4890726f80d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTozYjhkOTdmNTAxYzE0YzcyYWMxMTE1M2IyZDcyYzdiNS90YWJsZXJhbmdlOjNiOGQ5N2Y1MDFjMTRjNzJhYzExMTUzYjJkNzJjN2I1XzQtNy0xLTEtMjg4_8dc4d635-6c66-4360-98fb-07b91a378cea"
      unitRef="number">0.035</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEzOTA5_d6e313b3-6f16-4013-af20-907a5d6535f1"
      unitRef="usd">134000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzEzOTI1_afafb7a1-cfc1-4452-a444-e90b7d21f3e2"
      unitRef="usd">124000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LongTermPurchaseCommitmentTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90ZXh0cmVnaW9uOmRkYjMwMmNlM2I4MjQ4YjM5OTcwOGIyNWQyMjUzNDBlXzE0NTQ2_59eab7e9-7f6d-4ee9-af28-74b5087bb70f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecorded Purchase Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;812&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongTermPurchaseCommitmentTextBlock>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzEtMS0xLTEtMA_67da3e5d-c9f0-47f4-b7b3-24ca970b71cd"
      unitRef="usd">631000000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzItMS0xLTEtMA_ac395c41-37c2-4c04-96bc-79e8287ee41b"
      unitRef="usd">82000000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzMtMS0xLTEtMA_5387f512-e7b0-44f7-9813-2869808368d1"
      unitRef="usd">58000000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzQtMS0xLTEtMA_b18a987d-0290-439a-9322-01abb7c156af"
      unitRef="usd">31000000</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:PurchaseObligationDueInFifthYear
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzUtMS0xLTEtMA_5508480a-4916-460d-9457-671c1f413a90"
      unitRef="usd">11000000</us-gaap:PurchaseObligationDueInFifthYear>
    <us-gaap:PurchaseObligationDueAfterFifthYear
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzYtMS0xLTEtMA_d8243a4c-6520-469f-87c6-28f8efb6fad2"
      unitRef="usd">0</us-gaap:PurchaseObligationDueAfterFifthYear>
    <us-gaap:PurchaseObligation
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMDkvZnJhZzpkZGIzMDJjZTNiODI0OGIzOTk3MDhiMjVkMjI1MzQwZS90YWJsZTpkYTQ4MTMxOWQxMGU0MzM1ODIxZDRhZTY1YWQzNDc3Ny90YWJsZXJhbmdlOmRhNDgxMzE5ZDEwZTQzMzU4MjFkNGFlNjVhZDM0Nzc3XzctMS0xLTEtMA_ed47aa33-a30a-4e3a-9b7b-a6dbe83c7e50"
      unitRef="usd">812000000</us-gaap:PurchaseObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MzI_45715bb6-e995-4051-9a0e-291b0a8d7eba">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE G &#x2013; LEASES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have operating and finance leases for real estate including corporate offices, land, warehouse space, and vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet, unless the arrangement includes an option to purchase the underlying asset, or an option to renew the arrangement, that we are reasonably certain to exercise (short-term leases). We recognize lease expense on a straight-line basis over the lease term for short-term leases that we do not record on our balance sheet. If there is a change in our assessment of the lease term and, as a result, the remaining lease term extends more than 12 months from the end of the previously determined lease term, or we subsequently become reasonably certain that we will exercise an option to purchase the underlying asset, the lease no longer meets the definition of a short-term lease and is accounted for as either an operating or finance lease and recognized on the balance sheet. In accordance with FASB ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we account for the lease components and the non-lease components as a single lease component, with the exception of our warehouse leases. Our leases have remaining lease terms of less than 1 year to approximately 55 years, some of which may include options to extend the leases for up to 15 years. If we are reasonably certain we will exercise an option to extend the lease, the time period covered by the extension option is included in the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of the arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, we utilize the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating lease right-of-use assets are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and corresponding liabilities are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our consolidated balance sheets. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for information regarding our finance leases. The following table presents supplemental balance sheet information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_5c57a388-4a11-402a-ac98-8db5289b32b1"&gt;71&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_02fd6496-c14e-4d01-8da6-bd43092a2153"&gt;70&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_2643a84a-4741-454c-9f77-8a94ad26cb86"&gt;389&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_18293d37-bb2b-40b9-aa4f-ac327a0961c8"&gt;401&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating lease cost under FASB ASC Topic 842 was $90 million in 2021, $92&#160;million in 2020 and $80&#160;million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for operating lease obligations were $68 million as of December 31, 2021 and $202 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2021 (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;528&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i048f5701adc84d0daa997ae6c06ef6ea_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzEyMzM_a73ab03c-2d91-4b22-950f-7749ba6743c5">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i617fc320c955455ab7389624fb17f118_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzEyNTM_f0d0571a-bdf7-468a-a2d3-1186f952b0b6">P55Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <bsx:LesseeOperatingAndFinanceLeasesOptionToExtend
      contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzEzMjI_4faa50c9-fce7-4813-bcfb-b41b19d48ab8">P15Y</bsx:LesseeOperatingAndFinanceLeasesOptionToExtend>
    <bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MTg_3e3daa1b-0c13-4712-96e9-0e3a6382c99b">The following table presents supplemental balance sheet information related to our operating leases:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_5c57a388-4a11-402a-ac98-8db5289b32b1"&gt;71&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_02fd6496-c14e-4d01-8da6-bd43092a2153"&gt;70&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_2643a84a-4741-454c-9f77-8a94ad26cb86"&gt;389&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_18293d37-bb2b-40b9-aa4f-ac327a0961c8"&gt;401&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzMtMS0xLTEtMA_0816bc38-3c5a-4747-ac84-83ac3fbbaaa5"
      unitRef="usd">435000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzMtMy0xLTEtMA_d724538a-a052-4256-80f8-1280a330a170"
      unitRef="usd">458000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie4b63f2e0707444f8d067bcb2fe459f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMS0xLTEtMA_e71c9d43-f4ce-479f-bbdf-c29f84c6ddc1"
      unitRef="usd">71000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i98488b74746f4325a718729aa016bf1f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzUtMy0xLTEtMA_1cee8cb9-6fc6-4d53-8fa2-93166f559964"
      unitRef="usd">70000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMS0xLTEtMA_820ab817-7208-49e9-ab9f-43b254250edd"
      unitRef="usd">389000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTphNzBhZGE0OWZjOGE0YWUwYmZiMmQ0OTk3ZmVmODVjNS90YWJsZXJhbmdlOmE3MGFkYTQ5ZmM4YTRhZTBiZmIyZDQ5OTdmZWY4NWM1XzYtMy0xLTEtMA_3930432e-335b-45b3-9fa0-f02f1753b40c"
      unitRef="usd">401000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0Mjg_35b009cf-48fd-4a39-be8b-407868e43d0f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzItMS0xLTEtMA_b0347ae7-7c54-4503-b5f4-c233a8d5cde8">P10Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzItMy0xLTEtMA_dc393725-03b4-4282-b7d7-6f57509a6480">P11Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzMtMS0xLTEtMA_bb14a6ed-a47f-4f2e-97c4-f53f90537c45"
      unitRef="number">0.026</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTpmNTFmMGFlYWU5NWI0Y2Q2YjdiNDcxYjdlOTAwN2I2ZS90YWJsZXJhbmdlOmY1MWYwYWVhZTk1YjRjZDZiN2I0NzFiN2U5MDA3YjZlXzMtMy0xLTEtMA_16bc7215-02b1-4a6d-bc18-6dd9cf07306b"
      unitRef="number">0.024</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzI3OTU_1c5f36fa-f57f-4713-bbd5-d013904b47de"
      unitRef="usd">90000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzI4MDg_3570d7f5-8e22-47e1-8e87-d425fd06b445"
      unitRef="usd">92000000</us-gaap:OperatingLeaseCost>
    <bsx:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MTk_0cb09b30-13a2-4853-985b-5ef7df462e7c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTplNGJmMmU2MWQ5MmU0N2M2YmI2ZTdhMTAwMGZmNjY1NS90YWJsZXJhbmdlOmU0YmYyZTYxZDkyZTQ3YzZiYjZlN2ExMDAwZmY2NjU1XzMtMS0xLTEtMA_d964f60a-37db-4a70-98d5-5a480b73fe47"
      unitRef="usd">87000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTplNGJmMmU2MWQ5MmU0N2M2YmI2ZTdhMTAwMGZmNjY1NS90YWJsZXJhbmdlOmU0YmYyZTYxZDkyZTQ3YzZiYjZlN2ExMDAwZmY2NjU1XzMtMy0xLTEtMA_97f9ce9f-1a0a-4887-b527-f849f40846d0"
      unitRef="usd">91000000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzMwNDE_d5cfe4fb-cd0d-45c7-bb62-e646813e3285"
      unitRef="usd">68000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzMwNzA_6871573a-ee2d-4484-833e-fa2de427ebf1"
      unitRef="usd">202000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <bsx:MaturitiesOfLeaseLiabilitiesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90ZXh0cmVnaW9uOjE0OWMxMWFkNTZlYzQ2MThhZWRjZGI1NDU4YjQ1MzBmXzM0MjU_610630d0-0845-48e9-96d0-b10beac6656a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2021 (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;528&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:MaturitiesOfLeaseLiabilitiesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzEtMS0xLTEtMA_73bb5d9d-3715-4045-8864-8a175c5bdfab"
      unitRef="usd">86000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzItMS0xLTEtMA_6ff40207-15e1-44e1-a333-e4bbeb264279"
      unitRef="usd">69000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzMtMS0xLTEtMA_9d81319f-6172-4d17-a885-a39f20582d9c"
      unitRef="usd">56000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzQtMS0xLTEtMA_3eb9e768-afff-4d90-b9f8-5f179d66c182"
      unitRef="usd">49000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzUtMS0xLTEtMA_7c4b9c56-0795-45e9-b550-ceb4bba65a1a"
      unitRef="usd">40000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzYtMS0xLTEtMA_a1b7ea87-6be5-4409-9b12-da9addaa113f"
      unitRef="usd">228000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzctMS0xLTEtMA_17ba3c51-8b04-489f-b2f0-110b1e930159"
      unitRef="usd">528000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzgtMS0xLTEtMA_09c62e33-f719-43a7-bcc8-80283b956b13"
      unitRef="usd">68000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTIvZnJhZzoxNDljMTFhZDU2ZWM0NjE4YWVkY2RiNTQ1OGI0NTMwZi90YWJsZTo1MjcwYmQ5YWRkOWU0MGFiYjY3ODZmNzIyZjllYTNlNy90YWJsZXJhbmdlOjUyNzBiZDlhZGQ5ZTQwYWJiNjc4NmY3MjJmOWVhM2U3XzktMS0xLTEtMA_1c0b3807-90bb-4824-8613-dcd58cc1bb6a"
      unitRef="usd">460000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4Nzg_bca29d4b-af9b-43ae-9f4a-0735f8e4bf28">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE H &#x2013; RESTRUCTURING-RELATED ACTIVITIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 Restructuring Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 15, 2018, our Board of Directors approved, and we committed to a global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan is intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 22, 2021, our Board of Directors approved an extension and expansion of the 2019 Restructuring Plan to include additional cost optimization activities, including the centralization of certain functional capabilities within the international regions in which we operate, and a one-year extension of the program to complete these activities along with certain other initiatives that were delayed in 2020 due to restrictions related to the COVID-19 pandemic. In addition, on February 22, 2022, we increased and our Board of Directors approved cost estimates to complete additional activities identified under the program. We continue to expect the majority of activity associated with our 2019 Restructuring Plan, including the recent expansion, to be substantially complete by the end of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, by major type of cost, of which approximately $375 million to $475 million are expected to result in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Estimated Amount Expected to be Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$525 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2016 Restructuring Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 6, 2016, our Board of Directors approved, and we committed to a restructuring initiative (the 2016 Restructuring Plan). The 2016 Restructuring Plan was intended to&#160;develop global commercialization, technology and manufacturing capabilities in key growth markets, build on our Plant Network Optimization (PNO) strategy which is intended to simplify our manufacturing plant structure by transferring certain production lines among facilities and expand operational efficiencies in support of our operating income margin goals. Key activities under the 2016 Restructuring Plan included strengthening global infrastructure through evolving global real estate assets and workplaces, developing global commercial and technical competencies, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;enhancing manufacturing and distribution expertise in certain regions and continuing implementation of our PNO strategy. These activities were initiated in the second quarter of 2016 and substantially completed in 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2021, related to our ongoing Restructuring Plans by major type: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;622&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;LOTUS Discontinuation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#x2122; Aortic Valve System, and our decision to retire the entire LOTUS&#x2122; Valve platform. We recorded restructuring and restructuring-related net charges associated with the product discontinuation of $20 million in 2021 and $55 million in 2020, which are included in the tables above for the year ended December 31, 2021 and December 31, 2020. The restructuring activities were completed in 2021 and resulted in total pre-tax restructuring and restructuring-related net charges of approximately $80 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition, during 2020 we recorded $119 million of inventory charges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and $8 million of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; associated with the product discontinuation.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ia2af2c7ed77b498eb719fa78d5da83ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4NTU_48201228-b394-4157-933d-2bf59741aad6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, by major type of cost, of which approximately $375 million to $475 million are expected to result in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Estimated Amount Expected to be Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$525 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:EffectOnFutureCashFlowsAmount
      contextRef="ica411c80fdf24d109ac19137eaa6f96e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzE2ODY_d264b394-ced9-4547-8012-bcb2d931c4a6"
      unitRef="usd">375000000</us-gaap:EffectOnFutureCashFlowsAmount>
    <us-gaap:EffectOnFutureCashFlowsAmount
      contextRef="if1252f564c6d428c98f594fc337b97b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzE2OTI_484a4fab-5148-417a-afd0-7b4c14386374"
      unitRef="usd">475000000</us-gaap:EffectOnFutureCashFlowsAmount>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="icd865108013d4bcca24cc4a6e429770d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzItMS0xLTEtMA_8d0d615f-5a19-4490-a4cf-6507a5f34936"
      unitRef="usd">75000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i050247ca3e5f4d8792f99eed4db2251f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzItMy0xLTEtMA_a6272a61-ec45-4390-a907-e265814eea41"
      unitRef="usd">100000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="if9881105cc7c458785ea4390c09d5c34_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzMtMS0xLTEtMA_717ed4f9-b83c-459e-98bb-e2e3ba8ea852"
      unitRef="usd">25000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ifc33409cd1684f7c94717750ee9c914f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzMtMy0xLTEtMA_c19cac51-4cb2-4b16-94e1-cde3c07de46e"
      unitRef="usd">50000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <bsx:RestructuringrelatedCostExpectedCost
      contextRef="ifa5fab8b1c884ba48ab6fe7638fedd7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzUtMS0xLTEtMA_c78e1c1a-96a4-460a-806f-b71debab20da"
      unitRef="usd">325000000</bsx:RestructuringrelatedCostExpectedCost>
    <bsx:RestructuringrelatedCostExpectedCost
      contextRef="i80ab67bc08d646feb8bcd26b4e7f25d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzUtMy0xLTEtMA_62f5d5ba-189b-407d-a961-aac446e6469d"
      unitRef="usd">375000000</bsx:RestructuringrelatedCostExpectedCost>
    <bsx:RestructuringandRestructuringrelatedCostExpectedCost
      contextRef="ibbc81bf26f074c4781cd0bbddfe60c72_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzYtMS0xLTEtMA_1c70199d-24d4-4c06-9246-eba7085829fc"
      unitRef="usd">425000000</bsx:RestructuringandRestructuringrelatedCostExpectedCost>
    <bsx:RestructuringandRestructuringrelatedCostExpectedCost
      contextRef="i8ea968104af64d01994c09ee3b458889_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo1NzcwZTdmMWU4OGM0YzU4YTNiNjJiYTJhY2ZkNDFlZC90YWJsZXJhbmdlOjU3NzBlN2YxZTg4YzRjNThhM2I2MmJhMmFjZmQ0MWVkXzYtMy0xLTEtMA_d0700ee5-cc01-413f-b1f4-e2632281af2e"
      unitRef="usd">525000000</bsx:RestructuringandRestructuringrelatedCostExpectedCost>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i764b1d4f04ed46a6948921a252c5d8a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4MzU_bb9f3760-1eb1-4fae-ad64-a364d83305d1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzMxODg_9b0d37a6-4e98-46f3-81ab-f7b75bbac087"
      unitRef="usd">255000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzItMS0xLTEtMA_46b23ea2-a03d-4592-bd8f-c0c4d982fcae"
      unitRef="usd">86000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzMtMS0xLTEtMA_dfda1117-5786-4eeb-b0f6-e1b7b7935dd4"
      unitRef="usd">21000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzUtMS0xLTEtMA_45a8e3a2-1215-4df9-942e-1e9a5bdbe8a1"
      unitRef="usd">164000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTpjNWM0YTVhYzVkYmE0NGZkYTQ5ZjhlNDQ5NTQ4NDkwZC90YWJsZXJhbmdlOmM1YzRhNWFjNWRiYTQ0ZmRhNDlmOGU0NDk1NDg0OTBkXzYtMS0xLTEtMA_66e614ae-0641-410e-a519-8e008dc3928e"
      unitRef="usd">271000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4Nzc_c30e26f9-6228-46a4-981b-270e33f53144">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtMS0xLTEtMA_75188935-4147-4e52-8490-d8e29eb0cc39"
      unitRef="usd">20000000</us-gaap:SeveranceCosts1>
    <bsx:TransferCosts
      contextRef="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtMy0xLTEtMA_7465ea55-017b-4879-af67-7fa57b7eaf32"
      unitRef="usd">0</bsx:TransferCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtNS0xLTEtMA_d6f24653-5cad-4811-89b1-a8e7b12cb81c"
      unitRef="usd">20000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzEtNy0xLTEtMA_2bee5bf7-e1fe-4c0c-8c26-587883f7ef5d"
      unitRef="usd">40000000</us-gaap:RestructuringCharges>
    <bsx:RestructuringRelatedExpenses
      contextRef="i0ebacdb932654dc8a1cdfd75fbdd467c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtMS0xLTEtMA_a37bfe04-bd8d-465a-9510-c34a1fa76ff9"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ia7bc828b5a044f45b01faf25a60e9c78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtMy0xLTEtMA_5e0bedf0-659c-4868-9cc2-9402419a7a83"
      unitRef="usd">79000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i96e07352147f42009d9cd8b62d7b1df6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtNS0xLTEtMA_8f73b6ce-1bad-439f-bb48-bb6e22b02b70"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ib5a809506747427492eaf2ed10add804_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzMtNy0xLTEtMA_10d09db1-7c8f-4474-bd4c-7399644235d8"
      unitRef="usd">79000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id117a9767e20473d910b25f606a1e323_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtMS0xLTEtMA_b8d29bde-2c2e-4a41-a5b5-dc3a27b4b1f8"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i0c56158760a14fc7b71e8385501fece8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtMy0xLTEtMA_cde5da3b-bec0-4321-8392-fe0816c7274e"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i9348686cc963447c935d4482b79d2c75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtNS0xLTEtMA_ee398368-65f5-44ec-b4e1-2edde548651e"
      unitRef="usd">72000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i63979d9af7f74e27b56796a2814939d0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzQtNy0xLTEtMA_6c74b7bd-7a23-4f03-aead-0688b6190370"
      unitRef="usd">72000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i6d63013b85484f03ad0cce1d4df4bc84_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtMS0xLTEtMA_6787ab8a-b0be-4727-91a1-3efde2a2f464"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id8259fbfc86d41e2b865f4365a602b30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtMy0xLTEtMA_6643b251-6f6a-4b96-aa8f-c5de46692848"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i93f2550ce37a400e84700479f1651ade_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtNS0xLTEtMA_ed8f7be9-657e-4874-8df4-867355644564"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="iee11ea97704a4ea8a16e4725ab7a428a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzUtNy0xLTEtMA_c4a92823-d746-4d28-a062-13d4917d2592"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtMS0xLTEtMA_4a716d7e-8dc1-458b-baae-0d7e745a46af"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtMy0xLTEtMA_c349331d-0aaf-4dc0-aaee-a57632ebe917"
      unitRef="usd">79000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtNS0xLTEtMA_84e47a04-26b0-4702-8e0e-4110fbffe1d3"
      unitRef="usd">72000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzYtNy0xLTEtMA_49d6356c-c3e8-4575-8841-284f617bc5d1"
      unitRef="usd">151000000</bsx:RestructuringRelatedExpenses>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i1dc741c9218a4bed9a0bdededcc8422c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctMS0xLTEtMA_79f91fa7-44cc-4187-b0b2-e8fadab68388"
      unitRef="usd">20000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ifcb0e841d6584d12bcc1ce267d7ac544_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctMy0xLTEtMA_efec6a6f-2c38-4c04-8b0c-bb8adcc47eae"
      unitRef="usd">79000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="icbc2c53446584551b0b2d8295b48aa04_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctNS0xLTEtMA_b4a0479f-931e-400d-83d6-f1da58f5f1db"
      unitRef="usd">92000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo2ZDhlYTMxYTEzOTI0MzE2YTJhYzkxYjg3YTRiMDBjZi90YWJsZXJhbmdlOjZkOGVhMzFhMTM5MjQzMTZhMmFjOTFiODdhNGIwMGNmXzctNy0xLTEtMA_8f870fc7-21e6-43a6-a03f-f6a6e8d68a6f"
      unitRef="usd">191000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:SeveranceCosts1
      contextRef="i5803b285b4d846bea82279aeafe39223_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtMS0xLTEtMA_3294ed4e-e2b9-4e7b-88b2-b177c41695c5"
      unitRef="usd">27000000</us-gaap:SeveranceCosts1>
    <bsx:TransferCosts
      contextRef="i5a55a21282ed4611a789274532e46db2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtMy0xLTEtMA_d8a020ff-4458-44e4-b37f-4b5426a420f8"
      unitRef="usd">0</bsx:TransferCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtNS0xLTEtMA_ff0ed30c-7861-41be-9e3c-018c94c35c58"
      unitRef="usd">24000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzEtNy0xLTEtMA_832999e3-7cbe-4464-9568-1f17a5f11283"
      unitRef="usd">52000000</us-gaap:RestructuringCharges>
    <bsx:RestructuringRelatedExpenses
      contextRef="ib86edd9c6f8940f09b7cb40123e5cf7e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtMS0xLTEtMA_1115e04a-222f-4044-b452-afb3df8ba14e"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i356a0c4641ce409d99e92a91a23e56f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtMy0xLTEtMA_da4f218c-c713-4a26-8b3e-ee0a3e46ee18"
      unitRef="usd">64000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i3ea22f9173a842c3a6a6aa67253d4913_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtNS0xLTEtMA_511ee6bb-4377-4388-b08e-5e42844386fd"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i335029b57a154f92b77a7911aeddac43_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzMtNy0xLTEtMA_27183dd4-06df-42a6-a040-982b72b47362"
      unitRef="usd">64000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id8e3e16a28194313a0ad082eb5bb8785_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtMS0xLTEtMA_8990da51-259a-42a1-b05f-be8c0c6722d2"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id412cfa512b949ec907ca18d0cd1c46b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtMy0xLTEtMA_69571890-d860-4d45-be72-9aa1f8005e28"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id57a42ba8f784b46a76bcdd531d63e18_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtNS0xLTEtMA_694e8647-fe41-4fa5-a07f-259dcde0f54e"
      unitRef="usd">51000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i3645a52d5198438e9a8689f203c0cf54_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzQtNy0xLTEtMA_bfb93c15-dc39-430d-be4f-8ca044a87b8f"
      unitRef="usd">51000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="iba2692c4ecf242c1b4befbf697da23d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtMS0xLTEtMA_d117d1a3-b86f-448d-bbfd-7ad4c4b5aecb"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i90551e630dbe44ad87da029f9c03ab34_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtMy0xLTEtMA_c1f58122-c5ff-48c1-90e0-3b16ae94c91f"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5f1bd6c6a8a9457c865b6f6d2377b05f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtNS0xLTEtMA_eefa8086-7e6b-4b53-bf6b-d2c678210458"
      unitRef="usd">4000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id4ba129a320747d88fecf483bb2dc190_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzUtNy0xLTEtMA_ef823738-d27e-4c13-b6b9-3322449ee4a1"
      unitRef="usd">4000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5803b285b4d846bea82279aeafe39223_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtMS0xLTEtMA_839cb632-a6ae-4d4b-a14f-615081f73d7e"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5a55a21282ed4611a789274532e46db2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtMy0xLTEtMA_181e3ebe-66bd-4428-beb2-05a74f954ec2"
      unitRef="usd">64000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtNS0xLTEtMA_e55f9ac3-9ee9-4280-8e8d-e802e5e4a00a"
      unitRef="usd">55000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzYtNy0xLTEtMA_508016b5-91b2-4db3-b848-07fc8c455fd6"
      unitRef="usd">119000000</bsx:RestructuringRelatedExpenses>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5803b285b4d846bea82279aeafe39223_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctMS0xLTEtMzEw_6c32f98d-01b6-4d17-a9dc-52785ee6b24b"
      unitRef="usd">27000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5a55a21282ed4611a789274532e46db2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctMy0xLTEtMzE0_3513afa6-ed5c-4226-9c1e-884e6176a9ce"
      unitRef="usd">64000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5ecedec0f42e4b1fad6af6b0824c1a49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctNS0xLTEtMzE4_4c23187b-1ecc-4947-9c2b-aa114b81c3ca"
      unitRef="usd">79000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5b47a6f6c32a40df8bf41be547c1c014_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYjQwZjNjYTdiZGY0ZWYzYTkwOTIwOWMxYWU2ZWU3Ni90YWJsZXJhbmdlOmViNDBmM2NhN2JkZjRlZjNhOTA5MjA5YzFhZTZlZTc2XzctNy0xLTEtMzIy_823d2aa9-f36a-42db-b4a5-66b98cff2cef"
      unitRef="usd">171000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:SeveranceCosts1
      contextRef="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtMS0xLTEtMA_a6498e6d-cdef-470b-8b06-0503398e2420"
      unitRef="usd">38000000</us-gaap:SeveranceCosts1>
    <bsx:TransferCosts
      contextRef="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtMy0xLTEtMA_a23daeb5-018d-425a-8afd-f584c2489982"
      unitRef="usd">0</bsx:TransferCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtNS0xLTEtMA_8dba8eee-a98c-43e1-8d85-acca0ae282e7"
      unitRef="usd">0</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i670166b7b500445f9d43034e4175db7b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzEtNy0xLTEtMA_287f24aa-1982-436e-a411-7b4d2db0acaa"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <bsx:RestructuringRelatedExpenses
      contextRef="i9b35f447b40b455ead67f66c9f4bfa5b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtMS0xLTEtMA_a78b8e9e-8bea-4cd5-b075-54c466e1a57b"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id7264ea4939f4943af5a24c4278c439f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtMy0xLTEtMA_05720bdf-aa7a-4dc4-9da1-361de96789b2"
      unitRef="usd">32000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i3ace6dde67bd4f898df25357d3c29937_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtNS0xLTEtMA_783e8314-51cb-434d-b6af-442efa568a10"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i244bfd1f3457405c99a68939b39f1e1c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzMtNy0xLTEtMA_53785b5f-b7c1-435f-ae5c-d999bd360a8b"
      unitRef="usd">32000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i87e1cea449b84a3abb1aa082d8446440_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtMS0xLTEtMA_923afa67-59d3-4d21-bfd8-8c91ad25bb87"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ied974547e60f42538926f26d479f2cd4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtMy0xLTEtMA_355e957a-013d-41d9-b353-452f50ae7e63"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i0ad73371f1eb4bf5b2448c9cc099490a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtNS0xLTEtMA_56ec2fa8-a538-43b7-9f05-4348f468e233"
      unitRef="usd">13000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i17d2f64bd733453ab060f8ba6b991f03_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzQtNy0xLTEtMA_2a16179a-5358-4a7c-8a42-23389b45cab3"
      unitRef="usd">13000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtMS0xLTEtMA_3add2141-588b-4b21-a65a-d2ff71c83b7d"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtMy0xLTEtMA_78cb4a46-4295-434e-90bf-3736aa085f09"
      unitRef="usd">32000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtNS0xLTEtMA_86404e9f-8226-48da-8b6d-9b2cea330e5e"
      unitRef="usd">13000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i670166b7b500445f9d43034e4175db7b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzUtNy0xLTEtMA_bcfdca9a-50e7-4031-b5a6-3a3c40e45b94"
      unitRef="usd">44000000</bsx:RestructuringRelatedExpenses>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ibea1d19a12cf4261a131338b85aa1f04_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtMS0xLTEtMA_5f26c897-bc2b-4849-95a6-350c37690c2d"
      unitRef="usd">38000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="iff56d14d7de04dd5a47e4ccdd8381ca9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtMy0xLTEtMA_c2a2edaf-53f3-4e99-99ac-fb932a69bb3a"
      unitRef="usd">32000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i6432c13b0fcb4eb8b29a3fb69f57619b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtNS0xLTEtMA_cc043507-9a16-43a0-aad4-29f8d111d211"
      unitRef="usd">13000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i670166b7b500445f9d43034e4175db7b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTo5MGU2ZTdlM2RhOTY0ZTIxYjQzNGQyMTFkNDhmMDU1MC90YWJsZXJhbmdlOjkwZTZlN2UzZGE5NjRlMjFiNDM0ZDIxMWQ0OGYwNTUwXzYtNy0xLTEtMA_d66aa673-418b-4297-8880-35d37a199dd2"
      unitRef="usd">82000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <bsx:CumulativeRestructuringChargesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ4MTg_8dda5e54-4a74-4fcc-bc4a-650162a502c2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2021, related to our ongoing Restructuring Plans by major type: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;622&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.&lt;/span&gt;&lt;/div&gt;</bsx:CumulativeRestructuringChargesTableTextBlock>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzEtMS0xLTEtMA_7317d193-7198-4a08-b96d-924e6b0b4394"
      unitRef="usd">86000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i10777e0a13844245a66a3a04333ca671_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzEtMy0xLTEtMA_010b2613-9499-4f2d-9d3a-573460148058"
      unitRef="usd">59000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="ia32581cb18484982a8776dc9b9f8eea2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzEtNy0xLTEtMA_1d90a964-bdca-4846-b41c-a62b23defb18"
      unitRef="usd">145000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzItMS0xLTEtMA_3d56d5e8-71c2-4c8a-9a04-83faabaa86ff"
      unitRef="usd">21000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i1785b428f97549d8ae81b21532bc254f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzItMy0xLTEtMA_aa10cfbd-ef3c-44c1-9b47-8017a77d0b2a"
      unitRef="usd">44000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i379c2756c93a4bf38d84777eb83466fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzItNy0xLTEtMA_16b389bb-8b75-41fb-a82b-a4d2877b5a14"
      unitRef="usd">64000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzMtMS0xLTEtMA_afb0dca2-605f-4b29-8fa2-1a73344b73a7"
      unitRef="usd">106000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzMtMy0xLTEtMA_3a0def53-7224-4c46-85c9-0a7d65ce9931"
      unitRef="usd">102000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i8fad2ab117924655ba224551660eddab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzMtNy0xLTEtMA_52d6025d-798a-4744-9b42-1d6c9e9cd036"
      unitRef="usd">209000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i02efe013a1cb40fa9325d57e55e78b92_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzQtMS0xLTEtMA_b6dc47e5-7f7d-4bce-98e6-20119fdd7dde"
      unitRef="usd">126000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i1626115a196044c7964d18ab75d20b9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzQtMy0xLTEtMA_a9e5d260-b47e-483b-bb8b-9e079b64303d"
      unitRef="usd">166000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i9eb67a96dc904adf81eb688fc53e83cf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzQtNy0xLTEtMA_6200c8dc-7c47-4ad0-befb-ea495941283a"
      unitRef="usd">292000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzUtMS0xLTEtMA_fd4e1f7c-41a3-492a-880a-97fb155f3276"
      unitRef="usd">39000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i1785b428f97549d8ae81b21532bc254f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzUtMy0xLTEtMA_64c3e75f-0b23-452e-a674-411ab82a64ab"
      unitRef="usd">82000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i379c2756c93a4bf38d84777eb83466fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzUtNy0xLTEtMA_70119425-92e4-4c60-b725-61e237a9e1a9"
      unitRef="usd">121000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzYtMS0xLTEtMA_f673845b-fa0e-4698-962e-08a0f8213558"
      unitRef="usd">164000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzYtMy0xLTEtMA_cbc6659b-826f-4061-b3ed-a6fdc2d1ea75"
      unitRef="usd">249000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i8fad2ab117924655ba224551660eddab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzYtNy0xLTEtMA_9222df96-304b-47f7-8444-08c62eba0967"
      unitRef="usd">413000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzctMS0xLTEtMA_2da66e16-29d8-4932-9231-b5d917c5bb71"
      unitRef="usd">271000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzctMy0xLTEtMA_3e9f4333-9675-4d3b-86b3-beaec510d7f3"
      unitRef="usd">351000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i8fad2ab117924655ba224551660eddab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZTplYTA2OWM3MWYyMzA0OTI0ODBiMjUzYjkxZTU4ZWVmMy90YWJsZXJhbmdlOmVhMDY5YzcxZjIzMDQ5MjQ4MGIyNTNiOTFlNThlZWYzXzctNy0xLTEtMA_2930aee9-2500-442a-ac47-d1964b363875"
      unitRef="usd">622000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <bsx:AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzQ5MDY_c2d3bd66-6b7b-4bd3-9948-dea71b6a19ea">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;LOTUS Discontinuation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#x2122; Aortic Valve System, and our decision to retire the entire LOTUS&#x2122; Valve platform. We recorded restructuring and restructuring-related net charges associated with the product discontinuation of $20 million in 2021 and $55 million in 2020, which are included in the tables above for the year ended December 31, 2021 and December 31, 2020. The restructuring activities were completed in 2021 and resulted in total pre-tax restructuring and restructuring-related net charges of approximately $80 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition, during 2020 we recorded $119 million of inventory charges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and $8 million of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; associated with the product discontinuation.&lt;/span&gt;&lt;/div&gt;</bsx:AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i32b9680a6d6a40c68ab8e71fd5c1c58b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzEtMS0xLTEtMA_6862d305-fb57-4739-a948-b37c8c59ef1e"
      unitRef="usd">89000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i10777e0a13844245a66a3a04333ca671_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzEtMy0xLTEtMA_dc800d18-46eb-46fe-b527-89a95cccc629"
      unitRef="usd">35000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="ia32581cb18484982a8776dc9b9f8eea2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzEtNS0xLTEtMA_211b4229-0cb6-4c88-90fb-a057a6e5f7de"
      unitRef="usd">123000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i02efe013a1cb40fa9325d57e55e78b92_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzItMS0xLTEtMA_f601eb6c-0a41-470f-b4f5-5b2f7409d976"
      unitRef="usd">125000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i1626115a196044c7964d18ab75d20b9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzItMy0xLTEtMA_0707e255-d479-421d-8011-63921c51b20b"
      unitRef="usd">156000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i9eb67a96dc904adf81eb688fc53e83cf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzItNS0xLTEtMA_33e214a4-93b9-4d38-94ca-1a10db866b7a"
      unitRef="usd">281000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i33c2d5faf95f49dc9254955b9429d578_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzMtMS0xLTEtMA_361de6d0-6a1a-4fec-a367-248a3092cf98"
      unitRef="usd">41000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i1785b428f97549d8ae81b21532bc254f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzMtMy0xLTEtMA_5a35ba38-44dd-4bd5-9089-a004c93b1d07"
      unitRef="usd">72000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i379c2756c93a4bf38d84777eb83466fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzMtNS0xLTEtMA_9e16489b-041b-414e-bee5-35d8e5ae314a"
      unitRef="usd">114000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i789a5ae0df854c6e9c37f4a337dcc452_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzQtMS0xLTEtMA_832f1065-cdd2-4c03-9f2c-21b71c05d4ca"
      unitRef="usd">255000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i5a4390f74c6b4ddd8e4958620a9c5f59_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzQtMy0xLTEtMA_af67a8e4-c615-4aaf-a18a-04c8dceeb6e6"
      unitRef="usd">263000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i8fad2ab117924655ba224551660eddab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90YWJsZToxNmZkODE1N2UwZTY0ODg3Yjg4ZTZhNzJhMTQ0N2U2My90YWJsZXJhbmdlOjE2ZmQ4MTU3ZTBlNjQ4ODdiODhlNmE3MmExNDQ3ZTYzXzQtNS0xLTEtMA_c65d00c0-c286-4f6d-934d-ca4774836ed8"
      unitRef="usd">517000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i0df90b8ebd7c4c70bb72f12619218a79_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjM3ODU_c4c4943f-eafd-45f1-a063-e7f69ca2bcc8"
      unitRef="usd">20000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i8f8abbaa26ce4c349b56fdf51f523b44_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjM3OTc_fb41c292-5862-4019-8cd5-572d7f962010"
      unitRef="usd">55000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <bsx:RestructuringandRestructuringrelatedCostExpectedCost
      contextRef="i0683bdec183a43d1af27f889bfe2f888_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjM5MTI_490f5240-6851-44ef-a86c-c31f98d6bb68"
      unitRef="usd">80000000</bsx:RestructuringandRestructuringrelatedCostExpectedCost>
    <us-gaap:InventoryWriteDown
      contextRef="i4119e3f71c984843b6e8313e74d94802_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjQwMDk_40d792d2-ffc3-4da2-af24-089009e84afa"
      unitRef="usd">119000000</us-gaap:InventoryWriteDown>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i0df90b8ebd7c4c70bb72f12619218a79_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTUvZnJhZzoxYzBiNzg5NmY3ZTE0ZDkxOGQ4ZDBhYmE1NjkzMzE2Zi90ZXh0cmVnaW9uOjFjMGI3ODk2ZjdlMTRkOTE4ZDhkMGFiYTU2OTMzMTZmXzIxOTkwMjMyNjQwNjc_c9d28c21-767e-4acf-9eee-dff5e94e8333"
      unitRef="usd">8000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNTI_c2cd0a84-cf26-4a9f-a96e-753709f7f7b3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE I &#x2013; SUPPLEMENTAL BALANCE SHEET INFORMATION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in our accompanying consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,531&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note: Effective January 1, 2020, we adopted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Prior period amounts have not been restated and are presented in accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 310&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,610&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 30 percent of our finished goods inventory as of December&#160;31, 2021 and approximately 33 percent as of December 31, 2020 was at customer locations pursuant to consignment arrangements or held by sales representatives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;799&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,084&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $352 million in 2021, $333 million in 2020 and $311 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,921&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_1ed815c9-5da2-4587-b032-4aa6994bd099"&gt;389&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_bbf05a7c-f990-4fcb-b0f0-f7abb412ae4f"&gt;401&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNTc_84c5ff3e-9fb4-4c60-b7d7-0e703c5c3f17">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,531&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note: Effective January 1, 2020, we adopted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Prior period amounts have not been restated and are presented in accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 310&lt;/span&gt;.</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzItMS0xLTEtMA_7a208425-c272-42e6-8b7b-bb3969e334d7"
      unitRef="usd">1886000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzItMy0xLTEtMA_ae40b77f-7334-4eb2-8f46-685c8a3f6971"
      unitRef="usd">1637000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzMtMS0xLTEtMA_5af66706-5c9c-4a83-8727-52888a6b8ca3"
      unitRef="usd">108000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzMtMy0xLTEtMA_eab25138-55f0-4ac0-beee-fdf83da69bb6"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzUtMS0xLTEtMA_e58e9a71-9a90-45eb-8dcf-fd293e0ef644"
      unitRef="usd">1778000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTo1Yzk4ZWQzOGI0OWE0ZWM4OTJjMzRkMjY4YTkyMjA1Ny90YWJsZXJhbmdlOjVjOThlZDM4YjQ5YTRlYzg5MmMzNGQyNjhhOTIyMDU3XzUtMy0xLTEtMA_cec5c5e4-b74d-4e2b-ae30-97870498b144"
      unitRef="usd">1531000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzItMS0xLTEtMA_bd2a027b-e2b5-41ff-b0ca-803320ed1b85"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzItMy0xLTEtMA_73887a69-b411-4311-bca6-795ce665fe4b"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzItNS0xLTEtMA_3edd9654-cee7-4a2b-abc1-d149b006e172"
      unitRef="usd">68000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzMtMy0xLTEtNDg1OTU_12be1cdf-900d-4a34-8fe9-a3c3a3c7d65f"
      unitRef="usd">10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzQtMS0xLTEtMA_d1203326-5e22-4d9e-9437-6526a6f0b9f1"
      unitRef="usd">28000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzQtMy0xLTEtMA_0e1159c3-03f2-447a-87ab-a9f9104e372a"
      unitRef="usd">49000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzQtNS0xLTEtMA_e116028f-d264-4bc6-9d1e-a1df00916446"
      unitRef="usd">23000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzUtMS0xLTEtMA_a749d49c-c293-4191-a18c-2b20d897c6f6"
      unitRef="usd">25000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzUtMy0xLTEtMA_10393d49-bf56-4729-b0ba-6c65c6e29fde"
      unitRef="usd">27000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzUtNS0xLTEtMA_6ca61b72-d638-424f-8631-449332504856"
      unitRef="usd">17000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzYtMS0xLTEtMA_bc3a862a-17e6-4f26-99d2-5636b3fbe40e"
      unitRef="usd">108000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzYtMy0xLTEtMA_397cabda-b14b-4064-aafc-b9522f0ca241"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTowOTY2ZjM5YzkyODQ0M2U4YWU5YjMzNjBiZjJjOTFjOC90YWJsZXJhbmdlOjA5NjZmMzljOTI4NDQzZThhZTliMzM2MGJmMmM5MWM4XzYtNS0xLTEtMA_e8fa04a5-653b-4695-ae00-672d1bfe7546"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNDg_f7982083-e313-483b-b23e-dc5da258d5ad">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,610&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzItMS0xLTEtMA_eaae286e-05c0-424e-8cb7-cb22f7b43ef5"
      unitRef="usd">1029000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzItMy0xLTEtMA_fcdb9fca-aa4f-4e23-a687-fccb69164b7b"
      unitRef="usd">893000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzMtMS0xLTEtMA_e971fd44-ff13-4fbc-a011-814dfe455414"
      unitRef="usd">128000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzMtMy0xLTEtMA_70f29432-c395-430c-8a13-a297452cfd8a"
      unitRef="usd">109000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzQtMS0xLTEtMA_96eff83e-ee2c-46ad-90e0-67ee17454a62"
      unitRef="usd">452000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzQtMy0xLTEtMA_0ea19b4d-b119-44bc-8891-8c619ba5245d"
      unitRef="usd">349000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzUtMS0xLTEtMA_f0ba7bfa-7420-4c7a-aba3-e221f01fde9a"
      unitRef="usd">1610000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYTVlYWZmMWZkODM0ZGZlYWYxZGZkOTVjYTA1NDQ4Mi90YWJsZXJhbmdlOjNhNWVhZmYxZmQ4MzRkZmVhZjFkZmQ5NWNhMDU0NDgyXzUtMy0xLTEtMA_86b9f44c-780f-440b-adb2-a9f3e0995b50"
      unitRef="usd">1351000000</us-gaap:InventoryNet>
    <bsx:PercentOfFinishedGoodsAtConsignment
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzU5Mg_b7bf8cdc-937d-4058-be84-f2c3050e31de"
      unitRef="number">0.30</bsx:PercentOfFinishedGoodsAtConsignment>
    <bsx:PercentOfFinishedGoodsAtConsignment
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzY1NA_9e96d74b-2d74-47ac-95ae-822838cd8f66"
      unitRef="number">0.33</bsx:PercentOfFinishedGoodsAtConsignment>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMjc_d648d3e4-536e-43d8-b0cf-2543355ed36c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;799&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzItMS0xLTEtMA_9e62258b-0fd8-4a11-ab7d-ff1c35dc839d"
      unitRef="usd">188000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzItMy0xLTEtMA_c34989d6-8f48-4a71-862a-42a138ac815f"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzMtMS0xLTEtMA_c59ad85b-4299-4b9b-a411-38a2bcd2c55f"
      unitRef="usd">226000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzMtMy0xLTEtMA_d3cfc672-6483-479a-b049-3ce26f6811f2"
      unitRef="usd">133000000</us-gaap:DerivativeAssetsCurrent>
    <bsx:LicensingArrangements
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzQtMS0xLTEtMA_9c2ec21d-cd9c-47f0-8604-d9214ea0d681"
      unitRef="usd">132000000</bsx:LicensingArrangements>
    <bsx:LicensingArrangements
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzQtMy0xLTEtMA_5112fae7-62d1-47c8-9bed-003797c13815"
      unitRef="usd">148000000</bsx:LicensingArrangements>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzYtMS0xLTEtMA_169f011b-92ee-4ad7-9a77-c2a50cb86ade"
      unitRef="usd">254000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzYtMy0xLTEtMA_0950c227-fc0e-4c89-869c-3ba8d238b8d0"
      unitRef="usd">263000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzctMS0xLTEtMA_4da3d35b-87f4-4314-8319-d6c8ac280f25"
      unitRef="usd">799000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpmZmI3ZThlNjM2Nzg0ZDc4YWExYjk1ZDY4YTAxOWNlNC90YWJsZXJhbmdlOmZmYjdlOGU2MzY3ODRkNzhhYTFiOTVkNjhhMDE5Y2U0XzctMy0xLTEtMA_13c4f7d6-4fd7-4525-aa05-dfd48892135e"
      unitRef="usd">751000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwNTk_da152f71-c080-4849-ade1-3be004dcd5b2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,084&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzItMS0xLTEtMA_0eeeabc9-ae4d-4d9c-a61b-6fc7246efaa7"
      unitRef="usd">109000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzItMy0xLTEtMA_8987b05a-ac1d-4a1c-861b-18d9b2d68edb"
      unitRef="usd">104000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzMtMS0xLTEtMA_3d5daeb6-15ce-4a98-a0a2-e881ee9b6e8d"
      unitRef="usd">1335000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzMtMy0xLTEtMA_adcb4a37-478a-40d1-af05-00d8c34b52dd"
      unitRef="usd">1292000000</us-gaap:BuildingsAndImprovementsGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzQtMS0xLTEtMA_39f01405-4d96-435d-8242-073f0e78f10b"
      unitRef="usd">3475000000</bsx:EquipmentFurnitureAndFixturesGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzQtMy0xLTEtMA_f61bcf73-13ef-461a-bf87-b46fe613d2f5"
      unitRef="usd">3465000000</bsx:EquipmentFurnitureAndFixturesGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzUtMS0xLTEtMA_20bc5415-7efa-4f66-a059-9d322173d3b2"
      unitRef="usd">605000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzUtMy0xLTEtMA_4705309b-0e3d-40d3-a10c-072fc8e2da56"
      unitRef="usd">446000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzYtMS0xLTEtMA_ad880048-ebf8-4191-a4a2-517ed4d77599"
      unitRef="usd">5525000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzYtMy0xLTEtMA_08ac8ab2-2be8-4a29-9781-b29929e0e619"
      unitRef="usd">5308000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzctMS0xLTEtMA_6b5d56bc-5b82-4bfb-9128-6a0a8d98dcda"
      unitRef="usd">3273000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzctMy0xLTEtMA_77f8cfdb-ea09-454e-a24a-16208509885a"
      unitRef="usd">3224000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzgtMS0xLTEtMA_d39034e4-9b7a-4e17-be46-fc8fb3d78bfa"
      unitRef="usd">2252000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTozYjVjZjYwMDgwYWQ0YzUzODQzY2Q1ZTkyZTkyNGI2My90YWJsZXJhbmdlOjNiNWNmNjAwODBhZDRjNTM4NDNjZDVlOTJlOTI0YjYzXzgtMy0xLTEtMA_86d4b18c-cea4-4df1-a9a9-da7965a4e64c"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzg2NA_c48cfca4-c5a3-4c02-95a8-8d10332443d6"
      unitRef="usd">352000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzg3NA_227752b4-0ce5-4392-b6fc-68ba9f65a2cb"
      unitRef="usd">333000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzg4Nw_93299047-d833-4d6d-9626-9cc2637d973d"
      unitRef="usd">311000000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMDY_44e58940-eed6-4a3b-b16e-4ea474d77647">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,921&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzItMS0xLTEtMA_a0f9640a-7d98-49c0-b029-941776e46ecd"
      unitRef="usd">55000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzItMy0xLTEtMA_7e282d4a-bf15-4489-9950-936674055352"
      unitRef="usd">52000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id80ded4802ba46d3832724842de8285c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzMtMS0xLTEtMA_86b132cf-932a-41a0-8fd6-e83a0ade93e5"
      unitRef="usd">435000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3fed35511829459da5a38d83c0ca798b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzMtMy0xLTEtMA_0ba13a5d-5fd0-4d75-ac5c-1ca79a740e7a"
      unitRef="usd">458000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzQtMS0xLTEtMA_765c7ff5-b756-4c62-8593-bc168362d328"
      unitRef="usd">169000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzQtMy0xLTEtMA_aa36ec5a-5655-4cef-9e2e-03443a683913"
      unitRef="usd">109000000</us-gaap:DerivativeAssets>
    <us-gaap:Investments
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzUtMS0xLTEtMA_b81e7f5a-9fa9-4d41-b62d-688a4235e9b8"
      unitRef="usd">412000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzUtMy0xLTEtMA_4ba3350d-00f6-45b6-9267-e9a9f1cfe514"
      unitRef="usd">918000000</us-gaap:Investments>
    <bsx:LicensingArrangementsAsset
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzYtMS0xLTEtMA_33af333d-16a9-4149-a93c-db66a2c39ff2"
      unitRef="usd">114000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzYtMy0xLTEtMA_ac476060-71c7-4510-972a-8a41bfe92237"
      unitRef="usd">218000000</bsx:LicensingArrangementsAsset>
    <bsx:OtherOtherLongTermAssets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzctMS0xLTEtMA_38cf3aca-9c9e-4788-abec-52a906bdb684"
      unitRef="usd">225000000</bsx:OtherOtherLongTermAssets>
    <bsx:OtherOtherLongTermAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzctMy0xLTEtMA_5a927c9f-4d91-4787-9ddc-df0faaf85ee8"
      unitRef="usd">166000000</bsx:OtherOtherLongTermAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzgtMS0xLTEtMA_c9f435c5-ac52-45e3-8f01-67c9b1c5f0a9"
      unitRef="usd">1410000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpkZGEzNmM0NTZhMWE0ZmIwOWFkY2QyMTA5OTQxZTI5ZC90YWJsZXJhbmdlOmRkYTM2YzQ1NmExYTRmYjA5YWRjZDIxMDk5NDFlMjlkXzgtMy0xLTEtMA_5c4f81f5-1d15-4eb6-8d36-502ae3d5ef08"
      unitRef="usd">1921000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMjg_87b32b60-f667-464e-8837-8a1302060696">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserveCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzItMS0xLTEtMA_7e0ceb2c-dca0-4df0-8958-084335d9ee34"
      unitRef="usd">264000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzItMy0xLTEtMA_dc30b93f-dbb6-4bfb-8ffe-4c77c068c123"
      unitRef="usd">505000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzMtMS0xLTEtMA_42b0415c-399c-4d50-9627-0292b3756728"
      unitRef="usd">848000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzMtMy0xLTEtMA_c9955e50-2333-485b-a5a3-9d128e8e9551"
      unitRef="usd">681000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzQtMS0xLTEtMA_61dbfbf0-0746-4148-9839-429cdc147bb1"
      unitRef="usd">350000000</bsx:AccruedRebatesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzQtMy0xLTEtMA_4fc4a0cd-5352-42c4-93cc-a0f2b51c9f52"
      unitRef="usd">331000000</bsx:AccruedRebatesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzUtMS0xLTEtMA_76eafdf5-4fe6-4216-85e4-1eca8e9f40aa"
      unitRef="usd">289000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzUtMy0xLTEtMA_19aee47e-8422-4cb9-9b24-236c4af4dac1"
      unitRef="usd">26000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzYtMS0xLTEtMA_d35bf3b4-e251-4811-bb05-4fd4aa62350c"
      unitRef="usd">686000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzYtMy0xLTEtMA_a2daaf3f-c240-4af2-95da-c3ee8753478b"
      unitRef="usd">656000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzctMS0xLTEtMA_1a07543b-93f7-4c22-bce3-70f7ec363dbb"
      unitRef="usd">2436000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZToxYjY0NmJmYzVlY2U0MGM2OTVmMWIzMjkwMTQ2ZGMyYS90YWJsZXJhbmdlOjFiNjQ2YmZjNWVjZTQwYzY5NWYxYjMyOTAxNDZkYzJhXzctMy0xLTEtMA_7c00a002-5c41-43ac-a92a-8b96a2a1631b"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMzk_6a05dc93-f92a-45d8-84ce-62f882745c6a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzItMS0xLTEtMA_4561f928-5772-4ed8-9f54-dd23638f9ad3"
      unitRef="usd">208000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzItMy0xLTEtMA_d9151341-4608-49ac-9270-94b97501f6c9"
      unitRef="usd">138000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzMtMS0xLTEtMA_7c21493d-bb77-45dc-958d-684b85921b17"
      unitRef="usd">138000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzMtMy0xLTEtMA_b117dfca-4b1a-4f88-b5c9-08e283820977"
      unitRef="usd">153000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzQtMS0xLTEtMA_abda3adc-061e-4487-a077-18db23634e6f"
      unitRef="usd">209000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzQtMy0xLTEtMA_91a821c3-becc-4229-808e-92e52dc63cc1"
      unitRef="usd">158000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzUtMS0xLTEtMA_6234d9a1-16b6-4e01-8456-bf118b5c6ccb"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzUtMy0xLTEtMA_c2722f75-98ff-4879-9186-36b191d325b4"
      unitRef="usd">200000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzYtMS0xLTEtMA_c9c724f4-28c7-4260-8db7-9b24790d2b44"
      unitRef="usd">228000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzYtMy0xLTEtMA_66072e13-e7ad-4489-a84c-58af487a0155"
      unitRef="usd">307000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzctMS0xLTEtMA_6913e841-98a2-4255-a701-1a537044fa3a"
      unitRef="usd">783000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjMDM4NGU1NjY4YmY0ZWUxYWQ5ZWJiOTU1NDA5YjQyNC90YWJsZXJhbmdlOmMwMzg0ZTU2NjhiZjRlZTFhZDllYmI5NTU0MDliNDI0XzctMy0xLTEtMA_309afe14-cfa1-4e6d-a42c-067d0da25c1e"
      unitRef="usd">958000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90ZXh0cmVnaW9uOjFjMTlmODdjMjljOTRkOWFhOTI5ZGZkZmY2ZGZjMzJjXzEwMjI_901b319e-7faf-49d8-9d8e-8448aadda760">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_1ed815c9-5da2-4587-b032-4aa6994bd099"&gt;389&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_bbf05a7c-f990-4fcb-b0f0-f7abb412ae4f"&gt;401&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzItMS0xLTEtMA_d8e24c89-4c5f-46d1-b8ba-baed6bc2ae2d"
      unitRef="usd">442000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzItMy0xLTEtMA_1d31bdbc-dcc9-47af-a86c-124653b6dc69"
      unitRef="usd">547000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzMtMS0xLTEtMA_b95a86bb-5317-4f9e-874f-89d5c9a74f41"
      unitRef="usd">284000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzMtMy0xLTEtMA_e232e51d-4e85-46f4-9210-d21c9dc6c2f9"
      unitRef="usd">64000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzQtMS0xLTEtMA_8bf607a8-c397-42d4-b22e-d582d61ca310"
      unitRef="usd">197000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzQtMy0xLTEtMA_78739f36-98f1-402a-80c9-430d792ad6a7"
      unitRef="usd">171000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <bsx:LicensingArrangementsLiability
      contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzUtMS0xLTEtMA_6f3da8ab-9008-4c54-bf11-d02e1b1bc1c0"
      unitRef="usd">143000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzUtMy0xLTEtMA_ca1054bd-373d-4f3b-bcc4-9086ecc6307c"
      unitRef="usd">253000000</bsx:LicensingArrangementsLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMS0xLTEtMA_7e90ba1e-cec3-457d-b651-b50748ed3ece"
      unitRef="usd">389000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzYtMy0xLTEtMA_f4d2fb04-7238-475f-8525-ab855157d3e8"
      unitRef="usd">401000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRevenue
      contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzctMS0xLTEtMA_ab9431bd-1241-408f-abd4-ca2ce2d4a51d"
      unitRef="usd">276000000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzctMy0xLTEtMA_e3215d0e-a753-4425-85d1-7cb422c8d945"
      unitRef="usd">257000000</us-gaap:DeferredRevenue>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i59918f0ebd684c1d8379289da4defc20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzgtMS0xLTEtMA_5df10f46-34be-4ba0-8403-05e042eb777c"
      unitRef="usd">489000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i579de7aa53774d52a5d838a68bce863a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzgtMy0xLTEtMA_3c605bfe-925b-41a4-b581-4693e18e82c8"
      unitRef="usd">615000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzktMS0xLTEtMA_8601f805-586d-4d5a-af0f-64d45a8c31e0"
      unitRef="usd">2220000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMTgvZnJhZzoxYzE5Zjg3YzI5Yzk0ZDlhYTkyOWRmZGZmNmRmYzMyYy90YWJsZTpjNDhlYWJjZmFmNzU0NDc4OGY4OTQ0YjIwODE3OTc5OC90YWJsZXJhbmdlOmM0OGVhYmNmYWY3NTQ0Nzg4Zjg5NDRiMjA4MTc5Nzk4XzktMy0xLTEtMA_26fd67ec-bb7d-42e4-a4f3-92c758093841"
      unitRef="usd">2309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNzA_786e5de8-b8d1-43e3-962a-67b6a9d22e44">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE J &#x2013; INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related expense (benefit) for income taxes consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic taxes on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intra-entity asset transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(584.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(reclassified)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory costs and related reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit of net operating losses and credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves and accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and product liability reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal benefit of uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains and losses on derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,038&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional deferred items in 2021, we have reclassified select items in prior years to align with the new categories disclosed in the current year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,038&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $560 million. As of December&#160;31, 2020, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $474 million. In addition, we had foreign tax net operating loss carryforwards and tax &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;credits, the tax effect of which was $60 million as of December&#160;31, 2021, as compared to $83 million as of December&#160;31, 2020. These tax attributes expire periodically beginning in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, we completed intra-entity asset transfers of certain intellectual property rights among various wholly owned subsidiaries. These transactions occurred to more closely align the global economic ownership of our intellectual property rights with our current and future business operations. These transactions did not result in a taxable gain in any jurisdiction, however, some of the transactions did create a step-up in the tax-deductible basis in the transferred intellectual property rights in certain jurisdictions. As a result, we recorded deferred tax assets in the amount of $4.102 billion, which represents the book and tax basis differences measured at applicable statutory tax rates, net of a valuation allowance of $542 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After consideration of all positive and negative evidence, we believe that it is more likely than not that a portion of our deferred tax assets will not be realized. As a result, we recorded a valuation allowance of $1,014 million as of December&#160;31, 2021 and $887 million as of December&#160;31, 2020, representing an increase of $127 million. The increase in the valuation allowance as of December&#160;31, 2021, as compared to December&#160;31, 2020, is primarily due to an increase of US state loss carryforwards and the concurrent build of the related valuation allowance. The income tax impact of the unrealized gain or loss component of other comprehensive income and stockholders' equity was a charge of $81 million in 2021, a benefit of $78 million in 2020 and a charge of $13 million in 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain tax incentives through Free Trade Zone Regime offered in Costa Rica which allows 100.0 percent exemption from income tax in the first eight years of operations and 50.0 percent exemption in the following four years. This tax incentive resulted in income tax savings of $149 million for 2021, $64 million for 2020 and $173 million for 2019. The tax incentive for 100.0 percent exemption from income tax was renewed during 2019 and is expected to expire in 2027. The impact on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss) per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was $0.10 for 2021, $0.04 for 2020 and $0.12 for 2019. Additionally, we benefit from tax incentives in Puerto Rico resulting in income tax savings of $27 million for 2021, $30 million for 2020 and immaterial amounts for 2019. The impact on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss) per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was $0.02 for 2021 and 2020, and less than $0.01 for 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, we had $255 million of gross unrecognized tax benefits, of which a net $177 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2020, we had $261 million of gross unrecognized tax benefits, of which a net $183 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $455 million of gross unrecognized tax benefits, of which a net $355 million, if recognized, would affect our effective tax rate. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitation expirations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to U.S. Federal income tax as well as income tax of multiple state and foreign jurisdictions. We have concluded all U.S. federal income tax matters through 2016 and substantially all material state and local income tax matters through 2010. We have concluded all foreign income tax matters through 2013, with the exception of issues for Italy, which have concluded through 2002.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91&#160;million to release the reserves related to these years. We received a refund of $62&#160;million from the IRS reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize interest and penalties related to income taxes as a component of income tax expense. We had $43 million accrued for gross interest and penalties as of December&#160;31, 2021 and $41 million as of December&#160;31, 2020. Net tax expense related to interest and penalties was immaterial in 2021, 2020 and 2019. The increase in our net tax expense related to interest and penalties as of December&#160;31, 2021, as compared to December&#160;31, 2020, is related to reaching settlements with the taxing authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that within the next 12&#160;months we will resolve transactional-related issues with foreign and state taxing authorities, in which case we could record a reduction in our balance of unrecognized tax benefits of up to approximately $54 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2017, we were required under the TCJA to calculate a one-time transition tax based on our total post-1986 foreign subsidiaries' earnings and profits (E&amp;amp;P) that we previously deferred from U.S. income taxes. As a result of various audit activities, the revised amount of transition tax was approximately $938 million as of December 31, 2021 as compared to $939 million as of December 31, 2020. We anticipate offsetting this liability against existing tax attributes reducing the required payment to approximately $590 million, which will be remitted over an eight-year period. We have begun remitting the required installment payments, with a balance remaining of $430 million as of December&#160;31, 2021. In addition, we have provided for U.S. state income taxes of $19 million on all U.S. dollar-denominated E&amp;amp;P accumulated through December 31, 2017, which constitutes the preponderance of our foreign subsidiaries' accumulated E&amp;amp;P through December 31, 2017. We intend to indefinitely reinvest the unremitted foreign earnings of all other subsidiaries as of December 31, 2017, as well as all subsequent earnings generated by all of our foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings and additional outside basis difference in these entities is not practicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to a territorial tax system under the TCJA, in which we are required to provide for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have established an accounting policy election to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we did not apply for government loans, we took advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNDk_514b83b1-b345-4e3f-b5f6-1b41418ac966">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzItMS0xLTEtMA_93f1450a-3199-4f94-86b2-6689d21f6de7"
      unitRef="usd">-648000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzItMy0xLTEtMA_cb564ace-35f7-46cb-980d-e79011f4758d"
      unitRef="usd">-660000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzItNS0xLTEtMA_9eb0052a-6ef4-44df-bdf3-bef83e26aa19"
      unitRef="usd">-1145000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzMtMS0xLTEtMA_96559e9b-a8ff-41fb-8efa-2810501549c3"
      unitRef="usd">1724000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzMtMy0xLTEtMA_f3d8c49b-2611-428f-bbfb-52e8e9ae0cbc"
      unitRef="usd">581000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzMtNS0xLTEtMA_85dcd1f2-420d-4043-bf2e-fce2195cbbc6"
      unitRef="usd">1832000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzQtMS0xLTEtMA_b689577a-c967-4dcb-89f4-f0f8074737c3"
      unitRef="usd">1076000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzQtMy0xLTEtMA_3c7c6b5f-b28c-4163-84fb-43e2f65b89da"
      unitRef="usd">-79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZToyMjQxMGFiNzU4YjY0ZWUzODM3MjI5YWZmOTA0NGI1Yy90YWJsZXJhbmdlOjIyNDEwYWI3NThiNjRlZTM4MzcyMjlhZmY5MDQ0YjVjXzQtNS0xLTEtMA_54f9496c-1b0c-4e0b-8b01-f1a32927b4e8"
      unitRef="usd">687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzMTg_4d3a8b8e-9c1e-46f1-818c-6171924d990f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related expense (benefit) for income taxes consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzMtMS0xLTEtMA_e9b5f651-9a2f-48b4-9b17-ae5cf9b15cb4"
      unitRef="usd">18000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzMtMy0xLTEtMA_d17fb634-21f0-45fa-8b33-e496a9d4cbe9"
      unitRef="usd">-29000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzMtNS0xLTEtMA_9e0f02a1-151a-4770-8b61-3b463a65c6a7"
      unitRef="usd">120000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzQtMS0xLTEtMA_08c6125b-d306-42dc-9c6b-40096cb23184"
      unitRef="usd">33000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzQtMy0xLTEtMA_04be3dab-d874-4ed6-a46d-a054f1edcfd2"
      unitRef="usd">-35000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzQtNS0xLTEtMA_b27cf1c8-076b-46e5-b462-40c5853a1784"
      unitRef="usd">54000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzUtMS0xLTEtMA_c308d052-0f44-4946-801f-4dbc8dc7e59c"
      unitRef="usd">127000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzUtMy0xLTEtMA_edc188be-3b2e-4450-866d-1f4e43f21ce7"
      unitRef="usd">151000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzUtNS0xLTEtMA_c5c8ce2d-72e0-4720-863a-07e5e7a2ecae"
      unitRef="usd">101000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzYtMS0xLTEtMA_eb9a452f-ee92-4684-8f9e-6dfa3d88d02f"
      unitRef="usd">178000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzYtMy0xLTEtMA_c9d2aacc-5c44-4f00-9675-214ce12978ff"
      unitRef="usd">87000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzYtNS0xLTEtMA_73ffcd45-32f5-4bcf-ab59-c3d651e6bbba"
      unitRef="usd">275000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzktMS0xLTEtMA_1cf5bce1-dd48-4283-91da-1f88bb65687e"
      unitRef="usd">-256000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzktMy0xLTEtMA_6908e328-2095-4bfe-8390-3e672bc5990c"
      unitRef="usd">-26000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzktNS0xLTEtMA_e458f23b-7d12-4aef-9f9f-d04daa94a287"
      unitRef="usd">-146000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEwLTEtMS0xLTA_86279fb1-0949-47e3-9257-237c372d99d0"
      unitRef="usd">-3000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEwLTMtMS0xLTA_350e5e5b-167f-476e-b671-9687a11f1211"
      unitRef="usd">-6000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEwLTUtMS0xLTA_0deb380e-046c-436a-8490-85d5c314804f"
      unitRef="usd">-18000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzExLTEtMS0xLTA_a403ada1-7118-4c49-a334-0486bf763519"
      unitRef="usd">117000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzExLTMtMS0xLTA_83e4ac46-0b3a-4746-bcd6-d1b94b0959d5"
      unitRef="usd">-53000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzExLTUtMS0xLTA_3d43d33e-9dd4-4d57-b911-ca0f82da6876"
      unitRef="usd">-4124000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEyLTEtMS0xLTA_b4ea7cdc-2e67-4cf1-9e32-93b7a4efaad0"
      unitRef="usd">-142000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEyLTMtMS0xLTA_8e2b3ebc-0a63-4e9b-85b7-d7b79fa6d161"
      unitRef="usd">-85000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEyLTUtMS0xLTA_b8986b48-0eb5-4ed0-800e-b674f8c4592b"
      unitRef="usd">-4288000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEzLTEtMS0xLTA_7e31240f-4c76-419a-a6b4-f8396e1bd5b7"
      unitRef="usd">36000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEzLTMtMS0xLTA_35aedb1f-9b9d-4aac-ab30-38e1a894c99c"
      unitRef="usd">2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo2MGYxZDM1ZTVlZmU0N2U3ODI0NmQ1OTIyNjM0NjgwOS90YWJsZXJhbmdlOjYwZjFkMzVlNWVmZTQ3ZTc4MjQ2ZDU5MjI2MzQ2ODA5XzEzLTUtMS0xLTA_1dc40a82-2ab7-4508-a592-05934fea84fb"
      unitRef="usd">-4013000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNTE_6346e01f-6d7b-408a-8dd5-5f1a6182dbd3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic taxes on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intra-entity asset transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(584.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzMtMS0xLTEtMA_d2c0f4aa-9d11-4ba1-b608-340773ffe5d3"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzMtMy0xLTEtMA_cd04a318-0e81-4c54-9cae-061b358b41d1"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzMtNS0xLTEtMA_ab81c3ad-3221-4828-a381-117c4289e99c"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzQtMS0xLTEtMA_4852e9d8-fafe-4dd6-94d8-621840a95080"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzQtMy0xLTEtMA_871bbdf6-7ff9-4690-a41d-dbf135c505ed"
      unitRef="number">0.166</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzQtNS0xLTEtMA_2d724d9b-9d97-4d68-8887-5b6cb7d3ff55"
      unitRef="number">0.067</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzUtMS0xLTEtMA_2b159cf8-5199-4bdd-9411-b2a8f9653cff"
      unitRef="number">0.068</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzUtMy0xLTEtMA_fa2aa1ac-515d-43e4-9fc2-e8d11cffdbca"
      unitRef="number">1.554</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzUtNS0xLTEtMA_9716cf46-8e1f-4846-b1a5-3203e7b232d6"
      unitRef="number">0.219</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzYtMS0xLTEtMA_7ece31ef-9a31-4280-aec5-53a266a32dbf"
      unitRef="number">-0.143</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzYtMy0xLTEtMA_f13e998b-8060-4aef-9e0d-df2fd17c04c1"
      unitRef="number">-0.407</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzYtNS0xLTEtMA_be0a4b3c-55a3-4cd0-ac12-56a0f9a3fd5d"
      unitRef="number">-0.476</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzctMS0xLTEtMA_d59ccac2-2308-4376-8641-e7dc975eacf4"
      unitRef="number">0.081</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzctMy0xLTEtMA_3afee21f-e89a-47ba-ac1c-f6fcc11f4d22"
      unitRef="number">-0.167</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzctNS0xLTEtMA_7262867a-41d1-4586-b8ef-19a7b53847d7"
      unitRef="number">0.122</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzgtMS0xLTEtMA_9bae33cc-7805-4ee2-8c07-606a1bac8915"
      unitRef="number">0.030</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzgtMy0xLTEtMA_1fcd6d6a-5f16-4d0e-b93e-d95ebf09e1f0"
      unitRef="number">0.430</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzgtNS0xLTEtMA_155647cc-2b26-4cb1-bc4b-60a246de753a"
      unitRef="number">0.042</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzktMS0xLTEtMA_f0b8a88c-ae10-4883-b798-3ec17abfec7b"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzktMy0xLTEtMA_a382a3f9-073e-4f65-9e07-eb32269d7893"
      unitRef="number">-0.420</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzktNS0xLTEtMA_c96aa240-3ddb-4007-8acf-707489167b1b"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzExLTEtMS0xLTA_7eebcb92-3f43-4a80-a67b-84468cfa6a47"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzExLTMtMS0xLTA_096d28ff-9444-445a-97ec-3018ba64e5bd"
      unitRef="number">0.037</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzExLTUtMS0xLTA_11fef62a-205e-4e63-96bd-17a9a6d8c759"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEyLTEtMS0xLTA_5795371a-4f20-4bb7-b3a1-1ae56e6bed9c"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEyLTMtMS0xLTA_f1638662-a532-488c-b8b9-c9a969f348eb"
      unitRef="number">-0.077</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEyLTUtMS0xLTA_60e3feaf-38f1-49cf-903e-035f0356958a"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEzLTEtMS0xLTA_3d386d9f-4c83-4110-be26-2ffa33ca5d95"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEzLTMtMS0xLTA_a3e86f72-2413-418f-8782-03987db5c230"
      unitRef="number">0.644</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzEzLTUtMS0xLTA_1b042561-93ff-4d28-af8e-42eac05d4d65"
      unitRef="number">0.036</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE0LTEtMS0xLTA_bb00b383-b6b0-42c8-9484-6ded0b21be52"
      unitRef="number">0.012</bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions>
    <bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE0LTMtMS0xLTA_b99cc965-6fc5-43ae-89db-7b196b100195"
      unitRef="number">-0.968</bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions>
    <bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE0LTUtMS0xLTA_233ca52b-62bb-480c-a83b-c13bed86aa7b"
      unitRef="number">0.014</bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions>
    <bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE2LTEtMS0xLTA_584d1000-7d20-4bd4-bae2-d4fe81c46255"
      unitRef="number">0</bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers>
    <bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE2LTMtMS0xLTA_05cb20b9-604f-4a3f-b86e-0a0e8b45d224"
      unitRef="number">0.102</bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers>
    <bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE2LTUtMS0xLTA_51bc8971-4dda-4043-8973-fb5b630098ab"
      unitRef="number">-5.970</bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers>
    <bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE4LTEtMS0xLTA_cc3defaf-fd9d-47a7-ac36-96bffcdd2380"
      unitRef="number">-0.057</bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision>
    <bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE4LTMtMS0xLTA_832af8f2-b376-4ab2-9af6-f31229ec91c3"
      unitRef="number">-0.373</bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision>
    <bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE4LTUtMS0xLTA_96127435-f1e5-4512-821e-a08302caed48"
      unitRef="number">-0.002</bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE5LTEtMS0xLTA_cd137c0e-b783-4bad-844a-d9ea5a3ef72d"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE5LTMtMS0xLTA_14acc412-da89-4e2d-bead-36bddf64f5a9"
      unitRef="number">0.518</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzE5LTUtMS0xLTA_3f090dc6-7454-4a13-be1d-c6575084267d"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIwLTEtMS0xLTA_0b82f75b-42f1-4051-b6ad-42cbd3e8d6bf"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIwLTMtMS0xLTA_b42091f4-537a-4896-94fe-eccf4e8c6fd3"
      unitRef="number">0.060</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIwLTUtMS0xLTA_3ab59dc4-9501-4e61-a15d-af15156c48eb"
      unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIxLTEtMS0xLTA_5c6a9f5b-dd92-4b35-84db-afe0cb8b5546"
      unitRef="number">0.033</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIxLTMtMS0xLTA_e8d8041b-0ffc-4605-a50a-3488d69bab09"
      unitRef="number">0.029</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTo4OGE3ZGEyNDc2YTk0YWU1YjY3ZTg1M2MzMjEzODEyMy90YWJsZXJhbmdlOjg4YTdkYTI0NzZhOTRhZTViNjdlODUzYzMyMTM4MTIzXzIxLTUtMS0xLTA_094d3a72-6cf4-4463-ab0b-40c82d0f1660"
      unitRef="number">-5.840</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNzY_4d73d1e5-64e4-47bf-b4cf-291e2c3bf532">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(reclassified)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory costs and related reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit of net operating losses and credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves and accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and product liability reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal benefit of uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains and losses on derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,038&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,038&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzQtMS0xLTEtMA_c390d9fd-e1f4-411c-ad79-0a6a909160f3"
      unitRef="usd">10000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzQtMy0xLTEtMA_4cf206b2-5ddb-4015-9775-222028fb7c5a"
      unitRef="usd">10000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzUtMS0xLTEtMA_62457995-47f7-45e2-8b4e-d951a7906614"
      unitRef="usd">620000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzUtMy0xLTEtMA_7e9af25c-74bc-4017-85e7-eaa287e3dc79"
      unitRef="usd">557000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzYtMS0xLTEtMA_2aa7d206-2259-451c-bb2f-33cec486376e"
      unitRef="usd">324000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzYtMy0xLTEtMA_99983cb4-5cad-40cd-9a00-18c3d2489e45"
      unitRef="usd">308000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzctMS0xLTEtMA_9d4fcaa2-ee82-48f9-bbc5-fba41cdec79c"
      unitRef="usd">14000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzctMy0xLTEtMA_454d2f2e-12f0-4ea1-a923-163b6c9c24ef"
      unitRef="usd">23000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzgtMS0xLTEtMA_c0187302-e3bd-467c-ba19-33387baf9632"
      unitRef="usd">127000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzgtMy0xLTEtMA_51f26bb6-9f41-459c-8aa1-29461716a118"
      unitRef="usd">82000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzktMS0xLTEtMA_924936f8-7dbc-4ba2-96a5-23a417e16160"
      unitRef="usd">31000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzktMy0xLTEtMA_05a18510-87da-4eb9-8d78-e4f80f8920af"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEwLTEtMS0xLTA_6e3259f9-0c75-41ca-a1f5-33f66f498300"
      unitRef="usd">130000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEwLTMtMS0xLTA_be12f91f-db91-4979-af77-197c00a25ccb"
      unitRef="usd">134000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <bsx:FederalBenefitOfUncertainTaxPositions
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzExLTEtMS0xLTA_b7e6b158-5d12-4e30-834f-70910951da9a"
      unitRef="usd">8000000</bsx:FederalBenefitOfUncertainTaxPositions>
    <bsx:FederalBenefitOfUncertainTaxPositions
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzExLTMtMS0xLTA_ae997dbc-d4bf-4695-b45a-abf226702977"
      unitRef="usd">9000000</bsx:FederalBenefitOfUncertainTaxPositions>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEyLTEtMS0xLTA_d4f199e7-01e7-471c-aa59-97614eeb42b4"
      unitRef="usd">3546000000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEyLTMtMS0xLTA_024a8a4d-1681-4518-bebf-97ba82b86181"
      unitRef="usd">3551000000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTEtMS0xLTU4NjI1_e4db2bc9-5935-4c79-987b-5fcd83748bc2"
      unitRef="usd">67000000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTMtMS0xLTU4NjI1_d6dc3659-7713-49e0-96df-af38f4b6228f"
      unitRef="usd">4000000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTEtMS0xLTU4NjI1_a03c7207-f8af-4250-b746-7063464d7175"
      unitRef="usd">14000000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTMtMS0xLTU4NjI1_0b7916a9-e3a0-4235-af5b-7ea1442e02ee"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTEtMS0xLTA_958354f9-2598-41af-b481-7632359ef216"
      unitRef="usd">35000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzEzLTMtMS0xLTA_1336ecf4-21bb-41e4-b44a-1152f2d6cba3"
      unitRef="usd">-10000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTEtMS0xLTA_9ac5058d-1dfb-46b8-801b-0f1a00edb186"
      unitRef="usd">4926000000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE0LTMtMS0xLTA_27afdd19-dd29-4182-850a-e1c04cb212a6"
      unitRef="usd">4668000000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE1LTEtMS0xLTA_6fd36407-06e8-4197-b2f9-462a7d8e1f76"
      unitRef="usd">1014000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE1LTMtMS0xLTA_d3dcc897-0f08-4b77-b6fa-19657d16dd06"
      unitRef="usd">887000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE2LTEtMS0xLTA_f79dc010-9e62-439d-8bc9-6541b63f38bf"
      unitRef="usd">3912000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE2LTMtMS0xLTA_33e2eb91-87b7-431e-809d-733fbcb180ea"
      unitRef="usd">3781000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE4LTEtMS0xLTA_7e977a51-a731-4f2f-8cfa-441ebb890280"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE4LTMtMS0xLTA_72bb18a7-9825-463e-bb1d-53d06cb8a739"
      unitRef="usd">1000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesDerivatives
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE5LTEtMS0xLTA_32c3ef8d-98b1-4f62-9625-9dd5ed9e7c7e"
      unitRef="usd">79000000</us-gaap:DeferredTaxLiabilitiesDerivatives>
    <us-gaap:DeferredTaxLiabilitiesDerivatives
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzE5LTMtMS0xLTA_6b4c9c66-8a4c-43a9-95f7-1c8406e3b5ce"
      unitRef="usd">12000000</us-gaap:DeferredTaxLiabilitiesDerivatives>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIwLTEtMS0xLTA_307aef47-b288-455a-97e1-0549b979a51f"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIwLTMtMS0xLTA_7407fca8-aafb-4bc5-abae-c791e1f6095c"
      unitRef="usd">34000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIzLTEtMS0xLTA_f6030a32-ffdd-4f1b-812a-0a7f5df6ec4e"
      unitRef="usd">79000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzIzLTMtMS0xLTA_42f9f7f5-d007-4155-940d-9fb8b4d25442"
      unitRef="usd">47000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI1LTEtMS0xLTA_001a92ad-e136-490b-8f62-6a7dfa482e74"
      unitRef="usd">3833000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI1LTMtMS0xLTA_ab3269a7-58ec-4a9c-a831-0a89d14e377c"
      unitRef="usd">3734000000</us-gaap:DeferredTaxAssetsGross>
    <bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI2LTEtMS0xLTA_9ffd2b75-3cc7-4832-8da0-a009637af291"
      unitRef="usd">205000000</bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit>
    <bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI2LTMtMS0xLTA_c1b418c8-a113-4b42-89a0-085ea0750b50"
      unitRef="usd">194000000</bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI3LTEtMS0xLTA_9f7328d5-bedf-4cba-9558-89155530d8de"
      unitRef="usd">4038000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTowYTU3NzRkMjIxOTk0NTk4OGNmMWMxMzRiMmUyZTBkYy90YWJsZXJhbmdlOjBhNTc3NGQyMjE5OTQ1OTg4Y2YxYzEzNGIyZTJlMGRjXzI3LTMtMS0xLTA_5e7fa9c4-fd2c-4b44-a961-f870821b645c"
      unitRef="usd">3928000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="id02c5663b02141118d004b9caa3424ef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzItMi0xLTEtMA_2c72034b-a748-41fb-be53-7d8192bf46a8"
      unitRef="usd">205000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i61ba8102128e4d5ca7ba5fd85188b839_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzItNC0xLTEtMA_b07618d8-2152-487f-9953-ccd4fc6450eb"
      unitRef="usd">194000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i193a2e3116b8454aa87e65f1058e0278_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzMtMi0xLTEtMA_7cfd7791-4e9a-40b5-a8f2-0fa2d148b509"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ibb74a863f3154f8db49c64618640bd85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzMtNC0xLTEtMA_a15b144a-018a-48d5-b545-cb52ebae4a1b"
      unitRef="usd">2000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i2c897d04f2364feeb5c3c6a2fa36d797_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzQtMi0xLTEtMA_70b47e39-c5d9-43aa-af52-8c522cd879ea"
      unitRef="usd">4142000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i6b55c014808f40fa88ef1b3f959db8d2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzQtNC0xLTEtMA_b836b34d-33ca-42c7-8ca4-595df51d9e14"
      unitRef="usd">4210000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzUtMi0xLTEtMA_b047accf-2c9a-453b-9913-eb896f761357"
      unitRef="usd">4348000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzUtNC0xLTEtMA_65a229af-9258-48da-9ef3-1ca6a81cdee1"
      unitRef="usd">4406000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i93bd60f6d70c420a9bc09e7c7bf6fc5f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzctMi0xLTEtMA_9fae340d-b7f4-4e1c-a33a-eda51c66a74b"
      unitRef="usd">310000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ib8d817c2bd28479980edad681c6a2071_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzctNC0xLTEtMA_d4f298d6-48fb-4632-9a6f-6acccf0125ac"
      unitRef="usd">330000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="idb1d6977085e41d8b212c9975e19b482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzktMi0xLTEtMA_f0058019-1792-4cb7-8032-7fdfae7de503"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i1dbe26c3626844cc8fca8bfbd336dd73_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzktNC0xLTEtMA_17378f43-80f3-4e4b-a4fe-43790e778350"
      unitRef="usd">148000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEwLTItMS0xLTA_ef659cd4-f8dc-46f9-a982-ef86883999d1"
      unitRef="usd">310000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEwLTQtMS0xLTA_a2f5ae9e-9794-4e2c-b647-53ca9454b265"
      unitRef="usd">478000000</us-gaap:DeferredTaxLiabilities>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEyLTItMS0xLTA_8c5ed14c-e9eb-4bad-8753-8df7eb1798e2"
      unitRef="usd">4038000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTozMDNmZjlmOTE1NjI0NGY2OWZlMDVlYmUxM2IyZWFlMi90YWJsZXJhbmdlOjMwM2ZmOWY5MTU2MjQ0ZjY5ZmUwNWViZTEzYjJlYWUyXzEyLTQtMS0xLTA_23409947-7dc7-43e9-a1da-5b6035bb96db"
      unitRef="usd">3928000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzg3OA_2cb65b73-cca8-4489-b960-12caf494d51c"
      unitRef="usd">560000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzEwMDQ_8f2388a3-0e3e-4651-b0c1-78f93862ff53"
      unitRef="usd">474000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzExMTg_a58ba60c-a9d4-4c65-94fa-ea296eac74cd"
      unitRef="usd">60000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzExNDY_b1987b22-41ac-4e68-a51e-43f9a536a8ce"
      unitRef="usd">83000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzE4MzU_3a8b3b35-8fdd-4643-a312-359b79949177"
      unitRef="usd">4102000000</us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory>
    <bsx:DeferredTaxAssetValuationAllowanceIntraEntity
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzE5Njc_cf61e4a8-56a6-4a94-9b36-1f90bf9200c6"
      unitRef="usd">542000000</bsx:DeferredTaxAssetValuationAllowanceIntraEntity>
    <bsx:DeferredTaxAssetValuationAllowanceIntraEntity
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzE5Njc_fc514005-b277-4fb3-86ad-c599681d7ce9"
      unitRef="usd">542000000</bsx:DeferredTaxAssetValuationAllowanceIntraEntity>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTE_6fd36407-06e8-4197-b2f9-462a7d8e1f76"
      unitRef="usd">1014000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIyMDc_d3dcc897-0f08-4b77-b6fa-19657d16dd06"
      unitRef="usd">887000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <bsx:ChangeinDeferredTaxAssetsValuationAllowance
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIyMzk_62abcb22-fc06-4250-9b8a-b21dfe33cc04"
      unitRef="usd">127000000</bsx:ChangeinDeferredTaxAssetsValuationAllowance>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI1NzE_8f9c033b-5f73-4f9f-977c-4d1457110ff7"
      unitRef="usd">81000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI1OTM_ec8fdca9-5b79-4221-a0ef-a1c48a3f655c"
      unitRef="usd">-78000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI2MTg_12059cb0-1a00-45b5-a518-3f95defda103"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <bsx:FreeTradeZoneRegimeTaxIncentive
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI5MDk_0d549799-91d0-42af-8f00-e5d38f496e8b"
      unitRef="usd">149000000</bsx:FreeTradeZoneRegimeTaxIncentive>
    <bsx:FreeTradeZoneRegimeTaxIncentive
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI5MjA_db8de4cb-503c-45aa-be46-36dd996b1e76"
      unitRef="usd">64000000</bsx:FreeTradeZoneRegimeTaxIncentive>
    <bsx:FreeTradeZoneRegimeTaxIncentive
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzI5MzQ_64e56835-4e9a-46af-9db1-3553aafcf31d"
      unitRef="usd">173000000</bsx:FreeTradeZoneRegimeTaxIncentive>
    <bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzU5Njc_c978e5c2-0e1f-4e0e-b116-607364653d5b"
      unitRef="usdPerShare">0.10</bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution>
    <bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzU5ODQ_8fd5e774-67d1-4791-850a-df54b2f93e82"
      unitRef="usdPerShare">0.04</bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution>
    <bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzYwMDA_7e695703-5500-45e3-9053-dd2387fab096"
      unitRef="usdPerShare">0.12</bsx:FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution>
    <bsx:TaxIncentivesInPuertoRico
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNjUwNzI_c81372b8-a192-4b14-b87b-5b16a5421650"
      unitRef="usd">27000000</bsx:TaxIncentivesInPuertoRico>
    <bsx:TaxIncentivesInPuertoRico
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNjUwNDQ_88148784-091b-44bf-b740-dc27595e09b6"
      unitRef="usd">30000000</bsx:TaxIncentivesInPuertoRico>
    <bsx:TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzYwOTI_fb2cb211-7f42-40f8-b7e5-ab4700cc0463"
      unitRef="usdPerShare">0.02</bsx:TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzMzMzc_a54198b0-4070-4aca-93fc-7cc63a5ee2bd"
      unitRef="usd">255000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzMzOTE_a7c2cb63-7907-438a-a095-0f032ba4bb3f"
      unitRef="usd">177000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM0NjQ_e3545016-453b-4fd6-bcad-8a79fdf32a96"
      unitRef="usd">261000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM1MTg_02a92c52-23e0-450b-bfff-af22a4ee1d2c"
      unitRef="usd">183000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM1OTE_272dc6b9-b532-428e-a422-970608db5582"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzM2NDU_d5f0485e-9bd8-46d4-9d74-12cec8cfe293"
      unitRef="usd">355000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzkzNDU_91855ff3-b8b9-46a8-ad1b-5a4c1c24042a">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitation expirations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzItMS0xLTEtMA_419a898f-f448-48a2-a93e-c97a01cb3d72"
      unitRef="usd">261000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzItMy0xLTEtMA_fecd6dfc-63be-4572-a361-549cebd98df7"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzItNS0xLTEtMA_f83dd147-ca34-44bd-b6b5-8c38809cfe54"
      unitRef="usd">427000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzMtMS0xLTEtMA_b51c85ce-19f6-40b0-968e-99a61bbcb690"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzMtMy0xLTEtMA_4b1c3cc3-eafe-4630-a464-826df71dc91a"
      unitRef="usd">28000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzMtNS0xLTEtMA_49a6d75b-beef-4794-96c1-89291b60a304"
      unitRef="usd">30000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzQtMS0xLTEtMA_46309aa2-d136-4afa-8ed0-e8c3c74420cf"
      unitRef="usd">41000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzQtMy0xLTEtMA_7cccc69b-020f-44be-8955-528357930d62"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzQtNS0xLTEtMA_8ac02a01-53f4-419b-8668-1785611f9aa3"
      unitRef="usd">45000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzUtMS0xLTEtMA_601127a3-342c-43d2-b4c1-c80c592c774f"
      unitRef="usd">36000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzUtMy0xLTEtMA_27c827ca-3107-4c3d-9f01-c89df8ddb5b1"
      unitRef="usd">186000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzUtNS0xLTEtMA_dbd2484a-2764-41d6-b444-bfa690336afc"
      unitRef="usd">34000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzYtMS0xLTEtMA_2b795ccd-2db6-474d-afc8-9ad364166654"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzYtMy0xLTEtMA_e47e7c7b-ff97-4287-87e7-22755d3df131"
      unitRef="usd">27000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzYtNS0xLTEtMA_f20e07f7-1565-4259-aaf6-7638bcd60326"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzctMS0xLTEtMA_687e4438-8150-485d-9788-74d1b62e34b7"
      unitRef="usd">17000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzctMy0xLTEtMA_2a3b5c4e-e837-412d-8d28-ba67772dc198"
      unitRef="usd">15000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzctNS0xLTEtMA_ef3b397d-67b0-4a7a-8612-a805ddaf1561"
      unitRef="usd">9000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzgtMS0xLTEtMA_a54198b0-4070-4aca-93fc-7cc63a5ee2bd"
      unitRef="usd">255000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzgtMy0xLTEtMA_e3545016-453b-4fd6-bcad-8a79fdf32a96"
      unitRef="usd">261000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90YWJsZTpjNjI0YWI4MGQ5OTM0YTM5OTM1NzYwMDVlYjY3YTRkYS90YWJsZXJhbmdlOmM2MjRhYjgwZDk5MzRhMzk5MzU3NjAwNWViNjdhNGRhXzgtNS0xLTEtMA_272dc6b9-b532-428e-a422-970608db5582"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i6419e203999942329c84202801da4c46_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzU2MjQ_b29f9928-5d91-44cd-bb00-51c20b500e1b"
      unitRef="usd">91000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzU3Mjg_37985d09-defc-4400-a4be-aec57d601907"
      unitRef="usd">62000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzYwMDI_ca1aef5e-7522-4cb8-9299-b121a3db9d63"
      unitRef="usd">43000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzYwNTk_1c04874b-91f4-4395-b6cb-2420b80da248"
      unitRef="usd">41000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzY2NzA_cfa66d85-04fd-4c16-ae9d-876152e3fdf9"
      unitRef="usd">54000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzMxNzI_7a7baa1b-0060-4008-a8d5-d5911df3176a"
      unitRef="usd">938000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzcyNzY_5edbbbc9-5a1f-46f6-a528-7e16181b7cfb"
      unitRef="usd">939000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability>
    <bsx:Onetimetransactiontaxpost1986EPnetpayment
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzc0MjM_c287dcaa-40a3-4267-b0e9-c216e956f821"
      unitRef="usd">590000000</bsx:Onetimetransactiontaxpost1986EPnetpayment>
    <bsx:TransitionTaxPaymentRemaining
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzIxOTkwMjMyNzMxODE_cf6f5235-ca5d-4541-aafe-1074234d9d66"
      unitRef="usd">430000000</bsx:TransitionTaxPaymentRemaining>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzc2Mzg_5d031da1-2a09-4181-9ae2-cfa965330379"
      unitRef="usd">19000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <bsx:TheCARESAct
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjEvZnJhZzphZDA0MzY1YmFjNTQ0ZmJjYTllYWViZmM2ODJjZGZhMC90ZXh0cmVnaW9uOmFkMDQzNjViYWM1NDRmYmNhOWVhZWJmYzY4MmNkZmEwXzg3NTU_c361bd00-2073-4c07-a39e-1434a9a30bd1"
      unitRef="usd">2200000000000</bsx:TheCARESAct>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzI3NTM1_d9ad75a8-7445-483c-9d35-95e58dbf4b04">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE K &#x2013; COMMITMENTS AND CONTINGENCIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accrual for legal matters that are probable and estimable was $548 million as of December&#160;31, 2021 and $569 million as of December&#160;31, 2020 and includes certain estimated costs of settlement, damages and defense. We recorded litigation-related net charges of $430 million in 2021, primarily related to ongoing litigation associated with our transvaginal surgical mesh products principally in the U.S. and Australia, as well as anticipated legal fees to defend certain other legal matters. We increased the accrual associated with transvaginal mesh claims to account for increased settlement and litigation activity related to the remaining cases and claims we face, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity and changes to our expectations regarding the rate of incoming cases and claims. These increases were partially offset by settlement payments, primarily associated with a coalition of state attorneys general. A portion of our legal accrual for transvaginal surgical mesh product claims is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $188 million as of December&#160;31, 2021 and $208 million as of December&#160;31, 2020. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded litigation-related net charges of $278 million in 2020, primarily related to transvaginal surgical mesh product litigation, inclusive of a reserve related to claims made by a coalition of state attorneys general, which has since been settled. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded litigation-related net charges of $115 million in 2019, which included a net charge of $223 million, primarily related to litigation with Channel Medsystems, Inc., net charges of $40 million primarily related to transvaginal surgical mesh product liability litigation, and a gain of $148 million, which represents a portion of the total $180 million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;in our&#160;consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As such, a portion of the related gain from this settlement was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant. In management's opinion, we are not currently involved in any legal proceedings other than those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#x2019;s Instinct&#x2122; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against the four asserted patents. All IPRs have concluded, and Cook and the Company both appealed the Patent Office&#x2019;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Company's patents remain valid, remanding two of the patents for further review by the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;USPTO's Patent Trial and Appeal Board. In November 2020, the Patent Office issued remand rulings invalidating several additional claims. The district court stayed the case pending the appeals court decision on &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the IPRs, which is now complete. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in February 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro Corp. (Nevro) in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro's Senza&#x2122; Spinal Cord Stimulation (SCS) System. The company seeks lost profits, a reasonable royalty and a permanent injunction. At a trial held in October and November 2021 regarding six of Boston Scientific's originally asserted patent claims, a jury granted Boston Scientific a monetary award, finding that each asserted claim is valid, that four of the six claims are infringed by Nevro, and that two of the claims are willfully infringed by Nevro. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#x2019;s Senza&#x2122; I and Senza&#x2122; II SCS Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our SCS systems infringe five Nevro patents. Nevro seeks lost profits, a reasonable royalty and a permanent injunction.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No trial date has been set for the theft of trade secrets and patent counterclaims. The patent infringement claims from case 18-cv-664 were stayed pending IPRs. On January 6, 2021, the court stayed one of the patent infringement claims from case 16-cv-1163, such that it will proceed with the stayed patent infringement claims from case 18-cv-664.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2021, Nevro filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#x2019;s spinal cord stimulation systems. Nevro seeks lost profits, a reasonable royalty and a permanent injunction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2017, The Board of Regents, University of Texas System (UT) and TissueGen. Inc., served a lawsuit against us in the Western District of Texas. The complaint against us alleges patent infringement of two U.S. patents owned by UT, relating to &#x201c;Drug Releasing Biodegradable Fiber Implant&#x201d; and &#x201c;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#x201d; and affects the manufacture, use and sale of our Synergy&#x2122; Stent System. UT seeks a reasonable royalty. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the UT&#x2019;s Petition for Certiorari. UT is proceeding with its case against BSC in Delaware. Trial is scheduled for November 14, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 26, 2022, in the United States, approximately 54,500 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. Outside the United States, approximately 2,700 cases or claims have been asserted, predominantly in Canada, the United Kingdom, Ireland and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 26, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately&#160;52,500&#160;cases and claims in the United States, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,500 cases and claims, approximately 51,000 have met the conditions of the settlement and are final. In Canada, we have settled approximately 300 claims. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 26, 2022, the company is facing fewer than 300 pending cases and claims asserted in various jurisdictions in the United States. Outside the United States, the company is facing fewer than 90 cases and claims in the United Kingdom, Ireland and Canada. In Australia, two class actions were filed against the Company in in the first quarter of 2021. In the second quarter of 2021, one of these class actions was permanently stayed, while the other was allowed to proceed. The registration process for this Australian action closed on January 28, 2022. Complete registration information is not yet available but preliminary &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;information indicates that approximately 2,250 women have completed registration forms alleging they received and were injured by Boston Scientific implants in Australia. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#x2019;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In February 2021, the Multi-District Litigation (MDL) established in February 2012 by the United States Federal Courts was closed after all pending cases were dismissed or remanded to courts of primary jurisdiction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. We continue to engage in discussions with plaintiffs&#x2019; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle, and expect that more cases will go to trial through 2023. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently named a defendant in 67 filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and actively selling in the fourth quarter of 2018. The plaintiffs assert they are entitled to monetary damages related to alleged injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 377 claims, none of which have been filed. As of January 26, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering with certain plaintiffs' counsel to resolve approximately 200 cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Governmental Investigations and Qui Tam Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#x201c;technical note,&#x201d; announced that it was launching a formal administrative proceeding against Boston Scientific&#x2019;s Brazilian subsidiary, Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#x2019;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. The full Commission is considering this recommendation but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments are due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents. Labcoat seeks monetary damages related to an earn-out provision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#x2122; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all others similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. Under the terms of the Court-approved Scheduling Order, Counsel for Mr. Errichiello was required to file an Amended Complaint on or before June 4, 2021, which they did. The Amended Complaint seeks unspecified compensatory damages in favor of the alleged class as well as unspecified equitable relief. In response, the Company brought a Motion to Dismiss the Amended Complaint which it filed on July 19, 2021, and argued on November 19, 2021. On December 15, 2020, the Securities and Exchange Commission&#x2019;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#x2019;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company cooperated fully with the requests, and on January 3, 2022, the SEC informed us that it was concluding its investigation and that it did not intend to recommend an enforcement action. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#x2019;s Board of Directors conduct an investigation into actions by the Company&#x2019;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above. The Company received letters on behalf of the Union Excavators Local 731 Pension Fund and Diane Nachbaur, two stockholders of the Company, on July 26, 2021, and July 29, 2021, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Matters Concluded Since December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for Boston Scientific and three of its employees, as well as numerous other defendants charged in criminal proceedings. The charges arose from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials. A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Boston Scientific employee but acquitted two others and levied a fine of &#x20ac;245 thousand against us and imposed joint and several civil damages of &#x20ac;620 thousand on all defendants. We continued to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against Boston Scientific and its employee and acquitted them of all charges. This judgment of acquittal became final as to the Company and its employee on April 15, 2021 when the prosecution chose not to appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general regarding our transvaginal surgical mesh products and related alleged violations of states&#x2019; consumer protection statutes. On December 12, 2019, the Mississippi Attorney General filed suit against us in a Mississippi state court alleging violations of the Mississippi Consumer Protection Act. In the fourth quarter of 2020 and the first quarter of 2021, we reached settlements with 48 states, including Mississippi, and the District of Columbia. These settlements were finalized in March of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. On April 8, 2021, the parties settled the dispute, and, on April 12, 2021, the parties filed stipulations with the court to dismiss the remaining legal proceedings. The settlement did not result in any material benefit or liability to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena sought information related to the launch of the Cognis&#x2122; CRT-D and Teligen&#x2122; ICD line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of our Physician Guided Learning Program. We cooperated with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. federal government and the State of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to our Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint. We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018. In February 2021, we filed a motion for summary judgment, which the relator opposed, and on August 13, 2021, the Court granted the motion in its entirety. Subsequently, the parties resolved the matter, effective October 4, 2021, and the matter is now concluded. The resolution did not result in any material liability to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2020, Koninklijke Philips N.V. and IP2IPO Innovations, Ltd. (Philips) served a complaint against the Company in the United States District Court for the District of Delaware. The complaint alleged that certain BSC cardiovascular diagnostic devices infringed six Philips patents. The parties have settled the dispute through a confidential settlement agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 18, 2019, Blue Cross &amp;amp; Blue Shield of Louisiana and HMO Louisiana, Inc., alleged indirect purchasers of ZYTIGA&#x2122;, filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia. The complaint alleges that the defendants violated the Sherman Act and the antitrust and consumer protections laws of several states by pursuing patent litigation relating to ZYTIGA&#x2122; in order to delay generic entry. On June 21, 2019, the case was transferred to the United States District Court for the District of New Jersey and has been consolidated with similar complaints.&lt;/span&gt;&lt;span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 27, 2021, the court granted BTG and Janssen's motion to dismiss all claims in the indirect purchaser action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2017, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC, and Johnson &amp;amp; Johnson (collectively, Janssen) were served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;complaint filed on behalf of the United States, 29 states, and the District of Columbia. The complaint, which was filed in the United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA to the government in connection with direct government sales and government-funded drug reimbursement programs. The case has been transferred to United States District Court for the District of New Jersey. On June 20, 2019, the complaint was amended to include BTG International Limited as a defendant. In May 2020, a class action complaint was filed in New Jersey federal court against Janssen and BTG by a direct purchaser of Zytiga on behalf of similarly situated entities. The complaint was amended in February 2021 and alleges that BTG and Janssen violated antitrust laws by attempting to enforce certain patents against potential generic competitors. On October 12, 2021, the court granted BTG and Janssen&#x2019;s motion to compel arbitration in the direct purchaser action and stayed all direct purchaser proceedings. On December 17, 2021, the court granted BTG&#x2019;s motion to dismiss the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; action. On January 10, 2022, the court granted the parties&#x2019; stipulation of dismissal with prejudice as to the claims of the direct purchaser plaintiff, whose claims had been stayed in the October 12, 2021, order compelling arbitration.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="i46f8fa0b6c8c432d9384623e2768c3a3_D20211001-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzI3NTQw_210b40cb-32ea-4825-9359-0af08ed7417a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM5MTY_7cab1e5d-2a0f-401c-a11b-f35ffb1963c6"
      unitRef="usd">548000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM5MzI_c37672b4-3990-4db8-bd12-11a423c4fa95"
      unitRef="usd">569000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzkzNDU4NDg5MTAzMTE_44b6b3bc-f400-49db-bc76-ade645239fe0"
      unitRef="usd">430000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ0Njg_84a81e43-b988-4534-aaab-d995e9c73279"
      unitRef="usd">188000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ0ODQ_02d6f285-ec4c-4e77-82af-a37bf5765d4c"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LitigationSettlementExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2MjE_6ffa83c5-7487-4d92-bd4c-afd08eec32b8"
      unitRef="usd">278000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NTU4MjM_eebac84a-d848-4205-bfd7-73ba6e1f8a3b"
      unitRef="usd">115000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i9a23f29987844bacb827e4e0bf7ebd5b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2MzI_5af2889e-4227-4454-bd2d-555425b3fc0c"
      unitRef="usd">223000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6419e203999942329c84202801da4c46_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2NDI_53b08e22-499e-47c7-842e-60e622e10114"
      unitRef="usd">40000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6c9e3d1c87f245508ec3d21cac73b819_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2NTQ_aa06037f-c438-4cf9-afb8-9c85d837530c"
      unitRef="usd">-148000000</us-gaap:LitigationSettlementExpense>
    <bsx:LitigationSettlementReceivedGain
      contextRef="iaa4713eca034411386bd8958667ff155_I20190115"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzQ2NjA_a8e2b91a-8e0f-42d9-b73c-425263176c67"
      unitRef="usd">180000000</bsx:LitigationSettlementReceivedGain>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwMDQ4_f783c11c-4e03-4cfe-b576-4bf76b4abafd"
      unitRef="claims">54500</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:AssertedClaimsOutsideTheUS
      contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMzMjE0MDA_e1c7d934-38ad-4e66-ac2f-550fc258dc1b"
      unitRef="usd">2700</bsx:AssertedClaimsOutsideTheUS>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i3a44a33716c34232840446222d515685_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwNDI1_428ec294-a814-449e-815a-ae330daf32c5"
      unitRef="claims">52500</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i3a44a33716c34232840446222d515685_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwNzkz_428ec294-a814-449e-815a-ae330daf32c5"
      unitRef="claims">52500</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct
      contextRef="i3a44a33716c34232840446222d515685_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwODI4_95eb2e1e-1996-4233-a0b7-34e681697a92"
      unitRef="claims">51000</bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct>
    <bsx:CanadaSettledClaims
      contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM4NDgyOTA3NjMxNTM_13c775ee-5dac-4347-818e-43ba545e67fd"
      unitRef="claims">300</bsx:CanadaSettledClaims>
    <bsx:PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS
      contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzM4NDgyOTA3NzE0MjE_182efefe-7a7d-4e53-bc94-dddba1fa147c"
      unitRef="claims">300</bsx:PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom
      contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEyMTk5_59a0454e-6305-4548-9042-8ecd11066033"
      unitRef="claims">90</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom>
    <bsx:CertifiedClassActionsInAustraliaMesh
      contextRef="if82ad8d4e79140ae9ff32488143d6d7b_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMzNDc5NTg_80b6df81-1db1-4796-abe1-c93fb8c2fc1e"
      unitRef="claims">2</bsx:CertifiedClassActionsInAustraliaMesh>
    <bsx:PermanentlyStayedClassActionInAustraliaMesh
      contextRef="i68f3333d6cce460dbc252aac2c3a29cb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMzNDc5NTk_4ac1fd9d-8931-44e7-95c9-06ca51bc9a8f"
      unitRef="claims">1</bsx:PermanentlyStayedClassActionInAustraliaMesh>
    <bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia
      contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEyMjQ2_7a5b7bbc-6919-4b3e-bd5b-747146c974b5"
      unitRef="usd">2250</bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia>
    <bsx:ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMyODMxMDI_10edb065-3519-4220-8ea6-0496c860698c"
      unitRef="claims">67</bsx:ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter>
    <bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzIxOTkwMjMyODMxMDg_02c5aad0-34ad-4447-adb5-22a6d9396230"
      unitRef="claims">377</bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter>
    <bsx:CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter
      contextRef="i30b040b90f0b41758b9ded39e98a67e1_I20220126"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NjY0MDM_ba129460-3ace-4451-82b6-9689636a50fa"
      unitRef="claims">200</bsx:CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i66f21ac1ac454c5d80b0c27572fa871f_D20171110-20171110"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NjcxNDk_6ead058a-6d08-41cc-81e1-06063f8ffa35"
      unitRef="eur">245000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i66f21ac1ac454c5d80b0c27572fa871f_D20171110-20171110"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjQvZnJhZzoxMGQyOTkwYmVlZTg0Y2MzODYxYjE2N2VhMjA0ZmJmOC90ZXh0cmVnaW9uOjEwZDI5OTBiZWVlODRjYzM4NjFiMTY3ZWEyMDRmYmY4XzEwOTk1MTE2NjcyMTE_48ce6def-238f-4d8b-8116-4104b0a37743"
      unitRef="eur">620000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2ODE_e41d74ca-25cd-4616-88ea-396c707d2aba">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE L &#x2013; STOCKHOLDERS' EQUITY &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. As of December&#160;31, 2021, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared and we paid quarterly cash dividends of $1.3750 per MCPS share to holders, representing dividend periods through November 2021. On February 1, 2022, the Committee declared a cash dividend of $1.3750 per MCPS share to holders of our MCPS as of February 15, 2022, representing a dividend period from December 2021 through February 2022. We have presented cumulative, unpaid dividends within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets as of December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 2.000 billion shares of common stock, $0.01 par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The remaining proceeds were used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $535 million in cash, which represented the full amount remaining under that authorization. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program) and as of December&#160;31, 2021, we had the full amount remaining available under the 2020 share repurchase program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not repurchase any shares of our common stock during 2021. There were approximately 263 million shares in treasury as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU1_c12845f9-1076-492c-837c-f3c244c09916"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia1b7da4d442341ae9e6ed840e1f4cd33_I20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU1Mg_3eecba56-9e94-4441-b718-2f7accaf4427"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2NQ_0e477b4a-9b09-4aee-8341-0503ef33b4be"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="ia1b7da4d442341ae9e6ed840e1f4cd33_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzY3OA_03a361eb-ba25-4346-8bc5-1cf1663e4198"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1Xzc1MQ_05e54756-541c-411c-b349-8baa43759100"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1Xzg5NA_ef32461f-c7a0-4e75-a0b5-1b650aa8fdf2"
      unitRef="usd">1006000000.000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i2f25834762dc46f49ccfef148a7ba63d_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzExMTk_0e477b4a-9b09-4aee-8341-0503ef33b4be"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzExNTU_d9e11a25-b47a-48b3-9a2a-849583918a16"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i1bbfe5f751e2420aba91fef2ec7d64a7_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzIyNjM_d9e11a25-b47a-48b3-9a2a-849583918a16"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="i2c11391a90f343a8a29ca5a651461834_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzI0ODA_15c628d4-602e-497a-b9d5-e921cdbfbb66">2.3834</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="i0157a31857394755b58f1cb928f3509e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzI0ODc_4283ea6b-1ddf-47ae-ace0-16927e5237a6">2.9197</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="i0d4d9ed29ca94dcfbf1f5b2c318fcc67_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzM1Njg_67729731-f764-454e-b406-26c5ba79cf41"
      unitRef="usdPerShare">1.3750</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="i5bb7cb06378a4432bb97c143cc5f5952_D20220201-20220201"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzIxOTkwMjMyNjQzMDc_7803e8a8-e23c-468b-a17a-2be97b4ed4fd"
      unitRef="usdPerShare">1.3750</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzQzMTc_0cbe2f0f-70f6-4b40-904d-8872e3d5f297"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzQzNDQ_9de384b0-6f0a-4dc6-bb14-1d2c28046f9c"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id85bcc6a4b684d52a383187a1856dd57_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzUwODA_65e89811-7e30-4b2a-864c-89823bf3034b"
      unitRef="shares">29382500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i419713e280d4402f8c14fa84298a0ccd_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzUxMzY_543e8820-02ef-4dd7-971d-0239c8e9730b"
      unitRef="usdPerShare">34.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id85bcc6a4b684d52a383187a1856dd57_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzUyMTc_c67d6792-d25a-4a13-8391-d614f26cb618"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i72aa8f882331458e90a94bf23ae61e59_I20130125"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MDE_79f8e933-caa6-49a9-8e47-3db37c1ae55a"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MDc_6d4ecc21-5368-44ea-b858-53347abda38f"
      unitRef="shares">15700000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MTM_6c32d1ea-bf60-4fc8-92bc-6ff9ecb04f16"
      unitRef="usd">535000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i76d5c1eb8c3c498e932fff915c09dd38_I20201214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2MjM_38fe6cba-6adb-4862-b0b2-8680c0eb471f"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockShares
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMjcvZnJhZzplZWEwYmU1MzQwNDI0OTliOGQwNGM3NzIzMzljYjFkNS90ZXh0cmVnaW9uOmVlYTBiZTUzNDA0MjQ5OWI4ZDA0Yzc3MjMzOWNiMWQ1XzU2NTQ_c64383f6-bcc7-4efe-9664-6267822d7fce"
      unitRef="shares">263000000</us-gaap:TreasuryStockShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MDE_58da0afc-5ada-4eb0-a863-3f68466e802f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE M &#x2013; STOCK INCENTIVE AND PURCHASE PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee and Director Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, our Board of Directors and stockholders approved amendments to our 2011 Long-Term Incentive Plan effective October 1, 2020 (Amended and Restated 2011 LTIP), authorizing for issuance up to 171 million shares of our common stock. The Amended and Restated 2011 LTIP covers officers, directors, employees and consultants and provides for the grant of restricted or unrestricted common stock, restricted stock units (RSUs), options to acquire our common stock, stock appreciation rights, performance awards (market-based and performance-based RSUs) and other stock and non-stock awards. Shares reserved under our current and former stock incentive plans totaled approximately 180 million as of December&#160;31, 2021. The Executive Compensation and Human Resources Committee (the Committee) of the Board of Directors, consisting of independent, non-employee directors may authorize the issuance of common stock and cash awards under the Amended and Restated 2011 LTIP in recognition of the achievement of long-term performance objectives established by the Committee. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-qualified options issued to employees are generally granted with an exercise price equal to the market price of our stock on the grant date, vest over a four-year service period and have a ten-year contractual life. In the case of qualified options, if the recipient owns more than ten percent of the voting power of all classes of stock, the option granted will be at an exercise price of 110 percent&#160;of the fair market value of our common stock on the date of grant and will expire over a period not to exceed five years. Non-vested stock awards, including restricted stock awards (RSAs), RSUs and deferred stock units (DSUs) issued to employees are generally granted with an exercise price of zero and typically vest in four or five equal annual installments. These awards represent our commitment to issue shares to recipients after the vesting period. Upon each vesting date, such awards are no longer subject to risk of forfeiture and we issue shares of our common stock to the recipient.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the impact of stock-based compensation on our consolidated statements of operations:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Black-Scholes Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years, weighted)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Expected Volatility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use our historical volatility and implied volatility as a basis to estimate expected volatility in our valuation of stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Expected Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the expected term of options using historical exercise and forfeiture data. We believe that this historical data provides the best estimate of the expected term of new option grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use yield rates on U.S. Treasury securities for a period approximating the expected term of the award to estimate the risk-free interest rate in our grant-date fair value assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Expected Dividend Yield&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not historically paid cash dividends on our common stock and currently we do not intend to pay cash dividends on our common stock. Therefore, we have assumed an expected dividend yield of zero in our grant-date fair value assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to stock options under stock incentive plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,448&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total vested and expected to vest as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised was $137 million in 2021, $84 million in 2020 and $140 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-Vested Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value RSAs, RSUs and DSUs based on the closing trading value of our shares on the date of grant. Information related to non-vested stock awards is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Vested&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Award Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant-Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(658)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vesting date fair value of shares that vested was approximately $148 million in 2021, $172 million in 2020 and $193 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Market-based RSU and DSU Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, we granted market-based RSU awards, and in 2020 and 2019, we granted market-based DSU awards to certain members of our senior management team. The number of shares ultimately issued to the recipient is based on the total stockholder return (TSR) of our common stock as compared to the TSR of the common stock of the other companies in the S&amp;amp;P 500 Healthcare Index over a three-year performance period. The number of RSUs and DSUs ultimately granted under this program range from 0 percent to 200 percent of the target number awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout the three-year performance period to attain the full amount of the market-based RSU's and DSUs that satisfied the market performance criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the fair value of the market-based RSU and DSU awards to be approximately $11 million for 2021, $8 million for 2020 and $10 million for 2019. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price on date of grant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the expense on these awards in our consolidated statements of operations on a straight-line basis over the three-year measurement period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Free Cash Flow Performance-based RSU and DSU Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During 2021, we granted free-cash flow performance-based RSU awards, and in 2020 and 2019, we granted free-cash flow performance-based DSU awards to certain members of our senior management team. The attainment of these performance-based RSUs and DSUs is based on our adjusted free cash flow (AFCF) measured against our goal set by the Executive Compensation and Human Resources Committees of our Board, based on our internal annual financial plan performance for AFCF. AFCF is measured over a one-year performance period beginning January 1st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;of each year and ending December 31st. The number of RSUs and DSUs ultimately granted under this program range from 0 percent to 150 percent of the target number of performance-based RSUs and DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout a three-year service period (inclusive of the one-year performance period) to attain the full amount of the performance-based RSUs and DSUs that satisfied the performance criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 AFCF&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, net of forfeitures to date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Achievement of target payout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year-end stock price used in determining fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the expense on these awards in our consolidated statements of operations over the vesting period which is three years after the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expense Attribution&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize compensation expense for our stock incentive plan using a straight-line method over the substantive vesting period. Most of our stock awards provide for immediate vesting upon death or disability of the participant. In addition, our stock grants to employees provide for accelerated vesting of our stock-based awards, other than performance-based and market-based awards, upon retirement, if the stock award has been held for at least one year by the recipient. In accordance with the terms of our stock grants, for employees who will become retirement eligible prior to the vest date we expense stock-based awards, other than performance-based and market-based awards, over the greater of one year or the period between grant date and retirement-eligibility. The performance-based and market-based awards discussed above do not contain provisions that would accelerate the full vesting of the awards upon retirement-eligibility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize stock-based compensation expense for the value of the portion of awards that are ultimately expected to vest. FASB ASC Topic 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; allows forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term &#x201c;forfeitures&#x201d; is distinct from &#x201c;cancellations&#x201d; or &#x201c;expirations&#x201d; and represents only the unvested portion of the surrendered stock-based award. We have applied, based on an analysis of our historical forfeitures, a weighted-average annual forfeiture rate of approximately five percent to all unvested stock-based awards as of December&#160;31, 2021, which represents the portion that we expect will be forfeited each year over the vesting period. We re-evaluate this analysis annually or more frequently if there are significant changes in circumstances and adjust the forfeiture rate as necessary. Ultimately, we will only recognize expense for those shares that vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized Compensation Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Compensation Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vesting Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;214&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Amounts presented represent compensation cost, net of estimated forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our global employee stock purchase plan provides for the granting of options to purchase up to 50 million shares of our common stock to all eligible employees. Under the global employee stock purchase plan, we grant each eligible employee, at the beginning of each six-month offering period, an option to purchase shares of our common stock equal to not more than ten percent of the employee&#x2019;s eligible compensation or the statutory limit under the U.S. Internal Revenue Code. Such options may be exercised only to the extent of accumulated payroll deductions at the end of the offering period, at a purchase price equal to 85 percent of the fair market value of our common stock at the beginning or end of each offering period, whichever is less. As of December&#160;31, 2021, there were approximately 4 million shares available for future issuance under the employee stock purchase plan. We temporarily suspended our global employee stock purchase plan for the offering period for the second half of 2020 due to cost-savings initiatives in response to the COVID-19 pandemic and resumed the plan beginning with the offering period for the first half of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued or to be issued&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Range of purchase prices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36.47&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recognized&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes option-pricing model to calculate the grant-date fair value of shares issued under the employee stock purchase plan. We recognize expense related to shares purchased through the employee stock purchase plan ratably over the offering period.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id9728f3b38444f35b64ff2f079ea4b3d_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzI1Mw_b616d84c-acaa-4a0c-bf89-d9116f1a8147"
      unitRef="shares">171000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzY5OQ_fd7f44c0-0282-46f2-ab72-f70af4dd1a0d"
      unitRef="shares">180000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <bsx:VotingPowerOfAllClassesOfStock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzEzMTk_78e1bf24-8e94-4894-ae6f-cb1820e6ff96"
      unitRef="number">0.10</bsx:VotingPowerOfAllClassesOfStock>
    <bsx:Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzE0MjY_eaae602b-9a9b-4833-9ce8-35cfde7af72f"
      unitRef="number">1.10</bsx:Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant>
    <bsx:Nonvestedstockawardsexerciseprice
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzE3MjE_6e209436-e977-4e3d-b022-cd2db5e62304"
      unitRef="usdPerShare">0</bsx:Nonvestedstockawardsexerciseprice>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MjQ_cb2074fb-7774-4314-93e1-d0d843cd10fd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the impact of stock-based compensation on our consolidated statements of operations:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="if59bff74575c44e3a5039251cf9b8592_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzItMS0xLTEtMA_6a5482a1-942c-4b94-9b61-7c64d342bd3b"
      unitRef="usd">11000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i51e61128384f479281522b42f68d88de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzItMy0xLTEtMA_35d99e43-74c4-4087-bab2-50b7b8e8132f"
      unitRef="usd">9000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9d964f1e8fde4f869b9572107e4cd663_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzItNS0xLTEtMA_c8ea8910-e359-44c4-a9d3-3da30b418e83"
      unitRef="usd">8000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3a649302b88643399da73bbaa811ad27_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzMtMS0xLTEtMA_4172e3fa-f48e-47d7-b683-1f79c160c7e0"
      unitRef="usd">147000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i03336283c2ff4b398efa41236e67a2d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzMtMy0xLTEtMA_35603e0b-5823-48d8-b426-68ba6d901ee9"
      unitRef="usd">130000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6b7e7bf22b2b40ce8673e049908bce94_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzMtNS0xLTEtMA_b61459e2-6cff-47a8-b590-a5634a17e1be"
      unitRef="usd">120000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0db9ac2d795d4e17aee7151bfb6ee932_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzQtMS0xLTEtMA_9f6be812-5f40-4632-a59c-25c7c02e81cd"
      unitRef="usd">36000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3ae1671df59943f7acd666541a997122_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzQtMy0xLTEtMA_9b63143c-4f0d-4401-8401-89fa2a6d17be"
      unitRef="usd">30000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i92048bcac2e04d9983b5f962b19cad96_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzQtNS0xLTEtMA_3ba96741-2f01-4647-892a-d57b845c5702"
      unitRef="usd">28000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzUtMS0xLTEtMA_26e36d58-15da-4ca9-b547-4a6992bc9081"
      unitRef="usd">194000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzUtMy0xLTEtMA_85fa94f1-fd88-49ee-ab2d-960b920bdbbb"
      unitRef="usd">170000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzUtNS0xLTEtMA_dfe94eed-2ea8-4362-88ca-11d34d55d506"
      unitRef="usd">157000000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzYtMS0xLTEtMA_cfd5a0d6-7dcb-4e68-a928-c4d0677a4eb1"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzYtMy0xLTEtMA_d97645fb-580b-4917-855f-05a39a9ea7f1"
      unitRef="usd">28000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzYtNS0xLTEtMA_bd232886-e7e4-4f54-9264-7a328bd2fc03"
      unitRef="usd">24000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <bsx:ShareBasedCompensationNetOfTaxBenefit
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzctMS0xLTEtMA_51e20579-e437-419d-bf3d-37b3a0623d46"
      unitRef="usd">165000000</bsx:ShareBasedCompensationNetOfTaxBenefit>
    <bsx:ShareBasedCompensationNetOfTaxBenefit
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzctMy0xLTEtMA_0c204fa5-3636-490a-b98b-64c960bf117c"
      unitRef="usd">142000000</bsx:ShareBasedCompensationNetOfTaxBenefit>
    <bsx:ShareBasedCompensationNetOfTaxBenefit
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzctNS0xLTEtMA_5339afef-1c89-4e80-bf12-b92348d0fa75"
      unitRef="usd">133000000</bsx:ShareBasedCompensationNetOfTaxBenefit>
    <bsx:CompensationExpensePerShareBasic
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzgtMS0xLTEtMA_7621b0b4-e4f7-4e76-9cab-13ba83249c2e"
      unitRef="usdPerShare">0.12</bsx:CompensationExpensePerShareBasic>
    <bsx:CompensationExpensePerShareBasic
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzgtMy0xLTEtMA_ad553a47-d4f8-4576-8742-42c9b4127c06"
      unitRef="usdPerShare">0.10</bsx:CompensationExpensePerShareBasic>
    <bsx:CompensationExpensePerShareBasic
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzgtNS0xLTEtMA_8a39ae69-3ab7-4a07-83c1-c8298c22e454"
      unitRef="usdPerShare">0.10</bsx:CompensationExpensePerShareBasic>
    <bsx:CompensationExpensePerShareDiluted
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzktMS0xLTEtMA_dc6d80f8-8831-4f6d-bbc7-4f554541613d"
      unitRef="usdPerShare">0.12</bsx:CompensationExpensePerShareDiluted>
    <bsx:CompensationExpensePerShareDiluted
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzktMy0xLTEtMA_a28ca517-1ffd-44ee-a9dd-03044800939b"
      unitRef="usdPerShare">0.10</bsx:CompensationExpensePerShareDiluted>
    <bsx:CompensationExpensePerShareDiluted
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo2N2MwMTU3ZDBlYmU0YTJhOTdmZGMyMjg0MzJmNjlhNy90YWJsZXJhbmdlOjY3YzAxNTdkMGViZTRhMmE5N2ZkYzIyODQzMmY2OWE3XzktNS0xLTEtMA_204d4677-61bd-433b-8df9-bcaa4448be34"
      unitRef="usdPerShare">0.09</bsx:CompensationExpensePerShareDiluted>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MTg_12f0e766-8278-42a6-b30b-5f058970d1b0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Black-Scholes Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years, weighted)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzItMS0xLTEtMA_af6888f5-f361-4a4c-bce9-ea9ba9c52463"
      unitRef="shares">3822000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzItNS0xLTEtMA_b66fcf07-7fc0-4a3e-9bff-a0f1e18b4355"
      unitRef="shares">3819000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzItOS0xLTEtMA_661ef1ed-8bc8-494e-be6e-add8b6f5884f"
      unitRef="shares">2992000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzMtMS0xLTEtMA_b65f498d-f092-409e-bd71-cab6f497dec2"
      unitRef="usdPerShare">37.69</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzMtNS0xLTEtMA_49e09d70-7e5c-4b67-ad15-cb271531f421"
      unitRef="usdPerShare">41.79</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzMtOS0xLTEtMA_cc15678e-1602-4731-9186-cc939dbe5b24"
      unitRef="usdPerShare">40.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzQtMS0xLTEtMA_0bf58f5c-333e-439b-8f45-ebf241578440"
      unitRef="usdPerShare">10.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzQtNS0xLTEtMA_81e470d9-aaa6-42ff-a284-6b095919b6c9"
      unitRef="usdPerShare">10.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzQtOS0xLTEtMA_a9f78dd5-fe68-4f92-9c9f-6d50e1cc74ee"
      unitRef="usdPerShare">11.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzYtMS0xLTEtMA_3f7ec6cf-9fd6-4774-9208-77e6f00f979b"
      unitRef="number">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzYtNS0xLTEtMA_795f8e6b-0c3e-430b-b0db-65c3ca926d60"
      unitRef="number">0.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzYtOS0xLTEtMA_aa02ec8d-4aae-46da-b281-321e6bd16aab"
      unitRef="number">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzctMS0xLTEtMA_698cc882-384d-4d88-b390-9bb56370f283">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzctNS0xLTEtMA_aea1fb7d-9714-48d6-9d12-6d9662641de5">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzctOS0xLTEtMA_2632a865-6757-45b2-a818-779f4e0dcb16">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie188534f742842feac06df7e1c74aa45_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtMS0xLTEtMA_e60f0bad-3ccb-4c12-b41f-668bfb1f66d0"
      unitRef="number">0.0066</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtMy0xLTEtMA_8cdff411-fd23-44fe-b6b8-33cbecc19e2a"
      unitRef="number">0.0120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0aae52091d8944baa48514791518f001_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtNS0xLTEtMA_1fcf2b99-b6a1-4995-84b7-5377ee6c43c6"
      unitRef="number">0.0027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i18d0f7d58dbe4881a08e6c6c4d798dc7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtNy0xLTEtMA_e02739d9-77f5-4f14-9be0-4acdafc4e5c8"
      unitRef="number">0.0172</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i28b5c1f16ae04ad0863e335580139350_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtOS0xLTEtMA_736c396f-3bce-4bb9-82ff-723a9c886e19"
      unitRef="number">0.0138</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7bc526be42e743bb9a8a6576a16447ee_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo1OWY2ZjJhZjU3MDQ0MzcwYjc5Yzc0YmE0YTBjNGM3ZS90YWJsZXJhbmdlOjU5ZjZmMmFmNTcwNDQzNzBiNzljNzRiYTRhMGM0YzdlXzgtMTEtMS0xLTA_5fe5864e-cb1d-4adf-baaa-0d591193d106"
      unitRef="number">0.0261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MDg_785430fe-cb48-4e35-8d86-21f61466692b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to stock options under stock incentive plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,448&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total vested and expected to vest as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzUtMS0xLTEtMA_7354bfcb-3608-407f-928c-721d8e571b04"
      unitRef="shares">25304000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzUtMy0xLTEtMA_b24f25e6-5940-4d15-a0ca-9296b9696e5b"
      unitRef="usdPerShare">16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzYtMS0xLTEtMA_41e6e2d9-f239-42ac-b07c-411761dad31b"
      unitRef="shares">2992000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzYtMy0xLTEtMA_b4192bc4-754b-4845-95df-f592655b2c52"
      unitRef="usdPerShare">40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzctMS0xLTEtMA_87e71f36-552d-47b4-85b3-2f34a96aded0"
      unitRef="shares">4872000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzctMy0xLTEtMA_be81df8b-7c57-4775-8281-78a445b91bcd"
      unitRef="usdPerShare">12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzgtMS0xLTEtMA_b5b830b5-e5d6-49a0-80b7-ffc95cfe0880"
      unitRef="shares">359000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzgtMy0xLTEtMA_9e1b3b15-fc62-41be-9d0e-76885afcfdc1"
      unitRef="usdPerShare">24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzktMS0xLTEtMA_f2152516-9317-4246-9c94-e03348617dc3"
      unitRef="shares">23065000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzktMy0xLTEtMA_f30e3a1d-22a2-4c14-9091-0af74d79861e"
      unitRef="usdPerShare">19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEwLTEtMS0xLTA_f3b90bfa-2bac-4265-bd33-e7d03c17bebe"
      unitRef="shares">3819000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEwLTMtMS0xLTA_b4d863a7-7eb0-452e-ae7f-f813c1e63520"
      unitRef="usdPerShare">42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzExLTEtMS0xLTA_18ec695a-3794-4982-a9d5-05983604a75a"
      unitRef="shares">3096000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzExLTMtMS0xLTA_3ab76744-7ff6-4e48-b36e-2c9cc1aa24dd"
      unitRef="usdPerShare">13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEyLTEtMS0xLTA_40be8b13-8904-4f0d-b722-e7642eb8bec4"
      unitRef="shares">666000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEyLTMtMS0xLTA_096046a3-a884-4f9c-8133-86facf36495b"
      unitRef="usdPerShare">27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEzLTEtMS0xLTA_f33534d1-8c1f-4153-bd96-b01f246d844b"
      unitRef="shares">23122000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzEzLTMtMS0xLTA_2996eb7c-2e71-452d-b586-d9c9f1f283d4"
      unitRef="usdPerShare">24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTEtMS0xLTQwMA_cf71c0ea-ca74-42f2-a560-5e44a61c18cc"
      unitRef="shares">3822000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTMtMS0xLTQwMA_468d7749-af0c-4353-8bf4-16cd49d7ff58"
      unitRef="usdPerShare">38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTEtMS0xLTQwMA_0289a0d6-416c-4451-b907-dd671d14bd90"
      unitRef="shares">4796000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTMtMS0xLTQwMA_1adf8d39-add0-47b5-a2fb-b3bb77e32857"
      unitRef="usdPerShare">13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTEtMS0xLTQwMA_9a2d85fb-6b2a-4d38-83ec-fb3a2ef5ce2a"
      unitRef="shares">699000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTMtMS0xLTQwMA_e16b89d1-2c9b-4bd5-b3c8-bcad739684d9"
      unitRef="usdPerShare">26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTEtMS0xLTQwMA_6ca330d6-7809-4b09-a33f-9eaa46bffe91"
      unitRef="shares">21448000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTMtMS0xLTQwMA_e35e109c-cc17-4747-b308-c6ca1f5abeab"
      unitRef="usdPerShare">29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTUtMS0xLTQwNg_583c3a66-578e-471c-8888-dd607db1ef9e">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE3LTctMS0xLTQwNg_7b3d7485-0003-4f26-838f-e497248c1426"
      unitRef="usd">296000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTEtMS0xLTA_d9859cfb-9393-4fe8-b9a9-1a3198bc19ce"
      unitRef="shares">13248000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTMtMS0xLTA_c62477ae-f360-444f-b2f8-75a53aaff427"
      unitRef="usdPerShare">23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTUtMS0xLTA_9c20c5d3-e7cf-47b5-b111-0386c199dc3f">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE0LTctMS0xLTA_46eebe64-e2d0-467e-b569-7995390394bf"
      unitRef="usd">263000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <bsx:OptionsExpectedToVest
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTEtMS0xLTA_2f5123df-0766-4a2e-9ca4-96112e6b2878"
      unitRef="shares">7893000</bsx:OptionsExpectedToVest>
    <bsx:OptionsExpectedToVestWeightedAverageExercisePrice
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTMtMS0xLTA_0cb800e2-af72-45cd-b49a-726468d9c568"
      unitRef="usdPerShare">38</bsx:OptionsExpectedToVestWeightedAverageExercisePrice>
    <bsx:OptionsExpectedToVestWeightedAverageRemainingContractualLife
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTUtMS0xLTA_106f347f-beec-4ef6-a88f-e188263d67fb">P8Y3M18D</bsx:OptionsExpectedToVestWeightedAverageRemainingContractualLife>
    <bsx:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE1LTctMS0xLTA_49017475-37cb-414e-bdc0-ab526f2685b1"
      unitRef="usd">32000000</bsx:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTEtMS0xLTA_e28a2869-e71a-4465-9294-ca33c22bb2df"
      unitRef="shares">21141000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTMtMS0xLTA_63f04bd2-47ba-4c4f-bccd-b1e39b6b76a2"
      unitRef="usdPerShare">29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTUtMS0xLTA_aa50e527-6375-43fe-918c-bf703c1bd02b">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpiNTUyNDVmNGM4MTQ0NGNlODdlMzdmNTNmMmYwYjEyMC90YWJsZXJhbmdlOmI1NTI0NWY0YzgxNDQ0Y2U4N2UzN2Y1M2YyZjBiMTIwXzE2LTctMS0xLTA_64bd8bcc-db46-43c6-b099-b5d551cba791"
      unitRef="usd">295000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzMzNjU_9d7caf60-8c88-4367-83d7-b324f9b8380e"
      unitRef="usd">137000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzMzNzU_a8d323ae-13da-4fb7-9c7e-6454635b5bb5"
      unitRef="usd">84000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzMzODg_ead91237-44e7-45eb-94f6-a6735cebba93"
      unitRef="usd">140000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5Njc_ab01b4c0-c751-4e8e-9059-70356d143336">Information related to non-vested stock awards is as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Vested&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Award Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant-Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(658)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzUtMS0xLTEtMA_0d31eab6-c4bb-4a91-a0d7-cb1301829fad"
      unitRef="shares">12683000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzUtMy0xLTEtMA_81321546-afa7-4144-a710-5325938887db"
      unitRef="usdPerShare">22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzYtMS0xLTEtMA_ec049422-a3a7-4bd8-84b1-1ffbd9553272"
      unitRef="shares">3656000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzYtMy0xLTEtMA_69970d5d-6e97-48c0-8cca-db223fa07944"
      unitRef="usdPerShare">39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzctMS0xLTEtMA_557161ab-a279-45d0-a797-b83975f1cad9"
      unitRef="shares">4811000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzctMy0xLTEtMA_21981fdc-a2f2-45c0-bd37-85abe1675a65"
      unitRef="usdPerShare">20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzgtMS0xLTEtMA_e9391597-ef28-4a21-9115-c010d9f0ab19"
      unitRef="shares">449000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzgtMy0xLTEtMA_12866fb4-4965-4bca-8b93-3618ee7bca1a"
      unitRef="usdPerShare">27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzktMS0xLTEtMA_8a982c67-a6ac-47cb-ab91-3d7b6971637a"
      unitRef="shares">11079000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzktMy0xLTEtMA_3b6f9399-a517-472c-8822-6edaf42dd449"
      unitRef="usdPerShare">29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEwLTEtMS0xLTA_916cc3d9-014b-4531-9ca3-0bf3ab70c6ce"
      unitRef="shares">3609000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEwLTMtMS0xLTA_d43674a5-5ca1-47ae-bc19-4b522917521d"
      unitRef="usdPerShare">41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzExLTEtMS0xLTA_ab2e12e0-a803-4249-8235-b0082ace0ab8"
      unitRef="shares">4147000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzExLTMtMS0xLTA_50433a25-47aa-4308-b065-59189e1aadf0"
      unitRef="usdPerShare">25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEyLTEtMS0xLTA_ca17f52d-5b51-4665-946d-4a35a7e04543"
      unitRef="shares">554000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEyLTMtMS0xLTA_b4caca77-32b9-45ec-8548-534d8b2e9a5b"
      unitRef="usdPerShare">34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEzLTEtMS0xLTA_d20850b8-e2aa-42cc-bed3-7553ba907841"
      unitRef="shares">9987000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzEzLTMtMS0xLTA_dfed17db-d091-4766-8c17-740dda2f51c1"
      unitRef="usdPerShare">34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE0LTEtMS0xLTQzNw_cce2ce62-af8b-4bcd-a117-33219fa7947c"
      unitRef="shares">4240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE0LTMtMS0xLTQ0MQ_20e2a17c-211f-4eaa-bce3-3414a5f51b2e"
      unitRef="usdPerShare">39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE1LTEtMS0xLTQzNw_67b58450-9f36-4945-a3e7-d485ce874d55"
      unitRef="shares">3823000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE1LTMtMS0xLTQ0MQ_a6bcfb22-82cb-4a72-98bb-5b9f76cd8656"
      unitRef="usdPerShare">31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE2LTEtMS0xLTQzNw_44c8639b-bd40-4ccf-8423-ad591b1fa751"
      unitRef="shares">658000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE2LTMtMS0xLTQ0MQ_0cb40d50-8292-4326-bb9b-942fe1f376a8"
      unitRef="usdPerShare">36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE3LTEtMS0xLTQzNw_b78eade1-ab4e-4b01-81b9-3847b388dbd9"
      unitRef="shares">9745000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTowMjQ1MjEyODM3Mjc0Mjg3OGIyMWI2YjE0ODQ2N2QzNy90YWJsZXJhbmdlOjAyNDUyMTI4MzcyNzQyODc4YjIxYjZiMTQ4NDY3ZDM3XzE3LTMtMS0xLTQ0MQ_6c3a1b1a-1e71-46e1-a346-edf68fda94e6"
      unitRef="usdPerShare">37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzM3ODQ_847d96bf-b689-4395-bd29-1e6ea6dbd040"
      unitRef="usd">148000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzM3OTQ_908b04b6-1eeb-48af-870f-404b138126d7"
      unitRef="usd">172000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzM4MDc_cd04a785-0944-4e68-98f6-b3ec7a078e3f"
      unitRef="usd">193000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <bsx:RangeofthetargetnumberofmarketbasedDSUsawarded
      contextRef="ie188534f742842feac06df7e1c74aa45_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQyNzc_64fa8dce-a01e-4fbb-baf4-21abf8984e8d"
      unitRef="number">0</bsx:RangeofthetargetnumberofmarketbasedDSUsawarded>
    <bsx:RangeofthetargetnumberofmarketbasedDSUsawarded
      contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQyODM_5fc3e241-6d7e-41eb-b33b-c391cc58d8b6"
      unitRef="number">2</bsx:RangeofthetargetnumberofmarketbasedDSUsawarded>
    <bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5NjE_0b2893cd-91fe-42ac-8f9e-96c0e1be3ca1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the fair value of the market-based RSU and DSU awards to be approximately $11 million for 2021, $8 million for 2020 and $10 million for 2019. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price on date of grant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock>
    <bsx:Fairvalueofmarketbasedawards
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQ3Mjc_f6638e5f-84ca-442b-bf93-9fecec1147b8"
      unitRef="usd">11000000</bsx:Fairvalueofmarketbasedawards>
    <bsx:Fairvalueofmarketbasedawards
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQ3Mzg_48a57b0c-195d-424b-af6f-0cdcfb3582c1"
      unitRef="usd">8000000</bsx:Fairvalueofmarketbasedawards>
    <bsx:Fairvalueofmarketbasedawards
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzQ3NTI_19fa0c55-1ecb-49c9-9bf5-281e75792ae4"
      unitRef="usd">10000000</bsx:Fairvalueofmarketbasedawards>
    <us-gaap:SharePrice
      contextRef="i2aad1bab8c3f42188e8caee5487fc161_I20210217"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzItMS0xLTEtMA_b06e54e0-e729-42a8-842d-00c7f541d7e0"
      unitRef="usdPerShare">37.50</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i58d60bf54d9b477b9441568e22f085d1_I20200218"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzItMy0xLTEtMA_3b82f167-2ebe-4798-8ce2-f45f6fca0f7f"
      unitRef="usdPerShare">42.16</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i9292f58cc599475cbe04d0e8c11e9935_I20190221"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzItNS0xLTEtMA_b0749930-82fc-416b-8821-f2565e287a50"
      unitRef="usdPerShare">40.12</us-gaap:SharePrice>
    <bsx:Measurementperiodmarketbasedaward
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzMtMS0xLTEtMA_7047c081-503a-4b24-86f0-15462191dbaa">P2Y10M24D</bsx:Measurementperiodmarketbasedaward>
    <bsx:Measurementperiodmarketbasedaward
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzMtMy0xLTEtMA_a1b7b3ed-4f78-4cdd-9598-3eb39bb437ba">P2Y10M24D</bsx:Measurementperiodmarketbasedaward>
    <bsx:Measurementperiodmarketbasedaward
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzMtNS0xLTEtMA_ee2ed28a-f215-45a1-a610-feca6f745435">P2Y10M24D</bsx:Measurementperiodmarketbasedaward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzQtMS0xLTEtMA_d310bc56-38bc-464b-b04c-ef55f6082043"
      unitRef="number">0.0020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzQtMy0xLTEtMA_4c8914d3-849f-4456-9ad3-455f6cd96b30"
      unitRef="number">0.0137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4ODllMDA5YmJjMjE0YTExYmU4NWU5MDk3OTY3ZTlkMS90YWJsZXJhbmdlOjg4OWUwMDliYmMyMTRhMTFiZTg1ZTkwOTc5NjdlOWQxXzQtNS0xLTEtMA_61b029f9-f548-4464-b199-e111ab612a97"
      unitRef="number">0.0248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <bsx:RangeofthetargetnumberofperformancebasedDSUsawarded
      contextRef="ie188534f742842feac06df7e1c74aa45_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzU1MzA_b2ca6e63-d5a1-449b-a623-428e11a3e140"
      unitRef="number">0</bsx:RangeofthetargetnumberofperformancebasedDSUsawarded>
    <bsx:RangeofthetargetnumberofperformancebasedDSUsawarded
      contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzU1MzY_deca2896-3812-4a51-b9e7-e86477ef5614"
      unitRef="number">1.50</bsx:RangeofthetargetnumberofperformancebasedDSUsawarded>
    <bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5MzE_c9d132e6-9838-4b11-b423-8bcc8a326de7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 AFCF&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, net of forfeitures to date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Achievement of target payout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year-end stock price used in determining fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock>
    <bsx:FairValueOfFreeCashFlowFcfPerformanceAwards
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzEtMS0xLTEtMA_07767e81-52e4-4104-aef3-f0812f66e0c0"
      unitRef="usd">12000000</bsx:FairValueOfFreeCashFlowFcfPerformanceAwards>
    <bsx:FairValueOfFreeCashFlowFcfPerformanceAwards
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzEtMy0xLTEtMA_252b4073-3dbd-418e-b210-d86052647b4a"
      unitRef="usd">6000000</bsx:FairValueOfFreeCashFlowFcfPerformanceAwards>
    <bsx:FairValueOfFreeCashFlowFcfPerformanceAwards
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzEtNS0xLTEtMA_487937b7-4672-4633-819f-90b8ef8cec9c"
      unitRef="usd">8000000</bsx:FairValueOfFreeCashFlowFcfPerformanceAwards>
    <bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzItMS0xLTEtMA_5b28b43e-40ed-4d4a-a1af-b4aeb02b5507"
      unitRef="number">1.31</bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards>
    <bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzItMy0xLTEtMA_345d06c0-9e75-47a3-9387-81ef21a4f2bf"
      unitRef="number">0.89</bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards>
    <bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzItNS0xLTEtMA_eb8b6074-6be7-4f92-a727-1219e5bfa245"
      unitRef="number">0.90</bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards>
    <us-gaap:SharePrice
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzMtMS0xLTEtMA_a6eb490a-4fc2-4154-a5eb-bd9a3100cbba"
      unitRef="usdPerShare">42.48</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzMtMy0xLTEtMA_bd1cd11b-2617-486e-96a2-507e99ff3f2f"
      unitRef="usdPerShare">35.95</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTpjN2Y2YmUzYzMxNDA0ODY4YjU3ZDYyYzg0MTBhMzhlNS90YWJsZXJhbmdlOmM3ZjZiZTNjMzE0MDQ4NjhiNTdkNjJjODQxMGEzOGU1XzMtNS0xLTEtMA_28562fe6-aaa9-4a59-8bcd-c6e6b01b1a34"
      unitRef="usdPerShare">45.22</us-gaap:SharePrice>
    <bsx:Annualweightedaverageforfeiturerate
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzc3Mjg_01846671-c43f-46f6-8e73-e223bf3bd902"
      unitRef="number">0.05</bsx:Annualweightedaverageforfeiturerate>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5NDA_2e43a1c1-24d9-49f1-91aa-b2a734be31a7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Compensation Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vesting Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;214&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Amounts presented represent compensation cost, net of estimated forfeitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <bsx:UnrecognizedCompensationCostStockOptions
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzEtMS0xLTEtMA_08bc7ad8-aefd-4a63-94ce-c1adf8ae6892"
      unitRef="usd">36000000</bsx:UnrecognizedCompensationCostStockOptions>
    <bsx:UnrecognizedCompensationCostNonVestedStockAwards
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzItMS0xLTEtMA_af892d82-9a6d-4bd9-967b-686859375fac"
      unitRef="usd">178000000</bsx:UnrecognizedCompensationCostNonVestedStockAwards>
    <bsx:UnrecognizedCompensationCost
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzMtMS0xLTEtMA_4db835b9-874b-4348-90a3-4cb8f5189a81"
      unitRef="usd">214000000</bsx:UnrecognizedCompensationCost>
    <bsx:WeightedAverageRemainingVestingPeriod
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTo4NzQ0N2EzZjFiOTU0MjZiODA1ZDFhZWUzYmM5ZGQ1NC90YWJsZXJhbmdlOjg3NDQ3YTNmMWI5NTQyNmI4MDVkMWFlZTNiYzlkZDU0XzMtMy0xLTEtMA_f129f6c6-beea-487f-869b-a58063253b3f">P1Y8M12D</bsx:WeightedAverageRemainingVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzg0MzA_de58a562-08c1-478a-9a89-bca917bdddcb"
      unitRef="shares">50000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <bsx:AmountOfEmployeesTotalCompensationEligibleForGesopPurchase
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzg2OTE_3f842289-ae3b-4443-9c47-55f158e8d231"
      unitRef="number">0.10</bsx:AmountOfEmployeesTotalCompensationEligibleForGesopPurchase>
    <bsx:GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzg5NTA_d4181d87-9873-41c8-873b-cf12ce552ec1"
      unitRef="number">0.85</bsx:GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzkxMDE_553bd9af-ed91-4929-87ed-b75f81e01c61"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90ZXh0cmVnaW9uOmFiYjZiNjg4MzZkODQwZTU4OTJlMTJjOTYyMzNmMzlkXzk5NTg_8439ed0b-66b5-4cd6-9685-29400c6ecf4a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued or to be issued&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Range of purchase prices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36.47&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recognized&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzItMS0xLTEtMA_2cbc0e73-9f00-4813-a5ff-8acefcc585c0"
      unitRef="shares">2578000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzItNS0xLTEtMA_4b9a580c-a10e-4b6f-8ee7-8681e3b18773"
      unitRef="shares">1387000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzItOS0xLTEtMA_df270175-aac1-4031-b56e-aeb5f9231e38"
      unitRef="shares">2196000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtMS0xLTEtMA_8450cbaa-f361-4752-add2-53e200ec6e74"
      unitRef="usdPerShare">29.98</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="ia129bbdd046f45cc9bfde791f7aaca51_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtMy0xLTEtNTc0ODI_7d06a3a7-e5f6-4bb9-b9a3-08e081ca40af"
      unitRef="usdPerShare">36.11</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtNS0xLTEtMA_6234887f-695f-4af5-9e14-bb64133da619"
      unitRef="usdPerShare">29.84</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i28b5c1f16ae04ad0863e335580139350_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtOS0xLTEtMA_0110caac-bd29-4a1c-9848-e62f92ba3531"
      unitRef="usdPerShare">29.29</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i7bc526be42e743bb9a8a6576a16447ee_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzMtMTEtMS0xLTA_a0b782b7-1a39-41b4-9442-54e0138a164a"
      unitRef="usdPerShare">36.47</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzQtMS0xLTEtMA_9e3d707c-a6ef-483d-ba64-515d26d239e3"
      unitRef="usd">24000000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzQtNS0xLTEtMA_d6d7a413-2dd6-4999-a31e-a29302071a27"
      unitRef="usd">10000000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzAvZnJhZzphYmI2YjY4ODM2ZDg0MGU1ODkyZTEyYzk2MjMzZjM5ZC90YWJsZTozZGM3OTdkYjYxZTY0ZTJkYjQ1NmM4NjE0Y2U3OTMwNC90YWJsZXJhbmdlOjNkYzc5N2RiNjFlNjRlMmRiNDU2Yzg2MTRjZTc5MzA0XzQtOS0xLTEtMA_aef0f5e7-a378-4594-aa94-693ca2130403"
      unitRef="usd">19000000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90ZXh0cmVnaW9uOmY1OTE0YmY4ZDg3OTRjNTVhNjg2MWNlNjNhZTU1ZTE0XzE3NDM_3d962af3-fced-420f-9941-5578520aab05">&lt;div style="margin-top:20pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE N &#x2013; WEIGHTED AVERAGE SHARES OUTSTANDING&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,416.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,433.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,416.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; position in this period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss)&#160;per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021 and 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was reduced by cumulative &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Preferred stock dividends&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as presented in our consolidated statements of operations, for purposes of calculating &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss) available to common stockholders&lt;/span&gt;.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90ZXh0cmVnaW9uOmY1OTE0YmY4ZDg3OTRjNTVhNjg2MWNlNjNhZTU1ZTE0XzE3MjM_ee63350c-7179-495d-9ae7-9ecfa71a7a57">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,416.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,433.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,416.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzItMS0xLTEtMA_9d179421-772a-49df-9f0b-724eecc6df3b"
      unitRef="shares">1422300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzItMy0xLTEtMA_d08e578e-6377-4d79-b528-532fb3d8a5b1"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzItNS0xLTEtMA_5c4231f3-226a-4215-ba1b-0898fdc7b3b0"
      unitRef="shares">1391500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzMtMS0xLTEtMA_aa0c4c7c-f92d-4d3f-bc25-6cd97f53ecbf"
      unitRef="shares">11500000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzMtMy0xLTEtMA_ea5ba9a3-4c31-40c2-9df0-53d855d00f1e"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzMtNS0xLTEtMA_7f4de6e8-cc2b-496f-901f-56563fd53e8d"
      unitRef="shares">19000000.0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzQtMS0xLTEtMA_fdc032fb-450c-408e-9c98-fa57daed566b"
      unitRef="shares">1433800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzQtMy0xLTEtMA_04fae409-81f2-465a-8b70-b78928cebfb6"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZTo5MzE3OTkxNDdiMDk0MTliOTQ1NDQyZWQzYmZkMWE0OS90YWJsZXJhbmdlOjkzMTc5OTE0N2IwOTQxOWI5NDU0NDJlZDNiZmQxYTQ5XzQtNS0xLTEtMA_fd788a8e-6f83-48c5-81cf-2b43748a53b8"
      unitRef="shares">1410600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90ZXh0cmVnaW9uOmY1OTE0YmY4ZDg3OTRjNTVhNjg2MWNlNjNhZTU1ZTE0XzE3MjQ_867fd612-1e42-4a6f-ba39-a0c5be3cdeff">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; position in this period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i56d2063406334ffa9e99fa12a46b4055_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzItMy0xLTEtMA_179addfd-12f6-4609-9038-f269a94d32ba"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i57fa53402a1e4d61946e5928f0177f07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzMtMS0xLTEtMA_9e24f847-ab05-484b-913e-0b8b84c40b3d"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i69bc7b2173af4ec4be135c607f06064b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzMtMy0xLTEtMA_1e4ed3cb-45f0-4679-b383-89c50a94c6a2"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3dcc1d9f587e4bdf84dc58e0c744f18f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzMtNS0xLTEtMA_c2d4bc5e-9d54-4d10-80bf-d4098ab6b46a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibcc7a0cac76948efb6e5fa18d4642442_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzQtMS0xLTEtMA_a4f75e6b-0051-49d3-8850-683eb4bbc72b"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i979c7d5f5f30414bb30ba5f9f9d3c752_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzMvZnJhZzpmNTkxNGJmOGQ4Nzk0YzU1YTY4NjFjZTYzYWU1NWUxNC90YWJsZToyN2MwMzM0YjJlYWQ0OTIzYWQwYjk5NTAxNTAxYmU3YS90YWJsZXJhbmdlOjI3YzAzMzRiMmVhZDQ5MjNhZDBiOTk1MDE1MDFiZTdhXzQtMy0xLTEtMA_b63b7ee6-2aea-406a-828d-9713830c847b"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2NTA_8d4b7905-005b-4b42-a7e2-769eca4e417e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE O &#x2013; SEGMENT REPORTING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), certain investment portfolio net losses (gains) and EU Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations and are included in the reconciliation below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we are reorganizing our operational structure in order to strengthen our category leadership in the markets we serve, and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we will aggregate our core businesses into two reportable segments: MedSurg and Cardiovascular.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation expense of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;352&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income of reportable segments as a percentage of net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other corporate assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the announcement of our plan to sell our Specialty Pharmaceuticals business, as of December 31, 2020, we classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet at their respective carrying values, which approximated fair value, less costs to sell. Accordingly, the total assets of the Specialty Pharmaceuticals business as of December 31, 2020 reflected above include goodwill and intangible assets attributable to the disposal group that were not previously allocated to our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,477&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzU1_3152b077-bd86-447d-af6b-e70e12aa05b9"
      unitRef="reportablesegments">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI1NzI_e9132fe3-b9c2-4f3c-99c2-dda98a76d0c8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzItMS0xLTEtMA_eb316aa9-a3ce-4f2d-bcf6-dd87c9514d10"
      unitRef="usd">3724000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzItMy0xLTEtMA_c1f53f11-3355-4d05-849e-84582f1543a0"
      unitRef="usd">3066000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzItNS0xLTEtMA_e23af42f-81ca-4752-8724-5940a10a5923"
      unitRef="usd">3307000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzMtMS0xLTEtMA_821fecdf-b87e-4a23-a4d7-dfec4b3d6038"
      unitRef="usd">3293000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzMtMy0xLTEtMA_277a387d-3f91-4af6-a259-71987644b5f7"
      unitRef="usd">2752000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzMtNS0xLTEtMA_df5c03a2-2730-4fde-9be2-7efe2296f8ee"
      unitRef="usd">3140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzQtMS0xLTEtMA_6b24d2e6-93e1-485c-903e-29f3913264ce"
      unitRef="usd">4858000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzQtMy0xLTEtMA_450ef1a8-1325-464e-9d65-645724db1cca"
      unitRef="usd">3876000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzQtNS0xLTEtMA_bd55b44b-f19d-4d17-9186-964bac13aa4b"
      unitRef="usd">4208000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfdac215247a41d5a190631edb467695_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzUtMS0xLTEtMA_ab55ea39-6038-4483-8cdb-feb81ca5797f"
      unitRef="usd">11875000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzUtMy0xLTEtMA_f14c10b4-9fb2-4c50-b737-6948117773a0"
      unitRef="usd">9694000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzUtNS0xLTEtMA_5cc7bdeb-4896-4485-83c6-9fee07e6db5e"
      unitRef="usd">10654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzYtMS0xLTEtMA_df3a1bd9-44e8-463e-b430-3c50bb29bec1"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzYtMy0xLTEtMA_f74589d3-be8f-4116-8772-914c18f13770"
      unitRef="usd">219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzYtNS0xLTEtMA_7f0a264f-41fc-4b09-b0cc-0707bef8357f"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzctMS0xLTEtMA_87b78e8f-5558-4fa8-bf9a-a9a31bf246a1"
      unitRef="usd">11888000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzctMy0xLTEtMA_18807ea1-0f7d-4b6d-b7b9-6a2a7d111db5"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozMTA2MzRhZDJiNzE0MDVlOGY3ZTBlMGUzYWZlNDRmMi90YWJsZXJhbmdlOjMxMDYzNGFkMmI3MTQwNWU4ZjdlMGUwZTNhZmU0NGYyXzctNS0xLTEtMA_5d170cd5-bbdc-47f4-bf67-935d67dbb4ce"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2NDU_8e36ddec-e7cc-4ea0-a52f-72e4b0a44684">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation expense of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;352&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzItMS0xLTEtMA_b2f3cc7e-a57a-4f3f-8075-5c0afb8a0c14"
      unitRef="usd">81000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzItMy0xLTEtMA_4bd06d7a-98dc-4f49-a345-ae127a1ede82"
      unitRef="usd">80000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzItNS0xLTEtMA_527f6aec-760b-47e2-9b8e-6526c0df2820"
      unitRef="usd">75000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzMtMS0xLTEtMA_20c653ac-f0fd-41c1-9a11-ad4d08883cf9"
      unitRef="usd">104000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzMtMy0xLTEtMA_a4f9a4fb-18a5-40c7-9026-28862a80d767"
      unitRef="usd">96000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzMtNS0xLTEtMA_67e74291-1fa8-49ec-83a3-f36412be11c2"
      unitRef="usd">92000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzQtMS0xLTEtMA_26fd7bc5-a1ab-4e2d-8cd7-046727de76aa"
      unitRef="usd">167000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzQtMy0xLTEtMA_fdab94ff-4b8b-48fb-85ec-401f4377c523"
      unitRef="usd">154000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzQtNS0xLTEtMA_28d3d0ac-0776-4056-a573-83b857bdb0ab"
      unitRef="usd">138000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="icfdac215247a41d5a190631edb467695_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzUtMS0xLTEtMA_84423087-9c9c-4aab-ae20-c6915d1471ad"
      unitRef="usd">352000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzUtMy0xLTEtMA_f389f9b4-77a0-4465-a47e-58121bad17fc"
      unitRef="usd">330000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzUtNS0xLTEtMA_d1bb469b-d60a-49df-a135-c05f63d6aa60"
      unitRef="usd">306000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzYtMS0xLTEtMA_6ec0acab-2014-4d96-b27e-fa3021bb61e6"
      unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzYtMy0xLTEtMA_a69c086d-862b-4576-8953-0fb51cf12af9"
      unitRef="usd">3000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i998fc4c852bb4712a6ac361d50f1addb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzYtNS0xLTEtMA_381986c0-0bc3-4a73-999e-b9b6579b00d8"
      unitRef="usd">6000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzctMS0xLTEtMA_a4e73f77-255c-42d0-b82b-cc696c50743d"
      unitRef="usd">352000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzctMy0xLTEtMA_fff3e2f0-4c2f-4a7f-8305-cea0b0acdafe"
      unitRef="usd">333000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTphODJjYzFjNTAzNjM0OGE1YTI2MDE2N2QyM2RlMDZiNS90YWJsZXJhbmdlOmE4MmNjMWM1MDM2MzQ4YTVhMjYwMTY3ZDIzZGUwNmI1XzctNS0xLTEtMA_6bbc45ca-d8e2-4a97-85e2-b900c658e5ff"
      unitRef="usd">311000000</us-gaap:Depreciation>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI1Nzk_28679f2a-f600-4296-8bb6-3834233f754e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzItMS0xLTEtMA_cc11985c-08c5-486d-93ac-e2db03f3b438"
      unitRef="usd">1399000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzItMy0xLTEtMA_3bd0ca95-6e01-4301-9f3e-5173ad3a0e18"
      unitRef="usd">1079000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzItNS0xLTEtMA_7fdf6b51-8773-4a64-a754-759756135793"
      unitRef="usd">1204000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzMtMS0xLTEtMA_205efa0b-6e02-4421-b5c6-52913e84011d"
      unitRef="usd">607000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzMtMy0xLTEtMA_9142a755-99e7-4225-bfb3-1a83f6d6c184"
      unitRef="usd">439000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzMtNS0xLTEtMA_3bce66bf-cecb-471e-9c93-f1d7e00c978b"
      unitRef="usd">666000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzQtMS0xLTEtMA_9f972e83-cae8-45f2-830d-5497589a78ae"
      unitRef="usd">1448000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzQtMy0xLTEtMA_059493a3-6c1a-4d49-8011-a51fb7cd82c1"
      unitRef="usd">661000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzQtNS0xLTEtMA_de1d7272-cced-4af2-8887-e307a2f4e916"
      unitRef="usd">1137000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5c616e504e944e48bc57a78d5f0bcc4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzUtMS0xLTEtMA_42b70322-43e8-4277-a8ab-9b79630db2b4"
      unitRef="usd">3454000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6cd23720dcf441b893aa13e8563d15ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzUtMy0xLTEtMA_e4e0a532-0e14-4500-97c1-0c4a38200700"
      unitRef="usd">2179000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib6d4db93b38040f2a515f954395082f3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzUtNS0xLTEtMA_f24e4880-edcd-488c-9630-347e00d35142"
      unitRef="usd">3007000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i047f4abd397a46ac982bc251e8b2c251_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzYtMS0xLTEtMA_26dacf02-3c87-4c65-9a5b-ce69c037e6f9"
      unitRef="usd">4000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7e0bffd5d89145fe9c3cd91e8409b62f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzYtMy0xLTEtMA_522daffd-cd8c-4638-b771-4e9d63a81f12"
      unitRef="usd">143000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i998fc4c852bb4712a6ac361d50f1addb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzYtNS0xLTEtNDY1_635a6a63-8866-4f29-ba7d-f937fc521e6e"
      unitRef="usd">56000000</us-gaap:OperatingIncomeLoss>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i3af6a1df22a242a4b23b635ddeb5a981_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzgtMS0xLTEtMA_22fac884-6fdb-4466-88a5-99055bcdb6d1"
      unitRef="usd">-447000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i88f0a448c20c42a59fc6c0a04e829f95_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzgtMy0xLTEtMA_404465c2-355e-47b9-9752-95f4cc15bac0"
      unitRef="usd">-405000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ibb04350660a44a988ce323d0808bb5a2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzgtNS0xLTEtMA_629e3038-7b45-4c77-ae2a-4d9ad2dcd2be"
      unitRef="usd">-264000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ibb392f0b52d04562bbafef2c2e3bd024_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzktMS0xLTEtMA_30a91274-7b8f-4de9-9ff0-c7b87da21d0d"
      unitRef="usd">-1070000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i7d2aee8e67d5473ca756655b97f76be1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzktMy0xLTEtMA_269b1b61-26ef-44ec-9718-b768acffd386"
      unitRef="usd">-1208000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="id43b6011336d44cda836897ad0a99eef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzktNS0xLTEtMA_ffe24ddb-5dc8-4c12-bee1-178ffa72a012"
      unitRef="usd">-582000000</bsx:OperatingIncomeUnallocatedToSegment>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEwLTEtMS0xLTA_dbed11af-284f-4ad5-a70a-d3751da0e02d"
      unitRef="usd">741000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEwLTMtMS0xLTA_ff7cdae9-e7fb-4231-a4c6-3e03e2796f05"
      unitRef="usd">789000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEwLTUtMS0xLTA_03ac60e1-136b-4415-a9ee-7d2b5e1fd275"
      unitRef="usd">699000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzExLTEtMS0xLTA_6d10cbb9-cef3-43f7-b078-1c9f24def8bd"
      unitRef="usd">1199000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzExLTMtMS0xLTA_1a3e59d0-7abc-49a4-8c9d-734adb9c5deb"
      unitRef="usd">-80000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzExLTUtMS0xLTA_41db3d2b-768f-4d47-aee8-1699cd5024a8"
      unitRef="usd">1518000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEyLTEtMS0xLTA_f0538627-c0ef-41e8-a05f-c663f3521a97"
      unitRef="usd">-123000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEyLTMtMS0xLTA_11ba1c12-04ac-4a33-891f-4fae4ffe84fe"
      unitRef="usd">1000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEyLTUtMS0xLTA_bc9018c1-e41f-478e-865d-92170769d025"
      unitRef="usd">-831000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEzLTEtMS0xLTA_b72d74c8-9d91-4f68-89d3-df6445dc90f9"
      unitRef="usd">1076000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEzLTMtMS0xLTA_90b065d3-76a2-4b0c-ba0c-21de1ae62dc4"
      unitRef="usd">-79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo1MGVjOTNiZDJiYTI0ODI3ODViMDdjMTcwMDYyNjQ4MC90YWJsZXJhbmdlOjUwZWM5M2JkMmJhMjQ4Mjc4NWIwN2MxNzAwNjI2NDgwXzEzLTUtMS0xLTA_26dedb6f-a4cb-4d0c-a0c3-7acf4be28e11"
      unitRef="usd">687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <bsx:SegmentoperatingincomeaspercentageofnetsalesTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2NDA_acbbedc3-64a5-469e-acc2-c61f2357b221">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income of reportable segments as a percentage of net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:SegmentoperatingincomeaspercentageofnetsalesTableTextBlock>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i5e0ecf57665b462885e9fc86f45d0410_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzItMS0xLTEtMA_5ae0da87-f37f-49b0-85ab-504fc8c7e715"
      unitRef="number">0.376</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i99c4f84929eb400bb61cecb4d7c301ef_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzItMy0xLTEtMA_5c047d72-fb0b-4e8f-bec2-b4a12e1cbef1"
      unitRef="number">0.352</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i04991ed25715473bae686eada34ce8e3_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzItNS0xLTEtMA_52706b8d-a8fc-4005-a083-13fad98bf3c4"
      unitRef="number">0.364</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i35e27f44c00a4381a7bc20435ec67af4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzMtMS0xLTEtMA_88828721-1617-4b06-85c1-7a705bc4e77f"
      unitRef="number">0.184</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i93fcc3b3ad5d4cfdbbdf3df22489d86c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzMtMy0xLTEtMA_f9523d70-1b1f-45ca-af7c-4832766eda2e"
      unitRef="number">0.159</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ib3595f016be44152b0810b7941073c20_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzMtNS0xLTEtMA_78ca7f7d-cf8f-416a-b2da-d07377e1c23e"
      unitRef="number">0.212</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i71634376771a4713b50f023688e510ea_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzQtMS0xLTEtMA_91bea39b-fcbe-4b92-9146-8aac93e80a2e"
      unitRef="number">0.298</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ibbb9686d915d496b9624afc7ab5397ff_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzQtMy0xLTEtMA_e956b9f4-36f2-4854-950b-db5989244d67"
      unitRef="number">0.171</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ibf04babfe9814c8ca7f1737ddfd96ea1_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTo2YzUxMjRlNmFlOGY0N2Y0YjYwNzYzZWIzZGEyN2M2Ni90YWJsZXJhbmdlOjZjNTEyNGU2YWU4ZjQ3ZjRiNjA3NjNlYjNkYTI3YzY2XzQtNS0xLTEtMA_17622f84-3254-4d47-aab1-3434c527b48a"
      unitRef="number">0.270</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2MjY_7f98abb6-09ec-4aec-87cb-513573c1b0ed">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other corporate assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:OtherAssets
      contextRef="i57688279666042d3a293e8a1628747b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzItMS0xLTEtMA_0a263bd9-33ba-4e38-bdea-9750127a68b3"
      unitRef="usd">1794000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="idac6c44071294ea9849175fac9191b7e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzItMy0xLTEtMA_af5431e9-b6ab-45de-8110-e6cd9c976b43"
      unitRef="usd">1638000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ic90da61ebdeb44219dc8a12648b8a069_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzMtMS0xLTEtMA_a6b25a6f-3f70-4052-9904-5a80e49f044e"
      unitRef="usd">1981000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i4143ca6110b349138f60bc19e3247ec2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzMtMy0xLTEtMA_a4314e5b-0fcb-4d54-849b-4b33d9e86506"
      unitRef="usd">1827000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i82aece15df8345618f0e67a8da516a4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzQtMS0xLTEtMA_716c7206-e270-49e4-a1f5-1370f028c4ad"
      unitRef="usd">2821000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ia7ac69cebdf54652867c133c8113b7f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzQtMy0xLTEtMA_3ef3c87f-ddbe-4596-9649-07cf3f37f18c"
      unitRef="usd">2461000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i248c898d732b4314b0a88247e5686fb7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzUtMS0xLTEtMA_628e0bd1-ad9d-4bac-a98e-3383df79cd43"
      unitRef="usd">6595000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i1917903eab064ebd8f9b5c4561e2f754_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzUtMy0xLTEtMA_1be7d354-c2df-4258-9a65-2750b35959b4"
      unitRef="usd">5926000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i25175389829c4c00b8fd64f6b1b9bf50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzYtMS0xLTEtMA_a786d1fa-4c9a-47a4-abfc-2a0f061c6dd9"
      unitRef="usd">0</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="id7df2e64a9b0450b929459426005d498_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzYtMy0xLTEtMA_a9fbf08b-7f0a-4aee-bc18-434e9d20c86d"
      unitRef="usd">1133000000</us-gaap:OtherAssets>
    <us-gaap:Goodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzctMS0xLTEtMA_4e76c49e-a4cd-4128-9b97-d35ce1893863"
      unitRef="usd">11988000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzctMy0xLTEtMA_a3088370-fca3-4a36-9d7e-ec4a8df41e89"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzgtMS0xLTEtMA_5c52718c-7822-4f24-ac06-4d6f5bf062f9"
      unitRef="usd">6121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzgtMy0xLTEtMA_8267de7a-3467-4c60-98cd-09558539f448"
      unitRef="usd">5917000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets
      contextRef="ieb9ed43167d04cf5a5e8be0581a2d3c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzktMS0xLTEtMA_6dafa1e2-3f6a-440e-b9c7-302468a1cfcc"
      unitRef="usd">7525000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ib195a39da918458daa4a2a7c922e5626_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzktMy0xLTEtMA_7f5e4303-cfb7-4fed-9ac1-6a083f3583ff"
      unitRef="usd">7850000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ia58f50b0109e41fd8e438c82c71e3141_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzEwLTEtMS0xLTA_88c18cbf-3d61-4a2e-a855-35f62f6ef203"
      unitRef="usd">32229000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i7af8a989c1284f24a421723a037abca7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTozYjhjMDBiNmJkZTM0ZTk0YjFmZTAxYzE4NGUzMmE3NS90YWJsZXJhbmdlOjNiOGMwMGI2YmRlMzRlOTRiMWZlMDFjMTg0ZTMyYTc1XzEwLTMtMS0xLTA_9a6a1397-ec67-4d89-939a-442e74bfe96f"
      unitRef="usd">30777000000</us-gaap:OtherAssets>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90ZXh0cmVnaW9uOjU2YjEwYzA1ODg0ODQwZTFiOGI2ZDIzNmU3NjIxNjY0XzI2MzY_7315f8f3-b270-4548-acf8-6019605b8d14">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,477&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="i7a5ed8dbde274fb797a84e2782bb541f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzItMS0xLTEtMA_b78b9a62-8f2b-42fa-ac4a-1245fa1df654"
      unitRef="usd">1190000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id384c54f72144cdf8fee9a2d43b64754_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzItMy0xLTEtMA_84d8ab39-b956-4033-acf4-49b34e34397f"
      unitRef="usd">1151000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i1a97fc47966f4c888c420993a4ecc84c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzItNS0xLTEtMA_a64477d1-b164-482e-b1b2-accc01537698"
      unitRef="usd">1148000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i4883d6ab73714fa080e66ddc8068d9e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzMtMS0xLTEtMA_f382d6fb-85b0-41e1-9577-65536e0f99e7"
      unitRef="usd">436000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id679dd594dfe40169b0716db7018f794_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzMtMy0xLTEtMA_b0f1adc3-7f12-4b06-a105-3253e40495b7"
      unitRef="usd">382000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ie3a0e6b8dba74575aee5f5f86c271bbb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzMtNS0xLTEtMA_50244f29-6c49-41a6-a38c-2309d91ed3e9"
      unitRef="usd">327000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i8968316c251443599b1cc42fc078d2fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzQtMS0xLTEtMA_ee6deffe-8cad-49be-a256-664132d55825"
      unitRef="usd">625000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="iee1badc1b55e4c3580f690a018638da5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzQtMy0xLTEtMA_b6ba981a-f813-4ee8-b6d3-d738706f9a9b"
      unitRef="usd">551000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i1ca302daf1c74047b3c5899ea8e0aca6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzQtNS0xLTEtMA_576281ca-e248-4550-8160-457dd1353569"
      unitRef="usd">604000000</us-gaap:NoncurrentAssets>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzUtMS0xLTEtMA_75402024-2eb8-4d08-982c-fee92516c59d"
      unitRef="usd">2252000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzUtMy0xLTEtMA_040c97ee-a3d4-46f4-a4d6-f5555087db68"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzUtNS0xLTEtMA_69d0e31b-4f99-4ed7-b10f-c78d78fc9834"
      unitRef="usd">2079000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzYtMS0xLTEtMA_d1ef4ca6-e98f-404a-a0d0-e6d1064e7b76"
      unitRef="usd">11988000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzYtMy0xLTEtMA_18c06cf8-de8e-40b2-aee3-47f551680e51"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzYtNS0xLTEtMA_88a8260b-43e2-4da3-b253-df3bba266e84"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzctMS0xLTEtMA_b1aec063-5a8d-4ed1-9f76-cb163b536b94"
      unitRef="usd">6121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzctMy0xLTEtMA_b69e709e-7639-490c-9ad7-7bdc577e3eea"
      unitRef="usd">5917000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzctNS0xLTEtMA_b49b4968-4a71-4b88-8b04-020212cdb9f6"
      unitRef="usd">7886000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzgtMS0xLTEtMA_0816bc38-3c5a-4747-ac84-83ac3fbbaaa5"
      unitRef="usd">435000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3fed35511829459da5a38d83c0ca798b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzgtMy0xLTEtMA_66275872-d31a-428d-b484-b45e59d80acc"
      unitRef="usd">458000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i411673321b714ce89c57299921fae970_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzgtNS0xLTEtMA_3510ead4-7921-4d29-ba3f-19c9aabdac3f"
      unitRef="usd">336000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:NoncurrentAssets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzktMS0xLTEtMA_2d25bf23-57f9-4100-a480-647ea1638f9a"
      unitRef="usd">20795000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzktMy0xLTEtMA_e20fa2c8-8aed-411f-a5c5-ff9ad7d7ffbd"
      unitRef="usd">18409000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzYvZnJhZzo1NmIxMGMwNTg4NDg0MGUxYjhiNmQyMzZlNzYyMTY2NC90YWJsZTpiZDdiM2EzYjg4NDE0ZTcxODIyZjVkMjQwODY1NmM4MS90YWJsZXJhbmdlOmJkN2IzYTNiODg0MTRlNzE4MjJmNWQyNDA4NjU2YzgxXzktNS0xLTEtMA_fe2e6e36-95c5-4eba-8125-f9d68e9569f8"
      unitRef="usd">20477000000</us-gaap:NoncurrentAssets>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzI5Mjk_2e629fca-c793-451a-b267-30a2ce1fd1d7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE P &#x2013; REVENUE &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,978&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,212&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,875&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,694&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying consolidated balance sheets. Our deferred revenue balance was $484 million as of December&#160;31, 2021 and $395 million as of December&#160;31, 2020. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#x2122; Patient Management System within our Cardiac Rhythm Management (CRM) business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $159 million in 2021 that was included in the above contract liability balance as of December&#160;31, 2020. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize sales force commissions related to contracts with customers when the associated revenue is expected to be earned over a period that exceeds one year. Deferred commissions are primarily related to the sale of devices enabled with our LATITUDE&#x2122; Patient Management System. We have elected to expense commission costs when incurred for contracts with an expected duration of one year or less. Capitalized commission fees are amortized over the period the associated products or services are transferred. Similarly, we capitalize certain recoverable costs related to the delivery of the LATITUDE&#x2122; Remote Monitoring Service. These fulfillment costs are amortized over the average service period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We received FDA approval in mid-2020 and began the U.S. launch of our next generation WATCHMAN FLX&#x2122; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#x2122; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In 2020, we recorded $179 million in revenue reserves primarily related to our conversion to a consignment commercial model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#x2122; Device in the U.S. In connection with the conversion, we repurchased customer-owned inventory and will recognize revenue for consigned units as they are consumed by customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on our accounting policies relating to revenue recognition.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzI5MzQ_8bf81edc-9b2b-4fef-a50e-496d55ceb20f">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): &lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,978&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,212&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes include Specialty Pharmaceuticals up to the date of the closing of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,875&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,694&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0381e81002ea48aea3c5b8276a4bdfe2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMS0xLTEtMA_14cf5a34-adcd-4f42-8bc0-a66ab93fa407"
      unitRef="usd">1222000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib323af1d123f4f288409892c6d582c3a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMy0xLTEtMA_e52d1ac8-b2ba-4d16-b0ca-c7f5b0b1d6f3"
      unitRef="usd">919000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i492788538a3b4d079d5f2e01ce834568_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtNS0xLTEtMA_3c0c9eaf-09f8-4094-b077-e20c49f97678"
      unitRef="usd">2141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83749835aad04c27823ee7e3e441d8d5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtNy0xLTEtMA_d789b3b1-ba58-4b9b-8e1b-1221a7fb5b81"
      unitRef="usd">1000000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieebda7efcc984eaaa323a3965ae8afc2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtOS0xLTEtMA_7830f180-bdf7-4dbe-9bfa-47d7c2bee112"
      unitRef="usd">780000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice8b818c14fa4356b602a04c1ab17b68_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTEtMS0xLTA_b7bc376c-e8d0-4b91-89f3-d887efae694d"
      unitRef="usd">1780000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief070d59a8a74c6883609bd434bfbfdd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTMtMS0xLTA_c26a5d0e-6692-4851-a118-021fcfa036a1"
      unitRef="usd">1080000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19e08cc88e42477f8b204d52aefeefae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTUtMS0xLTA_5388e7a3-4596-4472-a908-cf3f516237f2"
      unitRef="usd">814000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4226949d0cdc471da19b2ef5376d32b7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzMtMTctMS0xLTA_853640b2-a58f-455c-849e-e931f2dd296d"
      unitRef="usd">1894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i296c600288ba4126abba2c8e6654d659_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMS0xLTEtMA_954a78ed-c5b6-42b2-9944-86ce44265b8d"
      unitRef="usd">1120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7877e3175114481298066be0fb237a24_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMy0xLTEtMA_af34035e-6377-4674-9d8f-e3c1019707b6"
      unitRef="usd">463000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46048892559447039913345bc4184710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtNS0xLTEtMA_a9094612-6589-4a2a-a904-7619774a6447"
      unitRef="usd">1583000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d0a46f763a34fcfbb98da18cb232850_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtNy0xLTEtMA_f83181a4-aa22-4038-ba0f-3c0fab048826"
      unitRef="usd">918000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98c2a656422d4982be4f1876ef15fbd7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtOS0xLTEtMA_13bfd5fe-8d01-43c4-a7c6-f1aef18a6b27"
      unitRef="usd">368000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05500613984e4170ae63706134751f68_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTEtMS0xLTA_7429cf07-b02d-4fc4-ba6e-35afd0c4f11b"
      unitRef="usd">1286000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7e6f6584f284ab5b2bbf59c9911ab30_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTMtMS0xLTA_fa8265d7-1c86-4e1d-ab0d-88b7bde4ba6e"
      unitRef="usd">1005000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d69f6e362124b848580bbf31ad6ad84_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTUtMS0xLTA_ee41b45a-d286-48da-97f1-1b52576a4f8c"
      unitRef="usd">408000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1fb275aaa7347e884e5e734e95e6439_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzQtMTctMS0xLTA_65a6fa98-df03-41e9-8bba-e9e71d65b44c"
      unitRef="usd">1413000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0296cee599414719bd3d27b8e535a348_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMS0xLTEtMA_070711b0-9163-4f00-abfb-4e92b2933334"
      unitRef="usd">1214000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47108644abed4ca48d40f6618e8766e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMy0xLTEtMA_2a6ae24a-1156-4f8c-a62e-1b693c42f60b"
      unitRef="usd">805000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66be153aa8a64bd3a8549033c030d988_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtNS0xLTEtMA_64227d20-b99d-4f19-b8ee-17bf457b8d86"
      unitRef="usd">2019000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d91f24a77dd4e05a3909ceb50bdb176_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtNy0xLTEtMA_611b5aea-38c1-41a1-83c6-9cd93d0d3a78"
      unitRef="usd">992000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i139438da5f5c43439b7f6cb237aefe53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtOS0xLTEtMA_3a582696-7274-43aa-a300-401479d07cd6"
      unitRef="usd">712000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5414046eeaee4c90baf8f05d81103cf9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTEtMS0xLTA_0e8b641b-39e9-4823-8816-f4abc69b3656"
      unitRef="usd">1704000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1028c0ccdd44e579fc1a7e93e864c8e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTMtMS0xLTA_d031974b-b389-4417-8f4f-716f14d8ad16"
      unitRef="usd">1135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e624f8fff1b4416a9d5d3cd9c9a3a8c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTUtMS0xLTA_d5062ca8-5b7a-4aab-8bbe-91c97a6a31c4"
      unitRef="usd">804000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e89d505d51c40cf9c9b06a4a255d695_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzUtMTctMS0xLTA_3230989c-e24e-46eb-b6fd-7119b025f2e4"
      unitRef="usd">1939000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0559f366b4db4027814a50efc3811d7c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMS0xLTEtMA_3c82adca-394b-4674-bd95-ac1ff24bb45d"
      unitRef="usd">128000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i792d16e027b94051b1350ad706ae61b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMy0xLTEtMA_1e583090-3e43-4193-b7ac-581ce8bec266"
      unitRef="usd">237000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffbec07d746b4648b462392b1200914a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtNS0xLTEtMA_44cf92bf-c28b-47fa-aa9f-a6ee970df11e"
      unitRef="usd">365000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7a8d5dfc7cc449b8eaea3d0a207bca7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtNy0xLTEtMA_4ce7efee-1cf8-4d48-b2f5-bb2c460bb681"
      unitRef="usd">118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1f761ed299c43aaba3aeb4c183b4bb1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtOS0xLTEtMA_05188b08-ca01-44bb-893c-e5725c7d413d"
      unitRef="usd">169000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie15626b1bdc1459ebc740a7d9123e3a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTEtMS0xLTA_42e97fb2-d977-48e3-906f-427f8f6f542a"
      unitRef="usd">287000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3ee6b1033014d9e89c4ef9c0d696921_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTMtMS0xLTA_d1bf9f1f-a938-4f26-9934-3334994348ab"
      unitRef="usd">148000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46e7887ed9b64aaa828480abdd1350e3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTUtMS0xLTA_f7f4f276-2887-47ec-b48d-530ea444386e"
      unitRef="usd">180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7f200406b1741da8d29e0597b3ef799_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzYtMTctMS0xLTA_acd8af1c-b15d-4cdf-807a-2e93111a4551"
      unitRef="usd">329000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6ac600b424e4c36ae326ac78fc6acb0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMS0xLTEtMA_c12ebefe-41b0-4a33-a41d-fb9d61693400"
      unitRef="usd">713000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b2d57381d214a61974a25af56e0fe97_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMy0xLTEtMA_847bb395-4914-4407-b270-954a893db433"
      unitRef="usd">196000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b7c862ab83b44a6823252694cfedafa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctNS0xLTEtMA_e1297273-8800-4f8f-af48-7b9f3a82270b"
      unitRef="usd">909000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8b9a583488948c3ac09adffaa7c62b4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctNy0xLTEtMA_0dfe561c-ed98-4cb6-9058-d2c171f62cd8"
      unitRef="usd">610000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61903be42d074c65b668c3852b09debb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctOS0xLTEtMA_6246bde6-f7dd-45e5-b713-7e020e52e578"
      unitRef="usd">151000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fc90b63ec344bb382c1ac4ac757ec55_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTEtMS0xLTA_14526fe1-2472-4816-b9df-951826cd3bc1"
      unitRef="usd">761000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2950edca24e646cf92832d6acc6da711_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTMtMS0xLTA_a9f41009-9d10-4f97-864c-ebd6f890155a"
      unitRef="usd">695000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ecfae37eff349aabd3cffa238c04a7a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTUtMS0xLTA_fdccc31d-81af-41d9-bcd4-504d3a350847"
      unitRef="usd">178000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i448b76a8a955443b853399bdede98723_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzctMTctMS0xLTA_feee13da-ced1-4130-ac2d-8ff12e53fcfb"
      unitRef="usd">873000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0ed2f4d1bd545449a2f19715b187d67_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMS0xLTEtMA_23f3b0f3-8982-48c9-9b81-e8f88dfaa1c4"
      unitRef="usd">1508000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3c8df2ca0184543adf70bfad9cb539d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMy0xLTEtMA_14f22a8d-e2d4-4e52-9951-e67cf818d4b0"
      unitRef="usd">1530000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6851f3461e914845861fc25f808129ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtNS0xLTEtMA_79a70508-d790-4967-a2d1-97e7693db6c6"
      unitRef="usd">3038000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11b6ff9b41f34af7bf8811c4d7d9280c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtNy0xLTEtMA_d050f1c6-fa37-444a-8734-3f0a48c1df23"
      unitRef="usd">981000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7448b8ca366f4827bc4f258c57c93261_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtOS0xLTEtMA_f5ba1e8b-0924-4b00-9bd2-18b6774cc974"
      unitRef="usd">1317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcb61ff1feec4e518decbdf1ca114591_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTEtMS0xLTA_16d9bb16-7cab-4f1e-a5da-16bddf1a7e93"
      unitRef="usd">2299000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i969834eefc47426fa7387f6ee8b1085b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTMtMS0xLTA_82afedc1-89e7-41bb-a9c8-fc7b715083ab"
      unitRef="usd">1293000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4178008f18a6432bb79c295f035843c1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTUtMS0xLTA_6d2628a4-eece-49b8-a57d-ee57b6cc036e"
      unitRef="usd">1522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5edb697c55bc4cf4b947643bcd30a7fd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzgtMTctMS0xLTA_778316d1-2d9e-41d1-959f-522c5b932345"
      unitRef="usd">2816000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i363f7457787448d5a0978accd8392066_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMS0xLTEtMA_cecb3631-2c43-46e5-a51c-0c1771aef951"
      unitRef="usd">996000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i990fcdb4d4d64102a6e2a01d782d3da7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMy0xLTEtMA_ee659b82-bb9b-4bf2-bb58-a7be348708e7"
      unitRef="usd">824000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i219bdc71c5134494a8e8468f8d87edbf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktNS0xLTEtMA_e3190057-313d-48fb-a78e-c22f399e925c"
      unitRef="usd">1820000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77a4631fadd7470dbdb228646d0d1e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktNy0xLTEtMA_6dee6bc7-72c2-4d5d-a551-d15e42fb5d5c"
      unitRef="usd">888000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id47b9b05ad00409f8e34ab200b239f73_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktOS0xLTEtMA_5bfbd338-86e9-4ce3-96c0-4a90cdadf1d9"
      unitRef="usd">689000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f59541845b541a398a1c956947b253e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTEtMS0xLTA_be311cf6-2439-42f4-bd1b-94053b039849"
      unitRef="usd">1577000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia608cda32d2c4a75acba41461285ef9f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTMtMS0xLTA_44bc2228-dea3-4fcd-861d-59e54862ee02"
      unitRef="usd">741000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddebf93ed35b4294bfc7d57c147f14a0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTUtMS0xLTA_dd49f53d-f4ed-4aa6-b5af-a1a7d29db95d"
      unitRef="usd">651000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i230686786fb8479c8e8b3aa250c6294a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzktMTctMS0xLTA_5bfcd0a2-891f-41c3-84e7-950c55495af0"
      unitRef="usd">1392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5daeb0eea7624d95bd33a61b6630acf1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTEtMS0xLTA_0aae7f4a-837b-4185-85f6-a84cb2232f61"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if745267c77af430eb139ec47097f83b4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTMtMS0xLTA_7131fa64-c70a-411c-9371-de8b29d514ae"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTUtMS0xLTA_df3a1bd9-44e8-463e-b430-3c50bb29bec1"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ce9f4d10e55459c9da61e0b45861feb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTctMS0xLTA_cff60cc3-c931-481e-8ca1-5e23e7cdf94f"
      unitRef="usd">193000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic65e05bd72794ad69c38ad937bbdd8c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTktMS0xLTA_ba70d2aa-233e-4490-a83f-b3b388dc5fe0"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTExLTEtMS0w_f74589d3-be8f-4116-8772-914c18f13770"
      unitRef="usd">219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11feaaacdaf46dbbaad088de02198bb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTEzLTEtMS00NzI_39d93e9f-2065-42da-a502-34708d8b640d"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0798aac718394b2e885e3eec15b7a1b7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTE1LTEtMS00NzY_ee661b86-7246-4c5d-b70e-314de0075359"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzEwLTE3LTEtMS00ODA_66af8ca6-a42a-4625-819f-8d658402788b"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29e3a0a6440d4892b49e46f886fbcb2a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTEtMS0xLTA_86832892-9997-4126-9a8a-c25ec2ad1f92"
      unitRef="usd">6911000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7510a4849a314540abc54995d58f29a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTMtMS0xLTA_391b7f78-dab8-4f40-8d8f-e23e50106028"
      unitRef="usd">4978000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTUtMS0xLTA_281d06f2-e1f9-4904-afdb-a138206b155a"
      unitRef="usd">11888000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ba9db017ca54a60b7e7c1ea9f933ffd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTctMS0xLTA_bddf3662-033e-4171-bb10-8fa173f4f732"
      unitRef="usd">5701000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6afa1156f16c40a9bfe1aaca76cb5002_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTktMS0xLTA_e56aec33-5a13-4ed9-bc4b-b524d7d2d0ca"
      unitRef="usd">4212000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTExLTEtMS0w_18807ea1-0f7d-4b6d-b7b9-6a2a7d111db5"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3aa17098a29b48e894a6b05f541a6034_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTEzLTEtMS0w_d5068758-4ae3-4a50-b258-eb3c93e11d6a"
      unitRef="usd">6167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e61f5e37fc74a6f81ea7c5928a92766_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTE1LTEtMS0w_8cbd8b4a-eecf-45ba-85a4-0c88b0c6b97f"
      unitRef="usd">4569000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTo4MGU3Y2EwYTQzNzA0YzQwOWUwZDZmYjNkZGE1YzQ0Yy90YWJsZXJhbmdlOjgwZTdjYTBhNDM3MDRjNDA5ZTBkNmZiM2RkYTVjNDRjXzExLTE3LTEtMS0w_5d170cd5-bbdc-47f4-bf67-935d67dbb4ce"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37d5ca208074462f876fe31f23b1fed5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzItMS0xLTEtMA_dbc706d3-9060-4ee0-81ce-8005ad6afc10"
      unitRef="usd">6901000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3934f348ffb740b0af4a20a77601e650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzItMy0xLTEtMA_7647c234-2f60-433a-bf9c-3362d5891fac"
      unitRef="usd">5508000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbd3c076197c4394a0b5a998e05dbd49_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzItNS0xLTEtMA_e3094697-6004-4903-a17d-243971419c17"
      unitRef="usd">6097000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia58a0bdc221345bfbf3c6181a5c06176_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzMtMS0xLTEtMA_5455200f-294f-4b21-ae1d-4bdf937c8035"
      unitRef="usd">2518000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9c7d84961bb4190a76e256fa88277af_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzMtMy0xLTEtMA_52b755eb-41cc-40de-b714-628fa5c143a4"
      unitRef="usd">2097000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia85ece485aa444be8199976328f65690_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzMtNS0xLTEtMA_57193b36-6752-4caa-84d6-b83f9c95e67c"
      unitRef="usd">2264000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38022f0994a44701b3f50846a6fd4016_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzQtMS0xLTEtMA_8bf6db42-2812-4f1b-8af0-3d33f6819485"
      unitRef="usd">2070000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i240079c64e2b40068b8e05779f120de1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzQtMy0xLTEtMA_6f43aa4b-a9d1-47ac-bbef-b1e0d6c24f77"
      unitRef="usd">1781000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97644286dfd2411eb21e3c030a24a491_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzQtNS0xLTEtMA_6efe11e0-de56-4b24-97ea-f25ad6ee2c7b"
      unitRef="usd">1898000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib93b9e8e344744818491704b2f2d822e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzUtMS0xLTEtMA_7c9b0620-4a0b-4503-9228-e98703da181b"
      unitRef="usd">386000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie419b41857fe446fb2fd54d0467e3cc3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzUtMy0xLTEtMA_57ca4a5e-afe7-4e91-a432-ea7d220d11f0"
      unitRef="usd">307000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if99c383051264d1c8e894654e1c8eea9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzUtNS0xLTEtMA_f8004dd9-7b78-494e-8ad5-3dae9670a109"
      unitRef="usd">395000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfdac215247a41d5a190631edb467695_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzYtMS0xLTEtMA_864c875a-6ffb-4100-ae25-c367f5e646ea"
      unitRef="usd">11875000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea551cf2b1634409ac0e83d79458415c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzYtMy0xLTEtMA_c4b3a610-9ec4-4396-b58d-a9412d2cd496"
      unitRef="usd">9694000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifac0e79af11e4bc58f1a58bd6a8caf8f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzYtNS0xLTEtMA_d6d6652f-9ca9-4904-a862-cf9345c1a418"
      unitRef="usd">10654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5daeb0eea7624d95bd33a61b6630acf1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzctMS0xLTEtMA_0aae7f4a-837b-4185-85f6-a84cb2232f61"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ce9f4d10e55459c9da61e0b45861feb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzctMy0xLTEtMA_cff60cc3-c931-481e-8ca1-5e23e7cdf94f"
      unitRef="usd">193000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11feaaacdaf46dbbaad088de02198bb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzctNS0xLTEtNDA5NjQ_39d93e9f-2065-42da-a502-34708d8b640d"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if745267c77af430eb139ec47097f83b4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzgtMS0xLTEtMA_7131fa64-c70a-411c-9371-de8b29d514ae"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic65e05bd72794ad69c38ad937bbdd8c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzgtMy0xLTEtMA_ba70d2aa-233e-4490-a83f-b3b388dc5fe0"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0798aac718394b2e885e3eec15b7a1b7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzgtNS0xLTEtNDA5NjQ_ee661b86-7246-4c5d-b70e-314de0075359"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b94096260f47e8811aa8abcec2fedc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzktMS0xLTEtMA_df3a1bd9-44e8-463e-b430-3c50bb29bec1"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19d070386ab248d5818a973f2f0b7c56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzktMy0xLTEtMA_f74589d3-be8f-4116-8772-914c18f13770"
      unitRef="usd">219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia87be50979384414ba4ca5dd0f7a8a40_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzktNS0xLTEtNDA5NjQ_66af8ca6-a42a-4625-819f-8d658402788b"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEwLTEtMS0xLTA_56441e32-75b9-452d-8269-184e0c51aee8"
      unitRef="usd">11888000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEwLTMtMS0xLTA_f2a77e51-b508-4191-9ffb-c05ffb99076e"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEwLTUtMS0xLTA_771f34e7-ac37-4513-a8d5-bdf95579e853"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i876002865abc4f97ba83a0ef52267bbf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEyLTEtMS0xLTA_7a728ce2-c35f-42b4-9314-cd58c8842a70"
      unitRef="usd">1429000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b08a70a845343069de514f02498dcd4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEyLTMtMS0xLTA_2c41c729-2ddb-47f3-8269-b690f0d8dec3"
      unitRef="usd">1138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i093d7ccd7bf04c0db289d031e28a2247_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90YWJsZTpkYmI2ZmM1ZjBiZDU0N2Q5YTk4MGQ1MDhkMGVlOTM5NC90YWJsZXJhbmdlOmRiYjZmYzVmMGJkNTQ3ZDlhOTgwZDUwOGQwZWU5Mzk0XzEyLTUtMS0xLTA_eb553cc3-37e9-41da-a6fe-96c6b1159884"
      unitRef="usd">1282000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:EmergingMarketsTotalNumberOfCountries
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzMwNA_08ae090d-2d0c-4b6b-95b3-914d94de0130"
      unitRef="countries">20</bsx:EmergingMarketsTotalNumberOfCountries>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzYwOQ_fee19bf8-d2c7-4d7f-a59a-02bba22c326e"
      unitRef="usd">484000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzYyNQ_46cf77f0-a791-404c-ab87-99b58b7dc1a6"
      unitRef="usd">395000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzg4OA_c877401c-33c4-4a58-a9d9-b4e7dafc07b8"
      unitRef="usd">159000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xMzkvZnJhZzo0ZjM2YTQyNjkyNWU0NzAxYmE4YmQ3N2U1Y2FjYmQ0ZC90ZXh0cmVnaW9uOjRmMzZhNDI2OTI1ZTQ3MDFiYThiZDc3ZTVjYWNiZDRkXzI0ODU_51a15128-99b0-48d6-8286-1973ed1fa7f7"
      unitRef="usd">179000000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90ZXh0cmVnaW9uOmE1MzBkNjVhYWMyZTQwOGU4OTZkOWFmZGVmMGNkZTI5XzYwMg_1646ef76-e55a-469f-bb1e-aa3618b97ad3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE Q &#x2013; CHANGES IN OTHER COMPREHENSIVE INCOME &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further detail on our net investment hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our cash flow hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt; were reduced by immaterial income tax impacts in 2021 and in 2020.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90ZXh0cmVnaW9uOmE1MzBkNjVhYWMyZTQwOGU4OTZkOWFmZGVmMGNkZTI5XzYxNQ_b44959d3-0e0a-4bae-b2e8-1b70e02c0c49">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtMS0xLTEtMA_d718a00a-d774-48c8-baf5-ad7dff41c6a2"
      unitRef="usd">218000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtMy0xLTEtMA_54028fa1-73f6-4a99-ad55-12de85addd94"
      unitRef="usd">36000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtNy0xLTEtMA_18535293-0f8e-4065-996c-5393c7e5a1ad"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzEtOS0xLTEtMA_843c7679-f2f8-426a-9e5e-9a0d7daaaa3e"
      unitRef="usd">207000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItMS0xLTEtMA_e66ac216-5aad-4171-b814-b1ca4ac51e56"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItMy0xLTEtMA_eb41b50e-f97e-482f-a077-953617bdf89c"
      unitRef="usd">208000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItNy0xLTEtMA_4cd42c39-d5c9-45cd-9eab-b04b89460725"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzItOS0xLTEtMA_740ba57c-0973-4475-9e48-54f3db649aa9"
      unitRef="usd">228000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtMS0xLTEtMA_8d08c46e-b3e6-4283-a0c2-1fb47f118b02"
      unitRef="usd">-137000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtMy0xLTEtMA_9bff7635-b458-4818-b27a-1f151c559b42"
      unitRef="usd">38000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtNy0xLTEtMA_6343de7c-5d1f-402b-938e-2f34af0d7ce9"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzMtOS0xLTEtMA_1f6aa64f-3613-4062-a5eb-5d41dfc81290"
      unitRef="usd">-173000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtMS0xLTEtMA_b44d4e4a-887b-465d-bc34-1f2ce07551c9"
      unitRef="usd">-125000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtMy0xLTEtMA_3560ed04-c7a4-43d7-90ea-b51d9f897e8e"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtNy0xLTEtMA_14f25da8-2cdf-4de2-bfde-264f4e75ff49"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzQtOS0xLTEtMA_74b78182-fa7e-4b0b-beac-d07020d0017f"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtMS0xLTEtMA_37b693a2-9bfa-4ca6-9475-aa660e1a0aec"
      unitRef="usd">93000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtMy0xLTEtMA_32979c3b-147a-428f-8dd9-3c91fed4ac6e"
      unitRef="usd">206000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtNy0xLTEtMA_66b88c54-9030-40a6-8391-5f944ca4c9e5"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTpiMzJlMmNiYzExODk0ZGNiYTRkOTk0Y2VlMTE0Y2ViNi90YWJsZXJhbmdlOmIzMmUyY2JjMTE4OTRkY2JhNGQ5OTRjZWUxMTRjZWI2XzUtOS0xLTEtMA_64b2bf90-3a51-4e81-b157-25781222e9f7"
      unitRef="usd">263000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtMS0xLTEtMA_d470c76f-2e6e-4e69-a1da-d07917228d73"
      unitRef="usd">142000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtMy0xLTEtMA_ce5fb1a6-bead-4695-b789-102845dcd5c4"
      unitRef="usd">173000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtNy0xLTEtMA_c54df623-e077-4a0e-8f34-88bcd8d343e0"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzEtOS0xLTEtMA_074d423c-69e2-4603-b404-1729f042812b"
      unitRef="usd">270000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItMS0xLTEtMA_15732711-8486-4fa7-9288-d157a1406dfc"
      unitRef="usd">95000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItMy0xLTEtMA_a614bd2b-031c-4f56-b546-5c7e1f85098b"
      unitRef="usd">-77000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItNy0xLTEtMA_d7f56712-506d-482d-9760-8d9d6a30a263"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzItOS0xLTEtMA_1f6776da-d3fd-4b4d-b62f-2b87ad804fad"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtMS0xLTEtMA_59fda323-f2aa-4beb-b113-3922bc22bed1"
      unitRef="usd">-19000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtMy0xLTEtMA_2fc67334-37d9-4379-beb1-08f0939c4622"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtNy0xLTEtMA_11e7eba6-5c60-49bd-927f-ef401984b055"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzMtOS0xLTEtMA_5940ae71-e1fb-4300-968d-93d230cd151e"
      unitRef="usd">-76000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtMS0xLTEtMA_13017434-f635-4505-af00-980a3069e6fd"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtMy0xLTEtMA_7287c84e-06b4-43b3-aa8f-b5f666dd5baa"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtNy0xLTEtMA_ca3efc00-fc79-4455-93b0-818ee6e218e5"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzQtOS0xLTEtMA_8abe1284-b8e7-47b2-8ad8-52d77755ac07"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtMS0xLTEtMA_ef858bef-c986-41d4-9a59-d4e8767a6137"
      unitRef="usd">218000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtMy0xLTEtMA_c185e99a-7e3a-43c2-94b7-845bb65501ff"
      unitRef="usd">36000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtNy0xLTEtMA_215802bd-f754-465c-bacd-d29b16e1bfe7"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDIvZnJhZzphNTMwZDY1YWFjMmU0MDhlODk2ZDlhZmRlZjBjZGUyOS90YWJsZTo5MjllOTAzODQ0Y2M0ZDIzYjlhNjZmYmNhODZkNGVkNy90YWJsZXJhbmdlOjkyOWU5MDM4NDRjYzRkMjNiOWE2NmZiY2E4NmQ0ZWQ3XzUtOS0xLTEtMA_8255bafb-f9f6-4489-a3d5-2b52b863bb5e"
      unitRef="usd">207000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <bsx:NewAccountingPronouncementsPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3Mzc_69f48ab3-2541-49f0-af0e-55b5b2297dae">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE R &#x2013; NEW ACCOUNTING PRONOUNCEMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting Standards Implemented in 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-08&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASC Update No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in Update No. 2021-08 improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Update No. 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2021-08 in the fourth quarter of 2021. We applied the amendments retroactively to all business combinations that we completed during 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-10&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. We adopted Update No. 2020-10 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. We adopted Update No. 2020-06 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2019-12 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. We adopted Update No. 2019-12 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Standards to be Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-05&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Lessors&#x2014;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No other new accounting pronouncements, issued or effective, during the period had, or is expected to have, a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</bsx:NewAccountingPronouncementsPolicyTextBlock>
    <bsx:ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzIxOTkwMjMyNzE4ODQ_52aa9163-a34a-49ba-9696-51c715981c57">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-08&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASC Update No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in Update No. 2021-08 improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Update No. 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2021-08 in the fourth quarter of 2021. We applied the amendments retroactively to all business combinations that we completed during 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock>
    <bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3MjE_069f000d-e47c-480f-acce-eefc35b184e5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-10&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. We adopted Update No. 2020-10 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock>
    <bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3MzI_1b75f5eb-a579-4ad6-9803-7ba5e48c1cdb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. We adopted Update No. 2020-06 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock>
    <bsx:ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzY3Mjc_6fe62edd-cbf5-4e2a-a68c-bead27012c3a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2019-12 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. We adopted Update No. 2019-12 in the first quarter of 2021. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock>
    <bsx:ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNDUvZnJhZzo3OWQyM2Y4YTljZjQ0M2JlOWI0MzRiMTgwZmZhYTU1NC90ZXh0cmVnaW9uOjc5ZDIzZjhhOWNmNDQzYmU5YjQzNGIxODBmZmFhNTU0XzIxOTkwMjMyNzA3NTk_a7015672-2fad-4eb9-8e50-1e3b36dc7845">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-05&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Lessors&#x2014;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively. The adoption did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNzA_be120695-2bb2-4f29-933a-85ab957f0d6f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE S &#x2013; EMPLOYEE RETIREMENT PLANS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following our 2006 acquisition of Guidant, we assumed the Guidant Supplemental Retirement Plan, a frozen, non-qualified defined benefit plan for certain former officers and employees of Guidant. The Guidant Supplemental Retirement Plan was partially funded through a Rabbi Trust that contains segregated company assets within restricted cash used to pay the benefit obligations related to the plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also maintain an Executive Retirement Plan, a defined benefit plan covering executive officers and other key contributors. Participants may retire with benefits once retirement conditions have been satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.K. Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of our acquisition of BTG, we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom (U.K.) employees (U.K. Plan). The U.K. Plan was closed to new entrants as of June 1, 2004. Prior to the acquisition close date of August&#160;19, 2019, the Trustees of the U.K. Plan executed buy-in arrangements (Buy-in Contracts), which effectively, as structured under the Buy-in Contracts, are intended to provide payments designed to equal all future designated contractual benefit payments to covered participants. The benefit obligation of the pension plan is not transferred to the insurers, and we remain responsible for paying pension benefits. We do not anticipate any additional material contributions or payments to the U.K. Plan or the insurer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the final purchase price allocation of BTG, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rate of Compensation Increase&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the measurement date of August&#160;19, 2019, the funded status was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on our acquisition of BTG.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information about the U.K. Plan presented below is as of the December 31, 2021 and 2020 measurement dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we maintain retirement plans covering certain international employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As of December 31, 2021 and 2020, the funded status of our plans were unfunded or underfunded in aggregate. The outstanding obligation is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded&lt;br/&gt;PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;502&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;336&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the PBO for our retirement plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments and assumption changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;502&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2021 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.82%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2020 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;336&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our defined benefit plans excluding our U.K. Plan, we base our discount rate on the rates of return available on high-quality bonds with maturities approximating the expected period over which benefits will be paid. The rate of compensation increase is based on historical and expected rate increases. We base our rate of expected return on plan assets on historical experience, our investment guidelines and expectations for long-term rates of return. Our assets are invested in a variety of securities, primarily equity securities and government bonds. These securities are considered Level 1 and Level 2 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our U.K. Plan, we utilize the insurance buy-in methodology and base our discount rate on a yield curve reflective of the market pricing obtained in the most recent buy-in transaction, which occurred prior to the acquisition of BTG, and movements in market-observed buy-in pricing as of December&#160;31, 2021. We believe this is a reasonable proxy for an effective settlement rate of the buy-in assets. The discount rate is calculated as the single equivalent assumption that gives the same value of the liabilities as if the figures were calculated using the full yield curve. We assume that all pension increases will continue to be linked to the Retail Price Inflation (RPI), both before and after retirement, for all members, with the exception of post-88 Guaranteed Minimum Pensions (GMP), which will be based on Consumer Price Inflation (CPI). We base our rate of expected return on plan assets as equal to the discount rate used to value the buy-in assets. The U.K. Plan assets' investment policy is to invest in fully matching assets. This has been achieved through the purchase of two buy-in policies (Buy-in contracts), which provide payments designed to equal all future benefit payments due from the fund. As of December&#160;31, 2021, the Buy-in contracts represented 100 percent of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. As of December 31, 2020, the Buy-in contracts represented 100 percent of the total plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2021: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the U.K. Plan Level 3 assets were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Buy-in Contracts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out for benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments are estimated based on the same assumptions used in determining our benefit obligation as of December&#160;31, 2021. Actual benefit payments will depend on future employment and compensation, average years employed and average life spans, in addition to other factors. Changes in any of these factors could significantly impact these estimated future benefit payments. Benefit payments expected to be paid during the next ten years for our Domestic Retirement Plans, our U.K. Plan and our Other International Retirement Plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post Retirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $118 million in 2021, $102 million in 2020 and $98 million in 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNzQ_e459b26a-ba48-43de-8914-01da491130c7">The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rate of Compensation Increase&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the measurement date of August&#160;19, 2019, the funded status was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2021 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.82%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2020 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by relative fair value. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpjYTQ3OGI2M2NhZDc0MzM3YWU5NWFlZWEyNTFmZGU0MS90YWJsZXJhbmdlOmNhNDc4YjYzY2FkNzQzMzdhZTk1YWVlYTI1MWZkZTQxXzEtMS0xLTEtMA_ae316208-a3f3-49b3-a66d-acd2bcb4345b"
      unitRef="number">0.004</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i9677d942cddf415f979a5572240cb314_D20190819-20190819"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpjYTQ3OGI2M2NhZDc0MzM3YWU5NWFlZWEyNTFmZGU0MS90YWJsZXJhbmdlOmNhNDc4YjYzY2FkNzQzMzdhZTk1YWVlYTI1MWZkZTQxXzEtMy0xLTEtMA_c2c09678-e083-4eb2-b8de-d4d6991df56c"
      unitRef="number">0.004</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpjYTQ3OGI2M2NhZDc0MzM3YWU5NWFlZWEyNTFmZGU0MS90YWJsZXJhbmdlOmNhNDc4YjYzY2FkNzQzMzdhZTk1YWVlYTI1MWZkZTQxXzEtNS0xLTEtMA_928421b7-0942-4f09-b9b4-2dae8588779b"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2YjYxMTk3ODZlNmM0MGYyOTJiZjFkNjhiMTYyZjU2OC90YWJsZXJhbmdlOjZiNjExOTc4NmU2YzQwZjI5MmJmMWQ2OGIxNjJmNTY4XzEtMS0xLTEtMA_d3842ef7-2e9d-4e9a-a00b-afd73271b517"
      unitRef="usd">213000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2YjYxMTk3ODZlNmM0MGYyOTJiZjFkNjhiMTYyZjU2OC90YWJsZXJhbmdlOjZiNjExOTc4NmU2YzQwZjI5MmJmMWQ2OGIxNjJmNTY4XzItMS0xLTEtMA_2bf17e69-c3be-4dd0-83d4-763439601d31"
      unitRef="usd">216000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="idd2a04e716dc4d76ada198ae8de3512c_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2YjYxMTk3ODZlNmM0MGYyOTJiZjFkNjhiMTYyZjU2OC90YWJsZXJhbmdlOjZiNjExOTc4NmU2YzQwZjI5MmJmMWQ2OGIxNjJmNTY4XzMtMS0xLTEtMA_b3d9bd84-5650-4b2c-a952-b0ae1319df57"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNjI_7f01581d-a6f5-4709-8a8a-73cf30a7cff5">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;.</us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNzk_9d837581-32eb-48da-8a5c-ee8fb03f1645">The outstanding obligation is as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded&lt;br/&gt;PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;502&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;336&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItMS0xLTEtMA_1397f4a5-5737-4334-b0a5-87857e728513"
      unitRef="usd">56000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItMy0xLTEtMA_1dd7cd29-30f5-49fd-80a2-8dc20f435211"
      unitRef="usd">59000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItNS0xLTEtMA_85648f01-1f17-4941-b50f-7e73cb6c2e6c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="if2959d13185e44b0b5c23911f7e0c9b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzItNy0xLTEtMA_e6be04ad-be79-4065-8246-ebe323281d80"
      unitRef="usd">59000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtMS0xLTEtMA_955e22b5-43d6-41bf-b35f-b3c81f4e09c0"
      unitRef="usd">209000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtMy0xLTEtMA_93e3ca83-b693-4ee3-8e5a-a85dac17ad24"
      unitRef="usd">209000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtNS0xLTEtMA_4a72bcea-64d1-404f-a651-005db1e5f02c"
      unitRef="usd">205000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzQtNy0xLTEtMA_e7099fd8-5c4a-4a27-9b1d-d5aceee51342"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i96369c0f230346708d64ca28018edad7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtMS0xLTEtMA_e283ad4a-237f-4f2e-b803-6b04fce2358b"
      unitRef="usd">214000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i96369c0f230346708d64ca28018edad7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtMy0xLTEtMA_2d142420-e0a3-4aaa-a230-dbd8919eb2da"
      unitRef="usd">234000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i96369c0f230346708d64ca28018edad7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtNS0xLTEtMA_3625e9d0-0186-4dd7-8357-abd21e22f5fa"
      unitRef="usd">130000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i96369c0f230346708d64ca28018edad7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzUtNy0xLTEtMA_9fea900e-9c0b-44a2-836a-b6ddb38b97c7"
      unitRef="usd">103000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtMS0xLTEtMA_ed4d2dee-c23d-4cf5-a85a-7e6d3326acc1"
      unitRef="usd">478000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtMy0xLTEtMA_cd964117-cafb-42c8-8d63-5ef0442dc330"
      unitRef="usd">502000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtNS0xLTEtMA_ab7f5076-5b83-4c8d-8caf-61913b60948d"
      unitRef="usd">336000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmZWQ0MjRhZTNlYWU0ODllYjQxZjJhYmM2ZTdlZTAyNi90YWJsZXJhbmdlOmZlZDQyNGFlM2VhZTQ4OWViNDFmMmFiYzZlN2VlMDI2XzYtNy0xLTEtMA_0873c6dc-d660-4bf0-8ddb-f066aab814b5"
      unitRef="usd">166000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItMS0xLTEtMA_469b52a7-420b-45ef-acea-acb03202a6dd"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItMy0xLTEtMA_83695620-5402-4a94-98e7-0cdb8848659f"
      unitRef="usd">58000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItNS0xLTEtMA_a129fc26-d070-4f2d-9e43-0281372daac2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i1704cd4a6e4d4195bd594fd45e78d251_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzItNy0xLTEtMA_20db4fd8-64c6-416d-8936-f6321cf4ba24"
      unitRef="usd">58000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtMS0xLTEtMA_c02c0336-ebb5-464a-86ce-d4411a7e5acc"
      unitRef="usd">226000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtMy0xLTEtMA_b7ea2e5e-cea5-4079-b4f0-3cf6933ac300"
      unitRef="usd">226000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtNS0xLTEtMA_7136282e-0084-4c8c-a1ac-9eddb3896767"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzMtNy0xLTEtMA_a0138e41-f9ad-48e8-9dca-0a2b69c599d0"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtMS0xLTEtMA_9ddf8af5-8778-4c5b-bc4e-e0fbabb22b8c"
      unitRef="usd">225000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtMy0xLTEtMA_af0217c3-3886-4d2a-92ed-a8fd79b175a9"
      unitRef="usd">247000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtNS0xLTEtMA_d7aa7ea1-553e-4947-a4f4-24f80184f063"
      unitRef="usd">132000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i2233b84039de4a86bf1e039d4ebd672b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzQtNy0xLTEtMA_fba86b00-fa9e-41da-a1bb-a217f6486e18"
      unitRef="usd">115000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtMS0xLTEtMA_f8b786e7-1011-4ee4-aca6-936a57a8cb47"
      unitRef="usd">506000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtMy0xLTEtMA_480c631a-92c7-413c-bf0b-269dd63733da"
      unitRef="usd">532000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtNS0xLTEtMA_112af46e-ef07-4e79-93d0-42afefcce4f8"
      unitRef="usd">355000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplYzM4NWI1YWM2ZDc0MGFkYmQzMmMyYzA1ZTRiOTZlYy90YWJsZXJhbmdlOmVjMzg1YjVhYzZkNzQwYWRiZDMyYzJjMDVlNGI5NmVjXzUtNy0xLTEtMA_da2ca774-a1e6-4b18-90fe-b9ab07918b66"
      unitRef="usd">177000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzODA_3612e7fe-1c40-45fc-8548-eecdeb7963f9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the PBO for our retirement plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments and assumption changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;502&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzItMS0xLTEtMA_0720e043-4d68-4bdf-ab22-863b4c8c10db"
      unitRef="usd">532000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzItMy0xLTEtMA_873b0c91-083f-4498-90e1-4c4ab84f9f8f"
      unitRef="usd">488000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzMtMS0xLTEtMA_5df4e31d-3e92-4283-8171-d953a0414289"
      unitRef="usd">4000000</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzMtMy0xLTEtMA_dd4f6e40-90ce-4f84-837d-5d507ff29091"
      unitRef="usd">0</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzQtMS0xLTEtMA_46c38fa7-736c-4526-9d57-232c5cbd0276"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzQtMy0xLTEtMA_2056f2b8-2d1e-4630-a456-c6029e1748e4"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzUtMS0xLTEtMA_3f612de9-340e-4776-bb46-03b2e17fb985"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzUtMy0xLTEtMA_35b4c03a-c31d-4d9b-9773-81390d535b3f"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzYtMS0xLTEtMA_6de20178-4f6e-49e7-a9c8-7aa902ae9197"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzYtMy0xLTEtMA_d54268eb-e599-44ff-b408-9de3f93c8412"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzctMS0xLTEtMA_a7479601-aed4-4893-b955-57fce2beebff"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzctMy0xLTEtMA_a9016452-d232-472e-b2de-9efb05bcf980"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <bsx:Pensionbenefitobligationbenefitspaid
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzgtMS0xLTEtMA_5b157289-d12f-4ce7-8da3-f60e3ba3879e"
      unitRef="usd">22000000</bsx:Pensionbenefitobligationbenefitspaid>
    <bsx:Pensionbenefitobligationbenefitspaid
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzgtMy0xLTEtMA_e77eb24e-9019-4eea-87c7-cbb73030f00a"
      unitRef="usd">23000000</bsx:Pensionbenefitobligationbenefitspaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzktMS0xLTEtMA_1ea91cc0-cb4a-4c30-ab31-26cb36146cfd"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzktMy0xLTEtMA_be11ca1b-32f5-47f3-92fd-3dd182832857"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzEwLTEtMS0xLTA_66aaa718-5a94-484e-9204-5e2da39f66ef"
      unitRef="usd">502000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTowNTUwM2E3YzI2MzQ0YjAyYTU5MGRmYjQyZDQ3Y2NiZC90YWJsZXJhbmdlOjA1NTAzYTdjMjYzNDRiMDJhNTkwZGZiNDJkNDdjY2JkXzEwLTMtMS0xLTA_34ce5f38-6f6c-4c04-8c32-a844fbf8745b"
      unitRef="usd">532000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i84912b2290e843e7ba4e06ea51b35268_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzItMS0xLTEtMA_d4a539b7-0b22-40c2-9121-48bd73e9b3a9"
      unitRef="number">0.0240</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i84912b2290e843e7ba4e06ea51b35268_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzItOS0xLTEtMA_4e3e7a2b-b60a-4d2c-b1b6-faa0e7d364f1"
      unitRef="number">0.0150</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i25ddf18419df442eb0b2829d76375ae3_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzMtMS0xLTEtMA_2becff28-152c-4b40-ba84-36dd64533f87"
      unitRef="number">0.0070</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="i25ddf18419df442eb0b2829d76375ae3_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzMtNS0xLTEtMA_bd6f1207-2f29-4e96-b272-993392dba68f"
      unitRef="number">0.0070</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i9f13d53946094d0597052e0d0c1fed72_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzQtMS0xLTEtMA_73f1cc43-6918-4fee-a183-5e106abe2c80"
      unitRef="number">0.0082</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="i9f13d53946094d0597052e0d0c1fed72_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzQtNS0xLTEtMA_652e4598-4c2e-4fce-b722-51d20728122c"
      unitRef="number">0.0216</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i9f13d53946094d0597052e0d0c1fed72_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpiYmIyMmJkMThkNWM0OTlhOWUxODkxMjY2MzZjMGU3Ny90YWJsZXJhbmdlOmJiYjIyYmQxOGQ1YzQ5OWE5ZTE4OTEyNjYzNmMwZTc3XzQtOS0xLTEtMA_a6a120cc-a926-4c2e-a5f6-a2e6b4b9a98e"
      unitRef="number">0.0260</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i98b179ab6b284836b5b7e104d9b796fa_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzEtMS0xLTEtMA_a87c93d4-cc5e-4e5d-94bb-66997b75fec3"
      unitRef="number">0.0190</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i98b179ab6b284836b5b7e104d9b796fa_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzEtNS0xLTEtMA_e7e40c28-09ca-43af-b466-e19ba2ef2006"
      unitRef="number">0.0150</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ibadf8b569527469ab651f550d716b4c3_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzItMS0xLTEtMA_4bcfe07f-44a2-4835-b41b-26071ed498e9"
      unitRef="number">0.0010</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="ibadf8b569527469ab651f550d716b4c3_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzItMy0xLTEtMA_ace80736-5eb0-4f68-8512-3fd4782eee3f"
      unitRef="number">0.0010</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="if28e5bd9680c4874b621bceaa941ea18_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzMtMS0xLTEtMA_ae4fb592-7d8a-4427-aa4f-44696d3d2918"
      unitRef="number">0.0067</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="if28e5bd9680c4874b621bceaa941ea18_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzMtMy0xLTEtMA_626c88da-0b4f-41f6-8e99-aa3f84010961"
      unitRef="number">0.0198</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="if28e5bd9680c4874b621bceaa941ea18_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo2MWU1NWYwMmEwNmQ0MTBhYTRhNDQwZTliYTEyMWM2My90YWJsZXJhbmdlOjYxZTU1ZjAyYTA2ZDQxMGFhNGE0NDBlOWJhMTIxYzYzXzMtNS0xLTEtMA_f08bb31a-cb32-4556-91a3-2c7b7ee081a4"
      unitRef="number">0.0240</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzNTY_72ea5b39-2ca2-4333-b486-a04a33efe971">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;336&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the U.K. Plan Level 3 assets were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Buy-in Contracts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out for benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzItMS0xLTEtMA_324045dd-c9a3-45d5-b129-7eef327509fc"
      unitRef="usd">355000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzItMy0xLTEtMA_f1300caa-bfca-4c64-b7b1-266ab2891a24"
      unitRef="usd">332000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzMtMS0xLTEtMA_f02d1c3d-a837-4233-9a5b-3859070f65e5"
      unitRef="usd">1000000</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzMtMy0xLTEtMA_b4ea93a5-f481-4e38-bbad-f7c22e3bb44c"
      unitRef="usd">0</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzQtMS0xLTEtMA_f36308d0-8815-4ed5-8a13-99ceaac70489"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzQtMy0xLTEtMA_c2ae183f-e776-4699-8e78-69d3b6385a45"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzUtMS0xLTEtMA_66a743ce-6481-4b6d-b475-4f33fb3b7253"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzUtMy0xLTEtMA_f4b73608-5e82-480f-b8f8-56fa07ef39e0"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzYtMS0xLTEtMA_77f30e9f-af04-4a7f-8574-3614db2961d2"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzYtMy0xLTEtMA_a3e13a77-9a20-4413-9956-d3ea7f5fd0e3"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzctMS0xLTEtMA_be132391-3f4c-4b78-9283-b3ac561f389d"
      unitRef="usd">-4000000</bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss>
    <bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzctMy0xLTEtMA_667eb10c-b2bd-49f8-8185-c7a35aaecfe2"
      unitRef="usd">14000000</bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzgtMS0xLTEtMA_1e5971a9-bbbd-4638-baac-f811989c4852"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzgtMy0xLTEtMA_2acdc997-b163-4b77-af89-0dc9e623a611"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzktMS0xLTEtMA_5df7ce41-7fc1-4761-b318-97e3cb989d8c"
      unitRef="usd">-13000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzktMy0xLTEtMA_ddf1ad40-61fb-4af0-801f-b573293aa834"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzEwLTEtMS0xLTA_7bbbc37a-cc7f-4b99-9836-8ceef3448e83"
      unitRef="usd">336000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTozMzg0MDZlOWY4MTU0YjIyOTA4ZWFiMjk2NjMyMmU2YS90YWJsZXJhbmdlOjMzODQwNmU5ZjgxNTRiMjI5MDhlYWIyOTY2MzIyZTZhXzEwLTMtMS0xLTA_4902f965-cebd-42e3-a815-098c897fa204"
      unitRef="usd">355000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzODM_1a7cf7e2-dff3-4876-b724-b08045ac9160">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2021: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5c99c0d845c344c2aaaa4f9075b3cc36_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtMS0xLTEtMA_1bfc84e5-fca4-4b82-ba82-3d500926aa07"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f7c5cd724b943808b5b4a790359037e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtMy0xLTEtMA_e8f91df8-f9b6-4efa-9325-07893a9a985f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9107422a10134aa88c15d6264e4b0a15_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtNS0xLTEtMA_b14e7836-9fa0-4975-8883-9a66d2cb24bd"
      unitRef="usd">205000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i32babe1b5a2d4787946bcd2130f04a6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzMtNy0xLTEtMA_f241975b-f3e8-4e5f-9fdb-e72bff177811"
      unitRef="usd">205000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i479839a4abc848c0822e4fc438e2f790_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtMS0xLTEtMA_3792d39d-7ca6-428f-89d6-7b125640cf78"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i22e137b5ac4e443db82fce619d7addda_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtMy0xLTEtMA_93a4ee25-2979-42a2-9007-2e5be517c6ff"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieed3b64471e4431396082d1b7661d187_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtNS0xLTEtMA_a6212ce4-f603-4ba7-af18-889e8e7296bf"
      unitRef="usd">205000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTplZGMxOGM0YjgwYTg0YzYyYWRhM2MzZmRhZDNjYjI5MC90YWJsZXJhbmdlOmVkYzE4YzRiODBhODRjNjJhZGEzYzNmZGFkM2NiMjkwXzUtNy0xLTEtMA_bfa9052a-33d8-482b-8c8a-2ac45ff37024"
      unitRef="usd">205000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id4fe210a6ecd4082b33c83f96d710db0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtMS0xLTEtMA_c2329ae5-5cdf-4130-9a58-f3e134dd1f58"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i57226788691947098831b210f4d9e6f8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtMy0xLTEtMA_80e65338-438c-4a31-b100-d8041216920c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7387bc40a28d42d3a310a107abc8db02_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtNS0xLTEtMA_738424b6-ae6c-4ea1-acb3-47596b6beb52"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia5cd235ef6f2496e8f2b3c361e6c2083_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzMtNy0xLTEtMA_c7ee8d52-5249-4409-a2da-903a6cc86d82"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia22158488b3a459c88e0b1f6a927db8c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtMS0xLTEtMA_b1ca23e4-9611-441b-b88d-d9dae77afe92"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibc049394c7014a64935dbc97f6fdef13_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtMy0xLTEtMA_2f6b6225-07a9-4c6c-8339-f0b402150d27"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i699d1eb2cebb41f1bfb906a93a9f96f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtNS0xLTEtMA_a5ece1eb-e8fe-4757-a0c0-b9cd055194f0"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTpmNWVkYTY5ZDAxYjA0ZWE5YjE4Mzg4OTBhNThhYTJlNC90YWJsZXJhbmdlOmY1ZWRhNjlkMDFiMDRlYTliMTgzODg5MGE1OGFhMmU0XzUtNy0xLTEtMA_234dc023-ac88-43cc-bca1-c6f05ae24c89"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia9ba8f98eb3545039f395219720cc097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzEtMS0xLTEtMA_f3bc045b-3c75-4e12-862f-6c4e4dd5ee86"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzItMS0xLTEtMA_a726f9d0-f576-4ce7-97e7-a16e5f5007d6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzMtMS0xLTEtMA_5757b137-24af-4f5d-a36c-59119ae2a608"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzYtMS0xLTEtMA_c6dce3b5-3fb8-4fbe-a2b8-71ba79636593"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="id1ddb686a9cc4bc580d7a0ff128c0a54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzctMS0xLTEtMA_40187e18-6d85-4fa7-ae03-30941991062b"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifd4ca7ed078d47f4a4017d9d1cf1d5c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo0OTUzOGFhNDcxZjI0MmNlOWQ4MDkwNjg5ODAxMzRjOC90YWJsZXJhbmdlOjQ5NTM4YWE0NzFmMjQyY2U5ZDgwOTA2ODk4MDEzNGM4XzgtMS0xLTEtMA_d7102e56-a5f2-4e31-bd18-267bef35d109"
      unitRef="usd">205000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjM1OTQ_7c6c490e-0937-4a29-88ce-04b49e205de3">Benefit payments expected to be paid during the next ten years for our Domestic Retirement Plans, our U.K. Plan and our Other International Retirement Plans are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post Retirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzEtMS0xLTEtNTMyNzE_bf3b395b-a29c-4636-8d3b-4b1146bc0f50"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzItMS0xLTEtNTMyNzE_6dcc76d2-4669-4751-bd3a-c1ed0e4269d8"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzMtMS0xLTEtNTMyNzE_b7964729-cbf6-423e-8df0-2ad6f925cfd4"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzQtMS0xLTEtNTMyNzE_63188f8d-7197-4b27-90bc-fe72cfe52140"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzUtMS0xLTEtNTMyNzE_ebde7aba-645d-49f6-9d53-1d873ffd014f"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90YWJsZTo5ZTRhMWM5MTJiNzE0ODI3YjhlMTNiMmEyMTY2MmM5NC90YWJsZXJhbmdlOjllNGExYzkxMmI3MTQ4MjdiOGUxM2IyYTIxNjYyYzk0XzYtMS0xLTEtNTMyNzE_3eaaa753-c7ba-4bd8-8c33-190b494a968e"
      unitRef="usd">109000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzYzOTA_9ebd8e95-7dac-4714-9282-aa3db170dbf1">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $118 million in 2021, $102 million in 2020 and $98 million in 2019.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <bsx:ExpenseRelatedToMatchingContributions
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjE5ODA_59e95ecb-9050-49c2-b156-4e5576dba5d8"
      unitRef="usd">118000000</bsx:ExpenseRelatedToMatchingContributions>
    <bsx:ExpenseRelatedToMatchingContributions
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjE5NzY_70531a89-2a21-475c-a262-8c46c180f290"
      unitRef="usd">102000000</bsx:ExpenseRelatedToMatchingContributions>
    <bsx:ExpenseRelatedToMatchingContributions
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xNTEvZnJhZzo2ZmEwZTdlNjllN2U0MjU2YjVjNDJkYmFhNjhkYTIzMS90ZXh0cmVnaW9uOjZmYTBlN2U2OWU3ZTQyNTZiNWM0MmRiYWE2OGRhMjMxXzIxOTkwMjMyNjE5NzI_a36534db-b99f-46fa-a53d-2a18d5cc1dfc"
      unitRef="usd">98000000</bsx:ExpenseRelatedToMatchingContributions>
    <dei:AuditorFirmId
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xODEvZnJhZzphOGFjM2ZmYzM4MGQ0OWQyYWUxNTBlZTE4OGRhMDJjOS90ZXh0cmVnaW9uOmE4YWMzZmZjMzgwZDQ5ZDJhZTE1MGVlMTg4ZGEwMmM5XzIxOTkwMjMyNTU5Mjk_1a35f972-7936-4398-828f-b5805c1612c0">42</dei:AuditorFirmId>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i51845faa20174064ac84a92ea5ff121a_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90ZXh0cmVnaW9uOjhkYTdmMTljOTMyZDQyNTQ4ZDU0ZDJjNTgyYTY3YWM2XzE0NTI_b25d9071-81a7-4de1-958c-7dd39efbb784">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.988%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;&#160;Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Credit loss exposure (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Write-offs (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses (b)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances for uncollectible accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:20pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&#160;Following the adoption of FASB ASC Topic 326 as of January 1, 2020, we record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and recorded a corresponding increase in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a contra &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; account. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Amounts shown within credit loss exposure above were established through selling, general and administrative expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&#160;Beginning in 2020, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for uncollectible accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; are referred to as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&#160;Represents actual write-offs of uncollectible accounts.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItMS0xLTEtMA_c733287a-3154-4b1e-897f-ecdb543b3fcd"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItNS0xLTEtMA_d1203326-5e22-4d9e-9437-6526a6f0b9f1"
      unitRef="usd">28000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItNy0xLTEtMA_a749d49c-c293-4191-a18c-2b20d897c6f6"
      unitRef="usd">25000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i17733ef333a04949b7d70a7bfa14f475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzItMTEtMS0xLTA_3b4ff472-f6d8-4442-828c-45d43211ad6a"
      unitRef="usd">108000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtMS0xLTEtMA_6e83842f-f182-4af7-80b8-7d5f86847105"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtNS0xLTEtMA_bb1544d4-becf-4913-bd8c-859556c7c6bb"
      unitRef="usd">49000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i88982097e17e4e148f4e0e1928230864_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtNy0xLTEtMA_81ac64df-fd95-443f-9cc6-5b35d7f351dc"
      unitRef="usd">27000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i28a14163a2a74f7b8d354e3243028f49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzQtMTEtMS0xLTA_72d9c088-438e-4acd-9af6-2cbcb601c5c5"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ieeb6b9827a034737b65cc571b9c0c7f6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtMS0xLTEtMA_7c27c78d-90a4-45de-8d94-f483fb7ab975"
      unitRef="usd">68000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtNS0xLTEtMA_5c301913-c911-4549-b175-ff284dc3cec8"
      unitRef="usd">23000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="iac0bf134c1e14c8a8d585067f673de6e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtNy0xLTEtMA_abc5376f-c13b-4d96-8a97-9d8587814c86"
      unitRef="usd">17000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icea25cb690174465b8215ce1c263a42a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MTNhMzZmYjFhYTRlNDRhY2Q4NzIwNmIwYWVkNzM3L3NlYzo0NTEzYTM2ZmIxYWE0ZTQ0YWNkODcyMDZiMGFlZDczN18xOTYvZnJhZzo4ZGE3ZjE5YzkzMmQ0MjU0OGQ1NGQyYzU4MmE2N2FjNi90YWJsZToyOGFiMTk0NDJlMmQ0YmY0ODcyOTY2NGFhMDZhYzkwZS90YWJsZXJhbmdlOjI4YWIxOTQ0MmUyZDRiZjQ4NzI5NjY0YWEwNmFjOTBlXzYtMTEtMS0xLTA_276edf89-1f3c-466f-8876-3a181fecbe76"
      unitRef="usd">74000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>93
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1- NP:X?E,)CX#;H+MGX'U!+ P04    " !%A%=4FEH8!& &  #U&@  &
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MZL,[EL.!EIOFK<.SU%J6S=<USZ Q&@#\OI12OQZ8"W1ONF[_!5!+ P04
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MA)'G5:(#@K B"*U5]PC!#YT1B9*#S71 =(TX0,*&T_CU]D3*>M6$O9,I@_,
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M#;J^A<ZMM)#/1&E6CP_UQ83<-MCK GP>(\H478C6B#(YCUO?H,.7*,PO0-_
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M6%8P:03P]ZT0^OC&?$'W#-;-_P%02P,$%     @ 18175+/^\U6Q @  F @
M !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6R55EUOFS 4_2L6VD,K=>4[
M'Q6)M(96V\.TJE&W9Q=N@E6#J6V2[M_/-@31X*99'N*O<R[W'%]LDCWC+Z(
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M99\,D4;#+\7YD,J6*(II3;:UN#C1VGWH_XP\X)[+CS42K+>0)^4EQV*'T1<
MVIX<_K(Y^,A%Y G\OK;W*ZD.N,T_2\^I-8>&6&$<N-['*;]P%Z5 "AZHQT!H
M$1/\B?/E-V8I__N[ENCY8Q'[<+619^PN*<<.RC*@ (:K-.8\[T(YP[$0_,?@
MBSUD0:'ER=6Y1-;IX=9';ZM\9W"+8VAL%A4.^,OJ-=Z<R&MGU_&TG950P_[*
MEY F%L9IH"!$N;_8MES.XCMMN.S 2=_*<D(V9U],&)DYE.90"<%V.&??1=#&
M-Y].+'9\?ZI6AX0EL"!*[N%.E%&-. ^;C8-:%8B8=KA/[!_L'*RFH<#")*4;
M?7'")SPD;.X_*!;5MIJSYS\=@V(DV%$VLIQ]%;NDQ-5"S&5*B?'];?@=*[-Y
MOOB4UL,FM32L?^0KK0 ,D@J@ES7R*W4]\&K\R6[;H;!U2FEHQ6^<HD&QUK8V
M[;,<W97B/^<E!5>$PGF]29U%$/%1%%.B^_9GJY+@;W4":-AF2,UDE]8E]'=R
MO?%5PNS1[>7?+Q[/S(N,T]%H;VMQJ1K."R-+A_J!YQG?D1J^!Q&^8L .@GX,
MK=:V)]-<&):8X,>JF4L\U +J/S4[5HR%:<E'/U[]='OUV.[]1;&9NEOH"";4
M>O@=Y.3>-=@QOJDH/5@>50BJ%B6Z7)6_8%?R_5U&206Z:1EVE,3YNW>^$NT>
M?_ENW!06OH07,FS^-'WCLA2SAM2 =WA'[X?M>3;&$9,/R^ES"<5)[OLG;UDN
M.;,S]=64N"+'<XGVQ+#UL^\957[XN)@)I5LLKPE !KOS?=5Z=X$V\LY;ZTBR
M)L!9' (3^=?&9;_T\/TJCN*R@M1[WEAYV)><:"3W26^&2\5>DDXH4W%+S3\P
M:%RU?*W/S%_9(IU@L8>49*HTR:$QC,@Y.KA9R7_7@>_>XCB5REUTK]#HBS$
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MV;5^?0%.C2=6.U@='2?AT?*VOWW<\W7:L%]&5<F>B?Q!F<0Y!0ZBBP3$MPD
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ME]G_*V.^ 0I)WC#,2T@YMTL0MBX!$N/AFX%2A')4;5I#G?)??IJ-IN.G\\%
M;(,PQ$\P UBO$[E&5@%:C!#0A58&/^A/AY.?P0HB3#X@?T74E:8YD_T.U)G(
MI 2%ZD(Y20LHO;+]2 <T;]-K9$E-M[%":PJUG9H."ES77]*-<NA(97V8XQKZ
M7B79Q/?3=1/\ F#QO8[\5F%)N.244C.3R=FH+$&Q4^2P&O"&X!Q33M(Q8\P0
MA\./80 9H5\R0PM9:$Z:'/-0^&!TWQT!SV3S6+U ;&)[.R"_"0YT8%=26#T,
M<B[5B3L5P"C))"NR2E5=2:<%](^D[/2S?KPQ>2)LR^IZ::VPW3]SO<A%#!8
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ME7>#'E29R5-]%F^5N%N)A[=)R3P()+P_764)[J*VL8\V1JSCN]P$I$^4Z9G
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MT&Q9JI>=Z1P2[;D838;P_9!V6GXP?>.AN)JK>N()_,&*PGR,A2)XL?/Y-[9
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M:&5E=#$U+GAM;+T\:7/;.)9_!>5QS]I5LJS;<CI)E>TD/9Z*XU3L=-?LUGZ
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MS=X-4&(?$,]@$=<Q=O5PS:X>;MBC6H.JF$Y LSZBBS#')!5"]"#TDZ0[2MV
MD1RQB">-M:"C8.%FHRM1(0QTCZ4ER 6B)0NWIE'AI.!.2[P;ZQ/ >#4![SZ
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ML!5?+C!'*4<;L%Y8-+QT0P>T'QBO_@902P,$%     @ 18175,.GR+V*"@
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MQ=C*I;%^:DTYF0KU:++'UC*TKXS*K:0F1+ /UI'SX:^$1H<* 2VB)0AX,0-
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MOV_+G)0N#XD.'$.#J><P<"Q_P!CHND;87&2JL1<#>DAPDX2_8A;^+Z"SLL@
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M7!?L!9?)* PBL7"F//1> 6RCK)<2*AI.7<W6I1S]J88C00M+6'2N)"4H*34
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MHEKP(;0D>IG_2[I(!UK:7NRC[7MWFS*M5D.?X38%#K46^ 4_7Q,>%XRF68F
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M8FV&31NYM079\Q$9M)J,#(8GVZ(64#R6L%'><#6/\XBU_K>^)%NY98L#MM?
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MPI3$WC7WV/MV[>C81$#*)IWK0+10KM ;S7*(/G:[X@8];8Z@:.;%>0@:4!X
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MX!A$7YQ_W3B?IU)GOEZ[DGM;#Y ?< QO5=84,63Q6(?'LTC:A[XKFO,AQRZ
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M5$ 6_MC0R-M(G^4X22O"O#8>G$;PJ=7(#Y\X*CG#D3(D-)W3PZ18C&$C"@U
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M7 ""T%PU(W<U+SOY28+D2J0$/03ID3-LI^PKI(XG?0AZKIQ"X[4#M@Y9>NZ
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MQ&ZD+EBC9K7;J^NSG@C*8I/EZ@^5W@D@F5!:EP&6%^66B'M3#\X5Q[0AFG9
MDQ#$4I@E"3TD"?KB=B/%T[0PX9ZDS-9K%>)-3T1.%3TAK5Z-5L(LU<".@!1
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MHM>/7-V5B)J/7.?P1!1>IOKG)F5=/UM_:E:XW7K 5LV4W5C6R*7:O4"XS.R
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M[9L.F'#$#@].E_Y8N]2.#LG^-J-_)6AX 7U?:6KX^H$=M/]S+O\#4$L#!!0
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M8D]YR89QZ&% G*1X1BF>-Z\-H[-:& \,<9BX]#GU$G;3<6X'=0*A*NDS]/P
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MZ<#JL?G1J,I<(<]4@^.9^5R:@Q\-0/]<J6;S@Q;H_T_A_#]02P,$%     @
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MH;D7'ZJW)N>X=$EYLIJ^<K*SDWG.Y!H-< GW-D<-<U50=G-'^RO"C4Q4@>/
MTE7.($AJV%D%&QV #2.X5=+F!A8RQ?1+@(!\;!R-=H[.HJ.(EYB<0AR>0-2-
MPB-X<1-X[/'B WB'HX7VS\J8#MQ12:@,ENSM!!Y0<Y5"Q1;\/ET9JTE0GXXX
MTFL<Z7E'>H<R<,P%9>FV);Y9F F5O'SZ*!/'X>_NEPOX!7[X;A2%X8\POY[>
M_;1X@IL[N%]>+QYA?G_[\+BX7MP]W3PO:)O6"UCF")D25+%<KL&RE4#8:/7*
M4Y(*$4?EF AF#,]XPEQU&:""=VQ5M"9?Q,1]3"<@*T(M>X-S:)/B"BZ$,^X
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M1'*#J-I")*1%8)RK52KF:^&72OP\O;\0Q@J#!T@]!E0XY7G^'):5&X@[E<!
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M]-TFH;B*=>S>P<E9QY?<%9WVJM@_UYH!.-"NP%<NOI[?+\C/2WC0M4QA')^
ML'SP0:B&>B?TA@V@16J-J3;9MDVT9=$\$2^G7UCNL+PM4#$$6B>24MH"'HS(
MML@3-LHGP0;)_ =A06&F>)/!Y![]1*[Q9M"9^\-"2HV!*XBR&2B?<0AS$F%F
MU"_9E%_;O&4=:1"@:$81@Z;KYV0:CR9VGT%'XX?N4+AX@URE?G057:(,ISLD
MQZHW)OL<U_EN_Q'.VQ[A:MVB1Q\D5VN5,2>I")#&!7UX??O",/#2[*]]VKJ]
M(=P:20@UTA^IK;J+A:#:5=I!@LC3DJQC8YDBQZEFBQ3O2.613.:YM-(5/WD^
M&E&P>EQ;Z%;Y:R28[JITD5#L*5)FRZ?LYL+H9E4 #6!J0JL!K%"AH63PE#(:
M99);;-=S*(N4I13A2ES@2BK5N;!/\M>^>Z/.V$R:Z$A!\$&F@MF;^IU)NC'L
M>JM+F7F/)7V7\B/5#GWGNL/>?Q;ZC&Y?6ANESFY&PUVS(]P:U16:E7^0<+60
M1#>U-[N;-\^\&_4OU[L'TT=AR%,62LQ)=#0\/0[ =(^0;N%T[0=_HAT](_QG
M0>\V-'R!SG.MW7K!"C8OP=E_4$L#!!0    ( $6$5U0=2A<SB2X  $F=   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;.U]:6\;5Y;V7RGH'4S; "5;
MLIW-20!9=A+U)!W#LI,!&O.A2%Z2U2Y6L6L1S?SZ.<]9[E(L4I)[,I@/+Q#$
M(EEUEW//OMUOMW7SL5TYUV6?UF75?G>RZKK--T^>M+.56^?M6;UQ%?VRJ)MU
MWM''9OFDW30NG_-+Z_+)Q=.G7SQ9YT5U\OVW_-W;YOMOZ[XKB\J];;*V7Z_S
M9O?*E?7VNY/S$_OB7;%<=?CBR???;O*ENW'=A\W;ACX]\:/,B[6KVJ*NLL8M
MOCNY//_FZN(Y7N G?BO<MHW^SK"5:5U_Q(?K^7<G3[$B5[I9AR%R^N?67;FR
MQ$BTCG_JH"=^3KP8_VVC_\";I\U,\]9=U>7OQ;Q;?7?RU4DV=XN\+[MW]?8G
MIQMZ@?%F==GR_[.M/OOT))OU;5>O]65:P;JHY-_\DP+B/B]<Z L7]WWAF;[P
MC#<J*^-MO<Z[_/MOFWJ;-7B:1L,?#!M^FW935#C&FZZA7PMZK_O^IEA6Q:*8
MY5677<YF=5]U1;7,WM9E,2M<F]WU^R/[Z_&W3SI:#T9],M.Y7\G<%P?F?I;]
M4E?=JLW>5',W'WG_ZOC[YQ='!GA"@/#0N#!HO+HX.N)K-SO+GIU/LHNG%^=C
M"_KLUY/E//.'\XS'>_:9A_/WRVG;-40)_W5DLN=^LN<\V?,#D_W:+/.J^",'
M=4VRJ[IJ:9IY+L16S;.WC6M=U<D7]2+[H:CR:E;D979#7SHB[:[-7A?MK*S;
MOG'9W]^[3UWVJJQG'_]K#)3'5_.V*6CP34F[I+G2U?S:-]G,?^/FV<(OI0U+
MH??+?NZR;N6(63#P>*Q7-1%5E=T0! F<!%T:O=G43=AI3>-O5W59[D[K;47C
MM_VT+>9%WA#0)UF^Z%S#P[JR()+T$"DJ^F%6KS=YM<OH7*HV9U[5GF6_KUR5
M]2V-553T:M$2"Z0YNPF/0Z^MV^QDZR8GV4G?XO^TAA->S D>N))!B?)=7MUC
M!P5M=5[<%F"V+7\3;X&60R!I6]>VT?2T 6R\J&Y=VP&$LA_Z0$_5Q!KQ&)U2
M5BPR;#!YWM$YK2%U,!YQT:(J#"IY=DNSYM/2^0$SK+O;98]^NW[S.#O+B"'S
MD/21X+MUV<8UD%#T)?V7E[NV&*QANW(T4\,KV!N^S98D&@C<-#?A2=?048)N
M IK8DV?9>V"'35',!:!.X+)I"HBV;.HJVA&]V.QD0[1.@I^@ $:B!UL@6MYE
M*_I^6G>K[/RQC%%O@2RT]J(AR25BBV C>"U#\8MK.M2L#01?[K*"#GW6V30$
ML'__?U]=G'_YLLT<;:M>T\$KH&A;CH_Y0F:MIV6Q%'2@J?-I6S?3C.BRE6G#
MB%DMF-Q VN%96J0#\&3/!,I%4Z^C%\ZR5SG0&&=+L!<L$H+KB0G+:/EF0QR*
MSV39$XW2ZOA8Y\4\JVH B68X?C*@7X\3V!I3"HGXNJ&Q;*"("X2'YWV#,<&#
MF1,_Q28OGIY_S6LO& (),WNO'()I#*_>S5P :UJ ($KC"'"\IZDC,B=U:I,W
M0NH8MF$ D%PGK,@#%]\$#K<D8#<Y\1O\[C:=L0F7?2 ZHD_,84G8?CB[.<M^
MO+Q\^YA7P$/BL:(B.= +L\$I0L/)SI^>_@<_]LXM^U*V>G/ZGV?9Y5J8H; @
MF6Q=T$G@;8R9\JB,-I,!.CV>G=KQ\T'K2/Q"W;<T&W&72Q > 9@T*>%OI",:
MVF&<NG('IU_G.SY9]\^>(,[<J>[H+YEI_)UY[QAUZ8DY0?8LNW)-1QHL35;V
M:V6 ) W#YH":8:Y\/K<Q,"&Q::R6AZ.9JGX]=0UMZRTQ=^#,DE[="/[0SPR<
MO)P!PL 6(Q>FAI+124? FN>$\#D-=D1>O_#R^L51"7E#')V@!$;]YA8 G8AB
ML,O^KO_>(8 ?.#R$AKO-RQ[$YN2K>C;K&Z:V(!29&%4X'*:J:5XR5;#F2ER&
M2'1#]$2D08=-3*A>F@1IB-J]4E$(V[F30,'8:SI'HIXU,.V??<'+C$=6$ANE
M[T#->*,!'@")="7XQ(1-0Y:[0W-%RWY4U=6ISOV'*A0*7('DXWNNYL "WKF%
M2)F_$0RS5QD+BO.7I#328MJB\VH G3"-NB3)<>WE?)M-Y+V?_'OOG/ 3YJ2T
M<,'M2R^[](7_\"^0@K(NNL ;26$#DW/5+#S]LW_ZIB.<) 6+**3]2_:&UDB2
M"*_Q<[^&Y]R2%9%W3/4L* @=%GW#LI^T@;PHC]+2%YZ6OCB*[!^$Y-^T'4G\
MSCV8E(Z/'JGN?H;L?6V"XGX8/29-O#B8$"^KB#$QM-;Y1QK?^9D 6)+3_7JC
M\H'5#>)]^6+A5+_P?-4XNA$PR7<]TI*4K*+4XV="#_A-3\_LQ+OX2:A)ROEC
MOG _ 7ML80WHIM?=N4\;5T&W4=$?7F1!ZYJBGI^QV4#Z5,\,!L))),"\6(!X
MC'$3)GC0181UU=!^B,]GHX>IM@:+I6O:0O;E6?:+/Y&_B%W4MZWIYY>F<29V
M%!'-O/ Z_#M=(SWR*VTAE\-C8-*+EU6%C0AE0!P'D9_0B)_W&)E\Z<GDRZ.(
M?)6W*R%O_ &Z)7GP.:+GZ#3P7'W3DNKKOCMA.=O<NA.>>S(R,;.J8@84\<L;
M?A>]D!W< ^2;,/OPS Q_N.B9,?DS$&4YU-*6-)_MJIBMH LW]2?%DT5>P%XI
M>R?HN!%HB74CEA0A\PR&&4]-T[4K.N!3V#V$K<U'Q[I+UCH2O$)A+F\JEL#Z
M>]8HH7EK"[RB[CMA GB4=),>.G_[$<_!+L"_JI!Z9:LUVTYD'^GO,'<[!H!:
M,T1XP@!H^=&25'6O82S25'08;&@4-+]KV/H$ (NYD-;4[<.9E.&[=\X\L'%P
M5K*\S7<,1P(UGF!;[>NG\C7-7@*J7CW;],V,;#5E2\P2R>K"6N ,+4@5IR7>
M.F8]-"86>+:'5Y<>3H'\F_ ,[XKXD.B*\I$H=<7J**L),O@4N\+Q$$2RZ<ZL
M5N55^;)QPMA-#GLSC0&RH.=JT<&:)J^6$0.=@WMA$FAAQ"'%!M@0NJI48(TJ
MK!V ^97Y!M0Z3*G\?Y:S[##]^0X2()ED!LU$>;' A#E8M M6>,:77^8;.IQ<
MI!.Q60?\H[,NY!OQC-)"-_E.7B!='ZYA+&8'TQ]<$*R#['8VMMQM008*G2NM
M>A[>#X!L;46&&DTX<%XX1AR'J"QV"Q^/D0Y N\D+OTVWWI3USKE])(I9T+L!
M\L0D(=X(8&9 *9N-9R)ZK]D90OO,8#[!DS$':G6E(-"""#\Y !QD72UK%IIP
M6-WF2Q)'1'M]LV1QMW:T#,CR9? N>>3P=F0R('3=,/U&7?[ NC\7Z=[?@6GW
M ,V63$I#O188Q]S[UD6 WC'1@264.1T(RR!"4V'VAJA535R5<+D1U9V]*XQ?
ML(N).U6F%.T?X/U6>G845<;!BQ4).U4 ']$(OO(:P5?'-8*Z@DVLKL=WD"@/
M< $_8&QQ Q/E$0/@:7Z(7$8P5H0+,"/WAB2HO9_^ Y*J9_#/]H:<R9 L"UDH
MD;P,E(8'#ND"$V(&#7U &"IQ8(75,+J;ZSFXC +/$2T@<KFJ0L""MDW$Z_&E
M\P)78)\L?543F)E"2?ARA56XA@P.EITTXOB:>4YG\.(IO &H'D3%*K9<L1 B
M^,@/R?+=O-],M>,3B3\,;FJR @7+ETW=;S#B.O]'/7ROZ/K.>ZABF"V;G.2F
M02.':FZ@Q]G0,:YK,OG%TTGZU\B3S ?[CNP/]B#1,9C13$ (6H^^:<=R1D8T
M0Z+"UDL"=]^T;L*/JEQ2WSHOV60.88X0*&9:U>VFZ/*2OERYO.Q6,_#'W%O.
M,Z**8@9DJR$GR5RN%XMBIH9/S82]8304!_"2N%538>H!V";,>+O=!FR=8/),
M-2-S-,*4G/9B&))"HNRKJ$2-E" 'Y %CELP>W);SFAUIJM2P+*8%T6]GD5:M
MT&-U4]5ZAN]E6=9;YN20L-%34/$@4[=LDA&]%$2![_FT/55%BE"Q&+R,#<,T
M9"8)N C+!?/[2YOH6,1E!6_AW>3S"^9SO1A?.30YXA:DNT!.8IZF<.:'S^?_
MZ&$#D!2I'/3YO($N!,5M 37%R[I HD1RXJ'*6X(T-B1QFPTL/-'T:MIM#M\X
M>RU+:*H[&S%P^VA5O.*BDF@_C$#LD?"A+/YP'%P9 2,T@*4(OAPB+0Z[J#('
M *@6BH/-N]&!2$5: R BM7"TYI8-A(!(@3H'Z74Q$QJWI*6>MG1P'-P2#;%E
M:E,^8T9^"#^(7R!0\,B")A@Y;^9L"+#'8C EQRB _]XZB>(QM@QH%>X67S!3
M9J53W!V[F*X[=@GZ/;#H]TIGV\,P; G;JH]-O^EF]"K)E&6W(N6?\)3(WS.0
MV6Y6*K43\;)AIWOCP]R2I>-.B2=X5<*?EMD6?:7++.1X<[ %<_#S64I L'&,
M5W-'*MN<02IF'-"R=#$SF:@PLY_\QG1E<.H05-=UPZ85H:7CHYOY@R(MD>13
MFY<B3J)8#4>QGIY__9)8XY9$3$.@R1L"B @'5<X!XCH*6(-]*B?%R)P%,QFP
MKGD!C8EX'$Y1S".:OXDYZ;1G9.2IO-N5\)@U5E F^UL1F --"@Y@,U/0+M!*
M3#NOGK.C%P]"B+$_2F*B"0#$((97-Q)5,2['-DKJ*+>#14H-J0'M/@8&9Q_'
M*-G^]='#P'SPHL0MO3#@.'("0'T/*X;:(J='$ @R1^/E,+V$;[EY3.VL?"!2
MT@"(%9EB/<!>96_ZIMXX$5&FL8%D*H.[C\, >F+1Q^*:U&5V)1C1L,)2").2
MDQ5BY[7_ K0$3!%D%0/UZM??KE^?GG]- Q#J S2(XR(85\+SQAX0;RBU0G&G
M8EU"UW% H 49(L5"0WOUS,VAN-TB N52*=N1M&OF;"9YG(5^#VUD *-\/45<
MJ6YV;)$Y^G?&$6=%6E8%3B4D5^;3EKV..S4NVD"8(@M;4E)*EH)YI>A!#(^Q
M/,@,EN;$ZCU*BYY&LP&+^&&F:]:*,&U!,G_.D>'?=3 1?FY^3T&Z$,TL7NY$
M.;)L,T93' M$$QTY#2HRVY4%,0J>[8@N<<3:^=I;.U\?M4C>B=.9;"\?17JH
MY_/!$V"'Q!E*T2J;>M[/$F= MR)FM11-FGUR0I:T_9DHJ"9U1_4X%GG[P]N@
M116D0<(^V17"W#-UYZE;7B4/7).$!N(8P1QB]"YJG!)+?4@O.DE&S[7KQH(<
MP="+7.\W('VBHC9[58.8'OUP>?/J\?@35_6<93A#\]'ES=7C['U-:G#VQ=,O
MX#^6%3-GO%*=4+'^RI//-QR3NOCB94!RKT":)>.EH'@3B6T!ZUW%1\$:D?H!
MF'1]A@:=@8W]EM90@);]07@GEJJS/D-E'MZ"WR/*-@)N(-]",SLT<+XU53A*
M\IC \6SJ@M<XAQOEH;W7BW,V[" WMEX)?:KWPN!P!EV=7[7X$%ZE*=TMMD$<
M,NLW6"]I<=!X,&C1Z2H2Y_1@8-)H6(?;BM(2NU+AK8$7-9\+QV#6*O!3NY1.
M!8QZLV$MD6:".[84%12JM6J88/D<TH[.M9Z"D-HA%)9U/6>^E"WZ<E&4I>AM
MR.<1=8"59.5P/ <_#*K#M!J\$BHA<0?#8.[M)@X8>[)B)&5B6[*\37VF/C5#
MT8<L"H(K8P)I+"6I(1:4(+H&03AUF'".1@X=KV7'9NF4M885Y(F)T&EN4\%9
M8M[M)811L<99^0/PN44JG<^RMXEQ_#]IEYYEK\U#:X0=#-"(9"U$N9MDL5=7
MX3SQ=J?M*$VH\ECF(1WH= ]9@0.FEQ1FCXB2A"@,.-[\EMF=*H:I+T47PCR:
M>+SC.93C+/H.2H;-'!8IV58<NS34T8R=OE(D9==L2!Z+-FA(*P>O=H(.8D:T
M>81L:HNQ_A)E!EX1]RWR6?9NM>M6ZR@>FCVZ>O?+XP [Q%_9%4.X-S4SD_&1
M4^3B/6/<GR_?7[__\/H-,:KG7UT0UZ1E8]1H@IL=Z1]KPW:OD+?'8)9$+0"^
M.N2JU5,\S[AOS,NHGY70O(3*9!3-#'CH%3\X;_LRSFS;AO"S#)^,*2X"PD?O
MUF VLRDYUY%H8 ET4M-=K#H2M3,;;$]*Z(#^1*$R']P0R><5SOA]R)'*2Z7!
MVRAJ#EV[G&N,G?%;8^PA9L#Y58I30GQP%5T-J;-0J3<K242(BU"# 6G ('F>
ML'?H[XY_M\3%>V8FG5FV<>0K2A<75#'.;6,6O-AC*<-@A"'Q8>P]\QQ,N(;E
M#@5'EGH*4AHT#A^) R4@840R&[/16];:C^ZO;&N?2'WGEC[\Y^GK3T:5UR33
MU&]EC. 7M6T?75\1^;=*HSQ'%.,AWN"-CPFK\4;%GP.-(1#\QAD<+""#X>+4
MD0:ZYY1=2;8Z0#M&6@R GF.!K8:\QOBJ.C,Y/9=$(H?9(C)6U">K4;@PDD.(
M!'>D0UOTFM5YTVPF7CQAM4$O1/@;*G5Y#U;?CH.7,VN%M& -ZK&?9;]9HO65
MJONY&2A1 BM4>W&6>^69-4Z.>F$L=LI/2,BO"?9S2>TM@IDRHP.C<R?(L$[G
M->%@SXT[:B7@R[:/3-:*=AEY0]E0;P=*F7&D7))6YY)%*VL6B&QC$2S9MH4X
M=&1M^\?"_A8&Q!@0HEBTA9H'^ZS(ACP5F"J^#22EI,R+2AD7&B1R/\JA7 S5
M ).N',?)&S*@FVQD0J$>AB.$CH$Z"5Y*ZH@\+V:?[-,,/PZ0C&](W1+0Q@,;
M">;#A\J0HBO8Y8M8TP'02*"6XRA2#\#:'1#+GBAS4DM76:L9D$ R^PEN];(4
MS."W+3_4*]+L,E?U"(J89,ZE_HV(':9X*#X,R,19#L'ID]#D9^8T1W+06(H3
MC^33]T-/?6X?V)2X?N&1'OK88[/GR*L#](\PAE<O GBG*=S$#MI-+;XWKTEC
M".4:/*?'%IN079=V\%NH/*+X@.6T/5Q9+)HB@HTB%\3?\Z*TV/L&C$!3%\7%
MAA5[;JJZEDY,]+DP6[&O; @?9]FE"I<?1-^>2.*)&A!AM^JU0BU>L>[7^KAY
MN<6>A<XSC\0+)V3-_1GYS!YU-QSW<$N.U9ZGIE:/8;'A>&8(*,)*J]RR[@K&
M2I99[3&[4A O6E3PTPC+6+M(] ?NXITXFFP(ICZM$55X2\KIZ;68GMF-^3%^
M=]Z @@\TUCV\KP.8')R!@BQI((ULYKXQ4V$A:.H6*EY,/_6^+UF#FZL:0'!X
MY8081?<=56B*M9>E?F&I]C%EK1T/[QB]YJY$.!O>F2U+)/;TDJ[9]$YI1\NI
M# ("].#CB1*>I)0J^'Z0N!3'4V./ HUX(\KZQ(2QQB&)<1;,\UA'MT390SDU
M408NK#B?=YI2=,K\>;'M!K0[W6ER[L;7U\##FT;MDOU*FB^B\G%"E?H?D;08
MH,!1VOUXI"E\  39$)H$,0S,;(!B;'@U<9''OV+ R+&*"78LN_;\::C%?7K4
M_8N<_ K>_H=ZE>\Y;B'4QX?,&13VI:)=R<5JM+5%T1#E%J3-R%\X"+8T:XE;
M$?.$/ 0KU6S6.*ZL)F0CH.&0B>KZLYQY4_$'OF1)6P$+IJ[;HKK!3F!NZ1M]
MT+*8TS"N:Y*W*/BM)*!P_D5X4@*4=%3$&?]@G+GBU2\"X^0T0+8>#! DW2"/
M!=75*4<:<X_ KTP95KR_AGPZL@I+.^6(RY<OXAAH.C(!)I^Q.?;:5Z\]C40/
M@>3?SI]_;35/R82'UIAWXJ\WB2>G&X&S)+97MHKG7%UAV;'[\3"N )!:1NS%
M4A&8HZ[QXZ)N$LG$8+0Z/9.?U6X,3OMPQ1I@^<!]CKV_)M;/T3\KKO8E?<?H
M+JJ!/[^CV!B<#L[ MRRJL!^D96[ "1],B__"7($Z-_XQ==PZ_PP?!6*BJ*"!
M:$.&HB:<)>J3<$2$9U8<06>D)C.%Y*9H8\B<[ESEJT=1CU*(K6($()EO2K7!
MKRZ<.YF;/<D$&J>5&\RMU5*(BN$X_>8L5@(DKY8DQDP5[^"4@N""]_@44%0'
M%#;9!-]UE%\O^IOG(<3BR0#.2A9!9K)PYJ/@IDV)6&=1SMD#R0PA]TJ=[>'Y
M4T''E_[1=.^17]2RT?WL 0K^72NN<B_#L4Y0LU'QX3!L%\4G.2A=$HE$IWGV
MQ*[$+X#!7Q[#![\NSJ47WJ[2;[BXZ#V3D>P[TY]]"B F.DIU%X'J+HY2PBN3
MS5?L]E4M]X'$=GR*W[A<41GF^'Q#'ZFET6PY!8>1TR$/*@^E=*8?:AHM3(N9
M)+X-ZJ3X)Q1=N*1LEK2=4 CBA:_51T43Q>D<YN&Q2G=2<R2?)U1H%=4I9QYH
M<#UO9BO-<R$^7POS>'3]]MV_Y^O-R]>/S3WN"G:71@DB:0$""[&E#^2@5I\=
MV61W2%H:7D$0#-G3P3DCR?VV32Y(N6,+,XWCL<;E-;=9.*T8'GX?$_'NH1;0
MS;-;.W%E#]#S$C-R4 RG3(BK!D(-G8'&Q[7#3[X&?\K%.G%V0U%M>LOZ'=;;
M^>H<;ZTA*,MZ)BUQX*JO/3A99&I%D"]9$?>CI^T4R.)N(93RT 5FW _R&K'-
M8VV+'JEG8D):N7GK8B0->985FWZM#V+Z-(('F2:2M)!K]F?C$OK*K+T&X8@<
M$>@T.-16KN1<'2<UI21+/TI0Q90A#MJ%1*RD%$C@:E4@?M!3'E1'M**J2?"S
MP[@LAI7Q4K7NAYXE'E,Y:57+F+M8,(D$M=/"V!C9]SI^3$+]KUB316TE3X.%
MMF=)!!39?TS1DADJH9()8XR6W,OVS>"9.:^=JY3@O:8X)WH?<K"0_]7 H><+
M.-'!29\D>]K-@4KP?%K*%C/2@$T<\6PT.35P7-+1ZQ)R/(\+30=0#;%PKSE;
M\#KX;9)=[I-.-+HO+4IR)U!=&U6UQHN<YSYL?KHF.2G^"<*0:/9<XI%):6KL
MD8Z2^ <+-&*Z.K1_/D-5VQYI_X['%N^ZIY5_K>EVFN%C'_97LP^N=#%ARRBK
M4U-:TA?"#LW]*/K<Q,RIB?E[U8@+3N9_F&M.G=F-]PQ#&?KHRF*%9 R6HJN"
M")BS)Y>:0S>)7^3LY 9Y1>I@TS0ZLK <B T^(LM3P'@AH23=:!&W[XC 81TR
M3*@9XVJ  FSRJ6\J#LV$R:.&"D,4BQD#L375-S75.(*.F'>3"!3FSHX5@@ZF
M@4BM)[7EN*1P"\[UU(=;5,E( SUF2-C'=,;0$.O\V1V>#"1)L3A\%ZLXK\,Z
M'FROW36CMC-RIR7G;5Q[\2FBWBLB6LLS>'Q/VOK"8,VWCO-=Q6&1Z#H1"DTA
M-ZQ'%>MLG9NMJKJLE[MXU 4ZEUABS*#*+Q![$G-%A)9.N.7$4Y[@%S>_Z9NE
MU\.<)%]N.0^EC7;].8J<1)W#&%&&QOYPHC\USO?/.JC<1LV5D#+DHZ,[<5G-
M5M!)#&1L(B^0TVV90&EY@+688N>NY %%SD(-,;#N]GX5]8KB#D-BTHJ7TFS9
M@Q,K-T+65=!*6!UA?L<^YZ-D*6*)M<N!L1V3:EXE?9E<O6SR#>&,IMIJ%KK&
M><+1(#!4W8W6&=(N2Y4)82^$2U,ZI;HR/JIVDZF4!X_2+0B&4%X^;%@5'8#G
M(6.P,L#*=.HX'C&" SWQ8%/'^31"E7'-2=?&M3QBTK%'677RHHD\ >R T(T0
M]1&G9UP-<)$%^D*.U(\P([5&'"?!X9[N_S I2NP/=DI]+]8$%@X#'SXFM)=
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M>4)OAL>__W:3+]TO?.$9])0%O?KT[,L7)Q*>LP]=O<&0D"ZT>_YSY<C::_
M_;ZHR3K2#YB [XW&\K[_;U!+ P04    " !%A%=4RQ3@Z7($   O"P  &0
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M4,9 - B^- Z'_H=>?4DI$I;/G2QTP,SA/#1"R7Q#H4#913]0&Y,>[CB BB@
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MZG3RCN[6MN-9N_"F#B-18CP-6.&SI(D6+0O0>6ZH![H%.^AGY,6_4$L#!!0
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MN,?T?+GY!U\Z4#?3Z;9.4R[&]Z&-.F= 84Z9X"K.S"TC_#A<#,6/\_EMP)H
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M7QE/]R**%1UHM"& _&MC?*^$ L/)7_P#4$L#!!0    ( $6$5U11-M^H4 H
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ME@(F2P/P?*FU;;Z0@/9'9J?_!E!+ P04    " !%A%=4&S+.DQH#  #8!@
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M?RYN%?9&G96<551H)@4H6ESTIO[956+GNPE_,;K46VVPD<RD_&8[-_E%S[.
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;*U8;6_;.!+^*X2O.+2
M4TO4J[-)@#AM<3UD=X,FNXO#8C_0$FWS*HE:DHK3^_7W#*4X;IL(]NU](?5"
MS@SGF6=FI+.M-I_M1DK''NJJL>>3C7/MZ6QFBXVLA7VK6]G@S4J;6CC<FO7,
MMD:*TF^JJQD/@G16"]5,+L[\LQMS<:8[5ZE&WAAFN[H6YLM"5GI[/@DGCP\^
MJ?7&T8/9Q5DKUO)6NE_:&X.[V4Y*J6K96*4;9N3J?'(9GBY"O\&O^%7)K=V[
M9G24I=:?Z>9C>3X)R")9R<*1"('I7E[)JB))L.//0>ADIY,V[E\_2O_@#X_#
M+(655[KZ395N<S[))ZR4*]%5[I/>_D,.!TI(7J$KZT>V[=<F\805G76Z'C;#
M@EHU_2P>!D?L;<B#%S;P80/W=O>*O)7OA!,79T9OF:'5D$87_JA^-XQ3#:%R
MZPS>*NQS%[==VU82;G:B8@M1B::0[-;'P\>F!YV<]_I.+"MIWYS-')32UEDQ
M*%CT"O@+"D+.?M2-VUCVOBEE^;6 &:S=F<P?35[P48GO9/&61>&4\8"'(_*B
MG0LB+R_Z:R[X_7)IG4$4_3&B,][IC+W.^ 6==T:4$B%9Z*YQ%N%=2'5/+IZR
M!GI_]^YF=_+!L46EB\]_/.?XOZ3BTC*]8O"EK)?2>'^^5@U"K*IP6OO&>Y>&
M@+THB;UBX33/4S^G4<8N*[#<^P]^8X61I7*LTM9*RUZ'0?Z&QN2-7Y]EN9^3
M*&1W&]I!FU6S9LHRP0QN(60K3$F&ZLZ,2C]E_Y+"]#%VV*EX$,[90JY5TY#2
MY0 \3 H2C%F,(<W955=WE:#4P>1JA5S"1/EO\)+BQ=LA2MWZ (&5E[>_D-ST
M)(Q8,Q,0Y:>K)U.9?$!"M9+QG,5SQB/VFU%.GNC5"B[B\,UKGI&;,. PWUJ6
M[]OWDW;RE+WW5I%]_Q1-A\S*>FH$4[:5O75PR8?+VP7,NV)WNE4%BWC*.DO2
M'5Q?ZU*M%%89Z8RV[2"OEFZC2XC9J&*#=W]VRL#5;B,<B48<Z'6C_B/WH<!3
M*\T]EFTWLF$KU<!V!6()P(3@$09^M [1HY"T2J96WP#I%SR0"7BK[P$B6>AW
M__UO.0^S'RPKD%"(B1WD5FHEW[(;HP!%*S&53-1]H&X$#M%HQY924@F!6A(J
MFM)K:<G4AIZHQD>W*;V?M\IMOO-7&(RP/MFQ/AFEY"UJ:MF!-PB5C\T]E&OS
M98H0,P;7SU%\5!Y5[%/;BD*>3]K![Y.+1\$*SCR"Y!]4TR.RUKJTGID!GV/.
MYXA15-83U9RT1A<2((>(WC"8LT]BBV+DX'91618GG$7QO,\&"'V:HR1D(YY+
M=YY+#_;<SP@(\^@T'-''U6$9<U3)\^[LM16#MB&*C_#K)X2=43Z:"V$W/OK,
M-\^(6?>BDA2T<%I.+.?@^CLX]K[//8-B#MZ&4<2N54&=$?@KC!'-VI<OX!)Q
M%L;YX"*>Q(RG$26+.:&2C6.1[;#(1K&X,>@)C4/@MDA,SI^(3M"2#<?4KU$U
MSZ-Q@.XCL+FF[:]\)-,8LT6G*LJYU@M6->+]_M&UTRA*,/(Y9^^?-*XZTRC7
M(9W0CI5ZH&O+HFF<)32F";L2K:+6 D9 WMH0@5+D\#A.63)->((Q MK7>'%*
MB:BO. B.4N+DR)Z^O$13GD4T<JI,?,K!-IJ#/!Y#-=^AFA_)L*.8-2I\C%F5
M;M8GR"#U_X%;7_,HH3())_V,B($+P95*HG]GAAIU%-R3SNYX%0/;.'F.<6$Z
M]P%":;6O^EB-IG8>YB^R, 3OPAT+ 7"8]CU2/&3%.1]EXGR'V?Q@S"Z+PG1P
MQ+422U4I1^G_,.A&=3P/W:.RH9DY"K1KN089=FT"0CBE@$[ B!OQA=J^(4?V
M'*CVSI,CM:5Y"-R7> >6)0&+T#Y>H1\ "I2@T1I857K P1F>H\5*!R!2-*II
MDGK2Q%$_A_-L#(@P>/J,"D:A^+HH'0_"N/A#2M.^HXZ XYU<20@@AZ-OZ.10
M>A"ET<L!CE=A$K$[\0!EK?CB3\C!DC#)OSK\1E:E[Y(M:,E\ \=_P,I@1XZ<
M14%&Q2FG0C7'_C$\]CYKPP/P>$HNU?&(C"HX+*7]CY@\TDLUA:XE<][-KU P
M*.,G<?8MASA* $CT(@THRL,L?!'..$*O$'V7*/>MC\"D. B_#Q>>I=B<#7C&
M6):&25^@>.#G"''Q'*:SO;\6M31K_V^&FGLT[_T/C-W3W?^?R_ZOQ]/R_N?1
MC\+@.\["[A6V!F\S],VF_Q_3WSC=^G\@2^V<KOWE1N*KUM "O%]I?$L--Z1@
M]U?LXK]02P,$%     @ 18175(X2:O,U"   [14  !D   !X;"]W;W)K<VAE
M971S+W-H965T-#,N>&ULK5AK;]M&%OTK VVVH %%XE.D7-N +2?= &ECV$D7
MBZ(?1N1(&H0BU9F1'_OK>^X,25&IK A%/XBDR+EWSGV=>\F+IUI]U2LA#'M>
MEY6^'*R,V9R/QSI?B377HWHC*CQ9U&K-#?ZJY5AOE."%%5J7X]#W)^,UE]7@
MZL+>NU-7%_76E+(2=XKI[7K-U<N-*.NGRT$P:&_<R^7*T(WQU<6&+\6#,%\V
M=PK_QIV60JY%I65=,246EX/KX/PFH_5VP:]2/.G>-2-+YG7]E?Y\*"X'/@$2
MI<@-:> X/8J9*$M2!!A_-#H'W98DV+]NM;^WML.6.==B5I?_E85970ZR 2O$
M@F]+<U\__4<T]B2D+Z]+;8_LR:U-L3C?:E.O&V$@6,O*G?ESXX>>0.:_(A V
M J'%[3:R*&^YX5<7JGYBBE9#&UU84ZTTP,F*@O)@%)Y*R)FK#U5>KP7[S)^%
M9MYG/B^%/KL8&ZBF!>.\47/CU(2OJ E"]G-=F95F[ZI"%/L*QL#4 0M;8#?A
M48VW(A^Q*!BRT ^#(_JBSM#(ZHN^:RB[E3HO:[U5@OUV/==&(35^/[)%W&T1
MVRWB5[8@W8H;<<A]WY%<"61X7E>Y+"6WZ5HOF'20C8T--\Q@U4(40O&2:</-
MUM3JQ>[(3&V?PI M'HIGU*P6S)N+2BRD.6.HWGUU$AHU;I>H2GW._B>X<J%C
M<+Q8SX7JG$\''X=@RKZ,'D8'(.PT.S1A,/+9OYE'YS-<-/\?##WLPQBR"KP#
M4UN=#6 6CA((!)/1!*?)*,7Q%E+:R+PQ "Z"42BZB@%[):NEQL*,I))D%+M=
MISB]6RS  ':39KU3X 7Q*")T7NR/4G>1CB9T<9W_L95:4AS>*E$"=<&\;!38
M10!E5P?A*,3I7FCLGZ]8KD0!Y%[D;/;B[F(4TOE77FY=:#DYG5>Y8+X%[,6A
M6QJ, AQ_JNOB298ED^L-EPH,:%B^XFH)T#_\*PN#\$>LBJQ3=O]G]9J"SO=!
M^\X@+VTL])W)OV -8KT%):+@VWS1P$..F\3V%%GG?P%.9<#N-KR;VKE% RM9
M[TWA<P>=1#Y4**:W "S-"_)+([BX4>F%4'WL@>^$DVGJ#+\79JLJRN*-JA^E
M97PO:3!':1,GWSERMN+5DO*H2SA"0Z%. N?/9N$GE(1R*=88UJ3E*#ZS]D64
M)5;22[+80CE" TE' \G18GYP_8TRKD<Z,] CDE2@Q('W-\NT[+-X-NRFK/.O
MOQ\BC:/[4+L^UQN>B\L!^K$6ZE$,KJX/\ @QPUPL9455PGA5,%$5]G)=;RM;
M&MN*Q):5_#^RAMS:%.+)1.$A'&LD+>7&V;>T<=-M?L-+F_AO6#@)<(R3A(YA
MRJZ+HLDL:K(%U?<NV=I\;F@NWRI%5?%"8#(69BSR3U:P41)D2**:Q0&;  /R
MS]8"K22FW,]TN*<OXT4H*2_(Z!@AD3"WF%)0E6KT;K,B:>O<K5G5"CJ(:Y"/
M7HAT]DC \J8@O:5<2^/BA!J4BKL=O8"6!@D.TS/R]C>NLT[;.?!(SDZZG)T<
MSUD,>\6V%+VDG0OBRUX*#W<43#GTOF'3TU+YZ/:'4_G35K6[>VC72*L&TEXC
M0[)KJ2FV3::[5(7'_F:R=D:^8=XD!KG1>>+;<S ,8D2E-3T8IF',DBS 51:%
M6!$,_71"*],I"4RR]%ATTBXZZ<G1N14@4[0:2RK71+':AN.CY',4O3F=78[N
M>3@D#[!:+F3.J26AX=2537O JA&LHH5&]<-WT,H>-([X]?GD6CNC3HC. <O/
MF0?>*K$74(F"BN8,.?,(5#27Y+5N(+3UWUBB*52^.WS>L1U!L0/)1E IHN@H
M[X13X?H[A@Q 29+4-GZKBA[R/%>8O#2+D!"1G]%3H\ I6P4U73]NVW@0LS!"
MR(Q<-B,!=*#U$0MU[GK9H0U D%EH+=/&#@1/8!;QMJB?*OBL:ZW](:"S.0 Y
M!E',WG\S8UG:/]S<,S:E7HX^:^>#)I;1,(DG=$P"-N,;,%=I^\7]#WR]^?&6
M35(6LSM%WC,O0[8I*4ULN\$XM;&P87B+U79G%B6(&8HK'DY#4/%P,LG81Z$1
MV<<#\Q(*T ] H5Z6@2&CX13O'=$P10'N)4>O%LZ_ ZA%$V#0P4NM,V@)CS2I
MZ^(/$/"=?.3T"LD6L@(:"5=B&:+LN#^=(DQ_#=%VT^V!&&!1G+)?D&.'ZC@"
MBT1D4$1^%)C^;!N3E1&*RHU7+Y0E=D#V$Q9,XU=5$?B>B@]]%7=.!9K'T(\R
MG.%(]-!/ATMXN']SKYAMUA[#.;0%#\(NM\3"E&A]BH9_\Z;G4>O$8^(1%)-3
M0BN(W^M2%C:5YTT/M.^[>I\ISMG'1AEAF?7%VM;YX,0.<,ZL);,>WWPG NWC
MO6[TQ@;FC0L-ANQV4OFK7]M K419V*%#<U1:FRKA]Z1O#W!MC.X4XA@&!\GR
ME)R(AU&<X1C[D]<1[ CJ]K7,B  A N^<H*/?N/:=@>@ZDF@U]'?H"A=X7RM^
M"R-.LW^R2HZT\ZQKY]G)[7RVUT5[[POOVG?XF_8=_K2N?GQK]Z'!]843OA+\
MX\/5K(EDVXM0*>1:+[3C4H!E[B,!:-"+,&DE\6[80@\,T'D"'S_$%*-5F":[
ML+8JO3"AT3RT4WH\.6LT>GB']-SDWAO@@A2O?O0$M1/&5H)&]2RQM\+,CG\1
M370TW>&6'T1GAU)@W/L$MQ9H\O2AD1R(%RSW-:Z[VWW+O':?\';+W8?0GS$C
M4/\IQ0*B_BC%:Z!R'Q?='U-O[ >]>6U,O;:7*\%A/2W \T5=F_8/;=!]X;WZ
M$U!+ P04    " !%A%=4;?WMKV()  #@&@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6RU66EOXS@2_2N$D08Z@&+KLFPUD@!)NK,;8&8ZB/O 8C$?
M&(FVA=;A(:D<\^OW%2G)LI.HW8M=P-9)5A7)5Z^JJ-/'2OY0:R$T>RKR4IV-
MUEIO/DPF*EF+@JMQM1$EWBPK67"-6[F:J(T4/#6=BGSBNVXT*7A6CLY/S;-;
M>7Y:U3K/2G$KF:J+@LOG2Y%7CV<C;]0^N,M6:TT/)N>G&[X2"Z&_;FXE[B:=
ME#0K1*FRJF12+,]&%]Z'2\]T,"V^9>)1]:X9#>6^JG[0S4UZ-G+)(I&+1),(
MCM.#N!)Y3I)@QU^-T%&GDSKVKUOIUV;P&,P]5^*JRK]GJ5Z?C>8CEHHEKW-]
M5SW^4S0#FI*\I,J5.;+'IJT[8DFM=%4TG6%!D97VS)^:B3BD@]]T\(W=5I&Q
M\B/7_/Q45H],4FM(HPLS5-,;QF4EK<I"2[S-T$^?+W25_& W92)*FA[&RY3=
MUC)98Z3L-N>E8N^_\/M<J./3B89"ZC9)&N&75KC_AG#/9[]7I5XK]JE,1;HK
M8 )+.W/]UMQ+?U#B1Y&,6> YS'=];T!>T T_,/*"-^1=2R'8%5=K=@U\LELA
M#= Q'2>TUBG[N/C*+AZY3)7#KGDFV3>>UX)=*,!X0[A2[-^_02B[T:)0?PZ8
M%'8FA<:D\/]IDEDR]D4\:7:98X7_?&WQ!NT@.OB@-CP19R/XNQ+R08S.OZP%
M6U8Y#,O*%=-&BWE;:L6J6C+>LZ(F:[,23J*%!'9-%Q) 1C\8HZNEZ75Q?77-
MN!D30"\EQ.7/3#QMX+N0H2OV()2&<.H #(CB7L@.!Q_,T0K!E=M>>;&]NN[T
M.:P$T4$&IG0I,EW#=)*><BW8>YA:9'E.MA^S(P;T'K$(_SF[2-:9>!!@(]-;
M<[F"G U_!L\Q+_#8.S:/<8A='/XEN#P1\"-E?&LCLT2\.A>]>3ABH3\.YS@'
MTW$\I?OIV/?9 )ZF'9ZF@WA:@,C3.C=S_:G8Y-4S\+7 <I)9BS67+:ZNJ@)<
MKS@MGL,NL,B)N::.=R*I5F7V-YH!D%E%K94^%&B#!AX"M YB!)^L0&.S#F:"
M&^N3GO6,?H!5@I6L\HQ6EU8#I\("%:C;"&G:J@]FP2Q#[6*K#P@':$S$!HN.
MEXIFC4##CRWT#.H,X&A:2/Y&5FF=0!<,2 E,'@ZQ =,"(0B#<MA*E# B-YS+
M4P*%TF04:)B@7RJ TPMG )@+,+I8! 5+D[7ID */>;4QD.Q:!Q%#6W_.O#AD
MW@S=IC,B]ZH0 .T3>W\/E<M,'[==V'L_/L9A3H?0H#XB]'DA@=\+ O8'@-[,
M. T=H@K,KIV!$PJ(68*6[MAX"TYN>QKN:'B"EC;-\MJLV4LA;CR$_ZC#?W0P
M_OMPO^7/9O(,E3K,!L+/EKH<PZD62[_.J\/V?#=D8)!\F7/@%P96B*^ )"DY
M(;Z@B2FJ5.1$3@G/DSHGAJ(^*\E+?6((:Y='+=M4C:6FF:5.T3@]"!D8E\8S
M;..L"_L;BO1C!MLZ;>D^5X,S7XBO54?JG;."J;/""'@T.9%(3_@#@+X2_>CP
MMMOM>=3G/97DE7I=U0I> )X.G#EX$D<T]9TX]C&(/:WB2<@D4Z*A8G#L;!R1
M+X;>>&;.[AC:7O1[?:KA%NYX-K/G,#2^/9Y%>XO91\VG-HX]5)C8+,_T,_,I
M7/@!'4(<NB84'<P0GS$[P&$[A<<,<0'_.8O&'KO+U(^3)24*&>9$4FR49*8[
MCJ)W\"X/XWF'.W]F[V;^.QR#.=WYX\A[-^!7L\ZO9O^57^V&$7"6QJS3T*R'
M?2TSL*)Q.H15@(]FXS"_&K;GIK0UBBT7&@17K(1+4?(@VGC<I!F9HG3"HA9@
M_ /-OMEFUDYKH;5V#W(M4-A% Y1+GE-^]GI^XH&-?2>:!T *D/J/!L:!$TW!
MUC%KM+[W0,$A8.Q13&'7-D&A%V$(BO9G/]$2 X:.:^ ,;/6T@$5#;T\+H@I$
M3OM:IE/0?Q .:X%AL1//"?QHVBH)'3\DQMX;#'EF0"$%^5%/431%L$&@&E;D
M0=$LG!IG->(H(2AKTX3(C@"G6+.PX+&\3G'?/'[,]'HM$'<!A7NQYOF2^FQY
M$+ @?*KEL\D*:EW)9Q,?34<$;*(Q*?ZJ,VDSAO& O\P[?YG_#_QEFZ$9%.Z4
M8LZO.LR@0:_G76]X43.Q&5@-#Q (\.Q>M/=P#Z1:95-HTR2:D-!.>)L(MV.A
M8,/LX-&\:P41H(K[VI(FY3@D!!A;F3G;=B<6?^' !T:3Q>! ]AS==Z8S>*\3
M /&^X\41NWO+&O*Z<3P'OP*QH&C//IDC/N $C\0+/$<V]ZG)O.0VI=ZO/'P3
M5<BEO,$4*.Z@%Q\,O:]E3W$?>R9U=8@(&Z^R->:!4!LVX+MHBCF:[D[_7MZP
MK*D>ZS)32C<:KD:5!3\MC5N^60,.#VQOCHE17M#XG:!M+%)"-$;GIM;IXO%Q
MXY9M&D1K;4+':Q'&FU$]YWLA!6"C\:*H:JH_FG(&':1HKG?KE\0L15.K;O.I
M7M4ZQ$B>N]W\<0?7Y7<N?PC=$!%O]A0>NM27_W+J^Q-]P$%; +_,+ZFPQI.B
M;]/=XJMA MKS:*;5.BS?H,)Z,O.2/[,C^%NSN 8WA B''<WW'[I&V!%<:_>%
M%YO<=]<VU;=.;0F+MK1HAT;FX,6LH&39,I9JAV!21ER;!-)A->5\?[],E'>R
MX3V>:IQO][3H;2C D!TU-JV=NG8KP8ML6DL[<(*KVL8Q*L3V\.PCJVS_VZRR
M229]VLY WCBC-)6V)X;R1J^WY>@-T]&;T6^O"/O%<#>L]M?BW8Z;V[KIU9J)
M43G;CT,[0W@S<QS@GBL*@ZB::YZSW[*EZ*_6Q6HEQ8H6YX9B94G%M]W]VZ6W
MSS\C3"2E_M0)7!-HHBZ3LP44DKE/3<F4FIQTYA_3;M@5Y6MY+M+)<IO.!5/*
M3L,#5 )D@>/:[85^ADJ56^CW5:)9'$%E\+K**(I,0OQ3E>1,@>/YOHVI/954
M,LYW1SD;5!G3**,#5,*)/2<T6WE^;(HV'WE#H\F@^*U^7H \>DY%83B>0EG0
MJPJ'-T#9S)G' 8UH/L;)9U\J#?0T08DH[]"M5#+>"[VM\70Q?34'F?0^.A1"
MKLRG%870A1!GOS]T3[O/-Q?VH\6VN?WV@S"T IA9+I;HBNIZ.F+2?DZQ-[K:
MF$\8]Y7656$NUX+#*:D!WB^K2K<WI*#[J'7^'U!+ P04    " !%A%=4?ID"
MS!L$  #7"0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6R=5FU/XS@0
M_BNCG'17)$B:M+# MI4*R^E..CA$N5N=5OO!32:-A6-G_4+AW]_824/1T@KQ
M)8D=SS//S#QC>[)6^L%4B!:>:B'--*JL;<Z3Q.05ULS$JD%)?TJE:V9IJ%>)
M:32R(AC5(LF&PY.D9EQ&LTF8N]6SB7)6<(FW&HRK:Z:?+U"H]31*H\W$'5]5
MUD\DLTG#5KA ^T]SJVF4]"@%KU$:KB1H+*?1/#V_./;KPX)_.:[-UC?X2)9*
M/?C!G\4T&GI"*#"W'H'1ZQ$O40@/1#1^=)A1[](;;G]OT'\/L5,L2V;P4HFO
MO+#5-#J-H,"2.6'OU/H/[.()!',E3'C"NEL[C"!WQJJZ,R8&-9?MFSUU>7B/
M0=899(%WZRBP_,(LFTVT6H/VJPG-?X10@S61X](796$U_>5D9V=? VTL8/Z(
MFJH BXII-/"WL\8R67"Y@L$]6PHT!Y/$DD=OE^0=^D6+GNU 3S.X5M)6!JYD
M@<5K@(2H]GRS#=^+;"_B%\QC&*6'D VS= _>J(]_%/!&._"NF)84HX%;U&WL
M\&V^-%:37+[OP1_W^.. /]Z!OZ N*IQ 4"7\E.L;5R_)+?WJLOXM9!KN\<G"
MA5#YP_>W<K[7H^_B<].P'*<1M:E!_8C1[#]DNJT!4 8QN/59''!)JA*"&L0<
MA)SZQY >Z=D+7];Q-2U+M:6-(]\3/(?T<)QE\<B_TY/X$[U'9VE\##>TKV!9
M4@_Z,'-5U]2*I.K\ ?"'XX],H+0&4K_VUU].LS3[#.E9/'RG<V9H-_&?!1<N
MM#D1&(WBTRTBXW08G\">6A[WM3Q^=RWGTO+6YR/U#.9.<\N)WM53+IQ/<ZE5
M#9>J;IQE@1@9_2RVM\J[G\1]A5 J09NI#]N\>%XC:1=?N;>T-F<B=Z*GL/Y@
M6I>8,V?00W*]J2B)Q[MH4'-5& ARDQY\Z3=[VH^=** B3S2!M -OY>P</B3)
MRUT"&J0'(!,&Z3B\%F&!:CSWU\$-L@,8P0D,X?KR=@&#$?D8;\P\RAUV<9C=
M<FV<-H[" :L(G/)1-T(]([9+C_PQ47AK.CI-F_I&,&D.85WQO *_R_AD'/4*
MHIA#D(7##:;O'*$,.5.&!XR0;FZZ?,<AE"VV9F?,'Z1+1Y&M2%*H<TZE;S3/
M22FV8K85VXIN 9:J1C.M$#::*AEIA,[X!PJ!4N9"QWC'KQ)*-XI@I9'D200Z
M&<6A)KNJP$F988]TC6J=YDJ26]/IVQ<U)NO2\U)PHRS"7^W.DGYN95$I49#!
M;W!%%;7/@0<KBI!C)BC+[56'1O%;FT:R==C6J%?A2N%9.FG;<[>?[6\M\_:P
M?EG>7GFNF5YQRK/ DDR'\2=J?=U>(]J!54TXNI?*TD4@?%9T\T+M%]#_4E%\
MW< [Z.]RL_\!4$L#!!0    ( $6$5U0LDCZ#Z 8   L3   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;*U8:V_;.!;]*X0W7=B :HMZ*YL$2)J9V0+M
M-$C:62R*^<!(M$U4$CTDE<?^^CFD;,5.8HTSV \F98J\]_#R\%R*)_=2_=!+
MS@UYJ*M&GXZ6QJR.9S-=+'G-]%2N>(,W<ZEJ9O!7+69ZI3@KW:"ZF@6^G\QJ
M)IK1V8EKNU)G)[(UE6CXE2*ZK6NF'B]X)>]/1W2T:;@6BZ6Q#;.SDQ5;\!MN
MOJVN%/[->BNEJ'FCA6R(XO/3T3D]OLAM?]?A-\'O]=8SL3.YE?*'_?.Q/!WY
M%A"O>&&L!8;JCG_@564- <8?:YNCWJ4=N/V\L?ZSFSOF<LLT_R"K_XC2+$]'
MV8B4?,[:RES+^W_S]7QB:Z^0E78EN5_W]4>D:+61]7HP$-2BZ6KVL([#(0."
M]8# X>X<.927S+"S$R7OB;*]8<T^N*FZT0 G&KLH-T;AK< X<W;#%PBQ(==\
M)941S8*,O[+;BNO)R<S ONTU*]:V+CI;P1Y;-""?96.6FOS4E+S<-3 #L!Y=
ML$%W$0Q:O.3%E(34(X$?T %[83_;T-D+#Y[M]_-;;12X\?N ^:@W'SGST1[S
MU[R032$JP1SCY!R.[GC3<C)7LB9K[YH823[(1LM*E,SPDGQW(2=?^8,A%Y4L
M?OS^6O '?=O->ZQ7K."G(^Q.S=4='YV=8]\\AV26'  ,JS1>VC   #:W:^\:
M'!B]!=:^8JM5)0KWRKHFPO!:$P&3K<+>*F2]8LVC#6FQ/35M4'6&X!M:HAP0
MC-2$:3BN( N:C&&H%E5E7WF$/Q1\90@Z%Q@);="38_)?SE1'+ ):\/J6*T>-
M7Z%<FH&QCB2V\%'0G'SFY4VK%N2(A%X:1*[VD\35H9^2Z^6C6=:$-25LM$JB
M.<A#$GAI'."91C[YP%0IY!W315O!>^1E<89769K@.? S\M4&DC0]!,SQM1A2
MBC$QR;TDCPCUO22.R'E5$8G(*C*^6?%"L,H\DJLE@]04O#6(=:4GA (0YG)$
M,KK+F2>?1\Y\EN$A]W(,.+(NTC F Y2.>TK';Z1TR<&O8OW_]O&5^3K*N, <
M1NQ!!*\3>Q\9+K?!\0>D+LWW\P(Q1>&CP.*\H /U(Y(G) ^>TX F*:%801IN
M"%"^YG8/%T++KM GH9\<R(%__B,+:/ O2US\DET>O.KZR'E!&=H1(:5#5$AZ
M*B1OI,*7;CMCSU\I.1>&C#])#<#_#[4;Q/(V4GQLH$Z<C"L'[I9#[:!?7:-A
M#T/*0;TPSUWMIUT=@!4OJ)) 3J(P)PGDY3E9O"C*\(+BB8;IFC"RC]P:QSZR
M>!&(%G@4WJ%><',894#.*"1Q0KXU# I;N,"S6K8P>HSE4'"%M@UAH+G 4;6E
M1;3DY<+6[L DC$!\QE&43E#Z,<H@B2;D%RG+>PBV"T*'1T"JFX6P^)G6D">!
ME""44X0" !?6#2O^:(46ED&S$N<Q;81I%7^O>-7+VKHS&1>*E\+HB8?8($NW
M!;HZ9/"YT_)7PPN.P"+%5'"\</0='N$\_/3-$L$&%'2Z$P5'-E]@31W[QY\O
MKR=VAI7+;EUC(376;&S)XD]LC12!.LZ""3FO[8GC?[O[=)Q&%!W2+$>9Y"B_
M/"?&FK4@#X@XSGS[&-.,?%G'O.NT-HBIVOF,:1"B'[J',/_7]._X;3/C. 4&
M:$R6#BE&VBM&.J@8F^/6"[8C\S\E=\O]IVQVF#H,^WT1Q#V["S#87B![QNP3
MF3T2$J;3A+R#'$\#6R73"-7+5).Y=AI/<U0!=9V?"4F03S/;)YU2VR>=^N3=
MP!IE_1IE;U3U<[MY]8Z(_TT-'_2\Y\3J K\3V4XQ68?J*<S;(IWFD:L39.27
MP?7RS*IO%J0O8HI&F/,BR/..FSV+GWAQ'I/8RX.WYFXK_N&3:E(+*K/GM9CV
M6WE7/G6WEQ./ B)<TFWM+WH%7P-.O3B(46:Q/<Z$@1<$-E^%. BF@WLY[WF2
M#^_E GFAK=PFN12Z@)I MPDH\PN7"\562U&0<\49<'^2D.1/4/=R0R9H[\<&
M>B_*%D'&]S2^EAM0"OE(V02#<V3WY_% :@V"/9A:#FCE@+[@E]O&WZ8W4\<L
MFOM='=.N1E+_:',(:!:%"0DSG.I L"_KY=E,+,&JQ!B3X-B 0Q+$QCQZ9(5Q
MQE&4(QVN++FZU<:ZX> 6>'YFL[X]<[Q.&1SP*03[8.: &%FRE5PJK!,^]^R5
MQ7LY?]_JGDA8J<YJ96-CN*HW;R)\443V^R>TF2( L[ 7$(O,B_R\:XGV<&VV
M=4%1<^1:>PVCNS!U=Q5]:W_3<]Y=<#QU[ZZ)/B-5"WP_5GR.H?XTQ=>#ZJY>
MNC]&KMQUQZTT1M;N<<E9R97M@/=S*<WFCW70WW^=_0E02P,$%     @ 1817
M5*S6D;@,!0  0@H  !D   !X;"]W;W)K<VAE971S+W-H965T-#<N>&ULE5;;
M;N,V$/V5@;$/">#&HJY4D!APLFF[P*9KY-*B*/:!EFA+B"2J)!7'?]]#RO:F
MBTV*OD@D19XY,W-FQ(NMTD^FDM+22]MTYG)26=N?SV:FJ&0KS)GJ98<O:Z5;
M83'5FYGIM12E/]0VLS (TEDKZFXRO_!K2SV_4(-MZDXN-9FA;87>7<E&;2\G
M;')8N*LWE74+L_E%+S;R7MK'?JDQFQU1RKJ5G:E51UJN+R<+=GX5N_U^P^^U
MW)I78W*>K)1Z<I-/Y>4D<(1D(POK$ 1>S_):-HT# HV_]YB3HTEW\/7X@/ZS
M]QV^K(21UZKYHRYM=3GA$RKE6@R-O5/;7^7>G\3A%:HQ_DG;<6^<3*@8C%7M
M_C 8M'4WOL7+/@ZO#O#@C0/A_D#H>8^&/,N/PHKYA59;TFXWT-S N^I/@US=
MN:3<6XVO-<[9^9U\EMT@Z>1!K!II3B]F%JCNVZS8(UR-".$;""RD6]79RM!-
M5\KRWP ST#ER"@^<KL)W$3_*XHPB-J4P"-D[>-'1Q\CC16_AU49L-EINA!>"
M6M/!Z[\6*V,UE/'U'3/QT4SLS<3_WXP/+CW(%TM7C2J>OOXHS.^BN^(\-[TH
MY.4$U6>D?I:3^4,E::T:5%;=;<CZ%%+YC8<D-6C4SDACK55+!7+E/#80FJWV
M$I/:T&I'J\' JC$DNI(V4FVTZ*L:[.3&>712=Y!@TV!L3L_I3RGTF'-"QF2[
MDOJ8-?<(\& Y7>U!P>SQ[/Z,OCS>TX.RHOF/*9"5*52_HP_$IF$8XIT#[P.%
M4Q8SOQH$ =X9#_SL\ [\F[/8SW@>TZ-6C=KLO%]+V3S#IU^E:. _FS(0C=,(
MHX1'L, I2KFSR%-O(:$X</.8170M=%F+@NZJG:U:NA4=&A=:E'7[88]C=SAU
M7N=Y2!E* ZR"V%F)$GQUHSS*Z<8U):WZ:H?FYIFQD%,89;"=$ ,'EN84\HQ8
MC#'\B<*<?I,#,JC*H1D5EH$1RU/*@YQ2%A!+&&4IHS0'1L:)9Q%]ZJR32N<.
M(*C>@;W%:>+]2B*@3X.(4\X9YA'+X$.8Y\ZGW,<%L0^GG*6(G:[[2FH@O08V
M<#<E'CKW.,+).:>4.X DRRA#LM+$0R,H][TL:H1^1\M*H*T6<K!U(1I#\
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M.-FD<K+)R4YVCR(G-;_*/?X^U#XBD2%:)WI7.T=*QKD7D&8[##5LT2*0:90
M2UXL./',BWTC1=#(LA"Q!DQA$>F'-O/8<LGS1,)UN6Z6K;'U10>XL(6PY&+=
M-,!U5U9=B<T-?,);+%MI'FN8"#*5 /*I9R@[A\*SWF9\2'QL';"N[Q*-TQ^>
MYP>/#K-*GGW^MIHV9;S((<BS'Y8PDVG;!M2#J1DTS8Q:!^(,<[U7V;<&7M=E
MZ+GO&TS.H(L>2^;R58@I%@.C;JT:UMO0;&S05WW/J^BGM&"#F:--ZZ)_L=L;
M)#)[$@JW:WL&>/7XF$5>36RW39?U6FJ'VQ\ZYY ,.+#^"*_JEIPXY\61GI]4
M-)S^U#U'HFQ,QS$N)?8DH'6$1I,:EA+::* V<UMJMGQ!7+&N4I^Z"XD^N9/.
M_$WN*#RVX"EA4S>EJMS/@A"E+[PN3-*LR&&8E8D'WW'A.7[]_['EG;^'Y5G_
M\JCEF;4\^VV6'T_.B>CTO'"JOX'E6\K*M"HKT]-W!VAO/U>QV> =JAVM9(]W
M][N"8FR%:D!0*Q^;$%54_N:E!&1GWR)%%AD9T3#UA?SPQJ!EQ]!(R?\23R("
M5IS=XNP5&\%Y]O(=3K?;/FP/=*-CW5U12Y\?\V554G]C\E^'CW,,'^=/P<?U
MBN,I^%236]S]LG+WR]_3JO_1K6XKT]_?IJ^.]@=E\UYT&W]>#U\3H=PU>=C0
M[K7PK+*7[<TC$JC(_'6I<4<&Q>M&M??NA+GT6W"%R3Y,>6+VGKO@UOI^:ONA
M2VT_MNO#'N"^^ \W\@PGLZJ1;^IM=]:D_5V;@9IA6$9&H;NM%<=;P2)R[JK(
MF7,DXA^-UR(D6N%NV.0U;KC[>51HO950FMZZ6*=:-F%D[+=LA7IO2,V*1-<2
MR,S9O;9V3@[EJN.H=D3\Q6[_#KZZ;J5[.%I+NFE!U[X2M!QQ![04.5I!IFSB
M1C=(*%\8D< +1MXN7(^V,Q?V<2V'8]VGD9-ZE_U^K>E9]-H9#KWN1H.XUB!T
MY4$>^T.* 3R/:"^-9[SQZ#SYSG4\!LRY/&B]0>W[0RS4VGYET6"[Q/Q31#5:
M?<F9Y=\O=M/SST _<(7)1T,D5K@4&_A1!U3^926_,3*U7S.6TA@9V\N-X(%0
M- &?KZ0TY0TQJ+YOW?X74$L#!!0    ( $6$5U2+)P.-S0(  "L(   9
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MJ>&QWL=YDJ.-?&Q=S[+!0[P!H:/F[+GK>+H8J&;)]?%IE@ 14,,#MC:D;7*
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M&1CV:($XAA>H,!DZ I$O"(9\X;"\<X[I1C9Y*50@0@?A'+Q[SFFZYX!^$Y5
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M)\#SE83K1=ZQWPF*#TG3OP!02P,$%     @ 18175$A.MDUD!P  A"D  !D
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M6NXJ&<2DQ D!FBA//R'U&XB>G#GI\;7M':Y'U$D?N6=D%)/",@*D/.>#5'?
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MA()#L?F+0)LO5;YN_F#(0UY5^:KY^(CC.2YH _+[19Y7W1?Z-TBV?YCI[?\
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MU@8[0D&3<]BIS $&E%,8.OK#CE"WY(R)O]^5]; C5$(Y5DJA'*$6RCDL73[
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MV<[!X)683#G#AO= 0E%_+8"0;PMY&D^^FT]O/3,\6QX],":F@*@("07])0/
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M/_/FE:_F2RFV]4M0"U&68E-_?.1,'F<E(/^^$J+<?5$7V+]X=_$?4$L#!!0
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MS&Z!X!U7L(?8 ?K[X%[@ B5$Y""?!83#R=DL5';AOI# QZLD]$YRI 7:2O'
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MD]:HA7RVHG&@[\3^DJ4!)00]$:CD%^W3N4X+>;'2(DR-@4'(H\-_^C5-1,&
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M5GTE>1$@]47@@]"P86U4"R?ON$L*G&^>XUQ1$W"Y8>X6/K&9S],W5*XYG.2
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MDHQ'0-#-6>\<OK_&3@)(+;XPNI>5:Y!,9<WYM^3FQC_KV0DC&E!/)2Z(_O=
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M*?&I2 ST\PWGZNDF.5LO?D":_P]02P,$%     @ 18175!\NX\''#0  NU8
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M,AV(;]+#)X#>&YUY)5[&>L#\^U;Z+P78+MHVO78PZ-)0W(X#VG&:)I6P'0_
M[7LQZ6V1J7J"I]4)=4>F2TP@>@*4%%, $8"4+D<%RO@I(3S68_C?9[Q?\D>@
M<&B7D  -:==A$(W*I+("P3TER-Y,>IZD<Q;TNV2WWCBR+:!^@0@MBP(."1!2
MZJG]498P6%_#_%;C_9)+NKI:MK(O0-/!H%T:XBBL*@LFO/.*:6NW+^L\R_UX
MQBMK756$N]4)P91"7@=0FI@0P.T@2L/NUEJ7$*5E&E3IH4361F3GM9$F1U^D
M20:"U4JJ!H1V 2.-04(,@'* D'@>49M(EC-DY^7,UD1G/UDZ#3+64[.0;H5Q
M1)UF4Z6R#T!I&@#E!!S3=306DF4+T6/X'5L("&0;*G6#LQ*YT5(UV\;KIYE
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M%T)Q;#AH@TY%:#@(&&)(P!Z*M8?"Z^'EH@VJ__7!)'\H.:TEY(2PV\<I,IR
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M][E9:+,RH>9Z: R@,+)2>I"MT)5^Y9J[^7ON=;A]BRMBUIT= ,5B[& &KJ6
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M_Z4IE]T[F ]ETY2+[N-<)E-9M0#U^V-9-B]?V@K6[_U>_!]02P,$%     @
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;,U<:6_C.!+]*X0Q"W2
MMBU1IP=)@)R[C>V>#CJ362P&^T&6F9@8'1Z)RK'8'[^DY)BR6*05N3/M+_%5
M1=53D?6JR%*.G_+BCW))"$//:9*5)Z,E8ZN?I],R7I(T*B?YBF3\E_N\2"/&
M/Q8/TW)5D&A1*Z7)%%N6/TTCFHU.C^OO;HK3X[QB"<W(38'**DVCXN6<)/G3
MR<@>O7[QC3XLF?AB>GJ\BA[(+6%WJYN"?YIN1EG0E&0ES3-4D/N3T9G]\]7,
M$@JUQ&^4/)6M]TA F>?Y'^+#I\7)R!(6D83$3 P1\9='<D&21(S$[?AS/>AH
M<TVAV'[_.OIU#9Z#F4<EN<B3?]$%6YZ,PA%:D/NH2MBW_.D?9 W($^/%>5+6
M?]'36M8:H;@J69ZNE;D%*<V:U^AY?2-:"K:K4<!K!=Q7P5DK.'T5W+6"VU?!
M6RO4T*<-]OK&748L.CTN\B=4"&D^FGA3W_U:F]\OFHF)<LL*_BOE>NST*ETE
M^0LAZ!MAM"!\"C!TDT19B3Y<$A;1I#Q"8W1W>XD^_'2$?D(T0U]HDG ?E\=3
MQ@T0PTSC]<7.FXMAS<7.JH<)LF<?$;;L&:!^85:_)/$$.;90QS:@?ME?W0+4
MKWJK=XV?\IN^N?-X<^=Q/9ZC'>^>% 59H(L\Y<N^C.J%<U844?;0^.&)LB7Z
ME"WH(UU44?(1W>0E*Z2?SDE&[BDKT>^?^=CH$R-I^1^#9<[&,J>VS-5;QK]9
MO(Y?SX>/Z"R.J[1*(M;ZY>L\H0^UX9 WFZMX]55$P'H\=8/P>/K8=IDJXUG^
M1F;+?'=COCO _'XF-R,'+7/&GH4[-D-"3D?HRE6 C=TPA)%Y&V3> &3B+SHK
M2\)*[J4TKS(&0?,4JQW'[R #9#RO PP:!\.X_ TN?\B$JZ&4B+-A P]]^$RC
M.4TH>SGB\2K.'S+Z7Z[&8](MX_.R7A3Y/;JF693%-$K$@J$Z5_L*#MOOW@]
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !%A%=4_R+I^H$%  #;+@  #P
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M/+#_IQG-<BEK<6KJKA7:#^UHA0J VJWEQHV8YJV8C4[,@[#A]\ 7G#?#;_,
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M<F]P<R]A<' N>&UL4$L! A0#%     @ 18175-LJ8/[N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 1817
M5)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !%A%=4J*4I1MX&  #M'@  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 1817
M5-/U1](@ @  < 4  !@              ("!(0\  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( $6$5U2:6A@$8 8  /4:   8
M      " @7<1  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" !%A%=4AKQV+3X#   !"@  &               @($-&   >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ 18175*QPT&8E!P   AT  !@
M             ("!@1L  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( $6$5U2;W+9GMP(  -$(   8              " @=PB  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !%A%=4S2&/[P((   "
M*P  &               @('))0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ 18175(4H6& K"P  CS4  !@              ("! 2X
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( $6$5U2S_O-5
ML0(  )@(   8              " @6(Y  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " !%A%=4]W5S4XDJ   2A0  &0
M@(%)/   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( $6$
M5U3-S]'R01D  *I3   9              " @0EG  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ 18175*<$>#H$!0  ?PL  !D
M         ("!@8   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " !%A%=4*7CTQ4('  "]$@  &0              @(&\A0  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( $6$5U1P[:ZO8AP  (-I
M   9              " @36-  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ 18175.6-R5-]%0  UD0  !D              ("!SJD
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !%A%=4(KZ9
M'K0'  !L%   &0              @(&"OP  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( $6$5U3#I\B]B@H  )4@   9
M  " @6W'  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M18175)4*%(;C!@  ]@\  !D              ("!+M(  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " !%A%=4]J-$@)\1  !Y,0  &0
M            @(%(V0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( $6$5U2@D V$)"@  +QZ   9              " @1[K  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 18175!@M.AJ!"@
MCAP  !D              ("!>1,! 'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " !%A%=4)]3%@4P3  #K.   &0              @($Q
M'@$ >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( $6$5U2O
MY3I<7@4  /,,   9              " @;0Q 0!X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ 18175"G+$8 6"0  7Q@  !D
M     ("!23<! 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $6$5U3^GN?F. 0  !4*   9              "
M@<UF 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 1817
M5!U*%S.)+@  29T  !D              ("!/&L! 'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " !%A%=4RQ3@Z7($   O"P  &0
M        @('\F0$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( $6$5U2RRJ!OIP4   $/   9              " @:6> 0!X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ 18175*"+$K?6!P  SA@
M !D              ("!@Z0! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " !%A%=4]^E#::\"  #^!0  &0              @(&0K $
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( $6$5U11-M^H
M4 H  ' F   9              " @7:O 0!X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ 18175!LRSI,: P  V 8  !D
M ("!_;D! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !%
MA%=4$8(N"L,%   -#P  &0              @(%.O0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( $6$5U0V<8NY/PP  "<K   9
M          " @4C# 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#
M%     @ 18175.(Z!%Y0"   NA4  !D              ("!OL\! 'AL+W=O
M<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " !%A%=4?1B?&M8#   2
M"P  &0              @(%%V $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM
M;%!+ 0(4 Q0    ( $6$5U03$*T"I@<   ,:   9              " @5+<
M 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 18175-=/
MAIW!!@  (1,  !D              ("!+^0! 'AL+W=O<FMS:&5E=',O<VAE
M970T,BYX;6Q02P$"% ,4    " !%A%=4CA)J\S4(  #M%0  &0
M    @($GZP$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M $6$5U1M_>VO8@D  . :   9              " @9/S 0!X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ 18175'Z9 LP;!   UPD  !D
M             ("!+/T! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    " !%A%=4+)(^@^@&   +$P  &0              @(%^ 0( >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( $6$5U2LUI&X# 4
M $(*   9              " @9T( @!X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ 18175&/;?M1_ P  )PD  !D              ("!
MX T" 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " !%A%=4
M&MW?R_D'  #K&@  &0              @(&6$0( >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( $6$5U2+)P.-S0(  "L(   9
M      " @<89 @!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ 18175*4Y0W=:%   6ZH  !D              ("!RAP" 'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " !%A%=4<[*/M <&  "F)
M&0              @(%;,0( >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( $6$5U05D#B1'P,   0)   9              " @9DW @!X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ 18175*JW\I]M
M!   5!(  !D              ("![SH" 'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    " !%A%=42$ZV360'  "$*0  &0
M@(&3/P( >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( $6$
M5U39]P-7J!,  -R7   9              " @2Y' @!X;"]W;W)K<VAE971S
M+W-H965T-38N>&UL4$L! A0#%     @ 18175%* K;,P$   I&D  !D
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M=#8Q+GAM;%!+ 0(4 Q0    ( $6$5U3(_:]C\PL  + ^   9
M  " @;*, @!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @
M18175,I/ X.S!0  @Q<  !D              ("!W)@" 'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6Q02P$"% ,4    " !%A%=4H]<96*P%  !,&@  &0
M            @('&G@( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4
M Q0    ( $6$5U0?+N/!QPT  +M6   9              " @:FD @!X;"]W
M;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ 18175 <3 >IU P
MF T  !D              ("!I[(" 'AL+W=O<FMS:&5E=',O<VAE970V-BYX
M;6Q02P$"% ,4    " !%A%=4M;S8WWL*   #/   &0              @(%3
MM@( >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( $6$5U0I
MKLH+<0D  .,]   9              " @07! @!X;"]W;W)K<VAE971S+W-H
M965T-C@N>&UL4$L! A0#%     @ 18175*P8:2S7!   ;!0  !D
M     ("!K<H" 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4
M" !%A%=4AVKSE,,)  "A00  &0              @(&[SP( >&PO=V]R:W-H
M965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( $6$5U0UE(S^70,  #D*   9
M              " @;79 @!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L!
M A0#%     @ 18175(@@=>U' P  +A0   T              ( !2=T" 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " !%A%=4EXJ[',     3 @  "P
M        @ &[X ( 7W)E;',O+G)E;'-02P$"% ,4    " !%A%=4_R+I^H$%
M  #;+@  #P              @ &DX0( >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ 18175+ % +TV @  '"H  !H              ( !4N<" 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 18175.'+1LC] 0
M/2D  !,              ( !P.D" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     $\ 3P"@%0  [NL"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>619</ContextCount>
  <ElementCount>785</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>158</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - Consolidated Balance Sheet Paranthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical</Role>
      <ShortName>Consolidated Balance Sheet Paranthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1007009 - Statement - Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure</Role>
      <ShortName>Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2105102 - Disclosure - Acquisitions and Strategic Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</Role>
      <ShortName>Acquisitions and Strategic Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Assets and Liabilities Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale</Role>
      <ShortName>Assets and Liabilities Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Hedging Activities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</Role>
      <ShortName>Hedging Activities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Contractual Obligations and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</Role>
      <ShortName>Contractual Obligations and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2126108 - Disclosure - Restructuring Related Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RestructuringRelatedActivities</Role>
      <ShortName>Restructuring Related Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2132110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2136111 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2139112 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2141113 - Disclosure - Stock Inventive and Purchase Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockInventiveandPurchasePlans</Role>
      <ShortName>Stock Inventive and Purchase Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2144114 - Disclosure - Weighted Average Shares Outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</Role>
      <ShortName>Weighted Average Shares Outstanding</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2147115 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2150116 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2153117 - Disclosure - Changes in Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</Role>
      <ShortName>Changes in Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2156118 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2158119 - Disclosure - Employee Retirement Plans (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes</Role>
      <ShortName>Employee Retirement Plans (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2162120 - Disclosure - Schedule II</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ScheduleII</Role>
      <ShortName>Schedule II</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2217202 - Disclosure - Fair Value Measures and Disclosures (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies</Role>
      <ShortName>Fair Value Measures and Disclosures (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2238203 - Disclosure - Commitment and Contingencies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentandContingenciesPolicies</Role>
      <ShortName>Commitment and Contingencies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2257204 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2259205 - Disclosure - Employee Retirement Plans Employee Retirement Plans (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies</Role>
      <ShortName>Employee Retirement Plans Employee Retirement Plans (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2306302 - Disclosure - Acquisitions and Strategic Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</Role>
      <ShortName>Acquisitions and Strategic Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2311303 - Disclosure - Assets and Liabilities Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables</Role>
      <ShortName>Assets and Liabilities Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2314304 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2318305 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2321306 - Disclosure - Contractual Obligations and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</Role>
      <ShortName>Contractual Obligations and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2324307 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2327308 - Disclosure - Restructuring Related Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables</Role>
      <ShortName>Restructuring Related Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RestructuringRelatedActivities</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2330309 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2333310 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2342311 - Disclosure - Stock Incentive and Purchase Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables</Role>
      <ShortName>Stock Incentive and Purchase Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2345312 - Disclosure - Weighted Average Shares Outstanding (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</Role>
      <ShortName>Weighted Average Shares Outstanding (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2348313 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReporting</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2351314 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Revenue</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2354315 - Disclosure - Changes in Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</Role>
      <ShortName>Changes in Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2360316 - Disclosure - Employee Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansTables</Role>
      <ShortName>Employee Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Acquisitions and Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails</Role>
      <ShortName>Acquisitions and Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContingentConsiderationDetails</Role>
      <ShortName>Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StrategicInvestmentsDetails</Role>
      <ShortName>Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Goodwill and Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2419407 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2422408 - Disclosure - Contractual Obligations and Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails</Role>
      <ShortName>Contractual Obligations and Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2425409 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/LeasesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2428410 - Disclosure - Restructuring Related Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails</Role>
      <ShortName>Restructuring Related Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2431411 - Disclosure - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2434412 - Disclosure - Income Taxes (Details - Rate Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable</Role>
      <ShortName>Income Taxes (Details - Rate Table)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2435413 - Disclosure - Income Taxes Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails</Role>
      <ShortName>Income Taxes Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2437414 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/CommitmentsandContingencies</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2440415 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockholdersEquity</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2443416 - Disclosure - Stock Incentive and Purchase Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails</Role>
      <ShortName>Stock Incentive and Purchase Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446417 - Disclosure - Weighted Average Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails</Role>
      <ShortName>Weighted Average Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2449418 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReportingTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2452419 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RevenueTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2455420 - Disclosure - Changes in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Changes in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2461421 - Disclosure - Employee Retirement Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails</Role>
      <ShortName>Employee Retirement Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="bsx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2463422 - Disclosure - Schedule II (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ScheduleIIDetails</Role>
      <ShortName>Schedule II (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ScheduleII</ParentRole>
      <Position>71</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="bsx-20211231.htm">bsx-20211231.htm</File>
    <File>bsx-20211231.xsd</File>
    <File>bsx-20211231_cal.xml</File>
    <File>bsx-20211231_def.xml</File>
    <File>bsx-20211231_lab.xml</File>
    <File>bsx-20211231_pre.xml</File>
    <File>exhibit21-listofsubsidiari.htm</File>
    <File>exhibit23-2021eyconsent.htm</File>
    <File>exhibit311-ceo302202110xk.htm</File>
    <File>exhibit312-cfo302202110xk.htm</File>
    <File>exhibit321-ceo906202110xk.htm</File>
    <File>exhibit322-cfo906202110xk.htm</File>
    <File>exhibit42-descriptionofthe.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>bsx-20211231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1972">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>99
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20211231.htm": {
   "axisCustom": 2,
   "axisStandard": 35,
   "contextCount": 619,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 1064,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 6,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 11
   },
   "keyCustom": 124,
   "keyStandard": 661,
   "memberCustom": 92,
   "memberStandard": 58,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.bostonscientific.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://www.bostonscientific.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i7862dc97bbe245dc92c012be4bc24ff9_D20210806-20210806",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105102 - Disclosure - Acquisitions and Strategic Investments",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments",
     "shortName": "Acquisitions and Strategic Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i7862dc97bbe245dc92c012be4bc24ff9_D20210806-20210806",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Assets and Liabilities Held for Sale",
     "role": "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale",
     "shortName": "Assets and Liabilities Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Hedging Activities and Fair Value Measurements",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
     "shortName": "Hedging Activities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Contractual Obligations and Commitments",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitments",
     "shortName": "Contractual Obligations and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Leases",
     "role": "http://www.bostonscientific.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126108 - Disclosure - Restructuring Related Activities",
     "role": "http://www.bostonscientific.com/role/RestructuringRelatedActivities",
     "shortName": "Restructuring Related Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Supplemental Balance Sheet Information",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132110 - Disclosure - Income Taxes",
     "role": "http://www.bostonscientific.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.bostonscientific.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136111 - Disclosure - Commitments and Contingencies",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139112 - Disclosure - Stockholders' Equity",
     "role": "http://www.bostonscientific.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141113 - Disclosure - Stock Inventive and Purchase Plans",
     "role": "http://www.bostonscientific.com/role/StockInventiveandPurchasePlans",
     "shortName": "Stock Inventive and Purchase Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144114 - Disclosure - Weighted Average Shares Outstanding",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding",
     "shortName": "Weighted Average Shares Outstanding",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147115 - Disclosure - Segment Reporting",
     "role": "http://www.bostonscientific.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150116 - Disclosure - Revenue",
     "role": "http://www.bostonscientific.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153117 - Disclosure - Changes in Other Comprehensive Income",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome",
     "shortName": "Changes in Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156118 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158119 - Disclosure - Employee Retirement Plans (Notes)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes",
     "shortName": "Employee Retirement Plans (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i51845faa20174064ac84a92ea5ff121a_D20180101-20181231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162120 - Disclosure - Schedule II",
     "role": "http://www.bostonscientific.com/role/ScheduleII",
     "shortName": "Schedule II",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i51845faa20174064ac84a92ea5ff121a_D20180101-20181231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - Consolidated Statements of Operations",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Policies)",
     "role": "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2217202 - Disclosure - Fair Value Measures and Disclosures (Policies)",
     "role": "http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies",
     "shortName": "Fair Value Measures and Disclosures (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i46f8fa0b6c8c432d9384623e2768c3a3_D20211001-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2238203 - Disclosure - Commitment and Contingencies (Policies)",
     "role": "http://www.bostonscientific.com/role/CommitmentandContingenciesPolicies",
     "shortName": "Commitment and Contingencies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2257204 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2259205 - Disclosure - Employee Retirement Plans Employee Retirement Plans (Policies)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies",
     "shortName": "Employee Retirement Plans Employee Retirement Plans (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306302 - Disclosure - Acquisitions and Strategic Investments (Tables)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
     "shortName": "Acquisitions and Strategic Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i88982097e17e4e148f4e0e1928230864_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311303 - Disclosure - Assets and Liabilities Held for Sale (Tables)",
     "role": "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables",
     "shortName": "Assets and Liabilities Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i88982097e17e4e148f4e0e1928230864_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314304 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318305 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables",
     "shortName": "Hedging Activities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321306 - Disclosure - Contractual Obligations and Commitments (Tables)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables",
     "shortName": "Contractual Obligations and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324307 - Disclosure - Leases (Tables)",
     "role": "http://www.bostonscientific.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327308 - Disclosure - Restructuring Related Activities (Tables)",
     "role": "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables",
     "shortName": "Restructuring Related Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330309 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333310 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342311 - Disclosure - Stock Incentive and Purchase Plans (Tables)",
     "role": "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables",
     "shortName": "Stock Incentive and Purchase Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345312 - Disclosure - Weighted Average Shares Outstanding (Tables)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables",
     "shortName": "Weighted Average Shares Outstanding (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348313 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351314 - Disclosure - Revenue (Tables)",
     "role": "http://www.bostonscientific.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354315 - Disclosure - Changes in Other Comprehensive Income (Tables)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables",
     "shortName": "Changes in Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2360316 - Disclosure - Employee Retirement Plans (Tables)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables",
     "shortName": "Employee Retirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Details)",
     "role": "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i88982097e17e4e148f4e0e1928230864_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProductionRelatedImpairmentsOrCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Acquisitions and Strategic Investments (Details)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
     "shortName": "Acquisitions and Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i37ca5fe42a2b44c498ee39b80b6e9c8a_I20210301",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Contingent Consideration (Details)",
     "role": "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
     "shortName": "Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bsx:PaymentOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Strategic Investments (Details)",
     "role": "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
     "shortName": "Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Assets and Liabilities Held for Sale (Details)",
     "role": "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i08b0dfa99eed4161a4a7fe92ff91c858_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Goodwill and Other Intangible Assets (Details)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419407 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422408 - Disclosure - Contractual Obligations and Commitments (Details)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
     "shortName": "Contractual Obligations and Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425409 - Disclosure - Leases (Details)",
     "role": "http://www.bostonscientific.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428410 - Disclosure - Restructuring Related Activities (Details)",
     "role": "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
     "shortName": "Restructuring Related Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "ieb47c6e02c3a415cb0b197ae67d91c5b_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - Consolidated Balance Sheet Paranthetical",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
     "shortName": "Consolidated Balance Sheet Paranthetical",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431411 - Disclosure - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails",
     "shortName": "Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434412 - Disclosure - Income Taxes (Details - Rate Table)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable",
     "shortName": "Income Taxes (Details - Rate Table)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435413 - Disclosure - Income Taxes Income Taxes (Details)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
     "shortName": "Income Taxes Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i28a14163a2a74f7b8d354e3243028f49_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437414 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440415 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.bostonscientific.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i76d5c1eb8c3c498e932fff915c09dd38_I20201214",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bsx:Fairvalueofmarketbasedawards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443416 - Disclosure - Stock Incentive and Purchase Plans (Details)",
     "role": "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
     "shortName": "Stock Incentive and Purchase Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bsx:Fairvalueofmarketbasedawards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446417 - Disclosure - Weighted Average Shares Outstanding (Details)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails",
     "shortName": "Weighted Average Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449418 - Disclosure - Segment Reporting (Details)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingDetails",
     "shortName": "Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:EmergingMarketsTotalNumberOfCountries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "countries",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452419 - Disclosure - Revenue (Details)",
     "role": "http://www.bostonscientific.com/role/RevenueDetails",
     "shortName": "Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:EmergingMarketsTotalNumberOfCountries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "countries",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455420 - Disclosure - Changes in Other Comprehensive Income (Details)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
     "shortName": "Changes in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "icea25cb690174465b8215ce1c263a42a_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i55c9f4684ac746bda57f532f6a87f684_I20181231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i55c9f4684ac746bda57f532f6a87f684_I20181231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461421 - Disclosure - Employee Retirement Plans (Details)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
     "shortName": "Employee Retirement Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i28a14163a2a74f7b8d354e3243028f49_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463422 - Disclosure - Schedule II (Details)",
     "role": "http://www.bostonscientific.com/role/ScheduleIIDetails",
     "shortName": "Schedule II (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "icea25cb690174465b8215ce1c263a42a_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i5a7e85edfd944485b37c2bfb0a6ba2db_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "i17733ef333a04949b7d70a7bfa14f475_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007009 - Statement - Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
     "shortName": "Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20211231.htm",
      "contextRef": "icea25cb690174465b8215ce1c263a42a_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 158,
   "tag": {
    "bsx_A2011LtipPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2011 LTIP Plan [Member]",
        "label": "2011 LTIP Plan [Member]",
        "terseLabel": "2011 LTIP Plan [Member]"
       }
      }
     },
     "localname": "A2011LtipPlanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2016RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Restructuring Plan [Member]",
        "label": "2016 Restructuring Plan [Member]",
        "terseLabel": "2016 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "A2016RestructuringPlanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2019AcquisitionsVertiflexAndMillipedeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Acquisitions (Vertiflex and Millipede)",
        "label": "2019 Acquisitions (Vertiflex and Millipede) [Member]",
        "terseLabel": "2019 Acquisitions (Vertiflex and Millipede)"
       }
      }
     },
     "localname": "A2019AcquisitionsVertiflexAndMillipedeMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2019RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Restructuring Plan [Member]",
        "label": "2019 Restructuring Plan [Member]",
        "terseLabel": "2019 Restructuring Plan [Member]",
        "verboseLabel": "2019 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "A2019RestructuringPlanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2020TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Term Loan",
        "label": "2020 Term Loan [Member]",
        "terseLabel": "2020 Term Loan [Member]"
       }
      }
     },
     "localname": "A2020TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2021AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Acquisitions",
        "label": "2021 Acquisitions [Member]",
        "terseLabel": "2021 Acquisitions"
       }
      }
     },
     "localname": "A2021AcquisitionsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]",
        "label": "ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]",
        "terseLabel": "ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2019-12, Income Taxes (Topic 740)",
        "label": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2019-12, Income Taxes (Topic 740)"
       }
      }
     },
     "localname": "ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)",
        "label": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)"
       }
      }
     },
     "localname": "ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2020-10 Codification Improvements",
        "label": "ASC Update No. 2020-10 Codification Improvements [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-10 Codification Improvements"
       }
      }
     },
     "localname": "ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments",
        "label": "ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments [Policy Text Block]",
        "terseLabel": "ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments"
       }
      }
     },
     "localname": "ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers",
        "label": "ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers [Policy Text Block]",
        "terseLabel": "ASC Update No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers"
       }
      }
     },
     "localname": "ASCUpdateNo202108AccountingForContractAssetsAndContractLiabilitiesFromContractsWithCustomersPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AccruedRebatesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Rebates, Current",
        "label": "Accrued Rebates, Current",
        "terseLabel": "Accrued Rebates, Current"
       }
      }
     },
     "localname": "AccruedRebatesCurrent",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ActualCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actual Covenant.",
        "label": "Actual, Covenant [Member]",
        "terseLabel": "Actual, Covenant [Member]"
       }
      }
     },
     "localname": "ActualCovenantMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]",
        "label": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]",
        "terseLabel": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "AggregateSeniorUnsecuredDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AllOther2021AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other 2021 Acquisitions",
        "label": "All Other 2021 Acquisitions [Member]",
        "terseLabel": "All Other 2021 Acquisitions"
       }
      }
     },
     "localname": "AllOther2021AcquisitionsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid in the period to fully or partially settle a specified type of restructuring cost.",
        "label": "Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Table Text Block]",
        "terseLabel": "Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Text Block]"
       }
      }
     },
     "localname": "AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of employees total compensation eligible for GESOP purchase",
        "label": "Amount of employees total compensation eligible for GESOP purchase",
        "terseLabel": "Amount of employees total compensation eligible for GESOP purchase"
       }
      }
     },
     "localname": "AmountOfEmployeesTotalCompensationEligibleForGesopPurchase",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_Annualweightedaverageforfeiturerate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Weighted Average Forfeiture Rate The weighted average of estimated forfeitures for grants based on historical trends",
        "label": "annualweightedaverageforfeiturerate",
        "terseLabel": "annualweightedaverageforfeiturerate"
       }
      }
     },
     "localname": "Annualweightedaverageforfeiturerate",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_April2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 2021 Term Loan",
        "label": "April 2021 Term Loan [Member]",
        "terseLabel": "April 2021 Term Loan [Member]"
       }
      }
     },
     "localname": "April2021TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AssertedClaimsOutsideTheUS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asserted claims outside the U.S.",
        "label": "Asserted claims outside the U.S.",
        "terseLabel": "Asserted claims outside the U.S."
       }
      }
     },
     "localname": "AssertedClaimsOutsideTheUS",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_AssetsHeldForSaleDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for sale",
        "label": "Assets held for sale [Domain]",
        "terseLabel": "Assets held for sale [Domain]"
       }
      }
     },
     "localname": "AssetsHeldForSaleDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bsx_August2019TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 2019 Term Loan [Member]",
        "label": "August 2019 Term Loan [Member]",
        "terseLabel": "August 2019 Term Loan [Member]"
       }
      }
     },
     "localname": "August2019TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BSXReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BSX Reportable Segments",
        "label": "BSX Reportable Segments [Member]",
        "terseLabel": "BSX Reportable Segments"
       }
      }
     },
     "localname": "BSXReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BTGAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BTG Acquisition",
        "label": "BTG Acquisition [Member]",
        "terseLabel": "BTG Acquisition [Member]"
       }
      }
     },
     "localname": "BTGAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items]",
        "label": "Business Combination, Consideration Transferred, Additional Revenue Payment, period",
        "terseLabel": "Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items]"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest",
        "label": "Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest",
        "terseLabel": "Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CanadaSettledClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canada, settled claims",
        "label": "Canada, settled claims",
        "terseLabel": "Canada, settled claims"
       }
      }
     },
     "localname": "CanadaSettledClaims",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CardiovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiovascular [Member]",
        "label": "Cardiovascular [Member]",
        "terseLabel": "Cardiovascular [Member]"
       }
      }
     },
     "localname": "CardiovascularMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cases in final stages of resolution, related to Greenfield Vena Cava Filter",
        "label": "Cases in final stages of resolution, related to Greenfield Vena Cava Filter",
        "terseLabel": "Cases in final stages of resolution, related to Greenfield Vena Cava Filter"
       }
      }
     },
     "localname": "CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash flow impact of deferred income tax expense (benefit)",
        "label": "Cash flow impact of deferred income tax expense (benefit)",
        "terseLabel": "Deferred and prepaid income taxes"
       }
      }
     },
     "localname": "CashFlowImpactOfDeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CertifiedClassActionsInAustraliaMesh": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certified class actions in Australia, Mesh",
        "label": "Certified class actions in Australia, Mesh",
        "terseLabel": "Certified class actions in Australia, Mesh"
       }
      }
     },
     "localname": "CertifiedClassActionsInAustraliaMesh",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest",
        "label": "Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest",
        "terseLabel": "Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest"
       }
      }
     },
     "localname": "ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_ChangeinDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Deferred Tax Assets, Valuation Allowance",
        "label": "Change in Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Change in Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "ChangeinDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CompensationExpensePerShareBasic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "compensation expense, per share - basic",
        "label": "compensation expense, per share - basic",
        "terseLabel": "compensation expense, per share - basic"
       }
      }
     },
     "localname": "CompensationExpensePerShareBasic",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_CompensationExpensePerShareDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "compensation expense, per share - diluted",
        "label": "compensation expense, per share - diluted",
        "terseLabel": "compensation expense, per share - diluted"
       }
      }
     },
     "localname": "CompensationExpensePerShareDiluted",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_ConsolidatedBSXDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated BSX",
        "label": "Consolidated BSX [Domain]",
        "terseLabel": "Consolidated BSX [Domain]"
       }
      }
     },
     "localname": "ConsolidatedBSXDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ConsolidatedBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Balance Sheet (Parenthetical)",
        "label": "Consolidated Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "ConsolidatedBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Cash Flow Supplemental Disclosure [Abstract]",
        "label": "Consolidated Cash Flow Supplemental Disclosure [Abstract]",
        "terseLabel": "Consolidated Cash Flow Supplemental Disclosure [Abstract]"
       }
      }
     },
     "localname": "ConsolidatedCashFlowSupplementalDisclosureAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bsx_ContingentConsiderationLiabilityProbabilityOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration liability, probability of payment",
        "label": "contingent consideration liability, probability of payment",
        "terseLabel": "contingent consideration liability, probability of payment"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityProbabilityOfPayment",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration payments made to prior shareholders to date",
        "label": "Contingent consideration payments made to prior shareholders to date",
        "terseLabel": "Contingent consideration payments made to prior shareholders to date"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentsMadeToPriorShareholdersToDate",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CorporateExpensesincludinghedgingactivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Expenses including hedging activities [Member]",
        "label": "Corporate Expenses including hedging activities [Member]",
        "terseLabel": "Corporate Expenses including hedging activities [Member]"
       }
      }
     },
     "localname": "CorporateExpensesincludinghedgingactivitiesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CovenantAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Axis]",
        "terseLabel": "Covenant [Axis]"
       }
      }
     },
     "localname": "CovenantAxis",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CovenantDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Domain]",
        "terseLabel": "Covenant [Domain]"
       }
      }
     },
     "localname": "CovenantDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Restructuring and Restructuring-Related Payments Made To Date",
        "label": "Cumulative Restructuring and Restructuring-Related Payments Made To Date",
        "terseLabel": "Cumulative Restructuring and Restructuring-Related Payments Made To Date"
       }
      }
     },
     "localname": "CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CumulativeRestructuringChargesIncurredToDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Restructuring Charges Incurred to Date",
        "label": "Cumulative Restructuring Charges Incurred to Date",
        "terseLabel": "Cumulative Restructuring Charges Incurred to Date"
       }
      }
     },
     "localname": "CumulativeRestructuringChargesIncurredToDate",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CumulativeRestructuringChargesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative restructuring charges.",
        "label": "Cumulative Restructuring Charges [Table Text Block]",
        "terseLabel": "Cumulative Restructuring Charges [Text Block]"
       }
      }
     },
     "localname": "CumulativeRestructuringChargesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_CumulativeRestructuringRelatedCostsIncurredToDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Restructuring-related Costs Incurred to Date",
        "label": "Cumulative Restructuring-related Costs Incurred to Date",
        "terseLabel": "Cumulative Restructuring-related Costs Incurred to Date"
       }
      }
     },
     "localname": "CumulativeRestructuringRelatedCostsIncurredToDate",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_December2027NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2027 Notes",
        "label": "December 2027 Notes [Member]",
        "terseLabel": "December 2027 Notes [Member]"
       }
      }
     },
     "localname": "December2027NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DeemedConsolidatedEBITDA": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deemed Consolidated EBITDA",
        "label": "Deemed Consolidated EBITDA",
        "terseLabel": "Deemed Consolidated EBITDA [Member]"
       }
      }
     },
     "localname": "DeemedConsolidatedEBITDA",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DeferredTaxAssetValuationAllowanceIntraEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Valuation Allowance, Intra-entity",
        "label": "Deferred Tax Asset, Valuation Allowance, Intra-entity",
        "terseLabel": "Deferred Tax Asset, Valuation Allowance, Intra-entity"
       }
      }
     },
     "localname": "DeferredTaxAssetValuationAllowanceIntraEntity",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DeferredTaxAssetsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets",
        "label": "Deferred tax assets [Domain]",
        "terseLabel": "Deferred tax assets [Domain]"
       }
      }
     },
     "localname": "DeferredTaxAssetsDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Prepaid on Intercompany Profit",
        "label": "Deferred Tax Assets, Prepaid on Intercompany Profit",
        "terseLabel": "Deferred Tax Assets, Prepaid on Intercompany Profit"
       }
      }
     },
     "localname": "DeferredTaxAssetsPrepaidonIntercompanyProfit",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DeferredTaxLiabilitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities",
        "label": "Deferred tax liabilities [Domain]",
        "terseLabel": "Deferred tax liabilities [Domain]"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Acquired and Established Plan Changes, PBO",
        "label": "Defined Benefit Plan, Acquired and Established Plan Changes, PBO",
        "terseLabel": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets",
        "label": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets",
        "terseLabel": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan, plan assets, actuarial gain loss",
        "label": "Defined benefit plan, plan assets, actuarial gain loss",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsActuarialGainLoss",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return",
        "label": "Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "label": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "label": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DevoroMedicalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Devoro Medical, Inc.",
        "label": "Devoro Medical, Inc. [Member]",
        "terseLabel": "Devoro Medical, Inc."
       }
      }
     },
     "localname": "DevoroMedicalIncMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DiscountRateFairValueInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount Rate, Fair Value Input",
        "label": "Discount Rate, Fair Value Input",
        "terseLabel": "Discount Rate, Fair Value Input"
       }
      }
     },
     "localname": "DiscountRateFairValueInput",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DivestitureAgreementTransferOfFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture, agreement, transfer of facilities",
        "label": "Divestiture, agreement, transfer of facilities",
        "terseLabel": "Divestiture, agreement, transfer of facilities"
       }
      }
     },
     "localname": "DivestitureAgreementTransferOfFacilities",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_DivestitureAgreementTransferOfGlobalEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture, agreement, transfer of global employees",
        "label": "Divestiture, agreement, transfer of global employees",
        "terseLabel": "Divestiture, agreement, transfer of global employees"
       }
      }
     },
     "localname": "DivestitureAgreementTransferOfGlobalEmployees",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers",
        "label": "Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Return to provision",
        "label": "Effective Income Tax Rate Reconciliation, Return to provision",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Return to provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvision",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions",
        "label": "Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets [Member]",
        "label": "Emerging Markets [Member]",
        "terseLabel": "Emerging Markets [Member]"
       }
      }
     },
     "localname": "EmergingMarketsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EmergingMarketsTotalNumberOfCountries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets total number of countries",
        "label": "Emerging Markets total number of countries",
        "terseLabel": "Emerging Markets total number of countries"
       }
      }
     },
     "localname": "EmergingMarketsTotalNumberOfCountries",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_EquipmentFurnitureAndFixturesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment, furniture and fixtures Gross.",
        "label": "Equipment, furniture and fixtures Gross",
        "terseLabel": "Equipment, furniture and fixtures"
       }
      }
     },
     "localname": "EquipmentFurnitureAndFixturesGross",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_EuroDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Factoring Arrangements [Member]",
        "label": "Euro Denominated Factoring Arrangements [Member]",
        "terseLabel": "Euro Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "EuroDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EuroDenominatedOutstandingDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro-denominated outstanding debt",
        "label": "Euro-denominated outstanding debt [Member]",
        "terseLabel": "Euro-denominated outstanding debt [Member]"
       }
      }
     },
     "localname": "EuroDenominatedOutstandingDebtMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ExclusionFromEbitdaForRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion from EBITDA for Restructuring Charges",
        "label": "Exclusion from EBITDA for Restructuring Charges",
        "verboseLabel": "Exclusion from EBITDA for Restructuring Charges"
       }
      }
     },
     "localname": "ExclusionFromEbitdaForRestructuringCharges",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ExecutiveRetirementPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive retirement plan [Member]",
        "label": "Executive retirement plan [Member]",
        "terseLabel": "Executive retirement plan [Member]"
       }
      }
     },
     "localname": "ExecutiveRetirementPlanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price of the fair market value of our common stock on the date of grant",
        "label": "Exercise price of the fair market value of our common stock on the date of grant",
        "terseLabel": "Exercise price of the fair market value of our common stock on the date of grant"
       }
      }
     },
     "localname": "Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ExpenseRelatedToMatchingContributions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to matching contributions",
        "label": "Expense related to matching contributions",
        "terseLabel": "Expense related to matching contributions"
       }
      }
     },
     "localname": "ExpenseRelatedToMatchingContributions",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_FairValueOfFreeCashFlowFcfPerformanceAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the Free Cash Flow (FCF) performance awards",
        "label": "Fair value of the Free Cash Flow (FCF) performance awards",
        "terseLabel": "Fair value of the Free Cash Flow (FCF) performance awards"
       }
      }
     },
     "localname": "FairValueOfFreeCashFlowFcfPerformanceAwards",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Fairvalueofmarketbasedawards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of market based awards",
        "label": "Fair value of market based awards",
        "terseLabel": "Fair value of market based awards"
       }
      }
     },
     "localname": "Fairvalueofmarketbasedawards",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_FarapulseIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Farapulse, Inc.",
        "label": "Farapulse, Inc. [Member]",
        "terseLabel": "Farapulse, Inc."
       }
      }
     },
     "localname": "FarapulseIncMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_February2019AggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2019 Aggregate Offering",
        "label": "February 2019 Aggregate Offering [Member]",
        "terseLabel": "February 2019 Aggregate Offering [Member]"
       }
      }
     },
     "localname": "February2019AggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_February2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 Term Loan",
        "label": "February 2021 Term Loan [Member]",
        "terseLabel": "February 2021 Term Loan [Member]"
       }
      }
     },
     "localname": "February2021TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_FederalBenefitOfUncertainTaxPositions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal benefit of uncertain tax positions",
        "label": "Federal benefit of uncertain tax positions",
        "terseLabel": "Federal benefit of uncertain tax positions"
       }
      }
     },
     "localname": "FederalBenefitOfUncertainTaxPositions",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ForeignCurrencyDenominatedInDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign currency denominated in debt",
        "label": "Foreign currency denominated in debt [Member]",
        "terseLabel": "Foreign currency denominated in debt [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedInDebtMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForwardCurrencyContractsTimetoMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Contracts, Time to Maturity in Months",
        "label": "Forward Currency Contracts, Time to Maturity",
        "terseLabel": "Forward Currency Contracts, Time to Maturity"
       }
      }
     },
     "localname": "ForwardCurrencyContractsTimetoMaturity",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_FreeTradeZoneRegimeTaxIncentive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Trade Zone Regime Tax Incentive",
        "label": "Free Trade Zone Regime Tax Incentive",
        "terseLabel": "Free Trade Zone Regime Tax Incentive"
       }
      }
     },
     "localname": "FreeTradeZoneRegimeTaxIncentive",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution",
        "label": "Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution",
        "terseLabel": "Free Trade Zone Regime Tax Incentive, impact on Net income (loss) per common share - assuming dilution"
       }
      }
     },
     "localname": "FreeTradeZoneRegimeTaxIncentiveImpactOnNetIncomeLossPerCommonShareAssumingDilution",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_GlobalCrmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global CRM Reporting Unit [Member]",
        "label": "Global CRM Reporting Unit [Member]",
        "terseLabel": "Global CRM Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalCrmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalElectrophysiologyEpReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "label": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "terseLabel": "Global Electrophysiology (EP) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalElectrophysiologyEpReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)",
        "label": "Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)",
        "terseLabel": "Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)"
       }
      }
     },
     "localname": "GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_GlobalEndoscopyEndoReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "label": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "terseLabel": "Global Endoscopy (Endo) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalEndoscopyEndoReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalInterventionalCardiologyIcReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "label": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "terseLabel": "Global Interventional Cardiology (IC) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalInterventionalCardiologyIcReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalNeuromodulationNmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "label": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "terseLabel": "Global Neuromodulation (NM) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalNeuromodulationNmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalPeripheralInterventionsPiReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "label": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "terseLabel": "Global Peripheral Interventions (PI) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalPeripheralInterventionsPiReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalUrologyandPelvicHealthReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "label": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "terseLabel": "Global Urology and Pelvic Health Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalUrologyandPelvicHealthReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GoodwillTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill (Textuals) [Abstract]",
        "label": "Goodwill (Textuals) [Abstract]",
        "terseLabel": "Goodwill (Roll Forward)"
       }
      }
     },
     "localname": "GoodwillTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_IncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Abstract]",
        "label": "Income Taxes [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxesAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bsx_InternationalRetirementPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International retirement plans [Member]",
        "label": "International retirement plans [Member]",
        "terseLabel": "International retirement plans [Member]"
       }
      }
     },
     "localname": "InternationalRetirementPlansMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_InventoryStepUpAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Step Up Amortization",
        "label": "InventoryStepUpAmortization",
        "terseLabel": "Inventory step-up amortization"
       }
      }
     },
     "localname": "InventoryStepUpAmortization",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_January2020NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2020 Notes [Member]",
        "label": "January 2020 Notes [Member]",
        "terseLabel": "January 2020 Notes [Member]"
       }
      }
     },
     "localname": "January2020NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_January2040NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2040 Notes [Member]",
        "label": "January 2040 Notes [Member]",
        "terseLabel": "January 2040 Notes [Member]"
       }
      }
     },
     "localname": "January2040NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2025 Notes",
        "label": "June 2025 Notes [Member]",
        "terseLabel": "June 2025 Notes [Member]"
       }
      }
     },
     "localname": "June2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2030NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2030 Notes",
        "label": "June 2030 Notes [Member]",
        "terseLabel": "June 2030 Notes [Member]"
       }
      }
     },
     "localname": "June2030NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LatinAmericaandCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America and Canada [Member]",
        "label": "Latin America and Canada [Member]",
        "terseLabel": "Latin America and Canada [Member]"
       }
      }
     },
     "localname": "LatinAmericaandCanadaMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "label": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Legal payments remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LesseeOperatingAndFinanceLeasesOptionToExtend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Leases, Option to Extend",
        "label": "Lessee, Operating and Finance Leases, Option to Extend",
        "terseLabel": "Lessee, Operating and Finance Leases, Option to Extend"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesOptionToExtend",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities held for sale in Other current liabilities",
        "label": "Liabilities held for sale in Other current liabilities [Domain]",
        "terseLabel": "Liabilities held for sale in Other current liabilities [Domain]"
       }
      }
     },
     "localname": "LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingArrangementAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement assets",
        "label": "Licensing arrangement assets [Member]",
        "terseLabel": "Licensing arrangement assets (Member)"
       }
      }
     },
     "localname": "LicensingArrangementAssetsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingArrangementLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement liabilities",
        "label": "Licensing arrangement liabilities [Member]",
        "terseLabel": "Licensing arrangement liabilities (Member)"
       }
      }
     },
     "localname": "LicensingArrangementLiabilitiesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements",
        "label": "Licensing arrangements",
        "terseLabel": "Licensing arrangements"
       }
      }
     },
     "localname": "LicensingArrangements",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingArrangementsAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, asset",
        "label": "Licensing arrangements, asset",
        "negatedTerseLabel": "Licensing arrangements, asset",
        "terseLabel": "Licensing arrangements, asset"
       }
      }
     },
     "localname": "LicensingArrangementsAsset",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingArrangementsLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, liability",
        "label": "Licensing arrangements, liability",
        "terseLabel": "Licensing arrangements, liability"
       }
      }
     },
     "localname": "LicensingArrangementsLiability",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationAndDebtExclusionFromEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion of litigation payments and any debt Issued to fund tax deficiency payments",
        "label": "Litigation and Debt Exclusion from EBITDA",
        "terseLabel": "Litigation and Debt Exclusion from EBITDA"
       }
      }
     },
     "localname": "LitigationAndDebtExclusionFromEbitda",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationSettlementReceivedGain": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement Received, Gain",
        "label": "Litigation Settlement Received, Gain",
        "terseLabel": "Litigation Settlement Received, Gain"
       }
      }
     },
     "localname": "LitigationSettlementReceivedGain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LotusDiscontinuationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lotus Discontinuation",
        "label": "Lotus Discontinuation [Member]",
        "terseLabel": "Lotus Discontinuation [Member]"
       }
      }
     },
     "localname": "LotusDiscontinuationMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LumenisLTDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lumenis LTD",
        "label": "Lumenis LTD [Member]",
        "terseLabel": "Lumenis LTD"
       }
      }
     },
     "localname": "LumenisLTDMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2024NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2024 Notes",
        "label": "March 2024 Notes [Member]",
        "terseLabel": "March 2024 Notes [Member]"
       }
      }
     },
     "localname": "March2024NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2026NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2026 Notes",
        "label": "March 2026 Notes [Member]",
        "terseLabel": "March 2026 Notes [Member]"
       }
      }
     },
     "localname": "March2026NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2028 Notes [Member]",
        "label": "March 2028 Notes [Member]",
        "terseLabel": "March 2028 Notes [Member]"
       }
      }
     },
     "localname": "March2028NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2029NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2029 Notes",
        "label": "March 2029 Notes [Member]",
        "terseLabel": "March 2029 Notes [Member]"
       }
      }
     },
     "localname": "March2029NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2039NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2039 Notes",
        "label": "March 2039 Notes [Member]",
        "terseLabel": "March 2039 Notes [Member]"
       }
      }
     },
     "localname": "March2039NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2049NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2049 Notes",
        "label": "March 2049 Notes [Member]",
        "terseLabel": "March 2049 Notes [Member]"
       }
      }
     },
     "localname": "March2049NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market-based awards, valuation assumptions [Table Text Block]",
        "label": "Market-based awards, valuation assumptions [Table Text Block]",
        "terseLabel": "Market-based awards, valuation assumptions [Table Text Block]"
       }
      }
     },
     "localname": "MarketBasedAwardsValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturities of Lease Liabilities",
        "label": "Maturities of Lease Liabilities [Table Text Block]",
        "terseLabel": "Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "MaturitiesOfLeaseLiabilitiesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_MaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum leverage ratio permitted by revolving credit facility agreement.",
        "label": "Maximum Leverage Ratio",
        "terseLabel": "Maximum Leverage Ratio"
       }
      }
     },
     "localname": "MaximumLeverageRatio",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_May2020NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2020 Notes [Member]",
        "label": "May 2020 Notes [Member]",
        "terseLabel": "May 2020 Notes [Member]"
       }
      }
     },
     "localname": "May2020NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2020SNAggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2020 SN Aggregate Offering",
        "label": "May 2020 SN Aggregate Offering [Member]",
        "terseLabel": "May 2020 SN Aggregate Offering [Member]"
       }
      }
     },
     "localname": "May2020SNAggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2022NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2022 Notes [Member]",
        "label": "May 2022 Notes [Member]",
        "verboseLabel": "May 2022 Notes [Member]"
       }
      }
     },
     "localname": "May2022NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2025 Notes [Member]",
        "label": "May 2025 Notes [Member]",
        "terseLabel": "May 2025 Notes [Member]"
       }
      }
     },
     "localname": "May2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Measurementperiodmarketbasedaward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement period - market based awards",
        "label": "Measurement period - market based award",
        "terseLabel": "Measurement period - market based awards"
       }
      }
     },
     "localname": "Measurementperiodmarketbasedaward",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_MedsurgMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedSurg [Member]",
        "label": "MedSurg [Member]",
        "terseLabel": "MedSurg [Member]"
       }
      }
     },
     "localname": "MedsurgMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MillipedeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Millipede [Member]",
        "label": "Millipede [Member]",
        "terseLabel": "Millipede [Member]"
       }
      }
     },
     "localname": "MillipedeMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NetCurrencyExchangeGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net currency exchange gain (loss)",
        "label": "Net currency exchange gain (loss)",
        "negatedTerseLabel": "Foreign exchange (gain) loss",
        "terseLabel": "Foreign exchange (gain) loss"
       }
      }
     },
     "localname": "NetCurrencyExchangeGainLoss",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Deferred Tax Assets and Prepaid on Intercompany Profit",
        "label": "Net Deferred Tax Assets and Prepaid on Intercompany Profit",
        "terseLabel": "Net Deferred Tax Liabilities and Prepaid on Intercompany Profit"
       }
      }
     },
     "localname": "NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NewAccountingPronouncementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Accounting Pronouncements, Policy",
        "label": "New Accounting Pronouncements, Policy [Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_NonCashImpactOfTransferredRoyaltyRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash impact of transferred royalty rights",
        "label": "Non-cash impact of transferred royalty rights",
        "terseLabel": "Non-cash impact of transferred royalty rights"
       }
      }
     },
     "localname": "NonCashImpactOfTransferredRoyaltyRights",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Nonvestedstockawardsexerciseprice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-vested stock awards exercise price",
        "label": "Non-vested stock awards exercise price",
        "terseLabel": "Qualified options exercise price"
       }
      }
     },
     "localname": "Nonvestedstockawardsexerciseprice",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_November2019AggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2019 Aggregate Offering",
        "label": "November 2019 Aggregate Offering [Member]",
        "terseLabel": "November 2019 Aggregate Offering [Member]"
       }
      }
     },
     "localname": "November2019AggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_November2035NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2035 Notes [Member]",
        "label": "November 2035 Notes [Member]",
        "terseLabel": "November 2035 Notes [Member]"
       }
      }
     },
     "localname": "November2035NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_October2023NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 Notes [Member]",
        "label": "October 2023 Notes [Member]",
        "terseLabel": "October 2023 Notes [Member]"
       }
      }
     },
     "localname": "October2023NotesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Onetimetransactiontaxpost1986EPnetpayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time transaction tax post-1986 E&amp;P - net payment",
        "label": "One-time transaction tax post-1986 E&amp;P - net payment",
        "terseLabel": "One-time transaction tax post-1986 E&amp;P - net payment"
       }
      }
     },
     "localname": "Onetimetransactiontaxpost1986EPnetpayment",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeLossAllocatedToReportableSegments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Allocated to Reportable Segments",
        "label": "Operating Income (Loss) Allocated to Reportable Segments",
        "terseLabel": "Operating Income (Loss) Allocated to Reportable Segments"
       }
      }
     },
     "localname": "OperatingIncomeLossAllocatedToReportableSegments",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeUnallocatedToSegment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Unallocated to Segment",
        "label": "Operating Income Unallocated to Segment",
        "terseLabel": "Operating Income Unallocated to Segment"
       }
      }
     },
     "localname": "OperatingIncomeUnallocatedToSegment",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OptionsExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options expected to vest",
        "label": "Options expected to vest",
        "terseLabel": "Options expected to vest"
       }
      }
     },
     "localname": "OptionsExpectedToVest",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bsx_OptionsExpectedToVestWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options expected to vest, weighted average exercise price",
        "label": "Options expected to vest, weighted average exercise price",
        "terseLabel": "Options expected to vest, weighted average exercise price"
       }
      }
     },
     "localname": "OptionsExpectedToVestWeightedAverageExercisePrice",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options expected to vest, weighted average remaining contractual life",
        "label": "Options expected to vest, weighted average remaining contractual life",
        "terseLabel": "Options expected to vest, weighted average remaining contractual life"
       }
      }
     },
     "localname": "OptionsExpectedToVestWeightedAverageRemainingContractualLife",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other countries [Member]",
        "label": "Other countries [Member]",
        "terseLabel": "Other countries [Member]"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets",
        "label": "Other Current Assets [Abstract]",
        "terseLabel": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentAssetsAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherIntangibleAssetsTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Intangible Assets (Textuals) [Abstract]",
        "label": "Other Intangible Assets (Textuals) [Abstract]",
        "terseLabel": "Other Intangible Assets (Textuals) [Abstract]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherInternationalPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other International Plans",
        "label": "Other International Plans [Member]",
        "terseLabel": "Other International Plans"
       }
      }
     },
     "localname": "OtherInternationalPlansMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, net",
        "label": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNet",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherOtherLongTermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, Other Long-term Assets",
        "label": "Other, Other Long-term Assets",
        "terseLabel": "Other, Other Long-term Assets"
       }
      }
     },
     "localname": "OtherOtherLongTermAssets",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of contingent consideration",
        "label": "Payment of contingent consideration",
        "terseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentsForRoyaltyRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for royalty rights",
        "label": "Payments for royalty rights",
        "negatedTerseLabel": "Payments for royalty rights"
       }
      }
     },
     "localname": "PaymentsForRoyaltyRights",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Paymenttonetsharesettleemployeeequityawards": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment to net share settle employee equity awards",
        "label": "Payment to net share settle employee equity awards",
        "negatedTerseLabel": "Cash used to net share settle employee equity awards"
       }
      }
     },
     "localname": "Paymenttonetsharesettleemployeeequityawards",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending cases and claims asserted in various jurisdictions in the U.S.",
        "label": "Pending cases and claims asserted in various jurisdictions in the U.S.",
        "terseLabel": "Pending cases and claims asserted in various jurisdictions in the U.S."
       }
      }
     },
     "localname": "PendingCasesAndClaimsAssertedInVariousJurisdictionsInTheUS",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_Pensionbenefitobligationbenefitspaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "pension benefit obligation, benefits paid",
        "label": "pension benefit obligation, benefits paid",
        "negatedTerseLabel": "pension benefit obligation, benefits paid"
       }
      }
     },
     "localname": "Pensionbenefitobligationbenefitspaid",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PercentOfFinishedGoodsAtConsignment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of finished goods at consignment",
        "label": "Percent of finished goods at consignment",
        "terseLabel": "Percent of finished goods at consignment"
       }
      }
     },
     "localname": "PercentOfFinishedGoodsAtConsignment",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_PermanentlyStayedClassActionInAustraliaMesh": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Permanently stayed class action in Australia, Mesh",
        "label": "Permanently stayed class action in Australia, Mesh",
        "terseLabel": "Permanently stayed class action in Australia, Mesh"
       }
      }
     },
     "localname": "PermanentlyStayedClassActionInAustraliaMesh",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_PreventiceSolutionsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preventice Solutions, Inc.",
        "label": "Preventice Solutions, Inc. [Member]",
        "terseLabel": "Preventice Solutions, Inc. [Member]"
       }
      }
     },
     "localname": "PreventiceSolutionsIncMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from (payments for) investments and acquisitions of certain technologies",
        "label": "Proceeds from (payments for) investments and acquisitions of certain technologies",
        "negatedLabel": "Proceeds from (payments for) investments and acquisitions of certain technologies"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from secured borrowings relating to royalty arrangements",
        "label": "Proceeds from secured borrowings relating to royalty arrangements",
        "terseLabel": "Proceeds from royalty rights transfer"
       }
      }
     },
     "localname": "ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - Australia",
        "label": "Product liability cases or claims related to mesh product - Australia",
        "terseLabel": "Product liability cases or claims related to mesh product - Australia"
       }
      }
     },
     "localname": "ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases related to Greenfiled Vena Cava filter",
        "label": "Product liability cases related to Greenfiled Vena Cava filter",
        "terseLabel": "Product liability cases related to Greenfiled Vena Cava filter"
       }
      }
     },
     "localname": "ProductLiabilityCasesRelatedToGreenfiledVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability claims, not filed, related to Greenfield Vena Cava Filter",
        "label": "Product liability claims, not filed, related to Greenfield Vena Cava Filter",
        "terseLabel": "Product liability claims, not filed, related to Greenfield Vena Cava Filter"
       }
      }
     },
     "localname": "ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_Productliabilitycasesorclaimsrelatedtomeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims asserted related to mesh products",
        "label": "Product liability cases or claims related to mesh product",
        "terseLabel": "Product liability cases or claims related to mesh product"
       }
      }
     },
     "localname": "Productliabilitycasesorclaimsrelatedtomeshproduct",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - United Kingdom",
        "label": "Product liability cases or claims related to mesh product - United Kingdom",
        "terseLabel": "Product liability cases or claims related to mesh product - United Kingdom"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_RDRegulatoryandCommercializationbasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "label": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "terseLabel": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]"
       }
      }
     },
     "localname": "RDRegulatoryandCommercializationbasedMilestoneMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RangeofthetargetnumberofmarketbasedDSUsawarded": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range of the target number of market-based DSUs awarded",
        "label": "Range of the target number of market-based DSUs awarded",
        "terseLabel": "Range of the target number of market-based DSUs awarded"
       }
      }
     },
     "localname": "RangeofthetargetnumberofmarketbasedDSUsawarded",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_RangeofthetargetnumberofperformancebasedDSUsawarded": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range of the target number of performance-based DSUs awarded",
        "label": "Range of the target number of performance-based DSUs awarded",
        "terseLabel": "Range of the target number of performance-based DSUs awarded"
       }
      }
     },
     "localname": "RangeofthetargetnumberofperformancebasedDSUsawarded",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of depreciation by reportable segment to total [Table Text Block]",
        "label": "Reconciliation of depreciation by reportable segment to total [Table Text Block]",
        "terseLabel": "Reconciliation of depreciation by reportable segment to total [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_RenminbiDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renminbi Denominated Factoring Arrangements",
        "label": "Renminbi Denominated Factoring Arrangements [Member]",
        "terseLabel": "Renminbi Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "RenminbiDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of December 31, 2021 and through remaining term of facility",
        "label": "Requirement, as of December 31, 2021 and through remaining term of facility [Member]",
        "terseLabel": "Requirement, as of December 31, 2021 and through remaining term of facility"
       }
      }
     },
     "localname": "RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfJune302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of June 30, 2021",
        "label": "Requirement, as of June 30, 2021 [Member]",
        "terseLabel": "Requirement, as of June 30, 2021"
       }
      }
     },
     "localname": "RequirementAsOfJune302021Member",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfMarch312021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of March 31, 2021",
        "label": "Requirement, as of March 31, 2021 [Member]",
        "terseLabel": "Requirement, as of March 31, 2021"
       }
      }
     },
     "localname": "RequirementAsOfMarch312021Member",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfSeptember302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of September 30, 2021",
        "label": "Requirement, as of September 30, 2021 [Member]",
        "terseLabel": "Requirement, as of September 30, 2021"
       }
      }
     },
     "localname": "RequirementAsOfSeptember302021Member",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, eighth quarter and thereafter following qualified acquisition",
        "label": "Requirement, eighth quarter and thereafter following qualified acquisition [Member]",
        "terseLabel": "Requirement, eighth quarter and thereafter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementFourQuartersFollowingMaterialAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, four quarters following qualified acquisition",
        "label": "Requirement, four quarters following material acquisition [Member]",
        "terseLabel": "Requirement, four quarters following material acquisition"
       }
      }
     },
     "localname": "RequirementFourQuartersFollowingMaterialAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, seventh quarter following qualified acquisition",
        "label": "Requirement, seventh quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, seventh quarter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementSeventhQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, sixth quarter following qualified acquisition [Member]",
        "label": "Requirement, sixth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, sixth quarter and thereafter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementSixthQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, fifth quarter following qualified acquisition [Member]",
        "label": "Requirement, fifth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fifth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfifthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, by Type of Restructuring Three [Domain]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge [Domain]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge [Domain]"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, by Type of Restructuring Three [Axis]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.",
        "label": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA",
        "verboseLabel": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan [Member]",
        "label": "Restructuring Plan [Member]",
        "terseLabel": "Restructuring Plan [Member]"
       }
      }
     },
     "localname": "RestructuringPlanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringRelatedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring related expenses.",
        "label": "Restructuring Related Expenses",
        "terseLabel": "Restructuring Related Expenses"
       }
      }
     },
     "localname": "RestructuringRelatedExpenses",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RestructuringRelatedToPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Related To Plan [Member]",
        "label": "Restructuring Related To Plan [Member]",
        "terseLabel": "Restructuring Related To Plan [Member]"
       }
      }
     },
     "localname": "RestructuringRelatedToPlanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]"
       }
      }
     },
     "localname": "RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]"
       }
      }
     },
     "localname": "RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringandRestructuringrelatedCostExpectedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Restructuring-related Cost, Expected Cost",
        "label": "Restructuring and Restructuring-related Cost, Expected Cost",
        "terseLabel": "Restructuring and Restructuring-related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringandRestructuringrelatedCostExpectedCost",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RestructuringrelatedCostExpectedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring-related Cost, Expected Cost",
        "label": "Restructuring-related Cost, Expected Cost",
        "terseLabel": "Restructuring-related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringrelatedCostExpectedCost",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "revenue-based payments [Member]",
        "label": "revenue-based payments [Member]",
        "terseLabel": "revenue-based payments [Member]"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RhythmandNeuroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rhythm and Neuro [Member]",
        "label": "Rhythm and Neuro [Member]",
        "terseLabel": "Rhythm and Neuro [Member]"
       }
      }
     },
     "localname": "RhythmandNeuroMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Line Items]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Line Items]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationLineItems",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Table]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Table]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationTable",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_Segmentoperatingincomeaspercentageofnetsales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment operating income as percentage of net sales",
        "label": "Segment operating income as percentage of net sales",
        "terseLabel": "Segment operating income as percentage of net sales"
       }
      }
     },
     "localname": "Segmentoperatingincomeaspercentageofnetsales",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment operating income as percentage of net sales",
        "label": "Segment operating income as percentage of net sales [Table Text Block]",
        "terseLabel": "Segment operating income as percentage of net sales [Table Text Block]"
       }
      }
     },
     "localname": "SegmentoperatingincomeaspercentageofnetsalesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ShareBasedCompensationNetOfTaxBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation, net of tax benefit",
        "label": "Share-based compensation, net of tax benefit",
        "terseLabel": "Share-based compensation, net of tax benefit"
       }
      }
     },
     "localname": "ShareBasedCompensationNetOfTaxBenefit",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Abstract]",
        "label": "Significant Accounting Policies [Abstract]",
        "terseLabel": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bsx_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SpecialChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Charges [Member]",
        "label": "Special Charges [Member]",
        "terseLabel": "Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs"
       }
      }
     },
     "localname": "SpecialChargesMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialtyPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharmaceuticals",
        "label": "Specialty Pharmaceuticals [Member]",
        "terseLabel": "Specialty Pharmaceuticals [Member]"
       }
      }
     },
     "localname": "SpecialtyPharmaceuticalsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "statement [Axis]",
        "label": "statement [Axis]",
        "terseLabel": "statement [Axis]"
       }
      }
     },
     "localname": "StatementAxis",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for statement [Axis]",
        "label": "statement [Domain]",
        "terseLabel": "statement [Domain]"
       }
      }
     },
     "localname": "StatementDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StatementOfOperationsCaptionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement of Operations Caption [Axis]",
        "label": "Statement of Operations Caption [Axis]",
        "terseLabel": "Statement of Operations Caption [Axis]"
       }
      }
     },
     "localname": "StatementOfOperationsCaptionAxis",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementOfOperationsCaptionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement of Operations Caption [Domain]",
        "label": "Statement of Operations Caption [Domain]",
        "terseLabel": "Statement of Operations Caption [Domain]"
       }
      }
     },
     "localname": "StatementOfOperationsCaptionDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StockIncentiveAndPurchasePlansAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive and Purchase Plans [Abstract]",
        "label": "Stock Incentive and Purchase Plans [Abstract]",
        "terseLabel": "Stock Incentive and Ownership Plans [Abstract]"
       }
      }
     },
     "localname": "StockIncentiveAndPurchasePlansAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Common stock)",
        "label": "Stock Issued During Period, Value, New Issues (Common stock)",
        "terseLabel": "Common stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesCommonStock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "label": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "terseLabel": "Preferred stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesPreferredStock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of term loan and revolving credit facility agreement compliance with debt covenants.",
        "label": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]",
        "terseLabel": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalBalanceSheetInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information [Abstract]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalBalanceSheetInformationTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information (Textuals)",
        "label": "Supplemental Balance Sheet Information (Textuals) [Abstract]",
        "verboseLabel": "Supplemental Balance Sheet Information (Textuals)"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow Information Related to Leases",
        "label": "Supplemental Cash Flow Information Related to Leases [Policy Text Block]",
        "terseLabel": "Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow Information Related to Leases",
        "label": "Supplemental Cash Flow Information Related to Leases [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Target payout of Free Cash Flows (FCF) performance awards",
        "label": "Target payout of Free Cash Flows (FCF) performance awards",
        "terseLabel": "Target payout of Free Cash Flows (FCF) performance awards"
       }
      }
     },
     "localname": "TargetPayoutOfFreeCashFlowsFcfPerformanceAwards",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_TaxIncentivesInPuertoRico": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Incentives in Puerto Rico",
        "label": "Tax Incentives in Puerto Rico",
        "terseLabel": "Tax Incentives in Puerto Rico"
       }
      }
     },
     "localname": "TaxIncentivesInPuertoRico",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution",
        "label": "Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution",
        "terseLabel": "Tax Incentives in Puerto Rico, impact on Net income (loss) per common share, assuming dilution"
       }
      }
     },
     "localname": "TaxIncentivesInPuertoRicoImpactOnNetIncomeLossPerCommonShareAssumingDilution",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_TaxRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Rate [Axis]",
        "label": "Tax Rate [Axis]",
        "terseLabel": "Tax Rate [Axis]"
       }
      }
     },
     "localname": "TaxRateAxis",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_TaxRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Rate [Domain]",
        "label": "Tax Rate [Domain]",
        "terseLabel": "Tax Rate [Domain]"
       }
      }
     },
     "localname": "TaxRateDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_The2018FacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the 2018 Facility",
        "label": "the 2018 Facility [Domain]",
        "terseLabel": "the 2018 Facility [Domain]"
       }
      }
     },
     "localname": "The2018FacilityDomain",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The CARES Act",
        "label": "The CARES Act",
        "terseLabel": "The CARES Act"
       }
      }
     },
     "localname": "TheCARESAct",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ThreeYearDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three-Year Delayed Draw Term Loan",
        "label": "Three-Year Delayed Draw Term Loan [Member]",
        "terseLabel": "Three-Year Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "ThreeYearDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalAllocatedToReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total allocated to reportable segments [Member]",
        "label": "Total allocated to reportable segments [Member]",
        "terseLabel": "Total allocated to reportable segments [Member]"
       }
      }
     },
     "localname": "TotalAllocatedToReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Product liability cases and claims settled related to Mesh product",
        "label": "Total Product liability cases and claims settled related to Mesh product",
        "terseLabel": "Total Product liability cases and claims settled related to Mesh product"
       }
      }
     },
     "localname": "TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_TransferCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer Costs",
        "label": "Transfer Costs",
        "terseLabel": "Transfer Costs"
       }
      }
     },
     "localname": "TransferCosts",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_TransferCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer costs [Member].",
        "label": "Transfer costs [Member]",
        "terseLabel": "Transfer costs [Member]"
       }
      }
     },
     "localname": "TransferCostsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TransitionTaxPaymentRemaining": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Tax Payment Remaining",
        "label": "Transition Tax Payment Remaining",
        "terseLabel": "transition tax payment remaining"
       }
      }
     },
     "localname": "TransitionTaxPaymentRemaining",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_TwoYearDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-Year Delayed Draw Term Loan [Member]",
        "label": "Two-Year Delayed Draw Term Loan [Member]",
        "terseLabel": "Two-Year Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "TwoYearDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_UKPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Plan",
        "label": "U.K. Plan [Member]",
        "terseLabel": "U.K. Plan"
       }
      }
     },
     "localname": "UKPlanMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_UnrecognizedCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Compensation Cost",
        "label": "Unrecognized Compensation Cost",
        "terseLabel": "Unrecognized Compensation Cost"
       }
      }
     },
     "localname": "UnrecognizedCompensationCost",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_UnrecognizedCompensationCostNonVestedStockAwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Compensation Cost - Non-vested stock awards",
        "label": "Unrecognized Compensation Cost - Non-vested stock awards",
        "terseLabel": "Unrecognized Compensation Cost - Non-vested stock awards"
       }
      }
     },
     "localname": "UnrecognizedCompensationCostNonVestedStockAwards",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_UnrecognizedCompensationCostStockOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Compensation Cost - Stock Options",
        "label": "Unrecognized Compensation Cost - Stock Options",
        "terseLabel": "Unrecognized Compensation Cost - Stock Options"
       }
      }
     },
     "localname": "UnrecognizedCompensationCostStockOptions",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_VertiflexIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertiflex, Inc.",
        "label": "Vertiflex, Inc. [Member]",
        "terseLabel": "Vertiflex, Inc. [Member]"
       }
      }
     },
     "localname": "VertiflexIncMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_VotingPowerOfAllClassesOfStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voting power of all classes of stock",
        "label": "Voting power of all classes of stock",
        "verboseLabel": "Voting power of all classes of stock"
       }
      }
     },
     "localname": "VotingPowerOfAllClassesOfStock",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_WeightedAverageRemainingVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "weighted average remaining vesting period",
        "label": "weighted average remaining vesting period",
        "terseLabel": "weighted average remaining vesting period"
       }
      }
     },
     "localname": "WeightedAverageRemainingVestingPeriod",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_YenDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yen denominated factoring arrangements.",
        "label": "Yen Denominated Factoring Arrangements [Member]",
        "terseLabel": "Yen Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "YenDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20211231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "IRELAND"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States [Member]",
        "verboseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r980",
      "r981",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r980",
      "r981",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r980",
      "r981",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r980",
      "r981",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share",
        "terseLabel": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r980",
      "r981",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r411",
      "r450",
      "r588",
      "r598",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r887",
      "r940",
      "r943",
      "r975",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "High end of range [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r411",
      "r450",
      "r588",
      "r598",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r887",
      "r940",
      "r943",
      "r975",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r263",
      "r487",
      "r491",
      "r889",
      "r939",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r263",
      "r487",
      "r491",
      "r889",
      "r939",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r411",
      "r450",
      "r530",
      "r588",
      "r598",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r887",
      "r940",
      "r943",
      "r975",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r411",
      "r450",
      "r530",
      "r588",
      "r598",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r887",
      "r940",
      "r943",
      "r975",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r196",
      "r201",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]",
        "verboseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r184",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleII"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r264",
      "r265",
      "r487",
      "r492",
      "r942",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r992",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r264",
      "r265",
      "r487",
      "r492",
      "r942",
      "r959",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r992",
      "r993"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Entity-Wide Disclosure on Geographic Areas, Revenue from External Customers Attributed to Individual Foreign Countries [Axis]",
        "verboseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r196",
      "r201",
      "r379",
      "r593",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Statement, Scenario [Axis]",
        "verboseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r860",
      "r862",
      "r865",
      "r975",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance.",
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average (Member)"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r24",
      "r51",
      "r87",
      "r269",
      "r270",
      "r920"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Trade accounts receivable, net",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r73",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal": {
     "auth_ref": [
      "r293"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.",
        "label": "Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)",
        "terseLabel": "Cumulative effect adjustment for adoption of ASC 2016-13"
       }
      }
     },
     "localname": "AccountsReceivableChangeInMethodCreditLossExpenseReversal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r269",
      "r270"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r45",
      "r901",
      "r923"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued Income Taxes, Noncurrent"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued liabilities, current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r33",
      "r34",
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued Royalties, Current"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r70",
      "r348"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r103",
      "r108",
      "r550"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Unrealized costs associated with defined benefit pensions and other items"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r98",
      "r105",
      "r107",
      "r108",
      "r799"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r54",
      "r105",
      "r107",
      "r108",
      "r926",
      "r951",
      "r955"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r104",
      "r108",
      "r117",
      "r118",
      "r119",
      "r186",
      "r187",
      "r188",
      "r729",
      "r946",
      "r947",
      "r1008"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Asset, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r633",
      "r634",
      "r635",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r189",
      "r190",
      "r191",
      "r192",
      "r201",
      "r272",
      "r273",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r396",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r680",
      "r681",
      "r682",
      "r683",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r848",
      "r891",
      "r892",
      "r893",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r271",
      "r292",
      "r295",
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Accounts Receivable, Allowance for Credit Loss (ending balance)",
        "periodStartLabel": "Accounts Receivable, Allowance for Credit Loss (beginning balance)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r56",
      "r271",
      "r292"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedLabel": "Utilization of allowances",
        "negatedTerseLabel": "Utilization of allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r157",
      "r328",
      "r337"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization expense",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r175",
      "r245",
      "r252",
      "r259",
      "r285",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r725",
      "r731",
      "r801",
      "r849",
      "r851",
      "r899",
      "r922"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r26",
      "r28",
      "r91",
      "r175",
      "r285",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r725",
      "r731",
      "r801",
      "r849",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r787"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r16",
      "r19",
      "r345",
      "r352"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r274",
      "r276",
      "r303",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Notes receivable"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r745",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r31",
      "r347"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r580",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r580",
      "r594",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]",
        "verboseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r711",
      "r712",
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1": {
     "auth_ref": [
      "r700",
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination",
        "verboseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r156",
      "r720"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration net expense (benefit)",
        "verboseLabel": "Contingent consideration net expense (benefit)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r718"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "auth_ref": [
      "r718"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r710",
      "r713",
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "negatedLabel": "Fair value of contingent consideration",
        "terseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r710",
      "r714"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r710",
      "r714"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "ACQUISITIONS AND STRATEGIC INVESTMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "verboseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r705",
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r705",
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r702"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations Policy [Policy Text Block]"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease Obligations [Member]",
        "terseLabel": "Finance Lease Obligation"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r66",
      "r851",
      "r956",
      "r957"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash Acquired from Acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r22",
      "r66",
      "r159"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r37",
      "r161",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r149",
      "r159",
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period",
        "terseLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r149",
      "r816"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease)\u00a0in cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]",
        "terseLabel": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r172",
      "r175",
      "r205",
      "r206",
      "r207",
      "r209",
      "r211",
      "r221",
      "r222",
      "r223",
      "r285",
      "r397",
      "r401",
      "r402",
      "r403",
      "r406",
      "r407",
      "r448",
      "r449",
      "r453",
      "r457",
      "r801",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r82",
      "r378",
      "r907",
      "r930"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r389",
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r186",
      "r187",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized",
        "verboseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r50",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.01 par value - authorized 2,000,000,000 shares; issued 1,688,810,052 shares as of December 31, 2021 and 1,679,911,918 shares as of December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r501",
      "r504",
      "r599",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Compensation and Employee Benefit Plans [Text Block]"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r113",
      "r115",
      "r124",
      "r724",
      "r735",
      "r910",
      "r934"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r123",
      "r135",
      "r909",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income (Loss) Note [Text Block]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentration Risk Disclosure [Text Block]"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Capital in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r475",
      "r476",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": {
     "auth_ref": [
      "r477"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.",
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
        "terseLabel": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockTermsOfConversion": {
     "auth_ref": [
      "r48",
      "r49",
      "r465",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of conversion terms for preferred stock.",
        "label": "Preferred Stock, Convertible, Terms",
        "terseLabel": "Convertible Preferred Stock, Terms of Conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockTermsOfConversion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate Segment"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r129",
      "r889"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": {
     "auth_ref": [
      "r366",
      "r367",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.",
        "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]",
        "terseLabel": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r176",
      "r677",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current Federal Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r176",
      "r677"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Current Foreign Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r176",
      "r677",
      "r686",
      "r688"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r176",
      "r677",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current State and Local Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r906",
      "r932"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current",
        "verboseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r171",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r425",
      "r432",
      "r433",
      "r435",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "CONTRACTUAL OBLIGATIONS AND COMMITMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r174",
      "r181",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r438",
      "r439",
      "r440",
      "r441",
      "r831",
      "r900",
      "r903",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r423",
      "r438",
      "r439",
      "r800"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r79",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "negatedTerseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r80",
      "r174",
      "r181",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r438",
      "r439",
      "r440",
      "r441",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r80",
      "r174",
      "r181",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r434",
      "r438",
      "r439",
      "r440",
      "r441",
      "r465",
      "r468",
      "r469",
      "r470",
      "r828",
      "r829",
      "r831",
      "r832",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r421",
      "r436",
      "r438",
      "r439",
      "r830"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in Unrecognized Tax Benefits is Reasonably Possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]",
        "terseLabel": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r176",
      "r678",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Federal Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r176",
      "r678",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Foreign Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r176",
      "r678",
      "r686",
      "r687",
      "r688"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r46",
      "r47",
      "r668",
      "r902",
      "r918"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "terseLabel": "Deferred Tax Liabilities, Gross"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r176",
      "r678",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred State and Local Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory": {
     "auth_ref": [
      "r675"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.",
        "label": "Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory",
        "terseLabel": "Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Deferred Tax Assets, Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r669"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Deferred Tax Assets, Gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Deferred Tax Assets, in Process Research and Development"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Deferred Tax Assets, Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Deferred Tax Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Deferred Tax Assets, Net of Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Deferred Tax Assets, Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Deferred Tax Assets, Property, Plant and Equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpense": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from contingent liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from restructuring reserve.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r652",
      "r671"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Deferred Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDerivatives": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from derivatives.",
        "label": "Deferred Tax Liabilities, Derivatives",
        "terseLabel": "Deferred Tax Liabilities, Derivatives"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "terseLabel": "Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Deferred Tax Liabilities, Property, Plant and Equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r520",
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r505",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "terseLabel": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r40",
      "r505",
      "r506",
      "r528",
      "r573",
      "r898",
      "r921"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Assets for Plan Benefits, Defined Benefit Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Executive Retirement Plan Discount Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Executive Retirement Plan Rate of Compensation Increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r553",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r515",
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r555",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r522",
      "r531",
      "r532",
      "r571",
      "r573",
      "r574"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year One"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r519",
      "r531",
      "r532",
      "r533",
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r505",
      "r528",
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "terseLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r507",
      "r511",
      "r543",
      "r565",
      "r573",
      "r574"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Defined Benefit Plan, Interest Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r509",
      "r542",
      "r564",
      "r573",
      "r574"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Defined Benefit Plan, Service Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r557",
      "r558",
      "r561",
      "r562",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r157",
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r157",
      "r240"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r800"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCashReceivedOnHedge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period on settlement of a hedge.",
        "label": "Derivative, Cash Received on Hedge",
        "terseLabel": "Derivative, Cash Received on Hedge"
       }
      }
     },
     "localname": "DerivativeCashReceivedOnHedge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]",
        "verboseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r92",
      "r95",
      "r96",
      "r748",
      "r868"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Asset, Fair Value, Gross Asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r92",
      "r95",
      "r96",
      "r748",
      "r868"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative Liability, Fair Value, Gross Liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r95",
      "r746",
      "r749",
      "r758",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r743",
      "r746",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r743",
      "r746",
      "r758",
      "r766",
      "r767",
      "r771",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Assets, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Liabilities, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r750"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r750"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r800"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r738",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r737",
      "r739",
      "r740",
      "r743",
      "r744",
      "r752",
      "r758",
      "r768",
      "r770",
      "r773",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r180",
      "r737",
      "r739",
      "r743",
      "r744",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r487",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockInventiveandPurchasePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r343",
      "r344",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r16",
      "r343",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r345",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r345",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as income tax obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Non-current deferred tax liability, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r345",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Goodwill, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r345",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r345",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r345",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r345",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r157",
      "r344",
      "r350"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedTerseLabel": "Gain on disposal of businesses and assets"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r20",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "ASSETS AND LIABILITIES HELD FOR SALE"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r580",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r471",
      "r915"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "terseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r471",
      "r915"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "terseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r579",
      "r583",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r125",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r202",
      "r205",
      "r209",
      "r210",
      "r211",
      "r216",
      "r217",
      "r785",
      "r786",
      "r911",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Net income (loss) per common share \u2014 basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r125",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r205",
      "r209",
      "r210",
      "r211",
      "r216",
      "r217",
      "r785",
      "r786",
      "r911",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Net income (loss) per common share \u2014 assuming dilution"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r212",
      "r214",
      "r215",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r816"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOnFutureCashFlowsAmount": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The quantified amount of the future effect on cash flows.",
        "label": "Effect on Future Cash Flows, Amount",
        "terseLabel": "Effect on Future Cash Flows, Amount"
       }
      }
     },
     "localname": "EffectOnFutureCashFlowsAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r178",
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "negatedLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Other Adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r641",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "effective income tax reconciliation, compensation-related"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Tax Credits, Research"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "negatedTerseLabel": "Employee Service Share-based Compensation, Tax Benefit from Compensation Expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": {
     "auth_ref": [
      "r640"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of plan compensation cost recognized during the period.",
        "label": "Employee Stock Ownership Plan (ESOP), Compensation Expense",
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Compensation Expense"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average purchase price of capital shares purchased through an employee stock ownership plan.",
        "label": "Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased",
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r117",
      "r118",
      "r119",
      "r186",
      "r187",
      "r188",
      "r190",
      "r198",
      "r200",
      "r220",
      "r289",
      "r464",
      "r471",
      "r633",
      "r634",
      "r635",
      "r682",
      "r683",
      "r784",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r824",
      "r946",
      "r947",
      "r948",
      "r1008"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r67",
      "r246",
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r798"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Measurement alternative investments (1)"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r787",
      "r788",
      "r789",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r423",
      "r438",
      "r439",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r573",
      "r788",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r787",
      "r788",
      "r791",
      "r792",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r423",
      "r531",
      "r532",
      "r537",
      "r573",
      "r788",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r423",
      "r438",
      "r439",
      "r531",
      "r532",
      "r537",
      "r573",
      "r788",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r423",
      "r438",
      "r439",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r573",
      "r788",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r793",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r794"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "verboseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r423",
      "r438",
      "r439",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r573",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r795",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r163",
      "r164",
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "negatedTerseLabel": "Fair Value of Assets Acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r294",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r434",
      "r462",
      "r775",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Future Amortization Expense, Year One"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Future Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Future Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Future Amortization Expense, Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Future Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r329",
      "r332",
      "r336",
      "r340",
      "r890",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r336",
      "r894"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r329",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r810",
      "r812",
      "r814",
      "r815"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Net gain (loss) from foreign currency transaction exposures",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions and Translations Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r95",
      "r531",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract (Member)"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet": {
     "auth_ref": [
      "r756"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness.",
        "label": "Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net",
        "terseLabel": "Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net"
       }
      }
     },
     "localname": "GainLossOnCashFlowHedgeIneffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r746",
      "r757"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "terseLabel": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r132",
      "r157",
      "r275"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Net loss (gain) on investments and notes receivable"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r157",
      "r730"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain (Loss) on Disposition of Assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r157",
      "r442",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r315",
      "r317",
      "r851",
      "r897"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r318",
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, Gross"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r318",
      "r323"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r157",
      "r316",
      "r320",
      "r325"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r321",
      "r322",
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Translation and Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r127",
      "r175",
      "r245",
      "r251",
      "r255",
      "r258",
      "r261",
      "r285",
      "r397",
      "r398",
      "r399",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r801"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r743",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r157",
      "r341"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r157",
      "r341"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Goodwill and other intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "auth_ref": [
      "r71",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.",
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "terseLabel": "In Process Research and Development, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r177",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r122",
      "r245",
      "r251",
      "r255",
      "r258",
      "r261",
      "r895",
      "r908",
      "r913",
      "r937"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r177",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r580",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r6",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r15",
      "r17",
      "r18",
      "r19",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r351",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]",
        "verboseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r178",
      "r655",
      "r666",
      "r673",
      "r684",
      "r691",
      "r695",
      "r696",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r656"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Income Tax Examination, Penalties and Interest Accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r179",
      "r199",
      "r200",
      "r243",
      "r653",
      "r685",
      "r693",
      "r938"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax (benefit) expense",
        "verboseLabel": "Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r649",
      "r650",
      "r666",
      "r667",
      "r672",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r152",
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income Taxes Paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).",
        "label": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option",
        "terseLabel": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in operating assets and liabilities, excluding purchase accounting:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r331",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r331",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite Lived Intangible Assets Major Class Name [Domain]",
        "verboseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r327",
      "r334"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r121",
      "r239",
      "r827",
      "r830",
      "r912"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r147",
      "r151",
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest Paid, Excluding Capitalized Interest, Operating Activities"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r95",
      "r531",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Unamortized Gain on Fair Value Hedges"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r58",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r23",
      "r88",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r36",
      "r89",
      "r168",
      "r219",
      "r308",
      "r310",
      "r312",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r60",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r59",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory Write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Investment [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r283",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r931"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r30",
      "r69"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentandContingenciesPolicies",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r55",
      "r175",
      "r285",
      "r801",
      "r851",
      "r904",
      "r928"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r78",
      "r175",
      "r285",
      "r397",
      "r398",
      "r399",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r726",
      "r731",
      "r732",
      "r801",
      "r849",
      "r850",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r787"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r16",
      "r19",
      "r345",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r44",
      "r903",
      "r919"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r74",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r74",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r82",
      "r378",
      "r387"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal reserves"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r82",
      "r378"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Estimated Litigation Liability, Noncurrent"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation-related net charges (credits)",
        "verboseLabel": "Litigation Settlement, Expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r44",
      "r422",
      "r437",
      "r438",
      "r439",
      "r903",
      "r925"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Capital Lease Obligations",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-term Purchase Commitment [Table Text Block]",
        "terseLabel": "Long-term Purchase Commitment"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r80",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r386",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r378"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "verboseLabel": "Accrual for legal matters that are probable and estimable"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r378",
      "r381",
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Loss Contingency, Damages Awarded, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r378",
      "r381",
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Loss Contingency, Damages Paid, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money Market Funds, at Carrying Value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash provided by (used for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r149",
      "r154",
      "r158"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r196",
      "r202",
      "r203",
      "r208",
      "r211",
      "r245",
      "r251",
      "r255",
      "r258",
      "r261"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "verboseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r245",
      "r251",
      "r255",
      "r258",
      "r261"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)",
        "verboseLabel": "Operating income allocated to reportable segments"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r839",
      "r846"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "verboseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r837",
      "r840"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r834"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r843",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r842",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r21",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r77"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r40",
      "r898",
      "r921"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "verboseLabel": "Assets (segment reporting)"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r90",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "totalLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other Assets, Miscellaneous, Current"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other long-term assets (total)",
        "verboseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r99",
      "r105",
      "r811",
      "r813",
      "r817"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r108",
      "r117",
      "r118",
      "r120",
      "r818",
      "r820",
      "r824"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r101",
      "r105"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net change in derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r101",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r101",
      "r105",
      "r747",
      "r753",
      "r772"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r105",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r105",
      "r109",
      "r755"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r102",
      "r105",
      "r754",
      "r772"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax": {
     "auth_ref": [
      "r102",
      "r105",
      "r754",
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r760"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r761"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r112",
      "r115",
      "r117",
      "r118",
      "r120",
      "r123",
      "r464",
      "r818",
      "r823",
      "r824",
      "r909",
      "r933"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income (loss)",
        "verboseLabel": "Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r103",
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r103",
      "r105"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Net change in defined benefit pensions and other items",
        "terseLabel": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax",
        "verboseLabel": "Net change in defined benefit pensions and other items"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r105",
      "r109",
      "r110",
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r106",
      "r117",
      "r123",
      "r653",
      "r692",
      "r694",
      "r818",
      "r821",
      "r824",
      "r909",
      "r933"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherContractMember": {
     "auth_ref": [
      "r95",
      "r531",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is classified as other.",
        "label": "Other Contract [Member]",
        "terseLabel": "Other Contract"
       }
      }
     },
     "localname": "OtherContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r32",
      "r33",
      "r77",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "totalLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Other long-term liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other Operating Income (Expense), Net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other Restructuring Costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r359",
      "r360",
      "r369",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring [Member]"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r77",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other Sundry Liabilities, Current"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedLabel": "Payment of contingent consideration previously established in purchase accounting"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeInvestingActivities": {
     "auth_ref": [
      "r141",
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Payments for Hedge, Investing Activities",
        "terseLabel": "Payments for Hedge, Investing Activities"
       }
      }
     },
     "localname": "PaymentsForHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow or inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Payments for (Proceeds from) Hedge, Investing Activities",
        "negatedTerseLabel": "Proceeds from (payments for) settlements of hedge contracts"
       }
      }
     },
     "localname": "PaymentsForProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r138",
      "r141"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Payments for repurchase of common stock",
        "terseLabel": "Payments for repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedTerseLabel": "Payments for Royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid on preferred stock",
        "terseLabel": "Payments of Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r139",
      "r716"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for acquisitions of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment and internal use software"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy": {
     "auth_ref": [
      "r557",
      "r575",
      "r578",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]",
        "terseLabel": "Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPensionsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r557",
      "r575",
      "r576",
      "r578",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension and Other Postretirement Plans, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r555",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r602",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareCashPaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Preferred Stock, Dividends, Per Share, Cash Paid"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r49",
      "r172",
      "r453",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r172",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Preferred Stock, Liquidation Preference, Value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r49",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r49",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r49",
      "r851"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, $0.01 par value - authorized 50,000,000 shares; issued 10,062,500 shares as of December 31, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r26",
      "r64",
      "r65"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r25",
      "r27",
      "r313",
      "r314"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestiture of certain businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Net proceeds from issuance of preferred stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Proceeds from long-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from borrowings on credit facilities"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r143",
      "r145",
      "r160"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Net increase (decrease) in commercial paper"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "terseLabel": "Proceeds from Royalties Received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionRelatedImpairmentsOrCharges": {
     "auth_ref": [
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.",
        "label": "Production Related Impairments or Charges",
        "terseLabel": "Production Related Impairments or Charges"
       }
      }
     },
     "localname": "ProductionRelatedImpairmentsOrCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r19",
      "r111",
      "r114",
      "r119",
      "r148",
      "r175",
      "r189",
      "r199",
      "r200",
      "r245",
      "r251",
      "r255",
      "r258",
      "r261",
      "r285",
      "r397",
      "r398",
      "r399",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r724",
      "r727",
      "r728",
      "r734",
      "r735",
      "r786",
      "r801",
      "r913"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r70",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r69",
      "r347"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r38",
      "r39",
      "r349",
      "r851",
      "r914",
      "r929"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r68",
      "r349",
      "r964",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r38",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, plant and equipment, net [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r38",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r126",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Net (credits) charges to expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "totalLabel": "Purchase Obligations, Future Minimum Payments Due"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueAfterFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, after Year Five",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due Thereafter"
       }
      }
     },
     "localname": "PurchaseObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Five",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Five Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Four Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase Obligations, Future Minimum Payments Due, Current"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Two Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Three Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate": {
     "auth_ref": [
      "r829",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.",
        "label": "Receivable with Imputed Interest, Effective Yield (Interest Rate)",
        "verboseLabel": "Average interest rate of de-recognized receivables"
       }
      }
     },
     "localname": "ReceivableWithImputedInterestEffectiveYieldInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r108",
      "r117",
      "r118",
      "r120",
      "r818",
      "r822",
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r251",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r250",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r145",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "terseLabel": "Repayments of Lines of Credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedLabel": "Payments on borrowings from credit facilities"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedLabel": "Payments on long-term borrowings and debt extinguishment costs"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Payments on short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r644"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expense [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r22",
      "r37",
      "r159",
      "r166"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash and restricted cash equivalents included in Other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r29",
      "r40",
      "r166",
      "r960",
      "r961",
      "r962"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash equivalents included in Other long-term assets",
        "verboseLabel": "Restricted Cash Equivalents included in Other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r358",
      "r360",
      "r363",
      "r372",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r359",
      "r362",
      "r369",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and Related Cost, Cost Incurred to Date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r359",
      "r362",
      "r369",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and Related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r359",
      "r362",
      "r369",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Restructuring and Related Cost, Incurred Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r157",
      "r357",
      "r367",
      "r369"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges",
        "verboseLabel": "Restructuring net charges (credits)"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r359",
      "r360",
      "r369",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "verboseLabel": "Restructuring and Related Cost [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r53",
      "r471",
      "r636",
      "r851",
      "r927",
      "r950",
      "r955"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r186",
      "r187",
      "r188",
      "r190",
      "r198",
      "r200",
      "r289",
      "r633",
      "r634",
      "r635",
      "r682",
      "r683",
      "r784",
      "r946",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r558",
      "r559",
      "r560",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r558",
      "r559",
      "r560",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r502",
      "r503",
      "r505",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r553",
      "r554",
      "r555",
      "r556",
      "r558",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r594",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r502",
      "r503",
      "r505",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r553",
      "r554",
      "r555",
      "r556",
      "r558",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r594",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r236",
      "r237",
      "r250",
      "r256",
      "r257",
      "r263",
      "r264",
      "r267",
      "r486",
      "r487",
      "r889"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r490",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r841",
      "r846"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "verboseLabel": "Trade accounts receivable, net [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r559",
      "r560",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r108",
      "r823",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r80",
      "r181",
      "r438",
      "r440",
      "r465",
      "r468",
      "r469",
      "r470",
      "r828",
      "r829",
      "r832",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable": {
     "auth_ref": [
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting pension and other postretirement benefit arrangements with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]",
        "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r557",
      "r558",
      "r561",
      "r562",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r746",
      "r758",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Table Text Block)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r6",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r15",
      "r17",
      "r18",
      "r19",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "verboseLabel": "Tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r601",
      "r625",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r324",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r324",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r36",
      "r61",
      "r62",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r958"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions (Table Text Block)"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r757",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments (Table Text Block)"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r369",
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r364",
      "r365",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "verboseLabel": "Impact of restructuring costs on the accompanying financial statements"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r245",
      "r248",
      "r254",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r602",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of employee stock purchase plan activity.",
        "label": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r604",
      "r615",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Compensation, Stock Options, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r83",
      "r172",
      "r221",
      "r222",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r457",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "verboseLabel": "Schedule of Weighted Average Number of Shares [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Expected Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r232",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r267",
      "r362",
      "r371",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r232",
      "r234",
      "r235",
      "r245",
      "r249",
      "r255",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "SEGMENT REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Selling, General and Administrative Expenses, Policy"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance Costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r606",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r618"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r621",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (Shares Issued)",
        "periodStartLabel": "Shares, Issued"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r41",
      "r851",
      "r900",
      "r924"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r167",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Standard Product Warranty, Policy"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r7",
      "r232",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r267",
      "r324",
      "r353",
      "r362",
      "r371",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r172",
      "r175",
      "r205",
      "r206",
      "r207",
      "r209",
      "r211",
      "r221",
      "r222",
      "r223",
      "r285",
      "r397",
      "r401",
      "r402",
      "r403",
      "r406",
      "r407",
      "r448",
      "r449",
      "r453",
      "r457",
      "r464",
      "r801",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r86",
      "r117",
      "r118",
      "r119",
      "r186",
      "r187",
      "r188",
      "r190",
      "r198",
      "r200",
      "r220",
      "r289",
      "r464",
      "r471",
      "r633",
      "r634",
      "r635",
      "r682",
      "r683",
      "r784",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r824",
      "r946",
      "r947",
      "r948",
      "r1008"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r220",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Payment Arrangement [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r600",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r49",
      "r50",
      "r464",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Stock Issued During Period, Shares, Employee Stock Purchase Plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r49",
      "r50",
      "r464",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issuance (Shares)",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the number of shares issued.",
        "label": "Stock Issued During Period, Shares, Period Increase (Decrease)",
        "terseLabel": "Stock-based compensation (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r49",
      "r50",
      "r464",
      "r471",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r118",
      "r175",
      "r186",
      "r187",
      "r188",
      "r190",
      "r198",
      "r285",
      "r289",
      "r471",
      "r633",
      "r634",
      "r635",
      "r682",
      "r683",
      "r722",
      "r723",
      "r733",
      "r784",
      "r801",
      "r818",
      "r819",
      "r824",
      "r947",
      "r948",
      "r1008"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodStartLabel": "Total Stockholders' Equity",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r173",
      "r449",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r471",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDER'S EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r464",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stock Issuance (Par value)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r825",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r825",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r825",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r657",
      "r665",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of Income Tax Contingencies [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL BALANCE SHEET INFORMATION"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r646",
      "r647"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "terseLabel": "Tax Adjustments, Settlements, and Unusual Provisions"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense": {
     "auth_ref": [
      "r679"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense",
        "terseLabel": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability": {
     "auth_ref": [
      "r697"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability",
        "terseLabel": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes Payable, Current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r867"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r434",
      "r462",
      "r775",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": {
     "auth_ref": [
      "r100",
      "r761"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.",
        "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "negatedTerseLabel": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "terseLabel": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r85",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r85",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r85",
      "r472",
      "r473"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 263,289,848 shares as of December 31, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r464",
      "r471",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r189",
      "r190",
      "r191",
      "r192",
      "r201",
      "r272",
      "r273",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r396",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r680",
      "r681",
      "r682",
      "r683",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r848",
      "r891",
      "r892",
      "r893",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r359",
      "r360",
      "r369",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized Gain (Loss) on Investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r648",
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r662"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt [Member]"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r182",
      "r183"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow [Member]"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r204",
      "r211"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Assuming dilution"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r202",
      "r211"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r1000": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1001": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1002": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r1003": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3098-108585"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3,4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121321822&loc=d3e3913-113898"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121323062&loc=d3e15009-113911"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28511-109314"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28446-109314"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r977": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r978": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r979": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r980": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r981": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r982": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r983": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r984": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r985": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r986": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r987": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r988": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r989": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r990": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r991": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r992": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r993": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r994": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r995": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r996": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r997": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r998": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r999": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>100
<FILENAME>0000885725-22-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-22-000006-xbrl.zip
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M_W;!>6YTAF5#@K^$C"6I6-&4/ ;R15]0!QF"0'*P,X+_FJ!9H]J'U%H3S 5
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MI-PJ4[$@X'JQ=7>QZLF=KY71!Z.$YL'D^'CR0NJ&-\^>+7AR5UTF\^ZAGU.
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M-) JCV+[P)^!]-WI?/9.F]!'2A&]4W6UD?*C_4*'@A&84C.84$"X[^J@' *
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MM#"F$<\=9_@HZ<7D(KH"4IH#5RP#2^,6,55RONX<O?9K(+\(6J,)P4KTIK(
M4,U*9^.P83&>V.]IO3-JX(N0N:%9KK%$RH004LDQ<&RQ.I\2F]#V=-X5.G]9
MXK8"]U[AY)U)D&K.374(9,_L:K%H]KS>Q_Y/E[1"MEJD/N0%+EJRWGJ?.0<B
MV\Z*(BBWSDAE<<BDV@O)MV2R>&4RZ:%KJP/90JP6:JIBH-9 D 1*J;UMM"V$
M8R734.+=-<NW[9 H@M?4VK-IA:'W3^DAKW'$%E*TR'L2C5,T;8E-R=@8.7$P
M!B TK."-!P&;0M67OTPVC1)*9!\:0&(P#"$(U9A:C 4;<*,P6BB'._$\[#5
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M(3 YUQNVQFAZ%8%Q]YP?*RC&21-C/=E>%ZH1JA2K(4D(DC+CV*37H)J]7\/
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M,+8)L>5&AF/IY1)<19\A.B\NQ5P\G?4OL?^/O:]M;AM'UOTKK)Q[STFJ(B\
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ME3O.J/&QRHC0/*-<QR*A-,X4EUZI6&TYS!TK[^65??:93+C'%0@1]MDKT1'
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MYHX ,2EN3;/]13%]0Q#MP[D+M0FNP=I#VNSK. =2AH!F(S4<SE!M$>ZT:RZ
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MNLVZ[\*./>/+77S3HMR=R_O94)UMHLGZH26QCW\9GL2$>M'Q)#8=SA3KB,P
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M2?N%F=9[9>8'4=?4XQBKT;BQ<>OUL@]^/\+09I,8>@LW;--'WR.'+3Y>1N%
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MT=&+\/ON\>MH?_=D=XN]&R'Q;,N#-TNH-&F)L-R"[WI);>^/W?YSX+F].OP
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MKH(IB9(J9@.!;2F=AY?'7JEWC40GJA[5L[+X@"IT =-F,AWGJ+#X+.S_U<D
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M[7$>-3E )H126K>O-S8[7W,K TE$GNJG8/[G^6H8BBM"$GU3B&9>5[4NG!I
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MC>^S)\<\*@Y;K^W;S2:Z'Q@6!!JZH2Z5980W<#T]PK2,L/0-PS+Q=LO!W/%
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M'AQ5[A->N\9X'H)@[/9+LX^33+''>0H9[:.7()80VX]+K?[K5N.YO_WQ-'4
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ME^CLPUY^TKU4H(,_;+039%X#$P+LB6L/6_(IC]<*[6,K18%PR,MG95Y+3\B
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M=Z2A!LC'.-5^KWC6S0">G@B%U=%\W<YB_ X%M2K?\E!T4'4WDEL!'(J6F-G
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M E]B,)07X"4YSLMP9CP0&HL1^P6D\ 'L%-M].A]3\%BN:J58UP;WCF=":U<
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M(  8%I]$6;MSX"9Z="\OHP/_)GAY7#Y:TB7)3$'F>_96^86]W/^Y($76LK.
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M_'#:,VN+1C<R5S)'A<VF1') _N![47UY\UX<GVO/%+.Q*3OE5OB"5"&[C+'
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M[+CZM)YQNJQGBA ^J7][)JRZM)ECH]1+D17.7WH) OE[Q6OR)9AE:9)%-N(
M90@V[6H!ZH,C/#Z0%NYQ:I&/-RV'.!SO6Q"M;F5W91).?6KV<M[GXB32^MR_
MN5><;N%.9E+:X>A;2?"3>S7R4]0IX19;IX1L.J''1DHU4HM/QW 9Z2PH7D^V
MQKX%A97>2AZYFVLE,VB?.HH^[,3GAZ<VOB1&RZ,,YBHA*9M7D$O5\HT0CZ%I
MC\];4[]%!*3MV5&,$)78(#E1!0)WS\LLC$L.96I)NLUQQ8LQR;D>F='PX>G&
MCXH>3>.373_/$%G8N7[7M'=V63=+'>P^Q298PMMS (FQ]*GM='#2?)T[X=[9
MO8G"-C2<EQ_J+*]]-XLV'#>7WL5@[Y%"-\J>U!#KW@G#FZW'E,R#.]B,6M'^
M4B[2LU^O\8?'JF2>+2OC8>AF-4<^7)^H.&43>RY<\A8H56.QJUP, N0)4TC>
M*T[LEI'Z2,@U^9GUG8?PH0\AP(/!:KP"\()=$$-+7GUE%XGI-=(KC<6:\HBA
MBLZWA1%;[KMTOUB8&S,GW'+V0<\JZ8K9NN<9T%+9R'-EW/+J^HW'*&,GS2Z)
M*+H+FL8GT&;R)Q<68VPE6Z3=;48FKW\>1EHO@L=T0&04XKJ-;7-]%Q$[YC-(
M?C^;W'[5QTJZHSX['009:"E%FXE%;R^CFGP60O%Z=D[K"A37F@>C'^OL:X9V
M3@SVJ+,F$,.RO? AZ;IE1@(FM=#J7_P[PSN \V#J3-L(@;< 6;=NSABH<:.5
M\$?6#1P=$]->1=PN:[@X5OR*EI40'G[U\(O?]:%OL9E,+(R.F(>-5LAV"DBX
MB4YBCGZ61ZIP/6&?!_XBG_1C[)K.&]5\VXP39(I@TD!FUX.0Q2-GK!96V,76
M)+)\$DL<L;6=8])ILQY8IN-M(]@FN[W-F)6[2$<?68@>\RIT.-&@0T65P5=&
MVG)#/YR[)K8[Q_1_C*-=<,W3$F($W58IJ1R),W>.)AO/AA([*)2YP@Q%YERP
MLYSQTK1_LQ9-S]T>]2]"#(4JK!J-%A66;"*7;+]>@5E5+YC+8+1;\ZY;P=U:
M49!@X(@X K>7PI&"DA#,\^A<I,%TI$,TJ.N!%,.D0.>C,H+'FX,>N3WGTM$9
MO6509A%YQ,MR #'PJS 7'-+UXD8\Z7JRT_#<7LMX!V7O^T-Y$+>8#;^ZYQ0S
M6?8GB9&0:W44-FZT.SXQ()Y$%@.I"L>D>9I@_J$<B#9-(C$AWFR+>66_)#--
M%"<E1R2WX37WS!A>;<]&D5"8NY9!CK+F,&6*^*+7+*3ZWSIC7/*1363R(Q7)
ML_2R&IP/M$Y*05X]24-<OI6JZ@FI0+0SJB_\'7!HKDD;@5@)G#Q R*=MVUTD
MG^4G[2UZO:PI//F0\0=;PPV^>,"\'3N?.?_D@[\JPX>SIKBT_7:P]NS(TS?)
M(4P")_ !@^0WOK0K6,B2(X9%%>\</$O&W?HPW M<QI_&+_M07M8 .BGQ,GI3
M>2=:RLMSD/;$T>M[D4:HZ,TD9919^<B*QN0Y0B:GU>J\4LNS;LZ976P6%;,7
M,)7!,UP(0R4R(\^5=DP=VJ^<:%/.ZO9HU2WEF%R;T_A=+0=#M]6\J#[$]A!>
MME#Y%:-%840 8RO'HX)8SI#<Z[6LK_4#[6'?S>QO8:US(7!A/IENJ!.NS</0
M*)22I_JYFUI_4&3/&4;S4*M.C W0%1W[ATJ\P^U/.LY)R*_:.-'I0CP43@U[
MR@V_\<MRX\F?E(V\">^X"9#567JH"7 %<F\;FFA+:MG1T?G*IU5*X0]NT(5@
M-LHHH58A8'S&+V%(%S[7CFU'/08^_/;&LT9]I+OE]/[3-+SK- [ONM%K\;XH
MK]))*V%8B5 Z=)#&-)P4NCP/;9SK%<]'RH>!:V?I@\ TM] P0S8)-MK)U7G/
M'Y?.-I57]-"T9^I63MP,-;XH[X\RMW0S'K$S1L5$>$V.#-\"V[ BLO<P1>\4
MV8HI.A(/+2[IZS72V9 2?K6,Z1&" *'\2)/0F$J,U NZACF;JW,1(VJ KZZQ
M4A^TI3"6-M)CD=F+L^MX@@6]H=IO\ICGF-/9%L?TUOC'7WBHVH1;_ME_@9#5
ML[_\ "7Q;A(_)Z/?V[\<-^7P5B@1 $:2_Q;?E9=EC3^_8'_[92GIK-,!8^(U
MAU:L+GD !I,M]"5"P3NK[BS@&Q.AII$-ALYGJW'WO3X1OUE<"]+GC^Y#S&;.
M4G_3 1F'BW &@K%_>)HOOAY_T@7*67/TH[_Z3Z9U'J<L7JY#3_OUJIYU:5HM
M+WKV<I^@=/(Y0C&^.$ Q?D7'#.3<TCB+DA,H%B0[G7.)(R,C&"U) \4OHX8J
MLX5I$BU&=LG(97:#MJVE,+4D>WGGR5/^U>E=?AK-,.$^RL3\Z,>7\+? N&!<
MS*E4FT4YA?!2ZPE%98=3\$EMUNT.;<DYQZ08=VF?0CD&F22.63^M7:$$S$1*
MM;2D7SR*Z@%_?QA_G+A.8JD7FAXK5(4]?)^"^^*!5SV+F$LI^@X=MI<\80M#
M\>CB\6TF?J U::>Q<J*+/XR7S2Z1+X/3A\C"/GW'+=L702=Q&,)VMY(5P>A8
M$$@DA?$J^I51AF(*E(OO'$R@TMQ6PA43B<541<_B#!!N%9(AH542MUV357F$
M68RA72VE-*IM29EDJ5QY+#LQFF;ZIFLI>'M)-NTVE[]S8A!Z^Q8IDZ>V=:\L
ML?JMH$WN/'WU[7!7(.H10)M&P-I!CP'>O0)?X,]?D*7AP283:],Y8@Z4KG?Q
MHJ%:.$B1^$M"F="$*0?:/*U6G33V3UT4R'[@)@Z'I?U=+XRSDQ$F]*RM=(J#
MYKYL.W%'QE='Z*4XXA1DN5@/U4V9QUX,;^NFT1A2JZG<\4VOC3,FG4\2@BDR
MG]$_G9 (VQG3A1BL+4_#QS11)B;4]732U6?GY7*U$V(PBUFJ6*7 ']/PQ,R3
MM1"<DV)(7%UTD>I4*I2IAYJW[6;'@A]B1&D'UE4DV)-]XU+"K#LC;S]4*@&\
M1C'P]TJHW)6:GY+O?<:;=:0O-.?_/?Z]7F]V7@<9ZTSBS/-F$8H]J0>M)_S]
M]!^Q=8[G&Z4_P;9++QV%!N$=;/KI7:E\2RI:Q_N>T/DO:2/_3/^,R;'Q=T_H
MN[QV/X1ARI'(MR6IA6_J(;Q;(Z?X!@C$,X:8L7S^<QWH7W=^^/:;-_^\^W_%
MZ\G]_^O'UV\L$UZ\H3<C1XX"OV$E/460661$7J=9S]*4MBF>89$M6W*2&BLF
M?^R *29LZ2D"+[Y!%*[*6*3M)[;[O#EXQ8D?6DB+]C8A)E:\$EQMX8O]>8B+
MHF'>GT<WD#/_)//XE+5P%FJTZ@N,C8= <.WWI%RAJ$/ZA)U(,;T/)^*%\6$Q
M%XQ+?RY8!L>,&0L/RY/$/2?C1GY<9N;UY-%:W'#C_-&5P 7XW=.*?*/9Q!N]
M"._3R9P+]<G4B7??%",\\TMC +E)5-J":B7ABJX&CLW1-&B3O7#U:])IXE).
MFN).TBQDGDV6LRXU-[;9\DG,I#.T2O/$'%KQ\9(WBW ^P6O.,*RU"=59B$&%
M[P/3'F;E;H\*&WWWL0F.+'=71W?AO,/)1R^:W0COD"IGEF=*89^E@AD\(%EH
M!3U"/2>_1.II1OV55M2KI?UKLXVS$-9<[0;:L5-L>'TW8Y4Y\@9C3,L3DW]>
M^=QPG7%UQ73@FHGI7 ;6,$':);,%0(#F) X=QT=;!VN[2A$IEV*I@AW&^1PT
M6/B1*<'":KSNH)@9KDZV,8] .9SK 1[*IA2"'^F?&SUPHB[ =RBF1WB6SKFP
M4$4B?\/&B&5*>D!.L/Y.\]D1#HMR4UU)(PDMC51H>),@=Q=\'%=*FD WO.#A
MB.3[M4Q_73=5Q.#& .IX0&\$"^?+[)13?$&OB0Q&/'U.'Z64!T7K2TF8R*F+
M95^.1/3I\ QM!#6)FB =!EC07_C!.&<_T2G628^ 3X_Q-\HZ=WN/!;N,+-U,
M%\4_&82@[SH=A07!T^HM[SU\]=CQT/F"8.LV(=-H+\N-)2;J04DU4)$$)-6=
M2[0O'3'?APL-<Q-F>^H(%17^(P/4XWW20*&.1XQ9>BZ9KW+%[:R(3,B=NS3T
M+FJJ1@&%>_?A7(?',!\&2QHWZ*BB?Q=_@-?GJ"P1S#,<FM3&[-R([P'7TS/-
M&CM6*7"MAMD!5\@.H=>HEMG863KB,D0*#8Z_F%<$(%M!J&5@\$F1IFQS)Z.
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MA\>*Y^-C&)\Q#9=C5F>2VW6:%&#GL$-[''R$/:I>1N;U@ UOQ4310X3Z868
M1>!6]6R5FW!!L@%]QJVXBT#.,)LD_CG-O<[F7,XTT']+RO.\ZRIA[1'Q,?6U
MI;9,33=-2GR84<^?50PBE[;%_]4GQWE:]]*>*\8G(BUEDL-4$"):R:"#V7!4
M0\]F-+;,:"9(:O@J2SL7.L\HI7MB5^>^Y8_:WAE/W6@_0P.X+>!LB].)3+UY
M<"P6)'D]6)44KL8X\#T#;#C5Z--+DP0OQ6,I:P-=2F[O[B^WW'X([/%Z.B"+
M1"]^=:(T1N8,>.+4%XKMG!O4&_S$(,990U$7FU8.563!2>%-&U48O,%K^G'6
MQ*?N>BX$\Y9L]AMCP7NF*D.BGV0HD'>_>,"ZZOM)/CB!A*7N9^N%S0ESM6:<
MCNPR&@BSNZQS67,QD#:9>#"4H"MSC7C%U#D:>40N8W&55Z\+_ 8RHMX-?-"T
M+F"2(<.K"5NH,FS2?I?X8[(EOWTL]3G6$[\ZU!,_*+ %$IE]&0P3[!81/9<K
MZ&A(W$A1\<+9I']H:+*E->KV:@4TB'W9GB2VRZ;X!Q7#L-,@W/"JY-Y>YMUY
M;T JOE''*/R*W/;OSK:Z]Q&7P$6V9T=-F*_^_NBO.^<PR:]J9J#Z^]&#KY=_
ME/[A7,M?'_]QO+6/L^5Z\,6]+[$6;[:BX)W1;\2C,B)=PMG-* C6Z&JBWE[$
MD/,$3D/ ND:+<6:+_>A: =W<%XTX[8)<4,BJ9D69+;'9I+A7DRS6+2&-6O:D
MDQ@?2O!"ILV:_3A9$"\.1TSU'D/*NN72'FM8(K7!3,6V,@PWI4B@E.06W;,3
M*L*%!F7ZU=3MPW>/4 A;V<EOKG<.1^*W.1+[=F[K<'@A!C1-^WYVI3?V968.
M0G!-A>!]>E%[XX.A_[2"& Q7+JW+B_I(@GSIIM'Q[X>C?U-WO<LZ_]]'!Z?S
M['-+Y_JC?1HR&BLM14I:+.9M,>FYO/28%;X;2H2B;WXWF?IC!>C!EW^X -$C
M[!:@%WD^$Y3&%RGI\,'"E0:!N+1X D)/K+\A9;[S;F?7A@4:A24GR30W+"V"
MXC/17X3Z@_]RT<%\,39T2R(.XO(IQ"77-S:;G30(AITC9LVK*)/8"8:![)+Z
ME$1>[!Q&>MJ#T&?EJ@0!"5<6#);0CO/N28L%5U(R"X;\L5-3^]7,AYB@@S'[
MO8S9B2.-MUFUUM(G\5@54(_2YF9T!)X%&SS-A;"P72H[^"W7<:O?N.JUZ9.1
M)<' U]3#@L6U?'YD4Y@XB@E2,#KIX<Q5O(5TG'E=,@H&:WB1&BQJA=M=+Y9&
M,#+]Q+N;O&*#2X7JH&1NCN1YQN)NKH0^6;^4ME%!&N8Z0;#6:7:Y\VNT"@S6
M[K5.DX8-6IWV(!TW1SI4'TFUG6FQ>$-56[EJ?8Z-&+3@+#[KBA0/4)M M2$U
MV$H-?S(6C(0_2<,&5):86YIG9!F2))=;I<,?7_'/_X[I^_W% %7*@TA_0I'^
M%_*^L585959+71.!MZEGW?57R=H._(D3MG^O['%0<;^7/+P8(YAXT@NV7DL@
M$VU"]CE@[F1'9S,M;:*4N<(6IMJ+(DKQ<(E7"@ H4F^,_K:>*D9EU<9<A.**
M@G@2(1[BOE8GA?"U;):9MA)AJB#0B+YU^N#_7T,A?!,K7,*\9CWE!MV+4%-A
M%MZ7-JHZ%R_T3)O/M?OTZX/C=3,$XDDL+Z7]CBD>+G&*(NI26PEDI&L%K95R
MS)T+_0LE%9F7=;,6ICE&"8=,Q9A.:92^\B*,DN2 !Z8T%@//&!^^D CA?4]Q
MD,"X_?<?_>$22(_P@791D+T:\OTL>&J=FM$7B_J=9@+86](L-W=&+\)VG039
M[$X8G>;U2B!W8-YBU_\@(C=$28U%9"6SXR1#R3I)>/Y\^>PMIL<SXU@;P$3&
MT/!5B/[+ML-BQ-[6NRZ>C<R(B4VG;JPL-T')[!FX66 'U7)-CSFJPL<H8P=B
M:HO!TZFM9KNNPSDQ1M,'&4<IU2%N^<L(]&RL%=T;LY8&H+"%NY.9M4#FIA,.
M2@9K'V3]!E5ZVA@8)K.[-7HP"0;]B[D_05U]Q.BH2J8'&CG_?E"*YC'2':48
MV:_KE3L^W%OM*\@Z[\C8P]#IXO#Z'X!;^OR$[CHKV+R\&-KSDGFS=!III%3I
MIBR)DF]3)>D)LI0.:VO 9=F#!"YA [V>?OIC\?S)JX1H2(IZ5<?!#09K,+.?
M^.=N?*KM<T38?WU=$?8'7?);ZY+4IL9=PQQ4MKNQ2^Q>L0&I^^I(IO_FW:[C
M&K-U;EM1\&/TSCB-I<!BKW&$G1Z4DG'>!*-I\)/O$'5-I]L9N5^CH@X6[_>1
MT@'\7Y)GUT2KM+8Q'RR)SDH[2F0,CSGMSR*0_3A]ZG7\E)"EJF/T?AXM#CL.
M(G)=120JLC1F\JSK*FX]T"9NVE#NAL68<AXZ6M:]I*B8#RS"J*S)"8Y\;$.]
MV?0G']E1]"KYBB<\S:CD&0D_Q YU7M(G&+OQLJ?UGGT29L3K=C8^<A%OQ&GQ
M(V P@L8:@&VVZUD]B'LK2C>*A3&L.TLNI((4)NRRZ)ROZ2K:L:W80*[LW0?V
M%(;1O-I2:!3H0N@C9'Z%EFMBG+FQJJW-Z1(RCK(OC0_>]0K%0"4@-8/Y'YML
MYG8.ZQ7P@5NG/J#NF]:&3,,A>KX1HJ^L,Z,4HZA\1\UB"H\%Q9#]<1@14Y''
M62D?*O]>DA<AL-"ZFR;?)>\YWVY&L.=)9^36Z]V;*&IY_99T!7(@;L.["*ZT
MH;"<N-$>E!%(_*!>;L2>CZH?:%]=T"6Y/'K1U1$6-Z]#4^E88*Z$/GMR7%S*
MK'42E15S;$M:2>8F[0ZE!^L+\$Q7=8NJ@K7T9^ZP W!6%#QU/?27:^3]]6BY
M@QA>)S'<E]<99OV:)(IK%1 ;N5  8XFJ'>_?M3S]5K(YY<SZW'(:>;IX17O2
M"XE2I$F.C&A;K&?B6KJAB99K2C#/RSKO(Q?:0\X4'9,<'WU?S][R('"P^:[1
M#<5_>U8V T7K(,H1.E=/.]J4EVRIQ97+JG#V]8X\T+.6HIT>* N*:IBK6ZEA
M[SP[>7E\]\,OB0_&W-9<+QW>,0V,DBJ1L]"#N"HLIA1[=N*3,GO_P-<^'+:;
M<=A../W(<K[3N9PI%;Y#12/]T#-6(H;3A]V^&;N=>W4\F#5/B;#5I5N79Q;)
MJA[)*+9#,Z=%)KT7HPP?=*3@0O-1#29'";'R&06KG*MFCU+&OPV)#+(<SHLY
MYHX>D.T'<1UY A,=N:G5?R>DY<I(Y7(.PHDKL/!H3!VYS)IM8J+/ OP7SN$,
M77,1WMMRQ@XF!@"J"SQ)LYT,9S\1,QF[3(1WT$1^%@+>]6 C;Y 8IBF+['\Z
MP.E2$LB*;ME/D)I"G=1SA';X=G4PI#=.)$:ALBD6V?)FH\+@!LIH]HVYZ6Q>
M9=X-FS,Y>ZGB\>!"XFLE[!A-<\!2"D'R$2E"1!:QXVPJ$XV5VQ6Z,8[EH1":
MQQ>;-Y#WYB+5LURO2F/JW%E1.A04KZMTBL*RO(E:4*#T>#X23S/F(*X0*A!'
M&@ZYE-1NRMZD*S$QL\$_&4)M8S+1X$$;Q.2AH'1@E-8JS7/#$.4TLUI.AWV.
M2]L.7?%952I/=1*I^M\V_N9;8:8^3<S4AX-V30^:8'DF!:[%>\BD*;%%P-K>
M9CO8QGU#<39&]BK\D/D9?) QN;CLM97/,1RF4=0*)Y+/H]\N#I7YP.]F77_F
MPY UT Q_IV3:VL.72.['[YF_X,'/N1$"/O)S.,P/VC$ ;3_ND$^=G!C2IS#>
M'<A=+<]+&VJKPY[1?%KL:C[=T<S%!F=@[UGR5%P/MV%*8WHSUV"JKZ!1I#;^
MJ!]5MT=:F=A[. Z">R,%5Z>6F?-<=\#*_1(^5)F*E!108/.NJ;N8!S#%JGD"
M^73\E,BP]8.EX;AJ"?+)X1[ X7J#F+55Y7H+JIYX8Z,@*WI4NMEZ\&NM@W2U
MI2X*<>?K-)5Z!YKT=Y#SSQ&1_K<#(OVS43J1;L%W.CN7[THX=V9*C6-AJZ79
MFEE29FI,/Y/RCSG_3'J^] Q0#_X1.'$ T%H8P>'''VR[=N:YW3#;@PYD0'GS
M8#!OHNQ::R@[;$L0S 0WLXB;](8X*Y.G#(>CJKO4;!%)2= 1<]+%P"7[*)_O
M,[29__;1+EJ:XY!WW6JCK1K?LOJYG$DU*J_='^3UQLAK%9903C:Z+^^Q;J0>
MJ6-_S#L;- _&FBSD*GBLU;1-.\ _M+X-%9N5B9&UYYA#Z([07 &4"[ZP_AS+
MH"3LY4:>:+M#J.-ABKM?1TQ!?)^KL[ 'F;U.,IOG93UIB;?U-JXO*/R(!^BZ
M8:(\]K0-%%9D>I(CX&%#;H%T@T6&YY2!^D"1 O$.CWY#D+U>2.3!@,^-^U4^
M1?0S2]HJDPSSQ3P7%7!(T%[#$Y=9B4W!Y$-^[U),[AAA1+7G<S1D+*)KR#SX
M"3=# E**7K,F7)_WM!=6HS)[G/72=.,$J+B\.L.+]:Y]'U0O]052/<:-8GHT
M?;CL>T!(]3X'$;HQ(I0XK&T>KS*?1%6B6&'Y8<5!\Z&WY5KNY[>ARR'>.[C!
M,\^JOJB;8MVB_#VAK>U[.LS#RI".FQ%+>42)9^5R(R-(NH3<LG:8\T0$)BZG
MZ_5 2DZ[GF6G6)7TRG.?PEG&9E7<?Q'*X?.>W'.=Z>:V)_?\V-;PI+^GCU;=
M H_]X*O'& 6-G!PWUIC+_G0-(!&]!WWE  J[*7HEM9);HFLG'O!@]V_(?NXJ
M?F\D6T.:G1R]>CC788^:?H2UV&J<$=SOJ)7(,UYY6X-.G8GGJOJ0AIV#/-UT
M>3IT6WT6$I#[!,94P1"9G#_"NO<8K@!>BRM+\K=]2Z\]C6;<4H!@ZSD%%K2+
MV<#AKJ< 0ADVN?X*//@BMIPZ48C$8BFH<#/0T7 J8!:U*:0ASM"$*G&G3/H<
MQR_IXGQAT251K+(X0^ A9?)B9&8;(+J]E(1#'U;=1 ?ZD3D#W/WDO&[+@Q*Z
M&4IHW.8?68A[&^((US7-=U"T@F%MHI!BWG2W'G;R]@L:0'C=0WAKYHX! 1Z:
MUW?KL_.L]E!'W)_U>^$X18#T. TKZ*=R*+[IRU]J,I2OUG06RDEQ2I%\*9CJ
M@W#>6.&,, 17"2/=JI-$4R$LU?Q'LK25MC^42V^,+.3ETM2W;#ZR]*;/-L6\
M62/$3MU37.0A,1"JS^S/VNF43ZX-K7&1)&@D"0P)SN?5C?)#35%I16?OLW4U
MK_-Y&.E&1<H#W:X\<*O401\!)[Y?SQ+-+/&TS9P\-O(4MOV#S&>)G1L3AFTY
MDH AK%:-$G7CO/R\KLXTB2%CG-$XV)/':0<JH0^\9A86LH1&\"4W<T@8-Y9I
M].*,/5?AS+/NF;8\LT]68;HRK#,'T[&S#4.OVU*GN1@=9.;"CD<K[)Z80"L;
M<)^%QNJ_^QCBSQ S_?#^ 3/]V2@U:RD]CW/$M6/C@KO-5(&9\W]Y'EHZC4/=
M:QX6X+YA6 =1!8AH2,> _3#1(Z,0%]#<!EHI"IJG@%?379<K(RU<'_)I-T1X
MX"&NVWEYT?76T@B59KD+LG+%JGR'KG<97H^LZJ"8.S?Q"Y\Q[@[?Y;@S51=3
MM3F2B*]Q92KV("C76E"<D_,^>=DF-#*VX8S3Z*!%;HYPN*$T[^B^K1\Q#Z+*
M0?S6Z::H0,^\4L.TI0,8Y+5>G7=]1H$%[> $(_-,%7*RGV?C($8W1HQ&-$&<
M-P^]C!BIPKQD8JI6@Q5V:M OE:2A!B7X^@#LOV%;OU799= 'F)Z8&-O ITJ@
MZ(&BRCTV(/;UOU_'IKL$'B4%0@'PXO-*28&@LGB%CK)8 WBQ!*!7QTH?*%*N
M]]'8S5EO_O0"^1PI/$EG"YV>:9!?1TKGL[+5W=::9[2-]#/TY4P&92[7/>;L
MN&'A]D<^/3SDTN69D-F:KWLN<.8?15['RYA\]3)P!PR?S%7Y=M0 LZL#C YT
M=]:B9A'K%'%V0V\BK;4+Z^+G$WY0_3=&OK\Q K<J#;B60J6,S\3OF0E2^2DO
M0RQJ<3>J$N8G_E25@<E()D7NMX22P6<U<U2NA(=Z+O.!&')@?&[6XP7J$TZD
M\L%BR7?=85NBZ3/!^XW.YYB2?+ _)8FGK:O_^T_U%U\^>%0^^NM\^J LOPA?
M?%'.JJ^_>GC_K]/[9:B^>O35__?@;W^Z'GE,*74=K;JE+, ?P+&[I]'NS=/G
MQ8/C>\6KT]??%\^.3]Z\>/5ZKR!>@]?8+2ZG;<P>V 1 .7R>(A+YA+(6"CUP
M-0S%<=L"-_PJ"%MD"Y;W1?'@_M'W,4,5WIU3N$&'W6 Y;) B6HCIG,6!'(KA
MO%LW*)D+>1)9,1 XE7VPMM,B7)3-6GC_/!ODO>)%Q@VY(WB=..[FO8$LPB%Y
M *.A1.I5B"CQ+R[PRLQJ)0N@MQF",)/?*]Y@308%6.MJ,:<-YBD=-5W',[#)
MX5Y)?>I>\3_=VMZ:WC+TMOCD;9#RS 8)\U@:0YIH.H=T[2I5C???"$4Q_!FL
M BNY 93UO/C$MFJO)[U'"NEQBP?W"K-8?YPE_=/_H^,WKY)Q;'@25;<O0E3/
MW"0BZ07JCNHFJH/)D,J&Y)ELW7DHF6Z9)'C%'MPTI#_"5;0!6?(I]1#O%<<I
MX2>W;+L5X^]HSTE<W[:@N^!R@0QAI.<!\DD(\QO$^[3>]2)2KN+693-T6R(_
MHE[]M<=KOX6^!HIQ3W!G15:.$J[E\W]DN/K&S;)1WVYW)=D&U]CD=,CP>7DA
MKMX>>EY?RT]20K]D*Q*Y^*.HW"M^"GSA=6NU+9)?M VH&F3^/ QU9]R>'ZB^
M\QEY&&5L@5UY2;;\Z6Y*XSV/.]E'+.P^K:YAHCJ2)FWQ8L<4F]WT9YF3=\-S
M)%<"H5_\"DF0/N1I"&W1AC-VR^.FB<7U0YBV)'82EY\"]Z8)K4+J9GVWHW>2
M[KL>TE7312+R<\*Z&/J4C2S'_1,700ETSZZ<^BPS5B ;QKP>S&&)0(SQI?0D
M@GB[X3$^-1:N*:=QC)E.O?'X[8L.\0O'\K6T_<JJ9O.D200QIE6Q+J''6"'V
M5>"XN"6)/9P#VX$E@*W*G'I)SEEH,1*C%%1L5TS[KD3^+RX!J)4HOLMQW64K
MIBM6) W)8]]"0I&1X63T V^*$(+0^>EY/1<EO>YJ705Y>UK/S"G:K;G@;OI=
M'\+_KH/PB+"J490['>YR65>-CDWB79=H%6@E),*3.IID@A([(U/3]=ZQMB.<
M3Z9<7*X'SYQ?;0?(-%->IE0B/4IBL\U)3ONP8$<TOOC>M[Q7/)-TTR3GT,V[
M1+<7_=>]O_)>L.^ZX%R7Q@'LJ6"K</[461+6..TUVG],Z<&[OV?=SI.T8K),
MI#'KBERZ07<QSHE3%GI30V4D0Q)30DX9DFJM=,/(2$'SU^-*W$G"O]5<W=.E
MZ7$NRMF,G@>O7 D5+/=9LWNII^TMCP9+L[M$+NFXK^F-;+8A?QN-?10W]""L
MI=^2,5K1@ZG7CUIA(^;&J:.[CT?0@2VK&A=DZW6[J*DR,@$];/HN_)99U[KI
MQ\?;X^Z!E@UPG^D['+!,F(J=9]:V77O$JL-(VBS[^%BAA4Z3I-X55H9OP\:>
MU!-@)3G4GH&D0A]O*:>1<E38'A;5/B$\+(^C[7$T'K2XS+"-#"L)XT:00+N/
MS[">(H2@U1,W)T:AWOR51;M>3%%RF=M!\:K6S!37<"OIV2]GJC_TT%UMDRQ
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M_6>Y6#Y^4BSK)6=@38!82^&.<SK7788\BHD2[;K286^\ZMR<VYZ7' E6N@C
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MU5J+"EK3RC(@>>#V28GX]WZBS]5OTM9<PY$I2GR/L.XEEH./2.4:BJY#MNJ
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MU:08?+PNLH1@!.BS5.M H1AU%1!$(OA6",@8BZ)I3CMJN<&/FWE\?^W@U<*
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MP5<L0XU76S3'OT+7IQ#4NA9DT!&WM@\68P$:KO$HCUV5*;'<<LD-#+X8I(Y
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M&"I6 M@^@A8EB?-4V';9AN)<&!=($1MW7&(-@.<0OPFJF8ETI;+M%S3.6VP
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MY4;/<\5;_@*-'RD%@4/."]'H<V_2(MQYWR^<]GUN_L !Q\R;.MYP4*WGC3^
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MWU X\"2+==VI7EBN1<^]Z#_0NVJB W6LFS0Z;_,M&K])@\L'AJ&:N$E'ESZ
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M1=JW08T-F$T/3*9I-[?YFWOQP+JR@]O;%Q9>N1RLQ%=:BGZ7(CN[K"9$/5+
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MD^9CD".Z=UI,.$_J 10>6/"8J8,CR!@BQO=AI7B>0/[-@E"BG/4#4BR.6"S
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M+S6L$;,HF0PP*[#R2)KQ)Z_ZER7D*G-Y,@:-KJ]C$0-"?W&JOT!#A$!/<C(
M_Y#:K9%WY$'9%CN.G,Y :'($KQ G082.#T==Z-8,K[3Q0EI-W4R'KZ5O*=8Z
M5U>_*!M@*EZP@)& *M],G+(85EFJ.8ZS$ EH$[R.3E)S_5>Z*;[%*5@.-QSK
M,4(?Y#[#=YE14Y;@>+K_0!DZQ\NT7)L;**)BDAH4WZ2K6!U"CI9H,.D(\A+U
M/<B)7"8=ATX3'Z)[CA08'ZN6#L5."PGL*I09)!.]V+;T*U8K7KFM:H3.!IZ7
MLG_>'SYA3.B(I>9/]5Z7=<%:%PNWX_[WZV2WJ<XQ19%_,E'D0_"5&Q1@UCB8
M#/NE, 3AA>B7P$O'2]YV"=;S^KN1EWA[VF_J[>D^T8MV  &J@?]!)H9/O"18
MV DRE(6%NC^()O!PZIR 4J)_O?YA+4MN18463NC $'H.:K+;P0FU($$;0((.
M ?KG(88+%V:C6\7V\H9&ND<*T-*" K6@0,]-N0HHT(N'^J'0E,FI!%/_),=
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M9!>M=<=,N^O'(RRT.5L;B[ .@N$-C1'$-5R5ILV(L3&Z,.F=S6N(]RE/O)G
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M#<6KYKY=5&O(1;=U.C9.$8$)A0,(G$J'3.''J9SJ& IFR?,EWUAB2F'=[S!
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MEAUPNW9-3=B7H5BF3E&UK8ND-G#V]_<A?LGY&A=-S==H!<\C*T["?RM*.^&
M3<"W4N)#29JJ2,'*;U9.:>ZA&3;)"<('/66J >$@O?HHA5T1 <,=D <'CR=@
MK'%J@@Z>61Z'$2^LDG7(_!F.>LM=W\]=QG*W31#D-.R,&F)8(>>ZX 7X<(@C
MG1D 2*T(M,V/$:""ZW2$4KE^1EO%2;E+K($;(-REZL];/CH0/C+N'C488SE#
M_IRRK*WR+(S9BD0%H.WB;CD!T5:]L6>+O;CFJG;H":)*F>':X9G3(HE3P[ #
M!I;&Q&V6I6.*P?GBK3#!6HX\!HZDO(Y(3'64JPB$FJ)JNE.)N*F!*9%46G%%
MY=ZO!R5%7X-TQI?W-S*)3"Y2-@L2GT*J2ZSZ)3@WRYG$QGYVV+TPSU>YGIE;
MA;1EF<M1E$_Y$EPO4M_8TP JPEI<>)<,A9;A#X3AK=RENB@:*5Z^R,L2D&0H
MBE7 S>1O*#0O"G@6=R*)C),I'(G_F'0(6PAC*!^KQ\"CS56#2'4?&"<VGR%O
MMIQT$)Q4DBY%L.-[+G]._KBZOGZ]*KO6C)Z).[[;TG$S"\( O@K%K8H6VCEZ
M191B2[#:[V*TQ@3G?]4FO"T (FDRUDWO!I/#*.9X 4G7C)3N6K[F4*?>NMQ!
M@)[I4V!4-H2&F^HWMFG_<JQTH9M_ G;%_%6$+T'3!!FJP+56 (D*<<7GG)8$
M@6]5(T$NB#4&MM57T#;T:]U-U\%X%><G:40\%VLX\H23X2QWE$*P&J_)[%":
MZU3A%#,6%.HP&4RA"( \&74W_*9PBM-2,C#?PR>8AC)1B8,N%GV +86I ,7)
MX?9&=BB4L"I\K1&3-3XRN;PVBA=G #(6'^:*,4:6KZP[M&-EEH7*.#13#F-2
ML!9.I@V@@NM,&7^9V+I ];2RELT+$%4X2J65S6[A:N*JDH#KAQ.=SPBL2K$E
MG1VD9L,U,(@X$DKKIAG^ZG AZ6V0JBX%"M>#A90R9.GFAO G# "#C4LLBK'Q
M?9B"(51&!<7*8YWDH9(XR#%DK(M2JC/S;P%^B/D(B,II(1;J)SMP\._A-MWM
MBP_$C.Z*,95/7X"[)N<JSC-,H5%H2"8AU!X ;YL##V6R!5PJN'@)BSR6'>>*
M+'5,![183[?48OCV BG*SK= GBM.Y^I"A!)L#*I?BU.V[1!\5\ X(VA>UC<F
M&DLF1RD!*Z](B-H^1B2>.*F $.NL G?-^E,@?9K1<!EU94,YQL EBP4<0<)?
MM<42MSCT P4-)9)QH&]VJ,.)/H/V4R]2.=HMSXYU_50%9KQX"B]A)SJ#%U]*
M4S3QR]C$J*RR"FZ--Q.@Z*(IW5VG"RRKYKPM5#,%I )9P I)OC081^\Q,A!S
M6PK.E;&2=+1;1Y:RE3JN='1:+RZ,P+?D$5J,J!U*58MLP]<A+ =%6K_)W^(L
M?+R"N%-KFII<(LM6^!-4>HHBCM<)9GW*^6S3$.1\6((9^XW4F-41$PW>Q.?^
MXD7+'NQ.7L! PJM5ECOK?_B 0RYSX*UM(8FDV0O&KH'M-)&A0KBK6Q*-0X0?
M&<"JM "E\37B3$C6M4&*Y:H<-0=Z^:BK\:'+K 3&$==4$70_<"9>5UKIM>JM
MH"BLA+$2OYK>3C["V5&"M 'ZFQ L6L$^U;P)H&@I)7N)'U&L-X>W):H6HV#>
M3'R3D6H[FTI^OOAE.:'(-- L$HHHM&;0C;6#Z.J,L3(6G6O77^DMT[[DBT@1
M3 E 47,"2&CG.F?[X5_Q. 77)7-.OE[_Z^JU,>%M@#%,-TVPQPT2$&G-36Y*
M**[57JB%C!312FM!C:<*K*7S@W%8V)6?^8!;N)^_Q+>D4DQ+S9.?W__R]?UK
M;&$1,0*E/M9X%XKU3##W%$8&82*M['U3?!!C4Q"=1:XX:N+0J!SS4HA2G(].
M#@OU50Q4PQ!-2L:FXX1]2R = QO5XP7@,':OS22.8A2J=.0/#_GI,_5, 79H
M%F@,-3K];!J=;D7T?9#O4-J<4F83]IY+_+1(?T"#BYM(J[)WW_H5*U3KM^MU
MPTO,,+IL:H91 T1-O>2\*ECS?<&:QZ I=G42KTT-[A>=6U2/V'U("^96C':R
ME(QN I#4),9"UTEC$G4H9?C6E^K_=5<)56ZQ"!0H/%77IMIQ4SZ/#K*J]O:Z
MV@IC7;A^O';1R'._190,_ZMRK+Y8\WIKI4#\'.O,!KYW449VAF 4J0KDZ ER
M$$MASX#))9PQO-]7832*6U%9!J\1HX#T1XIF_BP.?8QC:8V&)<UTE1RI6BB5
M;,8+#57S1@G2-UY*>C<H/':F;N,DQ.+KY!NOEJ[$ ]V+B$.TI>M)=FPX+U=G
MO08V.&UJ;P/]>";#!>J2A%($TC0OA[IF##\">P'&+D:ES8V3'Z18?XF?>2$'
M)W6H"VEB<P0:OQF7H9##CF4RG.^BC&_RYYG4-&WT@$\GH/<U[$IQC)BU/E,S
MI310 ;<OF:2N<?!#7##\Y7(;RGN>NT;;(@CYQ^]*4[9P5[Z(B<2@M11SQ2BJ
M83@_IXQX-1;IYO><>4\!-"NFCF'#6(--\\HH8JN+Y#03J*K:^1QOKY= RZF&
M7@%"3A.81@5&@*9_)[V<_$-#A!+\!M4@DW/NEV[!T-C@R)^*%:H3.)44:L"I
M4+CAI%1.\"D'+R1V/@=>_-J9HV^,X5HJ/YB:@U9"_U"CJW+Q!-SS6R4[9*(@
M;Q+I+;V0 YZ^O..1CMA1_4,JF(04<P:_X<)YBX@PM->$I!I3GR(XU@L&TQU+
M#)7KRTK3#B44V%IE3&$,0:$"%#5\M*D\C"F-%JS*T,<JL&2,^.)S./HFK^P6
M,VRM=@9V33BSEH)=P WBFVX:)9)YE@C=083%;)1C((UM3QS[FURBZ"C@$\ <
ME!1!Z7<'71:&UDET]4&D/@[Z*)Z\^R?]_>6U<XT6*Z&9O;OS\!I-\7JB3[HJ
M"@<3,DZX)273&";D6E SA>?+%2]EVK/H9,XN!+?:OTGLY2I^*$CL][MOK@?T
M#Y#_JLY@^0,&(3)K'W*\ [J.(U"0W"TJ7CT5*1!1QQVO3><G^#'I T7V>#)!
M3%=5ZZ?[Q$4$6L8$+>0@4--7"'!PY.E@EW;#8W(6:M+>/VY(!EMKG7[2X0K@
M"'M@B43/G2)E<72*&^S@V1=AJ*,&'PG< %T7<C]47)<6B]<,!DV:HAA8A92I
M\0H*:=(0Y_2''(+D/\Y=A9Z@7H!Z[K*((U)996AM@V\'76&Y-6 J]D24S&9A
M)_ >6,5#ZV?H%L7ZS&CH:F'\&I/*=6,!S6B,3#;HUARI0ID?MTA4O>)5SN'[
M+Q^=$;RS]T._V[MP3D$XT+:M].=.*3!60$UKL5CP_LSB?>3B#R()QS%U 7'A
MCS0%"S/'&RZEV->>#GCV_\N!-Y:5Q^X[-E\6*)T2%Y2W'\#\T1C" GIJ>%N
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M%R_N<\WM&SC#_9ZFG>?#!C;M+.JPVK/U#ZR'JI=MZZ4JYG+L^Q3B_U?/DIY
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MLICB/#.Y_@K/ NUA-99RQ<%L0(4%!\RVA_VMIWC8!Z0]'PT\'^^+4"K>X$_
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M\"HY!4JZ#"!C%17$$R5BUH-86--.>&TN7I<NRB>\+A6O-=$>0<>EL!F01F2
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MJUAB$0N8VT@)T(Y3P+P@'GK%"6%KFS191U<8I ]1S"B!=&&03K0#2S)*'><
M(16-H(0!)3$%DAIML'+$>[.VR7 "Z>J"]"'J$"60+@K2FA /-72.R Q #GT
M*=1 0>.!S 2Q7%CL\XK%RVJME!P5=T;;^\ZH\RU76\' ==7(V26*\\_73/&4
MXOQD2P[<:-1UM5)HB8ONQ$5'4_G*5&>:: -\V/(@U5L-M.$94.&FH R3F% 5
MI'JRL%B?;(K-!>O2Q?H$UB6"=2+=9]XK00P#G H.J)48:$L-4-["V".:8"W6
M-C%?6')(8&TN6)<NWB>P+@^L-2G?N7! !57 "BH Q9 ![2T'G&B5.>2%(GIM
M$Z%4A>CI,I55IS=L!;C9SO"L/U3=5M^W=.D%"Z_)6Z;ED7HOS&[_R+%(5]*I
MPJ[$!*K]WD'@GGU?N243&=V)C$Q=S-<"&>F%!Q!Z#ZC3'DA#./"<48F5=%SA
M6.9D ;]A,@DV5V98?F;RM1A-28_+P6ZMV&B6>11[%3K#8TDQAX#PF ,DC.+4
M,(>57UK28T)Q<U&\_,3EA.*'17&])BF5DEL;='?%64Q=%B"P,@0\["C,$''<
MJB:B>$F6_T;K ?-7]RXFAUNWLE\]5EJZ_#]NCEX:(8:IF<GR..E;72MPT!),
M" &:>0JHIP9H3"0P4"K/#<N(96N;V;I<FD7QUCAY1N;&%XS]I>L5"?L/B_V)
M5J&$(]8["C#&"-#,8" )S8 34BDDF!+"1NPSG+"?L/\8VDC"_H-BOZ:+>(ZE
MS8@&C 7$TXQZH(5 P,JPGXCAS.$L8A_!A0,%'PO[2_)<-%I-&0.DU>F9_JEK
M_=8-ROOOK46<$R^8P!Y.<=G-MV>V"%RBL$4H['M==2$:,BMY!@BV$E#%*1!:
M<4 L,E3(3#FN\TZ,2ZL$W1CQ98GVTE5#?S.RJ.?R0(+ZW:!>BWI"6KHLYCSZ
M+$"=0ATCI35 G'K!A*$4B;5-L4C"<X+XLX%X(S24=,$_#.KK21(80PJ=!4X@
M#BC'" 0510(!H2;4RBR+Z89HG:%EY4D\EHY2#:0ZUBS']K*-%^D9RWG&BU L
M1\=N,%8JRT)<O[^Z5J]<QM65GO'BLJIVP]T\<,/1"^W,_J1!E=7:I\#N>T@F
M)U/]7CP1!"FB@-3( :HR B3+1!#ZD/0P0T[GZ9MS6CRF"DPK <[EEWA.X%P,
MG!-C ;7(2Z4$@-R3&"R)@<8J-HDS0GB%*),R@#-+X%Q1<"Z_@',"YT+@K.OT
MEB(4FZ019BV@G@5U'F$')**<&!%W0ZUMTCGMEU+YLD?2 M=CH8,7ENWTI#[#
MN.CM?J\_;5I,9',?LIGJQH(SF668^R"F:PUHQBP0)) -RY0W&3/614D +\U\
M^$S] ZN-U^4'*":\+A6O-<F=.ZUT1H''&,?V*P(H@RVPG&30&P+#]Z/DGFJ7
M/3>\-J.Z<4+N4I%;$^LY"OHTS33P6F6 "J/#30MMV"!#B816<Z5C4>*&9!>_
MA(RFW:D 0>U\?^ J!\](_5RL$_L+#BEX +M\%4GP=M _+6JGGX?U*T,-^KWA
MZWSSBM\[C%NW\W,T4&$+.CTUN-@=N=-A8+4XRD&_V\UYK3!8I-"$Y?'=5 ,6
MZJ77DG%@18P]1)D!6FH$$,Z0@8@K%<LPH77(9UNP-#1\.J5./#</PC52SH/R
M2:*,NU'&1:TY'8=6"0.8#=(1=88!X1T!2B/D12"/S,7Z*[.QRG<V?":J:#Y5
M/*T[(Q%$4PBBID-1)SS3Q@9N4!Y0I3A07F/@!*0:AC^HXVN;F>#/1:)X8<Z3
MW;%N-6E@N5"<T_,U]SR].A58JS3KO"ZV(C'3G9AIJN\+LQ1I+3Q03E- M45
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M9TQF/=&Q;B#%>&-6CGKVX1H)XDO,?4D0;Q#$)R8:"X5C7#B0$<X!M5P"S;
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M@\96=:DR6\)@W<UL\)Q_\X7YA:ZJ8$'S<K:E72]\-6J=1?[H]X8MU;.M?N[
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MO;-S.![AH[?,XY#?IV4>S\*!D4MO["8W,D@>I G=_9[ZJ[&R9?:@>U*SN%S
M0C:>DVQ:K[RKLYIOT=X:QB+2S[I+WGBB^0/OUR1OO>5^&A<ME+'#>)[!?A:6
MH_A;N-35JG31N]VI2$WT[K]P\"X >L:=X&[)+P<'M2O^/E[;Y[<2][H_EI&
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M1*<W4KUOG5ATNO"") /#XZ1O5LM>6$*#4K+SLPSB2I2T?$K:JXL0S##,D3"
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MSB1@3 6R(2X#.O,9R) P,-.0,>N#=M.H@HHI;J*9<D."Z9)A6BL"P;W)M)3
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ME=YI[).7]]9NG<4>3,DIT1#=H_AZMV<&+FS5MBO^F^25I5'9;*BE\&$?K8&
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M:P*/2"4I$8]<(HTY1M%P++@C\+,!K+/E*(F2%=UZO+=5E124/S#*KVL1L,$
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M4@9"I3047MS9$Z4']-.$YT/U@"[PO \\9Z9_X)([:1+R(-L1-W4:DV2(1)L
MJ_!_P>WL45W@N1(\S[LA].(S-/EO0F=QQ:T%M7.&O4Q><I4H8@S7==$YLBDP
M%*FQ8/?0I$A+,ARF0'B&APJYO-+%PL'"]-A@D*Y;^$W1I7X_-J#]U!V==2XN
M7:_KX<WP1GC\<LRPV6.&@T&_'A_7BV\GD_<^SUVAN+50W$+?Z!2M)5(ZQ 2G
MB,L4<]]H!;J!)^LH%CRN+W:I>"5;B^U'.FWX"K8+AE?#\$Q<8.L8E50C3)1$
M7.2PI6 E(II8*IC1/*3<6_K>M5J?(WZ?K<0H>_-&<#TG/ZQESFF9D.<&]N9
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MFJ&$K^G58S,M/#LU)SHP59T\]Y=- =HQ0=54-+Y2_8'!)=Q4&+YHAG _[P\
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M"HQ'ED?#9;*:!4/7E33JF)!IC8O9/I4_V%37F!K)==F7A24Y_EQ> UG.-7B
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M?A".:_HS-41RP"WZ]'6]&W&R?NY <S[$@.7"Z^\[S%38E/^,![!U?V&.>_K
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M9.#WAU@:=44U#%;]-^U+:XJ7U?2*/RS&PZ(!;[G6CX%M>3E&-VV$>7]%A.=
MSP[+5[!8]XGJ^?(&?/D%["E6YG"7F).<I=*. 3"E)RQ-F)(%X[D"OLS#R_FR
M!@@PQ.(33]MM\[UC]OQ(\_UJS_!;3?B>N&Y 7!<')\<BSG)1<$K"$NQTRD)&
M1,@RPI1.$D6+4!08DTJN-M8=L/"2<>Z"URTSO(D65JX-S$*EUO' 5R[2\?;T
M8G9Z%NPW0*H^B/@#L&">(AY%LOYX%-=71G0K*72H=%9D"2]+1C7G/-$@EGB4
M\2Q6(2\>KD3ONK#HSOP$FV:S[XV+_LJG?#(?XC T&PRM_W!5+-3T_W93NSP
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MD#26)<U2+K($U&></^*(^'<'Q'^$?=D'Q.^1$3 V$@HM0IF#PJ4*[$C)%2G
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MP%N>C*>V>QV$(CSEO'I^J6("^0_2VRMI"HMW?T'%7'1=$0E&I9["CAEMV8A
MH\AAYX9\4NGG_H<77ML.1N;]S44ONL]#2;&@Q\WS[,>-$'D66D'BTOONR>[C
M9^:C!:O$?I8FSUA^^<?AL^C2SZZZ;10_*Y+TFVY[]6=I\L07FSY+DOC.UQH]
MR\.[7VOV+,S8C>YZ36G*M46DRU^];:!@M0RL&?HA?.:=,_ 99@'H0EA*"V/C
M"M/YOM=K[OA\,(.GR9O4UPU& 3QHB(;KSPM&S?5'^+1.^V_S"RB['>,PZ,"/
M"C9Z[PW<=+RI)'"A^?0NS[^XR?G;?5BK(-C;0?6)["@TK."<=P>5- QN3/ZW
M8)54P;PR,YN"-]ZF>6-LFAUK"0$A=$(,WUK0=YN9WVL<:;5+4UJ.K2?]'-Y4
M3_%;6R_?&$<:%JJ?7]IN>%<[=0,Y]>T(#(]^D8_O[H^KO_=2V^3R.?;?QG(W
M;1CJ[[$^][@CN#L3P<YM7&P]J'ZU,7/D@ZP7Q 0^EX'OOAN28^W>^=;9S+7,
M2GYW:WXLJ8R8SBF7!0WC0E"MF*1%CCU;6<(>?#+NHT@\_G/ZX>-?PP\?3^(/
M']^>'A[]F>[__9_!/W_#<V'-![M_G1T<G="#H_\,EQ*/9[\.#O[^:W (ZSGX
M[75ZL/OIRX>S_PSQ'??CU^'!WQ^BP]V3:/]LY<1'*:,T8DH1%F)GGN0Y82S2
M1$H:Q5G$M=1LZV7\_2#L:PSV]7TPI0_J;UW)WBMS&64L5)Y&213G,8W+G&DX
M[R*+%9<TU?0FN0S/F[]>GL'P3KWSZ=]7NIP/_QB4NE-% .\GGZOY%/WDGGUO
MPKZ+=<&14&7.(X&CH'#P/(U(H2@E5,5%DHI$I5G80E6O$]??X1K>(DKQN-AI
M65N.YF="3Q<4IHQXK$5:L# O:<GAOPFCC/$LEZR PUG)8(WFC#VWB>K+<Q\J
MP2#)KWPP_8L/YWIO-)G/:KU'XIYS;L(Y2S62BHHX22/"=<$)S1-)!!P1"6E1
M:-" !8UQB-HRS/G_<YM0U/H!=6_*-^\HF+ I'I:="'<W4^LW%Y?@%GY)'BLP
M8B(6RCBD420XY;F,,LU*H7/@Z]XOV1SQ?/!N>1)]IF1>(/B F40O9$985DJ2
MEDD9<YJ#[([!+_GN$9=K#!#T?9'3];6C5I=89:I,% ^U+&)0QAE82E$A0Y;G
M,<M!%?=NR3IS[_(L^3+-BZ@@3'%&*-.*<,X42=,LYV7,.!5\ZR6[$[?DINQT
ME5NRR>QT0[<DI@*<P53D24EIJ7.N>0J>2I*SC)7P8^^6/ CG+.-RYTIF%%@E
M#S-"::&(2#)%BC1C2N>E8$74NR5KZY:LWX(WY9L/!-+TI!OOGDQKW3KB2R_:
MIB8"<'3*1[X1IW<A;Z%*5R LT40+*6).0)WFA&:,$L'@'YFE6<RR!/Z_!!<R
M>43X2NN!B;$NI5>/_AZ/O^#JJE+'/T"*C@;?5W35XIO%-M2UKC_J[W$O]5AK
MS GW4GJX"4*NO\>]"/U-28Q]1^GA3?-@:_?.-_?G5KWBNGAMWYWBHY)G&<^$
M++.4RCPO.(NY9DR5@NDP[4L/-\@_V[>^F?'1#G;WSP^//AS+,F)162:D5'E$
M:!X5I!!I3&B2E$J5NI11NO4R8<L#0/HDW[IG)58F^529RDCRB*9,4IE$(M)A
MD6G%<REY0>,^R;?>_'O1Y5^6QGF&@[^+#+-\608_I3PF/%9,91&<J@(W+8K[
M--^/2_/Q+%>\%*5.2DU%*$019\!KA4Q2A U>G4?OTWSWSCNVQ&5_=O!1TOVO
MGXZCN BS/%0D3#+@G1"T8"$C2ACP3EZ(1&>)6CE_M\_SW7GJ:,,\HKLL%=S<
M@<FW\2/"B(6)T@G8'&!ETD(HD8DH2BB-0%#VI8(;)4OWE_R(A L<7"2)*C)!
M:)0A.'J<$YH*P0OP+7)>@A_1MS!MGM6SNH6I"-,(_L=#7= TYX5D,2TB&H$S
M(>&L>S=BO=EWP8V(LC@3<1:33(1@"J4Y>!!2I"22.-H@42H)X[8IU#<Q_8@F
M)L9*,$%%DBB: +=IH1G-8I;G893FK'<C'H9W%MV(3(5YR,J(Y(R#ZDN3@G M
M$A+Q)&<TSJ-(Z.]W(QY!(GGK98.Y288H[WOXCJ=[CR?F,>Z-R&0ZEN"Z!%-=
M@:4B3PU4LM*?]7 \.0-M%?RT]^;MO_C9Y,7NTC3/WI.L+4^X(E5"*5HR&A94
MB%AD<5&&,N0J*VGO26Z2.GV_Y$E2"3Z$B#B1>2$)C6F$3<&:Z%(F19'D89*E
M6R^SHO<D-\?P/?CW3N\IW)^GP"B-TR0561$)&L649;%@,1<Z"[6BT6H\D=Y3
MN'?1=K @VN*8@6>= 6F&&D1;KB/"I%0D59GB(DO 55#M9-T]>0HW;M-8+M!\
M0FT:MWOY=3&O-GW":=^F\0,DTX<EHRO3<1A&*B14,O@G5Q'AI= DS,)<%RI+
MDZC8>DF+C9YL>BN.WL#BI/X>3[HZ_:H^C9WA,#!2\ZX0J>^T4V,32KX?TSV>
M0JBY!XGN[_'THLP]2/23!8G6O)!E%B:92CC-<E4PD>99R)0H1"%SWL?%-\E%
M^[3DHHF0*PW^&(E*1&.3L21,%"D!7RUG+(RX3@6X:%E?8K5Y<=Z5)5824?;R
M)"Q%S&@8TT( ];(DH3D5*4V3OL1JO?EWH<2JD%'*9<)(FL::4"P882R2<'9%
M*G0L&1SOG75J/'6&NF'B)*4BIT6215D:TB*.>)2D' M68Z4XCW6?.'D8WEE,
MG*2IC#-..>$91=U'0\*X2$UV6":A+*,8RQ.S:Q(GCYKRR=-YU=LQ>42EE$4N
MBR0*:4:!Y;-0T(*G(8M3%:XN5>Z9_/Z9W"O((TD/=W>.0Q$E.4L3HL(H(U0+
M2HHB*4F:Q&5>X/_*#)A\&2JJ;\=:AQ:O]5OPIGSS*81C^\K?_AY/-";;5_[>
M4813J3A-64A#'G&*T*&*21D76H#5D*8Z[R.<&V0 ?ESN(=5,@8^7YB0N$]-#
MFF&$)":4EU&F2ZW "]QZ29,^P+DYKEI?^7NOOJW0,>6:,Z8216.5"NROUS0N
MXY!*(;+>MWT8T;84P-(9*V08$L5*$&AYK(G(TY1$I=*YB!4-9?3]OFU?^=M7
M_GY/Y:^.DS@& E6:\ARDATJRK-01I9E(9-)7_FZ^9/IS&;A#Z:Q,!26J4"E(
M)AZ10K*(I%&9,J;#B(ELZV4:+@, ]I6_?>7O)MS#*4U_L:<C:K[Q  9\7T7[
M..YAZ.K?,]1D\%\U^/QR*74/?_3W;LF2C_,*5.#%CW<PXJN+Q%&]![N#SQJ6
M-YM/=2U>S;O=Y%U>_H^8_OOE[:_[L7NP]?)P%.R;.%RT'>!;;P?G&@CB;#+4
M,ZT",#("U>Q#,"[-G]Y-P.KAP]E%\.:43\^XU'.C#:I .),GF(V#=S,^_13L
MH6-IC1\^#/Z8?PG>/=MY]O;9'\^V3?#OW>NWOP3O=M[!;V4)-@_X7!4^!_\.
M?PM>SZ?CB<:=J1\ZZ3PT0$*=;&.1#GQ],H>WX94.)D!W9L%\,IF.OX"1-M/#
MB^"_;V$')KGD:0E.)(\%I9(63.ND$"P4F0;3P!42ADEXC1T(_N1D7/'A;[C0
MO9$<SI&'C)<))N!HKM7A1%LJ?#4>50/E?ND4'CT'MY>HL2%9?-*FVWM#_?O;
MBW_^5A,1TVP_?A]]^+A_?K KP\/=G8N#W;UD_^.G^/#H?7APMA_NPSKV/_[R
MZ9^C?\!V>YT>'NU<[,.]][^^_GIP?LP4SS(:123G98$5@8)PE91$ET4D:9*K
MM BW7K)P>5!= #PUA!^>!4= U_QDJK4)0P_,*3D.F$V!PTH]16JZ=_+9._BU
M&XNHN6_'K^[(K>>P_)5+YR8L%ZD!O9R#@JWTJ":5\&F32KS_YS&76906B2))
M3C6A,>)[)5H3468\2JDJ\CS?>EG"KB_32EGOMI%<7<&R7H3QVW L^/ UR/'Q
MA6Y%Y)\Z!1S^>5R$89)JGA-%"TJHSB4IJ 39D<8A94F:2HHF %LA++3?S^#$
M[._PXEEP"QUO38[!"#W_YTEF#*A-,A;^!M-@R*MJ4 Z<9+0):\,-PR9D<0LS
MX2?E=*/5XC_#'8-3/51&F\.?=7 ^F)T.1L%X/D4F,IXJ=G,$L/U\!!J^.M5Z
MAI?!0W>UU!@;#A)KSH0!G^%*!E-,.,)J9L T@>33Z04HX. SQG4K,'E.!YB)
M;-@9'L_A&O/Y=C#$A<IQ-3-63:6'PV>!#<+XQ5DSJ?TB 9^B":(KC*LK_[U[
M#A28.SX?S(!6Y V.T[U#9[L?*)1AUK-$1ANPAQ;^6,ZG4[0:VHM_R)W\+IYY
M%H"6@M^!UM=KKP_&,QV\"O[U7RR.HA>>!9%H6N'2X'=/SN]0>CSD*1B'!-QE
MY_H,1M9"0VOSL3J45SO541&8&'=EMJ1ZBIOPR]%OP60H'^NKFX#"SOP$EF #
MTU&!0@7_[<054#+QAA10#KF="7Z"'W[>-IZ\&)I.H#-XC8M@/#WA)G$2F.TT
M.G?(SXT,>STZ&1J+'/[W-[!]]<S<[I2CE0*V<?!)7P23\716@B@<@\:W%T]/
MP(+&ZZT!,*B" 0B4 08L/F-RQK#MF58#":_97!_\M-?]RK[[RL]P7S X],BL
M&<33TLW&(VEZ4G$!4SXQ]E P\ZVJ*+Y0:$R ;. 2:UX$6"4X-:_V::!&\"(2
M9?@4W@($^#E8(_A?#L9*)>?P3JUUXKUF4\UGQJ6%]U1:3X+/VE@LT_&9&%<#
MN,UD/CR#U4TOP+X5<&%UMNV_.1K/88-%-9O.K5>#RZCF$STM!VC:^:^ \:-Y
MI9\%OXZ'P_$Y&E>XQ7((3X"?G3W8.G%##[@Y)U.CF>"X_M\JN&1?&W,1KA@;
MXGD#U#G!/1QV+L*5?(9'H$/_>'EL;U3K%=32N+67[1R8M J.+L";.+HWC%;3
M"%CCXVZTXWJK?=LPY13.7)D FYS/C%4-)PP+4&.,X.&ZD/2",5"O_@*F,<8/
MX:] NC,.%&CXBMM#0ZJ:@>T] L:]?43R\@7??4@P9")4)2\*C7AR6<0ISTM=
MQ"5&FIB; A=>GQKN0X)WZ^7#?<^/"U84A50*G/HP)%31D/ X*TB64I[0+*$Z
M+:\+ SX>V_=!7;D;V[YX$H[FN4VFWX&D=FNAL:V)!DXS"WEND"! >+PX'ZC9
MJ2\,:5UH\]C/P^82+L!] OEVZ26+J?$'T@DL7=C7UK^G=<IWPD\T$2"7/Q%>
M@L9XSH?G_*+:^G?GE<X&([*PA8MO?_DQV'\73M6*HS)6*=61%#SDE-*<9R5G
MNF!IGBF:Q,S*6B/]=E#"Y6%6J*3(J. Y30K*5)2DB5"94"S1L;KT(!Y6/1\M
M*=ER/G5CDIR>Y:"0I1X9XZAE5_Y1_Y%/IWQT8H*ZE3,K3_1(6V-I!,[[='P!
M*@^9WL&;H,S"IZ)1-1QJ.9L#WTTP=S8%S8B2HK$%\"FM; =H73 I8.]'VBI
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M)R?J]30G#Z:,V-_=(?MSSS_<FC;_,+-ED^YF=GE:=Z=9O9.9;K==M[V2<F'
MVW#=#.V31,Z0F']=ZFJ$3TP:89S%=NN\^)))OD&G7LA&X@5NA[]#LQ>*GYWI
MG&:QT;K,+MJMLU!</#$]=%JN7A!(7-:[\(5>M]>&BPZ:=.""6]D$S\1"0LB$
MPC083XCFN60Z.)T'*Y0*1&O+*R%<CA#N78,08NFDQ]0C@I5!/"B!M"$,41>X
MCMX'PUD20J;O]ED,A##)5*O7+GJ@+TY#VS2R@A(JS=8JY*4="I:1YDGQV@O!
M6D0@)!;:2$YSR1D7!+3%X> QEM*+/$I?S7-=DD#PVJ?O+@01F=,HLK1/DL>
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M#N%":>H'86V5IGDAR1& NH1P9GWTB%*N$0?51=I* C*$08NE9(2FJO"?2<X
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M>,?C&W.DUAVA=ONO\=!<56#U0+ :SUH93',IP97"G )8.:J12=OYN?0"?N.
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MS%]= #,?M)/Y,_ <[FOV-S.3__JMWCV]LX?9F=S$G-SQ' +K@!'TE31M/'^
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MZ\X55*Z7^OQ9SI<*/CM*/&B/='=?X0(!'M!JXO6"*\9?+&>S=DO%'@Q3LS<
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MB^XRW1:C-5C#<J]N0!@_?O,ON9*/TIGY]X;[U^1T2Z;&];M=[7TJX;+@;NS
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MS0(A'I7EN?1!!L8E%YJ:J)7/-3-$.I=7I3&KAT<34]HBEMYK*Y!4RB/NTRP
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MMYU2I086@(A:=?QCZ^,68 E 3[^2"6/ANI"(-<$SN%34S'DVU1TZ$>147C/
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MY0 P^KTZF%<_V48"9N* HS;:<N*29B)W3T^212>MM"O5X.!8[4Y.5<FG>!R
M/9K-IR!6ID!D0-96K8BD02Y@B82+FL3D,%$63,4'-U5_I.%5+Y,]EU& 5L"?
M]U" INUDWO_C.V<AAOS!7A?8%C[4CX"P[V+];\VY.R&W9ZB*)PO'WH-CISYI
MJ13V+EIDO4B@!_&$M) :8989ED5B#&A$9'[&\=TUHL*L+T"6/H1%B^ER7SZ=
MAO25(0$GJX ['=@KV7S)33)1Q,PRFR@(5]! ^8-GD3=X+.2+FWR[FU<$ZFDK
M?J>RZM5#W<JCWV/2CVK:"C(MB4PS46V9/-:8,D FXA&WV".GDD3>F$0M3Y((
ML['-^(-CV@V&II?)H,TW'&ZV\$LD>%6L/A,))M29H(&W4]("<:44<@Y^2&>(
M\XDQR7TQ%AHI05=F+.3&W/=CR:K%;@F@KH C9QUNCE-J$MCKW*#<'A]IQSPR
M3O!(DB=*@OG>5*O@97+E$XO-J]+RL \KKWOJ32WP#[W^/%M>-]OA$P>IL.,]
MK/29 *-@)ADJ'!*YR(?KH)$)!"-EE0D&&QYM3FAX2'W/8\^%O[4+0Z/+MF]L
MM'#[J)BFS(<OUWCD:Y1X^IK%TUF)IW]'?XC9(8:%4"P)KB5W0MK -<@9[PV.
MIL33UTV?^#(;3Y=1>(85:!)"$5#OI4$Z!8*8BUI1P9E/9&-;/S@_LNCWCZ3?
MKX _2SR]^1P[]8838[P6+* HE$<<]AT9F32B4B07L*"4Y'CZ_(3+XB)[5;*T
MQ-.?@T^G\71'<Z1**&1MEJP^!.#3"&S+K')>QR"2VMB6\T5-S9"L)9Z^@-<K
M?MO,8Z)>621]J1*'AX?2;]-(1G,,NE]JJ!O%U\%R*&"U)%C-A-A=BB9))9#D
M,H%2H3$RWF(4'1@'G)# I=O8IF2^G\>S:Q4ENKYNFLF]8NJS'2-2^Q\0I)>Q
MWRL\OR3/S\3:0R VP.8B)EP>A1TX,B0Z%",E5F@I5!!Y-KVFA/[44"VE,.ZJ
M&/<QHNZ%9U?#LU-W791"""<#$E$ZQ!D)2#M)4& N2<*QBCD:7WCV=?#L*D/R
MA5=7XP"8"=5[RA350J,4I44\&0M*M0I(116,C)PK9IK(K*\B:#])C0=C,LX.
M"7[8E(1UB%*7:SQOU+Z)HP66D<[+C(Q]>=([1<*T4@FT+<,9CR8&BZ7P.@1K
MF2;/W:N_"/(5"/+WYY7"/1+D-&$18(N1C"IGI6.&G&8662>U\<Y*[M.J!?F2
M<YF?0BLO?-]$OB],OTJFWYTP/0L.FV@4,'W48&ICA;1V"1G,-!;,8B))8?K"
M],_<P[YP_HHX?V_*^5C!1FN# LWUII1R9'002(:@2536&;-RQ_A3<_[=9[2M
M9.3KBAZ[X>D!JRRW?]VX6\KQ&X>/1],>AT]<C_\2L;$@P.-K7J7G>_-0Y,LT
M.A)P#(Y[E*@&^THYBEQB!CF#=2122\SEQK984PQYG?R]3)I@@QF\L/9]6/O;
MA+6#%C0(FY!6QB&.M4,V@&4J! XN41:B<1O;\^K!TKF$A:M?GM0N7<V;PM"3
M(,CY9Y9XD"0JQ(0DP-%4(FN MQ.S,CJKHZ%X8WM5M0Q/P=:+@[XSJO]=)M0W
MS2VQ.-7A*-I^ZWT7$+CU+OIXXF*_Q<AF"S@07]F:Y1,_KF[8TL1J7%;(AU[_
MW/;#I)7# [-!EB'/"MQHY0;E!@]*;&ET'M?]$EO**)V7.DH'F,(PPVW,N914
M<&V49I@XN#*QGM)*U\1C71,__23[TIWB/HKGY6SFC3)&1:,]XBQ(Q'/]K'4$
MS$DJ>9+&8H7IQK9Y2+%[F=SU>N'F:='F\=)_"L(LB3#3-!^OE J$:81]X(A[
M&P%<+$<><X)UT'EO-[9I&1!88*9H-<6A]B#4F:88)9H$I4HB8T2NXPL!:2DX
M(EP%Q0TUFKF-;:4:H]<\5Z%&TSQL-QBAO<&PU4NMTWXOG/GA(!OGH5BBZXS9
M2T"VUD93#(8*49%'PG7B$4=BJ*8,:\F75@WS<3I(O_1Z80 VY,?8_[OMX^ C
MG*FK^9[=LQ,4>D,TNE9!Y*41>9K49%VDP:2$O$L1$#E;FBD)1*332EG)G,I]
MSC>Y?'!*0O.0N4#3.D'3FJJ3)8UJ=;@U3:-BA+DHK$+",8FX(-5\!H44,58'
M:QRF@%OZ(1-3BNGZ>K%FK3QDQ3>V"FR9YG%%FJ*05B!*<,86:Y$1,J&@M<(V
M:*8M7MAJMOC&"L"\+F6F>,7N'^V;IIE)12KW%^(2-!ING$9&$8H2)5*#0H.Q
M=0M[YCZ+,E.F?:S9M _Z.J=]+ .QFJF$A;%@4CCN(W8*C A!:?18&FN6]V65
M<1_/#;%X-J$BP69B8AA2-E?=8)K#G5PB203A'O8UB.SF>DC@H;0-?"0W\\-9
MLTSZ6 -FG>8F4,RC$X)E=0B8->B(M$@>.-88Q:UT*H$Z--^3N_3Y?(7"M,S[
M>!9NG<;TA06^E$HCP;T%T<IRC0SA"%,J!69$4H(WMFD#!_.461^/W,QC#7'N
M.>/?I5G'0U%I&M<VB1-.24 $>XHX#QPY:BPB#%N*9>#):E#XY:J:=301FUXF
MAS96$[G7?(_"XDNR^#0$G(Q.V(*F(9T&6X%ZA@P![<-0RA,U0GCN0?%XB->T
MF B-M>D?;WQ'8<DE67(:.64L,!HD02SDXB7J(C)&6J1UH(PK&Q0AJVMN4]BR
M@?+R!E_;*F9U%,9<UO\]#3%RXXEU(B(>6*[W :48-ALX,_D NK(2G"W.:7@6
M8?DJ1G' Z8<_NY.F"RC$;N^DW;7#&("IW,W#-M=]\D2YQO-.XB@1]0=&U%F)
MJ'\W:8F!148-(<%A3DATR6.JN:-"6N>X?IRP70FM/X5J06=#ZQ[C)(*0R&N:
M&UIZC&QNF05'AG 7A,'<;&SKAF@6+Y])GY9'2T2]N3PZC:@#&\;<G1)1L.V
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MEU=Z401[=05[6;4*1;"?- @V+6*PV'"9HD.PLBD?-@_JVA.-5-")*R*89>7
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M0G0 %P[&:AL1.P4G:)&3! E8K2PFQIC%W'#C5%#8*I<LX8DK<9/=.@Y<[,!
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M.8[LQ!Z"@NE%^Q7509?7MGUJS_H;_SA'"!!_=('P%VEVM3-VBRW(#6CM@58
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M9L$K9[-"5+AVSON=:A?4-\%CS7(*C%,KEEI==T$_=.!-_[6 NQZ"E90HZZ4
M-ST)XXG#@H-['H)0A#0A6"P(OL%=A\'NIV8IQBNQ:_]N'0^/WW1[O5H[@0\/
MWPS.;N>TFV?JM'_Z]Q'VQW]V[%]FN'_\V]>/7W9/=X_WVKOT ]_]\BN'O\7^
M@3^%9YSM_?7KV>Z7/\ Q?]/^]_>O8N_TLZ6.14L%LM)XQ+7+O4&(0E(ZH9P)
M/@B7#UJ=UX.\<F 4Y07O381CI/G36#A^J('C2N'YL<9YX*/#=A>0O>J?@>KT
M(YO#=X\!/WP+/G>V\[5?XT_.%X[@+NL&@+MON>[IW!N)ON:-C?5W_; ::P]8
M9MBK3=$9*9"OFB%W05C.LME?VZ']3(7N2:TU7U7]H?N2P10DQ(,/GO=V@!"$
M^CC4?GY_:V:\V59N9=LI^\UY+-G?:-3>9/HG%DRO?"686<>O:CK,&AJ7K@PM
M,,P:"S4,?7[V6"; QVN$ H0TQ,:QN9X6-;V #*?Y1Z<[\2YG!S!]UM4DO5:S
MP)3OJECNB[8CQ..T29A?/K;VM!4&1^/ Y,R-H^ -GMYB'=@IP\'5MUP,T3P1
MKAMS@:HS/X]Z4POJ,"('_L)79!.(W6O;/K5G_8U_G)L2"".Z0,*+L[]Z&9J?
ML*991[3 =Z[51PW#6 0GL50^>LV5Y4YJHG!2,BGML+&-7H%[8MC.R&Y]))1)
MC8GQ/!AK2=38\12IE9;@<.5"K)JAD8/0U2]=>.9Z6Q;;)[U6NZ(C.7_51 <
MXFSCU_8'\:1V)U/JQT&-+2?=[/%GE&L= X@-,I[DS]_N__EA!Q$#X <X=-SR
M8V>^?]3M#9H*DW;K/\,6X-'9/"-F$0/&"Z:]\R1:;GF47--@9'1*A&ACM*-\
M ^;TAGS#[WEL>:TGYLHMDPLOST[Y\#<\\W3WR^[9_LXNWSOPGZEE'*Q%"XMN
M!>(&S!?CG$$V8,T)($&*8F.+;-+KC):&+T#0QD:+/>S%.FH%I#X"Q=EN@C-3
M,V#$LB-SN/IA_#?\/I%:L"_^BM4PNUK S#[& +J^USVN.77>#?D5O7@"%@:P
M?P[A9N9M&/MZ57N]G=,82W!9+QZ# 5('=.K'S3QAUK'$,R,":\3W6BY[V['=
M/=VL/C0F4".HMC]S 4AM&O;J.%6(8.FTFUMJ*:N)<&E2EZDR?O3Y !@(/F +
M#!OH<](0:!$Y-5%%;R,C#.14P ],/?9"1.$MD<9^WJGE5!"-QK]<+["_Y2'4
M,<W]M/[MSY8FK5]V/PMC(PXT(<XE2*O&!CF:\E'3RH/O1S#S>F-+S.F*5!V/
M9!5XYWIAF"=9C:%\B0'!6G:M''CM@%XYSXU9:>S"37;0[9U5;[N=.H66(Z?_
MZHW[$/T^Z/JOU0^[;__U^X_U"[+UW<T:-'\^YMK^5*QK$0%WXKPP+L++D7G#
MG9)::<5=X#HDQG3PA$L+9A$9\S)5:/Q+X>5E\_*OI[O?_6>6K'3$.10$SP=V
M<8>,I!$I;I1/+";JQ?P#NZ:\?&L&;C"\F\/WDV1>BCGM%/\^ :<S]L<AO]R]
M SZN[?113@ITP2E ]=1?OCH,OP[FY+1SLAI;E/<S]$2D8.51AZF*L+C!!7#^
MB;-.2DPM5R-#C]XD:\70NYNXP7A^_<QYWM(/.MJF*'-5B$,6) Q9&T22'KS"
MR+.AA^<IC[L;>E-F$F-;;Z8S]Q7FWGSCYHK[INIAGHUV7LN-0O8'1S!J]#''
MG'8 #,YRW[R>/9W5=Y<,MU$$E^HK90) !B@1:FJ,%>1%*F4(RC RJ$9J(U_9
MBX?#MNVUSV:(^!^8*3P</JM+"0 J6@$>WL!4M[82VRUX#EQ:7S#60F.'+:=/
MX;NL6V=N\4TMUDC#CJYQ9T#U<?Z]U<\1)!=!%<><<FXT>"N/8T:'UQ/N]B:Y
MCSHEFJ-M_2/;JRW.2=QMK,^;8.%5:YC3_OUIJC4G3"<U ./$Z2\?WNS_5IVT
MAT $&%GOL%4;(HOU B4^[VTR)DJ#>0#'Q_#@C4I2:198<O,+E_E+[@2Z)!0"
M _;P<V"<$(PMTN \(#"Z,-(V4&2L JT OTE!-K;PIIYS $3#09=$"CAV)DIL
MJ]1TMZR+1[Y%^'UP49A'ML(#U[HM&*QZ/QGVV]&PGZ@6KQ[-R.!O][NU^ "D
M]BL/A@D\&80W?FN@)@%EDQVV!V/T.%^B4CO>WL=V[-FQVV [9Y<"[JU!#5U3
M_+_!TVU\B^L\W4OX_>J.OB_X6CQIF"4UV5]@-H W3%*0DL7@6!CY"QR3QE^0
M[(9L6_$7%H>./_[>W_GZ.2I.DZ8&&<? 7^ F(!-U0@36Q6OA<B_GF_R%FWS?
MJ]33B)G[,2>?QKHY/ZY.K.2@3OYZ<-3J7?JV-A1JSFM=C"(MPH@$G")*DHY2
M>^X]M9$#$^:]-]IA(?R($=68$4UAQ =@Q.^[WS]^)C&RP!-#1EN-.%8T;Y+'
MR( Y#;_X8(G:V)H;,!TSXH7TZS6L=TU=SCKXFI.X:>T=$'/OG(*502I*L!6.
M QH;H4@DBBL*3[>DWI=&#+Q>/)"K^<(%!,/GG[5GBGB*46+*(P!J@YR/"F&9
M0A3)<8D3(/5U4<JK'<VQJ9$C,E?XG!.F8HVO5OUP17@>7,[S98A5DRP?\>&1
M#8L%%[D*BLD0-..<2IM/FG <G O")!&:C)GOI@TTA?GNQGQD[^##9X<UL8QR
M9'S,<?+(D$V2(R<R*.!H?(HW,-]\V^ *'FHLY=-YD8NKTU$'I]T%PP]@8DS/
M8!Y9%2.C8A$65=9YYH)D6E >M7,I!M!BX A3I8-V(S."C,T(=A.O%C/B#HS*
M=K^_^QQ#$LH(@@06X J#V8"<!91DSE*:#RPQ(LX_P736GKVJ4GKTU55YR;KP
MZK)7=56A5,U_D[@Z?C6?WV^9G+TY3'=S7G6. 77%I>L=JY],.JNLG,:^MP%%
M'$O@7FBI9%9G6CIE# ?_U]'@M*YUF":4F&4?;_6R@_0?3_>^YU.-3;:=* I6
M4\ $RY%VD2!&#58B"AUS3HQ>'Z0?142&'7!7AYD-0J-D4,A*9FI93>HF\ZZ
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M$^R\)4&5\H)WRA^ "=*+IPAQ[F74-BG&N3: XCH(XRDS"E:@HS6F/^(:\.S
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MY@<A..\Q$4C((E29!-)%^X3(!":!8A^+2N9Y1Q)S:/"V[?FC3(;Y8A%K"=M
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MFWL'@4I>V D07H.XX IIL![DO*/!,.*YE6OOF!+72Y, TBXR^XE009.0W,O
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MD5*'J5.XWFY?@17#/JNQ$5@JKCA5W-"8&W($@N&Q]0(G&?5VNVQKG6RW! >
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M@TI&PJ1@\$6O'@]=6AN95 ^Z_J#2D)HJN56,63%-M;T""3E@XCPSU8LGT8Z
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M9/O3^_[>V[U^I_^^OWO:/MD]N89S=WK][<UPV#[L'6YGSOWTYF![9TO Y[[
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MP+I*H:ZJLP@:IE0$+![1C+]=Z+^:FVV8FL(_=^*?N6)%J[@)W'CDJ6&(PU8
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M(HQ[ C/NM=5!:(&E2E*Q$&7,DT[,V:034R:]EDGGG6^?#:/&8*Y0T Q@'F1
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M2IG\N @::>XCDC1I31477MJ&:T14T]LZ$^"YK@"@B$44L8BFV.)%+**(1:R
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M[58REP2:99@>(OE=9,H];?1IC,UV$.V5(F++<FCZ+@)U4&P^=RG,CAM/L4O
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M!HOAU8?ZN/(OVA]^<45U/-2G+XI1?('XI5^.='D RM[@'BKZF;TZ/K#^N,$
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MZMF;8??7@: <5WU9\KO$]87,M"2A6C'MB*=I1KA*@+#A"4VF<Q<TE\SGL=>
M3-,5LKUZ+\J*\Z]>?>]3?3LMC$S*,J5S(J2WA&MEB98I!7M+*D=A!?/<QH#Q
M)^4Z^:$.;=Z6_E@#>P4%+$#C2C!,8!2G@^-R'(J;19<^BR/CNVAVN*2L:%R,
M\6BKLQ1OXTKT.'0]'%K(5U,A.&9R05)KP3R4*2/2Z83H)%%9FNO %%U[R9*^
MNM\3UMB[Z'K8:^R]:NR<.5AJ.)56$DVQCX#AH+$*-#:1PNLD%XD1V Y=/<%.
M BM"%Y;['^K9O< +$2-'.X2BJQ.#MTL)Q143 .MW?I'"RKCQ%'LNMJ]ZNR3:
ME9O?_WG$"5H5I%\^,P_,S4#$SX']YL@UTKV[%.][,_+.-H-TD;[E*9-.$.-=
M(-P:3900$G8$*H1($R>=Q\)J27J^L-K#.&NOD^KY<!K]R/ZK'MM[;+]S;+\+
M%M]C^V-C^YSH"Y\'K2PG8*%;)/J<:)51$F2>2$9-QF-HU;IB/;;?F9'RKXF&
MA\Z."^MIW9D>P538>+S:ODCS1()8^B+-6H M1LZ/)B\(E1'P[W3^U?>FG\7:
M=O3G>@7.__EZZ@>3\6!RZ >NJ.QP7$U+/QB' ;X+RHT> C(TQDLQ\4?5H!@-
MD!&N#T[\X%!_\8/2VZ&NJB(4<$WEA]Y.YI<>E\6X')QZ75;XH#C+@Y-B<AB?
M.8+WLWKB#\9E :_;# $?-8J?VRD\>#2)W]]8/+>=G6N__']-^:^7U_@05A!1
MLA@UI4LC#%%&/6/"V"1Q'!BQ@;]S"2Q8LSP#]5I;6.J.&'V:5I,BG#Z\2R<N
M[>ZTG*_/!(Q+'0%Z??&7PWGD3#0[CR_U8Z\/-,A ,;+#J9LO11AC34*0[\%P
M;./$57$=X>,Q#$+;YB9X!4QO5$9863<P>HB5# ?5H4>S]R?X DS$$&_P\XMS
MRW;I#$=-G.%&K?TPTT-]7/D7[0^_M%$7Q2C.5_S2+T>Z/"A&+9B(XW.:'Q]8
M?_S+2>$FAR^4VLB3''?<QD_1/+C^E&[$S?@,F-6?B60CR=,+/TXVZ(6?779;
MEFZ(].YO2Y.-++WXX\MN>_EG]S;8JPVH<3&U%[1Z(R(,+Z?M5ZD64XY/SCJ)
M+W%*68\*ME($\H]&?U']7W4U]==&4]]'3;WP.$O]H.^]6>'&]MI;?V1\.4CI
M^K(R.6?%A5]!7'X$@^H5P/-X=%D1G([U>@UBM>*+CE3EKM[X*C6DGM3,);>K
M(_6] -#OS,E3.?Z_QREZ5+&Y?)**&+:-]-.?VTKN;#I6S9>U?$JN[LNZ]ONO
MBJOJU@?.+F%69!G878QR2JET2<*-LEJGG'$?;AQTVLD:B/5.GX;[Z=OVZYVC
M?SX-CW;WWM"=3UO)SN\?V>[?_PRW7_\U_'CTX>LVVSK]Y^_?AMO%6??3]@F.
M</?OCV)[[P/;_@3/^_11_'/TX60'GX?O\.G?\.P/I__YMC79+M#U]&:RO;G/
ML$5TR@W1.<?.!\$0XT5*<B>I8B;P3,N[# Q9&=?]=Z)&>C3KT>P,FF74:$D!
ML)CTW FK<Z-%<%)0*8U,;QZ#VZ/9K=!LY]4,S4R29[#+2,*H8(3+/!"E ,VL
M=3S8C(O$F[L,FEF]ZLPK'5&S7 5WQB/2^H3/NSUOQ,"_/PLK2+*;$*)#/W1X
MV#:H  7Z\C$7AKBH5#.?4IH9R0776N8^$X$F0OJ$Y?+.N.73+@[S0"B]W>6<
MN0TNSQ4EW"M->&($T3(PD@3-'.72B$3UM6&>@0X;DW,ML5T*%3Q(9[B"31IV
M\ R$ HA5SZ@>1U<[C$I382AV%T^H!%V-,6B""V*-8-YHSS4%1G5736Y6*'GI
MN5&F[\_""E*FU^=/R?N$K0L#Q[!MGDMX8&G&@_=&V-1FF@6=9BY7^;TPIB<:
M*?9 4/SG FU*#,]]JH@53F'U3TUT #-76L&8=3)7V'R(KU.^2@5 ^RRNNW9#
M&2%L C0YD8$#99;2!VK2H(1R1CIV9Z2I5^.[4^.NCTJFF4FY(VEJ@5$QFX,&
M:TZ$$BX(ZI2G'-68T62%U/AI.:*NT)_KQ@E=/_[L]%U>5RY9O@?M!P?M#UWN
M91*>:VL#819=5B(U1"F:$F^DRD*>T53D"-HI/Q^DOZ*-'_M^KS]2[GT/ (\
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M3!#%@R9>,Y6!@.;<NK67E^S: WTIE81/H\T8(WK'J[ZG]B+S'9'9>?UQWU
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MO\"%((]Q&S=^6 #I /35V&)V (@;6=6P^(RD"GX]BDPF?J[ACF7[@/'R/JG
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M#FXG![@/25B#7'*2*&H(YR80D_.$.,MRH81/E &@65*"?;E=6AS!K ,1QES
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M'6VZL]1(4WU]L0LV!&P[':X)+X([#&XP;]["I\V8>Y&\0"03 +A]RV3NK-:
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M3GW*4^6US!,:TLPR)6U&[:.;Y,O7HM\3'W!/G%M_P^*S;\DK!O:-.K;2&==
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M'67ZT ^C)+<D';_6W?QHA\Y6Q5><QG,3@>8TP#R^RO#T+$N;E7#16#;V='
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MA^>-9&3<C!NDS#P(/S4Z;M^6@@[R_B=$U5+X"A(DHXMJAB(=#;V:&EY-][2
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M>*X\-#L_O:R;9UOHNA+)3>7=]M_^_?/FC)$%/HYN&18K[:L;,@%D 0ESFHH
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M(;C#D$NW145[;+?']@)<%-KDA(<CF[B"T2 ]2BB>%T$%Y(P%O:^%BR< %SL
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MB^J'7VUW=-93YR^Z_7B(QB_]&B3LJ-NO(L!+XI+Q@>GC7[]V[?CXA91;.<=
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M,E!#X-2-H]P2/+G%.NC:<'#S+5>7YS/-&:'TR@!-_3SL35QN!Q&Y7K3?D$V
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MV/JKA]4J4J=[D'U._0',?*]>&Z?0IGK[?G-)!50+YZC]59NK;M7[VDB1BB,
MF-7F*_U]<-;]H1IWC<ZVH-7RN,;\AQF\RC9!I1_F2+*Q4;#7_6-*#%^QC4^@
MW5^C(8RFR) SGB*>F$<F_Q:"-=HJ&;#72V:S7R_Q6U?WJC'>=0<9&R]5B$G
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M7#UR\@+:]P;M&6)QRZ-B22E$A?"(TX"1TZ I>B^-] (KSFXXY2H4A(5L=DF
MJ$#T,K**%XA^"$1/'5BFQ")-&'%/4]:K$](,"^2CQ;"!^F!3S >6A0^\0'2!
MZ)<,T0OG R\0_0"(GLXQ<\YSX2T*.E* :*-RB#E%SN"<N*VC2 D@FLSS=!6(
M?BB1]Q4*[QN)O<<=&PT!IW5BW&FWW\XS\5LO=D ._HDC-N>1<$[=..HQGMQB
M'71N.+CYEJO]>GKO*LU-(E1<SG(]/%,_#WL3NMV#B%POVF_(ID'L_68[9_:\
MO_:OF3X=MT_0E3&\VOVZEYO_G^O]:_.Z%\/D9%QKGPQK3U0%-Y0;1W'40N+(
M/=>::YJXC!I'I23U-1;"/3%LY3-I#1\:K )-GG-!C<8X.B9T\,S1D!.N'I/.
M?5)189;2??<T]N#7DX._>MW4'OQ/M]_/U19&C.[]O>ZT/^X5D[J3UL6WKU1+
M91*U*$D,ZBTU$FGG)&*:<<I84H+'0NI^#?7X2O&DKU1C"ZE[(76?=/?=B>\>
MQ\8O'8#Q7QLNIFXO-MKUAP/[?;ZRZW6FXTMBVRX,[X7A_:E'KC"\%X;WPBVZ
M+ SON8[5I9%3[X_9R-GJ@!U3V33=N3I6_5=10XXTW_Y]M+O7:N<:<OM[[\ "
M>L=VM_]N-[?#47//GS6W]\];1^]Y\X\K?J>C3V=?/C=%D_[YK7G\YV$S7W/D
M>>LS](DVO[<NML[ <J+0CK,K]/#>$V*T\ AK+Q#/<7XFLP1&,%XQ2\QQIL'\
M7V?&K HW::%7+A"XY SQ!0*?'0(GIZ/,!>RM$4A&F#@.,XE,8A$)HI@-S.)(
M*@C$JD!@@<!7#H$+8Y@O$/C<$#AU^JA22-()@K12.?!:<F25X$@)HX0D3"B3
M":[6Z</IH0M#?6&H?QD,]?=#L )2=P"I*PSV(B:+7=;3*.*<$N2$ETA00UC.
M$R0DK&U*_&".S$*2O;S2NS &^R*]3R&]$RO+$$Y!IQ#(F*@0IU0@EQQ#Q&J6
M9)">:+ZVR=F#;:PBO<LKO0NCN"_2^P32.YV9Z7R4TB64_5V(*Q(SJ1U#B005
M,?9&:0=[KURF A6% [\PWCPF!W[Q8#PO0,T0Z)MD%(V:(6^C1EPDFE-< A+<
M**&-5=K&[,'@?)EH@ M)][)2Z!<%XRGD=V(>8&&XR45UP!"PB,/D(8US>3I!
MDE,^:.I)5C 65:>\2.\R2N^B*/;+UOS<HCU-JQG!2*"*(EC# 0$<P]:LM4*1
M865IXM$0F;=FPI:INLW+8G;Y$4-_=RPHX[CDZ]GY&X6>_WYQ<UX2&06&=<YY
MY-IYH4 =#2)AYSU/=R8NN0;8"G8M#KMF*/PY=0HS2A%GV:R@2B&KK4/&*2/!
MOG#4\;5-MLX?7ONGD'V_1.F7/E"F* X^<4Z<!AW7YM,J(5D@X@XA8T7ZGTKZ
M)T9)Y!%;P2C",7/M"HR149X@[+EE&J9-8;RV2=?)PR/#BO2_1.EW,O#@#'-,
M8XX3!6M6)",X,P)KFFX?+56D_XFD?\IN232K:QJC&#S8+5I[E/=\Q'@^\@A,
M$$[SWH\7%G&P?$%1I2# :_/!++P@P+6055#I#JBT/ULI.%B?,$7,:X6XEP(9
M*QSR,?-T,Q5EIN,NE4A?L(@NG"J_B.@"1'1B-@A*@X4)0CZ SL ET\@I11"/
M)DAF-4D$% ?"7R!G?A'21R.9+T+Z<"$=:_>M[7WR53(!DR(9TEI*Q!,UR%D5
M4#),)2\HB3*N;8I"-_^T,O;IQ(Z/Z1KV&#HSZ/]V&^*+>[LPRC->7ZQ<MW?:
M!32-XQ(&_?5\^-49YLXT#F,XR/_-XOY/>]#^ 4G/R]SF?KE+.HU-TI(<@6\I
MIY8[RAP@:PC1"6OT;>S%/G08?OO!X?T4)NQU1P?V9?.[T^9W,&-$TF2]UAS)
M%%RN8"MA$[0Y-A\+X7QP,A P(OF\8VO.<U*4TU646JT3MIQK3[$'J14F>>FQ
MQ3QJ:M*H9OR/3<@BM4\CM1.[DN-<:]I3Q(2(B"MGD%&"(B,2]YX(6,P8I!:+
M(K4O4VJ=RWFJ6,HLN["Y:A\990%KK!WLMO06-F61VB>1VFEF;VHBPTPCY;A
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MP+.:Y_M[GEQ)[L"62N:"08PYBWAD&KD0+3)*8$*5E=JQ3'NFS"K$/"[2KU.
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M1]_.6Y\_X=;%UO?]XQV^?_R>M>@GLD_?','O^,M<2<\/Q]"^P];V.[J[]X[
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MB>-91$T06%)O-1).6<2M=?FX/2)#O%%66D8\S][O(JI7&L4:< L*N(#5QJ"
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M73X2 Q1KRJC(W5I]BL&F$JS21A#/!:M$0HVB*F>0YB3QI!.RB6NDG$G,:@J
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M 38JY2M6&,0YJHU*Y96RB3,<'6$F>JZP42FW<2D@;B6(9[:_(OF@5'+D%;8
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MC+C:L8//<33\(=0@U\4U!O/;<7_8R?ST=!"[=M3Y)_Z6EPRQ^ML79\X.8[[
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MYC_[R[/7.[]6[F28U6/0CV'#5*<''5"R)_?O#.&E[W_J =W"",'>K\<!NNT
M+@*VQB!WY)EHME-+)=2->FI<'(^'F*4"_'5T]IVYZ0YGEL)WI^/M?]#S+Y/)
MV.[!<&IWP_21=_H 0GBH7[:?P8,.ZZEYTMQC?H)>[_S 29@^>#T=)T/X2FT@
MS%UR<B/8 3>AD7O/HO@FGXP]@J^GPRX$LYA@/O&]S8]>*\4Q\8BQW/3""IV[
MC1OD>%3!)H^!]<%*$9</1J<$ [NSEBZ-LP#H9@R+D-^I-Z"#O3A%TA1&9U--
MY=L4-3%28Q?,>+AJKU^;Z:$S]%T@I/H6<.7><+P3@;+R-<%P]Q,0GL";H\ZP
MUMQA^]?[(=^X#P;ZI]I@&0*68C/</MB#8-%WJ_CEN+GC=.CA9# V;V#$O5@;
MP/#YJ@N(7 =@5]DUF#]0^RKJ4>?1=K)GL+$;8!\"_.#B)[UTTDTPA=\8TD*(
MYPN.57Q@Y0GUK)\WQVYKQK71'(/U]_:X5NZ_ HOEU+T\,SYOJ:.C#EAD>:[F
M*'>R7,.:/&&R&H:86V(PX_J^4W]^;F:GZPW7<+#?[* WX5$[8<UZD\<O/L8P
MVP+KL'?'$F!^2.?EYP69D)^C$:5UK[@J]K)$: S+FNVO+4,O(P1ND9\%Y,S<
M>.#E<#2> T#H23W<O,,N3!<L\'0BIOL=!GIYOS^;KLK\<U>@Q3;/;H_Z@]%Y
M632=Q7-K<#SHAY,\ +CT6$HU5ZAA/=[@U9L.;"X[&#L"Y[:$S^(4N"9+JBSK
MLF1M'O;"G(?8[< 'SO+C+%)37L>C_BA.I'&VOMXTHUFO]@\BS.88LO7D-W>X
MXCD7R]SU:J51"O,?87Y#]<?SS<H>PZK^ T0'"W/4"74(0JU9N/C)-BC,;2FJ
MKCWI <'E#0:;O@>/4WV*O3C>=^\V]Y_]>V=SM_KCK_],5NFOF$;5YJAFT<UC
MV.8AS_0SD 4GL!B__+6Y^>S7<0O&>>VIKB/[3R;B7$BV4;U@;CZ=376J>I6O
M-83QU3M9UF7O]'B/P38]\8U &G2&G_-#96?YYY@G8:Q@CE$&DA3![/QS CNZ
MLLW#I(X#IN@VM_UE]^_-/WX%N/9A1'!YF#/;'5?"!:C#W?H#^(Z%Y_%]^^ED
M_+7LV;#'\$QG><_!JC9B(DO*O)_[J=GY^>QJ<EL[F<-:@N5UJ@&6T33(4OPF
MJMZ])VI]4]5[=G)TTGB&G]F1/WA[O!DR"#(\]_MC/?#9@06]=KNW!>#(PG<O
M[<]TA9=952CZX6+]<!OO/7_[41!+!*$ZFYP8<1TDTE1+1(QB,9!D55*@(*IO
M*X@SPR@S8APNEHO]QN "[JP%"?S%UOXO8+<QY1[!\N>Z;_GD)G9K\=7(RLUG
M58)U]0>=88/Z9IM?(A=T363/,=1V%IV]7FPV__3:LX&.X7)\,O 'M5$UT3A0
M_[17J\&9=OJ#QK(ZA5F9&573F1E+XORL\)4,L<D1ZUGC>X;W3HZR#_!LIM&L
ML-;W.FM4>0NTRW6\FQ6$S0JV"QBJOX%. JN80 + [MST]1EAIMF7?;C:S_8F
MYQTUL4=J.=S07*W.S1S-XQ$?CT?<P#'_I99G$]36NW5\OG?Q,.]RH$1-E#F!
MR#*9'+&61\ZM#UI1+,'LCT$Q]9%PNC:W []YMC0[,+P'U\)%"7-T/(B@%0]!
MCFSW@&-B7N1]N,?O8$)^_LF\#UP]YOWC@]W]G=,/S]^3]^_^.-PY>HMWGA]T
M]YY_ICD^Y\/1Z^Z'P]\//[QX>[;WY@+O'VV1G:^_?]X]_/O@_;N=,[C?Z=Z+
MMWQO_\/GO7=_''UXD6-]=C]_V-\6V16]\^DCR9UXDY(H"I&KZIB$G",165A2
MHIU1-K!&]L/2Q["9I6?0T3+/A<$.5@,3AW-AGJA5TIAHY=:J",+T.+/,X"3^
M],._2^F0#<#W]K>J5U. /_OWYNZ+K3?5]FZUM__OK=?5L[V=EZ^W_KVU^V;[
M[RWX,_R^=5FM_UF;^8T_ !VT"UH.L%&C'<50'W<MV.9_]8?#_6PM/>*]_F7W
MU4?'N1&Y@AV.N?2^LQ'ERLV(Y**_F'KLN5FT=W\.K^^?"TMI_,C9U.J$V$1D
M 5N/SZG]V(_4/ZD#9=HE2<>'U?/;,OLE8%\^ 4VM'O#(?OF9$O3IY.;-)$]C
M3>K4/QA$UQX/X]/)B]]"9WC<M6=/.[WZ4O67?@,E]U.GA\8!*@NRSFKB:]Z>
M!6NLXR9@8YPN.+[S^.WU^JT+$9+->URN&V.N?!NODRO?^]9E"5EG5-[JLM]^
M3["K;_HP@UT0K3Y91Z#I>*M/+M4$M&"PC%WKLM])H&U9#;KKLV$-]5]J-UEM
M+P]_O1@%?;.G]3%[NEI58^*/_@!^[57/ZG,+?U;5/IBQRVKFM+FZ>/OE![]&
M]O9RS5&N2]@XJ[+WX3E<Y)_&U?='IV=[M=-CNS<$[>.Z,W5G'GO,LY]CWD/U
M>^S!JU'U,NLG]9%.+U2-XK(]BD>/>K_64??G)N"V%0YN4HGC9]/Z-Z?D]X7G
MV=7D*+L4'"T5EAXHXNZ:UO]8+D_$\IQ4G@EE8,:]U*9"U;?U$HPSXSH[7__L
M[ASM=MY_W?H"G\4?7L#K_=>?]_8_X_?T[^[._E;^V=GM7,R,V_X*]SA[3_\\
MA,_P/?@.O#[8??%*P.O##^_>?MFI?V[3_WS=.M>=0Q%M,;8H*,41UUXC9Y-
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MF"0L!])19$5T 'I.0O*:4),[8*K+./\I.L1C".FH\R>_X;\8!W;<)7[C;L&
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MD@G1*",8^-(@2X+-@7*&*$IU4&QM@_#+55B7UL!?%>=K8=_"OC=FWT<9M_"
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MC$;:&/+J#R[D!(*?2*7T,0'UQ"<O<Z88>Q(_0@-Y1'LGU,-S>:C$9J(B3HA
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M_Q&G&RV5*8.\W6BD[?Q2YXF3W^N<V\!4PR#(6N4_G1(<?")H=_,@'P1(7K@
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MRF_$/=87Q+KR6/=8WSBL4X85%CBB[$TL)(]D"?7>(9?89@(V 2>VY<KFNKU
MN17X2[>Z.K_N"X@Z5G(\[]X W^P-%DN>XK,/P,8Y/IKZ3DI1$*P\S#W,Y\_Q
MPI[FGN:;1/.^:@##$6-4OM&$(2*)P$XV@">L(CJ,;#I&]#T@^I'IM &8056>
M@<UDN=-@'K"<ATNSG,WM9^F>N5"X,NB,,,]PS_#Y&>X3=3W#-Y+A(6:"LA 8
M'@+@&!]E.)NPROL>>DI7QN%QK1<Z6UG/L]>S=X*]7L[*0VTNJ/$^U*33<ID&
MM7'QT.4=!2N#VEBHD%=9>0"">+DH3Y!^, ,7/');6QR%H7JC*24A4_27O4+\
M6T\N:OH!5"FFI/J;QUEG3Y^W3[;+$Z>5)%@%DW(P@ZI2?1*=(!:\[F$G8,SM
MU:4B\K=^T9_6R*-['CT]CQ9)7/4\>LX\ZNNO.UE@,!_>##15KJZN6LYT <L%
M#!?9][G!Q\9,F[W*M)&+@F5FS-.0:?/.QKD[G^FIU+F$S4G[)O! >6J@+)(9
MZ8'R$H"B2J!$0T!A/,1#1+G9+/&QS5)_K\3G XI=$BAD6<5?SY.'Y\DBR7N>
M)R^1)PPQ,<*3J,\3,8,G<V:_V84<RIXG&\&319)>/$]>(D\X@@<8YHF:M>/I
M\T0MRI-Y?+F>)QO!DT7R'CQ/7B)/0L3#8?N$W? DG&Z?L(5Y$GJ>/!>>+!)P
M_X \\=!X6FA$B(MA(X3?0$.,&R&5UY7/"8V!UW6FF,>BT/!>UZ>F!ETDL-M3
M8_.I494:*JDA,7>EAL)(X="5&N*8CN;"X^UH6G0T[%O$0QS4]//2@\@3XW9B
M5$HK3P>-IZV]??/V?O>R1D@IJY=Q*<KJ94Q(,A4I9%O-<(4L'-8V#U+*L#;N
MBX>M-4V>-C;6TV2#:,)&:4*WHQF.D-5E8'F:;!9-GC9.UM-D;6DRL[+JU/*(
MO2I=<Q5372(<]D'+GGHISSNE/,58VWDI3R_EN:B4YPM9T)_4/>FCS%_V4CXX
MZ+A=WES^6$K:/+A1->_GPKQM%QV7H6(R^(XS!F#AKU9VE[CBLF/JYY4<6ZG@
M"8UUVLY_!#7;:+0G"Q7U]=J*KC&V*)R6:/O1*AL%M^FNCU?)"&Z1[?3[FB?%
M(,&^QKJG]2;0>E)P6;B-ER@%EPEVBLM<]0^D^TZ<HV8KB[M%L .X3LJDP&%,
MCXJ7#2"EF^W6V7#FXM84=+^#%X$!-(SPK>!OG6>E_7SS5WV1N76BGP+YX<,N
M?"HSY;;O&.Z?_72?+VY=">KM']=M5,LZ13?.BO,L^/SNKZW@0R>!!>!FE7B;
MZY8Y#UX/7G4@W>/ /7RS$PV/N'.6VRI1TMUORM>4^]HN[$2SZB,WNM4WW_QM
M"9%0( [="G9:K2XTRV#=@![\SXT@]K75>0#/,R$PQ^Y7ML,O)P^_G'B/NT?U
M-%332(E^(%&%ZS 4O%(T[N.ZA)##,]#FV!:=$BJW@&MV#=!*>%[,3$.W&E@)
MWP*F!GM9;@U *'?6?/7SE_-VHW&-CBY;S@_7C8LLR0#MUJGHZT[P)["M]-H$
M;Z&U7 =HH&.C ;]P?RK;K32MW6VK/Q25//_L=:1<&7I?>=N]ADLMR]9EE/I[
M[>5%WU9O83Y?U"]R'/+\^M7O'#9N.>K'M99G-H2_,:5QJ_OK2;5WZ%F\TU>9
MRI]1%69VFD9QM9Q,V3&X?Q06!@.8N0VWK.5%<*%A:-A>*99.N[<D]*Q\6/QR
M&#=#GIV3:U@:3+4GV#F#1]F:0[Y_)VEFK9X<RD];?6\QUX[S"<SMVADTA3^S
M7C]">Q>W1]^X-!P5/**E-)R":>J4X0A.R/SLPWTEMQ'VW>K;GI.&"Y!P#4'(
MO<+=^H+0"\!X$([:@)'[F<HW#G_AM[@PJ2LSK_MNT$X['ZX^?^,>W1I!8E_,
MG;+^Y =\E&;@&$BW;B7IO1!ZO11 5V1*WH+.<(J7MR3G7:[>H/+R>@5D[XB8
MD^Z+R/$\OW[UB]#F+4*],G\,EB"LHC<Q#Z-0EF7^"+Z,*J_XAPRF6C%R4%>N
M$SNMLZS=L>8\^'BN\Z8VMEOV<[$5'+0,H'NWW?[A?AQ@VK%^V 7>+\+7N [4
M5D"4$M5Z4 9K.I-V; ,P5N:)E=]9++?WQD,=S5@7^A]8X!R0>G^U7R;F7R:\
MRI+G[^BY)-R.4A;U0DC(-\((I15]!P$1_3/$.[@[ [*CYVS51@'SH-E.H,/=
MP9^C\$TI5(?BX '!OQ2QYZ[J.OU=5Q2L0;U;9.5$]/6Q'QK<#_K&]1R^#$"N
M=O5370TC!43E381;$>@JUF*V4O].[()I@@\Z=K1HE]$/<^&CWP-^*7O$B@VN
M8CB-HO"-IB02D@A7L8'@;UQ4;JQQIG,Q3-^G&+Q;?J"LU4"1,P:*] /%#Y3A
M@:)F#!3UU .E7+;\6%FCL1+BZ6,EQ$\]5N9S0MWE@ K]D'NJ2 :7J,<$)X-$
M/3H<R3"QAWWZ 3=G%69W-C@<E'M;LH-W<'H'Y]!V?DUD6KV#\\DAV8]R",M(
M5SI(O"#H^_>Q@-<3V^E4"<T3'L>_VN>M D#U?W3SXM_]?VT%[[M9HN%#'S[L
MCGL81[T/-TJMI!<@,7_X "RPG^"K,,4:UU,B"#[='!+]4WVJMTS7-+1+P+"/
M(/#D7"0)>A&MVN?7L9[P&T?XX2,L1F3O""MT1UAL+*WNL-U"P-)&EF8WLE)'
M%Z->X^"U^]1^\Z+1OK:VEQ/7SHLE4WQG:O^/F[MCD07XCB.C_^7I[>D]26^O
M8>'I_0SH'4VCMTN$SC/3N4'WSJ7.DP<C]TQ5'T_N-2*WEV&\4X91C@TV+\/H
M91@7E6%\)N;1(IHLSX^>WCS:./-H)%&?JF'WY3_4I9L3?/7/J-37\F92^;BE
M*Q&N3((/[=89JENXZD'+36:7^O2Q ;V^;.SD+#?FS5GC+%_F7]V6[;LR9X>Z
M>\/*;XFG,-^+LVQT:&<?:[=KQNY?.>G7X*UMV33KE)@:#N[T\9KKM[3U=_ZA
MJZS(U1M ?U.B'[#SCV9%5FU,[();L'JQ_\K'QSSQ ),NMX5&0YI[_!N)*)L1
MDL4W99"-^9W*@GY8WF8>>=/(FT;#IM'3JB)YB=*UQ&5_/1Z1*!VLR7U[K!+5
M'VP9%[;/'EC6<W()7G;C.)Y_YV6)'@!%B^@2/;\UQGOF-A67Q#UY&(E!YG0D
M&:]0>3L2]_KES=ZV6]WB?IZU^9!8EE:L)(6P]Z)Y4W$1/B^B+.0CJI\S^$K)
M'LH %R0DA+Z))0NYK 1[F)J'?!R3US]^ UAULKPZDCC1/V$T%#V_W33U^ZW
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MQ&<P/P1??3EMS]>-Y.N$&P3NA_IH=2QMC/+UIAC+5H]1[VR<NR*% >'].B9
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MGOOD6L_SY\%SWN-YJ]VZ^L=IP"_!\_E*'B\(]%MJ?'B@>Z"O&.B^BK$'^O,
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MV4C[A^X9(3.))H=6X,CL2:3)CL909IB!H3,;D< B?)DETESDJ=%Q(4-52P?
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MV=%\^@H /Q[*C]DG$\_CH<"!W\3?S>?,&W/Y!7R%V^9SLG<>Z3AALCF9L>:
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M2J;:MCI6/@%>DZ![R%IE-X0A>:U^!-.@2E;9QL2PMS2)VS (\/U<[WJ,+X]
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M]8-@RZ6HQS<UL:HYYW$[KRUJ$&\?66?9>M=DGKIHU>SSI&/ETIFTZ+B'_'-
M)VBC/E*\'*0&O\S!J_GCJ;5&^9<H&DL<>[S\-;7&]5C4W.ZLO4:_?TN*?>1M
M;U>SKB)8@$;-N\X[5BZ':0U5]I!3/5*P.J/*\:@$3,F7CIM67N..(?=OB>LF
M\*6!E;SGV&KGU>08?A\Y3CSUVIEW&6@E?SG&PK'"E=]#KM*;$F]" ^:)XO(U
MEV]4#B:4(E1SHK:55UYCG WFQ37PZR[P^"#::HUKEH9IHE7SMDX[K^)J$7 ?
M.5_IDM>-Q>KB57/+XTXKERND2<L]Y*7W]"75I=?G'GRTZW6A4*%2\\\3*Z]
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M71U@8W,-"NY$2''_3:Y6*$)C@G>L;O:I+&S==DYK@G4[%NET@<L0C6A]BW3
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M54J=O\%Y [:QO<J*-VAWO"JH4<<5,6\=5\66JQK(T&C)/7^.VXI7[A&A!6J
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M4%;&X8V'T0>Q^Y+NNN&4A#.R&-%5AUWJC'T^Z_9[-R&_(CZZ$H(7V,7,&[Z
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MM*FVV@5EKTI&'TN3U9)B$UWV>K@8_6S>X7KXCG000 @&N  ,1ZM:LH3>OK%
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M(-H[BDK8N @/Z9V'W](G5[JRY"M/\2/<]'4)].I,1%YP96*=*Y<P94]"])Z
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M72>Z8GQE."JYAV5UOST[[R9?EF&?Y9@D]Z!,5.5JA-+*D>*8&'-$E<S8)*0
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MX_'FYV' ??*]6G+QYD9V#/E6LX;NF)A;.%_ZZ3 .DI9<*UVN;,X(,:#N#PR
M -?,Z^BX36VJI':"V2=O[-&)5T66QVFW!B=E'7R$\W)H>LA.>]>3JC92VP9M
MI9UTV?CAW62ZN$UKZ7?/\9VK_#\$^!+RI(,K#2)^^S;K/'(=??7NXBU2=)&,
M5!JN3T;XFI.WXQD@*U#K)",2-8HD[ETQYY!P$I401SM;JIC0ZF[C[S0<5+5,
MU^\8!X".!IJG&5V/TLO29R#.QE!N+XLAT.P=:Q/7W0"F3SMK7[AY9V[LGC*L
M=SG/9#RYCN6W;^<PGL* ,Z.9,H :V!3?AX;2C!E=6G"4,I4X^#;IDW="ZM/.
MV5=BU9'GECOJZO/R(_@I_.TO_Q]02P,$%     @ 1H175,'F$6F+ P$ '2$+
M !0   !B<W@M,C R,3$R,S%?9&5F+GAM;.R]VW9;.9(M^MY?D2?[]: 2]TN-
MSM[#:6=F>>Q,V\-V5>US7C@"0,!B%T6J2<J7_OH=X$6B)$HBM18HB9E=72Y)
MEKDF8LX%1 "!B/_X7U]/1]]]QNEL.!G_^+WX"__^.QRG21Z./_WX_=\__L+\
M]__K/__MW_[C_V'L__ST_K?O7DW2^2F.Y]^]G"+,,7_W93@_^>Z?&6?_^JY,
M)Z??_7,R_=?P,S#VGXM_]')R]FTZ_'0R_TYR*:__[?2O"C$*HQ+36F6FHTLL
M)NV94$EP#D$$6_[?3W\U@ !:>.:4-4S+H!EH:QFZZ%,1PDL?%Q\Z&H[_]=?Z
M1X09?D>#&\\6W_[X_<E\?O;7'W[X\N7+7[[&Z>@OD^FG'R3GZH?U;W^_^O6O
M-W[_BUK\M@@A_+#XVXM?G0VW_2)]K/CA__S^VX=T@J? AN/9',;I\@'T^#R_
M^(>;:,P/R[^D7YT-_SI;_/O?)@GF"WKN'<)WM_Y&_8ZM?XW5'S$AF1)_^3K+
MW__GOWWWW=)R,$W3R0C?8_EN]>7?W[^^B70XGO^0AZ<_K'[G!QB-"/'B$^;?
MSO#'[V?#T[,1KG]V,L5R*_KUD"LH4^'\>_VT'SIC.B$@TW0>D=%/<5P%WB/&
M;9_>'?/%9[&,!<Y'\QX1W_SL7O%.3F'8IX%O?'0/:!<?Q$[Q-.*T3ZA7/G<#
MYQKD=83U(^-D-I^,9VE(D^FP#--?TN3TAP7,EY//N\"+LZ\$00HAEV_QOR__
MW<;CB>?A>%BGCM_HV]4_KH]X.!#\.L=QQOS]=\/\X_=#D1-:"%&&I#1HY;5,
MR1N.W$>K0QPL/Z)"6H,:3=*53QS5V6UR\9@11!PM?CK(.!S\3)CFWUZ/RV1Z
M"JN1X.LYGLX&-J(Q/ !3CMY">G9F4:3(@D$>,Q@G@[Q)Z&PMD!FFOWR:?/Z!
MGO)#->-_Z_HE6WZYI/7.YR\-_;!1K1?1C_2[@Z0<CP$C0\3 M N%@5*>>>&,
M#(%'8V/G<6P^\2KR2Y&\F*['L'IA'OA&53>@=P;GDQ[,M^2&P'__W62:<?KC
M][P/&E^,Q^<P>H]GD^E\4&(0#J"PH"PP+92DKXIBWL2@/:!+0O=&Y^:3CX;6
M!YOS)KVB#WK?X70XR3^/\RMR> <8E/2>8.2"FNE,HP,7)=/!2X>HM$'HC=\K
MCSX:@A]NT)L,RU[FX2F0JU$'N5)==MZJZ"Q344>:5"C2",X[9A)HC-DZ[OHC
M^?K3CX;G3F:]2;7J0O5RF+\,1_CFO!IC8, 6XSQGJ7"*/A5%E %!,FE$06_0
M9UEZ<A\NG_KLJ>UDQIN4ZNZ4OL=/P]F<E#9_ Z<XH&5!T?I?UPL03$<56+1*
ML6!%\,;$),P6-_]!M%Y]\I%0V\&<-^DUW>E]/4Z3*4T>BT%^F-."\7)R/IY/
MO[V<9!QP[TT01K+$$SE_60D&( O38+,140>N4V\QP!U CH3\_HQ]4PNVNQ8^
MPM?7>16E+B"NYJ"D?32*:_+YBV':9T]SD-&L6"]01('D2O2D@EL@' G_?1CX
M)O.N._,O<I[B;+;ZGSI<,0BB@+02F#6>1&BT9]%H$B8X$WV(*?CN@=:MCS\2
MQKL:]B;;OC>V7]*7;Z<?)U_& YE%-C:1EY&#)4BF,.^*9<8K*V3P6!SOE^O+
MAQ\7TP\TZDV>0V\\+Q::M]-WT\GGX3CAP J3<\J*)5]HG%I$%EU(3 6)P5K+
M<^F^(787@N-BO(MYM^RH=-HQNP+LW60VA]'_/SQ;>!=>H5#9(1/%4?"?D-88
MJ06A1!D%-X+W/9U?>?YQ<?YPTVYAO-,F6IUO7DP1%D!RX3J4R)E3  3$!XK_
MLV'>2('&@XHE=^9X\XG/GM4'FV\+CYVVRNHA].C=R62\#ORQJ"2+,Q0*5E&I
M(%B@&871JH' I>4A=0^]KC_UV?/9R8Q;..VT)_8!T_F41BAD_#B<CVBBX(XK
M#IGQ3(ATMN3Q0R8_WVL(.KE@O>K,Z?6G/GM..YEQ"Z>=-L4^3J'F[GSX=AHG
MHP%X9]$B,&,+J4L[Q;Q'PPP$11,)ER2QSH1>>>2S9_/A!MQ"9:<-L+6N?OZ:
M3F#\"1<;<CF58#0B*\HGIJ74#)+(+"<E-%3'78G>7M'-)S][8CN;<PN_/6QJ
M_1-'H_\]IGCL \*,UH7\>C8[IX4AF.R#<K02>",H.HN6AJF 0=$J"NLH2 \]
M^<.W0'CVC/=GX"W4]["K]8_)Z'P\A^GB/&4Z&VBCLBQ*,26M9SK@ A&R3/&:
M)B,XKTQ/E%][])%0W<6@6RCN82OKY?ETBN/Y\ORS+BL4C)_3, D*Y\(3.9XS
MS4/U$"QG-.GX)&Q,*+L'0G<A.!+">S#O%MY[V-IZ/9[C%-)\^!E?P1Q6. <Y
M>(M1::8LQ=\$!IE/X)D*Q<20N,S8UZ2^'<&1\-Z#>;>DDO2PM;68>%["'#]-
MIM\&FI/B8J1!@B#O0I12 W9@T@LM  (WLGL\M>7!1\+RPXVYA=Q.NUA+/!].
M833ZZ7Q&PYO-!L)+<,DFEDP(3!<K&4B9F2-/$CF%"UGUM6%YY<%'0N[#C;F%
MW$Y;6TL\/Y_B]!,M(;].)U_F)R\GIV<P_C8H!:T!+,Q93C-*R#0\B8$ES;,2
MRI'VNB>"W0'@2,CN;MPMI'?:^WJ=RO3%>1[2;[R8SW$V7XSWEQ%\&H0DA"6*
M6(%(L)0-S >2IN B*)E\M+;[BWW[\Y\]Y3V9=@OC/:2+?3BA<' M0"6#\(Z>
M[[Q6-3YP+(:2:)A%!R$\.8M]I0]M/O?9,]S1E%N8[2%3[-UY' W3+Z,)S.MR
M8GB2B?GB:& I<5I.$N&"0(,2%/"7OJ;MC<<>":\/->066GO8'_MM.*N1W3N8
M_@-&Y_@.IQ].8(H#GN@_7#F6(%)LGQ0P[Z%NMTL)V@"'W%<(?0N$(Z&[#P-O
MH;Z'_3&:6TYK'N(D_6L!:?;V?%YOTM;]^0'WBGO,AJ$V%.,'HUC$>M(22)/U
M[XKM*[:Z"\>1B* W4V]10A_;:!3=3V'T>ISQZ__&;P,ODH,2:8A.V)J 2N$"
MS4@,9<F9PHA<5%\9G]<>?2Q\=S#H%HH[[9BM=F]^&<X2C/X_A.GZ9A  &NZ]
M8H7;&A_(PF+6A4F*&LB?,*XXUSU=Y):G/WNB>S'KEELXO5R9O$3U"_UD-@"!
M(3L#+ N@^%_7G--<.,TX$$%DB+*';));'O[LF>[#J%N([N7RY!+3\L;?"E5(
MTH)$%F+U)@S-,MX%Q[(A/[-8G6GP/5.]\?@C(_NAAMU"=Z<]M!<$*2]@U3!?
MY\05%LL<+_6F""$!C9X5(20HGI7UW2?N*X]\]K0^W(!;J.Q^4W*(LX\01SB(
MQBJ=G&,V:<TTS[+*RY+O!UHFPU70/9U8K1_9(Y4;96D.XU<]R&S;KJU_MZPQ
M\M<TFLPP__C]?'J.ES^<C.?X=?[S"*M@?OQ^AI].;YSM[4[Z^8Q] C@;+!+%
MZP>]',%L]K8LHH$77X>S0;)"&PH&F8XQ4BA8,O.F)'(1(WF)V@:I[XJU"LSB
M@I_5DQ9*^ %'\]GZ)PM!,"Y6!8G^_5Y(/8KDCCI!6T3S,(8G+2S=8[F#-;!-
M/*\6\^!.B ;7JA7UJH&;F/J<[&\KN'1)?<^D39I8_#!:((>2YP*>)4U^A<Y<
ML^"JYGUT.3KM);_K&M;3U\"5(E:/*(%]#-V"^LO=H-\7;M! >,5#SHDY2Y&B
MSA0S>I$T,YDK(3R(XFP;YJ]#.9RGUQ<_U^GN9-P>2QC%V=?!!QP/)],WDSGF
M<R0*W I2410Q)' L&D>KFS.%Q2 E@\2#1L=-R=<.4&Z4([OCXY\MAWV9K,=W
MMD)Z01[K[R_???A T2#.7JP A<!-,AY8X:;.2;'NV(K$,,@H1- ZJ[ #AUL_
M_%DSV-U<M]8A^H\?KAF$ HM_=2\(.)Y-1L-<ZZU>+$&S27E+CNLB>IE=Q;5C
MM<![/[374H+[#>%:G4&I<S8(%(?Q2%\6;U)22=;TD53O+PYV^/R>@J/+2#%8
MY"$HSQQ"34C+BB* 7)CB+B>G12KBKM"XAZCH DO7!?\]?L;Q.?Y";QU9<EY3
M*_\YG)^\/"<^3W'Z\]<T.J]'02]F,Z3_SQ_AZP"=TR4IQYPS;GEDX*4*C"L-
M--4Y _RN DH/'_X#P!Y^NNJHE^M.0VN">G0K+OV<V?QM^74RR;,7XTQS[>=A
MPMF'R2@/Z/DB91U8YDA3+1C!O#6>62ZX\"Z:(%IYD[=A>O8*Z<G<#:*)7Z>3
MV>S==%*&\X%67 ME KFZP= (!=1JG<AJF3\P@ 3EKG.>AS._ >+94_U0@_98
M/7$-9;6^CC_]_/6,@FCRIN)L,3L-+*<1U#1\$0N%Q4)F%B@*)FJ$4\ESP'37
M&<##F;X5TK/GO1]C]UA8\6*<.!K5[%X<$\ 133\O\BD9MX*K5S16< ?.B>AY
MI&%'@<L#J@ V,N0 H*-W6-I,^[OA.[P^>B+T^NYR_VPT6!7>XPSI T\(WRMR
M;D:3L_JBK,!=^C/IO\^'4\ROQS3?I5J_B):Y05#%\7H-6RTR&)SA+/KL&&A5
ME,9 _W=7A: NKN>#01^+N@[%6X/%ZOWD&XSJ!?#E"^"S+AB+99@3, HK:>FL
M^S>R)**?A^SOO$K?0457<!R-,!YNW09+THO3>B/T?Q:Q_]OR>CR'\:=A'&$-
MD.:S02UTEHM-K!1?*Q$+<HESK>N0LZH73Q3>6<7[X=S?C>M8M-"C]7LL&GSA
M/U.0]&4X&KT^/8/A=.&?D4,]D,&4"-FPE+*G,,DG%E(AQ6*0 K4P.;39S]F.
MYUBTT(.U>ZPLO$9UB>:F/B]6L35TFLR R^P*B[I.9C98$JP2+-B44X@V0J-@
M9B^8QZ*8=MST6)9X#79]A?7EY#0.QXL9K^[0$<)Z3CP9SX9YM07]8CJM=6<6
M.],O%R5H7H]IHCROP[SEG_PVA#@<U=I2 Y4S*JDR@V+K_9MZ2%A*80FSL?0?
MH1J=P!YH@,<BWJ>HAQYK,F^$ ?/I>9J?3PDFH9]^PMF '/H<$A1F4=&K6&\"
MQJBKJ (MZUE A#;3Y#8TQR*HSI;NL4;S&M-O9,E/RRKQ.)\O\Q#7CG_*0F#T
MH09Y=5\AD41KWP 90T /.LC<)JRZ ]2Q:*$ON_=8SOG"S2.K5,?N[?@#C/!M
MN2CM8&T)3M5+WLYH6I^]81!\9E@O)&@L6<4VYX2W(3H6,?1B\3XK/-\ZW$$B
MISXEHLC4:X1:EUJYEKPU*3G20J6=<VU"JQM0CH7\;C;NL\KS#42UB\@I+H,\
M'A0W7!,(41L(&+\LKQ@2Z1.\$=FV>?>W@#F>XY\'&KC!3LK;^0E.WTS&DZO0
M5IJ\$+I,*@NM):, OS M1;UG&B7C3HH$)AMAVK@$N^%[_LKHGX866RZU:!LY
MLVN'!8#&G U-4[7!E%;58?&)I.PMP:)5R]@V$>TU((^P)#3@Z_H>2@=C-SCM
MNWO$@VB$@ZPX$P&P7J9!%KA=E&Z,0@5ON&ISL>!N7$>IC!ZI:'!&=[FVK7/=
MAN-S GF9R/D3ELD4E[_W$;[B[.>O9!1Z_G ,TV^+R91&5^_(D>%'B_$M7X4!
M+S)$B8D6RT)6T]+18ADS2S(8%XTD8[9)/FHXJ&>_=CT5PAML#5] 7KU;/^$8
M:\X6F.0X!\% 5W/9E&I/X\RL 0>JF%SD707FNNKP!J CT5 W0S?8(UVFZ"W\
M=.&3AT(S=#3<,>UB9-Z&PE*V.D$P$7D;RB\Q/'N6'VC.!MN?KX:?AQG'>?:.
MJ,+IM-XYJ)63ZA\#6WA6B:(Q;STMH$[7@TT,C'.T*D?%<VFSUW$7JF=/?F\F
M;[#U^0;GEZO8B\\P'-4;XA\G&S?]3B8C>M;L)Y@-T\#H6-#DR(RLE=7*$BX!
MST5;76^0AC;>[IY G[UH6A+38N/T9YB.R7^9K6OP+5$5M,)+'2A60TFHH&[L
M>7+VBU/:6R50WM46XN%RV0KGV8NBNY%;[)Y>1_5J.#J?8QX$] HMJ1$,:L)5
M-/.25CI>,O @?.'RK@Y._9&_ G1T]#_$T'TVUUOC^B<./YT0D!>?*>[YM&H/
M][;<J,9XL0=03(R8K&9.FLQT](E%K&T/I":G-PHLMHTR]D7Z["73E)H^F_KM
M"W@Y]=7R1D+27"=-[9(CI66@!#!$S46R.9H[&QFT%](CK3MM:7^@QO:GK,%N
M[BU@5U/IS0*R,4A-,;=FJ=04/1DX@^S)71<T"!-U=N6@"KL-Z!]38[W0UF K
M^&(67Q;<"I@DY%B8!2A,<TS,)UN8%"E']-S;T&:]NXJC=7FZ1FM8!V,^=GVZ
MV71^"?]#PC%,AY-%U25?LHPV"P9)DL^FJ]-.7AQ]A4F309SQ=Y42O9 $/6%#
M#O3==2G<"N'0=>CZH'/2IUE[7%T6@%8X_CZ>G6$:EB'F5;&774#M4X=N-\YO
M@W/8$G0]435I9>>#B8#4[6TTM1)]<?7<DS.O,3"K5$UX$SGYG1R)ITC^+;7G
M#LG]/N:]E?.#ED"J[6>F>%)M^!DW<KVN@.Q4#^FV)QR@.-).@[M6*4D7KY/"
MZ&)*VG(#'KS@7'%)K@(7\M9*2;<]K/>R2<H7E$H;)DRMLR4"K55!U=9?5DGT
M6H)J<_6R_[))&R=2RMA$GKFDY^K =#*6!<3"DC/*@HGU_?DC'/#MP^X=!WS[
MF+-![:)%CLPM;\0;G+\M'^'KLO0Z_7R*,,-7N/S?BT#-.2F44H+E+ S3-+,R
ML([B=!=]T+[8V*AF<G?LSUY(!Z:O5;[<+2/X93*E0'Z\[.^1OGV<PGA6>^$2
M0>.\^&ZTO%^6_^M\-J]678]Y($..&LFHUB51*R;6C'/%&?<JH.%&FD9GTVW&
M\TCY>0=4UA["/I L#BSVES [^64T^?(WS)]P?>/E19GC]#VF6A*TNE*P'B6-
MA="CD!:8$^2^:DFC B,3LP609A)M73S\O+OO*/X4]J$DT*(FVAUC>;>,]@CH
MXK?>44PPQ?EPNEC\5FEK[T;TKFYY2WG1OF[H,"-2;<@7R2?*.C/E598Y.*4;
M[:(W&M"?(G\$830HM;.+5<FACQB*+0RUTH31*@8J1@8('.HE)DQMDEAV0?>G
M$KM2UN!NV19X:VCTW;((R+M:9HAXFL^GPW@^7V9WW9(,KEQT&)5A7-=NXYQ;
MYDUM/BXSB)BE$-AF^NQY(,\^.GM,8ML?4PKKI+/%LNB<8AJ%9X%SSW@"&2!Y
MY5R;Y,XG<TS911L=C/ETCRDE^*@C"$9?%)JIN68Q^$#3=70@5#0Z[E2N\MD?
M4^Y%Y[W'E/N8]6 G5+N ^N,=4^Y%U4Y'50^Q\\%$D*2@&)1B3\3LF*:O6=0E
M,A^M#<EP,'FGPX"G2/[>QY3]<[^/>1ML5UT,\^?_/E^V3C^;C.LAVF*XF&VJ
MK168\[6H1W:I@E,L.*FS46!];',0=">L9[P ]&_V!D[@-4PKH>X"JFGOQ*VP
M'KE]8G?ZKF?T]V;[!I/%=G 28J 0&AG-5/5B<K LT'3(G 4C(@\RB?S<!;%K
M+\4#Z6$?DS?0P=5KBZN68]&*2+$K,)]H$M2^MGFVJK @'(_THP2I37FD;6@.
MOZ_0 U$W,@@Z6OG67(+F64T_P0C&"3^<8*T#WBU_Z>IG-<I4N@/PM9RD*(K0
MQ49/[IJ6(4.*VACA7$9CDW*#VS^V]^RCF'.68!,#E)'I(&K/0!U9@!"2E9Z+
MW+B5]6]]91\M"R)?[ =K;44JL3#(+M.4B31E>LZ9=5J[(A%*:5-\]2J.)[$]
MN0_+-VK7/]RL#3*1EFB6A_KS2U"8LW/)LJ*4K5V?# M)$CQ9O#<QA"C;!!E;
MX1R>\BX<;:6[BX%;-&"&66VP4O^G+I*?8;3PC.8O83K]-AQ_^@>,SG& 6G),
M.K.@Z@F0K?=!I(JL9&.4D0&#;?/&[P3OL531B<KK1Q6]\]! +"]2JD7#9[4E
M<>W]]]L$QK/WF)#P4M#]!N<KDPPX\LR%%LP#DE=-SC3S-:NR<%0<P90";1:_
MG2$>@VC:\-&DUMIG0C&9?B-(@Y2S+CER5J!6$M5*,7*.=>TK&&W)'%HU9]M$
M<0ST/]BJ#5(S*!XZ@V%>5$T;"!^40V&92D$QG;)AWH!BQKN(P9%#KMLD?VZB
M. :&'VS5!ED2R]'52[RSL\D,1K].)^=G%\?H]-.TK*B'^:*@WL7L4T0(*"@0
MCHLB6L6S8"PP66*,( H/N4U*SL,Q'X-Z#L18@P*^*]VOBY&N4M6N6&A01.(&
M*KI$W.M@"XL\1I:#2!"<5T&W649V '<,ZNF;@P9E+Z^"<=G')%-DT;JP;,\4
M:D= D8R0*I<@0INTJZ.C_N%V;5/;DF:G^;>:DSHG&=;PZ&R5E3K@*20%L;*2
M"V&KU]$EH:0?!00I>:MZ[W>A>M:[%+V9NT$8<=&)+3OOI0=>&UC4.+C6&*]%
MI%,MP A%1-6X@>*SIOA!9FP0,USON$<*N]ETS[D(QE,T0V#K!FO2S!=+?^B2
M! G0.&S3@7D7=,]:!KV;OT'0\6IURG91=_D"ZD"I&*T"6MN6;>F29X \L$P@
M34Q&<M\F_?5V3,]:#CV9ND$TL.%XUL3LE5L"WDAGI&<"4NU"1O @:1(J)K H
M?(IVIY(\>_._%<ZSIKZ[@9LY]P.1K/'<TY!,K)5"-##/LZQXE/3):[1M7O/'
MZI/=^XG37B9LX,"O6XD.%WO4F[60EVD9%T--.AN;@Z>U!GT]W=#D6%(TJ3.%
ME]'RD!N=->Z*\-F?.#>AHL%!TP;.ZW%MTL) "I$Y:^H-<A68#]8RKG5RF&01
MKE73S]LP'5X6;7B\72Q=2&@@CU<8+TZVE/'1(VA65*P5J6AP(2C+Z"7)*LMB
MG&N3V;8!XE$%T(F;&S[@PPS;\*SY'7RK9YEK5+9$78!"D>0<H?(^T,3G%:V)
M!1PYI:!CF]=_.YZC8;X'<S?8\"%4TW/,-\<\, 9TJ85I,];.LZHF76HIF90F
MU#S+(!IUV+H5TC%)H0>CM[K^OP66E=+EI"2+-G."%34-UM2V&B4&RY6-C>:$
M6P =C1+Z,'B#3:$MB++/N5[.9L)Z4J9;;$S7'I26&YF#(5^G3<GF(V:_HYD;
M; 3]-AE_^HC3T^JF+)+ESH9S&/U6BU6\C:-5O_K9H!CEG$N*!5'+242K6+WO
MQ9!L88KP,4$;EW W?,<:+O1/3@./XL8NYX9MZE9G2"9A1L[DHKZU%9YYSSV+
M ATD7[)OU#[O'F!'*IH^Z3B Q[&Q.QH<>&V58DG5+CY H'PJ@65/OI#3 FC<
M!W$Z'G,/^B :Z8F$-H6#3H>+"EEU^,N.LI]PG(8U6T]D0D"S&Y9HF0Y*, A9
M,)060 91HFKCE-X!ZD@%TA<-;1+9-GM(+AJ?O)[-*+P:>,%1<Y!,%4E36P+/
M@H? ;+#9I1R-"VVJ4]^.Z4CUT1,)#<ZX[ABPC%*24A-3RDD:9C(LE.@9EUFX
MG'E4N543FJ=S_'$0>?1$0I/4MTWA+J\ \5B3\30Q)VO>I3*%>8N!@23=)FD=
MWZWB2\=IXY$N7O7%U9TSQ/Z&;G$Q[[)S[!(/@",Q>\\LKVF<.3H6H41F(OB4
MDO9HVB1"74=R-*QW,G&#V/1C+;MY/OVVL4P-1)$I<F>8EKFFWD2D<-D;EA6
M!HFT@+79R]@"YFB([VKH!I'F%4A+-195#!2AF%I,0-H6!LYJ%I%42@$.K71M
M+MW>Q'*<S.]OYA;7JG)>F!)&[V"87X]7^V8;<],@F9)<"8+9I&J:+HIZM0\8
M(=/!*Y5M:'1]ZEYL1R.,GFEH$$J^QSG9!_.ZK?2+E,Y/ST>UDLDKLGL:S@?
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MB-"HP'7_Q?JOMW%]/;YIP/<4<?TRF7Z!:1YD84%K1X&_J1<R-+EM,9 '#<D
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MH=+%1W+L@F3:UFK2&1)#X9WU9*OL55^:>=2K"D]*, ]EH,EY.8'X=0KC^1;
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MQ=QWT:9^7G>Y*(1;NM4OIM-ZL7&!>GW'D;RG\ZKW6_[)NCS^-S$P%H)WW+,
MI;I6P!D8K1@O6IGH1$B-,AH/-,!GK\ZG*(0>*SQ4!["^=F/ZZV\?YGCV][,K
MKK^RG*-8;#G42M#)% 8Q65940:N-1XH2=_"G[WC$LU5(GZ;KL81"A?4&Y^L;
M3[2F+K2XGF4'SNG:$L8S%WQ-!G6)Q9@\RPE!".,AZ+P#HW<\XEDSVI?I^BR/
M4'$MCLP(W"!(%10YVLQF;>O */PR"5E"1_Z0BAK]+F_D^O.>-5D/,DJ+H@$W
M+_)>;.NN<B(N]G312Y>TC@Q-4B2B4-,K56'2@M#&!2NAS56\W3$^6TTTIJ-%
M$8&;4&^6SAB@CD88FFF"JG592@ &64E&*PC*G'-I%KGN@.X(U=*1@BTZZ9S-
M=!/DVO<8XFP0K48L/C$E8RU"Z!4+(1&ZR$$78:4W;=):[X1UA,IXJ-%;E$/8
M,LO5]?#R0'&QQS+@8,''2&MC4C4W,RH6:UN7[),.P6KR4]MD-^V&[PA%TIF&
M+6KIOG5ZZRSW#K[5*:Z>^J0T/<>\T;YOH%-QN7A)L'.IY9@"JTG]3!JP7A5(
MOE%_[X?A/4(U]4[3%G5UWBFM8=-NR0T#)3+:C()1R$36L8)F3)X3<R)$8S1Y
MZ] F86MWC,]>18WHV**<SCNMMT!=[@7?DA8#!;(E3QU\0?+%9&)>6,W0AWK7
M(*44VH10^V,]5B7U1<\6176N5DL3Y2H/:U6NF\"3\.??:JF(.<V?-;?YK/[*
MP*6"R5A%,1\DIFD19L$2:.M]%BHCA]!F^WUWC(=74&O*KZ=IMJ&KR47224+,
MLU_(9!]@A&_+[5"]-(9'E5BNNPG:F,P"",-\H2 RZ\P#M/&Z]P!Y_-)J1%B#
M7+@;;\'ZX F717BJV=;=!P;>1Y%*<2P:;FO+=WH/9*X=QR2H#"+)1CTA]D%Y
M_.IJ15F#RW";;\*KX<(>\_,IO1"7F <^HE:!>U9"/7*O*:&AI,#0*2W .M2Z
M32FM'< =OYAZ)JA!YMU:[[],IIMH%[L=6\Q"<*5 5V]]@N$UA0,6A4J9E#YX
M'J*RT.:FY9Y CU];#8EKD.1W"]Q%I<-M< %S". 4O1%8:HTT01%LX,PJ$[@H
MLNC4INS3GD#_J#KKA;B>6R=MXMN O9&!MMAGH\5[MN!H1LLY^8UD](^83L:3
MT>33XDU)L9!5(E.QWBLK!)[L5RBRSD;FH&T6U\Y=MA[&]X/F:/7U2(0U2"O<
MW6 #)51:--?TRFNF?>W (G5@B6L/P62A39LSW]TQ'JW@&M/5H$/3+4A_&8YA
MG+8;)CHOG0/.JE/)Z+^E-JXCV$(G0X81 MKL?>V/]5AW4?NB9\M>5_<63,M)
MEN;8^Y)7MXQB("Q/3M>*'\75]G:>WCHM#'-H=-(JYQ+;7,?I!/O)3&B]"6.[
MAW8 4GO<?ETL_Y=+_OO)-QC-O[T??CJ9SP8!N;:J9.:"%4SS1(8P')DS)F2K
M%(3K9T';/;!;/O]H%=&;47O<"[WNYWW =#XE$TRFT\F76ECH/8X6QY<?)RN\
MFSGW@^0RMU)PYJ V20R.LZ@B^7;1:Y^+XM'I/9WQ_1 <MU@.0TR30F!G*Z&_
M+1].)M/Y1YR>OL(X'R1K$"4MZ8@0F99:L.!KBX1LHA(E6]UHA^I62$<KH7[)
M:+&[N:GO*\"X!<LQ+MJ"+[HB!N9S="P%D81U%$3F-@DKMT(Z>I7T0T:+O<D-
M8)M2KI50<9J&M1+B&4X'/COA. @F U_TG."U#JIFAG,DH<N OM'>]VX _U *
MZHNH!C>,-Z']-J$%E'1>0\Z*=-$B<P# 1=(1F9*<C, ULN!*S3Y/#JP-WJ4V
M8?J]T(Y>0_V2TV [<5/DVP%Z):P/-C&>N&/:D]<%BB;.XDSB&HSVI5D=N;NA
M';UZ^B6GP9[A%5<,Q\/)=+'"9J%2=(1%NKI%KB2PD&MJ**$R6BIN7!MW9SN>
MH]=)#S2TZ<!^H=[:7):&CFM\:S4O< H5A48TS&A5&]_Z1,%=JG4;5+9)&RUX
MFV3<71$>O8":4-6BO?N["YU?M'4>.)&B42HS56H39X6T>!KP+.AB>0Q:\T:U
M K> .7ZE="2@Q=7I[>I].1E_QNF\E@JZVEAD$++34LK$')2Z"1UP41.&"8B0
MG!7*^3;GHGL"/7XQ-22NQ4WKV_!>M# 9I 3%ZAAJL0[ZPUAZ%1Q*)I6WVF,"
MK]IO]&R%]H<5T\/(:7$!>_.P!,_.I^D$9M<A>AE-S3+($C49 "@:%$8S*XQ"
M;=$IUSSA\19LQR^@?NGI\[[VQE';?#+&^:R65ISA?#Y"/#T;3;XAXJ+; GR!
M*:W(WGL=ZQXX>O+5M/&.14"*$LE+4Z:X@/R:C.XZTMSED4>KCI:F;W%)^\J^
M=Q7MHKOQ0&@(RG-3$R7KT.L.DU"<18NY".Y%5&TN86_'<[1RZ9&& UZRWI:J
M4<!$J3$R$<@$Y,-#+=%::]LD8CJ+".JQD[N.7D6-Z&IQ"?OG4K#6?EZ7/'L/
M<WP[KNCK?^LEN<\PPD5%'#+,,,TQ+VXWC?/5'VS\YB!:J9R32 Y;_4.'S, *
M,B)R#)Q+**)-9-]@,,\^ ?&Q"=Z2)=2]NV<7].]P.ISDF]4V5A6(-^VTM-W
MY @QQ5B3HLC\@1?F;=TW07#*TSI0;)N4QL..\]E+_0G+8LM;T'G_K-L[' )
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MZ5XP#QT$MY#'Y% T-=B(_TB_][:\R).S:O7?%_/T3ICVR:'96T+;4!TV\#X
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M_I4F6FHA@DK6T38WXY464)')_NSL^/P]IGZ[;,6_%7&EQ;^5G#%(__QM,;N
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M2;:F:,>!:#,9I!O/SV@45]3007BS*L'H@ZMIS=\V9,<IZJNAO0<),4#T#2[
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M"2;A#BVS,5;B_VV;H-H1:/) 7.TX+-E% 2W:2$WGB[?Y@S^[,L2$C=3P;$B
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M8,>\UU<^XM^]/29X/1Q8*2^HU*4YID9#(Y3+)JXYB3JXI()!H]'UH$3_-YX
M%QJ)MV);P8+ROV'2$Z3CV09G@0A=&J2*J-'89(JX $Y'JH!N#FGMY$#O%YX
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M!"\,@T&NG,,(0RJ5#7]CZQ2X$RJ_D9@?.V5NR^LZE"ZMH^@4@Z@V/H^9?,5
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M(A>E33GQ'8 >X11C!'TMQA?VB-E*J^7ZVBCKT7E'<BN\1D%^>""CAYSQH!E
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M=]ZM%^F_/BYF]*)5+96P_GIXO9W=SQJQS,Y P+>JZ[A:,!.\]]QJ+6NI=5.
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MSB.EIS_*VK._-D8LL7,U\EUT?H_+3ZM+NM?3J(D*I>3(D27(A#2&Q"#4(B^
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M9%[EP**0"/2?T:%-@N) @.? EA:Z&+,&SOTX_WE1Y44"N65FOU_\A-]^.4^
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M[@DSJI6-D6R4PD*0G.FL:@H8!B:*=-QK)W-H$^GWQ#*JFUEQ(\B]0>SY[IS
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M1=&*@=E8XUZ(J\!]3K1T\!I$I@.9=1Y*US4V2V$LSTXV&?O@"_'Q#O^"$T$
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M%1:<S3"_F9Z<T;JS%,2;S<+IY\5(52/FW6F>?)WDBW"\,5"=?]\W27J&D+P
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MJJ]C-E"HPYG_C<2E2]-\K%OQ0),P+R@!1<6;68(H60;Z9.NU",HQ?JC\L^M
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M!?<PH4X/O]]&K6Y.Z["N;0<Z:,E+R0*D80A*"05>17H13:&9/0<67!]EGP?
ML'LBI ='L&U\U9-8[T[/+L[G"POPU8+.@C5"(*T?SM5>R9I#5)A!A)AL4A0V
MN#[MX^X -7X U=&=MQ%G3U_T#*ZN01.7%V<YQ"(" QU#/?,L"*&*7W E$D_)
M.^1])"/N /7<:+*++T::3>3E@6?B+&H7P#K/04F1P'$?(:9< HL^N]@GL_P.
M4,^-)KOXHL,MY8\7^9_H7RT6W:BD3C%(R)6RBAN:XWS6H(5Q6GON3*?&'YOQ
MO&S%6CFK8;^^VU&M7IDAN$;,9/V.["%DLN[FO7L)L8?INV>R7L/',"HC:-8+
M27E0-DEP2BG(4HC <[;:]+G'&I<26V6R]F7$-A;OT85]>H+S\TFZEN55%7R4
MJWH0L98W9\L@"(\@+#)%2ZH)OE-]VPTLATZ@V]5/ZU>.^QFY<8KK#RE]-)CF
MR=060XQPV&B)T\J M3ZP;"-W<4C/IX>4];BGT_8R4>.4DL4=P@\YM-<S9Y-T
M+!74M,35AF+..PB8&$@*93!BR<;; ;Z[<Y GX,QV1FP8Y\]GYT>_URAU62/!
M$R;I:2EQB[29(L$+I-VI0Z-0H@I^T#$2?>JUZ9:^6Y]J?QCVF4?ON[N@8:OC
M*Q K.@Z!L4UL/IP1[=_W^T/P/5RP[L0][-=PTEZ'@Y$QY24';2/-+J@T1.DD
M<%H["KI<%!N4=/$PW'A+V-S>B]N8K;'W?@U_34XN3B[IQ"Q+.2?(,6>*U0H'
MQV4!+S,W@EF#?%!BQ"#__3#T> OO7L:?MK!<PP!W 81,]1U(],5$:QB@$L1"
MI1&\E1(L!A45S[H@MG/A]:$?H0MWMMRM;^%__GWMZ=_3M__XV^K']4L,<_S'
MW_X-4$L#!!0    ( $:$5U3EP9;)\WH  #*F   3    8G-X+3(P,C$Q,C,Q
M7V<Q+FIP9^R[!51<S98O?G#70'"WX!;<(4 ((;@V$ER:QEV"!1+< B00W-UI
M7()[\-!8\ !!&G<>WYT[=^;>F;7^\V;^,^^M];Y?K]U=YYRJVK7+]J_V6?WP
MX^$G@/]*04D!0$!  -X^?H"'50) WLO6"@!45  V  #0 60$,0#Q,47X>/'J
M@RV _)A&>$P;?DW_XQ=@! #\Z5U* .WQ'O;CM>2C )2[?RG[)_[$G_@3?^)/
M_(G_1Z%KZP9V]'0%VW+0RD!,'2Q, 0 E#NDOG(+HD3N4Q"'_+=V>$/^7-!(?
M+P D)/Q+^E_X!7K&'W7^R2_^Q)_X$W_B3_R)_[?!Q\/')\K#*\K+2\O+(\HG
M),HC_._>>V0B@"W@!H !1\ 3<'W\M04X %I !H  IH #8/'X_4<$!(O1QLW-
M292;V\&5R]3"T<R2R]P1PNUEZL3-R\7##8A+>3F9FH,MW6C-+*UM'218#ELZ
M6&AM+218= 54>%2<Y"QM;%_ZN%AJ^KS1,O<!FXM8L$A)XF"*>XEZ09P@EFZF
MM%X0>P=742\)^K_4+OJ8_N,V-[VDN(N%E:C&"X6_YGB\DJ#_:UL\/3VY//FY
M'%VLN7E%1$2X>?BX^?@X'W-PNGH[N)EZ<3JX,ORU@A>6KN8NMDYNMHX.M']<
MFYHYNKM)T+N[VUJ(6IE:"9A96 APFIGR6W#R\EJ8<II:\/-R6O#S6P@)\ KS
M6?&:T?]5O87YW[0[N;O8_T6WA3FWI;TEQ-+!S?6Q-WBYZ;G__]7YV$5_4_KO
M=O^CC8]Y1.5<+$W=+%\\BN0?0\W)P_M8L=8_#S47'X^ ./<_Y!/G_H>&_A_H
M+4EQ"W-1\S_:Y.CR3^HU+9W_:Z-M;ROY;PCV/YGZ^.2?$H\Z'B<@!@:&./>_
M5O]O^X/[K_/O,?6WV?I8DO9_ '\J^5/)GTK^5/*GDC^5_*GD_RXE_\)X+1T>
M::[G(Y]]6 #D #04%%049#14%%1T-#1T3 *L1XZ!28R'CTU 2DQ.1DI,2D)!
MS4)'0<5$14)*ST7/](R5G8.=G):;GYN-CX6-G>V/2A#0T-$Q,3")L+"(V"A)
M*=G^M_'0"1"@(S(@OD9"H <0"1"0"! >>@ : $! 0?@+_OF8@("(A(R"BH:.
M@8GUF*$>'T!$0$)"1$9"04%&?GSJ__@<0"9 (:3CE4%]HFZ*1N],Q!<4GXW.
M(%O=1:PQ<<3(;^82C('YE(24C)R)F>49*]MS 4$A81%1N1?R"HHOE5YI:FGK
MZ.KI&YA;6%I9V]C:N;JY>WAZ>?N$O \-^_ Q/"(A\5-2<LKG+ZDYN7GY!85%
MQ24UM77U#=#&IN9OW3V]??T#@T.34],SLW,_YF&K:^L;FUO;OW9VX<<GIV?G
M%Y=7UW_8A0 @(?PS_EV["![M0D1&1D)&^\,N!$3//S(0(*/0\:(2RJBCF3H_
MH><+0B>2C<^N[L)@X-<X(C9SF<!\ROA\E0G^AVE_L>P_9ECP?\JROQGV+W;!
M &PDA,?!0R( I(!KA8AG68A_)\<KX3>W\G"LKGN4II:,A9<ST:-]V52MH>0[
M9K$N/7JN=:LU8AMNM.30PEN)J792R:8U/(PE(Y#M3L$@RSG#ZTE0W4!^ZS>]
MY$',W&#T[:^4 )YB3BMW5P!&G2JEGT0]W"2\XK#B5K,DU^@!L+^K>9$P?W+3
M%H&NAO^LDW;]Z]NW>,)PC\+2RP>@JP.WTJ$@;K?4NJ0Q_=UMI3T2>T"K7W;B
M7BIP?1!QI;F&]S%@50S>'WIVH^]J7:B2M\"'T)_I1NVQ/8VLIFB7[,__[>)>
M KX*QPN\55KSK2Y]W7!!_IRO669NTRP&$-E.<NS/!_Q5Y/T6RA0],I N_8\.
MUW!+J=.9?D\:[;H:+;&1<IHMFD4OQ8@, -;!@1ZE/'L/ &REYDU'P:@[\<QL
MR - .,\8VLV0\SH#Q$I)_$,+45@X"R_'IO+3[[I#G.6]=Y23[927BL9'AU&S
M8-^&UFE+FR<#P%4-<%QMR<""V41+Z:FY:TP=L140DTFT6O59QITI/;B+'9=@
MM($X]OO/[VCEZB9\7HC?:#!O98]^2]+7S/K1K7DTI2[OGOM?"+;3K4 W^$A@
MI+78$.PFF-)2E/L[XJ.P)+BO"5RG:7TC31.$8^7/]VUX7T.1.$]]?U.69[.&
MSS?^JQI:H[H)YV7E?O]JX<=; M>B\0#'[,MDV%C?P0YT@"[18]K\%L2[/X<$
M ((IO;K-VQ\E:7[=TU_Y*:X^ /@",7EY"19T/(D69[@((@<R#%%J:!-:NNFW
M]K-G$C2=YU4V*96%B[NP]/:OCO202L272E::/U:=,UVCR-?%_8]NY"[E5I^U
M6OZD<RW83=6J*BL_+W3OB$[7SDW2BP_INI*F=-L)Q//,:;><LV_E+_)S@U?#
M=8/]9-8""T8Z4\4)11I&D#SN$ICY^_@SF\$KK22F!3OMV%.<=1)<>TI5^(=A
M?4<\J3@;U;K8(W*6,3(L1 A-\GZ#63 #VPR!R)[']M]3[>(_ '9>27FU<RQM
M7JDPA40WMMDFDT_$8UN4,?U!QE-PJ2['=2F,3U.9 [.G._('22Z%8'FGKT7C
M;WU\K-&JLG"'(N#<'Q)-_'3@6%XW/1[!L 7YAAO<-"MO=1?-.WI[ZJ]Q:)?E
MWH7=;2R=4&.TFC232Y.UNW=WJ:K\:E.<UEY,=^MO6?4_.?'@(<79(.U%L/?<
M\ROG[C9#W]\B%-EY7$M^86L[VX#JTA,0.?<-8B;TIX\VOLTH-3S/76.HO.\G
MSQ,B(1CWSFLE=^_N6YW^?)"#+H?7BDFTW?$<X11"?+R<5G#I<-'73CG53G:I
M:'0T'E'.E=W:E*F9E$5C@4287LG^%)LBRUC!)RKB/#.:FJ']J/(;Q%QCDLG&
M4; ?6Y.U*]:W))GZ/:*3+Z4:FJ>\MW]*9QN24L>DNPF>G4%R>JG!ZYJE7=[%
MU@0[K)E9Z9[*,:<WJ*)1E!-'"_>O+AY[^/JV]@&84)6FSI;W*RS5B]9<I3K(
M&%,SNE5(0.R^]&0UO*]7[+O>G(MX]\3+53I9@ZM5PMS9M;COC?YKPDB]VK/%
M %'@>C<"7OGA 3@&%3P U;+]#X!%!7]?QS&''^0!J,K(? !R$P(E/^>4[JP<
M8]4_ !6L#T!6Q%6 $5SE?0>^.TVX,]@CTC//*YB"'8Q7SYW&&<P:H?ORI/'#
M2D;F<A9>R;-*_+OL6ZK5EO$/S2E1LP/*96P@1J%2\<_'(R4=GA[=Q]7;5+LX
MCIT9%$<?>DS"SHVIIU#*V\Z6%A;[II2>Q5VA2T7'.GP+E(!%7 T-]Z10(U^J
MK%>BL+H6VXI&VE[;OTW?)YZ7U#>^ZHI_  CTVUF.,H(>UTYX!OG1Q4=Q@9++
MU+'^;^JY!C9PL2&KDTU.+H+I_460^./LS,(K_%6!MBJ9MCJ,0WUWR[E*!?X&
M5W)"GKWNT5!DS./&SEZZ-W:.4Z2=8[A1\&+IGKS$TX;;I[YS'Y!O5?+<5OIV
M5=(XW^*HP%#H YP/L7>Y.R+\\FB7/)KKWB=GK:O$LZL:+-YM^&XTI'*CT,%A
M/](3>N4-Q#3M(I"7KMY(A4J1M+*:_MS*F%.$/VL*OE"V7=;K[HL89CMD#!L$
MOIZ2'DI3#\O[W:P'A!ICAZPK!I_^JH,TI*ZO*!4IGA?'9@R3NHNL)'43OC/4
M%8"C2E#<$Z8;2^!IUTXJ!G*4YW[?9VX#AIUJPBU^4$'%GJ'PCM/9(.WZL/>W
M@LH6+B-[ ]#/(OD_<U=LI$M 7Q32J$\=59H^^J.KM'[E5:;+G76*3,I+D!X<
M):FM/#=LBF"@_F[HP!MS($V&="-C1E-SZ@ B915+9 3J%:C\X'AF4_&<7>0
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MJ^MI@CUJ'H!O^HXY=FJ_KJW#(5G196^K*#CSPH,(N:@4<"G8@X:MQ<W:%"*
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M,D*G_=CF-&4DA@=)$T0X9S 9J*I7+4U#D<2M65*7[N<FQ"76,XF%HKCV.1Z
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M59PN.@F#34XI9VI $X3XAAPM>6-9H4"0-,X)ZIASOP'LJ".V7L*Z)]5/J,J
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MV]:Q=K>5"_CQ2CF@\[C:+EXVKK^(N0&97P340JCU%NX7\.EI(B-4Z[R&-1^
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M/U";O6BH8E5?J4A\IED[- >:J!'#Z>@S=U'R'3M39WAO=T40O<&=?AILQZJ
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MZ?$1ME-7,LEGO!W=V@E:IMF]98WL]*SCP%EV;4U<(N4U%6?<<2 UX7MU(Y;
MX,6$/'TPPX#LC&E+]/A6CY[,]Q*KJ3?:.E9?=0H_^VS3@AJ&.'<IT4L%6>-.
M^9110_2E-E0VRT5E&^>>Q!\*1A5O'N)FI@>G:'A;=F<7&[FKF=( 9A?3;K/Z
MR="[')1D_O9XURCU#U5HP&#BZZ-WXAD.SYKWIO=Q7P:^L"UN5I4OM^;Z 7D&
M>@D?I-=OTG'7+ F5+? *RI,*>M69J^W1/>K/1*(F3Y8.Q[Y]8;TX!GS)H.UK
M9YH36/#M_FAL<6H_LZ99WM8%$2K?@+PA[RP>_ABR^[IB!V@>7&GU)Z^PMWHQ
M./SVK<AN'61>X8<ECU3>R[P7X$SB?.LDH35?S].FU2K;)9E3RZSS:NC12.ED
MP=&4!Q&&S00)9 E4K@E]21V'3B=E3,,@T6*>Y&="5\)_FJB,&EU1XNX.IY*J
MF6V5O!6LUZ/)1"@8(V>"=T,^O3S%[E4;#=QC/(V_4\YQE.UMTUN;'E#6U]$>
M<!2(I(XGP^&7/EE8WPUC1^1$IR"@9P&9K&&OL]G?L# ACC]3:Q>VE-PQTT[S
ME3MR<.S&V=H7CI7U',<+N-_;QXH$5NTA%FEUS3#, 5%-^!9=TWRQN^C;GG/,
M"=+EV1BV1C\11)I]OD_&5.S][$87M!S^5\[!TR=;&-+L*>)AENF,ZM[P<^<C
MG[EMPR*PQWGX/AWTY%6/:4/K*J&:I3;YA%-PEP.4W['RK"/LL&]J\?(R==$H
M3)3&JV/'?]_Z'44E *#;%:U4-BE)G(D[)P/=S!"!:6>)G,H+F7T'X?8PCK?R
MOB>IM^NB-HG&1JM@[?K*/\/?$9:@D:%PZM)T?%H@[Q4<.!9@81:&3A#-9=SI
MU@V,%U^-7 9U7=5!@SCIFS_W3N7FM2NQ%(3'=-9^=64'@"7"6]]Y>)1^O%WJ
M=;(B_&3-P@<R" O*5UE<>:E3HE/E@CXPNE+>L@-XP?(;$.XM7]FW66XM:QD7
M!4D1+YX"F6+TL>=)(G'S\-@,I%Y@&L2SWP/3'Q7P$6!Z-/#@FM3DL+JC#+VU
M9[[P35BM''6JJ"MH]K,\7NX0'D*T_AC(_52UU4S7?2"3IH;TN#YUC9_,=!:I
M66(19G^\8!@5U?9S=?V2(')GA-9C!1M%+#<<L/7$7GP(>^R%$,U/69T5M7+:
M7$J3VWF/N#I3G<ZJD]5&\_ZDFT^U6IHK@G6@0 OF0W=F:!H5.'2E<>< ;!4F
M;='"[,0>)@!$O)VA9!3NQB2CHK4_,Z7@791I3L%I?'/&<Y!-_5Q\>7L6C-7^
M+GF<E_A>GR5N&+#T$O-MRZMO9HTG7EIU$ D<O9%"_L:ILI/"ABFSILO*"H1D
M!VN&)'=>YB!$ 7<^NQ[TMWAG?V@<[MLM*ACM+0U;SA $35!JEZ8QA.C&;T/[
MHFW*T\6:-!1_-:WDBY@\N%:,#/@N;O5ZTL"UNM=(7^EZ=%]2&3^J&5U\G<Q*
MY%@7M;03-+ZK_^M3W6!RK=6QQ".OS7*!E[C#%)IUU]6-@O4F'FX%J0NA6ZND
M3;ZQ+P19_1P[IUKA? E'S08)_6E7H:ZRX3BX'FY;+VTBFD,6M\F%EEO,4&!%
MNR3_0N /]J$/][[8IS-Z2]=!@?I:H[$]%*.\BK0\90ID'YR:V-S[2Y*HN <K
M'C>C1K$V%$1FS2)7WH!HWY/;?[',1P@]1&#II#(^T/7Y,R/*:C3J$RK!0J8K
MDS_.%";+/T]ZT#SR:F_0-RG3\3B+"*!)2DR1929Z,S?&SW>)C/6UV$ H6!5=
M;!"#2760R*D\KY>8$'O7>YMG@ZXCYY=N8QL>%.,$<LK%"FK$4A78AXS(1I;P
MG/*M.QSTN3)!='LC,%TGBVLE7$VP?^:>_!0_FE&3O(6C.[G@!=N'SHH7^"H9
MV=Q;N^1[*_QB/%AZ/X_G575E*3<6ZUH@BQ<2RV%)U2?I*@66:EH,*=A9!5W;
MVN\RPAJKA^B_0XSDN>G^*+=XD# ? NRA(=15"6L(AEH'UZC#J%AI&U:\&>)6
MP1=%,I.+M'&+?_]Q< KI7L<PRI,JE%],2_X,34M#7ZG(U^KC;X 5LSUQ;%"#
MAYMMK-!;34DQ.:3(O=1CBVP<G,DG9]CJ.YD9LT8X0X*U\XU%02.(?LTE1:$[
M3^;15F YJE#Z%_Q[B>1*L;.*$IRH#_?@P7KY2&V.:6Y:'FLN%T[=D6)N<I$\
M'&#HA(_T&Z"RP^=_B]74_5B.C[!3>U>J/V4T"U3P*-'1M4QUJQ1+?]!QFTQZ
M==QK*A<SRD%O0IY.(,;#^SDD'&AJN%4J1O5ICDT5K#5,:PX,CRD.>T52(*>Z
MNNKGS!*LJ8(WC'R'J3W_AR=4YX*AT05;I5BR6G D=?40J:R3N0LV1U^S\7DN
ME 91R?[I((2+>Q*Z4X+C_U<'J/\7!=7OQ?\!4$L#!!0    ( $:$5U12L=W1
M"?L! /??%0 4    8G-X+3(P,C$Q,C,Q7VQA8BYX;6SLO7MSXSB6+_C_? IL
M]8W9J@BAB@_PU3TS-YRO:N_-2N=DNKKO1,6& D^;V[+H(J7,]'SZ!4A*HFV)
M D@09O5N='26+)'$.;\#_G!P )SS;__SV]T*?.%EE1?K?__._]'[#O U+5B^
MOOGW[WZ]?@?3[_[G?_S+O_S;_P'A_W[UZ3UX4]#M'5]OP.N2XPUGX&N^N05_
M9[SZ!Q!E<0?^7I3_R+]@"/^CONEU<?]0YC>W&Q!X0?#TU_+/(>?$CT(*$0H9
M1"2AD%"40C^DON?AS,]BL;CY<X0YQLA/81+&$41!AB!&<0QY0E(J?#\-4E(_
M=)6O__%G]0_!%0=2N755__GOW]UN-O=__NFGKU^__OB-E*L?B_+FI\#SPI]V
M5W_77O[MV?5?P_IJ/\NRG^I?]Y=6^;$+Y6/]G_[W+^\_TUM^AV&^KC9X354#
M5?[GJO[R?4'QIL;\K%S@Y!7J+[B[#*JOH!_ T/_Q6\6^^X]_ :"!HRQ6_!,7
M0/WWUT^7)YO,?E)7_+3F-\JR'WF9%^SS!I>;]YCPE92^?MKFX9[_^W=5?G>_
MXKOO;DLNCC]V59:/GJJDS)24?JRD_-.IQGX:(;XE>3?/9;4@7*WN!ULR]F'Z
MP9JXUY(?^/0"=YH9+7+3H=ZNF:N^NV]JM.C32VRK6Q0;O'+0+0[-=$1>J2_>
MRT]M,^I!/61:M]-2=T=4_FW#UXPW;/GHT2!G__Z=_+3<5O &X_OEY^V]U$J-
M?7CU&E>W[U;%U\NU*,J[FL@O2+4I,=TL14A1&'H<HE"$$&5^#'&2I3!.4T\.
M@0E#GK^4(RXIVLZ^Y&OXZ^>=7'7C@UK^S@");ON/$2EY56Q+>A@-[U;'AC@Y
MNJGQ,/UIC>]X=8_;&Z3XRG%H-/J/KN"@(_&__710U1[PJY<"<^40124R4#)W
M\02_[<3^OT]"6]!' JZ4_U&43X$JZ%"@#J]Y)76L41*X(K6:[2,E9('_$U]M
MJMTW4'T#/;_U6?YDVO9/SWK/1;G3$Y?TC/':*WZBA73.[C?PD1V5,SL*D$TQ
MJN,U9I(B?@>*DO%2.N='U'WVLKSA(E]S]HJOY8?-1]F1+NAFB\L<KW[&^?I]
M455+SJ,PYEX L?!2B"*60NQE#(;,%R+.D,?2:+G9#\9G7RF--DU>I\T);\/F
M.]6*#%J9@1)ZL?_KBJSRF]HJ"[!7!2A=P/=*FQ_,"$S')GKD91GIB8EK*I"-
MJ<P -JLTIM.N4PHS .(I?9G<.HRZ/M_BDK^2,UGVNKB[Y^NJX<6RE'VJYLU7
M#X=+/N(']=7%5URRM[]O\\W#I9QEEW5LHKK:W/+R^A:OK^[5(ZJ_\4KZD9?K
MQE-?$I\R["4)3/R$0I0F!*:8I)+_8DHR/X@(#9;/YB3G/0M'\FN]X7H3.*MN
MBM(-JD@$ UT 0 <!0!Y ][H6!5##L  -$*"#!*BA !N)!6C!6( &#B")H@'$
MT)UTU<TT_=$Y]1I'#NW\>HJY=^S8;';=:U?"N_7/'9ODF8/ONOUAP^SK;5G*
M1CYOY,!PL68J$+VZQM_>?E,B\W9\7^+,"T-/8,CCF$'DI0)F&:.0Q/)_2<18
MFB8F<P2M5N<V2VB%!K74 *\9J.4&4G#02@Z^;V4WG!/H64%O"+&.[<3\;P=6
M8\HV@LDJW^JU[)0LC<!XRG1F-P^<#=!;SK8K?B5>;2LY\ZBJ"RIYLLIK1GSU
MT/GKFG_;O)+*_6/I(\H3*CU[0M(0HL3G4#KZ(4Q%%(4TC+T$>R:L-42(N9'8
M3@=0"+#3 G356"A?J_,%^.T:$WF]T@C4*IV.*MHSG::W/+%!IO9\I[2%N0\[
M DR[_N@00=SZEB.@>N8GCGG6,#*M'<K+]4;VQ5QVIXNJXIOJ%WY'>+G$,654
MK5>%&0X@"I#DS$C^0]-$D)@1G++ A#-[VIH;-393QH.LH!$6_-:(:TA[?2#K
ML9LEZ"8FL<&H&1.4!AY6>:BO/:=THZ'X4U;1N648>;R7#,7YU3TOY81V??.>
MR_GK^QR3?"5GK>T\MGJSY1="OK.?BI5\U,U_<5R^R[_P9<C]-(PI@8BKM2;L
MAY D@8#,]S*"49)Y46S"+F.$F1O]-+HLP%X;4*NS 'N%%KNXEW0,I%( *ZU
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MY$5^!%D0<>E-9!Y,$R[]"HIYEB#"D1#+;G:CL\P]2AXMPCV;U<DF[^XXM!"
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M\QK\86-YVL:9,JRG+X1YA*_=LG0E3E1W6#(2$)'X L:16KQBQ(<D]BB,O2C
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MC:?'?!.:9&("_/C($I<=2W2D!WOQ02V_/18<")Q5,C25P2DG#@3H*34.?<S
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MZGBP!',CWS8VH[)\*('!3N(%:%7;?5/_;%INPM0\>M&W24&?F$0MX3V@BL1
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M)C@B>KR]%SC6V:OX\:.8_;<,W>7^^0ZO5KNLS$L:DC0D"89>1#E$B8@@":F
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ME^7R#=DLLY0GF&<8TB )(?(S!$D4$?E/1K"'4,R)]A*I"X'G1M([G0$]*+T
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M'US,SAXRS,WX--Z=DJY<*;H/^G;\,C*F(S-/(STP'PYHY0<_M *@U6 !]CJ
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MB0*)9.!$6*^JS=Q(L<Z_>89&6W?D)R/WSPMPOD^T46Q_R4O8P &W.IK)(+<
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M*E'ZD\7?3QY=/Y_8^3Z1\4/CWLO-=OD;_3._W]TW-3#B1&2(XP1FB,2:,>(
MT@P',(P(C5.1QH&D-HQQ\N2YT4,CG&.]D5/ !*(D#1,.288E1'$J(0LH@9IA
M0QJ&.$L8MPL('@39-+&_?\]O[X#4-I+>:%?)%X/AZZ;.09",S)/6+Y U+U[4
MMHL$]4U'!*A_>DE^IT^=A.DN*M/2VN4+^OJL'K6E56R>OM(?OU%-(3E=E9^D
MWF^;T^7-HRR7:2131E@*)<8((I%R36Y1#&DB%"9Q2*,$N3FLK@TY-];;2[P
M6F:P%WH!M-CFJVX%=_5+7<7>UBGE$]'1/5)#P>SA>[+%Q[/CZ>JP$WN=;&$X
M=3E9W]F/AK[Q.REV*_E9W7"^V4G1%BC,F_W>P0/ @B0-B=1[,H[T[@QG&:2Q
M(!"Q($(\X)@BJ[1"]Z'G1DNMY.:C:60'1\(/=N4X3(H=3XT#]<A\Y1%E9^)R
M!\PK@3D,/RF1N</RDM!Z/*$?L6F2-$'G7S;%8RZD^.7I]]*X.M[KK>B:/PL^
MVI^+A F+XUBF,(OTCA))JB Q\T,2EH4RH)'DJ5NRI+L0\]M$[86U"<CS-15V
MM#8NO"/3FS&ZJCR75GS GL!/1@.0KW\&YV ?Y5BK/XA>*:^'&)-27W^87E+@
M@"?UM/'D=KLR3+O-;^E1 =F0*FW3,0)3$<3:H#-=FS+3MHVI#*F$:;JS.CR[
M,L[LK+=:3'"0LV>[QTNX6MIDP]$:VP#K 92[I=4-@U^SZL)8T]I0W0J?&$Q7
M+G?/C_MU53"Z>G?_L"J>I*R:2W_1K\P=+67=<$AN>%[*F_MBM]Z:JKJ/=*4W
MH=L")X5Z3_/-;W3SWW+[#[K:R4*]*>[OB[I%-=TR>9NOUYK#BHU<BT))RN\*
MI?2V=7W[H/];B!]WN;8 M>62ERM9EDN&,JDXX3 1(88(10G$21Q!+$@<13%&
M ;7J'#<WQ>9&>C4VH 6G;AT/6GCJ$I\0M!"!&B-P ,DDW>+D_S9[,8,4J*$"
M%5;F'VNTFL?2+=@#IE_+]@C>@ 9:U$ -&_AI#QS(2V"@NUQI8MZO<C?MSTW<
M&:TS__^[.?J[:9^(.B>Q7=[1B;)?_[=X5YW2<N?X0G3D L]*W,D2D&>E]0M+
M=K;RN1==?)-OGVXVDKXIA%QF4O DYA1F3$B(9!) 8LI=QUD4QR$G,K:K;_OR
MP7,S'8ULP @'C'3V=12?@=5M' V!8&3CQ%)[I]*(YU3M70SQV<,F*W]X3H7C
M@H=G?]\W4H)O3(F8M[+^\\/ZAG/#$^47^F1<!C=K<>I,6"*2D5@P"47$0HB$
MWF/JN98P45%(49JE&&5NT1-]Q)C;Q]S*#!YJH1> -JXU65>2JX/*BRJH?'70
MPS7 HM>4V09=C#T1HP=BU(*#GUH5?@;Y&NRGIE&CFH@SCD^?X1E#D/0<LM%+
ME(G#.(; =1K:,>AI[N=^M7'U6;566/F],)6YBGOSW5?;IG>KO,H#>U]L?M7O
M^T-KHBTCA81D,H.QE)I+<4@AI@&%7* DSA+]O]0J;7B8&+/CTGIS9W9DK2YZ
M>V?JU_$C;8!LU*F*GOSZ[MOG+^"AT<C^-&' Y%T_EYIF2D9FU;_(;-B?Q$PS
M*Q.=FXPX.TZG&<-![3A[&/#PR4X*A@-PO*_W\+2>[:9HOOY8E.7G=5M:\N]2
MW.I%5.JMOW&@2Y-[\DENER*+$QSKS3EB7&_3]>)5EWU, KT%B)) <OU8ES94
MMB//;;DR@H.?C.@_ _VI'6JL5O*#%PI44<&.[:NLY\3.T!\%Z;%]&1Y!=F^'
MY0J8WS99UJ-/VS[+%923MEK.#^A':5]EN=WD?"N%&4=;_^:/=_NST/)F^X9N
M-D_Y^K8Z!EV**"-")A%,$Q9#1,WY(PL0S"0/(II*Q-SJF3F./S=Z.X@/N/GJ
MS.YY\^+?#B?+I=YQ\]5.5-%V30X]WVTVQD5SI:BIE\FS8\ 1IV1D'CR:C3?M
M;%1_.9)^ =[4B/MCP)Z >>5!5QDF9<.> +WDQ+Z/Z1G >$<WDFFC41Q;ED<-
MM7YY.ES2E)Z\^4$WXO-#E7;<N)?,H<J'M99[7>:\DBM<1B1AH4(19#)FFD0C
M!$F08B@(44RH+!.QTRGQ>*+.C6\K-6"E!SC6];@1G@EI/KZN41A4&B] H_,"
M'&F] 'N]:Z^X8TSF>*^*'67/XP48F=U??>[=PTQ'GQ:_D:KCB3MML.OHL)_$
MRXX_8N\R9U7A]PMB_3/?WGU8B_PQ%SNZ.EN/I_RX;T1(>9"2"*50!"J%*-0K
M%L6)A"A)5,)10#/&':N=>1-N;@O5OF'!1:;ZH=4#!_T6%ZIIE3T:2HXR^W8K
MT6O-Z<AKS]33V:<@FG?<?==%\R?@U.71O$-[IDJ:_S'<O;75#FO'MSL3QZ8W
M6$V[I#=ZP%^>ONOG524 #I>\T8O:K6SZSJ2)))(B#$D61*8B9@0))1RJA$H9
MQJ'I^VGKKQTBR-R6@F>"5F<2;4\QH\["F*Q&HZ88QM&EM5(].@,-FL;KGMNI
M)F>*TZ*_SKS8^W"GFI^)O+B]Y^F[7L LILG)E>L#VPYG[J#'3^;.]0'"L4/7
MR_/Z;I#*_'9M1KLIC8>EZG%KAC(O=I-:F\29R@C&$ NS[XE4"#$1*0RCE,19
M(!1)4[=]S]4QY[:&'40V=>0;H<%!ZI[)S#;HV^X[O&(Z^G9B*)P]-@C6 'FV
M^Z^/.[$Y;PW$J95N?VO/").B$#_RU:HJF/^\0OZA)O*^8 EF&2<94C E(8(H
MQ!DDC%'( Y1F7&%$4.049>(R^MPHJA6^:8SQL@_&08'>]8W=)L<RW&0LR,<.
M.?&)MGO,21_4_,:=.$DP;>Q)'W!.XD]Z/<2-]*K \\W3\L.[91PIE/$LA6D4
M"HB8)) $.( LY(S$4<"2S*HJS.&1<Z.G#U_??;SY]-:.<8Z0Z::1?OJ.S W7
M5+7^W$^UZTA8:RZN/^'FA^KKK;[;HT=-\C&>BMY^86=^TS=TZZ%I>/E9?9/K
MO-B\E6R[)#2B))&F,+G"VB@($X@CS6&94B2F@NG=2MAVV;4S"\X/9/7"/>^C
M._(GMF_T6JS!JEC?0OU=WP-6;#;%#VVJU4EF0HL.Y)^F%>@N+^\J:YOKC:9S
MZ-59\.T6_0& 3G4T]K#'4H%:1&!D]!DTU86!Y]BHLT--' +5I>YII%/GU>X'
M^T<-P(_RNIJ311F'09*E 8R%25HE7$#*<003(0*!$&.1P+8']UT#S6U)?M94
M?G5<Y-7Y9+<3W^LGZKY0F\H+.C)@]D?=OH";Z"C[$H!^SJ9MP.@X>^Z\?;*S
M91LECL^.K:[O9V =]1/7A-RD$'T^+@2RQ"'"@E$$-4DJB&*,(8T8@E)F2:8$
MD9P$K;'UW?X@YOK(/:RO[Q-0ZMX$,ZETF[WHQHK@=9&ATDCO9FM9S ,/.(E%
MR&&695P;O4FHYR&6D"6$,A%A&@BGJJ*>)F#"Q>RUD+>S>/WB.?(R]PS*K\^@
M/*Z4Y<\6MD?'JUUL,>RD-K(]#"_M98<[AW40K-K4EKFQ$JJ SB^;G,MEC"/&
M4"2AXDRO @$)(<YH"H.(XQ0G5(7$R4'8.=K<B&??"^](VD4=A TJ@?LU$3R/
MM!W;>,-O9*+I#UWO/H*=D(S22/#\B*_22;!3^4NM!+MOZIE;9"CIKECI.TJ3
MP+1]VKN-HI!13K'4#!)'$"4!A]C4DHJY2)-8!&G$K#;CUX>:&Y$<2_K__%\X
M"K/_M\J=W#[]#\=TG,OHVO&''\Q&)H]C(?\-U&*"F^UVD[/=MBKEM"W %UHE
MEX[A@[L.DM_DE,O#39M<<E7MD^20ZW?TC%W*RX>BI*M?-\7NX5.Q-8ZY8KW-
MUSLI/C_(3768<4@D;R]?!D+32LPH9-*TG,ED!@D7"B9I)I$*9"BI[+%I[2G.
M3'>R54T%;>J+1DQC_;-F26CJU?5)V>X[9W;$->843'3$V,)=J;  6@EPK 78
MJ[$ +\I>M+=ZC)D:!J??.*J>LDP;6S4,L)-XJX&/<_>3?)%K80),]?;1M*E_
MLZ+Y?6G"'C9;TR[G'W23%[OR?^XV>2ER7N7N?5A_OY._?UL&6'+%2*HMM51O
M @4/()$9AH$DE,8J2C&Q2NH>)L;<C+I&$U,)HV%-7BE3D:?1QE3">*SU ?]U
MK)#YQ?9.@M__]NUO]GZ% 1-XW4TSS;2,?;KUUYD1>S_0-#,SD9=HY!ER\BD-
M![;#XS3@X9/YHX8#<.RM\O"T?GN%C_HU6J8"APD/ Q@04Y4N,Z%!<1Q#(6FD
M5R\DD\2I[HAYZ-P6'".3FTE>06-G7[LJ/#*5=^KJ;.T>*^?5=*T>/*D=>JS*
M2Z/RV>_Z?4R-[;F^_6AJ*+=NYZ=/6KBZMM0RB!AE:1A"BDS;ZM!4^!$R@3)%
M$0T$1D'D5"KAZHAS^PSW H-*XL6^EOB3V=.U4KM]J-=AM_N*O8(Y\B<^$$=G
M$K#&QBM#7!]U4OJP!N$EM]C?V(]X;L1_[<IMZ^K\)'\TU=OUB%\VQ5K_E5<U
M <J;/_-R2:CB*>(93$BFE_N4!A#C.(4AYC** J50*EU(R&GTN1'2D?"57U^+
M#P[R@^<*@#^,"H[I06Z38T=5HT$^,FT=(?MMJQ=<NA$E^/U!T*V\AJTS9?7"
MR"M]N4DP*97U N<EK?5[2)_3-_WZF<K>[_-U7MY)8;*03%E'O0W*;]=FB*6(
MXT"Q3, (*PJ12D+(4& **.(P#@+%<61=9<1BO+G16".R\4:H1FAP:Z0V??OX
M06Z7\YGKH-L<C7F%<O0SL-= T>4XRRN:DYU;#435\63*&J/.(ZCK3YGPK,E:
MI>>'2O:W];,[FY+)']:\N)??Z9_OZK9=3>FI)>4$)::!=LJ8-C1#F4'&5  5
MH6&D&%58*1=#LWNXN5%R(RVHQ05:7M (#'YJ1+;LX&L)MYWIZ _$D<EX$'[.
MUJ(=+%[-PRM#3FH/VJG_T@"TO*MGFL6FX%**\KT6]MM=L=E^EYO[*ILR342"
M2!;# /,((HH$9#1#4(09833%/.9.S08NCC0W2FD%!68"06E$?9G,N@!K62VU
M54)K7I8[JE^ /JFLE_&W(QHOJ(YM\#T#]-L!4+])K5>A\!N_?W&T:</VKRE]
M$JU_]8:>IV-<F[F[JG18U5O#%-/<R#O-5/FCK+G+!(J\U9RUEJ(AKR_FU\7Z
M9EW?\[RVIFD3;9JL?%::])8T"R6-%8=22 P1UYM0') 4!E1)(I"@$4MZQ,V-
M++;55SA]?-WOZXVDJ_Q_F2XIAK.,<[O@>543JZJE*VI] :L5!@^UQL>M8G-3
M[M3QD&[D=X1':9AEL8G]B3.(2"(@35$(590I)L,T#*AC]87YO1YCG]0>%&YZ
MY#Q3&?Q4*_TS,&HO0*,X:#0'1KL%H$K3N[$EY_5Z6)[ZSF#*)SLGGF*NW<^4
MIYD!OZ?0(\L\[;GU-!-P<M(]T;#]#)RVX>4WN7G,N:S2D7YYV75"#]/(9>RK
M9UTQZUW;,J;F#<)4[Z," 9'2VRJ,N#1UNV,4!$(BU<>.\2/=3,V55CG0: <N
M=:-95 <8+4%5VXUG/0,:-=V6)4\3;[?Z3#B/TS<.VC<$.A377[1S\FSJ_*TE
M?O'TNF1X$FW2E<$OG"\7 ,]/']!ZKDYXQE0QI9(8\D2%$"%*(299JB>292E"
M@5#2*89COGGDO3/&G=/#9YD+/DK6]\@IWJ^5SWT]>=MOIO;Q%V[LN:8R>88R
MSJF*(0F,VXM'YGA:89@%:<@$H1@G3D&>'6/-\F.]O*3V+ ??!;;EI^T'PM<U
M2$:H_FZ!B_]L[0OC39^NW:WXV7SM*[?T3,(PN</R>9"H.?LVE6K634GW.,$H
M8 B&$=9[,PTOQ*8J(XEI&J,(2:$"IQ2-JT/.C5IJB1?@)/+9B%W78*H%=\SR
MN(Z]'<7X171DIAD.IGL:B34^?I-,K@\[;0J*-0PG"2KV=[J'6'[;/3RLJE6&
MKGZA*^,S_G8GY?;#6A6;^[KOW+X4#>$B0QIJ$IFB>B20D,9I"I5B7.C]1XCL
M^MXXCCLW0CH6'32R@TIX<"2]?:B@RQ1T4]*(P(YM 5EAZMRIPQ5>^XC,D6">
M*#+3#FY/*<,]H.H(T'1YVF2!FCU4/ [8['-[S^VK7.G?WOXJUWHU,<T\;L2]
M"1+=FK7E43;'5>678I7SI^_RS^TO*U/4,U09DB@D4*68081("C&**50QPP%E
M 0V%DQ7:3XS9+02U%@O0Z%%%(CS7I#U*+DW_7Z.,XP:XWW19[HU'GX2Q%XT>
M^(,_FC^-0J#2R.>V>A"D?G?<_429=C,^"*Z3??JPI[G;SA]S;CR]Z]NCLYIR
M28,X94QPR(),::Z,!21!)&#"]58^B /.,^NZ/V='F!L-[H4$]$A*>P/M/(S7
M+=W!X(R]UQX%%WL3=3 ^$QFCCC@YV9Z=&'18F>?OF\R>[!3[V'+LOK!/P_=_
M[9I E6_R4?_W[C]V=*-9Y'VQ6E6!YOKG5:YR*8[JX#9'\C)*&4F#",8JU59B
M0D-(&8I@)E HB)!!Q)!]P_?^@LR-((]T68"RU@;\JU8'J%8?\R^U0H >-')I
M)CY@ZJZS[503,C(I#YD+1R_6X$EQZ? ^S>1,UN%]A _&L:W[<$ [V[H/>/R$
M;=V'@_"\K;N'Y_4\]^!W4NQ65>-X7MRN39[!!Z%%J$>K"O=68V[T3VMQU#E(
M_TZ_\N*[J:!]V&&KA* X23$, ZF7.IEQ2(GDD"BB!%-AP"EQ.A#Q*]_<5L!6
M/>-A.B@(#AJV?8);':NM_)&6H%$3_%$I:K5[G^1%L#QJ>;WI'?L,YC5FUOU<
M9AS\_1[8>)9QVI.<<0 ^.>(9:9B>]?:;5G/[-.BC\98!BJ,$FQY 1 80A7I;
MQ 37:T6<A$FD1)*%3C40N@:;&]WOVQJ:^.DC.1>FBGOI6B&_"V4[^O6%W<A<
MVA<V]SKV%GCX+5;?->"T%>DM5#\I.V]SC[<^8A_U/WPPB:S+4$@9\#B#,HD%
M1$$60L(IATI& 0LC)@/D9&1V#38W"CG7"@O\8<0%E;R.9E\GSG8DX@N]D4FD
M/W ^>HB=(#)V"['#@*_=0>Q$=8L&8J?W]*,1;0W)_-'8-O_,MW<?[A]V5?EP
M_:'*<OM.*<F-!^P_<[G:_^M7NI5+%:,0\1C#6#$.D2"Q-E)"33@L%!B'<9JD
MZ?)1;EAARS$])7'Y@([E&>\[NM'#T%L)\D9*L#&U*JOZ*G!SV.AL]OHZFC5]
MI\R.K":8AM$/:EL-ZO(/C0Z@%7<!]FJ 2@^3&]Y,E5'%8XFH@6!ZI<"^LDS*
MC@,!>TF<0Q_7,[FZ:LWVF]S>%?JQC[(I>+IDJ5 X)A%,F SU=HYDD-(4PRA*
M4X)"@D7@E(%W89RY&61-0\%:3G DJ&/F\@54[6C- U8CTY8[3.[YP]T@^$T(
MOC#6M!F^W0J?I.Q>N;P?'?R#KG9ULJ_D=^O\7SM9=1_;:<(1;VAY]WY5_&C\
M=G$4AEP0!15E"40*IY#@((5!1N(P#F0<AE9^</>AYT8:>\G!7O0%. @/C/3
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MA6D0D-#M['@"J>=WSKSWUQR)N0#/] 9'BB_ 7G70G#7LCSWS=1ME(X'1'U0
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M[7T3FHK-5N_U[]]*5I6AK([C6!+%F,L,8H(#35)! G&2A9 )AG!, Q;'3A%
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MUI-HO(K?WH H"%,8QFX4U'_B["AJDNF8QC-9@H,2Q[G6M2+Z7RI5@-$%-,J
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M*9AH;1AG*IS6BP% =BP@?9XZV8HR0.7C)6;(8_IM]_<Y.!NZ+E=U[>&U:,N
M'G)+;_8^]'*)4Z1DH!3D 4,042$@P4D(I0R"),E"&G'F<B;00X;9K3V-"@MP
MI$3E9-A7PSW*TSU2Q.T4H<]LV1TUC#P'8Z\_WN%W/IP8 *#7$XP^<DQZS#$
MJ)=G(4,>Y9Y=^$WRW2;?/H41^YYO5W*)3+$PFE!(I8GE#"(.<8 PC 6F)-2V
M.1)6Y1C./7QN!%<)9<[\PN@G]C-HQ;5/,SQ!KYN7AF(R,N&XPN&4;WA)[]X)
MAR</G"SC\)(JQRF'%Z_IDW-XL6?X+T]G8CC?W)FJE68S;_K\5%VJ0QG%61QB
MR%1B=M:Q-FZ$IEE&$*8Q0A3;&3=^Q)D;#3R/1C8+;*,3,$HM 'L"YP.7:]5
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M".A.Q;Q^4'8C94>XNEC:]E'3T;:C<L]XW/7>?CMCXYC^A_%+_Z(-8VJB#,U
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MC+0])"G$L3)Y[))R;1"%%'.[LD)]17!Y_?\_\KZUN6T=R_:OX&.ZRICA P3
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MJ4/9B9\-,[G;O&'E]R_%YL=2*OGZEQ49^[#>1Z+<VIGD<KM4!RGW+,J%PI)
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MKF,:I\1I$[6GC;E1:1-'_-W8::?'H#26>G[N?8A>#E4(@-/8D])Q(7(/0P@
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M:MK"<P'CB$FD.$(%YVZE[2X/.C4OJ)6Y+?]3B3T#K>"F'M!F"VK974O569C
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MAA5C*A.I&U&='VQZY%3+:A;JZ[VT8-.(Z\9%/1C;\4\8W ;FG -@!S'!UTN
M.5/,92R"TDK/<*-2R66U7]*'Q1WNT4C/0NN;X*<F*6<SETKPK% 8$NT[0B1,
MM3*6)?I?A61YRJ(DL<J4N330U+S'YWD?;1AG*ZU]1$HON/U,$1*R@7EB%+3L
MXW-"H392_,US]-JRP;(1^+^%B:RQP:0G<J;W]M$B8VR4Z$:^6%T?*'U(_]#^
M73.$'EVN?U2=E&\X7^_H8O-,H+?:Z_NF7VQ2) E73,$(FT5[C#)(D&)0\4S&
M>98(B:Y++O(6;6JL?#(?QOR\_T6CWPRT&E:[>:V.LQ?Y?(V:5Z8G^5O>SE5\
M'7L./&6,;<KKTY^N1GW8Y"A_\5XW=>IJ6"\F5ET_@M\4\5%N#2G>J;=ZY')[
MM]MNMOH5WF\0SU62)CGC&<QRJ8F?) H2$]F?I(B2A!9)E#KUT;LTX-3HO)&W
MRIJJ) 8=D6?-<8P;.5_$W(YR0R(Y,)%>!Z(S+=HB$Y3L+@XZ*H790O"2F*SO
M\PS*7*UE^6WYMNK:QY_NUW2YH=PL7?Z@Y?+C:K-Y(Y6^1M/A'*<9RV2D74Z:
M%A!)+"&A,84IE87^?ZQ9*'<*TK0?>VHDU(@.6ME!1WA@I >_&?E_GP%6J6"<
M%,<@3@?#I#P7B.0IS+-J2F ,,FTL6*1$%IG^/%"1M]5,[U_//L\KFMZ/8"93
MIO%;98V%L08PGZ4I<5K9CK>VVW9LIQ?057:?HWOO8BV[R62@CV/@>27H=^$>
MHNN.6=B078?QQPWA=0?F**37XQ$>2:ZF;,OM4E/XLMH_HXO/^OUJ$U@HI6F4
M) 3&,<\ARN),\QS.88ZR)*>9R#,[U_?B2%.;;NJR0L^D!96X#EF.O<A>WE0.
MAM? #'06*H]V&?V8.:1^AL)NK-Q.Y]?-+5_3!HZ^A,S>^\?+N+11XUE*I=4-
MWM5:Z+=O:^-:Z2>;P[ZJVO['?7LLQ2,>RX)!C+BI7D<Q9#G&$%,2D82C"'.G
M;8-+ TZ-0I_+6Y].-STC/KIV);,&W7*K-B"40V_ 7H>B3QD4*VA"USGI'W3L
M0B96$)RH5&)WGV>\T&JY:OL[UV4YFVW2N<1%FI"H@#$Q?24+_1,316*R!G@B
M8Y4CYK1-<':DJ5%,/6W*]@1B*1VW(<]#:L<C08 :F$"Z,K:5?G]KQ#P?9NL>
M''0)BK"Q06='&S<TZ)+21Y%!%V_P3])<:@,]?9+;&[:I2D/,49)P6401%)EQ
M0&@J(1$HA2J)"T+BG,:)4X#YJ4&FQ@A[&>N.(7^W<GJD5Q[A:<<)UZ(T,!VX
M ^25]G@.@>!9C4<#C9ZT>$[54SF)9Z_U^^SWM2B;WBG=8.6YPG$N.4EADO("
MHD0D$*<HAU0["%$B>)H73O$J?8--C09:66?[7D'/8_'=V* 79CM6" 7>P.S@
MC9LS2=@ $I0L>@<<E31L5'])'E;W^)'(V]7#0UGG0]\LA2DLI9\LEZ:Y\ERB
MA&<RYQ#%J5Y9I%D&F>(2*HR30K&L(%*Z<$C/6%.CD(ZH5403[PKKQA]]"-O1
M1R#<!F:/EY"]M8+,F3HLP C*''WCC4H<%HJ_Y V;6_QHXX;SW<.NBM6MEN&F
M-NM:?M>+F?*'K-<VYHRJZN]F#F%55L0R8@GD>E4"$2$$TL2T]8@(8H9+.'=R
M1QS'GQJ]=,0']3;&,P7V*_7F\+9I?^@<U.!J)3LZ&A#[@2DJ/.S.].4)7E!*
M<Y5A5)KS!.@E]?D^QHT.A2SG[S6K;I_>/\CU-\VN?ZQ7/[??S6AT^30G/(M$
MS@E$4D:FA(N S"S*<ID1E&>Q<:=L:._".%.CMUI4T,H*:F%!(ZT=AUV"MI^K
M @(V,"=Y8F5-/)9(G""8C>3_[=OJQW_73ZBXY9_(_ CK'RM"N?3L48C#4L&6
M(&PO]_2+%HO53U/+XL-J_6ZU8UNUTZLV;B)'-U\DE^4/DQ!:1_5LYYF462Z4
MA'J9A2%B.86$D@1B0?.X$$C()'5KB^XTOM57,&I?]+WX56-T7H=*FUA"UT67
MFQTL_9[@V([F]50R@H.0,_ <Z28HW<R(LR:8,& XNA=P83T>)PG&]7=\P#GR
M=KP>XA$OR+<K)M<:Y;1;Z3JCHLA2Q6""30)Z5E0UZS*81HC(-(M2BJS<G/-#
M3,W#::0$1DROLN$]:/:S41B,!J:<(>%QB .\&J:Q @ ]X'(+ >Q%HB_V[_2-
MXP7]]0K^+-JO_TIWKFN;"6E*_;)ZHHOMTQ?3C6$S5P5-$<9<3S(IA4@SG?;:
M1 HS@7*1B(3$C#FD?_2-Y>&AC9'GL6^+9GR'=2TP6%<2VW_>9_&]S']7P34.
M PX+D3T'AH!J)!;T@<R)!2]AT<.#9V\=C0DO"=_EPHO7>F_ZKW=2[+N"R\TG
M+7>SALJE2*E$%$HD$$0I0I D&,&,R9@)I(2&U'&'_^Q@4_,&&UG;_>-*VADX
MR.N\:W\>9NLM^B#@#;\R]</-9]O](B"A]]C/#SCVAOI%U4_LGE^^Y\I@Q7]?
MEUOY;O5S.2=Q4NB5HX0%+CA$+).0,8UJ1GA,8EZH0B&O4,7]$%,CC+V$H!(1
M"BVC9XSB 48[:K@.G($)P0D7_]#$(]6'"4P\#/,Z88E':IX-2CR^\LH2A70I
MGOUY?>C7VK:X,S_/*2LP+A($*3(U#N(T@D3D^OM/99Y*DF&96'6*\15@:L3P
MO%Z2":-Y]C=PW>E5/0.M)M4?/2OXV5KJ\JIL:/P'YI[I0N]95'$ $[Q*L<4P
MIO OQ.B(HVV!1MO'OD[A1D>ESQ9T='V.=Z''<BG%&[G4/VQ-FN^+^@GO?_'O
MIH7\%SWXV^JG37/Q'5N4=<[>G$C*TX(FD G3]I0G&!*9I)#H>0C'*F$J%VZ%
MMX/(Y?*!CE.CNU$+-*)6R>JS_9\.DL_ Z0(E"_JR0(ES=<< YK;SET<WX<#3
MW(BV\RGG& [KT)4< T@V=A''<&">J-\8\.'>J0LF>[)ZU,U2O']X7*R>I.S(
MM#DT/XQI+")64(@BE&EN9YKE$6*0*%DPRA0C<>&8RV ]^-06&5W9*^^JE?X9
M*9CNB+X-*IU,8\?#0P$^,-T&Q=HG6<(9M-#9$_8"C)U.X0S-B?P*]V>X[ZS\
ML5@QNO@D=UJ)E=C5,_"GA[K!A/:I_UJ6VR8X I,TYIA@&"G"(&)<:H:+,>29
MJ0YA0HY3ZU80]L-.C>!JR<$+T<%OG_[\'>S%!T9^C[ 4!VM<WC,9!N.!.6TJ
M\-KOBPP#\TB[(2'A=MH%<4>M9^_#X6&C[7BX*]C=Y_"XV[.WL%*2;_=Y*_?T
ME_&JOTBC8;DHZW%72R'%3E_&%FU9D=N'1UJNS1OZL0JAGN<YC7"<Q9!'YJ -
M1=K_E22'D9XU$I&36*1.?=E#"3:U^6.O5^=D&AC5P'/=JK/J@W:';@@'!<%'
MC^CU8 :W<ZU?PXP#3U'A+3@S11!XT*"$T+B';3(<2KAQFPP'AO2HR7#HYWN7
MGWQ<;>CBC_5J]_AV03>;4I6\7H?\*C=S3B5C6#'(E.(FW3J&% D"J42Q0#%+
MD%OI^ OC38V_6W%!)2]X+C#XVXCL7GJR%W#+O>1P, Z]2WP-@CYE)VUP"5UU
MLG?,L8M.V@!PHN:DU6U^)-.7-_W9_$6UZ5%=]7FUV:[EMEQ+0W'=_8\;\9^[
MNA-[7:]<4^5S.?>_/Y0AD)&4:<$(S%E20%0@4W<\3V%*S?_R/..(N[#7:RDR
M-5JT*'G0P%'M5-:7/T?D^:[E#!RTWK<8> E,YYJ-?RF+5WL9[9C]7^$5&WC*
M./5V_5:C\'N367KZ[/'R>S,#5.D/)&PECM<V6=#9[-64&76:?&V3O9Q_7UT>
M][.$#VLI[]=4R/]_M=1#?2NK18P66S]?RS_/$B5R+@L81\@DMS$&J8HRR&,J
MLD@*Q)%5++;%6%.;'HVXH)(7&(%!+7&U<["7V7X?^Q+0E\\& L(W,/6/BYS]
MMG] !$?:Z[\*2:?-?4ML>G;T+SUAM&U\2U6Z>_>VM[B7@[K9B5*C_DD;>9YC
MHK)8*4B3'$$DXAR25'-KH5<P>FV3(T2LR/3%<Z=&G(UHP,AF7]RI"U0_&5ZA
M_L#$9Z6Y4ZFF$WIZEV;J/FNT4DPG%.B67CKU:_>/[.WJAUQ;EF8_NGY"[T\E
M5] R[&>U]7Z+GC]MM/?HI!+=-^GT!>&WNDY[Y8<- A(SD10205E4V8L(029R
M[38GF$8\XHB*8+M5%V29VL1@L>%T9O$_T$[1)5M>O]D3T$*OL%\3TCA!-V0L
M81UM3^62/)/9%K$$SF5GP_:1[IL3-J>K7^1VMU[>KSZO5S]*L\,RUPR;8L0C
M6)CT491H?YN@N( )IY(3HFC.K"I/>$LP-=JU#WZH50';%7ALE;%?I_M9Z_*^
MQ^ VF$SLR2O ;[]Y,K@91MI2&<8<3GLM5T'9LP/C]]S1]F6N4KN[6W/=@_R6
M!$WAI+8E8(H*D9D&!B0O&$0I3R%1^H]8XI3A D>,9BY>_O/'3VT&::1KFRNZ
M.> OD+/SJ?WQ&)C-6RC>7X#"V=T]K7%0#_;%$*,ZI:?5>^EGGKG*-PM\7?Z@
M-4^8E//ZS&RU?2<WY;>E23N_V?Q#BF]5^\7]!1]+RC2);)]NMA]HN?XWNMC)
M.9,R3V+%8$8H@:@H<DACBF"2$!%'*8N*U*DD43C1ID85!\U 1W)3Q10<E -T
M QKUNE?-P%[#&:!;8)0$E9:N^>#!#&_'5J]CSH&9;F1+>F2'AP8]<(IX,/%&
MSA,/#>MQLGCP$?PFB/NUI)O=^NGK=L7_]]?O5'\]\R+E663XO4!%9G)BN&;Z
M+(4YQ2FE:904=KL'/6-,C;);$4$EXPS44KI1[BDH[;CS2H &)D%';)Q)K$?[
MH&QT:IQ1::5'T9?\T'?I-><Y=;W*ED=*N;DW71 .A0<XDB(C3,$H1P5$2G"(
MB5"F^%R:Q7&:R21R/[FY,.K4R* Y!JBE!AVQP=^5X,"["(2=$5R.7 )".\[A
MRG6H>IZ@6*(TP%G)I9%?X53$$HS3YQ^V-[N?=-PL%M40!LZJJ^^FK Y1FLSV
M2*J"2$9@(LUNDXPQ))A)&&51S@7)9,R)[9%&_U!3HR,M;9-X8.0%78'MM\8O
MH'OY""(<9@/S3 ]<'K47+N!F?W80#K^1#@E\7CNG(P [1'KV^B\\8+1-?3M%
MNKOWEG>XD^A7O7JLSI^7VZ;9E>F*OEJ4IL'Q/CHLBG)6(,5@%$6:2V.!(<69
M@E0J19*8RA1;>7G6(TZ-4CM"@X/4H!7;)OS,$_K+1!L<T('Y]O6PM"??X)B.
MQ,$!L'6B9"><>IC9[CFC$;236EV>=KO1G:Z/:T96L\%:"KH4[S=;[5N7F^]2
MF-\T)2,_O[F;%RR+DR3CIK\6@2A-,T@8S6'!4L$%BXLHH;;\[2?"U C]=!IE
MJTE=9?"@2_5KT&@SJ_]TL]E(ET94GJ:[S/_#&V3P0Y-K;/'F;G ;V,\;P]MB
MI(ED,)LX32_7P=DSWW@^>+0)Z#K%NS/2E4]RGZ+N?Z[^0]+U.[F@3U*\6].?
M]W+]\'%%E\T2F&.A$,L2*'(F()(\ASCC>D41(:EBI&AAWZ_DTF!3FW:TO- (
M#!J)@1$9&)F!$=ICO^$BW)<GD) @#GVT-#Y^]N0?$L>1:/YJ/)WHW!:@'N*^
M^(C1*-I6F2X96]_C=V3W46J?5-X]RC4UZXZ/DFI":T, _EJ*<E,M2:1X_XOK
M2V\>S)_F0L:8$Y1 7!08(BX$I*F4,!&Y7A@0+B53#KUXKQ+&ZA,9OUEOK<L,
M[+4!E3K/(G:Z*H%:)U KY7;DYV=$NR/ X6PR#OT/9 ?G0\*K< QZ:.@GR:B'
MB%>!]?)0\;J'A>J,I-?^NX?':@?^KXT4;^F"5[6+E]^.&G28*/L[U:UR?[OD
M)EA#SC,D6!4@2Y#VAE&F.&2%*J! *(NR1*4BEVX!LH/(.34?^OTOR7=5B.67
M0TVU:@%:9:2L%'C6,*)5X]KV2&%L;L?3$[#DZ^SY'+0$1DW0T7-_:;>_DI_%
M S15"FJ/@=LLA9'UE1LO!07\<BNFL,-Y-F>BF^]SE62$JIS!3)JF2X4BD"2(
M0\ZU9UX4A'+E5!K!/'1JC&YD<FR.9*"QXU)7A0<FOEY=W9L3=90+VW3(/'C<
M9D(=58Z:!'5_Y]-6>?E0+EGY3BY7^@>S:OQ N496?\XWZ[79]*S"Y9L='X5,
M#\N(:$=,"8ABA"$E2)C*WRF-42H1LNISYC[TU#[,5GK0$1_LY0==!3RVWAS-
M<GDC<SBP!R:%2>'LTBIY*+Q':Y)LC7NHIL@^B/6V0W9ZX(B-D'T4?=X"V>L)
M?J[6!SW DI=T<4B>JGH2B#1.,$5Z=9X*!I&0.<2$1%!DE&.&6"H)=O&^SHPS
M-=[?B]G)3_3J^7 .5SO7+0!: Q.W#U#.3MX%&(+Z?>?&&M45O*#P2^_PTN5^
ME/#U^VJ]-<<S[R3;?M3+P]NM?-C,BT1$BC$!E9($HBPU_6\U-\1I*E3*9<Y3
MITV[T\-,C1 J*>'6G L:.<'?1E)0B>K("&=@M2.$Z\$:F ^\<'(FA'X8@O+!
MF:%&I8-^=5^RP86K?;=B'LLM753'#8>=GWVJ48'R%&$"B4P+B$BD]$^)U/Y"
MP1F/L$J%57BEU6A3HX::?65]$M?9G'7=T.D#V':G)Q!L@V\!57(>(6:QMO/8
M(++ )/#.4=^((V\I62A_O-=D<Y,?C7S6K]#W9\]]MY.WRZ^F"I<PD2%S2A-)
MJ, P*G@*$<\$)%E$(2.4IG'&*)%.5')QQ*G122MP][N8@0^[[6XMP9_ELGS8
M/8#/]*DIF:*U >42W/]< :.-8P6&R_:P8YZ@* _,/B< GIEZ?4QJ6$LQJW T
M@(8C(6MX@A+1Y5%')2-K$%X2DOV-GJ34?$QWZEWYHQ1R*3;S+-6O49YB&(O(
MK'*0A$P(!7F4Y"2."H$E]H@).S'41".^S(D#$*V0X%%_&6"U!(_Z!95K$P&_
M,84V'-GF!-!*%"J*M:\8Y43S/8I32#C!D&<T$BR-4F(7#'TMPF,R?".B.;??
M"WD]DI9,?1T^0W.S$S3N/'Q>^;#,>V*<<;GVO*)'[-ISJ1^?OMEM]*ISLWF[
M>F!FWUH3]M>M?.RD;;_7/VV?;I?Z:Y.;[6V;D2'W-;KB.2T2G!#,($X2IOW
MA$*:9@ED.&(RC0J&E1,OA!!J:D32Z@0Z2LV 4:M;?& &:LU JYKQ%UOE9M[U
M$H-8V8ZSQK;=P"0WEMF<Z3$DSD'Y-(A@HQ)P2"A?,G;09[L'DWS40]1N^%>Y
MW2ZJ0\@ODLORAQ1_T'(Y9R31B_4<0U8@#!&-.,1,,%@4:<;S(B]2IFS#1RX-
M-C5*/L@+#@*#5N(9,#+;!RY<A+J?/T,#.# OCHR=?9A'2 Q'"NRX"DNGB Y;
M<'IB."X^8K2H#5MENG$:UO=XGKRL'AX,P>O5=G,8D!.6TKQ0,,EP A%.$*19
M2F'"(I9%B9#:078Z;7DYPM1(M1:PKJ;J&/YU'D7+(Y5KL!GZ&,4)%O>3DW.J
MASTM.1IEW!.2<TH>G8J<O=#OLSZTPOJ@A7J[,H5R=N7R6Y/9M5HV+;+VW4KD
MYH/^8_EM.4_SF$I52--/6T&4)MK3BD4*<1%G,D:28^IT1.(ORM2(XEGK.6"L
M#0[J@(,^;5.Z0S,?4[6C4<J-6*ZPHQT#C6.=@:EJ6,,X4]OUF ;EP"O$&94L
MKX?M):L&>*)G<>\V@?8@P3PM&"-,$4A34P<@(1R2).6PB'"6J!P1Q++Y=F7.
MQJV^W!-C.!'F?J3AOLM#'GG9?*$+\X4ZUN@^@27)99ZD2L(BT],38E)"DE$,
M4R9(A$2<LIC/?\@U6UD71K\.S>Y8(^))%Q4;26%.F-?R<;7>5J6[-_);?U2]
M-=)VL\B5Z T\/1Q@>S91!"QJ?E[]L"7,3XPS;L'R\XH>E2?ON?1*4GU>E: I
M@3Y'49RK2.00IU%6)Q0PQ1!,%,,JQRS!B=.ZM7^XJ?FF?24[&I$]R> TVHZ\
M<#6&HU&$.WS^=-&+RC#,<7K(UR&17O7/\DG_7=[Y2>56/_2'%+?+K7XQ2CV+
MUA5(;Q[TI%K^5^4N-CT 35#0_<_57$0REW&2PB+-(HBB1$'"(@$S11/)<,13
MZI0[[B7%U(BH"27L"MPVIK2(?0MH'3N&&ASS@8FKEA]6"H"#!G7YW%F%/#?^
M85>9(6(0K\(Q=(J5AR1C)V#Y@W4B/>N*A_GQ9=,*K^V.IQ]?I1WR*,)Q'%.8
MR52[8)G^B62:$"G5"UPLN$*954^8_F&FQGAMK\F.F%[)G&= M>.QZZ$:F*@\
M4'(FH7X0@K+,F:%&I9%^=5_RQ(6K_8C@AO/=@ZG<(T7=CVKU\+B6WS73[%NA
M5]MO]:Y:[:SQI_LU76X6M0SB/W>;K=FL^"2W=^J>_IKC+$TC3K1'Q6D,$='X
MTYRF)LI#$L&I7L@Q%Q890,:I45 C.^"-\&![D![0O?AN?#2$;6-MR B3!,:H
M,G!FTGN+%%*9D)QHC[E@F=O&W2M;=YR-OXZ230^H9VH^W]?:GVB 5EO041<<
M])T!K;&)A=8ZO_ZK83?/O;*Y!YXD7]'.SI/M@)8(.E,/(>>HT_R 0+_T$88<
MRK=,!%W+-]34".Q4 )QCB65$,KV^2*2$*!(4ZI6'A+D)54(,%[FRJB'6/\S4
MIODJ/@0R(R;@W9*<LE[<N9:*. FM'0]?#]C 5%H)V&#5)*%T"TYI3M1?G\E"
M>W\!.X_R$7W0!"X?<7*HD<M']*E[7#ZB]VH_DO@B36$:OMU5Q:N6XHNL*.R&
M;\L?55/<=^6&+U:;W;K3U9EH3Y2DE$-9B!RB!&M7E)K6VE%"%<&1Z;SM0B$^
M0DR-8)[I4'4A:K0 !S7 00_PMW?G;2^3V5'3T(88F+@&L8$SB5T#8E"*\Q)D
M5 *\!JJ7]'C5LSS+[Y>;Q]6&+OY8KW:/VL=;[(39)C*5_JMX*>T*MN%2M\L?
M>NI<K?>GP++(D"SB&*HB1J;75 099AGD,:,(\2*/8J=8T2MDF1J5MJJ 2I<9
MV&L#NNH<@A/-%8U&GB?VUQC2CEE',L_ !#NH9=QKWU^/:=CZ]E?(,VX-^^N!
M.ZI3'^"1_K7H-=V;_YCLRA]T8<+W;K9OZ7K]I&6HTBKG5. 8*Y+"/),1-)6R
M(1$\@PC3E/"8IH@*M]U3JW&GMQ]:E0\QKE&U@I,'R=W+W%]&G44Q*A!6,)>B
M@(C*!&(6,2BB-&-2ZJDN=5HH!,=\K!X"HR%N-QL%QW'@>6</8?5#1^09H%O0
M2ATZZ]X)I> ]#BZ//'H3!&LP3G5)L+_9MQ?6XUKRLMZ)2_(\Q7&L(,UP#%&2
MQQ GFOC31,589@6.DMRM@=7AX5/CEZYLKJVD.I!9^K&>0 SMF-I@X-%<Z5C9
MP!V1.@.,W,;H6+7CWD,GKO'[..\E_[Y<+5;?GJH-S)?15DWF+\T$CO0_4,2<
MZS5Q3+231A/M+HBD("0OI%M4J-6H4_N<#T+#2NJCT$371AMN-K"C@>#(#LP/
M(4!UI@\GD(+RBMW(HQ*.$Q@OF<CM9O?*.9]6>DVZV4I1U4ZD/^E:;.0ON>;E
M1G-@R>6<Y"K#*.*0DT*O9%+3["S%$22<T9@1S'-AE2)C-=K4*.E_[NBB5*7^
M;%9-"\167%#):U_[Y3+0_?P3'+Z!>4?+"FMAZ[*<H!9W0/SLB^<$Q7&DZCE7
MXNE4/\<:GYX".I>?,5H%'6MUNB5T[&_R] M--\K=^JE;_T7Q*!<93Z'**(6(
M9A'$,1:P('DDE4Q1YK9V.S'&U BV%?&J2CJGL+3TYJY#:&C?S1$<=S_MO/IA
MO;(3XXSK@YU7],CCZKG4I\UE5>:PZG^TN5-?M:S5(]/(0-56S\IEGD=Y HEB
M.40BBR&+%8>$QEQ%+,5YBNR;6UX><&HDT)%Y!FA5:7DO-TBC&3"BN_16M,#\
MLK<5&LF!R<(*1*].E19HNO2G#(OJ:%TIKWE%'?M1VB/4VX72XC$C]IZT5^IY
MQTF'^SQ[+;3] RK&_UCJ 47U-M6_D%JW>4P)5S0GD$?F$+6@>A$<"0$Q%SB)
M!68D=:H383'FU$AZ+W+MC9AJ!WNIP4%L\%E_$%7 IF/[  LKV/ET@;$=F+;#
MP>K>>L >J+"M""S&';<U@3T01ZT*'&YU]QY-<>P?YH1PI1[H^G_+;16:7B]&
MYZ3("GV'7BTFIIX55CFD48%@P?.<J"B.8FRU6KPTT-2(J"HS7PEK9N%:7%#'
M[-<"V_LVO?A>]A!#H38PQ8P%F+T3& JXD9P_?P"='#\;5'H<OM[;1W/T;)3H
M.GA6UP?L['>C-$=]*-7V>]5++H\0*Q*<05;D'*(D%?HG3:(LIS0IE(RCY/K>
M?L_'G!J?>G3WN_^NIS9JM K0V^^%12R=O+ X#^WD7>KO5V%95]CY4/X(Z>/9
MXS1\H[\7X[Y^J[_30%@U^SMSJV?"*O\NQ6XA]0+W9*I;E>%1FII,E9OYU[+<
M;FX,138Y'D_WIH+G(><)X:A07,80TXA"9*KK,($4C)4@6&5%(I1339W \DV-
M 5OUJEV=3@IH5\49."C9[,=7:H)*SS;-Z@G\7:D*O'/<0K\*=G3ZB@8>F'HO
MIO2>-.O,RZ#N6;_#P!XV73BPC./F&0\#\%&"\D##7-/'H:I,;KR+>:2*+$J+
M&"98(3T;R R2 E.H5(IBSAG#L71OSK!__M38O%NHOW*O?+HG'-"S(] K,!F8
M .WA\.Q9<*3T (T(#F.\0G>!(P5/MPPXOLQ]P^\M75)!ZZ9-XNV"E@^;.<,9
MSEBJ/]J4F-XJ5"]68ZQ_RG&:LBPE" O;?;X3SY_:YUN+. .;6DC *RGMMZA.
M07AY*^]*8 ;^AH? Q'ZW[DIL1MJD<\3(:6>N!X&>#;E3=XVV#]<C<G?[K>^R
M(2KN?]6O0>5XWZD/Y9(N>4D7GU=-B]!?6U,T2GM"'\O-=BY5P0E)(Y@AE4 4
M2029B@E4+(TBGD<)CN-PM?GM!9L:88Y<Q=_!@G:NTVO896"^MC")Z:[<:&:V
M'?:Z@58Y\/=!/?!^J2FT3B(/N/P,C?R(W0<<A)M0GP)W2-TZ&G@\WS?E=%W^
MT'+\D)]6YN%T<?.PVIGB+H(*F6$),8]S[:+&&:09XU#%1<Q08GJ!.NT\GAMH
M:B1\D-,4B:LE!;6HKIFI9Y"U(],0> U,CCY0>22P]N,0.)GUS& C)[;VJWR<
MY'KA>O?EZ[LF&$8OA:O\-)/=7I?X7"Q6/S4?R=OE=DW?+[>:L^9%FC%$,PYC
MD^2@E[,"XC@K3)L[+%&BB418![ XC3P]\FA"P+3T;1..O0)@KX&I*:1U@+)2
MPG[UYV:5RVOEP; >G'@F!+/]\GLPN$=:F(>%W6G=[@5=SXK>[7FCK?6]U.SN
M O@]P-=U5.52BC=RJ7_8?M:O2O/CX7B]^8OF]"+/I&)Q 2.E_4@4"PP9)BFD
MG$5Q&G/M<4;SI?QF2A[>NSB63F)8?5>D_JZ.A!GTVS):@$948/28[?_4C39I
ME?$X$7&UF*VG&MX H\TC04'W<&Z]H OL\[K),+(K[ 70L8?L]QAWQ_DFB>+X
MX[9\-(.T-6%D&B-9F,(+#$-4Q DDDG/-?HG(8Y3G!;(NO'#B^5-S@HV$X./]
M[>?J>_)(5#N%X65G]DID!J::04"Q=SVO!&<D!],5)"<7L@>"'D?QU%VCN8,]
M(G>=OK[+0KEVYI^Z4LWY]A]_T')9M0UG:89R%:>0Q"R"B%!SY(T(9)&(A7X+
M6!%9I4&'$6=J_'C:ZZC>^%JE"ZU]C%Z7FI@/855?;W H6[V*<QC63 $<1A]T
M!_8?G41Z97?2![[+WJ774SUS8YI\COO5#:\RK#^O5X]RO7TR,FQOEL)4*WTT
ME\RUMTF*A M(E"EE7%"]]LX+##&2BF!:R%B@=@%N1\SV@WLLNP>FX389H"H!
M\-C(/0./1O*J4*]L9:_^5"[UW& ..'8;"38KM?WIGAEM;RH[K@T,_T@I-(W0
M)FVF$1M\WL-?23ZK$-\+'S")QAFPL+DT]L./FU+C#,M19HW[$SR#DDQCNO:T
MO)2;MH4%88A*I%+(>:37V%$:0<Q3"O,LDZ)(F634J:[#F7&FYDO6;2+KQJ];
ML#C(ZQ@H= 95.QH*@-7 G%/#U!%Q@%8>%U (&U)S9JQQ(V3Z%3X*>+EPN1\?
M[ \XJOJJY3]WLFJ;KE>;&9)48Q>)*E.B@%10"16+,(X35E#N5(;Y]#!38X/.
M8=RC]F@HKSL.[&7V:DQ_!F$[:K@>MX&9X5K(G&FB'Y&@+'%FJ%%)HE_=EQQQ
MX6K/[CI5^YYOFFOT3YM2-.&7;Y[N]?.J=[G -%5%RF$AF6:+O(@AR5/3EYR:
M.#>%$7?J.7]QQ*D1QT%@\$QBP)Z D=F+."[C;L<A0=$<F$ZN!=*]P8LM.&&;
MNUP<==S&+K8@'#5UL;[1_210KX"XE&+S08O;+H\^K-:W537BZD]Z652MENJP
MWLV=>JM73+1<[DO%:R]IK@AE!<LEQ((SB+)8+VQ,9>&"\ QG-,X%)G:;-N&$
MFN!F3J,7,"\'^.VQW6-0J_7OH#QH5TWNM*.?V?SAM89@VU'1_F ND)TO'W".
M:+NQ*N;]JQO-_@!V?..-=&8[GA&=3GO#XMUS0!QHH-'.E,,"TSV&#OSD4"?7
M9HY?EVQ7#?GFZ?W#XV+U9&IU)TBAE)AVQ;F>6!5AD(J(ZGFV2#(L8YG%R76'
MU&=&GIKS;W'0^4P3X\NVNEQ[ 'W..+YGS0$@?_UC97>T YPC7T!NX"/C<Z._
M\NGP!5 N'P1?>D HDKOA>K+?5=WBCR(;YYP4,B<Y@8Q0;%+Y"*1,%% (D1>Q
M(EG$G#9#W8;_UZ"[C@8G H"OI;E>\_AR72C07X7P//$.0'0VL W,=KTBO#+E
MV<!SF?>LGN*^I_+^E^0[D^CX16Z;9@*=<%A$<YX6,H8JI@*B-,N@?CD)1#@3
M.9$TB[%5RO+%D:9&:7MAP7HO;17(XA%GW _QY5V*8, -3$OC86:_21 ,NY'6
M_E=@Z+28M\*E9XW>?_]H2V\K-;HK:KL;O&CTT/YNI;;?I:+ENJ[:W93P-N_(
MZN%!>ZVFSJ'V8K]+H=E\I;ZMZ7([+U@>%QDK]&I9,)/G'4.2,=/M2B2<I$R0
M-'.@VNNDF2 ==SHYFGTN+2\P2K4EY_<EZ/68H-:L:0:I?S 7&^W,[RO]G(CH
M2L-:$?QXYAI^$OB7M933M#*>Q<:;>L:QG.M$%0;I_LGLRC'&G/#"P/%B4@ST
M4+_-EP_ELMS*CWI6/FKB??.P6F_+_Z)UE293-%A^DK^V]S_EXH?\T\BQF2.1
M%AR1'')L:J50)2'#*8),)%F<<)DQ:E4$-(PX4YLZFV857<E!(_JL[JIPMW2,
MNK_27G:[,^-98> 9L58$5IJ @RIMN0^C0%5AO:N5A66<]VW" !IT'^=*D4;=
MUPD#W\M]GD!/]6RM<;(@>Z<#P.;-T^&:Y@"RJLU^]UAMO_]AR']SN_PLU^5*
M_+LLOWW7;_+-#[FFWV0[JWRN.M GBF4TRQ$D15I E),$XCQ/8<8364B21'GF
MU+][1-FGQNCGVG!T>S>8,ZZ3[1T, C/08# #-0J@7((:AQEHD0 -%&#O%U9@
M.';L&/$-LYM6)OK>##P'V;PRF_'?&?>F(.-;+VS#D!'E'[>9R/B&.6HT\@HB
M##3O7A#T;K?=:%]!E,MOIO98N=R4W,3YR[D4B8HR%$.J%T409<+D(Q,&LYQ)
MQB45L6-SJZ$D_;]Y3NTH71?NJ]2NZOJ%GCZ]7Y1 D^48YI_ U#BHY<-/@M=:
M9=PISUO::4UPUX+N/)U=/:#[*=<7666BFZ&4:>_XSQU=:W96*U,*4P^D_[PH
M52E%)RJYC22(E9"(YWI2(JGIU,,@B;"$(N4HX9SF>6$5&WJ=&%.;=CJ:S$"E
M"VB4 7MMP%Z=;K"WQYGZ%=:[?(8UCDT&G@O^5<QA?U UCEE&.J$:TCQ.AU+7
MH]IS&G7%PT<[AKH>@.[Y4X"GN<]E_X,N]3!/&O[HTVHK-\VGE:(8$4(5) CI
M>4K%2J^EM%<CLU3Q @N6%-9A&*>'F-H<U$@)C)B@DM.#S,Z@>7G>N!ZC@>>$
M(>&QY_'K81J)HWW@<N+>?B1Z>/7,C:-Q9K_@73Z\<*5/Z\S-]P^:2V\?M-6V
M=ZJM:;]OSMF<+S6!Q7-<,$Z(R"#)20$1+\QA.HIA+EF6\AQC9=<5UV/LJ;'C
MOD.#2;9\7,M'6IK*=57?V*WI:NK2:=+-"I?)<T!L!V95(SE06G105K*;J"'1
M0GV %\A: ? ;JU6PK,_J [=+T\_!8!^M(6AH^!U[AGH!V-M/U.V)(_8:]5+U
M>1]2OT>XSQ-_5B%?U8Y2M96T.30[V6QV#_7&TO-^[/."Q80*ED,>%=IA3C"%
ME&4%3#.>$AG'."7*=J[P&']J\T6M0K-/3"LE9E7@9+VI3 ]Z@+\K38!1!52Z
M.#B4/I:Z/)\,C/_ <\J$H;>?6P8VP4CSRS"F<)ICK@"R9Y[Q>>IH<\T5*G?G
MFVL>XUM/SH06?S6AQ=69QN96#R3%G'-:(%1$$%$D(6(1AQ1+!5F":)YQQ?/,
M*;+WS#A3FT-J,4$EYZP^>-2?3RVK:\&XT\#:'?\&@&OH980/4AX5X7IQ"%P'
M[O18(U=_ZU7XN.9;_^6>43+\NQ2[A;Q3;[^;,\_-[?(#+=?5&>:=.O0#>#'5
M1CF)XXQ**&F60T28@E2E$:09PIC15&!LM8%[G1A3HY16"[/0:_0P 7Q&DSH\
MP?RB4S+%VT.ZTGJ6<2F#VV3HH),!S>$>3W(5FF&#1?Q$&3<2Y"JXCL(\KGN:
M9X>3=;.%<.P9*!PAF>;:T2J*&")%,20Y55#0E*HB%YQ'L0M]GA]J:A2YE_2Y
M.^'E=_4 ;,=P86 ;F,4\$7/O,7(1C+ ]1<X/-VX/D8MJ'_4,N7R'9WFL<O.X
MVM#%'^O5[O%VR1<[$U>F_Y97Y7[U '>/3:7?JBE!TXF@IJYYGB6Y+ B!B4P4
M1#'*(!8$P5CJOY5Y(2+J5A?P&FFF1CNM,J#2QH2--OJ KD)@K]$,U*TW]J7M
M+G3=&,">=A0VFI4&9KFA#>1>@"L$L&'K<5TET;CEN4* =U2M*\A#_:CYS6Y3
M+N5FHQ?AK%Q68WR1?/5M6?Z7%+="#U.JDAZR2NMF4N)F*3J=8ZJ-/7.B)$S=
ML7,9J?,L1AC%,H5YPC.(>,8AX8K"! N64AK%F4CF/^2:K6RI?$3I72BEJ\-P
MS-(J#SK:S\!!?] %H%T)MA!4 0D=$$"#@B&H%H<S2>>.K:S&?,/LII:)OC4#
M3T33>UV<IZY7,%S0B6Y,^4>=%E_!,"\GT=<0P3U$XLW7__5%/J[66R/)5_FM
M2BQMPCEY*J1,XABR--7KG%R:'!?)(68T3PDJ$E58[9U<&&=J*Q@M*CC("EIA
M[4_4^S"]'+00"*FAR?LT2!ZQQ'UHV<<9!$)MI'@"UU?,*5+  HJ>B("^NT<[
M^;=0H7O";W.Y&S4*6<[?:X;>/MT(L38LKG^\6]^O?B[GA"2$(91 0DD.4<%B
M2.)8085I6A2,"Q1918CUC#$U2JS%!(V<,V DU3@"(ZO=E]X':#\G!H)I8#[T
M0LCZL[; X(1?N)'\OWU;_?CO^N[*)?PG,C_"^L?J@^][[B@?NX5B[8=N<ZG?
MEL,?M%QN/JZT*[6Y6[[_9?J][<K-=\,B)CJ5;>>"\#PBB)F=@00B%160FKU?
MRBB.45KDBF"7'=^+(TZ- (S X#<C\>^@*KC7%=D<[AJAW9;AEU&W6SP'Q7)@
MEK@.1N?EJ34T01>5ET<==2EH#<++!9S]C>[+KD^K'Y5[DD1IULV@DSDB!<$4
MQDDD(,(*0^UD9!"17))(TTV"K#.5SHPQ-6IIQ01&3N^,Q'. 7EYO!8!I8-88
M%B'[-58 I$9:7WDAYK3(NH!%SP+KW)VC+:[^#WMOW]NVKJ6/?A4"/V!N-Q">
MT0LED7?^2M_.]$YW4[39=S#8?QA\33WCV#FVT]W,I[^D)-MR8LLD12HZP 7.
MZ4X;25SKH?1P<7&]7!"]N[&Z=.G02,B^)C";3YITN;;S;I1-I!U3)4X4([ L
MD&EAI8TUG+$2TI1@$U^MJLSI4#Z&D%.CWF[87G^[I3J<K]'47#Q&G&7 =\/.
MD'SM&8]][G^^K>!?\^V/"R_ \?R/'\H9?DHB!7H&%/25PD##0WT^2#3"6$/7
MI%T!\UVOLK9/[3-*(4K(0BH%N4CT<L-+#$FN*LA(FF=89BRMG%)Y',>?\DJR
MKP"_9YI6!=^5P&Y&7$D^.,Z1^=L*XI'8V F[2$1K)\,K<:@30.?IT>TQ :WQ
M)JQK=?^PEC_D<C/_*9OL?.,.>?;=I;(HB2@(3,J\@"@I$*22(LA91I)<966%
MG7K'#I1GRLS8-;&:H,HCE4"CT\Y!&,64=IC8 59SG.D:D6"CS508$]@=W_C6
MKH-,KV_8N@-H9<-Z/-:/M(_;/=[JAUS_FF]FE"HI!,*0<:*M4L)+;94*!K%,
M:9XD@E0"N7#QZ6&F1K$'*9N-J9$3_&DD=63,,ZC:$>%PK"+SFP],SG35CT)0
M%CHSU*CDTJ_N<\ZX<+5GP#S5S^+R^P\IMY_-_)C"%N:U+3#-*)$YY%7)())4
M0I:JTMAI2+ TJ9AP.K0^-]#4Z*"5$]2"@IVD7H1P%EL[2@B!6&12\ /+/5#Z
M A)AHYK/#39N"/(%E5_$"U^ZWKL6S7-KQ)SD=&HY2582A2I(BC2#J,JIL1DP
MS#*45H(G98:I8U&:W@&G1A=]AKT17%OWOCNPB]C;T4A(1"/321@P?2K:6"$4
MNK1-_Z!CU[BQ@N!$L1N[^X9ZE[[_6*VWMW)];T)GZLW0C.055HIDD&2*0D1Q
M :G0?Z4<RX2C-!%Y[N<Z>CG8U&BGZVVHI85ZU/LZ *SU)WB[>TX@[>K+&8;?
MB(X:5^@&^%_.8Q+)N7)BP%?RG)Q7_;Q;I.<>S[;:NT/ WR7=/#;[J(]K^8]'
MN>1/[U?W=+Z<5:K*\Y)A*,H\A]J R2'%IDM/AF3*\I0A[,0H%F-.C5@.L1E7
MH",UV(L-_FP$=^07&_CM:"8PJ)'9QA-#]W[6]JB$;5IM,>ZXG:GM@7C1?MKA
M5C\2^K34W[#<;-L:U;,BSTG%4@%Q5A"(.#(>URR#55'E1<I*E7 Z6\H[XQVV
MHYQG(UA]":3Y$KKCQ/L@=@+NJJF[T<AS !G.*5$I@HE0)LY9,&T#)I5^6W/%
M3%F=RJV1M@]\([+S'KP/(<"SX]L!D$3F5FLTG-GTC,Y!F?/Y&*.RY!D%GS/B
MN<L\ZV8U,82[<(0F%&M70OD/T]N1+K@Y"ILO[[[(;=-Y>,[;Z]^M&CE,1,/G
MU?+.&(??Y/9QO;QI0[IFF:AXE2<4RJ:M8DD@2],<ZA>)I:BH4,HKI]):D06>
M&KV<#O+LZ S^J!O#'K0&6FVPTWM_G]'\ZA!F9)1O-EG?] )C]ET-#":)J1,+
MZEBT*_;+9,>.4WI%(M/M1-\.]XIA(TU9V*)BL84>M^[82%/PHC396.-Z%Y9\
M62-M<[T41R75-M=LLUU3OITEC+(*XQP65#&(!*T@KI0P=58(*Q*&"V65[^<Y
M_N26KY,5"#=UL:?CNH4;\.=."4<_ANL46:XB\8"/O2B$Q=RG_*,/<J$+/CK)
M,':)1Q^ 3A1U]'J,>W+S'_]A>'F77DHJ(E7)(4*XTA8]T@Q7DA(62!!5<92Q
MTKJ?5O?!4Z.N/_[V'W^KK1W[C-PCG/II9HCVD?ECK[A'3O+QFV*=B.R+Q$C9
MQY=?!:=4XU/:]N07'UT^6E+Q*2&[F<0G?S]JA=B_KU;BK_EB<;+ GC859T6&
MBY*K J8%$YJN3*OLO,20%2BC:9%D&7$*GHTDY]2(;U 9SRNP4_?J?$5/K?0H
M%5XOOB%VIN $YCTRY;_NE(]5I=5V0J90D?6BK/\,U5=M 0]4:=5ZN%"^\IWG
MX>/C]G&]:V^[R^G[(G]M;_^2BY_R=VVE_]C,>"FX,"\)J\H2HJ2J(,N3'-8U
M!E/,RHI:&<Z!Y)G:LG/:E[GW238Z'7[;:'4%_DO2-;A9.IZ[#9U+7T]TM!EZ
M%4?S\,D)X"GV@C2R(]A-IE?V\WH!>-F-Z_=8C\IK<MNTJ^!/'W[QND>9*?1F
M0I1GN<JJ2O,K1$J99F%,DZ_0>P&:,E$*DLHJ$[M@CEO+(FSGA_.([+@=(WYL
MM9;SNR60K;C@S9T6^#>PT"([5!OK@9FE7&',.:PPUS!C2B#!50%IR51&<D0Y
M(=9%[@;B.V9@7G1@+_N0 L$5>?DPAXZ\%?, UUU=/-.@]5L8N!PJWX6!;:SJ
M=][PN97 NPQ*7QF\GKO'*X5W686C<G@6EWOG<U.S('Z@Z^5\>;?IY)2;I9+/
MM[,<BU2O!Q164@B("D(@+5@.<55A24NB,D[=FA5='M3EY1ZGQU"W,(-HA'3.
M\;Z$M)VU'A:]R(RZ$Q;LI 5ONDBV @<@!G=T0N>$7QIV[/QP2QA.Y(K;WNE&
M.9OU=O9YOFV+K+VC&VD2T=L ?D%$D2O*H.+&#"Y5#IFDPC"-5%@(3C.KEB]]
M@TS-+CO("8R@CND1O7#V,TDHD")SAS,^UF1A T ?/>C[.]2@__:<%GH'&(4(
M;%3<??I6UWJF86J;4S:5R^M>NC]6"WWSYL,_'DT_A5VH"T=8 YCGD";:ND"B
MTB9&Q9'^^O-<*4+34CG%XEN-.C4ZV M=IQ=VQ/Z_0".X=^21W23861_!H8U,
M(D%0=4_>=$$I;!:GU<CCIG.Z@/$BK]/I9E^2T@]N^GN_?UQKHZ>)WFSZ?G^X
M?UBLGJ2L+_JJ7\L?FA^-XW S*Q#G-$D4S#5'082+"C*%2ZB04AG+*$N06RU6
M/SFF1V1:PK9Y/6@4:4.Y=YWMK\!.F^:3!#M]:H>]:[U6S]FSY;OH<Q*= 6--
MAP<M#@(S,%'ZR3(R=0X"["69#GN<^ZE'79BP_F,7]M[FR"1YEN2)0%"J#$&4
M9]KXXWK#)XD42&&&B%WUUKY!ID:,M8B[MO:'Y!67'*9>3"^[X4,@%9FN8H-D
M[WP/ =9(GG<_T)R\[I?0Z'&YG[UU-'_[)>&[SO:+U_IV]/PX7\CU.VW.WJW6
M3S-M'B*>( 33G"80J4+J/6]*85E6O%"YYL;$*N/TS/.GQGUMG\I:1K 3TK6%
MYS&"_707 )?(3.<&B4?/SI.*#^S7>?S,D7MUGE3H99_.TY?Y'I 9Z>:+><W@
M-^J;_"F7C_*CEF[7\/=V]6ZUW*P6<]&$2NR*[*DD*[E("90H%Q!)E4!6$@&+
ME*DR34E>%8Y%D7U%F1H9'&O2).[6N@ SZX>FWML5Z.HSN#+]@,FT/9L;8XJB
MG]E%GQV/8[VAP 8^[O,69^1CP*&PO3P>'/Q$/R+N*W'_16X_+7_*S=:,_^]2
M',(CM+@+NMG,U;PI;/M6JM5:WM)?,YSS"A->0,(5@2C5/V&1E+"J.$\+S'E2
M.ITY!)9O:I1]L1E%G3L!#FJ"6L\KT&D]7*=J'*E[!5BM,- :NU%YZ-?!CM]?
M<9+'V':_SOPZ+P:19B'H"A%:QE&7C4@ /U]+8@WCM\#LGG^S/ R\F66)(JPL
M*2P$EQ EF$.:XQP*2E*4EE3DRB4TNW<P*SH8/S#;?/<F?',7-UPWY=P+7>?2
M+>M.QVO)Y?RG,0+=N/PT\G:,[ _D.+S:H4<#7$?(<'S8BT%05CL]TJC<U*OL
M<X;IO]CSM-B<EKREIN2/IB[-6TW'A/7:A.6: =X^'2YI$TFN_Z)KL2\2VJD<
M]&V^^9^/:REWY?),(:M9F0C$.48093*!J!0*,G-*DJF*R3)E!4V=' ?1)9Z:
ML5IK QFMBXIU5 8=G0%[ MWK6KU!K?A5M]-T1WEMX6CU33E>8QVU-20- HY'
MUM%?(<O#[2F]&+&/P:?S3KB?FX\U3V%/V*-+/>Y9_%B3\.+4?K2!A[;:>"_7
MVO[;UH;\9KNN3SXWNS7XT[(3R_5QOJ1+/J>+KW*MS?=[TX'HX&PM"JP4+5+(
MTD(;W1DGD'']UX)@FC"]^B4J\^O/$4C"J2UX![5 1Z^CS7G MJZAIMERD7K-
MR8N\* 6>MP%-1@)C&ZDS22@I7ZF=26"0S_= "3W0\!Y,IY:PLQ%GUUR+/M\^
M/6L,305%1<ER*+(R@XCF"6292&!2I2G"@E5%DOBV;0H@W]06A>-V1:>MW_[0
MSRNPTS3@ZA'F77!=.T:?X=C;F5>:W$%]K ).0;365R%D?+5N60$![FNP%7(8
M]YCB[X\/#XMZ^:*+;O/23\MZ 3/"F&$>Z>)03)DQ4E:4ZLT$S@A$*C']'9(2
MYKC2O\DXJ@2S2V+WE,"%.L;):.\J 8[;\7;T &]VFC@4O_"9H7Y"'P'UV(3M
M"K=SNI\O\O81T9%G8*1@Z7 OOE, ]0#P>F*K?9XZ6MCU )6[$=E#'C.PY6.G
M0&/;VDW<F"*/CVN3/J,7P?GFC^6*;>2Z/O?\M'QXW!Z'2!U,5B8ES<L40;WD
MZ.T+3C.(DT+I-:C,2$ZK+)&%5X_(@$).;0_3;2K9+=BZT].<J>XU!;6J5Z"K
M+*BU!<]B&H?N9J*\'W9;FM>>]<C+Y.M/N'\#S0@S$J?C9DA!7Z=%9P2HS_;T
MC#&6;S+"0UN8\D9]-J6';]0[+<U\.ZLXDI4@".JOJH"H*CC$199!@G.6YP(5
MN+0J;7AQI*DM$ =!C2>D%M7\T CKFAUP#ET[9@Z"661Z]8/+(US_ A2!H_'/
MC39RL/T%I5_&TE^Z84"H_!<M=%TS<-ND+[;-3A*5Y4DA2UCEB$!49@)B@3'$
M2$A>44Q)[M3HLF>LJ5%%$^)\D'77(,"M?8P-R'9\$0BZR(SAC9I?6'<_'N%#
MM,^,-WZX=;_B)T.G+]SBVVC<E+=<SK?:[ODIQ2>]Z5[>S?=-##[\XHM'H>V>
M71<#T[X&T824,!5*0I0S;7J4DD.J"IRI#)4D=]K6N@HP-9HYR \71@%PT&#W
M[;S9*['O26+I7?6>)3M*BHE]9)X*#;M'YV\_[ *W!G<48N3>X7X0O6PN[OF<
M@=[ MH_+4=\6SRWAH1,KH46B3.?QG*40I06!%',$>6;*'O*"5-(IUBVFL%.C
MVJZSJ/W&GW=V&NHW\BRY&/65<704OO*+,*+#\-7> 7^?8<3)B>,[C"'PZ_@0
M(T)_UI<8<TS/Q>W\.OKVZ7?ZWZOU.Y-N>?UKOC$G6+E*\@QRI'*("I1!(@F!
M+,\KI7)<(*K<6@$XC#Z]"(I&>/CYC+G)GD"M :A5T#2BE7!=1APF)Z%(,JDR
MF"NJ(")9#G&J]V$980E+<4$YRYT,B3A3,XI=,*F)L5RNX\ =>_4-B;3[*NJ.
M6=A%T6'\<=<X=V!>+%D>CQA0?OFHKO.G9;N!^[I:UTO==KN>L\=M'4&X,FZO
MU7*K\= /O=LE,LT45E3*5*]+*<U,01=J*HIF4*4E03C34\CI;+O:TH4=_X41
MRXD:]\+%^V!OS1A@T]'M7_X/SM+JWX"L=?2HO3Q\ZC@I:$ZD_KY0I:>.,1,9
MPRLH<$XE+S->)L7LH:E5NZ7K[50G\+F(L:?Q5#W[5YG (L65T*8@5#ACVC L
MF+8)<0&+M-"F!\ISF:7M!'[0MN^DIV\G8,0 Q!/3=@7VVH%6/=#5SU1;.]9P
MGVS\*C-N9]2,/X>1[9VQILZOM'HPI,-76A\NVOB%UX/!>;(.>[BGNQ<DOKZ7
M2V$B#SXNZ-TLS;B>.9K )$D$1%F10,*J"J:5HA7!#%%AE5?WXLE3VQ?NA0-&
M.OOJP\=P]5/?(! BLY>E_DZEAD_JZEUD^/AIHY47/JE$M[#PZ0L&]L1J/GV3
M1+5:FBB@QL=6"%QF&8&%HMCXV!)($YY"A0HA"$Z*@KH5_^D;;6H?Z%[8JUUW
MIH.\7GZ:?JQMC9A "$;^NIT1\V]KU8=$G'96)T=\G396?<J?;5_5>Y,?C_R^
M^ED_^M/2'"TT9P*+Q>HODQ]CCAB^27-Z(#??M-GP<;4V%6%FG"<%RTH")48E
M1 (SB%660[U/P[0J*TE)X>;!]Y!B>I[\O<1 K=9 K![95CTN .5\]=A7JB_8
MO-@Q462L8^^=/KP#NRSB*Y!F,"%78*<2F"_!7BEPT*H^S-WI!?XTFH%6M8#$
M-@#8H'3G(\>H)#@ J.?4..11 ^-XWL\W?+$RAZZ=+-A*)+2@%.8B81"5N814
MYA06J29(K'^'J55#*IO!IF9V=0K;=:0='OQR"F?+T[! Z,4^_O(&SC]BI >1
M.!$?IP9\G8B-'M7/1ESTW>-'(]?+[5S,%X^FO-)W$[%11W$T08=2F$X(QLQ[
MW+8=$G:-U+_*=5,YX^GT ^H="::)R!!-8293!5'%S"%6Q2%)DT1PG*<L<XH&
MC"CKU$BL*RDXB.JU;8PYQ78$.)&)B^V0\ILS9_(< <V@W!M3WE&I>P3@GS/_
M&$/Z+1QZ*:)W=VM3N;_;.Z=.39]E)..E4ABJDA"(B,@AEE)OSTF*B61*9M2I
MF73?8%.C[F-9NQVGFKQ]1_;NQ=F.?D.A%YD__8%SIE ;1()R8.^ HY*8C>K/
M6<CJ'O?:9WNS]D:9*L[OZ.;'1[UG_LA5IWYG7?S9M%BN&%-*09&(!")69I Q
MX_!#:4%)R97*K#I<.8X[-7*I]V@_ZSV:_CZV/V13JMVH (P.X,W'=Q]_ P\'
M/0"M%;&ONN4R*_W\$Q'K,;;"TX'9OJA9)+A'*F86'G:GHF8>X/44,W-YVFA%
MS#Q4[!8O\[G=-W-;+S%ZJIZ^R.U,2<XR;&(Z2E) A),$8BX0S,L$I4DF<4FI
MVT%/]_'3.\'92:<M===,Z@YJ,DDD+S"!')<:-<J-$4[TDIG(*JE*G&,NW7+9
M_3 ;)T\]!&)VYK0O#I'7K+U8=7/#D*G@+]4-G.;=&6#D%.Z7JKU,SSYQC8>M
M*]GZD:Z?LB0EUZTMK5E429,AUU9:H8G""B--<WJ+#%%228C+G)ADZKP@M"A4
MQJQMW,OC3>T;WHD,C,Q@+S382>U8V\86=0L;-BR6L6W7UX'1P48-"^=8MND%
M6 .9H/;8])F>%D\9S^2T5^G(U'2XS9V.NTV]=U9LMS+OX:!M?]9;8,494@CB
MS*2D\AQ#4DH!6<8QS@2N"F%UFN4W_-3(NJM!9X-V5([ZH(57^6^/.;K,Y7&1
MCTSMTP3=GOGC@C_20A!^$IQ6"'\,>Q8,CX>.MG[X*]Q=3@8\Q?-\3.JE:BW%
M1ZGOH8NF&?@M_?7AE^DR(M_*I53S[8R6I>(J+Z&4IHXZ4BED*%.0<XHSE*0\
MP59^;;=AI[::[*0&K=B@D1MHP4$K.7C3RNY87,YR'BQ/TH*C&_M,+0BP[N=K
M3CB%/6FS&WK<,S<G.%Z<OKG=/4Y9.'W!E]5R?53CY_-\*3]MY?UFAHJ4Y"*M
MH"*\@DCE##(A"YAK2D,YRRM2.N7]!)5N:N3G7?3+7-55LZD"!OXTFH):U<B%
MWOI? CM*?;6I'>,(<>Q9C5ZZS0K]5ZW5UB_AI(NS68$[M!J;W2 #:K6;@+2U
M_*&7IKICJUFL/J[6<GZW?%?7=^9/MVNZW&@+VR1)+$7]MT6]:=LU=;U>SS=:
MMO>/1L*O=2&++W)[H_2B-TNRC&)94$B0,9C+C$.<F+Q2DF0)R=-,,*?4AA%D
MGMJ"TU1!/])Y9Q<V;9JO0*L]V*D/.OK7#-5!X*C!<PL#:'  #1#UB90YTM=@
M>!2FC_Q&V:U3$WM/(J]>TWQ%_*KPCS-IX:OY1Y9[_*X XTS$R>X"(PWM?A#Q
MV;@L]0I\^[X]1T."YBQ)*BA(B2&2:0&)$BEDO.*$T[+DQ*I^R:F'3VTA:N4#
M6D![#_4+Q"X[_8?@$)EH.Q!X',R^P,+>%S\$DY$\[3:OAY/O_)S./9[Q%[>,
MYO<^)VS7JWWV&H]&U&TR^TKM'4S?Z%8>EVD^;.XKD@E-19E&C)8044U8M"0E
M9 E)9)(+D=CE]KD//342ZS:O[WA7C08OBJ\[>V8\9N8R'<;#.S)93@UJAV;3
MT2 ?B8N[>-9U15SF(E3ZCC^2?4VGW1XX7K]I+T6/6DW[/<'/]_/V<6.Z_FVT
MI<WFR_K1[U;+K;:5]<MI3E_GYO2B&;'Q3ST=6G[-B$JH8!F!5 D.D;9Q(14E
M@S(3.5:5J!!SZKLU2)JIK3 [94!'FRMPT <<*71H-6PB@?=*N?E=ALVFG4=E
MM#F*O"K%G1YGGT<06(-Z,X9)-*J?(@AXSST081[J1LN;]7;V=;T2CWQ[L_XN
MUS_G7-85&T1>%=IR1Y 6$D.4L!RR4IOPN2@12U1.DL0JX.3< %,CSU;&VB/9
MBNE41>,LD/TD%P*>R+SE@8PU&5U2OX]?]+T=;M%_>\XK9Q\^"E5<4FWW]5^\
MSL_.:FHO'DHY_.=\^V-EVBE1,5\\O9?ZF[K7)*,-[L/)X+TI_#>KL"2<<:Z_
M=ZEM+*$!):9#7RH0RTM>HH0J%QO+6Y*I441[2EI7[J,+/:+AZ)\2S)<_Y6;;
M-!A_DSK&G?G/DYWU- KZD1FH+?+:J97S5Z,%:-4 73W 44A%K4LXJVDPG$$M
M)G]I1K66!H/VW%(:_D _4OVZ;F/LZF+V7^E:,[8I=BOJ(7;5=&8R+W&.,@Z)
MH!0BJ;C>I28YK%*1J:)@14Y3%P:U&W9J=+F7NFG9<@6TX,!XA&K1VPJ"6GA0
M2^_&FI8384>1X>&-;I$%0=:9_-R "LITED./2FMN<#SG,,>[W?M=?-!;Q^W3
MUT>VF/./BQ7=SC*5L*)0!+(,:5XBM("$Y@R2K.15P822967;\^+%TZ=&/XV
MH)$0U"+:-[]XB5T_E0Q&)+8%Y0"&4R>,LTI[=\-X^<31.F*<5:;;%>/\17XV
MQ1?YUW53<MW$BZQ72_TCKS<9)DCSW0\]C7+S:=F]9K[D\X=%I[XP$IP)1C)8
M%#31!D>>0,8R"EG"DB+3?RJ!70R. #)-C0ZT2N @+SA6JO9MM&J9HNQ'%^XT
M\RX-'6*&[2R9D><M,FEU9D&OC$MAR@6!/QY,;EYGPL[-5Y2"U $!#FH>A9!K
M5-LI()#/#:N0CW:/CWDOU7PI19MM]56_T.;_;=#]9O-X_V <^)O'C13;U6ZG
M*DV.%M>VWS>Y?5PO9TI6K%!"09)4!40B32'!K-+T7I2F*C\GN55;ZU "38W,
M6YU JQ0P&EW5?[8Y-'4NS4XU8'0S#0GWVH&=>J#1SS[R(\CT]I/Y:TQ:9";_
M)Y\O^_B=L>=MI*B>T>;/*<0G)-@]@3]!AADM'"@D*-T@H:#/]2TE_G,NY%)L
MCETG]1^SDI85$YQ"F2(,4841I)CEL,@3QB1*$$NH6RGQ\X--;3D\^ /K'N=
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M@B:L5!F#C"&B=X!E#DU%=)CFE<1Y*C+]@\L.<* \4V/(_3EUK<(5V"L!NEJ
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M9KRD%";6I!(0RR+3F\RD)(+Q2B96!4/.#3 U6MO)"!HA02.E'6>=!;&?DT)
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M)18L3W!1.<:EO!AC:DQK1.P4M_!CT5-8V@9'#$(HMA>J<WC[>;6\.SBDNO5
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M\IR[W!_@7C/BLW[0'6WK4+R7K.DGN=%__Z@5^L#F6T%G M%2%16!68XY1(5
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MONJ Q!5HL'",0QCKU;+;$4SQA8F\N$[R77$/JQAYXL(&9XPE_+@A'B-/R8M
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MK$"7/RVN=N\I\&&YK?<0S3&^P)B7A&K3/94<HA012!'B$+.T3# F(N'*MJ?
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MKKXHP]%+GM/%]F W+S9+/>3'8G55WM*%+*\>S4_>R]7N//@\3D)*4I1"G,H
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M?_Y3BGOY"\V7YH??)%_0LLQ5SBO/\IU4Q<K4N9GS$%&.F( 8,PHQ%0'4G!-
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MK^-%RO427M.%S&A&LHP(&3DUQGPUPN2HP9QS*12H1.RY8_P:1EM.N "<P9G
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M#U:?HJ!;E=GSRI;V(.LF,/-Z3D^#M)Y^PE>PABNV)CEXBU%IIJPFT^@3,I_
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M Y9YDH4%K9UCP=2^N=HF\@0IYH1D2'(\ZHC#7 /=D]!&LD8'XN+!$,?AE-0
M!N^</6=;AU JR8J.I7:<K&?/9,Y-21X=IH+HAS%3^Q[^#X:>0=5]WX(=*ON#
M<7.!R^FB'C<NURU=]THZFLB+9R"P]M8!S6*I@PE!T]:/,<DR3/W)":][#;:E
MGA2QI]=W6UC?+M97E\O*\?8%FT7\&_ZQ^=5JHH((Q1':I*I]HNI708)E)7$>
MLA+HW5!'@%WH&S=C=G*L]JNO%O;KI[C:?GU?R!,O1591 $5-B5A$7N<#*V"<
M"VE"'?*9ARILV)O8<5-QS>"S!TVV M8[PGN$KU!7FE*%)25K.Q-/<MS<$!!%
MR0 AAX%F '6E<-STWKA;? \Z:P"+#ULZODC$'A'R<K%:_XKKCXL\"5DKJPLR
M%QQQ H)$:+UG(IB0>3*9YV&F('2A;MP$X"DQV+NN1L1?+05^Q-1O.+OQ1.X6
M%Y"/;(V'4K:#1;0Q>NN7&,\S6,E#P'M0W'G_^(!7C]M][A0X.X5.G@/D;O<<
MS0F5+CZ2XQLDT]9JYC,DAL([ZTFVV:N^\+9OB]?!NE0T!;9#M=' YKHA^N?:
MO&$'@QN/-I)T<SWBP?EJH]Z)=S%!RH9Y54-_823SUEOF71%HN(X*!PR4]R.V
M$TK#<T;IJ339 %C?+A=ENJ[-N2882X&D,C-!&K+JF(EH;1BHP'4 M&B&JI:\
MIJ%;NIO_&;!UH.";N#IY/1#\'2:<?MK,!/\(\S.2U]8=?4E$;7G[\7-=&?@.
MZ?4KF$TH'@+!4V**O >FHTX,+"T1H845-F>/;MAQ[7N3W V2?XHCF-.HM0&C
M]VKZ:9IQGN^YM+6-YR1E92-JP6I 3VZM(/N=E&/*"0ZYQ"2&&E_Z.%'=,/BG
M.%3I2S4-H.SN369CI<Y&L!0,K1#E @,A2IVUXFMW&1W20$F]O4^3_QP''H<*
M_\@CMA_GN1?P=&G=NCL7>7,OT2>RNA93S8^3^$1.S$<+3)1D#$<0-@YCR8ZG
MO1M0_Q0G'R=6= -V<=^^[\3BMDWPTUW@H\I0;!3,HA=,6Z=9Y-HQ9YSF 9%"
MKV&*5H?A9]S*GU.C<H]%<2*(-!%H/26'.TWG[[2:)_]]!JM5;;$ UW(A[JWV
MPENC6.:;Z>_1;GOU"*4\(!;#!W)!^N1BW/*BAI?%H'!H?-=XLI/\=;?YVE!^
MATTH0113@!2 &.N-,D&[.%JF$1QH:>@'I_>2CF!HW)JFAA?(J4#2Q,;14VVB
M"LGDVFBW'K(PG7,FGY:TDKS,H6I#XK.O115_TDJ5P17>:Z1\XFY9U[OEZBXS
M1S7)^OK,D_3&>H2%_EMBW;SH:W\V;WCV-1%7D%P'XSR#4F2M!+ JT*^2'+BS
MSPZJ>FZ Y;S0HG9U$B4;IA-2K)!]O9R5:X6L1CU0?^Y&&V =AX)O]+W:1]@C
M^J*KY?HKY>\3SH$,V:;_3@'N8H' 7*AW/^6F_PYF9K-5Q:("+CLE'^@-MY!"
MW]U'R:,D- *4 _2YZ%.X8Z/CBN[?YZL+3&3(,5_=#LXN.8=$NBJUB 658;YP
M2?H-Q4<9L_"=HN]N"'F,C'%0TI-J%WW+N8&P=L<%39M\<?6@(F9P3,<LR:Z2
M=(1Q$&6-VLTP WH;OQ]]B%'I2<P- .56O4AQVJ3D#!,Z$?N.MF"PP3'010OD
MG.*(-@IU!@?&@=I\O!1G']$V (JOJ8K5A\4[I(@N36?X&ZZ_ICT^+*KG1BS6
M<_7\PY??5YA?S]]0#$;JFI^]2.OII^W0L&N_+F?NLTG$M#=U+@725ZY0-!A1
M69YC*7Z@ <L#<-.(!>L'J*.KNP'(OYJN+A8KF/V\7%Q>_+98T_<UD3&=7V*^
M8G,QO\Y_OYE??WQB2BU)IXU#ZAJC&)3,@T56I!0E%J%,&6:*\H$$CYO'[1FX
MIU!:.W-?7R$1D*8;INCK&5Z=NKPXKYFX_][6"5NCC3(NTV+3]9Z8L(P"9L%"
M]-S+HJ,=J'-@%^K&O7C:-_CZ5L?(MUFN,S&OSR_(?K\IKZY(V&X"'^#S577F
MU9G&)&;'H^2%&12YW@WC+&17&*H$]?ZLY:++Y:D]7SON)=&>(#2TN!O83S>%
M<C\\N,90!"T$LJ[,JEA[47C#@D?+ $/6I?9GD0-VOWE S[C7/7LV2#V(O '@
MU/4P76Z3PZ])&?.S*47I+U8K7*]>SW,=]3Y=XVSZ"?./GZ^.HGY>+/(?T]EL
MDE1)LDA:%460N0T4;$6= LN6@\TQ<:V&.5@\ANIQ[X+V#,*3J:\!J'[U+%_/
M/^%5!#4Q0I&84+ LZQ39H *+LH['CJYPCT7Z,DPGD)WDC'OWLV=P'2_P=KSY
M'RY7))-5O9$:I_.-1EYN8I<S8JH>SE*@O;Q2U+)>E]DP>WUSAIS,R\WQV>X_
MN1[:_D5,C(7@'?<L0*D>*' &1BO&BU8F.A'20!-W3L3@N-=&>P9XBZ 8M?"H
M>LIUK<_IUU_>K_'B]XL[\96RG*/8I)6D9CJ9PB FRXHJ:+7Q2-%\AR#DB5>,
M?'>TQXBC+SF.'*?^ANOK(FWR(#;0O]X7)LYI'E7VS(7-"8Y++,;D64X(0A@/
M0><.<'CB%2/?V^P1#GW)<?PMM7*S*;XDEB9!JJ HJF$V:UO%07&R2<@2.G(@
M5=3HNUB$Z^>-?$>R1WT?)*$&O.R'Y8XWQPY7,Q=NSAS02Y>TC@Q-4@3;4(_]
M56'2@M#&!2MAF*L(W6D<^:YDW]'>,+II$G4/K[%/4$<C#-G%H&J'A1* 05:2
MT6:),N=<!DLW=*!NY,N.@R/M2'V,OVT]SMJUIS;%U21:C5A\8DK&VH+-*Q9"
M(IXB!UV$E=X,,SGL2;)&+H$?'%R':J!E5&T<@*]']IN4W(2#!1\C.0-)U<E7
M4;&H*03(/ND0K*; 8)CKK=WHZX:SYY*A'T G+0/NVD*_A2_5/->ST926ET3@
M52:BKBZ=BLO%2V(VE]KC); Z[9%) ]:K LG;4PW<Z$)O-T ^FVS]\#IKP)>K
MD6ZWZJ6)$AEM1L$HRJU#MP69>9X3<R)$8S1%1S!,D6QW&KLA\+FD] ?2S>&H
M6U#0,B3JMB<7C]3,08%L*3("7Y#\5YF8%U8S]*$.H4PIA6'BU_UI[8;"YY)W
M'UA73=S=)8M^5>)YU>B9N*55MOY2;R>OR=#7^YT7]2,3EPHF8Q5%Z)"8)H>#
M!4M<6N^S4!DYA&'.C+K3.&ZE^-!XN5])/HSJCO4=^[J D!#SZB<2\GN8X9OR
M.'->&L.C2BS7S)$V)K, HM[$H: _Z\P##!.L[$'DN)7AIP;F0,IKP&E\L.:N
MSV9QVW&BBOFZ8_[$^RA2*8Y%PRW3.=&JD[E.%Y.@,H@D!YIIL ^5XY9^CVTR
M^U)?<T;SU70CP?7EDI;?5RXG/J)6@7M60BV+J97NH:3 T"DMP#K4>I@.-!V(
M&[<0?$0CV8>R&C*./RV6M[G;9+-VB)'8DP)='8(.AM<2+=AT'V%2^N!YB,K"
M,(/$]R1TW.KRD4SD$$IL)RWY")>;?F:[N 3,(8!3M AK^XF<!8L\<&:5"5P4
M670:I@G)GH2.6[K>!E1[4>+X4*W5&;?9NL7MK3K732J6');5M"IY12X,^=DP
MG7_ ]'&^F"W.-FLTQ4+"C$S%>M&X$,\D]L*$R4;FH&T6]TX+=U:_]$/-N(7M
M)X+H2,IKP@WM+N*)$BIM1H!ZY373OLXOD3JPQ+6'8++09IA2B>XTCELJ?V*+
M.I#JVLV[_S2=PSSM%F1T7CH'G%4GG-'_ESKFCM@4.AD2I! P3+YS?UJ[I9=:
M+T<^D:Y:RKO3?O"MNOP=;$^$Y<GI7,-!5\?A>5KC6ACFT.BD5<XE#G-A\BBR
MF\S.]X:JW<[I"10\ZJ:_<72^.C?O%E]@MO[R;GKV<;V:!.3:JI*9"U8PS1.)
MSG!DSIB0K5(0[I]<[O8['WE^DTGUOO'4FX#;BVC>8[HD(GY8+)>+/TABJW<X
MVQSO?UA<L7G[/M,DN<RM%)PYJ,W6@N,LJDB.</2U*Y?BT>D]HYC]*&@R53X(
MWDZCI 92EN_PXFIMO2GO/RZ6:T+Y^2N,ZTFR!E&2 X,(D6FI!0N^-K#/)BI1
MLM4#)2<?):G)]/A0VV<_BAG?YNT\$[W##[=@.<;-^/;-0,; ?(Z.I2"2L(X"
M_CQ,<=FC)#69[Q[,3^M%,0V8LMN,W%X]=;@Q+M,49F_A I<3GYUP' 23@6^&
M"G#F;=;,<(ZTMF1 /]"I2S<"FTQAGP)]?2FM 2S>9N67!?D*M*9J;J!RMIGK
M.0'@(NF(3$E.0N,:67"EWLQ)#JP-WJ5ADBO?)*W)_/0IMMGC%=5$^OGVDMK-
MDE?"^F 3XXD[ICVYIZ#(Q!=G$M=@M"^#M;1]FK0FD\VGL'W'*ZHQJ_<>Y]/%
M<N-'9*%2=$2[=/4 1TE@(==:=>+":*FX<<,X>+OI&;<URIAAQ&$J:<ZHU3FS
M)"R\YNAZ[6PX$RH*C6B8T:I.G_6)XN]4NR"I;),V6O!A+@MTI7#DSBDCVKC>
M]-: J7M[LZIN9FA/G$C1*)69*G5BMD)R$@QX%G2Q/ :M^4!-CW<0,W)#EG'.
M&@[61IMIDJ_KY>5B_@F7Z]HS\.ZD]DG(3DLI$W-0ZCE)P$V#-R8@0G)6*.>'
M*2#8D]"1&\8T8?7ZT6(+QN\1]L[/%]NA>Y.4H%@=0^V91?\82XO/H612>:L]
M)O!J^)S>3M)&[C33"! /TU0+T+MU$H@7E\OT$5;W.?(RFEKZDR5JDA=0P"Z,
M9E88A=JB4V[PJNI':!NY^<Q(NW)/NAI_D[YU%+U>S'&]JJVE5[A>SQ#/+V:+
M+XBXF08*=<+H:N*]U[$>TJ GQU8;[U@$I&B>7%IEB@O([R'QJ>/_+J\<N0'-
MZ4L">M?#^"C;>3!35\MF7O)$: C*<U.+N*O :BI2*,ZBQ5P$]R*J83J#[*9G
MY%8T8QZ6'::3!C;1[D*;%#!1:HQ,!)(8Q4Q0.^37)G6)4))%!#5V#>C(O6=.
MC,"!=-= A?*/I6 =^7'==O4=F=,W\\IL_?]Z8_H3S'#3VH[D.$UD;#?75>?Y
M[@]N?7(2K53.223OMOZC0V9@!<D<.0;.)10Q3$IF &:Z5?NUWF.W%6TW8(:/
M8O;M9JS[PTY55\,C;HMU*^J)R1%BBK'62I*V B_,VYH?0W#*TW95[# UTZ?E
ML]LR:;TU\3/ 2 -;QG'F(@2 4.N&O4:LXT>1@7*<"1N5RY$'Z#9&_+0+HAN^
MGTNKY--I\&"X7FQ6$?&]7#< 6IE<-)%6J+$U55R28$$)PU22SMI<P/-A,JLG
M .USZ;I\.@T>"=H?Y_V<OK^_O+B8;00(LYL)??.R6)YO=7@=V)#_%6SDC@(;
MD^OVX2@$#HK0)(-*1:CHA^D2T)' ;C!\+OV9A]!*$W<#;X8]XNHM3/.D>&52
MR)P9#XH"61^8=YPSBZ&@U,5H-U@WYMN$C#R'?0AU/^Q\>[#D&XBH7L_I661X
M*^UUI@?$K'PAO2)87FL D'F>#'-&<PL*39;#V*-[A(P\%_TDP#E<\@T YR>8
M+O\&LTO\E2*DR^5&6'^?KC_^/E_$%2XW<Q1>SR\N-W,5-H/@MQ..W]7+84N*
MI7Z U71U<Z/U[=5AUVHB#'!T1K""Y)QJS+5!?G;,6DA&.!<A#(/ H3@:>5+Z
M":#<!!;&GB:VV*3BKJ<P?UC"?+4EXN[]6Z\C1&*+*9>J+UL[K-8!>DYK(4LP
M-HI[.:7=D\6ZO6[D0>D#8F\HF?<&HW_[_H',R8G]Q^97F]_4OWJ'Y;OZW]_?
MO;[S?'(,UXOY*DWI3Z=EFOY*3L;V-;4AP&(VS?7D],8[7BW*M7Q7.S]PZ_>W
ME?)JNDJS15VR=]E?3<_I,]^ X5"4?/]51/>%=T70 Y".+"[\O,9YQOR7P\W'
M;3*NW[W[U3>K1FI9(BT-!HI'IG4.+ 216?8<M% 6<Z?+[?N_^>C8^%K,'S;#
MEHR,13KRDR&+VA;(.08IDQVP,L0H3 EYF+LU=^D8)U0Y@>X?!,&'BW_D/?:&
M\A>?IZL)4BB5@TF,ESJ/GLBI9\+(HG=*H')&89<!C7<>.G*\>H1F%GV(J17]
MOEJ<PW0^R4)F97EFPJ=0&X5Z(MU&9D7)J=@$<#\8?5K#V\>.M]"/4,PN]1X@
MI08"QQTIO1 X%T+5Z52)@)ZC9C%HXD4+'HE*)_PP&?J'M(R<=SC> /0DY@:
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M,%O<6C$32!1N!\,)!38QK5(==>0EQ3.A<%5GS. P]2B=R!NI9?RIMLZ^%=0
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M^N'S+<)CTKG4(S>.HA[G8J:-*R0FE%,H(-J2.QT<=%/_[5>/XV_VIOZ#I=B
M)_D387>-OTP_X8/J_!^^_ K_M5B^G,%J&\!)%1)HR$PF0\:1_F41:KPE+9E+
MI831PS26V(/(1CN='!^Z#*6H)@:E/L'<5]9^@W.\\K%MD$4&RVE?ED@^MI(,
M9%2,!P=0 OHR5%7G?H2.&_D,!IGNT#Q:>PV8R+>PKCFL:_M><A2A> 8VUX:K
MIM1;)85%EX6SQD*"8=HPWB&C66 =K_#[/0(.EGX+T'FLP<$/7VI&<[/R"G>%
M^)!, ;F*VB<2CO7T;71% &T97 Q3XMB!N$:[-1V_F_:MF):Q5AFZ6H@B!5V/
M$UG62M-"#(5YZ20S)H=::\*'RC1W(&Y<D]8[(+H"[D#MC!PY7A78O5F^Q^6G
M:=K*1UO & *2TT 67FN7F4_:,E\[!,7$M56^"[HZ!9"[*&BTX==Q^<2C1=T&
M5.K]GBL.5E=X=R;ZY IGWF"=U^(Y;>96U7E 5F4M:(5U*I#=!R\/R1@O]W2\
M9A_"Y$@Q-["/O?\XO;BH]USF^3]AGNEC9U?.G\1D403.I!&T@F2MQ.1^<W[#
M-7#+I1UH1L1C)(V.G6/5?;]>M1?9CSVO]"E;_,O-Y!\#Q=:J*D:+C3@R=E/7
M:UDNRF7MG-#WVX+L7WGVRUX#+$]_R^WPG6D@0;=@?SK5;$^"0NF<-^2BD>2T
M489%[8%9U*B=5S8.-;"F$WV-%IP=B(J#RNKW4E$#P+LRZ;5W,,Y@>Q<4ILM-
M =6;Y<N/]8;H:A*R<+[>UP^\=JSV 9C7PC, XBA+$4(<YE91)_(:K1SJ!W;]
M*ZCURQLO$H6IJTU[X7IG^7U=8'@V35]O\!UR"Z#+4WNM\]^;C9XFO>WJ/GE3
M\%U*49A+8"(CUN'1R,"HFDW@Y/7'(+,?J%#K":H&Z'RZJPEZ*;9 =IQE4=.X
M,0<611(,I=8\"YVU&N;\IAM](Q>L]86:#LU0CU5.CZ>'XYFP@R^:=7_VJ<W9
MDU?'!C1JTBJ*,&MS\+KO:5=J&8P&)BTGURL;$<,PK<J&-&KOTT?,ES-\4Z[?
M<EL#/WRY]=TVH)+"&@E15I_3D@N@ _/1*29=S);B\^3T0#>_]Z2T84.W#Y(>
MQ =#*JR!2&$'5]N*9@Y).NE8<HXVAP0D/0.<>0[>"9X"P6;0U7>/H''A-2P*
M'ME;CU%)$Z4XNQBI7R[Q^IBJE  Q9,VD-G5P-:W1F*)G&%R2%.IH$X>I@/@F
M:6V8LZ,@T %6AVMCY,3L#Q]^OL7'=;DL1,YK68A51E7I<!:,E(Q+:44VX(SB
MWW##'GMV>W X0G6+'N4X,@[^ADOR:&?X^?4\75_E$R&"U)Q%3X&'EJ(P@%R8
MC>@#3Y#1A XH>/CD<1)2PV/@2!F.C(!?I[/9] +S=>FU-!%RT(K!IL-CMHG%
MX#)%H$D!=]PEX3NH_]YCQ[E>-+SNCY'>V*TQ)1?AMAMV@^,7\WR?+V>34L9D
MAC+2QIE]G3XE2$B .60G='%=C,(^[QRG?'QXR PF]Y'Q]'99Y^"MIPG?+V:7
M&\Z^&D0O2HPQD!=O-?GS/"CFE4 &B7NIM$HZN0[X>>H=XQ1(#H^7WN0Z,CY^
MN3S'^73URX=7UP7$*%2T(3*PH;81MHI% <"DL2XHDZ'$+N[F_>>.4WDV/ Z.
MDM_8>\UL]F;]$9=5>;=-W_6NZ:R4$CQS5M6N.]JS>C;(K-&HI:$(K5/GH:??
M,D[=QPGVD_YD.S9*'F'!YFABU(D)+)IIBY:%.IM& PB?=/16?NMXX(G'CS/5
M\21^QM'2;"#!NITI\YXTLNE?\\OMMA$EY1B$J RH&F;YP$ DR8PS 96("MTP
M$QR?(&K<*/>DB=:^5--$LO419JXK.741)F;'4-=2X!(HKO/),^YUUIGS'%.G
M>OJ^D-9"DK4W]7>#U0&:&+G<_LT?<WK.Q^G%1B0\9XNNCLNUMM31&<@")A*.
MT\&)E$7H-CR[4XG]G5>/FWPYB4DZ3MRMX.36CF^$,N2R27+L"PD :F&<RSE[
M$:/!U&E;VP\I8U_!.$)]NT!P@"P;\'9NK-[FWNZ;\GZ]2/_8" 2S<QZ\9LC)
MY&F-F07A2)52V^R#<^9^!J6_%O:[21HW07=23Z<?M32 K]OT7ZV01)%@-G4,
MLI>EUI@YVE!IK4CNM,F>&^.&J9Y_2,O(10K]*/G^@+CC)-X 9G:LKU]NBKAM
MKE>9"BTC:<DZ%W#,FRQ8C,F@C[Z._3Q5!<(-5>.F@L<N=CE,.0T ;1_!W93(
M2LBTQT?#,$O/-"<)!NL3L]G)4B="1#5,)Z1#J&VN#.) K!Q1Y'>0XIH"YSM,
MB[/Y]+\QO\[;@F#,VXXK5YF[_&*>?YE"G,XVL^'H=Y?GF#=K_2O[";G-4$^*
MK7:T\KUDY*D:ILCXZYQ<5##,G8.>&6FNJJ-O2)]>W0V@_59;H<VP^(SE\49#
M-W)8O87E^JL1N%5,?$\:W@4=%*]U$;9N>QD8>&$9>3]9>^4@=VLW<$S3L 'X
M:J[*I9^UT! 86E@:,%W^#6:7>&O-_XI0+^[D-W.R%I?+.M[Y!UA-5[_/%W&%
MRT^5X=?SB\MU-2;S1'\%=S=#,(I,0*C1@!:,#(*GD,!J5D@VD+4(*7=*#NZ_
M( ;@IKG*G9Z6P=B*;PG\5XO]SLZW0QCT@=\6\^4=V=2_OY)"^CB?_O/RJOG!
M+:%8Y4LQB163\[;#A4=T3$CCK,_&%8C#KH8AV6NN4*GGY=$,-!I8+U_O ?[G
M8I:)S=57Q_+^'<%;USZ]*YBT8<5Z14Q2D 11529!6<N3DV&87.]!Y#97<-4/
MGH=7W9^@Y<#A\P?W>/BI;^P.,5&PTT5+;B!JGG3M_*N9)H/&HC"*A5S'Y08%
MQCZ_/@1[IT-]"3S5B_3:!EJTL18HY<1KO"R$54Y1=#!Z1J_Q*[O[(.GH*[O[
M**R!/?FQRX$&7!1:>V9%'3@227K!UE9<GD0)'*0(P^#NSW%E=R\4=+RRNX]*
M&D76W6+.()5U3AAF?4T#.@DL\H#,1)*>X"C@_A7+_[LO[.X%@+TO[.ZCC18O
M[)(0T)J"##UYMMIGRWQRY'NJ4(Q2RLC[LQ?^-!=V]U+=MR[L[B/']B[L(H:B
M@Z:0F.PMT\E+%B$H9D+-*467[?W"PC_)A=U#,7"D#!N[L!M5L9G"2V9$KM>
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MMGGHF^1$)!5SE/7*JJ'%GBD.Y+4U"0FM"%E1[M*FS/9QNGKI!33NJC:>*CH
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M0X,ZJ ]_]J@]U/=D::0NZB]Q.?M&U-<)? 31B\VUOWG^@:HMG;&#4J6(.A+
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M7]L32 ].6#V>5KL"\]:X]A_DS&OE_NOY=6O/=W44=YC7+E[O<5D6RS/ZXI8
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M6X'Q\S=-?PPU*D!&%NW40/ES\3@OT@2!1FM(0MJZ<TB\I%0 :UE+=BKQR(?
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MB9PH\Y7^P&6CQ6L+,<,@\Q1V/,>2> >@N7OGZ0-F//M:5?(>E[-%_O3GXNI
MQP3+K*U[.(ZR.:<DA)(9F)2"8"4Q(=K,TQA(X#!P/84-U9::Z1]PM7/)U09"
M*2[Y6C>@<BU0IQPBUO(1'J)FP7HE?9OIK(-)' :ZI["3VU8[4W<'N?A\L3JO
MI<[W>E%@EM%F)BF[8)X8001GHP:T6I*0,*0\J/?8 \\?!H^GLLL[BA0[<$!O
M9G-\5^X-.Z@W-E$;)Z50P+#VSL+DP$?!@$65F2$^BF@SR_<ABGKJ2C7";>@Q
MY-XI?M[4V0C+JY&U+B41C 02#_'C-7T6ZSTK&Y+%' TKC>;M_(2RB:_!CJ+_
M :#:6QE3]SG[@N1=W14;EPPXSR(3BD&N287*NI!WK=,D$PM,2<YX'E*$L/7A
M_0%B?]TMQA1D!VYFBZ'(DHOC*8%UPH**N78U219$,D8KH:V7;0+B/9>F(_7"
M.WQI.E#6W:'EJ@N.TBASH.@\2+T9&>I#I$0QT7^%Y,%#FZDZVZB9N/7_@1I^
M%#![B+L#R#Q^78?E'+.AW #IL^HMR9Q*B2!D\E(;E2/33;!S^)VI(X%H'ZWO
M=&-J%Q5,'+I<381;&U:1WB5O*)XCRR*)4&[ID/+!E*,--BFMRI"BV=O/[*EK
MYO[+S4&2ZD3#EZ@7PB"6&" SA<1^)-37XIX44K$I(?)!O7ON/G4:ZSY,*UM4
MNX>(IMX@6P\$O*+_JG:?_ N7GH$N6,6@UNLC@U371TE)F9!#^@EN>_;TBMY'
M1XL1!39Y:\E_7<R6ZUZ&SU;ORKIZ1_*JN^O;6T+$A E0R)HLD6 "K720BB?'
M9D5R8D@_TI^]9YJF2R,"851!]@6*6M@MV2U61.0E)PI 5!V/IDS-G4.MZI?%
M%,N1%1RR6_Z3UTS3>JD=) X28U^(^(A?S]<\W.&GE.RB9[64IIX!1%HI RV?
MP +9@?>64S2T.RRVOFN:#?%VV#A<H'T!Y.H:X,8#/IO7 \/%Q><O'[!*;;:9
MC/ZNW,MS D57KMX*-YK7\Z/:BT[7_C,A&LIR6 EB2+.6,6B99ENK'<#:*Z0?
M +Y:7"S_ST58U@>_6IR>+OZLK:P"?3D+I\\2_=YJ5C5Y5:<38K3,"RBQGCK4
M<<-.*P59,J.-H1_J(:7=>Q,P34K;!FH-1=\/OLJLG'_YUX;+<L4D?7TZ*S/,
MX0<NK779<%< 0[W_XGP&SZ(%:Q03(D2)0>X&L!TIF*9/51N$M11^/Q#[./OK
M_,NE(5W;T?^YXO)'0U(QIVRY!I-<#26+!E>\!6=M$4SS,K3E_[X43-/#J@W$
M6@J_(X@AR6TG/J-VF?@48%T5K0D)(M:K/%PIIHMU1>X8GNU,PS0-LAK!K*D"
M^@':;[//7Z[97$>>N,10!O*,BOELA(/ ZJD*R@C!U2ZU/DEKI79%[[C_=! ]
M$S7J:H/ XVFF@U/.CU\6R_-/]X<S^"(H)F %M(YU"I!%B,*1 ]?6\U2<RZ7-
MM8BMY/0TR^OP8HK#)=XC;"[-3VDC,J=57BK*7Y12&6+A 8R1MJ0@,-[?[&H%
MG!ZJ*D90]<_ LX?<.X#/B\79&2X39;_OPU=<7FWL&6UYHH@Q(DJR*D[!8LU1
M; H\B4+V9MK45&PEIS/H[*/H^U4Y!TM]ZG/8!TOL+=-"2@'99S(I;20X)CTP
MIKQ)OBACV8!PZ+"+"D\!"J-)L0,G<G=A?C.;X^MS/%N=6)=BJ3=2HZML<$&N
MU8@(2L3D?7%*8YO@Y0&">IHE>7CX,H;4.P$/Q?8/W(<_P2255"Q#8?66JA(>
M(J<HGDFC548K$K:[6_<P7=.N2:.H?@N<1M)#)ZAZ<;&LPCS13+#,'2E9)46D
M%R+=EP"2Q!58-4#>9G#D+2*F7;A:X64?"7<"CAMQ_#$/9[2NS_X+\\O9*BTN
MYN?OEW@VNS@C<UC_ZFIU$>8)7RQ6YZNW>'YBD\A.DYQDK<I63B0()7$H4F3!
M67;9M1G3<"#A/0TM'0^$Q])D!\"M%V6OXL]'?#4%H"G4^FZ.@9$Y)@HHO$Q0
MHDF*&XO*8A-\#J.OI]NBX\"P@5XZ0-M=2=UI?G5>!TZ_IQ2V:NXSGKAL6,JE
MCKJOP\J+-;0 ,%H%M)8J"<UL;G.3=#B-/5T$:^'\1M//[LCS&^3-U[/9\J?1
M /C^ZO4?SQ?IGR]GWV89Y[DR>(LUAM&IR%4= %7'-S!36V4I8LUQQJ*3J5&G
MJ2'4]70=9!S0C:Z3#AS=];[.\\5RN3Y6JOF.5E44P$MMI!6<K9DYUA[1 9$\
M=3%MUM MQ/1T[#(.B@Z5> >@^8!?P_<JD77U8CP_44%$;9P S9P$I9T'+Y($
MSTJ]N,D"LVW2S/N4]+3--0Y<#I)U!UAY<ZN!P(EB6<C:G<_(3.BN>RHA6D$?
M7*:$.63OVG38O$W%M)/<FL3@^\IX\G;.?\W.+L[>X#=<TMKYH2KA1!43+;((
MM&"2( Q]<#5>XUQ'(YAU.@\IR=SV[(E'N8VI^E'$-_E0)SS#_(+2P\7I[/\G
M[\V:W,B1=-&_,C;O/HU],9L7E:3JJW-5+9FDFK9S7VA8'!)/4Z2&9*I*\^NO
M(YB9RCV#9( 1K%,/E50N$;Y\<+@#ON3J/[_^Y<VG5R]FTL@@L[+ A;<5PAJ"
M\@C('"8ILO6]B@T>>_[(<]V&AL$@8AP9"J__3(N+#6G@5Q+7ZSC?YO#K:OT!
MJY32]J(.O'[Y):P_XV86)/E*3-:IM^CKN"H&WG,$:951/AC#<Y^&__W?./(D
MN*'ATDC4!P-HJ"G3#W'PLX1F]0MVC&?,E>^789$N%IT2:>.\N70Z@<PHAM,>
M$[E64=+2\;8ZY.16*&^TC\5'KU4/D U)T\C#Z(:&X6CJ&AVH;^?;RV/1RZ/Y
M!U;DS)'\T#*$X"3Q$<F !^D-!)%YIFV<D[/? X!]WC7RD+NA@36X>"<01+W^
M<TNKXF*^^5)EM L$7WRMESPSG[/@2DB(1I%PT"%XR1QD*1+SR=D0VB0[/D[3
MR'/S6D18 RE@ E#ZM [+#;WY7?EUO@S+FHCW8K/![>9%ZFX-R>"NUB\V'\,"
M-SL.7^$:T^KSLMXMSI(5UC)G0$L70!7,$(42(#B6E*R/9'>;P.TXND<>Y]<"
MDB=4Y 1@^P$3SK_7Q+%_SK=?WGS]=D$,7MW[O"X%TW;^'?_W'!?YYFW0S!2E
MZH [\-JXFDY8ZG@(!]8(Y0PF$;5L@M<#"1YYZ&";$\SVJAO5J;L^AL-M!?S5
M2=R[B^UF&Y:9-H[+K4+37I"=#L!"3;K'6(_FC 8M="D^B>!XH^//9R@;>=)A
MDS/1(94Q 0-X,\]BUO5X<!HA<T10J79C-J* I#C=BFRT;%0:=9.*D8<CMDYF
MV4O($P#(S8NB*HUKZ,\0A<E.$/DU3U$)1Y]<%B!M$BH5AH6UOYV[1=+(<Q5;
MW],=+OZ1CV'?XN=:E[/CX^#3F%!L#)H'R#'77"^?P3E+ G687!!%1M6GM^@@
MQ(P\B7'PPXV3*V@"ENWOQ.7F[8J"F\V[Y4.1. 4SD9/$2)RQA)HU8>IT$PX6
M13 N,^Y2FZD@SY(V\O3&%I9N6'6,W3+W2UA^QC=+6B5;>NS[]>K[O)X5DCF_
M6*<O88/OU_.$[\J+SY_779(?_9N"[6^T#!<7-=9>7V!^L<R_+[^%^74 ,RN>
M\>2,!Y=]]2ZS)><A%"B*F/=%,\7[--QK1-[(@R&'MHI34.($[.3[2V9_YEV_
MNB"I_ /_W'[Z Q??\3>2SY=-'?EL)9<,2JJ]"ZT-$(3(-1"JP[Z-#*%-]-"3
MP)%G4#9)'6V@FNDB[B.FU3+_;PSKF0M:NV 9!.X,J&@5;04B %+TE)246;@V
MY\7/DC;R,,H3HNQ =4P77Y^^S-<[?G(TF9A@P%,D&05B)2:E($E)@957,C<J
MLWZ.LI&G3IX078<I8[K@JGTRMU\ZAK03WJ!,P&LCS%J2#D[E",):6BH\D:O6
MYN#D6=)&GEIY0G@=J(X)XZMVR>SX(9$(%8T!H8N]G&%1L$;EDJO $G?89ESS
M<Y3U0]=970<,JHRI@NM%UQ_NFB4=95;( Y10V]!I;2&H$@%]E(%;C/YN#-H2
M7[>)ZP>QL[H\&%HEDT39+'!I<V$1,F>FEHV[6M]&GUCVTJ>83:-Y=?=IZ5?3
M?U:W"$<*_'#(K&K1]M#U/M<MZW>%"M<%;R_#-_K)]L?,LI!-5!Q\K.UY<[TD
M069!)NN]49&^MNDFL0^5_6!V%E<(S94TF,WZS[_=DS81_:_N1]U/ZE]]P/)O
M]>OO'][<>GY<;;:KY2;-Z4_G99[^(ZV^[E[3]278W*9V,__Z;?'<(+3+/_S;
M3P+NDG;Y]_=TOQ\Q^.>V3M?-_WYL*DI]](M(L EI.S-:(--!D#=3$_EM\.0Y
M&PM>&:4XQL2*:+/.;M%Q?(+-9H/X[ANN0[UUV#W\$XGL%_JM?\VR,$8&6@)&
M(B>@2@;>$5G)!$S"6:E*(VOR)%TC#W ^' GW4VH&$_]YV(FN4=WAUN+RSQO8
MC(<(:V,Y(H_&H8V@D==J4F$@\)# ,I.,"M8JIB9L.>KMT,>+;Z2QNGF&Q<NP
M^?+K8O7'FV59K;]V>OB BZYUQVKWQO>KQ3S]^(EJ%= (&S.@,H1JK+=!.A*J
M!:; :FF)\\^@X6@B)F5!]D'$S4NZTZEA H%3QT1MM=6MU)]L,)0U<U4!D9UJ
M8_8,9"(YD"=%PN-8F&]SY/,(0>/VYAL 64,*?.14A/T6R!T^,Z*+40A@HAXL
M,&M)=KX 8RDJ::TF!WYP,W4 EIKE%(QBI8Y0PNBM%VKEY79>\Q0[7M[.0ZQQ
MX/P>5XPS$ZUA$$W-@I 4^E$D*$!$%FU@5F/LT]>Z_QO';9(W$) :"?@\'.=7
MN WSQ>&>\]7?-W"='R2MC>^,T2/7$<%J1GL/_7Z=L<"!EZ[UG-4E-\K2'S3J
M_IB^8+Y8X+MR._3+NW*S73?OZ+65=4A@$%Z!BEJ %X%!2,$1NR6:N[.HA^H9
MUH.Z2?G/^Z#B7N^PH54QXBZT66]G'VK>7C>/A DG0T8#+->";$W6T#,E(6&N
M$P:"+:57KW-ZZ@WLT+_NXN;6:T<>KS&X-E?'BG8*>+@:P2UT2$HCR-J\LSO?
M#J&.E\B*18P)#?8:Q-(?$6..7#E"97>5?H#\1E;[;_-EO7JXFFP<&1>F]D&L
MKK02W-:QH $\<1]*M-G=+1\Y0O&W7CVRZ@]1W&H(*8ZM_MW-TR7AF6P:LX:#
M,#6+C.4"T2D.FG"?+.,AJEXGCOW4?_/5XQR&#*;^@Z4X@?.R7\*B-J?_^ 5Q
M^[;^=A5ZM80B9.MU]B!9'7.>A"4^; )31) RDY5T;7K1/D;1R&.86KD,@RIB
MHH"Z'%GE:[>6;,D!CT2_8BC!UXD=5GJ=4O%.A#99G8_3-*X?.HS.>P#I  5,
M $KOME]P_8_5,NTFONQ6VI6QELEGLJ;@!(E)D;P@<I>!;#@+T04CL4W8^P11
MTP/3(7I?M5'"5/!T.3[HQJ'@)3.&]O@BE8;:.8J8H3W;1:- 2DF>G/*%VS8W
M1$^2->ZNUQ)3@RAB*JCZN4#N\V.5DZ+(!,S6[/E:S-A-:HQ9&BV]9"6TN<E_
MCK)Q[XU.8Z^.4\<4X/60N_GV.ADQ)2VM(T?3V7I+8AQ"L$'08O'9<!EK6\4V
MX'J2KG&AU=Q9'U I$X#80^EEM1E/U\)B=W9>HBHY452;;*F]%J4#'TP=.1NB
M]26SDEKE,3Y'V[A>UY!(Z)'U=X1:1N]P<XN;%\N\ZYZ(NUN:=]^JQCZM7G<7
M@C/NBF*U*(AC<+5<MM#BK%VP112<OI_%7;P]TLEFCY>.ZVHU %);L4_ <-V6
MV8?YYR_;=^7W#7;"FYF0A)><@413!T+5V3YURY=<6Q^D5YZWR4I^DJQQ=\:&
MYFHX94P.65=.Y(_+F*4;=;=KNW/= O;]:C.O6NQ6TF9.'L;;^68[<Y863G <
MBE(%E J!' R5 )GPQ>:DE#V%?W8X!^/F!)T,KR=2\72A_3-DFG&*NG3""-)2
M#*9J#$;F'Z&($#@R'YUOX^P]2]JX\S1/#\8#E3)=E%T-[S8R6>,9Q?4N9G)<
MB:]0^S,B+X$[IV-)O;).!C:+XX[.',W8[:6.Z8+KYVK9PWH+'I3*V@$/.I'U
MCAI<+@Q2R3(I)PUY)^,8NX'WZ&8]2<8TBXT4/8FNYK>9_R=6CYK$>SES[JH%
MZ?6Q )^E$'G)14+.)&2562U1UAE\4=HJKJ5AC>[$]J1TW&&A)\/KP"J;G.&]
MP]^K^::;?W%C+C/YQE$6YR4XAS7LHXW%*6%!"160):D+MNF$LB^EX\XF'0N2
MQZIL<I"LA6@S;I7!% /$*.J$%4X!6>;$D"[)JI"X9VV:$M^G9>3!IR?#U=YR
MGQQRKGI[ST3@*OJ*?TZB4+[+ #0)$A89K%<I-&IF\# ](\],/1F"#I+_!%!T
MYZ#S7=S2)E_'[+S^,W7=D7]=K1]Q8V=9>B&%MI"-TW7!2(KII8-,P;Q-UKJ,
M;7JT'D'TR$-9&^+Q5)J< &@?NEJ\9N9J);ZZP-HF^<-JL:BC#FYV2W8E:(%)
M0B" @<*@(*"($"1SVCF18K-J^J,('WF4ZXDOBUMI](P _&9YR6QM OCIC]5,
M2<F#C0R4#C4]7S/PVA8H*7NNLC:FM/$-#Z5XY"&Q$X#L43H\6ZP2^'#&F8I"
M:]I14DV%K)VC?$H9@HG%<?*-G&P3/A].\\@S:">'U[WU>*Z(K?VB9RPX$336
M(;RTER@N',1:1)FC=E+JY'AI4^)Q,,DC#ZB=&E[WUN+9PG7^'6=6*1UM"> ]
M4Z ".? N"?HGQ:"&>^%U;C47]$"21QY3.SFX[JO%,X)KU\'Z+J]1.)M";8,3
M329>+8)G)0(3A?R>9%7I5Z/=#+$/43WRE-L)@/9H79X1;F=.$!LY%5#%UP(>
MVD.B-!Y2*25(5(J5-IW*^U(X\@#=">!Q+QU-'7N_+_/E/1;FUW\F^M7+2=-2
M&TLNC "F"VT,N0[U,IS^Z;,2M#MX.080'R-WY-F\8Z%R$.WM#U&_@^BRFTJ8
M/[7.39I)'@-%@(RLNTR@K"D02^%0<ZNX1&<4/\6EY'[G^.WF\YX^:6@O#4R]
MV]\'K',)4NUTN/Q\V1OS1=K.OW>5CK>YZ-7^[YD'#MH/<!_B!VH0>.N5+Y;Y
MWENON\2I$F5D-H+,N:*$41R1/0/+M"E&&!]SFVK=WB0>/Z_^F1?5K)#%:G.Q
MOM$JTR(O/&=R3E7@H)1D$(4*P!/CD7$F!6^SE1Y"[;@E@6VP=G_L?6,MGK<)
M/'B"0*_'GM <-IPXT!^H!$@GF20'+&!MG>DM.)YK\0%31>K,DVN3)'TRH_BS
M9/R15]8,I\O*<5_02XK9@6M%CJFJE_VE6$A**I6E-:[14)<]B#P7$[@/LAYO
MRCJLSB80[]YBZ/TB[-I"24_R<<@A:4?"BJX.J>8:E$B:*V>0N3;'U0^2,Y4>
MK@,K_ZE]]B!-3!%.EXU64HQ"QD@RT?4H* 4'P4D-)"^*M^L@X4;-HQ\A:$)6
MZS!5/P>> ^0^<M^&%X)Q?X^/JU9-ROM<M(-2:KM<7RL7)%J00CG&C&-&]&G3
M\-0[)@:)0Q2X:B#-D5'QD,_Z:76#%Y6#\M%E(-H,**DE!"-J.XF@# F.!Z=[
M(..Y]XS;LV-H= PJU2DAY 8+@?9:(T@BI.8Z2]P*H._HJGI;>/2UD\V^P-@3
M#\WR.YOBX4 93F#[,(_Q43 DSZ4'GZ,CX13B Y4&XR//3L:LH^RY?3SVCG';
M5[38/@:1YM1\TNJL=Z[[!M??\><]@*5]S\JDH>MRI7)1X'30@$(Q+TH13K;I
M$]"'NJETI#YA #2$GB917-U3>M<GIY*\,2PJ0,FU>KPX!XX,+SC#N=0B<DR]
MAF*T.O.9X-'W(%@Y[,CG(+6-BLMJW5]>?+T@)N;?\;8<OX3UY_LC[T3@+J<$
M%)7661.6$U/TR;G"T>6H9>PS'G6?=T[(V1X26TU%/[;[U:52O"MUHN+[,,]O
MEN]Q/5]15/'KQ6+QX]WZ?5AOYX$^?L3M=H$?OV&:ESF%'?3P.XOL@2&?.I(#
MPSR)VS"W&W@2DHL@G)*.2:.BZN/,MZ5R0C'!T+"=D'K/^[KP\+F)_9Y[P@O#
MEG,6^]_K,"%J7T<$G3,ANMA0!VG5,1;)D.W,)L61\@7&N#&DX"ZE4!*P2&%Z
M;4-$FX4,(+RW5D0KA&A3%O,7O#'<!UG'W!CNH[,)A--OEF0?\+H?UMN;XV3(
M.<&2> 2M,]GQ+!)XH3,(05],PJAY&_@]0=3YW![N!815&ZU,(F9^A)G+,ZT<
M<Q1>DM,2"[%#/@N%6MR"25Y%;]"A;),C\B19X\)L,/7W@]4!FIB Y?J(75G,
MWW&)Z["@)?@B?YTOY]7<UX#L]9_?<+FY'M\A*9#/LIOM7AM).V? FVP@YVR\
MLEF*T*8]SUYD3A)VA\#C[@;:3%<3 &*U^>_*Q["X9B!F<O25*Y"E0E"B=L4(
M3 '#+&.2W!G19I#X/5+&/7MI!ZCC9#X!T-18G@CX0FOA%7['Q>I;E=#E0KB:
MD\:$D4Y3',UJDIL4!F(.!8*.5OLDZF5>JV#H.>+&/1UI!ZRA]3*EZ_1PRTV-
M/^IISJH\<'+Y9M<G-U_.MB8'MF@!+#%:6#XP<-XZX"F@,DR;>Z,(GK]Y/XB2
M\[DW.\3U'T%;9XW-R[5>2)[)Y@"&U=066UM1.4VN0_#H@N%.J- <G6/&#&/@
M9C#('J#$*8'VH5PK+C QY338K&H?RH#@L/HAUC".*@IFR[Z /#2#;8)@.T3C
M^Z2Z[2/^*4'I!@L>8_:./ LF"K&0E0<OG0")2)XL2\CNNGV#I[H-OHM."S@'
M"GMDO-P86G!9J[Q:;EZ&;]='0U9H9A(&<#Q%XL7(.IV40PQ*HU0IN9)Z .>Y
M]TQE2&<[/VQ024\8-5?QDI2&2RN Z[JFM$H4REA;YUQ$5B=19<&/Q,W8'M*P
M&NT)E0/$.X&3B?M'*\IZBG31 F>UM38C&^D8)YOK-,_D'@KIV[23/.PXZ^0
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MJ4!KR0M*5RB8WO>:?-R\P*9;UN'"FX"MN)_JL6/#,A4L([1&Q2R!MZ8*E<B
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M:TO'#3'4S8/K%F/-OY#!URJUA+K."S7@M71@F%&:9V-H4;:%U>/$C1LU'X^
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M77*.8>WFF$%A#=.M"T +22B9N4JNS\CD_=_<#UYG=XMP C5,<0N\L9W7PY_
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M0:%JX8DB5Z[J0"_M9)N,G+W(/#;"[?6R3Z2 7^BO_C73BB?/*(8)O"9FJ^S
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M7?R]I3(B1&WUS=KBC5$*(LN9],%+"$$'X&1ZD_>:M+!1B_)KZQC6Z=I?GO<
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MQ#0V.I?NN,#&!327$^ED1$)YO79FL5YV)Y;XE.LXJ6QE3E[2LX=@Q$BFOK?
MTX[5,OO)ZHG8I'5=Y3XS Z__?@O[=-?2CFRE)"K'D=M:DDS[F"='QB5FP0?%
M?9;!E-SF'/E(5NKU=!E.3A8U4[3.5&U?>T&_-R5ZC@I*Y@Z4B0ZBM0)LDMF5
MVNA=MBGI>V1A3\,F[8*>.V[ ]R:9$3C6]Y!S8P:W1Z6$5QFL] 54PE ;OT2B
MT2/3WOG,^#'AML>L]):WY?L#1#>P'2"=)[+[[3\R]\8#6NQ_+0?D=C5AGDFI
M5/9@N'%UN@N#0($[)&FB-#P5X=N<J0R[ 6YNF\@Z[,@62S&G(, '9\!;E^H
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M?]][=]#<.7Q_ /\H<(317RJP?/U;[;R"L*WJ+RV4?_/AY$]02P,$%     @
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M]N86"1>N[N.F]C.K)_\'4$L#!!0    ( $:$5U3O_TX^2 D  -M5   =
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M9N;V*NL2.[=(N'!UGSVU'V ]^3]02P,$%     @ 1H175,PX36&3!0  TB@
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MN?C"SDE.ETR&M+OBT]'S^XZ>">E,N;_L=GQV#LQ_5V)V8#9KU/;LNE6IU+V
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MZ-[FS@MJGV.5!LG^/(5,$=.%VCSEOE/A#1;>N&;OWJ5O 3;_ 5!+ P04
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M8N #^N^++*NC-'BG%GE1!7D6_)@7\^#D^.C_Q2NN+Y/))5R7E('Z=)F,DRJ
M/Z-@$155&/R0EQ7<\7Z2P-:2:3(!-E+ <R)D7,$!/A[1_/3XQ<M\OHBR&_IT
M\N(PN(Q*>&JA5#!)H[)4M+123>H"F!Y\*M0L*0&^R*X <$7P7DWHH8!CLO#W
M]NK7GR:743:#S4PJ_!G/, S@%1$PK!B>X2[%O5BOYZ_?GC]]$1R<' 9Y7023
M?#Z'5\'>)A_#X#ODQ[#?X"I*:Q4L8#'E952H,#@XY>O/1^?'?PE^B3* :U[<
M !"R*U54R3A5P=M"356!^WC/CWL/AP=+O@B=9WYW3.^P3X9'!0=G_/3CT>/3
M\[_ ?5F2%\&O>05WQW 3\.DGHP .M2[AZ4G&IP1<?5(D"X15"*!+50F@A=T7
MUTFIX P7!7R3WL#F2!; $Q$T$T >0%+GRD+]IT[@6EA+F@:T"95-X-55K@%Y
MK4*!G_ZF+LTW\&#Y$O:@OYRK*%N!-.K3)*UC%%!)509E/2Z3.(D09*--Z6LY
M4<ZC8@9"9YQ753XG$KISLGS2098O:/&QF@@ GA.ZXU4@/^Q9(E:_9+0D/-IU
M7O,!D&J:IVE^C4<9^QM!C /:GAM^Y!(<< $X^"DPH\M@ E04 6;/5*8*8%*+
M(K]*2GA*]YU \(C(< <3!%+/2R H>!=1U/CF*(VN2_H;2.4_P/< __A:Q#;$
MQT)5-W"AQ7A$^%<*[@/"#. ?NKOOR42%*BG,HS9&VOL^J+]^>_+X^$5KE0]!
M"M_\XY]\SO>^FHU LV,'^(<*$#-!%@*Z5L#9H[JZS MX0HRHFY0ER(IZ@7^?
MAK 4_7\6-41(OKSK%4LD;.#R_XI 8P Q=W82HA Z#A'G80G7^)^3\.S9X_#D
MV7EX]NB9\XZF7(4O*I!!&;)Z>##(&.>+9??A9J=U"AM=1$E,U)>!E80Z1!F!
MQ!T%OS5O 5I/49N(4;U!KO'KO]^_%KT"/Y8W\W&>:GGUP_O_&8G VO6SWP\,
M_2E/ =+=IWD972DX/^#L2LU!0%R!\H-"W^HPH#K1+R@Z\&94K5 $!&2M,C-O
M20(X\2RO\$E_@MZ(N&\?,PI0./'=(;[8J#;XJ$617"6IFC'V7=JEMY#0/ISU
MM7ETP^<Q!HJ,<94*J7$ZA8L4B@BB$[UL_^&@&@<E*8;\"/AJ811'H<OK2X5T
MYE"Z2S$ &Y"R8)B06L<2#BA?%$,DF:I&$MYU9-DI>?0*< $ $I>#1-K$N+94
MAYCG4IB/]2T43X@2PJ5DAYI5E;)PB_7YL%)&Y!$#IR^2<5V1F@A$D[$EB!0Q
M!1H!>[,@<B1F-,ZC(L;WQ*"N3<!Z*Y&J\(MIC<\%3A"AK(FNHB1%\<*R#M13
M>B+(*9!<)*T"A?HD4F6&]K$6FL$X*A-2#.G*&JSIE:L>E,9-B/1?>84,\!WQ
MU8%0-UCEZT\3M:B0.JS=3R96S 2"U@X@.OQ%3B,1+XX1YY!V""K6/*DB)CM$
M[ *,)A3HCL1;1\SA<Z_X2!<YJ)3!=0*6(&B#"^$I=8GB_5*EM,;+?N5B%+R.
M@-SXBA8O24J/E>09O1:M5K#>\#XF7WS/*!C$YB84^7/RGSJ)&5,0$UZ!*I*G
MQ-L&^KQ%^B2U%QV-TV0B'EV72!'TMT24HD2J*XPCR3U"<:D][!#%F#[I$%G'
M=<+::;VP^NL57)!5:$#"!4EF/H*8GJ(_91'=S/5KR"S$=T3C)&5?+\G,<9K,
MG%WY-Z)O>:Q4!AIY3.X;AT<P92_=K69N:&0&T3R'U>%#M"=<W7AJB*>L]")4
M([2UR#FV]UP?1RO8I6\4]^2QO24:$X3;MZR(C_%_+PO]Y$4T4T?C0D4?CPA\
MSZ/T.KHIO[G]L-S#$$^W>P,P$DYU[*N1XG0OH@HT/#C>R20O"&U%@\WJ^9@E
M2,]#M3""B^>AUO4*-8^2#!^#S@FT5(T.B3+&U?@:2-HT9P=]<!/I\U*<QF\]
M9[%QX?X<7;.2X?IO\?,/[,,=))2_2GKB<Q B:3)98]T_8'8!!IU>YO-QD@F3
M)AWN#09,%?GA*(8A&*_W^!!0'@7B/BV;-FLST&#P1WS4)F@E&"6!M%?_?/GS
M2 <K^0Q/C\_,0^!7?#8%4BF,6H,DFP#/(0YBWC%Q F+3(I\#MYI%,PJ*H7$I
MCLJQ!O7$@EI'V@C@4:8O32SH2PMZ?3%9LVBR)GG,2\7 [(V*@!VQ:&T&C2M,
M3XDX(@M+,K(1'U+"=V,UB>8*%]#]9A.:Q'NZ]D%1Y@4> [NP(I32Z!4<*_2T
M97 &H^!B'4@D&084 67FJIC!ZD+T(8((%9T% YS,GLLHI7"GL<F=36) NJS3
MRAS!%-Z239((94FFIHG!G.[] DI8!--1+47JG:QAS:/BX#L#^?HR!TZ6SUBM
MXA.?3D%/BC!$G%_C<W/^@?0W>ZAQ$N/O87!R_A>\9)X7R@H>@WN2HE)J>VRO
MA='.<\Z?1<DES?J5<4<A/OX&QSIY<%9Y42+F@3U16?,#.5KHA4/%0$'2CBKZ
MQ;K62/E"Q_Q8<PKRF*%ZGRJQ[0$=\28']RD:##B:*;(:XF@>H7L>OT3]%3@/
MNNN2N 9ZQ-]K "%Z_,R+0R$U)%U-?).DF-1S=)^C7Y+,D"O$\>LBSV:@^H,6
MB.$!<MA%PJ?,R^RC#8G06^&G-+^)T@J-F4G%FYF#322^2.22_"IF%!DG^ 5P
M"3 EV$ 5$"O^F''<_"K)4^-P$6\,NQYO/!9,,L(R8;TXL 8+,"Y*XL-S.!CT
M2FJX:\;%\3)[1BA_HK3,79&8&M3TDG&8TDZ>/'+E6R@+F4<?,5'%/+=]WK@3
M$ /1-8+;.D7=;UF]+M2B+B9@UBGZU89R2G3IXHO-#1J,"2,;?D5W(/,N&4Z9
MFH'UB$ZK@97=RBI_)YSH2XDX(,][)E85DAN+*A^''IV[.'0(2*286^#VYEDR
MO=$"%LUR$(] TD@_W1R)",1*R> Z(L0QF6LW\@EE(@C+C,U 8$KD,=#7P%=$
M:.:B$)YIHFV@:BQ21<&V"?L[RCHA^@5"FRC%@>T/EZI46@<!IG.5I*" % D8
MUA'\%<7P!QJ"$8<^@3G WLBW 2P"N0?)=OO$DG-3HM(Z8:<1$BDR6T<!2VC#
MM.],:5>-(4;@V")1\"H@)N!:2K&Z8.\$=+@2A8<>/XD6T21AX%%$)0 ^#$<@
M;!XSQO!@F$'QPLG*OF$6(R<)]T]RC(YB,IK*2GSMGW4\0]<-_#E%18Z=.N1Z
M*3G,C^HUG1!]@A6!R@;F._E[8/\<>6$'%\*&['B >DUN'63W.:B,S"P)^]BA
M/<7WX[.=IY%W:\F9:I8C@(XHN(LY2CDHS].(]6[165E1=2]WEC=6::*N#.HE
M%-]&X9@O%GDI7FD,42%0M5:(SPY;+G%$4XU4LG1_T6%P&6&>A'T_(&-4EXI?
M3@LQ.)04AHTB&FC>2K92@R:-+DK;)7'#J"N+<'(LT![ QR:B\8I(II?"PO0S
MT9,I^K\E;=POAN4 3Q)2NMDT@#_\PT "CQ&9#%0]U0(6"1<"?LZ)#6$PDK&=
M(G U(NJKYA9$(,K?0'RLHDAV&6?,5SF!NL8+#2[K2Z;155XP!1"YE%ZB0 F'
MED8%8:L  #E*)7(<+!ZEY7]WN'($9C5LFL%*;)-2*B@YF1"S:L,VFF&V!:V%
M,$FK-;ZRAEBL/JE)S;Q(&(9F:<XS1.-S7,K-%V)&!VA:54)D*GMFQ(U#5RL3
MG ;T&!=YQ+@3(?O).US?'=)FD.AW9)R\3H5[NK;)7[\]?_8B>*?F2(K\X5_1
M!.UB]<"FRF\]RHA&52,N+;IS*!\]PRDG[, 51!@1)\C/E:I$]$<5!TT 51/G
M%W(5@Z7,K(6U8+J&:)KB)PX4'4)C!;U2<_S>^#)0CI+Y(<\?!;2MSJW00C,P
M-3*EO<MB K2V)6I41^*#D!7Z$(!#$M531%3TC'GT9UZ(>7I%6>B3J*Q"X:HE
MBQQX!BSL$]@_\C3'K2W.<]?S3L]'<!H@P@>&7!3\I\Z+>DZ2 .Z#VQC%-!O
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MU2(O5]FD10RUHO>FD[G.$J>(1U"6Y!^UQ1E\#O=H7GJ5V4W.YSB/>N(I)MG
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M>;"';6CU]3USP(I[#5C9C(6B,=C48Q9H$)$ABF*B4X6@/@6.%M&^P_OYP(C
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M%:UB.P>WB<*'@4X@]EQ$IJ#;\;J'VW<[T@ZLIDL1N:?W7A*W+"&)#U..' U
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MNO7^1BL]"?E,]3![<CA%U,?O,DJG1Y=XK=C:TB;,AH8$@YK8@_>4NE-F69>
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M >27Z"8X?4+M:-9"^UL%!E5_[1(T3D=/SQ^=?@X<]&Z/<:_??-VP?/+L[&R
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M6,4/=V3 AXFQ&ANJC_N2V>;/!NGLJMGH&.ZK(-.ZJ@OE) VT_!O-9^Z#))/
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M:R$7[?U*!4;1P\%>[@8/:UDO/DF2<K!H><,@XL36K'GR.A5/L&33W5J1=4:
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M,#(Q,3(S,5]D968N>&UL4$L! A0#%     @ 1H175.7!ELGS>@  ,J8  !,
M             ( ![Y,' &)S>"TR,#(Q,3(S,5]G,2YJ<&=02P$"% ,4
M" !&A%=44K'=T0G[ 0#WWQ4 %               @ $3#P@ 8G-X+3(P,C$Q
M,C,Q7VQA8BYX;6Q02P$"% ,4    " !&A%=4H\*3+C0T 0"2^@T %
M        @ %."@H 8G-X+3(P,C$Q,C,Q7W!R92YX;6Q02P$"% ,4    " !&
MA%=48N%;-W8)  !.8@  '@              @ &T/@L 97AH:6)I=#(Q+6QI
M<W1O9G-U8G-I9&EA<FDN:'1M4$L! A0#%     @ 1H175*#RK_T?!   8!
M !L              ( !9D@+ &5X:&EB:70R,RTR,#(Q97EC;VYS96YT+FAT
M;5!+ 0(4 Q0    ( $:$5U1&,;YA/ D  ,%5   =              "  ;Y,
M"P!E>&AI8FET,S$Q+6-E;S,P,C(P,C$Q,'AK+FAT;5!+ 0(4 Q0    ( $:$
M5U3O_TX^2 D  -M5   =              "  356"P!E>&AI8FET,S$R+6-F
M;S,P,C(P,C$Q,'AK+FAT;5!+ 0(4 Q0    ( $:$5U3,.$UADP4  -(H   =
M              "  ;A?"P!E>&AI8FET,S(Q+6-E;SDP-C(P,C$Q,'AK+FAT
M;5!+ 0(4 Q0    ( $:$5U0TMB,UH@4  & H   =              "  89E
M"P!E>&AI8FET,S(R+6-F;SDP-C(P,C$Q,'AK+FAT;5!+ 0(4 Q0    ( $:$
M5U3\EGZK'*X  #T/!0 >              "  6-K"P!E>&AI8FET-#(M9&5S
G8W)I<'1I;VYO9G1H92YH=&U02P4&      X #@#2 P  NQD,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
